PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hone, DWE; Tischlinger, H; Frey, E; Roper, M				Hone, David W. E.; Tischlinger, Helmut; Frey, Eberhard; Roeper, Martin			A New Non-Pterodactyloid Pterosaur from the Late Jurassic of Southern Germany	PLOS ONE			English	Article							LIMESTONE; EVOLUTION; EXTENT; FLIGHT; CHINA	Background: The `Solnhofen Limestone' beds of the Southern Franconian Alb, Bavaria, southern Germany, have for centuries yielded important pterosaur specimens, most notably of the genera Pterodactylus and Rhamphorhynchus. Here we describe a new genus of non-pterodactyloid pterosaur based on an extremely well preserved fossil of a young juvenile: Bellubrunnus rothgaengeri (gen. et sp. nov.). Methodology/Principal Findings: The specimen was examined firsthand by all authors. Additional investigation and photography under UV light to reveal details of the bones not easily seen under normal lighting regimes was completed. Conclusions/Significance: This taxon heralds from a newly explored locality that is older than the classic Solnhofen beds. While similar to Rhamphorhynchus, the new taxon differs in the number of teeth, shape of the humerus and femur, and limb proportions. Unlike other derived non-pterodacytyloids, Bellubrunnus lacks elongate chevrons and zygapophyses in the tail, and unlike all other known pterosaurs, the wingtips are curved anteriorly, potentially giving it a unique flight profile.	[Hone, David W. E.] Univ Coll Dublin, Dept Biol & Environm Sci, Dublin 2, Ireland; [Frey, Eberhard] Staatl Museum Naturkunde Karlsruhe, Karlsruhe, Germany; [Roeper, Martin] Museum Solnhofen, Solnhofen, Germany	University College Dublin	Hone, DWE (corresponding author), Univ Bristol, Dept Earth Sci, Bristol, Avon, England.	dwe_hone@yahoo.com	Benton, Michael J/A-5639-2008	Benton, Michael J/0000-0002-4323-1824				Andres B, 2010, J VERTEBR PALEONTOL, V30, P163, DOI 10.1080/02724630903409220; Bennett SC, 2007, PALAEONTOL Z, V81, P376, DOI 10.1007/BF02990250; Bennett S. Christopher, 2000, Historical Biology, V14, P255; Bennett SC, 1996, J VERTEBR PALEONTOL, V16, P432, DOI 10.1080/02724634.1996.10011332; BENNETT SC, 1995, J PALEONTOL, V69, P569, DOI 10.1017/S0022336000034946; Carpenter K., 2003, SPECIAL PUBLICATIONS, V217, P45; Claessens LPAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004497; Colbert E. H., 1969, American Museum Novitates, VNo. 2370, P1; Dyke GJ, 2009, J EVOLUTION BIOL, V22, P890, DOI 10.1111/j.1420-9101.2008.01682.x; Elgin RA, 2011, ACTA PALAEONTOL POL, V56, P99, DOI 10.4202/app.2009.0145; Frey Eberhard, 2003, Geological Society Special Publication, V217, P233, DOI 10.1144/GSL.SP.2003.217.01.14; FRICKHINGER K.A., 1994, FOSSILIEN SOLNHOFEN; Gasparini Z, 2004, PALAEONTOLOGY, V47, P919, DOI 10.1111/j.0031-0239.2004.00399.x; Hone DWE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009223; Jenkins Farish A. Jr., 2001, Bulletin of the Museum of Comparative Zoology, V156, P151; Kaup J, 1834, ISIS, V3, P311; Kellner Alexander W.A., 2003, Geological Society Special Publication, V217, P105, DOI 10.1144/GSL.SP.2003.217.01.10; Kellner AWA, 2000, NATL SCI MUSEUM MONO, V17, P1, DOI 10.1159/000061634; Lu JC, 2012, ZOOTAXA, P1; Lu JC, 2011, ACTA GEOL SIN-ENGL, V85, P507, DOI 10.1111/j.1755-6724.2011.00444.x; Lu JC, 2010, P ROY SOC B-BIOL SCI, V277, P383, DOI 10.1098/rspb.2009.1603; Lu JC, 2009, ACTA GEOL SIN-ENGL, V83, P189, DOI 10.1111/j.1755-6724.2009.00062.x; Muller M, 1961, ERLANG GEOL ABH; Padian K, 2008, SPEC PAP PALAEONTOL, P5; Prondvai E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031392; Roper M, 1998, ACTA ALBERTINA RATIS, V50, P77; Roper M, 2005, ZITTELIANA, V26, P57; ROPER M., 1996, PLATTENKALKE BRUNN L; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Schweigert G, 2007, NEUES JAHRB GEOL P-A, V245, P117, DOI 10.1127/0077-7749/2007/0245-0117; Seeley H.G., 1870, ORNITHOSAURIA ELEMEN, P135; Tischlinger H., 2005, ZITTELIANA B, V26, P26; Tischlinger H., 2002, ARCHAEOPTERYX, V20, P1; Tischlinger H., 2010, ACTA GEOSCIENTICA SI, V31, P62; Tischlinger Helmut, 2005, Archaeopteryx, V23, P33; Unwin D. M, 2005, PTEROSAURS DEEP TIME; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Wang XL, 2008, P NATL ACAD SCI USA, V105, P1983, DOI 10.1073/pnas.0707728105; Wellnhofer P., 1975, PALAONTOGRAPHICA A, V148, P1; Wellnhofer P., 1970, ABH BAYER AKAD WISS, V141, P1; Wellnhofer P., 1975, PALAONTOGRAPHICA A, V148, P132; WILD R, 1978, Bollettino della Societa Paleontologica Italiana, V17, P176	42	22	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39312	10.1371/journal.pone.0039312	http://dx.doi.org/10.1371/journal.pone.0039312			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792168	Green Submitted, Green Published, gold			2022-12-27	WOS:000306436300006
J	Alessandri, S; Sancho, A; Vieths, S; Mills, CEN; Wal, JM; Shewry, PR; Rigby, N; Hoffmann-Sommergruber, K				Alessandri, Stefano; Sancho, Ana; Vieths, Stefan; Mills, Clare E. N.; Wal, Jean-Michel; Shewry, Peter R.; Rigby, Neil; Hoffmann-Sommergruber, Karin			High-Throughput NMR Assessment of the Tertiary Structure of Food Allergens	PLOS ONE			English	Article							ARA H 1; MAJOR PEANUT ALLERGEN; PROTEIN-STRUCTURE MODELS; MOLTEN-GLOBULE STATE; PRU P 3; CRYSTAL-STRUCTURE; ALPHA-LACTALBUMIN; IGE-BINDING; PURIFICATION; QUALITY	Background: In vitro component-resolved diagnosis of food allergy requires purified allergens that have to meet high standards of quality. These include the authentication of their conformation, which is relevant for the recognition by specific IgE antibodies from allergic patients. Therefore, highly sensitive and reliable screening methods for the analysis of proteins/allergens are required to assess their structural integrity. In the present study one-dimensional 1H Nuclear Magnetic Resonance (1D 1H-NMR) analysis was adopted for the assessment of overall structural and dynamic properties and authentication of a set of relevant food allergens, including non-specific lipid transfer proteins from apple, peach and hazelnut, 7/8S seed storage globulins from hazelnut and peanut, 11S seed storage globulins from hazelnut and peanut, caseins from cows' and goats' milk and tropomyosin from shrimp. Methodology/Principal Findings: Two sets of 1D 1H-NMR experiments, using 700 MHz and 600 MHz instruments at 298 K were carried out to determine the presence and the extent of tertiary structure. Structural similarity among members of the individual allergen families was also assessed and changes under thermal stress investigated. The nuclear magnetic resonance (NMR) results were compared with structural information available either from the literature, Protein Data Bank entries, or derived from molecular models. Conclusions/Significance: 1D H-1-NMR analysis of food allergens allowed their classification into molecules with rigid, extended and ordered tertiary structures, molecules without a rigid tertiary structure and molecules which displayed both features. Differences in thermal stability were also detected. In summary, 1D H-1-NMR gives insights into molecular fold of proteins and offers an independent method for assessing structural properties of proteins.	[Alessandri, Stefano] Univ Florence, CERM, Ctr Ric Risonanze Magnet, Florence, Italy; [Alessandri, Stefano] Univ Florence, Dept Agr Biotechnol, Florence, Italy; [Sancho, Ana; Mills, Clare E. N.; Rigby, Neil] AFRC, Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Vieths, Stefan] Paul Ehrlich Inst, D-6070 Langen, Germany; [Wal, Jean-Michel] CEA Saclay, INRA, Immunoallergie Alimentaire UR496, CEA iBiTeC S SPI, F-91191 Gif Sur Yvette, France; [Shewry, Peter R.] Rothamsted Res, Harpenden, Herts, England; [Hoffmann-Sommergruber, Karin] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria	University of Florence; University of Florence; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Quadram Institute; University of East Anglia; Paul Ehrlich Institute; CEA; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Medical University of Vienna	Alessandri, S (corresponding author), Univ Florence, CERM, Ctr Ric Risonanze Magnet, Florence, Italy.	Karin.hoffmann@meduniwien.ac.at	Alessandri, Stefano/Q-6314-2019; Alessandri, Stefano/L-2055-2013	Alessandri, Stefano/0000-0001-8228-7559; Hoffmann-Sommergruber, Karin/0000-0002-8830-058X; Sancho, Ana/0000-0002-6064-6159	EU through the EuroPrevall project [FOOD-CT-2005-514000]; Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom; Austrian (FWF) Science Fund [SFB-F46-B19]; BBSRC [BBS/E/C/00005206] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00041800, BBS/E/C/00005206] Funding Source: researchfish	EU through the EuroPrevall project; Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Austrian (FWF) Science Fund(Austrian Science Fund (FWF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the EU through the EuroPrevall project (FOOD-CT-2005-514000). Rothamsted Research and the Institute of Food Research are funded by the Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom. KHS is supported by the Grant SFB-F46-B19 from the Austrian (FWF) Science Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2008, MOL NUTR FOOD RES, V52, pS186, DOI 10.1002/mnfr.200700424; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAUM J, 1989, BIOCHEMISTRY-US, V28, P7, DOI 10.1021/bi00427a002; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35; Beyer K, 2002, J ALLERGY CLIN IMMUN, V110, P517, DOI 10.1067/mai.2002.127434; Blanc F, 2008, MOL NUTR FOOD RES, V52, pS166, DOI 10.1002/mnfr.200700283; BRERETON IM, 1989, MAGNET RESON MED, V9, P118, DOI 10.1002/mrm.1910090114; BURKS AW, 1995, J CLIN INVEST, V96, P1715, DOI 10.1172/JCI118216; Cabanos C, 2011, MOL IMMUNOL, V49, P115, DOI 10.1016/j.molimm.2011.08.004; Cabanos C, 2010, ACTA CRYSTALLOGR F, V66, P1071, DOI 10.1107/S1744309110029040; Chruszcz M, 2011, J BIOL CHEM, V286, P39318, DOI 10.1074/jbc.M111.270132; Farrell HM, 2004, J DAIRY SCI, V87, P1641, DOI 10.3168/jds.S0022-0302(04)73319-6; Frye J, 2010, BIOCHEMISTRY-US, V49, P4908, DOI 10.1021/bi100349a; Fukuda T, 2008, J AGR FOOD CHEM, V56, P4145, DOI 10.1021/jf072667b; Gaier S, 2008, MOL NUTR FOOD RES, V52, pS220, DOI 10.1002/mnfr.200700274; Greenfield NJ, 2001, J MOL BIOL, V312, P833, DOI 10.1006/jmbi.2001.4982; Hansen KS, 2009, J ALLERGY CLIN IMMUN, V123, P1134, DOI 10.1016/j.jaci.2009.02.005; Hoffmann-Sommergruber K, 2009, ANAL BIOANAL CHEM, V395, P25, DOI 10.1007/s00216-009-2953-z; Hoffmann-Sommergruber K, 2008, MOL NUTR FOOD RES, V52, pS159, DOI 10.1002/mnfr.200800466; Jenkins JA, 2005, J ALLERGY CLIN IMMUN, V115, P163, DOI 10.1016/j.jaci.2004.10.026; Jenkins JA, 2007, J ALLERGY CLIN IMMUN, V120, P1399, DOI 10.1016/j.jaci.2007.08.019; Jin TC, 2009, J AGR FOOD CHEM, V57, P8643, DOI 10.1021/jf9017355; Jin T, 2009, MOL IMMUNOL, V46, P1796, DOI 10.1016/j.molimm.2009.01.023; Johnson P, 2011, J AGR FOOD CHEM, V59, P12420, DOI 10.1021/jf203151e; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kleber-Janke T, 1999, INT ARCH ALLERGY IMM, V119, P265, DOI 10.1159/000024203; Lauer I, 2004, BIOCHEM J, V383, P327, DOI 10.1042/BJ20041062; Le TM, 2011, J ALLERGY CLIN IMMUN, V127, P677, DOI 10.1016/j.jaci.2010.10.003; Manjasetty BA, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-21; Marsh J, 2008, MOL NUTR FOOD RES, V52, pS272, DOI 10.1002/mnfr.200700524; Mills ENC, 2008, CURR OPIN ALLERGY CL, V8, P249, DOI 10.1097/ACI.0b013e3282ffb123; Nicolaou N, 2010, J ALLERGY CLIN IMMUN, V125, P191, DOI 10.1016/j.jaci.2009.10.008; Oberhuber C, 2008, MOL NUTR FOOD RES, V52, pS208, DOI 10.1002/mnfr.200700522; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Page R, 2005, P NATL ACAD SCI USA, V102, P1901, DOI 10.1073/pnas.0408490102; Pasquato N, 2006, J MOL BIOL, V356, P684, DOI 10.1016/j.jmb.2005.11.063; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Perrocheau L, 2006, J AGR FOOD CHEM, V54, P3108, DOI 10.1021/jf052910b; Pieper U, 2004, NUCLEIC ACIDS RES, V32, pD217, DOI 10.1093/nar/gkh095; Reese G, 2006, CLIN EXP ALLERGY, V36, P517, DOI 10.1111/j.1365-2222.2006.02454.x; Rehm T, 2002, STRUCTURE, V10, P1613, DOI 10.1016/S0969-2126(02)00894-8; Rigby NM, 2008, MOL NUTR FOOD RES, V52, pS251, DOI 10.1002/mnfr.200800083; Rosner HI, 2009, J MOL BIOL, V394, P351, DOI 10.1016/j.jmb.2009.09.025; Rouge P, 2009, MOL IMMUNOL, V46, P1067, DOI 10.1016/j.molimm.2008.09.030; Sancho AI, 2010, CLIN EXP ALLERGY, V40, P973, DOI 10.1111/j.1365-2222.2010.03534.x; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; Toda M, 2011, J ALLERGY CLIN IMMUN, V128, P1022, DOI 10.1016/j.jaci.2011.04.020; Vissers YM, 2011, CLIN EXP ALLERGY, V41, P1631, DOI 10.1111/j.1365-2222.2011.03830.x; Whitby FG, 2000, PROTEINS, V38, P49; Wijesinha-Bettoni R, 2010, BIOCHEMISTRY-US, V49, P2130, DOI 10.1021/bi901939z	52	17	17	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39785	10.1371/journal.pone.0039785	http://dx.doi.org/10.1371/journal.pone.0039785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768312	Green Submitted, Green Published, gold			2022-12-27	WOS:000305966500025
J	Acton, JH; Gibson, JM; Cubbidge, RP				Acton, Jennifer H.; Gibson, Jonathan M.; Cubbidge, Robert P.			Quantification of Visual Field Loss in Age-Related Macular Degeneration	PLOS ONE			English	Article							WAVELENGTH AUTOMATED PERIMETRY; BLUE-ON-YELLOW; MULTIFOCAL ELECTRORETINOGRAM; MACULOPATHY; SENSITIVITY; VULNERABILITY; DISEASE; DRUSEN; ACUITY; CLASSIFICATION	Background: An evaluation of standard automated perimetry (SAP) and short wavelength automated perimetry (SWAP) for the central 10-2 visual field test procedure in patients with age-related macular degeneration (AMD) is presented in order to determine methods of quantifying the central sensitivity loss in patients at various stages of AMD. Methods: 10-2 SAP and SWAP Humphrey visual fields and stereoscopic fundus photographs were collected in 27 eyes of 27 patients with AMD and 22 eyes of 22 normal subjects. Results: Mean Deviation and Pattern Standard Deviation (PSD) varied significantly with stage of disease in SAP (both p < 0.001) and SWAP (both p < 0.001), but post hoc analysis revealed overlap of functional values among stages. In SWAP, indices of focal loss were more sensitive to detecting differences in AMD from normal. SWAP defects were greater in depth and area than those in SAP. Central sensitivity (within 1 degrees) changed by -3.9 and -4.9 dB per stage in SAP and SWAP, respectively. Based on defect maps, an AMD Severity Index was derived. Conclusions: Global indices of focal loss were more sensitive to detecting early stage AMD from normal. The SWAP sensitivity decline with advancing stage of AMD was greater than in SAP. A new AMD Severity Index quantifies visual field defects on a continuous scale. Although not all patients are suitable for SWAP examinations, it is of value as a tool in research studies of visual loss in AMD.	[Acton, Jennifer H.] NYU, Dept Ophthalmol, New York, NY 10016 USA; [Acton, Jennifer H.; Gibson, Jonathan M.; Cubbidge, Robert P.] Aston Univ, Sch Life & Hlth Sci, Ophthalm Res Grp, Birmingham B4 7ET, W Midlands, England; [Gibson, Jonathan M.] Birmingham & Midland Eye Ctr, Birmingham, W Midlands, England	New York University; Aston University	Acton, JH (corresponding author), NYU, Dept Ophthalmol, 550 1St Ave, New York, NY 10016 USA.	jenniferhacton@gmail.com	Acton, Jennifer/AAU-3307-2021	Acton, Jennifer/0000-0002-0347-7651; Gibson, Jonathan M/0000-0002-9281-5244; Cubbidge, Robert P/0000-0002-7851-1375	College of Optometrists	College of Optometrists	Presented in part at the 2009 annual meeting of the Association for Research in Vision and Ophthalmology, Florida, for which the College of Optometrists provided a travel grant to J Acton.	Agardh E, 2006, DIABETOLOGIA, V49, P200, DOI 10.1007/s00125-005-0072-8; Anderson AJ, 2011, OPTOMETRY VISION SCI, V88, P806, DOI 10.1097/OPX.0b013e31821861bd; APPLEGATE RA, 1987, APPL OPTICS, V26, P1458, DOI 10.1364/AO.26.001458; ATCHISON DA, 1990, OPTOMETRY VISION SCI, V67, P179, DOI 10.1097/00006324-199003000-00006; Bengtsson B, 2005, DIABETOLOGIA, V48, P2494, DOI 10.1007/s00125-005-0001-x; Bengtsson B, 2008, ACTA OPHTHALMOL, V86, P170, DOI 10.1111/j.1600-0420.2007.01019.x; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; CHENG AS, 1993, OPTOMETRY VISION SCI, V70, P89, DOI 10.1097/00006324-199302000-00001; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Conway M, 2008, EPILEPSIA, V49, P108, DOI 10.1111/j.1528-1167.2007.01249.x; CRABB DP, 1995, BRIT J OPHTHALMOL, V79, P213, DOI 10.1136/bjo.79.3.213; Cubbidge RP, 2002, GRAEF ARCH CLIN EXP, V240, P650, DOI 10.1007/s00417-002-0509-4; Durad AC, 1910, J AMER MED ASSOC, V55, P369, DOI 10.1001/jama.1910.04330050007004; EISNER A, 1987, INVEST OPHTH VIS SCI, V28, P1832; Feigl B, 2005, EYE, V19, P1169, DOI 10.1038/sj.eye.6701711; FRENNESSON C, 1995, DOC OPHTHALMOL, V90, P377, DOI 10.1007/BF01268123; Gerth C, 2003, ARCH OPHTHALMOL-CHIC, V121, P1404, DOI 10.1001/archopht.121.10.1404; Goldstein M, 2005, RETINA-J RET VIT DIS, V25, P296; GREENSTEIN VC, 1989, INVEST OPHTH VIS SCI, V30, P1732; HAEGERSTROMPORTNOY G, 1989, CLIN VISION SCI, V4, P165; HART WM, 1983, OPHTHALMOLOGY, V90, P1028; HOOD DC, 1984, INVEST OPHTH VIS SCI, V25, P864; Hudson C, 1998, DIABETOLOGIA, V41, P918, DOI 10.1007/s001250051008; Johnson C A, 1994, J Glaucoma, V3 Suppl 1, pS32; JOHNSON CA, 1993, ARCH OPHTHALMOL-CHIC, V111, P645, DOI 10.1001/archopht.1993.01090050079034; JOHNSON CA, 1993, ARCH OPHTHALMOL-CHIC, V111, P651, DOI 10.1001/archopht.1993.01090050085035; Li J, 2001, BRIT J OPHTHALMOL, V85, P287, DOI 10.1136/bjo.85.3.287; MAYER MJ, 1992, INVEST OPHTH VIS SCI, V33, P3136; Midena E, 1997, INVEST OPHTH VIS SCI, V38, P469; MIDENA E, 1994, DOC OPHTHALMOL, V88, P179, DOI 10.1007/BF01204616; Owsley C, 2000, INVEST OPHTH VIS SCI, V41, P267; Phipps JA, 2004, INVEST OPHTH VIS SCI, V45, P3355, DOI 10.1167/iovs.04-0253; Rein DB, 2009, ARCH OPHTHALMOL-CHIC, V127, P533, DOI 10.1001/archophthalmol.2009.58; Remky A, 2005, BRIT J OPHTHALMOL, V89, P464, DOI 10.1136/bjo.2004.050260; Remky A, 2001, BRIT J OPHTHALMOL, V85, P1432, DOI 10.1136/bjo.85.12.1432; Remky A, 2000, INVEST OPHTH VIS SCI, V41, P274; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; SAMPLE PA, 1994, AM J OPHTHALMOL, V118, P632, DOI 10.1016/S0002-9394(14)76578-X; Scholl HPN, 2004, INVEST OPHTH VIS SCI, V45, P574, DOI 10.1167/iovs.03-0495; STEINMETZ RL, 1993, BRIT J OPHTHALMOL, V77, P549, DOI 10.1136/bjo.77.9.549; SWANN PG, 1991, OPHTHAL PHYSL OPT, V11, P59, DOI 10.1111/j.1475-1313.1991.tb00196.x; TOLENTINO MJ, 1994, VISION RES, V34, P409, DOI 10.1016/0042-6989(94)90099-X; van Leeuwen R, 2003, ARCH OPHTHALMOL-CHIC, V121, P519, DOI 10.1001/archopht.121.4.519; Wild JM, 1998, INVEST OPHTH VIS SCI, V39, P54; WILD JM, 1995, OPHTHALMOLOGY, V102, P911, DOI 10.1016/S0161-6420(95)30935-9	45	14	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39944	10.1371/journal.pone.0039944	http://dx.doi.org/10.1371/journal.pone.0039944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768178	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000305892100148
J	Bauer, M; Goldstein, M; Heylmann, D; Kaina, B				Bauer, Martina; Goldstein, Michael; Heylmann, Daniel; Kaina, Bernd			Human Monocytes Undergo Excessive Apoptosis following Temozolomide Activating the ATM/ATR Pathway While Dendritic Cells and Macrophages Are Resistant	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; BASE EXCISION-REPAIR; DNA-REPLICATION; LIGASE-III; INHIBITOR; CANCER; O-6-METHYLGUANINE; IMMUNOTHERAPY; P53; RECOMBINATION	Immunodeficiency is a severe therapy-limiting side effect of anticancer chemotherapy resulting from sensitivity of immunocompetent cells to DNA damaging agents. A central role in the immune system is played by monocytes that differentiate into macrophages and dendritic cells (DCs). In this study we compared human monocytes isolated from peripheral blood and cytokine matured macrophages and DCs derived from them and assessed the mechanism of toxicity of the DNA methylating anticancer drug temozolomide (TMZ) in these cell populations. We observed that monocytes, but not DCs and macrophages, were highly sensitive to the killing effect of TMZ. Studies on DNA damage and repair revealed that the initial DNA incision was efficient in monocytes while the re-ligation step of base excision repair (BER) can not be accomplished, resulting in an accumulation of DNA single-strand breaks (SSBs). Furthermore, monocytes accumulated DNA double-strand breaks (DSBs) following TMZ treatment, while DCs and macrophages were able to repair DSBs. Monocytes lack the DNA repair proteins XRCC1, ligase III alpha and PARP-1 whose expression is restored during differentiation into macrophages and DCs following treatment with GM-CSF and GM-CSF plus IL-4, respectively. These proteins play a key role both in BER and DSB repair by B-NHEJ, which explains the accumulation of DNA breaks in monocytes following TMZ treatment. Although TMZ provoked an upregulation of XRCC1 and ligase IIIa, BER was not enhanced likely because PARP-1 was not upregulated. Accordingly, inhibition of PARP-1 did not sensitize monocytes, but monocyte-derived DCs in which strong PARP activation was observed. TMZ induced in monocytes the DNA damage response pathways ATM-Chk2 and ATR-Chk1 resulting in p53 activation. Finally, upon activation of the Fas-receptor and the mitochondrial pathway apoptosis was executed in a caspase-dependent manner. The downregulation of DNA repair in monocytes, resulting in their selective killing by TMZ, might impact on the immune response during cancer chemotherapy.	[Bauer, Martina; Goldstein, Michael; Heylmann, Daniel; Kaina, Bernd] Univ Med Ctr, Dept Toxicol, Mainz, Germany	Johannes Gutenberg University of Mainz	Bauer, M (corresponding author), Univ Med Ctr, Dept Toxicol, Mainz, Germany.	kaina@uni-mainz.de	Kaina, Bernd/AAE-4692-2020	Heylmann, Daniel/0000-0002-8335-2313	Deutsche Forschungsgemeinschaft [KA724/13, KA724/14]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants of the Deutsche Forschungsgemeinschaft, KA724/13 and KA724/14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell S, 2008, CLIN CANCER RES, V14, P4032, DOI 10.1158/1078-0432.CCR-07-5138; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Bauer M, 2011, P NATL ACAD SCI USA, V108, P21105, DOI 10.1073/pnas.1111919109; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briegert M, 2007, DNA REPAIR, V6, P1255, DOI 10.1016/j.dnarep.2007.02.008; Briegert M, 2007, CANCER RES, V67, P26, DOI 10.1158/0008-5472.CAN-06-3712; BURKLE A, 1993, CARCINOGENESIS, V14, P559, DOI 10.1093/carcin/14.4.559; Chen D, 2008, J BIOL CHEM, V283, P15381, DOI 10.1074/jbc.M710296200; Chen J, 2010, GENE DEV, V24, P2146, DOI 10.1101/gad.1968910; Christmann M, 2003, TOXICOLOGY, V193, P3, DOI 10.1016/S0300-483X(03)00287-7; De Vleeschouwer S, 2008, CLIN CANCER RES, V14, P3098, DOI 10.1158/1078-0432.CCR-07-4875; Eich M, 2010, MOL PHARMACOL, V78, P943, DOI 10.1124/mol.110.066076; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goldstein M, 2008, TOXICOL APPL PHARM, V229, P20, DOI 10.1016/j.taap.2008.01.001; Gottipati P, 2009, MUTAGENESIS, V24, P203, DOI 10.1093/mutage/gen072; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hazeki O, 1996, J LIPID MEDIAT CELL, V14, P259, DOI 10.1016/0929-7855(96)00534-2; Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008; Iliakis G, 2009, RADIOTHER ONCOL, V92, P310, DOI 10.1016/j.radonc.2009.06.024; Jiang XX, 2004, MOL CANCER THER, V3, P1221; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lau A, 2005, NAT CELL BIOL, V7, P493, DOI 10.1038/ncb1250; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Nardin A, 2008, FRONT BIOSCI-LANDMRK, V13, P3494; Nikolova T, 2010, DNA REPAIR, V9, P1050, DOI 10.1016/j.dnarep.2010.07.005; Parchment RE, 1998, ANN ONCOL, V9, P357, DOI 10.1023/A:1008245906772; Pereg Y, 2005, P NATL ACAD SCI USA, V102, P5056, DOI 10.1073/pnas.0408595102; Quiros S, 2010, CELL CYCLE, V9, P168, DOI 10.4161/cc.9.1.10363; Roos W, 2004, ONCOGENE, V23, P359, DOI 10.1038/sj.onc.1207080; Roos WP, 2012, CANC LETT IN PRESS, P8; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Roos WP, 2009, DNA REPAIR, V8, P72, DOI 10.1016/j.dnarep.2008.09.003; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Voss CY, 2004, TRANSFUS MED REV, V18, P189, DOI 10.1016/j.tmrv.2004.03.005; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e	40	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39956	10.1371/journal.pone.0039956	http://dx.doi.org/10.1371/journal.pone.0039956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768182	gold, Green Submitted, Green Published			2022-12-27	WOS:000305892100153
J	Bilgin, T; Wagner, A				Bilgin, Tugce; Wagner, Andreas			Design Constraints on a Synthetic Metabolism	PLOS ONE			English	Article							GENOME-SCALE RECONSTRUCTION; FLUX BALANCE ANALYSIS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; BIOTECHNOLOGICAL PRODUCTION; ADAPTIVE EVOLUTION; GENE-EXPRESSION; NETWORK MODEL; BIOLOGY; OPTIMIZATION	A metabolism is a complex network of chemical reactions that converts sources of energy and chemical elements into biomass and other molecules. To design a metabolism from scratch and to implement it in a synthetic genome is almost within technological reach. Ideally, a synthetic metabolism should be able to synthesize a desired spectrum of molecules at a high rate, from multiple different nutrients, while using few chemical reactions, and producing little or no waste. Not all of these properties are achievable simultaneously. We here use a recently developed technique to create random metabolic networks with pre-specified properties to quantify trade-offs between these and other properties. We find that for every additional molecule to be synthesized a network needs on average three additional reactions. For every additional carbon source to be utilized, it needs on average two additional reactions. Networks able to synthesize 20 biomass molecules from each of 20 alternative sole carbon sources need to have at least 260 reactions. This number increases to 518 reactions for networks that can synthesize more than 60 molecules from each of 80 carbon sources. The maximally achievable rate of biosynthesis decreases by approximately 5 percent for every additional molecule to be synthesized. Biochemically related molecules can be synthesized at higher rates, because their synthesis produces less waste. Overall, the variables we study can explain 87 percent of variation in network size and 84 percent of the variation in synthesis rate. The constraints we identify prescribe broad boundary conditions that can help to guide synthetic metabolism design.	[Bilgin, Tugce; Wagner, Andreas] Univ Zurich, Inst Evolutionary Biol & Environm Sci, Zurich, Switzerland; [Bilgin, Tugce; Wagner, Andreas] Swiss Inst Bioinformat, Zurich, Switzerland; [Wagner, Andreas] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Zurich; Swiss Institute of Bioinformatics; The Santa Fe Institute	Bilgin, T (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Sci, Zurich, Switzerland.	tugce.bilgin@ieu.uzh.ch			Swiss National Science Foundation [315230-129708]; YeastX project of SystemsX.ch; University Priority Research Program in Systems Biology at University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); YeastX project of SystemsX.ch; University Priority Research Program in Systems Biology at University of Zurich	We acknowledge support through Swiss National Science Foundation grant 315230-129708, as well as through the YeastX project of SystemsX.ch, and the University Priority Research Program in Systems Biology at the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoni D, 2007, APPL MICROBIOL BIOT, V77, P23, DOI 10.1007/s00253-007-1163-x; BAILEY JE, 1991, SCIENCE, V252, P1668, DOI 10.1126/science.2047876; Becker SA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-8; Beller HR, 2010, APPL ENVIRON MICROB, V76, P1212, DOI 10.1128/AEM.02312-09; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; Beste DJV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r89; Brooks SP, 1998, J ROY STAT SOC D-STA, V47, P69, DOI 10.1111/1467-9884.00117; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Cases I, 2005, INT MICROBIOL, V8, P213; Ciliberti S, 2007, PLOS COMPUTATIONAL B, V3, P10; Cooper GM, 2008, CELL, V77, P67; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; Diaconis P, 2009, B AM MATH SOC, V46, P179; Domingues A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-113; Duenas-Sanchez R, 2010, INT J FOOD MICROBIOL, V143, P150, DOI 10.1016/j.ijfoodmicro.2010.08.009; Ebenhoh O, 2001, B MATH BIOL, V63, P21, DOI 10.1006/bulm.2000.0197; Edwards JS, 2000, BMC BIOINFORMATICS, V1, DOI 10.1186/1471-2105-1-1; Edwards JS, 2000, BIOTECHNOL PROGR, V16, P927, DOI 10.1021/bp0000712; Exposito O, 2009, ANTI-CANCER AGENT ME, V9, P109, DOI 10.2174/187152009787047761; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100046; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Fong SS, 2005, GENOME RES, V15, P1365, DOI 10.1101/gr.3832305; Fong SS, 2003, J BACTERIOL, V185, P6400, DOI 10.1128/JB.185.21.6400-6408.2003; Forster AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100090; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gil R, 2003, P NATL ACAD SCI USA, V100, P9388, DOI 10.1073/pnas.1533499100; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Gonzalez OR, 2007, BIOINFORMATICS, V23, P480, DOI 10.1093/bioinformatics/btl522; Goto S, 2002, NUCLEIC ACIDS RES, V30, P402, DOI 10.1093/nar/30.1.402; Goto S, 2000, NUCLEIC ACIDS RES, V28, P380, DOI 10.1093/nar/28.1.380; Handorf T, 2008, J THEOR BIOL, V252, P530, DOI 10.1016/j.jtbi.2007.10.036; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Ho NWY, 1998, APPL ENVIRON MICROB, V64, P1852; Julius AA, 2008, IEEE DECIS CONTR P, P762, DOI 10.1109/CDC.2008.4739111; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Kim J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-53; Klasson L, 2004, TRENDS MICROBIOL, V12, P37, DOI 10.1016/j.tim.2003.11.006; Kuwahara H, 2007, CURR BIOL, V17, P881, DOI 10.1016/j.cub.2007.04.039; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Leuchtenberger W, 2005, APPL MICROBIOL BIOT, V69, P1, DOI 10.1007/s00253-005-0155-y; LI XR, 1992, FIRST IEEE CONFERENCE ON CONTROL APPLICATIONS, PROCEEDINGS, VOLS 1 AND 2, P654, DOI 10.1109/CCA.1992.269770; Liang JC, 2011, MOL CELL, V43, P915, DOI 10.1016/j.molcel.2011.08.023; Liu EK, 2010, BIOCHEM ENG J, V48, P204, DOI 10.1016/j.bej.2009.10.011; Madhavan A, 2009, APPL MICROBIOL BIOT, V82, P1037, DOI 10.1007/s00253-008-1818-2; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Metzger P, 2005, APPL MICROBIOL BIOT, V66, P486, DOI 10.1007/s00253-004-1779-z; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Mizoguchi H, 2008, DNA RES, V15, P277, DOI 10.1093/dnares/dsn019; Morot-Gaudry JF, 2001, MED BIOCH, V28, P299; Mukhopadhyay A, 2008, CURR OPIN BIOTECH, V19, P228, DOI 10.1016/j.copbio.2008.05.003; Murtas G, 2007, ORIGINS LIFE EVOL B, V37, P419, DOI 10.1007/s11084-007-9090-5; Nakabachi A, 2008, BACTERIAL ENDOSYMBIO; Neal R. M, 1993, CRGTR931 U TOR DEP C, P144; Nevoigt E, 2008, MICROBIOL MOL BIOL R, V72, P379, DOI 10.1128/MMBR.00025-07; Nishikawa T, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000236; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Oh YK, 2007, J BIOL CHEM, V282, P28791, DOI 10.1074/jbc.M703759200; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Patil KR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-308; Paul G, 2005, BIOINFORMATICS MOL E; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Raab AM, 2011, APPL ENVIRON MICROB, V77, P1981, DOI 10.1128/AEM.02219-10; Raghevendran V, 2006, J BIOL CHEM, V281, P12308, DOI 10.1074/jbc.M512972200; Rasmussen S, 2004, SCIENCE, V303, P963, DOI 10.1126/science.1093669; Riley M, 1997, NUCLEIC ACIDS RES, V25, P51, DOI 10.1093/nar/25.1.51; Robert C.P., 2000, TECHNOMETRICS, V42, P430, DOI [10.2307/1270959, DOI 10.2307/1270959]; Rocha I, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-45; Rodrigues JFM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000613; Rude MA, 2009, CURR OPIN MICROBIOL, V12, P274, DOI 10.1016/j.mib.2009.04.004; Samal A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-30; Sanchez RG, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-13; Savage DF, 2008, ACS CHEM BIOL, V3, P13, DOI 10.1021/cb700259j; Schellenberger J, 2007, NATURE PROTOCOLS, V2, P1290; Schilling CH, 2002, J BACTERIOL, V184, P4582, DOI 10.1128/JB.184.16.4582-4593.2002; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Schmidt CW, 2010, ENVIRON HEALTH PERSP, V118, pA118, DOI 10.1289/ehp.118-a118; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Smallbone K, 2009, J THEOR BIOL, V258, P311, DOI 10.1016/j.jtbi.2009.01.027; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Smolke CD, 2011, CELL, V144, P855, DOI 10.1016/j.cell.2011.02.020; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Steen EJ, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-36; STEPHANOPOULOS G, 1991, SCIENCE, V252, P1675, DOI 10.1126/science.1904627; Thomas GH, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-24; Tomshine J, 2006, BIOPHYS J, V91, P3196, DOI 10.1529/biophysj.106.083485; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; VANDAMME EJ, 1992, J CHEM TECHNOL BIOT, V53, P313; Wang Z, 2009, GENOME BIOL EVOL, V1, P23, DOI 10.1093/gbe/evp002; Weber J, 2005, MICROBIOL-SGM, V151, P707, DOI 10.1099/mic.0.27482-0; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wessely F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.46; Wisselink HW, 2009, APPL ENVIRON MICROB, V75, P907, DOI 10.1128/AEM.02268-08; Yang L, 2008, COMPUT CHEM ENG, V32, P2072, DOI 10.1016/j.compchemeng.2007.10.015; Yarmush ML, 2003, ANNU REV BIOMED ENG, V5, P349, DOI 10.1146/annurev.bioeng.5.031003.163247	101	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39903	10.1371/journal.pone.0039903	http://dx.doi.org/10.1371/journal.pone.0039903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768162	Green Published, Green Accepted, gold			2022-12-27	WOS:000305892100131
J	Greco, S; Perfetti, A; Fasanaro, P; Cardani, R; Capogrossi, MC; Meola, G; Martelli, F				Greco, Simona; Perfetti, Alessandra; Fasanaro, Pasquale; Cardani, Rosanna; Capogrossi, Maurizio C.; Meola, Giovanni; Martelli, Fabio			Deregulated MicroRNAs in Myotonic Dystrophy Type 2	PLOS ONE			English	Article							EXPANDED-REPEAT TRANSCRIPTS; SKELETAL-MUSCLE; GENE-EXPRESSION; MUSCULAR-DYSTROPHY; NUCLEAR FOCI; IN-VIVO; RNA; AKT2; DM2; DIFFERENTIATION	Myotonic Dystrophy Type-2 (DM2) is an autosomal dominant disease caused by the expansion of a CCTG tetraplet repeat. It is a multisystemic disorder, affecting skeletal muscles, the heart, the eye, the central nervous system and the endocrine system. Since microRNA (miRNA) expression is disrupted in Myotonic Dystrophy Type-1 and many other myopathies, miRNAs deregulation was studied in skeletal muscle biopsies of 13 DM2 patients and 13 controls. Eleven miRNAs were deregulated: 9 displayed higher levels compared to controls (miR-34a-5p, miR-34b-3p, miR-34c-5p, miR-146b-5p, miR-208a, miR-221-3p and miR-381), while 4 were decreased (miR-125b-5p, miR-193a-3p, miR-193b-3p and miR-378a-3p). To explore the relevance of DM2 miRNA deregulation, the predicted interactions between miRNA and mRNA were investigated. Global gene expression was analyzed in DM2 and controls and bioinformatic analysis identified more than 1,000 miRNA/mRNA interactions. Pathway and function analysis highlighted the involvement of the miRNA-deregulated mRNAs in multiple aspects of DM2 pathophysiology. In conclusion, the observed miRNA dysregulations may contribute to DM2 pathogenetic mechanisms.	[Greco, Simona; Perfetti, Alessandra; Cardani, Rosanna; Meola, Giovanni; Martelli, Fabio] IRCCS, Policlin San Donato, Milan, Italy; [Meola, Giovanni] Univ Milan, Milan, Italy; [Fasanaro, Pasquale; Capogrossi, Maurizio C.] IRCCS, Ist Dermopat Immacolata, Rome, Italy	IRCCS Policlinico San Donato; University of Milan; IRCCS Istituto Dermopatico dell'Immacolata (IDI)	Greco, S (corresponding author), IRCCS, Policlin San Donato, Milan, Italy.	lcm.psd@grupposandonato.it	Martelli, Fabio/AAL-3788-2020; Perfetti, Alessandra/O-4849-2019; cardani, rosanna/ABH-6525-2020; Perfetti, Alessandra/J-8166-2016; greco, simona/J-5374-2016; Meola, Giovanni/K-4775-2016; greco, simona/AAD-3211-2021	Martelli, Fabio/0000-0002-8624-7738; Perfetti, Alessandra/0000-0001-9514-9032; cardani, rosanna/0000-0001-8858-4327; Perfetti, Alessandra/0000-0001-9514-9032; greco, simona/0000-0002-0275-7221; Meola, Giovanni/0000-0001-6396-717X; greco, simona/0000-0002-0275-7221	Ministero della Salute; FMM-Fondazione Malattie Miotoniche; Association Francaise contre les Myopathies	Ministero della Salute(Ministry of Health, Italy); FMM-Fondazione Malattie Miotoniche; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This research was funded by Ministero della Salute, FMM-Fondazione Malattie Miotoniche, and Association Francaise contre les Myopathies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MI, 2011, MUTAT RES-FUND MOL M, V717, P1, DOI 10.1016/j.mrfmmm.2011.03.009; Altomare DA, 1998, ONCOGENE, V16, P2407, DOI 10.1038/sj.onc.1201750; ALTOMARE DA, 1995, ONCOGENE, V11, P1055; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Botta A, 2007, GENE EXPRESSION, V13, P339; BROOK, 1992, CELL, V69, P385; Burge JA, 2012, CURR NEUROL NEUROSCI, V12, P62, DOI 10.1007/s11910-011-0238-3; Cacchiarelli D, 2011, EMBO REP, V12, P136, DOI 10.1038/embor.2010.208; Cacchiarelli D, 2010, CELL METAB, V12, P341, DOI 10.1016/j.cmet.2010.07.008; Cardani R, 2004, EUR J HISTOCHEM, V48, P437; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Day JW, 2003, NEUROLOGY, V60, P657, DOI 10.1212/01.WNL.0000054481.84978.F9; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; ERDREICH LS, 1981, AM J EPIDEMIOL, V114, P649, DOI 10.1093/oxfordjournals.aje.a113236; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fardaei M, 2001, NUCLEIC ACIDS RES, V29, P2766, DOI 10.1093/nar/29.13.2766; Fasanaro P, 2010, PHARMACOL THERAPEUT, V125, P92, DOI 10.1016/j.pharmthera.2009.10.003; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Gambardella S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-48; Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; Greco S, 2012, DIABETES; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harper P, 2009, MYOTONIC DYSTROPHY; HENDERSON AR, 1993, ANN CLIN BIOCHEM, V30, P521, DOI 10.1177/000456329303000601; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Le Brigand K, 2010, BIOINFORMATICS, V26, P3131, DOI 10.1093/bioinformatics/btq589; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; McCarthy JJ, 2009, PHYSIOL GENOMICS, V39, P219, DOI 10.1152/physiolgenomics.00042.2009; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; Perbellini R, 2011, NEUROMUSCULAR DISORD, V21, P81, DOI 10.1016/j.nmd.2010.11.012; Rau F, 2011, NAT STRUCT MOL BIOL, V18, P840, DOI 10.1038/nsmb.2067; Rotwein P, 2009, J CELL PHYSIOL, V219, P503, DOI 10.1002/jcp.21692; Schoser BGH, 2004, MUSCLE NERVE, V29, P275, DOI 10.1002/mus.10545; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; Toscano A, 2005, FREE RADICAL RES, V39, P771, DOI 10.1080/10715760500138932; Turner C, 2010, J NEUROL NEUROSUR PS, V81, P358, DOI 10.1136/jnnp.2008.158261; Udd B, 2011, Neuromuscul Disord, V21, P443, DOI 10.1016/j.nmd.2011.03.013; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Vihola A, 2003, NEUROLOGY, V60, P1854, DOI 10.1212/01.WNL.0000065898.61358.09; Vihola A, 2010, ACTA NEUROPATHOL, V119, P465, DOI 10.1007/s00401-010-0637-6; Wojciechowska M, 2011, HUM MOL GENET, V20, P3811, DOI 10.1093/hmg/ddr299	52	67	70	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39732	10.1371/journal.pone.0039732	http://dx.doi.org/10.1371/journal.pone.0039732			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768114	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100084
J	Herzog, N; Friedrich, A; Fujita, N; Gais, S; Jauch-Chara, K; Oltmanns, KM; Benedict, C				Herzog, Nina; Friedrich, Alexia; Fujita, Naoko; Gais, Steffen; Jauch-Chara, Kamila; Oltmanns, Kerstin M.; Benedict, Christian			Effects of Daytime Food Intake on Memory Consolidation during Sleep or Sleep Deprivation	PLOS ONE			English	Article							DECLARATIVE MEMORY; GLUCOSE; PERFORMANCE	Sleep enhances memory consolidation. Bearing in mind that food intake produces many metabolic signals that can influence memory processing in humans (e.g., insulin), the present study addressed the question as to whether the enhancing effect of sleep on memory consolidation is affected by the amount of energy consumed during the preceding daytime. Compared to sleep, nocturnal wakefulness has been shown to impair memory consolidation in humans. Thus, a second question was to examine whether the impaired memory consolidation associated with sleep deprivation (SD) could be compensated by increased daytime energy consumption. To these aims, 14 healthy normal-weight men learned a finger tapping sequence (procedural memory) and a list of semantically associated word pairs (declarative memory). After the learning period, standardized meals were administered, equaling either similar to 50% or similar to 150% of the estimated daily energy expenditure. In the morning, after sleep or wakefulness, memory consolidation was tested. Plasma glucose was measured both before learning and retrieval. Polysomnographic sleep recordings were performed by electroencephalography (EEG). Independent of energy intake, subjects recalled significantly more word pairs after sleep than they did after SD. When subjects stayed awake and received an energy oversupply, the number of correctly recalled finger sequences was equal to those seen after sleep. Plasma glucose did not differ among conditions, and sleep time in the sleep conditions was not influenced by the energy intake interventions. These data indicate that the daytime energy intake level affects neither sleep's capacity to boost the consolidation of declarative and procedural memories, nor sleep's quality. However, high energy intake was followed by an improved procedural but not declarative memory consolidation under conditions of SD. This suggests that the formation of procedural memory is not only triggered by sleep but is also sensitive to the fluctuations in the energy state of the body.	[Herzog, Nina; Friedrich, Alexia; Fujita, Naoko; Jauch-Chara, Kamila; Oltmanns, Kerstin M.] Univ Lubeck, Dept Psychiat & Psychotherapy, Lubeck, Germany; [Gais, Steffen] Univ Munich LMU, Munich, Germany; [Benedict, Christian] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	University of Lubeck; University of Munich; Uppsala University	Herzog, N (corresponding author), Univ Lubeck, Dept Psychiat & Psychotherapy, Lubeck, Germany.	nina.herzog@psychiatrie.uk-sh.de	Benedict, Christian/K-2190-2017	Benedict, Christian/0000-0002-8911-4068	German Research Foundation (DFG) [SFB 654, B7]; Novo Nordisk	German Research Foundation (DFG)(German Research Foundation (DFG)); Novo Nordisk(Novo Nordisk)	The study was supported by the German Research Foundation (DFG, SFB 654, B7). Dr. Christian Benedict received a research grant from Novo Nordisk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhaus J, 2007, LEARN MEMORY, V14, P336, DOI 10.1101/lm.470507; Benedict C, 2007, NEUROENDOCRINOLOGY, V86, P136, DOI 10.1159/000106378; Benton D, 1998, AM J CLIN NUTR, V67, p772S, DOI 10.1093/ajcn/67.4.772S; Born J, 2012, PSYCHOL RES-PSYCH FO, V76, P192, DOI 10.1007/s00426-011-0335-6; BOYLE PJ, 1994, J CLIN INVEST, V93, P529, DOI 10.1172/JCI117003; Diekelmann S, 2011, NAT NEUROSCI, V14, P381, DOI 10.1038/nn.2744; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Jauch-Chara K, 2007, DIABETES CARE, V30, P2040, DOI 10.2337/dc07-0067; Jung CM, 2011, J PHYSIOL-LONDON, V589, P235, DOI 10.1113/jphysiol.2010.197517; Kaplan RJ, 2000, AM J CLIN NUTR, V72, P825; Lieberman HR, 2008, AM J CLIN NUTR, V88, P667, DOI 10.1093/ajcn/88.3.667; MAQUET P, 1995, BEHAV BRAIN RES, V69, P75, DOI 10.1016/0166-4328(95)00017-N; McNay EC, 2001, J GERONTOL A-BIOL, V56, pB66, DOI 10.1093/gerona/56.2.B66; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rechtschaffen A, 1993, NEUROLOGICAL INFORM; Sunram-Lea SI, 2002, BEHAV BRAIN RES, V134, P505, DOI 10.1016/S0166-4328(02)00086-4; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011	22	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40298	10.1371/journal.pone.0040298	http://dx.doi.org/10.1371/journal.pone.0040298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768272	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100246
J	Hu, QH; Zhu, YY; Tu, J; Yin, YC; Wang, XL; Han, XG; Ding, C; Zhang, BM; Yu, SQ				Hu, Qinghai; Zhu, Yinyu; Tu, Jing; Yin, Yuncong; Wang, Xiaolan; Han, Xiangan; Ding, Chan; Zhang, Beimin; Yu, Shengqing			Identification of the Genes Involved in Riemerella anatipestifer Biofilm Formation by Random Transposon Mutagenesis	PLOS ONE			English	Article							SIGNATURE-TAGGED MUTAGENESIS; FLAVOBACTERIUM-PSYCHROPHILUM; BACTERIAL BIOFILMS; ESCHERICHIA-COLI; GLIDING MOTILITY; IDENTIFY GENES; PATHOGENESIS; INFECTIONS; SURFACES	Riemerella anatipestifer causes epizootics of infectious disease in poultry that result in serious economic losses to the duck industry. Our previous studies have shown that some strains of R. anatipestifer can form a biofilm, and this may explain the intriguing persistence of R. anatipestifer on duck farms post infection. In this study we used strain CH3, a strong producer of biofilm, to construct a library of random Tn4351 transposon mutants in order to investigate the genetic basis of biofilm formation by R. anatipestifer on abiotic surfaces. A total of 2,520 mutants were obtained and 39 of them showed a reduction in biofilm formation of 47%-98% using crystal violet staining. Genetic characterization of the mutants led to the identification of 33 genes. Of these, 29 genes are associated with information storage and processing, as well as basic cellular processes and metabolism; the function of the other four genes is currently unknown. In addition, a mutant strain BF19, in which biofilm formation was reduced by 98% following insertion of the Tn4351 transposon at the dihydrodipicolinate synthase (dhdps) gene, was complemented with a shuttle plasmid pCP-dhdps. The complemented mutant strain was restored to give 92.6% of the biofilm formation of the wild-type strain CH3, which indicates that the dhdp gene is associated with biofilm formation. It is inferred that such complementation applies also to other mutant strains. Furthermore, some biological characteristics of biofilm-defective mutants were investigated, indicating that the genes deleted in the mutant strains function in the biofilm formation of R. anatipestifer. Deletion of either gene will stall the biofilm formation at a specific stage thus preventing further biofilm development. In addition, the tested biofilm-defective mutants had different adherence capacity to Vero cells. This study will help us to understand the molecular mechanisms of biofilm development by R. anatipestifer and to study the pathogenesis of R. anatipestifer further.	[Hu, Qinghai; Zhu, Yinyu; Tu, Jing; Wang, Xiaolan; Han, Xiangan; Ding, Chan; Zhang, Beimin; Yu, Shengqing] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China; [Yu, Shengqing] China Natl Engn Technol Res Ctr Poultry, Shanghai, Peoples R China; [Yin, Yuncong] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Nanjing Agricultural University	Hu, QH (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China.	yus@shvri.ac.cn		Han, Xiangan/0000-0001-5625-637X	Shanghai Nature Science Fund [09ZR1438600]; National Natural Science Foundation of China [31072156, 31072161]; Shanghai Key Project on Agricultural Development through Science and Technology [2009HNG5-3]	Shanghai Nature Science Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Project on Agricultural Development through Science and Technology	This work is supported by Shanghai Nature Science Fund (09ZR1438600), the National Natural Science Foundation of China (31072156 and 31072161), and Shanghai Key Project on Agricultural Development through Science and Technology (2009HNG5-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez B, 2006, APPL ENVIRON MICROB, V72, P4044, DOI 10.1128/AEM.00128-06; Alvarez B, 2004, APPL ENVIRON MICROB, V70, P581, DOI 10.1128/AEM.70.1.581-587.2004; BISGAARD M, 1982, AVIAN PATHOL, V11, P341, DOI 10.1080/03079458208436109; Boddicker JD, 2006, INFECT IMMUN, V74, P4590, DOI 10.1128/IAI.00129-06; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Cooper AJ, 1997, J BACTERIOL, V179, P6221, DOI 10.1128/jb.179.20.6221-6227.1997; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cuccui J, 2007, INFECT IMMUN, V75, P1186, DOI 10.1128/IAI.01240-06; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hartmann I, 2010, APPL ENVIRON MICROB, V76, P2251, DOI 10.1128/AEM.00930-09; Hu Q., 2002, ANIMAL HUSBANDRY VET, V34, P8; Hu QH, 2011, VET MICROBIOL, V150, P278, DOI 10.1016/j.vetmic.2011.01.022; Hu QH, 2010, VET MICROBIOL, V144, P429, DOI 10.1016/j.vetmic.2010.02.023; McBride MJ, 1996, J BACTERIOL, V178, P583, DOI 10.1128/jb.178.3.583-590.1996; McBride MJ, 2003, J BACTERIOL, V185, P6648, DOI 10.1128/JB.185.22.6648-6657.2003; Mukherjee PK, 2006, INFECT IMMUN, V74, P3804, DOI 10.1128/IAI.00161-06; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; OCHMAN H, 1988, GENETICS, V120, P621; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Pathanasophon P, 2002, AVIAN PATHOL, V31, P267, DOI 10.1080/03079450220136576; Pearson MM, 2007, INFECT IMMUN, V75, P4316, DOI 10.1128/IAI.01347-06; Puttamreddy S, 2010, INFECT IMMUN, V78, P2377, DOI 10.1128/IAI.00156-10; Sambrook J., 2001, MOL CLONING LABORATO, V3; Sandhu T.S., 2008, DIS POULTRY, P758; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; Tsai HJ, 2005, AVIAN PATHOL, V34, P55, DOI 10.1080/03079450400025471; Wang X, 2006, CELL MOL LIFE SCI, V63, P2352, DOI 10.1007/s00018-006-6222-4; Wu MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023500; Yousef-Coronado F, 2008, FEMS MICROBIOL LETT, V288, P118, DOI 10.1111/j.1574-6968.2008.01339.x	35	33	35	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39805	10.1371/journal.pone.0039805	http://dx.doi.org/10.1371/journal.pone.0039805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768127	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100097
J	Kalajdzic, P; Oehler, S; Reczko, M; Pavlidi, N; Vontas, J; Hatzigeorgiou, AG; Savakis, C				Kalajdzic, Predrag; Oehler, Stefan; Reczko, Martin; Pavlidi, Nena; Vontas, John; Hatzigeorgiou, Artemis G.; Savakis, Charalambos			Use of Mutagenesis, Genetic Mapping and Next Generation Transcriptomics to Investigate Insecticide Resistance Mechanisms	PLOS ONE			English	Article							BARBITAL-INDUCED EXPRESSION; DROSOPHILA-MELANOGASTER; REGULATORY ELEMENTS; PERMETHRIN RESISTANCE; SUSCEPTIBLE STRAINS; OVER-EXPRESSION; MOLECULAR-BASIS; CYP6A2; GENOME; BIOINFORMATICS	Insecticide resistance is a worldwide problem with major impact on agriculture and human health. Understanding the underlying molecular mechanisms is crucial for the management of the phenomenon; however, this information often comes late with respect to the implementation of efficient counter-measures, particularly in the case of metabolism-based resistance mechanisms. We employed a genome-wide insertional mutagenesis screen to Drosophila melanogaster, using a Minos-based construct, and retrieved a line (MiT[w(-)]3R2) resistant to the neonicotinoid insecticide Imidacloprid. Biochemical and bioassay data indicated that resistance was due to increased P450 detoxification. Deep sequencing transcriptomic analysis revealed substantial over-and under-representation of 357 transcripts in the resistant line, including statistically significant changes in mixed function oxidases, peptidases and cuticular proteins. Three P450 genes (Cyp4p2, Cyp6a2 and Cyp6g1) located on the 2R chromosome, are highly up-regulated in mutant flies compared to susceptible Drosophila. One of them (Cyp6g1) has been already described as a major factor for Imidacloprid resistance, which validated the approach. Elevated expression of the Cyp4p2 was not previously documented in Drosophila lines resistant to neonicotinoids. In silico analysis using the Drosophila reference genome failed to detect transcription binding factors or microRNAs associated with the over-expressed Cyp genes. The resistant line did not contain a Minos insertion in its chromosomes, suggesting a hit-and-run event, i.e. an insertion of the transposable element, followed by an excision which caused the mutation. Genetic mapping placed the resistance locus to the right arm of the second chromosome, within a similar to 1 Mb region, where the highly up-regulated Cyp6g1 gene is located. The nature of the unknown mutation that causes resistance is discussed on the basis of these results.	[Kalajdzic, Predrag] Univ Belgrade, Inst Biol Res, Belgrade, Serbia; [Kalajdzic, Predrag; Savakis, Charalambos] Univ Crete, Sch Med, Iraklion, Greece; [Oehler, Stefan; Savakis, Charalambos] Biomed Sci Res Ctr Alexander Fleming, Inst Cellular & Dev Biol, Varkiza, Greece; [Reczko, Martin; Hatzigeorgiou, Artemis G.] Biomed Sci Res Ctr Alexander Fleming, Inst Mol Oncol, Varkiza, Greece; [Pavlidi, Nena; Vontas, John] Univ Crete, Dept Biol, Iraklion, Greece	University of Belgrade; University of Crete; Alexander Fleming Biomedical Sciences Research Center; Alexander Fleming Biomedical Sciences Research Center; University of Crete	Kalajdzic, P (corresponding author), Univ Belgrade, Inst Biol Res, Belgrade, Serbia.	pedja@ibiss.bg.ac.rs	Vontas, John/X-5112-2018; Hatzigeorgiou, Artemis/Z-1976-2019; Reczko, Martin/O-8935-2019	Vontas, John/0000-0002-8704-2574; Reczko, Martin/0000-0002-0005-8718	Greek State Scholarships Foundation [1021]; Ministry of Education and Science, Republic of Serbia [173012]	Greek State Scholarships Foundation(Greek Ministry of Development-GSRT); Ministry of Education and Science, Republic of Serbia	This project was funded by Greek State Scholarships Foundation (I Delta P gamma MA KRATIK Omega N gamma Pi OTPO Phi I Omega N - IKY program for postgraduate studies (PhD), contract No. 1021 (2006-2010) (www.iky.gr)) and Ministry of Education and Science, Republic of Serbia (Grant No. 173012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ahmed S, 1998, INSECT BIOCHEM MOLEC, V28, P629, DOI 10.1016/S0965-1748(98)00061-7; [Anonymous], 1999, SPSS BAS 10 0 WIND U; APPERSON CS, 1975, J ECON ENTOMOL, V68, P153, DOI 10.1093/jee/68.2.153; Araujo RA, 2008, B ENTOMOL RES, V98, P417, DOI 10.1017/S0007485308005737; Arca B, 1997, GENETICS, V145, P267; Chung H, 2007, GENETICS, V175, P1071, DOI 10.1534/genetics.106.066597; Chung H, 2011, INSECT BIOCHEM MOLEC, V41, P863, DOI 10.1016/j.ibmb.2011.07.002; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; Daborn P, 2001, MOL GENET GENOMICS, V266, P556, DOI 10.1007/s004380100531; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Dombrowski SM, 1998, GENE, V221, P69, DOI 10.1016/S0378-1119(98)00436-3; Dunkov BC, 1997, DNA CELL BIOL, V16, P1345, DOI 10.1089/dna.1997.16.1345; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Ffrench-Constant RH, 2000, ANNU REV ENTOMOL, V45, P449, DOI 10.1146/annurev.ento.45.1.449; Finney D.J., 1971, PROBIT ANAL; Fiston-Lavier AS, 2010, GENE, V463, P18, DOI 10.1016/j.gene.2010.04.015; Giraudo M, 2010, PESTIC BIOCHEM PHYS, V97, P115, DOI 10.1016/j.pestbp.2009.06.009; Gonzalez JR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-166; GOSSEN M, 1993, TRENDS BIOCHEM SCI, V18, P471, DOI 10.1016/0968-0004(93)90009-C; Green CD, 2001, J IMMUNOL METHODS, V250, P67, DOI 10.1016/S0022-1759(01)00306-4; Hemingway J, 2000, INSECT BIOCHEM MOLEC, V30, P1009, DOI 10.1016/S0965-1748(00)00079-5; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inceoglu AB, 2009, J MED ENTOMOL, V46, P83, DOI 10.1603/033.046.0111; Ivics Z, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-25; Karunker I, 2009, INSECT BIOCHEM MOLEC, V39, P697, DOI 10.1016/j.ibmb.2009.08.006; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Koukidou M, 2006, INSECT MOL BIOL, V15, P95, DOI 10.1111/j.1365-2583.2006.00613.x; Lister R, 2009, CURR OPIN PLANT BIOL, V12, P107, DOI 10.1016/j.pbi.2008.11.004; Lopes KVG, 2010, J INSECT PHYSIOL, V56, P1050, DOI 10.1016/j.jinsphys.2010.02.020; Maitra S, 2000, GENE, V248, P147, DOI 10.1016/S0378-1119(00)00129-3; Maitra S, 1996, GENE, V180, P165, DOI 10.1016/S0378-1119(96)00446-5; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Metaxakis A, 2005, GENETICS, V171, P571, DOI 10.1534/genetics.105.041848; Morra R, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00954.x; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Mushtaq AS, 2003, PAK J ZOOL, V35, P197; Oakeshott JG, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-202; Pavlopoulos A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S2; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; Perry T, 2011, INSECT BIOCHEM MOLEC, V41, P411, DOI 10.1016/j.ibmb.2011.03.003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pollock DD, 2004, GENETICS, V168, P489, DOI 10.1534/genetics.103.024430; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Saner C, 1996, ENVIRON MOL MUTAGEN, V27, P46, DOI 10.1002/(SICI)1098-2280(1996)27:1<46::AID-EM7>3.0.CO;2-C; SCOTT JG, 1986, BIOCHEM GENET, V24, P25, DOI 10.1007/BF00502976; Scott JG, 2004, PESTIC BIOCHEM PHYS, V78, P171, DOI 10.1016/j.pestbp.2004.01.002; SCOTT JG, 1986, PESTIC SCI, V17, P195, DOI 10.1002/ps.2780170302; Silva LB, 2010, COMP BIOCHEM PHYS B, V155, P12, DOI 10.1016/j.cbpb.2009.09.011; Singh ND, 2005, GENETICS, V169, P709, DOI 10.1534/genetics.104.032250; Smith AD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-128; Soderlund DM, 2008, PEST MANAG SCI, V64, P610, DOI 10.1002/ps.1574; Taskin V., 2007, J MOL CELL BIOL, V6, P31; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; WATERS LC, 1992, P NATL ACAD SCI USA, V89, P4855, DOI 10.1073/pnas.89.11.4855; Wilson TG, 2001, ANNU REV ENTOMOL, V46, P545, DOI 10.1146/annurev.ento.46.1.545; WILSON TG, 1988, J ECON ENTOMOL, V81, P22, DOI 10.1093/jee/81.1.22	62	20	21	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40296	10.1371/journal.pone.0040296	http://dx.doi.org/10.1371/journal.pone.0040296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768270	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100244
J	Price, AE; Reinhardt, RL; Liang, HE; Locksley, RM				Price, April E.; Reinhardt, R. Lee; Liang, Hong-Erh; Locksley, Richard M.			Marking and Quantifying IL-17A-Producing Cells In Vivo	PLOS ONE			English	Article							DELTA-T-CELLS; ROR-GAMMA-T; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CHRONIC MUCOCUTANEOUS CANDIDIASIS; KLEBSIELLA-PNEUMONIAE INFECTION; CYTOKINE GM-CSF; HOST-DEFENSE; TH17 CELLS; CUTTING EDGE; T(H)17 CELLS	Interleukin (IL)-17A plays an important role in host defense against a variety of pathogens and may also contribute to the pathogenesis of autoimmune diseases. However, precise identification and quantification of the cells that produce this cytokine in vivo have not been performed. We generated novel IL-17A reporter mice to investigate expression of IL-17A during Klebsiella pneumoniae infection and during experimental autoimmune encephalomyelitis, conditions previously demonstrated to potently induce IL-17A production. In both settings, the majority of IL-17A was produced by non-CD4(+) T cells, particularly gamma delta T cells, but also invariant NKT cells and other CD4(-)CD3 epsilon(+) cells. As measured in dual-reporter mice, IFN-gamma-producing Th1 cells greatly outnumbered IL-17A-producing Th17 cells throughout both challenges. Production of IL-17A by cells from unchallenged mice or by non-T cells under any condition was not evident. Administration of IL-1 beta and/or IL-23 elicited rapid production of IL-17A by gamma delta T cells, invariant NKT cells and other CD4(-)CD3 epsilon(+) cells in vivo, demonstrating that these cells are poised for rapid cytokine production and likely comprise the major sources of this cytokine during acute immunologic challenges.	[Price, April E.; Reinhardt, R. Lee; Liang, Hong-Erh; Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Price, April E.; Reinhardt, R. Lee; Liang, Hong-Erh; Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Price, AE (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu			United States National Institutes of Health [AI30663, AI078869]; Howard Hughes Medical Institute; Sandler Asthma Basic Research Center at University of California San Francisco; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI078869, R01AI030663] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sandler Asthma Basic Research Center at University of California San Francisco; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by AI30663 and AI078869 from the United States National Institutes of Health, the Howard Hughes Medical Institute, and the Sandler Asthma Basic Research Center at University of California San Francisco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Chang SH, 2009, CYTOKINE, V46, P7, DOI 10.1016/j.cyto.2008.12.024; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Croxford AL, 2009, J IMMUNOL, V182, P1237, DOI 10.4049/jimmunol.182.3.1237; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Doisne JM, 2011, J IMMUNOL, V186, P662, DOI 10.4049/jimmunol.1002725; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Ferber IA, 1996, J IMMUNOL, V156, P5; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gray EE, 2011, J IMMUNOL, V186, P6091, DOI 10.4049/jimmunol.1100427; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kurschus FC, 2010, EUR J IMMUNOL, V40, P3336, DOI 10.1002/eji.201040755; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Moore TA, 2002, INFECT IMMUN, V70, P6310, DOI 10.1128/IAI.70.11.6310-6318.2002; Moore TA, 2000, J IMMUNOL, V165, P2643, DOI 10.4049/jimmunol.165.5.2643; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Toh ML, 2009, CYTOKINE, V48, P226, DOI 10.1016/j.cyto.2009.07.013; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Woolard MD, 2008, INFECT IMMUN, V76, P2651, DOI 10.1128/IAI.01412-07; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	56	63	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39750	10.1371/journal.pone.0039750	http://dx.doi.org/10.1371/journal.pone.0039750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768117	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100087
J	Wang, JN; Teves, ME; Shen, XN; Nagarkatti-Gude, DR; Hess, RA; Henderson, SC; Strauss, JF; Zhang, ZB				Wang, Jiannan; Teves, Maria E.; Shen, Xuening; Nagarkatti-Gude, David R.; Hess, Rex A.; Henderson, Scott C.; Strauss, Jerome F., III; Zhang, Zhibing			Mouse RC/BTB2, a Member of the RCC1 Superfamily, Localizes to Spermatid Acrosomal Vesicles	PLOS ONE			English	Article							MAMMALIAN ORTHOLOGUE; CHLAMYDOMONAS PF16; LIFE-HISTORY; GENE; PROTEINS; SPERMATOGENESIS; SPERMIOGENESIS; ACROPLAXOME; EXPRESSION; MANCHETTE	Mouse RC/BTB2 is an unstudied protein of the RCC1 (Regulator of Chromosome Condensation) superfamily. Because of the significant remodeling of chromatin that occurs during spermiogenesis, we characterized the expression and localization of mouse RC/BTB2 in the testis and male germ cells. The Rc/btb2 gene yields two major transcripts: 2.3 kb Rc/btb2-s, present in most somatic tissues examined; and 2.5 kb Rc/btb2-t, which contains a unique non-translated exon in its 59-UTR that is only detected in the testis. During the first wave of spermatogenesis, Rc/btb2-t mRNA is expressed from day 8 after birth, reaching highest levels of expression at day 30 after birth. The full-length protein contains three RCC1 domains in the N-terminus, and a BTB domain in the C-terminus. In the testis, the protein is detectable from day 12, but is progressively up-regulated to day 30 and day 42 after birth. In spermatids, some of the protein co-localizes with acrosomal markers sp56 and peanut lectin, indicating that it is an acrosomal protein. A GFP-tagged RCC1 domain is present throughout the cytoplasm of transfected CHO cells. However, both GFP-tagged, full-length RC/BTB2 and a GFP-tagged BTB domain localize to vesicles in close proximity to the nuclear membrane, suggesting that the BTB domain might play a role in mediating full-length RC/BTB2 localization. Since RCC1 domains associate with Ran, a small GTPase that regulates molecular trafficking, it is possible that RC/BTB2 plays a role in transporting proteins during acrosome formation.	[Wang, Jiannan; Teves, Maria E.; Shen, Xuening; Nagarkatti-Gude, David R.; Strauss, Jerome F., III; Zhang, Zhibing] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA 23284 USA; [Nagarkatti-Gude, David R.; Strauss, Jerome F., III; Zhang, Zhibing] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA USA; [Henderson, Scott C.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA; [Hess, Rex A.] Univ Illinois, Coll Vet Med, Dept Comparat Biosci, Urbana, IL 61801 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of Illinois System; University of Illinois Urbana-Champaign	Wang, JN (corresponding author), Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA 23284 USA.	zzhang4@vcu.edu	Nagarkatti-Gude, David/AAF-6996-2020; Teves, Maria/AAJ-9523-2020; Henderson, Scott/AAP-2785-2021	Teves, Maria/0000-0001-7035-2202; Henderson, Scott/0000-0002-1076-3867; Hess, Rex/0000-0003-2649-3563	Virginia Commonwealth University; National Institutes of Health [HD37416]; National Institute of Child Health and Human Development [IF3IHD0G2314-01]; Fogarty International Center [5D43TW007692]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037416] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW007692] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER	Virginia Commonwealth University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by Virginia Commonwealth University Presidential Research Incentive Program (PRIP) (to ZZ), National Institutes of Health grants HD37416 (JFS), National Institute of Child Health and Human Development F31 Predoctoral Fellowship IF3IHD0G2314-01 (to DRNG). MET is a visiting scholar from Centro de Biologia Celulary Molecular, Universidad Nacional de Cordoba, Argentina, and supported by the Fogarty International Center (5D43TW007692). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armellini A, 2008, BRIT J HAEMATOL, V141, P212, DOI 10.1111/j.1365-2141.2007.06956.x; Berruti Giovanna, 2011, Spermatogenesis, V1, P95; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Fawcett D. W., 1970, Biol Reprod, V2, P90, DOI 10.1095/biolreprod2.Supplement_2.90; Garcia-Gonzalo FR, 2005, FEBS LETT, V579, P343, DOI 10.1016/j.febslet.2004.11.095; Hao Y, 2008, J CELL BIOL, V182, P827, DOI 10.1083/jcb.200803110; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; HARTREE EF, 1975, J REPROD FERTIL, V44, P125, DOI 10.1530/jrf.0.0440125; Hecht NB, 1998, BIOESSAYS, V20, P555, DOI 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.3.CO;2-J; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P320, DOI 10.1002/jemt.20784; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P279, DOI 10.1002/jemt.20787; Hu ZZ, 2007, INT J MASS SPECTROM, V259, P147, DOI 10.1016/j.ijms.2006.09.024; Huizing M, 2008, ANNU REV GENOM HUM G, V9, P359, DOI 10.1146/annurev.genom.9.081307.164303; Kierszenbaum Abraham L, 2007, Soc Reprod Fertil Suppl, V65, P33; Kierszenbaum AL, 2004, BIOL REPROD, V70, P1400, DOI 10.1095/biolreprod.103.025346; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kierszenbaum AL, 2003, CYTOGENET GENOME RES, V103, P337, DOI 10.1159/000076822; Kierszenbaum AL, 2003, MOL BIOL CELL, V14, P4628, DOI 10.1091/mbc.E03-04-0226; Kim KS, 2001, BIOL REPROD, V64, P36, DOI 10.1095/biolreprod64.1.36; KLUIN PM, 1982, INT J ANDROL, V5, P282, DOI 10.1111/j.1365-2605.1982.tb00257.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Latil A, 2003, PROSTATE, V57, P39, DOI 10.1002/pros.10272; Liu WM, 2001, NAT IMMUNOL, V2, P939, DOI 10.1038/ni1001-939; Mabuchi H, 2001, CANCER RES, V61, P2870; Marshall J, 2011, ADV EXP MED BIOL, V717, P115, DOI 10.1007/978-1-4419-9557-5_10; MartinezMenarguez JA, 1996, J HISTOCHEM CYTOCHEM, V44, P313, DOI 10.1177/44.4.8601690; Meistrich ML, 2003, CHROMOSOMA, V111, P483, DOI 10.1007/s00412-002-0227-z; MORTIMER D, 1990, HUM REPROD, V5, P99, DOI 10.1093/oxfordjournals.humrep.a137050; OHTSUBO M, 1987, GENE DEV, V1, P585, DOI 10.1101/gad.1.6.585; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Rivkin E, 1997, MOL REPROD DEV, V48, P77, DOI 10.1002/(SICI)1098-2795(199709)48:1&lt;77::AID-MRD10&gt;3.0.CO;2-T; Rodriguez CI, 2007, DEV BIOL, V312, P501, DOI 10.1016/j.ydbio.2007.09.053; Selva DM, 2002, J BIOL CHEM, V277, P45291, DOI 10.1074/jbc.M205903200; Smith Temple F., 2008, V48, P20, DOI 10.1007/978-0-387-09595-0_3; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; TANG XM, 1982, AM J ANAT, V163, P283, DOI 10.1002/aja.1001630402; Tange Y, 2002, J CELL SCI, V115, P4375, DOI 10.1242/jcs.00135; Tsuneoka M, 2006, INT J ANDROL, V29, P323, DOI 10.1111/j.1365-2605.2005.00572.x; Xu BF, 2008, DEV BIOL, V319, P201, DOI 10.1016/j.ydbio.2008.03.043; Yan W, 2009, MOL CELL ENDOCRINOL, V306, P24, DOI 10.1016/j.mce.2009.03.003; Yatsenko AN, 2010, J ANDROL, V31, P34, DOI 10.2164/jandrol.109.008227; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zhang ZB, 2006, BIOL REPROD, V74, P751, DOI 10.1095/biolreprod.105.049254; Zhang ZB, 2005, MOL CELL PROTEOMICS, V4, P914, DOI 10.1074/mcp.M400177-MCP200; Zhang ZB, 2004, P NATL ACAD SCI USA, V101, P12946, DOI 10.1073/pnas.0404280101; Zhang ZB, 2002, MOL CELL BIOL, V22, P7993, DOI 10.1128/MCB.22.22.7993-8004.2002; Zhang ZB, 2008, BIOL REPROD, V79, P75, DOI 10.1095/biolreprod.107.066308; Zhang ZB, 2009, P NATL ACAD SCI USA, V106, P17055, DOI 10.1073/pnas.0906414106	48	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39846	10.1371/journal.pone.0039846	http://dx.doi.org/10.1371/journal.pone.0039846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768142	Green Published, gold			2022-12-27	WOS:000305892100111
J	Cleto, S; Matos, S; Kluskens, L; Vieira, MJ				Cleto, Sara; Matos, Sonia; Kluskens, Leon; Vieira, Maria Joao			Characterization of Contaminants from a Sanitized Milk Processing Plant	PLOS ONE			English	Article							SERRATIA-PLYMUTHICA; PASTEURIZED MILK; DAIRY; BIOFILM; BACTERIA; COMPONENT; MULTIPLE; INDUSTRY; REMOVAL; SPP.	Milk processing lines offer a wide variety of microenvironments where a diversity of microorganisms can proliferate. We sampled crevices and junctions where, due to deficient reach by typical sanitizing procedures, bacteria can survive and establish biofilms. The sampling sites were the holding cell, cold storage tank, pasteurizer and storage tank - transfer pump junction. The culturable bacteria that were isolated after the sanitation procedure were predominantly Pseudomonas spp., Serratia spp, Staphylococcus sciuri and Stenotrophomonas maltophilia. We assayed several phenotypic characteristics such as the ability to secrete enzymes and siderophores, as well as the capacity of the strains to form biofilms that might contribute to their survival in a mixed species environment. The Pseudomonas spp. isolates were found to either produce proteases or lecithinases at high levels. Interestingly, protease production showed an inverse correlation with siderophore production. Furthermore, all of the Serratia spp. isolates were strong biofilm formers and spoilage enzymes producers. The organisms identified were not mere contaminants, but also producers of proteins with the potential to lower the quality and shelf-life of milk. In addition, we found that a considerable number of the Serratia and Pseudomonas spp. isolated from the pasteurizer were capable of secreting compounds with antimicrobial properties.	[Cleto, Sara; Matos, Sonia; Kluskens, Leon; Vieira, Maria Joao] Univ Minho, Ctr Biol Engn, IBB, Braga, Portugal	Universidade do Minho	Cleto, S (corresponding author), Univ Minho, Ctr Biol Engn, IBB, Campus Gualtar, Braga, Portugal.	sara.cleto@deb.uminho.pt	Kluskens, Leon/J-3019-2013	Kluskens, Leon/0000-0002-0070-7837; Vieira, Maria Joao/0000-0002-1379-890X; Cleto, Sara/0000-0003-1273-0142	Portuguese Foundation for Science and Technology [CHEMBIO-PTDC/EBB-EBI/104263/2008, SFRH/BD/38298/2007]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	The authors acknowledge the financial support provided by the Portuguese Foundation for Science and Technology (www.fct.pt): Project CHEMBIO-PTDC/EBB-EBI/104263/2008; Ph.D grant SFRH/BD/38298/2007 to SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS BW, 1983, J HYG-CAMBRIDGE, V91, P479, DOI 10.1017/S0022172400060526; Aguilar C, 2007, CURR OPIN MICROBIOL, V10, P638, DOI 10.1016/j.mib.2007.09.006; Almeida C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014786; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Andrews SC, 1998, ADV MICROB PHYSIOL, V40, P281, DOI 10.1016/S0065-2911(08)60134-4; AUSTIN JW, 1995, J DAIRY RES, V62, P509, DOI 10.1017/S0022029900031204; Banning N, 2003, MICROBIOL-SGM, V149, P47, DOI 10.1099/mic.0.25938-0; Bore E, 2005, J APPL MICROBIOL, V98, P96, DOI 10.1111/j.1365-2672.2004.02436.x; Bush K, 2009, 29 CLIN LAB STAND I, P29; Coffey A, 1996, APPL ENVIRON MICROB, V62, P1252, DOI 10.1128/AEM.62.4.1252-1256.1996; Dogan B, 2003, APPL ENVIRON MICROB, V69, P130, DOI 10.1128/AEM.69.1.130-138.2003; Eneroth A, 2000, INT DAIRY J, V10, P325, DOI 10.1016/S0958-6946(00)00055-8; Eneroth A, 1998, INT DAIRY J, V8, P829, DOI 10.1016/S0958-6946(98)00123-X; Epstein AK, 2011, P NATL ACAD SCI USA, V108, P995, DOI 10.1073/pnas.1011033108; ESSELMANN M, 1961, J BACTERIOL, V81, P939, DOI 10.1128/JB.81.6.939-945.1961; INGLIS TJJ, 1989, J CLIN MICROBIOL, V27, P2014, DOI 10.1128/JCM.27.9.2014-2018.1989; Kagkli DM, 2007, INT J FOOD MICROBIOL, V114, P243, DOI 10.1016/j.ijfoodmicro.2006.09.016; Latorre AA, 2010, J DAIRY SCI, V93, P2792, DOI 10.3168/jds.2009-2717; LIU PV, 1964, J BACTERIOL, V88, P1421, DOI 10.1128/JB.88.5.1421-1427.1964; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; MAGWOOD SE, 1967, CAN J COMPARAT MED, V31, P88; Meyer B, 2003, INT BIODETER BIODEGR, V51, P249, DOI 10.1016/S0964-8305(03)00047-7; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Moons P, 2006, APPL ENVIRON MICROB, V72, P7294, DOI 10.1128/AEM.01708-06; Mortimore S. E., 2001, HACCP; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Sabour PM, 2004, J CLIN MICROBIOL, V42, P3449, DOI 10.1128/JCM.42.8.3449-3455.2004; Salustiano VC, 2009, FOOD CONTROL, V20, P439, DOI 10.1016/j.foodcont.2008.07.004; Schlegelova J, 2010, CZECH J FOOD SCI, V28, P450, DOI 10.17221/65/2009-CJFS; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sharma M, 2002, FOOD CONTROL, V13, P469, DOI 10.1016/S0956-7135(01)00068-8; Sharma M, 2002, FOOD MICROBIOL, V19, P627, DOI 10.1006/fmic.2002.0472; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; STEVENS MG, 1993, J IMMUNOL METHODS, V157, P225, DOI 10.1016/0022-1759(93)90091-K; Tang X, 2009, J APPL MICROBIOL, V107, P443, DOI 10.1111/j.1365-2672.2009.04214.x; Van Houdt R, 2005, FEMS MICROBIOL LETT, V246, P265, DOI 10.1016/j.femsle.2005.04.016; WHITTAKER C, 1984, APPL ENVIRON MICROB, V48, P395, DOI 10.1128/AEM.48.2.395-403.1984; WILLIAMS HN, 1995, J AM DENT ASSOC, V126, P1255, DOI 10.14219/jada.archive.1995.0360; Zhao T, 2006, APPL ENVIRON MICROB, V72, P3314, DOI 10.1128/Aem.72.5.3314-3320.2006	42	56	56	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e40189	10.1371/journal.pone.0040189	http://dx.doi.org/10.1371/journal.pone.0040189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761957	Green Published, gold, Green Submitted			2022-12-27	WOS:000305826400058
J	Colizoli, O; Murre, JMJ; Rouw, R				Colizoli, Olympia; Murre, Jaap M. J.; Rouw, Romke			Pseudo-Synesthesia through Reading Books with Colored Letters	PLOS ONE			English	Article							BRAIN STRUCTURE CHANGES; INDIVIDUAL-DIFFERENCES; NEURAL BASIS; GRAY-MATTER; SYNAESTHESIA; INTERFERENCE; ASSOCIATIONS; PERCEPTION; ACTIVATION; FREQUENCY	Background: Synesthesia is a phenomenon where a stimulus produces consistent extraordinary subjective experiences. A relatively common type of synesthesia involves perception of color when viewing letters (e.g. the letter 'a' always appears as light blue). In this study, we examine whether traits typically regarded as markers of synesthesia can be acquired by simply reading in color. Methodology/Principal Findings: Non-synesthetes were given specially prepared colored books to read. A modified Stroop task was administered before and after reading. A perceptual crowding task was administered after reading. Reading one book (>49,000 words) was sufficient to induce effects regarded as behavioral markers for synesthesia. The results of the Stroop tasks indicate that it is possible to learn letter-color associations through reading in color (F(1, 14) = 5.85, p = .030). Furthermore, Stroop effects correlated with subjective reports about experiencing letters in color (r(13) = 0.51, p = .05). The frequency of viewing letters is related to the level of association as seen by the difference in the Stroop effect size between upper-and lower-case letters (t(14) = 2.79, p = .014) and in a subgroup of participants whose Stroop effects increased as they continued to read in color. Readers did not show significant performance advantages on the crowding task compared to controls. Acknowledging the many differences between trainees and synesthetes, results suggest that it may be possible to acquire a subset of synesthetic behavioral traits in adulthood through training. Conclusion/Significance: To our knowledge, this is the first evidence of acquiring letter-color associations through reading in color. Reading in color appears to be a promising avenue in which we may explore the differences and similarities between synesthetes and non-synesthetes. Additionally, reading in color is a plausible method for a long-term 'synesthetic' training program.	[Colizoli, Olympia; Murre, Jaap M. J.; Rouw, Romke] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands	University of Amsterdam	Colizoli, O (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	o.colizoli@uva.nl	Murre, Jaap MJ/A-3813-2010	Colizoli, Olympia/0000-0001-5288-2437; Murre, Jaap/0000-0003-4447-9482	Department of Psychology, University of Amsterdam	Department of Psychology, University of Amsterdam	This research was supported by the Department of Psychology, University of Amsterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher JE, 2009, AM J HUM GENET, V84, P279, DOI 10.1016/j.ajhg.2009.01.012; Barnett KJ, 2008, COGNITION, V106, P871, DOI 10.1016/j.cognition.2007.05.003; BARONCOHEN S, 1987, PERCEPTION, V16, P761, DOI 10.1068/p160761; Beeli G, 2007, PSYCHOL SCI, V18, P788, DOI 10.1111/j.1467-9280.2007.01980.x; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Brang D, 2011, J COGNITIVE NEUROSCI, V23, P1681, DOI 10.1162/jocn.2010.21486; Chomsky N., 1957, SYNTACTIC STRUCTURES; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Cytowic R. E., 2002, SYNESTHESIA UNION SE; Dixon MJ, 2004, COGN AFFECT BEHAV NE, V4, P335, DOI 10.3758/CABN.4.3.335; Dixon MJ, 2000, NATURE, V406, P365, DOI 10.1038/35019148; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Elias LJ, 2003, COGNITIVE BRAIN RES, V16, P232, DOI 10.1016/S0926-6410(02)00278-1; Galton F, 1880, SYNAESTHESIA CLASSIC, P43; Grainger J, 2004, TRENDS COGN SCI, V8, P58, DOI 10.1016/j.tics.2003.11.006; Green JAK, 2008, COGNITION, V106, P463, DOI 10.1016/j.cognition.2007.01.013; Hanggi J, 2008, NEUROIMAGE, V43, P192, DOI 10.1016/j.neuroimage.2008.07.018; Halliday M. A. K., 1975, EXPLORATIONS FUNCTIO; Hancock P, 2006, CORTEX, V42, P147, DOI 10.1016/S0010-9452(08)70338-1; Hubbard EM, 2005, NEURON, V48, P509, DOI 10.1016/j.neuron.2005.10.012; Hubbard EM, 2005, NEURON, V45, P975, DOI 10.1016/j.neuron.2005.02.008; Jancke L, 2009, EUR J NEUROSCI, V29, P1287, DOI 10.1111/j.1460-9568.2009.06673.x; Kadosh RC, 2005, J COGNITIVE NEUROSCI, V17, P1766, DOI 10.1162/089892905774589181; Kwok V, 2011, P NATL ACAD SCI USA, V108, P6686, DOI 10.1073/pnas.1103217108; MACLEOD CM, 1988, J EXP PSYCHOL LEARN, V14, P126, DOI 10.1037/0278-7393.14.1.126; Mattingley JB, 2001, NATURE, V410, P580, DOI 10.1038/35069062; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; Meier B, 2009, NEUROPSYCHOLOGIA, V47, P1208, DOI 10.1016/j.neuropsychologia.2009.01.009; Nunn JA, 2002, NAT NEUROSCI, V5, P371, DOI 10.1038/nn818; Palmeri TJ, 2002, P NATL ACAD SCI USA, V99, P4127, DOI 10.1073/pnas.022049399; Pelli DG, 2004, J VISION, P4; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Ramachandran VS, 2001, P ROY SOC B-BIOL SCI, V268, P979, DOI 10.1098/rspb.2000.1576; Rich AN, 2005, COGNITION, V98, P53, DOI 10.1016/j.cognition.2004.11.003; Rothen N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005037; Rouw R, 2007, NAT NEUROSCI, V10, P792, DOI 10.1038/nn1906; Rouw R, 2011, J NEUROPSYCHOL, V5, P214, DOI 10.1111/j.1748-6653.2011.02006.x; Rouw R, 2010, J NEUROSCI, V30, P6205, DOI 10.1523/JNEUROSCI.3444-09.2010; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Simner J, 2005, COGN NEUROPSYCHOL, V22, P1069, DOI 10.1080/02643290500200122; Simner J, 2006, PERCEPTION, V35, P1024, DOI 10.1068/p5469; Simner J, 2012, BRIT J PSYCHOL, V103, P1, DOI 10.1348/000712610X528305; Simner J, 2009, BRAIN, V132, P57, DOI 10.1093/brain/awn292; Smilek D, 2005, NEUROCASE, V11, P363, DOI 10.1080/13554790500205413; Smilek D, 2002, PSYCHOL SCI, V13, P548, DOI 10.1111/1467-9280.00496; Smilek D, 2001, J COGNITIVE NEUROSCI, V13, P930, DOI 10.1162/089892901753165845; Smilek D, 2007, PSYCHOL SCI, V18, P793, DOI 10.1111/j.1467-9280.2007.01981.x; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tang YY, 2010, P NATL ACAD SCI USA, V107, P15649, DOI 10.1073/pnas.1011043107; Wagner K, 2011, PSYCHOL SCI, V22, P1067, DOI 10.1177/0956797611416250; Weiss PH, 2009, BRAIN, V132, P65, DOI 10.1093/brain/awn304; Witthoft N, 2006, CORTEX, V42, P175, DOI 10.1016/S0010-9452(08)70342-3; Wollen KA, 1983, J MENT IMAG, V7, P83; Yaro C, 2007, Q J EXP PSYCHOL, V60, P681, DOI 10.1080/17470210600785208	56	31	32	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39799	10.1371/journal.pone.0039799	http://dx.doi.org/10.1371/journal.pone.0039799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966GL	22761905	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800071
J	Jourdan, C; Petersen, AK; Gieger, C; Doring, A; Illig, T; Wang-Sattler, R; Meisinger, C; Peters, A; Adamski, J; Prehn, C; Suhre, K; Altmaier, E; Kastenmuller, G; Romisch-Margl, W; Theis, FJ; Krumsiek, J; Wichmann, HE; Linseisen, J				Jourdan, Carolin; Petersen, Ann-Kristin; Gieger, Christian; Doering, Angela; Illig, Thomas; Wang-Sattler, Rui; Meisinger, Christa; Peters, Annette; Adamski, Jerzy; Prehn, Cornelia; Suhre, Karsten; Altmaier, Elisabeth; Kastenmueller, Gabi; Romisch-Margl, Werner; Theis, Fabian J.; Krumsiek, Jan; Wichmann, H. -Erich; Linseisen, Jakob			Body Fat Free Mass Is Associated with the Serum Metabolite Profile in a Population-Based Study	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; METABOLOMICS; CONSUMPTION; PHENOTYPES; EQUATION	Objective: To characterise the influence of the fat free mass on the metabolite profile in serum samples from participants of the population-based KORA (Cooperative Health Research in the Region of Augsburg) S4 study. Subjects and Methods: Analyses were based on metabolite profile from 965 participants of the S4 and 890 weight-stable subjects of its seven-year follow-up study (KORA F4). 190 different serum metabolites were quantified in a targeted approach including amino acids, acylcarnitines, phosphatidylcholines (PCs), sphingomyelins and hexose. Associations between metabolite concentrations and the fat free mass index (FFMI) were analysed using adjusted linear regression models. To draw conclusions on enzymatic reactions, intra-metabolite class ratios were explored. Pairwise relationships among metabolites were investigated and illustrated by means of Gaussian graphical models (GGMs). Results: We found 339 significant associations between FFMI and various metabolites in KORA S4. Among the most prominent associations (p-values 4.75 x 10(-16) -8.95 x 10(-06)) with higher FFMI were increasing concentrations of the branched chained amino acids (BCAAs), ratios of BCAAs to glucogenic amino acids, and carnitine concentrations. For various PCs, a decrease in chain length or in saturation of the fatty acid moieties could be observed with increasing FFMI, as well as an overall shift from acyl-alkyl PCs to diacyl PCs. These findings were reproduced in KORA F4. The established GGMs supported the regression results and provided a comprehensive picture of the relationships between metabolites. In a sub-analysis, most of the discovered associations did not exist in obese subjects in contrast to non-obese subjects, possibly indicating derangements in skeletal muscle metabolism. Conclusion: A set of serum metabolites strongly associated with FFMI was identified and a network explaining the relationships among metabolites was established. These results offer a novel and more complete picture of the FFMI effects on serum metabolites in a data-driven network.	[Jourdan, Carolin; Doering, Angela; Wichmann, H. -Erich; Linseisen, Jakob] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Petersen, Ann-Kristin; Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Meisinger, Christa; Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Illig, Thomas; Wang-Sattler, Rui] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Adamski, Jerzy; Prehn, Cornelia] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Expt Genet, Genome Anal Ctr, Neuherberg, Germany; [Adamski, Jerzy] Tech Univ Munich, Chair Expt Genet, Munich, Germany; [Suhre, Karsten; Altmaier, Elisabeth; Kastenmueller, Gabi; Romisch-Margl, Werner; Theis, Fabian J.; Krumsiek, Jan] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Suhre, Karsten] Weill Cornell Med Coll, Dept Physiol & Biophys, Educ City, Qatar; [Wichmann, H. -Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, Neuherberg, Germany; [Wichmann, H. -Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Munich; University of Munich	Jourdan, C (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany.	j.linseisen@helmholtz-muenchen.de	Suhre, Karsten/AAF-1778-2020; Meisinger, Christine/B-5358-2014; Krumsiek, Jan/B-3961-2013; Linseisen, Jakob/B-5353-2014; Peters, Annette/A-6117-2011; Wichmann, Heinz Erich/AAA-5695-2022; Wang-Sattler, Rui/B-5354-2014; Theis, Fabian J/ABD-5212-2021; Kastenmüller, Gabi/ABF-5987-2020	Suhre, Karsten/0000-0001-9638-3912; Linseisen, Jakob/0000-0002-9386-382X; Peters, Annette/0000-0001-6645-0985; Wang-Sattler, Rui/0000-0002-8794-8229; Theis, Fabian J/0000-0002-2419-1943; Kastenmuller, Gabi/0000-0002-2368-7322; Meisinger, Christa/0000-0002-9026-6544; Gieger, Christian/0000-0001-6986-9554; Adamski, Jerzy/0000-0001-9259-0199; Prehn, Cornelia/0000-0002-1274-4715	German Federal Ministry of Education and Research (BMBF); Helmholtz Zentrum Munchen - German Research Centre for Environmental Health; BMBF; State of Bavaria; German National Genome Research Network (NGFN)	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Helmholtz Zentrum Munchen - German Research Centre for Environmental Health(Helmholtz Association); BMBF(Federal Ministry of Education & Research (BMBF)); State of Bavaria; German National Genome Research Network (NGFN)	This study was supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Centre Diabetes Research (DZD e.V.). The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen - German Research Centre for Environmental Health, which is funded by the BMBF and by the State of Bavaria. Part of this work was financed by the German National Genome Research Network (NGFN). No additional sources of funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmaier E, 2008, ENDOCRINOLOGY, V149, P3478, DOI 10.1210/en.2007-1747; Altmaier E, 2011, EUR J EPIDEMIOL, V26, P145, DOI 10.1007/s10654-010-9524-7; Altmaier E, 2009, MOL NUTR FOOD RES, V53, P1357, DOI 10.1002/mnfr.200900116; Assfalg M, 2008, P NATL ACAD SCI USA, V105, P1420, DOI 10.1073/pnas.0705685105; Dumas ME, 2007, NAT GENET, V39, P666, DOI 10.1038/ng2026; FDA, 2018, BIOANALYTICAL METHOD; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Krumsiek J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-21; Kyle UG, 2003, CLIN NUTR, V22, P537, DOI 10.1016/S0261-5614(03)00048-7; Kyle UG, 2003, NUTRITION, V19, P597, DOI 10.1016/S0899-9007(03)00061-3; Kyle UG, 2001, NUTRITION, V17, P248, DOI 10.1016/S0899-9007(00)00553-0; Layman DK, 2003, J NUTR, V133, p261S, DOI 10.1093/jn/133.1.261S; Layman DK, 2006, J NUTR, V136, p319S, DOI 10.1093/jn/136.1.319S; Lewis GD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001006; Nimptsch K, 2010, PUBLIC HEALTH NUTR, V13, P1636, DOI 10.1017/S1368980009993041; Pedersen Bente Klarlund, 2011, J Exp Biol, V214, P337, DOI 10.1242/jeb.048074; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Romisch-Margl W, 2012, METABOLOMICS, V8, P133, DOI 10.1007/s11306-011-0293-4; RUDERMAN NB, 1975, ANNU REV MED, V26, P245, DOI 10.1146/annurev.me.26.020175.001333; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Tom A, 2006, J NUTR, V136, p324S, DOI 10.1093/jn/136.1.324S; Vinayavekhin N, 2009, ACS CHEM BIOL, V4, P617, DOI 10.1021/cb900075n; Wang-Sattler R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003863; Watson AD, 2006, J LIPID RES, V47, P2101, DOI 10.1194/jlr.R600022-JLR200; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776	28	80	82	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e40009	10.1371/journal.pone.0040009	http://dx.doi.org/10.1371/journal.pone.0040009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761945	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800087
J	Zhang, QP; Wang, FY; Zeng, D; Wang, T				Zhang, Qingpeng; Wang, Fei-Yue; Zeng, Daniel; Wang, Tao			Understanding Crowd-Powered Search Groups: A Social Network Perspective	PLOS ONE			English	Article							SCIENTIFIC COLLABORATION; WEB	Background: Crowd-powered search is a new form of search and problem solving scheme that involves collaboration among a potentially large number of voluntary Web users. Human flesh search (HFS), a particular form of crowd-powered search originated in China, has seen tremendous growth since its inception in 2001. HFS presents a valuable test-bed for scientists to validate existing and new theories in social computing, sociology, behavioral sciences, and so forth. Methodology: In this research, we construct an aggregated HFS group, consisting of the participants and their relationships in a comprehensive set of identified HFS episodes. We study the topological properties and the evolution of the aggregated network and different sub-groups in the network. We also identify the key HFS participants according to a variety of measures. Conclusions: We found that, as compared with other online social networks, HFS participant network shares the power-law degree distribution and small-world property, but with a looser and more distributed organizational structure, leading to the diversity, decentralization, and independence of HFS participants. In addition, the HFS group has been becoming increasingly decentralized. The comparisons of different HFS sub-groups reveal that HFS participants collaborated more often when they conducted the searches in local platforms or the searches requiring a certain level of professional knowledge background. On the contrary, HFS participants did not collaborate much when they performed the search task in national platforms or the searches with general topics that did not require specific information and learning. We also observed that the key HFS information contributors, carriers, and transmitters came from different groups of HFS participants.	[Zhang, Qingpeng; Wang, Fei-Yue; Zeng, Daniel] Chinese Acad Sci, State Key Lab Management & Control Complex Syst, Beijing, Peoples R China; [Zhang, Qingpeng] Univ Arizona, Dept Syst & Ind Engn, Tucson, AZ 85721 USA; [Zeng, Daniel] Univ Arizona, Dept Management Informat Syst, Tucson, AZ 85721 USA; [Wang, Tao] Natl Univ Def Technol, Res Ctr Computat Expt & Parallel Syst, Changsha, Hunan, Peoples R China	Chinese Academy of Sciences; University of Arizona; University of Arizona; National University of Defense Technology - China	Zhang, QP (corresponding author), Chinese Acad Sci, State Key Lab Management & Control Complex Syst, Beijing, Peoples R China.	qpzhang@email.arizona.edu	Zhang, Qingpeng/D-4682-2011; Zeng, Daniel/B-5888-2013	Zhang, Qingpeng/0000-0002-6819-0686; 	National Natural Science Foundation of China [90924302, 91024030, 71025001, 70890084, 60921061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) under grants 90924302, 91024030, 71025001, 70890084, and 60921061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ahn YY, 2007, P 16 INT C WORLD WID, DOI [DOI 10.1145/1242572.1242685, 10.1145/1242572.1242685]; [Anonymous], 2011, P 20 INT C WORLD WID, DOI DOI 10.1145/1963405.1963508; Bird C, 2006, P 2006 INT WORKSHOP, P137, DOI [DOI 10.1145/1137983.1138016, 10.1145/1137983.1138016]; Blogpulse, 2006, 3 ANN WORKSH WEBL EC; Bordons M, 1996, SCIENTOMETRICS, V37, P279, DOI 10.1007/BF02093625; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; Chi EH, 2009, COMPUTER, V42, P42, DOI 10.1109/MC.2009.87; Chmiel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022207; Doan A, 2011, COMMUN ACM, V54, P86, DOI 10.1145/1924421.1924442; Farahat A, 2006, SIAM J SCI COMPUT, V27, P1181, DOI 10.1137/S1064827502412875; Fu F, 2008, PHYSICA A, V387, P675, DOI 10.1016/j.physa.2007.10.006; Goetz M., 2009, P 3 INT C WEBL SOC M, P26; Goh K-I, 2008, PHYS REV E, V67; Grujic J, 2009, 2009 16TH INTERNATIONAL CONFERENCE ON DIGITAL SIGNAL PROCESSING, VOLS 1 AND 2, P259; Ha J., 2011, 2011 ACM S APPL COMP, P773; Howe J., 2006, WIRED MAG, V14, P1; Java Akshay, 2007, P JOINT 9 WEBKDD 1 S, P56, DOI 10.1145/1348549.1348556; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Kolari P, 2004, INT C WEBL SOC MED I, P113; Kumar R, 2004, COMMUN ACM, V47, P35, DOI 10.1145/1035134.1035162; Kumar R, 2002, COMPUTER, V35, P32, DOI 10.1109/MC.2002.1046971; Kumar R., 2006, P 12 ACM SIGKDD INT, P611; Kwak H., 2010, WEB C 2010 P WORLD W, P591; Leskovec J., 2010, P 19 INT C WORLD WID, P641, DOI [10.1145/1772690.1772756, DOI 10.1145/1772690.1772756]; Leskovec J., 2005, P 11 ACM SIGKDD INT, P177, DOI 10.1145/1081870.1081893; Leskovec J, 2007, PROCEEDINGS OF THE SEVENTH SIAM INTERNATIONAL CONFERENCE ON DATA MINING, P551; Liaoruo Wang, 2011, Proceedings of the 2011 IEEE 11th International Conference on Data Mining (ICDM 2011), P784, DOI 10.1109/ICDM.2011.48; Liu XM, 2005, INFORM PROCESS MANAG, V41, P1462, DOI 10.1016/j.ipm.2005.03.012; McKelvey M, 2003, RES POLICY, V32, P483, DOI 10.1016/S0048-7333(02)00020-3; Mitrovic M, 2010, EUR PHYS J B, V77, P597, DOI 10.1140/epjb/e2010-00279-x; Mitrovic M, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/02/P02005; Mitrovic M, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026123; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Page L, 1999, PAGERANK CITATION RA, DOI DOI 10.1109/IISWC.2012.6402911; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Sai H., 2011, Proceedings of the 11th IEEE/IPSJ International Symposium on Applications and the Internet (SAINT 2011), P592, DOI 10.1109/SAINT.2011.108; Shi X, 2007, INT C WEBL SOC MED I, P153; Shi XL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006547; Soffer SN, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.057101; Surowiecki James, 2004, WISDOM CROWDS WHY MA; Valente Thomas W, 2008, Connect (Tor), V28, P16; Wang B, 2009, IEEE ACM DIS SIM, P82, DOI 10.1109/DS-RT.2009.36; Wang F-Y, 2010, CHINESE HUMAN FLESH; Wang FY, 2010, COMPUTER, V43, P45, DOI 10.1109/MC.2010.216; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; ZALD MN, 1966, SOC FORCES, V44, P327, DOI 10.2307/2575833; Zhang J., 2007, P 16 INT C WORLD WID, P221, DOI DOI 10.1145/1242572.1242603; Zhang Q, 2011, SOCIAL NETWORK ANAL; Zhang Q. P., 2010, 2 CHIN C SOC COMP BE; Zhang QP, 2010, IEEE INTELL SYST, V25, P67, DOI 10.1109/MIS.2010.136; Zlatic V, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016115	54	15	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39749	10.1371/journal.pone.0039749	http://dx.doi.org/10.1371/journal.pone.0039749			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966GL	22761888	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800065
J	Tiberio, P; Cavadini, E; Callari, M; Daidone, MG; Appierto, V				Tiberio, Paola; Cavadini, Elena; Callari, Maurizio; Daidone, Maria Grazia; Appierto, Valentina			AF1q: A Novel Mediator of Basal and 4-HPR-Induced Apoptosis in Ovarian Cancer Cells	PLOS ONE			English	Article							FENRETINIDE-INDUCED APOPTOSIS; ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; CARCINOMA CELLS; BREAST-CANCER; FUNCTIONAL-ROLE; ONCOGENE AF1Q; MECHANISMS; INDUCTION; PATHWAY	Background: Fenretinide (4-HPR) is a synthetic retinoid that exhibits potent antitumor and chemopreventive activities against different malignancies, including ovarian tumors. We previously showed that in ovarian cancer cells, 4-HPR induces apoptosis through a signaling cascade starting from reactive oxygen species (ROS) generation and involving endoplasmic reticulum (ER) stress response, Jun N-terminal Kinase (JNK) activation, and induction of the proapoptotic PLAcental Bone morphogenetic protein (PLAB). Since recent studies have shown that the oncogene ALL1-fused from chromosome 1q (AF1q), a retinoic acid target gene, is implicated in apoptosis induction by several therapeutic agents, we investigated its possible involvement in the apoptosis induced by 4-HPR in ovarian cancer cells. Methodology/Principal Findings: Protein expression analysis, performed in ovarian cancer cells and extended to other histotypes (breast, neuroblastoma, and cervical), revealed that 4-HPR enhanced AF1q expression in cancer cells sensitive to the retinoid but not in resistant cells. Through gene silencing, AF1q was found functionally involved in 4-HPR-induced apoptosis in A2780, an ovarian cancer cell line highly sensitive to retinoid growth inhibitory and apoptotic effects. Inhibition of the signaling intermediates of the 4-HPR apoptotic cascade showed that AF1q upregulation was depended on prior generation of ROS, induction of ER stress response, JNK activation, and PLAB upmodulation. Finally, we found that direct overexpression of AF1q, in the absence of external stimuli, increased apoptosis in ovarian cancer cell lines. Conclusions/Significance: The study expands the knowledge of the 4-HPR mechanism of action, which has not yet been completely elucidated, identifying AF1q as a novel mediator of retinoid anticancer activity. In addition, we demonstrate, for the first time, that AF1q plays a role in the onset of basal apoptosis in ovarian cancer cells, thus providing new information about the activity of this protein whose biologic functions are mostly unknown.	[Tiberio, Paola; Cavadini, Elena; Callari, Maurizio; Daidone, Maria Grazia; Appierto, Valentina] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan	Tiberio, P (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy.	paola.tiberio@istitutotumori.mi.it	Daidone, Maria Grazia/E-9232-2017; Callari, Maurizio/AAF-7089-2019; Appierto, Valentina/B-9325-2017	Daidone, Maria Grazia/0000-0002-4786-1321; Callari, Maurizio/0000-0001-5239-0918; Appierto, Valentina/0000-0002-8726-6981	Fondazione IRCCS Istituto Nazionale Tumori	Fondazione IRCCS Istituto Nazionale Tumori	This study was funded by funds from Italian citizens who allocated the 5x1000 share of their tax payment in support of the Fondazione IRCCS Istituto Nazionale Tumori, according to Italian laws (INT-Institutional strategic projects '5x1000'; www.lavoro.gov.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appierto V, 2007, ONCOGENE, V26, P3952, DOI 10.1038/sj.onc.1210171; Appierto V, 2004, CELL DEATH DIFFER, V11, P270, DOI 10.1038/sj.cdd.4401349; Appierto V, 2001, BRIT J CANCER, V84, P1528, DOI 10.1054/bjoc.2001.1826; Appierto V, 2009, CARCINOGENESIS, V30, P824, DOI 10.1093/carcin/bgp067; Bushue N, 2010, ADV DRUG DELIVER REV, V62, P1285, DOI 10.1016/j.addr.2010.07.003; Chang XZ, 2008, BREAST CANCER RES TR, V111, P65, DOI 10.1007/s10549-007-9761-y; Chiesa F, 2005, INT J CANCER, V115, P625, DOI 10.1002/ijc.20923; Co NN, 2008, MOL CANCER THER, V7, P3160, DOI 10.1158/1535-7163.MCT-08-0416; Co NN, 2010, ONCOL REP, V24, P547, DOI 10.3892/or_00000891; De Palo G, 2002, GYNECOL ONCOL, V86, P24, DOI 10.1006/gyno.2002.6663; Dmitrovsky E, 2004, J NATL CANCER I, V96, P1264, DOI 10.1093/jnci/djh268; Garattini E, 2004, CURR PHARM DESIGN, V10, P433, DOI 10.2174/1381612043453351; Garaventa A, 2003, CLIN CANCER RES, V9, P2032; Hail N, 2006, APOPTOSIS, V11, P1677, DOI 10.1007/s10495-006-9289-3; Huang HL, 2003, ONCOGENE, V22, P8168, DOI 10.1038/sj.onc.1206979; Jacques C, 2005, J CLIN ENDOCR METAB, V90, P2314, DOI 10.1210/jc.2004-1337; Kuznetsov AV, 2011, BBA-MOL CELL RES, V1813, P1144, DOI 10.1016/j.bbamcr.2011.03.002; Li DQ, 2006, EUR J CANCER, V42, P3274, DOI 10.1016/j.ejca.2006.07.008; Liu T, 2005, BRIT J CANCER, V93, P310, DOI 10.1038/sj.bjc.6602700; Ma Y, 2003, ONCOGENE, V22, P4924, DOI 10.1038/sj.onc.1206728; Mimeault M, 2010, J CELL PHYSIOL, V224, P626, DOI 10.1002/jcp.22196; Mukhopadhyay P, 2009, AM J PHYSIOL-HEART C, V296, pH1466, DOI 10.1152/ajpheart.00795.2008; Nagy L, 1998, CELL DEATH DIFFER, V5, P11, DOI 10.1038/sj.cdd.4400337; Parcelier A, 2011, BLOOD, V118, P1784, DOI 10.1182/blood-2011-01-333179; Schneider BJ, 2009, INVEST NEW DRUG 0219; Skotheim RI, 2006, CELL ONCOL, V28, P315; Sogno I, 2010, CRIT REV ONCOL HEMAT, V75, P2, DOI 10.1016/j.critrevonc.2009.10.007; Strunk CJ, 2009, AM J HEMATOL, V84, P308, DOI 10.1002/ajh.21396; Supino R, 1996, INT J CANCER, V65, P491, DOI 10.1002/(SICI)1097-0215(19960208)65:4<491::AID-IJC17>3.0.CO;2-D; Tiberio P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013362; Tse W, 2005, BRIT J HAEMATOL, V128, P218, DOI 10.1111/j.1365-2141.2004.05306.x; Tse W, 2004, BLOOD, V104, P3058, DOI 10.1182/blood-2003-12-4347; TSE W, 1995, BLOOD, V85, P650, DOI 10.1182/blood.V85.3.650.bloodjournal853650; Veronesi U, 2006, ANN ONCOL, V17, P1065, DOI 10.1093/annonc/mdl047; Villani MG, 2006, CANCER RES, V66, P3238, DOI 10.1158/0008-5472.CAN-05-3362; Villani MG, 2004, CLIN CANCER RES, V10, P6265, DOI 10.1158/1078-0432.CCR-04-0655; Xiong Y, 2011, BRIT J HAEMATOL, V153, P753, DOI 10.1111/j.1365-2141.2011.08662.x	37	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39968	10.1371/journal.pone.0039968	http://dx.doi.org/10.1371/journal.pone.0039968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761939	Green Submitted, Green Published, gold			2022-12-27	WOS:000305808700055
J	Zhang, ZY; Ye, WM; Qian, Y; Zheng, ZG; Huang, XH; Hu, G				Zhang, Zhaoyang; Ye, Weiming; Qian, Yu; Zheng, Zhigang; Huang, Xuhui; Hu, Gang			Chaotic Motifs in Gene Regulatory Networks	PLOS ONE			English	Article							NEGATIVE FEEDBACK LOOPS; BELOUSOV-ZHABOTINSKY REACTION; PEROXIDASE-OXIDASE REACTION; DETERMINISTIC CHAOS; ESCHERICHIA-COLI; COMPLEX DYNAMICS; BUILDING-BLOCKS; TIM PROTEINS; MODEL; OSCILLATIONS	Chaos should occur often in gene regulatory networks (GRNs) which have been widely described by nonlinear coupled ordinary differential equations, if their dimensions are no less than 3. It is therefore puzzling that chaos has never been reported in GRNs in nature and is also extremely rare in models of GRNs. On the other hand, the topic of motifs has attracted great attention in studying biological networks, and network motifs are suggested to be elementary building blocks that carry out some key functions in the network. In this paper, chaotic motifs (subnetworks with chaos) in GRNs are systematically investigated. The conclusion is that: (i) chaos can only appear through competitions between different oscillatory modes with rivaling intensities. Conditions required for chaotic GRNs are found to be very strict, which make chaotic GRNs extremely rare. (ii) Chaotic motifs are explored as the simplest few-node structures capable of producing chaos, and serve as the intrinsic source of chaos of random few-node GRNs. Several optimal motifs causing chaos with atypically high probability are figured out. (iii) Moreover, we discovered that a number of special oscillators can never produce chaos. These structures bring some advantages on rhythmic functions and may help us understand the robustness of diverse biological rhythms. (iv) The methods of dominant phase-advanced driving (DPAD) and DPAD time fraction are proposed to quantitatively identify chaotic motifs and to explain the origin of chaotic behaviors in GRNs.	[Zhang, Zhaoyang; Ye, Weiming; Zheng, Zhigang; Huang, Xuhui; Hu, Gang] Beijing Normal Univ, Dept Phys, Beijing 100875, Peoples R China; [Ye, Weiming] Beijing Normal Univ, Sch Management, Beijing 100875, Peoples R China; [Qian, Yu] Baoji Univ Arts & Sci, Nonlinear Res Inst, Baoji, Peoples R China	Beijing Normal University; Beijing Normal University; Baoji University of Arts & Sciences	Zhang, ZY (corresponding author), Beijing Normal Univ, Dept Phys, Beijing 100875, Peoples R China.	hxhoneness@gmail.com; ganghu@bnu.edu.cn	Qian, Yu/A-7862-2012	huang, xu hui/0000-0003-1477-9572; Zheng, Zhigang/0000-0002-1421-0442	National Natural Science Foundation of China [10975015, 11174034, 11105003]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China under Grant No. 10975015, 11174034 and 11105003 and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; BRONNIKOVA TV, 1995, J PHYS CHEM-US, V99, P9309, DOI 10.1021/j100023a001; DECROLY O, 1982, P NATL ACAD SCI-BIOL, V79, P6917, DOI 10.1073/pnas.79.22.6917; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Ferrell JE, 2011, CELL, V144, P874, DOI 10.1016/j.cell.2011.03.006; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Glass L., 1988, CLOCKS CHAOS RHYTHMS; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Goldbeter A, 2001, CHAOS, V11, P247, DOI 10.1063/1.1345727; Goldbeter A., 1996, BIOCH OSCILLATIONS C; GYORGYI L, 1992, NATURE, V355, P808, DOI 10.1038/355808a0; GYORGYI L, 1989, J CHEM PHYS, V91, P6131, DOI 10.1063/1.457432; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Hauser MJB, 1997, J PHYS CHEM B, V101, P5075, DOI 10.1021/jp9707549; Ishihara S, 2005, GENES CELLS, V10, P1025, DOI 10.1111/j.1365-2443.2005.00897.x; Kappler K, 2003, SIGNAL PROCESS, V83, P789, DOI 10.1016/S0165-1684(02)00479-6; Kobayashi Y, 2010, EUR PHYS J B, V76, P167, DOI 10.1140/epjb/e2010-00200-9; LARTER R, 1991, PHILOS T ROY SOC A, V337, P291, DOI 10.1098/rsta.1991.0124; Leloup JC, 1999, J THEOR BIOL, V198, P445, DOI 10.1006/jtbi.1999.0924; Leloup JC, 1998, J BIOL RHYTHM, V13, P70, DOI 10.1177/074873098128999934; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; OLSEN LF, 1977, NATURE, V267, P177, DOI 10.1038/267177a0; Otto ER, 1977, B MATH BIOL, V39, P275; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pigolotti S, 2007, P NATL ACAD SCI USA, V104, P6533, DOI 10.1073/pnas.0610759104; Pigolotti S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.088701; Qian Y, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036101; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Suguna C, 1999, PHYS REV E, V60, P5943, DOI 10.1103/PhysRevE.60.5943; Svetoslav N, 2009, CHAOS SOLITON FRACT, V42, P385; Tian XJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011926; Trosko James E., 1998, Frontiers in Bioscience, V3, pD208; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457; Ye WM, 2010, PHYS LETT A, V374, P2521, DOI 10.1016/j.physleta.2010.04.015; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101; Zhang DM, 1993, CHAOS, V3, P723, DOI 10.1063/1.165933; Zhigulin VP, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.238701	42	32	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39355	10.1371/journal.pone.0039355	http://dx.doi.org/10.1371/journal.pone.0039355			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792171	gold, Green Submitted, Green Published			2022-12-27	WOS:000306461800009
J	Friederich-Persson, M; Aslam, S; Nordquist, L; Welch, WJ; Wilcox, CS; Palm, F				Friederich-Persson, Malou; Aslam, Shakil; Nordquist, Lina; Welch, William J.; Wilcox, Christopher S.; Palm, Fredrik			Acute Knockdown of Uncoupling Protein-2 Increases Uncoupling via the Adenine Nucleotide Transporter and Decreases Oxidative Stress in Diabetic Kidneys	PLOS ONE			English	Article							SKELETAL-MUSCLE MITOCHONDRIA; PROXIMAL TUBULAR CELLS; PROTON CONDUCTANCE; ENDOTHELIAL-CELLS; OXYGEN; MEMBRANE; NEPHROPATHY; SUPEROXIDE; ISOFORMS; TRENDS	Increased O-2 metabolism resulting in chronic hypoxia is common in models of endstage renal disease. Mitochondrial uncoupling increases O-2 consumption but the ensuing reduction in mitochondrial membrane potential may limit excessive oxidative stress. The present study addressed the hypothesis that mitochondrial uncoupling regulates mitochondria function and oxidative stress in the diabetic kidney. Isolated mitochondria from kidney cortex of control and streptozotocin-induced diabetic rats were studied before and after siRNA knockdown of uncoupling protein-2 (UCP-2). Diabetes resulted in increased UCP-2 protein expression and UCP-2-mediated uncoupling, but normal mitochondria membrane potential. This uncoupling was inhibited by GDP, which also increased the membrane potential. siRNA reduced UCP-2 protein expression in controls and diabetics (-30-50%), but paradoxically further increased uncoupling and markedly reduced the membrane potential. This siRNA mediated uncoupling was unaffected by GDP but was blocked by ADP and carboxyatractylate (CAT). Mitochondria membrane potential after UCP-2 siRNA was unaffected by GDP but increased by CAT. This demonstrated that further increased mitochondria uncoupling after siRNA towards UCP-2 is mediated through the adenine nucleotide transporter (ANT). The increased oxidative stress in the diabetic kidney, manifested as increased thiobarbituric acids, was reduced by knocking down UCP-2 whereas whole-body oxidative stress, manifested as increased circulating malondialdehyde, remained unaffected. All parameters investigated were unaffected by scrambled siRNA. In conclusion, mitochondrial uncoupling via UCP-2 regulates mitochondria membrane potential in diabetes. However, blockade of the diabetes-induced upregulation of UCP-2 results in excessive uncoupling and reduced oxidative stress in the kidney via activation of ANT.	[Friederich-Persson, Malou; Nordquist, Lina; Palm, Fredrik] Uppsala Univ, Dept Med Cell Biol, Div Integrat Physiol, Uppsala, Sweden; [Friederich-Persson, Malou; Aslam, Shakil; Welch, William J.; Wilcox, Christopher S.] Georgetown Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens,Kidney & Vasc Res Ctr, Washington, DC 20007 USA; [Palm, Fredrik] Linkoping Univ, Dept Med Hlth Sci, Linkoping, Sweden	Uppsala University; Georgetown University; Linkoping University	Friederich-Persson, M (corresponding author), Uppsala Univ, Dept Med Cell Biol, Div Integrat Physiol, Uppsala, Sweden.	Malou.Friederich@mcb.uu.se		Nordquist, Lina/0000-0002-8552-5388	Swedish Research Council; Swedish Society for Medical Research; Lars Hierta Foundation; Magnus Bergvall Foundation; Ake Wiberg Foundation; NIH/NIDDK K99/R00 [DK077858]; NHLBI [HL-68686]; NIDDK [DK-49870]; George E. Schreiner Chair of Nephrology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049870, K99DK077858, R00DK077858] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society for Medical Research; Lars Hierta Foundation; Magnus Bergvall Foundation; Ake Wiberg Foundation; NIH/NIDDK K99/R00; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); George E. Schreiner Chair of Nephrology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Fredrik Palm was funded by the Swedish Research Council, the Swedish Society for Medical Research, the Lars Hierta Foundation, the Magnus Bergvall Foundation, the Ake Wiberg Foundation and NIH/NIDDK K99/R00 grant (DK077858). Christopher S. Wilcox and William J. Welch were funded by grants from the NHLBI (HL-68686) and NIDDK (DK-49870) and by the George E. Schreiner Chair of Nephrology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzu V, 2008, BIOCHEM J, V413, P323, DOI 10.1042/BJ20080321; Bevilacqua L, 2010, BBA-BIOENERGETICS, V1797, P1389, DOI 10.1016/j.bbabio.2010.02.018; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Cadenas S, 2000, BIOCHEM J, V351, P307, DOI 10.1042/0264-6021:3510307; Dahout-Gonzalez C, 2006, PHYSIOLOGY, V21, P242, DOI 10.1152/physiol.00005.2006; Dorner A, 1999, BBA-BIOMEMBRANES, V1417, P16, DOI 10.1016/S0005-2736(98)00245-4; Duval C, 2002, BIOCHEM CELL BIOL, V80, P757, DOI 10.1139/O02-158; Echtay KS, 2001, P NATL ACAD SCI USA, V98, P1416, DOI 10.1073/pnas.98.4.1416; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Friederich M, 2008, BBA-BIOENERGETICS, V1777, P935, DOI 10.1016/j.bbabio.2008.03.030; Harvey JN, 2003, CURR OPIN NEPHROL HY, V12, P317, DOI 10.1097/00041552-200305000-00015; Klingenberg M, 1999, J BIOENERG BIOMEMBR, V31, P419, DOI 10.1023/A:1005440221914; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Koulintchenko M, 2003, EMBO J, V22, P1245, DOI 10.1093/emboj/cdg128; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; Munusamy S, 2009, FREE RADICAL BIO MED, V46, P1149, DOI 10.1016/j.freeradbiomed.2009.01.022; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; NICHOLLS DG, 1976, EUR J BIOCHEM, V62, P223, DOI 10.1111/j.1432-1033.1976.tb10151.x; Palm F, 2003, DIABETOLOGIA, V46, P1153, DOI 10.1007/s00125-003-1155-z; Palm F, 2006, CLIN EXP PHARMACOL P, V33, P997, DOI 10.1111/j.1440-1681.2006.04473.x; Quijano C, 2007, AM J PHYSIOL-HEART C, V293, pH3404, DOI 10.1152/ajpheart.00761.2007; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Shabalina IG, 2006, BIOCHEM J, V399, P405, DOI 10.1042/BJ20060706; Vallon V, 2011, AM J PHYSIOL-REG I, V300, pR1009, DOI 10.1152/ajpregu.00809.2010	24	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39635	10.1371/journal.pone.0039635	http://dx.doi.org/10.1371/journal.pone.0039635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768304	Green Published, gold, Green Submitted			2022-12-27	WOS:000305966500017
J	Kohler, S; Bausch, AR				Koehler, Simone; Bausch, Andreas R.			Contraction Mechanisms in Composite Active Actin Networks	PLOS ONE			English	Article							FRACTIONAL DYNAMICS APPROACH; RABBIT SKELETAL-MUSCLE; BUNDLING PROTEINS; ALPHA-ACTININ; IN-VITRO; MYOSIN; CYTOKINESIS; DIFFUSION; CELLS	Simplified in vitro systems are ideally suited for studying the principle mechanisms of the contraction of cytoskeletal actin systems. To shed light on the dependence of the contraction mechanism on the nature of the crosslinking proteins, we study reconstituted in vitro active actin networks on different length scales ranging from the molecular organization to the macroscopic contraction. Distinct contraction mechanisms are observed in polar and apolar crosslinked active gels whereas composite active gels crosslinked in a polar and apolar fashion at the same time exhibit both mechanisms simultaneously. In polar active actin/fascin networks initially bundles are formed which are then rearranged. In contrast, apolar cortexillin-I crosslinked active gels are bundled only after reorganization of actin filaments by myosin-II motor filaments.	[Koehler, Simone; Bausch, Andreas R.] Tech Univ Munich, Lehrstuhl Biophys E27, D-8046 Garching, Germany	Technical University of Munich	Kohler, S (corresponding author), Tech Univ Munich, Lehrstuhl Biophys E27, D-8046 Garching, Germany.	abausch@mytum.de		Kohler, Simone/0000-0002-1119-8855	European Research Council under the European Union [279476]	European Research Council under the European Union(European Research Council (ERC))	Financial support from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC CompNet (279476) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aratyn-Schaus Y, 2011, MOL BIOL CELL, V22, P1330, DOI 10.1091/mbc.E10-11-0891; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Bendix PM, 2008, BIOPHYS J, V94, P3126, DOI 10.1529/biophysj.107.117960; Claessens MMAE, 2008, P NATL ACAD SCI USA, V105, P8819, DOI 10.1073/pnas.0711149105; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Faix J, 1996, CELL, V86, P631, DOI 10.1016/S0092-8674(00)80136-1; FERAMISCO JR, 1979, P NATL ACAD SCI USA, V76, P3967, DOI 10.1073/pnas.76.8.3967; Field CM, 2011, J CELL SCI, V124, P2086, DOI 10.1242/jcs.082263; He L, 2010, NAT CELL BIOL, V12, P1133, DOI 10.1038/ncb2124; Ishikawa R, 2003, J NEUROCHEM, V87, P676, DOI 10.1046/j.1471-4159.2003.02058.x; KANE RE, 1983, J CELL BIOL, V97, P1745, DOI 10.1083/jcb.97.6.1745; Kohler S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023798; Kohler S, 2011, NAT MATER, V10, P462, DOI [10.1038/NMAT3009, 10.1038/nmat3009]; LAZARIDES E, 1975, CELL, V6, P289, DOI 10.1016/0092-8674(75)90180-4; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Metzler R, 2000, EUROPHYS LETT, V51, P492, DOI 10.1209/epl/i2000-00364-5; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; POLLARD TD, 1981, J CELL BIOL, V91, pS156, DOI 10.1083/jcb.91.3.156s; Reichl EM, 2008, CURR BIOL, V18, P471, DOI 10.1016/j.cub.2008.02.056; Reymann AC, 2010, NAT MATER, V9, P827, DOI 10.1038/nmat2855; Schaller V, 2011, P NATL ACAD SCI USA, V108, P19183, DOI 10.1073/pnas.1107540108; Schmoller KM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.118102; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Thoresen T, 2011, BIOPHYS J, V100, P2698, DOI 10.1016/j.bpj.2011.04.031; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; WANG K, 1975, P NATL ACAD SCI USA, V72, P4483, DOI 10.1073/pnas.72.11.4483	30	39	39	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39869	10.1371/journal.pone.0039869	http://dx.doi.org/10.1371/journal.pone.0039869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768316	gold, Green Submitted, Green Published			2022-12-27	WOS:000305966500029
J	Shi, TY; He, J; Qiu, LX; Zhu, ML; Wang, MY; Zhou, XY; Han, JL; Yu, HP; Zang, RY; Wei, QY				Shi, Ting-Yan; He, Jing; Qiu, Li-Xin; Zhu, Mei-Ling; Wang, Meng-Yun; Zhou, Xiao-Yan; Han, Jiali; Yu, Hongpin; Zang, Rong-Yu; Wei, Qingyi			Association between XPF Polymorphisms and Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; DNA-REPAIR; BREAST-CANCER; GENETIC POLYMORPHISMS; XERODERMA-PIGMENTOSUM; LUNG-CANCER; ENDOMETRIAL CANCER; SMOKING; ERCC4; VARIANTS	Background: Xeroderma pigmentosum complementation group F (XPF or ERCC4) plays a key role in DNA repair that protects against genetic instability and carcinogenesis. A series of epidemiological studies have examined associations between XPF polymorphisms and cancer risk, but the findings remain inconclusive. Methodology/Principal Findings: In this meta-analysis of 47,639 cancer cases and 51,915 controls, by searching three electronic databases (i.e., MEDLINE, EMBASE and CNKI), we summarized 43 case-control studies from 29 publications on four commonly studied polymorphisms of XPF (i.e., rs1800067, rs1799801, rs2020955 and rs744154), and we did not find statistical evidence of any significant association with overall cancer risk. However, in stratification analyses, we found a significant association of XPF-rs1799801 with a reduced cancer risk in Caucasian populations (4,845 cases and 5,556 controls; recessive model: OR = 0.87, 95% CI = 0.76-1.00, P = 0.049, P = 0.723 for heterogeneity test, I-2 = 0). Further genotype-phenotype correlation analysis showed that the homozygous variant CC genotype carriers had higher XPF expression levels than that of the TT genotype carriers (Student's t test for a recessive model: P = 0.046). No publication bias was found by using the funnel plot and Egger's test. Conclusion: This meta-analysis suggests a lack of statistical evidence for the association between the four XPF SNPs and overall risk of cancers. However, XPF-rs1799801 may be associated with cancer risk in Caucasian populations, which needs to be further validated in single large, well-designed prospective studies.	[Shi, Ting-Yan; He, Jing; Zhu, Mei-Ling; Wang, Meng-Yun; Zhou, Xiao-Yan; Wei, Qingyi] Fudan Univ, Canc Res Lab, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Shi, Ting-Yan; He, Jing; Qiu, Li-Xin; Zhu, Mei-Ling; Wang, Meng-Yun; Zhou, Xiao-Yan; Zang, Rong-Yu] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Qiu, Li-Xin] Fudan Univ, Dept Med Oncol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Zang, Rong-Yu] Fudan Univ, Dept Gynecol Oncol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Han, Jiali] Harvard Univ, Brigham & Womens Hosp, Dept Dermatol, Sch Med, Boston, MA 02115 USA; [Han, Jiali] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Han, Jiali] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Yu, Hongpin; Wei, Qingyi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	Fudan University; Fudan University; Fudan University; Fudan University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; UTMD Anderson Cancer Center	Shi, TY (corresponding author), Fudan Univ, Canc Res Lab, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.	fudanGOG@gmail.com; weiqingyi@yahoo.com	He, Jing/M-5774-2015	He, Jing/0000-0002-1954-2892	China's Thousand Talents Program at Fudan University	China's Thousand Talents Program at Fudan University	This study was supported by the funds from China's Thousand Talents Program at Fudan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi R, 2009, INT J CANCER, V125, P1431, DOI 10.1002/ijc.24442; Agalliu I, 2010, CANCER CAUSE CONTROL, V21, P289, DOI 10.1007/s10552-009-9461-5; Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Chang JS, 2008, INT J CANCER, V123, P2095, DOI 10.1002/ijc.23801; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Crew KD, 2007, CANCER EPIDEM BIOMAR, V16, P2033, DOI 10.1158/1055-9965.EPI-07-0096; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding DP, 2011, BREAST CANCER RES TR, V129, P203, DOI 10.1007/s10549-011-1447-9; Doherty JA, 2011, CANCER EPIDEM BIOMAR, V20, P1873, DOI 10.1158/1055-9965.EPI-11-0119; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Fung KL, 2009, BBA-PROTEINS PROTEOM, V1794, P860, DOI 10.1016/j.bbapap.2009.02.014; Garcia-Closas M, 2006, CANCER EPIDEM BIOMAR, V15, P536, DOI 10.1158/1055-9965.EPI-05-0749; Gaudet MM, 2009, CANCER EPIDEM BIOMAR, V18, P1610, DOI 10.1158/1055-9965.EPI-08-0745; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gil J, 2012, MOL BIOL REP, V39, P527, DOI 10.1007/s11033-011-0767-5; Han JL, 2009, BREAST CANCER RES TR, V115, P613, DOI 10.1007/s10549-008-0089-z; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holm K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-600; Hooker S, 2008, PROSTATE CANCER P D, V11, P349, DOI 10.1038/sj.pcan.4501027; Hsu MS, 2010, ANN SURG ONCOL, V17, P760, DOI 10.1245/s10434-009-0802-0; Huang WY, 2006, CANCER EPIDEM BIOMAR, V15, P306, DOI 10.1158/1055-9965.EPI-05-0751; Hung RJ, 2008, CANCER EPIDEM BIOMAR, V17, P3081, DOI 10.1158/1055-9965.EPI-08-0411; Jorgensen TJ, 2007, BREAST CANCER RES TR, V101, P65, DOI 10.1007/s10549-006-9263-3; Joshi AD, 2009, CARCINOGENESIS, V30, P472, DOI 10.1093/carcin/bgn260; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kovacs MS, 1999, BRIT J CANCER, V80, P1245, DOI 10.1038/sj.bjc.6690492; KRAEMER KH, 1994, ARCH DERMATOL, V130, P1018, DOI 10.1001/archderm.130.8.1018; Krupa R., 2011, Experimental Oncology, V33, P55; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lee SA, 2005, EXP MOL MED, V37, P86, DOI 10.1038/emm.2005.12; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Leibeling D, 2006, J MOL HISTOL, V37, P225, DOI 10.1007/s10735-006-9041-x; LIU P, 1993, MUTAGENESIS, V8, P199, DOI 10.1093/mutage/8.3.199; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; MANTEL N, 1959, J NATL CANCER I, V22, P719; Manuguerra M, 2006, AM J EPIDEMIOL, V164, P297, DOI 10.1093/aje/kwj189; Matullo G, 2005, CANCER EPIDEM BIOMAR, V14, P2569, DOI 10.1158/1055-9965.EPI-05-0189; McWilliams RR, 2008, CANCER RES, V68, P4928, DOI 10.1158/0008-5472.CAN-07-5539; Mechanic LE, 2006, CARCINOGENESIS, V27, P1377, DOI 10.1093/carcin/bgi330; Millikan RC, 2006, CARCINOGENESIS, V27, P610, DOI 10.1093/carcin/bgi252; Milne RL, 2006, CANCER RES, V66, P9420, DOI 10.1158/0008-5472.CAN-06-1418; Moreno V, 2006, CLIN CANCER RES, V12, P2101, DOI 10.1158/1078-0432.CCR-05-1363; Mort R, 2003, BRIT J CANCER, V89, P333, DOI 10.1038/sj.bjc.6601061; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Nishino T, 2003, STRUCTURE, V11, P445, DOI 10.1016/S0969-2126(03)00046-7; Oliveira C, 2011, EUR J CANCER, V47, pS654, DOI 10.1016/S0959-8049(11)72517-5; Povey JE, 2007, CARCINOGENESIS, V28, P1087, DOI 10.1093/carcin/bgl257; Rajaraman P, 2008, INT J CANCER, V123, P2713, DOI 10.1002/ijc.23779; Rajaraman P, 2010, NEURO-ONCOLOGY, V12, P37, DOI 10.1093/neuonc/nop012; Roberts MR, 2011, CARCINOGENESIS, V32, P1223, DOI 10.1093/carcin/bgr096; Shen M, 2005, INT J CANCER, V116, P768, DOI 10.1002/ijc.21117; Shen MR, 1998, CANCER RES, V58, P604; SHIELDS PG, 1991, JAMA-J AM MED ASSOC, V266, P681, DOI 10.1001/jama.266.5.681; Smith TR, 2008, CARCINOGENESIS, V29, P2132, DOI 10.1093/carcin/bgn193; Smith TR, 2011, CARCINOGENESIS, V32, P1354, DOI 10.1093/carcin/bgr117; Smith TR, 2003, CANCER EPIDEM BIOMAR, V12, P1200; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Tripsianes K, 2005, STRUCTURE, V13, P1849, DOI 10.1016/j.str.2005.08.014; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Tsodikov OV, 2005, P NATL ACAD SCI USA, V102, P11236, DOI 10.1073/pnas.0504341102; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang M, 2010, ONCOGENE, V29, P1920, DOI 10.1038/onc.2009.484; Weiss JM, 2005, CANCER EPIDEM BIOMAR, V14, P2524, DOI 10.1158/1055-9965.EPI-05-0414; Weiss JM, 2006, GYNECOL ONCOL, V103, P891, DOI 10.1016/j.ygyno.2006.05.020; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Yu H, 2011, ASS SINGLE NUCLEOTID; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	71	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e38606	10.1371/journal.pone.0038606	http://dx.doi.org/10.1371/journal.pone.0038606			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768293	Green Published, Green Submitted, gold			2022-12-27	WOS:000305966500006
J	Villanueva, S; Suazo, C; Santapau, D; Perez, F; Quiroz, M; Carreno, JE; Illanes, S; Lavandero, S; Michea, L; Irarrazabal, CE				Villanueva, Sandra; Suazo, Cristian; Santapau, Daniela; Perez, Francisco; Quiroz, Mariana; Carreno, Juan E.; Illanes, Sebastian; Lavandero, Sergio; Michea, Luis; Irarrazabal, Carlos E.			NFAT5 Is Activated by Hypoxia: Role in Ischemia and Reperfusion in the Rat Kidney	PLOS ONE			English	Article							OSMOTIC RESPONSE ELEMENT; ENHANCER-BINDING PROTEIN; ACUTE-RENAL-FAILURE; TRANSCRIPTION FACTOR TONEBP/OREBP; OXYGEN SPECIES CONTRIBUTE; NACL-INDUCED ACTIVATION; ALDOSE REDUCTASE GENE; CELLULAR-RESPONSE; OXIDATIVE STRESS; NITRIC-OXIDE	The current hypothesis postulates that NFAT5 activation in the kidney's inner medulla is due to hypertonicity, resulting in cell protection. Additionally, the renal medulla is hypoxic (10-18 mmHg); however there is no information about the effect of hypoxia on NFAT5. Using in vivo and in vitro models, we evaluated the effect of reducing the partial pressure of oxygen (PO2) on NFAT5 activity. We found that 1) Anoxia increased NFAT5 expression and nuclear translocation in primary cultures of IMCD cells from rat kidney. 2) Anoxia increased transcriptional activity and nuclear translocation of NFAT5 in HEK293 cells. 3) The dose-response curve demonstrated that HIF-1 alpha peaked at 2.5% and NFAT5 at 1% of O-2. 4) At 2.5% of O-2, the time-course curve of hypoxia demonstrated earlier induction of HIF-1 alpha gene expression than NFAT5. 5) siRNA knockdown of NFAT5 increased the hypoxia-induced cell death. 6) siRNA knockdown of HIF-1 alpha did not affect the NFAT5 induction by hypoxia. Additionally, HIF-1 alpha was still induced by hypoxia even when NFAT5 was knocked down. 7) NFAT5 and HIF-1 alpha expression were increased in kidney (cortex and medulla) from rats subjected to an experimental model of ischemia and reperfusion (I/R). 7) Experimental I/R increased the NFAT5-target gene aldose reductase (AR). 8) NFAT5 activators (ATM and PI3K) were induced in vitro (HEK293 cells) and in vivo (I/R kidneys) with the same timing of NFAT5. 8) Wortmannin, which inhibits ATM and PI3K, reduces hypoxia-induced NFAT5 transcriptional activation in HEK293 cells. These results demonstrate for the first time that NFAT5 is induced by hypoxia and could be a protective factor against ischemic damage.	[Villanueva, Sandra; Suazo, Cristian; Santapau, Daniela; Quiroz, Mariana; Carreno, Juan E.; Illanes, Sebastian; Irarrazabal, Carlos E.] Univ Los Andes, Fac Med, Lab Mol Physiol, Santiago, Chile; [Perez, Francisco; Michea, Luis] Univ Chile, Lab Integrat Physiol, ICBM, Santiago, Chile; [Perez, Francisco; Lavandero, Sergio; Michea, Luis] Univ Chile, Fac Med, Ctr Estudios Mol Celula, Santiago 7, Chile; [Lavandero, Sergio] Univ Chile, Fac Ciencias Quim & Farmaceut, Santiago, Chile; [Lavandero, Sergio] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dept Internal Med, Dallas, TX 75390 USA	Universidad de los Andes - Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; University of Texas System; University of Texas Southwestern Medical Center Dallas	Villanueva, S (corresponding author), Univ Los Andes, Fac Med, Lab Mol Physiol, Santiago, Chile.	cirarrazabal@uandes.cl	Lavandero, Sergio/B-6001-2013	Lavandero, Sergio/0000-0003-4258-1483; Irarrazabal, Carlos Ernesto/0000-0002-6538-5314; Illanes, Sebastian/0000-0001-5433-9315	Fondecyt [1100885, 1090223]; FAI-Med [001-08, 003-09]; Fondecyt-FONDAP [15010006]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FAI-Med; Fondecyt-FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYTCONICYT FONDAP)	This work was supported by the following grants: Fondecyt 1100885 (National Fund for Science and Technology Development-Chile); FAI-Med 001-08-(Research Fund, University of Los Andes); FAI-Med 003-09 (Research Fund, University of Los Andes); and Fondecyt-FONDAP 15010006 (National Fund for Science and Technology Development-Chile); FONDECYT 1090223. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo M, 2006, CURR OPIN NEPHROL HY, V15, P72, DOI 10.1097/01.mnh.0000191912.65281.e9; Bhoumik A, 2007, PIGM CELL RES, V20, P498, DOI 10.1111/j.1600-0749.2007.00414.x; Bindra RS, 2007, CANCER METAST REV, V26, P249, DOI 10.1007/s10555-007-9061-3; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006; BREZIS M, 1993, ANNU REV MED, V44, P27, DOI 10.1146/annurev.me.44.020193.000331; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Cai Q, 2005, AM J PHYSIOL-RENAL, V289, pF803, DOI 10.1152/ajprenal.00448.2004; Cha JH, 2001, J AM SOC NEPHROL, V12, P2221, DOI 10.1681/ASN.V12112221; Colla E, 2006, BIOCHEM J, V393, P411, DOI 10.1042/BJ20051082; Cristol JP, 1996, J LIPID MEDIAT CELL, V13, P9, DOI 10.1016/0929-7855(95)00010-0; Dahl SC, 2001, AM J PHYSIOL-CELL PH, V280, pC248, DOI 10.1152/ajpcell.2001.280.2.C248; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; FERRARIS JD, 1994, P NATL ACAD SCI USA, V91, P10742, DOI 10.1073/pnas.91.22.10742; Ferraris JD, 1999, AM J PHYSIOL-CELL PH, V276, pC667, DOI 10.1152/ajpcell.1999.276.3.C667; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P16800, DOI 10.1073/pnas.222659799; Ferraris JD, 1996, J BIOL CHEM, V271, P18318, DOI 10.1074/jbc.271.31.18318; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P739, DOI 10.1073/pnas.241637298; Gallazzini M, 2006, P NATL ACAD SCI USA, V103, P15260, DOI 10.1073/pnas.0607133103; Gong H, 2004, KIDNEY INT, V66, P683, DOI 10.1111/j.1523-1755.2004.00791.x; Hammond EM, 2004, DNA REPAIR, V3, P1117, DOI 10.1016/j.dnarep.2004.03.035; Hammond EM, 2003, J BIOL CHEM, V278, P12207, DOI 10.1074/jbc.M212360200; Irarrazabal CE, 2008, J BIOL CHEM, V283, P2554, DOI 10.1074/jbc.M703490200; Irarrazabal CE, 2006, P NATL ACAD SCI USA, V103, P8882, DOI 10.1073/pnas.0602911103; Irarrazabal CE, 2010, P NATL ACAD SCI USA, V107, P906, DOI 10.1073/pnas.0913415107; Irarrazabal CE, 2004, P NATL ACAD SCI USA, V101, P8809, DOI 10.1073/pnas.0403062101; Ko BCB, 2000, BIOCHEM BIOPH RES CO, V270, P52, DOI 10.1006/bbrc.2000.2376; Ko BCB, 2002, J BIOL CHEM, V277, P46085, DOI 10.1074/jbc.M208138200; Kuper C, 2009, AM J PHYSIOL-RENAL, V296, pF1100, DOI 10.1152/ajprenal.90402.2008; Kwon TH, 1999, AM J PHYSIOL-RENAL, V277, pF413, DOI 10.1152/ajprenal.1999.277.3.F413; Lam AKM, 2004, J BIOL CHEM, V279, P48048, DOI 10.1074/jbc.M407224200; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; LOPEZNEBLINA F, 1994, CIRC SHOCK, V44, P91; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Priyadarshi A, 2002, KIDNEY INT, V61, P542, DOI 10.1046/j.1523-1755.2002.00140.x; Rosas-Rodriguez JA, 2010, LIFE SCI, V87, P515, DOI 10.1016/j.lfs.2010.08.003; SADOWSKI J, 1985, Acta Physiologica Polonica, V36, P339; SCHRAMM L, 1994, RENAL FAILURE, V16, P555, DOI 10.3109/08860229409044885; Sykes E, 2007, ANN ROY COLL SURG, V89, P22, DOI 10.1308/003588407X155536; Trama J, 2002, J IMMUNOL, V169, P5477, DOI 10.4049/jimmunol.169.10.5477; Villanueva S, 2006, AM J PHYSIOL-REG I, V290, pR861, DOI 10.1152/ajpregu.00384.2005; Woo SK, 2000, AM J PHYSIOL-RENAL, V278, pF1006; Woo SK, 2000, BIOCHEM BIOPH RES CO, V278, P269, DOI 10.1006/bbrc.2000.3798; Xue Y, 2011, AM J PHYSIOL-HEART C, V300, pH2169, DOI 10.1152/ajpheart.00970.2010; Yuan K, 2010, PEPTIDES, V31, P1319, DOI 10.1016/j.peptides.2010.04.008; Zhou BY, 2007, AM J PHYSIOL-CELL PH, V292, pC1280, DOI 10.1152/ajpcell.00070.2006; Zhou XM, 2006, AM J PHYSIOL-RENAL, V290, pF1169, DOI 10.1152/ajprenal.00378.2005; Zhou XM, 2005, AM J PHYSIOL-RENAL, V289, pF377, DOI 10.1152/ajprenal.00463.2004	47	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39665	10.1371/journal.pone.0039665	http://dx.doi.org/10.1371/journal.pone.0039665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768306	Green Published, gold			2022-12-27	WOS:000305966500019
J	Chen, MB; Zhu, YQ; Xu, JY; Wang, LQ; Liu, CY; Ji, ZY; Lu, PH				Chen, Min-Bin; Zhu, Ya-Qun; Xu, Jun-Ying; Wang, Li-Qiang; Liu, Chao-Ying; Ji, Zhang-Yi; Lu, Pei-Hua			Value of TP53 Status for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Meta-Analysis	PLOS ONE			English	Article							GENE-EXPRESSION; P53 STATUS; PACLITAXEL; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; MUTATIONS; MARKERS; TUMOR; PROLIFERATION	Background: Numerous studies have yielded inconclusive results regarding the relationship between tumor suppressor protein TP53 overexpression and/or TP53 gene mutations and the response to neoadjuvant chemotherapy in patients with breast cancer. The purpose of the current study was therefore to evaluate the relationship between TP53 status and response to chemotherapy in breast cancer. Methods and Findings: A total of 26 previously published eligible studies including 3,476 cases were identified and included in this meta-analysis. TP53 status (over expression of TP53 protein and/or TP53 gene mutations) was associated with good response in breast cancer patients who received neoadjuvant chemotherapy (total objective response: risk ratio [RR] = 1.20, 95% confidence interval [CI] = 1.09-1.33, p < 0.001; pathological objective response: RR = 1.37, 95% CI = 1.20-1.57, p < 0.01; total complete response: RR = 1.33, 95% CI = 1.15-1.53, p, 0.001; pathological complete response: RR = 1.45, 95% CI = 1.25-1.68, p < 0.001). In further stratified analyses, this association also existed among the studies using anthracycline-based neoadjuvant chemotherapy, and the association between response and the presence of gene alterations was stronger than that between response and immunohistochemistry positivity. Conclusion: The results of the present meta-analysis suggest that TP53 status is a predictive factor for response in breast cancer patients undergoing neoadjuvant chemotherapy. Further larger and well-designed prospective studies are required to evaluate the predictive role of TP53 status in clinical practice.	[Chen, Min-Bin; Wang, Li-Qiang; Ji, Zhang-Yi] Jiangsu Univ, Dept Med Oncol, Kunshan Peoples Hosp 1, Kunshan, Peoples R China; [Zhu, Ya-Qun] Soochow Univ, Dept Radiotherapy & Oncol, Affiliated Hosp 2, Suzhou, Peoples R China; [Xu, Jun-Ying; Liu, Chao-Ying] Nanjing Med Univ, Dept Med Oncol, Wuxi Peoples Hosp, Wuxi City, Peoples R China; [Lu, Pei-Hua] Nanjing Med Univ, Dept Gen Surg, Wuxi Peoples Hosp, Wuxi City, Peoples R China	Jiangsu University; Soochow University - China; Jiangnan University; Nanjing Medical University; Jiangnan University; Nanjing Medical University	Lu, PH (corresponding author), Nanjing Med Univ, Dept Gen Surg, Wuxi Peoples Hosp, Wuxi City, Peoples R China.	lphty1_1@yahoo.com.cn		Lu, Peihua/0000-0002-4622-3061	Natural Science Foundation of Jiangsu Province [BK2010160, BK2011374]; National Natural Science Foundation [81108676, 81101801]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of Jiangsu Province (No. BK2010160, BK2011374) and the National Natural Science Foundation (No. 81108676, 81101801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas T, 2003, EUR J CANCER, V39, P438, DOI 10.1016/S0959-8049(02)00732-3; Anelli A, 2003, ANN ONCOL, V14, P428, DOI 10.1093/annonc/mdg104; Berry DA, 2006, JAMA-J AM MED ASSOC, V295, P1658, DOI 10.1001/jama.295.14.1658; Bertheau P, 2007, PLOS MED, V4, P585, DOI 10.1371/journal.pmed.0040090; Bonnefoi H, 2003, ANN ONCOL, V14, P406, DOI 10.1093/annonc/mdg108; Bonnefoi H, 2011, LANCET ONCOL, V12, P527, DOI 10.1016/S1470-2045(11)70094-8; Deissler H, 2004, ONCOL REP, V11, P1281; Geisler S, 2003, CLIN CANCER RES, V9, P5582; Geisler S, 2001, CANCER RES, V61, P2505; Hayes DF, 2007, NEW ENGL J MED, V357, P1496, DOI 10.1056/NEJMoa071167; Kandioler-Eckersberger D, 2000, CLIN CANCER RES, V6, P50; Keam B, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-203; Kim SJ, 2005, CLIN CANCER RES, V11, P8425, DOI 10.1158/1078-0432.CCR-05-0449; Learn PA, 2005, CANCER-AM CANCER SOC, V103, P2252, DOI 10.1002/cncr.21037; Lee J, 2008, CANCER CHEMOTH PHARM, V61, P569, DOI 10.1007/s00280-007-0506-8; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Makris A, 1997, CLIN CANCER RES, V3, P593; Martin-Richard M, 2004, ONCOLOGY-BASEL, V66, P388, DOI 10.1159/000079487; Masuda H, 2011, CANCER CHEMOTH PHARM, V67, P911, DOI 10.1007/s00280-010-1371-4; Mathieu MC, 2004, EUR J CANCER, V40, P342, DOI 10.1016/j.ejca.2003.08.015; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Ono M, 2011, BREAST CANC RES TREA; Oshima K, 2011, CANCER LETT, V307, P149, DOI 10.1016/j.canlet.2011.03.027; Pakos EE, 2004, CLIN CANCER RES, V10, P6208, DOI 10.1158/1078-0432.CCR-04-0246; Sanchez-Munoz A, 2010, AM J CLIN ONCOL-CANC, V33, P432, DOI 10.1097/COC.0b013e3181b4eff9; Schneider J, 2001, BREAST CANCER RES, V3, P183, DOI 10.1186/bcr293; Shekhar MPV, 2010, MED ONCOL, V27, P466, DOI 10.1007/s12032-009-9235-7; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Tewari M, 2008, SURG ONCOL, V17, P301, DOI 10.1016/j.suronc.2008.03.003; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tiezzi DG, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-36; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Yonemori K, 2009, MED ONCOL, V26, P344, DOI 10.1007/s12032-008-9127-2; Zhou B, 2008, CHINESE MED J-PEKING, V121, P387, DOI 10.1097/00029330-200803010-00001	35	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39655	10.1371/journal.pone.0039655	http://dx.doi.org/10.1371/journal.pone.0039655			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768103	gold, Green Submitted, Green Published			2022-12-27	WOS:000305892100073
J	Chen-An, PP; Andreassen, KV; Henriksen, K; Li, YD; Karsdal, MA; Bay-Jensen, AC				Chen-An, Pingping; Andreassen, Kim Vietz; Henriksen, Kim; Li, Yadong; Karsdal, Morten Asser; Bay-Jensen, Anne-Christine			The Inhibitory Effect of Salmon Calcitonin on Tri-Iodothyronine Induction of Early Hypertrophy in Articular Cartilage	PLOS ONE			English	Article							CRUCIATE LIGAMENT TRANSECTION; GROWTH-PLATE CHONDROCYTES; OSTEOARTHRITIC CARTILAGE; ENDOCHONDRAL OSSIFICATION; TERMINAL DIFFERENTIATION; BONE CHANGES; EX-VIVO; RECEPTOR; EXPRESSION; DEGRADATION	Objective: Salmon calcitonin has chondroprotective effect both in vitro and in vivo, and is therefore being tested as a candidate drug for cartilage degenerative diseases. Recent studies have indicated that different chondrocyte phenotypes may express the calcitonin receptor (CTR) differentially. We tested for the presence of the CTR in chondrocytes from tri-iodothyronin (T3)-induced bovine articular cartilage explants. Moreover, investigated the effects of human and salmon calcitonin on the explants. Methods: Early chondrocyte hypertrophy was induced in bovine articular cartilage explants by stimulation over four days with 20 ng/mL T3. The degree of hypertrophy was investigated by molecular markers of hypertrophy (ALP, IHH, COLX and MMP13), by biochemical markers of cartilage turnover (C2M, P2NP and AGNxII) and histology. The expression of the CTR was detected by qPCR and immunohistochemistry. T3-induced explants were treated with salmon or human calcitonin. Calcitonin down-stream signaling was measured by levels of cAMP, and by the molecular markers. Results: Compared with untreated control explants, T3 induction increased expression of the hypertrophic markers (p<0.05), of cartilage turnover (p<0.05), and of CTR (p<0.01). Salmon, but not human, calcitonin induced cAMP release (p<0.001). Salmon calcitonin also inhibited expression of markers of hypertrophy and cartilage turnover (p<0.05). Conclusions: T3 induced early hypertrophy of chondrocytes, which showed an elevated expression of the CTR and was thus a target for salmon calcitonin. Molecular marker levels indicated salmon, but not human, calcitonin protected the cartilage from hypertrophy. These results confirm that salmon calcitonin is able to modulate the CTR and thus have chondroprotective effects.	[Chen-An, Pingping; Karsdal, Morten Asser; Bay-Jensen, Anne-Christine] Nord Biosci AS, Cartilage Biol & Biomarkers, Herlev, Denmark; [Andreassen, Kim Vietz; Henriksen, Kim] Nord Biosci AS, Bone Biol & Pharmacol, Herlev, Denmark; [Li, Yadong] Beijing Friendship Hosp, Orthoped Surg Unit, Beijing, Peoples R China	Nordic Bioscience; Nordic Bioscience; Capital Medical University	Chen-An, PP (corresponding author), Nord Biosci AS, Cartilage Biol & Biomarkers, Herlev, Denmark.	acbj@nordicbioscience.com	Bay-Jensen, Anne-Christine/AEQ-7281-2022	Bay-Jensen, Anne-Christine/0000-0001-7952-9297; Karsdal, Morten/0000-0001-5026-8740	Danish Research Foundation (Den Danske Forskningsfond); university of Southern Denmark; Nordic Bioscience	Danish Research Foundation (Den Danske Forskningsfond); university of Southern Denmark; Nordic Bioscience	The authors gratefully acknowledge the funding from the Danish Research Foundation (Den Danske Forskningsfond) supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Nordic Bioscience is involved in the development of oral salmon calcitonin for the treatment of osteoporosis and osteoarthritis. ACBJ, KH and MAK are full-time employees of Nordic Bioscience. PCA and KAN are PhD students funded by the university of Southern Denmark and Nordic Bioscience. MAK owns stock in Nordic Bioscience. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. YL has no competing interest to declare. There are no patents, products in development or marketed products to declare related to the presented FDC model nor the expression of the CTR.	Abramson SB, 2006, NAT CLIN PRACT RHEUM, V2, P304, DOI 10.1038/ncprheum0193; Archer CW, 2003, INT J BIOCHEM CELL B, V35, P401, DOI 10.1016/S1357-2725(02)00301-1; Bay-Jensen AC, 2010, ASSAY DRUG DEV TECHN, V8, P118, DOI 10.1089/adt.2009.0199; Bay-Jensen AC, 2010, RHEUMATOL INT, V30, P435, DOI 10.1007/s00296-009-1183-1; Behets C, 2004, J BONE MINER RES, V19, P1821, DOI 10.1359/JBMR.040609; BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9; Born W, 2002, RECEPTOR CHANNEL, V8, P201, DOI 10.1080/10606820213683; Bos SD, 2008, CURR OPIN RHEUMATOL, V20, P553, DOI 10.1097/BOR.0b013e32830aba48; Brondello Jean-Marc, 2010, Open Rheumatol J, V4, P10, DOI 10.2174/1874312901004010010; BURCH WM, 1984, ENDOCRINOLOGY, V114, P1196, DOI 10.1210/endo-114-4-1196; Chen PY, 2012, J ELECTROANALYTICAL, V675, P1, DOI [10.1109/ RSETE.2012.6260647, DOI 10.1109/RSETE.2012.6260647]; Christopoulos G, 1999, MOL PHARMACOL, V56, P235, DOI 10.1124/mol.56.1.235; Cranney A, 2002, ENDOCR REV, V23, P540, DOI 10.1210/er.2001-6002; Di Nino DL, 2003, ENDOCRINOLOGY, V144, P1979, DOI 10.1210/en.2002-220905; ELIMA K, 1989, FEBS LETT, V258, P195, DOI 10.1016/0014-5793(89)81651-5; Felson DT, 2004, ARTHRITIS RHEUM-US, V50, P341, DOI 10.1002/art.20051; Goldring MB, 2006, BEST PRACT RES CL RH, V20, P1003, DOI 10.1016/j.berh.2006.06.003; Grimsrud CD, 2001, J ORTHOPAED RES, V19, P18, DOI 10.1016/S0736-0266(00)00017-6; Hajjaji HE, 2004, OSTEOARTHR CARTILAGE, V12, P904, DOI 10.1016/j.joca.2004.08.005; Hayami T, 2006, BONE, V38, P234, DOI 10.1016/j.bone.2005.08.007; Hayami T, 2004, ARTHRITIS RHEUM-US, V50, P1193, DOI 10.1002/art.20124; Henriksen K, 2010, EXPERT OPIN BIOL TH, V10, P1617, DOI 10.1517/14712598.2010.526104; Ishikawa Y, 1998, J BONE MINER RES, V13, P1398, DOI 10.1359/jbmr.1998.13.9.1398; Jiang J, 2008, OSTEOARTHR CARTILAGE, V16, P70, DOI 10.1016/j.joca.2007.05.014; Kawaguchi H, 2008, MOL CELLS, V25, P1; Lassova L, 2009, J CELL PHYSIOL, V219, P595, DOI 10.1002/jcp.21704; Lin Z, 2008, OSTEOARTHR CARTILAGE, V16, P450, DOI 10.1016/j.joca.2007.08.003; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Madsen SH, 2009, SCAND J RHEUMATOL, V38, P222, DOI 10.1080/03009740802464186; MARTIN TJ, 1993, OSTEOPOROSIS INT, V3, pS121, DOI 10.1007/BF01621884; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Minina E, 2001, DEVELOPMENT, V128, P4523; Naot D, 2008, BONE, V43, P813, DOI 10.1016/j.bone.2008.07.003; NICHOLSON GC, 1986, J CLIN INVEST, V78, P355, DOI 10.1172/JCI112584; Nielsen RH, 2011, OSTEOARTHR CARTILAGE, V19, P466, DOI 10.1016/j.joca.2011.01.008; Pullig O, 2000, CALCIFIED TISSUE INT, V67, P230, DOI 10.1007/s002230001108; Purdue BW, 2002, RECEPTOR CHANNEL, V8, P243, DOI 10.1080/10606820213681; Segovia-Silvestre Toni, 2011, BMC Res Notes, V4, P407, DOI 10.1186/1756-0500-4-407; Sexton PM, 1999, CURR MED CHEM, V6, P1067; Sondergaard BC, 2007, ANN RHEUM DIS, V66, P116; Sondergaard BC, 2006, OSTEOARTHR CARTILAGE, V14, P759, DOI 10.1016/j.joca.2006.01.014; Sondergaard BC, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-62; Steinert AF, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2822; Stokes DG, 2001, BIOCHEM J, V360, P461, DOI 10.1042/0264-6021:3600461; Sumer EU, 2007, OSTEOARTHR CARTILAGE, V15, P212, DOI 10.1016/j.joca.2006.07.009; Tilakaratne N, 2000, J PHARMACOL EXP THER, V294, P61; Udawela M, 2004, SEMIN CELL DEV BIOL, V15, P299, DOI 10.1016/j.semcdb.2003.12.019; Wang Bijue, 2009, BMC Res Notes, V2, P259, DOI 10.1186/1756-0500-2-259; Wang L, 2007, J BONE MINER RES, V22, P1988, DOI 10.1359/JBMR.070806; Wookey PJ, 2008, HISTOPATHOLOGY, V52, P605, DOI 10.1111/j.1365-2559.2008.02979.x	50	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40081	10.1371/journal.pone.0040081	http://dx.doi.org/10.1371/journal.pone.0040081			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768225	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100197
J	Franke, AG; Lieb, K; Hildt, E				Franke, Andreas G.; Lieb, Klaus; Hildt, Elisabeth			What Users Think about the Differences between Caffeine and Illicit/Prescription Stimulants for Cognitive Enhancement	PLOS ONE			English	Article							PRESCRIPTION STIMULANTS; ILLICIT USE; MODAFINIL; NEUROENHANCEMENT; METHYLPHENIDATE; AMPHETAMINE; PERFORMANCE; PREVALENCE; STUDENTS; MOTIVES	Pharmacological cognitive enhancement (CE) is a topic of increasing public awareness. In the scientific literature on student use of CE as a study aid for academic performance enhancement, there are high prevalence rates regarding the use of caffeinated substances (coffee, caffeinated drinks, caffeine tablets) but remarkably lower prevalence rates regarding the use of illicit/prescription stimulants such as amphetamines or methylphenidate. While the literature considers the reasons and mechanisms for these different prevalence rates from a theoretical standpoint, it lacks empirical data to account for healthy students who use both, caffeine and illicit/prescription stimulants, exclusively for the purpose of CE. Therefore, we extensively interviewed a sample of 18 healthy university students reporting non-medical use of caffeine as well as illicit/prescription stimulants for the purpose of CE in a face-to-face setting about their opinions regarding differences in general and morally-relevant differences between caffeine and stimulant use for CE. 44% of all participants answered that there is a general difference between the use of caffeine and illicit/prescription stimulants for CE, 28% did not differentiate, 28% could not decide. Furthermore, 39% stated that there is a moral difference, 56% answered that there is no moral difference and one participant was not able to comment on moral aspects. Participants came to their judgements by applying three dimensions: medical, ethical and legal. Weighing the medical, ethical and legal aspects corresponded to the students' individual preferences of substances used for CE. However, their views only partly depicted evidence-based medical aspects and the ethical issues involved. This result shows the need for well-directed and differentiated information to prevent the potentially harmful use of illicit or prescription stimulants for CE.	[Franke, Andreas G.; Lieb, Klaus] Univ Med Ctr, Dept Psychiat & Psychotherapy, Mainz, Germany; [Hildt, Elisabeth] Johannes Gutenberg Univ Mainz, Dept Philosophy, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Franke, AG (corresponding author), Univ Med Ctr, Dept Psychiat & Psychotherapy, Mainz, Germany.	afranke@uni-mainz.de			German Ministry of Education and Research (BMBF) [01GP0807]	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Ministry of Education and Research (BMBF) (Project No. 01GP0807) which has supported the work until September 2011. The BMBF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman SM, 2009, MOL PSYCHIATR, V14, P123, DOI 10.1038/mp.2008.90; Bramstedt KA, 2007, SUBST USE MISUSE, V42, P1237, DOI 10.1080/10826080701208962; Bryant A, 2007, SAGE HDB GROUNDED TH; Bublitz JC, 2009, BIOETHICS, V23, P360, DOI 10.1111/j.1467-8519.2009.01725.x; CAPLAN A, 2002, NEUROETHICS MAPPING, P95; Caplan JP, 2007, NEUROPSYCHOL REV, V17, P363, DOI 10.1007/s11065-007-9037-7; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Elliott C, 2000, HASTINGS CENT REP, V30, P7, DOI 10.2307/3528306; Farah MJ, 2004, NAT REV NEUROSCI, V5, P421, DOI 10.1038/nrn1390; Ferre S, 2008, FRONT BIOSCI-LANDMRK, V13, P2391, DOI 10.2741/2852; Fisone G, 2004, CELL MOL LIFE SCI, V61, P857, DOI 10.1007/s00018-003-3269-3; Franke AG, 2011, PHARMACOPSYCHIATRY, V44, P331, DOI 10.1055/s-0031-1286347; Franke AG, 2011, PHARMACOPSYCHIATRY, V44, P60, DOI 10.1055/s-0030-1268417; Franke AG, 2010, BUNDESGESUNDHEITSBLA, V53, P853, DOI 10.1007/s00103-010-1105-0; Franke AG, 2012, PSYCHIAT PR IN PRESS; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Hildt E, 2011, NERVENHEILKUNDE, V30, P833; HUGHES JR, 1992, AM J PSYCHIAT, V149, P33; Juengst Eric T., 1998, ENHANCING HUMAN TRAI, P29; Kass LR, 2003, PRESIDENTS COUNCIL B; Killgore WDS, 2008, J SLEEP RES, V17, P309, DOI 10.1111/j.1365-2869.2008.00654.x; Maher B, 2008, NATURE, V452, P674, DOI 10.1038/452674a; Mayring P., 2010, QUALITATIVE INHALTSA, V2nd Aufl, DOI [10.1007/978-3-531-92052-8_42, DOI 10.1007/978-3-531-92052-8_42]; Metzinger T., 2011, OXFORD HDB NEUROETHI, P245; NEHLIG A, 1992, BRAIN RES REV, V17, P139, DOI 10.1016/0165-0173(92)90012-B; Oades RD, 2005, DEVELOPMENTAL SCI, V8, P122, DOI 10.1111/j.1467-7687.2005.00399.x; Prince J, 2008, J CLIN PSYCHOPHARM, V28, pS39, DOI 10.1097/JCP.0b013e318174f92a; Racine E, 2009, J MED ETHICS, V35, P469, DOI 10.1136/jme.2009.030460; Racine E, 2010, NEUROETHICS-NETH, V3, P1, DOI 10.1007/s12152-008-9023-7; Repantis D, 2010, PHARMACOL RES, V62, P187, DOI 10.1016/j.phrs.2010.04.002; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; Satel S, 2006, AM J DRUG ALCOHOL AB, V32, P493, DOI 10.1080/00952990600918965; SCHREIBER GB, 1988, PREV MED, V17, P280, DOI 10.1016/0091-7435(88)90004-7; Sententia W, 2004, ANN NY ACAD SCI, V1013, P221, DOI 10.1196/annals.1305.014; Smith ME, 2011, PSYCHOL BULL, V137, P717, DOI 10.1037/a0023825; Teter CJ, 2006, PHARMACOTHERAPY, V26, P1501, DOI 10.1592/phco.26.10.1501; Teter CJ, 2005, J AM COLL HEALTH, V53, P253, DOI 10.3200/JACH.53.6.253-262; Wesensten NJ, 2005, J SLEEP RES, V14, P255, DOI 10.1111/j.1365-2869.2005.00468.x; Wilens TE, 2008, J CLIN PSYCHOPHARM, V28, pS46, DOI 10.1097/JCP.0b013e318173312f; Wilens TE, 2008, J AM ACAD CHILD PSY, V47, P21, DOI 10.1097/chi.0b013e31815a56f1	40	55	56	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40047	10.1371/journal.pone.0040047	http://dx.doi.org/10.1371/journal.pone.0040047			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768218	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100190
J	Lee, SM; Park, JW; Park, CW; Yoon, BH				Lee, Seung Mi; Park, Jeong Woo; Park, Chan-Wook; Yoon, Bo Hyun			"Early Rupture of Membranes" during Induced Labor as a Risk Factor for Cesarean Delivery in Term Nulliparas	PLOS ONE			English	Article							ELECTIVE INDUCTION; WOMEN; PREDICTION; SECTION	Objective: To determine if "early rupture of membranes" (early ROM) during induction of labor is associated with an increased risk of cesarean section in term nulliparas. Study Design: The rate of cesarean section and the timing of ROM during the course of labor were examined in term singleton nulliparas whose labor was induced. Cases were divided into 2 groups according the timing of ROM: 1)"early ROM", defined as ROM at a cervical dilatation <4 cm during labor; and 2) "late ROM", ROM at a cervical dilatation >= 4 cm during labor. Nonparametric techniques were used for statistical analysis. Results: 1) In a total of 500 cases of study population, "early ROM" occurred in 43% and the overall cesarean section rate was 15.8%; 2) patients with "early ROM" had a higher rate of cesarean section and cesarean section due to failure to progress than did those with "late ROM'' (overall cesarean section rate: 24%[51/215] vs. 10%[28/285], p<0.01; cesarean section rate due to failure to progress: 18%[38/215] vs. 8%[22/285], p<0.01 for each) and this difference remained significant after adjusting for confounding variables. Conclusion: "Early ROM" during the course of induced labor is a risk factor for cesarean section in term singleton nulliparas.	[Lee, Seung Mi; Park, Jeong Woo; Park, Chan-Wook; Yoon, Bo Hyun] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Lee, Seung Mi] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Obstet & Gynecol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Lee, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.	yoonbh@snu.ac.kr	Yoon, Bo Hyun/H-6344-2011; Park, Chan-Wook/J-5498-2012; PARK, Chan-Wook/G-3663-2013	PARK, Chan-Wook/0000-0002-1290-6438; Park, Jeong Woo/0000-0001-6499-0814				ACOG technical bulletin, 1996, INT J GYNECOL OBSTET, V53, P73; Al Housseini A, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.001; [Anonymous], 2009, OBSTET GYNECOL, V114, P386, DOI [10.1097/AOG.0b013e3181b48ef5, DOI 10.1097/AOG.0B013E3181B48EF5]; [Anonymous], 2003, OBSTET GYNECOL; Boulvain M, 2001, PAEDIATR PERINAT EP, V15, P131; Bueno B, 2007, J PERINATOL, V27, P4, DOI 10.1038/sj.jp.7211619; Cammu H, 2002, AM J OBSTET GYNECOL, V186, P240, DOI 10.1067/mob.2002.119643; Cunningham FG, 2010, WILLIAMS OBSTET; DUFF P, 1983, AM J OBSTET GYNECOL, V147, P391, DOI 10.1016/S0002-9378(16)32231-1; Edris FE, 2006, SAUDI MED J, V27, P1167; Feinstein U, 2002, INT J GYNECOL OBSTET, V77, P7, DOI 10.1016/S0020-7292(02)00007-3; Hin LY, 1999, STAT MED, V18, P1101, DOI 10.1002/(SICI)1097-0258(19990515)18:9<1101::AID-SIM99>3.3.CO;2-H; Hin LY, 1997, OBSTET GYNECOL, V90, P183, DOI 10.1016/S0029-7844(97)00238-X; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Isono W, 2011, J OBSTET GYNAECOL RE, V37, P1784, DOI 10.1111/j.1447-0756.2011.01607.x; Johnson DP, 2003, AM J OBSTET GYNECOL, V188, P1565, DOI 10.1067/mob.2003.458; Kim LH, 2010, J MATERN-FETAL NEO M, V23, P383, DOI 10.3109/14767050903168432; Lee SM, 2011, J MATERN-FETAL NEO M, V24, P37, DOI 10.3109/14767058.2010.482622; Lee SM, 2010, EUR J OBSTET GYN R B, V148, P152, DOI 10.1016/j.ejogrb.2009.10.031; Luthy DA, 2004, AM J OBSTET GYNECOL, V191, P1511, DOI 10.1016/j.ajog.2004.07.001; Manzanares S, 2007, J MATERN-FETAL NEO M, V20, P221, DOI 10.1080/14767050601127391; Maslow AS, 2000, OBSTET GYNECOL, V95, P917, DOI 10.1016/S0029-7844(00)00794-8; Moore LE, 2006, CLIN OBSTET GYNECOL, V49, P698, DOI 10.1097/00003081-200609000-00026; Park HS, 2010, PLACENTA, V31, P792, DOI 10.1016/j.placenta.2010.06.013; Park KH, 2006, J OBSTET GYNAECOL RE, V32, P482, DOI 10.1111/j.1447-0756.2006.00443.x; Peregrine E, 2006, OBSTET GYNECOL, V107, P227, DOI 10.1097/01.AOG.0000196508.11431.c0; SATIN AJ, 1992, OBSTET GYNECOL, V79, P913; Seyb ST, 1999, OBSTET GYNECOL, V94, P600, DOI 10.1016/S0029-7844(99)00377-4; Sheiner E, 2002, ACTA OBSTET GYN SCAN, V81, P222, DOI 10.1034/j.1600-0412.2002.810306.x; SILVER RK, 1986, OBSTET GYNECOL, V68, P587; Vahratian A, 2005, OBSTET GYNECOL, V105, P698, DOI 10.1097/01.AOG.0000157436.68847.3b; Venturini P, 2005, J MATERN-FETAL NEO M, V17, P129, DOI 10.1080/14767050400029566; Verhoeven CJM, 2009, ULTRASOUND OBST GYN, V34, P316, DOI 10.1002/uog.7315; Vrouenraets FPJM, 2005, OBSTET GYNECOL, V105, P690, DOI 10.1097/01.AOG.0000152338.76759.38; Yeast JD, 1999, AM J OBSTET GYNECOL, V180, P628, DOI 10.1016/S0002-9378(99)70265-6; YOON BH, 1995, AM J OBSTET GYNECOL, V172, P960, DOI 10.1016/0002-9378(95)90028-4	36	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39883	10.1371/journal.pone.0039883	http://dx.doi.org/10.1371/journal.pone.0039883			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768153	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100122
J	Levesque, D; Reymond, C; Perreault, JP				Levesque, Dominique; Reymond, Cedric; Perreault, Jean-Pierre			Characterization of the Trans Watson-Crick GU Base Pair Located in the Catalytic Core of the Antigenomic HDV Ribozyme	PLOS ONE			English	Article							HEPATITIS-DELTA-VIRUS; SELF-CLEAVING RIBOZYMES; METAL-ION; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; CLEAVAGE ACTIVITY; RNA; SEQUENCE; SUBSTRATE; SPECIFICITY	The HDV ribozyme's folding pathway is, by far, the most complex folding pathway elucidated to date for a small ribozyme. It includes 6 different steps that have been shown to occur before the chemical cleavage. It is likely that other steps remain to be discovered. One of the most critical of these unknown steps is the formation of the trans Watson-Crick GU base pair within loop III. The U-23 and G(28) nucleotides that form this base pair are perfectly conserved in all natural variants of the HDV ribozyme, and therefore are considered as being part of the signature of HDV-like ribozymes. Both the formation and the transformation of this base pair have been studied mainly by crystal structure and by molecular dynamic simulations. In order to obtain physical support for the formation of this base pair in solution, a set of experiments, including direct mutagenesis, the site-specific substitution of chemical groups, kinetic studies, chemical probing and magnesium-induced cleavage, were performed with the specific goal of characterizing this trans Watson-Crick GU base pair in an antigenomic HDV ribozyme. Both U-23 and G(28) can be substituted for nucleotides that likely preserve some of the H-bond interactions present before and after the cleavage step. The formation of the more stable trans Watson-Crick base pair is shown to be a post-cleavage event, while a possibly weaker trans Watson-Crick/Hoogsteen interaction seems to form before the cleavage step. The formation of this unusually stable post-cleavage base pair may act as a driving force on the chemical cleavage by favouring the formation of a more stable ground state of the product-ribozyme complex. To our knowledge, this represents the first demonstration of a potential stabilising role of a post-cleavage conformational switch event in a ribozyme-catalyzed reaction.	[Levesque, Dominique; Reymond, Cedric; Perreault, Jean-Pierre] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Levesque, D (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1K 2R1, Canada.	Jean-Pierre.Perreault@usherbrooke.ca			Canadian Institute of Health Research (CIHR) [MOP-44022]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institute of Health Research (CIHR; grant number MOP-44022) to JPP. JPP holds the Canada Research Chairs in genomics and catalytic RNAs, and is a member of the Centre de Recherche Clinique Etienne Lebel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Been MD, 2006, CURR TOP MICROBIOL, V307, P47; Chen JH, 2010, BIOCHEMISTRY-US, V49, P6508, DOI 10.1021/bi100670p; Chen JH, 2009, BIOCHEMISTRY-US, V48, P1498, DOI 10.1021/bi8020108; Deschenes P, 2000, ANTISENSE NUCLEIC A, V10, P53, DOI 10.1089/oli.1.2000.10.53; Deschenes P, 2003, NUCLEIC ACIDS RES, V31, P2087, DOI 10.1093/nar/gkg307; Eickbush DG, 2010, MOL CELL BIOL, V30, P3142, DOI 10.1128/MCB.00300-10; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Fiola K, 2002, J BIOL CHEM, V277, P26508, DOI 10.1074/jbc.M203468200; Gopinath SCB, 2009, ANAL CHIM ACTA, V636, P117, DOI 10.1016/j.aca.2009.01.052; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KAZAKOV S, 1991, P NATL ACAD SCI USA, V88, P9193, DOI 10.1073/pnas.88.20.9193; Ke AL, 2004, NATURE, V429, P201, DOI 10.1038/nature02522; Krasovska MV, 2005, J MOL BIOL, V351, P731, DOI 10.1016/j.jmb.2005.06.016; Lafontaine DA, 1999, NUCLEIC ACIDS RES, V27, P3236, DOI 10.1093/nar/27.15.3236; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Leontis NB, 2002, NUCLEIC ACIDS RES, V30, P3497, DOI 10.1093/nar/gkf481; Nehdi A, 2006, NUCLEIC ACIDS RES, V34, P584, DOI 10.1093/nar/gkj463; Nehdi A, 2007, NUCLEIC ACIDS RES, V35, P6820, DOI 10.1093/nar/gkm674; Ouellet J, 2004, RNA, V10, P1059, DOI 10.1261/rna.7230604; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Perrotta AT, 1996, NUCLEIC ACIDS RES, V24, P1314, DOI 10.1093/nar/24.7.1314; Reymond C, 2010, STRUCTURE, V18, P1608, DOI 10.1016/j.str.2010.09.024; Reymond C, 2009, CELL MOL LIFE SCI, V66, P3937, DOI 10.1007/s00018-009-0124-1; Reymond C, 2009, BIOPHYS J, V96, P132, DOI 10.1016/j.bpj.2008.09.033; Rocheleau L, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-24; Salehi-Ashtiani K, 2006, SCIENCE, V313, P1788, DOI 10.1126/science.1129308; Sanchez-Luque FJ, 2011, NUCLEIC ACIDS RES, V39, P8065, DOI 10.1093/nar/gkr478; Tanaka Y, 2002, GENES CELLS, V7, P567, DOI 10.1046/j.1365-2443.2002.00541.x; TANNER NK, 1994, CURR BIOL, V4, P488, DOI 10.1016/S0960-9822(00)00109-3; THILL G, 1993, BIOCHEMISTRY-US, V32, P4254, DOI 10.1021/bi00067a013; Veeraraghavan N, 2011, J PHYS CHEM B, V115, P8346, DOI 10.1021/jp203202e; Veeraraghavan N, 2011, BIOCHEMISTRY-US, V50, P2672, DOI 10.1021/bi2000164; Wadkins TS, 1999, RNA, V5, P720, DOI 10.1017/S1355838299990209; Webb CHT, 2011, RNA BIOL, V8, P719, DOI 10.4161/rna.8.5.16226; Webb CHT, 2009, SCIENCE, V326, P953, DOI 10.1126/science.1178084; Wrzesinski J, 2001, NUCLEIC ACIDS RES, V29, P4482, DOI 10.1093/nar/29.21.4482	36	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40309	10.1371/journal.pone.0040309	http://dx.doi.org/10.1371/journal.pone.0040309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768274	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100248
J	Shang, YS; Ju, WQ; Kong, Y; Schroder, PM; Liang, WH; Ling, XT; Guo, ZY; He, XS				Shang, Yushu; Ju, Weiqiang; Kong, Yuan; Schroder, Paul M.; Liang, Wenhua; Ling, Xiaoting; Guo, Zhiyong; He, Xiaoshun			Performance of Polymerase Chain Reaction Techniques Detecting Perforin in the Diagnosis of Acute Renal Rejection: A Meta-Analysis	PLOS ONE			English	Article							MOLECULE GENE-EXPRESSION; ALLOGRAFT-REJECTION; KIDNEY-TRANSPLANTATION; GRANZYME-B; NONINVASIVE DIAGNOSIS; MESSENGER-RNA; BLOOD; URINE; RECIPIENTS; COMPLICATIONS	Background: Studies in the past have shown that perforin expression is up-regulated during acute renal rejection, which provided hopes for a non-invasive and reliable diagnostic method to identify acute rejection. However, a systematic assessment of the value of perforin as a diagnostic marker of acute renal rejection has not been performed. We conducted this meta-analysis to document the diagnostic performance of perforin mRNA detection and to identify potential variables that may affect the performance. Methodology/Principal Findings: Relevant materials that reported the diagnostic performance of perforin mRNA detection in acute renal rejection patients were extracted from electronic databases. After careful evaluation of the studies included in this analysis, the numbers of true positive, true negative, false positive and false negative cases of acute renal rejection identified by perforin mRNA detection were gathered from each data set. The publication year, sample origin, mRNA quantification method and housekeeping gene were also extracted as potential confounding variables. Fourteen studies with a total of 501 renal transplant subjects were included in this meta-analysis. The overall performance of perforin mRNA detection was: pooled sensitivity, 0.83 (95% confidence interval: 0.78 to 0.88); pooled specificity, 0.86 (95% confidence interval: 0.82 to 0.90); diagnostic odds ratio, 28.79 (95% confidence interval: 16.26 to 50.97); and area under the summary receiver operating characteristic curves value, 0.9107+/-0.0174. The univariate analysis of potential variables showed some changes in the diagnostic performance, but none of the differences reached statistical significance. Conclusions/Significance: Despite inter-study variability, the test performance of perforin mRNA detected by polymerase chain reaction was consistent under circumstances of methodological changes and demonstrated both sensitivity and specificity in detecting acute renal rejection. These results suggest a great diagnostic potential for perforin mRNA detection as a reliable marker of acute rejection in renal allograft recipients.	[Shang, Yushu; Ju, Weiqiang; Kong, Yuan; Liang, Wenhua; Ling, Xiaoting; Guo, Zhiyong; He, Xiaoshun] Sun Yat Sen Univ, Organ Transplant Ctr, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Schroder, Paul M.] Univ Toledo, Dept Med Microbiol & Immunol, Coll Med, Toledo, OH 43606 USA	Sun Yat Sen University; University System of Ohio; University of Toledo	Shang, YS (corresponding author), Sun Yat Sen Univ, Organ Transplant Ctr, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.	rockyucsf1981@126.com; gdtrc@163.com		Wenhua, Liang/0000-0002-1391-8238	National High Technology Research and Development Program of China (863 Program) [2012AA021008]; Key Clinical Project from the Ministry of Health [2010159]; National Natural Science Foundation of China [30972951, 81102244, 81102245, 81170448]; Special Fund for science research by Ministry of Health [201002004]; Research Fund for the Doctoral Program of Higher Education of China by Ministry of Education [20100171110063, 20110171120077]; Science and Technology Planning Key Clinical Project of Guangdong Province [2011A030400005]; Division of Medical Service Management of Ministry of Health	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Key Clinical Project from the Ministry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for science research by Ministry of Health; Research Fund for the Doctoral Program of Higher Education of China by Ministry of Education; Science and Technology Planning Key Clinical Project of Guangdong Province; Division of Medical Service Management of Ministry of Health	This study was supported by the National High Technology Research and Development Program of China (863 Program) (2012AA021008), the Key Clinical Project from the Ministry of Health (2010159), the National Natural Science Foundation of China (30972951, 81102244, 81102245, and 81170448), the Special Fund for science research by Ministry of Health (201002004), the Research Fund for the Doctoral Program of Higher Education of China by Ministry of Education (20100171110063 and 20110171120077), the Science and Technology Planning Key Clinical Project of Guangdong Province (2011A030400005), and Project by Division of Medical Service Management of Ministry of Health(2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Aquino-Dias EC, 2008, KIDNEY INT, V73, P877, DOI 10.1038/sj.ki.5002795; BECKINGHAM IJ, 1994, BRIT J UROL, V73, P13, DOI 10.1111/j.1464-410X.1994.tb07449.x; Colvin RB, 1997, J AM SOC NEPHROL, V8, P1930; Deeks~ JJ, 2001, SYSTEMATIC REV HLTH; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Deville Walter L, 2002, BMC Med Res Methodol, V2, P9, DOI 10.1186/1471-2288-2-9; Dias ECA, 2004, CLIN TRANSPLANT, V18, P281, DOI 10.1111/j.1399-0012.2004.00161.x; Dugre FJ, 2000, TRANSPLANTATION, V70, P1074, DOI 10.1097/00007890-200010150-00014; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Galante NZ, 2006, TRANSPL IMMUNOL, V16, P73, DOI 10.1016/j.trim.2006.03.014; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; HURAIB S, 1989, AM J KIDNEY DIS, V14, P13, DOI 10.1016/S0272-6386(89)80087-3; Li BG, 2001, NEW ENGL J MED, V344, P947, DOI 10.1056/NEJM200103293441301; LICHTENHELD MG, 1988, NATURE, V335, P448, DOI 10.1038/335448a0; LIPMAN ML, 1994, J IMMUNOL, V152, P5120; Lipman ML, 1998, TRANSPLANTATION, V66, P1673, DOI 10.1097/00007890-199812270-00018; MATAS AJ, 1994, TRANSPLANTATION, V57, P857, DOI 10.1097/00007890-199403270-00015; Matas AJ, 1998, TRANSPL P, V30, P1766, DOI 10.1016/S0041-1345(98)00422-9; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Muthukumar T, 2005, NEW ENGL J MED, V353, P2342, DOI 10.1056/NEJMoa051907; Netto MVP, 2002, TRANSPLANT P, V34, P476, DOI 10.1016/S0041-1345(02)02601-5; Nickel P, 2001, TRANSPLANTATION, V72, P1158, DOI 10.1097/00007890-200109270-00031; Ozbay A, 2009, SCAND J IMMUNOL, V69, P357, DOI 10.1111/j.1365-3083.2009.02226.x; PERRELLA RR, 1990, AM J KIDNEY DIS, V15, P544, DOI 10.1016/S0272-6386(12)80524-5; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Rush D, 2009, Transplant Proc, V41, pS6, DOI 10.1016/j.transproceed.2009.06.092; Sabek M, 2002, TRANSPLANTATION, V74, P701, DOI 10.1097/00007890-200209150-00019; Schold JD, 2010, AM J TRANSPLANT, V10, P1163, DOI 10.1111/j.1600-6143.2010.03104.x; Shin GT, 2005, NEPHRON CLIN PRACT, V100, pC63, DOI 10.1159/000085050; Simon T, 2003, AM J TRANSPLANT, V3, P1121, DOI 10.1034/j.1600-6143.2003.00187.x; Strehlau J, 1997, P NATL ACAD SCI USA, V94, P695, DOI 10.1073/pnas.94.2.695; Suthanthiran M, 1997, AM J MED SCI, V313, P264, DOI 10.1097/00000441-199705000-00003; Vasconcellos LM, 1998, TRANSPLANTATION, V66, P562, DOI 10.1097/00007890-199809150-00002; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Yannaraki M, 2006, TRANSPLANT INT, V19, P759, DOI 10.1111/j.1432-2277.2006.00351.x; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31	38	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39610	10.1371/journal.pone.0039610	http://dx.doi.org/10.1371/journal.pone.0039610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768097	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100067
J	Cerbone, A; Toaldo, C; Minelli, R; Ciamporcero, E; Pizzimenti, S; Pettazzoni, P; Roma, G; Dianzani, MU; Ullio, C; Ferretti, C; Dianzani, C; Barrera, G				Cerbone, Angelo; Toaldo, Cristina; Minelli, Rosalba; Ciamporcero, Eric; Pizzimenti, Stefania; Pettazzoni, Piergiorgio; Roma, Guglielmo; Dianzani, Mario Umberto; Ullio, Chiara; Ferretti, Carlo; Dianzani, Chiara; Barrera, Giuseppina			Rosiglitazone and AS601245 Decrease Cell Adhesion and Migration through Modulation of Specific Gene Expression in Human Colon Cancer Cells	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; PPAR-GAMMA; PROLIFERATOR; METALLOTHIONEIN; INHIBITION; LIGAND; THIAZOLIDINEDIONE; DIFFERENTIATION; IDENTIFICATION; GROWTH	PPARs are nuclear receptors activated by ligands. Activation of PPAR gamma leads to a reduction of adhesion and motility in some cancer models. PPAR gamma transcriptional activity can be negatively regulated by JNK-mediated phosphorylation. We postulated that the use of agents able to inhibit JNK activity could increase the effectiveness of PPAR gamma ligands. We analysed the effects of rosiglitazone (PPAR gamma ligand) and AS601245 (a selective JNK inhibitor) alone or in association on adhesion and migration of CaCo-2, HT29, and SW480 human colon cancer cells and investigated, through microarray analysis, the genes involved in these processes. Cell adhesion and migration was strongly inhibited by rosiglitazone and AS601245. Combined treatment with the two compounds resulted in a greater reduction of the adhesion and migration capacity. Affymetrix analysis in CaCo-2 cells revealed that some genes which were highly modulated by the combined treatment could be involved in these biological responses. Rosiglitazone, AS601245 and combined treatment down-regulated the expression of fibrinogen chains in all three cell lines. Moreover, rosiglitazone, alone or in association with AS601245, caused a decrease in the fibrinogen release. ARHGEF7/beta-PIX gene was highly down-regulated by combined treatment, and western blot analysis revealed that beta-PIX protein is down-modulated in CaCo-2, HT29 and SW480 cells, also. Transfection of cells with beta-PIX gene completely abrogated the inhibitory effect on cell migration, determined by rosiglitazone, AS601245 and combined treatment. Results demonstrated that beta-PIX protein is involved in the inhibition of cell migration and sustaining the positive interaction between PPAR gamma ligands and anti-inflammatory agents in humans.	[Cerbone, Angelo; Roma, Guglielmo] Ist Ric Biomed A Marxer, MerckSerono Ivrea RBM SpA, Turin, Italy; [Toaldo, Cristina; Ciamporcero, Eric; Pizzimenti, Stefania; Pettazzoni, Piergiorgio; Dianzani, Mario Umberto; Ullio, Chiara; Barrera, Giuseppina] Univ Turin, Dept Med & Expt Oncol, Sect Gen Pathol, Turin, Italy; [Minelli, Rosalba; Ferretti, Carlo; Dianzani, Chiara] Univ Turin, Dept Sci & Pharmaceut Technol, Turin, Italy	University of Turin; University of Turin	Cerbone, A (corresponding author), Ist Ric Biomed A Marxer, MerckSerono Ivrea RBM SpA, Turin, Italy.	giuseppina.barrera@unito.it	Ciamporcero, Eric/M-6580-2017; Pizzimenti, Stefania/AAB-8250-2022; Pettazzoni, Piergiorgio/GRJ-3011-2022	Ciamporcero, Eric/0000-0002-3856-6435; Pizzimenti, Stefania/0000-0001-6937-8632; Dianzani, Chiara/0000-0002-2246-3183	Regione Piemonte; Universita degli Studi di Torino	Regione Piemonte(Regione Piemonte); Universita degli Studi di Torino	This work was supported by grants from Regione Piemonte (http://www.ricerca-sanitaria-finalizzata.it/) and Universita degli Studi di Torino (http://www.unito.it/unitoWAR/page/istituzionale/ricerca1/Ricerca_601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atrian S, 2009, METALLOTHIONEINS REL; Barrera G, 2008, PPAR RES, V2008, DOI 10.1155/2008/524671; Burgermeister E, 2007, CELL CYCLE, V6, P1539, DOI 10.4161/cc.6.13.4453; Burgermeister E, 2007, MOL CELL BIOL, V27, P803, DOI 10.1128/MCB.00601-06; Camp HS, 1999, ENDOCRINOLOGY, V140, P392, DOI 10.1210/en.140.1.392; Carter JC, 2011, J ONCOL, V2011, DOI 10.1155/2011/594258; Chacko BK, 2011, J BIOL CHEM, V286, P38738, DOI 10.1074/jbc.M111.247981; Chintharlapalli S, 2006, MOL CANCER THER, V5, P1362, DOI 10.1158/1535-7163.MCT-06-0002; Cimini AM, 2005, INT J CANCER, V117, P923, DOI 10.1002/ijc.21272; Dianzani C, 2003, BRIT J PHARMACOL, V139, P1103, DOI 10.1038/sj.bjp.0705344; Diradourian C, 2005, BIOCHIMIE, V87, P33, DOI 10.1016/j.biochi.2004.11.010; Dubuquoy L, 2006, GUT, V55, P1341, DOI 10.1136/gut.2006.093484; Farnesi-de-Assuncao TS, 2012, CELL IMMUNOL, V273, P23, DOI 10.1016/j.cellimm.2011.11.010; Ferrandi C, 2004, BRIT J PHARMACOL, V142, P953, DOI 10.1038/sj.bjp.0705873; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Genini D, 2006, J RECEPT SIG TRANSD, V26, P679, DOI 10.1080/10799890600928202; Hsu HH, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-61; Jackson L, 2003, GUT, V52, P1317, DOI 10.1136/gut.52.9.1317; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Janssen AML, 2002, CLIN CANCER RES, V8, P1889; Kaoud TS, 2011, ACS CHEM BIOL, V6, P658, DOI 10.1021/cb200017n; KARIN M, 1979, SCIENCE, V204, P176, DOI 10.1126/science.432639; Koh SH, 2011, STEM CELLS IN PRESS; Kumari MVR, 1998, FREE RADICAL RES, V29, P93, DOI 10.1080/10715769800300111; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lemay DG, 2006, J LIPID RES, V47, P1583, DOI 10.1194/jlr.M500504-JLR200; Marin HE, 2006, CANCER RES, V66, P4394, DOI 10.1158/0008-5472.CAN-05-4277; McAlpine CA, 2006, INT J CANCER, V119, P2339, DOI 10.1002/ijc.22115; Nakajima A, 2008, CANCER SCI, V99, P1892, DOI 10.1111/j.1349-7006.2008.00904.x; Ogino S, 2009, GASTROENTEROLOGY, V136, P1242, DOI 10.1053/j.gastro.2008.12.048; Pedersen MO, 2009, PROG HISTOCHEM CYTO, V44, P29, DOI 10.1016/j.proghi.2008.10.001; Reddy RC, 2008, BLOOD, V112, P4250, DOI 10.1182/blood-2007-12-128967; Staton CA, 2003, EXPERT OPIN BIOL TH, V3, P1105, DOI 10.1517/eobt.3.7.1105.21272; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; SUMMER KH, 1989, BIOL TRACE ELEM RES, V21, P165, DOI 10.1007/BF02917248; Takayama T, 2009, J MED INVESTIG, V56, P1, DOI 10.2152/jmi.56.1; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Theocharis S, 2007, DIGEST DIS SCI, V52, P2305, DOI 10.1007/s10620-007-9794-4; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; Yamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x; Yoshizumi T, 2004, INT J ONCOL, V25, P631	43	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e40149	10.1371/journal.pone.0040149	http://dx.doi.org/10.1371/journal.pone.0040149			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761953	gold, Green Published, Green Submitted			2022-12-27	WOS:000305826400057
J	Flores, R; Shi, JX; Gail, MH; Gajer, P; Ravel, J; Goedert, JJ				Flores, Roberto; Shi, Jianxin; Gail, Mitchell H.; Gajer, Pawel; Ravel, Jacques; Goedert, James J.			Association of Fecal Microbial Diversity and Taxonomy with Selected Enzymatic Functions	PLOS ONE			English	Article							BETA-GLUCURONIDASE; GUT MICROBIOME; HUMAN FECES; GLUCOSIDASE; EXPRESSION; BACTERIA; ENZYMES	Few microbial functions have been compared to a comprehensive survey of the human fecal microbiome. We evaluated determinants of fecal microbial beta-glucuronidase and beta-glucosidase activities, focusing especially on associations with microbial alpha and beta diversity and taxonomy. We enrolled 51 healthy volunteers (26 female, mean age 39) who provided questionnaire data and multiple aliquots of a stool, from which proteins were extracted to quantify beta-glucuronidase and beta-glucosidase activities, and DNA was extracted to amplify and pyrosequence 16S rRNA gene sequences to classify and quantify microbiome diversity and taxonomy. Fecal beta-glucuronidase was elevated with weight loss of at least 5 lb. (P = 0.03), whereas beta-glucosidase was marginally reduced in the four vegetarians (P = 0.06). Both enzymes were correlated directly with microbiome richness and alpha diversity measures, directly with the abundance of four Firmicutes Clostridia genera, and inversely with the abundance of two other genera (Firmicutes Lactobacillales Streptococcus and Bacteroidetes Rikenellaceae Alistipes) (all P = 0.05-0.0001). Beta diversity reflected the taxonomic associations. These observations suggest that these enzymatic functions are performed by particular taxa and that diversity indices may serve as surrogates of bacterial functions. Independent validation and deeper understanding of these associations are needed, particularly to characterize functions and pathways that may be amenable to manipulation.	[Flores, Roberto; Goedert, James J.] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA; [Flores, Roberto] NCI, Canc Prevent Fellowship Program, Rockville, MD USA; [Shi, Jianxin; Gail, Mitchell H.] NCI, Biostat Branch, Div Canc Epidemiol & Genet, Rockville, MD USA; [Gajer, Pawel; Ravel, Jacques] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore	Flores, R (corresponding author), NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA.	floresr2@mail.nih.gov	Ravel, Jacques/D-2530-2009	Ravel, Jacques/0000-0002-0851-2233	National Cancer Institute, National Institutes of Health [Z01-CP010214]; NATIONAL CANCER INSTITUTE [ZIACP010214] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project (Z01-CP010214) was funded by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barone Michele, 2012, J Gastrointest Cancer, V43, P13, DOI 10.1007/s12029-011-9332-7; COLE CB, 1985, J APPL BACTERIOL, V59, P549, DOI 10.1111/j.1365-2672.1985.tb03359.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dabek M, 2008, FEMS MICROBIOL ECOL, V66, P487, DOI 10.1111/j.1574-6941.2008.00520.x; Flores R, 2012, EUR J CLIN INVEST, V42, P848, DOI 10.1111/j.1365-2362.2012.02660.x; Flores R, 2012, EUR J CLIN INVEST, V42, P855, DOI 10.1111/j.1365-2362.2012.02659.x; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gloux K, 2011, P NATL ACAD SCI USA, V108, P4539, DOI 10.1073/pnas.1000066107; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Key TJ, 2011, BRIT J CANCER, V105, P709, DOI 10.1038/bjc.2011.254; Koning CJM, 2008, AM J GASTROENTEROL, V103, P178, DOI 10.1111/j.1572-0241.2007.01547.x; LING WH, 1992, J NUTR, V122, P924, DOI 10.1093/jn/122.4.924; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; McIntosh FM, 2012, ENVIRON MICROBIOL, V14, P1876, DOI 10.1111/j.1462-2920.2012.02711.x; Mroczynska M, 2010, POL J MICROBIOL, V59, P265; Nakamura J, 2002, MICROBIOL IMMUNOL, V46, P487, DOI 10.1111/j.1348-0421.2002.tb02723.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Relman DA, 2011, NEW ENGL J MED, V365, P347, DOI 10.1056/NEJMra1003071; Stringer AM, 2008, CANCER BIOL THER, V7, P1919, DOI 10.4161/cbt.7.12.6940; Tryland I, 1998, APPL ENVIRON MICROB, V64, P1018; Turnbaugh PJ, 2010, ACTA CRYSTALLOGR F, V66, P1261, DOI 10.1107/S1744309110029088; Zhu BL, 2010, PROTEIN CELL, V1, P718, DOI 10.1007/s13238-010-0093-z	22	39	41	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39745	10.1371/journal.pone.0039745	http://dx.doi.org/10.1371/journal.pone.0039745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761886	gold, Green Submitted, Green Published			2022-12-27	WOS:000305826400034
J	Feig, JE; Vengrenyuk, Y; Reiser, V; Wu, CW; Statnikov, A; Aliferis, CF; Garabedian, MJ; Fisher, EA; Puig, O				Feig, Jonathan E.; Vengrenyuk, Yuliya; Reiser, Vladimir; Wu, Chaowei; Statnikov, Alexander; Aliferis, Constantin F.; Garabedian, Michael J.; Fisher, Edward A.; Puig, Oscar			Regression of Atherosclerosis Is Characterized by Broad Changes in the Plaque Macrophage Transcriptome	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN-CHOLESTEROL; MARKOV BLANKET INDUCTION; MONOCYTE-DERIVED CELLS; APOE-DEFICIENT MICE; APOLIPOPROTEIN-E; GENE-EXPRESSION; FEATURE-SELECTION; CAUSAL DISCOVERY; RAPID REGRESSION; LOCAL CAUSAL	We have developed a mouse model of atherosclerotic plaque regression in which an atherosclerotic aortic arch from a hyperlipidemic donor is transplanted into a normolipidemic recipient, resulting in rapid elimination of cholesterol and monocyte-derived macrophage cells (CD68+) from transplanted vessel walls. To gain a comprehensive view of the differences in gene expression patterns in macrophages associated with regressing compared with progressing atherosclerotic plaque, we compared mRNA expression patterns in CD68+ macrophages extracted from plaque in aortic aches transplanted into normolipidemic or into hyperlipidemic recipients. In CD68+ cells from regressing plaque we observed that genes associated with the contractile apparatus responsible for cellular movement (e. g. actin and myosin) were up-regulated whereas genes related to cell adhesion (e.g. cadherins, vinculin) were down-regulated. In addition, CD68+ cells from regressing plaque were characterized by enhanced expression of genes associated with an anti-inflammatory M2 macrophage phenotype, including arginase I, CD163 and the C-lectin receptor. Our analysis suggests that in regressing plaque CD68+ cells preferentially express genes that reduce cellular adhesion, enhance cellular motility, and overall act to suppress inflammation.	[Feig, Jonathan E.; Vengrenyuk, Yuliya; Fisher, Edward A.] NYU, Sch Med, Dept Med, Div Cardiol, New York, NY 10012 USA; [Feig, Jonathan E.; Vengrenyuk, Yuliya; Fisher, Edward A.] NYU, Sch Med, Dept Med, Marc & Ruti Bell Program Vasc Biol, New York, NY USA; [Reiser, Vladimir] Merck Res Labs, Dept Cardiovasc Dis, Rahway, NJ USA; [Wu, Chaowei; Garabedian, Michael J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Statnikov, Alexander; Aliferis, Constantin F.] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY USA; [Statnikov, Alexander] NYU, Sch Med, Dept Med, Div Translat Med, New York, NY USA; [Aliferis, Constantin F.] NYU, Sch Med, Dept Pathol, New York, NY USA; [Puig, Oscar] Merck Res Labs, Informat & Anal, Kenilworth, NJ USA	New York University; New York University; Merck & Company; New York University; New York University; New York University; New York University; Merck & Company	Feig, JE (corresponding author), NYU, Sch Med, Dept Med, Div Cardiol, New York, NY 10012 USA.	edward.fisher@nyumc.org; oscar.puig@roche.com	Puig, Oscar/ABG-3370-2021; Fisher, Edward/ABE-7469-2020; Puig, Oscar/GVR-8557-2022	Puig, Oscar/0000-0003-0918-2528; Fisher, Edward/0000-0001-9802-143X	National Institutes of Heatlh [HL-084312, AG-029748, T32HL098129, R56 LM007948-04A1, 1UL1RR029893]; Philip Morris USA; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098129, R01HL084312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG029748] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R56LM007948] Funding Source: NIH RePORTER	National Institutes of Heatlh; Philip Morris USA; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by National Institutes of Heatlh grant HL-084312 (EAF), NIH fellowship AG-029748 (JEF), NIH training grant T32HL098129 (YV), NIH grant R56 LM007948-04A1 (AS and CFA), NIH grant 1UL1RR029893 (AS and CFA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Vladimir Reiser and Oscar Puig worked for Merck at the time the research was carried out. Dr Garabedian has previously received research funds from Philip Morris USA, for research projects not related to the study reported in the manuscript. The remaining authors do not have any competing interests. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aliferis CF, 2010, J MACH LEARN RES, V11, P171; Aliferis CF, 2010, J MACH LEARN RES, V11, P235; Aliferis CF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004922; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Chen SN, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-111; Chereshnev I, 2003, J SURG RES, V111, P171, DOI 10.1016/S0022-4804(03)00039-8; Choudhury RP, 2004, ARTERIOSCL THROM VAS, V24, P1904, DOI 10.1161/01.ATV.0000142808.34602.25; Feig JE, 2011, P NATL ACAD SCI USA, V108, P7166, DOI 10.1073/pnas.1016086108; Feig JE, 2011, CIRCULATION, V123, P989, DOI 10.1161/CIRCULATIONAHA.110.984146; Gaziano TA, 2005, CIRCULATION, V112, P3547, DOI 10.1161/CIRCULATIONAHA.105.591792; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; GRUNDY SM, 1986, JAMA-J AM MED ASSOC, V256, P2849, DOI 10.1001/jama.256.20.2849; Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, P1329, DOI 10.1161/01.ATV.0000139012.45265.e0; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; LAROSA JC, 1970, BIOCHEM BIOPH RES CO, V41, P57, DOI 10.1016/0006-291X(70)90468-7; Lieu HD, 2003, CIRCULATION, V107, P1315, DOI 10.1161/01.CIR.0000054781.50889.0C; Llodra J, 2004, P NATL ACAD SCI USA, V101, P11779, DOI 10.1073/pnas.0403259101; McMahan CA, 2007, ATHEROSCLEROSIS, V190, P370, DOI 10.1016/j.atherosclerosis.2006.02.008; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; OTTO JJ, 1990, CELL MOTIL CYTOSKEL, V16, P1, DOI 10.1002/cm.970160102; Puig O, 2010, PHYSIOL GENOMICS, V42A, P24, DOI 10.1152/physiolgenomics.00010.2010; Rong JX, 2001, CIRCULATION, V104, P2447, DOI 10.1161/hc4501.098952; Skogsberg J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000036; Sugiura Y, 2010, J BIOL CHEM, V285, P7135, DOI 10.1074/jbc.M109.082545; Trogan E, 2002, P NATL ACAD SCI USA, V99, P2234, DOI 10.1073/pnas.042683999; Trogan E, 2004, ARTERIOSCL THROM VAS, V24, P1714, DOI 10.1161/01.ATV.0000139313.69015.1c; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Williams KJ, 2008, NAT CLIN PRACT CARD, V5, P91, DOI 10.1038/ncpcardio1086; Williams KJ, 2007, CURR OPIN LIPIDOL, V18, P443, DOI 10.1097/MOL.0b013e32823bcb15; Winrow CJ, 2009, BRAIN RES, V1271, P1, DOI 10.1016/j.brainres.2009.02.083; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	34	85	90	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39790	10.1371/journal.pone.0039790	http://dx.doi.org/10.1371/journal.pone.0039790			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761902	Green Submitted, Green Published, gold			2022-12-27	WOS:000305825800070
J	Lapointe-Shaw, L; Fischer, HD; Newman, A; John-Baptiste, A; Anderson, GM; Rochon, PA; Bell, CM				Lapointe-Shaw, Lauren; Fischer, Hadas D.; Newman, Alice; John-Baptiste, Ava; Anderson, Geoffrey M.; Rochon, Paula A.; Bell, Chaim M.			Potential Savings of Harmonising Hospital and Community Formularies for Chronic Disease Medications Initiated in Hospital	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITORS; PROTON PUMP INHIBITORS; CLOPIDOGREL; DISCONTINUATION; PREVENTION; GUIDELINES; MANAGEMENT; CORONARY; OUTCOMES; UPDATE	Background: Hospitals in Canada manage their formularies independently, yet many inpatients are discharged on medications which will be purchased through publicly-funded programs. We sought to determine how much public money could be saved on chronic medications if hospitals promoted the initiation of agents with the lowest outpatient formulary prices. Methods: We used administrative databases for the province of Ontario to identify patients initiated on a proton pump inhibitor (PPI), angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) following hospital admission from April 1st 2008-March 31st 2009. We assessed the cost to the Ontario Drug Benefit Program (ODB) over the year following initiation and determined the cost savings if prescriptions were substituted with the least expensive agent in each class. Results: The cost for filling all PPI, ACE inhibitor and ARB prescriptions was $2.48 million, $968 thousand and $325 thousand respectively. Substituting the least expensive agent could have saved $1.16 million (47%) for PPIs, $162 thousand (17%) for ACE inhibitors and $14 thousand (4%) for ARBs over the year following discharge. Interpretation: In a setting where outpatient prescriptions are publicly funded, harmonising outpatient formularies with inpatient therapeutic substitution resulted in modest cost savings and may be one way to control rising pharmaceutical costs.	[Lapointe-Shaw, Lauren; Rochon, Paula A.; Bell, Chaim M.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Fischer, Hadas D.; Newman, Alice; Anderson, Geoffrey M.; Rochon, Paula A.; Bell, Chaim M.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [John-Baptiste, Ava; Anderson, Geoffrey M.; Rochon, Paula A.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON M5S 1B2, Canada; [Anderson, Geoffrey M.; Rochon, Paula A.; Bell, Chaim M.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Bell, Chaim M.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Lapointe-Shaw, L (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	bellc@smh.ca	Rochon, Paula A/J-2918-2016; Lapointe-Shaw, Lauren/ABG-2601-2021; Bell, Chaim/C-4611-2015	Rochon, Paula A/0000-0002-5973-4151; Bell, Chaim/0000-0002-3778-9469; John-Baptiste, Ava/0000-0001-6108-1105; Lapointe-Shaw, Lauren/0000-0003-4485-6719	Canadian Institutes of Health Research Institute of Nutrition, Metabolism and Diabetes [OTG-88591]; Canadian Institutes of Health Research; Canadian Patient Safety Institute chair in Patient Safety and Continuity of Care; Ontario Ministry of Health and Long-Term Care (MOHLTC)	Canadian Institutes of Health Research Institute of Nutrition, Metabolism and Diabetes(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Patient Safety Institute chair in Patient Safety and Continuity of Care; Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This work was supported by a Team Grant (OTG-88591) from the Canadian Institutes of Health Research Institute of Nutrition, Metabolism and Diabetes. CMB is supported by a Canadian Institutes of Health Research and Canadian Patient Safety Institute chair in Patient Safety and Continuity of Care. This study was conducted at the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. The corresponding author had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data anaylsis.	Aaserud M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005979; Angiolillo DJ, 2001, CLIN PHARMACOL THER, V89, P65; Armstrong D, 2005, CAN J GASTROENTEROL, V19, P15, DOI 10.1155/2005/836030; BALLIN JC, 1987, JAMA-J AM MED ASSOC, V257, P528, DOI 10.1001/jama.257.4.528; Bell C, 2010, GENERIC DRUG PRICING; Bell CM, 2007, CAN J HOSP PHARM, V60, P315; Bell CM, 2011, JAMA-J AM MED ASSOC, V306, P840, DOI 10.1001/jama.2011.1206; Bell CM, 2007, J GEN INTERN MED, V22, P1024, DOI 10.1007/s11606-007-0194-4; Bell CM, 2006, ARCH INTERN MED, V166, P2525, DOI 10.1001/archinte.166.22.2525; Boockvar K, 2004, ARCH INTERN MED, V164, P545, DOI 10.1001/archinte.164.5.545; Canadian Institute for Health Information Research Institute, 2010, HEALTHC CAN 2010; Furuta T, 2010, BRIT J CLIN PHARMACO, V70, P383, DOI 10.1111/j.1365-2125.2010.03717.x; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Gordon Guyatt, 2001, DONT ALLOW DRUG FIRM; Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261; Howlett K., 2010, GLOBE MAIL; Jackevicius CA, 2008, CIRCULATION, V117, P1028, DOI 10.1161/CIRCULATIONAHA.107.706820; Jackevicius CA, 2009, CAN MED ASSOC J, V181, pE19, DOI 10.1503/cmaj.081913; Lambert M, 2011, AM FAM PHYSICIAN, V83, P993; Levine S, 2000, HEALTH AFFAIR, V19, P185, DOI 10.1377/hlthaff.19.2.185; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Menon D, 2001, HEALTH AFFAIR, V20, P92, DOI 10.1377/hlthaff.20.3.92; Metge C, 2003, PHARM THERAPEUTIC IN; Ministry of Health and Long-Term Care, LEG DRUG SYST REF; Ministry of Health and Long-Term Care, 2007, 2007 2008 INT REP CA; Ministry of Health and Long-Term Care, FORM DOWNL ED 41; Ministry of Health and Long-Term Care, ONT DRUG BEN PROGR; Morgan SG, 2003, HEALTH AFFAIR, V22, P49, DOI 10.1377/hlthaff.22.3.49; Pilote L, 2004, ANN INTERN MED, V141, P102, DOI 10.7326/0003-4819-141-2-200407200-00008; Public Health Agency of Canada, 2005, LEAD CAUS DEATH HOSP; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Richardson S P, 1991, Dimens Health Serv, V68, P17; Schneeweiss S, 2002, CAN MED ASSOC J, V167, P1250; Schneeweiss S, 2002, CAN MED ASSOC J, V166, P737; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Tordoff JM, 2008, VALUE HEALTH, V11, P1214, DOI 10.1111/j.1524-4733.2008.00353.x; Williams J., 1996, PATTERNS HEALTHCARE, P339; World Health Organization, DEF DAIL DOS DDD IND	38	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39737	10.1371/journal.pone.0039737	http://dx.doi.org/10.1371/journal.pone.0039737			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761882	Green Published, gold, Green Submitted			2022-12-27	WOS:000305808700046
J	Augusto, DG; Lobo-Alves, SC; Melo, MF; Pereira, NF; Petzl-Erler, ML				Augusto, Danillo G.; Lobo-Alves, Sara C.; Melo, Marcia F.; Pereira, Noemi F.; Petzl-Erler, Maria Luiza			Activating KIR and HLA Bw4 Ligands Are Associated to Decreased Susceptibility to Pemphigus Foliaceus, an Autoimmune Blistering Skin Disease	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; IMMUNOGLOBULIN-LIKE RECEPTORS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; FOGO-SELVAGEM; CLASS-I; ANKYLOSING-SPONDYLITIS; AMERINDIAN RESERVATION; GENETIC POLYMORPHISMS; PSORIATIC-ARTHRITIS; HIGH PREVALENCE	The KIR genes and their HLA class I ligands have thus far not been investigated in pemphigus foliaceus (PF) and related autoimmune diseases, such as pemphigus vulgaris. We genotyped 233 patients and 204 controls for KIR by PCR-SSP. HLA typing was performed by LABType SSO reagent kits. We estimated the odds ratio, 95% confidence interval and performed logistic regression analyses to test the hypothesis that KIR genes and their known ligands influence susceptibility to PF. We found significant negative association between activating genes and PF. The activating KIR genes may have an overlapping effect in the PF susceptibility and the presence of more than three activating genes was protective (OR = 0.49, p = 0.003). A strong protective association was found for higher ratios activating/inhibitory KIR (OR = 0.44, p = 0.001). KIR3DS1 and HLA-Bw4 were negatively associated to PF either isolated or combined, but higher significance was found for the presence of both together (OR = 0.34, p<10(-3)) suggesting that the activating function is the major factor to interfere in the PF pathogenesis. HLA-Bw4 (80I and 80T) was decreased in patients. There is evidence that HLA-Bw4(80T) may also be important as KIR3DS1 ligand, being the association of this pair (OR = 0.07, p = 0.001) stronger than KIR3DS1-Bw4(80I) (OR = 0.31, p = 0.002). Higher levels of activating KIR signals appeared protective to PF. The activating KIR genes have been commonly reported to increase the risk for autoimmunity, but particularities of endemic PF, like the well documented influence the environmental exposure in the pathogenesis of this disease, may be the reason why activated NK cells probably protect against pemphigus foliaceus.	[Augusto, Danillo G.; Lobo-Alves, Sara C.; Petzl-Erler, Maria Luiza] Univ Fed Parana, Dept Genet, Lab Genet Mol Humana, BR-80060000 Curitiba, Parana, Brazil; [Melo, Marcia F.; Pereira, Noemi F.] Univ Fed Parana, Lab Imunogenet, Hosp Clin, BR-80060000 Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Federal do Parana	Augusto, DG (corresponding author), Univ Fed Parana, Dept Genet, Lab Genet Mol Humana, BR-80060000 Curitiba, Parana, Brazil.	perler@ufpr.br	Augusto, Danillo G/H-8179-2019; Petzl-Erler, Maria Luiza/H-8221-2012; Augusto, Danillo/F-3147-2013	Augusto, Danillo G/0000-0001-5665-8547; Petzl-Erler, Maria Luiza/0000-0002-0345-5276; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); PRONEX; Institutos do Milenio; Fundacao Araucaria; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PRONEX; Institutos do Milenio; Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This project received financial support from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), PRONEX, Institutos do Milenio, Fundacao Araucaria, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Aoki V, 2004, J INVEST DERM SYMP P, V9, P34, DOI 10.1111/j.1087-0024.2004.00833.x; Augusto DG, 2012, IMMUNOGENETICS, V64, P143, DOI 10.1007/s00251-011-0565-1; Braun-Prado K, 2000, TISSUE ANTIGENS, V56, P417, DOI 10.1034/j.1399-0039.2000.560504.x; Carr WH, 2005, J IMMUNOL, V175, P5222, DOI 10.4049/jimmunol.175.8.5222; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; Chidgey M, 2002, HISTOL HISTOPATHOL, V17, P1179, DOI 10.14670/HH-17.1179; Eaton DP, 1998, J MED ENTOMOL, V35, P120, DOI 10.1093/jmedent/35.2.120; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faure M, 2002, J IMMUNOL, V168, P6208, DOI 10.4049/jimmunol.168.12.6208; Foley B, 2008, INT IMMUNOL, V20, P555, DOI 10.1093/intimm/dxn013; Garcia-Leon JA, 2011, MOL IMMUNOL, V48, P1896, DOI 10.1016/j.molimm.2011.05.018; Gumperz JE, 1997, J IMMUNOL, V158, P5237; Hans G, 1996, J INVEST DERMATOL, V107, P68, DOI 10.1111/1523-1747.ep12298213; Hsu KC, 2002, J IMMUNOL, V169, P5118, DOI 10.4049/jimmunol.169.9.5118; Jiao YL, 2008, J CLIN IMMUNOL, V28, P343, DOI 10.1007/s10875-008-9183-6; Karlsen TH, 2007, J HEPATOL, V46, P899, DOI 10.1016/j.jhep.2007.01.032; Kikuchi-Maki A, 2003, J IMMUNOL, V171, P3415, DOI 10.4049/jimmunol.171.7.3415; Kimoto Y, 2010, RHEUMATOLOGY, V49, P1346, DOI 10.1093/rheumatology/keq050; Kulkarni S, 2010, METHODS MOL BIOL, V612, P365, DOI 10.1007/978-1-60761-362-6_25; Kulkarni S, 2008, SEMIN IMMUNOL, V20, P343, DOI 10.1016/j.smim.2008.06.003; Luszczek W, 2004, HUM IMMUNOL, V65, P758, DOI 10.1016/j.humimm.2004.05.008; Malheiros D, 2009, GENES IMMUN, V10, P547, DOI 10.1038/gene.2009.36; MANTEL N, 1959, J NATL CANCER I, V22, P719; Martin MP, 2002, J IMMUNOL, V169, P2818, DOI 10.4049/jimmunol.169.6.2818; Moesta AK, 2010, J IMMUNOL, V185, P4233, DOI 10.4049/jimmunol.1001951; Nikitina-Zake L, 2004, ANN NY ACAD SCI, V1037, P161, DOI 10.1196/annals.1337.027; Parham P, 2005, MOL IMMUNOL, V42, P459, DOI 10.1016/j.molimm.2004.07.027; Parham P, 2004, IMMUNOL LETT, V92, P11, DOI 10.1016/j.imlet.2003.11.016; Pavoni DP, 2006, BRAZ J MED BIOL RES, V39, P1227, DOI 10.1590/S0100-879X2006000900010; Pavoni DP, 2003, GENES IMMUN, V4, P110, DOI 10.1038/sj.gene.6363939; Pellett F, 2007, TISSUE ANTIGENS, V69, P106, DOI 10.1111/j.1399-0039.2006.762_6.x; Pereira NF, 2004, CYTOKINE, V28, P233, DOI 10.1016/j.cyto.2004.08.006; Petz-Erler ML, 2005, J AUTOIMMUN, V25, P121, DOI 10.1016/j.jaut.2005.08.001; PETZLERLER ML, 1989, TISSUE ANTIGENS, V33, P408, DOI 10.1111/j.1399-0039.1989.tb01684.x; Pincerati MR, 2010, GENET MOL BIOL, V33, P442, DOI 10.1590/S1415-47572010005000073; Probst CM, 2000, HUM BIOL, V72, P597; SAMPAIO SAP, 1994, DERMATOL CLIN, V12, P765, DOI 10.1016/S0733-8635(18)30140-2; Schleinitz N, 2010, IMMUNOLOGY, V131, P451, DOI 10.1111/j.1365-2567.2010.03360.x; Sekiguchi M, 2001, J IMMUNOL, V167, P5439, DOI 10.4049/jimmunol.167.9.5439; Shi FD, 2000, NAT IMMUNOL, V1, P245, DOI 10.1038/79792; Stern JNH, 2008, CLIN EXP IMMUNOL, V152, P472, DOI 10.1111/j.1365-2249.2008.03638.x; Suzuki Y, 2004, J INVEST DERMATOL, V122, P1133, DOI 10.1111/j.0022-202X.2004.22517.x; Tajik N, 2011, INT J IMMUNOGENET, V38, P403, DOI 10.1111/j.1744-313X.2011.01024.x; Takahashi H, 2007, J INVEST DERMATOL, V127, P324, DOI 10.1038/sj.jid.5700527; Thananchai H, 2007, J IMMUNOL, V178, P33, DOI 10.4049/jimmunol.178.1.33; Trundley AE, 2006, IMMUNOGENETICS, V57, P904, DOI 10.1007/s00251-005-0060-7; Uhrberg M, 2002, IMMUNOGENETICS, V54, P221, DOI 10.1007/s00251-002-0463-7; van der Slik AR, 2007, TISSUE ANTIGENS, V69, P101, DOI 10.1111/j.1399-0039.2006.762_5.x; Vilches C, 2007, TISSUE ANTIGENS, V70, P415, DOI 10.1111/j.1399-0039.2007.00923.x; von Bubnoff D, 2010, J ALLERGY CLIN IMMUN, V125, P60, DOI 10.1016/j.jaci.2009.11.020; Williams F, 2005, HUM IMMUNOL, V66, P836, DOI 10.1016/j.humimm.2005.04.005; Winter CC, 1998, J IMMUNOL, V161, P571; Yen JH, 2001, J EXP MED, V193, P1159, DOI 10.1084/jem.193.10.1159; Yusa S, 2002, J IMMUNOL, V168, P5047, DOI 10.4049/jimmunol.168.10.5047	55	56	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39991	10.1371/journal.pone.0039991	http://dx.doi.org/10.1371/journal.pone.0039991			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768326	Green Submitted, gold, Green Published			2022-12-27	WOS:000305966500039
J	Finan, K; Torella, JP; Kapanidis, AN; Cook, PR				Finan, Kieran; Torella, Joseph P.; Kapanidis, Achillefs N.; Cook, Peter R.			T7 RNA Polymerase Functions In Vitro without Clustering	PLOS ONE			English	Article							ELONGATION COMPLEXES; TRANSCRIPTION ELONGATION; REPLICATION FACTORIES; ESCHERICHIA-COLI; STRUCTURAL BASIS; STATE KINETICS; DNA-POLYMERASE; INITIATION; BACTERIOPHAGE-T7; VISUALIZATION	Many nucleic acid polymerases function in clusters known as factories. We investigate whether the RNA polymerase ( RNAP) of phage T7 also clusters when active. Using 'pulldowns' and fluorescence correlation spectroscopy we find that elongation complexes do not interact in vitro with a K-d < 1 mu M. Chromosome conformation capture also reveals that genes located 100 kb apart on the E. coli chromosome do not associate more frequently when transcribed by T7 RNAP. We conclude that if clustering does occur in vivo, it must be driven by weak interactions, or mediated by a phage-encoded protein.	[Finan, Kieran; Cook, Peter R.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Torella, Joseph P.; Kapanidis, Achillefs N.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England	University of Oxford; University of Oxford	Finan, K (corresponding author), Univ Wurzburg, Dept Biotechnol & Biophys, Wurzburg, Germany.	peter.cook@path.ox.ac.uk		Cook, Peter/0000-0002-6639-188X	E.P. Abraham Trust; University of Oxford; UK government; European Commission [FP7/2007-2013 HEALTH-F4-2008-201418]; UK BBSRC [BB/H01795X/1]; BBSRC [BB/H01795X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H01795X/1] Funding Source: researchfish	E.P. Abraham Trust; University of Oxford; UK government; European Commission(European CommissionEuropean Commission Joint Research Centre); UK BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	K.F. was supported by the E.P. Abraham Trust, a Clarendon Fund award from the University of Oxford, and an Overseas Research Student Award from the UK government. J.P.T. was supported by a Clarendon Award from the University of Oxford. A.N.K. was supported by a European Commission Seventh Framework Program grant (FP7/2007-2013 HEALTH-F4-2008-201418) and a UK BBSRC grant (BB/H01795X/1). P.R.C. is E.P. Abraham Professor of Cell Biology and a Professorial Fellow of Lincoln College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Anand VS, 2006, J BIOL CHEM, V281, P35677, DOI 10.1074/jbc.M608180200; Cabrera JE, 2003, MOL MICROBIOL, V50, P1493, DOI 10.1046/j.1365-2958.2003.03805.x; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Choudhry MA, 2004, BIOCHEM SOC T, V32, P1103, DOI 10.1042/BST0321103; Cook PR, 2010, J MOL BIOL, V395, P1, DOI 10.1016/j.jmb.2009.10.031; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; COOK PR, 1992, NUCLEIC ACIDS RES, V20, P3591, DOI 10.1093/nar/20.14.3591; Cseresnyes Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-88; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Durniak KJ, 2008, SCIENCE, V322, P553, DOI 10.1126/science.1163433; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; HOZAK P, 1993, CELL, V73, P361, DOI 10.1016/0092-8674(93)90235-I; Jin DJ, 2012, FEMS MICROBIOL REV, V36, P269, DOI 10.1111/j.1574-6976.2011.00279.x; Jung G, 2007, MODERN RES ED TOPICS, V1, P855; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lemon KP, 1998, SCIENCE, V282, P1516, DOI 10.1126/science.282.5393.1516; Lyle JM, 2002, SCIENCE, V296, P2218, DOI 10.1126/science.1070585; Marenduzzo D, 2007, TRENDS GENET, V23, P126, DOI 10.1016/j.tig.2007.01.007; MASLAK M, 1994, BIOCHEMISTRY-US, V33, P6918, DOI 10.1021/bi00188a022; MCCLELLAND M, 1988, NUCLEIC ACIDS RES, V16, P364, DOI 10.1093/nar/16.1.364; Mentesana PE, 2000, J MOL BIOL, V302, P1049, DOI 10.1006/jmbi.2000.4114; Miele A, 2006, CURR PROTOC MOL BIOL, V21, P1; MILLER OL, 1970, SCIENCE, V169, P392, DOI 10.1126/science.169.3943.392; Mukherjee S, 2002, CELL, V110, P81, DOI 10.1016/S0092-8674(02)00815-2; Muller C, 2008, EPL, V83, DOI [10.1209/0295-5075/1283/46001, DOI 10.1209/0295-5075/1283/46001]; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Papantonis A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000419; PATA JD, 1995, RNA, V1, P466; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; ROBINOW C, 1994, MICROBIOL REV, V58, P211, DOI 10.1128/MMBR.58.2.211-232.1994; Santoso Y, 2009, ANAL CHEM, V81, P9561, DOI 10.1021/ac901423e; Sastry SS, 1997, J BIOL CHEM, V272, P8644, DOI 10.1074/jbc.272.13.8644; Skinner GM, 2004, J BIOL CHEM, V279, P3239, DOI 10.1074/jbc.M310471200; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; SOUSA R, 1995, EMBO J, V14, P4609, DOI 10.1002/j.1460-2075.1995.tb00140.x; Spagnolo JF, 2010, RNA, V16, P382, DOI 10.1261/rna.1955410; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; TENHEGGELERBORDIER B, 1992, EMBO J, V11, P667, DOI 10.1002/j.1460-2075.1992.tb05098.x; Umbarger MA, 2011, MOL CELL, V44, P252, DOI 10.1016/j.molcel.2011.09.010; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464; ZAWADZKI V, 1991, NUCLEIC ACIDS RES, V19, P1948, DOI 10.1093/nar/19.8.1948; Zhou Y, 2006, J BIOL CHEM, V281, P24441, DOI 10.1074/jbc.M604369200	47	2	2	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40207	10.1371/journal.pone.0040207	http://dx.doi.org/10.1371/journal.pone.0040207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768341	Green Published, Green Submitted, gold			2022-12-27	WOS:000305966500054
J	Liao, SY; Liu, YQ; Tan, YD; Gan, L; Mei, J; Song, WZ; Chi, S; Dong, XJ; Chen, XJ; Deng, SP				Liao, Shunyao; Liu, Yunqiang; Tan, Yuande; Gan, Lu; Mei, Jie; Song, Wenzhong; Chi, Shu; Dong, Xianjue; Chen, Xiaojuan; Deng, Shaoping			Association of Genetic Variants of Melatonin Receptor 1B with Gestational Plasma Glucose Level and Risk of Glucose Intolerance in Pregnant Chinese Women	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DIABETES-MELLITUS; COMMON VARIANT; MTNR1B; POPULATION; GLYCEMIA	Background: This study aimed to explore the association of MTNR1B genetic variants with gestational plasma glucose homeostasis in pregnant Chinese women. Methods: A total of 1,985 pregnant Han Chinese women were recruited and evaluated for gestational glucose tolerance status with a two-step approach. The four MTNR1B variants rs10830963, rs1387153, rs1447352, and rs2166706 which had been reported to associate with glucose levels in general non-pregnant populations, were genotyped in these women. Using an additive model adjusted for age and body mass index (BMI), association of these variants with gestational fasting and postprandial plasma glucose (FPG and PPG) levels were analyzed by multiple linear regression; relative risk of developing gestational glucose intolerance was calculated by logistic regression. Hardy-Weinberg Equilibrium was tested by Chi-square and linkage disequilibrium (LD) between these variants was estimated by measures of D' and r(2). Results: In the pregnant Chinese women, the MTNR1B variant rs10830963, rs1387153, rs2166706 and rs1447352 were shown to be associated with the increased 1 hour PPG level (p = 8.04 x 10(-10), 5.49 x 10(-6), 1.89 x 10(-5) and 0.02, respectively). The alleles were also shown to be associated with gestational glucose intolerance with odds ratios (OR) of 1.64 (p = 8.03 x 10(-11)), 1.43 (p = 1.94 x 10(-6)), 1.38 (p = 1.63 x 10(-5)) and 1.24 (p = 0.007), respectively. MTNR1B rs1387153, rs2166706 were shown to be associated with gestational FPG levels (p = 0.04). Our data also suggested that, the LD pattern of these variants in the studied women conformed to that in the general populations: rs1387153 and rs2166706 were in high LD, they linked moderately with rs10830963, but might not linked with rs1447352; rs10830963 might not link with rs1447352, either. In addition, the MTNR1B variants were not found to be associated with any other traits tested. Conclusions: The MTNR1B is likely to be involved in the regulation of glucose homeostasis during pregnancy.	[Liao, Shunyao; Gan, Lu; Deng, Shaoping] Sichuan Acad Med Sci, Ctr Diabet, Chengdu, Peoples R China; [Mei, Jie] Sichuan Prov Peoples Hosp, Sichuan Acad Med Sci, Dept Obstet & Gynecol, Chengdu, Peoples R China; [Liu, Yunqiang] Sichuan Univ, W China Hosp, Dept Med Genet, Chengdu 610064, Peoples R China; [Liu, Yunqiang] Sichuan Univ, W China Hosp, Div Morbid Genom, State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Tan, Yuande] Hunan Normal Univ, Coll Life Sci, Changsha, Hunan, Peoples R China; [Song, Wenzhong; Chi, Shu] Sichuan Prov Peoples Hosp, Sichuan Acad Med Sci, Clin Isotop Lab, Chengdu, Peoples R China; [Dong, Xianjue] Chongqing Med Univ, Dept Endocrinol, Chongqing, Peoples R China; [Chen, Xiaojuan] NW Univ Hosp, Dept Surg, Chicago, IL USA; [Deng, Shaoping] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Human Islet Lab, Boston, MA USA	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan University; Sichuan University; Hunan Normal University; Sichuan Provincial People's Hospital; Chongqing Medical University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Liao, SY (corresponding author), Sichuan Acad Med Sci, Ctr Diabet, Chengdu, Peoples R China.	shunyaol@yahoo.com; sdeng1@partner.com	Liao, Shunyao/M-4123-2018		Key Project of Sichuan Province [416001004085]; Sichuan Academy of Medical Science and Sichuan Provincial Hospital [303005002153008, 303005002271027]	Key Project of Sichuan Province; Sichuan Academy of Medical Science and Sichuan Provincial Hospital	This study was supported by the research grant (to Shaoping Deng) from the Key Project of Sichuan Province (416001004085) and by grants (to Shaoping Deng and to Shunyao Liao) from Sichuan Academy of Medical Science and Sichuan Provincial Hospital (303005002153008 & 303005002271027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Chambers JC, 2009, DIABETES, V58, P2703, DOI 10.2337/db08-1805; Cho YM, 2009, DIABETOLOGIA, V52, P253, DOI 10.1007/s00125-008-1196-4; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; HARRIS M, 1979, DIABETES, V28, P1039; Heude B, 2011, J CLIN ENDOCR METAB, V96, pE1656, DOI 10.1210/jc.2011-0381; Kim JY, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-82; Landon MB, 2011, OBSTET GYNECOL, V117, P1230, DOI 10.1097/AOG.0b013e31821769ff; Langenberg C, 2009, DIABETOLOGIA, V52, P1537, DOI 10.1007/s00125-009-1392-x; Lauenborg J, 2009, J CLIN ENDOCR METAB, V94, P145, DOI 10.1210/jc.2008-1336; Lawrence JM, 2008, DIABETES CARE, V31, P899, DOI 10.2337/dc07-2345; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Menashe I, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-36; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Mulder H, 2009, DIABETOLOGIA, V52, P1240, DOI 10.1007/s00125-009-1359-y; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; REPPERT SM, 1995, P NATL ACAD SCI USA, V92, P8734, DOI 10.1073/pnas.92.19.8734; Retnakaran R, 2010, J CLIN ENDOCR METAB, V95, P670, DOI 10.1210/jc.2009-1990; Retnakaran R, 2009, CLIN ENDOCRINOL, V71, P208, DOI 10.1111/j.1365-2265.2008.03460.x; Ronn T, 2009, DIABETOLOGIA, V52, P830, DOI 10.1007/s00125-009-1297-8; Ross Glynis, 2006, Aust Fam Physician, V35, P392; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Shaat N, 2005, DIABETOLOGIA, V48, P2544, DOI 10.1007/s00125-005-0035-0; Sparso T, 2009, DIABETES, V58, P1450, DOI 10.2337/db08-1660; Takeuchi F, 2010, DIABETOLOGIA, V53, P299, DOI 10.1007/s00125-009-1595-1; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026953	28	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40113	10.1371/journal.pone.0040113	http://dx.doi.org/10.1371/journal.pone.0040113			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768333	Green Published, Green Submitted, gold			2022-12-27	WOS:000305966500046
J	Pekkinen, M; Viljakainen, H; Saarnio, E; Lamberg-Allardt, C; Makitie, O				Pekkinen, Minna; Viljakainen, Heli; Saarnio, Elisa; Lamberg-Allardt, Christel; Makitie, Outi			Vitamin D Is a Major Determinant of Bone Mineral Density at School Age	PLOS ONE			English	Article							PARATHYROID-HORMONE CONCENTRATIONS; PHYSICAL-ACTIVITY; BODY-COMPOSITION; D DEFICIENCY; CALCITROPIC HORMONES; 25-HYDROXYVITAMIN D; SEASONAL-VARIATION; YOUNG; PREVENTION; CHILDREN	Background: Vitamin D insufficiency in children may have long-term skeletal consequences as vitamin D affects calcium absorption, bone mineralization and bone mass attainment. Methodology/Principal Findings: This school-based study investigated vitamin D status and its association with vitamin D intake and bone health in 195 Finnish children and adolescents (age range 7-19 years). Clinical characteristics, physical activity and dietary vitamin D intake were evaluated. Blood and urine samples were collected for serum 25-hydroxyvitamin D (25-OHD) and other parameters of calcium homeostasis. Bone mineral density (BMD) and body composition were measured with dual-energy X-ray absorptiometry (DXA). Altogether 71% of the subjects were vitamin D insufficient (25-OHD <50 nmol/L). The median 25-OHD was 41 nmol/L for girls and 45 nmol/L for boys, and the respective median vitamin D intakes 9.1 mu g/day and 10 mu g/day. In regression analysis, after adjusting for relevant factors, 25-OHD concentration explained 5.6% of the variance in lumbar BMD; 25-OHD and exercise together explained 7.6% of the variance in total hip BMD and 17% of the variance in whole body BMD. S-25-OHD was an independent determinant of lumbar spine and whole body BMD and in magnitude surpassed the effects of physical activity. Conclusions/Significance: Vitamin D insufficiency was common even when vitamin D intake exceeded the recommended daily intake. Vitamin D status was a key determinant of BMD. The findings suggest urgent need to increase vitamin D intake to optimize bone health in children.	[Pekkinen, Minna; Makitie, Outi] Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland; [Pekkinen, Minna; Saarnio, Elisa; Lamberg-Allardt, Christel] Univ Helsinki, Dept Food & Environm Sci, Calcium Res Unit, Helsinki, Finland; [Viljakainen, Heli; Makitie, Outi] Univ Helsinki, Dept Pediat, Childrens Hosp, Cent Hosp, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Pekkinen, M (corresponding author), Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland.	minna.pekkinen@helsinki.fi	Saarnio, Elisa/L-2611-2019	Saarnio, Elisa/0000-0003-1227-567X; Makitie, Outi/0000-0002-4547-001X; Lamberg-Allardt, Christel/0000-0001-7326-1904	Foundation for Pediatric Research, Helsinki, Finland; Yrjo Jahnsson Foundation, Helsinki, Finland; Ministry of Education, Helsinki, Finland; Academy of Finland, Helsinki, Finland; Helsinki University Hospital, Helsinki, Finland; Folkhalsan Research Foundation, Helsinki, Finland; Sigrid Juselius Foundation, Helsinki, Finland; Ella and Georg Ehrnrooth foundation, Helsinki, Finland	Foundation for Pediatric Research, Helsinki, Finland; Yrjo Jahnsson Foundation, Helsinki, Finland; Ministry of Education, Helsinki, Finland; Academy of Finland, Helsinki, Finland(Academy of Finland); Helsinki University Hospital, Helsinki, Finland; Folkhalsan Research Foundation, Helsinki, Finland; Sigrid Juselius Foundation, Helsinki, Finland(Sigrid Juselius Foundation); Ella and Georg Ehrnrooth foundation, Helsinki, Finland	This work was supported by the Foundation for Pediatric Research, the Yrjo Jahnsson Foundation, the Ministry of Education, the Academy of Finland, the Helsinki University Hospital research funds, the Folkhalsan Research Foundation, the Sigrid Juselius Foundation and the Ella and Georg Ehrnrooth foundation, all Helsinki, Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey DA, 1999, J BONE MINER RES, V14, P1672, DOI 10.1359/jbmr.1999.14.10.1672; Baim S, 2008, J CLIN DENSITOM, V11, P6, DOI 10.1016/j.jocd.2007.12.002; Bischoff-Ferrari HA, 2007, J STEROID BIOCHEM, V103, P614, DOI 10.1016/j.jsbmb.2006.12.016; Boot AM, 2011, J PEDIATR ENDOCR MET, V24, P355, DOI 10.1515/JPEM.2011.052; Brannon PM, 2008, AM J CLIN NUTR, V88, p483S, DOI 10.1093/ajcn/88.2.483S; Carter GD, 2004, CLIN CHEM, V50, P2195, DOI 10.1373/clinchem.2004.040683; Cheng SL, 2003, AM J CLIN NUTR, V78, P485, DOI 10.1093/ajcn/78.3.485; Christel Lamberg-Allardt Heli Viljakainen and a working group, 2006, SOSIAALI JA TERVEYSM, P9; Daly RM, 2007, MED SPORT SCI, V51, P33; Ginde AA, 2009, J AM GERIATR SOC, V57, P1595, DOI 10.1111/j.1532-5415.2009.02359.x; Hagenau T, 2009, OSTEOPOROSIS INT, V20, P133, DOI 10.1007/s00198-008-0626-y; HealthyPeople.gov, 2020, NUTR PHYS ACT; Holick MF, 2007, DRUG AGING, V24, P1017, DOI 10.2165/00002512-200724120-00005; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Kohrt WM, 2004, MED SCI SPORT EXER, V36, P1985, DOI 10.1249/01.MSS.0000142662.21767.58; Kontulainen S, 2003, J BONE MINER RES, V18, P352, DOI 10.1359/jbmr.2003.18.2.352; Lehtonen-Veromaa MKM, 2002, AM J CLIN NUTR, V76, P1446, DOI 10.1093/ajcn/76.6.1446; Leonard CM, 2009, PEDIATR RADIOL, V39, P148, DOI 10.1007/s00247-008-1067-7; Maimoun L, 2009, CALCIFIED TISSUE INT, V85, P277, DOI 10.1007/s00223-009-9277-z; McMichael AJ, 1997, EPIDEMIOLOGY, V8, P642, DOI 10.1097/00001648-199710000-00005; Misra M, 2008, PEDIATRICS, V122, P398, DOI 10.1542/peds.2007-1894; Munns C, 2006, MED J AUSTRALIA, V185, P268, DOI 10.5694/j.1326-5377.2006.tb00558.x; National Public Health Institute, 2008, NAT FINDIET 2007 SUR; Neville CE, 2002, BONE, V30, P792, DOI 10.1016/S8756-3282(02)00711-1; Outila TA, 2001, AM J CLIN NUTR, V74, P206; Pere A, 2000, ANN HUM BIOL, V27, P35, DOI 10.1080/030144600282361; Rizzoli R, 2006, ANN ENDOCRINOL-PARIS, V67, P114, DOI 10.1016/S0003-4266(06)72564-1; SORVA R, 1990, ACTA PAEDIATR SCAND, V79, P498, DOI 10.1111/j.1651-2227.1990.tb11503.x; Steingrimsdottir L, 2005, JAMA-J AM MED ASSOC, V294, P2336, DOI 10.1001/jama.294.18.2336; Trump DL, 2010, CANCER J, V16, P1, DOI 10.1097/PPO.0b013e3181c51ee6; VALIMAKI MJ, 1994, BMJ-BRIT MED J, V309, P230, DOI 10.1136/bmj.309.6949.230; Valimaki VV, 2004, J CLIN ENDOCR METAB, V89, P76, DOI 10.1210/jc.2003-030817; Vicente-Rodriguez G, 2007, INT J SPORTS MED, V28, P386, DOI 10.1055/s-2006-924397; Viljakainen HT, 2010, J CLIN ENDOCR METAB, V95, P1749, DOI 10.1210/jc.2009-1391; Viljakainen HT, 2006, BRIT J NUTR, V96, P124, DOI 10.1079/BJN20061719; Viljakainen HT, 2009, J BONE MINER RES, V24, P346, DOI [10.1359/jbmr.081009, 10.1359/JBMR.081009]; Wagner CL, 2008, PEDIATRICS, V122, P1142, DOI 10.1542/peds.2008-1862; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888; Zemel BS, 2004, J BONE MINER RES, V19, pS231	40	71	73	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40090	10.1371/journal.pone.0040090	http://dx.doi.org/10.1371/journal.pone.0040090			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768331	Green Published, Green Submitted, gold			2022-12-27	WOS:000305966500044
J	Vasanthakumar, B; Ravishankar, H; Subramanian, S				Vasanthakumar, Balasubramanian; Ravishankar, Honnavar; Subramanian, Sankaran			A Novel Property of DNA - As a Bioflotation Reagent in Mineral Processing	PLOS ONE			English	Article							SPHALERITE; FLOTATION; ACID	Environmental concerns regarding the use of certain chemicals in the froth flotation of minerals have led investigators to explore biological entities as potential substitutes for the reagents in vogue. Despite the fact that several microorganisms have been used for the separation of a variety of mineral systems, a detailed characterization of the biochemical molecules involved therein has not been reported so far. In this investigation, the selective flotation of sphalerite from a sphalerite-galena mineral mixture has been achieved using the cellular components of Bacillus species. The key constituent primarily responsible for the flotation of sphalerite has been identified as DNA, which functions as a bio-collector. Furthermore, using reconstitution studies, the obligatory need for the presence of non-DNA components as bio-depressants for galena has been demonstrated. A probable model involving these entities in the selective flotation of sphalerite from the mineral mixture has been discussed.	[Vasanthakumar, Balasubramanian; Ravishankar, Honnavar; Subramanian, Sankaran] Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Vasanthakumar, B (corresponding author), Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India.	ssmani@materials.iisc.ernet.in						Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; Bhavsar AP, 2004, J BACTERIOL, V186, P7865, DOI 10.1128/JB.186.23.7865-7873.2004; BROMFIELD SM, 1954, J GEN MICROBIOL, V11, P1; Chandraprabha MN, 2010, MIN PROC EXT MET REV, V31, P1, DOI 10.1080/08827500903404682; Draghi JA, 2006, MICROBIOL-SGM, V152, P2683, DOI 10.1099/mic.0.29013-0; DUGUID J, 1993, BIOPHYS J, V65, P1916, DOI 10.1016/S0006-3495(93)81263-3; FELSENFE.G, 1967, ANNU REV BIOCHEM, V36, P407, DOI 10.1146/annurev.bi.36.070167.002203; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fuerstenau D.W., 1957, ENG MIN J, V158, P93; Gaudin A.M., 1957, FLOTATION, P573; HARRISON STL, 1991, BIOTECHNOL ADV, V9, P217, DOI 10.1016/0734-9750(91)90005-G; Holmes DS, 1995, MINERAL BIOPROCESSIN, VII; HUANG PC, 1966, ANAL BIOCHEM, V16, P107, DOI 10.1016/0003-2697(66)90085-6; IZATT RM, 1971, CHEM REV, V71, P439, DOI 10.1021/cr60273a002; Kuyucak N, 1998, 3 INT C MIN BIOPR BI; Pelta J, 1996, J BIOL CHEM, V271, P5656, DOI 10.1074/jbc.271.10.5656; Perks B, 2000, AM J RESP CRIT CARE, V162, P1767, DOI 10.1164/ajrccm.162.5.9908107; Rao KH, 2010, HYDROMETALLURGY, V104, P465, DOI 10.1016/j.hydromet.2010.01.016; Rao KH, 2001, INT J MINER PROCESS, V62; RAO KH, 2007, MICR PROC MET SULF, P267; RASANEN L, 1982, IMMUNOLOGY, V46, P481; Rath RK, 1999, INT J MINER PROCESS, V57, P265, DOI 10.1016/S0301-7516(99)00028-9; RUBIN RL, 1977, J BACTERIOL, V129, P916, DOI 10.1128/JB.129.2.916-925.1977; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santhiya D, 2002, J COLLOID INTERF SCI, V256, P237, DOI 10.1006/jcis.2002.8681; Santhiya D, 2001, J COLLOID INTERF SCI, V235, P289, DOI 10.1006/jcis.2000.7374; Smith R.W., 1991, MINERAL BIOPROCESSIN; Smith RW, 2006, MINER ENG, V19, P548, DOI 10.1016/j.mineng.2005.09.007; STOLL VS, 1990, METHOD ENZYMOL, V182, P24; Vollmer W, 2012, NAT CHEM BIOL, V8, P14, DOI 10.1038/nchembio.748; Wickham SFJ, 2012, NAT NANOTECHNOL, V7, P169, DOI [10.1038/nnano.2011.253, 10.1038/NNANO.2011.253]; Xia F, 2010, J AM CHEM SOC, V132, P1252, DOI 10.1021/ja908890q	32	14	14	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39316	10.1371/journal.pone.0039316	http://dx.doi.org/10.1371/journal.pone.0039316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768298	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000305966500011
J	April, KT; Moher, D; Stinson, J; Byrne, A; White, M; Boon, H; Duffy, CM; Rader, T; Vohra, S; Tugwell, P				April, Karine Toupin; Moher, David; Stinson, Jennifer; Byrne, Ani; White, Meghan; Boon, Heather; Duffy, Ciaran M.; Rader, Tamara; Vohra, Sunita; Tugwell, Peter			Measurement Properties of Questionnaires Assessing Complementary and Alternative Medicine Use in Pediatrics: A Systematic Review	PLOS ONE			English	Review							STATUS MEASUREMENT INSTRUMENTS; METHODOLOGICAL QUALITY; COSMIN CHECKLIST; CHILDREN; PREVALENCE; CANCER; DEFINITIONS; CONSENSUS; PATTERNS; CRITERIA	Objective: Complementary and alternative medicine (CAM) is commonly used by children, but estimates of that use vary widely partly due to the range of questionnaires used to assess CAM use. However, no studies have attempted to appraise measurement properties of these questionnaires. The aim of this systematic review was to critically appraise and summarize measurement properties of questionnaires of CAM use in pediatrics. Study design: A search strategy was implemented in major electronic databases in March 2011 and conference websites, scientific journals and experts were consulted. Studies were included if they mentioned a questionnaire assessing the prevalence of CAM use in pediatrics. Members of the team independently rated the methodological quality of the studies (using the COSMIN checklist) and measurement properties of the questionnaires (using the Terwee and Cohen criteria). Results: A total of 96 CAM questionnaires were found in 104 publications. The COSMIN checklist showed that no studies reported adequate methodological quality. The Terwee criteria showed that all included CAM questionnaires had indeterminate measurement properties. According to the Cohen score, none were considered to be a well-established assessment, two approached the level of a well-established assessment, seven were promising assessments and the remainder (n = 87) did not reach the score's minimum standards. Conclusion: None of the identified CAM questionnaires have been thoroughly validated. This systematic review highlights the need for proper validation of CAM questionnaires in pediatrics, which may in turn lead to improved research and knowledge translation about CAM in clinical practice.	[April, Karine Toupin; Moher, David] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [April, Karine Toupin; Rader, Tamara; Tugwell, Peter] Univ Ottawa, Ctr Global Hlth, Inst Populat Hlth, Ottawa, ON, Canada; [Moher, David; Tugwell, Peter] Ottawa Hosp, Clin Epidemiol Unit, Res Inst, Ottawa, ON, Canada; [Stinson, Jennifer; White, Meghan] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Stinson, Jennifer] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada; [Byrne, Ani; Boon, Heather] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Duffy, Ciaran M.] Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON K1H 8L1, Canada; [Duffy, Ciaran M.] Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; [Vohra, Sunita] Univ Alberta, Dept Pediat, CARE Program, Fac Med & Dent, Edmonton, AB, Canada; [Vohra, Sunita] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Tugwell, Peter] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Alberta; University of Alberta; University of Ottawa	April, KT (corresponding author), Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada.	ktoupina@uottawa.ca	Rader, Tamara/H-9469-2013; Tugwell, Peter/AFD-8076-2022; Moher, David/I-3408-2019; Vohra, Sunita/F-5755-2016	Tugwell, Peter/0000-0001-5062-0556; Moher, David/0000-0003-2434-4206; Vohra, Sunita/0000-0002-6210-7933; Rader, Tamara/0000-0002-9059-3756	Canadian Arthritis Network; Arthritis Society; Canadian Institutes of Health Research; Ministry of Health and Long-term Care Career Scientist Award	Canadian Arthritis Network; Arthritis Society; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ministry of Health and Long-term Care Career Scientist Award	This project was funded by the Canadian Arthritis Network (http://www.arthritisnetwork.ca/about_can/about_can_en.php). Dr. Karine Toupin April has been supported by a postdoctoral fellowship from the Canadian Arthritis Network, The Arthritis Society and the Canadian Institutes of Health Research. Dr. Moher holds a University Research Chair. Dr. Stinson's research is supported by a Ministry of Health and Long-term Care Career Scientist Award. Dr. Ciaran M Duffy holds an Endowed Chair, Department of Paediatrics, University of Ottawa. Dr. Sunita Vohra receives salary support as an Alberta Innovates-Health Solutions Health Scholar. Dr. Peter Tugwell holds a Canada Research Chair in Health Equity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	April KT, 2009, COMPLEMENT THER MED, V17, P208, DOI 10.1016/j.ctim.2009.03.003; Bennett C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001069; Bishop FL, 2010, PEDIATRICS, V125, P768, DOI 10.1542/peds.2009-1775; Bot SDM, 2004, ANN RHEUM DIS, V63, P335, DOI 10.1136/ard.2003.007724; Braun Carie A, 2005, J Adolesc Health, V37, P76, DOI 10.1016/j.jadohealth.2004.07.010; Bussing R, 2002, PSYCHIAT SERV, V53, P1096, DOI 10.1176/appi.ps.53.9.1096; Carlton P, 2009, CLIN CHIROPR, V2, P11; Cincotta DR, 2006, ARCH DIS CHILD, V91, P153, DOI 10.1136/adc.2005.074872; Cohen LL, 2008, J PEDIATR PSYCHOL, V33, P911, DOI 10.1093/jpepsy/jsj115; Dannemann K, 2008, PEDIATR DIABETES, V9, P228, DOI 10.1111/j.1399-5448.2008.00377.x; De Vet H, 2011, MEASUREMENT IN PRESS; FDA, 2009, GUID IND PAT REP OUT; Fennell D, 2009, COMPLEMENT THER MED, V17, P71, DOI 10.1016/j.ctim.2008.09.002; Fernandez C, 1998, J CLIN ONCOLOGY; FISHER P, 1994, BRIT MED J, V309, P107, DOI 10.1136/bmj.309.6947.107; Gaboury I, 2010, 5 INT C COMPL MED RE; Gerasimidis K, 2008, ALIMENT PHARM THERAP, V27, P155, DOI 10.1111/j.1365-2036.2007.03552.x; Green VA, 2006, RES DEV DISABIL, V27, P70, DOI 10.1016/j.ridd.2004.12.002; Hagen LEM, 2003, ARTHRIT RHEUM-ARTHR, V49, P3, DOI 10.1002/art.10931; Hamidah A, 2009, PEDIATR BLOOD CANCER, V52, P70, DOI 10.1002/pbc.21798; Heuschkel R, 2002, AM J GASTROENTEROL, V97, P382, DOI 10.1111/j.1572-0241.2002.05474.x; Hurvitz EA, 2003, DEV MED CHILD NEUROL, V45, P364, DOI 10.1017/S0012162203000707; Kemper KJ, 2008, PEDIATRICS, V122, P1374, DOI 10.1542/peds.2008-2173; Kristoffersen AE, 2008, J ALTERN COMPLEM MED, V14, P911, DOI 10.1089/acm.2008.0127; Loman Deborah G, 2003, J Pediatr Health Care, V17, P58, DOI 10.1016/S0891-5245(02)88329-8; MacLennan AH, 2006, MED J AUSTRALIA, V184, P27, DOI 10.5694/j.1326-5377.2006.tb00092.x; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mokkink LB, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-82; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Mokkink LB, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-22; Mottonen M, 1997, MED PEDIATR ONCOL, V28, P205, DOI 10.1002/(SICI)1096-911X(199703)28:3&lt;205::AID-MPO10&gt;3.0.CO;2-D; Post-White J, 2009, J PEDIATR ONCOL NURS, V26, P7, DOI 10.1177/1043454208323914; Quandt SA, 2009, J ALTERN COMPLEM MED, V15, P331, DOI 10.1089/acm.2008.0521; Sampson M, 2009, J CLIN EPIDEMIOL, V62, P944, DOI 10.1016/j.jclinepi.2008.10.012; Shenfield G, 2002, J PAEDIATR CHILD H, V38, P252, DOI 10.1046/j.1440-1754.2002.00770.x; Simpson N, 2001, BRIT J GEN PRACT, V51, P914; Smith C, 2006, J PAEDIATR CHILD H, V42, P538, DOI 10.1111/j.1440-1754.2006.00918.x; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Tsao JCI, 2005, EVID-BASED COMPL ALT, V2, P521, DOI 10.1093/ecam/neh132	40	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39611	10.1371/journal.pone.0039611	http://dx.doi.org/10.1371/journal.pone.0039611			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768098	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100068
J	Bi, Q; Tang, SH; Xia, L; Du, R; Fan, R; Gao, LC; Jin, J; Liang, SH; Chen, Z; Xu, GH; Nie, YZ; Wu, KC; Liu, J; Shi, YQ; Ding, J; Fan, DM				Bi, Qian; Tang, Shanhong; Xia, Lin; Du, Rui; Fan, Rui; Gao, Liucun; Jin, Jiang; Liang, Shuhui; Chen, Zheng; Xu, Guanghui; Nie, Yongzhan; Wu, Kaichun; Liu, Jie; Shi, Yongquan; Ding, Jie; Fan, Daiming			Ectopic Expression of MiR-125a Inhibits the Proliferation and Metastasis of Hepatocellular Carcinoma by Targeting MMP11 and VEGF	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL; INVASION; CANCER; HSA-MIR-125A-5P; MODULATION; LIVER	Background: Studies have been shown that miR-125a plays an important role in carcinogenesis, however, the role of miR-125a in hepatocellular carcinoma (HCC) remains elusive. Methodology/Principal: Real time-PCR (qRT-PCR) was performed to test the significance of miR-125a in HCC. Ectopic expression of miR-125a was used to test the influences of miR-125a on proliferation and metastasis of HCC cells in vitro and in vivo. Predicted target genes of miR-125a were determined by dual-luciferase reporting, qRT-PCR, and western blot (WB) analyses. Then immunohistochemical staining (IHC) was used to detect the expression of target genes, and the correlations and prognostic values of miR-125a and its target genes were also investigated. Conclusions/Significance: Decreased miR-125a was observed in both HCC tissues and cell lines, and associated with patients' aggressive pathologic features. Up-regulating miR-125a significantly inhibited the malignant phenotypes by repressing the expression of matrix metalloproteinase 11 (MMP11) and vascular endothelial growth factor A (VEGF-A) both in vitro and in vivo. Furthermore, miR-125a expression was inversely correlated with both MMP11 and VEGF-A expression in HCC tissues. Inhibiting miR-125a could increase both MMP11 and VEGF-A expression, and RNA interference targeting MMP11 or VEGF-A mRNA could rescue the loss of miR-125a functions. MiR-125a inhibits the proliferation and metastasis of HCC by targeting MMP11 and VEGF-A. Up-regulation of miR-125a might be a promising approach and a prognostic marker for HCC.	[Bi, Qian; Tang, Shanhong; Xia, Lin; Du, Rui; Fan, Rui; Gao, Liucun; Jin, Jiang; Liang, Shuhui; Chen, Zheng; Xu, Guanghui; Nie, Yongzhan; Wu, Kaichun; Liu, Jie; Shi, Yongquan; Ding, Jie; Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Liu, Jie] Fudan Univ, Huashan Hosp, Dept Digest Dis, Shanghai 200433, Peoples R China	Air Force Military Medical University; Fudan University	Bi, Q (corresponding author), Fourth Mil Med Univ, Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian 710032, Peoples R China.	shiyquan@fmmu.edu.cn; dingjie@fmmu.edu.cn	Shi, Yongquan/AAE-3954-2020; BI, QIAN/GWV-4943-2022; gao, Liu/AAH-5970-2019		National Basic Research Program of China [2010CB732400]; National Natural Science Foundation of China [30973428, 30900674, 30970149]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (No. 2010CB732400) and National Natural Science Foundation of China (No. 30973428, 30900674 and 30970149). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chow NH, 1997, HUM PATHOL, V28, P698, DOI 10.1016/S0046-8177(97)90179-9; Dahl KDC, 2009, NEOPLASIA, V11, P1208, DOI 10.1593/neo.09942; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Fan R, 2011, INT J CANCER, V128, P2980, DOI 10.1002/ijc.25624; Guo X, 2009, RNA BIOL, V6, P575, DOI 10.4161/rna.6.5.10079; He XX, 2011, ONCOGENE; Huang XH, 2011, J PATHOL, V225, P463, DOI 10.1002/path.2877; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang LL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-318; Li D, 2011, J BIOL CHEM, V286, P36677, DOI 10.1074/jbc.M111.270561; Li XM, 1998, J EXP CLIN CANC RES, V17, P13; Li Y, 2004, J CANCER RES CLIN, V130, P460, DOI 10.1007/s00432-004-0564-9; Liang S, 2011, PLOS ONE, V18; Lung RWM, 2009, NEOPLASIA, V11, P1174, DOI 10.1593/neo.09888; Meng F, 2009, GASTROENTEROLOGY, V133, P647; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Nishida N, 2011, CLIN CANCER RES, V17, P2725, DOI 10.1158/1078-0432.CCR-10-2132; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Potenza N, 2011, NUCLEIC ACIDS RES, V39, P5157, DOI 10.1093/nar/gkr067; Raskop E, 2011, CURR PHARM BIOTECHNO, V24; Raskopf E, 2008, J HEPATOL, V49, P977, DOI 10.1016/j.jhep.2008.07.022; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Tang SH, 2010, CANCER BIOL THER, V9, P88, DOI 10.4161/cbt.9.2.10283; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Yang F, 2011, NEOPLASIA, V13, P590, DOI 10.1593/neo.11422; Zhang YJ, 2009, FEBS LETT, V583, P3725, DOI 10.1016/j.febslet.2009.10.002; Zhao YM, 2011, CANCER	29	150	159	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40169	10.1371/journal.pone.0040169	http://dx.doi.org/10.1371/journal.pone.0040169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768249	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100222
J	Chan, SCC; Chan, CCH; Kwan, ASK; Ting, KH; Chui, TY				Chan, Sam C. C.; Chan, Chetwyn C. H.; Kwan, Anne S. K.; Ting, Kin-hung; Chui, Tak-yi			Orienting Attention Modulates Pain Perception: An ERP Study	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; LASER-EVOKED-POTENTIALS; GO/NOGO TASK; RESPONSE-INHIBITION; STIMULUS PROBABILITY; NEURAL MECHANISMS; SPATIAL ATTENTION; CINGULATE CORTEX; STROOP TASK; BRAIN	Introduction: Research has shown that people with chronic pain have difficulty directing their attention away from pain. A mental strategy that incorporates focused attention and distraction has been found to modulate the perception of pain intensity. That strategy involves placing attention on the nociceptive stimulus felt and shifting attention to a self-generated sub-nociceptive image and rehearsing it. Event-related potential was used to study the possible processes associated with the focus-then-orient strategy. Methods: Eighteen pain-free participants received different levels of 50-ms nociceptive stimulations elicited by electric shocks at the right lateral malleolus (ankle). In perception trials, participants maintained the perceived nociceptive stimulus in working memory for 3,000 ms. In imagery trials, participants mentally generated and maintained the corresponding sub-nociceptive image they had learned previously. After both types of trials, participants evaluated the pain intensity of the incoming stimulus by recalling the feeling of the nociceptive stimulation at the beginning of the trial. Results: Shifting attention from the incoming nociceptive to a self-generated sub-nociceptive image elicited central P2 and centro-parietal P3 waves, which were found to correlate with proportional scores on the Stroop Test. They were followed by a frontal N400 and a parietal P600, denoting generation of sub-nociceptive images in working memory. The voltages elicited in these potentials correlated moderately with attenuation of the pain ratings of the recalled nociceptive stimulations. Conclusions: Focus-and-orient attention across nociceptive and sub-nociceptive images appears to be related to response inhibition. Mental rehearsal of the sub-nociceptive images was found to modulate the perception of the nociceptive sensation felt prior to the imagery. Such modulation seems to be mediated by generating and maintaining sub-nociceptive images in working memory. Future studies should explore the mental processes associated with orienting attention for pain modulation among people with pathological pain and frontal lobe dysfunction.	[Chan, Sam C. C.; Chan, Chetwyn C. H.; Ting, Kin-hung] Hong Kong Polytech Univ, Dept Rehabil Sci, Appl Cognit Neurosci Lab, Hong Kong, Peoples R China; [Chui, Tak-yi] Haven Hope Hosp, Hong Kong, Peoples R China; [Kwan, Anne S. K.] United Christian Hosp, Dept Anaesthesiol, Hong Kong, Peoples R China	Hong Kong Polytechnic University; United Christian Hospital	Chan, SCC (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Appl Cognit Neurosci Lab, Hong Kong, Peoples R China.	Chetwyn.Chan@inet.polyu.edu.hk	Ting, Kin-Hung/A-2677-2017	Ting, Kin-Hung/0000-0002-6071-3569; Chan, Chetwyn C. H./0000-0003-0307-6337	Hong Kong Polytechnic University [J-BBZP, 1-ZV1D]; Research Grant Council of Hong Kong [PolyU 5601/10 M]	Hong Kong Polytechnic University(Hong Kong Polytechnic University); Research Grant Council of Hong Kong(Hong Kong Research Grants Council)	This study was funded by The Hong Kong Polytechnic University's internal research grant (J-BBZP and 1-ZV1D) and a General Research Grant, of which CCHC is the principal investigator, from the Research Grant Council of Hong Kong (PolyU 5601/10 M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2007, J AM ACAD AUDIOL, V18, P573, DOI 10.3766/jaaa.18.7.5; Alexander MP, 2007, NEUROLOGY, V68, P1515, DOI 10.1212/01.wnl.0000261482.99569.fb; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Arendt-Nielsen, 1994, ACTA ANAESTHESIOL S, V1994, p[101, 7]; Barber H, 2004, NEUROREPORT, V15, P545, DOI 10.1097/00001756-200403010-00032; Bekker EM, 2005, COGNITIVE BRAIN RES, V22, P221, DOI 10.1016/j.cogbrainres.2004.08.011; Belardinelli MO, 2009, ACTA PSYCHOL, V132, P190, DOI 10.1016/j.actpsy.2009.06.009; Bokura H, 2001, CLIN NEUROPHYSIOL, V112, P2224, DOI 10.1016/S1388-2457(01)00691-5; Bruin KJ, 2002, CLIN NEUROPHYSIOL, V113, P1172, DOI 10.1016/S1388-2457(02)00141-4; Chow KWS, 2007, NEUROREPORT, V18, P999, DOI 10.1097/WNR.0b013e32815277d7; De Pascalis V, 2008, PAIN, V134, P197, DOI 10.1016/j.pain.2007.09.005; Debruille JB, 2007, BRAIN RES REV, V56, P472, DOI 10.1016/j.brainresrev.2007.10.001; DeLong KA, 2005, NAT NEUROSCI, V8, P1117, DOI 10.1038/nn1504; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Dowman R, 2004, BRAIN TOPOGR, V17, P3, DOI 10.1023/B:BRAT.0000047332.24629.8e; Dowman R, 2004, PSYCHOPHYSIOLOGY, V41, P749, DOI 10.1111/j.1469-8986.2004.00207.x; Dowman R, 2007, PSYCHOPHYSIOLOGY, V44, P420, DOI 10.1111/j.1469-8986.2006.00491.x; Dowman R, 2007, PSYCHOPHYSIOLOGY, V44, P407, DOI 10.1111/j.1469-8986.2007.00508.x; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; EIMER M, 1993, BIOL PSYCHOL, V35, P123, DOI 10.1016/0301-0511(93)90009-W; Eimer M, 2003, EXP BRAIN RES, V151, P24, DOI 10.1007/s00221-003-1437-1; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Floden D, 2011, J COGNITIVE NEUROSCI, V23, P867, DOI 10.1162/jocn.2010.21492; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; GarciaLarrea L, 1997, NEUROREPORT, V8, P3785, DOI 10.1097/00001756-199712010-00026; Goldstein A, 2002, PSYCHOPHYSIOLOGY, V39, P781, DOI 10.1017/S004857720201048X; HANDWERKER HO, 1993, PHYSIOL REV, V73, P639, DOI 10.1152/physrev.1993.73.3.639; Hatem SM, 2007, CLIN NEUROPHYSIOL, V118, P1503, DOI 10.1016/j.clinph.2007.03.021; Huster RJ, 2010, HUM BRAIN MAPP, V31, P1260, DOI 10.1002/hbm.20933; JOHNSON JE, 1974, J PERS SOC PSYCHOL, V29, P710, DOI 10.1037/h0036555; Johnson MH, 1997, PAIN, V69, P43, DOI 10.1016/S0304-3959(96)03272-1; KATAYAMA Y, 1985, BRAIN RES BULL, V14, P423, DOI 10.1016/0361-9230(85)90019-X; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Legrain V, 2002, PAIN, V99, P21, DOI 10.1016/S0304-3959(02)00051-9; LEVENTHAL EA, 1989, J CONSULT CLIN PSYCH, V57, P365, DOI 10.1037/0022-006X.57.3.365; LEVENTHAL H, 1979, J PERS SOC PSYCHOL, V37, P688, DOI 10.1037/0022-3514.37.5.688; LOGAN HL, 1995, PSYCHOSOM MED, V57, P475, DOI 10.1097/00006842-199509000-00010; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Metzler MP, 2011, COGSCI 2011 33 ANN M; Moseley GL, 2008, PAIN, V137, P600, DOI 10.1016/j.pain.2007.10.021; Nakata H, 2004, CLIN NEUROPHYSIOL, V115, P361, DOI 10.1016/j.clinph.2003.09.013; Nouwen A, 2006, J PAIN, V7, P62, DOI 10.1016/j.jpain.2005.08.004; Ohara PT, 2005, CELL MOL LIFE SCI, V62, P44, DOI 10.1007/s00018-004-4283-9; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; POSNER MI, 1994, P NATL ACAD SCI USA, V91, P7398, DOI 10.1073/pnas.91.16.7398; Qiu J, 2007, BRAIN RES, V1184, P202, DOI 10.1016/j.brainres.2007.09.068; Quevedo AS, 2007, J NEUROSCI, V27, P11635, DOI 10.1523/JNEUROSCI.3356-07.2007; Rode S, 2001, PAIN, V94, P193, DOI 10.1016/S0304-3959(01)00356-6; Roelofs J, 2004, J PAIN, V5, P250, DOI 10.1016/j.jpain.2004.04.001; Ruchkin DS, 1992, ELECTROENCEPHALOGR C, V79, P473; Seminowicz DA, 2004, PAIN, V112, P48, DOI 10.1016/j.pain.2004.07.027; Spironelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024932; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Swick D, 2002, NEUROPSYCHOLOGIA, V40, P1240, DOI 10.1016/S0028-3932(01)00226-3; Tracey Irene, 2007, Curr Opin Support Palliat Care, V1, P109, DOI 10.1097/SPC.0b013e3282efc58b; Van Damme S, 2010, NEUROSCI BIOBEHAV R, V34, P204, DOI 10.1016/j.neubiorev.2009.01.005; Veldhuijzen DS, 2006, J PAIN, V7, P11, DOI 10.1016/j.jpain.2005.06.003; Ventouras E, 2004, P ANN INT IEEE EMBS, V26, P80; West WC, 2000, J COGNITIVE NEUROSCI, V12, P1024, DOI 10.1162/08989290051137558; Wiech K, 2008, TRENDS COGN SCI, V12, P306, DOI 10.1016/j.tics.2008.05.005; Williamson A, 2005, J CLIN NURS, V14, P798, DOI 10.1111/j.1365-2702.2005.01121.x; WOODS DL, 1993, HEARING RES, V66, P46, DOI 10.1016/0378-5955(93)90258-3	62	28	29	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40215	10.1371/journal.pone.0040215	http://dx.doi.org/10.1371/journal.pone.0040215			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768257	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100230
J	Cohen, JF; Chalumeau, M; Levy, C; Bidet, P; Thollot, F; Wollner, A; Bingen, E; Cohen, R				Cohen, Jeremie F.; Chalumeau, Martin; Levy, Corinne; Bidet, Philippe; Thollot, Franck; Wollner, Alain; Bingen, Edouard; Cohen, Robert			Spectrum and Inoculum Size Effect of a Rapid Antigen Detection Test for Group A Streptococcus in Children with Pharyngitis	PLOS ONE			English	Article							DIAGNOSIS; SENSITIVITY; MANAGEMENT; GUIDELINES; BIAS; CULTURE; SCORE	Background: The stability of the accuracy of a diagnostic test is critical to whether clinicians can rely on its result. We aimed to assess whether the performance of a rapid antigen detection test (RADT) for group A streptococcus (GAS) is affected by the clinical spectrum and/or bacterial inoculum size. Methods: Throat swabs were collected from 785 children with pharyngitis in an office-based, prospective, multicenter study (2009-2010). We analysed the effect of clinical spectrum (i.e., the McIsaac score and its components) and inoculum size (light or heavy GAS growth) on the accuracy (sensitivity, specificity, likelihood ratios and predictive values) of a RADT, with laboratory throat culture as the reference test. We also evaluated the accuracy of a McIsaac-score-based decision rule. Results: GAS prevalence was 36% (95CI: 33%-40%). The inoculum was heavy for 85% of cases (81%-89%). We found a significant spectrum effect on sensitivity, specificity, likelihood ratios and positive predictive value (p<0.05) but not negative predictive value, which was stable at about 92%. RADT sensitivity was greater for children with heavy than light inoculum (95% vs. 40%, p<0.001). After stratification by inoculum size, the spectrum effect on RADT sensitivity was significant only in patients with light inoculum, on univariate and multivariate analysis. The McIsaac-score-based decision rule had 99% (97%-100%) sensitivity and 52% (48%-57%) specificity. Conclusions: Variations in RADT sensitivity only occur in patients with light inocula. Because the spectrum effect does not affect the negative predictive value of the test, clinicians who want to rule out GAS can rely on negative RADT results regardless of clinical features if they accept that about 10% of children with negative RADT results will have a positive throat culture. However, such a policy is more acceptable in populations with very low incidence of complications of GAS infection.	[Cohen, Jeremie F.; Chalumeau, Martin] INSERM, Unite Rech Epidemiol Sante Perinatale & Sante Fem, U953, Paris, France; [Cohen, Jeremie F.; Chalumeau, Martin] Hop Necker Enfants Malad, AP HP, Serv Pediat Gen, Paris, France; [Cohen, Jeremie F.; Chalumeau, Martin] Univ Paris 05, Paris, France; [Levy, Corinne; Wollner, Alain; Cohen, Robert] Assoc Clin & Therapeut Val de Marne ACTIV, St Maur Des Fosses, France; [Bidet, Philippe; Bingen, Edouard] Hop Robert Debre, AP HP, Microbiol Serv, F-75019 Paris, France; [Bidet, Philippe; Bingen, Edouard] Univ Paris Diderot, Paris, France; [Thollot, Franck] AFPA, Esseys Les Nancy, France; [Cohen, Robert] Ctr Hosp Intercommunal Creteil, Microbiol Serv, Creteil, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil	Cohen, JF (corresponding author), INSERM, Unite Rech Epidemiol Sante Perinatale & Sante Fem, U953, Paris, France.	jeremie.cohen@inserm.fr	Cohen, Robert/AAM-4426-2021; Cohen, Jérémie/H-4707-2019; LEVY, Corinne/AAM-3541-2021; Chalumeau, Martin/F-4293-2017	Cohen, Robert/0000-0001-6151-0686; Cohen, Jérémie/0000-0003-3572-8985; LEVY, Corinne/0000-0002-1927-6360; Chalumeau, Martin/0000-0001-8175-3706	Dectrapharm; Agence Regionale de Sante d'Ile-de-France; Assistance Publique-Hopitaux de Paris (PHRC Regional) [AOR 12089]; Laboratoires Guigoz - Societe Francaise de Pediatrie - Groupe de Pediatrie Generale - Groupe de Recherches Epidemiologiques en Pediatrie	Dectrapharm; Agence Regionale de Sante d'Ile-de-France; Assistance Publique-Hopitaux de Paris (PHRC Regional); Laboratoires Guigoz - Societe Francaise de Pediatrie - Groupe de Pediatrie Generale - Groupe de Recherches Epidemiologiques en Pediatrie	This study was funded by Dectrapharm, manufacturer of the RADT (Rapid Antigen Detection Test). JFC is a masters student supported by educational grants from Agence Regionale de Sante d'Ile-de-France and Laboratoires Guigoz - Societe Francaise de Pediatrie - Groupe de Pediatrie Generale - Groupe de Recherches Epidemiologiques en Pediatrie. This work was supported by a research grant from the Assistance Publique-Hopitaux de Paris (PHRC Regional 2012, AOR 12089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisno AL, 2002, CLIN INFECT DIS, V35, P113, DOI 10.1086/340949; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Charlier-Bret N, 2004, PATHOL BIOL, V52, P438, DOI 10.1016/j.patbio.2004.07.013; Choby BA, 2009, AM FAM PHYSICIAN, V79, P383; Cohen R, 2004, EUR J PEDIATR, V163, P281, DOI 10.1007/s00431-004-1416-y; DiMatteo LA, 2001, ANN EMERG MED, V38, P648, DOI 10.1067/mem.2001.119850; Edmonson MB, 2005, PEDIATRICS, V115, P280, DOI 10.1542/peds.2004-0907; Elie C, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-7; Gerber MA, 2005, PEDIATR CLIN N AM, V52, P729, DOI 10.1016/j.pcl.2005.02.004; Gerber MA, 2004, CLIN MICROBIOL REV, V17, P571, DOI 10.1128/CMR.17.3.571-580.2004; GERBER MA, 1986, J PEDIATR-US, V108, P654, DOI 10.1016/S0022-3476(86)81036-8; Goehring C, 2004, STAT MED, V23, P125, DOI 10.1002/sim.1591; Hall MC, 2004, PEDIATRICS, V114, P182, DOI 10.1542/peds.114.1.182; Johnson DR, 2010, CLIN INFECT DIS, V50, P481, DOI 10.1086/650167; Kuhn S, 1999, DIAGN MICR INFEC DIS, V34, P275, DOI 10.1016/S0732-8893(99)00027-9; Kurtz B, 2000, J CLIN MICROBIOL, V38, P279; Matthys J, 2007, ANN FAM MED, V5, P436, DOI 10.1370/afm.741; McIsaac WJ, 2000, CAN MED ASSOC J, V163, P811; McIsaac WJ, 2004, JAMA-J AM MED ASSOC, V291, P1587, DOI 10.1001/jama.291.13.1587; McIsaac WJ, 1998, CAN MED ASSOC J, V158, P75; Mulherin SA, 2002, ANN INTERN MED, V137, P598, DOI 10.7326/0003-4819-137-7-200210010-00011; Pelucchi C, 2012, CLIN MICROBIOL INFEC, V18, P1, DOI 10.1111/j.1469-0691.2012.03766.x; Pickering LK, 2009, RED BOOK 2009 REPORT, V2009, P616; Ruiz-Aragon J, 2010, AN PEDIATR, V72, P391, DOI 10.1016/j.anpedi.2009.12.012; Shaikh N, 2011, J PEDIAT; Shaikh N, 2010, PEDIATRICS, V126, pE557, DOI 10.1542/peds.2009-2648; Tanz RR, 2009, PEDIATRICS, V123, P437, DOI 10.1542/peds.2008-0488; WACHOLDER S, 1986, AM J EPIDEMIOL, V123, P174, DOI 10.1093/oxfordjournals.aje.a114212; Walker CLF, 2006, J PEDIATR-US, V149, P64, DOI 10.1016/j.jpeds.2006.03.005	30	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39085	10.1371/journal.pone.0039085	http://dx.doi.org/10.1371/journal.pone.0039085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768060	Green Published, gold			2022-12-27	WOS:000305892100030
J	Frezzato, F; Gattazzo, C; Martini, V; Trimarco, V; Teramo, A; Carraro, S; Cabrelle, A; Ave, E; Facco, M; Zambello, R; Tibaldi, E; Brunati, AM; Semenzato, G; Trentin, L				Frezzato, Federica; Gattazzo, Cristina; Martini, Veronica; Trimarco, Valentina; Teramo, Antonella; Carraro, Samuela; Cabrelle, Anna; Ave, Elisa; Facco, Monica; Zambello, Renato; Tibaldi, Elena; Brunati, Anna Maria; Semenzato, Gianpietro; Trentin, Livio			HS1, a Lyn Kinase Substrate, Is Abnormally Expressed in B-Chronic Lymphocytic Leukemia and Correlates with Response to Fludarabine-Based Regimen	PLOS ONE			English	Article							VARIABLE-REGION MUTATIONS; PROTEIN-TYROSINE KINASE; HEMATOPOIETIC LINEAGE; MEDIATED APOPTOSIS; ACTIN-BINDING; CELL; SRC; PHOSPHORYLATION; COMPLEX; ACTIVATION	In B-Chronic Lymphocytic Leukemia (B-CLL) kinase Lyn is overexpressed, active, abnormally distributed, and part of a cytosolic complex involving hematopoietic lineage cell-specific protein 1 (HS1). These aberrant properties of Lyn could partially explain leukemic cells' defective apoptosis, directly or through its substrates, for example, HS1 that has been associated to apoptosis in different cell types. To verify the hypothesis of HS1 involvement in Lyn-mediated leukemic cell survival, we investigated HS1 protein in 71 untreated B-CLL patients and 26 healthy controls. We found HS1 overexpressed in leukemic as compared to normal B lymphocytes (1.38 +/- 0.54 vs 0.86 +/- 0.29, p < 0.01), and when HS1 levels were correlated to clinical parameters we found a higher expression of HS1 in poor-prognosis patients. Moreover, HS1 levels significantly decreased in ex vivo leukemic cells of patients responding to a fludarabine-containing regimen. We also observed that HS1 is partially localized in the nucleus of neoplastic B cells. All these data add new information on HS1 study, hypothesizing a pivotal role of HS1 in Lyn-mediated modulation of leukemic cells' survival and focusing, one more time, the attention on the BCR-Lyn axis as a putative target for new therapeutic strategies in this disorder.	[Frezzato, Federica; Gattazzo, Cristina; Martini, Veronica; Trimarco, Valentina; Teramo, Antonella; Cabrelle, Anna; Ave, Elisa; Facco, Monica; Zambello, Renato; Semenzato, Gianpietro; Trentin, Livio] Ctr Eccellenza Ric Biomed, Venetian Inst Mol Med, Padua, Italy; [Frezzato, Federica; Gattazzo, Cristina; Martini, Veronica; Trimarco, Valentina; Teramo, Antonella; Carraro, Samuela; Ave, Elisa; Facco, Monica; Zambello, Renato; Semenzato, Gianpietro; Trentin, Livio] Univ Padua, Sch Med, Dept Med, Hematol & Clin Immunol Branch, Padua, Italy; [Tibaldi, Elena; Brunati, Anna Maria] Univ Padua, Dept Mol Med, Padua, Italy	Veneto Institute Molecular Medicine; University of Padua; University of Padua	Frezzato, F (corresponding author), Ctr Eccellenza Ric Biomed, Venetian Inst Mol Med, Padua, Italy.	g.semenzato@unipd.it	Frezzato, Federica/J-7260-2016; TRENTIN, LIVIO/L-6678-2019; Zambello, Renato/AAB-5280-2022; SEMENZATO, GIANPIETRO C/J-7727-2016; TERAMO, ANTONELLA/AFR-2599-2022; Facco, Monica/F-7732-2017; FREZZATO, Federica/V-5802-2019; Brunati, Anna Maria/I-8136-2018; Martini, Veronica/J-8656-2016; TRENTIN, LIVIO/J-7676-2016; Martini, Veronica/AAV-6339-2020; Teramo, Antonella/K-1988-2016	Frezzato, Federica/0000-0001-7093-2493; TRENTIN, LIVIO/0000-0003-1222-6149; Zambello, Renato/0000-0002-8799-5324; SEMENZATO, GIANPIETRO C/0000-0002-6061-4595; TERAMO, ANTONELLA/0000-0002-2754-699X; Facco, Monica/0000-0003-0100-5789; FREZZATO, Federica/0000-0001-7093-2493; Brunati, Anna Maria/0000-0002-3481-9503; Martini, Veronica/0000-0002-0887-4082; TRENTIN, LIVIO/0000-0003-1222-6149; Teramo, Antonella/0000-0002-2754-699X	Ministero dell'Istruzione dell'Universita e della Ricerca; University of Padova (Progetto di Ateneo); Associazione Italiana per la Ricerca sul Cancro (Milan); Regione Veneto on chronic lymphocytic leukemia	Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); University of Padova (Progetto di Ateneo); Associazione Italiana per la Ricerca sul Cancro (Milan)(Fondazione AIRC per la ricerca sul cancro); Regione Veneto on chronic lymphocytic leukemia(Regione Veneto)	This work was supported by grants (Prin 2008) from Ministero dell'Istruzione dell'Universita e della Ricerca and University of Padova (Progetto di Ateneo 2005), Associazione Italiana per la Ricerca sul Cancro (Milan), and Regione Veneto on chronic lymphocytic leukemia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunati AM, 1999, J BIOL CHEM, V274, P7557, DOI 10.1074/jbc.274.11.7557; Chen YR, 2001, BIOCHEM BIOPH RES CO, V288, P981, DOI 10.1006/bbrc.2001.5862; Chong YP, 2005, BBA-PROTEINS PROTEOM, V1754, P210, DOI 10.1016/j.bbapap.2005.07.027; Contri A, 2005, J CLIN INVEST, V115, P369, DOI 10.1172/JC1200522094; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Danilov AV, 2006, CURR MOL MED, V6, P665, DOI 10.2174/156652406778195008; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; FUKUDA T, 1995, P NATL ACAD SCI USA, V92, P7302, DOI 10.1073/pnas.92.16.7302; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Hamblin TJ, 2002, BLOOD, V99, P1023, DOI 10.1182/blood.V99.3.1023; Hamblin TJ, 1997, BLOOD REV, V11, P119, DOI 10.1016/S0268-960X(97)90007-2; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; He H, 1998, MOL CELL BIOL, V18, P3829, DOI 10.1128/MCB.18.7.3829; Hussein K, 2009, ANN HEMATOL, V88, P1059, DOI 10.1007/s00277-009-0727-5; KITAMURA D, 1989, NUCLEIC ACIDS RES, V17, P9367; Lee F, 2008, INT J BIOCHEM CELL B, V40, P334, DOI 10.1016/j.biocel.2007.10.001; Meulmeester E, 2008, CURR CANCER DRUG TAR, V8, P87, DOI 10.2174/156800908783769337; Onabajo OO, 2008, J IMMUNOL, V180, P6685, DOI 10.4049/jimmunol.180.10.6685; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pugh-Bernard AE, 2006, CURR OPIN RHEUMATOL, V18, P451, DOI 10.1097/01.bor.0000240353.99808.5f; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Ruzzene M, 2000, EUR J BIOCHEM, V267, P3065, DOI 10.1046/j.1432-1327.2000.01333.x; Ruzzene M, 2002, BIOCHEM J, V364, P41, DOI 10.1042/bj3640041; Scielzo C, 2005, J CLIN INVEST, V115, P1644, DOI 10.1172/JCI24276; Scielzo C, 2010, BLOOD, V116, P3537, DOI 10.1182/blood-2009-12-258814; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Trentin L, 2008, BLOOD, V112, P4665, DOI 10.1182/blood-2008-02-139139; Uruno T, 2003, BIOCHEM J, V371, P485, DOI 10.1042/BJ20021791; Warr MR, 2008, CURR MOL MED, V8, P138; Xu YK, 2005, IMMUNITY, V22, P9, DOI 10.1016/j.immuni.2004.12.004; Yamanashi Y, 1997, J EXP MED, V185, P1387, DOI 10.1084/jem.185.7.1387	34	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39902	10.1371/journal.pone.0039902	http://dx.doi.org/10.1371/journal.pone.0039902			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768161	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100130
J	Havermann, K; Volcic, R; Lappe, M				Havermann, Katharina; Volcic, Robert; Lappe, Markus			Saccadic Adaptation to Moving Targets	PLOS ONE			English	Article							PURSUIT EYE-MOVEMENTS; ADAPTIVE MODIFICATIONS; ERROR SIGNALS; VISUAL ERROR; SHORT-TERM; MECHANISMS; MEMORY	Saccades are so called ballistic movements which are executed without online visual feedback. After each saccade the saccadic motor plan is modified in response to post-saccadic feedback with the mechanism of saccadic adaptation. The post-saccadic feedback is provided by the retinal position of the target after the saccade. If the target moves after the saccade, gaze may follow the moving target. In that case, the eyes are controlled by the pursuit system, a system that controls smooth eye movements. Although these two systems have in the past been considered as mostly independent, recent lines of research point towards many interactions between them. We were interested in the question if saccade amplitude adaptation is induced when the target moves smoothly after the saccade. Prior studies of saccadic adaptation have considered intra-saccadic target steps as learning signals. In the present study, the intra-saccadic target step of the McLaughlin paradigm of saccadic adaptation was replaced by target movement, and a post-saccadic pursuit of the target. We found that saccadic adaptation occurred in this situation, a further indication of an interaction of the saccadic system and the pursuit system with the aim of optimized eye movements.	[Havermann, Katharina; Lappe, Markus] Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, Dept Psychol, Munster, Germany; [Volcic, Robert] Ist Italiano Tecnol, UniTn, Ctr Neurosci & Cognit Syst, Rovereto, Italy	University of Munster; Istituto Italiano di Tecnologia - IIT	Havermann, K (corresponding author), Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, Dept Psychol, Munster, Germany.	k.havermann@wwu.de	Volcic, Robert/B-4944-2009	Volcic, Robert/0000-0002-0170-4136	German Science Foundation DFG [LA-952/3]; German Federal Ministry of Education and Research	German Science Foundation DFG(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	ML is supported by the German Science Foundation DFG LA-952/3, the German Federal Ministry of Education and Research project Visuo-spatial Cognition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes GR, 2008, BRAIN COGNITION, V68, P309, DOI 10.1016/j.bandc.2008.08.020; de Brouwer S, 2002, J NEUROPHYSIOL, V87, P1772, DOI 10.1152/jn.00621.2001; de Xivry JJO, 2007, J PHYSIOL-LONDON, V584, P11, DOI 10.1113/jphysiol.2007.139881; Eggert T, 2005, ANN NY ACAD SCI, V1039, P149, DOI 10.1196/annals.1325.014; Etchells PJ, 2010, J VISION, V10, DOI 10.1167/10.6.7; Ethier V, 2008, J NEUROPHYSIOL, V99, P2577, DOI 10.1152/jn.00015.2008; Ethier V, 2008, J NEUROSCI, V28, P13929, DOI 10.1523/JNEUROSCI.3470-08.2008; Fuchs AF, 1996, J NEUROPHYSIOL, V76, P2522, DOI 10.1152/jn.1996.76.4.2522; Fujita M, 2002, COGNITIVE BRAIN RES, V13, P41, DOI 10.1016/S0926-6410(01)00088-X; Golla H, 2008, EUR J NEUROSCI, V27, P132, DOI 10.1111/j.1460-9568.2007.05996.x; Havermann K, 2010, J NEUROPHYSIOL, V103, P3302, DOI 10.1152/jn.00970.2009; HEYWOOD S, 1981, VISION RES, V21, P479, DOI 10.1016/0042-6989(81)90094-8; Kojima Y, 2004, J NEUROSCI, V24, P7531, DOI 10.1523/JNEUROSCI.1741-04.2004; Krauzlis RJ, 2005, NEUROSCIENTIST, V11, P124, DOI 10.1177/1073858404271196; MCLAUGHLIN SC, 1967, PERCEPT PSYCHOPHYS, V2, P359, DOI 10.3758/BF03210071; MILLER JM, 1981, J EXP PSYCHOL HUMAN, V7, P356, DOI 10.1037/0096-1523.7.2.356; Nagao S, 1998, NEUROSCI RES, V32, P157, DOI 10.1016/S0168-0102(98)00079-0; NEWSOME WT, 1985, J NEUROSCI, V5, P825; Noto CT, 2001, COGNITIVE BRAIN RES, V12, P301, DOI 10.1016/S0926-6410(01)00062-3; Ogawa T, 1997, EXP BRAIN RES, V116, P83, DOI 10.1007/PL00005747; Panouilleres M, 2009, J NEUROPHYSIOL, V101, P1550, DOI 10.1152/jn.90988.2008; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; Robinson FR, 2006, J NEUROPHYSIOL, V96, P1030, DOI 10.1152/jn.01151.2005; Schnier F, 2011, J NEUROPHYSIOL, V106, P1399, DOI 10.1152/jn.00236.2011; Schutz AC, 2011, EXP BRAIN RES, V209, P537, DOI 10.1007/s00221-011-2581-7; SEMMLOW JL, 1989, J EXP PSYCHOL HUMAN, V15, P249, DOI 10.1037/0096-1523.15.2.249; Shafer JL, 2000, J NEUROPHYSIOL, V84, P88, DOI 10.1152/jn.2000.84.1.88; Wallman J, 1998, J NEUROPHYSIOL, V80, P2405, DOI 10.1152/jn.1998.80.5.2405; Wong AL, 2011, J NEUROPHYSIOL, V105, P1130, DOI 10.1152/jn.00394.2010; Zimmermann E, 2010, J VISION, V10, DOI 10.1167/10.6.2	30	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39708	10.1371/journal.pone.0039708	http://dx.doi.org/10.1371/journal.pone.0039708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768109	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100079
J	Keshvari, S; van den Berg, R; Ma, WJ				Keshvari, Shaiyan; van den Berg, Ronald; Ma, Wei Ji			Probabilistic Computation in Human Perception under Variability in Encoding Precision	PLOS ONE			English	Article							VISUAL WORKING-MEMORY; ATTENTION; INFERENCE; RESPONSES; BRAIN; DISCRIMINATION; UNCERTAINTY; INFORMATION; PERFORMANCE; CAPACITY	A key function of the brain is to interpret noisy sensory information. To do so optimally, observers must, in many tasks, take into account knowledge of the precision with which stimuli are encoded. In an orientation change detection task, we find that encoding precision does not only depend on an experimentally controlled reliability parameter (shape), but also exhibits additional variability. In spite of variability in precision, human subjects seem to take into account precision near-optimally on a trial-to-trial and item-to-item basis. Our results offer a new conceptualization of the encoding of sensory information and highlight the brain's remarkable ability to incorporate knowledge of uncertainty during complex perceptual decision-making.	[Keshvari, Shaiyan; van den Berg, Ronald; Ma, Wei Ji] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine	Keshvari, S (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	wjma@bcm.edu		/0000-0002-5907-6259; Ma, Wei Ji/0000-0002-9835-9083; van den Berg, Ronald/0000-0001-7353-5960	National Eye Institute [R01EY020958]; Netherlands Organisation for Scientific Research; NATIONAL EYE INSTITUTE [R01EY020958] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	WJM is supported by award number R01EY020958 from the National Eye Institute (http://www.nei.nih.gov/). RvdB is supported by the Netherlands Organisation for Scientific Research (http://www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Baldassi S, 2002, J VISION, V2, DOI 10.1167/2.8.3; Brady TF, 2010, COGNITION IN FLUX, P411; Brady TF, 2011, PSYCHOL SCI, V22, P384, DOI 10.1177/0956797610397956; Churchland AK, 2011, NEURON, V69, P818, DOI 10.1016/j.neuron.2010.12.037; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Cohen MR, 2010, J NEUROSCI, V30, P15241, DOI 10.1523/JNEUROSCI.2171-10.2010; Connor CE, 1996, J NEUROPHYSIOL, V75, P1306, DOI 10.1152/jn.1996.75.3.1306; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Eckstein MP, 2000, PERCEPT PSYCHOPHYS, V62, P425, DOI 10.3758/BF03212096; Eng HY, 2005, PSYCHON B REV, V12, P1127, DOI 10.3758/BF03206454; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; FRENCH RS, 1953, J EXP PSYCHOL, V46, P1, DOI 10.1037/h0059543; Gershon ED, 1998, J NEUROPHYSIOL, V79, P1135, DOI 10.1152/jn.1998.79.3.1135; Girshick AR, 2011, NAT NEUROSCI, V14, P926, DOI 10.1038/nn.2831; Girshick AR, 2009, J VISION, V9, DOI 10.1167/9.9.8; Goris RLT, 2012, USING DOUBLY STOCHAS; Green DM, 1966, SIGNAL DETECTION THE; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Ma WJ, 2011, NAT NEUROSCI, V14, P783, DOI 10.1038/nn.2814; Ma WJ, 2010, VISION RES, V50, P2308, DOI 10.1016/j.visres.2010.08.035; Ma WJ, 2009, J VISION, V9, DOI 10.1167/9.11.3; MacKay D. J. C., 2003, INFORM THEORY INFERE; Matthias E, 2009, NEUROPSYCHOLOGIA, V47, P3255, DOI 10.1016/j.neuropsychologia.2009.08.004; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; Natarajan R, 2009, ADV NEURAL INFORM PR, V21; NOLTE LW, 1967, J ACOUST SOC AM, V41, P497, DOI 10.1121/1.1910360; Palmer J, 2000, VISION RES, V40, P1227, DOI 10.1016/S0042-6989(99)00244-8; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; Pestilli F, 2005, VISION RES, V45, P1867, DOI 10.1016/j.visres.2005.01.019; PHILLIPS WA, 1974, PERCEPT PSYCHOPHYS, V16, P283, DOI 10.3758/BF03203943; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Reddy L, 2006, CURR BIOL, V2006, P20; Sadaghiani S, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00020; Sapir A, 2005, P NATL ACAD SCI USA, V102, P17810, DOI 10.1073/pnas.0504678102; Saproo S, 2010, J NEUROPHYSIOL, V104, P885, DOI 10.1152/jn.00369.2010; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shadlen MN, 1996, J NEUROSCI, V16, P1486; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Van den Berg R, 2012, P NATL ACAD SCI US, V109; van den Berg R, 2012, P NATL ACAD SCI USA, V109, P3178, DOI 10.1073/pnas.1108790109; Whiteley L, 2008, J VISION, V8, DOI 10.1167/8.3.2; Wilken P, 2004, J VISION, V4, P1120, DOI 10.1167/4.12.11; Yule GU, 1902, BIOMETRIKA, V2, P121	49	42	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40216	10.1371/journal.pone.0040216	http://dx.doi.org/10.1371/journal.pone.0040216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768258	Green Submitted, gold, Green Published			2022-12-27	WOS:000305892100231
J	Le Vu, S; Velter, A; Meyer, L; Peytavin, G; Guinard, J; Pillonel, J; Barin, F; Semaille, C				Le Vu, Stephane; Velter, Annie; Meyer, Laurence; Peytavin, Gilles; Guinard, Jerome; Pillonel, Josiane; Barin, Francis; Semaille, Caroline			Biomarker-Based HIV Incidence in a Community Sample of Men Who Have Sex with Men in Paris, France	PLOS ONE			English	Article							SEROLOGIC TESTING ALGORITHM; UNDIAGNOSED INFECTION; GAY MEN; EPIDEMIC; IMMUNOASSAY; PREVALENCE; BIAS	Background: Population-based estimates of HIV incidence in France have revealed that men who have sex with men (MSM) are the most affected population and contribute to nearly half of new infections each year. We sought to estimate HIV incidence among sexually active MSM in Paris gay community social venues. Methodology/Principal Findings: A cross-sectional survey was conducted in 2009 in a sample of commercial venues such as bars, saunas and backrooms. We collected a behavioural questionnaire and blood sample. Specimens were tested for HIV infection and positive specimens then tested for recent infection by the enzyme immunoassay for recent HIV-1 infection (EIA-RI). We assessed the presence of antiretroviral therapy among infected individuals to rule out treated patients in the algorithm that determined recent infection. Biomarker-based cross-sectional incidence estimates were calculated. We enrolled 886 MSM participants among which 157 (18%) tested HIV positive. In positive individuals who knew they were infected, 75% of EIA-RI positive results were due to ART. Of 157 HIV positive specimens, 15 were deemed to be recently infected. The overall HIV incidence was estimated at 3.8% person-years(py) [95% CI: 1.5-6.2]. Although differences were not significant, incidence was estimated to be 3.5% py [0.1-6.1] in men having had a negative HIV test in previous year and 4.8% py [0.1-10.6] in men having had their last HIV test more than one year before the survey, or never tested. Incidence was estimated at 4.1% py [0-8.3] in men under 35 years and 2.5% py [0-5.4] in older men. Conclusions/Significance: This is the first community-based survey to estimate HIV incidence among MSM in France. It includes ART detection and reveals a high level of HIV transmission in sexually active individuals, despite a high uptake of HIV testing. These data call for effective prevention programs targeting MSM engaged in high-risk behaviours.	[Le Vu, Stephane; Velter, Annie; Pillonel, Josiane; Barin, Francis; Semaille, Caroline] Inst Veille Sanit, St Maurice, France; [Meyer, Laurence] Univ Paris Sud, Ctr Res Epidemiol & Populat Hlth, F-94275 Le Kremlin Bicetre, France; [Peytavin, Gilles] Paris VII Diderot Univ, Clin Pharmacokinet Dept, Bichat Claude Bernard Hosp, APHP, Paris, France; [Guinard, Jerome] Univ Tours, Univ Hosp Bretonneau, Natl HIV Reference Ctr, Natl Inst Hlth & Med Res,INSERM, Tours, France	Institute of Public Health Surveillance; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours	Le Vu, S (corresponding author), Inst Veille Sanit, St Maurice, France.	s.levu@invs.sante.fr		Le Vu, Stephane/0000-0002-1303-8281	French National Institute for Public Health Surveillance (InVS); French National Agency for Research on AIDS and Viral Hepatitis (ANRS)	French National Institute for Public Health Surveillance (InVS); French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR))	The Prevagay survey was funded by the French National Institute for Public Health Surveillance (InVS) and the French National Agency for Research on AIDS and Viral Hepatitis (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barin F, 2005, J CLIN MICROBIOL, V43, P4441, DOI 10.1128/JCM.43.9.4441-4447.2005; Barnighausen T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003640; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Chaillon A, 2011, 18 C RETR OPP INF BO; Dodds JP, 2007, SEX TRANSM INFECT, V83, P392, DOI 10.1136/sti.2006.021782; Folch C, 2009, Euro Surveill, V14; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Jung BH, 2007, BIOMED CHROMATOGR, V21, P1095, DOI 10.1002/bmc.865; Le Vu S, 2008, Euro Surveill, V13; Le Vu S, 2010, LANCET INFECT DIS, V10, P682, DOI 10.1016/S1473-3099(10)70167-5; Le Vu S, 2009, AIDS, V23, P1771, DOI 10.1097/QAD.0b013e32832d8754; Marinda ET, 2010, JAIDS-J ACQ IMM DEF, V53, P496, DOI 10.1097/QAI.0b013e3181b61938; McWalter TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007368; McWalter TA, 2010, J MATH BIOL, V60, P687, DOI 10.1007/s00285-009-0282-7; Pedrana AE, 2012, JAIDS-J ACQ IMM DEF, V59, P94, DOI 10.1097/QAI.0b013e3182396869; Remis RS, 2009, AIDS, V23, P493, DOI 10.1097/QAD.0b013e328323ad5f; Stall R, 2009, AIDS BEHAV, V13, P615, DOI 10.1007/s10461-008-9509-7; Sullivan PS, 2009, ANN EPIDEMIOL, V19, P423, DOI 10.1016/j.annepidem.2009.03.004; Vanden Berghe W, 2011, EUROSURVEILLANCE, V16, P10; Velter A., 2010, Bulletin Epidemiologique Hebdomadaire, P464; Velter A, 2009, Euro Surveill, V14; Velter A, 2006, B EPIDEMIOLOGIQUE HE, P178; Velter A, 2007, ENQUETE PRESSE GAY 2; White E, 2010, SEX TRANSM INFECT, V86, P254, DOI 10.1136/sti.2009.037291; Williamson LM, 2007, JAIDS-J ACQ IMM DEF, V45, P224, DOI 10.1097/QAI.0b013e318058a01e; Yeni P, 2010, PRISE CHARGE MED PER	28	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39872	10.1371/journal.pone.0039872	http://dx.doi.org/10.1371/journal.pone.0039872			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768150	Green Submitted, gold, Green Published			2022-12-27	WOS:000305892100119
J	Poole, B; Markowitz, JE; Gardner, TJ				Poole, Barish; Markowitz, Jeffrey E.; Gardner, Timothy J.			The Song Must Go On: Resilience of the Songbird Vocal Motor Pathway	PLOS ONE			English	Article							MALE ZEBRA FINCHES; SEQUENCE GENERATION; VISUAL-CORTEX; SLEEP; PLASTICITY; NEURONS; NETWORKS; REPLAY	Stereotyped sequences of neural activity underlie learned vocal behavior in songbirds; principle neurons in the cortical motor nucleus HVC fire in stereotyped sequences with millisecond precision across multiple renditions of a song. The geometry of neural connections underlying these sequences is not known in detail though feed-forward chains are commonly assumed in theoretical models of sequential neural activity. In songbirds, a well-defined cortical-thalamic motor circuit exists but little is known the fine-grain structure of connections within each song nucleus. To examine whether the structure of song is critically dependent on long-range connections within HVC, we bilaterally transected the nucleus along the anterior-posterior axis in normal-hearing and deafened birds. The disruption leads to a slowing of song as well as an increase in acoustic variability. These effects are reversed on a time-scale of days even in deafened birds or in birds that are prevented from singing post-transection. The stereotyped song of zebra finches includes acoustic details that span from milliseconds to seconds-one of the most precise learned behaviors in the animal kingdom. This detailed motor pattern is resilient to disruption of connections at the cortical level, and the details of song variability and duration are maintained by offline homeostasis of the song circuit.	[Poole, Barish; Gardner, Timothy J.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Markowitz, Jeffrey E.] Boston Univ, Dept Cognit & Neural Syst, Boston, MA 02215 USA; [Markowitz, Jeffrey E.; Gardner, Timothy J.] Ctr Excellence Learning Educ Sci & Technol, Boston, MA USA	Boston University; Boston University	Poole, B (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	timothyg@bu.edu	Markowitz, Jeffrey/GQP-3708-2022		National Science Foundation Science of Learning Center CELEST [SBE-0354378]; Burroughs Wellcome Fund; Smith family award	National Science Foundation Science of Learning Center CELEST(National Science Foundation (NSF)NSF - Office of the Director (OD)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Smith family award	This work is supported by the National Science Foundation Science of Learning Center CELEST (SBE-0354378) and by a Career Award at the Scientific Interface to TG from the Burroughs Wellcome Fund and a Smith family award to TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles M., 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; Foster EF, 1998, J COMP NEUROL, V397, P118; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hebb D.O., 2002, ORG BEHAV NEUROPSYCH; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Lashley K, 1951, PSYCHOLINGUISTICS BO; LASHLEY KS, 1950, SYM SOC EXP BIOL, V4, P454; Lim Y, 2011, IEEE WORKSH APPL SIG; Lombardino AJ, 2000, J NEUROSCI, V20, P5054; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Mooney R, 2005, J NEUROSCI, V25, P1952, DOI 10.1523/JNEUROSCI.3726-04.2005; MOONEY R, 1991, P NATL ACAD SCI USA, V88, P4075, DOI 10.1073/pnas.88.10.4075; O'Keefe J., 1971, BRAIN RES; Schmidt M, 2003, J NEUROPHYSIOLOGY; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	29	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38173	10.1371/journal.pone.0038173	http://dx.doi.org/10.1371/journal.pone.0038173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768040	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100011
J	Shoham, DA; Tong, LP; Lamberson, PJ; Auchincloss, AH; Zhang, J; Dugas, L; Kaufman, JS; Cooper, RS; Luke, A				Shoham, David A.; Tong, Liping; Lamberson, Peter J.; Auchincloss, Amy H.; Zhang, Jun; Dugas, Lara; Kaufman, Jay S.; Cooper, Richard S.; Luke, Amy			An Actor-Based Model of Social Network Influence on Adolescent Body Size, Screen Time, and Playing Sports	PLOS ONE			English	Article							US CHILDREN; OBESITY; OVERWEIGHT; SPREAD; PREVALENCE; CONTAGION; SELECTION; EPIDEMIC; SMOKING	Recent studies suggest that obesity may be "contagious" between individuals in social networks. Social contagion (influence), however, may not be identifiable using traditional statistical approaches because they cannot distinguish contagion from homophily (the propensity for individuals to select friends who are similar to themselves) or from shared environmental influences. In this paper, we apply the stochastic actor-based model (SABM) framework developed by Snijders and colleagues to data on adolescent body mass index (BMI), screen time, and playing active sports. Our primary hypothesis was that social influences on adolescent body size and related behaviors are independent of friend selection. Employing the SABM, we simultaneously modeled network dynamics (friendship selection based on homophily and structural characteristics of the network) and social influence. We focused on the 2 largest schools in the National Longitudinal Study of Adolescent Health (Add Health) and held the school environment constant by examining the 2 school networks separately (N = 624 and 1151). Results show support in both schools for homophily on BMI, but also for social influence on BMI. There was no evidence of homophily on screen time in either school, while only one of the schools showed homophily on playing active sports. There was, however, evidence of social influence on screen time in one of the schools, and playing active sports in both schools. These results suggest that both homophily and social influence are important in understanding patterns of adolescent obesity. Intervention efforts should take into consideration peers' influence on one another, rather than treating "high risk" adolescents in isolation.	[Shoham, David A.; Tong, Liping; Zhang, Jun; Dugas, Lara; Cooper, Richard S.; Luke, Amy] Loyola Univ Chicago, Dept Prevent Med & Epidemiol, Maywood, IL 60153 USA; [Tong, Liping] Loyola Univ, Dept Math & Stat, Chicago, IL 60611 USA; [Lamberson, Peter J.] Northwestern Univ, JL Kellogg Grad Sch Management, Evanston, IL USA; [Auchincloss, Amy H.] Drexel Univ, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Kaufman, Jay S.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	Loyola University Chicago; Loyola University Chicago; Northwestern University; Drexel University; McGill University	Shoham, DA (corresponding author), Loyola Univ Chicago, Dept Prevent Med & Epidemiol, Maywood, IL 60153 USA.	dshoham@lumc.edu		Dugas, Lara/0000-0002-0692-8585; Kaufman, Jay/0000-0003-1606-401X	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development [U01-HD061978]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01-HD31921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061978, P01HD031921] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD061978] Funding Source: NIH RePORTER	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was funded by the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, under grant number U01-HD061978, "Modeling Obesity through Simulation (MOTS)." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Add Health program project was funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. No direct support was received from grant P01-HD31921 for this analysis.	Alexander C, 2001, J ADOLESCENT HEALTH, V29, P22, DOI 10.1016/S1054-139X(01)00210-5; [Anonymous], SAS PROGR CDC GROWTH; Bahr DB, 2009, OBESITY, V17, P723, DOI 10.1038/oby.2008.615; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bearman PS, 2004, AM J SOCIOL, V110, P44, DOI 10.1086/386272; Berkman L. F., 2000, SOCIAL EPIDEMIOLOGY, V1, P137, DOI DOI 10.4135/9781412952576.N192]; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Cohen-Cole E, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2533; de la Haye K, 2011, J ADOLESCENT HEALTH, V49, P421, DOI 10.1016/j.jadohealth.2011.02.008; de la Haye K, 2010, SOC NETWORKS, V32, P161, DOI 10.1016/j.socnet.2009.09.001; Field AE, 2007, OBESITY, V15, P2357, DOI 10.1038/oby.2007.279; Fletcher A, 2011, J EPIDEMIOL COMMUN H, V65, P548, DOI 10.1136/jech.2010.113936; Gillum RF, 2005, NUTR J WEBSITE; Gordon-Larsen P, 2006, PEDIATRICS, V117, P417, DOI 10.1542/peds.2005-0058; Halliday TJ, 2009, ECON HUM BIOL, V7, P181, DOI 10.1016/j.ehb.2009.05.002; Harris KM, 2009, NATL LONGITUDINAL ST; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Johns D, 2010, SLATE; KLOVDAHL AS, 1985, SOC SCI MED, V21, P1203, DOI 10.1016/0277-9536(85)90269-2; Malina R.M., 2004, GROWTH MATURATION PH, V2nd ed., DOI DOI 10.1016/j.jsams.2011.04.003; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mercken L, 2010, ADDICTION, V105, P1280, DOI 10.1111/j.1360-0443.2010.02930.x; Merrill RM, 2009, VALIDITY SELF REPORT; Monasta L, 2010, OBES REV, V11, P695, DOI 10.1111/j.1467-789X.2010.00735.x; Moore S, 2009, J PUBLIC HEALTH-UK, V31, P175, DOI 10.1093/pubmed/fdn104; O'Malley AJ, 2011, STAT MED, V30, P950, DOI 10.1002/sim.4190; Ogden C.L., 2010, OBESITY SOCIOECONOMI; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Ripley R.M., 2022, MANUAL RSIENA; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Shalizi CR, 2011, SOCIOL METHOD RES, V40, P211, DOI 10.1177/0049124111404820; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; Snijders TAB, 2001, SOCIOL METHODOL, V31, P361, DOI 10.1111/0081-1750.00099; Snijders TAB, 2010, SOC NETWORKS, V32, P44, DOI 10.1016/j.socnet.2009.02.004; Steglich C, 2010, SOCIOL METHODOL, V40, P329, DOI 10.1111/j.1467-9531.2010.01225.x; Sterman JD, 2006, AM J PUBLIC HEALTH, V96, P505, DOI 10.2105/AJPH.2005.066043; Strauss RS, 2003, ARCH PEDIAT ADOL MED, V157, P746, DOI 10.1001/archpedi.157.8.746; Sturm R, 2008, PUBLIC HEALTH, V122, P739, DOI 10.1016/j.puhe.2008.01.004; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Valente T, 1995, NETWORK MODELS DIFFU; Valente T. W., 2009, SOCIAL NETWORKS HLTH; Wang YF, 2001, INT J EPIDEMIOL, V30, P1129, DOI 10.1093/ije/30.5.1129; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Woodard GA, 2011, ARCH SURG-CHICAGO, V146, P1185, DOI 10.1001/archsurg.2011.244; Yakusheva O, 2009, ECON HUM BIOL, V9, P119	51	85	86	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39795	10.1371/journal.pone.0039795	http://dx.doi.org/10.1371/journal.pone.0039795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768124	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100094
J	Skelly, LR; Decety, J				Skelly, Laurie R.; Decety, Jean			Passive and Motivated Perception of Emotional Faces: Qualitative and Quantitative Changes in the Face Processing Network	PLOS ONE			English	Article							PREFRONTAL CORTEX; SOCIAL-PERCEPTION; ORBITOFRONTAL CORTEX; FACIAL EXPRESSIONS; NEURAL ACTIVATION; AMYGDALA ACTIVITY; FUSIFORM GYRUS; HUMAN BRAIN; AUTISM; FMRI	Emotionally expressive faces are processed by a distributed network of interacting sub-cortical and cortical brain regions. The components of this network have been identified and described in large part by the stimulus properties to which they are sensitive, but as face processing research matures interest has broadened to also probe dynamic interactions between these regions and top-down influences such as task demand and context. While some research has tested the robustness of affective face processing by restricting available attentional resources, it is not known whether face network processing can be augmented by increased motivation to attend to affective face stimuli. Short videos of people expressing emotions were presented to healthy participants during functional magnetic resonance imaging. Motivation to attend to the videos was manipulated by providing an incentive for improved recall performance. During the motivated condition, there was greater coherence among nodes of the face processing network, more widespread correlation between signal intensity and performance, and selective signal increases in a task-relevant subset of face processing regions, including the posterior superior temporal sulcus and right amygdala. In addition, an unexpected task-related laterality effect was seen in the amygdala. These findings provide strong evidence that motivation augmentsco-activity among nodes of the face processing network and the impact of neural activity on performance. These within-subject effects highlight the necessity to consider motivation when interpreting neural function in special populations, and to further explore the effect of task demands on face processing in healthy brains.	[Skelly, Laurie R.; Decety, Jean] Univ Chicago, Dept Psychol, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Decety, Jean] Univ Chicago, Ctr Cognit & Social Neurosci, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Skelly, LR (corresponding author), Univ Chicago, Dept Psychol, Dept Psychiat & Behav Neurosci, 5848 S Univ Ave, Chicago, IL 60637 USA.	lskelly@uchicago.edu			NSF [BCS-0718480]	NSF(National Science Foundation (NSF))	This study was supported by an NSF grant (BCS-0718480) awarded to Dr. Jean Decety. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Anderson AK, 2003, J NEUROSCI, V23, P5627; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Atkinson AP, 2011, PHILOS T R SOC B, V366, P1726, DOI 10.1098/rstb.2010.0349; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Baker KB, 2004, BEHAV NEUROSCI, V118, P15, DOI 10.1037/0735-7044.118.1.15; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Berntson GG, 2003, EUR J NEUROSCI, V18, P2103, DOI 10.1046/j.1460-9568.2003.02967.x; Blair RJR, 2007, TRENDS COGN SCI, V11, P387, DOI 10.1016/j.tics.2007.07.003; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Dadds MR, 2008, J AM ACAD CHILD PSY, V47, P455, DOI 10.1097/CHI.0b013e31816407f1; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; DAVIDSON RA, 1992, NEUROPSYCHOLOGIA, V30, P1053, DOI 10.1016/0028-3932(92)90098-7; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; Deeley Q, 2006, BRIT J PSYCHIAT, V189, P533, DOI 10.1192/bjp.bp.106.021410; Elliott R, 2003, J NEUROSCI, V23, P303; Fairhall SL, 2007, CEREB CORTEX, V17, P2400, DOI 10.1093/cercor/bhl148; Fitzgerald DA, 2006, NEUROIMAGE, V30, P1441, DOI 10.1016/j.neuroimage.2005.11.003; Foley E, 2012, J COGNITIVE NEUROSCI, V24, P507, DOI 10.1162/jocn_a_00120; Furl N, 2011, J COGNITIVE NEUROSCI, V23, P1723, DOI 10.1162/jocn.2010.21545; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Glascher J, 2003, J NEUROSCI, V23, P10274; Gobbini MI, 2004, NEUROIMAGE, V22, P1628, DOI 10.1016/j.neuroimage.2004.03.049; Grelotti DJ, 2005, NEUROPSYCHOLOGIA, V43, P373, DOI 10.1016/j.neuropsychologia.2004.06.015; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Harenski CL, 2010, J ABNORM PSYCHOL, V119, P863, DOI 10.1037/a0020979; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Henson RNA, 2002, CEREB CORTEX, V12, P178, DOI 10.1093/cercor/12.2.178; Herrington JD, 2011, NEUROIMAGE, V56, P2348, DOI 10.1016/j.neuroimage.2011.03.072; Ishai A, 2002, NEUROIMAGE, V17, P1729, DOI 10.1006/nimg.2002.1330; Ishai A, 2004, P NATL ACAD SCI USA, V101, P9827, DOI 10.1073/pnas.0403559101; Kadosh KC, 2010, J COGNITIVE NEUROSCI, V22, P903, DOI 10.1162/jocn.2009.21224; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Kleinhans NM, 2011, NEUROIMAGE, V54, P697, DOI 10.1016/j.neuroimage.2010.07.037; Kleinhans NM, 2009, AM J PSYCHIAT, V166, P467, DOI 10.1176/appi.ajp.2008.07101681; Kosaka H, 2003, NEUROIMAGE, V20, P1734, DOI 10.1016/S1053-8119(03)00447-6; Koshino H, 2008, CEREB CORTEX, V18, P289, DOI 10.1093/cercor/bhm054; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Lane RD, 1999, NEUROPSYCHOLOGIA, V37, P989, DOI 10.1016/S0028-3932(99)00017-2; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; Lieberman MD, 2007, PSYCHOL SCI, V18, P421, DOI 10.1111/j.1467-9280.2007.01916.x; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Most SB, 2006, NEUROIMAGE, V31, P934, DOI 10.1016/j.neuroimage.2005.12.031; Muller JL, 2003, BIOL PSYCHIAT, V54, P152, DOI 10.1016/S0006-3223(02)01749-3; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Newman JP, 2003, SER AFFECTIVE SCI, P904; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Palermo R, 2007, NEUROPSYCHOLOGIA, V45, P75, DOI 10.1016/j.neuropsychologia.2006.04.025; Pelphrey KA, 2008, ANN NY ACAD SCI, V1145, P283, DOI 10.1196/annals.1416.007; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; Pessoa L, 2005, CURR OPIN NEUROBIOL, V15, P188, DOI 10.1016/j.conb.2005.03.002; Pessoa L, 2010, NEUROPSYCHOLOGIA, V48, P3416, DOI 10.1016/j.neuropsychologia.2010.06.038; Phillips ML, 2001, HUM BRAIN MAPP, V12, P193, DOI 10.1002/1097-0193(200104)12:4<193::AID-HBM1015>3.0.CO;2-A; Pierce K, 2004, BRAIN, V127, P2703, DOI 10.1093/brain/awh289; Pierce K, 2001, BRAIN, V124, P2059, DOI 10.1093/brain/124.10.2059; Pierce K, 2008, BIOL PSYCHIAT, V64, P552, DOI 10.1016/j.biopsych.2008.05.013; Pinkham AE, 2008, SCHIZOPHR RES, V99, P164, DOI 10.1016/j.schres.2007.10.024; Reinhardt I, 2010, EUR ARCH PSY CLIN N, V260, P443, DOI 10.1007/s00406-010-0099-9; Righart R, 2008, SOC COGN AFFECT NEUR, V3, P270, DOI 10.1093/scan/nsn021; Schultz J, 2009, EXP BRAIN RES, V194, P465, DOI 10.1007/s00221-009-1721-9; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; Seitz RJ, 2006, NEUROPSYCHOLOGY, V20, P743, DOI 10.1037/0894-4105.20.6.743; Van Bavel JJ, 2011, J COGNITIVE NEUROSCI, V23, P3343, DOI 10.1162/jocn_a_00016; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wager TD, 2003, NEUROIMAGE, V18, P293, DOI 10.1016/S1053-8119(02)00046-0; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Weng SJ, 2011, J CHILD PSYCHOL PSYC, V52, P296, DOI 10.1111/j.1469-7610.2010.02317.x; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wright CI, 2001, NEUROREPORT, V12, P379, DOI 10.1097/00001756-200102120-00039	78	18	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40371	10.1371/journal.pone.0040371	http://dx.doi.org/10.1371/journal.pone.0040371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768287	gold, Green Submitted, Green Published			2022-12-27	WOS:000305892100261
J	Takada, A; Miki, T; Kuno, A; Kouzu, H; Sunaga, D; Itoh, T; Tanno, M; Yano, T; Sato, T; Ishikawa, S; Miura, T				Takada, Akifumi; Miki, Takayuki; Kuno, Atsushi; Kouzu, Hidemichi; Sunaga, Daisuke; Itoh, Takahito; Tanno, Masaya; Yano, Toshiyuki; Sato, Tatsuya; Ishikawa, Satoko; Miura, Tetsuji			Role of ER Stress in Ventricular Contractile Dysfunction in Type 2 Diabetes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; HEART-FAILURE; MYOCARDIAL-INFARCTION; TAUROURSODEOXYCHOLIC ACID; CARDIAC-FUNCTION; GENE-TRANSFER; CA2+ ATPASE; CARDIOMYOPATHY; RAT; MODEL	Background: Diabetes mellitus (DM) is associated with an increased risk of ischemic heart disease and of adverse outcomes following myocardial infarction (MI). Here we assessed the role of endoplasmic reticulum (ER) stress in ventricular dysfunction and outcomes after MI in type 2 DM (T2DM). Methodology and Principal Findings: In hearts of OLETF, a rat model of T2DM, at 25 similar to 30 weeks of age, GRP78 and GRP94, markers of ER stress, were increased and sarcoplasmic reticulum calcium ATPase (SERCA) 2a protein was reduced by 35% compared with those in LETO, a non-diabetic control. SERCA2a mRNA levels were similar, but SERCA2a protein was more ubiquitinated in OLETF than in LETO. Left ventricular (LV) end-diastolic elastance (Eed) was higher in OLETF than in LETO (53.9 +/- 5.2 vs. 20.2 +/- 5.6 mmHg/mu l), whereas LV end-systolic elastance and positive inotropic responses to beta-adrenergic stimulation were similar in OLETF and LETO. 4-Phenylbutyric acid (4-PBA), an ER stress modulator, suppressed both GRP up-regulation and SERCA2a ubiquitination and normalized SERCA2a protein level and Eed in OLETF. Sodium tauroursodeoxycholic acid, a structurally different ER stress modulator, also restored SERCA2a protein level in OLETF. Though LV dysfunction was modest, mortality within 48 h after coronary occlusion was markedly higher in OLETF than in LETO (61.3% vs. 7.7%). Telemetric recording showed that rapid progression of heart failure was responsible for the high mortality rate in OLETF. ER stress modulators failed to reduce the mortality rate after MI in OLETF. Conclusions: ER stress reduces SERCA2a protein via its augmented ubiquitination and degradation, leading to LV diastolic dysfunction in T2DM. Even at a stage without systolic LV dysfunction, susceptibility to lethal heart failure after infarction is markedly increased, which cannot be explained by ER stress or change in myocardial response to sympathetic nerve activation.	[Takada, Akifumi; Miki, Takayuki; Kuno, Atsushi; Kouzu, Hidemichi; Sunaga, Daisuke; Itoh, Takahito; Tanno, Masaya; Yano, Toshiyuki; Sato, Tatsuya; Ishikawa, Satoko; Miura, Tetsuji] Sapporo Med Univ, Sch Med, Dept Internal Med 2, Sapporo, Hokkaido, Japan; [Kuno, Atsushi] Sapporo Med Univ, Sch Med, Dept Pharmacol, Sapporo, Hokkaido, Japan; [Sato, Tatsuya] Sapporo Med Univ, Sch Med, Dept Cellular Physiol & Signal Transduct, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Takada, A (corresponding author), Sapporo Med Univ, Sch Med, Dept Internal Med 2, Sapporo, Hokkaido, Japan.	miura@sapmed.ac.jp	Kouzu, Hidemichi/AAZ-3810-2020	Kouzu, Hidemichi/0000-0001-7815-1464; KUNO, ATSUSHI/0000-0001-6873-1297	Japanese Society for Promotion of Science, Tokyo, Japan [3591086]; Suhara Memorial Foundation, Sapporo, Japan	Japanese Society for Promotion of Science, Tokyo, Japan; Suhara Memorial Foundation, Sapporo, Japan	This study was supported by a Grant-in-Aid for Scientific Research (#3591086; T. Miura) from the Japanese Society for the Promotion of Science, Tokyo, Japan, and a grant from the Suhara Memorial Foundation (T. Miki), Sapporo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Belke DD, 2004, DIABETES, V53, P3201, DOI 10.2337/diabetes.53.12.3201; Bidasee KR, 2004, DIABETES, V53, P463, DOI 10.2337/diabetes.53.2.463; Bonito P, 2005, DIABETIC MED, V22, P1720, DOI 10.1111/j.1464-5491.2005.01685.x; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Boyer JK, 2004, AM J CARDIOL, V93, P870, DOI 10.1016/j.amjcard.2003.12.026; Ceylan-Isik AF, 2011, J MOL CELL CARDIOL, V50, P107, DOI 10.1016/j.yjmcc.2010.10.023; Chandler MP, 2007, AM J PHYSIOL-HEART C, V293, pH1609, DOI 10.1152/ajpheart.01338.2006; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; George I, 2011, CARDIOVASC RES, V91, P447, DOI 10.1093/cvr/cvr106; Greer JJM, 2006, AM J PHYSIOL-HEART C, V290, pH146, DOI 10.1152/ajpheart.00583.2005; Gwathmey JK, 2011, J MOL CELL CARDIOL, V50, P803, DOI 10.1016/j.yjmcc.2010.11.011; Hotta H, 2010, CIRC RES, V106, P129, DOI 10.1161/CIRCRESAHA.109.205385; Karakikes I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006474; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; Lipskaia L, 2010, EXPERT OPIN BIOL TH, V10, P29, DOI 10.1517/14712590903321462; Loo Tip W., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000361; Lujan HL, 2009, J CARDIOVASC PHARM T, V14, P199, DOI 10.1177/1074248409340160; Mariani JA, 2011, EUR J HEART FAIL, V13, P247, DOI 10.1093/eurjhf/hfq234; Matsushima S, 2009, AM J PHYSIOL-HEART C, V297, pH409, DOI 10.1152/ajpheart.01332.2008; Miki T, 2009, DIABETES, V58, P2863, DOI 10.2337/db09-0158; Masahiro N, 2007, J MOL CELL CARDIOL, V43, P564, DOI 10.1016/j.yjmcc.2007.08.010; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Radovits T, 2009, AM J PHYSIOL-HEART C, V297, pH125, DOI 10.1152/ajpheart.00165.2009; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Sakata S, 2007, AM J PHYSIOL-HEART C, V292, pH1204, DOI 10.1152/ajpheart.00892.2006; Sakata S, 2006, MOL THER, V13, P987, DOI 10.1016/j.ymthe.2006.01.002; Shah AM, 2010, EUR J HEART FAIL, V12, P1229, DOI 10.1093/eurjhf/hfq179; Shiomi T, 2003, J AM COLL CARDIOL, V42, P165, DOI 10.1016/S0735-1097(03)00509-6; Shrikhande GV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014240; Smith HM, 2005, J MOL CELL CARDIOL, V39, P657, DOI 10.1016/j.yjmcc.2005.07.004; Sulaiman M, 2010, AM J PHYSIOL-HEART C, V298, pH833, DOI 10.1152/ajpheart.00418.2009; Temsah RM, 1999, AM J PHYSIOL-HEART C, V277, pH584, DOI 10.1152/ajpheart.1999.277.2.H584; Trost SU, 2002, DIABETES, V51, P1166, DOI 10.2337/diabetes.51.4.1166; Vahtola E, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-5; Vetter R, 2002, FASEB J, V16, P1657, DOI 10.1096/fj.01-1019fje; Xu JC, 2009, J CELL MOL MED, V13, P1499, DOI 10.1111/j.1582-4934.2009.00833.x; Yano T, 2006, J AM COLL CARDIOL, V47, P626, DOI 10.1016/j.jacc.2005.09.037; Zhang L, 2008, DIABETES, V57, P2158, DOI 10.2337/db08-0140; Zhao H, 2008, HYPERTENS RES, V31, P1977, DOI 10.1291/hypres.31.1977	43	52	57	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39893	10.1371/journal.pone.0039893	http://dx.doi.org/10.1371/journal.pone.0039893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768157	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100126
J	MacNeilage, PR; Zhang, Z; DeAngelis, GC; Angelaki, DE				MacNeilage, Paul R.; Zhang, Zhou; DeAngelis, Gregory C.; Angelaki, Dora E.			Vestibular Facilitation of Optic Flow Parsing	PLOS ONE			English	Article							VENTRAL INTRAPARIETAL AREA; SELF-MOTION; PSYCHOMETRIC FUNCTION; OBJECT MOVEMENT; RETINAL MOTION; INTEGRATION; PERCEPTION; RESPONSES; DIRECTION; CORTEX	Simultaneous object motion and self-motion give rise to complex patterns of retinal image motion. In order to estimate object motion accurately, the brain must parse this complex retinal motion into self-motion and object motion components. Although this computational problem can be solved, in principle, through purely visual mechanisms, extra-retinal information that arises from the vestibular system during self-motion may also play an important role. Here we investigate whether combining vestibular and visual self-motion information improves the precision of object motion estimates. Subjects were asked to discriminate the direction of object motion in the presence of simultaneous self-motion, depicted either by visual cues alone (i.e. optic flow) or by combined visual/vestibular stimuli. We report a small but significant improvement in object motion discrimination thresholds with the addition of vestibular cues. This improvement was greatest for eccentric heading directions and negligible for forward movement, a finding that could reflect increased relative reliability of vestibular versus visual cues for eccentric heading directions. Overall, these results are consistent with the hypothesis that vestibular inputs can help parse retinal image motion into self-motion and object motion components.	[MacNeilage, Paul R.] Univ Hosp Munich, Vertigo Balance & Oculomotor Res Ctr, Munich, Germany; [Zhang, Zhou] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [DeAngelis, Gregory C.] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY USA; [Angelaki, Dora E.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	University of Munich; University of Southern California; University of Rochester; Baylor College of Medicine	MacNeilage, PR (corresponding author), Univ Hosp Munich, Vertigo Balance & Oculomotor Res Ctr, Munich, Germany.	p.macneilage@gmail.com		DeAngelis, Gregory/0000-0002-1635-1273	United States National Institutes of Health (NIH) [R01 DC007620]; NIH Institutional National Research Service Award [5-T32-EY13360-07]; National Space Biomedical Research Institute fellowship through National Aeronautics and Space Administration [PF-01103, 9-58]; German Federal Ministry of Education and Research [01 EO 0901]; NATIONAL EYE INSTITUTE [R01EY016178, T32EY013360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007620] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Institutional National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Space Biomedical Research Institute fellowship through National Aeronautics and Space Administration; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was supported by the United States National Institutes of Health (NIH) R01 DC007620 (to DEA), an NIH Institutional National Research Service Award 5-T32-EY13360-07, a National Space Biomedical Research Institute fellowship PF-01103 (to PRM) through National Aeronautics and Space Administration 9-58, and a grant from the German Federal Ministry of Education and Research under the Grant code 01 EO 0901. Experiments were performed at Washington University Medical School, St Louis, MO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelaki DE, 2005, NAT REV NEUROSCI, V6, P966, DOI 10.1038/nrn1804; Angelaki DE, 2001, VISION RES, V41, P3215, DOI 10.1016/S0042-6989(00)00304-7; Butler JS, 2010, J VISION, V10, DOI 10.1167/10.11.23; Calabro FJ, 2011, P ROY SOC B-BIOL SCI, V278, P2840, DOI 10.1098/rspb.2010.2757; Chen AH, 2011, J NEUROSCI, V31, P12036, DOI 10.1523/JNEUROSCI.0395-11.2011; Chen AH, 2011, J NEUROSCI, V31, P3082, DOI 10.1523/JNEUROSCI.4476-10.2011; CROWELL JA, 1993, PERCEPT PSYCHOPHYS, V53, P325, DOI 10.3758/BF03205187; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; Dyde RT, 2008, J VISION, V8, DOI 10.1167/8.14.5; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fajen BR, 2002, J EXP PSYCHOL HUMAN, V28, P1100, DOI 10.1037//0096-1523.28.5.1100; Fetsch CR, 2010, J NEUROPHYSIOL, V104, P1506, DOI 10.1152/jn.91247.2008; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Fetsch CR, 2011, NAT NEUROSCI; GOGEL WC, 1992, PERCEPT PSYCHOPHYS, V52, P75, DOI 10.3758/BF03206761; Gray R, 2004, VISION RES, V44, P179, DOI 10.1016/j.visres.2003.09.001; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Gu Y, 2010, NEURON, V66, P596, DOI 10.1016/j.neuron.2010.04.026; Kim H, 2010, SOC NEUR C; MacNeilage PR, 2010, J NEUROSCI, V30, P9084, DOI 10.1523/JNEUROSCI.1304-10.2010; MacNeilage PR, 2009, J VIS VIS SCI SOC AB, V9, P701; Mapstone M, 2010, BRAIN, V133, P2690, DOI 10.1093/brain/awq140; McHenry MQ, 2000, J NEUROPHYSIOL, V83, P1648, DOI 10.1152/jn.2000.83.3.1648; Morgan ML, 2008, NEURON, V59, P662, DOI 10.1016/j.neuron.2008.06.024; Royden CS, 2010, VISION RES, V50, P1014, DOI 10.1016/j.visres.2010.03.008; Royden CS, 1996, PERCEPT PSYCHOPHYS, V58, P836, DOI 10.3758/BF03205487; Rushton SK, 2007, COGNITION, V105, P237, DOI 10.1016/j.cognition.2006.09.004; Rushton SK, 2005, CURR BIOL, V15, pR542, DOI 10.1016/j.cub.2005.07.020; Schlack A, 2002, EUR J NEUROSCI, V16, P1877, DOI 10.1046/j.1460-9568.2002.02251.x; Takahashi K, 2007, J NEUROSCI, V27, P9742, DOI 10.1523/JNEUROSCI.0817-07.2007; WALLACH H, 1987, ANNU REV PSYCHOL, V38, P1, DOI 10.1146/annurev.ps.38.020187.000245; Warren PA, 2011, J VIS, V11, P925; Warren PA, 2008, VISION RES, V48, P655, DOI 10.1016/j.visres.2007.10.023; Warren PA, 2007, J VISION, V7, DOI 10.1167/7.11.2; Warren PA, 2009, CURR BIOL, V19, P1555, DOI 10.1016/j.cub.2009.07.057; Warren PA, 2009, VISION RES, V49, P1406, DOI 10.1016/j.visres.2009.01.016; WARREN WH, 1995, PERCEPTION, V24, P315, DOI 10.1068/p240315; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Zhang Z, 2008, SOC NEUR C, V857, P14	41	34	34	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40264	10.1371/journal.pone.0040264	http://dx.doi.org/10.1371/journal.pone.0040264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768345	Green Submitted, Green Published, gold			2022-12-27	WOS:000305966500058
J	Spooner, PM; Bonner, J; Maricq, AV; Benian, GM; Norman, KR				Spooner, Patrick M.; Bonner, Jennifer; Maricq, Andres V.; Benian, Guy M.; Norman, Kenneth R.			Large Isoforms of UNC-89 (Obscurin) Are Required for Muscle Cell Architecture and Optimal Calcium Release in Caenorhabditis elegans	PLOS ONE			English	Article							BODY-WALL MUSCLE; C-ELEGANS; SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; STRIATED-MUSCLES; RNA INTERFERENCE; LOCALIZATION; ORGANIZATION; SARCOMERES; CA2+	Calcium, a ubiquitous intracellular signaling molecule, controls a diverse array of cellular processes. Consequently, cells have developed strategies to modulate the shape of calcium signals in space and time. The force generating machinery in muscle is regulated by the influx and efflux of calcium ions into the muscle cytoplasm. In order for efficient and effective muscle contraction to occur, calcium needs to be rapidly, accurately and reliably regulated. The mechanisms underlying this highly regulated process are not fully understood. Here, we show that the Caenorhabditis elegans homolog of the giant muscle protein obscurin, UNC-89, is required for normal muscle cell architecture. The large immunoglobulin domain-rich isoforms of UNC-89 are critical for sarcomere and sarcoplasmic reticulum organization. Furthermore, we have found evidence that this structural organization is crucial for excitation-contraction coupling in the body wall muscle, through the coordination of calcium signaling. Thus, our data implicates UNC-89 in maintaining muscle cell architecture and that this precise organization is essential for optimal calcium mobilization and efficient and effective muscle contraction.	[Spooner, Patrick M.; Bonner, Jennifer; Norman, Kenneth R.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Benian, Guy M.] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA; [Bonner, Jennifer] Skidmore Coll, Dept Biol, Saratoga Springs, NY 12866 USA; [Maricq, Andres V.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Albany Medical College; Emory University; Skidmore College; Utah System of Higher Education; University of Utah	Spooner, PM (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA.	NormanK@mail.amc.edu			American Heart Association; Alzheimer's Association; National Institutes of Health [GM088213, AR051466]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070280, R01NS035812] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Alzheimer's Association(Alzheimer's Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the American Heart Association (www.heart.org), the Alzheimer's Association (www.alz.org), and National Institutes of Health grant GM088213 (www.nigms.nih.gov) to KRN, and NIH grant AR051466 (www.niams.nih.gov) to GMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnato P, 2003, J CELL BIOL, V160, P245, DOI 10.1083/jcb.200208109; Benian GM, 1996, J CELL BIOL, V132, P835, DOI 10.1083/jcb.132.5.835; Borisov AB, 2006, HISTOCHEM CELL BIOL, V125, P227, DOI 10.1007/s00418-005-0069-x; Borisov AB, 2004, J HISTOCHEM CYTOCHEM, V52, P1117, DOI 10.1369/jhc.3A6183.2004; Borisov AB, 2008, J CELL BIOCHEM, V103, P1621, DOI 10.1002/jcb.21551; Bowman AL, 2007, FEBS LETT, V581, P1549, DOI 10.1016/j.febslet.2007.03.011; BRENNER S, 1974, GENETICS, V77, P71; Butler TM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/725207; Carlsson L, 2008, HISTOCHEM CELL BIOL, V130, P91, DOI 10.1007/s00418-008-0413-z; Coisy-Quivy M, 2009, J CELL SCI, V122, P947, DOI 10.1242/jcs.040121; Etheridge T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002471; Ferrara TM, 2005, J MUSCLE RES CELL M, V26, P435, DOI 10.1007/s10974-005-9027-4; Ford-Speelman DL, 2009, MOL BIOL CELL, V20, P3905, DOI 10.1091/mbc.E08-10-1029; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Fukuzawa A, 2008, J CELL SCI, V121, P1841, DOI 10.1242/jcs.028019; Fukuzawa A, 2005, J MUSCLE RES CELL M, V26, P427, DOI 10.1007/s10974-005-9025-6; Garcia SM, 2007, GENE DEV, V21, P3006, DOI 10.1101/gad.1575307; Gokhin DS, 2011, J CELL BIOL, V194, P105, DOI 10.1083/jcb.201011128; Gokhin DS, 2010, J CELL BIOL, V189, P95, DOI 10.1083/jcb.201001125; HRESKO MC, 1994, J CELL BIOL, V124, P491, DOI 10.1083/jcb.124.4.491; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000780; Kontrogianni-Konstantopoulos A, 2004, AM J PHYSIOL-CELL PH, V287, pC209, DOI 10.1152/ajpcell.00497.2003; Kontrogianni-Konstantopoulos A, 2003, MOL BIOL CELL, V14, P1138, DOI 10.1091/mbc.E02-07-0411; Kontrogianni-Konstantopoulos A, 2006, FASEB J, V20, P2102, DOI 10.1096/fj.06-5761com; Kontrogianni-Konstantopoulos A, 2009, PHYSIOL REV, V89, P1217, DOI 10.1152/physrev.00017.2009; Lange S, 2009, J CELL SCI, V122, P2640, DOI 10.1242/jcs.046193; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; Littlefield RS, 2008, SEMIN CELL DEV BIOL, V19, P511, DOI 10.1016/j.semcdb.2008.08.009; Liu P, 2011, J PHYSIOL-LONDON, V589, P101, DOI 10.1113/jphysiol.2010.200683; Liu Q, 2005, J NEUROSCI, V25, P6745, DOI 10.1523/JNEUROSCI.1730-05.2005; Mariol MC, 2001, CURR BIOL, V11, P1691, DOI 10.1016/S0960-9822(01)00528-0; Maryon EB, 1996, J CELL BIOL, V134, P885, DOI 10.1083/jcb.134.4.885; Maryon EB, 1998, J CELL SCI, V111, P2885; McMullan R, 2006, GENE DEV, V20, P65, DOI 10.1101/gad.359706; MILLER DM, 1983, CELL, V34, P477, DOI 10.1016/0092-8674(83)90381-1; Moerman Donald G., 1997, Cold Spring Harbor Monograph Series, V33, P417; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Norman KR, 2005, CELL, V123, P119, DOI 10.1016/j.cell.2005.08.001; Qadota H, 2008, J MOL BIOL, V383, P747, DOI 10.1016/j.jmb.2008.08.083; Raeker MO, 2006, DEV DYNAM, V235, P2018, DOI 10.1002/dvdy.20812; Raeker MO, 2010, DEV BIOL, V337, P432, DOI 10.1016/j.ydbio.2009.11.018; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Sakube Y, 1997, J MOL BIOL, V267, P849, DOI 10.1006/jmbi.1997.0910; Shephard F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024686; Siegman MJ, 1998, P NATL ACAD SCI USA, V95, P5383, DOI 10.1073/pnas.95.9.5383; Small TM, 2004, J MOL BIOL, V342, P91, DOI 10.1016/j.jmb.2004.07.006; Swan KA, 2002, GENOME RES, V12, P1100, DOI 10.1101/gr.208902; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons Lisa, 2006, V351, P119; WATERSTON RH, 1980, DEV BIOL, V77, P271, DOI 10.1016/0012-1606(80)90475-3; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Yishi J, 1999, C ELEGANS PRACTICAL, P69; Young P, 2001, J CELL BIOL, V154, P123, DOI 10.1083/jcb.200102110; Zwaal RR, 2001, J BIOL CHEM, V276, P43557, DOI 10.1074/jbc.M104693200	55	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40182	10.1371/journal.pone.0040182	http://dx.doi.org/10.1371/journal.pone.0040182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768340	Green Published, Green Submitted, gold			2022-12-27	WOS:000305966500053
J	Wang, XF; Norris, JL; Liu, YJ; Vermund, SH; Qian, HZ; Han, L; Wang, N				Wang, Xiaofang; Norris, Jessie L.; Liu, Yingjie; Vermund, Sten H.; Qian, Han-Zhu; Han, Ling; Wang, Ning			Risk Behaviors for Reproductive Tract Infection in Women Who Have Sex with Women in Beijing, China	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; GENITAL HUMAN-PAPILLOMAVIRUS; BISEXUAL WOMEN; HIV SEROPREVALENCE; MENTAL-HEALTH; LESBIANS; TRANSMISSION; ORIENTATION; PREVALENCE; SYPHILIS	Objectives: To assess risk behaviors for reproductive tract infections (RTI) including sexually transmitted infections (STI) among women who have sex with women (WSW) in Beijing, China. Methods: A cross-sectional study of women recruited from venues and internet outreach analyzed using interviews. Results: We recruited 224 WSW, among whom were 37 couples. The average age of participants was 25.6 years. Sex with men in the past year was reported by 10.7% of participants. During the past year, 34.3% (77/224) had had >1 sexual partner and 72.4% (162/224) had ever had >1 sexual partner. Condom use in the last sex with a man was reported by 54.2% (13/24) of women; 12.5% (3/24) reported never having used a condom with a man in the past year. In the past year, 13.4% (30/224) reported using sex toys with their female partners; of these, 43.3% (13/30) reported consistent condom use with the sex toys and 36.7% (11/30) had shared sex toys. Among participants 65.2% (120/184) reported that their "G-spot" had been stimulated during sex, 49.2% (59/120) of whom reported bleeding during or after sex. Only 12.5% (8/64) of those never reporting "G spot" stimulation reported bleeding during or after sex (P < 0.001). Conclusions: WSW in Beijing engaged in high-risk sexual behaviors that may carry a substantial risk of being infected with STI/RTI. To implement STI/RTI prevention and intervention among women, women-women sexual behavior should be considered when doing research and intervention programs.	[Wang, Xiaofang; Norris, Jessie L.; Wang, Ning] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Liu, Yingjie] Beijing Chaoyang Dist Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Beijing, Peoples R China; [Vermund, Sten H.; Qian, Han-Zhu] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Dept Pediat, Nashville, TN 37212 USA; [Vermund, Sten H.; Qian, Han-Zhu] Vanderbilt Univ, Sch Med, Dept Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Han, Ling] Univ Calif San Diego, Dept Sociol, San Diego, CA 92103 USA	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Vanderbilt University; Vanderbilt University; University of California System; University of California San Diego	Wang, XF (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wangnbj@163.com	Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698; Han, Ling/0000-0002-1496-106X	National Center for AIDS/STD Control and Prevention; Mega-projects of National Science Research [2008ZX10001-003]	National Center for AIDS/STD Control and Prevention; Mega-projects of National Science Research	The study was funded by the National Center for AIDS/STD Control and Prevention (http://www.chinaaids.cn/n1971/index.html) and Mega-projects of National Science Research for the 11th Five-Year Plan (http://www.nmp.gov.cn/, project number 2008ZX10001-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDIEGO F, 1981, J SEX RES, V17, P13, DOI 10.1080/00224498109551094; [Anonymous], QQ IS CURRENTLY MOST; Bailey JV, 2008, SEX TRANSM DIS, V35, P533, DOI 10.1097/OLQ.0b013e31816766c2; Bailey JV, 2000, BRIT J GEN PRACT, V50, P481; Bailey JV, 2004, SEX TRANSM INFECT, V80, P244, DOI 10.1136/sti.2003.007641; Bailey JV, 2003, SEX TRANSM INFECT, V79, P147, DOI 10.1136/sti.79.2.147; Bauer GR, 2001, AM J PUBLIC HEALTH, V91, P1282, DOI 10.2105/AJPH.91.8.1282; Campos-Outcalt D, 2002, SEX TRANSM DIS, V29, P119, DOI 10.1097/00007435-200202000-00010; Carroll N, 1997, J GAY LESBIAN MED AS, V1, P15, DOI DOI 10.1023/B:JOLA.0000007008.17392.2D; Case P, 2004, J WOMENS HEALTH, V13, P1033, DOI 10.1089/jwh.2004.13.1033; Centers for Disease Control and Prevention, 2006, MMWR Recomm Rep, V55, P1; Cochran SD, 2001, AM PSYCHOL, V56, P931, DOI 10.1037/0003-066X.56.11.931; Cochran SD, 2000, J CONSULT CLIN PSYCH, V68, P1062, DOI 10.1037/0022-006X.68.6.1062; Copas AJ, 2002, SEX TRANSM INFECT, V78, P26, DOI 10.1136/sti.78.1.26; Diamant A. L., 2000, J GAY LESBIAN MED AS, V4, P41, DOI DOI 10.1023/A:1009513623365; EINHORN L, 1994, AIDS EDUC PREV, V6, P514; Fethers K, 2000, SEX TRANSM INFECT, V76, P345, DOI 10.1136/sti.76.5.345; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Gonzales V, 1999, AM J PUBLIC HEALTH, V89, P1841, DOI 10.2105/AJPH.89.12.1841; Grafenberg E, 1950, INT J SEXOLOGY, P145; JOHNSON SR, 1987, J REPROD MED, V32, P805; Kellock DJ, 1996, GENITOURIN MED, V72, P60; Kennedy M B, 1995, J Am Med Womens Assoc (1972), V50, P103; LEMP GF, 1995, AM J PUBLIC HEALTH, V85, P1549, DOI 10.2105/AJPH.85.11.1549; Li SW, 2008, CHINESE MED J-PEKING, V121, P1105, DOI 10.1097/00029330-200806020-00013; Marrazzo JM, 1998, J INFECT DIS, V178, P1604, DOI 10.1086/314494; Marrazzo JM, 2001, INT J STD AIDS, V12, P41, DOI 10.1258/0956462011916721; Marrazzo JM, 2001, AM J PUBLIC HEALTH, V91, P947, DOI 10.2105/AJPH.91.6.947; McNair R, 2009, AUST FAM PHYSICIAN, V38, P388; Mercer CH, 2007, AM J PUBLIC HEALTH, V97, P1126, DOI 10.2105/AJPH.2006.086439; Morrow KM., 2000, J GAY LESBIAN MED AS, V4, P159, DOI 10.1023/A:1026507721501; Norman AD, 1996, PUBLIC HEALTH REP, V111, P347; OHanlan KA, 1996, OBSTET GYNECOL, V88, P702, DOI 10.1016/0029-7844(96)00206-2; Pan SM, 2004, SEXUALITY CHINESE CO, P160; PETERSEN LR, 1992, J ACQ IMMUN DEF SYND, V5, P853; Pinto VM, 2005, AIDS, V19, pS64, DOI 10.1097/01.aids.0000191493.43865.2a; RAITERI R, 1994, GENITOURIN MED, V70, P200; Reisner SL, 2010, SEX TRANSM DIS, V37, P5, DOI 10.1097/OLQ.0b013e3181b41314; RICH JD, 1993, CLIN INFECT DIS, V17, P1003, DOI 10.1093/clinids/17.6.1003; Ruan YH, 2009, JAIDS-J ACQ IMM DEF, V52, P604, DOI 10.1097/QAI.0b013e3181b31f5c; Ryan C., 1998, LESBIAN GAY YOUTH CA; Scheer S, 2002, AM J PUBLIC HEALTH, V92, P1110, DOI 10.2105/AJPH.92.7.1110; Shotsky WJ, 1996, WOMEN HEALTH, V24, P1, DOI 10.1300/J013v24n02_01; Skinner CJ, 1996, GENITOURIN MED, V72, P277; TRONCOSO AR, 1995, MEDICINA-BUENOS AIRE, V55, P334; US CDC, 2006, HIV AIDS WOM WHO HAV; Vernazza PL, 1999, AIDS, V13, P155, DOI 10.1097/00002030-199902040-00003; Women's Institute at Gay Men's Health Crisis, 2009, HIV RISK LESB BIS OT; Xu FJ, 2010, SEX TRANSM DIS, V37, P407, DOI 10.1097/OLQ.0b013e3181db2e18	49	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40114	10.1371/journal.pone.0040114	http://dx.doi.org/10.1371/journal.pone.0040114			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	968GX	22768334	Green Submitted, Green Published, gold			2022-12-27	WOS:000305966500047
J	Bagavathiannan, MV; Begg, GS; Gulden, RH; Van Acker, RC				Bagavathiannan, Muthukumar V.; Begg, Graham S.; Gulden, Robert H.; Van Acker, Rene C.			Modelling the Dynamics of Feral Alfalfa Populations and Its Management Implications	PLOS ONE			English	Article							TRAITS PROMOTE PERSISTENCE; MEDICAGO-SATIVA L.; DENSITY-DEPENDENCE; GLYPHOSATE RESISTANCE; SEEDLING RECRUITMENT; GM CROPS; EVOLUTION; SPREAD	Background: Feral populations of cultivated crops can pose challenges to novel trait confinement within agricultural landscapes. Simulation models can be helpful in investigating the underlying dynamics of feral populations and determining suitable management options. Methodology/Principal Findings: We developed a stage-structured matrix population model for roadside feral alfalfa populations occurring in southern Manitoba, Canada. The model accounted for the existence of density-dependence and recruitment subsidy in feral populations. We used the model to investigate the long-term dynamics of feral alfalfa populations, and to evaluate the effectiveness of simulated management strategies such as herbicide application and mowing in controlling feral alfalfa. Results suggest that alfalfa populations occurring in roadside habitats can be persistent and less likely to go extinct under current roadverge management scenarios. Management attempts focused on controlling adult plants alone can be counterproductive due to the presence of density-dependent effects. Targeted herbicide application, which can achieve complete control of seedlings, rosettes and established plants, will be an effective strategy, but the seedbank population may contribute to new recruits. In regions where roadside mowing is regularly practiced, devising a timely mowing strategy (early-to mid-August for southern Manitoba), one that can totally prevent seed production, will be a feasible option for managing feral alfalfa populations. Conclusions/Significance: Feral alfalfa populations can be persistent in roadside habitats. Timely mowing or regular targeted herbicide application will be effective in managing feral alfalfa populations and limit feral-population-mediated gene flow in alfalfa. However, in the context of novel trait confinement, the extent to which feral alfalfa populations need to be managed will be dictated by the tolerance levels established by specific production systems for specific traits. The modelling framework outlined in this paper could be applied to other perennial herbaceous plants with similar life-history characteristics.	[Bagavathiannan, Muthukumar V.; Gulden, Robert H.] Univ Manitoba, Dept Plant Sci, Winnipeg, MB R3T 2N2, Canada; [Begg, Graham S.] James Hutton Inst, Dundee, Scotland; [Van Acker, Rene C.] Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada	University of Manitoba; James Hutton Institute; University of Guelph	Bagavathiannan, MV (corresponding author), Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA.	muthu@uark.edu		Begg, Graham/0000-0003-3590-2699	Agri-Food Research and Development Initiative of the government of Manitoba; Agri-Food Research and Development Initiative of the government of Canada; Natural Sciences and Engineering Research Council of Canada; Scottish Government; University of Manitoba	Agri-Food Research and Development Initiative of the government of Manitoba; Agri-Food Research and Development Initiative of the government of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Scottish Government; University of Manitoba	Funding was provided by the Agri-Food Research and Development Initiative of the governments of Manitoba and Canada, the Natural Sciences and Engineering Research Council of Canada, the Scottish Government (work package 1.7 Sustainable Crop Systems), and by a University of Manitoba Graduate Fellowship and Manitoba Graduate Scholarship for MVB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker R. C. van, 2007, The first decade of herbicide-resistant crops in Canada. 'Transgenic herbicide-resistant crops: agronomy, environment and beyond', a symposium held on November 28, 2005, in Niagara, Canada., P153; Bagavathiannan MV, 2011, WEED SCI, V59, P314, DOI 10.1614/WS-D-10-00144.1; Bagavathiannan MV, 2011, TRANSGENIC RES, V20, P397, DOI 10.1007/s11248-010-9425-2; Bagavathiannan MV, 2010, ENVIRON SCI POLLUT R, V17, P1448, DOI 10.1007/s11356-010-0330-2; Bagavathiannan MV, 2009, CRIT REV PLANT SCI, V28, P69, DOI 10.1080/07352680902753613; Bass L. N., 1988, Alfalfa and alfalfa improvement, P961; Begg GS, 2006, ECOL MODEL, V198, P195, DOI 10.1016/j.ecolmodel.2006.04.025; Buckley YM, 2001, ECOL LETT, V4, P551, DOI 10.1046/j.1461-0248.2001.00264.x; Bullock JM, 2008, ECOL APPL, V18, P945, DOI 10.1890/07-1128.1; Caswell, 2000, MATRIX POPULATION MO; Caswell H, 2008, DEMOGR RES, V18, P59, DOI 10.4054/DemRes.2008.18.3; Claessen D, 2005, OIKOS, V110, P30, DOI 10.1111/j.0030-1299.2005.13668.x; Claessen D, 2005, OIKOS, V110, P20, DOI 10.1111/j.0030-1299.2005.13667.x; Crawley MJ, 2004, P ROY SOC B-BIOL SCI, V271, P1909, DOI 10.1098/rspb.2004.2814; Crone EE, 2011, ECOL LETT, V14, P1, DOI 10.1111/j.1461-0248.2010.01540.x; Davis AS, 2004, ECOL APPL, V14, P655, DOI 10.1890/02-5385; Davis AS, 2003, WEED SCI, V51, P919, DOI 10.1614/P2002-133A; Eriksson O, 1996, OIKOS, V77, P248, DOI 10.2307/3546063; Garnier A, 2006, ECOL MODEL, V194, P141, DOI 10.1016/j.ecolmodel.2005.10.009; Garnier A, 2006, ECOL MODEL, V197, P373, DOI 10.1016/j.ecolmodel.2006.03.031; Goldberg DE, 2001, ECOL MONOGR, V71, P423, DOI 10.1890/0012-9615(2001)071[0423:DDIAAP]2.0.CO;2; Ibanez I, 2007, ECOL MONOGR, V77, P163, DOI 10.1890/06-1097; Jenczewski E, 1999, AM J BOT, V86, P677, DOI 10.2307/2656577; Jennings JA, 2002, AGRON J, V94, P1104, DOI 10.2134/agronj2002.1104; KENDRICK D, 2005, P N CENTR WEED SCI S, P124; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Menges E.S., 2000, ECOLOGICAL B, V48, P73; MMPP, 2011, VAR YIELD DAT; Neve P, 2011, WEED RES, V51, P99, DOI 10.1111/j.1365-3180.2010.00838.x; Pardini EA, 2008, AM MIDL NAT, V160, P310, DOI 10.1674/0003-0031(2008)160[310:CODDFM]2.0.CO;2; Pardini EA, 2009, ECOL APPL, V19, P387, DOI 10.1890/08-0845.1; PUTNAM DH, 2006, PUBLICATION U CALIFO, V8193; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramula S, 2010, METHODS ECOL EVOL, V1, P158, DOI 10.1111/j.2041-210X.2010.00022.x; ROLSTON MP, 1978, BOT REV, V44, P365, DOI 10.1007/BF02957854; RUMBAUGH MD, 1982, J RANGE MANAGE, V35, P84, DOI 10.2307/3898526; Thornby DF, 2009, ANN BOT-LONDON, V104, P747, DOI 10.1093/aob/mcp152; Ugarcovici I, 2004, NONLINEARITY, V17, P1689, DOI 10.1088/0951-7715/17/5/007; Uriarte M, 2005, J ECOL, V93, P291, DOI 10.1111/j.0022-0477.2005.00984.x; von der Lippe M, 2007, ECOGRAPHY, V30, P483, DOI 10.1111/j.2007.0906-7590.05072.x; WATKINSON AR, 1989, J ECOL, V77, P162, DOI 10.2307/2260923; Williams JL, 2011, J ECOL, V99, P1171, DOI 10.1111/j.1365-2745.2011.01845.x; Wright SJ, 2005, ECOLOGY, V86, P848, DOI 10.1890/03-0750; Zhang TJ, 2008, CROP SCI, V48, P794, DOI 10.2135/cropsci2007.06.0340	44	16	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39440	10.1371/journal.pone.0039440	http://dx.doi.org/10.1371/journal.pone.0039440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768079	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100050
J	Csaba, K; Kiss, G; Torocsik, B; Adam-Vizi, V; Chinopoulos, C				Csaba Konrad; Kiss, Gergely; Torocsik, Beata; Adam-Vizi, Vera; Chinopoulos, Christos			Absence of Ca2+-Induced Mitochondrial Permeability Transition but Presence of Bongkrekate-Sensitive Nucleotide Exchange in C. crangon and P. serratus	PLOS ONE			English	Article							CA-2&-INDUCED MEMBRANE TRANSITION; MULTIPLE SEQUENCE ALIGNMENTS; CRAB CALLINECTES-SAPIDUS; CYCLOPHILIN-D; CYCLOSPORINE-A; CELL-DEATH; ARTEMIA-FRANCISCANA; BRAIN MITOCHONDRIA; ADP/ATP CARRIER; PORE	Mitochondria from the embryos of brine shrimp (Artemia franciscana) do not undergo Ca2+-induced permeability transition in the presence of a profound Ca2+ uptake capacity. Furthermore, this crustacean is the only organism known to exhibit bongkrekate-insensitive mitochondrial adenine nucleotide exchange, prompting the conjecture that refractoriness to bongkrekate and absence of Ca2+-induced permeability transition are somehow related phenomena. Here we report that mitochondria isolated from two other crustaceans, brown shrimp (Crangon crangon) and common prawn (Palaemon serratus) exhibited bongkrekate-sensitive mitochondrial adenine nucleotide transport, but lacked a Ca2+-induced permeability transition. Ca2+ uptake capacity was robust in the absence of adenine nucleotides in both crustaceans, unaffected by either bongkrekate or cyclosporin A. Transmission electron microscopy images of Ca2+-loaded mitochondria showed needle-like formations of electron-dense material strikingly similar to those observed in mitochondria from the hepatopancreas of blue crab (Callinectes sapidus) and the embryos of Artemia franciscana. Alignment analysis of the partial coding sequences of the adenine nucleotide translocase (ANT) expressed in Crangon crangon and Palaemon serratus versus the complete sequence expressed in Artemia franciscana reappraised the possibility of the 208-214 amino acid region for conferring sensitivity to bongkrekate. However, our findings suggest that the ability to undergo Ca2+-induced mitochondrial permeability transition and the sensitivity of adenine nucleotide translocase to bongkrekate are not necessarily related phenomena.	[Csaba Konrad; Kiss, Gergely; Torocsik, Beata; Adam-Vizi, Vera; Chinopoulos, Christos] Semmelweis Univ, Dept Med Biochem, Budapest, Hungary	Semmelweis University	Csaba, K (corresponding author), Semmelweis Univ, Dept Med Biochem, Budapest, Hungary.	chinopoulos.christos@eok.sote.hu		Chinopoulos, Christos/0000-0003-0183-4149; Adam-Vizi, Vera/0000-0002-8350-8701; Torocsik, Beata/0000-0002-9838-3710	Orszagos Tudomanyos Kutatasi Alapprogram [OTKA NK81983]; Magyar Tudomanyos Akademia (MTA); OTKA-NKTH (Nemzeti Kutatasies Technologiai Hivatal) [NF 68294]; Egeszsegugyi Tudomanyos Tanacs (ETT) [55160]; European Community [227799]; OTKA [NNF 78905, NNF2 85658, K 100918]	Orszagos Tudomanyos Kutatasi Alapprogram; Magyar Tudomanyos Akademia (MTA); OTKA-NKTH (Nemzeti Kutatasies Technologiai Hivatal); Egeszsegugyi Tudomanyos Tanacs (ETT); European Community(European Commission); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by grants from Orszagos Tudomanyos Kutatasi Alapprogram (OTKA NK81983), and Magyar Tudomanyos Akademia (MTA) to Dr. Adam-Vizi, and OTKA-NKTH (Nemzeti Kutatasies Technologiai Hivatal) NF 68294, OTKA NNF 78905, OTKA NNF2 85658, OTKA K 100918 and Egeszsegugyi Tudomanyos Tanacs (ETT) grant 55160 and the European Community grant ASSEMBLE (project agreement no. 227799, BKA binding on ANT) to Dr. Chinopoulos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Azzolin L, 2010, FEBS LETT, V584, P2504, DOI 10.1016/j.febslet.2010.04.023; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; BECKER GL, 1974, J CELL BIOL, V61, P316, DOI 10.1083/jcb.61.2.316; Belyaeva EA, 2002, ARCH BIOCHEM BIOPHYS, V405, P252, DOI 10.1016/S0003-9861(02)00400-9; BUBEL A, 1976, CELL TISSUE RES, V167, P65; CARAFOLI E, 1971, BIOCHEM J, V122, P681, DOI 10.1042/bj1220681; CHEN CH, 1974, J CELL BIOL, V61, P301, DOI 10.1083/jcb.61.2.301; Chinopoulos C, 2003, J BIOL CHEM, V278, P27382, DOI 10.1074/jbc.M303808200; Chinopoulos C, 2012, MITOCHONDRION, V12, P41, DOI 10.1016/j.mito.2011.04.007; Chinopoulos C, 2011, FEBS J, V278, P1112, DOI 10.1111/j.1742-4658.2011.08026.x; Chinopoulos C, 2010, FEBS J, V277, P3637, DOI 10.1111/j.1742-4658.2010.07755.x; Chinopoulos C, 2009, BIOPHYS J, V96, P2490, DOI 10.1016/j.bpj.2008.12.3915; Di Lisa F, 2011, BBA-MOL CELL RES, V1813, P1316, DOI 10.1016/j.bbamcr.2011.01.031; Doczi J, 2011, J BIOL CHEM, V286, P6345, DOI 10.1074/jbc.M110.196600; Forte M, 2005, J BIOENERG BIOMEMBR, V37, P121, DOI 10.1007/s10863-005-6565-9; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; Holman JD, 2009, J EXP MAR BIOL ECOL, V376, P85, DOI 10.1016/j.jembe.2009.06.008; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P468, DOI 10.1016/0003-9861(79)90373-4; KEMP A JR, 1970, Biochimica et Biophysica Acta, V223, P460, DOI 10.1016/0005-2728(70)90210-0; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Konrad C, 2011, FEBS J, V278, P822, DOI 10.1111/j.1742-4658.2010.08001.x; Kristian T, 2007, J NEUROCHEM, V102, P1346, DOI 10.1111/j.1471-4159.2007.04626.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laszlo C, 2009, J GEN PHYSIOL, V133, P189, DOI 10.1085/jgp.200810109; Lei WW, 2011, CHEMOSPHERE, V84, P689, DOI 10.1016/j.chemosphere.2011.03.023; Leung AWC, 2008, BBA-BIOENERGETICS, V1777, P946, DOI 10.1016/j.bbabio.2008.03.009; Mcgee AM, 2012, BIOCHEM J, V443, P185, DOI 10.1042/BJ20111881; Menze MA, 2005, AM J PHYSIOL-REG I, V289, pR68, DOI 10.1152/ajpregu.00844.2004; Metelkin E, 2009, FEBS J, V276, P6942, DOI 10.1111/j.1742-4658.2009.07394.x; MUNDAY KA, 1962, COMP BIOCHEM PHYSIOL, V5, P95, DOI 10.1016/0010-406X(62)90122-6; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nury H, 2006, ANNU REV BIOCHEM, V75, P713, DOI 10.1146/annurev.biochem.75.103004.142747; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; POWERS MF, 1994, J BIOL CHEM, V269, P10614; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TSOKOS J, 1983, ARCH BIOCHEM BIOPHYS, V224, P707, DOI 10.1016/0003-9861(83)90259-X; Tyler D. D., 1967, METHOD ENZYMOL, V10, P75, DOI DOI 10.1016/0076-6879(67)10014-1; Vajda S, 2009, FEBS J, V276, P2713, DOI 10.1111/j.1742-4658.2009.06995.x; Yamada A, 2009, BBA-BIOENERGETICS, V1787, P1486, DOI 10.1016/j.bbabio.2009.07.001; Zolkiewska Anna, 1993, Acta Biochimica Polonica, V40, P241	48	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39839	10.1371/journal.pone.0039839	http://dx.doi.org/10.1371/journal.pone.0039839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768139	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100109
J	Harrison, LEA; Burton, JO; Szeto, CC; Li, PKT; McIntyre, CW				Harrison, Laura E. A.; Burton, James O.; Szeto, Cheuk-Chun; Li, Philip K. T.; McIntyre, Christopher W.			Endotoxaemia in Haemodialysis: A Novel Factor in Erythropoetin Resistance?	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RECOMBINANT-HUMAN-ERYTHROPOIETIN; PERITONEAL-DIALYSIS PATIENTS; CHRONIC HEART-FAILURE; RECEIVING HEMODIALYSIS; SYSTEMIC INFLAMMATION; BACTERIAL-ENDOTOXIN; DARBEPOETIN ALPHA; ANEMIA; HEMOGLOBIN	Background/Objectives: Translocated endotoxin derived from intestinal bacteria is a driver of systemic inflammation and oxidative stress. Severe endotoxaemia is an underappreciated, but characteristic finding in haemodialysis (HD) patients, and appears to be driven by acute repetitive dialysis induced circulatory stress. Resistance to erythropoietin (EPO) has been identified as a predictor of mortality risk, and associated with inflammation and malnutrition. This study aims to explore the potential link between previously unrecognised endotoxaemia and EPO Resistance Index (ERI) in HD patients. Methodology/Principal Findings: 50 established HD patients were studied at a routine dialysis session. Data collection included weight, BMI, ultrafiltration volume, weekly EPO dose, and blood sampling pre and post HD. ERI was calculated as ratio of total weekly EPO dose to body weight (U/kg) to haemoglobin level (g/dL). Mean haemoglobin (Hb) was 11.3 +/- 1.3 g/dL with a median EPO dose of 10,000 [IQR 7,500-20,000] u/wk and ERI of 13.7 [IQR 6.9-23.3] ((U/Kg)/(g/dL)). Mean pre-HD serum ET levels were significantly elevated at 0.69 +/- 0.30 EU/ml. Natural logarithm (Ln) of ERI correlated to predialysis ET levels (r = 0.324, p = 0.03) with a trend towards association with hsCRP (r = 0.280, p = 0.07). Ln ERI correlated with ultrafiltration volume, a driver of circulatory stress (r = 0.295, p = 0.046), previously identified to be associated with increased intradialytic endotoxin translocation. Both serum ET and ultrafiltration volume corrected for body weight were independently associated with Ln ERI in multivariable analysis. Conclusions: This study suggests that endotoxaemia is a significant factor in setting levels of EPO requirement. It raises the possibility that elevated EPO doses may in part merely be identifying patients subjected to significant circulatory stress and suffering the myriad of negative biological consequences arising from sustained systemic exposure to endotoxin.	[Harrison, Laura E. A.; Burton, James O.; McIntyre, Christopher W.] Royal Derby Hosp, Dept Renal Med, Derby, England; [Szeto, Cheuk-Chun; Li, Philip K. T.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China; [McIntyre, Christopher W.] Univ Nottingham, Sch Grad Entry Med & Hlth, Derby, England	University of Nottingham; Chinese University of Hong Kong; University of Nottingham	Harrison, LEA (corresponding author), Royal Derby Hosp, Dept Renal Med, Derby, England.	chris.mcintyre@nottingham.ac.uk	Burton, James O/AAQ-7361-2021; McIntyre, Christopher W/O-8927-2014; Li, Philip K. T./D-4051-2017; Szeto, Cheuk Chun/N-4954-2015	Burton, James O/0000-0003-1176-7592; Szeto, Cheuk Chun/0000-0002-8898-8505				Anker SD, 1997, AM J CARDIOL, V79, P1426, DOI 10.1016/S0002-9149(97)00159-8; Badve SV, 2011, NEPHROLOGY, V16, P144, DOI 10.1111/j.1440-1797.2010.01407.x; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brendt P, 2009, ANESTH ANALG, V109, P705, DOI 10.1213/ane.0b013e3181adc80f; Burton JO, 2009, CLIN J AM SOC NEPHRO, V4, P914, DOI 10.2215/CJN.03900808; Carrero JJ, 2010, SEMIN DIALYSIS, V23, P498, DOI 10.1111/j.1525-139X.2010.00784.x; Chan CT, 2002, KIDNEY INT, V61, P2235, DOI 10.1046/j.1523-1755.2002.00362.x; Charalambous BM, 2007, SHOCK, V28, P15, DOI 10.1097/shk.0b013e318033ebc5; DIEBEL L, 1993, SURGERY, V113, P520; Drueke T, 2001, NEPHROL DIAL TRANSPL, V16, P25, DOI 10.1093/ndt/16.suppl_7.25; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Feng SYS, 2010, AM J PHYSIOL-REG I, V298, pR760, DOI 10.1152/ajpregu.00398.2009; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gunnell J, 1999, AM J KIDNEY DIS, V33, P63, DOI 10.1016/S0272-6386(99)70259-3; Jakob SM, 2001, CRIT CARE MED, V29, P1393, DOI 10.1097/00003246-200107000-00015; John SG, 2011, CLIN J AM SOC NEPHRO, V6, P2389, DOI 10.2215/CJN.11211210; Kalantar-Zadeh K, 2003, AM J KIDNEY DIS, V42, P761, DOI 10.1016/S0272-6386(03)00915-6; Khanna A, 2001, J SURG RES, V99, P114, DOI 10.1006/jsre.2001.6103; Kotanko P, 2006, NEPHROL DIAL TRANSPL, V21, P2057, DOI 10.1093/ndt/gfl281; Krack A, 2005, EUR HEART J, V26, P2368, DOI 10.1093/eurheartj/ehi389; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P1, DOI 10.1093/ndt/gfh1024; LUMSDEN AB, 1988, HEPATOLOGY, V8, P232, DOI 10.1002/hep.1840080207; Macdougall IC, 2010, NEPHROL DIAL TRANSPL, V25, P914, DOI 10.1093/ndt/gfp550; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; MAXWELL A, 1986, LANCET, V1, P1148; McIntyre CW, 2008, CLIN J AM SOC NEPHRO, V3, P19, DOI 10.2215/CJN.03170707; McIntyre CW, 2011, CLIN J AM SOC NEPHRO, V6, P133, DOI 10.2215/CJN.04610510; Molina M, 2007, NEFROLOGIA, V27, P196; Ofsthun N, 2003, KIDNEY INT, V63, P1908, DOI 10.1046/j.1523-1755.2003.00937.x; Perlman RL, 2005, AM J KIDNEY DIS, V45, P658, DOI 10.1053/j.ajkd.2004.12.021; Peschel T, 2003, EUR J HEART FAIL, V5, P609, DOI 10.1016/S1388-9842(03)00104-1; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; RAIJ L, 1973, KIDNEY INT, V4, P57, DOI 10.1038/ki.1973.79; Regidor DL, 2006, J AM SOC NEPHROL, V17, P1181, DOI 10.1681/ASN.2005090997; Richardson D, 2002, NEPHROL DIAL TRANSPL, V17, P53, DOI 10.1093/ndt/17.suppl_1.53; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; STIVELMAN JC, 1989, SEMIN NEPHROL, V9, P8; Szeto CC, 2008, CLIN J AM SOC NEPHRO, V3, P431, DOI 10.2215/CJN.03600807; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; WINEARLS CG, 1986, LANCET, V2, P1175, DOI 10.1016/S0140-6736(86)92192-6	41	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40209	10.1371/journal.pone.0040209	http://dx.doi.org/10.1371/journal.pone.0040209			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768256	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100229
J	Hartig, G; Peters, RS; Borner, J; Etzbauer, C; Misof, B; Niehuis, O				Hartig, Gerrit; Peters, Ralph S.; Borner, Janus; Etzbauer, Claudia; Misof, Bernhard; Niehuis, Oliver			Oligonucleotide Primers for Targeted Amplification of Single-Copy Nuclear Genes in Apocritan Hymenoptera	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; EUKARYOTIC GENOMES; PARASITIC WASPS; DRAFT GENOME; PHYLOGENY; EVOLUTION; INSIGHTS; INSECTS; LIFE; DNA	Background: Published nucleotide sequence data from the mega-diverse insect order Hymenoptera (sawflies, bees, wasps, and ants) are taxonomically scattered and still inadequate for reconstructing a well-supported phylogenetic tree for the order. The analysis of comprehensive multiple gene data sets obtained via targeted PCR could provide a cost-effective solution to this problem. However, oligonucleotide primers for PCR amplification of nuclear genes across a wide range of hymenopteran species are still scarce. Findings: Here we present a suite of degenerate oligonucleotide primer pairs for PCR amplification of 154 single-copy nuclear protein-coding genes from Hymenoptera. These primers were inferred from genome sequence data from nine Hymenoptera (seven species of ants, the honeybee, and the parasitoid wasp Nasonia vitripennis). We empirically tested a randomly chosen subset of these primer pairs for amplifying target genes from six Hymenoptera, representing the families Chrysididae, Crabronidae, Gasteruptiidae, Leucospidae, Pompilidae, and Stephanidae. Based on our results, we estimate that these primers are suitable for studying a large number of nuclear genes across a wide range of apocritan Hymenoptera (i.e., all hymenopterans with a wasp-waist) and of aculeate Hymenoptera in particular (i.e., apocritan wasps with stingers). Conclusions: The amplified nucleotide sequences are (a) with high probability from single-copy genes, (b) easily generated at low financial costs, especially when compared to phylogenomic approaches, (c) easily sequenced by means of an additionally provided set of sequencing primers, and (d) suitable to address a wide range of phylogenetic questions and to aid rapid species identification via barcoding, as many amplicons contain both exonic and fast-evolving intronic nucleotides.	[Hartig, Gerrit; Etzbauer, Claudia; Misof, Bernhard; Niehuis, Oliver] Zentrum Mol Biodiversitatsforsch, Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Hartig, Gerrit] Univ Munster, Inst Bioinformat, Munster, Germany; [Peters, Ralph S.] Abt Arthropoda, Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Borner, Janus] Univ Hamburg, Biozentrum Grindel & Zool Museum, Hamburg, Germany	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); University of Munster; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); University of Hamburg	Hartig, G (corresponding author), Zentrum Mol Biodiversitatsforsch, Zool Forsch Museum Alexander Koenig, Bonn, Germany.	o.niehuis.zfmk@uni-bonn.de	Borner, Janus/E-1430-2012	Borner, Janus/0000-0001-9612-6668	German Research Foundation [DFG NI 1387/1]	German Research Foundation(German Research Foundation (DFG))	This research was supported by a grant of the German Research Foundation to ON (DFG NI 1387/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; BROWER AVZ, 1994, ANN ENTOMOL SOC AM, V87, P702, DOI 10.1093/aesa/87.6.702; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Desjardins CA, 2007, MOL PHYLOGENET EVOL, V45, P454, DOI 10.1016/j.ympev.2007.08.004; Dowton M, 2001, BIOL J LINN SOC, V74, P87, DOI 10.1006/bijl.2001.0577; DOWTON M, 1994, P NATL ACAD SCI USA, V91, P9911, DOI 10.1073/pnas.91.21.9911; Drummond AJ., 2011, GENEIOUS PRO 5 4; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Feau N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018803; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Grimaldi David, 2005, pi; Heraty J, 2011, MOL PHYLOGENET EVOL, V60, P73, DOI 10.1016/j.ympev.2011.04.003; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Nygaard S, 2011, GENOME RES, V21, P1339, DOI 10.1101/gr.121392.111; Peters RS, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-55; Pilgrim EM, 2008, ZOOL SCR, V37, P539, DOI 10.1111/j.1463-6409.2008.00340.x; Robinson GE, 2011, SCIENCE, V331, P1386, DOI 10.1126/science.331.6023.1386; Sharanowski BJ, 2010, MOL PHYLOGENET EVOL, V57, P101, DOI 10.1016/j.ympev.2010.07.006; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; Woodard SH, 2011, P NATL ACAD SCI USA, V108, P7472, DOI 10.1073/pnas.1103457108; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108	33	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39826	10.1371/journal.pone.0039826	http://dx.doi.org/10.1371/journal.pone.0039826			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768134	Green Published, gold			2022-12-27	WOS:000305892100104
J	Hoflehner, E; Hufnagl, K; Schabussova, I; Jasinska, J; Hoffmann-Sommergruber, K; Bohle, B; Maizels, RM; Wiedermann, U				Hoflehner, Elisabeth; Hufnagl, Karin; Schabussova, Irma; Jasinska, Joanna; Hoffmann-Sommergruber, Karin; Bohle, Barbara; Maizels, Rick M.; Wiedermann, Ursula			Prevention of Birch Pollen-Related Food Allergy by Mucosal Treatment with Multi-Allergen-Chimers in Mice	PLOS ONE			English	Article							AIRWAY INFLAMMATION; TGF-BETA; TOLERANCE INDUCTION; IMMUNE-RESPONSES; IGA PRODUCTION; I ALLERGY; IMMUNOTHERAPY; CELLS; INTRANASAL; APPLE	Background: Among birch pollen allergic patients up to 70% develop allergic reactions to Bet v 1-homologue food allergens such as Api g 1 (celery) or Dau c 1 (carrot), termed as birch pollen-related food allergy. In most cases, specific immunotherapy with birch pollen extracts does not reduce allergic symptoms to the homologue food allergens. We therefore genetically engineered a multi-allergen chimer and tested if mucosal treatment with this construct could represent a novel approach for prevention of birch pollen-related food allergy. Methodology: BALB/c mice were poly-sensitized with a mixture of Bet v 1, Api g 1 and Dau c 1 followed by a sublingual challenge with carrot, celery and birch pollen extracts. For prevention of allergy sensitization an allergen chimer composed of immunodominant T cell epitopes of Api g 1 and Dau c 1 linked to the whole Bet v 1 allergen, was intranasally applied prior to sensitization. Results: Intranasal pretreatment with the allergen chimer led to significantly decreased antigen-specific IgE-dependent beta-hexosaminidase release, but enhanced allergen-specific IgG2a and IgA antibodies. Accordingly, IL-4 levels in spleen cell cultures and IL-5 levels in restimulated spleen and cervical lymph node cell cultures were markedly reduced, while IFN-gamma levels were increased. Immunomodulation was associated with increased IL-10, TGF-beta and Foxp3 mRNA levels in NALT and Foxp3 in oral mucosal tissues. Treatment with anti-TGF-beta, anti-IL10R or anti-CD25 antibodies abrogated the suppression of allergic responses induced by the chimer. Conclusion: Our results indicate that mucosal application of the allergen chimer led to decreased Th2 immune responses against Bet v 1 and its homologue food allergens Api g 1 and Dau c 1 by regulatory and Th1-biased immune responses. These data suggest that mucosal treatment with a multi-allergen vaccine could be a promising treatment strategy to prevent birch pollen-related food allergy.	[Hoflehner, Elisabeth; Hufnagl, Karin; Schabussova, Irma; Jasinska, Joanna; Wiedermann, Ursula] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria; [Hoffmann-Sommergruber, Karin; Bohle, Barbara] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Maizels, Rick M.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland	Medical University of Vienna; Medical University of Vienna; University of Edinburgh	Hoflehner, E (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria.	ursula.wiedermann@meduniwien.ac.at		Wiedermann, Ursula/0000-0002-1302-3223; Bohle, Barbara/0000-0002-5105-7985; Schabussova, Irma/0000-0002-2109-2640; Hoffmann-Sommergruber, Karin/0000-0002-8830-058X; Jasinska, Joanna/0000-0002-0822-2084	Austrian Science Fund [F01814, P14634-PAT, Y0784GEN, FWF T163]; Wellcome Trust	Austrian Science Fund(Austrian Science Fund (FWF)); Wellcome Trust(Wellcome TrustEuropean Commission)	The work was funded by grants from the Austrian Science Fund (F01814, P14634-PAT, Y0784GEN, FWF T163). RMM is supported by a Wellcome Trust Programme Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma H, 1997, J IMMUNOL METHODS, V202, P123, DOI 10.1016/S0022-1759(96)00243-8; Asero R, 1998, CLIN EXP ALLERGY, V28, P1368, DOI 10.1046/j.1365-2222.1998.00399.x; Bohle B, 2007, ALLERGY, V62, P3, DOI 10.1111/j.1398-9995.2006.01258.x; Bohle B, 2003, EUR J IMMUNOL, V33, P3303, DOI 10.1002/eji.200324321; Bublin M, 2003, FASEB J, V17, P1697, DOI 10.1096/fj.02-0872fje; Bucher X, 2004, ALLERGY, V59, P1272, DOI 10.1111/j.1398-9995.2004.00626.x; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; Cuburu N, 2007, VACCINE, V25, P8598, DOI 10.1016/j.vaccine.2007.09.073; Geroldinger-Simic M, 2011, J ALLERGY CLIN IMMUN, V127, P616, DOI 10.1016/j.jaci.2010.10.027; Hansen KS, 2004, MOL NUTR FOOD RES, V48, P441, DOI 10.1002/mnfr.200400037; Hoffmann-Sommergruber K, 2000, INT ARCH ALLERGY IMM, V122, P155, DOI 10.1159/000024392; Hufnagl K, 2008, CLIN EXP ALLERGY, V38, P1192, DOI 10.1111/j.1365-2222.2008.02992.x; Hufnagl K, 2005, J ALLERGY CLIN IMMUN, V116, P370, DOI 10.1016/j.jaci.2005.04.002; Hufnagl K, 2003, CLIN EXP IMMUNOL, V133, P170, DOI 10.1046/j.1365-2249.2003.02210.x; Jahn-Schmid B, 2005, J ALLERGY CLIN IMMUN, V116, P213, DOI 10.1016/j.jaci.2005.04.019; Jutel M, 2003, EUR J IMMUNOL, V33, P1205, DOI 10.1002/eji.200322919; Leech MD, 2007, J IMMUNOL, V179, P7050, DOI 10.4049/jimmunol.179.10.7050; Mauro M, 2011, INT ARCH ALLERGY IMM, V156, P416, DOI 10.1159/000323909; Moingeon P, 2006, ALLERGY, V61, P151, DOI 10.1111/j.1398-9995.2006.01002.x; Pilette C, 2007, J IMMUNOL, V178, P4658, DOI 10.4049/jimmunol.178.7.4658; Radulovic S, 2008, J ALLERGY CLIN IMMUN, V121, P1467, DOI 10.1016/j.jaci.2008.03.013; Scadding GW, 2010, CLIN EXP ALLERGY, V40, P598, DOI 10.1111/j.1365-2222.2010.03462.x; SONODA E, 1989, J EXP MED, V170, P1415, DOI 10.1084/jem.170.4.1415; Steinman H, 2009, CURRENT ALLERGY CLIN, V22; Taher YA, 2008, J IMMUNOL, V180, P5211, DOI 10.4049/jimmunol.180.8.5211; Verhagen J, 2006, J ALLERGY CLIN IMMUN, V117, P176, DOI 10.1016/j.jaci.2005.10.040; Walker SM, 2011, CLIN EXP ALLERGY, V41, P1177, DOI 10.1111/j.1365-2222.2011.03794.x; Wiedermann U, 1999, J ALLERGY CLIN IMMUN, V103, P1202, DOI 10.1016/S0091-6749(99)70200-9; Wiedermann U, 2001, INT ARCH ALLERGY IMM, V126, P68, DOI 10.1159/000049496; Wild C, 2007, ALLERGY, V62, P33, DOI 10.1111/j.1398-9995.2006.01245.x; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; Winkler B, 2006, ALLERGY, V61, P173, DOI 10.1111/j.1398-9995.2006.01014.x; Winkler B, 2002, CLIN EXP ALLERGY, V32, P30, DOI 10.1046/j.0022-0477.2001.01214.x	33	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39409	10.1371/journal.pone.0039409	http://dx.doi.org/10.1371/journal.pone.0039409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768077	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100048
J	Liu, SP; Huang, X; Ke, GH; Huang, XW				Liu, Su-Ping; Huang, Xiao; Ke, Gui-Hao; Huang, Xiao-Wei			3D Radiation Therapy or Intensity-Modulated Radiotherapy for Recurrent and Metastatic Cervical Cancer: The Shanghai Cancer Hospital Experience	PLOS ONE			English	Article							GYNECOLOGIC-ONCOLOGY-GROUP; PARAAORTIC LYMPH-NODES; WHOLE PELVIC RADIOTHERAPY; SQUAMOUS-CELL CARCINOMA; GASTROINTESTINAL TOXICITY; PLATINUM COMPOUNDS; RADICAL SURGERY; UTERINE CERVIX; CISPLATIN; HYSTERECTOMY	We evaluate the outcomes of irradiation by using three-dimensional radiation therapy (3D-RT) or intensity-modulated radiotherapy (IMRT) for recurrent and metastatic cervical cancer. Between 2007 and 2010, 50 patients with recurrent and metastatic cervical cancer were treated using 3D-RT or IMRT. The median time interval between the initial treatment and the start of irradiation was 12 (6-51) months. Salvage surgery was performed before irradiation in 5 patients, and 38 patients received concurrent chemotherapy. Sixteen patients underwent 3D-RT, and 34 patients received IMRT. Median follow-up for all the patients was 18.3 months. Three-year overall survival and locoregional control were 56.1% and 59.7%, respectively. Three-year progression-free survival and disease-free survival were 65.3% and 64.3%, respectively. Nine patients developed grade 3 leukopenia. Grade 5 acute toxicity was not observed in any of the patients; however, 2 patients developed Grade 3 late toxicity. 3D-RT or IMRT is effective for the treatment of recurrent and metastatic cervical cancer, with the 3-year overall survival of 56.1%, and its complications are acceptable. Long-term follow-up and further studies are needed to confirm the role of 3D-RT or IMRT in the multimodality management of the disease.	[Liu, Su-Ping; Huang, Xiao; Ke, Gui-Hao; Huang, Xiao-Wei] Fudan Univ, Shanghai Canc Ctr, Dept Gynecol Oncol, Shanghai 200433, Peoples R China	Fudan University	Liu, SP (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Gynecol Oncol, Shanghai 200433, Peoples R China.	smilexiaohuang@sina.com						Ahmed RS, 2004, INT J RADIAT ONCOL, V60, P505, DOI 10.1016/j.ijrobp.2004.03.035; Brixey CJ, 2002, INT J RADIAT ONCOL, V54, P1388, DOI 10.1016/S0360-3016(02)03801-4; BURGHARDT E, 1992, CANCER, V70, P648, DOI 10.1002/1097-0142(19920801)70:3<648::AID-CNCR2820700318>3.0.CO;2-R; DELGADO G, 1990, GYNECOL ONCOL, V38, P352, DOI 10.1016/0090-8258(90)90072-S; Deodato F, 2009, ONCOL REP, V22, P415, DOI 10.3892/or_00000453; DEUTSCH M, 1974, CANCER, V34, P2051, DOI 10.1002/1097-0142(197412)34:6<2051::AID-CNCR2820340625>3.0.CO;2-G; Du XL, 2010, CROAT MED J, V51, P229, DOI 10.3325/cmj.2010.51.229; Grigsby PW, 1998, INT J RADIAT ONCOL, V41, P817, DOI 10.1016/S0360-3016(98)00132-1; Guckenberger M, 2010, RADIOTHER ONCOL, V94, P53, DOI 10.1016/j.radonc.2009.12.004; Hartmann JT, 2003, EXPERT OPIN PHARMACO, V4, P889, DOI 10.1517/14656566.4.6.889; Ito H, 1997, GYNECOL ONCOL, V67, P154, DOI 10.1006/gyno.1997.4855; JOBSEN JJ, 1989, GYNECOL ONCOL, V33, P368, DOI 10.1016/0090-8258(89)90529-5; Kato T, 1992, Gan To Kagaku Ryoho, V19, P695; Keys HM, 1999, NEW ENGL J MED, V340, P1154, DOI 10.1056/NEJM199904153401503; LARSON DM, 1988, GYNECOL ONCOL, V30, P381, DOI 10.1016/0090-8258(88)90252-1; Mabuchi S, 2010, INT J GYNECOL CANCER, V20, P834, DOI 10.1111/IGC.0b013e3181dcadd1; Monk BJ, 2009, J CLIN ONCOL, V27, P4649, DOI 10.1200/JCO.2009.21.8909; Moore DH, 2004, J CLIN ONCOL, V22, P3113, DOI 10.1200/JCO.2004.04.170; Mundt AJ, 2003, INT J RADIAT ONCOL, V56, P1354, DOI 10.1016/S0360-3016(03)00325-0; Mundt AJ, 2002, INT J RADIAT ONCOL, V52, P1330, DOI 10.1016/S0360-3016(01)02785-7; Peters WA, 2000, J CLIN ONCOL, V18, P1606, DOI 10.1200/JCO.2000.18.8.1606; PIVER MS, 1981, AM J OBSTET GYNECOL, V139, P575, DOI 10.1016/0002-9378(81)90519-6; Portelance L, 2001, INT J RADIAT ONCOL, V51, P261, DOI 10.1016/S0360-3016(01)01664-9; POTISH R, 1983, GYNECOL ONCOL, V15, P1, DOI 10.1016/0090-8258(83)90110-5; Roeske JC, 2003, RADIOTHER ONCOL, V69, P201, DOI 10.1016/j.radonc.2003.05.001; Rose PG, 1999, NEW ENGL J MED, V340, P1144, DOI 10.1056/NEJM199904153401502; STEHMAN FB, 1991, CANCER, V67, P2776, DOI 10.1002/1097-0142(19910601)67:11<2776::AID-CNCR2820671111>3.0.CO;2-L; THIGPEN T, 1995, SEMIN ONCOL, V22, P67; VANNAGELL JR, 1979, CANCER, V44, P2354, DOI 10.1002/1097-0142(197912)44:6<2354::AID-CNCR2820440653>3.0.CO;2-J; Wang CJ, 1999, AM J OBSTET GYNECOL, V181, P518, DOI 10.1016/S0002-9378(99)70486-2; Whitney CW, 1999, J CLIN ONCOL, V17, P1339, DOI 10.1200/JCO.1999.17.5.1339; Yamazaki A, 2000, JPN J CLIN ONCOL, V30, P180, DOI 10.1093/jjco/hyd049; Zhang MQ, 2010, INT J RADIAT ONCOL, V78, P821, DOI 10.1016/j.ijrobp.2009.08.069	33	7	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40299	10.1371/journal.pone.0040299	http://dx.doi.org/10.1371/journal.pone.0040299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768273	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100247
J	Lokk, K; Vooder, T; Kolde, R; Valk, K; Vosa, U; Roosipuu, R; Milani, L; Fischer, K; Koltsina, M; Urgard, E; Annilo, T; Metspalu, A; Tonisson, N				Lokk, Kaie; Vooder, Tonu; Kolde, Raivo; Vaelk, Kristjan; Vosa, Urmo; Roosipuu, Retlav; Milani, Lili; Fischer, Krista; Koltsina, Marina; Urgard, Egon; Annilo, Tarmo; Metspalu, Andres; Tonisson, Neeme			Methylation Markers of Early-Stage Non-Small Cell Lung Cancer	PLOS ONE			English	Article							DNA METHYLATION; TUMOR-SUPPRESSOR; EPIGENETIC INACTIVATION; DOWN-REGULATION; GENE; EXPRESSION; SUPPORTS; RECEPTOR; TISSUE	Background: Despite of intense research in early cancer detection, there is a lack of biomarkers for the reliable detection of malignant tumors, including non-small cell lung cancer (NSCLC). DNA methylation changes are common and relatively stable in various types of cancers, and may be used as diagnostic or prognostic biomarkers. Methods: We performed DNA methylation profiling of samples from 48 patients with stage I NSCLC and 18 matching cancer-free lung samples using microarrays that cover the promoter regions of more than 14,500 genes. We correlated DNA methylation changes with gene expression levels and performed survival analysis. Results: We observed hypermethylation of 496 CpGs in 379 genes and hypomethylation of 373 CpGs in 335 genes in NSCLC. Compared to adenocarcinoma samples, squamous cell carcinoma samples had 263 CpGs in 223 hypermethylated genes and 513 CpGs in 436 hypomethylated genes. 378 of 869 (43.5%) CpG sites discriminating the NSCLC and control samples showed an inverse correlation between CpG site methylation and gene expression levels. As a result of a survival analysis, we found 10 CpGs in 10 genes, in which the methylation level differs in different survival groups. Conclusions: We have identified a set of genes with altered methylation in NSCLC and found that a minority of them showed an inverse correlation with gene expression levels. We also found a set of genes that associated with the survival of the patients. These newly-identified marker candidates for the molecular screening of NSCLC will need further analysis in order to determine their clinical utility.	[Lokk, Kaie; Vooder, Tonu; Vaelk, Kristjan; Vosa, Urmo; Koltsina, Marina; Urgard, Egon; Annilo, Tarmo; Metspalu, Andres; Tonisson, Neeme] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Lokk, Kaie; Tonisson, Neeme] Tartu Univ Hosp, United Labs, Dept Genet, Tartu, Estonia; [Vooder, Tonu] Tartu Univ Hosp, Lung Clin, Tartu, Estonia; [Kolde, Raivo] Univ Tartu, Inst Comp Sci, EE-50090 Tartu, Estonia; [Roosipuu, Retlav] Tartu Univ Hosp, Dept Pathol, Tartu, Estonia; [Milani, Lili; Fischer, Krista; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia	University of Tartu; University of Tartu; University of Tartu	Lokk, K (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Ulikooli 18, EE-50090 Tartu, Estonia.	neeme.tonisson@ut.ee	Võsa, Urmo/AAJ-5928-2020; Kolde, Raivo/AAB-8149-2022; Milani, Lili/C-8759-2011; Milani, Lili/N-1097-2019; Annilo, Tarmo/J-2900-2013; Tonisson, Neeme/H-2783-2015	Võsa, Urmo/0000-0003-3476-1652; Kolde, Raivo/0000-0003-2886-6298; Milani, Lili/0000-0002-5323-3102; Milani, Lili/0000-0002-5323-3102; Annilo, Tarmo/0000-0002-9588-3058; 	European Union [MJD71]; Centre of Excellence in Genomics; Estonian Ministry of Education and Science [SF0180142s08]; Estonian Science Foundation [7473, 9293]; University of Tartu; Alexander von Humboldt Foundation; Kristjan-Jaak Foundation;  [245536 OpenGene]	European Union(European Commission); Centre of Excellence in Genomics; Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia); Estonian Science Foundation; University of Tartu; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Kristjan-Jaak Foundation; 	The study was supported by the European Union through European Regional Development Fund, Centre of Excellence in Genomics and project 245536 OpenGene. Additional support was obtained from Estonian Ministry of Education and Science core grant SF0180142s08, Estonian Science Foundation grants 7473, 9293 and University of Tartu Development Fund Project of Translational Genomics. LM has been supported by the European Union through the European Social Fund, fellowship MJD71. NT has been supported by the fellowship from Alexander von Humboldt Foundation. KL, MK and NT have received travel stipends from Kristjan-Jaak Foundation. Website of OpenGene project: www.geenivaramu.ee/opengene/. Website of Estonian Science Foundation: www.etf.ee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki J, 2005, EUR J CANCER, V41, P2360, DOI 10.1016/j.ejca.2005.04.043; Bartling B, 2005, CARCINOGENESIS, V26, P293, DOI 10.1093/carcin/bgh333; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Bertazza L, 2010, CURR MED CHEM, V17, P3337, DOI 10.2174/092986710793176339; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Chu XY, 2011, CANC BIOL THER, V11; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Di Pietro E, 2004, BBA-GEN SUBJECTS, V1674, P78, DOI 10.1016/j.bbagen.2004.06.014; Ehrich M, 2006, CANCER RES, V66, P10911, DOI 10.1158/0008-5472.CAN-06-0400; Faller WJ, 2010, MELANOMA RES, V20, P392, DOI 10.1097/CMR.0b013e32833d32a6; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Flonta SE, 2009, AM J PATHOL, V175, P201, DOI 10.2353/ajpath.2009.081124; Foley DL, 2009, AM J EPIDEMIOL, V169, P389, DOI 10.1093/aje/kwn380; Gronbaek K, 2007, APMIS, V115, P1039, DOI 10.1111/j.1600-0463.2007.apm_636.xml.x; Hillion J, 2009, MOL CANCER RES, V7, P1803, DOI 10.1158/1541-7786.MCR-08-0336; Hirai K, 2005, ANN THORAC SURG, V79, P248, DOI 10.1016/j.athoracsur.2004.06.118; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jin MJ, 2009, CANCER SCI, V100, P2325, DOI 10.1111/j.1349-7006.2009.01321.x; Kalari S, 2010, ADV GENET, V70, P277, DOI [10.1016/B978-0-12-380866-0.60010-1, 10.1016/S0065-2660(10)70010-9]; Khattar NH, 2005, J BIOMED SCI, V12, P65, DOI 10.1007/s11373-004-8185-5; Kim H, 2005, CANCER RES, V65, P8118, DOI 10.1158/0008-5472.CAN-04-4562; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Mountain CF, 2000, SEMIN SURG ONCOL, V18, P106, DOI 10.1002/(SICI)1098-2388(200003)18:2<106::AID-SSU4>3.0.CO;2-P; Muller-Hagen G, 2004, CURR OPIN DRUG DISC, V7, P290; Potapenko IO, 2010, MOL ONCOL, V4, P98, DOI 10.1016/j.molonc.2009.12.001; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Strassburg CP, 1999, BIOCHEM J, V338, P489, DOI 10.1042/0264-6021:3380489; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tekpli X, 2011, INT J CANC; Uribe-Lewis S, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001717; Valk K, 2010, ONCOLOGY-BASEL, V79, P283, DOI 10.1159/000322116; Yang RY, 2001, J BIOL CHEM, V276, P20252, DOI 10.1074/jbc.M010914200; Ye YW, 2011, CANC LETT; Yoo KH, 2010, PATHOL INT, V60, P661, DOI 10.1111/j.1440-1827.2010.02578.x	38	52	59	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39813	10.1371/journal.pone.0039813	http://dx.doi.org/10.1371/journal.pone.0039813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768131	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100101
J	Ota, S; Ishikawa, S; Takazawa, Y; Goto, A; Fujii, T; Ohashi, K; Fukayama, M				Ota, Satoshi; Ishikawa, Shumpei; Takazawa, Yutaka; Goto, Akiteru; Fujii, Takeshi; Ohashi, Ken-ichi; Fukayama, Masashi			Quantitative Analysis of Viral Load per Haploid Genome Revealed the Different Biological Features of Merkel Cell Polyomavirus Infection in Skin Tumor	PLOS ONE			English	Article							T-ANTIGEN; SIMIAN VIRUS-40; ABERRANT METHYLATION; DNA REPLICATION; CARCINOMA; EXPRESSION; TRANSFORMATION; ASSOCIATION; SEQUENCES; MUTANTS	Merkel cell polyomavirus (MCPyV) has recently been identified in Merkel cell carcinoma (MCC), an aggressive cancer that occurs in sun-exposed skin. Conventional technologies, such as polymerase chain reaction (PCR) and immunohistochemistry, have produced conflicting results for MCPyV infections in non-MCC tumors. Therefore, we performed quantitative analyses of the MCPyV copy number in various skin tumor tissues, including MCC (n = 9) and other sun exposure-related skin tumors (basal cell carcinoma [BCC, n = 45], actinic keratosis [AK, n = 52], Bowen's disease [n = 34], seborrheic keratosis [n = 5], primary cutaneous anaplastic large-cell lymphoma [n = 5], malignant melanoma [n = 5], and melanocytic nevus [n = 6]). In a conventional PCR analysis, MCPyV DNA was detected in MCC (9 cases; 100%), BCC (1 case; 2%), and AK (3 cases; 6%). We then used digital PCR technology to estimate the absolute viral copy number per haploid human genome in these tissues. The viral copy number per haploid genome was estimated to be around 1 in most MCC tissues, and there were marked differences between the MCC (0.119-42.8) and AK (0.02-0.07) groups. PCR-positive BCC tissue showed a similar viral load as MCC tissue (0.662). Immunohistochemistry with a monoclonal antibody against the MCPyV T antigen (CM2B4) demonstrated positive nuclear localization in most of the high-viral-load tumor groups (8 of 9 MCC and 1 BCC), but not in the low-viral-load or PCR-negative tumor groups. These results demonstrated that MCPyV infection is possibly involved in a minority of sun-exposed skin tumors, including BCC and AK, and that these tumors display different modes of infection.	[Ota, Satoshi] Chiba Univ, Chiba Univ Hosp, Dept Pathol, Chuo Ku, Chiba, Japan; [Ota, Satoshi; Ishikawa, Shumpei; Takazawa, Yutaka; Goto, Akiteru; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Bunkyo Ku, Tokyo, Japan; [Fujii, Takeshi; Ohashi, Ken-ichi] Toranomon Gen Hosp, Dept Pathol, Minato Ku, Tokyo, Japan	Chiba University; University of Tokyo; Toranomon Hospital	Ota, S (corresponding author), Chiba Univ, Chiba Univ Hosp, Dept Pathol, Chuo Ku, Chiba, Japan.	isikawas-tky@umin.org	Goto, Akiteru/P-5775-2014; Fujii, Takeshi/D-5877-2014	Fujii, Takeshi/0000-0001-7237-1183; Goto, Akiteru/0000-0001-8776-9004	New Energy and Industrial Technology Development Organization (NEDO) of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [23590389] Funding Source: KAKEN	New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Industrial Technology Research Grant Program of the New Energy and Industrial Technology Development Organization (NEDO) of Japan (S. I.) and Grants-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S. I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres C, 2010, J CUTAN PATHOL, V37, P28, DOI 10.1111/j.1600-0560.2009.01352.x; Becker JC, 2009, J INVEST DERMATOL, V129, P248, DOI 10.1038/jid.2008.198; Bhatia K, 2010, INT J CANCER, V126, P2240, DOI 10.1002/ijc.24676; Busam KJ, 2009, AM J SURG PATHOL, V33, P1378, DOI 10.1097/PAS.0b013e3181aa30a5; Carter JJ, 2009, JNCI-J NATL CANCER I, V101, P1510, DOI 10.1093/jnci/djp332; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; Duncavage EJ, 2009, MODERN PATHOL, V22, P516, DOI 10.1038/modpathol.2009.3; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Fischer N, 2010, INT J CANCER, V126, P2133, DOI 10.1002/ijc.24877; Foulongne V, 2010, BRIT J DERMATOL, V162, P59, DOI 10.1111/j.1365-2133.2009.09381.x; Garneski KM, 2009, J INVEST DERMATOL, V129, P246, DOI 10.1038/jid.2008.229; Helmbold P, 2009, MOL CARCINOGEN, V48, P903, DOI 10.1002/mc.20540; Houben R, 2010, INT J CANCER, V126, P796, DOI 10.1002/ijc.24790; Kassem A, 2008, CANCER RES, V68, P5009, DOI 10.1158/0008-5472.CAN-08-0949; Kassem A, 2009, INT J CANCER, V125, P356, DOI 10.1002/ijc.24323; Katano H, 2009, J MED VIROL, V81, P1951, DOI 10.1002/jmv.21608; Kuwamoto S, 2011, HUM PATHOL, V42, P632, DOI 10.1016/j.humpath.2010.09.011; LANIA L, 1981, J VIROL, V39, P422, DOI 10.1128/JVI.39.2.422-431.1981; LeBoit PE, 2006, WHO CLASSIFICATION T; Loyo M, 2010, INT J CANCER, V126, P2991, DOI 10.1002/ijc.24737; Mangana J, 2010, DERMATOLOGY, V221, P184, DOI 10.1159/000315067; MANOS MM, 1984, MOL CELL BIOL, V4, P1125, DOI 10.1128/MCB.4.6.1125; Nakajima H, 2009, J DERMATOL SCI, V56, P210, DOI 10.1016/j.jdermsci.2009.07.013; Neumann F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029112; Paulson KG, 2009, J INVEST DERMATOL, V129, P1547, DOI 10.1038/jid.2008.365; PRIVES C, 1983, MOL CELL BIOL, V3, P1958, DOI 10.1128/MCB.3.11.1958; Qin J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn518; Reisinger DM, 2010, J AM ACAD DERMATOL, V63, P400, DOI 10.1016/j.jaad.2009.08.064; Ridd K, 2009, J INVEST DERMATOL, V129, P250, DOI 10.1038/jid.2008.215; Sastre-Garau X, 2009, J PATHOL, V218, P48, DOI 10.1002/path.2532; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Shuda M, 2011, J CLIN INVEST, V121, P3623, DOI 10.1172/JCI46323; Shuda M, 2009, INT J CANCER, V125, P1243, DOI 10.1002/ijc.24510; Sihto H, 2009, JNCI-J NATL CANCER I, V101, P938, DOI 10.1093/jnci/djp139; SMALL MB, 1982, NATURE, V296, P671, DOI 10.1038/296671a0; Touze A, 2009, EMERG INFECT DIS, V15, P960, DOI 10.3201/eid1506.081463; Toyooka S, 2002, ONCOGENE, V21, P4340, DOI 10.1038/sj.onc.1205381; Toyooka S, 2001, CANCER RES, V61, P5727; Varga E, 2009, BRIT J DERMATOL, V161, P930, DOI 10.1111/j.1365-2133.2009.09221.x; Wetzels CTAH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004958; Wieland U, 2009, EMERG INFECT DIS, V15, P1496, DOI 10.3201/eid1509.081575; Woo KJ, 2010, J PLAST RECONSTR AES, V63, P2064, DOI 10.1016/j.bjps.2010.01.020	42	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39954	10.1371/journal.pone.0039954	http://dx.doi.org/10.1371/journal.pone.0039954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768181	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100152
J	Qiu, HY; KuoLee, R; Harris, G; Van Rooijen, N; Patel, GB; Chen, WX				Qiu, Hongyu; KuoLee, Rhonda; Harris, Greg; Van Rooijen, Nico; Patel, Girishchandra B.; Chen, Wangxue			Role of Macrophages in Early Host Resistance to Respiratory Acinetobacter baumannii Infection	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; NITRIC-OXIDE; ALVEOLAR MACROPHAGES; BACTERIAL CLEARANCE; MICE; EPIDEMIOLOGY; PHAGOCYTOSIS; ELIMINATION; NEUTROPHILS; DEFENSES	Acinetobacter baumannii is an emerging bacterial pathogen that causes nosocomial pneumonia and other infections. Although it is recognized as an increasing threat to immunocompromised patients, the mechanism of host defense against A. baumannii infection remains poorly understood. In this study, we examined the potential role of macrophages in host defense against A. baumannii infection using in vitro macrophage culture and the mouse model of intranasal (i.n.) infection. Large numbers of A. baumannii were taken up by alveolar macrophages in vivo as early as 4 h after i.n. inoculation. By 24 h, the infection induced significant recruitment and activation (enhanced expression of CD80, CD86 and MHC-II) of macrophages into bronchoalveolar spaces. In vitro cell culture studies showed that A. baumannii were phagocytosed by J774A.1 (J774) macrophage-like cells within 10 minutes of co-incubation, and this uptake was microfilament-and microtubule-dependent. Moreover, the viability of phagocytosed bacteria dropped significantly between 24 and 48 h after co-incubation. Infection of J774 cells by A. baumannii resulted in the production of large amounts of proinflammatory cytokines and chemokines, and moderate amounts of nitric oxide (NO). Prior treatment of J774 cells with NO inhibitors significantly suppressed their bactericidal efficacy (P<0.05). Most importantly, in vivo depletion of alveolar macrophages significantly enhanced the susceptibility of mice to i.n. A. baumannii challenge (P<0.01). These results indicate that macrophages may play an important role in early host defense against A. baumannii infection through the efficient phagocytosis and killing of A. baumannii to limit initial pathogen replication and the secretion of proinflammatory cytokines and chemokines for the rapid recruitment of other innate immune cells such as neutrophils.	[Qiu, Hongyu; KuoLee, Rhonda; Harris, Greg; Patel, Girishchandra B.; Chen, Wangxue] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Van Rooijen, Nico] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol, Amsterdam, Netherlands; [Chen, Wangxue] Brock Univ, Dept Biol, St Catharines, ON L2S 3A1, Canada	National Research Council Canada; Vrije Universiteit Amsterdam; Brock University	Qiu, HY (corresponding author), Cangene Corp, Winnipeg, MB, Canada.	HQiu@Cangene.com; wangxue.chen@nrc.gc.ca	Van Rooijen, Nico/Z-1578-2019					Anstey NM, 2002, J CLIN MICROBIOL, V40, P685, DOI 10.1128/JCM.40.2.685-686.2002; Breslow JM, 2011, INFECT IMMUN, V79, P3317, DOI 10.1128/IAI.00069-11; BrougHolub E, 1997, INFECT IMMUN, V65, P1139, DOI 10.1128/IAI.65.4.1139-1146.1997; BROWN EJ, 1995, BIOESSAYS, V17, P109, DOI 10.1002/bies.950170206; Brown LAS, 2007, AM J PHYSIOL-LUNG C, V292, pL824, DOI 10.1152/ajplung.00346.2006; CHEN WX, 1992, J EXP MED, V176, P713, DOI 10.1084/jem.176.3.713; Choi CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-216; de Breij A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010732; de Roux A, 2006, CHEST, V129, P1219, DOI 10.1378/chest.129.5.1219; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Dugas N, 1996, BLOOD, V88, P3528, DOI 10.1182/blood.V88.9.3528.bloodjournal8893528; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Gordon SB, 2002, BRIT MED BULL, V61, P45, DOI 10.1093/bmb/61.1.45; Joly-Guillou ML, 2005, CLIN MICROBIOL INFEC, V11, P868, DOI 10.1111/j.1469-0691.2005.01227.x; JolyGuillou MC, 1997, ANTIMICROB AGENTS CH, V41, P345, DOI 10.1128/AAC.41.2.345; Keefer LK, 1996, METHOD ENZYMOL, V268, P281; Kim SW, 2009, FEMS MICROBIOL LETT, V301, P224, DOI 10.1111/j.1574-6968.2009.01820.x; Knapp S, 2006, AM J RESP CRIT CARE, V173, P122, DOI 10.1164/rccm.200505-730OC; Knapp S, 2003, AM J RESP CRIT CARE, V167, P171, DOI 10.1164/rccm.200207-698OC; Kooguchi K, 1998, INFECT IMMUN, V66, P3164, DOI 10.1128/IAI.66.7.3164-3169.1998; Kuo LC, 2007, CLIN MICROBIOL INFEC, V13, P196, DOI 10.1111/j.1469-0691.2006.01601.x; Leemans JC, 2005, J INFECT DIS, V191, P65, DOI 10.1086/426395; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; March C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010033; Marriott HM, 2007, EXP LUNG RES, V33, P493, DOI 10.1080/01902140701756562; Marti-Lliteras P, 2009, INFECT IMMUN, V77, P4232, DOI 10.1128/IAI.00305-09; Nelson S, 2002, NAT REV IMMUNOL, V2, P205, DOI 10.1038/nri744; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Phipps JC, 2010, INFECT IMMUN, V78, P1214, DOI 10.1128/IAI.00963-09; Qiu HY, 2008, J IMMUNOL, V181, P2092, DOI 10.4049/jimmunol.181.3.2092; Qiu HY, 2009, INFECT IMMUN, V77, P1015, DOI 10.1128/IAI.01029-08; Renckens R, 2006, J INFECT DIS, V193, P187, DOI 10.1086/498876; ROSE RM, 1989, EUR J CLIN MICROBIOL, V8, P25, DOI 10.1007/BF01964116; Ruiz M, 1999, AM J RESP CRIT CARE, V160, P923, DOI 10.1164/ajrccm.160.3.9901107; Steele C, 2003, J EXP MED, V198, P1677, DOI 10.1084/jem.20030932; THEPEN T, 1989, J EXP MED, V170, P499, DOI 10.1084/jem.170.2.499; Tsai WC, 1997, INFECT IMMUN, V65, P1870, DOI 10.1128/IAI.65.5.1870-1875.1997; ValentinWeigand P, 1996, INFECT IMMUN, V64, P2467, DOI 10.1128/IAI.64.7.2467-2473.1996; Van Faassen H, 2007, INFECT IMMUN, V75, P5597, DOI 10.1128/IAI.00762-07; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; WILEMAN T, 1985, BIOCHEM J, V232, P1; Yan HB, 2009, BIOCHEM BIOPH RES CO, V387, P581, DOI 10.1016/j.bbrc.2009.07.061	43	72	76	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40019	10.1371/journal.pone.0040019	http://dx.doi.org/10.1371/journal.pone.0040019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768201	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100173
J	Sampath, R; Mulholland, N; Blyn, LB; Massire, C; Whitehouse, CA; Waybright, N; Harter, C; Bogan, J; Miranda, MS; Smith, D; Baldwin, C; Wolcott, M; Norwood, D; Kreft, R; Frinder, M; Lovari, R; Yasuda, I; Matthews, H; Toleno, D; Housley, R; Duncan, D; Li, F; Warren, R; Eshoo, MW; Hall, TA; Hofstadler, SA; Ecker, DJ				Sampath, Rangarajan; Mulholland, Niveen; Blyn, Lawrence B.; Massire, Christian; Whitehouse, Chris A.; Waybright, Nicole; Harter, Courtney; Bogan, Joseph; Miranda, Mary Sue; Smith, David; Baldwin, Carson; Wolcott, Mark; Norwood, David; Kreft, Rachael; Frinder, Mark; Lovari, Robert; Yasuda, Irene; Matthews, Heather; Toleno, Donna; Housley, Roberta; Duncan, David; Li, Feng; Warren, Robin; Eshoo, Mark W.; Hall, Thomas A.; Hofstadler, Steven A.; Ecker, David J.			Comprehensive Biothreat Cluster Identification by PCR/Electrospray-Ionization Mass Spectrometry	PLOS ONE			English	Article							TANDEM REPEAT ANALYSIS; YERSINIA-PESTIS; GENETIC-RELATIONSHIPS; RAPID IDENTIFICATION; UNIVERSAL BIOSENSOR; GENOME SEQUENCE; BACILLUS; PLAGUE; VIRUS; PSEUDOTUBERCULOSIS	Technology for comprehensive identification of biothreats in environmental and clinical specimens is needed to protect citizens in the case of a biological attack. This is a challenge because there are dozens of bacterial and viral species that might be used in a biological attack and many have closely related near-neighbor organisms that are harmless. The biothreat agent, along with its near neighbors, can be thought of as a biothreat cluster or a biocluster for short. The ability to comprehensively detect the important biothreat clusters with resolution sufficient to distinguish the near neighbors with an extremely low false positive rate is required. A technological solution to this problem can be achieved by coupling biothreat group-specific PCR with electrospray ionization mass spectrometry (PCR/ESI-MS). The biothreat assay described here detects ten bacterial and four viral biothreat clusters on the NIAID priority pathogen and HHS/USDA select agent lists. Detection of each of the biothreat clusters was validated by analysis of a broad collection of biothreat organisms and near neighbors prepared by spiking biothreat nucleic acids into nucleic acids extracted from filtered environmental air. Analytical experiments were carried out to determine breadth of coverage, limits of detection, linearity, sensitivity, and specificity. Further, the assay breadth was demonstrated by testing a diverse collection of organisms from each biothreat cluster. The biothreat assay as configured was able to detect all the target organism clusters and did not misidentify any of the near-neighbor organisms as threats. Coupling biothreat cluster-specific PCR to electrospray ionization mass spectrometry simultaneously provides the breadth of coverage, discrimination of near neighbors, and an extremely low false positive rate due to the requirement that an amplicon with a precise base composition of a biothreat agent be detected by mass spectrometry.	[Sampath, Rangarajan; Blyn, Lawrence B.; Massire, Christian; Kreft, Rachael; Frinder, Mark; Lovari, Robert; Yasuda, Irene; Matthews, Heather; Toleno, Donna; Housley, Roberta; Duncan, David; Li, Feng; Warren, Robin; Eshoo, Mark W.; Hall, Thomas A.; Hofstadler, Steven A.; Ecker, David J.] Abbott, Ibis Biosci, Carlsbad, CA 92008 USA; [Mulholland, Niveen; Waybright, Nicole; Harter, Courtney; Bogan, Joseph] MRIGlobal, Rockville, MD USA; [Whitehouse, Chris A.; Baldwin, Carson; Wolcott, Mark; Norwood, David] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Miranda, Mary Sue; Smith, David] Pentagon Force Protect Agcy, Lab Div, Chem Biol Radiol Nucl & Explos Directorate, Washington, DC USA		Sampath, R (corresponding author), Abbott, Ibis Biosci, Carlsbad, CA 92008 USA.	rangarajan.sampath@abbott.com		Smith, David/0000-0002-9465-988X; Kreft, Rachael/0000-0001-9817-8584; Ecker, David/0000-0003-4350-9037	Defense Advanced Research Projects Agency (DARPA) [MDA972-00-C-0053]; Centers for Disease Control and Prevention (CDC) [1R01-C1000099]; Department of Homeland Security (DHS) [NBCHC070019]; Ibis; Department of Homeland Security	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Department of Homeland Security (DHS)(United States Department of Homeland Security (DHS)); Ibis; Department of Homeland Security(United States Department of Homeland Security (DHS))	The authors acknowledge the Defense Advanced Research Projects Agency (DARPA: Contract MDA972-00-C-0053) and the Centers for Disease Control and Prevention (CDC: Contract 1R01-C1000099) for financial support to develop the hardware platform, and the Department of Homeland Security (DHS: Contract NBCHC070019) for support of the biothreat assay validation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; R.S. and other authors with affiliation listed as Ibis Biosciences Inc., are employees of Ibis Biosciences, a subsidiary of Abbott Molecular, Inc., which manufactures the instruments and reagents used in this study. N.M. and other authors with affiliations listed as MRIGlobal are employees of MRIGlobal, an independent, not-for-profit contract research organization that was funded by Ibis and the Department of Homeland Security to carry out the validation studies. The opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the United States Army or the Pentagon Force Protection Agency.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Anisimov AP, 2004, CLIN MICROBIOL REV, V17, P434, DOI 10.1128/CMR.17.2.434-464.2004; Beare PA, 2009, INFECT IMMUN, V77, P642, DOI 10.1128/IAI.01141-08; BERCOVIER H, 1980, CURR MICROBIOL, V4, P225, DOI 10.1007/BF02605861; Brenner DJ, 1984, BERGEYS MANUAL SYSTE, P408; Champion MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000459; Chen KF, 2011, J VIROL METH; Chen KF, 2011, DIAGN MICR INFEC DIS, V69, P179, DOI 10.1016/j.diagmicrobio.2010.10.010; Cowan G, 2000, POSTGRAD MED J, V76, P269, DOI 10.1136/pmj.76.895.269; Crowder CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010650; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Denison AM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-91; Deyde VM, 2011, EXPERT REV MOL DIAGN, V11, P41, DOI [10.1586/erm.10.107, 10.1586/ERM.10.107]; Deyde VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013293; Ecker D, 2006, J ASS LAB AUTOM, P341; Ecker DJ, 2008, NAT REV MICROBIOL, V6, P553, DOI 10.1038/nrmicro1918; Ecker DJ, 2005, J FORENSIC SCI, V50, P1380, DOI 10.1520/JFS2004462; Ecker DJ, 2005, P NATL ACAD SCI USA, V102, P8012, DOI 10.1073/pnas.0409920102; Eckert DJ, 2010, EXPERT REV MOL DIAGN, V10, P399, DOI [10.1586/erm.10.24, 10.1586/ERM.10.24]; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Eshoo MW, 2007, VIROLOGY, V368, P286, DOI 10.1016/j.virol.2007.06.016; Eshoo MW, 2011, MICROBIAL FORENSICS, 2ND EDITION, P155, DOI 10.1016/B978-0-12-382006-8.00010-4; Eshoo MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006342; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Grunow R, 2012, PLOS ONE, V7, pe39928, DOI [10.1371/journal.pone.0039928, DOI 10.1371/JOURNAL.PONE.0039928]; Hofstadler SA, 2005, INT J MASS SPECTROM, V242, P23, DOI 10.1016/j.ijms.2004.09.014; Janda J. M., 2003, MANUAL CLIN MICROBIO, P706; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Kaper J.B., 1998, ESCHERICHIA COLI 015; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Leslie T, 2010, EPIDEMIOL INFECT, P1; Lindler LE, 2004, INFECT DIS BIOL WEAP, P453; Metzgar D, 2010, J CLIN MICROBIOL, V48, P4228, DOI 10.1128/JCM.01336-10; Morens DM, 2010, CLIN INFECT DIS, V51, P1442, DOI 10.1086/657429; Morens DM, 2009, J INFECT DIS, V200, P1018, DOI 10.1086/644537; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001; Prentice MB, 2001, J BACTERIOL, V183, P2586, DOI 10.1128/JB.183.8.2586-2594.2001; Priest FG, 2004, J BACTERIOL, V186, P7959, DOI 10.1128/JB.186.23.7959-7970.2004; Rocke TE, 1998, J WILDLIFE DIS, V34, P744, DOI 10.7589/0090-3558-34.4.744; Roux V, 1997, INT J SYST BACTERIOL, V47, P1255, DOI 10.1099/00207713-47-4-1255; Sampath R, 2005, EMERG INFECT DIS, V11, P373, DOI 10.3201/eid1103.040629; Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489; Shapiro RL, 1998, ANN INTERN MED, V129, P221, DOI 10.7326/0003-4819-129-3-199808010-00011; Simonet M, 1996, INFECT IMMUN, V64, P375, DOI 10.1128/IAI.64.1.375-379.1996; Thomas RM, 2007, INFECT IMMUN, V75, P371, DOI 10.1128/IAI.01241-06; Whitehouse CA, 2010, APPL ENV MICROBIOL	48	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e36528	10.1371/journal.pone.0036528	http://dx.doi.org/10.1371/journal.pone.0036528			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768032	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100003
J	Galimberti, A; Spada, M; Russo, D; Mucedda, M; Agnelli, P; Crottini, A; Ferri, E; Martinoli, A; Casiraghi, M				Galimberti, Andrea; Spada, Martina; Russo, Danilo; Mucedda, Mauro; Agnelli, Paolo; Crottini, Angelica; Ferri, Emanuele; Martinoli, Adriano; Casiraghi, Maurizio			Integrated Operational Taxonomic Units (IOTUs) in Echolocating Bats: A Bridge between Molecular and Traditional Taxonomy	PLOS ONE			English	Article							TIME-EXPANDED RECORDINGS; MYOTIS-MYOTIS CHIROPTERA; MITOCHONDRIAL PSEUDOGENES; SPECIES IDENTIFICATION; GENETIC CONSEQUENCES; CRYPTIC DIVERSITY; ICE AGES; DNA; VESPERTILIONIDAE; PIPISTRELLUS	Background: Nowadays, molecular techniques are widespread tools for the identification of biological entities. However, until very few years ago, their application to taxonomy provoked intense debates between traditional and molecular taxonomists. To prevent every kind of disagreement, it is essential to standardize taxonomic definitions. Along these lines, we introduced the concept of Integrated Operational Taxonomic Unit (IOTU). IOTUs come from the concept of Operational Taxonomic Unit (OTU) and paralleled the Molecular Operational Taxonomic Unit (MOTU). The latter is largely used as a standard in many molecular-based works (even if not always explicitly formalized). However, while MOTUs are assigned solely on molecular variation criteria, IOTUs are identified from patterns of molecular variation that are supported by at least one more taxonomic characteristic. Methodology/Principal Findings: We tested the use of IOTUs on the widest DNA barcoding dataset of Italian echolocating bats species ever assembled (i.e. 31 species, 209 samples). We identified 31 molecular entities, 26 of which corresponded to the morphologically assigned species, two MOTUs and three IOTUs. Interestingly, we found three IOTUs in Myotis nattereri, one of which is a newly described lineage found only in central and southern Italy. In addition, we found a level of molecular variability within four vespertilionid species deserving further analyses. According to our scheme two of them (i.e. M. bechsteinii and Plecotus auritus) should be ranked as unconfirmed candidate species (UCS). Conclusions/Significance: From a systematic point of view, IOTUs are more informative than the general concept of OTUs and the more recent MOTUs. According to information content, IOTUs are closer to species, although it is important to underline that IOTUs are not species. Overall, the use of a more precise panel of taxonomic entities increases the clarity in the systematic field and has the potential to fill the gaps between modern and traditional taxonomy.	[Galimberti, Andrea; Crottini, Angelica; Ferri, Emanuele; Casiraghi, Maurizio] Univ Milano Bicocca, Dipartimento Biotecnol Biosci, ZooPlantLab, Milan, Italy; [Spada, Martina; Martinoli, Adriano] Univ Insubria, Dipartimento Ambiente Salute Sicurezza, Varese, Italy; [Russo, Danilo] Univ Naples Federico II, Fac Agr, Dipartimento ArBoPaVe, Lab Ecol Applicata, Naples, Italy; [Mucedda, Mauro] Grp Speleolog Sassarese, Sassari, Italy; [Mucedda, Mauro] Ctr Pipistrelli Sardegna, Sassari, Italy; [Agnelli, Paolo] Univ Florence, Sez Zool Specola, Museo Storia Nat, Florence, Italy; [Crottini, Angelica] Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Vairao, Portugal	University of Milano-Bicocca; University of Insubria; University of Naples Federico II; University of Florence; Universidade do Porto	Galimberti, A (corresponding author), Univ Milano Bicocca, Dipartimento Biotecnol Biosci, ZooPlantLab, Milan, Italy.	maurizio.casiraghi@unimib.it	Crottini, Angelica/I-7680-2013; Casiraghi, Maurizio/E-7273-2011; Galimberti, Andrea/ABF-7019-2020; Martinoli, Adriano/L-4924-2016	Crottini, Angelica/0000-0002-8505-3050; Casiraghi, Maurizio/0000-0002-2733-2094; Galimberti, Andrea/0000-0003-3140-3024; AGNELLI, PAOLO/0000-0002-0004-8325; Martinoli, Adriano/0000-0003-0298-0869; Russo, Danilo/0000-0002-1934-7130	Fondazione Cariplo "Dai geni all'ecosistema: il DNA barcoding come supporto innovativo per la protezione della biodiversita e l'analisi della funzionalita delle reti ecologiche'' [H71J08000600003]; Portuguese "Fundacao para a Ciencia e Tecnologia'' (FCT) [SFRH/BPD/72908/2010]	Fondazione Cariplo "Dai geni all'ecosistema: il DNA barcoding come supporto innovativo per la protezione della biodiversita e l'analisi della funzionalita delle reti ecologiche''; Portuguese "Fundacao para a Ciencia e Tecnologia'' (FCT)(Portuguese Foundation for Science and Technology)	The study was carried out with financial support of Fondazione Cariplo "Dai geni all'ecosistema: il DNA barcoding come supporto innovativo per la protezione della biodiversita e l'analisi della funzionalita delle reti ecologiche'', project number: H71J08000600003. AC was supported by a postdoctoral grant from the Portuguese "Fundacao para a Ciencia e Tecnologia'' (FCT): SFRH/BPD/72908/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli P, 2006, GUIDELINES BAT MONIT; Aliabadian M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004119; Artyushin IV, 2009, ZOOTAXA, P40; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Baron B, 2010, HYSTRIX, V21, P65; Barratt EM, 1997, NATURE, V387, P138, DOI 10.1038/387138b0; Benda Petr, 2000, Acta Societatis Zoologicae Bohemicae, V64, P331; Benda Petr, 2005, Lynx (Prague), P9; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Berthier P, 2006, P ROY SOC B-BIOL SCI, V273, P3101, DOI 10.1098/rspb.2006.3680; Blant M, 2010, HOLOCENE, V20, P711, DOI 10.1177/0959683609358912; Boero Ferdinando, 2010, Diversity, V2, P115; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Boston ESM, 2010, ACTA CHIROPTEROL, V12, P457, DOI 10.3161/150811010X538025; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; Brower AVZ, 2010, SYST BIODIVERS, V8, P485, DOI 10.1080/14772000.2010.534512; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Cabrera A, 1904, MEMORIAS SOC ESPANOL, V2, P249; Casiraghi M, 2010, BRIEF BIOINFORM, V11, P440, DOI 10.1093/bib/bbq003; Castella V, 2000, MOL ECOL, V9, P1761, DOI 10.1046/j.1365-294x.2000.01069.x; Castella V, 2001, J EVOLUTION BIOL, V14, P708, DOI 10.1046/j.1420-9101.2001.00331.x; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022648; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021460; Claridge M. F., 1997, SPECIES UNITS BIODIV; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Dietz C, 2004, ILLUSTRATED IDENTIFI; Ferri E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-1; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Francis CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012575; Garcia-Mudarra JL, 2009, BIOL J LINN SOC, V96, P434, DOI 10.1111/j.1095-8312.2008.01128.x; GERLOFF U, 1995, MOL ECOL, V4, P515, DOI 10.1111/j.1365-294X.1995.tb00247.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Holynski RB, 2010, ARTHROPOD SYST PHYLO, V68, P143; Hutson A, 2001, MICROCHIROPTERAN BAT; Ibanez C, 2006, ACTA CHIROPTEROL, V8, P277, DOI 10.3161/1733-5329(2006)8[277:TICTCD]2.0.CO;2; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jaarola M, 2004, HEREDITY, V92, P228, DOI 10.1038/sj.hdy.6800400; Jones G, 1997, ADV STUD BEHAV, V26, P317, DOI 10.1016/S0065-3454(08)60383-6; Jones M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019259; Juste J, 2004, MOL PHYLOGENET EVOL, V31, P1114, DOI 10.1016/j.ympev.2003.10.005; Kerr KCR, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-29; Kiefer Andreas, 2001, Myotis, V39, P5; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Mayer F, 2001, P ROY SOC B-BIOL SCI, V268, P1825, DOI 10.1098/rspb.2001.1744; Mayer F, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-4; Mayr E, 2002, WHAT EVOLUTION LONDO; Meiklejohn CD, 2007, TRENDS GENET, V23, P259, DOI 10.1016/j.tig.2007.03.008; Mucedda M, 2002, ACTA CHIROPTEROL, V4, P121, DOI 10.3161/001.004.0202; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Packer L, 2009, MOL ECOL RESOUR, V9, P42, DOI 10.1111/j.1755-0998.2009.02631.x; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Page TJ, 2011, ZOOTAXA, P65; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Preatoni DG, 2005, J WILDLIFE MANAGE, V69, P1601, DOI 10.2193/0022-541X(2005)69[1601:IBFTRO]2.0.CO;2; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Roca AL, 2001, SCIENCE, V293, P1473, DOI 10.1126/science.1059936; Ruedi M, 2003, MOL ECOL, V12, P1527, DOI 10.1046/j.1365-294X.2003.01828.x; Ruedi M, 2001, MOL PHYLOGENET EVOL, V21, P436, DOI 10.1006/mpev.2001.1017; Ruedi M, 2008, MOL ECOL, V17, P1801, DOI 10.1111/j.1365-294X.2008.03702.x; Russo D, 2000, MAMMALIA, V64, P187, DOI 10.1515/mamm.2000.64.2.187; Russo D, 2002, J ZOOL, V258, P91, DOI 10.1017/S0952836902001231; Salicini I, 2011, MOL PHYLOGENET EVOL, V61, P888, DOI 10.1016/j.ympev.2011.08.010; Santos LM, 2011, ZOOTAXA, P66, DOI 10.11646/zootaxa.3025.1.5; SOKAL R. R., 1963, Principles of numerical taxonomy., P359; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Spitzenberger Friederike, 2003, Natura Croatica, V12, P39; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Trizio Ilaria, 2003, Hystrix, V14, P113; Veith M, 2011, ACTA CHIROPTEROL, V13, P89, DOI 10.3161/150811011X578642; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; VOLLETH M, 1987, CYTOGENET CELL GENET, V44, P186, DOI 10.1159/000132371; von Helversen O, 2001, NATURWISSENSCHAFTEN, V88, P217, DOI 10.1007/s001140100225; Wicht B, 2003, REV SUISSE ZOOL, V110, P411, DOI 10.5962/bhl.part.80191	81	52	53	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e40122	10.1371/journal.pone.0040122	http://dx.doi.org/10.1371/journal.pone.0040122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761951	Green Published, Green Submitted, gold			2022-12-27	WOS:000305826400055
J	Lazarczyk, M; Dalard, C; Hayder, M; Dupre, L; Pignolet, B; Majewski, S; Vuillier, F; Favre, M; Liblau, RS				Lazarczyk, Maciej; Dalard, Cecile; Hayder, Myriam; Dupre, Loic; Pignolet, Beatrice; Majewski, Slawomir; Vuillier, Francoise; Favre, Michel; Liblau, Roland S.			EVER Proteins, Key Elements of the Natural Anti-Human Papillomavirus Barrier, Are Regulated upon T-Cell Activation	PLOS ONE			English	Article							EPIDERMODYSPLASIA-VERRUCIFORMIS; ZINC TRANSPORTER; FUNCTIONAL-CHARACTERIZATION; MEDIATED-IMMUNITY; IONS; GENE; PATHOGENESIS; MECHANISMS; EXPRESSION; INFECTION	Human papillomaviruses (HPV) cause a variety of mucosal and skin lesions ranging from benign proliferations to invasive carcinomas. The clinical manifestations of infection are determined by host-related factors that define the natural anti-HPV barrier. Key elements of this barrier are the EVER1 and EVER2 proteins, as deficiency in either one of the EVER proteins leads to Epidermodysplasia Verruciformis (EV), a genodermatosis associated with HPV-induced skin carcinoma. Although EVERs have been shown to regulate zinc homeostasis in keratinocytes, their expression and function in other cell types that may participate to the anti-HPV barrier remain to be investigated. In this work, we demonstrate that EVER genes are expressed in different tissues, and most notably in lymphocytes. Interestingly, in contrast to the skin, where EVER2 transcripts are hardly detectable, EVER genes are both abundantly expressed in murine and human T cells. Activation of CD4+ and CD8+ T cells via the TCR triggers a rapid and profound decrease in EVER expression, accompanied by an accumulation of free Zn2+ ions. Thus, EVER proteins may be involved in the regulation of cellular zinc homeostasis in lymphocytes. Consistent with this hypothesis, we show that the concentration of Zn2+ ions is elevated in lymphoblastoid cells or primary T cells from EVER2-deficient patients. Interestingly, we also show that Zn2+ excess blocks T-cell activation and proliferation. Therefore, EVER proteins appear as key components of the activation-dependent regulation of Zn2+ concentration in T cells. However, the impact of EVER-deficiency in T cells on EV pathogenesis remains to be elucidated.	[Lazarczyk, Maciej; Dalard, Cecile; Hayder, Myriam; Dupre, Loic; Pignolet, Beatrice; Liblau, Roland S.] Fac Med Toulouse, INSERM, U1043, F-31073 Toulouse, France; [Lazarczyk, Maciej; Dalard, Cecile; Hayder, Myriam; Dupre, Loic; Pignolet, Beatrice; Liblau, Roland S.] CNRS, UMR5282, Toulouse, France; [Lazarczyk, Maciej; Dalard, Cecile; Hayder, Myriam; Dupre, Loic; Pignolet, Beatrice; Liblau, Roland S.] Univ Toulouse, UPS, CPTP, Toulouse, France; [Majewski, Slawomir] Med Univ Warsaw, Dept Dermatol & Venereol, Warsaw, Poland; [Vuillier, Francoise; Favre, Michel] Inst Pasteur, Unite Genet Papillomavirus & Canc Humain, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Medical University of Warsaw; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lazarczyk, M (corresponding author), Fac Med Toulouse, INSERM, U1043, U317, F-31073 Toulouse, France.	roland.liblau@inserm.fr	Liblau, Roland/J-3530-2014; Vuillier, Françoise/T-4699-2019; dupre, loic/L-8174-2014	dupre, loic/0000-0002-7278-6503; LIBLAU, Roland/0000-0001-5477-5475; Vuillier, Francoise/0000-0002-5551-9876	Institut national de la sante et de la recherche medicale (INSERM); Agence de Recherche contre le Cancer (ARC); Agence Nationale de la Recherche (ANR-MIE); Region Midi-Pyrenees	Institut national de la sante et de la recherche medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence de Recherche contre le Cancer (ARC); Agence Nationale de la Recherche (ANR-MIE)(French National Research Agency (ANR)); Region Midi-Pyrenees(Region OccitanieRegion Provence-Alpes-Cote d'Azur)	This work was supported by Institut national de la sante et de la recherche medicale (INSERM), Agence de Recherche contre le Cancer (ARC), Agence Nationale de la Recherche (ANR-MIE 2009), and Region Midi-Pyrenees. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydemir TB, 2009, J LEUKOCYTE BIOL, V86, P337, DOI 10.1189/jlb.1208759; Barthel A, 2007, ARCH BIOCHEM BIOPHYS, V463, P175, DOI 10.1016/j.abb.2007.04.015; Barzegar C, 1998, BRIT J DERMATOL, V139, P122; CSERMELY P, 1989, ACTA PHYSIOL HUNG, V74, P195; Dupre L, 2002, IMMUNITY, V17, P157, DOI 10.1016/S1074-7613(02)00360-6; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; GLINSKI W, 1976, DERMATOLOGICA, V153, P218, DOI 10.1159/000251060; Haase H, 2006, ANAL BIOCHEM, V352, P222, DOI 10.1016/j.ab.2006.02.009; Haase H, 2009, ANNU REV NUTR, V29, P133, DOI 10.1146/annurev-nutr-080508-141119; HAFTEK M, 1985, DERMATOLOGICA, V170, P213, DOI 10.1159/000249535; Kaler P, 2007, AM J PHYSIOL-RENAL, V292, pF217, DOI 10.1152/ajprenal.00014.2006; Kaltenberg J, 2010, EUR J IMMUNOL, V40, P1496, DOI 10.1002/eji.200939574; Kawai K, 2009, DERMATOLOGY, V219, P274, DOI 10.1159/000235743; Kim YM, 2006, AM J PHYSIOL-LUNG C, V290, pL1028, DOI 10.1152/ajplung.00479.2005; Laffort C, 2004, LANCET, V363, P2051, DOI 10.1016/S0140-6736(04)16457-X; Landini MM, 2012, J INVEST DERMATOL, V132, P1305, DOI 10.1038/jid.2011.399; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; Lazarczyk M, 2008, J EXP MED, V205, P35, DOI 10.1084/jem.20071311; Lazarczyk M, 2008, J VIROL, V82, P11486, DOI 10.1128/JVI.01314-08; Lazarczyk M, 2009, MICROBIOL MOL BIOL R, V73, P348, DOI 10.1128/MMBR.00033-08; Lin RS, 1998, J BIOL CHEM, V273, P32878, DOI 10.1074/jbc.273.49.32878; Majewski S, 1997, CLIN DERMATOL, V15, P321, DOI 10.1016/S0738-081X(96)00169-1; MARGOSHES M, 1957, J AM CHEM SOC, V79, P4813, DOI 10.1021/ja01574a064; Orth G, 2008, CURR TOP MICROBIOL, V321, P59; Orth G, 2006, SEMIN IMMUNOL, V18, P362, DOI 10.1016/j.smim.2006.07.008; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; PRAWER SE, 1977, ARCH DERMATOL, V113, P495, DOI 10.1001/archderm.113.4.495; PULIDO P, 1966, BIOCHEMISTRY-US, V5, P1768, DOI 10.1021/bi00869a046; PYRHONEN S, 1980, BRIT J DERMATOL, V102, P247, DOI 10.1111/j.1365-2133.1980.tb08136.x; Ramoz N, 2000, J INVEST DERMATOL, V114, P1148, DOI 10.1046/j.1523-1747.2000.00996.x; Ramoz N, 1999, J INVEST DERMATOL, V112, P259, DOI 10.1046/j.1523-1747.1999.00536.x; Ramoz N, 2002, NAT GENET, V32, P579, DOI 10.1038/ng1044; Rogers HD, 2009, J AM ACAD DERMATOL, V60, P315, DOI 10.1016/j.jaad.2008.08.035; Romir J, 2007, J MOL BIOL, V365, P1417, DOI 10.1016/j.jmb.2006.10.058; Saxena A, 2008, J IMMUNOL, V181, P1617, DOI 10.4049/jimmunol.181.3.1617; Schiffman Mark, 2003, J Natl Cancer Inst Monogr, P14; Seo SR, 2001, J NEUROCHEM, V78, P600, DOI 10.1046/j.1471-4159.2001.00438.x; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tanaka S, 2005, BIOCHEM BIOPH RES CO, V335, P162, DOI 10.1016/j.bbrc.2005.07.059; Tobin E, 2003, BRIT J DERMATOL, V149, P627, DOI 10.1046/j.1365-2133.2003.05543.x; Vizler C, 2000, J IMMUNOL, V165, P6314, DOI 10.4049/jimmunol.165.11.6314; WANG SS, 2003, J NATL CANC I MONOGR, V31, P35, DOI DOI 10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A003480; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yu MC, 2011, J EXP MED, V208, P775, DOI 10.1084/jem.20100031	44	42	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39995	10.1371/journal.pone.0039995	http://dx.doi.org/10.1371/journal.pone.0039995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761942	Green Submitted, Green Published, gold			2022-12-27	WOS:000305826400051
J	Gao, JZ; Faraggi, E; Zhou, YQ; Ruan, JS; Kurgan, L				Gao, Jianzhao; Faraggi, Eshel; Zhou, Yaoqi; Ruan, Jishou; Kurgan, Lukasz			BEST: Improved Prediction of B-Cell Epitopes from Antigen Sequences	PLOS ONE			English	Article							SOLVENT ACCESSIBILITY; PROTEIN; RESIDUES; PROGRAM; SERVER; DETERMINANTS; ACCURACY; LOCATION; REGIONS; TOOLS	Accurate identification of immunogenic regions in a given antigen chain is a difficult and actively pursued problem. Although accurate predictors for T-cell epitopes are already in place, the prediction of the B-cell epitopes requires further research. We overview the available approaches for the prediction of B-cell epitopes and propose a novel and accurate sequence-based solution. Our BEST (B-cell Epitope prediction using Support vector machine Tool) method predicts epitopes from antigen sequences, in contrast to some method that predict only from short sequence fragments, using a new architecture based on averaging selected scores generated from sliding 20-mers by a Support Vector Machine (SVM). The SVM predictor utilizes a comprehensive and custom designed set of inputs generated by combining information derived from the chain, sequence conservation, similarity to known (training) epitopes, and predicted secondary structure and relative solvent accessibility. Empirical evaluation on benchmark datasets demonstrates that BEST outperforms several modern sequence-based B-cell epitope predictors including ABCPred, method by Chen et al. (2007), BCPred, COBEpro, BayesB, and CBTOPE, when considering the predictions from antigen chains and from the chain fragments. Our method obtains a cross-validated area under the receiver operating characteristic curve (AUC) for the fragment-based prediction at 0.81 and 0.85, depending on the dataset. The AUCs of BEST on the benchmark sets of full antigen chains equal 0.57 and 0.6, which is significantly and slightly better than the next best method we tested. We also present case studies to contrast the propensity profiles generated by BEST and several other methods.	[Gao, Jianzhao; Ruan, Jishou] Nankai Univ, Sch Math Sci, Tianjin 300071, Peoples R China; [Gao, Jianzhao; Ruan, Jishou] Nankai Univ, LPMC, Tianjin 300071, Peoples R China; [Faraggi, Eshel; Zhou, Yaoqi] Indiana Univ Purdue Univ, Sch Informat, Indianapolis, IN 46202 USA; [Faraggi, Eshel; Zhou, Yaoqi] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN USA; [Ruan, Jishou] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Kurgan, Lukasz] Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada	Nankai University; Nankai University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Nankai University; University of Alberta	Gao, JZ (corresponding author), Nankai Univ, Sch Math Sci, Tianjin 300071, Peoples R China.	gaojz@nankai.edu.cn; lkurgan@ece.ualberta.ca	Zhou, Yaoqi/B-3284-2009; Kurgan, Lukasz/B-5721-2009	Zhou, Yaoqi/0000-0002-9958-5699; Kurgan, Lukasz/0000-0002-7749-0314; Gao, Jianzhao/0000-0002-9943-4786	National Science Foundation of China (NSFC) [31050110432, 31150110577]; National Institutes of Health [GM R01 085003]; NSERC (National Science and Engineering Research Council) Canada [298328]; International Development Research Center, Ottawa, Canada [104519-010]; Tianjin science and technology support project [08ZCHHZ00200]; Fundamental Research Funds for the Central Universities [65011491]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085003] Funding Source: NIH RePORTER	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSERC (National Science and Engineering Research Council) Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); International Development Research Center, Ottawa, Canada; Tianjin science and technology support project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation of China (NSFC) grants 31050110432 and 31150110577 to LK and JR, National Institutes of Health grant GM R01 085003 to YZ, and by the Discovery grant 298328 from NSERC (National Science and Engineering Research Council) Canada to LK. JR was also supported by the International Development Research Center, Ottawa, Canada (No. 104519-010) and Tianjin science and technology support project 08ZCHHZ00200. JG was supported by the Fundamental Research Funds for the Central Universities grant 65011491. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Ahmad S, 2003, PROTEINS, V50, P629, DOI 10.1002/prot.10328; Alix AJP, 1999, VACCINE, V18, P311, DOI 10.1016/S0264-410X(99)00329-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6; Beck A, 2007, J PEPT SCI, V13, P588, DOI 10.1002/psc.852; Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505; Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9; Chen K, 2012, BIOINFORMATICS, V28, P331, DOI 10.1093/bioinformatics/btr657; Chen K, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S4; Chen Ping, 2011, Virologica Sinica, V26, P1, DOI 10.1007/s12250-011-3159-4; Dor O, 2007, PROTEINS, V66, P838, DOI 10.1002/prot.21298; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; Faraggi E, 2009, PROTEINS, V74, P847, DOI 10.1002/prot.22193; Flower Darren R., 2007, V409, P1, DOI 10.1007/978-1-60327-118-9_1; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Huang J, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-7; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Kulkarni-Kale U, 2005, NUCLEIC ACIDS RES, V33, pW168, DOI 10.1093/nar/gki460; Kurgan L, 2011, CURR PROTEIN PEPT SC, V12, P470, DOI 10.2174/138920311796957711; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liang SD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-381; LIU R, 2011, J PROTEOM BIOINFORM, V4; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Miri Disfani F, 2012, BIOINFORMAT IN PRESS; Mizianty MJ, 2011, BIOINFORMATICS, V27, pI24, DOI 10.1093/bioinformatics/btr229; Mizianty MJ, 2010, BIOINFORMATICS, V26, pi489, DOI 10.1093/bioinformatics/btq373; Mizianty MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-414; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Odorico M, 2003, J MOL RECOGNIT, V16, P20, DOI 10.1002/jmr.602; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A; PELLEQUER JL, 1991, METHOD ENZYMOL, V203, P176; PELLEQUER JL, 1993, J MOL GRAPH MODEL, V11, P204, DOI 10.1016/0263-7855(93)80074-2; Rubinstein ND, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-287; Rubinstein ND, 2009, MOL IMMUNOL, V46, P840, DOI 10.1016/j.molimm.2008.09.009; Saha S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-79; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Sollner J, 2006, J MOL RECOGNIT, V19, P200, DOI 10.1002/jmr.771; Sun J, 2009, NUCLEIC ACIDS RES, V37, pW612, DOI 10.1093/nar/gkp417; Sweredoski MJ, 2008, BIOINFORMATICS, V24, P1459, DOI 10.1093/bioinformatics/btn199; Sweredoski MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/protein/gzn075; Tong JC, 2007, BRIEF BIOINFORM, V8, P96, DOI 10.1093/bib/bbl038; Wang K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-385; Wee LJK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S21; WELLING GW, 1985, FEBS LETT, V188, P215, DOI 10.1016/0014-5793(85)80374-4; Yang XD, 2009, REV MED VIROL, V19, P77, DOI 10.1002/rmv.602; Zhang T, 2008, BIOINFORMATICS, V24, P2329, DOI 10.1093/bioinformatics/btn433; Zhang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-341; Zhao L, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-S1-S6	53	65	72	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e40104	10.1371/journal.pone.0040104	http://dx.doi.org/10.1371/journal.pone.0040104			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761950	Green Submitted, Green Published, gold			2022-12-27	WOS:000305825800088
J	Nirantharakumar, K; Marshall, T; Hodson, J; Narendran, P; Deeks, J; Coleman, JJ; Ferner, RE				Nirantharakumar, Krishnarajah; Marshall, Tom; Hodson, James; Narendran, Parth; Deeks, Jon; Coleman, Jamie J.; Ferner, Robin E.			Hypoglycemia in Non-Diabetic In-Patients: Clinical or Criminal?	PLOS ONE			English	Article							MILD HYPOGLYCEMIA; PREVALENCE; MANAGEMENT; MORTALITY; INSULIN; MURDER	Background and Aim: We wished to establish the frequency of unexpected hypoglycemia observed in non diabetic patients outside the intensive care unit and to determine if they have a plausible clinical explanation. Methods: We analysed data for 2010 from three distinct sources to identify non diabetic hypoglycaemic patients: bedside and laboratory blood glucose measurements; medication records for those treatments (high-strength glucose solution and glucagon) commonly given to reverse hypoglycemia; and diagnostic codes for hypoglycemia. We excluded from the denominator admissions of patients with a diagnosis of diabetes or prescribed diabetic medication. Case notes of patients identified were reviewed. We used capture-recapture methods to establish the likely frequency of hypoglycemia in nondiabetic in-patients outside intensive care unit at different cut-off points for hypoglycemia. We also recorded co-morbidities that might have given rise to hypoglycemia. Results: Among the 37,898 admissions, the triggers identified 71 hypoglycaemic episodes at a cut-off of 3.3 mmol/l. Estimated frequency at 3.3 mmol/l was 50(CI 33-93), at 3.0 mmol/l, 36(CI 24-64), at 2.7 mmol/l, 13(CI 11-19), at 2.5 mmol/l, 11(CI 9-15) and at 2.2 mmol/l, 8(CI 7-11) per 10,000 admissions. Admissions of patients aged above 65 years were approximately 50% more likely to have an episode of hypoglycemia. Most were associated with important co-morbidities. Conclusion: Significant non-diabetic hypoglycemia in hospital in-patients (at or below 2.7 mmol/l) outside critical care is rare. It is sufficiently rare for occurrences to merit case-note review and diagnostic blood tests, unless an obvious explanation is found.	[Nirantharakumar, Krishnarajah; Narendran, Parth; Coleman, Jamie J.; Ferner, Robin E.] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Nirantharakumar, Krishnarajah; Hodson, James; Coleman, Jamie J.] Univ Hosp Birmingham, EPrescribing Res Team, Birmingham, W Midlands, England; [Narendran, Parth] Univ Hosp Birmingham, Dept Diabet, Birmingham, W Midlands, England; [Coleman, Jamie J.; Ferner, Robin E.] City Hosp, W Midlands Ctr Adverse Drug React, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham	Nirantharakumar, K (corresponding author), Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England.	k.nirantharan@bham.ac.uk	Deeks, Jon/AAV-5745-2020	Deeks, Jon/0000-0002-8850-1971; Ferner, Robin/0000-0003-3769-1346; Coleman, Jamie/0000-0002-7512-5153; Narendran, Parth/0000-0002-4583-8793; Marshall, Tom/0000-0001-9277-5214; Hodson, James/0000-0003-3487-0090	National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme.	National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme.(National Institute for Health Research (NIHR))	This study was funded by the National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme. The funders also had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anabtawi A, 2010, DIABETES TECHNOL THE, V12, P635, DOI 10.1089/dia.2010.0009; Arinzon Z, 2007, ARCH GERONTOL GERIAT, V45, P191, DOI 10.1016/j.archger.2006.10.010; Becker C, 2001, MODERN HEALTHCARE, V33, P6; Ben Salem C, 2011, DRUG SAFETY, V34, P21, DOI 10.2165/11538290-000000000-00000; Berger B, 1998, DIABETES CARE, V21, P546, DOI 10.2337/diacare.21.4.546; Childs BP, 2005, DIABETES CARE, V28, P1245; Cryer PE, 2009, J CLIN ENDOCR METAB, V94, P709, DOI 10.1210/jc.2008-1410; FISCHER KF, 1986, NEW ENGL J MED, V315, P1245, DOI 10.1056/NEJM198611133152002; FLETCHER SM, 1983, J FORENSIC SCI SOC, V23, P5, DOI 10.1016/S0015-7368(83)71537-9; Ford Steve, 2008, Nurs Times, V104, P8; Galler A, 2010, HORM RES PAEDIAT, V74, P285, DOI 10.1159/000303141; Gamble JM, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.11.021; Griffiths MJ, 2005, HOSP MED, V66, P277; Hart SP, 1998, QJM-MON J ASSOC PHYS, V91, P505, DOI 10.1093/qjmed/91.7.505; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; Hook EB, J CLIN EPIDEMIOLOGY, V52, P917; Hunt J, 1997, MED SCI LAW, V37, P189, DOI 10.1177/002580249703700302; Joint British Diabetes Society, 2010, HOSP MAN HYP AD DIAB; Kagansky N, 2003, ARCH INTERN MED, V163, P1825, DOI 10.1001/archinte.163.15.1825; Krinsley J, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-49; Krinsley JS, 2011, CRIT CARE, V15, DOI 10.1186/cc10322; Lanoy E, 2011, INT J CANCER, V129, P467, DOI 10.1002/ijc.25903; Lupsa BC, 2009, MEDICINE, V88, P141, DOI 10.1097/MD.0b013e3181a5b42e; MALOUF R, 1985, ANN NEUROL, V17, P421, DOI 10.1002/ana.410170502; Mannucci E, 2006, AGING CLIN EXP RES, V18, P446; MARKS V, 2006, DIABETES VASC DIS, V6, P281; Marks V, 2009, MED LEG J, V77; Marks V, 2008, J ROY SOC MED, V101, P110, DOI 10.1258/jrsm.2008.071002; Marks V, 2009, DRUG TEST ANAL, V1, P162, DOI 10.1002/dta.38; Missliwetz J, 1994, ARCH KRIMINOLOGIE, V194; REGAL RR, 1984, STAT MED, V3, P287, DOI 10.1002/sim.4780030310; Reurings MCB, 2011, ANN EPIDEMIOL, V21, P648, DOI 10.1016/j.annepidem.2011.05.007; Samardzic M, 2010, PEDIATR DIABETES, V11, P412, DOI 10.1111/j.1399-5448.2009.00617.x; Service FJ, 1995, NEW ENGLAND J MED, V332; Shilo S, 1998, J AM GERIATR SOC, V46, P978, DOI 10.1111/j.1532-5415.1998.tb02752.x; StataCorp, 2011, STAT STAT SOFTW REL; Teo S. K., 1997, SMJ, V38, P432; Thornley S, 2010, NEW ZEAL MED J, V123, P76; Turchin A, 2009, DIABETES CARE, V32, P1153, DOI 10.2337/dc08-2127; Virally ML, 1999, DIABETES METAB, V25, P477; Wise J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4707; Yorker BC, 2006, J FORENSIC SCI, V51, P1362, DOI 10.1111/j.1556-4029.2006.00273.x	42	36	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40384	10.1371/journal.pone.0040384	http://dx.doi.org/10.1371/journal.pone.0040384			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768352	gold, Green Submitted, Green Published			2022-12-27	WOS:000305966500065
J	Alvarez-Rueda, N; Albassier, M; Allain, S; Deknuydt, F; Altare, F; Le Pape, P				Alvarez-Rueda, Nidia; Albassier, Marjorie; Allain, Sophie; Deknuydt, Florence; Altare, Frederic; Le Pape, Patrice			First Human Model of In Vitro Candida albicans Persistence within Granuloma for the Reliable Study of Host-Fungi Interactions	PLOS ONE			English	Article							POLYMORPHONUCLEAR NEUTROPHILS; VAGINAL CANDIDIASIS; TISSUE-REACTIONS; ACUTE-LEUKEMIA; CELLS; INFECTION; GENE; INFLAMMATION; DEGRADATION; MACROPHAGES	Backgound: The balance between human innate immune system and Candida albicans virulence signaling mechanisms ultimately dictates the outcome of fungal invasiveness and its pathology. To better understand the pathophysiology and to identify fungal virulence-associated factors in the context of persistence in humans, complex models are indispensable. Although fungal virulence factors have been extensively studied in vitro and in vivo using different immune cell subsets and cell lines, it is unclear how C. albicans survives inside complex tissue granulomas. Methodology/Principal Finding: We developed an original model of in vitro human granuloma, reproducing the natural granulomatous response to C. albicans. Persistent granulomas were obtained when the ratio of phagocytes to fungi was high. This in vitro fungal granuloma mimics natural granulomas, with infected macrophages surrounded by helper and cytotoxic T lymphocytes. A small proportion of granulomas exhibited C. albicans hyphae. Histological and time-lapse analysis showed that C. albicans blastoconidia were located within the granulomas before hyphae formation. Using staining techniques, fungal load calculations, as well as confocal and scanning electron microscopy, we describe the kinetics of fungal granuloma formation. We provide the first direct evidence that C. albicans are not eliminated by immunocompetent cells inside in vitro human granulomas. In fact, after an initial candicidal period, the remaining yeast proliferate and persist under very complex immune responses. Conclusions/Significance: Using an original in vitro model of human fungal granuloma, we herein present the evidence that C. albicans persist and grow into immunocompetent granulomatous structures. These results will guide us towards a better understanding of fungal invasiveness and, henceforth, will also help in the development of better strategies for its control in human physiological conditions.	[Alvarez-Rueda, Nidia; Albassier, Marjorie; Le Pape, Patrice] Nantes Atlantique Univ, Univ Nantes, Fac Pharm Nantes, Dept Parasitol & Mycol Med,CiMed EA1155 2, Nantes, France; [Le Pape, Patrice] CHU Nantes, Lab Parasitol Mycol, F-44035 Nantes 01, France; [Allain, Sophie; Deknuydt, Florence; Altare, Frederic] Univ Nantes, CNRS 6299, Inserm, CRCNA,U892, Nantes, France	Nantes Universite; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Alvarez-Rueda, N (corresponding author), Nantes Atlantique Univ, Univ Nantes, Fac Pharm Nantes, Dept Parasitol & Mycol Med,CiMed EA1155 2, Nantes, France.	nidia.alvarez-rueda@univ-nantes.fr; patrice.le-pape@univ-nantes.fr	Le Pape, Patrice/W-1472-2019; Le Pape, Patrice/AAY-3632-2021; altare, frederic/K-8664-2015	Le Pape, Patrice/0000-0001-5059-6402; altare, frederic/0000-0002-5077-4616; ALVAREZ RUEDA, Nidia/0000-0002-5629-1930; Allain, Sophie/0000-0003-2241-5736				Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Alvarez-Rueda N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021239; Andres RH, 2007, ACTA NEUROCHIR, V149, P953, DOI 10.1007/s00701-007-1260-8; Bachh AA, 2008, LUNG INDIA, V25, P165, DOI 10.4103/0970-2113.45285; Banuprakash S, 2009, J NEURORADIOLOGY, V36, P233, DOI 10.1016/j.neurad.2009.06.003; Barelle CJ, 2004, YEAST, V21, P333, DOI 10.1002/yea.1099; Beattie L, 2011, CELL MICROBIOL; Beattie L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000805; Brieland J, 2001, INFECT IMMUN, V69, P5046, DOI 10.1128/IAI.69.8.5046-5055.2001; Calderone R, 2000, MED MYCOL, V38, P125, DOI 10.1080/mmy.38.s1.125.137; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Calera JA, 2000, YEAST, V16, P1053, DOI 10.1002/1097-0061(200008)16:11&lt;1053::AID-YEA598&gt;3.0.CO;2-H; Collins CD, 2011, PATIENT PREFER ADHER, V5, P369, DOI 10.2147/PPA.S14047; Coste A, 2007, EUKARYOT CELL, V6, P1889, DOI 10.1128/EC.00151-07; Crawford CL, 2011, INT J DERMATOL, V50, P255, DOI 10.1111/j.1365-4632.2010.04805.x; Diniz SN, 2001, HUM IMMUNOL, V62, P799, DOI 10.1016/S0198-8859(01)00268-3; Dubey A, 2005, SURG NEUROL, V63, P254, DOI 10.1016/j.surneu.2004.04.020; Falagas ME, 2006, J ANTIMICROB CHEMOTH, V58, P266, DOI 10.1093/jac/dkl246; Flynn JL, 2011, MUCOSAL IMMUNOL, V4, P271, DOI 10.1038/mi.2011.14; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Fradin C, 2003, MOL MICROBIOL, V47, P1523, DOI 10.1046/j.1365-2958.2003.03396.x; Franco MVG, 1997, MYCOPATHOLOGIA, V137, P129, DOI 10.1023/A:1006883313078; Glittenberg MT, 2011, DIS MODEL MECH, V4, P515, DOI 10.1242/dmm.006627; Hanna S, 2011, J ALLERGY CLIN IMMUN, V127, P1433, DOI 10.1016/j.jaci.2011.03.026; Heinemann DEH, 1997, SCAND J IMMUNOL, V45, P596, DOI 10.1046/j.1365-3083.1997.d01-435.x; Iking-Konert C, 2008, RHEUMATOLOGY, V47, P609, DOI 10.1093/rheumatology/ken028; Iking-Konert C, 2005, ANN RHEUM DIS, V64, P1436, DOI 10.1136/ard.2004.034132; Jacobsen ID, 2010, INFECT IMMUN, V78, P1066, DOI 10.1128/IAI.01244-09; Jain V, 2009, SURV OPHTHALMOL, V54, P286, DOI 10.1016/j.survophthal.2008.12.008; Jouault T, 2009, CELL MICROBIOL, V11, P1007, DOI 10.1111/j.1462-5822.2009.01318.x; Lalla RV, 2010, SUPPORT CARE CANCER, V18, P985, DOI 10.1007/s00520-010-0892-z; Leroy O, 2009, CRIT CARE MED, V37, P1612, DOI 10.1097/CCM.0b013e31819efac0; Marcil A, 2002, INFECT IMMUN, V70, P6319, DOI 10.1128/IAI.70.11.6319-6329.2002; Masood A, 2005, LEUKEMIA RES, V29, P493, DOI 10.1016/j.leukres.2004.10.003; MEISTER H, 1977, J INFECT DIS, V135, P224, DOI 10.1093/infdis/135.2.224; MEISTER H, 1977, J INFECT DIS, V135, P235, DOI 10.1093/infdis/135.2.235; Montejo Miguel, 2011, Enferm Infecc Microbiol Clin, V29 Suppl 2, P15, DOI 10.1016/S0213-005X(11)70004-0; Mora-Montes HM, 2011, INFECT IMMUN, V79, P1961, DOI 10.1128/IAI.01282-10; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Panjabi C, 2009, J BRAS PNEUMOL, V35, P480, DOI 10.1590/S1806-37132009000500015; Pankhurst CL, 2009, CLIN EVID ONLINE; Park TH, 2012, J PLAST RECONSTR AES; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Pietrella D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022770; Poulain D, 2009, DIGEST DIS, V27, P104, DOI 10.1159/000268129; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Puel A, 2010, CURR OPIN IMMUNOL, V22, P467, DOI 10.1016/j.coi.2010.06.009; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Puissegur MP, 2004, CELL MICROBIOL, V6, P423, DOI 10.1111/j.1462-5822.2004.00371.x; Rubin-Bejerano I, 2003, P NATL ACAD SCI USA, V100, P11007, DOI 10.1073/pnas.1834481100; Sallah S, 2001, CANCER-AM CANCER SOC, V92, P1349, DOI 10.1002/1097-0142(20010915)92:6<1349::AID-CNCR1457>3.0.CO;2-E; Saunus JM, 2008, FRONT BIOSCI-LANDMRK, V13, P5345, DOI 10.2741/3085; Schaller M, 2003, INFECT IMMUN, V71, P3227, DOI 10.1128/IAI.71.6.3227-3234.2003; Semlali A, 2011, PEPTIDES, V32, P859, DOI 10.1016/j.peptides.2011.01.020; Spellberg BJ, 2005, J LEUKOCYTE BIOL, V78, P338, DOI 10.1189/jlb.0205072; Srikantha T, 2008, MICROBIOL-SGM, V154, P3309, DOI 10.1099/mic.0.2008/020578-0; Tsiodras S, 2000, MAYO CLIN PROC, V75, P1039, DOI 10.4065/75.10.1039; Turgut M, 2010, CHILD NERV SYST, V26, P733, DOI 10.1007/s00381-010-1149-3; Vazquez JA, 2010, SEMIN RESP CRIT CARE, V31, P79, DOI 10.1055/s-0029-1246289; VONEIFF M, 1990, MYCOSES, V33, P283; Wagner C, 2006, CLIN EXP IMMUNOL, V143, P70, DOI 10.1111/j.1365-2249.2005.02963.x; Yumoto E, 2008, LARYNGOSCOPE, V118, P932, DOI 10.1097/MLG.0b013e318163819b	63	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40185	10.1371/journal.pone.0040185	http://dx.doi.org/10.1371/journal.pone.0040185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768252	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100225
J	Baker, SE; Ellwood, SA; Tagarielli, VL; Macdonald, DW				Baker, Sandra E.; Ellwood, Stephen A.; Tagarielli, Vito L.; Macdonald, David W.			Mechanical Performance of Rat, Mouse and Mole Spring Traps, and Possible Implications for Welfare Performance	PLOS ONE			English	Article							THRESHOLDS; MOMENTUM; PEST	Lethal spring traps are widely used for killing small mammals in the UK. Many require government approval, based primarily on humaneness. However, mole traps and break-back traps for rats and mice are exempt; those available vary widely in price and apparent quality. The EU is considering implementing a Trapping Directive that would alter UK legislation, and a recent report advised the EU that trapping legislation should cover all trapped species and encourage improvement of traps. Mechanical trap performance is often used as an indicator of welfare impact. We examined the mechanical evidence for scope to improve the welfare standards of rat, mouse and mole spring traps. We measured mechanical performance among a range of rat, mouse and mole traps. Impact momentum values varied 6-8 fold, and clamping force values 4-5.5 fold, among traps for killing each species. There was considerable overlap in the performance of rat and mouse traps. Trap-opening angle and spring type were related to impact momentum and clamping force in traps for both species. There was no relationship between price and mechanical performance in traps for any species, except talpa mole traps. We are unable to judge the direct welfare impact of the traps tested, but rather the potential welfare threat associated with their exemption from approval. The wide variation in mechanical performance in traps for each species, overlap in performance between rat and mouse traps and increasing availability of weaker plastic rodent traps indicate considerable scope for improving the humaneness of spring traps for rats, mice and moles. We conclude that all such traps should be subject to the UK approval process. New welfare categories might improve trap standards further. Our results could also help improve rodent trap design and assist consumers in selecting more powerful traps. Many thousands of rats, mice and moles might benefit.	[Baker, Sandra E.; Ellwood, Stephen A.; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Oxford OX1 3PS, England; [Tagarielli, Vito L.] Univ London Imperial Coll Sci Technol & Med, Dept Aeronaut, London, England	University of Oxford; Imperial College London	Baker, SE (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, S Parks Rd, Oxford OX1 3PS, England.	sandra.baker@zoo.ox.ac.uk	Tagarielli, Vito/K-3612-2013	Tagarielli, Vito/0000-0002-6696-676X	Royal Society for the Prevention of Cruelty to Animals [WLD 49/06-8S25]	Royal Society for the Prevention of Cruelty to Animals	This study was funded by the Royal Society for the Prevention of Cruelty to Animals (www.rspca.org.uk); Project WLD 49/06-8S25. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, 109904 ISO; ATKINSON RPD, 1994, MAMMAL REV, V24, P73, DOI 10.1111/j.1365-2907.1994.tb00136.x; Benn DM, 1980, EFFECT CLAMPIN UNPUB; Cassidy D. C., 2002, UNDERSTANDING PHYS; Defra, 2010, WILDL MAN ENGL POL M; LLOYD HG, 1963, ANN APPL BIOL, V51, P329; Macdonald D., 1993, MAMMALS BRITAIN EURO; Mason G, 2003, ANIM WELFARE, V12, P1; Newcombe WR, 1981, WORLDWIDE FURBEARER, P1612; QUY R, 2004, REV METHODS USED EUR; SAS Institute, 2002, SAS STAT SOFTW VERS; Scott Henderson J, 1951, CMD8266; Talling JC, 2009, IMPROVEMENTS TRAPPIN; Warburton B, 2008, ANIM WELFARE, V17, P111; WARBURTON B, 1995, NEW ZEAL J ZOOL, V22, P39, DOI 10.1080/03014223.1995.9518022; Warburton B, 2006, LC0607039 LANDC RES; ZELIN S, 1983, J WILDLIFE MANAGE, V47, P863, DOI 10.2307/3808628	17	19	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39334	10.1371/journal.pone.0039334	http://dx.doi.org/10.1371/journal.pone.0039334			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768073	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100044
J	Brunenberg, EJL; Moeskops, P; Backes, WH; Pollo, C; Cammoun, L; Vilanova, A; Janssen, MLF; Visser-Vandewalle, VERM; Romeny, BMT; Thiran, JP; Platel, B				Brunenberg, Ellen J. L.; Moeskops, Pim; Backes, Walter H.; Pollo, Claudio; Cammoun, Leila; Vilanova, Anna; Janssen, Marcus L. F.; Visser-Vandewalle, Veerle E. R. M.; Romeny, Bart M. ter Haar; Thiran, Jean-Philippe; Platel, Bram			Structural and Resting State Functional Connectivity of the Subthalamic Nucleus: Identification of Motor STN Parts and the Hyperdirect Pathway	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; ADVANCED PARKINSON-DISEASE; DIFFUSION-WEIGHTED MRI; BASAL GANGLIA; STRIATAL CONNECTIONS; EFFERENT CONNECTIONS; EXTERNAL PALLIDUM; THALAMIC NUCLEI; FIBER TRACKING; CORTEX	Deep brain stimulation (DBS) for Parkinson's disease often alleviates the motor symptoms, but causes cognitive and emotional side effects in a substantial number of cases. Identification of the motor part of the subthalamic nucleus (STN) as part of the presurgical workup could minimize these adverse effects. In this study, we assessed the STN's connectivity to motor, associative, and limbic brain areas, based on structural and functional connectivity analysis of volunteer data. For the structural connectivity, we used streamline counts derived from HARDI fiber tracking. The resulting tracks supported the existence of the so-called "hyperdirect" pathway in humans. Furthermore, we determined the connectivity of each STN voxel with the motor cortical areas. Functional connectivity was calculated based on functional MRI, as the correlation of the signal within a given brain voxel with the signal in the STN. Also, the signal per STN voxel was explained in terms of the correlation with motor or limbic brain seed ROI areas. Both right and left STN ROIs appeared to be structurally and functionally connected to brain areas that are part of the motor, associative, and limbic circuit. Furthermore, this study enabled us to assess the level of segregation of the STN motor part, which is relevant for the planning of STN DBS procedures.	[Brunenberg, Ellen J. L.; Moeskops, Pim; Vilanova, Anna; Romeny, Bart M. ter Haar] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Backes, Walter H.] Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands; [Backes, Walter H.; Janssen, Marcus L. F.] Maastricht Univ, Sch Mental Hlth & NeuroSci, Maastricht, Netherlands; [Pollo, Claudio; Cammoun, Leila; Thiran, Jean-Philippe] Ecole Polytech Fed Lausanne, Signal Proc Inst, Lausanne, Switzerland; [Pollo, Claudio] Lausanne Univ Hosp CHUV, Dept Neurosurg, Lausanne, Switzerland; [Janssen, Marcus L. F.; Visser-Vandewalle, Veerle E. R. M.] Maastricht Univ, Med Ctr, Dept Neurosurg, Maastricht, Netherlands; [Janssen, Marcus L. F.; Visser-Vandewalle, Veerle E. R. M.] Maastricht Univ, Med Ctr, MIND, Maastricht, Netherlands; [Platel, Bram] Fraunhofer MEVIS, Bremen, Germany	Eindhoven University of Technology; Maastricht University; Maastricht University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Maastricht University; Maastricht University	Brunenberg, EJL (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, POB 513, NL-5600 MB Eindhoven, Netherlands.	ellenbrunenberg@gmail.com	Romenij, Bart M. ter Haar/A-5323-2013; Moeskops, Pim/K-6728-2017; Brunenberg, Ellen JL/M-6651-2015; Janssen, Mark/AAX-5137-2021; Platel, Bram/D-2132-2009; Janssen, Mark/ABE-3031-2021	Moeskops, Pim/0000-0002-8733-6716; Platel, Bram/0000-0002-1936-6825; Janssen, Mark/0000-0003-0030-7224; Backes, Walter H/0000-0001-7905-0681; Thiran, Jean-Philippe/0000-0003-2938-9657	Netherlands Organization for Scientific Research [021.001.055]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	EB is supported by the Netherlands Organization for Scientific Research (www.nwo.nl, grant number 021.001.055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abosch A, 2010, NEUROSURGERY, V67, P1745, DOI 10.1227/NEU.0b013e3181f74105; Ahrens James, 2005, VISUALIZATION HDB, V717, DOI [10.1016/B978-012387582-2/50038-1, DOI 10.1016/B978-012387582-2/50038-1]; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Amtage F, 2009, CLIN NEUROPHYSIOL, V120, P1755, DOI 10.1016/j.clinph.2009.06.018; Andersson J, 2008, P HUM BRAIN MAPP, V14; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Barnes KA, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00018; Baudrexel S, 2010, P INT SOC MAGN RES M, V18, P440; Baudrexel S, 2011, NEUROIMAGE, V55, P1728, DOI 10.1016/j.neuroimage.2011.01.017; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2005, PHILOS T R SOC B, V360, P903, DOI 10.1098/rstb.2005.1640; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Berney A, 2002, NEUROLOGY, V59, P1427, DOI 10.1212/01.WNL.0000032756.14298.18; Brunenberg E, 2010, LECT NOTES COMPUT SC, V6361, P175, DOI 10.1007/978-3-642-15705-9_22; CARPENTER MB, 1981, BRAIN RES, V224, P1, DOI 10.1016/0006-8993(81)91113-6; Cho ZH, 2011, MOVEMENT DISORD, V26, P713, DOI 10.1002/mds.23465; Cho ZH, 2010, J NEUROSURG, V113, P639, DOI 10.3171/2010.3.JNS091385; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Cook PA, 2005, LECT NOTES COMPUT SC, V3749, P164; Cook PA, 2006, P INT SOC MAGNETIC R, V14, P2759; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Forstmann BU, 2010, P NATL ACAD SCI USA, V107, P15916, DOI 10.1073/pnas.1004932107; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Guehl D, 2007, J NEUROSURG, V106, P101, DOI 10.3171/jns.2007.106.1.101; Haegelen C, 2009, MED HYPOTHESES, V72, P421, DOI 10.1016/j.mehy.2008.07.065; Hagmann P, 2003, NEUROIMAGE, V19, P545, DOI 10.1016/S1053-8119(03)00142-3; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hamani C, 2004, BRAIN, V127, P4, DOI 10.1093/brain/awh029; HARTMANNVONMONAKOW K, 1978, EXP BRAIN RES, V33, P395; Iturria-Medina Y, 2007, NEUROIMAGE, V36, P645, DOI 10.1016/j.neuroimage.2007.02.012; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Joel D, 1997, BRAIN RES REV, V23, P62, DOI 10.1016/S0165-0173(96)00018-5; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; KUNZLE H, 1978, BRAIN BEHAV EVOLUT, V15, P185, DOI 10.1159/000123779; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Le Jeune F, 2010, EUR J NUCL MED MOL I, V37, P1512, DOI 10.1007/s00259-010-1436-y; Leh SE, 2007, NEUROSCI LETT, V419, P113, DOI 10.1016/j.neulet.2007.04.049; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; Lehericy S, 2004, CEREB CORTEX, V14, P1302, DOI 10.1093/cercor/bhh091; Loucif KC, 2005, J PHYSIOL-LONDON, V567, P977, DOI 10.1113/jphysiol.2005.093807; Marrakchi-Kacem L, 2010, LECT NOTES COMPUT SC, V6362, P217; Nakano K, 2000, BRAIN DEV-JPN, V22, pS5; Nambu A, 2000, J NEUROPHYSIOL, V84, P289, DOI 10.1152/jn.2000.84.1.289; Nambu A, 1997, NEUROSCI LETT, V239, P13, DOI 10.1016/S0304-3940(97)00877-X; Nambu A, 1996, J NEUROSCI, V16, P2671; Nioche C, 2009, AM J NEURORADIOL, V30, P396, DOI 10.3174/ajnr.A1375; Nisino Y, 1940, Z MIKR ANAT FORSCH, V47, P401; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Peron J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009919; Piasecki SD, 2004, J CLIN PSYCHIAT, V65, P845; POLLAK P, 1993, REV NEUROL, V149, P175; Robinson S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-137; Rodriguez-Oroz MC, 2005, BRAIN, V128, P2240, DOI 10.1093/brain/awh571; Rodriguez-Oroz MC, 2004, J NEUROL NEUROSUR PS, V75, P1382, DOI 10.1136/jnnp.2003.031294; SADIKOT AF, 1992, J COMP NEUROL, V315, P137, DOI 10.1002/cne.903150203; Seunarine KK, 2007, IEEE I CONF COMP VIS, P2649; Shink E, 1996, NEUROSCIENCE, V73, P335, DOI 10.1016/0306-4522(96)00022-X; Smeding HMM, 2006, NEUROLOGY, V66, P1830, DOI 10.1212/01.wnl.0000234881.77830.66; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Strafella AP, 2005, IEEE IJCNN, P1525; Talairach J., 1988, COPLANAR STEREOTAXIC; Temel Y, 2005, PROG NEUROBIOL, V76, P393, DOI 10.1016/j.pneurobio.2005.09.005; Temel Y, 2006, PARKINSONISM RELAT D, V12, P265, DOI 10.1016/j.parkreldis.2006.01.004; Tsai ST, 2007, NEUROSURGERY, V61, P1024, DOI 10.1227/01.NEU-0000280085.60995.95; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Voon V, 2006, MOVEMENT DISORD, V21, pS305, DOI 10.1002/mds.20963; Wassermann D, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/526906; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929; Wiegell MR, 2003, NEUROIMAGE, V19, P391, DOI 10.1016/S1053-8119(03)00044-2; Williams D, 2002, BRAIN, V125, P1558, DOI 10.1093/brain/awf156; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013	81	85	90	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39061	10.1371/journal.pone.0039061	http://dx.doi.org/10.1371/journal.pone.0039061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768059	Green Published, gold			2022-12-27	WOS:000305892100029
J	Edwards, NC; Hing, ZA; Perry, A; Blaisdell, A; Kopelman, DB; Fathke, R; Plum, W; Newell, J; Allen, CE; Geetha, S; Shapiro, A; Okunji, C; Kosti, I; Shomron, N; Grigoryan, V; Przytycka, TM; Sauna, ZE; Salari, R; Mandel-Gutfreund, Y; Komar, AA; Kimchi-Sarfaty, C				Edwards, Nathan C.; Hing, Zachary A.; Perry, Avital; Blaisdell, Adam; Kopelman, David B.; Fathke, Robert; Plum, William; Newell, Jordan; Allen, Courtni E.; Geetha, S.; Shapiro, Aaron; Okunji, Chinyere; Kosti, Idit; Shomron, Noam; Grigoryan, Vahan; Przytycka, Teresa M.; Sauna, Zuben E.; Salari, Raheleh; Mandel-Gutfreund, Yael; Komar, Anton A.; Kimchi-Sarfaty, Chava			Characterization of Coding Synonymous and Non-Synonymous Variants in ADAMTS13 Using Ex Vivo and In Silico Approaches	PLOS ONE			English	Article							MESSENGER-RNA STABILITY; CODON USAGE; SECONDARY STRUCTURE; ENDOPLASMIC-RETICULUM; PROTEIN DISLOCATION; GENE-EXPRESSION; QUALITY-CONTROL; MUTATIONS; SEQUENCE; EVOLUTION	Synonymous variations, which are defined as codon substitutions that do not change the encoded amino acid, were previously thought to have no effect on the properties of the synthesized protein(s). However, mounting evidence shows that these "silent" variations can have a significant impact on protein expression and function and should no longer be considered "silent". Here, the effects of six synonymous and six non-synonymous variations, previously found in the gene of ADAMTS13, the von Willebrand Factor (VWF) cleaving hemostatic protease, have been investigated using a variety of approaches. The ADAMTS13 mRNA and protein expression levels, as well as the conformation and activity of the variants have been compared to that of wild-type ADAMTS13. Interestingly, not only the non-synonymous variants but also the synonymous variants have been found to change the protein expression levels, conformation and function. Bioinformatic analysis of ADAMTS13 mRNA structure, amino acid conservation and codon usage allowed us to establish correlations between mRNA stability, RSCU, and intracellular protein expression. This study demonstrates that variants and more specifically, synonymous variants can have a substantial and definite effect on ADAMTS13 function and that bioinformatic analysis may allow development of predictive tools to identify variants that will have significant effects on the encoded protein.	[Edwards, Nathan C.; Hing, Zachary A.; Perry, Avital; Blaisdell, Adam; Kopelman, David B.; Fathke, Robert; Plum, William; Newell, Jordan; Allen, Courtni E.; Geetha, S.; Shapiro, Aaron; Okunji, Chinyere; Sauna, Zuben E.; Kimchi-Sarfaty, Chava] US FDA, Lab Hemostasis, Div Hematol, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Kosti, Idit; Mandel-Gutfreund, Yael] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Shomron, Noam] Tel Aviv Univ, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel; [Grigoryan, Vahan; Przytycka, Teresa M.; Salari, Raheleh] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Komar, Anton A.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA	US Food & Drug Administration (FDA); Technion Israel Institute of Technology; Tel Aviv University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University System of Ohio; Cleveland State University	Edwards, NC (corresponding author), US FDA, Lab Hemostasis, Div Hematol, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	a.komar@csuohio.edu; chava.kimchi-sarfaty@fda.hhs.gov	Sauna, Zuben E./AAA-7149-2019; Mandel-Gutfreund, Yael/AAI-4365-2021	Mandel-Gutfreund, Yael/0000-0002-8946-8237; Kosti, Idit/0000-0003-2212-5472; Komar, Anton/0000-0003-4188-0633; Kopelman, David/0000-0002-7950-2390; Przytycka, Teresa/0000-0002-6261-277X; Kimchi-Sarfaty, Chava/0000-0002-9355-8585	Food and Drug Administration, Intramural Research Program of the National Institutes of Health, National Library of Medicine; HFSP [RGP0024]; NATIONAL LIBRARY OF MEDICINE [ZIALM200887] Funding Source: NIH RePORTER	Food and Drug Administration, Intramural Research Program of the National Institutes of Health, National Library of Medicine; HFSP(Human Frontier Science Program); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was supported by the Food and Drug Administration, Intramural Research Program of the National Institutes of Health, National Library of Medicine and by HFSP RGP0024 to AAK. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Bauer AP, 2010, NUCLEIC ACIDS RES, V38, P3891, DOI 10.1093/nar/gkq115; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Bohm M, 2002, ANN HEMATOL, V81, P430, DOI 10.1007/s00277-002-0502-3; Brodsky JL, 1999, SEMIN CELL DEV BIOL, V10, P507, DOI 10.1006/scdb.1999.0321; Calcagno AM, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-29; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Chen L, 1997, HUM GENE THER, V8, P125, DOI 10.1089/hum.1997.8.2-125; COLEMAN TA, 1991, MOL CELL ENDOCRINOL, V75, P91, DOI 10.1016/0303-7207(91)90223-F; Czech A, 2010, MOL BIOSYST, V6, P1767, DOI 10.1039/c004796c; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Franchini M, 2008, BLOOD TRANSFUS-ITALY, V6, P127, DOI 10.2450/2008.0055-07; Galtier N, 2001, GENETICS, V159, P907; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hovinga JAK, 2006, J THROMB HAEMOST, V4, P1146, DOI 10.1111/j.1538-7836.2006.01904.x; Hunt R, 2009, METHODS MOL BIOL, V578, P23, DOI 10.1007/978-1-60327-411-1_2; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jarosch E, 2002, TRAFFIC, V3, P530, DOI 10.1034/j.1600-0854.2002.30803.x; Kelley LA, 1999, RECOGNITION REMOTE P; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kokame K, 2002, P NATL ACAD SCI USA, V99, P11902, DOI 10.1073/pnas.172277399; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lavner Y, 2005, GENE, V345, P127, DOI 10.1016/j.gene.2004.11.035; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; LIEBHABER SA, 1984, J BIOL CHEM, V259, P5597; Mahdian R, 2006, THROMB HAEMOSTASIS, V95, P1049, DOI 10.1160/TH06-03-0166; Mannucci PM, 2004, BRIT J HAEMATOL, V126, P213, DOI 10.1111/j.1365-2141.2004.05009.x; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Plaimauer B, 2006, BLOOD, V107, P118, DOI 10.1182/blood-2005-06-2482; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Sauna ZE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006506; Schettert IT, 2010, THROMB RES, V125, P61, DOI 10.1016/j.thromres.2009.03.008; Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; SHARP PM, 1995, PHILOS T R SOC B, V349, P241, DOI 10.1098/rstb.1995.0108; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shomron N, 2010, THROMB HAEMOSTASIS, V104, P531, DOI 10.1160/TH09-12-0860; Tao Z, 2006, J THROMB HAEMOST, V4, P1931, DOI 10.1111/j.1538-7836.2006.02098.x; Tripodi A, 2004, J THROMB HAEMOST, V2, P1601, DOI 10.1111/j.1538-7836.2004.00879.x; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Ward NJ, 2011, BLOOD, V117, P798, DOI 10.1182/blood-2010-05-282707; Wildman KAH, 2002, BIOPOLYMERS, V64, P246, DOI 10.1002/bip.10180; Xayaphoummine A, 2005, NUCL ACIDS RES, V33; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zheng XL, 2001, J BIOL CHEM, V276, P41059, DOI 10.1074/jbc.C100515200; Zhou WH, 2004, THROMB HAEMOSTASIS, V91, P806, DOI 10.1160/TH03-11-0675; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	75	45	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38864	10.1371/journal.pone.0038864	http://dx.doi.org/10.1371/journal.pone.0038864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768050	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100020
J	Lucas, S; Taront, S; Magnan, C; Fauconnier, L; Delacre, M; Macia, L; Delanoye, A; Verwaerde, C; Spriet, C; Saule, P; Goormachtigh, G; Heliot, L; Ktorza, A; Movassat, J; Polakowska, R; Auriault, C; Poulain-Godefroy, O; Di Santo, J; Froguel, P; Wolowczuk, I				Lucas, Stephanie; Taront, Solenne; Magnan, Christophe; Fauconnier, Laurence; Delacre, Myriam; Macia, Laurence; Delanoye, Anne; Verwaerde, Claudie; Spriet, Corentin; Saule, Pasquine; Goormachtigh, Gautier; Heliot, Laurent; Ktorza, Alain; Movassat, Jamileh; Polakowska, Renata; Auriault, Claude; Poulain-Godefroy, Odile; Di Santo, James; Froguel, Philippe; Wolowczuk, Isabelle			Interleukin-7 Regulates Adipose Tissue Mass and Insulin Sensitivity in High-Fat Diet-Fed Mice through Lymphocyte-Dependent and Independent Mechanisms	PLOS ONE			English	Article							CENTRAL LEPTIN; IMMUNE CELLS; CRUCIAL ROLE; STEM-CELLS; T-CELLS; INFLAMMATION; OBESITY; IL-7; ACTIVATION; RESISTANCE	Although interleukin (IL)-7 is mostly known as a key regulator of lymphocyte homeostasis, we recently demonstrated that it also contributes to body weight regulation through a hypothalamic control. Previous studies have shown that IL-7 is produced by the human obese white adipose tissue (WAT) yet its potential role on WAT development and function in obesity remains unknown. Here, we first show that transgenic mice overexpressing IL-7 have reduced adipose tissue mass associated with glucose and insulin resistance. Moreover, in the high-fat diet (HFD)-induced obesity model, a single administration of IL-7 to C57BL/6 mice is sufficient to prevent HFD-induced WAT mass increase and glucose intolerance. This metabolic protective effect is accompanied by a significant decreased inflammation in WAT. In lymphocyte-deficient HFD-fed SCID mice, IL-7 injection still protects from WAT mass gain. However, IL-7-triggered resistance against WAT inflammation and glucose intolerance is lost in SCID mice. These results suggest that IL-7 regulates adipose tissue mass through a lymphocyte-independent mechanism while its protective role on glucose homeostasis would be relayed by immune cells that participate to WAT inflammation. Our observations establish a key role for IL-7 in the complex mechanisms by which immune mediators modulate metabolic functions.	[Lucas, Stephanie; Delacre, Myriam; Macia, Laurence; Delanoye, Anne; Verwaerde, Claudie] Univ Lille Nord France, Inst Pasteur, Lab Neuroimmunoendocrinol, IFR 142, Lille, France; [Taront, Solenne; Poulain-Godefroy, Odile; Froguel, Philippe; Wolowczuk, Isabelle] Univ Lille Nord France, Inst Pasteur, UMR 8199, CNRS,Lab Genom & Metab Dis, Lille, France; [Magnan, Christophe; Ktorza, Alain] Univ Paris 07, CNRS, UMR 7059, Lab Physiopathol Nutr, Paris, France; [Fauconnier, Laurence; Saule, Pasquine; Goormachtigh, Gautier; Auriault, Claude] Inst Pasteur, Inst Biol, CNRS, UMR 8527,Lab Cellular Immunopathol Infect Dis, F-59019 Lille, France; [Spriet, Corentin; Heliot, Laurent] Univ Lille Nord France, USR 3078, CNRS, Interdisciplinary Res Inst, Villeneuve Dascq, France; [Movassat, Jamileh] Univ Paris 07, CNRS, EAC 4413, Lab Biol & Pathol Endocrine Pancreas, Paris, France; [Polakowska, Renata] Univ Lille Nord France, CHU, U837, Inserm, Lille, France; [Polakowska, Renata] Univ Lille Nord France, CHU, Jean Pierre Aubert Res Ctr, Lille, France; [Di Santo, James] Inst Pasteur, Innate Immun Unit, Paris, France; [Di Santo, James] Inserm, U668, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Lucas, S (corresponding author), Univ Lille Nord France, Inst Pasteur, Lab Neuroimmunoendocrinol, IFR 142, Lille, France.	Isabelle.Wolowczuk@good.ibl.fr	FROGUEL, Philippe/O-6799-2017; magnan, christophe/AAJ-7622-2021; Macia, laurence/D-5983-2016; Poulain-Godefroy, Odile/AAF-5474-2021; Spriet, Corentin/ABE-4215-2021; Di Santo, James P/M-4298-2014; DEZITTER, Solenne/N-5219-2018	FROGUEL, Philippe/0000-0003-2972-0784; magnan, christophe/0000-0002-7044-2571; Macia, laurence/0000-0003-0835-851X; Spriet, Corentin/0000-0002-5805-3426; Di Santo, James P/0000-0002-7146-1862; POULAIN-GODEFROY, Odile/0000-0001-8805-9450; Goormachtigh, Gautier/0000-0003-1736-8269; DEZITTER, Solenne/0000-0001-5850-7291; wolowczuk, isabelle/0000-0001-6692-6904; LUCAS, Stephanie/0000-0001-7530-7486	Pasteur Institute in Lille; Institut Federatif de Recherche 142; Centre National de la Recherche Scientifique; French Region Nord/Pas-de-Calais	Pasteur Institute in Lille; Institut Federatif de Recherche 142; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); French Region Nord/Pas-de-Calais(Region Hauts-de-France)	The work was supported by the Pasteur Institute in Lille, the Institut Federatif de Recherche 142 and the Centre National de la Recherche Scientifique. S. L. was supported by a post-doctoral grant from the French Region Nord/Pas-de-Calais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; ALDERSON MR, 1991, J EXP MED, V173, P923, DOI 10.1084/jem.173.4.923; Alvehus M, 2010, OBESITY, V18, P879, DOI 10.1038/oby.2010.22; Anderson EK, 2010, CURR OPIN LIPIDOL, V21, P172, DOI 10.1097/MOL.0b013e3283393867; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; ARAUJO DM, 1993, BRAIN RES, V600, P49, DOI 10.1016/0006-8993(93)90400-H; ARNER P, 1995, ANN MED, V27, P435, DOI 10.3109/07853899709002451; Asterholm Ingrid Wernstedt, 2007, Drug Discov Today Dis Models, V4, P17; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Barra NG, 2010, OBESITY, V18, P1601, DOI 10.1038/oby.2009.445; Barros RPA, 2011, CELL METAB, V14, P289, DOI 10.1016/j.cmet.2011.08.005; Brown LM, 2010, J STEROID BIOCHEM, V122, P65, DOI 10.1016/j.jsbmb.2009.12.005; Brown LM, 2010, BRAIN RES, V1350, P77, DOI 10.1016/j.brainres.2010.04.056; Clegg DJ, 2003, DIABETES, V52, P682, DOI 10.2337/diabetes.52.3.682; Clegg DJ, 2006, DIABETES, V55, P978, DOI 10.2337/diabetes.55.04.06.db05-1339; Duffaut C, 2009, BIOCHEM BIOPH RES CO, V384, P482, DOI 10.1016/j.bbrc.2009.05.002; Eckel LA, 2011, PHYSIOL BEHAV, V104, P517, DOI 10.1016/j.physbeh.2011.04.014; Farag YMK, 2011, NEPHROL DIAL TRANSPL, V26, P28, DOI 10.1093/ndt/gfq576; FOXWELL BMJ, 1995, EUR J IMMUNOL, V25, P3041, DOI 10.1002/eji.1830251109; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Gimble JM, 2011, STEM CELLS, V29, P749, DOI 10.1002/stem.629; Grove KL, 2010, INT J OBESITY, V34, P989, DOI 10.1038/ijo.2010.12; Huang-Doran I, 2010, J ENDOCRINOL, V207, P245, DOI 10.1677/JOE-10-0272; Jacobs SR, 2010, J IMMUNOL, V184, P3461, DOI 10.4049/jimmunol.0902593; Jan V, 2004, ANTIVIR THER, V9, P555; Kelly EAB, 2009, J IMMUNOL, V182, P1404, DOI 10.4049/jimmunol.182.3.1404; Khaled AR, 2002, NAT REV IMMUNOL, V2, P817, DOI 10.1038/nri931; Kim S, 2000, J NUTR, V130, p3110S; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Lee SK, 2005, IMMUNOL REV, V208, P169, DOI 10.1111/j.0105-2896.2005.00339.x; Lolmede K, 2011, DIABETES METAB, V37, P283, DOI 10.1016/j.diabet.2011.03.002; Lucas S., 2009, IMMUNOL IMMUNOGENET, V1, P3, DOI [10.4137/III.S2145., DOI 10.4137/III.S2145]; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Macia L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009953; Maury E, 2007, AM J PHYSIOL-ENDOC M, V293, pE656, DOI 10.1152/ajpendo.00127.2007; NAMEN AE, 1988, J EXP MED, V167, P988, DOI 10.1084/jem.167.3.988; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Puel A, 2000, CURR OPIN IMMUNOL, V12, P468, DOI 10.1016/S0952-7915(00)00122-9; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Stubbins RE, 2012, DIABETES OBES METAB, V14, P58, DOI 10.1111/j.1463-1326.2011.01488.x; Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Williams IR, 1997, J IMMUNOL, V159, P3044; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu Y, 2011, CELL METAB, V14, P453, DOI 10.1016/j.cmet.2011.08.009	58	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40351	10.1371/journal.pone.0040351	http://dx.doi.org/10.1371/journal.pone.0040351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768283	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100257
J	Luo, JH; Cai, QQ; Wang, W; Huang, H; Zeng, H; He, W; Deng, WX; Yu, H; Chan, ED; Ng, CF; Huang, J; Lin, TX				Luo, Junhua; Cai, Qingqing; Wang, Wei; Huang, Hui; Zeng, Hong; He, Wang; Deng, Weixi; Yu, Hao; Chan, Eddie; Ng, Chi-fai; Huang, Jian; Lin, Tianxin			A MicroRNA-7 Binding Site Polymorphism in HOXB5 Leads to Differential Gene Expression in Bladder Cancer	PLOS ONE			English	Article							CYSTIC ADENOMATOID MALFORMATION; HOMEOBOX GENES; IN-VIVO; CELLS; OVEREXPRESSION; CARCINOMAS	Purpose: To investigate the biological function of HOXB5 in human bladder cancer and explore whether the HOXB5 3'-UTR SNP (1010A/G), which is located within the microRNA-7 binding site, was correlated with clinical features of bladder cancer. Methods: Expression of HOXB5 in 35 human bladder cancer tissues and 8 cell lines were examined using real-time PCR and immunohistochemistry. Next, we explored the biological function of HOXB5 in vitro using cell proliferation, migration and colony formation assays. Using bioinformatics, a SNP (1010A/G) was found located within the microRNA-7 binding site in the 3'-UTR of HOXB5. Real-time PCR was used to test HOXB5 expression affected by different alleles. Finally, multivariate logistic regression analysis was used to determine the relationship between SNP (1010A/G) frequency and clinical features in 391 cases. Results: HOXB5 was frequently over-expressed both in bladder cancer tissues and cell lines. Inhibition of HOXB5 suppressed the oncogenic function of cancer cells. Next, we demonstrated that a SNP (1010A/G), located within the microRNA-7 binding site in the 3'-UTR of HOXB5, could affect HOXB5 expression in bladder cancer mainly by differential binding activity of microRNA-7 and SNP-related mRNA stability. Finally, we also showed the frequency of 1010G genotype was higher in cancer group compared to normal controls and correlated with the risk of high grade and high stage. Conclusion: HOXB5 is overexpressed in bladder cancer. A miRNA-binding SNP (1010A/G) located within 3'-UTR of HOXB5 is associated with gene expression and may be a promising prognostic factor for bladder cancer.	[Luo, Junhua; He, Wang; Yu, Hao; Huang, Jian; Lin, Tianxin] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Qingqing] Sun Yat Sen Univ, Ctr Canc, Dept Internal Med, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Wei] Guangzhou Gen Hosp Guangzhou Mil Command, Guangzhou Liuhuaqiao Hosp, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Huang, Hui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China; [Zeng, Hong] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Weixi; Lin, Tianxin] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Lin Bai Xin Res Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Chan, Eddie; Ng, Chi-fai] Chinese Univ Hong Kong, Dept Surg, Div Urol, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Southern Theater Command General Hospital; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Chinese University of Hong Kong	Luo, JH (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China.	yehjn@yahoo.com.cn; tianxinl@sina.com	Ng, Chi-Fai/E-5134-2011; Chi-fai, NG/AAV-8270-2021; Luo, Junhua/AAS-3339-2020	Ng, Chi-Fai/0000-0002-1723-9646; Luo, Junhua/0000-0002-3179-7652	National Natural Science Foundation of China [81071688, 30972983, 81172431, 91029742]; Guangdong province Natural Scientific Foundation [07117366, 6104605]; Yat-sen Scholarship for Young Scientists; Public Health Ministry; Program for New Century Excellent Talents in University [NCET-10-0852]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong province Natural Scientific Foundation; Yat-sen Scholarship for Young Scientists; Public Health Ministry; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation of China (81071688, 30972983, 81172431, 91029742), Guangdong province Natural Scientific Foundation (07117366, 6104605), Yat-sen Scholarship for Young Scientists (For Tianxin Lin), Clinical Key Project of Public Health Ministry (for Jian Huang), and the Program for New Century Excellent Talents in University (NCET-10-0852, for Tianxin Lin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cantile M, 2003, ONCOGENE, V22, P6462, DOI 10.1038/sj.onc.1206808; CILLO C, 1992, INT J CANCER, V51, P892, DOI 10.1002/ijc.2910510610; Cillo C, 2001, J CELL PHYSIOL, V188, P161, DOI 10.1002/jcp.1115; Drabkin H, 2002, LEUKEMIA, V16, P186, DOI 10.1038/sj.leu.2402354; Feber A, 2004, ONCOGENE, V23, P1627, DOI 10.1038/sj.onc.1207274; Gehring NH, 2001, NAT GENET, V28, P389, DOI 10.1038/ng578; GEHRING WJ, 1986, ANNU REV GENET, V20, P147, DOI 10.1146/annurev.ge.20.120186.001051; GIAMPAOLO A, 1994, BLOOD, V84, P3637, DOI 10.1182/blood.V84.11.3637.bloodjournal84113637; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Huang L, 2011, INT J CANCER, V128, P1758, DOI 10.1002/ijc.25509; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lin TX, 2009, J UROLOGY, V181, P1372, DOI 10.1016/j.juro.2008.10.149; Lu JW, 2006, J HUM GENET, V51, P155, DOI 10.1007/s10038-005-0339-4; Messing E, 2007, CAMPBELL WALSH UROLO, P2407; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Morgan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-89; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Stein S, 1996, MECH DEVELOP, V55, P91, DOI 10.1016/0925-4773(95)00494-7; Tsai FJ, 2002, UROLOGY, V59, P458, DOI 10.1016/S0090-4295(01)01576-X; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; Volpe MV, 2009, AM J PHYSIOL-LUNG C, V297, pL143, DOI 10.1152/ajplung.90618.2008; Volpe MV, 2003, BIRTH DEFECTS RES A, V67, P550, DOI 10.1002/bdra.10086; Volpe MV, 1997, HISTOCHEM CELL BIOL, V108, P495, DOI 10.1007/s004180050190; Wang W, 2009, INT J CANCER, V125, P2836, DOI 10.1002/ijc.24721; Wang XY, 2011, FETAL DIAGN THER, V29, P315, DOI 10.1159/000322738; Winnik S, 2009, CARDIOVASC RES, V83, P558, DOI 10.1093/cvr/cvp133; Wu XF, 2009, CANCER METAST REV, V28, P269, DOI 10.1007/s10555-009-9190-y; Wu YX, 2003, MOL CELL BIOL, V23, P5680, DOI 10.1128/MCB.23.16.5680-5691.2003; YU S, 2004, UROLOGY, P959; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480	30	37	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40127	10.1371/journal.pone.0040127	http://dx.doi.org/10.1371/journal.pone.0040127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768238	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100210
J	Park, YN; Zhao, XH; Norton, M; Taylor, JP; Eisenberg, E; Greene, LE				Park, Yang-Nim; Zhao, Xiaohong; Norton, Mark; Taylor, J. Paul; Eisenberg, Evan; Greene, Lois E.			Huntingtin Fragments and SOD1 Mutants Form Soluble Oligomers in the Cell	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FLUORESCENCE CORRELATION SPECTROSCOPY; INCLUSION-BODY FORMATION; WILD-TYPE SOD1; POLYGLUTAMINE PROTEIN; SUPEROXIDE-DISMUTASE; MAMMALIAN-CELLS; NEURONAL DEATH; MOUSE MODELS; LIVING CELLS	Diffusion coefficients of huntingtin (Htt) fragments and SOD1 mutants expressed in cells were measured using fluorescence correlation spectroscopy. The diffusion mobilities of both non-pathological Htt fragments (25 polyQs) and pathological Htt fragments (103 polyQs) were much slower than expected for monomers suggesting that they oligomerize. The mobility of these fragments was unaffected by duration of expression or by over-expression of Hsp70 and Hsp40. However in cells with HttQ103 inclusions, diffusion measurements showed that the residual cytosolic HttQ103 was monomeric. These results suggest that both non-pathological and pathological Htt fragments form soluble oligomers in the cytosol with the properties of the oligomers determining whether they cause pathology. SOD1 with point mutations (A4V, G37R, and G85R) also had slower diffusional mobility than the wild-type protein whose mobility was consistent with that of a dimer. However, the decrease in mobility of the different SOD1 mutantsdid not correlate with their known pathology. Therefore, while soluble oligomers always seem to be present under conditions where cell pathology occurs, the presence of the oligomers, in itself, does not determine the extent of neuropathology.	[Park, Yang-Nim; Zhao, Xiaohong; Norton, Mark; Eisenberg, Evan; Greene, Lois E.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Taylor, J. Paul] St Jude Childrens Hosp, Memphis, TN 38105 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); St Jude Children's Research Hospital	Park, YN (corresponding author), NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	greenel@helix.nih.gov	Taylor, J. Paul/N-2482-2018	Taylor, J. Paul/0000-0002-5794-0349	National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded by the National Institutes of Health (intramural program). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; BLUSZTAJN JK, 1992, J NEUROSCI, V12, P793; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Brock R, 1999, P NATL ACAD SCI USA, V96, P10123, DOI 10.1073/pnas.96.18.10123; Bruening W, 1999, J NEUROCHEM, V72, P693, DOI 10.1046/j.1471-4159.1999.0720693.x; Chai YH, 1999, J NEUROSCI, V19, P10338; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Crick SL, 2006, P NATL ACAD SCI USA, V103, P16764, DOI 10.1073/pnas.0608175103; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Elsner M, 2003, EMBO REP, V4, P1000, DOI 10.1038/sj.embor.embor942; Hackam AS, 1999, HUM MOL GENET, V8, P25, DOI 10.1093/hmg/8.1.25; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Juneja T, 1997, NEUROLOGY, V48, P55, DOI 10.1212/WNL.48.1.55; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Krishnan U, 2006, MOL CELL BIOCHEM, V287, P201, DOI 10.1007/s11010-005-9112-4; Lajoie P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015245; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Liu J, 2005, J NEUROCHEM, V93, P875, DOI 10.1111/j.1471-4159.2005.03054.x; Lotz GP, 2010, J BIOL CHEM, V285, P38183, DOI 10.1074/jbc.M110.160218; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Miller J, 2010, J NEUROSCI, V30, P10541, DOI 10.1523/JNEUROSCI.0146-10.2010; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Mukai H, 2005, P NATL ACAD SCI USA, V102, P10887, DOI 10.1073/pnas.0409283102; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Ossato G, 2010, BIOPHYS J, V98, P3078, DOI 10.1016/j.bpj.2010.02.058; Prudencio M, 2010, HUM MOL GENET, V19, P4774, DOI 10.1093/hmg/ddq408; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; SALAZARGRUESO EF, 1991, NEUROREPORT, V2, P505, DOI 10.1097/00001756-199109000-00002; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Takahashi Y, 2007, J BIOL CHEM, V282, P24039, DOI 10.1074/jbc.M704789200; Takeuchi H, 2002, BRAIN RES, V949, P11, DOI 10.1016/S0006-8993(02)02568-4; Tarlac V, 2003, J NEUROSCI RES, V74, P406, DOI 10.1002/jnr.10746; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; VOGEL SS, 2006, SCI STKE, pRE2, DOI DOI 10.1126/STKE.3312006RE2; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wang J, 2009, P NATL ACAD SCI USA, V106, P1392, DOI 10.1073/pnas.0813045106; Wang LJ, 2009, HUM MOL GENET, V18, P1642, DOI 10.1093/hmg/ddp085; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Weisshart K, 2004, CURR PHARM BIOTECHNO, V5, P135, DOI 10.2174/1389201043376913; Yu ZX, 2003, J NEUROSCI, V23, P2193; Zhang FJ, 2006, BBA-GEN SUBJECTS, V1760, P404, DOI 10.1016/j.bbagen.2005.11.024	60	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40329	10.1371/journal.pone.0040329	http://dx.doi.org/10.1371/journal.pone.0040329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768276	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100250
J	Peeters, MW; Claessens, AL				Peeters, Maarten W.; Claessens, Albrecht L.			The Left Hand Second to Fourth Digit Ratio (2D:4D) Does Not Discriminate World-Class Female Gymnasts from Age Matched Sedentary Girls	PLOS ONE			English	Article							SPORTING SUCCESS; 4TH-DIGIT RATIO; 2D4D; PREDICTS; WOMEN; STRENGTH; FINGER; ELITE; TESTOSTERONE; METAANALYSIS	Introduction: The second to fourth-digit-ratio (2D:4D), a putative marker of prenatal androgen action and a sexually dimorphic trait, has been suggested to be related with sports performance, although results are not univocal. If this relation exists, it is most likely to be detected by comparing extreme groups on the continuum of sports performance. Methods: In this study the 2D:4D ratio of world-class elite female artistic gymnasts (n = 129), competing at the 1987 Rotterdam World-Championships was compared to the 2D:4D ratio of sedentary age-matched sedentary girls (n = 129), alongside with other anthropometric characteristics including other sexually dimorphic traits such as an androgyny index (Bayer & Bayley) and Heath-Carter somatotype components (endomorphy, mesomorphy, ectomorphy) using AN(C)OVA. 2D:4D was measured on X-rays of the left hand. Results: Left hand 2D:4D digit ratio in world class elite female gymnasts (0.921 +/- 0.020) did not differ significantly from 2D:4D in age-matched sedentary girls (0.924 +/- 0.018), either with or without inclusion of potentially confounding covariates such as skeletal age, height, weight, somatotype components or androgyny index. Height (161.9 +/- 6.4 cm vs 155.4 +/- 6.6 cm p < 0.01), weight (53.9 +/- 7.6 kg vs 46.2 6.3 kg p < 0.01), BMI (20.51 +/- 2.41 kg/m(2) vs 19.05 +/- 1.56 kg/m(2)), skeletal age (15.2 +/- 1.1 y vs 14.5 +/- 1.2 y p > 0.01), somatotype components (4.0/3.0/2.9 vs 1.7/3.7/3.2 for endomorphy (p < 0.01), mesomorphy (p < 0.01) and ectomorphy (p < 0.05) respectively) all differed significantly between sedentary girls and elite gymnasts. As expressed by the androgyny index, gymnasts have, on average, broader shoulders relative to their hips, compared to the reference sample. Correlations between the 2D:4D ratio and chronological age, skeletal age, and the anthropometric characteristics are low and not significant. Conclusion: Although other anthropometric characteristics of sexual dimorphism were significantly different between the two samples, the present study cannot discriminate sedentary girls from world-class female gymnasts by means of the left hand 2D:4D ratio.	[Peeters, Maarten W.; Claessens, Albrecht L.] Katholieke Univ Leuven, Dept Kinesiol, Louvain, Belgium	KU Leuven	Peeters, MW (corresponding author), Katholieke Univ Leuven, Dept Kinesiol, Louvain, Belgium.	Maarten.Peeters@faber.kuleuven.be			Research Foundation Flanders	Research Foundation Flanders(FWO)	MWP is supported by the Research Foundation Flanders as a post doctoral fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Allaway HC, 2009, AM J HUM BIOL, V21, P365, DOI 10.1002/ajhb.20892; [Anonymous], 2003, SCI ASPECTS WOMENS G; Bayley N, 1946, AM J PHYS ANTHROP-NE, V4, P433, DOI 10.1002/ajpa.1330040406; Bennett M, 2010, J SPORT SCI, V28, P1415, DOI 10.1080/02640414.2010.510143; Bescos R, 2009, J SPORT SCI, V27, P625, DOI 10.1080/02640410802707029; Brown J., 2001, SPORTS TALENT IDENTI; Claessens AL, 1991, J SPORT SCI, V9, P53, DOI 10.1080/02640419108729855; Claessens A. L., 1990, GROWTH FITNESS FLEMI, P21; CLAESSENS AL, 1992, MED SCI SPORT EXER, V24, P755; CLAESSENS AL, 1990, INT CONGR SER, V921, P725; CLAESSENS AL, 2008, PAEDIAT EXERCISE SCI, P23; Coates JM, 2009, P NATL ACAD SCI USA, V106, P623, DOI 10.1073/pnas.0810907106; Fink B, 2006, INT J OBESITY, V30, P711, DOI 10.1038/sj.ijo.0803154; Fink B, 2003, ANN HUM BIOL, V30, P728, DOI 10.1080/03014460310001620153; Fink B, 2006, AM J HUM BIOL, V18, P776, DOI 10.1002/ajhb.20549; Gallup AC, 2007, EVOL HUM BEHAV, V28, P423, DOI 10.1016/j.evolhumbehav.2007.07.001; Giffin NA, 2012, J SPORT SCI, V30, P135, DOI 10.1080/02640414.2011.630744; Helle S, 2010, AM J HUM BIOL, V22, P418, DOI 10.1002/ajhb.21000; Hill R, 2012, J SPORT SCI, V30, P129, DOI 10.1080/02640414.2011.637947; Honekopp J, 2006, HORM BEHAV, V49, P545, DOI 10.1016/j.yhbeh.2005.11.006; Honekopp J, 2010, AM J HUM BIOL, V22, P619, DOI 10.1002/ajhb.21054; Honekopp J, 2010, PERS INDIV DIFFER, V48, P4, DOI 10.1016/j.paid.2009.08.009; Kemper CJ, 2009, AM J HUM BIOL, V21, P188, DOI 10.1002/ajhb.20843; Longman D, 2011, AM J PHYS ANTHROPOL, V144, P337, DOI 10.1002/ajpa.21407; Malina R.M., 1995, PHYSL ASSESSMENT HUM, P205; Manning JT, 2009, AM J HUM BIOL, V21, P210, DOI 10.1002/ajhb.20855; Manning JT, 2007, AM J HUM BIOL, V19, P416, DOI 10.1002/ajhb.20603; Manning JT, 2010, AM J HUM BIOL, V22, P604, DOI 10.1002/ajhb.21051; Manning JT, 2000, LATERALITY, V5, P121, DOI 10.1080/135765000396744; Manning JT, 2005, ARCH SEX BEHAV, V34, P329, DOI 10.1007/s10508-005-3121-y; Manning JT., 2002, DIGIT RATIO POINTER; Matchock RL, 2008, AM J HUM BIOL, V20, P487, DOI 10.1002/ajhb.20763; Paul SN, 2006, BRIT J SPORT MED, V40, P981, DOI 10.1136/bjsm.2006.027193; Paul SN, 2006, TWIN RES HUM GENET, V9, P215, DOI 10.1375/twin.9.2.215; PHELPS VR, 1952, AM J HUM GENET, V4, P72; Pokrywka L, 2005, AM J HUM BIOL, V17, P796, DOI 10.1002/ajhb.20449; SIMONS J, 1990, GROWTH FITNESS FLEMI; Stein AD, 2010, AM J HUM BIOL, V22, P801, DOI 10.1002/ajhb.21085; Tester N, 2007, J PERS, V75, P663, DOI 10.1111/j.1467-6494.2007.00452.x; van Anders SM, 2007, AM J HUM BIOL, V19, P437, DOI 10.1002/ajhb.20634; Voracek M, 2010, SCAND J MED SCI SPOR, V20, P853, DOI 10.1111/j.1600-0838.2009.01031.x	41	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40270	10.1371/journal.pone.0040270	http://dx.doi.org/10.1371/journal.pone.0040270			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768268	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100242
J	Soltani, A; Sohal, SS; Reid, D; Weston, S; Wood-Baker, R; Walters, EH				Soltani, Amir; Sohal, Sukhwinder Singh; Reid, David; Weston, Steve; Wood-Baker, Richard; Walters, E. Haydn			Vessel-Associated Transforming Growth Factor-Beta1 (TGF-beta 1) Is Increased in the Bronchial Reticular Basement Membrane in COPD and Normal Smokers	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; FACTOR-BETA; MAST-CELLS; ANGIOGENESIS; EXPRESSION; ASTHMA; INFLAMMATION; MACROPHAGES; RECEPTORS; PATHOLOGY	Background: Transforming growth factor-beta1 (TGF-beta 1) is a multipotential cytokine with angiogenic activity. There are only limited data about its role in airway remodeling in COPD. We have previously shown that the reticular basement membrane (Rbm) is hypervascular in the airways of current smokers either with or without chronic obstructive pulmonary disease (COPD). This study evaluated TGF-beta 1 immunostaining in the Rbm and its relationship to vascularity in smokers with or without COPD. Methodology/Principal Findings: Bronchial biopsies from 15 smokers with normal lung function, 19 current and 14 ex-smokers with COPD were immunostained for TGF-beta 1 antibody and compared to 17 healthy controls. The percentage area of tissue and also number and area of vessels staining positively for TGF-beta 1 were measured and compared between groups. Some bronchial biopsies from current smoking COPD subjects were also stained for phosphorylated (active) Smad2/3. Epithelial TGF-beta 1 staining was not different between COPD current smokers and normal controls. TGF-beta 1 stained vessels in the Rbm were increased in smokers with normal lung function, current smoking COPD and ex-smokers with COPD compared to controls [median (range) for number of vessels/mm Rbm 2.5 (0.0-12.7), 3.4 (0.0-8.1) and 1.0 (0.0-6.3) vs. 0.0 (0.0-7.0), p<0.05]. Percentage of vessels stained was also increased in these clinical groups. Preliminary data suggest that in current smoking COPD subjects endothelial cells and cells in the Rbm stain positively for phosphorylated Smad2/3 suggesting TGF-beta 1 is functionally active in this situation. Conclusions/Significance: Vessel-associated TGF-beta 1 activity is increased in the bronchial Rbm in smokers and especially those with COPD.	[Soltani, Amir; Sohal, Sukhwinder Singh; Reid, David; Weston, Steve; Wood-Baker, Richard; Walters, E. Haydn] Univ Tasmania, Sch Med, NHMRC Natl Ctr Res Excellence Chron Resp Dis, Hobart, Tas, Australia	University of Tasmania	Soltani, A (corresponding author), Univ Tasmania, Sch Med, NHMRC Natl Ctr Res Excellence Chron Resp Dis, Hobart, Tas, Australia.	Haydn.Walters@utas.edu.au	Reid, David W/Y-2343-2018; WALTERS, Eugene/AAL-2264-2021	Reid, David W/0000-0001-9517-8212; Sohal, Sukhwinder Singh/0000-0001-9627-6498; Walters, Eugene/0000-0002-0993-4374	NHMRC (National Health Medical Research Council) Australia [490023]	NHMRC (National Health Medical Research Council) Australia	This study was supported by NHMRC (National Health Medical Research Council) Australia (grant number 490023). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	ASSOIAN RK, 1987, P NATL ACAD SCI USA, V84, P6020, DOI 10.1073/pnas.84.17.6020; Bertolino P, 2005, CHEST, V128, p585S, DOI 10.1378/chest.128.6_suppl.585S; Boulet LP, 2007, EUR RESPIR J, V30, P831, DOI 10.1183/09031936.00110107; Chapman KR, 2006, EUR RESPIR J, V27, P188, DOI 10.1183/09031936.06.00024505; de Boer WI, 1998, AM J RESP CRIT CARE, V158, P1951, DOI 10.1164/ajrccm.158.6.9803053; DUNNILL MS, 1960, J CLIN PATHOL, V13, P27, DOI 10.1136/jcp.13.1.27; Feltis BN, 2006, AM J RESP CRIT CARE, V173, P1201, DOI 10.1164/rccm.200507-1105OC; Global Initiative for Chronic Obstructive Lung Disease, 2022, GLOBAL STRATEGY DIAG; Gong Y, 2011, LUNG, V189, P213, DOI 10.1007/s00408-011-9294-3; Halbert RJ, 2003, CHEST, V123, P1684, DOI 10.1378/chest.123.5.1684; Hogg JC, 2008, INT J TUBERC LUNG D, V12, P467; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; Jackson JR, 1997, FASEB J, V11, P457, DOI 10.1096/fasebj.11.6.9194526; Knox AJ, 2005, THORAX, V60, P88, DOI 10.1136/thx.2004.030544; Konigshoff M, 2009, SWISS MED WKLY, V139, P554, DOI smw-12528; Kokturk N, 2003, J ASTHMA, V40, P887, DOI 10.1081/JAS-120023580; Kranenburg AR, 2005, THORAX, V60, P106, DOI 10.1136/thx.2004.023986; Levi-Schaffer F, 2001, CLIN EXP ALLERGY, V31, P521, DOI 10.1046/j.1365-2222.2001.01041.x; Li X, 1997, AM J RESP CRIT CARE, V156, P229, DOI 10.1164/ajrccm.156.1.9607066; MAGNAN A, 1994, THORAX, V49, P789, DOI 10.1136/thx.49.8.789; Makinde T, 2006, CURR MOL MED, V6, P831, DOI 10.2174/156652406779010795; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Puxeddu I, 2005, J ALLERGY CLIN IMMUN, V116, P531, DOI 10.1016/j.jaci.2005.06.007; Reid DW, 2008, RESPIROLOGY, V13, P799, DOI 10.1111/j.1440-1843.2008.01380.x; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Sohal Sukhwinder S, 2011, Respir Res, V12, P130, DOI 10.1186/1465-9921-12-130; Sohal SS, 2010, RESPIROLOGY, V15, P930, DOI 10.1111/j.1440-1843.2010.01808.x; Soltani A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-105; Takizawa H, 2001, AM J RESP CRIT CARE, V163, P1476, DOI 10.1164/ajrccm.163.6.9908135; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; Walters EH, 2008, PHARMACOL THERAPEUT, V118, P128, DOI 10.1016/j.pharmthera.2008.01.007; Zandvoort A, 2006, EUR RESPIR J, V28, P533, DOI 10.1183/09031936.06.00078405; Zanini A, 2009, THORAX, V64, P1019, DOI 10.1136/thx.2009.114629	33	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39736	10.1371/journal.pone.0039736	http://dx.doi.org/10.1371/journal.pone.0039736			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768115	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100085
J	Wu, PR; Kuo, CC; Yet, SF; Liou, JY; Wu, KK; Chen, PF				Wu, Pei-Rung; Kuo, Cheng-Chin; Yet, Shaw-Fang; Liou, Jun-Yang; Wu, Kenneth K.; Chen, Pei-Feng			Lobe-Specific Calcium Binding in Calmodulin Regulates Endothelial Nitric Oxide Synthase Activation	PLOS ONE			English	Article							ELECTRON-TRANSFER; BIDOMAIN STRUCTURE; REDUCTASE DOMAIN; STRUCTURAL BASIS; NO SYNTHASE; SITES; SUBUNIT; PURIFICATION; OXYGENASE; KINASE	Background: Human endothelial nitric oxide synthase (eNOS) requires calcium-bound calmodulin (CaM) for electron transfer but the detailed mechanism remains unclear. Methodology/Principal Findings: Using a series of CaM mutants with E to Q substitution at the four calcium-binding sites, we found that single mutation at any calcium-binding site (B1Q, B2Q, B3Q and B4Q) resulted in similar to 2-3 fold increase in the CaM concentration necessary for half-maximal activation (EC50) of citrulline formation, indicating that each calcium-binding site of CaM contributed to the association between CaM and eNOS. Citrulline formation and cytochrome c reduction assays revealed that in comparison with nNOS or iNOS, eNOS was less stringent in the requirement of calcium binding to each of four calcium-binding sites. However, lobe-specific disruption with double mutations in calcium-binding sites either at N-(B12Q) or at C-terminal (B34Q) lobes greatly diminished both eNOS oxygenase and reductase activities. Gel mobility shift assay and flavin fluorescence measurement indicated that N- and C-lobes of CaM played distinct roles in regulating eNOS catalysis; the C-terminal EF-hands in its calcium-bound form was responsible for the binding of canonical CaM-binding domain, while N-terminal EF-hands in its calcium-bound form controlled the movement of FMN domain. Limited proteolysis studies further demonstrated that B12Q and B34Q induced different conformational change in eNOS. Conclusions: Our results clearly demonstrate that CaM controls eNOS electron transfer primarily through its lobe-specific calcium binding.	[Wu, Pei-Rung; Kuo, Cheng-Chin; Yet, Shaw-Fang; Liou, Jun-Yang; Wu, Kenneth K.; Chen, Pei-Feng] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Miaoli County, Taiwan	National Health Research Institutes - Taiwan	Wu, PR (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Miaoli County, Taiwan.	kkgo@nhri.org.tw; 990419@nhri.org.tw	Liou, Jun-Yang/B-1065-2010; Yet, Shaw-Fang/B-1067-2010; Wu, Kenneth Kun-Yu/B-1070-2010; Yet, Shaw-Fang/O-8583-2019; Kuo, Cheng-Chin/B-1064-2010	Yet, Shaw-Fang/0000-0001-9097-3962	National Health Research Institutes at Taiwan [99A1-CSAP01-014]	National Health Research Institutes at Taiwan	The work was supported by the Grant of National Health Research Institutes (99A1-CSAP01-014) at Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; Aoyagi M, 2003, EMBO J, V22, P766, DOI 10.1093/emboj/cdg078; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Chen PF, 2009, ARCH BIOCHEM BIOPHYS, V486, P132, DOI 10.1016/j.abb.2009.03.015; Chen PF, 1996, J BIOL CHEM, V271, P14631, DOI 10.1074/jbc.271.24.14631; CHEN PF, 1994, J BIOL CHEM, V269, P25062; CHO HJ, 1992, J EXP MED, V176, P599, DOI 10.1084/jem.176.2.599; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Daff S, 2010, NITRIC OXIDE-BIOL CH, V23, P1, DOI 10.1016/j.niox.2010.03.001; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Ghosh DK, 2003, FRONT BIOSCI-LANDMRK, V8, pD193, DOI 10.2741/959; GHOSH DK, 1995, BIOCHEMISTRY-US, V34, P801, DOI 10.1021/bi00003a013; Govers R, 2001, AM J PHYSIOL-RENAL, V280, pF193, DOI 10.1152/ajprenal.2001.280.2.F193; Gribovskaja I, 2005, BIOCHEMISTRY-US, V44, P7593, DOI 10.1021/bi0474517; Haque MM, 2007, P NATL ACAD SCI USA, V104, P9254, DOI 10.1073/pnas.0700332104; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; Jama AM, 2011, J BIOL CHEM, V276; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Li HY, 2008, J BIOL CHEM, V283, P34762, DOI 10.1074/jbc.M806949200; LIU JW, 1994, J BIOL CHEM, V269, P11691; LIU JW, 1995, BIOCHEMISTRY-US, V34, P12333, DOI 10.1021/bi00038a029; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Newman E, 2004, J BIOL CHEM, V279, P33547, DOI 10.1074/jbc.M403892200; PERSECHINI A, 1994, J BIOL CHEM, V269, P16148; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; Rafikov R, 2011, J ENDOCRINOL, V210, P271, DOI 10.1530/JOE-11-0083; Rodney GG, 2001, BIOCHEMISTRY-US, V40, P12430, DOI 10.1021/bi011078a; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; Romanin C, 2000, FEBS LETT, V487, P301, DOI 10.1016/S0014-5793(00)02361-9; Sagami I, 2001, J BIOL CHEM, V276, P30036, DOI 10.1074/jbc.M104123200; Salerno JC, 1997, J BIOL CHEM, V272, P29769, DOI 10.1074/jbc.272.47.29769; SCHMIDT HHH, 1989, BIOCHEM BIOPH RES CO, V165, P813; SHETA EA, 1994, J BIOL CHEM, V269, P15147; Shifman JM, 2006, P NATL ACAD SCI USA, V103, P13968, DOI 10.1073/pnas.0606433103; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; Spratt DE, 2007, BBA-PROTEINS PROTEOM, V1774, P1351, DOI 10.1016/j.bbapap.2007.07.019; StevensTruss R, 1997, BIOCHEMISTRY-US, V36, P12337, DOI 10.1021/bi970973k; STUEHR DJ, 1991, P NATL ACAD SCI USA, V88, P7773, DOI 10.1073/pnas.88.17.7773; Tang W, 2003, BIOPHYS J, V85, P1538, DOI 10.1016/S0006-3495(03)74586-X; Tejero J, 2010, J BIOL CHEM, V285, P25941, DOI 10.1074/jbc.M110.126797; WANG CLA, 1985, BIOCHEM BIOPH RES CO, V130, P426, DOI 10.1016/0006-291X(85)90434-6; Xia CW, 2009, J BIOL CHEM, V284, P30708, DOI 10.1074/jbc.M109.031682; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522	50	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39851	10.1371/journal.pone.0039851	http://dx.doi.org/10.1371/journal.pone.0039851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768143	gold, Green Submitted, Green Published			2022-12-27	WOS:000305892100112
J	Zhang, M; Lu, J; Tao, K; Ye, WW; Li, AN; Liu, XY; Kong, L; Dong, SM; Zheng, XB; Wang, YC				Zhang, Meng; Lu, Jing; Tao, Kai; Ye, Wenwu; Li, Aining; Liu, Xiaoyun; Kong, Liang; Dong, Suomeng; Zheng, Xiaobo; Wang, Yuanchao			A Myb Transcription Factor of Phytophthora sojae, Regulated by MAP Kinase PsSAK1, Is Required for Zoospore Development	PLOS ONE			English	Article							GENE-EXPRESSION; OOMYCETE PHYTOPHTHORA; PROTEIN-KINASE; INFESTANS; CELL; PATHOGENICITY; PARASITICA; RESISTANCE; BIOLOGY	PsSAK1, a mitogen-activated protein (MAP) kinase from Phytophthora sojae, plays an important role in host infection and zoospore viability. However, the downstream mechanism of PsSAK1 remains unclear. In this study, the 3'-tag digital gene expression (DGE) profiling method was applied to sequence the global transcriptional sequence of PsSAK1-silenced mutants during the cysts stage and 1.5 h after inoculation onto susceptible soybean leaf tissues. Compared with the gene expression levels of the recipient P. sojae strain, several candidates of Myb family were differentially expressed (up or down) in response to the loss of PsSAK1, including of a R2R3-type Myb transcription factor, PsMYB1. qRT-PCR indicated that the transcriptional level of PsMYB1 decreased due to PsSAK1 silencing. The transcriptional level of PsMYB1 increased during sporulating hyphae, in germinated cysts, and early infection. Silencing of PsMYB1 results in three phenotypes: a) no cleavage of the cytoplasm into uninucleate zoospores or release of normal zoospores, b) direct germination of sporangia, and c) afunction in zoospore-mediated plant infection. Our data indicate that the PsMYB1 transcription factor functions downstream of MAP kinase PsSAK1 and is required for zoospore development of P. sojae.	[Zhang, Meng; Lu, Jing; Tao, Kai; Ye, Wenwu; Li, Aining; Liu, Xiaoyun; Kong, Liang; Dong, Suomeng; Zheng, Xiaobo; Wang, Yuanchao] Nanjing Agr Univ, Minist Educ, Coll Plant Protect, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhang, M (corresponding author), Nanjing Agr Univ, Minist Educ, Coll Plant Protect, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China.	wangyc@njau.edu.cn	Kong, Liang/AGE-7498-2022; Ye, Wenwu/AAE-4961-2022; wang, yuanchao/G-9667-2011; Ye, Wenwu/J-5624-2014	Ye, Wenwu/0000-0001-7347-8935; wang, yuanchao/0000-0001-5803-5343; Ye, Wenwu/0000-0001-7347-8935	National Natural Science Foundation of China [30900932]; Special Fund for Agro-scientific Research in the Public Interest from China; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest from China; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (30900932) to S.D., the Special Fund for Agro-scientific Research in the Public Interest (3 20) from China to Y.W., and Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Baumann K, 2007, DEVELOPMENT, V134, P1691, DOI 10.1242/dev.02836; Brett M, 1995, MOL PLANT MICROBE IN, V8, P515; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Dong SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020172; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Erwin DC, 1985, PHYTOPHTHORA; Fuchs BB, 2009, EUKARYOT CELL, V8, P1616, DOI 10.1128/EC.00193-09; Hardham AR, 2007, CELL MICROBIOL, V9, P31, DOI 10.1111/j.1462-5822.2006.00833.x; HEMMES DE, 1969, AM J BOT, V56, P300, DOI 10.2307/2440853; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hua CL, 2008, EUKARYOT CELL, V7, P2133, DOI 10.1128/EC.00286-08; HYDE GJ, 1991, MYCOL RES, V95, P577, DOI 10.1016/S0953-7562(09)80072-5; Judelson HS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-700; Judelson HS, 2005, NAT REV MICROBIOL, V3, P47, DOI 10.1038/nrmicro1064; Judelson HS, 2002, EUKARYOT CELL, V1, P687, DOI 10.1128/EC.1.5.687-695.2002; JUDELSON HS, 1991, MOL PLANT MICROBE IN, V4, P602, DOI 10.1094/MPMI-4-602; Kroon LPNM, 2012, PHYTOPATHOLOGY, V102, P348, DOI 10.1094/PHYTO-01-11-0025; Li AN, 2010, MOL PLANT MICROBE IN, V23, P1022, DOI 10.1094/MPMI-23-8-1022; Moriwaki A, 2007, MICROBIOL RES, V162, P108, DOI 10.1016/j.micres.2006.01.014; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Schmitthenner AF, 1999, PLANT HLTH PROGR; Segmuller N, 2007, EUKARYOT CELL, V6, P211, DOI 10.1128/EC.00153-06; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Urban M, 2003, MOL PLANT PATHOL, V4, P347, DOI 10.1046/J.1364-3703.2003.00183.X; Vega-Sanchez ME, 2005, PHYSIOL MOL PLANT P, V66, P175, DOI 10.1016/j.pmpp.2005.07.001; vonBroembsen SL, 1997, PHYTOPATHOLOGY, V87, P522, DOI 10.1094/PHYTO.1997.87.5.522; Walker Claire A., 2007, Fungal Biology Reviews, V21, P10, DOI 10.1016/j.fbr.2007.02.001; Xiang QJ, 2010, GENE, V453, P1, DOI 10.1016/j.gene.2009.12.006; Xu JR, 2000, FUNGAL GENET BIOL, V31, P137, DOI 10.1006/fgbi.2000.1237; Ye WW, 2011, MOL PLANT MICROBE IN, V24, P1530, DOI 10.1094/MPMI-05-11-0106; Yoshioka S, 2004, PLANT CELL, V16, P1466, DOI 10.1105/tpc.021162; Zhao XH, 2007, MOL MICROBIOL, V63, P881, DOI 10.1111/j.1365-2958.2006.05548.x	35	25	27	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40246	10.1371/journal.pone.0040246	http://dx.doi.org/10.1371/journal.pone.0040246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768262	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100236
J	Ayele, FT; Hailu, E; Finan, C; Aseffa, A; Davey, G; Newport, MJ; Rotimi, CN; Adeyemo, A				Ayele, Fasil Tekola; Hailu, Elena; Finan, Chris; Aseffa, Abraham; Davey, Gail; Newport, Melanie J.; Rotimi, Charles N.; Adeyemo, Adebowale			Prediction of HLA Class II Alleles Using SNPs in an African Population	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; SYMPATRIC ETHNIC-GROUPS; TYPING IDENTIFIED 2; EXTENDED HUMAN MHC; ASSOCIATION ANALYSIS; KENYAN POPULATION; GENOME-WIDE; GENE MAP; PODOCONIOSIS; SEQUENCE	Background: Despite the importance of the human leukocyte antigen (HLA) gene locus in research and clinical practice, direct HLA typing is laborious and expensive. Furthermore, the analysis requires specialized software and expertise which are unavailable in most developing country settings. Recently, in silico methods have been developed for predicting HLA alleles using single nucleotide polymorphisms (SNPs). However, the utility of these methods in African populations has not been systematically evaluated. Methodology/Principal Findings: In the present study, we investigate prediction of HLA class II (HLA-DRB1 and HLA-DQB1) alleles using SNPs in the Wolaita population, southern Ethiopia. The subjects comprised 297 Ethiopians with genome-wide SNP data, of whom 188 had also been HLA typed and were used for training and testing the model. The 109 subjects with SNP data alone were used for empirical prediction using the multi-allelic gene prediction method. We evaluated accuracy of the prediction, agreement between predicted and HLA typed alleles, and discriminative ability of the prediction probability supplied by the model. We found that the model predicted intermediate (two-digit) resolution for HLA-DRB1 and HLA-DQB1 alleles at accuracy levels of 96% and 87%, respectively. All measures of performance showed high accuracy and reliability for prediction. The distribution of the majority of HLA alleles in the study was similar to that previously reported for the Oromo and Amhara ethnic groups from Ethiopia. Conclusions/Significance: We demonstrate that HLA class II alleles can be predicted from SNP genotype data with a high level of accuracy at intermediate (two-digit) resolution in an African population. This finding offers new opportunities for HLA studies of disease epidemiology and population genetics in developing countries.	[Ayele, Fasil Tekola; Rotimi, Charles N.; Adeyemo, Adebowale] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA; [Hailu, Elena; Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Finan, Chris; Davey, Gail; Newport, Melanie J.] Brighton & Sussex Med Sch, Brighton, E Sussex, England	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Brighton; University of Sussex	Ayele, FT (corresponding author), NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA.	ayeleft@mail.nih.gov	Aseffa, Abraham/J-3248-2016	Aseffa, Abraham/0000-0002-8028-1150; Newport, Melanie/0000-0002-8946-7525; Adeyemo, Adebowale/0000-0002-3105-3231; Tekola-Ayele, Fasil/0000-0003-4194-9370; Davey, Gail/0000-0003-2796-7468	Wellcome Trust [079791]; National Human Genome Research Institute, National Institutes of Health, in the Center for Research on Genomics and Global Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200362] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Human Genome Research Institute, National Institutes of Health, in the Center for Research on Genomics and Global Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the Wellcome Trust [grant number 079791]; and the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health, in the Center for Research on Genomics and Global Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001184; Ayele FT, 2012, NEW ENGL J MED, V366, P1200, DOI 10.1056/NEJMoa1108448; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Blackwell JM, 2009, CLIN MICROBIOL REV, V22, P370, DOI 10.1128/CMR.00048-08; BUYSE I, 1993, TISSUE ANTIGENS, V41, P1, DOI 10.1111/j.1399-0039.1993.tb01970.x; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; CARRINGTON M, 1992, HUM IMMUNOL, V33, P208, DOI 10.1016/0198-8859(92)90073-V; Cesbron-Gautier A, 2004, ANN BIOL CLIN-PARIS, V62, P93; CSA, 2007, 2007 POPULATION HOUS; Davey G, 2007, T ROY SOC TROP MED H, V101, P1175, DOI 10.1016/j.trstmh.2007.08.013; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; [Department DPaC Federal Ministry of Health], 2006, NAT 5 YEAR STRAT PLA, P3; Destas K, 2003, TROP DOCT, V33, P217, DOI 10.1177/004947550303300410; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Fort M, 1998, TISSUE ANTIGENS, V51, P327; Geshere G, 2009, IDENTIFICATION ETIOL; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hall M., 2009, SIGKDD EXPLORATIONS, V11; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Li SYS, 2011, GENET EPIDEMIOL, V35, P85, DOI 10.1002/gepi.20549; Lulli P, 2009, HUM IMMUNOL, V70, P903, DOI 10.1016/j.humimm.2009.07.025; Luo M, 2005, TISSUE ANTIGENS, V65, P120, DOI 10.1111/j.1399-0039.2005.00339.x; Luo M, 2004, TISSUE ANTIGENS, V63, P609, DOI 10.1111/j.0001-2815.2004.00231.x; Luo M, 2003, TISSUE ANTIGENS, V62, P182, DOI 10.1034/j.1399-0039.2003.00066.x; Marsh SGE, 2010, TISSUE ANTIGENS, V75, P291, DOI 10.1111/j.1399-0039.2010.01466.x; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Modiano D, 1998, AM J TROP MED HYG, V58, P220, DOI 10.4269/ajtmh.1998.58.220; Modiano D, 1996, P NATL ACAD SCI USA, V93, P13206, DOI 10.1073/pnas.93.23.13206; Modiano D, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P193; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Peterson TA, 2008, HUM IMMUNOL, V69, P885, DOI 10.1016/j.humimm.2008.09.001; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; Setty MN, 2011, J COMPUT BIOL, V18, P483, DOI 10.1089/cmb.2010.0258; Solberg OD, 2008, HUM IMMUNOL, V69, P443, DOI 10.1016/j.humimm.2008.05.001; Teo YY, 2010, NAT REV GENET, V11, P149, DOI 10.1038/nrg2731; THURSZ MR, 1995, NEW ENGL J MED, V332, P1065, DOI 10.1056/NEJM199504203321604; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; World Health Organization, 2008, GLOB BURD DIS 2004 U; Xie MZ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S10; Zhang XC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-39	47	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e40206	10.1371/journal.pone.0040206	http://dx.doi.org/10.1371/journal.pone.0040206			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761960	Green Published, Green Accepted, gold			2022-12-27	WOS:000305826400061
J	Chen, WG; Liu, FL; Ling, ZX; Tong, XJ; Xiang, C				Chen, Weiguang; Liu, Fanlong; Ling, Zongxin; Tong, Xiaojuan; Xiang, Charlie			Human Intestinal Lumen and Mucosa-Associated Microbiota in Patients with Colorectal Cancer	PLOS ONE			English	Article							HUMAN GUT MICROBIOTA; ULCERATIVE-COLITIS; COMMENSAL BACTERIA; COLONIC MUCOSA; DIVERSITY; MECHANISMS; INDUCTION; ECOLOGY; UNIFRAC; OBESITY	Recent reports have suggested the involvement of gut microbiota in the progression of colorectal cancer (CRC). We utilized pyrosequencing based analysis of 16S rRNA genes to determine the overall structure of microbiota in patients with colorectal cancer and healthy controls; we investigated microbiota of the intestinal lumen, the cancerous tissue and matched noncancerous normal tissue. Moreover, we investigated the mucosa-adherent microbial composition using rectal swab samples because the structure of the tissue-adherent bacterial community is potentially altered following bowel cleansing. Our findings indicated that the microbial structure of the intestinal lumen and cancerous tissue differed significantly. Phylotypes that enhance energy harvest from diets or perform metabolic exchange with the host were more abundant in the lumen. There were more abundant Firmicutes and less abundant Bacteroidetes and Proteobacteria in lumen. The overall microbial structures of cancerous tissue and noncancerous tissue were similar; howerer the tumor microbiota exhibited lower diversity. The structures of the intestinal lumen microbiota and mucosa-adherent microbiota were different in CRC patients compared to matched microbiota in healthy individuals. Lactobacillales was enriched in cancerous tissue, whereas Faecalibacterium was reduced. In the mucosa-adherent microbiota, Bifidobacterium, Faecalibacterium, and Blautia were reduced in CRC patients, whereas Fusobacterium, Porphyromonas, Peptostreptococcus, and Mogibacterium were enriched. In the lumen, predominant phylotypes related to metabolic disorders or metabolic exchange with the host, Erysipelotrichaceae, Prevotellaceae, and Coriobacteriaceae were increased in cancer patients. Coupled with previous reports, these results suggest that the intestinal microbiota is associated with CRC risk and that intestinal lumen microflora potentially influence CRC risk via cometabolism or metabolic exchange with the host. However, mucosa-associated microbiota potentially affects CRC risk primarily through direct interaction with the host.	[Chen, Weiguang; Ling, Zongxin; Tong, Xiaojuan; Xiang, Charlie] Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Infect Dis Diagnost & Treatment, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Fanlong] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Anus & Intestine, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Chen, WG (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Infect Dis Diagnost & Treatment, Hangzhou 310003, Zhejiang, Peoples R China.	cxiang@zju.edu.cn	Ling, Zongxin/M-1657-2018; Chen, Weiguang/D-7467-2012; Ling, Zongxin/AAM-4059-2021	Ling, Zongxin/0000-0001-9662-099X; Chen, Weiguang/0000-0003-0859-8118; 	Chinese National Programs for Fundamental Research and Development [2007CB513001]	Chinese National Programs for Fundamental Research and Development	This work was supported by Project 2007CB513001 of Chinese National Programs for Fundamental Research and Development ( 973 program, http://www.973.gov.cn/AreaAppl.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrian E, 2006, J DENT RES, V85, P392, DOI 10.1177/154405910608500502; Atarashi K, 2010, VACCINE, V28, P8036, DOI 10.1016/j.vaccine.2010.09.026; Azcarate-Peril MA, 2011, AM J PHYSIOL-GASTR L, V301, pG401, DOI 10.1152/ajpgi.00110.2011; Beeckman DSA, 2010, CURR ISSUES MOL BIOL, V12, P17; Benus RF, 2010, INTENS CARE MED, V36, P1394, DOI 10.1007/s00134-010-1826-4; Brown K R, 1977, Trop Doct, V7, P111; Brown Nat F, 2011, Mob Genet Elements, V1, P118; Candela M, 2008, INT J FOOD MICROBIOL, V125, P286, DOI 10.1016/j.ijfoodmicro.2008.04.012; Candela M, 2011, CRIT REV MICROBIOL, V37, P1, DOI 10.3109/1040841X.2010.501760; Castellarin M, 2011, GENOME RES; Chen YF, 2011, HEPATOLOGY, V54, P562, DOI 10.1002/hep.24423; Claus SP, 2011, MBIO, V2, DOI 10.1128/mBio.00271-10; Costello EK, 2010, ISME J, V4, P1375, DOI 10.1038/ismej.2010.71; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dabard J, 2001, APPL ENVIRON MICROB, V67, P4111, DOI 10.1128/AEM.67.9.4111-4118.2001; Davis CD, 2009, J NUTR BIOCHEM, V20, P743, DOI 10.1016/j.jnutbio.2009.06.001; Domenici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009166; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Harris JI, 2002, ORAL MICROBIOL IMMUN, V17, P224, DOI 10.1034/j.1399-302X.2002.170404.x; Huycke MM, 2004, EXP BIOL MED, V229, P586, DOI 10.1177/153537020422900702; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Joly F, 2010, BIOCHIMIE, V92, P753, DOI 10.1016/j.biochi.2010.02.015; Kostic AD, 2011, GENOME RES; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Mai V, 2005, SCIENCE, V310, P1118, DOI 10.1126/science.310.5751.1118; Marchesi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020447; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martinez I, 2009, APPL ENVIRON MICROB, V75, P4175, DOI 10.1128/AEM.00380-09; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Ohkusa T, 2003, GUT, V52, P79, DOI 10.1136/gut.52.1.79; Ohkusa T, 2002, J GASTROEN HEPATOL, V17, P849, DOI 10.1046/j.1440-1746.2002.02834.x; Paillard D, 2007, ANTON LEEUW INT J G, V91, P417, DOI 10.1007/s10482-006-9121-7; Perez-Enciso M, 2003, HUM GENET, V112, P581, DOI 10.1007/s00439-003-0921-9; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ray Katrina, 2011, Nat Rev Gastroenterol Hepatol, V8, P662, DOI 10.1038/nrgastro.2011.208; Rowland IR, 2009, CURR PHARM DESIGN, V15, P1524, DOI 10.2174/138161209788168191; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Scharlau D, 2009, MUTAT RES-REV MUTAT, V682, P39, DOI 10.1016/j.mrrev.2009.04.001; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sears CL, 2011, J INFECT DIS, V203, P306, DOI 10.1093/jinfdis/jiq061; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Strauss J, 2011, INFLAMM BOWEL DIS; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; van der Waaij LA, 2005, INFLAMM BOWEL DIS, V11, P865, DOI 10.1097/01.mib.0000179212.80778.d3; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Vartoukian SR, 2007, ANAEROBE, V13, P99, DOI 10.1016/j.anaerobe.2007.05.004; Wang T, 2011, ISME J; Wei H, 2010, FEMS MICROBIOL ECOL, V73, P577, DOI 10.1111/j.1574-6941.2010.00924.x; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	61	415	458	10	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39743	10.1371/journal.pone.0039743	http://dx.doi.org/10.1371/journal.pone.0039743			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761885	Green Published, Green Submitted, gold			2022-12-27	WOS:000305826400033
J	Dai, AY; Yan, GJ; He, QY; Jiang, Y; Zhang, Q; Fang, T; Ding, LJ; Sun, JX; Sun, HX; Hu, YL				Dai, Anyi; Yan, Guijun; He, Qinyuan; Jiang, Yue; Zhang, Qun; Fang, Ting; Ding, Lijun; Sun, Jianxin; Sun, Haixiang; Hu, Yali			Orphan Nuclear Receptor Nur77 Regulates Androgen Receptor Gene Expression in Mouse Ovary	PLOS ONE			English	Article							INDUCED STAR TRANSCRIPTION; ENDOMETRIAL STROMAL CELLS; NGFI-B NUR77; KIT-LIGAND; 3-BETA-HYDROXYSTEROID DEHYDROGENASE; COACTIVATOR RECRUITMENT; FOLLICLE DEVELOPMENT; HORMONE RECEPTOR; GRANULOSA-CELLS; DEFICIENT MICE	The androgen receptor (AR) is a nuclear receptor that is expressed in growing follicles and involved in folliculogenesis and follicle growth. The orphan nuclear receptor, Nur77, also has an important role in steroid signaling and follicle maturation. We hypothesized that AR levels and androgen signaling through AR are regulated by Nur77 in the ovary. In the ovaries of Nur77 knockout mice (n = 5), real-time PCR results showed that the mRNA levels of AR and an androgen signaling target gene, Kitl, were decreased by 35% and 24%, respectively, relative to wild-type mice (n = 5), which suggested transcriptional regulation of AR by Nur77 in vivo. In cultured mouse granulosa cells and a steroidogenic human ovarian granulosa-like tumor cell line, KGN, mRNA and protein expression levels of AR were increased by overexpressing Nur77 but decreased by knocking down endogenous Nur77. Consistent with increased AR expression, chromatin immunoprecipitation showed that Nur77 bound to the NGFI-B response element (NBRE) in the AR promoter sequence. AR promoter activity was stimulated by Nur77 in HEK293T cells and attenuated in Nur77 knockout mouse granulosa cells (luciferase assay). Overexpression of Nur77 enhanced the androgenic induction of Kitl (200 nM; 48h), while knockout of Nur77 attenuated this induction. These results demonstrate that AR is regulated by Nur77 in the ovaries, and they suggest that the participation of Nur77 in androgen signaling may be essential for normal follicular development.	[Dai, Anyi; Yan, Guijun; He, Qinyuan; Jiang, Yue; Zhang, Qun; Fang, Ting; Ding, Lijun; Sun, Haixiang; Hu, Yali] Nanjing Univ, Affiliated Drum Tower Hosp, Reprod Med Ctr, Sch Med, Nanjing, Jiangsu, Peoples R China; [Sun, Jianxin] Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA	Nanjing University; Jefferson University	Dai, AY (corresponding author), Nanjing Univ, Affiliated Drum Tower Hosp, Reprod Med Ctr, Sch Med, Nanjing, Jiangsu, Peoples R China.	stevensunz@163.com; yali_hu@hotmail.com		Sun, Jianxin/0000-0001-5319-912X	State Key Development Program of Basic Research of China [2010CB945104]; National Natural Science Foundation of China [81070508, 30900727, 81070492, 81170570]; Health Department of Jiangsu Province of PR China [XK201102, LJ201102, RC2011005]; Natural Science Foundation of Jiangsu Province Grant of PR China [BK2009038]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103869] Funding Source: NIH RePORTER	State Key Development Program of Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Department of Jiangsu Province of PR China; Natural Science Foundation of Jiangsu Province Grant of PR China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the State Key Development Program of Basic Research of China Grant (973 Project No. 2010CB945104), the National Natural Science Foundation of China (No. 81070508, No. 30900727, No. 81070492, No. 81170570), the Special Grant for Principal Investigators from the Health Department of Jiangsu Province of PR China (No. XK201102, No. LJ201102, No. RC2011005), and the Natural Science Foundation of Jiangsu Province Grant of PR China (No. BK2009038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bassett MH, 2004, J BIOL CHEM, V279, P37622, DOI 10.1074/jbc.M405431200; BILLIG H, 1993, ENDOCRINOLOGY, V133, P2204, DOI 10.1210/en.133.5.2204; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; CRAWFORD PA, 1995, MOL CELL BIOL, V15, P4331; Ding LJ, 2011, FEBS LETT, V585, P2437, DOI 10.1016/j.febslet.2011.06.013; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Gill A, 2004, MOL ENDOCRINOL, V18, P97, DOI 10.1210/me.2003-0326; Havelock JC, 2005, MOL HUM REPROD, V11, P79, DOI 10.1093/molehr/gah139; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; Hickey TE, 2004, BIOL REPROD, V71, P45, DOI 10.1095/biolreprod.103.026484; HILDPETITO S, 1991, BIOL REPROD, V44, P561, DOI 10.1095/biolreprod44.3.561; Hutt KJ, 2006, BIOL REPROD, V75, P421, DOI 10.1095/biolreprod.106.051516; Hutt KJ, 2006, MOL HUM REPROD, V12, P61, DOI 10.1093/molehr/gal010; Jiang Y, 2011, BIOCHEM BIOPH RES CO, V404, P628, DOI 10.1016/j.bbrc.2010.12.027; Kelly SN, 2004, J ENDOCRINOL, V181, P355, DOI 10.1677/joe.0.1810355; Kipp JL, 2009, METHODS MOL BIOL, V590, P177, DOI 10.1007/978-1-60327-378-7_11; LEE SL, 1995, SCIENCE, V269, P532, DOI 10.1126/science.7624775; Li M, 2009, MOL HUM REPROD, V15, P149, DOI 10.1093/molehr/gap006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutz LB, 2001, P NATL ACAD SCI USA, V98, P13728, DOI 10.1073/pnas.241471598; Maira M, 2003, MOL CELL BIOL, V23, P763, DOI 10.1128/MCB.23.3.763-776.2003; Martin LJ, 2008, J MOL ENDOCRINOL, V41, P165, DOI 10.1677/JME-07-0145; Martin LJ, 2008, MOL ENDOCRINOL, V22, P2021, DOI 10.1210/me.2007-0370; Maruyama K, 1998, INT J ONCOL, V12, P1237; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Mei L, 2010, MOL CELL ENDOCRINOL, V319, P39, DOI 10.1016/j.mce.2010.01.014; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Murphy EP, 2001, ARTHRITIS RHEUM-US, V44, P782, DOI 10.1002/1529-0131(200104)44:4<782::AID-ANR134>3.3.CO;2-8; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Otsuka F, 2002, P NATL ACAD SCI USA, V99, P8060, DOI 10.1073/pnas.122066899; PACKER AI, 1994, DEV BIOL, V161, P194, DOI 10.1006/dbio.1994.1020; Parrott JA, 1999, ENDOCRINOLOGY, V140, P4262, DOI 10.1210/en.140.9.4262; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Sen A, 2010, MOL ENDOCRINOL, V24, P1393, DOI 10.1210/me.2010-0006; Shiina H, 2006, P NATL ACAD SCI USA, V103, P224, DOI 10.1073/pnas.0506736102; Song KH, 2001, ENDOCRINOLOGY, V142, P5116, DOI 10.1210/en.142.12.5116; Sullivan SD, 2004, P NATL ACAD SCI USA, V101, P7129, DOI 10.1073/pnas.0308058101; Sun HX, 2009, BIOCHEM BIOPH RES CO, V379, P16, DOI 10.1016/j.bbrc.2008.11.144; TETSUKA M, 1995, J ENDOCRINOL, V145, P535, DOI 10.1677/joe.0.1450535; Thomas FH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-19; Vendola KA, 1998, J CLIN INVEST, V101, P2622, DOI 10.1172/JCI2081; Walters KA, 2007, ENDOCRINOLOGY, V148, P3674, DOI 10.1210/en.2007-0248; Wansa KDSA, 2003, J BIOL CHEM, V278, P24776, DOI 10.1074/jbc.M300088200; WILSON TE, 1993, MOL CELL BIOL, V13, P5794, DOI 10.1128/MCB.13.9.5794; Wu YM, 2005, ENDOCRINOLOGY, V146, P237, DOI 10.1210/en.2004-0889; Yan GJ, 2008, CIRC RES, V103, P591, DOI 10.1161/CIRCRESAHA.108.173963; Ye YH, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-26; Zhang PL, 1997, MOL ENDOCRINOL, V11, P891, DOI 10.1210/me.11.7.891	49	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39950	10.1371/journal.pone.0039950	http://dx.doi.org/10.1371/journal.pone.0039950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761936	Green Published, gold			2022-12-27	WOS:000305826400050
J	Tao, Q; Li, DY; Zhang, L; Luo, SQ				Tao, Qiang; Li, Dongyue; Zhang, Lu; Luo, Shuqian			Using X-Ray In-Line Phase-Contrast Imaging for the Investigation of Nude Mouse Hepatic Tumors	PLOS ONE			English	Article								The purpose of this paper is to report the noninvasive imaging of hepatic tumors without contrast agents. Both normal tissues and tumor tissues can be detected, and tumor tissues in different stages can be classified quantitatively. We implanted BEL-7402 human hepatocellular carcinoma cells into the livers of nude mice and then imaged the livers using X-ray in-line phase-contrast imaging (ILPCI). The projection images' texture feature based on gray level co-occurrence matrix (GLCM) and dual-tree complex wavelet transforms (DTCWT) were extracted to discriminate normal tissues and tumor tissues. Different stages of hepatic tumors were classified using support vector machines (SVM). Images of livers from nude mice sacrificed 6 days after inoculation with cancer cells show diffuse distribution of the tumor tissue, but images of livers from nude mice sacrificed 9, 12, or 15 days after inoculation with cancer cells show necrotic lumps in the tumor tissue. The results of the principal component analysis (PCA) of the texture features based on GLCM of normal regions were positive, but those of tumor regions were negative. The results of PCA of the texture features based on DTCWT of normal regions were greater than those of tumor regions. The values of the texture features in low-frequency coefficient images increased monotonically with the growth of the tumors. Different stages of liver tumors can be classified using SVM, and the accuracy is 83.33%. Noninvasive and micron-scale imaging can be achieved by X-ray ILPCI. We can observe hepatic tumors and small vessels from the phase-contrast images. This new imaging approach for hepatic cancer is effective and has potential use in the early detection and classification of hepatic tumors.	[Tao, Qiang; Li, Dongyue; Zhang, Lu; Luo, Shuqian] Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China; [Li, Dongyue] Tianjin Med Univ, Sch Med Image, Tianjin, Peoples R China	Capital Medical University; Tianjin Medical University	Tao, Q (corresponding author), Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China.	shuqian_luo@yahoo.com.cn			National Natural Science Foundation of China [60532090, 30770593]; European Community [PIRSES-GA-2009-269124]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); European Community(European Commission)	This study was supported by National Natural Science Foundation of China, Grant Nos. 60532090 and 30770593, and by the 7th Framework Programme of the European Community, Grant Agreement Number: PIRSES-GA-2009-269124. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almajdub M, 2007, CONTRAST MEDIA MOL I, V2, P88, DOI 10.1002/cmmi.130; Astrid L, 2009, EUR J RADIOL EXTRA, V72, pe9; Carvalho ML, 2001, X-RAY SPECTROM, V30, P397, DOI 10.1002/xrs.517; Chan KT, 2010, CANCER LETT, V294, P118, DOI 10.1016/j.canlet.2010.01.029; Elshemey WM, 2003, PHYS MED BIOL, V48, pN239, DOI 10.1088/0031-9155/48/17/401; Furlan A, 2008, AM J ROENTGENOL, V191, P1430, DOI 10.2214/AJR.07.3419; Giuseppetti GM, 1998, EUR J RADIOL, V27, pS254, DOI 10.1016/S0720-048X(98)00076-X; Hatfield MK, 2008, AM J ROENTGENOL, V190, P413, DOI 10.2214/AJR.07.2676; Hong Y, 2009, APPL PHYS LETT, V95; Iwazawa J, 2009, AM J ROENTGENOL, V192, P1057, DOI 10.2214/AJR.08.1285; Killi RM, 1999, EUR J RADIOL, V32, P21, DOI 10.1016/S0720-048X(99)00112-6; Lewis RA, 2004, PHYS MED BIOL, V49, P3573, DOI 10.1088/0031-9155/49/16/005; Li ST, 2003, PATTERN RECOGN, V36, P2883, DOI 10.1016/S0031-3203(03)00219-X; Lucia M, 2011, PLOS ONE, V6; Luo W, 2009, AM J ROENTGENOL, V192, P165, DOI 10.2214/AJR.08.1107; Masato H, 2011, PLOS ONE, V6; Rand D, 2011, NANO LETT, V11, P2678, DOI 10.1021/nl200858y; Raty J, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3449127; Rod DB, 2012, PLOS ONE, V7; Sarah WI, 2009, EUR J RADIOL EXTRA, V71, pe25; Shuqian L, 2010, MED IMAGE PROCESSING, P39; Simone CC, 2011, PLOS ONE, V6; Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073; Tabuchi A, 2009, EUR J RADIOL, V71, P506, DOI 10.1016/j.ejrad.2008.06.001; Venkatesh SK, 2008, AM J ROENTGENOL, V190, P1534, DOI 10.2214/AJR.07.3123; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Wu J, 2009, KIDNEY INT, V75, P945, DOI 10.1038/ki.2009.42; Wu XZ, 2003, MED PHYS, V30, P2169, DOI 10.1118/1.1593836; Zhou SA, 2008, PHYS MEDICA, V24, P129, DOI 10.1016/j.ejmp.2008.05.006	29	6	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39936	10.1371/journal.pone.0039936	http://dx.doi.org/10.1371/journal.pone.0039936			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761929	Green Submitted, Green Published, gold			2022-12-27	WOS:000305826400045
J	Guessous, I; Bochud, M; Theler, JM; Gaspoz, JM; Pechere-Bertschi, A				Guessous, Idris; Bochud, Murielle; Theler, Jean-Marc; Gaspoz, Jean-Michel; Pechere-Bertschi, Antoinette			1999-2009 Trends in Prevalence, Unawareness, Treatment and Control of Hypertension in Geneva, Switzerland	PLOS ONE			English	Article							BLOOD-PRESSURE LEVELS; RISK-FACTORS; ARTERIAL-HYPERTENSION; EUROPEAN COUNTRIES; ADULT-POPULATION; CZECH POPULATION; AWARENESS; CANADA; PREVENTION; DISEASE	Background: There are no time trends in prevalence, unawareness, treatment, and control of hypertension in Switzerland. The objective of this study was to analyze these trends and to determine the associated factors. Methods/Findings: Population-based study conducted in the Canton of Geneva, Switzerland, between 1999 and 2009. Blood pressure was measured thrice using a standard protocol. Hypertension was defined as mean systolic or diastolic blood pressure >= 140/90 mmHg or self-reported hypertension or anti-hypertensive medication. Unawareness, untreated and uncontrolled hypertension was determined by questionnaires/blood pressure measurements. Yearly age-standardized prevalences and adjusted associations for the 1999-2003 and 2004-2009 survey periods were reported. The 10-year survey included 9,215 participants aged 35 to 74 years. Hypertension remained stable (34.4%). Hypertension unawareness decreased from 35.9% to 17.7% (P < 0.001). The decrease in hypertension unawareness was not paralleled by a concomitant absolute increase in hypertension treatment, which remained low (38.2%). A larger proportion of all hypertensive participants were aware but not treated in 2004-2009 (43.7%) compared to 1999-2003 (33.1%). Uncontrolled hypertension improved from 62.2% to 40.6% between 1999 and 2009 (P = 0.02). In 1999-2003 period, factors associated with hypertension unawareness were current smoking (OR = 1.27, 95% CI, 1.02-1.59), male gender (OR = 1.56, 1.27-1.92), hypercholesterolemia (OR = 1.31, 1.20-1.44), and older age (OR 65-74yrs vs 35-49yrs = 1.56, 1.21-2.02). In 1999-2003 and 2004-2009, obesity and diabetes were negatively associated with hypertension unawareness, high education was associated with untreated hypertension (OR = 1.45, 1.12-1.88 and 1.42, 1.02-1.99, respectively), and male gender with uncontrolled hypertension (OR = 1.49, 1.03-2.17 and 1.65, 1.08-2.50, respectively). Sedentarity was associated with higher risk of hypertension and uncontrolled hypertension in 1999-2003. Conclusions: Hypertension prevalence remained stable since 1999 in the canton of Geneva. Although hypertension unawareness substantially decreased, more than half of hypertensive subjects still remained untreated or uncontrolled in 2004-2009. This study identified determinants that should guide interventions aimed at improving hypertension treatment and control.	[Guessous, Idris; Theler, Jean-Marc; Gaspoz, Jean-Michel] Univ Hosp Geneva, Dept Community Med Primary Care & Emergency Med, Unit Populat Epidemiol, Div Primary Care Med, Geneva, Switzerland; [Guessous, Idris; Bochud, Murielle] Univ Lausanne Hosp, Univ Inst Social & Prevent Med, Community Prevent Unit, Lausanne, Switzerland; [Guessous, Idris; Pechere-Bertschi, Antoinette] Univ Hosp Geneva, Hypertens Unit, Dept Med Specialties, Geneva, Switzerland; [Guessous, Idris; Pechere-Bertschi, Antoinette] Univ Hosp Geneva, Hypertens Unit, Dept Community Med & Primary Care & Emergency Med, Geneva, Switzerland	University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Geneva	Guessous, I (corresponding author), Univ Hosp Geneva, Dept Community Med Primary Care & Emergency Med, Unit Populat Epidemiol, Div Primary Care Med, Geneva, Switzerland.	Idris.Guessous@hcuge.ch	Bochud, Murielle/A-3981-2010	Bochud, Murielle/0000-0002-5727-0218	Geneva University Hospitals through the General Directorate of Health (Canton of Geneva); Swiss Foundation for Science [33CM30-124087]; Swiss School of Public Health Plus	Geneva University Hospitals through the General Directorate of Health (Canton of Geneva); Swiss Foundation for Science; Swiss School of Public Health Plus	The Bus Sante study is funded by the Geneva University Hospitals through the General Directorate of Health (Canton of Geneva) http://ge.ch/dares/sante/accueil.html. IG is supported by a grant from the Swiss Foundation for Science, http://www.snf.ch/E/Pages/default.aspx (33CM30-124087). MB is supported by the Swiss School of Public Health Plus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Agyemang C, 2006, J HUM HYPERTENS, V20, P874, DOI 10.1038/sj.jhh.1002073; ASSMANN G, 1988, AM HEART J, V116, P1713, DOI 10.1016/0002-8703(88)90220-7; Beer-Borst S, 2009, EUR J CLIN NUTR, V63, P155, DOI 10.1038/sj.ejcn.1602922; BERNSTEIN M, 1994, SOZ PRAVENTIV MED, V39, P333, DOI 10.1007/BF01299665; Bernstein M, 1998, AM J EPIDEMIOL, V147, P147; Bersamin A, 2009, J GEN INTERN MED, V24, P521, DOI 10.1007/s11606-009-1094-6; Bielecka-Dabrowa A, 2011, CURR CARDIOVASC RISK, V5, P174, DOI 10.1007/s12170-010-0152-2; Bovet P, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-34; Brindel P, 2006, J HYPERTENS, V24, P51, DOI 10.1097/01.hjh.0000198028.84353.86; Centers for Disease Control and Prevention, 1999, JAMA-J AM MED ASSOC, V282, P724, DOI DOI 10.1001/JAMA.282.8.724; Chalmers J, 1999, J HYPERTENS, V17, P151; Chen R, 2003, J HUM HYPERTENS, V17, P751, DOI 10.1038/sj.jhh.1001612; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Cifkova R, 2004, J HYPERTENS, V22, P1479, DOI 10.1097/01.hjh.0000133737.77866.3e; Cifkova R, 2004, J HUM HYPERTENS, V18, P571, DOI 10.1038/sj.jhh.1001686; Cifkova R, 2010, J HYPERTENS, V28, P2196, DOI 10.1097/HJH.0b013e32833d4451; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Danon-Hersch N, 2009, EUR J CARDIOV PREV R, V16, P66, DOI 10.1097/HJR.0b013e32831e9511; Dorobantu M, 2010, INT J HYPERTENS, V2010, DOI 10.4061/2010/970694; Efstratopoulos AD, 2006, AM J HYPERTENS, V19, P53, DOI 10.1016/j.amjhyper.2005.07.011; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Falaschetti E, 2009, HYPERTENSION, V53, P480, DOI 10.1161/HYPERTENSIONAHA.108.125617; Ferrari P, 2004, J HYPERTENS, V22, P1221, DOI 10.1097/00004872-200406000-00024; Gaolbardes B, 2003, ANN EPIDEMIOL, V13, P537, DOI 10.1016/S1047-2797(03)00055-3; Gaspoz JM, 2009, SUIVI FACTEURS RISQU; Kannel WB, 1996, JAMA-J AM MED ASSOC, V275, P1571, DOI 10.1001/jama.275.20.1571; Kearney PM, 2004, J HYPERTENS, V22, P11, DOI 10.1097/00004872-200401000-00003; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Kronborg CN, 2009, J AM SOC HYPERTENS, V3, P19, DOI 10.1016/j.jash.2008.08.001; Leenen FHH, 2008, CAN MED ASSOC J, V178, P1441, DOI 10.1503/cmaj.071340; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lowe LP, 1998, ARCH INTERN MED, V158, P2007, DOI 10.1001/archinte.158.18.2007; Macedo ME, 2005, J HYPERTENS, V23, P1661, DOI 10.1097/01.hjh.0000179908.51187.de; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mancia G, 1997, LANCET, V349, P454, DOI 10.1016/S0140-6736(96)07099-7; Mancia Giuseppe, 2008, Ther Adv Cardiovasc Dis, V2, P5, DOI 10.1177/1753944707087409; McAlister FA, 2011, CAN MED ASSOC J, V183, P1007, DOI 10.1503/cmaj.101767; Mohan S, 2008, CAN MED ASSOC J, V178, P1458, DOI 10.1503/cmaj.080296; MORABIA A, 1994, SOZ PRAVENTIV MED, V39, P345, DOI 10.1007/BF01299666; Morabia A, 1997, PREV MED, V26, P311, DOI 10.1006/pmed.1997.0146; Muntner P, 2004, HYPERTENSION, V43, P578, DOI 10.1161/01.HYP.0000116302.08484.14; Ordunez-Garcia P, 2006, J HYPERTENS, V24, P845, DOI 10.1097/01.hjh.0000222753.67572.28; Reinhardt UE, 2004, JAMA-J AM MED ASSOC, V292, P1227, DOI 10.1001/jama.292.10.1227; Tian S, 2011, HYPERTENS RES, V34, P1087, DOI 10.1038/hr.2011.99; Varo JJ, 2003, INT J EPIDEMIOL, V32, P138, DOI 10.1093/ije/dyg116; Wagner A, 2011, J HYPERTENS, V29, P43, DOI 10.1097/HJH.0b013e32833f9c4d; WALKER WG, 1992, JAMA-J AM MED ASSOC, V268, P3085, DOI 10.1001/jama.268.21.3085; Wang YR, 2007, ARCH INTERN MED, V167, P141, DOI 10.1001/archinte.167.2.141; Whelton PK, 2004, J HUM HYPERTENS, V18, P545, DOI 10.1038/sj.jhh.1001701; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; Wolff H, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13165; Zdrojewski T, 2004, J HUM HYPERTENS, V18, P557, DOI 10.1038/sj.jhh.1001739	55	91	93	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39877	10.1371/journal.pone.0039877	http://dx.doi.org/10.1371/journal.pone.0039877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761919	Green Published, gold, Green Submitted			2022-12-27	WOS:000305825800077
J	Siedner, MJ; Lankowski, A; Haberer, JE; Kembabazi, A; Emenyonu, N; Tsai, AC; Muzoora, C; Geng, E; Martin, JN; Bangsberg, DR				Siedner, Mark J.; Lankowski, Alexander; Haberer, Jessica E.; Kembabazi, Annet; Emenyonu, Nneka; Tsai, Alexander C.; Muzoora, Conrad; Geng, Elvin; Martin, Jeffrey N.; Bangsberg, David R.			Rethinking the "Pre" in Pre-Therapy Counseling: No Benefit of Additional Visits Prior to Therapy on Adherence or Viremia in Ugandans Initiating ARVs	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; FOLLOW-UP; SOUTH-AFRICA; HIV CARE; PROGRAMS; BARRIERS; EFFICACY; DURBAN; ART; INTERVENTION	Background: Many guidelines recommend adherence counseling prior to initiating antiretrovirals (ARVs), however the additional benefit of pre-therapy counseling visits on early adherence is not known. We sought to assess for a benefit of adherence counseling visits prior to ARV initiation versus adherence counseling during the early treatment period. Methods: We performed a secondary analysis of data from a prospective cohort of HIV-infected patients in Mbarara, Uganda. Adults were enrolled upon initiation of ARVs. Our primary exposure of interest was ARV adherence counseling prior to initiating therapy (versus concurrent with initiation of therapy). Our outcomes of interest were: 1) average adherence >90% in first three months; 2) absence of treatment interruptions >72 hours in first three months; and 3) Viral load >400 copies/ml at the three month visit. We fit univariable and multivariable regression models, adjusted for predictors of ARV adherence, to estimate the association between additional pre-therapy counseling visits and our outcomes. Results: 300 participants had records of counseling, of whom 231 (77%) completed visits prior to initiation of ARVs and 69 (23%) on or shortly after initiation. Median age was 33, 71% were female, and median CD4 was 133 cell/ml. Median 90-day adherence was 95%. Participants who completed pre-therapy counseling visits had longer delays from ARV eligibility to initiation (median 49 vs 14 days, p<0.01). In multivariable analyses, completing adherence counseling prior to ARV initiation was not associated with average adherence >90% (AOR 0.8, 95% CI 0.4-1.5), absence of treatment gaps (AOR 0.7, 95% CI 0.2-1.9), or HIV viremia (AOR 1.1, 95% CI 0.4-3.1). Conclusions: Completion of adherence counseling visits prior to ARV therapy was not associated with higher adherence in this cohort of HIV-infected patients in Uganda. Because mortality and loss-to-follow-up remain high in the pre-ARV period, policy makers should reconsider whether counseling can be delivered with ARV initiation, especially in patients with advanced disease.	[Siedner, Mark J.; Lankowski, Alexander; Haberer, Jessica E.; Bangsberg, David R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA; [Lankowski, Alexander; Kembabazi, Annet; Emenyonu, Nneka; Muzoora, Conrad] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Tsai, Alexander C.; Bangsberg, David R.] Harvard Univ, Robert Wood Johnson Hlth & Soc Scholars Program, Boston, MA 02115 USA; [Geng, Elvin; Martin, Jeffrey N.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Bangsberg, David R.] Massahusetts Gen Hosp, Ctr Global Hlth, Boston, MA USA; [Bangsberg, David R.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Mbarara University of Science & Technology; Harvard University; Robert Wood Johnson Foundation (RWJF); University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Siedner, MJ (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA.	msiedner@partners.org	Lankowski, Alexander/AAE-6094-2020; Tsai, Alexander C./F-4247-2015; Haberer, Jessica/AAH-7976-2019; Muzoora, Conrad/AAV-7023-2021	Lankowski, Alexander/0000-0002-4769-7242; Tsai, Alexander C./0000-0001-6397-7917; Haberer, Jessica/0000-0001-5845-3190; Muzoora, Conrad/0000-0002-7866-5198	National Institutes of Health [R01 MH054907, K24 MH87227, P30 AI027793]; Mark and Lisa Schwartz Family Foundation; Robert Wood Johnson Health and Society Scholars Program; Doris Duke Charitable Foundation Clinical Research Fellowship at Harvard Medical School; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH087228, R01MH054907, K24MH087227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mark and Lisa Schwartz Family Foundation; Robert Wood Johnson Health and Society Scholars Program(Robert Wood Johnson Foundation (RWJF)); Doris Duke Charitable Foundation Clinical Research Fellowship at Harvard Medical School; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was funded by the National Institutes of Health (R01 MH054907, K24 MH87227, and P30 AI027793), and the Mark and Lisa Schwartz Family Foundation. Dr. Tsai received salary support from the Robert Wood Johnson Health and Society Scholars Program. Dr. Siedner received additional support from the Harvard Institute for Global Health and from the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University (R24 TW007988) and the American Relief and Recovery Act. Mr. Lankowski received support from the Doris Duke Charitable Foundation Clinical Research Fellowship at Harvard Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; [Anonymous], 2010, NAT GUID HIV AIDS CA; Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; *BOTSW MIN HLTH DE, 2008, BOTSW NAT HIV AIDS T; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Chung MH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000422; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Geng E, 2009, J ACQUIR IMMUNE DEFI; Geng E, 2011, FAILURE INITIATE ART; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Goujard C, 2003, JAIDS-J ACQ IMM DEF, V34, P191, DOI 10.1097/00126334-200310010-00009; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Maskew M, 2007, SAMJ S AFR MED J, V97, P853; McGrath N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-601; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; *MIN HLTH SOC WELF, 2008, NAT GUID MAN HIV AID; Ministerio de Saude, 2006, TRAT ANT INF OP AD A; Ministry of Health and Social Services Namibia, 2010, NAT GUID ANT THER; Ministry of Health Republic of Uganda, 2009, NAT ANT TREATM GUID; Mshana GH, 2006, AIDS PATIENT CARE ST, V20, P649, DOI 10.1089/apc.2006.20.649; Mulissa Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013268; Oyugi JH, 2004, JAIDS-J ACQ IMM DEF, V36, P1100, DOI 10.1097/00126334-200408150-00014; Pradier C, 2003, HIV CLIN TRIALS, V4, P121; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Simoni JM, 2006, JAIDS-J ACQ IMM DEF, V43, pS23, DOI 10.1097/01.qai.0000248342.05438.52; Tuldra A, 2000, J ACQ IMMUN DEF SYND, V25, P221, DOI 10.1097/00126334-200011010-00003; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Wanyenze RK, 2011, AIDS BEHAV, V15, P751, DOI 10.1007/s10461-010-9704-1; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; Zachariah R, 2011, T ROY SOC TROP MED H, V105, P421, DOI 10.1016/j.trstmh.2011.04.014	37	38	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39894	10.1371/journal.pone.0039894	http://dx.doi.org/10.1371/journal.pone.0039894			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966AK	22761924	Green Published, gold, Green Submitted			2022-12-27	WOS:000305808700053
J	Rivas, AL; Fasina, FO; Hoogesteyn, AL; Konah, SN; Febles, JL; Perkins, DJ; Hyman, JM; Fair, JM; Hittner, JB; Smith, SD				Rivas, Ariel L.; Fasina, Folorunso O.; Hoogesteyn, Almira L.; Konah, Steven N.; Febles, Jose L.; Perkins, Douglas J.; Hyman, James M.; Fair, Jeanne M.; Hittner, James B.; Smith, Steven D.			Connecting Network Properties of Rapidly Disseminating Epizoonotics	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; SPATIAL HETEROGENEITY; MATHEMATICAL-MODEL; COMPLEX NETWORKS; EPIDEMIC; SPREAD; SPACE; TIME; IDENTIFICATION; OUTBREAK	Background: To effectively control the geographical dissemination of infectious diseases, their properties need to be determined. To test that rapid microbial dispersal requires not only susceptible hosts but also a pre-existing, connecting network, we explored constructs meant to reveal the network properties associated with disease spread, which included the road structure. Methods: Using geo-temporal data collected from epizoonotics in which all hosts were susceptible (mammals infected by Foot-and-mouth disease virus, Uruguay, 2001; birds infected by Avian Influenza virus H5N1, Nigeria, 2006), two models were compared: 1) 'connectivity', a model that integrated bio-physical concepts (the agent's transmission cycle, road topology) into indicators designed to measure networks ('nodes' or infected sites with short-and long-range links), and 2) 'contacts', which focused on infected individuals but did not assess connectivity. Results: The connectivity model showed five network properties: 1) spatial aggregation of cases (disease clusters), 2) links among similar 'nodes' (assortativity), 3) simultaneous activation of similar nodes (synchronicity), 4) disease flows moving from highly to poorly connected nodes (directionality), and 5) a few nodes accounting for most cases (a "20:80" pattern). In both epizoonotics, 1) not all primary cases were connected but at least one primary case was connected, 2) highly connected, small areas (nodes) accounted for most cases, 3) several classes of nodes were distinguished, and 4) the contact model, which assumed all primary cases were identical, captured half the number of cases identified by the connectivity model. When assessed together, the synchronicity and directionality properties explained when and where an infectious disease spreads. Conclusions: Geo-temporal constructs of Network Theory's nodes and links were retrospectively validated in rapidly disseminating infectious diseases. They distinguished classes of cases, nodes, and networks, generating information usable to revise theory and optimize control measures. Prospective studies that consider pre-outbreak predictors, such as connecting networks, are recommended.	[Rivas, Ariel L.; Konah, Steven N.; Perkins, Douglas J.] Univ New Mexico, Hlth Sci Ctr, Ctr Global Hlth, Albuquerque, NM 87131 USA; [Rivas, Ariel L.] N Carolina State Univ, Coll Vet Med, Raleigh, NC USA; [Fasina, Folorunso O.] Univ Pretoria, Fac Vet Sci, ZA-0002 Pretoria, South Africa; [Fasina, Folorunso O.] Univ Utrecht, Fac Vet Med, Yalenaan, Netherlands; [Hoogesteyn, Almira L.; Febles, Jose L.] CINVESTAV, Merida, Yucatan, Mexico; [Hyman, James M.] Tulane Univ, Sch Sci & Engn, New Orleans, LA 70118 USA; [Fair, Jeanne M.] Los Alamos Natl Lab, Los Alamos, NM USA; [Hittner, James B.] Coll Charleston, Dept Psychol, Charleston, SC 29401 USA; [Smith, Steven D.] Cornell Univ, Coll Agr & Life Sci, Ithaca, NY 14853 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of North Carolina; North Carolina State University; University of Pretoria; Utrecht University; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Tulane University; United States Department of Energy (DOE); Los Alamos National Laboratory; College of Charleston; Cornell University	Rivas, AL (corresponding author), Univ New Mexico, Hlth Sci Ctr, Ctr Global Hlth, Albuquerque, NM 87131 USA.	alrivas@unm.edu	Hyman, James M/AAF-7389-2020; Fasina, Folorunso/B-6360-2015	Hyman, James M/0000-0001-5247-5794; Fasina, Folorunso/0000-0003-3088-8752	Defense Threat Reduction Agency (DTRA) [CBT-09-IST-05-1-0092]; FOGARTY INTERNATIONAL CENTER [D43TW005884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051305] Funding Source: NIH RePORTER	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was facilitated by the National Veterinary Research Institute, Vom, Plateau, Nigeria; the Center for Non-Linear Studies of Los Alamos National Laboratory; and partially funded by Defense Threat Reduction Agency (DTRA) Grant CBT-09-IST-05-1-0092 (to JMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SSU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024324; Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490; Aparicio JP, 2007, P ROY SOC B-BIOL SCI, V274, P505, DOI 10.1098/rspb.2006.0057; Badham J, 2010, THEOR POPUL BIOL, V77, P71, DOI 10.1016/j.tpb.2009.11.003; Bahl J, 2011, P NATL ACAD SCI USA, V108, P19359, DOI 10.1073/pnas.1109314108; Balcan D, 2012, J THEOR BIOL, V293, P87, DOI 10.1016/j.jtbi.2011.10.010; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Breslow NE, 2003, BIOMETRICS, V59, P1, DOI 10.1111/1541-0420.00001; Brooks CP, 2008, AM NAT, V172, P149, DOI 10.1086/589451; Carpenter TE, 2001, PREV VET MED, V48, P303, DOI 10.1016/S0167-5877(00)00199-9; Choo L, 2008, J R STAT SOC A STAT, V171, P395, DOI 10.1111/j.1467-985X.2007.00503.x; Clements ACA, 2009, VET J, V182, P21, DOI 10.1016/j.tvjl.2008.05.010; Colizza V, 2007, CR BIOL, V330, P364, DOI 10.1016/j.crvi.2007.02.014; Cooper B, 2006, P NATL ACAD SCI USA, V103, P12221, DOI 10.1073/pnas.0605502103; Dale MRT, 2010, ANNU REV ECOL EVOL S, V41, P21, DOI 10.1146/annurev-ecolsys-102209-144718; Danon L., 2011, Interdisciplinary Perspectives on Infectious Diseases, V2011, P284909, DOI 10.1155/2011/284909; de Oliveira DP, 2011, ADV ENG INFORM, V25, P380, DOI 10.1016/j.aei.2010.09.001; Durrett R, 2010, P NATL ACAD SCI USA, V107, P4491, DOI 10.1073/pnas.0914402107; Elliott P, 2004, ENVIRON HEALTH PERSP, V112, P998, DOI 10.1289/ehp.6735; Ellis AM, 2010, OIKOS, V119, P485, DOI 10.1111/j.1600-0706.2009.17918.x; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fuller MM, 2008, NAT RESOUR MODEL, V21, P225, DOI 10.1111/j.1939-7445.2008.00004.x; Funk S, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036118; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Givan O, 2011, J THEOR BIOL, V288, P21, DOI 10.1016/j.jtbi.2011.07.015; Gloster J, 2010, VET J, V183, P278, DOI 10.1016/j.tvjl.2008.11.011; Graf RF, 2007, LANDSCAPE ECOL, V22, P853, DOI 10.1007/s10980-006-9073-3; Green DM, 2006, J THEOR BIOL, V239, P289, DOI 10.1016/j.jtbi.2005.07.018; Gurarie D, 2009, J R SOC INTERFACE, V6, P495, DOI 10.1098/rsif.2008.0265; Haydon DT, 2003, P ROY SOC B-BIOL SCI, V270, P121, DOI 10.1098/rspb.2002.2191; Johnson BR, 2010, BIOL PHILOS, V25, P843, DOI 10.1007/s10539-010-9230-6; Kim PJ, 2007, EUR PHYS J B, V55, P109, DOI 10.1140/epjb/e2007-00033-7; Kostova T, 2009, J DIFFER EQU APPL, V15, P415, DOI 10.1080/10236190902766835; Kretzschmar M, 1996, MATH BIOSCI, V133, P165, DOI 10.1016/0025-5564(95)00093-3; Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; LONGINI IM, 1988, MATH BIOSCI, V90, P367, DOI 10.1016/0025-5564(88)90075-2; Luke DA, 2007, ANNU REV PUBL HEALTH, V28, P69, DOI 10.1146/annurev.publhealth.28.021406.144132; Martinez-Lopez B, 2009, TRANSBOUND EMERG DIS, V56, P109, DOI 10.1111/j.1865-1682.2009.01073.x; MAY RM, 1984, MATH BIOSCI, V72, P83, DOI 10.1016/0025-5564(84)90063-4; Mercer GN, 2011, STAT MED, V30, P984, DOI 10.1002/sim.4174; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Moore SM, 2011, B MATH BIOL, V73, P2707, DOI 10.1007/s11538-011-9654-4; Newman M, 2008, PHYS TODAY, V61, P33, DOI 10.1063/1.3027989; Nishiura H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017908; Parham PE, 2006, J R SOC INTERFACE, V3, P483, DOI 10.1098/rsif.2005.0105; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Picado A, 2007, PREV VET MED, V79, P3, DOI 10.1016/j.prevetmed.2006.11.009; Remais Justin, 2010, J R Soc Interface, V7, P1181, DOI 10.1098/rsif.2009.0523; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Rivas AL, 2010, EPIDEMIOL INFECT, V138, P192, DOI 10.1017/S0950268809990495; Rivas AL, 2004, J VET MED B, V51, P263, DOI 10.1111/j.1439-0450.2004.00768.x; Rivas AL, 2003, AM J VET RES, V64, P1519, DOI 10.2460/ajvr.2003.64.1519; Rivas AL, 2003, CAN J VET RES, V67, P307; Rocha LEC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001109; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; Smith DL, 2005, PREV VET MED, V71, P225, DOI 10.1016/j.prevetmed.2005.07.009; Smith DL, 2002, P NATL ACAD SCI USA, V99, P3668, DOI [10.1073/pnas.042400799, 10.1073/pnas.132272199]; Snow SJ, 2002, INT J EPIDEMIOL, V31, P908, DOI 10.1093/ije/31.5.908; Taylor NM, 2004, VET REC, V154, P617, DOI 10.1136/vr.154.20.617; Uddin S, 2011, COMPLEXITY, V16, P27, DOI 10.1002/cplx.20349; Vespignani A, 2012, NAT PHYS, V8, P32, DOI 10.1038/nphys2160; Wagner BG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-81; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Woolhouse MEJ, 2003, J APPL MICROBIOL, V94, p126S; Xie F, 2007, GEOGR ANAL, V39, P336, DOI 10.1111/j.1538-4632.2007.00707.x; Xu B, 2006, ANN ASSOC AM GEOGR, V96, P31, DOI 10.1111/j.1467-8306.2006.00497.x	70	14	16	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39778	10.1371/journal.pone.0039778	http://dx.doi.org/10.1371/journal.pone.0039778			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761900	gold, Green Published, Green Submitted			2022-12-27	WOS:000305781700066
J	Cairns, DM; Liu, RJ; Sen, M; Canner, JP; Schindeler, A; Little, DG; Zeng, L				Cairns, Dana M.; Liu, Renjing; Sen, Manpreet; Canner, James P.; Schindeler, Aaron; Little, David G.; Zeng, Li			Interplay of Nkx3.2, Sox9 and Pax3 Regulates Chondrogenic Differentiation of Muscle Progenitor Cells	PLOS ONE			English	Article							LASER-CAPTURE MICRODISSECTION; SKELETAL-MUSCLE; SATELLITE CELLS; STEM-CELLS; IN-VITRO; FRACTURE REPAIR; AXIAL SKELETON; BONE-MARROW; MYOGENIC DIFFERENTIATION; CHONDROCYTE MATURATION	Muscle satellite cells make up a stem cell population that is capable of differentiating into myocytes and contributing to muscle regeneration upon injury. In this work we investigate the mechanism by which these muscle progenitor cells adopt an alternative cell fate, the cartilage fate. We show that chick muscle satellite cells that normally would undergo myogenesis can be converted to express cartilage matrix proteins in vitro when cultured in chondrogenic medium containing TGF beta 3 or BMP2. In the meantime, the myogenic program is repressed, suggesting that muscle satellite cells have undergone chondrogenic differentiation. Furthermore, ectopic expression of the myogenic factor Pax3 prevents chondrogenesis in these cells, while chondrogenic factors Nkx3.2 and Sox9 act downstream of TGF beta 3 or BMP2 to promote this cell fate transition. We found that Nkx3.2 and Sox9 repress the activity of the Pax3 promoter and that Nkx3.2 acts as a transcriptional repressor in this process. Importantly, a reverse function mutant of Nkx3.2 blocks the ability of Sox9 to both inhibit myogenesis and induce chondrogenesis, suggesting that Nkx3.2 is required for Sox9 to promote chondrogenic differentiation in satellite cells. Finally, we found that in an in vivo mouse model of fracture healing where muscle progenitor cells were lineage-traced, Nkx3.2 and Sox9 are significantly upregulated while Pax3 is significantly downregulated in the muscle progenitor cells that give rise to chondrocytes during fracture repair. Thus our in vitro and in vivo analyses suggest that the balance of Pax3, Nkx3.2 and Sox9 may act as a molecular switch during the chondrogenic differentiation of muscle progenitor cells, which may be important for fracture healing.	[Cairns, Dana M.; Canner, James P.; Zeng, Li] Tufts Univ, Sackler Sch Grad Biomed Sci, Program Cellular Mol & Dev Biol, Boston, MA 02111 USA; [Liu, Renjing; Schindeler, Aaron; Little, David G.] Childrens Hosp Westmead, Orthopaed Res & Biotechnol Unit, Westmead, NSW, Australia; [Liu, Renjing; Schindeler, Aaron; Little, David G.] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia; [Sen, Manpreet; Zeng, Li] Tufts Univ, Sch Med, Bldg Divers Biomed Res Program BDBS, Boston, MA 02111 USA; [Sen, Manpreet; Zeng, Li] Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Boston, MA 02111 USA; [Zeng, Li] Tufts Med Ctr, Dept Orthopaed Surg, Boston, MA USA	Tufts University; University of Sydney; University of Sydney; Tufts University; Tufts University; Tufts Medical Center	Cairns, DM (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Program Cellular Mol & Dev Biol, Boston, MA 02111 USA.	li.zeng@tufts.edu		Cairns, Dana/0000-0003-0574-8395; Schindeler, Aaron/0000-0002-7757-6281	NSF [CBET-0966920]; NIH [R01AR059106, 5R25HL007786]; Sackler Dean's Fellowship from Tufts University; Australian Orthopaedic Research Fund (AORF); National Health and Medical Research Council (NH MRC) [457245]; Peter Bega scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL007786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059106, R03AR054611] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sackler Dean's Fellowship from Tufts University; Australian Orthopaedic Research Fund (AORF); National Health and Medical Research Council (NH MRC)(National Health and Medical Research Council (NHMRC) of Australia); Peter Bega scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	L.Z. was supported by a grant from NSF (CBET-0966920, www.nsf.gov) and NIH (R01AR059106, www.nih.gov). D.C. was supported by the Sackler Dean's Fellowship from Tufts University (sackler.tufts.edu). A.S. and D.G.L. were supported by the Australian Orthopaedic Research Fund (AORF, www.aoa.org.au) and the National Health and Medical Research Council (NH& MRC, grant no. 457245, www.nhmrc.gov.au). R.S. was supported by a Peter Bega scholarship (www.chw.edu.au). M.S. was supported by NIH (5R25HL007786, www.nih.gov), which funds the Building Diversity in Biomedical Sciences program (BDBS) at Tufts University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Bajard L, 2006, GENE DEV, V20, P2450, DOI 10.1101/gad.382806; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; BETTEXGALLAND M, 1987, EXPERIENTIA, V43, P610, DOI 10.1007/BF02126349; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bobick BE, 2009, BIRTH DEFECTS RES C, V87, P351, DOI 10.1002/bdrc.20167; Borycki AG, 1999, DEVELOPMENT, V126, P1665; Bosch P, 2000, J ORTHOP RES, V18, P933, DOI 10.1002/jor.1100180613; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brammer KS, 2011, ACTA BIOMATER, V7, P683, DOI 10.1016/j.actbio.2010.09.022; Brammer KS, 2010, MAT SCI ENG C-MATER, V30, P518, DOI 10.1016/j.msec.2010.01.013; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Burton N M, 2000, Methods Cell Sci, V22, P51, DOI 10.1023/A:1009830114804; Cairns DM, 2008, DEV BIOL, V323, P152, DOI 10.1016/j.ydbio.2008.08.024; CHALEPAKIS G, 1994, P NATL ACAD SCI USA, V91, P12745, DOI 10.1073/pnas.91.26.12745; Clark CA, 2009, J ORTHOP RES, V27, P785, DOI 10.1002/jor.20805; Collins CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004475; Colnot C, 2009, J BONE MINER RES, V24, P274, DOI 10.1359/JBMR.081003; Doherty MJ, 1998, J BONE MINER RES, V13, P828, DOI 10.1359/jbmr.1998.13.5.828; EPSTEIN JA, 1995, J BIOL CHEM, V270, P11719, DOI 10.1074/jbc.270.20.11719; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Espina Virginia, 2006, V319, P213; Evans CH, 2009, EUR CELLS MATER, V18, P96, DOI 10.22203/eCM.v018a09; Evans CH, 2007, TISSUE ENG, V13, P1987, DOI 10.1089/ten.2006.0302; Fenwick SA, 1997, INT J EXP PATHOL, V78, P187, DOI 10.1046/j.1365-2613.1997.210355.x; Han HS, 2010, J ORTHOP RES, V28, P1283, DOI 10.1002/jor.21129; Harry LE, 2008, J ORTHOP RES, V26, P1238, DOI 10.1002/jor.20649; HARTLEY RS, 1992, DEV BIOL, V153, P206, DOI 10.1016/0012-1606(92)90106-Q; Hashimoto N, 2008, MECH DEVELOP, V125, P257, DOI 10.1016/j.mod.2007.11.004; Hattori T, 2010, DEVELOPMENT, V137, P901, DOI 10.1242/dev.045203; Hellemans J, 2009, AM J HUM GENET, V85, P916, DOI 10.1016/j.ajhg.2009.11.005; Herbrand H, 2002, MECH DEVELOP, V117, P217, DOI 10.1016/S0925-4773(02)00207-1; Hollenbach AD, 1999, EMBO J, V18, P3702, DOI 10.1093/emboj/18.13.3702; Holzmann P, 2010, ALTEX-ALTERN ANIM EX, V27, P97; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kaback LA, 2008, J CELL BIOCHEM, V105, P219, DOI 10.1002/jcb.21816; Kanisicak O, 2009, DEV BIOL, V332, P131, DOI 10.1016/j.ydbio.2009.05.554; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kim DW, 2003, MOL CELL BIOL, V23, P8704, DOI 10.1128/MCB.23.23.8704-8717.2003; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lengner CJ, 2005, J BIOL CHEM, V280, P15872, DOI 10.1074/jbc.M411144200; Lettice L, 2001, J ANAT, V199, P181, DOI 10.1046/j.1469-7580.2001.19910181.x; Lettice LA, 1999, P NATL ACAD SCI USA, V96, P9695, DOI 10.1073/pnas.96.17.9695; Li G, 2004, P 50 ANN M ORTH RES; Lissenberg-Thunnissen SN, 2011, INT ORTHOP; Liu R, 2010, J MUSCULOSKEL NEURON, V10, P71; Liu RJ, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-288; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lu Chuanyong, 2006, Iowa Orthop J, V26, P17; Machida S, 2004, CELL PROLIFERAT, V37, P267, DOI 10.1111/j.1365-2184.2004.00311.x; Maeda Y, 2003, BONE, V32, P27, DOI 10.1016/S8756-3282(02)00917-1; Magnaghi P, 1998, NAT GENET, V20, P74, DOI 10.1038/1739; Hernandez-Hernandez JM, 2009, J MOL BIOL, V394, P1, DOI 10.1016/j.jmb.2009.08.057; Maroto M, 1997, CELL, V89, P139, DOI 10.1016/S0092-8674(00)80190-7; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Meech R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011612; Mello MA, 1999, IN VITRO CELL DEV-AN, V35, P262; Minear S, 2010, J BONE MINER RES, V25, P1196, DOI 10.1002/jbmr.29; Minear S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000231; Morrison JI, 2010, FASEB J, V24, P750, DOI 10.1096/fj.09-134825; Morrison JI, 2006, J CELL BIOL, V172, P433, DOI 10.1083/jcb.200509011; Murtaugh LC, 2001, DEV CELL, V1, P411, DOI 10.1016/S1534-5807(01)00039-9; NATHANSON MA, 1983, J BIOL CHEM, V258, P325; NATHANSON MA, 1986, CURR TOP DEV BIOL, V20, P39, DOI 10.1016/S0070-2153(08)60653-5; Natoli TA, 1997, DEVELOPMENT, V124, P617; Nehlin JO, 2011, BIOGERONTOLOGY, V12, P349, DOI 10.1007/s10522-011-9336-5; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Provot S, 2006, DEVELOPMENT, V133, P651, DOI 10.1242/dev.02258; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Rosier RN, 1998, CLIN ORTHOP RELAT R, pS294; Schindeler A, 2008, BONE, V42, P616, DOI 10.1016/j.bone.2007.11.006; Schindeler A, 2008, J ORTHOP RES, V26, P1053, DOI 10.1002/jor.20628; Schindeler A, 2009, DIFFERENTIATION, V77, P12, DOI 10.1016/j.diff.2008.09.007; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Schmidt K, 2003, J BIOL CHEM, V278, P29769, DOI 10.1074/jbc.M301539200; Secreto Frank J, 2009, Curr Osteoporos Rep, V7, P64; Sekiya I, 2005, CELL TISSUE RES, V320, P269, DOI 10.1007/s00441-004-1075-3; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; Starkey JD, 2011, J HISTOCHEM CYTOCHEM, V59, P33, DOI 10.1369/jhc.2010.956995; Takahata M, 2011, CELL TISSUE RES; Tribioli C, 1999, DEVELOPMENT, V126, P5699; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Wada MR, 2002, DEVELOPMENT, V129, P2987; Wang LH, 2007, CRYOBIOLOGY, V55, P138, DOI 10.1016/j.cryobiol.2007.06.005; Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022; WHITLEY CB, 1989, CLIN CHEM, V35, P374; Wiggan O, 1998, ONCOGENE, V16, P227, DOI 10.1038/sj.onc.1201534; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Xie C, 2009, AM J PATHOL, V175, P772, DOI 10.2353/ajpath.2009.081099; Yi SE, 2000, DEVELOPMENT, V127, P621; Yu YY, 2010, BONE, V46, P841, DOI 10.1016/j.bone.2009.11.005; Zeng L, 2002, GENE DEV, V16, P1990, DOI 10.1101/gad.1008002; Zhao YM, 2012, CELLS TISSUES ORGANS, V195, P414, DOI 10.1159/000329254	101	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39642	10.1371/journal.pone.0039642	http://dx.doi.org/10.1371/journal.pone.0039642			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768305	Green Published, Green Submitted, gold			2022-12-27	WOS:000305966500018
J	Morairty, SR; Revel, FG; Malherbe, P; Moreau, JL; Valladao, D; Wettstein, JG; Kilduff, TS; Borroni, E				Morairty, Stephen R.; Revel, Florent G.; Malherbe, Pari; Moreau, Jean-Luc; Valladao, Daniel; Wettstein, Joseph G.; Kilduff, Thomas S.; Borroni, Edilio			Dual Hypocretin Receptor Antagonism Is More Effective for Sleep Promotion than Antagonism of Either Receptor Alone	PLOS ONE			English	Article							HYPOTHALAMIC OREXIN NEURONS; BLOOD-BRAIN-BARRIER; P-GLYCOPROTEIN; PHARMACOLOGICAL CHARACTERIZATION; RAT-BRAIN; REM-SLEEP; MICE; WAKEFULNESS; NARCOLEPSY; DISCOVERY	The hypocretin (orexin) system is involved in sleep/wake regulation, and antagonists of both hypocretin receptor type 1 (HCRTR1) and/or HCRTR2 are considered to be potential hypnotic medications. It is currently unclear whether blockade of either or both receptors is more effective for promoting sleep with minimal side effects. Accordingly, we compared the properties of selective HCRTR1 (SB-408124 and SB-334867) and HCRTR2 (EMPA) antagonists with that of the dual HCRTR1/R2 antagonist almorexant in the rat. All 4 antagonists bound to their respective receptors with high affinity and selectivity in vitro. Since in vivo pharmacokinetic experiments revealed poor brain penetration for SB-408124, SB-334867 was selected for subsequent in vivo studies. When injected in the mid-active phase, SB-334867 produced small increases in rapid-eye-movement (REM) and non-REM (NR) sleep. EMPA produced a significant increase in NR only at the highest dose studied. In contrast, almorexant decreased NR latency and increased both NR and REM proportionally throughout the subsequent 6 h without rebound wakefulness. The increased NR was due to a greater number of NR bouts; NR bout duration was unchanged. At the highest dose tested (100 mg/kg), almorexant fragmented sleep architecture by increasing the number of waking and REM bouts. No evidence of cataplexy was observed. HCRTR1 occupancy by almorexant declined 4-6 h post-administration while HCRTR2 occupancy was still elevated after 12 h, revealing a complex relationship between occupancy of HCRT receptors and sleep promotion. We conclude that dual HCRTR1/R2 blockade is more effective in promoting sleep than blockade of either HCRTR alone. In contrast to GABA receptor agonists which induce sleep by generalized inhibition, HCRTR antagonists seem to facilitate sleep by reducing waking "drive".	[Morairty, Stephen R.; Valladao, Daniel; Kilduff, Thomas S.] SRI Int, Ctr Neurosci & Metab Dis Res, Menlo Pk, CA 94025 USA; [Revel, Florent G.; Malherbe, Pari; Moreau, Jean-Luc; Wettstein, Joseph G.; Borroni, Edilio] F Hoffmann La Roche Ltd, Neurosci Res, Basel, Switzerland	SRI International; Roche Holding	Morairty, SR (corresponding author), SRI Int, Ctr Neurosci & Metab Dis Res, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.	stephen.morairty@sri.com	Kilduff, Thomas S/K-3127-2012	Kilduff, Thomas S/0000-0002-6823-0094	United States Army Medical Research and Materiel Command (USAMRMC) [W81XWH-09-2-0081]; Roche	United States Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Roche(Roche Holding)	Work at SRI International was supported in part by United States Army Medical Research and Materiel Command (USAMRMC) grant W81XWH-09-2-0081 (http://cdmrp.army.mil/default.shtml) and in part by institutional funds. Work at Roche was funded by Roche. USAMRMC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Roche partly contributed to study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Adamantidis A, 2009, J PHYSIOL-LONDON, V587, P33, DOI 10.1113/jphysiol.2008.164400; Akanmu MA, 2005, BRAIN RES, V1048, P138, DOI 10.1016/j.brainres.2005.04.064; Baker DE, 2007, REV GASTROENTEROL DI, V7, pS11; Ballard TM, 2009, PSYCHOPHARMACOLOGY, V202, P207, DOI 10.1007/s00213-008-1357-7; Bingham S, 2001, PAIN, V92, P81, DOI 10.1016/S0304-3959(00)00470-X; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Boutrel B, 2005, P NATL ACAD SCI USA, V102, P19168, DOI 10.1073/pnas.0507480102; Brisbare-Roch C, 2007, NAT MED, V13, P150, DOI 10.1038/nm1544; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Coleman PJ, 2010, BIOORG MED CHEM LETT, V20, P4201, DOI 10.1016/j.bmcl.2010.05.047; Coleman PJ, 2012, CHEMMEDCHEM; Cox CD, 2010, J MED CHEM, V53, P5320, DOI 10.1021/jm100541c; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Di Fabio R, 2011, BIOORG MED CHEM LETT, V21, P5562, DOI 10.1016/j.bmcl.2011.06.086; DUGOVIC C, 2009, J PHARM EXP THER; Emerich DF, 1998, BRAIN RES, V801, P259, DOI 10.1016/S0006-8993(98)00571-X; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; Gozzi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016406; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Haynes AC, 2000, REGUL PEPTIDES, V96, P45, DOI 10.1016/S0167-0115(00)00199-3; Hirose M, 2003, BIOORG MED CHEM LETT, V13, P4497, DOI 10.1016/j.bmcl.2003.08.038; Johnson PL, 2010, NAT MED, V16, P111, DOI 10.1038/nm.2075; Kajiyama S, 2005, BRAIN RES, V1044, P76, DOI 10.1016/j.brainres.2005.03.007; KALINER MA, 1992, AM FAM PHYSICIAN, V45, P1337; Kilduff TS, 2000, TRENDS NEUROSCI, V23, P359, DOI 10.1016/S0166-2236(00)01594-0; Kilduff TS, 2005, SLEEP MED REV, V9, P227, DOI 10.1016/j.smrv.2005.04.002; Kuwaki T, 2010, RESP PHYSL NEUROBIOL; Kuwaki T, 2008, RESP PHYSIOL NEUROBI, V164, P204, DOI 10.1016/j.resp.2008.03.011; Langmead CJ, 2004, BRIT J PHARMACOL, V141, P340, DOI 10.1038/sj.bjp.0705610; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Lindemann L, 2008, J PHARMACOL EXP THER, V324, P948, DOI 10.1124/jpet.107.132647; Linnet K, 2008, EUR NEUROPSYCHOPHARM, V18, P157, DOI 10.1016/j.euroneuro.2007.06.003; Malherbe P, 2009, BRIT J PHARMACOL, V156, P1326, DOI 10.1111/j.1476-5381.2009.00127.x; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; McAtee LC, 2004, BIOORG MED CHEM LETT, V14, P4225, DOI 10.1016/j.bmcl.2004.06.032; Mieda M, 2011, J NEUROSCI, V31, P6518, DOI 10.1523/JNEUROSCI.6506-10.2011; Mobarakeh JI, 2005, PEPTIDES, V26, P767, DOI 10.1016/j.peptides.2005.01.001; Morairty SR, 2008, SLEEP, V31, P34, DOI 10.1093/sleep/31.1.34; Narita M, 2006, J NEUROSCI, V26, P398, DOI 10.1523/JNEUROSCI.2761-05.2006; Nattie E, 2010, J APPL PHYSIOL, V108, P1417, DOI 10.1152/japplphysiol.01261.2009; NORMAN PS, 1985, J ALLERGY CLIN IMMUN, V76, P366, DOI 10.1016/0091-6749(85)90655-4; Sadeque AJM, 2000, CLIN PHARMACOL THER, V68, P231, DOI 10.1067/mcp.2000.109156; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Samson WK, 2005, SLEEP MED REV, V9, P243, DOI 10.1016/j.smrv.2004.07.006; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; Siegel JM, 2004, ANNU REV PSYCHOL, V55, P125, DOI 10.1146/annurev.psych.55.090902.141545; Smart D, 2001, BRIT J PHARMACOL, V132, P1179, DOI 10.1038/sj.bjp.0703953; Smith MI, 2003, NEUROSCI LETT, V341, P256, DOI 10.1016/S0304-3940(03)00066-1; SNYDER SH, 1987, ANN ALLERGY, V59, P4; Thuerauf N, 2006, EUR ARCH PSY CLIN N, V256, P281, DOI 10.1007/s00406-006-0662-6; Trivedi P, 1998, FEBS LETT, V438, P71, DOI 10.1016/S0014-5793(98)01266-6; Weller T., 2005, [No title captured], Patent No. [WO2005118548, 2005118548, WO 2005/118548]; Whitman DB, 2009, CHEMMEDCHEM, V4, P1069, DOI 10.1002/cmdc.200900069; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Winrow CJ, 2012, NEUROPHARMACOLOGY, V62, P978, DOI 10.1016/j.neuropharm.2011.10.003; Winrow CJ, 2011, J NEUROGENET, V25, P52, DOI 10.3109/01677063.2011.566953; Winsky-Sommerer R, 2004, J NEUROSCI, V24, P11439, DOI 10.1523/JNEUROSCI.3459-04.2004; Xie XM, 2008, J CLIN INVEST, V118, P2471, DOI 10.1172/JCI35115; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Yoshida Y, 2001, EUR J NEUROSCI, V14, P1075, DOI 10.1046/j.0953-816x.2001.01725.x	63	95	96	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39131	10.1371/journal.pone.0039131	http://dx.doi.org/10.1371/journal.pone.0039131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768296	Green Published, gold, Green Submitted			2022-12-27	WOS:000305966500009
J	Pillai, A; Bruno, D; Sarreal, AS; Hernando, RT; Saint-Louis, LA; Nierenberg, J; Ginsberg, SD; Pomara, N; Mehta, PD; Zetterberg, H; Blennow, K; Buckley, PF				Pillai, Anilkumar; Bruno, Davide; Sarreal, Antero S.; Hernando, Raymundo T.; Saint-Louis, Leslie A.; Nierenberg, Jay; Ginsberg, Stephen D.; Pomara, Nunzio; Mehta, Pankaj D.; Zetterberg, Henrik; Blennow, Kaj; Buckley, Peter F.			Plasma BDNF Levels Vary in Relation to Body Weight in Females	PLOS ONE			English	Article							NEUROTROPHIC FACTOR BDNF; TRKB MESSENGER-RNA; RAT-BRAIN; DIABETIC MICE; ALZHEIMERS-DISEASE; GLUCOSE-METABOLISM; ANOREXIA-NERVOSA; DENDRITIC GROWTH; GENE-EXPRESSION; HUMAN PLATELETS	Brain derived neurotrophic factor (BDNF) has been implicated in the pathophysiology of depression as well as neuropsychiatric and neurodegenerative disorders. Recent studies show a role of BDNF in energy metabolism and body weight regulation. We examined BDNF levels in plasma and cerebrospinal fluid (CSF) samples from age matched elderly depressed and control subjects. Also, the association of BDNF levels with age, gender, body weight, body mass index (BMI), and cognitive performance was evaluated. We did not find any significant differences in plasma and CSF BDNF levels between depressed and control subjects. Plasma BDNF levels were negatively correlated with age (but not with BMI and body weight), when analyses were performed including both depressed and control subjects. A significant reduction in plasma BDNF levels was observed in females as compared to male subjects, and the change in BDNF levels were significantly and positively related to body weight in females. Furthermore, significant increases in Total Recall and Delayed Recall values were found in females as compared to males. In conclusion, the lower BDNF levels observed in females suggest that changes in peripheral BDNF levels are likely secondary to an altered energy balance. However, further studies using larger sample size are warranted.	[Pillai, Anilkumar; Buckley, Peter F.] Georgia Hlth Sci Univ, Med Coll Georgia, Dept Psychiat & Hlth Behav, Augusta, GA USA; [Bruno, Davide; Sarreal, Antero S.; Hernando, Raymundo T.; Pomara, Nunzio] Nathan S Kline Inst Psychiat Res, Div Geriatr Psychiat, Orangeburg, NY 10962 USA; [Saint-Louis, Leslie A.] Corinthian Diagnost Radiol, New York, NY USA; [Nierenberg, Jay; Ginsberg, Stephen D.] Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA; [Bruno, Davide; Nierenberg, Jay; Ginsberg, Stephen D.; Pomara, Nunzio] NYU, Sch Med, New York, NY USA; [Mehta, Pankaj D.] New York State Inst Basic Res Mental Retardat, Staten Isl, NY USA; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Gothenburg, Sweden	University System of Georgia; Augusta University; Nathan Kline Institute for Psychiatric Research; Nathan Kline Institute for Psychiatric Research; New York University; Sahlgrenska University Hospital	Pillai, A (corresponding author), Georgia Hlth Sci Univ, Med Coll Georgia, Dept Psychiat & Hlth Behav, Augusta, GA USA.	apillai@georgiahealth.edu	PILLAI, ANILKUMAR/N-4809-2017; , SDG/AAB-3329-2022; Bruno, Davide/E-1311-2012	Bruno, Davide/0000-0003-1943-9905; Ginsberg, Stephen/0000-0002-1797-4288; Pomara, Nunzio/0000-0003-2204-0102; Nierenberg, Jay/0000-0002-4643-1020	National Institute of Mental Health (NIMH) [R01 MH-080505]; NATIONAL CANCER INSTITUTE [R21CA094520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086385, F31MH080505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017617, R01AG043375, P01AG014449] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institute of Mental Health (NIMH) grant R01 MH-080505 to Dr. Pomara. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Benton AL, 1976, MULTILINGUAL APHASIA; Bimonte HA, 2003, NEUROBIOL AGING, V24, P37, DOI 10.1016/S0197-4580(02)00015-5; Bus BAA, 2011, PSYCHONEUROENDOCRINO, V36, P228, DOI 10.1016/j.psyneuen.2010.07.013; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Choi SW, 2011, PSYCHIAT RES, V186, P427, DOI 10.1016/j.psychres.2010.07.028; Cunha ABM, 2006, NEUROSCI LETT, V398, P215, DOI 10.1016/j.neulet.2005.12.085; Dwivedi Y, 2003, ARCH GEN PSYCHIAT, V60, P804, DOI 10.1001/archpsyc.60.8.804; Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728; Fumagalli F, 2004, EUR J NEUROSCI, V20, P1348, DOI 10.1111/j.1460-9568.2004.03592.x; Gervasoni N, 2005, NEUROPSYCHOBIOLOGY, V51, P234, DOI 10.1159/000085725; Ginsberg SD, 2006, J NEUROCHEM, V97, P475, DOI 10.1111/j.1471-4159.2006.03764.x; Ginsberg SD, 2010, BIOL PSYCHIAT, V68, P885, DOI 10.1016/j.biopsych.2010.05.030; Goodglass H., 1983, BOSTON NAMING TEST; Goodglass H., 2001, ASSESSMENT APHASIA R; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Hashimoto K, 2010, PSYCHIAT CLIN NEUROS, V64, P341, DOI 10.1111/j.1440-1819.2010.02113.x; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Karege F, 2005, BIOL PSYCHIAT, V57, P1068, DOI 10.1016/j.biopsych.2005.01.008; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Koponen E, 2005, CELL MOL NEUROBIOL, V25, P973, DOI 10.1007/s10571-005-8468-z; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Lang UE, 2004, NEUROPSYCHOPHARMACOL, V29, P795, DOI 10.1038/sj.npp.1300382; LAPCHAK PA, 1992, NEUROREPORT, V3, P405, DOI 10.1097/00001756-199205000-00007; Leuner B, 2004, PSYCHONEUROENDOCRINO, V29, P883, DOI 10.1016/j.psyneuen.2003.08.001; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; MacQueen Glenda, 2004, Can J Psychiatry, V49, p27S; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; Ming Y, 1999, NEUROSCI LETT, V273, P187, DOI 10.1016/S0304-3940(99)00655-2; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Molendijk ML, 2011, MOL PSYCHIATR, V16, P1088, DOI 10.1038/mp.2010.98; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Monteleone P, 2008, BIPOLAR DISORD, V10, P95, DOI 10.1111/j.1399-5618.2008.00459.x; Monteleone P, 2005, PSYCHOL MED, V35, P897, DOI 10.1017/S0033291704003368; Monteleone P, 2004, PSYCHOSOM MED, V66, P744, DOI 10.1097/01.psy.0000138119.12956.99; Nakagawa T, 2000, DIABETES, V49, P436, DOI 10.2337/diabetes.49.3.436; Neeper SA, 1996, BRAIN RES, V726, P49, DOI 10.1016/S0006-8993(96)00273-9; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Noble EE, 2011, AM J PHYSIOL-REG I, V300, pR1053, DOI 10.1152/ajpregu.00776.2010; Ono M, 2000, METABOLISM, V49, P129, DOI 10.1016/S0026-0495(00)90988-0; PELLEYMOUNTER MA, 1995, EXP NEUROL, V131, P229, DOI 10.1016/0014-4886(95)90045-4; Pillai A, 2010, INT J NEUROPSYCHOPH, V13, P535, DOI 10.1017/S1461145709991015; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Ribases M, 2003, MOL PSYCHIATR, V8, P745, DOI 10.1038/sj.mp.4001281; Ribases M, 2004, HUM MOL GENET, V13, P1205, DOI 10.1093/hmg/ddh137; Romanczyk TB, 2002, EUR J NEUROSCI, V15, P269, DOI 10.1046/j.0953-816x.2001.01858.x; Rosas-Vargas H, 2011, ARCH MED RES, V42, P482, DOI 10.1016/j.arcmed.2011.09.005; Scharfman HE, 2006, FRONT NEUROENDOCRIN, V27, P415, DOI 10.1016/j.yfrne.2006.09.004; Schwarz E, 2008, EXPERT REV MOL DIAGN, V8, P209, DOI 10.1586/14737159.8.2.209; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Siuciak JA, 1996, BRAIN RES, V710, P11, DOI 10.1016/0006-8993(95)01289-3; Skledar M, 2012, PROG NEURO-PSYCHOPH, V36, P136, DOI 10.1016/j.pnpbp.2011.08.003; Smith MA, 1995, ANN NY ACAD SCI, V771, P234, DOI 10.1111/j.1749-6632.1995.tb44684.x; Sohrabji F, 2006, FRONT NEUROENDOCRIN, V27, P404, DOI 10.1016/j.yfrne.2006.09.003; Sozeri-Varma G, 2011, NEUROL PSYCHIAT BR, V17, P84, DOI 10.1016/j.npbr.2011.09.001; Tsuchida A, 2001, DIABETOLOGIA, V44, P555, DOI 10.1007/s001250051661; Ueyama T, 1997, NEUROSCI RES, V28, P103, DOI 10.1016/S0168-0102(97)00030-8; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Zhang XY, 2007, J PSYCHIATR RES, V41, P997, DOI 10.1016/j.jpsychires.2006.08.007	65	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39358	10.1371/journal.pone.0039358	http://dx.doi.org/10.1371/journal.pone.0039358			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768299	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305966500012
J	de Carvalho, ECA; Batilana, AP; Claudino, W; Reis, LFL; Schmerling, RA; Shah, J; Pietrobon, R				Araujo de Carvalho, Elias Cesar; Batilana, Adelia Portero; Claudino, Wederson; Lima Reis, Luiz Fernando; Schmerling, Rafael A.; Shah, Jatin; Pietrobon, Ricardo			Workflow in Clinical Trial Sites & Its Association with Near Miss Events for Data Quality: Ethnographic, Workflow & Systems Simulation	PLOS ONE			English	Article							DECISION-SUPPORT-SYSTEMS; PHYSICIAN ORDER ENTRY; IMPLEMENTATION; TERMINOLOGY; MANAGEMENT; RADIOLOGY	Background: With the exponential expansion of clinical trials conducted in (Brazil, Russia, India, and China) and VISTA (Vietnam, Indonesia, South Africa, Turkey, and Argentina) countries, corresponding gains in cost and enrolment efficiency quickly outpace the consonant metrics in traditional countries in North America and European Union. However, questions still remain regarding the quality of data being collected in these countries. We used ethnographic, mapping and computer simulation studies to identify/address areas of threat to near miss events for data quality in two cancer trial sites in Brazil. Methodology/Principal Findings: Two sites in Sao Paolo and Rio Janeiro were evaluated using ethnographic observations of workflow during subject enrolment and data collection. Emerging themes related to threats to near miss events for data quality were derived from observations. They were then transformed into workflows using UML-AD and modeled using System Dynamics. 139 tasks were observed and mapped through the ethnographic study. The UML-AD detected four major activities in the workflow evaluation of potential research subjects prior to signature of informed consent, visit to obtain subjects informed consent, regular data collection sessions following study protocol and closure of study protocol for a given project. Field observations pointed to three major emerging themes: (a) lack of standardized process for data registration at source document, (b) multiplicity of data repositories and (c) scarcity of decision support systems at the point of research intervention. Simulation with policy model demonstrates a reduction of the rework problem. Conclusions/Significance: Patterns of threats to data quality at the two sites were similar to the threats reported in the literature for American sites. The clinical trial site managers need to reorganize staff workflow by using information technology more efficiently, establish new standard procedures and manage professionals to reduce near miss events and save time/cost. Clinical trial sponsors should improve relevant support systems.	[Araujo de Carvalho, Elias Cesar; Batilana, Adelia Portero] Duke Univ, Res Res Grp, Dept Surg, Durham, NC 27705 USA; [Araujo de Carvalho, Elias Cesar] Univ Ctr Maringa, Maringa, Parana, Brazil; [Araujo de Carvalho, Elias Cesar] Univ Estadual Maringa, UEM, Maringa, Parana, Brazil; [Claudino, Wederson] Oncologistas Assoc Canc Inst, Rio De Janeiro, Brazil; [Lima Reis, Luiz Fernando; Schmerling, Rafael A.] Sirio Libanes Hosp, Inst Teaching & Res, Sao Paulo, Brazil; [Shah, Jatin] Duke NUS Grad Med Sch, Res Res Grp, Singapore, Singapore; [Pietrobon, Ricardo] Duke Univ Hlth Syst, Dept Surg, Durham, NC USA	Duke University; Universidade Estadual de Maringa; Hospital Sirio Libanes; National University of Singapore; Duke University	de Carvalho, ECA (corresponding author), Duke Univ, Res Res Grp, Dept Surg, Durham, NC 27705 USA.	rpietro@duke.edu	Shah, Jatin/B-6039-2011; Reis, Luiz F. L./C-4556-2013; Carvalho, Elias/J-7086-2012	Shah, Jatin/0000-0002-2457-491X; Carvalho, Elias/0000-0002-2638-7202; Reis, Luiz/0000-0002-4040-2456	Sanofi Aventis	Sanofi Aventis(Sanofi-Aventis)	The study was funded by Sanofi Aventis. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-86; Anderson JG, 2002, COMPUT BIOL MED, V32, P151, DOI 10.1016/S0010-4825(02)00012-4; Barach P, 2000, BMJ-BRIT MED J, V320, P759, DOI 10.1136/bmj.320.7237.759; Bates DW, 1999, J AM MED INFORM ASSN, V6, P313, DOI 10.1136/jamia.1999.00660313; Bennett JW, 2003, MED J AUSTRALIA, V178, P217, DOI 10.5694/j.1326-5377.2003.tb05166.x; Borlawsky Tara, 2008, AMIA Annu Symp Proc, P885; Borycki Elizabeth M, 2006, AMIA Annu Symp Proc, P61; Bossel H, 2004, SYSTEME DYNAMIK SIMU; Breitfeld PP, 1999, J AM MED INFORM ASSN, V6, P466, DOI 10.1136/jamia.1999.0060466; Brixey Juliana J, 2007, ANS Adv Nurs Sci, V30, pE26; Campbell M K, 2007, Health Technol Assess, V11, pix; Campbell MK, 2007, HEALTH TECHNOL ASSES, V11; Cloutier LM, 2001, INNOVATION MANAGEMEN; de Carvalho ECA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009314; de Carvalho ECA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013893; Despont-Gros C, 2005, J BIOMED INFORM, V38, P244, DOI 10.1016/j.jbi.2004.12.004; Dumas M., 2001, INT C UNIFIED MODELI, P76; Dwivedi A, 2007, Int J Electron Healthc, V3, P382, DOI 10.1504/IJEH.2007.014555; Fishman G. S., 1978, PRINCIPLES DISCRETE; FOWLER M, 1999, UML DISTILLED BRIEF; Fuhrer MJ, 2005, AM J PHYS MED REHAB, V84, P823, DOI 10.1097/01.phm.0000184103.57599.01; Grossman Martin, 2008, VINE, V38, P118, DOI 10.1108/03055720810870932; Heller B, 2004, STUD HEALTH TECHNOL, V101, P46; Holden JD, 2001, J EVAL CLIN PRACT, V7, P65, DOI 10.1046/j.1365-2753.2001.00280.x; Homer J, 2000, SYST DYNAM REV, V16, P287, DOI 10.1002/sdr.200; Hunt DL, 1998, JAMA-J AM MED ASSOC, V280, P1339, DOI 10.1001/jama.280.15.1339; Institute of Medicine (TOM), 2000, ERR IS HUM BUILD SAF; Kaushal R, 2003, ARCH INTERN MED, V163, P1409, DOI 10.1001/archinte.163.12.1409; Khan SA, 2007, STUD HEALTH TECHNOL, V129, P247; Kumarapeli P, 2007, MED INFORM INTERNET, V32, P51, DOI 10.1080/14639230601097705; Landsberger HA, 1958, HAWTHORNE REVISITED; Lang M, 2007, STUD HEALTH TECHNOL, V129, P576; Lyneis JM, 2007, SYST DYNAM REV, V23, P157, DOI 10.1002/sdr.377; Marjamaa RA, 2009, HEALTH CARE MANAG SC, V12, P142, DOI 10.1007/s10729-008-9073-8; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; McDaniel R., 2001, ADV HLTH CARE MANAGE, P11, DOI DOI 10.1016/S1474-8231(01)02021-3; Merzweiler A, 2005, COMPUT METH PROG BIO, V78, P11, DOI 10.1016/j.cmpb.2004.11.001; Normile D, 2008, SCIENCE, V322, P214, DOI 10.1126/science.322.5899.214; Noumeir R, 2006, J BIOMED INFORM, V39, P103, DOI 10.1016/j.jbi.2005.07.001; Ohno-Machado L, 1999, J AM MED INFORM ASSN, P340; Payne Philip R O, 2007, AMIA Annu Symp Proc, P593; Pietrobon Ricardo, 2004, BMC Med Res Methodol, V4, P29, DOI 10.1186/1471-2288-4-29; Shah J, 2009, ACAD MED, V84, P511, DOI 10.1097/ACM.0b013e31819a8c3c; Shiffman RN, 1999, J AM MED INFORM ASSN, V6, P104, DOI 10.1136/jamia.1999.0060104; Silverman D., 2004, QUALITATIVE RES THEO, V2; Sterman J.D., 2000, BUSINESS DYNAMICS, DOI DOI 10.4324/9781351152723-7; Strauss A, 1997, GROUNDED THEORY PRAC; Thiers FA, 2008, NAT REV DRUG DISCOV, V7, P13, DOI 10.1038/nrd2441; van Ackere A, 1999, AID SDR171 3 0 CO 2; Walton R, 1999, BRIT MED J, V318, P984, DOI 10.1136/bmj.318.7189.984; WALTON RT, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002894; White S.A., 2004, WORKFLOW HDB, P265; Willenberg Kelly M, 2004, J Oncol Manag, V13, P24	53	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39671	10.1371/journal.pone.0039671	http://dx.doi.org/10.1371/journal.pone.0039671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768105	Green Published, gold			2022-12-27	WOS:000305892100075
J	Bustamante, C; Lamilla, J; Concha, F; Ebert, DA; Bennett, MB				Bustamante, Carlos; Lamilla, Julio; Concha, Francisco; Ebert, David A.; Bennett, Michael B.			Morphological Characters of the Thickbody Skate Amblyraja frerichsi (Krefft 1968) (Rajiformes: Rajidae), with Notes on Its Biology	PLOS ONE			English	Article							EGG CAPSULES; CHONDRICHTHYES; BIODIVERSITY; ELASMOBRANCHII; SYSTEMATICS; STRATEGIES; MATURITY; PACIFIC; SIZE; KEY	Detailed descriptions of morphological features, morphometrics, neurocranium anatomy, clasper structure and egg case descriptions are provided for the thickbody skate Amblyraja frerichsi; a rare, deep-water species from Chile, Argentina and Falkland Islands. The species diagnosis is complemented from new observations and aspects such as colour, size and distribution are described. Geographic and bathymetric distributional ranges are discussed as relevant features of this taxons biology. Additionally, the conservation status is assessed including bycatch records from Chilean fisheries.	[Bustamante, Carlos; Bennett, Michael B.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Bustamante, Carlos; Lamilla, Julio] Univ Austral Chile, Inst Ciencias Marinas & Limnol, Lab Elasmobranquios ELASMOLAB, Valdivia, Chile; [Concha, Francisco] Valparaiso Univ, Fac Ciencias Mar & Recursos Nat, Lab Biol & Conservac Condrictios, Renaca, Vina Del Mar, Chile; [Ebert, David A.] Pacific Shark Res Ctr, Moss Landing Marine Labs, Moss Landing, CA USA; [Ebert, David A.] S African Inst Aquat Biodivers, Grahamstown, South Africa; [Ebert, David A.] Calif Acad Sci, Dept Ichthyol, San Francisco, CA 94118 USA	University of Queensland; Universidad Austral de Chile; Moss Landing Marine Laboratories; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; California Academy of Sciences	Bustamante, C (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	c.bustamantediaz@uq.edu.au	Concha, Francisco/AAN-1529-2021; Bustamante, Carlos/A-7893-2011; Bennett, Michael/A-7218-2012; Bennett, Michael/L-4483-2019	Bustamante, Carlos/0000-0002-0816-6406; Bennett, Michael/0000-0001-8051-0040	Direccion de Investigacion of Universidad Austral de Chile (DID-UACH); Fondo de Investigacion Pesquera [FIP 2006-31/2008-60]	Direccion de Investigacion of Universidad Austral de Chile (DID-UACH); Fondo de Investigacion Pesquera	This contribution was supported by Direccion de Investigacion of Universidad Austral de Chile (DID-UACH) and Fondo de Investigacion Pesquera (FIP 2006-31/2008-60). The funders had no role in study design data collection and analysis decision to publish or preparation of the manuscript.	Acua E, 1987, 7 JORN CIENC MAR CON; [Anonymous], 2005, OCEANA; Bizikov V.A., 2004, IDENTIFICATION GUIDE; Cedrola PV, 2005, FISH RES, V71, P141, DOI 10.1016/j.fishres.2004.08.031; Compagno LJV, 1999, T ROY SOC S AFR, V54, P75, DOI 10.1080/00359199909520406; Concha F, 2010, J FISH BIOL, V77, P963, DOI 10.1111/j.1095-8649.2010.02736.x; Concha F, 2009, REV BIOL MAR OCEANOG, V44, P253, DOI 10.4067/S0718-19572009000100026; Cousseau MB, 2007, RAYAS CHUCHOS OTROS; Delpiani G, 2012, ZOOTAXA, P57; Dulvy NK, 2010, CRC MAR BIOL SER, P639; Ebert DA, 2007, BIOL SKATES; Ebert DA, 2008, ICES J MAR SCI, V65, P81, DOI 10.1093/icesjms/fsm169; Ebert DA, 2007, ENVIRON BIOL FISH, V80, P111, DOI 10.1007/s10641-007-9247-0; Ebert DA, 2010, CRC MAR BIOL SER, P115; Francis MP, 2001, NEW ZEAL J MAR FRESH, V35, P831, DOI 10.1080/00288330.2001.9517045; Frisk MG, 2010, CRC MAR BIOL SER, P283; Gomes U.L., 2010, GUIA IDENTIFICACAO T, V1st ed.; González H E, 2006, Gayana (Concepc.), V70, P26; Gravendeel R, 2002, INT J OSTEOARCHAEOL, V12, P420, DOI 10.1002/oa.645; Guerrero A, 2009, LAT AM J AQUAT RES, V37, P361, DOI 10.3856/vol37-issue3-fulltext-7; HOENIG J M, 1990, NOAA Technical Report NMFS, P1; Hulley P. A., 1970, Ann. S. Afr. Mus., V55, P151; Hulley PA, 1972, ANN S AFR MUS, V60, P1; ISHIYAMA REIZO, 1958, JOUR SHIMONOSEKI COLL FISH, V7, P193; KREFFT G, 1968, ARCH FISCHEREIWISS, V19, P1; Kyne PM, 2010, CRC MAR BIOL SER, P37; Lamilla J., 2010, ESTIMACION DESCARTE; Lamilla Julio, 2003, Investigaciones Marinas Universidad Catolica de Valparaiso, V31, P3; Last PR, 2007, ZOOTAXA, P45; Last Peter R., 2008, CSIRO Marine and Atmospheric Research Paper, V021, P1; Leible M.D., 1988, Gayana Zoologia, V52, P15; McEachran JD, 1998, COPEIA, P271; MCEACHRAN JD, 1990, NOAA TECH REP, V90, P305; Menni Roberto C., 2000, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V2, P69; Oddone MC, 2004, ZOOTAXA, P1; Oddone MC, 2004, ICES J MAR SCI, V61, P293, DOI 10.1016/j.icesjms.2003.11.004; Parent S, 2008, ZOO BIOL, V27, P145, DOI 10.1002/zoo.20170; Pequeno German, 1997, Revista de Biologia Marina y Oceanografia, V32, P77; PEQUENO-R G, 1985, Revista de Biologia Marina, V21, P225; Pequeno-R. German, 1993, Revista de Biologia Marina, V28, P203; Reyes PR, 2009, REV BIOL MAR OCEANOG, V44, P243, DOI 10.4067/S0718-19572009000100025; Sims DW, 2003, J FISH BIOL, V63, P53, DOI 10.1111/j.1095-8649.2003.00207.x; Sims DW, 2001, MAR BIOL, V139, P1165; Sosebee Katherine A., 2005, Journal of Northwest Atlantic Fishery Science, V35, P141, DOI 10.2960/J.v35.m499; Springer S, 1967, SHARKS SKATES RAYS, P149, DOI DOI 10.1111/J.1095-8649.2012.03244.X; STEHMANN M, 1970, ARCH FISCHEREIWISS, V21, P73; Thiel R, 2009, J APPL ICHTHYOL, V25, P9, DOI 10.1111/j.1439-0426.2009.01296.x; Treloar MA, 2006, ZOOTAXA, P53, DOI 10.11646/zootaxa.1231.1.3; Vargas M, 1989, 9 JORN CIENC MAR ANT; Walsh JH, 2007, ZOOTAXA, P31; ZORZI GD, 1988, CALIF FISH GAME, V74, P87	51	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39963	10.1371/journal.pone.0039963	http://dx.doi.org/10.1371/journal.pone.0039963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768186	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100158
J	Kusunose, K; Penn, MS; Zhang, YH; Cheng, YN; Thomas, JD; Marwick, TH; Popovic, ZB				Kusunose, Kenya; Penn, Marc S.; Zhang, Youhua; Cheng, Yuanna; Thomas, James D.; Marwick, Thomas H.; Popovic, Zoran B.			How Similar Are the Mice to Men? Between-Species Comparison of Left Ventricular Mechanics Using Strain Imaging	PLOS ONE			English	Article							SPECKLE-TRACKING ECHOCARDIOGRAPHY; REGIONAL MYOCARDIAL-FUNCTION; 2-DIMENSIONAL SPECKLE; SYSTOLIC STRAIN; VELOCITY; MODELS; MASS; HYPERTROPHY; VALIDATION; PRESSURE	Background: While mammalian heart size maintains constant proportion to whole body size, scaling of left ventricular (LV) function parameters shows a more complex scaling pattern. We used 2-D speckle tracking strain imaging to determine whether LV myocardial strains and strain rates scale to heart size. Methods: We studied 18 mice, 15 rats, 6 rabbits, 12 dogs and 20 human volunteers by 2-D echocardiography. Relationship between longitudinal or circumferential strains/strain rates (S-Long/SRLong, S-Circ/SRCirc), and LV end-diastolic volume (EDV) or mass were assessed by the allometric (power-law) equation Y = kM(beta). Results: Mean LV mass in individual species varied from 0.038 to 134 g, LV EDV varied from 0.015 to 102 ml, while RR interval varied from 81 to 1090 ms. While S-Long increased with increasing LV EDV or mass (beta values 0.047 +/- 0.006 and 0.051 +/- 0.005, p<0.0001 vs. 0 for both) S-Circ was unchanged (p = NS for both LV EDV or mass). Systolic and diastolic SRLong and SRCirc showed inverse correlations to LV EDV or mass (p<0.0001 vs. 0 for all comparisons). The ratio between S-Long and S-Circ increased with increasing values of LV EDV or mass (beta values 0.039 +/- 0.010 and 0.040 +/- 0.011, p>0.0003 for both). Conclusions: While S-Circ is unchanged, S-Long increases with increasing heart size, indicating that large mammals rely more on long axis contribution to systolic function. SRLong and SRCirc, both diastolic and systolic, show an expected decrease with increasing heart size.	[Kusunose, Kenya; Penn, Marc S.; Thomas, James D.; Marwick, Thomas H.; Popovic, Zoran B.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Zhang, Youhua; Cheng, Yuanna] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Kusunose, K (corresponding author), Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA.	popoviz@ccf.org	Kusunose, Kenya/AAC-9978-2021; Marwick, Thomas H/C-7261-2013	Kusunose, Kenya/0000-0002-4909-754X; Marwick, Thomas H/0000-0001-9065-0899; popovic, zoran/0000-0001-5692-2299				Amundsen BH, 2006, J AM COLL CARDIOL, V47, P789, DOI 10.1016/j.jacc.2005.10.040; Armstrong G, 2000, J AM SOC ECHOCARDIOG, V13, P731, DOI 10.1067/mje.2000.105912; Bachner-Hinenzon N, 2010, AM J PHYSIOL-HEART C, V299, pH664, DOI 10.1152/ajpheart.00017.2010; Bauer M, 2011, CIRC RES, V108, P908, DOI 10.1161/CIRCRESAHA.110.239574; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Cho GY, 2006, AM J CARDIOL, V97, P1661, DOI 10.1016/j.amjcard.2005.12.063; Collins KA, 2001, AM J PHYSIOL-HEART C, V280, pH1954, DOI 10.1152/ajpheart.2001.280.5.H1954; Costa KD, 1997, AM J PHYSIOL-HEART C, V273, pH1968, DOI 10.1152/ajpheart.1997.273.4.H1968; DAWSONSAUNDERS B, 1990, BASIC CLIN BIOSTATIS; Decloedt A, 2011, J VET INTERN MED, V25, P330, DOI 10.1111/j.1939-1676.2010.0663.x; Decloedt A, 2012, EQUINE VET J; Derumeaux G, 2002, CIRCULATION, V105, P1602, DOI 10.1161/01.CIR.0000012943.91101.D7; Greenberg NL, 2002, CIRCULATION, V105, P99, DOI 10.1161/hc0102.101396; GRIMM AF, 1976, BASIC RES CARDIOL, V71, P381, DOI 10.1007/BF01910776; Kukulski T, 2000, ECHOCARDIOGR-J CARD, V17, P639, DOI 10.1046/j.1540-8175.2000.00639.x; Kuznetsova T, 2008, EUR HEART J, V29, P2014, DOI 10.1093/eurheartj/ehn280; Liu W, 2006, AM J PHYSIOL-HEART C, V291, pH2515, DOI 10.1152/ajpheart.01016.2005; Marwick TH, 2009, JACC-CARDIOVASC IMAG, V2, P80, DOI 10.1016/j.jcmg.2007.12.007; MERCADIER JJ, 1981, CIRC RES, V49, P525, DOI 10.1161/01.RES.49.2.525; Noujaim SF, 2004, CIRCULATION, V110, P2802, DOI 10.1161/01.CIR.0000146785.15995.67; Oxborough D, 2009, EUR J ECHOCARDIOGR, V10, P677, DOI 10.1093/ejechocard/jep037; Peng Y, 2009, AM J PHYSIOL-HEART C, V297, pH811, DOI 10.1152/ajpheart.00385.2009; PLEHN JF, 1993, AM J PHYSIOL, V265, pH2066, DOI 10.1152/ajpheart.1993.265.6.H2066; Popovic ZB, 2005, J PHYSIOL-LONDON, V568, P255, DOI 10.1113/jphysiol.2005.090779; Popovic ZB, 2007, AM J PHYSIOL-HEART C, V292, pH2809, DOI 10.1152/ajpheart.01176.2006; Popovic ZB, 2006, AM J PHYSIOL-HEART C, V291, pH762, DOI 10.1152/ajpheart.00081.2006; PROTHERO J, 1979, GROWTH, V43, P139; REICHEK N, 1983, CIRCULATION, V67, P348, DOI 10.1161/01.CIR.67.2.348; Rosner A, 2009, EUR J ECHOCARDIOGR, V10, P271, DOI 10.1093/ejechocard/jen230; SCHWARTZ K, 1981, J MOL CELL CARDIOL, V13, P1071, DOI 10.1016/0022-2828(81)90297-2; Sebag IA, 2005, CIRCULATION, V111, P2611, DOI 10.1161/CIRCULATIONAHA.104.474411; Sun JP, 2004, J AM SOC ECHOCARDIOG, V17, P132, DOI 10.1016/j.echo.2003.10.001; Thibault H, 2011, CIRC-CARDIOVASC IMAG, V4, P550, DOI 10.1161/CIRCIMAGING.110.962282; Wang YT, CANADIAN J CARDIOLOG; WYATT HL, 1979, CIRCULATION, V60, P1104, DOI 10.1161/01.CIR.60.5.1104; Zar JH., 1999, BIOSTAT ANAL	36	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40061	10.1371/journal.pone.0040061	http://dx.doi.org/10.1371/journal.pone.0040061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768220	Green Published, gold			2022-12-27	WOS:000305892100192
J	Lourenco, A; Ferreira, A; Veiga, N; Machado, I; Pereira, MO; Azevedo, NF				Lourenco, Analia; Ferreira, Andreia; Veiga, Nuno; Machado, Idalina; Pereira, Maria Olivia; Azevedo, Nuno F.			BiofOmics: A Web Platform for the Systematic and Standardized Collection of High-Throughput Biofilm Data	PLOS ONE			English	Article							HELICOBACTER-PYLORI; MINIMUM INFORMATION; QUANTIFICATION; MICROBES; STRESS	Background: Consortia of microorganisms, commonly known as biofilms, are attracting much attention from the scientific community due to their impact in human activity. As biofilm research grows to be a data-intensive discipline, the need for suitable bioinformatics approaches becomes compelling to manage and validate individual experiments, and also execute inter-laboratory large-scale comparisons. However, biofilm data is widespread across ad hoc, non-standardized individual files and, thus, data interchange among researchers, or any attempt of cross-laboratory experimentation or analysis, is hardly possible or even attempted. Methodology/Principal Findings: This paper presents BiofOmics, the first publicly accessible Web platform specialized in the management and analysis of data derived from biofilm high-throughput studies. The aim is to promote data interchange across laboratories, implementing collaborative experiments, and enable the development of bioinformatics tools in support of the processing and analysis of the increasing volumes of experimental biofilm data that are being generated. BiofOmics' data deposition facility enforces data structuring and standardization, supported by controlled vocabulary. Researchers are responsible for the description of the experiments, their results and conclusions. BiofOmics' curators interact with submitters only to enforce data structuring and the use of controlled vocabulary. Then, BiofOmics' search facility makes publicly available the profile and data associated with a submitted study so that any researcher can profit from these standardization efforts to compare similar studies, generate new hypotheses to be tested or even extend the conditions experimented in the study. Significance: BiofOmics' novelty lies in its support to standardized data deposition, the availability of computerizable data files and the free-of-charge dissemination of biofilm studies across the community. Hopefully, this will open promising research possibilities, namely the comparison of results between different laboratories, the reproducibility of methods within and between laboratories, and the development of guidelines and standardized protocols for biofilm formation operating procedures and analytical methods.	[Lourenco, Analia; Ferreira, Andreia; Veiga, Nuno; Machado, Idalina; Pereira, Maria Olivia] Univ Minho, Ctr Biol Engn, IBB, Braga, Portugal; [Azevedo, Nuno F.] Univ Porto, Fac Engn, Dept Chem Engn, LEPAE Lab Proc Environm & Energy Engn, P-4100 Oporto, Portugal	Universidade do Minho; Universidade do Porto	Lourenco, A (corresponding author), Univ Minho, Ctr Biol Engn, IBB, Braga, Portugal.	nazevedo@fe.up.pt	Lourenço, Anália/Y-9447-2019; Azevedo, Nuno/I-4915-2013; Machado, Idalina/J-2892-2013; Pereira, Maria O/O-4859-2015; Lourenço, Anália/G-8879-2013	Lourenço, Anália/0000-0001-8401-5362; Machado, Idalina/0000-0003-0546-4915; Pereira, Maria O/0000-0002-4307-3985; Lourenço, Anália/0000-0001-8401-5362; Azevedo, Nuno/0000-0001-5864-3250	Institute of Biotechnology and Bioengineering - Center of Biological Engineering (IBB-CEB); Fundacao para a Ciencia e Tecnologia (FCT); European Community; Idalina Machado [SFRH/BD/31065/2006];  [PTDC/SAU-ESA/646091/2006/FCOMP-01-0124-FEDER-007480]	Institute of Biotechnology and Bioengineering - Center of Biological Engineering (IBB-CEB); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Community(European Commission); Idalina Machado; 	The financial support from the Institute of Biotechnology and Bioengineering - Center of Biological Engineering (IBB-CEB), Fundacao para a Ciencia e Tecnologia (FCT) and European Community fund FEDER (Program COMPETE), project PTDC/SAU-ESA/646091/2006/FCOMP-01-0124-FEDER-007480 and PhD grant of Idalina Machado (SFRH/BD/31065/2006) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014786; Azevedo NF, 2006, APPL ENVIRON MICROB, V72, P2936, DOI 10.1128/AEM.72.4.2936-2941.2006; Azevedo NF, 2009, BIOTECHNOL LETT, V31, P477, DOI 10.1007/s10529-008-9901-4; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Coenye T, 2010, FEMS IMMUNOL MED MIC, V59, P239, DOI 10.1111/j.1574-695X.2010.00682.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1978, SCI AM, V238, P86, DOI 10.1038/scientificamerican0178-86; Di Cagno R, 2011, J PROTEOMICS, V74, P19, DOI 10.1016/j.jprot.2010.09.003; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Giao MS, 2008, APPL ENVIRON MICROB, V74, P5898, DOI 10.1128/AEM.00827-08; Gibbons JG, 2012, EUKARYOT CELL, V11, P68, DOI 10.1128/EC.05102-11; Harrison JJ, 2010, NAT PROTOC, V5, P1236, DOI 10.1038/nprot.2010.71; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Lourenco A, 2012, ADV INTEL SOFT COMPU, V154, P113; Machado I, 2011, BIOFOULING, V27, P1151, DOI 10.1080/08927014.2011.636148; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Sousa AM, 2012, ADV INTEL SOFT COMPU, V154, P181; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Taylor CF, 2007, NAT BIOTECHNOL, V25, P887, DOI 10.1038/nbt1329; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Van Houdt R, 2010, J APPL MICROBIOL, V109, P1117, DOI 10.1111/j.1365-2672.2010.04756.x; Wilmes P, 2010, MBIO, V1, DOI 10.1128/mBio.00246-10; Wood TK, 2011, TRENDS BIOTECHNOL, V29, P87, DOI 10.1016/j.tibtech.2010.11.001; Yu J, 2010, WATER SCI TECHNOL, V61, P163, DOI 10.2166/wst.2010.813	25	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39960	10.1371/journal.pone.0039960	http://dx.doi.org/10.1371/journal.pone.0039960			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768184	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100156
J	Xu, ZW; Wan, SQ; Ren, HY; Han, XG; Li, MH; Cheng, WX; Jiang, Y				Xu, Zhuwen; Wan, Shiqiang; Ren, Haiyan; Han, Xingguo; Li, Mai-He; Cheng, Weixin; Jiang, Yong			Effects of Water and Nitrogen Addition on Species Turnover in Temperate Grasslands in Northern China	PLOS ONE			English	Article							OLD-FIELD SUCCESSION; MINNESOTA SAND PLAIN; ELEVATED CO2; LAND-USE; DEPOSITION; RICHNESS; DIVERSITY; ECOSYSTEM; DYNAMICS; CLIMATE	Global nitrogen (N) deposition and climate change have been identified as two of the most important causes of current plant diversity loss. However, temporal patterns of species turnover underlying diversity changes in response to changing precipitation regimes and atmospheric N deposition have received inadequate attention. We carried out a manipulation experiment in a steppe and an old-field in North China from 2005 to 2009, to test the hypothesis that water addition enhances plant species richness through increase in the rate of species gain and decrease in the rate of species loss, while N addition has opposite effects on species changes. Our results showed that water addition increased the rate of species gain in both the steppe and the old field but decreased the rates of species loss and turnover in the old field. In contrast, N addition increased the rates of species loss and turnover in the steppe but decreased the rate of species gain in the old field. The rate of species change was greater in the old field than in the steppe. Water interacted with N to affect species richness and species turnover, indicating that the impacts of N on semi-arid grasslands were largely mediated by water availability. The temporal stability of communities was negatively correlated with rates of species loss and turnover, suggesting that water addition might enhance, but N addition would reduce the compositional stability of grasslands. Experimental results support our initial hypothesis and demonstrate that water and N availabilities differed in the effects on rate of species change in the temperate grasslands, and these effects also depend on grassland types and/or land-use history. Species gain and loss together contribute to the dynamic change of species richness in semi-arid grasslands under future climate change.	[Xu, Zhuwen; Ren, Haiyan; Han, Xingguo; Li, Mai-He; Cheng, Weixin; Jiang, Yong] Chinese Acad Sci, State Key Lab Forest & Soil Ecol, Inst Appl Ecol, Shenyang, Peoples R China; [Wan, Shiqiang] Henan Univ, Coll Life Sci, Key Lab Plant Stress Biol, Kaifeng, Peoples R China; [Han, Xingguo] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Li, Mai-He] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Cheng, Weixin] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Henan University; Chinese Academy of Sciences; Institute of Botany, CAS; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of California System; University of California Santa Cruz	Xu, ZW (corresponding author), Chinese Acad Sci, State Key Lab Forest & Soil Ecol, Inst Appl Ecol, Shenyang, Peoples R China.	jiangyong@iae.ac.cn	Li, Mai-He/L-6390-2013; Wan, Shiqiang/L-9166-2019; Xu, ZhuWen/O-3635-2015; Wan, Shiqiang/B-5799-2009; Han, Xingguo/K-7552-2016; Ren, Haiyan/I-1863-2019; Jiang, Yong/A-2263-2012; Cheng, Weixin/F-4968-2011; Xu, Zhuwen/GLS-8029-2022	Li, Mai-He/0000-0002-7029-2841; Wan, Shiqiang/0000-0003-0631-1232; Xu, ZhuWen/0000-0002-8898-6577; Wan, Shiqiang/0000-0003-0631-1232; Han, Xingguo/0000-0002-1836-975X; Ren, Haiyan/0000-0002-2008-9626; Jiang, Yong/0000-0001-7518-5810; Cheng, Weixin/0000-0003-2964-2376; 	National Basic Research Program of China [2011CB403204]; National Natural Science Foundation of China [31000200]; Knowledge Innovation Project of CAS [KZCX2-YW-T06]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Project of CAS(Knowledge Innovation Program of the Chinese Academy of Sciences)	This work was financially supported by the National Basic Research Program of China (2011CB403204) and by the National Natural Science Foundation of China (31000200) and the Knowledge Innovation Project of CAS (No. KZCX2-YW-T06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KJ, 2007, AM NAT, V169, P780, DOI 10.1086/516653; Anderson TM, 2008, OIKOS, V117, P675, DOI [10.1111/j.2008.0030-1299.16516.x, 10.1111/j.0030-1299.2008.16516.x]; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Britton AJ, 2001, J VEG SCI, V12, P797, DOI 10.2307/3236867; CARSON WP, 1988, ECOLOGY, V69, P984, DOI 10.2307/1941253; CHAPIN FS, 1994, ECOL MONOGR, V64, P149, DOI 10.2307/2937039; Chen HYH, 2012, GLOBAL ECOL BIOGEOGR, V21, P441, DOI 10.1111/j.1466-8238.2011.00689.x; Cholaw B, 2003, ADV ATMOS SCI, V20, P755, DOI 10.1007/BF02915400; Clark CM, 2010, ECOLOGY, V91, P3620, DOI 10.1890/09-1268.1; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Dickson TL, 2008, J ECOL, V96, P937, DOI 10.1111/j.1365-2745.2008.01420.x; Foster BL, 1998, ECOLOGY, V79, P2593, DOI 10.1890/0012-9658(1998)079[2593:SRIASG]2.0.CO;2; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gaudnik C, 2011, GLOBAL CHANGE BIOL, V17, P3351, DOI 10.1111/j.1365-2486.2011.02463.x; Harpole WS, 2007, GLOBAL CHANGE BIOL, V13, P2341, DOI 10.1111/j.1365-2486.2007.01447.x; Hillebrand H, 2010, GLOBAL CHANGE BIOL, V16, P1181, DOI 10.1111/j.1365-2486.2009.02045.x; HULBERT L C, 1969, Ecology (Washington D C), V50, P874, DOI 10.2307/1933702; INOUYE RS, 1994, B TORREY BOT CLUB, V121, P266, DOI 10.2307/2997181; INOUYE RS, 1987, ECOLOGY, V68, P12, DOI 10.2307/1938801; Kang L, 2007, PHILOS T R SOC B, V362, P997, DOI 10.1098/rstb.2007.2029; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028601; [刘全友 Liu Quanyou], 2003, [生态学报, Acta Ecologica Sinica], V23, P1025; MAC ARTHUR ROBERT H., 1967; MAJOR J, 1974, HDB VEGETATION SCI, V8, P7; MCINTYRE S, 1994, J VEG SCI, V5, P373, DOI 10.2307/3235861; MCLENDON T, 1991, ECOLOGY, V72, P2016, DOI 10.2307/1941556; MYSTER RW, 1994, ECOLOGY, V75, P387, DOI 10.2307/1939542; Niu SL, 2009, ECOSYSTEMS, V12, P915, DOI 10.1007/s10021-009-9265-1; PHILLIPS OL, 1994, P NATL ACAD SCI USA, V91, P2805, DOI 10.1073/pnas.91.7.2805; PRACH K, 1993, OIKOS, V66, P343, DOI 10.2307/3544823; Price JN, 2007, PLANT ECOL, V188, P29, DOI 10.1007/s11258-006-9145-0; Reich PB, 2009, SCIENCE, V326, P1399, DOI 10.1126/science.1178820; Ren HY, 2011, ANN BOT-LONDON, V107, P145, DOI 10.1093/aob/mcq219; SHUGART HH, 1973, SCIENCE, V180, P1379, DOI 10.1126/science.180.4093.1379; Stevens CJ, 2010, ENVIRON POLLUT, V158, P2940, DOI 10.1016/j.envpol.2010.06.006; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Stevens MHH, 2006, PLANT ECOL, V183, P27, DOI 10.1007/s11258-005-9003-5; TILMAN D, 1985, AM NAT, V125, P827, DOI 10.1086/284382; TILMAN D, 1993, ECOLOGY, V74, P2179, DOI 10.2307/1939572; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1993, COMMUNITY DIVERSITY, P327; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Wijesinghe DK, 2005, J ECOL, V93, P99, DOI 10.1111/j.0022-0477.2004.00934.x; WOOD DM, 1987, ECOLOGY, V68, P780, DOI 10.2307/1938349; Xu ZW, 2010, RESTOR ECOL, V18, P217, DOI 10.1111/j.1526-100X.2009.00595.x; Yahdjian L, 2010, ECOSYSTEMS, V13, P575, DOI 10.1007/s10021-010-9341-6; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P2936, DOI 10.1111/j.1365-2486.2011.02423.x; [尤联元 You Lianyuan], 2003, [地理研究, Geographical Research], V22, P680; Yurkonis KA, 2006, PLANT ECOL, V184, P325, DOI 10.1007/s11258-005-9076-1; Zavaleta ES, 2003, ECOL MONOGR, V73, P585, DOI 10.1890/02-4053; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P7650, DOI 10.1073/pnas.0932734100; Zhou Z, 2006, FUNCT ECOL, V20, P753, DOI 10.1111/j.1365-2435.2006.01175.x	52	55	64	14	161	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39762	10.1371/journal.pone.0039762	http://dx.doi.org/10.1371/journal.pone.0039762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768119	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100089
J	Feng, J; Zhang, XS; Zhu, HJ; Wang, XD; Ni, SS; Huang, JF				Feng, Jian; Zhang, Xuesong; Zhu, Huijun; Wang, Xudong; Ni, Songshi; Huang, Jianfei			FoxQ1 Overexpression Influences Poor Prognosis in Non-Small Cell Lung Cancer, Associates with the Phenomenon of EMT	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTORS; PROTEIN EXPRESSION; BREAST-CARCINOMA; GROWTH	Background: We determined the expression of forkhead box Q1 (FoxQ1), E-cadherin (E-cad), Mucin 1 (MUC1), vimentin (VIM) and S100 calcium binding protein A4 (S100A4), all epithelial-mesenchymal transition (EMT) indicator proteins in non-small cell lung cancer (NSCLC) tissue samples. We also investigated the relationship between these five proteins expression and other clinicopathologic factors in NSCLC. Finally, we assessed the potential value of these markers as prognostic indicators of survival in NSCLC's patients. Methods: Quantitative real-time PCR and immunohistochemistry were used to characterize the expression of the FoxQ1 mRNA and protein in NSCLC. Expression of transcripts and translated products for the other four EMT indicator proteins was assessed by immunohistochemistry in the same clinical NSCLC samples. Results: FoxQ1 mRNA and protein were up-regulated in NSCLC compared with normal tissues (P = 0.015 and P<0.001, respectively). Expression of FoxQ1 in adenocarcinoma was higher than in squamous cell carcinoma (P = 0.005), and high expression of FoxQ1 correlated with loss of E-cad expression (P = 0.012), and anomalous positivity of VIM (P = 0.024) and S100A4 (P = 0.004). Additional survival analysis showed that high expression of FoxQ1 (P = 0.047) and E-cad (P = 0.021) were independent prognostic factors. Conclusion: FoxQ1 maybe plays a specific role in the EMT of NSCLC, and could be used as a prognostic factor for NSCLC.	[Feng, Jian; Zhang, Xuesong; Ni, Songshi] Nantong Univ, Affiliated Hosp, Dept Resp Med, Nantong, Jiangsu, Peoples R China; [Zhu, Huijun; Huang, Jianfei] Nantong Univ, Affiliated Hosp, Dept Pathol, Nantong, Jiangsu, Peoples R China; [Wang, Xudong] Nantong Univ, Affiliated Hosp, Dept Lab Med, Nantong, Jiangsu, Peoples R China	Nantong University; Nantong University; Nantong University	Feng, J (corresponding author), Nantong Univ, Affiliated Hosp, Dept Resp Med, Nantong, Jiangsu, Peoples R China.	ntyydoctor@126.com		Huang, Jianfei/0000-0002-1276-5962	Nantong government, China [S2010041]; Department of Health Jiangsu; Affiliated Hospital of Nantong University, Nantong, China	Nantong government, China; Department of Health Jiangsu; Affiliated Hospital of Nantong University, Nantong, China	This study was supported by grants from the Social Development and Applied Research Projects (S2010041) of Nantong government, China; International Cooperation and Exchanges (2011) from the Department of Health Jiangsu; and the Doctoral Fund (2010) of the Affiliated Hospital of Nantong University, Nantong, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieller A, 2001, DNA CELL BIOL, V20, P555, DOI 10.1089/104454901317094963; Cagle PT, 2011, ARCH PATHOL LAB MED, V135, P110, DOI 10.1043/2010-0567-RA.1; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Chai JY, 2010, BIOSCI TRENDS, V4, P130; Chen XF, 2012, MOL BIOL REP, V39, P3549, DOI 10.1007/s11033-011-1128-0; Feuerborn A, 2011, J CELL PHYSIOL, V226, P710, DOI 10.1002/jcp.22385; Gao W, 2011, CLIN LUNG CANCER, V12, P14, DOI 10.3816/CLC.2011.n.001; Ghoul A, 2009, CANCER RES, V69, P4260, DOI 10.1158/0008-5472.CAN-08-2837; Goldstraw P, 2009, J THORAC ONCOL, V4, P671, DOI 10.1097/JTO.0b013e31819e7814; Hoggatt AM, 2000, J BIOL CHEM, V275, P31162, DOI 10.1074/jbc.M005595200; Huang JF, 2011, J MOL HISTOL, V42, P597, DOI 10.1007/s10735-011-9355-1; Huang JF, 2011, J CLIN PATHOL, V64, P343, DOI 10.1136/jcp.2010.085142; Jonsson H, 2005, CELL MOL LIFE SCI, V62, P397, DOI 10.1007/s00018-004-4365-8; Kaneda H, 2010, CANCER RES, V70, P2053, DOI 10.1158/0008-5472.CAN-09-2161; Kim MA, 2009, HISTOPATHOLOGY, V54, P442, DOI 10.1111/j.1365-2559.2009.03247.x; Lee KW, 2012, ANN SURG ONCOL, V19, P326, DOI 10.1245/s10434-011-1867-0; Li LP, 2011, PROTEOMICS, V11, P429, DOI 10.1002/pmic.200900819; Liu LK, 2010, MODERN PATHOL, V23, P213, DOI 10.1038/modpathol.2009.160; Lo JF, 2011, CANCER RES, V71, P1912, DOI 10.1158/0008-5472.CAN-10-2350; Martinez-Ceballos E, 2005, J BIOL CHEM, V280, P16484, DOI 10.1074/jbc.M414397200; Okamoto S, 2009, ONCOL REP, V21, P1209, DOI 10.3892/or_00000343; Pirozzi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021548; Qiao YY, 2011, CANCER RES, V71, P3076, DOI 10.1158/0008-5472.CAN-10-2787; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Sato Y, 2010, AM J PATHOL, V177, P141, DOI 10.2353/ajpath.2010.090747; Sloan JA, 2011, CANCER J, V17, P63, DOI 10.1097/PPO.0b013e31820e15dc; Smith CB, 2010, SEMIN THORAC CARDIOV, V22, P193, DOI 10.1053/j.semtcvs.2010.10.002; Soini Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-73; Soltermann A, 2008, CLIN CANCER RES, V14, P7430, DOI 10.1158/1078-0432.CCR-08-0935; Tsuna M, 2009, ANTICANCER RES, V29, P2547; Uchikado Y, 2005, CLIN CANCER RES, V11, P1174; Ulahannan SV, 2011, CANCER INVEST, V29, P325, DOI 10.3109/07357907.2011.554476; Vaid M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021539; van Zijl F, 2011, MOL CANCER THER, V10, P850, DOI 10.1158/1535-7163.MCT-10-0917; Wang GH, 2011, EUR J CARDIO-THORAC, V39, P1028, DOI 10.1016/j.ejcts.2011.01.023; Wang XX, 2011, HUM PATHOL, V42, P1410, DOI 10.1016/j.humpath.2010.12.007; Wen CH, 2011, LANCET ONCOL, V12, P15, DOI 10.1016/S1470-2045(10)70303-X; Yi ZY, 2011, J INVEST SURG, V24, P67, DOI 10.3109/08941939.2010.542272; Zhang HJ, 2011, CANCER RES, V71, P1292, DOI 10.1158/0008-5472.CAN-10-2825	40	68	79	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39937	10.1371/journal.pone.0039937	http://dx.doi.org/10.1371/journal.pone.0039937			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761930	Green Submitted, gold, Green Published			2022-12-27	WOS:000305826400046
J	Butenko, O; Dzamba, D; Benesova, J; Honsa, P; Benfenati, V; Rusnakova, V; Ferroni, S; Anderova, M				Butenko, Olena; Dzamba, David; Benesova, Jana; Honsa, Pavel; Benfenati, Valentina; Rusnakova, Vendula; Ferroni, Stefano; Anderova, Miroslava			The Increased Activity of TRPV4 Channel in the Astrocytes of the Adult Rat Hippocampus after Cerebral Hypoxia/Ischemia	PLOS ONE			English	Article							BERGMANN GLIAL-CELLS; CORTICAL ASTROCYTES; CATION CHANNEL; IN-SITU; CALCIUM OSCILLATIONS; NA+-CA2+ EXCHANGER; GLUTAMATE RELEASE; MEMBRANE CURRENTS; NEURONAL-ACTIVITY; OXIDATIVE STRESS	The polymodal transient receptor potential vanilloid 4 (TRPV4) channel, a member of the TRP channel family, is a calcium-permeable cationic channel that is gated by various stimuli such as cell swelling, low pH and high temperature. Therefore, TRPV4-mediated calcium entry may be involved in neuronal and glia pathophysiology associated with various disorders of the central nervous system, such as ischemia. The TRPV4 channel has been recently found in adult rat cortical and hippocampal astrocytes; however, its role in astrocyte pathophysiology is still not defined. In the present study, we examined the impact of cerebral hypoxia/ischemia (H/I) on the functional expression of astrocytic TRPV4 channels in the adult rat hippocampal CA1 region employing immunohistochemical analyses, the patch-clamp technique and microfluorimetric intracellular calcium imaging on astrocytes in slices as well as on those isolated from sham-operated or ischemic hippocampi. Hypoxia/ischemia was induced by a bilateral 15-minute occlusion of the common carotids combined with hypoxic conditions. Our immunohistochemical analyses revealed that 7 days after H/I, the expression of TRPV4 is markedly enhanced in hippocampal astrocytes of the CA1 region and that the increasing TRPV4 expression coincides with the development of astrogliosis. Additionally, adult hippocampal astrocytes in slices or cultured hippocampal astrocytes respond to the TRPV4 activator 4-alpha-phorbol-12,-13-didecanoate (4 alpha PDD) by an increase in intracellular calcium and the activation of a cationic current, both of which are abolished by the removal of extracellular calcium or exposure to TRP antagonists, such as Ruthenium Red or RN1734. Following hypoxic/ischemic injury, the responses of astrocytes to 4 alpha PDD are significantly augmented. Collectively, we show that TRPV4 channels are involved in ischemia-induced calcium entry in reactive astrocytes and thus, might participate in the pathogenic mechanisms of astroglial reactivity following ischemic insult.	[Butenko, Olena; Dzamba, David; Benesova, Jana; Honsa, Pavel; Anderova, Miroslava] Acad Sci Czech Republic, Inst Expt Med, Dept Cellular Neurophysiol, Prague, Czech Republic; [Butenko, Olena; Dzamba, David; Benesova, Jana; Honsa, Pavel] Charles Univ Prague, Fac Med 2, Prague, Czech Republic; [Benfenati, Valentina] CNR, Inst Study Nanostruct Mat, Bologna, Italy; [Rusnakova, Vendula] Acad Sci Czech Republic, Inst Biotechnol, Gene Express Lab, Prague, Czech Republic; [Ferroni, Stefano] Univ Bologna, Dept Human & Gen Physiol, Bologna, Italy	Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio dei Materiali Nanostrutturati (ISMN-CNR); Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; University of Bologna	Butenko, O (corresponding author), Acad Sci Czech Republic, Inst Expt Med, Dept Cellular Neurophysiol, Prague, Czech Republic.	anderova@biomed.cas.cz	Novosadova, Vendula/G-6388-2014; Benfenati, Valentina/AAD-1821-2019; Novosadova, Vendula/AAJ-1449-2021; Butenko, Olena/AAL-3766-2021; Benfenati, Valentina/D-4579-2016; Anderova, Miroslava/H-2249-2014	Benfenati, Valentina/0000-0002-2858-8497; Butenko, Olena/0000-0003-2959-559X; Benfenati, Valentina/0000-0002-2858-8497; Anderova, Miroslava/0000-0002-9030-4571	Grant Agency of the Czech Republic [GA CR:P303/10/1338, GA CR:309/08/H079]; Academy of Sciences of the Czech Republic [AVOZ50390512]; Ministry of Education, Youth and Sports of the Czech Republic [LC554]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This study was supported by the grants GA CR:P303/10/1338 and GA CR:309/08/H079 from the Grant Agency of the Czech Republic, AVOZ50390512 from the Academy of Sciences of the Czech Republic, and LC554 from the Ministry of Education, Youth and Sports of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Anderova M, 2011, J CEREBR BLOOD F MET, V31, P894, DOI 10.1038/jcbfm.2010.168; Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; Bae CYJ, 2011, ACTA PHARMACOL SIN, V32, P725, DOI 10.1038/aps.2011.60; Bai JZ, 2010, NEUROTOXICOLOGY, V31, P204, DOI 10.1016/j.neuro.2010.01.001; Balazsi G, 2003, CHAOS, V13, P515, DOI 10.1063/1.1567652; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Benesova J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029725; Benesova J, 2009, J NEUROSCI RES, V87, P96, DOI 10.1002/jnr.21828; Benfenati V, 2007, NEUROSCIENCE, V148, P876, DOI 10.1016/j.neuroscience.2007.06.039; Benfenati V, 2010, NEUROSCIENCE, V168, P926, DOI 10.1016/j.neuroscience.2009.12.017; Benfenati V, 2011, P NATL ACAD SCI USA, V108, P2563, DOI 10.1073/pnas.1012867108; Bond CE, 2006, EUR J NEUROSCI, V24, P381, DOI 10.1111/j.1460-9568.2006.04898.x; Cali C, 2009, INT REV NEUROBIOL, V85, P261, DOI 10.1016/S0074-7742(09)85020-4; Cao DS, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-5; Cao X, 2010, NEUROSCI LETT, V479, P118, DOI 10.1016/j.neulet.2010.05.040; Chen HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011161; Chvatal A, 2008, PHYSIOL RES, V57, pS101, DOI 10.33549/physiolres.931604; Chvatal A, 2007, J NEUROSCI RES, V85, P260, DOI 10.1002/jnr.21113; Clemens JA, 1996, STROKE, V27, P527, DOI 10.1161/01.STR.27.3.527; Cotrina ML, 2009, PURINERG SIGNAL, V5, P223, DOI 10.1007/s11302-009-9138-2; Evanko DS, 2004, GLIA, V47, P233, DOI 10.1002/glia.20050; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058; Golovina VA, 2005, J PHYSIOL-LONDON, V564, P737, DOI 10.1113/jphysiol.2005.085035; Guler AD, 2002, J NEUROSCI, V22, P6408; Hill K, 2006, NEUROPHARMACOLOGY, V50, P89, DOI 10.1016/j.neuropharm.2005.08.021; Honsa P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036816; Jia YL, 2004, AM J PHYSIOL-LUNG C, V287, pL272, DOI 10.1152/ajplung.00393.2003; Jung C, 2009, PFLUG ARCH EUR J PHY, V459, P105, DOI 10.1007/s00424-009-0706-7; Kauer JA, 2009, TRENDS NEUROSCI, V32, P215, DOI 10.1016/j.tins.2008.12.006; Kim D, 2005, CURR PHARM DESIGN, V11, P2717, DOI 10.2174/1381612054546824; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; Kirischuk S, 1997, FASEB J, V11, P566, DOI 10.1096/fasebj.11.7.9212080; Kirischuk S, 2007, PFLUG ARCH EUR J PHY, V454, P245, DOI 10.1007/s00424-007-0207-5; Krebs C, 2003, J NEUROSCI, V23, P3364; Lalo U, 2006, J NEUROSCI, V26, P2673, DOI 10.1523/JNEUROSCI.4689-05.2006; Lanciotti A, 2012, HUM MOL GENET, V21, P2166, DOI 10.1093/hmg/dds032; Latour I, 2003, GLIA, V41, P347, DOI 10.1002/glia.10162; Liedtke W, 2006, J ENDOCRINOL, V191, P515, DOI 10.1677/joe.1.07000; Lipski J, 2006, BRAIN RES, V1077, P187, DOI 10.1016/j.brainres.2006.01.016; Liu XB, 2006, J BIOL CHEM, V281, P15485, DOI 10.1074/jbc.M600549200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makara JK, 2003, MOL CELL NEUROSCI, V23, P521, DOI 10.1016/S1044-7431(03)00080-0; Malarkey EB, 2008, GLIA, V56, P821, DOI 10.1002/glia.20656; Manning TJ, 1997, GLIA, V21, P332; Matsuda T, 2001, J PHARMACOL EXP THER, V298, P249; Matyash V, 2010, BRAIN RES REV, V63, P2, DOI 10.1016/j.brainresrev.2009.12.001; Meng F, 2008, RESP PHYSIOL NEUROBI, V164, P386, DOI 10.1016/j.resp.2008.09.002; MILLER B, 1992, NATURE, V355, P722, DOI 10.1038/355722a0; Miller BA, 2011, ADV EXP MED BIOL, V704, P531, DOI 10.1007/978-94-007-0265-3_29; Montana V, 2006, GLIA, V54, P700, DOI 10.1002/glia.20367; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Nedergaard M, 2010, CELL CALCIUM, V47, P140, DOI 10.1016/j.ceca.2009.11.010; Neprasova H, 2007, PFLUG ARCH EUR J PHY, V453, P839, DOI 10.1007/s00424-006-0151-9; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; O'Neil RG, 2005, PFLUG ARCH EUR J PHY, V451, P193, DOI 10.1007/s00424-005-1424-4; Paluzzi S, 2007, J NEUROCHEM, V103, P1196, DOI 10.1111/j.1471-4159.2007.04826.x; Pivonkova H, 2010, NEUROCHEM INT, V57, P783, DOI 10.1016/j.neuint.2010.08.016; Plant T. D., 2007, V179, P189; Price DL, 2002, BRAIN RES, V956, P183, DOI 10.1016/S0006-8993(02)03266-3; Rao SP, 2006, GLIA, V53, P817, DOI 10.1002/glia.20341; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; Rojas H, 2007, J NEUROCHEM, V100, P1188, DOI 10.1111/j.1471-4159.2006.04303.x; Runnels LW, 2011, CURR PHARM BIOTECHNO, V12, P42; Seifert G, 2009, J NEUROSCI, V29, P7474, DOI 10.1523/JNEUROSCI.3790-08.2009; Shibasaki K, 2007, J NEUROSCI, V27, P1566, DOI 10.1523/JNEUROSCI.4284-06.2007; Shirakawa H, 2010, J NEUROSCI, V30, P13116, DOI 10.1523/JNEUROSCI.1890-10.2010; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Strotmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010580; Takano T, 2009, STROKE, V40, pS8, DOI 10.1161/STROKEAHA.108.533166; TAKUMA K, 1994, GLIA, V12, P336, DOI 10.1002/glia.440120410; Verkhratsky A, 2009, FRONT BIOSCI-LANDMRK, V14, P2004, DOI 10.2741/3359; Vincent F, 2009, BIOCHEM BIOPH RES CO, V389, P490, DOI 10.1016/j.bbrc.2009.09.007; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Watanabe H, 2003, CELL CALCIUM, V33, P489, DOI 10.1016/S0143-4160(03)00064-2; Zhao XR, 2008, J NEUROTRAUM, V25, P1195, DOI 10.1089/neu.2008.0635; Zhou M, 2000, J NEUROPHYSIOL, V84, P2746, DOI 10.1152/jn.2000.84.6.2746	82	112	117	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39959	10.1371/journal.pone.0039959	http://dx.doi.org/10.1371/journal.pone.0039959			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761937	Green Submitted, Green Published, gold			2022-12-27	WOS:000305825800082
J	Parasuraman, R; de Visser, E; Lin, MK; Greenwood, PM				Parasuraman, Raja; de Visser, Ewart; Lin, Ming-Kuan; Greenwood, Pamela M.			Dopamine Beta Hydroxylase Genotype Identifies Individuals Less Susceptible to Bias in Computer-Assisted Decision Making	PLOS ONE			English	Article							PREFRONTAL CORTEX; CEREBROSPINAL-FLUID; NEURONAL-ACTIVITY; AUTOMATION BIAS; WORKING-MEMORY; POLYMORPHISMS; METAANALYSIS; RECEPTORS; ATTENTION; GENES	Computerized aiding systems can assist human decision makers in complex tasks but can impair performance when they provide incorrect advice that humans erroneously follow, a phenomenon known as "automation bias." The extent to which people exhibit automation bias varies significantly and may reflect inter-individual variation in the capacity of working memory and the efficiency of executive function, both of which are highly heritable and under dopaminergic and noradrenergic control in prefrontal cortex. The dopamine beta hydroxylase (DBH) gene is thought to regulate the differential availability of dopamine and norepinephrine in prefrontal cortex. We therefore examined decision-making performance under imperfect computer aiding in 100 participants performing a simulated command and control task. Based on two single nucleotide polymorphism (SNPs) of the DBH gene, - 1041 C/T (rs1611115) and 444 G/A (rs1108580), participants were divided into groups of low and high DBH enzyme activity, where low enzyme activity is associated with greater dopamine relative to norepinephrine levels in cortex. Compared to those in the high DBH enzyme activity group, individuals in the low DBH enzyme activity group were more accurate and speedier in their decisions when incorrect advice was given and verified automation recommendations more frequently. These results indicate that a gene that regulates relative prefrontal cortex dopamine availability, DBH, can identify those individuals who are less susceptible to bias in using computerized decision-aiding systems.	[Parasuraman, Raja; de Visser, Ewart; Lin, Ming-Kuan; Greenwood, Pamela M.] George Mason Univ, Ctr Excellence Neuroergon Technol & Cognit CENTEC, Fairfax, VA 22030 USA; [Parasuraman, Raja; de Visser, Ewart; Lin, Ming-Kuan; Greenwood, Pamela M.] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Lin, Ming-Kuan] George Mason Univ, Dept Mol Neurosci, Fairfax, VA 22030 USA	George Mason University; George Mason University; George Mason University	Parasuraman, R (corresponding author), George Mason Univ, Ctr Excellence Neuroergon Technol & Cognit CENTEC, Fairfax, VA 22030 USA.	rparasur@gmu.edu		lin, mingkuan/0000-0003-3895-9148	Air Force Office of Sponsored Research [FA9550-10-1-0385]	Air Force Office of Sponsored Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This research was supported by Air Force Office of Sponsored Research grant FA9550-10-1-0385 to Raja Parasuraman. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 2002, J NEUROSCI, V22, P3708, DOI 10.1523/jneurosci.22-09-03708.2002; Alberdi E, 2004, ACAD RADIOL, V11, P909, DOI 10.1016/j.acra.2004.05.012; Ando J, 2001, BEHAV GENET, V31, P615, DOI 10.1023/A:1013353613591; Avery RA, 2000, NEUROPSYCHOPHARMACOL, V23, P240, DOI 10.1016/S0893-133X(00)00111-1; Backman L, 2011, SCIENCE, V333, P718, DOI 10.1126/science.1204978; Bahner JE, 2008, INT J HUM-COMPUT ST, V66, P688, DOI 10.1016/j.ijhcs.2008.06.001; Barnett JH, 2007, MOL PSYCHIATR, V12, P502, DOI 10.1038/sj.mp.4001973; Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005; Citron D. K., 2007, WASH U L REV, V85, P1249; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; Cubells JF, 2004, PSYCHOPHARMACOLOGY, V174, P463, DOI 10.1007/s00213-004-1840-8; Cubells JF, 1998, HUM GENET, V102, P533, DOI 10.1007/s004390050736; Cummings M., 2006, J TECHNOLOGY STUDIES, V32, P23, DOI [DOI 10.21061/JOTS.V32I1.A.4, DOI 10.21061/J0TS.V32I1.A.4]; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; de Visser E., 2010, P HUM FACT ERG SOC A, V54, P1087, DOI DOI 10.1177/154193121005401408; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Goldberg TE, 2004, TRENDS COGN SCI, V8, P325, DOI 10.1016/j.tics.2004.05.011; Green AE, 2008, NAT REV NEUROSCI, V9, P710, DOI 10.1038/nrn2461; Greenwood PM, 2009, J COGNITIVE NEUROSCI, V21, P2139, DOI 10.1162/jocn.2008.21164; Greenwood PM, 2005, J COGNITIVE NEUROSCI, V17, P1611, DOI 10.1162/089892905774597281; LAYTON C, 1994, HUM FACTORS, V36, P94, DOI 10.1177/001872089403600106; Lipsky RH, 2001, CLIN CHEM, V47, P635; Markett SA, 2010, J COGNITIVE NEUROSCI, V22, P1944, DOI 10.1162/jocn.2009.21354; McNab F, 2009, SCIENCE, V323, P800, DOI 10.1126/science.1166102; McTeague J, 2011, CRAPSHOOT INVESTING; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mosier K.L., 2010, REV HUMAN FACTORS ER, V6, P198, DOI [https://doi.org/10.1518/155723410X12849346788822, DOI 10.1518/155723410X12849346788822]; Mosier KL, 2001, INT J AVIAT PSYCHOL, V11, P1, DOI 10.1207/S15327108IJAP1101_1; Mosier KL, 1998, INT J AVIAT PSYCHOL, V8, P47, DOI 10.1207/s15327108ijap0801_3; O'Connor DT, 1993, J HYPERTENS, V1, P227; OCONNOR DT, 1994, CLIN SCI, V86, P149, DOI 10.1042/cs0860149; OXENSTIERNA G, 1986, J PSYCHIAT RES, V20, P19, DOI 10.1016/0022-3956(86)90020-8; Parasuraman R, 2005, PSYCHOL SCI, V16, P200, DOI 10.1111/j.0956-7976.2005.00804.x; Parasuraman R, 1997, HUM FACTORS, V39, P230, DOI 10.1518/001872097778543886; Parasuraman R., 2004, COGNITIVE NEUROSCIEN, P245; Parasuraman R, 2010, HUM FACTORS, V52, P381, DOI 10.1177/0018720810376055; Posner MI, 2007, DEVELOPMENTAL SCI, V10, P24, DOI 10.1111/j.1467-7687.2007.00559.x; Punia S, 2010, PHARMACOGENET GENOM, V20, P435, DOI 10.1097/FPC.0b013e32833ad3bb; Rovira E, 2007, HUM FACTORS, V49, P76, DOI 10.1518/001872007779598082; Sapra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030844; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; Skitka LJ, 2000, INT J HUM-COMPUT ST, V52, P701, DOI 10.1006/ijhc.1999.0349; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Vijayraghavan S., 2011, NAT NEUROSCI, V19, P376; Wang J, 2005, BIOTECHNIQUES, V39, P885, DOI 10.2144/000112028; Weinshenker D, 2002, P NATL ACAD SCI USA, V99, P13873, DOI 10.1073/pnas.212519999; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Zabetian CP, 2001, AM J HUM GENET, V68, P515, DOI 10.1086/318198; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P20552, DOI 10.1073/pnas.0707106104	49	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39675	10.1371/journal.pone.0039675	http://dx.doi.org/10.1371/journal.pone.0039675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761865	gold, Green Submitted, Green Published			2022-12-27	WOS:000305825800059
J	Barrio, MM; Abes, R; Colombo, M; Pizzurro, G; Boix, C; Roberti, MP; Gelize, E; Rodriguez-Zubieta, M; Mordoh, J; Teillaud, JL				Marcela Barrio, Maria; Abes, Riad; Colombo, Marina; Pizzurro, Gabriela; Boix, Charlotte; Paula Roberti, Maria; Gelize, Emmanuelle; Rodriguez-Zubieta, Mariana; Mordoh, Jose; Teillaud, Jean-Luc			Human Macrophages and Dendritic Cells Can Equally Present MART-1 Antigen to CD8(+) T Cells after Phagocytosis of Gamma-Irradiated Melanoma Cells	PLOS ONE			English	Article							HUMAN TUMOR-ANTIGEN; CROSS-PRESENTATION; IN-VIVO; APOPTOTIC CELLS; METASTATIC MELANOMA; HLA-A2 MELANOMAS; B16 MELANOMA; PHASE-II; LYMPHOCYTES; VACCINATION	Dendritic cells (DC) can achieve cross-presentation of naturally-occurring tumor-associated antigens after phagocytosis and processing of dying tumor cells. They have been used in different clinical settings to vaccinate cancer patients. We have previously used gamma-irradiated MART-1 expressing melanoma cells as a source of antigens to vaccinate melanoma patients by injecting irradiated cells with BCG and GM-CSF or to load immature DC and use them as a vaccine. Other clinical trials have used IFN-gamma activated macrophage killer cells (MAK) to treat cancer patients. However, the clinical use of MAK has been based on their direct tumoricidal activity rather than on their ability to act as antigen-presenting cells to stimulate an adaptive antitumor response. Thus, in the present work, we compared the fate of MART-1 after phagocytosis of gamma-irradiated cells by clinical grade DC or MAK as well as the ability of these cells to cross present MART-1 to CD8(+) T cells. Using a high affinity antibody against MART-1, 2A9, which specifically stains melanoma tumors, melanoma cell lines and normal melanocytes, the expression level of MART-1 in melanoma cell lines could be related to their ability to stimulate IFN-gamma production by a MART-1 specific HLA-A*0201-restricted CD8(+) T cell clone. Confocal microscopy with Alexa Fluor (R) 647-labelled 2A9 also showed that MART-1 could be detected in tumor cells attached and/or fused to phagocytes and even inside these cells as early as 1 h and up to 24 h or 48 h after initiation of co-cultures between gamma-irradiated melanoma cells and MAK or DC, respectively. Interestingly, MART-1 was cross-presented to MART-1 specific T cells by both MAK and DC co-cultured with melanoma gamma-irradiated cells for different time-points. Thus, naturally occurring MART-1 melanoma antigen can be taken-up from dying melanoma cells into DC or MAK and both cell types can induce specific CD8(+) T cell cross-presentation thereafter.	[Marcela Barrio, Maria; Pizzurro, Gabriela; Paula Roberti, Maria; Mordoh, Jose] Fdn Canc FUCA, Ctr Invest Oncol, Buenos Aires, DF, Argentina; [Abes, Riad; Boix, Charlotte; Gelize, Emmanuelle; Teillaud, Jean-Luc] INSERM, UMR S 872, Paris, France; [Abes, Riad; Boix, Charlotte; Gelize, Emmanuelle; Teillaud, Jean-Luc] Univ Paris 06, UMR S 872, Ctr Rech Cordeliers, Paris, France; [Abes, Riad; Boix, Charlotte; Gelize, Emmanuelle; Teillaud, Jean-Luc] Univ Paris 05, UMR S 872, Paris, France; [Colombo, Marina; Rodriguez-Zubieta, Mariana; Mordoh, Jose] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, Inst Invest Bioquim Buenos Aires, RA-1033 Buenos Aires, DF, Argentina	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Barrio, MM (corresponding author), Fdn Canc FUCA, Ctr Invest Oncol, Buenos Aires, DF, Argentina.	jean-luc.teillaud@crc.jussieu.fr		Teillaud, Jean-Luc/0000-0003-4442-9565	INSERM (INSERM - Institut National de la Sante et de la Recherche Medicale (France)), Paris Descartes; UPMC (Universite Pierre et Marie Curie) universities; Evaluation-orientation de la Cooperation Scientifique Sud (ECOS Sud)/Secretaria de Promocion Cientifica y Tecnologica (SEPCyT) exchange program from Argentine SEPCyT [A03S03]; French Ministere des Affaires Etrangeres; INSERM/Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) exchange program; CONICET; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Fundacion Sales; Fundacion Cancer (FUCA); Fundacion Pedro F. Mosoteguy; Fundacion Maria Calderon de la Barca, Argentina; Laboratoire Francais du Fractionnement et des Biotechnologies (LFB)-Agence Nationale de la Recherche et de la Technologie (ANRT) (Conventions Industrielles de Formation par la Recherche (CIFRE) fellowship [173/2006]; Pole de Competitivite Meditech Sante, Ile-de-France (Immucan project)	INSERM (INSERM - Institut National de la Sante et de la Recherche Medicale (France)), Paris Descartes; UPMC (Universite Pierre et Marie Curie) universities; Evaluation-orientation de la Cooperation Scientifique Sud (ECOS Sud)/Secretaria de Promocion Cientifica y Tecnologica (SEPCyT) exchange program from Argentine SEPCyT; French Ministere des Affaires Etrangeres; INSERM/Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) exchange program; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Fundacion Sales; Fundacion Cancer (FUCA); Fundacion Pedro F. Mosoteguy; Fundacion Maria Calderon de la Barca, Argentina; Laboratoire Francais du Fractionnement et des Biotechnologies (LFB)-Agence Nationale de la Recherche et de la Technologie (ANRT) (Conventions Industrielles de Formation par la Recherche (CIFRE) fellowship; Pole de Competitivite Meditech Sante, Ile-de-France (Immucan project)	This work was supported by INSERM (INSERM - Institut National de la Sante et de la Recherche Medicale (France)), Paris Descartes and UPMC (Universite Pierre et Marie Curie) universities, by an Evaluation-orientation de la Cooperation Scientifique Sud (ECOS Sud)/Secretaria de Promocion Cientifica y Tecnologica (SEPCyT) exchange program grant (A03S03) from the Argentine SEPCyT and the French Ministere des Affaires Etrangeres, by a grant from an INSERM/Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) exchange program and by grants from the CONICET, the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), the Fundacion Sales, the Fundacion Cancer (FUCA), the Fundacion Pedro F. Mosoteguy and the Fundacion Maria Calderon de la Barca, Argentina. JM and MMB are members of CONICET, and MPR is a fellow of the same Institution. GP is a fellow from the ANPCyT. MC and MRZ were supported by fellowships from CONICET. JLT and EG are members of INSERM. RA was supported by Laboratoire Francais du Fractionnement et des Biotechnologies (LFB)-Agence Nationale de la Recherche et de la Technologie (ANRT) (Conventions Industrielles de Formation par la Recherche (CIFRE) fellowship # 173/2006. CB was supported by a grant from the Pole de Competitivite Meditech Sante, Ile-de-France (Immucan project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amigorena S, 2010, CURR OPIN IMMUNOL, V22, P109, DOI 10.1016/j.coi.2010.01.022; Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2000, NAT REV IMMUNOL, V1, P387; Baron-Bodo W, 2005, IMMUNOBIOLOGY, V210, P267, DOI 10.1016/j.imbio.2005.05.021; Barrio MM, 2006, J IMMUNOTHER, V29, P444, DOI 10.1097/01.cji.0000208258.79005.5f; BEATTY JD, 1987, J IMMUNOL METHODS, V100, P173, DOI 10.1016/0022-1759(87)90187-6; Birkholz K, 2010, BLOOD, V116, P2277, DOI 10.1182/blood-2010-02-268425; Blacher NE, 2005, PLOS BIOL, V3, P1070, DOI 10.1371/journal.pbio.0030185; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; BOVER L, 1991, BREAST CANCER RES TR, V19, P47, DOI 10.1007/BF01975204; Boyer A, 1999, EXP HEMATOL, V27, P751, DOI 10.1016/S0301-472X(98)00070-8; Brayer J, 2010, IMMUNOL LETT, V131, P126, DOI 10.1016/j.imlet.2010.03.004; BRICHARD V, 1993, J EXP MED, V178, P489, DOI 10.1084/jem.178.2.489; Brusa D, 2008, VACCINE, V26, P6422, DOI 10.1016/j.vaccine.2008.08.063; Chen YT, 1996, P NATL ACAD SCI USA, V93, P5915, DOI 10.1073/pnas.93.12.5915; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; De Maziere AM, 2002, TRAFFIC, V3, P678, DOI 10.1034/j.1600-0854.2002.30909.x; Gaipl US, 2003, IMMUNOBIOLOGY, V207, P73, DOI 10.1078/0171-2985-00217; Goldszmid RS, 2003, J IMMUNOL, V171, P5940, DOI 10.4049/jimmunol.171.11.5940; GUERRA L, 1989, PIGM CELL RES, V2, P504, DOI 10.1111/j.1600-0749.1989.tb00246.x; Hoashi T, 2005, J BIOL CHEM, V280, P14006, DOI 10.1074/jbc.M413692200; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P6458, DOI 10.1073/pnas.91.14.6458; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P3515, DOI 10.1073/pnas.91.9.3515; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; Lesterhuis WJ, 2011, CANCER IMMUNOL IMMUN, V60, P249, DOI 10.1007/s00262-010-0942-x; Mac Keon S, 2010, VACCINE, V28, P8162, DOI 10.1016/j.vaccine.2010.09.095; Moehler MH, 2005, HUM GENE THER, V16, P996, DOI 10.1089/hum.2005.16.996; Monnet I, 2002, CHEST, V121, P1921, DOI 10.1378/chest.121.6.1921; Mordoh J, 1997, MEDICINA-BUENOS AIRE, V57, P421; Motta I, 2001, J IMMUNOL, V167, P1795, DOI 10.4049/jimmunol.167.3.1795; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; Olazabal IM, 2008, MOL BIOL CELL, V19, P701, DOI 10.1091/mbc.E07-07-0650; Palucka AK, 2006, J IMMUNOTHER, V29, P545, DOI 10.1097/01.cji.0000211309.90621.8b; Pozzi LAM, 2005, J IMMUNOL, V175, P2071, DOI 10.4049/jimmunol.175.4.2071; Ribas A, 2009, CLIN CANCER RES, V15, P6267, DOI 10.1158/1078-0432.CCR-09-1254; Russo V, 2000, P NATL ACAD SCI USA, V97, P2185, DOI 10.1073/pnas.040540197; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Schadendorf D, 2006, ANN ONCOL, V17, P563, DOI 10.1093/annonc/mdj138; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Slingluff CL, 2008, J CLIN ONCOL, V26, P4973, DOI 10.1200/JCO.2008.17.3161; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Speiser DE, 2004, J IMMUNOTHER, V27, P298, DOI 10.1097/00002371-200407000-00006; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Thiounn N, 2002, J UROLOGY, V168, P2373, DOI 10.1016/S0022-5347(05)64148-1; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vely F, 1997, HYBRIDOMA, V16, P519, DOI 10.1089/hyb.1997.16.519; Vingert B, 2006, EUR J IMMUNOL, V36, P1124, DOI 10.1002/eji.200535443; Von Euw EM, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-6; von Euw EM, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-19; Wang RF, 1996, J EXP MED, V184, P2207, DOI 10.1084/jem.184.6.2207; Yee C, 1999, J IMMUNOL, V162, P2227	53	40	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40311	10.1371/journal.pone.0040311	http://dx.doi.org/10.1371/journal.pone.0040311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768350	Green Published, Green Submitted, gold			2022-12-27	WOS:000305966500063
J	Berkman, ET; Falk, EB; Lieberman, MD				Berkman, Elliot T.; Falk, Emily B.; Lieberman, Matthew D.			Interactive Effects of Three Core Goal Pursuit Processes on Brain Control Systems: Goal Maintenance, Performance Monitoring, and Response Inhibition	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; INFERIOR FRONTAL GYRUS; PREFRONTAL CORTEX; COGNITIVE CONTROL; NEURAL BASIS; COMMON; TASKS; FMRI; REPRESENTATION; METAANALYSIS	Goal attainment relies in part on one's ability to maintain a cognitive representation of the desired goal (goal maintenance), monitor the current state vis-a-vis the targeted end state and remain vigilant for lapses in progress (performance monitoring), and inhibit counter-goal behaviors (response inhibition). Because neurocognitive studies have typically examined these three processes in isolation from one another, little is known regarding if and how they interact during goal pursuit. However, these processes frequently co-occur during online, real-world goal pursuit. The present study employed a novel task to investigate how goal maintenance, performance monitoring, and response inhibition interact with one another. We identified functional activations distinct to each of the processes that correspond to results of prior investigations. In addition, we report interactive effects between response inhibition and goal maintenance in the dorsal anterior cingulate cortex and between performance monitoring and goal maintenance in the superior frontal gyrus and supramarginal gyrus. Implications for studying the neural systems of in situ goals include the need for both experimental designs that distinguish between process, but also more complex, realistic tasks to begin to map interactions among these neurocognitive processes and how they are altered by the presence or absence of one another.	[Berkman, Elliot T.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Falk, Emily B.] Univ Michigan, Dept Commun Studies, Inst Social Res, Ann Arbor, MI USA; [Falk, Emily B.] Univ Michigan, Dept Psychol, Inst Social Res, Ann Arbor, MI USA; [Lieberman, Matthew D.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA	University of Oregon; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles	Berkman, ET (corresponding author), Univ Oregon, Dept Psychol, Eugene, OR 97403 USA.	berkman@uoregon.edu	Berkman, Elliot T./Q-5233-2016; Lieberman, Matthew/ABD-8197-2020	Berkman, Elliot T./0000-0002-7113-5792; Lieberman, Matthew/0000-0002-4447-7359	National Institutes of Health [F31DA 024904-01]; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA024904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Support for this work was provided by the National Institutes of Health to ETB (F31DA 024904-01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonovich E, 2003, DRUG ALCOHOL DEPEN, V71, P207, DOI 10.1016/S0376-8716(03)00092-9; Aron AR, 2008, CURR DIR PSYCHOL SCI, V17, P124, DOI 10.1111/j.1467-8721.2008.00561.x; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Aron AR, 2004, BRAIN, V127, P1561, DOI 10.1093/brain/awh169; Baker SC, 1996, CEREB CORTEX, V6, P612, DOI 10.1093/cercor/6.4.612; Banich MT, 2000, J COGNITIVE NEUROSCI, V12, P988, DOI 10.1162/08989290051137521; Berkman E. T., 2009, PSYCHOL GOALS, P98; Berkman ET, 2011, PSYCHOL SCI, V22, P498, DOI 10.1177/0956797611400918; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brown SM, 2006, EMOTION, V6, P239, DOI 10.1037/1528-3542.6.2.239; Bunge SA, 2003, J NEUROPHYSIOL, V90, P3419, DOI 10.1152/jn.00910.2002; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Chikazoe J, 2009, J NEUROSCI, V29, P15870, DOI 10.1523/JNEUROSCI.3645-09.2009; Dikman ZV, 2000, PSYCHOPHYSIOLOGY, V37, P43, DOI 10.1017/S0048577200980983; Dodds CM, 2011, CEREB CORTEX, V21, P1155, DOI 10.1093/cercor/bhq187; Fletcher PC, 1998, BRAIN, V121, P1239, DOI 10.1093/brain/121.7.1239; Friston KJ, 1996, NEUROIMAGE, V4, P97, DOI 10.1006/nimg.1996.0033; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Grafton ST, 2007, HUM MOVEMENT SCI, V26, P590, DOI 10.1016/j.humov.2007.05.009; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Herd SA, 2006, J COGNITIVE NEUROSCI, V18, P22, DOI 10.1162/089892906775250012; Horn NR, 2003, NEUROPSYCHOLOGIA, V41, P1959, DOI 10.1016/S0028-3932(03)00077-0; Jahfari S, 2010, J COGNITIVE NEUROSCI, V22, P1479, DOI 10.1162/jocn.2009.21307; Johnson-Frey SH, 2004, TRENDS COGN SCI, V8, P71, DOI 10.1016/j.tics.2003.12.002; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Leung HC, 2007, J NEUROSCI, V27, P9893, DOI 10.1523/JNEUROSCI.2837-07.2007; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MACLEOD C, 1991, BEHAV RES THER, V29, P599, DOI 10.1016/0005-7967(91)90009-R; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Muraven M, 2010, J EXP SOC PSYCHOL, V46, P465, DOI 10.1016/j.jesp.2009.12.011; Oettingen G, 2001, J PERS SOC PSYCHOL, V80, P736, DOI 10.1037//0022-3514.80.5.736; Oettingen G., 2000, INT J EDUC RES, V33, P705, DOI [10.1016/S0883-0355(00)00046-X, DOI 10.1016/S0883-0355(00)00046-X]; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pham LB, 1999, PERS SOC PSYCHOL B, V25, P250, DOI 10.1177/0146167299025002010; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Shulman GL, 2007, CEREB CORTEX, V17, P2625, DOI 10.1093/cercor/bhl170; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Stroop JR, 1935, AM J PSYCHOL, V47, P499, DOI 10.2307/1416349; Taylor SF, 2007, NEUROSCIENTIST, V13, P160, DOI 10.1177/1073858406298184; Toni I, 2001, NEUROIMAGE, V14, pS110, DOI 10.1006/nimg.2001.0841; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; Venkatraman V, 2009, J NEUROSCI, V29, P13158, DOI 10.1523/JNEUROSCI.2708-09.2009; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Xue G, 2008, CEREB CORTEX, V18, P1923, DOI 10.1093/cercor/bhm220; ZIMMERMAN BJ, 1992, AM EDUC RES J, V29, P663, DOI 10.3102/00028312029003663	55	22	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40334	10.1371/journal.pone.0040334	http://dx.doi.org/10.1371/journal.pone.0040334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768277	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100251
J	Delucchi, F; Berni, R; Frati, C; Cavalli, S; Graiani, G; Sala, R; Chaponnier, C; Gabbiani, G; Calani, L; Del Rio, D; Bocchi, L; Lagrasta, C; Quaini, F; Stilli, D				Delucchi, Francesca; Berni, Roberta; Frati, Caterina; Cavalli, Stefano; Graiani, Gallia; Sala, Roberto; Chaponnier, Christine; Gabbiani, Giulio; Calani, Luca; Del Rio, Daniele; Bocchi, Leonardo; Lagrasta, Costanza; Quaini, Federico; Stilli, Donatella			Resveratrol Treatment Reduces Cardiac Progenitor Cell Dysfunction and Prevents Morpho-Functional Ventricular Remodeling in Type-1 Diabetic Rats	PLOS ONE			English	Article							ALPHA-SKELETAL ACTIN; OXIDATIVE STRESS; STEM-CELLS; MOLECULAR-MECHANISMS; RED WINE; VASCULAR INJURY; PROTEIN; HEART; EXPRESSION; CARDIOMYOPATHY	Emerging evidence suggests that both adult cardiac cell and the cardiac stem/progenitor cell (CSPC) compartments are involved in the patho-physiology of diabetic cardiomyopathy (DCM). We evaluated whether early administration of Resveratrol, a natural antioxidant polyphenolic compound, in addition to improving cardiomyocyte function, exerts a protective role on (i) the progenitor cell pool, and (ii) the myocardial environment and its impact on CSPCs, positively interfering with the onset of DCM phenotype. Adult Wistar rats (n = 128) with streptozotocin-induced type-1 diabetes were either untreated (D group; n = 54) or subjected to administration of trans-Resveratrol (i. p. injection: 2.5 mg/Kg/day; DR group; n = 64). Twenty-five rats constituted the control group (C). After 1, 3 or 8 weeks of hyperglycemia, we evaluated cardiac hemodynamic performance, and cardiomyocyte contractile properties and intracellular calcium dynamics. Myocardial remodeling and tissue inflammation were also assessed by morphometry, immunohistochemistry and immunoblotting. Eventually, the impact of the diabetic "milieu" on CSPC turnover was analyzed in co-cultures of healthy CSPCs and cardiomyocytes isolated from D and DR diabetic hearts. In untreated animals, cardiac function was maintained during the first 3 weeks of hyperglycemia, although a definite ventricular remodeling was already present, mainly characterized by a marked loss of CSPCs and adult cardiac cells. Relevant signs of ventricular dysfunction appeared after 8 weeks of diabetes, and included: 1) a significant reduction in +/- dP/dt in comparison with C group, 2) a prolongation of isovolumic contraction/relaxation times, 3) an impaired contraction of isolated cardiomyocytes associated with altered intracellular calcium dynamics. Resveratrol administration reduced atrial CSPC loss, succeeded in preserving the functional abilities of CSPCs and mature cardiac cells, improved cardiac environment by reducing inflammatory state and decreased unfavorable ventricular remodeling of the diabetic heart, leading to a marked recovery of ventricular function. These findings indicate that RSV can constitute an adjuvant therapeutic option in DCM prevention.	[Delucchi, Francesca; Berni, Roberta; Bocchi, Leonardo; Stilli, Donatella] Univ Parma, Dipartimento Biol Evolutiva & Funz, I-43100 Parma, Italy; [Frati, Caterina; Cavalli, Stefano; Graiani, Gallia; Lagrasta, Costanza] Univ Parma, Dipartimento Patol & Med Lab, I-43100 Parma, Italy; [Sala, Roberto] Univ Parma, Dipartimento Med Sperimentale, I-43100 Parma, Italy; [Chaponnier, Christine; Gabbiani, Giulio] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [Calani, Luca; Del Rio, Daniele] Univ Parma, Dipartimento Sanita Pubbl, I-43100 Parma, Italy; [Quaini, Federico] Univ Parma, Dipartimento Med Interna & Sci Biomed, I-43100 Parma, Italy; [Lagrasta, Costanza; Quaini, Federico; Stilli, Donatella] Univ Parma, Ctr Interdipartimentale Cellule Staminali Cardiac, I-43100 Parma, Italy	University of Parma; University of Parma; University of Parma; University of Geneva; University of Parma; University of Parma; University of Parma	Delucchi, F (corresponding author), Univ Parma, Dipartimento Biol Evolutiva & Funz, I-43100 Parma, Italy.	donatella.stilli@unipr.it	Stilli, Donatella/M-5630-2018; Sala, Roberto/B-9736-2013; Del Rio, Daniele/E-8696-2010	Sala, Roberto/0000-0002-9167-0020; Del Rio, Daniele/0000-0001-5394-1259; Quaini, Federico/0000-0003-2377-4810; BOCCHI, Leonardo/0000-0003-4799-2804; Frati, Caterina/0000-0002-3343-6471; Graiani, Gallia/0000-0003-1926-7568	Italian Ministry of Education, University and Research; European Commission CORDIS; Italian Ministry of Health "Regenerative Medicine THEAPLL"; Swiss National Science Foundation (SNSF) [310030_125320]; Fondazione Cassa di Risparmio di Parma; National Institute for Cardiovascular Research (INRC);  [NMP-214539 2007]	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); European Commission CORDIS; Italian Ministry of Health "Regenerative Medicine THEAPLL"; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Fondazione Cassa di Risparmio di Parma(Fondazione Cariparma); National Institute for Cardiovascular Research (INRC); 	This study was supported by the following grants: Italian Ministry of Education, University and Research PRIN2007, European Commission CORDIS FP7-BIOSCENT, NMP-214539 2007, Italian Ministry of Health "Regenerative Medicine 2007 THEAPLL", Swiss National Science Foundation (SNSF) grant #310030_125320 (CC), funding by "Fondazione Cassa di Risparmio di Parma" and from the National Institute for Cardiovascular Research (INRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiero M, 2011, DIABETOLOGIA, V54, P945, DOI 10.1007/s00125-010-2007-2; Amri A, 2012, J CONTROL RELEASE, V158, P182, DOI 10.1016/j.jconrel.2011.09.083; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Aragno M, 2008, ENDOCRINOLOGY, V149, P380, DOI 10.1210/en.2007-0877; Balestrieri ML, 2008, J BIOCHEM, V143, P179, DOI 10.1093/jb/mvm209; Balestrieri ML, 2008, BBA-PROTEINS PROTEOM, V1784, P936, DOI 10.1016/j.bbapap.2008.03.004; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Berni R, 2009, AM J PHYSIOL-HEART C, V296, pH1625, DOI 10.1152/ajpheart.01057.2008; Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7; Cohen BH, 2001, EXPLAINING PSYCHOLOG, P324; Das M, 2010, MOL ASPECTS MED, V31, P503, DOI 10.1016/j.mam.2010.09.001; DODGE HT, 1969, AM J CARDIOL, V23, P528, DOI 10.1016/0002-9149(69)90006-X; Driesen RB, 2009, J CELL MOL MED, V13, P896, DOI 10.1111/j.1582-4934.2008.00523.x; Dudley J, 2009, J NUTR BIOCHEM, V20, P443, DOI 10.1016/j.jnutbio.2008.05.003; Juan ME, 2010, J PHARMACEUT BIOMED, V51, P391, DOI 10.1016/j.jpba.2009.03.026; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gurusamy N, 2010, J CELL MOL MED, V14, P2235, DOI 10.1111/j.1582-4934.2010.01140.x; HEWETT TE, 1994, CIRC RES, V74, P740, DOI 10.1161/01.RES.74.4.740; Jian BX, 2012, MOL MED, V18, P209, DOI 10.2119/molmed.2011.00365; Khullar M, 2010, CAN J PHYSIOL PHARM, V88, P233, DOI 10.1139/Y10-016; Kroon PA, 2010, CURR MED CHEM, V17, P2442; Leri A, 2011, CIRC RES, V109, P941, DOI 10.1161/CIRCRESAHA.111.243154; Lin JF, 2008, LIFE SCI, V83, P313, DOI 10.1016/j.lfs.2008.06.016; Lu NH, 2010, FREE RADICAL BIO MED, V48, P873, DOI 10.1016/j.freeradbiomed.2010.01.010; Madonna R, 2011, VASC PHARMACOL, V54, P68, DOI 10.1016/j.vph.2011.03.005; Madonna R, 2011, VASC PHARMACOL, V54, P75, DOI 10.1016/j.vph.2011.03.007; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Mukherjee S, 2009, FREE RADICAL BIO MED, V46, P573, DOI 10.1016/j.freeradbiomed.2008.11.005; MYRENG Y, 1990, CIRCULATION, V81, P260, DOI 10.1161/01.CIR.81.1.260; Orlandi A, 2010, BASIC RES CARDIOL, V105, P703, DOI 10.1007/s00395-010-0109-0; Palsamy P, 2009, CHEM-BIOL INTERACT, V179, P356, DOI 10.1016/j.cbi.2008.11.008; Park DW, 2009, EXP MOL MED, V41, P171, DOI 10.3858/emm.2009.41.3.020; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Pasciu V, 2010, TOXICOL SCI, V114, P101, DOI 10.1093/toxsci/kfp301; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2777, DOI 10.1089/ars.2009.2804; Petrovski G, 2011, ANN NY ACAD SCI, V1215, P22, DOI 10.1111/j.1749-6632.2010.05843.x; Picchi A, 2010, WORLD J CARDIOL, V2, P377, DOI 10.4330/wjc.v2.i11.377; Poornima IG, 2006, CIRC RES, V98, P596, DOI 10.1161/01.RES.0000207406.94146.c2; Rota M, 2006, CIRC RES, V99, P42, DOI 10.1161/01.RES.0000231289.63468.08; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Stilli D, 2007, BASIC RES CARDIOL, V102, P488, DOI 10.1007/s00395-007-0665-0; Sulaiman M, 2010, AM J PHYSIOL-HEART C, V298, pH833, DOI 10.1152/ajpheart.00418.2009; Suurmeijer AJH, 2003, J PATHOL, V199, P387, DOI 10.1002/path.1311; Thirunavukkarasu M, 2007, FREE RADICAL BIO MED, V43, P720, DOI 10.1016/j.freeradbiomed.2007.05.004; Ungvari Z, 2010, AM J PHYSIOL-HEART C, V299, pH18, DOI 10.1152/ajpheart.00260.2010; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; Vang O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019881; Volz HC, 2010, BASIC RES CARDIOL, V105, P805, DOI 10.1007/s00395-010-0114-3; Westermann D, 2007, DIABETES, V56, P1834, DOI 10.2337/db06-1662; Yar AS, 2010, MOL BIOL REP, V37, P2323, DOI 10.1007/s11033-009-9737-6; Younce CW, 2010, BIOCHEM J, V426, P43, DOI 10.1042/BJ20090976; Yu W, 2009, J CELL BIOCHEM, V107, P741, DOI 10.1002/jcb.22169; Zaniboni M, 2000, AM J PHYSIOL-HEART C, V278, pH677, DOI 10.1152/ajpheart.2000.278.3.H677; Zhang HR, 2010, AM J PHYSIOL-HEART C, V299, pH985, DOI 10.1152/ajpheart.00489.2010	55	56	56	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39836	10.1371/journal.pone.0039836	http://dx.doi.org/10.1371/journal.pone.0039836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768138	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100108
J	Gramlich, HS; Reisbig, T; Schatz, DG				Gramlich, Hillary Selle; Reisbig, Tara; Schatz, David G.			AID-Targeting and Hypermutation of Non-Immunoglobulin Genes Does Not Correlate with Proximity to Immunoglobulin Genes in Germinal Center B Cells	PLOS ONE			English	Article							C-MYC ONCOGENE; HEAVY-CHAIN LOCUS; CLASS-SWITCH RECOMBINATION; DOUBLE-STRAND BREAKS; SOMATIC HYPERMUTATION; BURKITT-LYMPHOMA; CHROMOSOMAL TRANSLOCATIONS; IN-VIVO; SEQUENCING REVEALS; KAPPA-GENE	Upon activation, B cells divide, form a germinal center, and express the activation induced deaminase (AID), an enzyme that triggers somatic hypermutation of the variable regions of immunoglobulin (Ig) loci. Recent evidence indicates that at least 25% of expressed genes in germinal center B cells are mutated or deaminated by AID. One of the most deaminated genes, c-Myc, frequently appears as a translocation partner with the Ig heavy chain gene (Igh) in mouse plasmacytomas and human Burkitt's lymphomas. This indicates that the two genes or their double-strand break ends come into close proximity at a biologically relevant frequency. However, the proximity of c-Myc and Igh has never been measured in germinal center B cells, where many such translocations are thought to occur. We hypothesized that in germinal center B cells, not only is c-Myc near Igh, but other mutating non-Ig genes are deaminated by AID because they are near Ig genes, the primary targets of AID. We tested this "collateral damage" model using 3D-fluorescence in situ hybridization (3D-FISH) to measure the distance from non-Ig genes to Ig genes in germinal center B cells. We also made mice transgenic for human MYC and measured expression and mutation of the transgenes. We found that there is no correlation between proximity to Ig genes and levels of AID targeting or gene mutation, and that c-Myc was not closer to Igh than were other non-Ig genes. In addition, the human MYC transgenes did not accumulate mutations and were not deaminated by AID. We conclude that proximity to Ig loci is unlikely to be a major determinant of AID targeting or mutation of non-Ig genes, and that the MYC transgenes are either missing important regulatory elements that allow mutation or are unable to mutate because their new nuclear position is not conducive to AID deamination.	[Gramlich, Hillary Selle] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Reisbig, Tara; Schatz, David G.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Schatz, David G.] Howard Hughes Med Inst, Chevy Chase, MD USA	Yale University; Yale University; Howard Hughes Medical Institute	Gramlich, HS (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	david.schatz@yale.edu	Schatz, David/A-6748-2013	Schatz, David/0000-0002-5669-1176	Howard Hughes Medical Institute; National Science Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF))	Funding sources were Howard Hughes Medical Institute: http://www.hhmi.org/ and National Science Foundation (predoctoral fellowship to HSG): http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1982, P NATL ACAD SCI-BIOL, V79, P6966, DOI 10.1073/pnas.79.22.6966; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; Cario G, 2000, BRIT J HAEMATOL, V110, P537, DOI 10.1046/j.1365-2141.2000.02241.x; Carter RH, 2008, SEMIN IMMUNOL, V20, P43, DOI 10.1016/j.smim.2007.12.007; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Chowdhury M, 2008, P NATL ACAD SCI USA, V105, P15872, DOI 10.1073/pnas.0808462105; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; CREWS S, 1982, SCIENCE, V218, P1319, DOI 10.1126/science.7146913; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; CUMANO A, 1986, EMBO J, V5, P2459, DOI 10.1002/j.1460-2075.1986.tb04522.x; DENNY CT, 1985, MOL CELL BIOL, V5, P3199, DOI 10.1128/MCB.5.11.3199; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; ERIKSON J, 1983, P NATL ACAD SCI-BIOL, V80, P820, DOI 10.1073/pnas.80.3.820; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; Gong H, 2009, BIOCHEM BIOPH RES CO, V383, P11, DOI 10.1016/j.bbrc.2009.03.122; Gordon MS, 2003, P NATL ACAD SCI USA, V100, P4126, DOI 10.1073/pnas.0735266100; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; Gostissa M, 2009, P NATL ACAD SCI USA, V106, P2265, DOI 10.1073/pnas.0812763106; Hakim O, NATURE; HALUSKA FG, 1986, NATURE, V324, P158, DOI 10.1038/324158a0; HARTL P, 1987, MOL CELL BIOL, V7, P2037, DOI 10.1128/MCB.7.6.2037; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Hewitt SL, 2008, NAT IMMUNOL, V9, P396, DOI 10.1038/ni1567; Inlay MA, 2006, J IMMUNOL, V177, P1146, DOI 10.4049/jimmunol.177.2.1146; Jeevan-Raj BP, J EXP MED, V208, P1649; KATO S, 1991, GENE, V97, P239; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; KLOBECK HG, 1987, NUCLEIC ACIDS RES, V15, P4877, DOI 10.1093/nar/15.12.4877; Kozubek S, 1997, BLOOD, V89, P4537, DOI 10.1182/blood.V89.12.4537; Kuang FL, 2009, P NATL ACAD SCI USA, V106, P5288, DOI 10.1073/pnas.0901368106; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lansford R, 1998, INT IMMUNOL, V10, P325, DOI 10.1093/intimm/10.3.325; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; MARCU KB, 1983, P NATL ACAD SCI-BIOL, V80, P519, DOI 10.1073/pnas.80.2.519; Michael N, 2003, IMMUNITY, V19, P235, DOI 10.1016/S1074-7613(03)00204-8; Muschen M, 2000, J EXP MED, V192, P1833, DOI 10.1084/jem.192.12.1833; Neves H, 1999, BLOOD, V93, P1197, DOI 10.1182/blood.V93.4.1197.404k33_1197_1207; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Odegard VH, 2005, IMMUNITY, V23, P101, DOI 10.1016/j.immuni.2005.05.007; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Perlot T, 2005, P NATL ACAD SCI USA, V102, P14362, DOI 10.1073/pnas.0507090102; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; POTTER M, 1992, CARCINOGENESIS, V13, P1681, DOI 10.1093/carcin/13.10.1681; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; RAPPOLD GA, 1984, EMBO J, V3, P2951, DOI 10.1002/j.1460-2075.1984.tb02239.x; RETH M, 1978, EUR J IMMUNOL, V8, P393, DOI 10.1002/eji.1830080605; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Ronai D, 2005, P NATL ACAD SCI USA, V102, P11829, DOI 10.1073/pnas.0505449102; Roschke V, 1997, ONCOGENE, V14, P3011, DOI 10.1038/sj.onc.1201156; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Shen HM, 2000, INT IMMUNOL, V12, P1085, DOI 10.1093/intimm/12.7.1085; STANTON LW, 1983, NATURE, V303, P401, DOI 10.1038/303401a0; Takizawa M, 2008, J EXP MED, V205, P1949, DOI 10.1084/jem.20081007; TAUB R, 1984, CELL, V37, P511, DOI 10.1016/0092-8674(84)90381-7; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Teng G, 2007, ANNU REV GENET, V41, P107, DOI 10.1146/annurev.genet.41.110306.130340; TumasBrundage KM, 1997, MOL IMMUNOL, V34, P367, DOI 10.1016/S0161-5890(97)00065-5; Upton DC, IMMUNOL RES, V49, P14; van der Stoep N, 1998, IMMUNITY, V8, P743, DOI 10.1016/S1074-7613(00)80579-8; Walter J, 2003, J CELL BIOL, V160, P685, DOI 10.1083/jcb.200211103; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Wang LL, 2006, J EXP MED, V203, P215, DOI 10.1084/jem.20051774; Yamane A, NAT IMMUNOL, V12, P62; YELAMOS J, 1995, NATURE, V376, P225; Zan H, 2003, IMMUNITY, V18, P727, DOI 10.1016/S1074-7613(03)00151-1; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	82	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39601	10.1371/journal.pone.0039601	http://dx.doi.org/10.1371/journal.pone.0039601			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768095	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100065
J	Kaitu'u-Lino, TJ; Palmer, K; Tuohey, L; Ye, L; Tong, S				Kaitu'u-Lino, Tu'uhevaha J.; Palmer, Kirsten; Tuohey, Laura; Ye, Louie; Tong, Stephen			MMP-15 Is Upregulated in Preeclampsia, but Does Not Cleave Endoglin to Produce Soluble Endoglin	PLOS ONE			English	Article							METALLOPROTEINASES MT-MMPS; MEMBRANE-TYPE 1; MATRIX METALLOPROTEINASES; HUMAN PLACENTA; EXPRESSION; MT1-MMP; IDENTIFICATION; INVASION; MT2-MMP; GENE	Preeclampsia is a major pregnancy complication, characterized by severe endothelial dysfunction, hypertension and maternal end-organ damage. Soluble endoglin is an anti-angiogenic protein released from placenta and thought to play a central role in causing the endothelial dysfunction and maternal organ injury seen in severe preeclampsia. We recently reported MMP-14 was the protease producing placentally-derived soluble endoglin by cleaving full-length endoglin present on the syncytiotrophoblast surface. This find identifies a specific drug target for severe preeclampsia; interfering with MMP-14 mediated cleavage of endoglin could decrease soluble endoglin production, ameliorating clinical disease. However, experimental MMP-14 inhibition alone only partially repressed soluble endoglin production, implying other proteases might have a role in producing soluble endoglin. Here we investigated whether MMP-15-phylogenetically the closest MMP relative to MMP-14 with 66% sequence similarity-also cleaves endoglin to produce soluble endoglin. MMP-15 was localized to the syncytiotrophoblast layer of the placenta, the same site where endoglin was localized. Interestingly, it was significantly (p = 0.03) up-regulated in placentas from severe early-onset preeclamptic pregnancies (n = 8) compared to gestationally matched preterm controls (n = 8). However, siRNA knockdown of MMP-15 yielded no significant decrease of soluble endoglin production from either HUVECs or syncytialised BeWo cells in vitro. Importantly, concurrent siRNA knockdown of both MMP-14 and MMP-15 in HUVECS did not yield further decrease in soluble endoglin production compared to MMP-14 siRNA alone. We conclude MMP-15 is up-regulated in preeclampsia, but does not cleave endoglin to produce soluble endoglin.	[Kaitu'u-Lino, Tu'uhevaha J.; Palmer, Kirsten; Tuohey, Laura; Ye, Louie; Tong, Stephen] Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Translat Obstet Grp, Heidelberg, Vic, Australia	University of Melbourne	Kaitu'u-Lino, TJ (corresponding author), Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Translat Obstet Grp, Heidelberg, Vic, Australia.	t.klino@unimelb.edu.au	Palmer, Kirsten/X-2299-2018	Tong, Stephen/0000-0002-2319-0586; Tuohey, Laura/0000-0002-4255-0196; Palmer, Kirsten/0000-0001-7421-6291; Kaitu'u-Lino, Tu'uhevaha/0000-0001-6233-9737	Victorian Government; National Health and Medical Research Council of Australia [490970, 490995]	Victorian Government; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Victorian Government's Operational Infrastructure Support Program. The National Health and Medical Research Council of Australia provided salary support (#490970 to S.T.; #490995 to T.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG, 2002, OBSTET GYNECOL, V99, P869; Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285; BioGPS, 2012, GEN PORT SYST; Bjorn SF, 2000, PLACENTA, V21, P170, DOI 10.1053/plac.1999.0447; d'Ortho MP, 1997, EUR J BIOCHEM, V250, P751, DOI 10.1111/j.1432-1033.1997.00751.x; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; GOUGOS A, 1992, INT IMMUNOL, V4, P83, DOI 10.1093/intimm/4.1.83; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Kaitu'u-Lino TJ, 2012, AM J PATHOL IN PRESS; Lafleur MA, 2002, J CELL SCI, V115, P3427; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Maynard SE, 2011, SEMIN NEPHROL, V31, P33, DOI 10.1016/j.semnephrol.2010.10.004; Myers JE, 2005, HYPERTENS PREGNANCY, V24, P103, DOI 10.1081/PRG-200059836; Nakada M, 1999, AM J PATHOL, V154, P417, DOI 10.1016/S0002-9440(10)65288-1; Ohnishi Y, 2001, EUR J DERMATOL, V11, P420; Perentes JY, 2011, CANCER RES, V71, P4527, DOI 10.1158/0008-5472.CAN-10-4376; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Rozanov DV, 2008, CANCER RES, V68, P4086, DOI 10.1158/0008-5472.CAN-07-6458; Sabbota AL, 2010, CANCER RES, V70, P5558, DOI 10.1158/0008-5472.CAN-09-4416; Sato H, 1997, THROMB HAEMOSTASIS, V78, P497; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Szabova L, 2010, BLOOD, V116, P5752, DOI 10.1182/blood-2009-10-249847; TAKINO T, 1995, J BIOL CHEM, V270, P23013, DOI 10.1074/jbc.270.39.23013; Theret N, 1998, AM J PATHOL, V153, P945, DOI 10.1016/S0002-9440(10)65636-2; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429	25	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39864	10.1371/journal.pone.0039864	http://dx.doi.org/10.1371/journal.pone.0039864			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768148	Green Published, gold			2022-12-27	WOS:000305892100117
J	Li, XK; Qi, WB; He, J; Ning, ZY; Hu, Y; Tian, J; Jiao, PR; Xu, CG; Chen, JX; Richt, J; Ma, WJ; Liao, M				Li, Xiaokang; Qi, Wenbao; He, Jun; Ning, Zhangyong; Hu, Yue; Tian, Jin; Jiao, Peirong; Xu, Chenggang; Chen, Jianxin; Richt, Juergen; Ma, Wenjun; Liao, Ming			Molecular Basis of Efficient Replication and Pathogenicity of H9N2 Avian Influenza Viruses in Mice	PLOS ONE			English	Article							A VIRUSES; HONG-KONG; GENETIC-CHARACTERIZATION; SOUTHEASTERN CHINA; CONTINUING EVOLUTION; HUMAN INFECTION; CELL TROPISM; AMINO-ACID; HOST-RANGE; POULTRY	H9N2 subtype avian influenza viruses (AIVs) have shown expanded host range and can infect mammals, such as humans and swine. To date the mechanisms of mammalian adaptation and interspecies transmission of H9N2 AIVs remain poorly understood. To explore the molecular basis determining mammalian adaptation of H9N2 AIVs, we compared two avian field H9N2 isolates in a mouse model: one (A/chicken/Guangdong/TS/2004, TS) is nonpathogenic, another one (A/chicken/Guangdong/V/2008, V) is lethal with efficient replication in mouse brains. In order to determine the basis of the differences in pathogenicity and brain tropism between these two viruses, recombinants with a single gene from the TS (or V) virus in the background of the V (or TS) virus were generated using reverse genetics and evaluated in a mouse model. The results showed that the PB2 gene is the major factor determining the virulence in the mouse model although other genes also have variable impacts on virus replication and pathogenicity. Further studies using PB2 chimeric viruses and mutated viruses with a single amino acid substitution at position 627 [glutamic acid (E) to lysine, (K)] in PB2 revealed that PB2 627K is critical for pathogenicity and viral replication of H9N2 viruses in mouse brains. All together, these results indicate that the PB2 gene and especially position 627 determine virus replication and pathogenicity in mice. This study provides insights into the molecular basis of mammalian adaptation and interspecies transmission of H9N2 AIVs.	[Li, Xiaokang; Qi, Wenbao; He, Jun; Ning, Zhangyong; Hu, Yue; Tian, Jin; Jiao, Peirong; Xu, Chenggang; Chen, Jianxin; Liao, Ming] S China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Richt, Juergen; Ma, Wenjun] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Li, Xiaokang] Henan Univ Sci & Technol, Coll Anim Sci & Technol, Luoyang, Peoples R China	South China Agricultural University; Kansas State University; Henan University of Science & Technology	Li, XK (corresponding author), S China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China.	wma@vet.k-state.edu; mliao@scau.edu.cn	Jiao, Peirong/R-3060-2019; Xu, Cheng/GXH-4815-2022; Richt, Juergen/AAL-3632-2020	Jiao, Peirong/0000-0001-7750-239X; Xu, Cheng/0000-0003-1000-733X; 	National Science Foundation of China [81001375]; Program for National Broiler Industry [nycytx-42-G3-03]; Natural Science Foundation of Guangdong Province [10251064201000004]; Science and Technology Projects of Guangdong Province [20100206]; National Key Technology R&D Program in the 11th Five-Year Plan [2006BAD06A16]; CEEZAD program of the Department of Homeland Security [2010-ST-061-AG0001-02]; Kansas State University	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for National Broiler Industry; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Projects of Guangdong Province; National Key Technology R&D Program in the 11th Five-Year Plan(National Key Technology R&D Program); CEEZAD program of the Department of Homeland Security(United States Department of Homeland Security (DHS)); Kansas State University	This work was partially supported by the National Science Foundation of China (No. 81001375), Program for National Broiler Industry (nycytx-42-G3-03), Natural Science Foundation of Guangdong Province (No. 10251064201000004), Science and Technology Projects of Guangdong Province (No. 20100206), National Key Technology R&D Program in the 11th Five-Year Plan(2006BAD06A16), CEEZAD program of the Department of Homeland Security, under the cooperative Agreement number 2010-ST-061-AG0001-02 and start-up fund (SRO#001) from Kansas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir UB, 2007, VIROLOGY, V361, P45, DOI 10.1016/j.virol.2006.10.037; Alexander DJ, 2009, REV SCI TECH OIE, V28, P19, DOI 10.20506/rst.28.1.1856; Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; ALEXANDER P, 2009, CAN J INFECT DIS MED, V20, P35; Amonsin A, 2006, VIROLOGY, V344, P480, DOI 10.1016/j.virol.2005.08.032; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Cameron KR, 2000, VIROLOGY, V278, P36, DOI 10.1006/viro.2000.0585; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Choi YK, 2004, J VIROL, V78, P8609, DOI 10.1128/JVI.78.16.8609-8614.2004; Cong YL, 2007, J GEN VIROL, V88, P2035, DOI 10.1099/vir.0.82783-0; Cong YL, 2008, VIRUS GENES, V36, P461, DOI 10.1007/s11262-008-0227-z; Dong G, 2010, PLOS ONE, V6; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; HOMME P J, 1970, Avian Diseases, V14, P66, DOI 10.2307/1588557; Hossain MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003170; KAWAOKA Y, 1988, VIROLOGY, V163, P247, DOI 10.1016/0042-6822(88)90260-7; Kim JA, 2006, VET MICROBIOL, V118, P169, DOI 10.1016/j.vetmic.2006.07.007; Lee YJ, 2007, VIROLOGY, V359, P313, DOI 10.1016/j.virol.2006.09.025; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Naeem K, 1999, VET REC, V145, P560, DOI 10.1136/vr.145.19.560; Nili H, 2003, AVIAN DIS, V47, P828, DOI 10.1637/0005-2086-47.s3.828; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Quynh ML, 2009, J VIROL, V83, P5278, DOI 10.1128/JVI.00063-09; Shi WF, 2008, ARCH VIROL, V153, P211, DOI 10.1007/s00705-007-1083-1; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Songserm T, 2006, EMERG INFECT DIS, V12, P681, DOI 10.3201/eid1204.051396; Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Sun YP, 2010, VET MICROBIOL, V146, P215, DOI 10.1016/j.vetmic.2010.05.010; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; Wu R, 2009, VET MICROBIOL, V138, P85, DOI 10.1016/j.vetmic.2009.03.010; Xu CT, 2004, MICROBES INFECT, V6, P919, DOI 10.1016/j.micinf.2004.04.015; Yu H, 2008, VET MICROBIOL, V131, P82, DOI 10.1016/j.vetmic.2008.02.024; Yu H, 2011, VET MICROBIOL, V149, P254, DOI 10.1016/j.vetmic.2010.11.008	42	38	39	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40118	10.1371/journal.pone.0040118	http://dx.doi.org/10.1371/journal.pone.0040118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768236	gold, Green Published			2022-12-27	WOS:000305892100208
J	Naatsaari, L; Mistlberger, B; Ruth, C; Hajek, T; Hartner, FS; Glieder, A				Naeaetsaari, Laura; Mistlberger, Beate; Ruth, Claudia; Hajek, Tanja; Hartner, Franz S.; Glieder, Anton			Deletion of the Pichia pastoris KU70 Homologue Facilitates Platform Strain Generation for Gene Expression and Synthetic Biology	PLOS ONE			English	Article							YEAST PICHIA-PASTORIS; DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; BREAK REPAIR; RECOMBINANT PROTEINS; V(D)J RECOMBINATION; TARGETING SYSTEM; GENOME SEQUENCE; KU PROTEIN; TRANSFORMATION	Targeted gene replacement to generate knock-outs and knock-ins is a commonly used method to study the function of unknown genes. In the methylotrophic yeast Pichia pastoris, the importance of specific gene targeting has increased since the genome sequencing projects of the most commonly used strains have been accomplished, but rapid progress in the field has been impeded by inefficient mechanisms for accurate integration. To improve gene targeting efficiency in P. pastoris, we identified and deleted the P. pastoris KU70 homologue. We observed a substantial increase in the targeting efficiency using the two commonly known and used integration loci HIS4 and ADE1, reaching over 90% targeting efficiencies with only 250-bp flanking homologous DNA. Although the ku70 deletion strain was noted to be more sensitive to UV rays than the corresponding wild-type strain, no lethality, severe growth retardation or loss of gene copy numbers could be detected during repetitive rounds of cultivation and induction of heterologous protein production. Furthermore, we demonstrated the use of the ku70 deletion strain for fast and simple screening of genes in the search of new auxotrophic markers by targeting dihydroxyacetone synthase and glycerol kinase genes. Precise knock-out strains for the well-known P. pastoris AOX1, ARG4 and HIS4 genes and a whole series of expression vectors were generated based on the wild-type platform strain, providing a broad spectrum of precise tools for both intracellular and secreted production of heterologous proteins utilizing various selection markers and integration strategies for targeted or random integration of single and multiple genes. The simplicity of targeted integration in the ku70 deletion strain will further support protein production strain generation and synthetic biology using P. pastoris strains as platform hosts.	[Naeaetsaari, Laura; Ruth, Claudia; Hajek, Tanja; Hartner, Franz S.; Glieder, Anton] Graz Univ Technol, Inst Mol Biotechnol, A-8010 Graz, Austria; [Mistlberger, Beate; Ruth, Claudia; Hajek, Tanja; Hartner, Franz S.; Glieder, Anton] Austrian Ctr Ind Biotechnol ACIB GmbH, Graz, Austria	Graz University of Technology; Austrian Centre of Industrial Biotechnology	Naatsaari, L (corresponding author), Graz Univ Technol, Inst Mol Biotechnol, A-8010 Graz, Austria.	glieder@glieder.com		glieder, anton/0000-0002-5986-9689	Austrian Science Fund "Fonds zur Forderung der wissenschaftlichen Forschung" [W901]; VTU Technology GmbH; Fonds zur Forderung der wissenschaftlichen Forschung; VTU Technology; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Austrian Science Fund "Fonds zur Forderung der wissenschaftlichen Forschung"(Austrian Science Fund (FWF)); VTU Technology GmbH; Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); VTU Technology; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund "Fonds zur Forderung der wissenschaftlichen Forschung" [W901 DK Molecular Enzymology] and VTU Technology GmbH. Funding for the open access charge: Fonds zur Forderung der wissenschaftlichen Forschung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests: Construction of plasmid vectors and Pichia auxotrophy strains was co-financed by VTU Technology. VTU Technology is one of many international groups employing the described strains and vectors in their labs and all described strains and materials are available from Graz University of Technology for a modest fee covering costs for production and distribution of the materials. Some of the vectors are distributed by DNA2.0 as vector backbones with synthetic genes cloned into these expression plasmids which were designed for general FTO. However, there was no financial support by DNA2.0 in any means to the development of the described strains and vectors. There is no dependency from DNA2.0. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abad S, 2010, BIOTECHNOL J, V5, P413, DOI 10.1002/biot.200900233; AUSUBEL FM, 2007, CURRENT PROTOCOLS MO; Aylon Y, 2004, DNA REPAIR, V3, P797, DOI 10.1016/j.dnarep.2004.04.013; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; BROACH JR, 1982, CELL, V29, P227, DOI 10.1016/0092-8674(82)90107-6; Cereghino GPL, 2002, CURR OPIN BIOTECH, V13, P329, DOI 10.1016/S0958-1669(02)00330-0; Chu G, 1997, J BIOL CHEM, V272, P24097, DOI 10.1074/jbc.272.39.24097; Clikeman JA, 2001, GENETICS, V157, P579; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; CREGG JM, 1989, MOL CELL BIOL, V9, P1316, DOI 10.1128/MCB.9.3.1316; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Dudasova Z, 2004, FEMS MICROBIOL REV, V28, P581, DOI 10.1016/j.femsre.2004.06.001; Feldmann E, 2000, NUCLEIC ACIDS RES, V28, P2585, DOI 10.1093/nar/28.13.2585; FELDMANN H, 1993, J BIOL CHEM, V268, P12895; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Gravel S, 2002, MOL CELL BIOL, V22, P2182, DOI 10.1128/MCB.22.7.2182-2193.2002; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; Hartner FS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn369; Higgins D. R., 1998, PICHIA PROTOCOLS; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Inan M, 2001, J BIOSCI BIOENG, V92, P585, DOI 10.1263/jbb.92.585; Klinner U, 2004, FEMS MICROBIOL REV, V28, P201, DOI 10.1016/j.femsre.2003.10.002; Kooistra R, 2004, YEAST, V21, P781, DOI 10.1002/yea.1131; Krappmann S, 2006, EUKARYOT CELL, V5, P212, DOI 10.1128/EC.5.1.212-215.2006; Kuberl A, 2011, J BIOTECHNOL, V154, P312, DOI 10.1016/j.jbiotec.2011.04.014; Li PZ, 2007, APPL BIOCHEM BIOTECH, V142, P105, DOI 10.1007/s12010-007-0003-x; Lin-Cereghino J, 2005, BIOTECHNIQUES, V38, P44, DOI 10.2144/05381BM04; Meyer V, 2007, J BIOTECHNOL, V128, P770, DOI 10.1016/j.jbiotec.2006.12.021; Milne GT, 1996, MOL CELL BIOL, V16, P4189; MIMORI T, 1986, J BIOL CHEM, V261, P375; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Nussenzweig A, 1997, P NATL ACAD SCI USA, V94, P13588, DOI 10.1073/pnas.94.25.13588; Pahlman AK, 2001, J BIOL CHEM, V276, P3555, DOI 10.1074/jbc.M007164200; PAILLARD S, 1991, NUCLEIC ACIDS RES, V19, P5619, DOI 10.1093/nar/19.20.5619; Pastwa E, 2003, ACTA BIOCHIM POL, V50, P891; Poggeler S, 2006, GENE, V378, P1, DOI 10.1016/j.gene.2006.03.020; Raschke WC, 1996, GENE, V177, P163, DOI 10.1016/0378-1119(96)00293-4; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Ribes-Zamora A, 2007, NAT STRUCT MOL BIOL, V14, P301, DOI 10.1038/nsmb1214; Ruth C, 2010, Syst Synth Biol, V4, P181, DOI 10.1007/s11693-010-9057-0; Scharer OD, 2003, ANGEW CHEM INT EDIT, V42, P2946, DOI 10.1002/anie.200200523; Schroer K, 2010, METAB ENG, V12, P8, DOI 10.1016/j.ymben.2009.08.006; SOUTHERN EM, 1974, ANAL BIOCHEM, V62, P317, DOI 10.1016/0003-2697(74)90395-9; Takahashi T, 2006, BIOSCI BIOTECH BIOCH, V70, P135, DOI 10.1271/bbb.70.135; Ueno K, 2007, EUKARYOT CELL, V6, P1239, DOI 10.1128/EC.00414-06; Villalba F, 2008, FUNGAL GENET BIOL, V45, P68, DOI 10.1016/j.fgb.2007.06.006; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Weis R, 2004, FEMS YEAST RES, V5, P179, DOI 10.1016/j.femsyr.2004.06.016; Yamana Y, 2005, MOL GENET GENOMICS, V273, P167, DOI 10.1007/s00438-005-1108-y; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7; Zhu TC, 2009, BIOTECHNOL LETT, V31, P679, DOI 10.1007/s10529-009-9917-4	59	156	171	9	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39720	10.1371/journal.pone.0039720	http://dx.doi.org/10.1371/journal.pone.0039720			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768112	gold, Green Submitted, Green Published			2022-12-27	WOS:000305892100082
J	Rose, SB; Wei, Z; Cooper, AJ; Lawton, BA				Rose, Sally B.; Wei, Zhang; Cooper, Annette J.; Lawton, Beverley A.			Peri-Abortion Contraceptive Choices of Migrant Chinese Women: A Retrospective Review of Medical Records	PLOS ONE			English	Review							DISCONTINUATION	Background: Migrant Asian women reportedly have low levels of contraceptive use and high rates of abortion in New Zealand. Chinese make up the largest proportion of migrant Asian in New Zealand. This study aimed to describe the contraceptive choices of Chinese women seeking abortion; to examine method choice in relation to demographic characteristics (including length of stay) and to determine whether Chinese women were over-represented among abortion clinic attendees. Methods: Retrospective review of medical records at a public hospital abortion clinic involving 305 Chinese women. Previously collected data for European (n = 277) and Maori women (n = 128) were used for comparative analyses. Regression analyses explored correlates of contraceptive method choice. Population census data were used to calculate rates of clinic attendance across ethnic groups. Results: Chinese women were not over-represented among clinic attendees, and had similar rates of contraceptive non-use pre-abortion as women in comparison groups. Use of the oral contraceptive pill by Chinese was lower pre-abortion than for other ethnic groups, but choice of this method post-abortion was similar for Chinese (46.9%, 95% CI 41-52.7) and European women (43.7%, 95% CI 37.8-49.7). Post-abortion choice of an intrauterine device did not differ significantly between Chinese (28.9%, 95% CI 23.8-34.3) and Maori women (37%, 95% CI 28.4-45.7), but was higher than uptake of this method by European women (21.7%, 95% CI 17-27.0). Age, parity and previous abortion were significant predictors of post-abortion method choice by Chinese women (p<0.05). Conclusions: Following contraceptive counseling at the clinic, Chinese women chose more effective contraceptive methods for use post-abortion than they had used previously. As the population of migrant Chinese in New Zealand continues to increase, strategies are urgently needed to provide new arrivals with appropriate information and advice about contraception and where to access it, so women can be better prepared to avoid unplanned pregnancy.	[Rose, Sally B.; Wei, Zhang; Cooper, Annette J.; Lawton, Beverley A.] Univ Otago, Dept Primary Hlth Care & Gen Practice, Wellington, New Zealand	University of Otago	Rose, SB (corresponding author), Univ Otago, Dept Primary Hlth Care & Gen Practice, Wellington, New Zealand.	sally.rose@otago.ac.nz		Lawton, Beverley/0000-0003-2447-8386	New Zealand Lotteries Health Research Grant [276188]	New Zealand Lotteries Health Research Grant	This research was funded by a New Zealand Lotteries Health Research Grant (Ref 276188) (http://www.communitymatters.govt.nz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, ETHNIC DIFFERENTIALS; [Anonymous], 2005, LONG ACT REV CONTR E; Crampton Peter, 2007, N Z Med J, V120, pU2582; DeSouza R., 2005, ACCESS ISSUES CHINES; Goodyear-Smith Felicity A, 2003, N Z Med J, V116, pU683; Ministry of Health, 2006, AS HLTH CHART BOOK 2; National Ethics Advisory Committee, 2006, ETH GUID OBS STUD OB; Reid W, 2008, BUILDING HLTH COMMUN; Rose SB, 2010, CONTRACEPTION, V82, P345, DOI 10.1016/j.contraception.2010.04.021; Salmond C., 2007, NZDEP2006 INDEX DEPR; Scragg R., 2010, ASIAN HLTH AOTEAROA; Simon-Kumar R, 2005, CULT HEALTH SEX, V11, P1; Statistics New Zealand, 2007, 2006 NZ CENS DAT; Statistics New Zealand, 2006, NZ CENS ETHN DAT CHI; Statistics New Zealand, 2007, PROJ ETHN POP NZ SEX; Statistics New Zealand, 2001, BIRTHS; Statistics New Zealand, 2006, ETHN DEF; Trussell J., 2018, CONTRACEPTIVE TECHNO, V21st, P26; Ursin G, 1999, AM J EPIDEMIOL, V150, P561; Vaughan B, 2008, CONTRACEPTION, V78, P271, DOI 10.1016/j.contraception.2008.05.007; Vitzthum VJ, 2005, STUD FAMILY PLANN, V36, P13, DOI 10.1111/j.1728-4465.2005.00038.x; Wiebe ER, 2008, CONTRACEPTION, V78, P405, DOI 10.1016/j.contraception.2008.06.007; Wiebe ER, 2004, CONTRACEPTION, V69, P493, DOI 10.1016/j.contraception.2004.01.006; Wiebe ER, 2002, CONTRACEPTION, V65, P159, DOI 10.1016/S0010-7824(01)00297-9	24	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40103	10.1371/journal.pone.0040103	http://dx.doi.org/10.1371/journal.pone.0040103			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768231	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100203
J	Terabayashi, T; Sakaguchi, M; Shinmyozu, K; Ohshima, T; Johjima, A; Ogura, T; Miki, H; Nishinakamura, R				Terabayashi, Takeshi; Sakaguchi, Masaji; Shinmyozu, Kaori; Ohshima, Toshio; Johjima, Ai; Ogura, Teru; Miki, Hiroaki; Nishinakamura, Ryuichi			Phosphorylation of Kif26b Promotes Its Polyubiquitination and Subsequent Proteasomal Degradation during Kidney Development	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; UBIQUITIN LIGASE NEDD4-1; BRANCHING MORPHOGENESIS; DEACETYLASE COMPLEX; EPITHELIAL-CELLS; PROTEIN; CDK5; KINESIN; DOMAINS; SALL1	Kif26b, a member of the kinesin superfamily proteins (KIFs), is essential for kidney development. Kif26b expression is restricted to the metanephric mesenchyme, and its transcription is regulated by a zinc finger transcriptional regulator Sall1. However, the mechanism(s) by which Kif26b protein is regulated remain unknown. Here, we demonstrate phosphorylation and subsequent polyubiquitination of Kif26b in the developing kidney. We find that Kif26b interacts with an E3 ubiquitin ligase, neural precursor cell expressed developmentally down-regulated protein 4 (Nedd4) in developing kidney. Phosphorylation of Kif26b at Thr-1859 and Ser-1962 by the cyclin-dependent kinases (CDKs) enhances the interaction of Kif26b with Nedd4. Nedd4 polyubiquitinates Kif26b and thereby promotes degradation of Kif26b via the ubiquitin-proteasome pathway. Furthermore, Kif26b lacks ATPase activity but does associate with microtubules. Nocodazole treatment not only disrupts the localization of Kif26b to microtubules but also promotes phosphorylation and polyubiquitination of Kif26b. These results suggest that the function of Kif26b is microtubule-based and that Kif26b degradation in the metanephric mesenchyme via the ubiquitin-proteasome pathway may be important for proper kidney development.	[Terabayashi, Takeshi; Sakaguchi, Masaji; Nishinakamura, Ryuichi] Kumamoto Univ, Dept Kidney Dev, Inst Mol Embryol & Genet, Kumamoto, Japan; [Terabayashi, Takeshi; Sakaguchi, Masaji; Johjima, Ai; Ogura, Teru; Nishinakamura, Ryuichi] Kumamoto Univ, Global COE Cell Fate Regulat Res & Educ Unit, Honjo, Kumamoto, Japan; [Shinmyozu, Kaori] RIKEN, Ctr Dev Biol, Prote Lab, Kobe, Hyogo, Japan; [Ohshima, Toshio] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan; [Johjima, Ai; Ogura, Teru] Kumamoto Univ, Dept Mol Cell Biol, Inst Mol Embryol & Genet, Kumamoto, Japan; [Miki, Hiroaki] Osaka Univ, Microbial Dis Res Inst, Dept Cellular Regulat, Osaka, Japan	Kumamoto University; Kumamoto University; RIKEN; Waseda University; Kumamoto University; Osaka University	Terabayashi, T (corresponding author), Kumamoto Univ, Dept Kidney Dev, Inst Mol Embryol & Genet, Kumamoto, Japan.	ryuichi@gpo.kumamoto-u.ac.jp		Ogura, Teru/0000-0003-3784-0970; Terabayashi, Takeshi/0000-0001-7102-784X	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Global COE Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) and by the Global COE Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACALLAO R, 1989, J CELL BIOL, V109, P2817, DOI 10.1083/jcb.109.6.2817; BAUMANN K, 1993, FEBS LETT, V336, P417, DOI 10.1016/0014-5793(93)80849-P; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Edwin F, 2010, J BIOL CHEM, V285, P255, DOI 10.1074/jbc.M109.030882; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; Fouladkou F, 2010, J BIOL CHEM, V285, P6770, DOI 10.1074/jbc.M109.082347; Funato Y, 2010, CURR BIOL, V20, P1945, DOI 10.1016/j.cub.2010.09.065; Griffin SV, 2004, AM J PATHOL, V165, P1175, DOI 10.1016/S0002-9440(10)63378-0; Grindstaff KK, 1998, MOL BIOL CELL, V9, P685, DOI 10.1091/mbc.9.3.685; Hartwig S, 2010, DEVELOPMENT, V137, P1189, DOI 10.1242/dev.045732; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hou ZB, 2007, J BIOL CHEM, V282, P18666, DOI 10.1074/jbc.C700052200; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Kawabe H, 2010, NEURON, V65, P358, DOI 10.1016/j.neuron.2010.01.007; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kiefer SM, 2002, J BIOL CHEM, V277, P14869, DOI 10.1074/jbc.M200052200; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Lauberth SM, 2007, J BIOL CHEM, V282, P34858, DOI 10.1074/jbc.M703702200; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Lazaro JB, 1997, J CELL SCI, V110, P1251; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lillie SH, 1998, J CELL BIOL, V140, P873, DOI 10.1083/jcb.140.4.873; Linton JM, 2007, DEVELOPMENT, V134, P2501, DOI 10.1242/dev.005033; Lowman XH, 2010, MOL CELL, V40, P823, DOI 10.1016/j.molcel.2010.11.035; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Negash S, 2002, J CELL SCI, V115, P2109; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Pandithage R, 2008, J CELL BIOL, V180, P915, DOI 10.1083/jcb.200707126; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Park SK, 1997, KIDNEY INT, V51, P762, DOI 10.1038/ki.1997.107; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Pham N, 2001, J BIOL CHEM, V276, P46995, DOI 10.1074/jbc.M108373200; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Terabayashi T, 2007, J NEUROSCI, V27, P13098, DOI 10.1523/JNEUROSCI.3986-07.2007; Terabayashi T, 2009, J BIOL CHEM, V284, P26716, DOI 10.1074/jbc.M109.039313; Uchiyama Y, 2010, P NATL ACAD SCI USA, V107, P9240, DOI 10.1073/pnas.0913748107; Vainio S, 2002, NAT REV GENET, V3, P533, DOI 10.1038/nrg842; Watanabe T, 2004, DEV BIOL, V271, P98, DOI 10.1016/j.ydbio.2004.03.025; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Yoshimura Y, 2010, MOL CELL BIOL, V30, P2206, DOI 10.1128/MCB.01181-09; Zeng FH, 2009, FASEB J, V23, P1935, DOI 10.1096/fj.08-121947; Zhou RY, 2009, CELL, V139, P802, DOI 10.1016/j.cell.2009.10.023	58	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39714	10.1371/journal.pone.0039714	http://dx.doi.org/10.1371/journal.pone.0039714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768111	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100081
J	Zhang, W; Rao, HY; Feng, B; Liu, F; Wei, L				Zhang, Wei; Rao, Hui-Ying; Feng, Bo; Liu, Feng; Wei, Lai			Effects of Interferon-Alpha Treatment on the Incidence of Hyperglycemia in Chronic Hepatitis C Patients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							SUSTAINED VIROLOGICAL RESPONSE; GLUCOSE ABNORMALITIES; CONTROLLED TRIALS; PUBLICATION BIAS; RISK-FACTOR; HETEROGENEITY; VIRUS	Background: There is a significant association between effects of interferon-alpha treatment and the risk of developing hyperglycemia in patients with chronic hepatitis C virus (HCV) infection. The objective of this systematic review and meta-analysis on the basis of published observational studies was to estimate risk of hyperglycemia in chronic HCV patients who had acquired sustained virological responses (SVR) compared to those without SVR. Methodology: We identified eligible studies by searching the relevant databases, including PubMed, Embase, and Google, for papers published between January 1990 and April 2011. The selection of eligible papers was carried out using a scoring system based on guidelines and inclusion criteria that were established before the articles were identified. Heterogeneity across studies was determined and the meta-analysis was performed following standard guidelines. Conclusions: Eleven eligible studies provided data of the incidence of hyperglycemia in chronic hepatitis C patients with SVR in comparison with patients without these conditions. The results demonstrated that SVR was associated with a lower risk of hyperglycemia (odds ratio = 0.497, 95% confidence interval 0.421-0.587, p<0.001), and there was no evidence of any substantial between-study heterogeneity (I-2 = 24.4%, p>0.1). Results of meta-regression showed patients with different baseline glucose (normal vs. abnormal) and patients with co-infected HIV (presence vs. absence) as the sources of low heterogeneity (p<0.15). The lowest risk of hyperglycemia was described in patients with normal glucose baseline (OR = 0.402, 95% CI 0.297-0.543, p<0.001). This is the first systematic review and meta-analysis performed to examine the association between SVR and risk of hyperglycemia in patients with HCV infection. Our meta-analysis suggests that SVR reduce the risk of developing glucose abnormalities, especially in patients with normal glucose baseline.	[Zhang, Wei; Rao, Hui-Ying; Feng, Bo; Liu, Feng; Wei, Lai] Peking Univ, Peking Univ Peoples Hosp, Peking Univ Hepatol Inst, Beijing Key Lab Hepatitis & Immunotherapy Liver D, Beijing 100871, Peoples R China	Peking University	Zhang, W (corresponding author), Peking Univ, Peking Univ Peoples Hosp, Peking Univ Hepatol Inst, Beijing Key Lab Hepatitis & Immunotherapy Liver D, Beijing 100871, Peoples R China.	weilai@pkuph.edu.com		Liu, Feng/0000-0002-0316-4938	National Science and Technology Major Project for Infectious Diseases Control [2008ZX10002-012, 2008ZX10002-013, 2012ZX10002003]	National Science and Technology Major Project for Infectious Diseases Control	This work was supported by grants from the National Science and Technology Major Project for Infectious Diseases Control during the 11th Five-Year Plan (grant nos. 2008ZX10002-012 and 2008ZX10002-013) and the 12th Five-Year Plan (grant no. 2012ZX10002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Cesari M, 2009, HIV MED, V10, P580, DOI 10.1111/j.1468-1293.2009.00729.x; Chehadeh W, 2009, J MED VIROL, V81, P610, DOI 10.1002/jmv.21396; Control CfD Prevention, 1998, MMWR-MORBID MORTAL W, V47, pi, DOI DOI 10.1001/jamahealthforum.2021.0325; COOK DJ, 1993, JAMA-J AM MED ASSOC, V269, P2749, DOI 10.1001/jama.269.21.2749; Cox DR., 1989, ANAL BINARY DATA; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Giordanino C, 2008, AM J GASTROENTEROL, V103, P2481, DOI 10.1111/j.1572-0241.2008.02002.x; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; HETHERINGTON J, 1989, PEDIATRICS, V84, P374; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JulianPT, 2011, COCHRANE HDB SYSTEMA, P357; Juni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115; Kawaguchi Y, 2009, LIVER INT, V29, P871, DOI 10.1111/j.1478-3231.2009.01993.x; Konishi I, 2009, LIVER INT, V29, P1194, DOI 10.1111/j.1478-3231.2009.02043.x; Lecube A, 2007, AM J GASTROENTEROL, V102, P2189, DOI 10.1111/j.1572-0241.2007.01402.x; McAuley L, 2000, LANCET, V356, P1228, DOI 10.1016/S0140-6736(00)02786-0; Mizuta T, 2010, DIGEST DIS SCI, V55, P183, DOI 10.1007/s10620-008-0691-2; OZMINKOWSKI RJ, 1988, STAT MED, V7, P1207, DOI 10.1002/sim.4780071202; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Romero-Gomez M, 2008, J HEPATOL, V48, P721, DOI 10.1016/j.jhep.2007.11.022; Simo R, 2006, DIABETES CARE, V29, P2462, DOI 10.2337/dc06-0456; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Taylor S, 1998, AUSTRALASIAN EPIDEMI, V5, P14; THOMPSON SG, 1991, LANCET, V338, P1127, DOI 10.1016/0140-6736(91)91975-Z; THOMPSON SG, 1994, BMJ-BRIT MED J, V309, P1351, DOI 10.1136/bmj.309.6965.1351; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; Wong WCW, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-23	32	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39272	10.1371/journal.pone.0039272	http://dx.doi.org/10.1371/journal.pone.0039272			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768067	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100038
J	Pabian, SE; Ermer, NM; Tzilkowski, WM; Brittingham, MC				Pabian, Sarah E.; Ermer, Nathan M.; Tzilkowski, Walter M.; Brittingham, Margaret C.			Effects of Liming on Forage Availability and Nutrient Content in a Forest Impacted by Acid Rain	PLOS ONE			English	Article							WHITE-TAILED DEER; NORWAY SPRUCE; SUGAR MAPLE; GROUND VEGETATION; BODY-MASS; SOIL; GROWTH; LIME; FERTILIZATION; RESPONSES	Acidic deposition and subsequent forest soil acidification and nutrient depletion can affect negatively the growth, health and nutrient content of vegetation, potentially limiting the availability and nutrient content of forage for white-tailed deer (Odocoileus virginianus) and other forest herbivores. Liming is a mitigation technique that can be used to restore forest health in acidified areas, but little is known about how it affects the growth or nutrient content of deer forage. We examined the effects of dolomitic limestone application on the growth and chemical composition of understory plants in an acidified forest in central Pennsylvania, with a focus on vegetative groups included as white-tailed deer forage. We used a Before-After-Control-Impact study design with observations 1 year before liming and up to 5 years post-liming on 2 treated and 2 untreated 100-ha sites. Before liming, forage availability and several nutrients were below levels considered optimal for white-tailed deer, and many vegetative characteristics were related to soil chemistry. We observed a positive effect of liming on forb biomass, with a 2.7 fold increase on limed sites, but no biomass response in other vegetation groups. We observed positive effects of liming on calcium and magnesium content and negative effects on aluminum and manganese content of several plant groups. Responses to liming by forbs and plant nutrients show promise for improving vegetation health and forage quality and quantity for deer.	[Pabian, Sarah E.; Ermer, Nathan M.; Tzilkowski, Walter M.; Brittingham, Margaret C.] Penn State Univ, Sch Forest Resources, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Pabian, SE (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	sarah.pabian@colostate.edu	Pabian, Sarah/K-4831-2012		Pennsylvania's Wild Resources Conservation Program; Pennsylvania Department of Environmental Protection [41000155481ME352917]	Pennsylvania's Wild Resources Conservation Program; Pennsylvania Department of Environmental Protection	Funding was provided by Pennsylvania's Wild Resources Conservation Program, http://www.dcnr.state.pa.us/conservationscience/wrcp/index.htm, and an Environmental Stewardship and Watershed Protection Grant from the Pennsylvania Department of Environmental Protection, Grant no. 41000155481ME352917, http://www.portal.state.pa.us/portal/server.pt/community/growing_greener/13958/watershed_grants/588895. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MB, 2000, FOREST ECOL MANAG, V138, P301, DOI 10.1016/S0378-1127(00)00421-7; ANDERSSON F, 1986, WATER AIR SOIL POLL, V30, P17, DOI 10.1007/BF00305173; ANDERSSON M, 1988, WATER AIR SOIL POLL, V39, P439; [Anonymous], 2010, NSRP3 NADP PROGR OFF; [Anonymous], 1985, NUTR GRAZING RUMINAN; Baker TT, 1998, FOREST ECOL MANAG, V109, P21, DOI 10.1016/S0378-1127(98)00259-X; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; BELOVSKY GE, 1981, J MAMMAL, V62, P613, DOI 10.2307/1380408; BLAIR RM, 1977, J WILDLIFE MANAGE, V41, P667, DOI 10.2307/3799988; CONROY MJ, 1982, J WILDLIFE MANAGE, V46, P719, DOI 10.2307/3808564; CRAWFORD H S, 1989, Southern Journal of Applied Forestry, V13, P12; CRAWFORD HS, 1982, J WILDLIFE MANAGE, V46, P974, DOI 10.2307/3808230; Demchik M. C., 2000, Journal of Sustainable Forestry, V11, P69, DOI 10.1300/J091v11n04_04; Demchik MC, 2001, FOREST ECOL MANAG, V144, P239, DOI 10.1016/S0378-1127(00)00388-1; Driscoll CT, 2001, BIOSCIENCE, V51, P180, DOI 10.1641/0006-3568(2001)051[0180:ADITNU]2.0.CO;2; Duliere JF, 1999, ANN FOR SCI, V56, P361, DOI 10.1051/forest:19990501; Eckert D, 1995, NE REGIONAL B, V493, P11; FALKENGRENGRERUP U, 1995, ENVIRON EXP BOT, V35, P9, DOI 10.1016/0098-8472(94)00039-8; FRENCH C. E., 1956, JOUR WILDLIFE MANAGEMENT, V20, P221, DOI 10.2307/3796954; Gaillard JM, 1996, J WILDLIFE MANAGE, V60, P29, DOI 10.2307/3802036; GILL JOHN, 1956, JOUR WILDLIFE MANAGEMENT, V20, P286, DOI 10.2307/3796964; Gilliam FS, 2007, BIOSCIENCE, V57, P845, DOI 10.1641/B571007; GRASMAN BT, 1993, ECOLOGY, V74, P2279, DOI 10.2307/1939581; Gronflaten LK, 2005, FOREST ECOL MANAG, V213, P261, DOI 10.1016/j.foreco.2005.03.060; Gunn J, 2001, WATER AIR SOIL POLL, V130, P1439, DOI 10.1023/A:1013908913162; Hamburg SP, 2003, ECOSYSTEMS, V6, P399, DOI 10.1007/s10021-002-0174-9; HAYNES RJ, 1982, PLANT SOIL, V68, P289, DOI 10.1007/BF02197935; HEALY WM, 1971, J WILDLIFE MANAGE, V35, P717, DOI 10.2307/3799777; Herfindal I, 2006, J ANIM ECOL, V75, P1110, DOI 10.1111/j.1365-2656.2006.01138.x; Hindar A, 2003, FOREST ECOL MANAG, V180, P509, DOI 10.1016/S0378-1127(02)00647-3; Horsley SB, 2000, CAN J FOREST RES, V30, P1365, DOI 10.1139/cjfr-30-9-1365; Horsley SB, 2003, ECOL APPL, V13, P98, DOI 10.1890/1051-0761(2003)013[0098:WTDIOT]2.0.CO;2; HUANG CYL, 1985, COMMUN SOIL SCI PLAN, V16, P943, DOI 10.1080/00103628509367657; HUETTL RF, 1993, FOREST ECOL MANAG, V61, P325, DOI 10.1016/0378-1127(93)90209-6; Jones PD, 2010, WILDLIFE BIOL, V16, P430, DOI 10.2981/10-041; Jones PD, 2008, SOUTHEAST NAT, V7, P595, DOI 10.1656/1528-7092-7.4.595; Juice SM, 2006, ECOLOGY, V87, P1267, DOI 10.1890/0012-9658(2006)87[1267:ROSMTC]2.0.CO;2; Lehoczki R, 2011, BIOL TRACE ELEM RES, V139, P168, DOI 10.1007/s12011-010-8655-8; LJUNGSTROM M, 1995, FOREST ECOL MANAG, V74, P133, DOI 10.1016/0378-1127(94)03494-H; Long RP, 1997, CAN J FOREST RES, V27, P1560, DOI 10.1139/cjfr-27-10-1560; Lyon J, 1996, TREE PHYSIOL, V16, P923; MASCHINSKI J, 1989, AM NAT, V134, P1, DOI 10.1086/284962; MCCULLOUGH DR, 1985, J MAMMAL, V66, P682, DOI 10.2307/1380794; McDonald TL, 2000, J AGRIC BIOL ENVIR S, V5, P262, DOI 10.2307/1400453; McEWEN L. C, 1957, TRANS N AMER WILDLIFE CONF, V22-No. 91, P119; MCNAUGHTON SJ, 1988, NATURE, V334, P343, DOI 10.1038/334343a0; MEYER MW, 1984, J WILDLIFE MANAGE, V48, P527, DOI 10.2307/3801185; Misson L, 2001, ANN FOR SCI, V58, P699, DOI 10.1051/forest:2001157; Mizel NL, 2005, THESIS PENNSYLVANIA; Murphy D. A., 1966, Transactions of the North American Wildlife Conference, V31, P129; NYHOLM NEI, 1981, ENVIRON RES, V26, P363, DOI 10.1016/0013-9351(81)90212-7; Olsson BA, 2002, FOREST ECOL MANAG, V158, P127, DOI 10.1016/S0378-1127(00)00713-1; Pabian SE, 2007, ECOL APPL, V17, P2184, DOI 10.1890/07-0394.1; Pabian SE, 2012, INT J FORESTRY RES, V2012; Pinheiro J, 2001, MIXED EFFECTS MODELS; Plummer M, 2009, CODA OUTPUT ANAL DIA; RODENKIRCHEN H, 1992, WATER AIR SOIL POLL, V61, P279, DOI 10.1007/BF00482611; ROY AK, 1988, BOT REV, V54, P145, DOI 10.1007/BF02858527; Royo AA, 2006, CAN J FOREST RES, V36, P1345, DOI 10.1139/X06-025; Rummel SM, 2006, THESIS PENNSYLVANIA; SCHEUHAMMER AM, 1987, ENVIRON POLLUT, V46, P263, DOI 10.1016/0269-7491(87)90173-4; Schreffler AM, 2003, FOREST ECOL MANAG, V177, P471, DOI 10.1016/S0378-1127(02)00452-8; Sharpe W.E., 2006, EVALUATION WHOLE WAT; Sharpe WE, 2004, P 14 CENTR HARDW FOR, P265; Sharpe WE, 2006, P 15 CENTR HARDW FOR, P702; Simkiss K., 1967, CALCIUM REPROD PHYSL; SMITH F. H., 1956, Journal of Wildlife Management, V20, P359, DOI 10.2307/3797145; SMITH SH, 1975, J WILDLIFE MANAGE, V39, P582, DOI 10.2307/3800401; St Clair SB, 2005, TREE PHYSIOL, V25, P85, DOI 10.1093/treephys/25.1.85; Strickland BK, 2000, J WILDLIFE MANAGE, V64, P903, DOI 10.2307/3803198; Traaen TS, 1997, WHOLE CATCHMENT LIMI; ULLREY DE, 1967, J WILDLIFE MANAGE, V31, P679, DOI 10.2307/3797970; VANGILDER LD, 1982, J WILDLIFE MANAGE, V46, P711, DOI 10.2307/3808563; WALLMO OC, 1977, J RANGE MANAGE, V30, P122, DOI 10.2307/3897753; WEBB WILLIAM L., 1959, JOUR WILDLIFE MANAGEMENT, V23, P455, DOI 10.2307/3796497; Wherry ET, 1920, P ACAD NAT SCI PHILA, V72, P84; Wolf AM, 1995, NE REGIONAL B, V493, P25; Wolt JD, 1990, MECH FOREST RESPONSE, P62	78	14	15	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39755	10.1371/journal.pone.0039755	http://dx.doi.org/10.1371/journal.pone.0039755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761890	Green Submitted, Green Published, gold			2022-12-27	WOS:000305826400036
J	Wang, GZ; Konopka, G				Wang, Guang-Zhong; Konopka, Genevieve			Differential Functional Constraints on the Evolution of Postsynaptic Density Proteins in Neocortical Laminae	PLOS ONE			English	Article							HUMAN PREFRONTAL CORTEX; GENE-EXPRESSION; CEREBRAL-CORTEX; PYRAMIDAL NEURONS; MOUSE-BRAIN; TRANSCRIPTOME; PATHWAYS; DISEASE; SCHIZOPHRENIA; ORGANIZATION	The postsynaptic density (PSD) is a protein dense complex on the postsynaptic membrane of excitatory synapses that is implicated in normal nervous system functions such as synaptic plasticity, and also contains an enrichment of proteins involved in neuropsychiatric disorders. It has recently been reported that the genes encoding PSD proteins evolved more slowly than other genes in the human brain, but the underlying evolutionary advantage for this is not clear. Here, we show that cortical gene expression levels could explain most of this effect, indicating that expression level is a primary contributor to the evolution of these genes in the brain. Furthermore, we identify a positive correlation between the expression of PSD genes and cortical layers, with PSD genes being more highly expressed in deep layers, likely as a result of layer-enriched transcription factors. As the cortical layers of the mammalian brain have distinct functions and anatomical projections, our results indicate that the emergence of the unique six-layered mammalian cortex may have provided differential functional constraints on the evolution of PSD genes. More superficial cortical layers contain PSD genes with less constraint and these layers are primarily involved in intracortical projections, connections that may be particularly important for evolved cognitive functions. Therefore, the differential expression and evolutionary constraint of PSD genes in neocortical laminae may be critical not only for neocortical architecture but the cognitive functions that are dependent on this structure.	[Wang, Guang-Zhong; Konopka, Genevieve] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Wang, GZ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	Genevieve.Konopka@utsouthwestern.edu		Konopka, Genevieve/0000-0002-3363-7302	NIMH [R00MH090238]; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH090238] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	GK is a Jon Heighten Scholar in Autism Research and is also supported by the NIMH (R00MH090238). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbas H, 2007, J ANAT, V211, P237, DOI 10.1111/j.1469-7580.2007.00777.x; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Belgard TG, 2011, NEURON, V71, P605, DOI 10.1016/j.neuron.2011.06.039; Bernard A, 2012, NEURON, V73, P1083, DOI 10.1016/j.neuron.2012.03.002; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Crochet S, 2009, NEURON, V64, P298, DOI 10.1016/j.neuron.2009.10.024; de Sousa AA, 2010, CEREB CORTEX, V20, P966, DOI 10.1093/cercor/bhp158; DeFelipe J, 2002, J NEUROCYTOL, V31, P299, DOI 10.1023/A:1024130211265; DEFELIPE J, 1992, PROG NEUROBIOL, V39, P563, DOI 10.1016/0301-0082(92)90015-7; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Drummond DA, 2006, MOL BIOL EVOL, V23, P327, DOI 10.1093/molbev/msj038; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Hashimoto R, 2007, DRUG TODAY, V43, P645, DOI 10.1358/dot.2007.43.9.1088821; Kaas JH, 2011, BRAIN BEHAV EVOLUT, V78, P7, DOI 10.1159/000327316; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Khaitovich P, 2004, GENOME RES, V14, P1462, DOI 10.1101/gr.2538704; KUMA K, 1995, MOL BIOL EVOL, V12, P123, DOI 10.1093/oxfordjournals.molbev.a040181; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Meyer HS, 2010, CEREB CORTEX, V20, P2277, DOI 10.1093/cercor/bhq067; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Mirnics K, 2001, TRENDS NEUROSCI, V24, P479, DOI 10.1016/S0166-2236(00)01862-2; Morris JA, 2010, P NATL ACAD SCI USA, V107, P19049, DOI 10.1073/pnas.1003732107; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Pal C, 2001, GENETICS, V158, P927; Petanjek Z, 2008, CEREB CORTEX, V18, P915, DOI 10.1093/cercor/bhm124; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Pocklington AJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100041; Preuss TM, 2000, BRAIN BEHAV EVOLUT, V55, P287, DOI 10.1159/000006664; PREUSS TM, 1995, J COGNITIVE NEUROSCI, V7, P1, DOI 10.1162/jocn.1995.7.1.1; PREUSS TM, 1999, FUNDAMENTAL NEUROSCI, P1283; Raizada RDS, 2003, CEREB CORTEX, V13, P100, DOI 10.1093/cercor/13.1.100; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rivara CB, 2003, ANAT REC PART A, V270A, P137, DOI 10.1002/ar.a.10015; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Sheng M., 2011, COLD SPRING HARBOR P; SILVA LR, 1991, SCIENCE, V251, P432, DOI 10.1126/science.1824881; Striedter G.F., 2004, PRINCIPLES BRAIN EVO; Wang GZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018288; Wilson D, 2008, NUCLEIC ACIDS RES, V36, pD88, DOI 10.1093/nar/gkm964; Xu WF, 2011, CURR OPIN NEUROBIOL, V21, P306, DOI 10.1016/j.conb.2011.03.001; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052; Zhang YE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001179; Zilles K., 2011, HUMAN NERVOUS SYSTEM, P836	52	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39686	10.1371/journal.pone.0039686	http://dx.doi.org/10.1371/journal.pone.0039686			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761869	Green Published, Green Submitted, gold			2022-12-27	WOS:000305826400026
J	Orubu, T; Alharbi, NK; Lambe, T; Gilbert, SC; Cottingham, MG				Orubu, Toritse; Alharbi, Naif Khalaf; Lambe, Teresa; Gilbert, Sarah C.; Cottingham, Matthew G.			Expression and Cellular Immunogenicity of a Transgenic Antigen Driven by Endogenous Poxviral Early Promoters at Their Authentic Loci in MVA	PLOS ONE			English	Article							RECOMBINANT VACCINIA VIRUS; GENETICALLY-ENGINEERED POXVIRUSES; BACTERIAL ARTIFICIAL CHROMOSOME; GENE-EXPRESSION; INFECTIOUS-DISEASES; BIOLOGICAL-ACTIVITY; ESCHERICHIA-COLI; IMMUNE-RESPONSES; LIVE VACCINES; GROWTH-FACTOR	CD8(+) T cell responses to vaccinia virus are directed almost exclusively against early gene products. The attenuated strain modified vaccinia virus Ankara (MVA) is under evaluation in clinical trials of new vaccines designed to elicit cellular immune responses against pathogens including Plasmodium spp., M. tuberculosis and HIV-1. All of these recombinant MVAs (rMVA) utilize the well-established method of linking the gene of interest to a cloned poxviral promoter prior to insertion into the viral genome at a suitable locus by homologous recombination in infected cells. Using BAC recombineering, we show that potent early promoters that drive expression of non-functional or non-essential MVA open reading frames (ORFs) can be harnessed for immunogenic expression of recombinant antigen. Precise replacement of the MVA orthologs of C11R, F11L, A44L and B8R with a model antigen positioned to use the same translation initiation codon allowed early transgene expression similar to or slightly greater than that achieved by the commonly-used p7.5 or short synthetic promoters. The frequency of antigen-specific CD8(+) T cells induced in mice by single shot or adenovirus-prime, rMVA-boost vaccination were similarly equal or marginally enhanced using endogenous promoters at their authentic genomic loci compared to the traditional constructs. The enhancement in immunogenicity observed using the C11R or F11L promoters compared with p7.5 was similar to that obtained with the mH5 promoter compared with p7.5. Furthermore, the growth rates of the viruses were unimpaired and the insertions were genetically stable. Insertion of a transgenic ORF in place of a viral ORF by BAC recombineering can thus provide not only a potent promoter, but also, concomitantly, a suitable insertion site, potentially facilitating development of MVA vaccines expressing multiple recombinant antigens.	[Orubu, Toritse; Alharbi, Naif Khalaf; Lambe, Teresa; Gilbert, Sarah C.; Cottingham, Matthew G.] Univ Oxford, Jenner Inst, Oxford, England	University of Oxford; Jenner Institute	Orubu, T (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	matt.cottingham@ndm.ox.ac.uk	Gilbert, Sarah C./H-2857-2019; Lambe, Teresa/E-5733-2016	Gilbert, Sarah C./0000-0002-6823-9750; Lambe, Teresa/0000-0001-7711-897X; Cottingham, Matthew/0000-0003-0766-6465; Alharbi, Naif/0000-0002-6049-3383	Grand Challenges in Global Health grant; Jenner Institute, University of Oxford; Oxford Martin School; Wellcome Trust	Grand Challenges in Global Health grant; Jenner Institute, University of Oxford; Oxford Martin School; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded in part by a Grand Challenges in Global Health grant to Prof. Adrian V. S. Hill, Jenner Institute, University of Oxford administered by the Foundation for the National Institutes of Health. MGC and TL are supported by the Oxford Martin School. SCG is a Jenner Investigator. The authors are grateful to the Jenner Institute's Vector Core Facility, funded by the Wellcome Trust, for technical assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCAMI A, 1995, J VIROL, V69, P4633; Alcock R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000490; Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Assarsson E, 2008, P NATL ACAD SCI USA, V105, P2140, DOI 10.1073/pnas.0711573105; Baur K, 2010, J VIROL, V84, P8743, DOI 10.1128/JVI.00604-10; BENNINK JR, 1984, NATURE, V311, P578, DOI 10.1038/311578a0; Berthoud TK, 2011, CLIN INFECT DIS, V52, P1, DOI 10.1093/cid/ciq015; Blanchard TJ, 1998, J GEN VIROL, V79, P1159, DOI 10.1099/0022-1317-79-5-1159; BROWN JP, 1985, NATURE, V313, P491, DOI 10.1038/313491a0; Broyles SS, 2003, J GEN VIROL, V84, P2293, DOI 10.1099/vir.0.18942-0; BULLER RML, 1988, J VIROL, V62, P866, DOI 10.1128/JVI.62.3.866-874.1988; BULLER RML, 1988, VIROLOGY, V164, P182, DOI 10.1016/0042-6822(88)90635-6; Capone S, 2010, VACCINE, V29, P256, DOI 10.1016/j.vaccine.2010.10.041; Carter GC, 2005, J GEN VIROL, V86, P1279, DOI 10.1099/vir.0.80831-0; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; Cottingham MG, 2010, J VIROL METHODS, V168, P233, DOI 10.1016/j.jviromet.2010.04.012; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; Cottingham MG, 2012, METHODS MOL IN PRESS; DAVISON AJ, 1989, J MOL BIOL, V210, P749, DOI 10.1016/0022-2836(89)90107-1; Domi A, 2005, NAT METHODS, V2, P95, DOI 10.1038/NMETH734; Domi A, 2002, P NATL ACAD SCI USA, V99, P12415, DOI 10.1073/pnas.192420599; Draper SJ, 2010, J IMMUNOL, V185, P7583, DOI 10.4049/jimmunol.1001760; Earl PL, 1998, CURRENT PROTOCOLS MO; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; Gomez CE, 2011, CURR GENE THER, V11, P189; Gomez CE, 2001, ARCH VIROL, V146, P875, DOI 10.1007/s007050170122; Hill AVS, 2011, PHILOS T R SOC B, V366, P2806, DOI 10.1098/rstb.2011.0091; Hopkins R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020067; Krauss O, 2002, J GEN VIROL, V83, P2347, DOI 10.1099/0022-1317-83-10-2347; Kreijtz JHCM, 2010, J GEN VIROL, V91, P2745, DOI 10.1099/vir.0.024885-0; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; MACKETT M, 1984, J VIROL, V49, P857, DOI 10.1128/JVI.49.3.857-864.1984; Manuel ER, 2010, VIROLOGY, V403, P155, DOI 10.1016/j.virol.2010.04.015; MAYR A, 1978, ZBL BAKT MIK HYG B, V167, P375; MOSS B, 1984, NATURE, V311, P67, DOI 10.1038/311067a0; Moss B, 1996, P NATL ACAD SCI USA, V93, P11341, DOI 10.1073/pnas.93.21.11341; Oseroff C, 2008, J IMMUNOL, V180, P7193, DOI 10.4049/jimmunol.180.11.7193; PANICALI D, 1983, P NATL ACAD SCI-BIOL, V80, P5364, DOI 10.1073/pnas.80.17.5364; PAOLETTI E, 1984, P NATL ACAD SCI-BIOL, V81, P193, DOI 10.1073/pnas.81.1.193; PERKUS ME, 1985, SCIENCE, V229, P981, DOI 10.1126/science.2992092; PERKUS ME, 1989, J VIROL, V63, P3829, DOI 10.1128/JVI.63.9.3829-3836.1989; Reading PC, 2003, J VIROL, V77, P9960, DOI 10.1128/JVI.77.18.9960-9968.2003; Reading PC, 2003, J EXP MED, V197, P1269, DOI 10.1084/jem.20022201; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; Rollier CS, 2011, CURR OPIN IMMUNOL, V23, P377, DOI 10.1016/j.coi.2011.03.006; ROMERO P, 1990, IMMUNOL LETT, V25, P27, DOI 10.1016/0165-2478(90)90086-6; Rubins KH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002628; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Sette A, 2009, VACCINE, V27, pG21, DOI 10.1016/j.vaccine.2009.10.011; Sheehy SH, 2011, MOL THER, V19, P2269, DOI 10.1038/mt.2011.176; Skinner MA, 2005, EXPERT REV VACCINES, V4, P63, DOI 10.1586/14760584.4.1.63; SMITH GL, 1983, NATURE, V302, P490, DOI 10.1038/302490a0; SMITH GL, 1983, P NATL ACAD SCI-BIOL, V80, P7155, DOI 10.1073/pnas.80.23.7155; Sridhar S, 2008, J VIROL, V82, P3822, DOI 10.1128/JVI.02568-07; SUTTER G, 1992, P NATL ACAD SCI USA, V89, P10847, DOI 10.1073/pnas.89.22.10847; Tscharke DC, 2006, J VIROL, V80, P6318, DOI 10.1128/JVI.00427-06; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Valderrama F, 2006, SCIENCE, V311, P377, DOI 10.1126/science.1122411; Wang ZD, 2010, VACCINE, V28, P1547, DOI 10.1016/j.vaccine.2009.11.056; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wyatt LS, 2008, VIROLOGY, V372, P260, DOI 10.1016/j.virol.2007.10.033; Wyatt LS, 2008, VACCINE, V26, P486, DOI 10.1016/j.vaccine.2007.11.036; Wyatt LS, 2009, J VIROL, V83, P7176, DOI 10.1128/JVI.00687-09; Wyatt LS, 1996, VACCINE, V14, P1451, DOI 10.1016/S0264-410X(96)00072-2; Yang ZL, 2010, P NATL ACAD SCI USA, V107, P11513, DOI 10.1073/pnas.1006594107	65	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e40167	10.1371/journal.pone.0040167	http://dx.doi.org/10.1371/journal.pone.0040167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761956	Green Published, gold, Green Submitted			2022-12-27	WOS:000305825800092
J	Hunemeier, T; Amorim, CEG; Azevedo, S; Contini, V; Acuna-Alonzo, V; Rothhammer, F; Dugoujon, JM; Mazieres, S; Barrantes, R; Villarreal-Molina, MT; Paixao-Cortes, VR; Salzano, FM; Canizales-Quinteros, S; Ruiz-Linares, A; Bortolini, MC				Huenemeier, Tabita; Guerra Amorim, Carlos Eduardo; Azevedo, Soledad; Contini, Veronica; Acuna-Alonzo, Victor; Rothhammer, Francisco; Dugoujon, Jean-Michel; Mazieres, Stephane; Barrantes, Ramiro; Teresa Villarreal-Molina, Maria; Paixao-Cortes, Vanessa Rodrigues; Salzano, Francisco M.; Canizales-Quinteros, Samuel; Ruiz-Linares, Andres; Bortolini, Maria Catira			Evolutionary Responses to a Constructed Niche: Ancient Mesoamericans as a Model of Gene-Culture Coevolution	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; LACTASE-PERSISTENCE; LACTOSE DIGESTION; FRENCH-GUIANA; HUMAN GENOME; ALLELE; MAIZE; DOMESTICATION; POPULATIONS; VARIANT	Culture and genetics rely on two distinct but not isolated transmission systems. Cultural processes may change the human selective environment and thereby affect which individuals survive and reproduce. Here, we evaluated whether the modes of subsistence in Native American populations and the frequencies of the ABCA1*Arg230Cys polymorphism were correlated. Further, we examined whether the evolutionary consequences of the agriculturally constructed niche in Mesoamerica could be considered as a gene-culture coevolution model. For this purpose, we genotyped 229 individuals affiliated with 19 Native American populations and added data for 41 other Native American groups (n = 1905) to the analysis. In combination with the SNP cluster of a neutral region, this dataset was then used to unravel the scenario involved in 230Cys evolutionary history. The estimated age of 230Cys is compatible with its origin occurring in the American continent. The correlation of its frequencies with the archeological data on Zea pollen in Mesoamerica/Central America, the neutral coalescent simulations, and the F-ST-based natural selection analysis suggest that maize domestication was the driving force in the increase in the frequencies of 230Cys in this region. These results may represent the first example of a gene-culture coevolution involving an autochthonous American allele.	[Huenemeier, Tabita; Guerra Amorim, Carlos Eduardo; Contini, Veronica; Paixao-Cortes, Vanessa Rodrigues; Salzano, Francisco M.; Bortolini, Maria Catira] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil; [Azevedo, Soledad] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Puerto Madryn, Argentina; [Acuna-Alonzo, Victor] Escuela Nacl Antropol & Hist, Mol Genet Lab, Mexico City, DF, Mexico; [Rothhammer, Francisco] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Genet Humana, Santiago 7, Chile; [Rothhammer, Francisco] Univ Tarapaca, Inst Alta Invest, Arica, Chile; [Dugoujon, Jean-Michel] Univ Toulouse 3, Lab Anthropol Mol & Imagerie Synth, CNRS, UMR 5288, Toulouse, France; [Mazieres, Stephane] Aix Marseille Univ, CNRS, UMR 7268, EFS, Marseille, France; [Barrantes, Ramiro] Univ Costa Rica, Escuela Biol, San Jose, Costa Rica; [Teresa Villarreal-Molina, Maria] Inst Nacl Med Genom, Lab Genom Enfermedades Cardiovasc, Mexico City, DF, Mexico; [Canizales-Quinteros, Samuel] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Unit Mol Biol & Genom Med, Mexico City, DF, Mexico; [Canizales-Quinteros, Samuel] Univ Nacl Autonoma Mexico, Fac Quim, Dept Biol, Mexico City 04510, DF, Mexico; [Ruiz-Linares, Andres] UCL, Galton Lab, Dept Biol, London, England	Universidade Federal do Rio Grande do Sul; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad de Chile; Universidad de Tarapaca; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Universidad Costa Rica; Instituto Nacional de Medicina Genomica; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico; University of London; University College London	Hunemeier, T (corresponding author), Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil.	maria.bortolini@ufrgs.br	Hünemeier, Tábita/F-4181-2011; Salzano, Francisco M/L-7916-2015; Paixão-Côrtes, Vanessa R/H-3564-2011; Acuna Alonzo, Victor/E-2312-2013; Ruiz-Linares, Andres/AAR-1104-2021; Mazieres, Stephane/G-1702-2010; Mazières, Stéphane/R-2061-2019	Paixão-Côrtes, Vanessa R/0000-0003-2677-0903; Acuna Alonzo, Victor/0000-0003-2205-7625; Ruiz-Linares, Andres/0000-0001-8372-1011; Mazieres, Stephane/0000-0003-1266-4659; Hunemeier, Tabita/0000-0002-3156-2079; VILLARREAL MOLINA, TERESA/0000-0003-4450-7690	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); PRONEX (Brazil); Programme Interdisciplinaire CNRS: Amazonie-Analyse, Modelisation et Ingenierie des Systemes Amazoniens (France); Convenio de Desempeno Mecesup 2/UTA (Chile)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); PRONEX (Brazil); Programme Interdisciplinaire CNRS: Amazonie-Analyse, Modelisation et Ingenierie des Systemes Amazoniens (France); Convenio de Desempeno Mecesup 2/UTA (Chile)	This study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), PRONEX (Brazil); Programme Interdisciplinaire CNRS: Amazonie-Analyse, Modelisation et Ingenierie des Systemes Amazoniens (France); and Convenio de Desempeno Mecesup 2/UTA (Chile). These funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Alonzo V, 2010, HUM MOL GENET, V19, P2877, DOI 10.1093/hmg/ddq173; [Anonymous], 1988, AM ANTHROPOL; Beja-Pereira A, 2003, NAT GENET, V35, P311, DOI 10.1038/ng1263; Benedict FG, 1936, FOOD PRESENT DAY MAY; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Blake Michael, 2006, HIST MAIZE MULTIDISC, P55; Bocquet-Appel JP, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P35, DOI 10.1007/978-1-4020-8539-0_3; Bortolini MC, 2003, AM J HUM GENET, V73, P524, DOI 10.1086/377588; Bortolini MC, 2002, ANN HUM GENET, V66, P255, DOI 10.1017/S0003480002001148; Brown CH, 2010, PRE-COLUMBIAN FOODWAYS: INTERDISCIPLINARY APPROACHES TO FOOD, CULTURE, AND MARKETS IN ANCIENT MESOAMERICA, P273, DOI 10.1007/978-1-4419-0471-3_11; Burger J, 2007, P NATL ACAD SCI USA, V104, P3736, DOI 10.1073/pnas.0607187104; CHISHOLM B, 2006, HIST MAIZE MULTIDISC, P161; Cohen MN, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P481, DOI 10.1007/978-1-4020-8539-0_18; Combes V, 2005, AM J PATHOL, V166, P295, DOI 10.1016/S0002-9440(10)62253-5; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Dull Robert A., 2006, HIST MAIZE MULTIDISC, P357; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Gerbault P, 2011, PHILOS T R SOC B, V366, P863, DOI 10.1098/rstb.2010.0268; Gonzalez-Jose R, 2008, AM J PHYS ANTHROPOL, V137, P175, DOI 10.1002/ajpa.20854; Gonzalez-Martin A, 2008, AM J HUM BIOL, V20, P605, DOI 10.1002/ajhb.20787; HEYJ, 2005, PLOS BIOL, V3, pE193; Holden C, 1997, HUM BIOL, V69, P605; Holden C, 2009, HUM BIOL, V81, P597, DOI 10.3378/027.081.0609; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Hunley KL, 2007, AM J PHYS ANTHROPOL, V132, P622, DOI 10.1002/ajpa.20542; Ingram CJE, 2009, HUM GENET, V124, P579, DOI 10.1007/s00439-008-0593-6; Itan Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-36; Jaenicke-Despres Viviane, 2006, HIST MAIZE, P83; Kemp BM, 2010, P NATL ACAD SCI USA, V107, P6759, DOI 10.1073/pnas.0905753107; Kennett DJ, 2006, ORIG HUM BEHAV, V1, P103; KIMURA M, 1973, GENETICS, V75, P199; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08; Lesure RG, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P107, DOI 10.1007/978-1-4020-8539-0_6; Lewinsky RH, 2005, HUM MOL GENET, V14, P3945, DOI 10.1093/hmg/ddi418; Lia VV, 2007, P ROY SOC B-BIOL SCI, V274, P545, DOI 10.1098/rspb.2006.3747; LIVINGSTONE FB, 1958, AM ANTHROPOL, V60, P533, DOI 10.1525/aa.1958.60.3.02a00110; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Mazieres S, 2008, ANN HUM GENET, V72, P145, DOI 10.1111/j.1469-1809.2007.00392.x; Mazieres S, 2009, AM J HUM BIOL, V21, P113, DOI 10.1002/ajhb.20835; NEEL JV, 1962, AM J HUM GENET, V14, P353; NEEL JV, 1967, AM J HUM GENET, V19, P554; Odling-Smee F.J., 1988, P73; Parsons JR, 2010, PRE-COLUMBIAN FOODWAYS: INTERDISCIPLINARY APPROACHES TO FOOD, CULTURE, AND MARKETS IN ANCIENT MESOAMERICA, P109, DOI 10.1007/978-1-4419-0471-3_4; Pavlidis P, 2010, MOL ECOL RESOUR, V10, P723, DOI 10.1111/j.1755-0998.2010.02832.x; Peng Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-15; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Piperno DR, 2007, P NATL ACAD SCI USA, V104, P11874, DOI 10.1073/pnas.0703442104; Poinar HN, 2001, P NATL ACAD SCI USA, V98, P4317, DOI 10.1073/pnas.061014798; Ranere AJ, 2009, P NATL ACAD SCI USA, V106, P5014, DOI 10.1073/pnas.0812590106; Rannala B, 2008, PACIFIC S BIOCOMP, V8, P526; Raymond J. S., 2006, HIST MAIZE MULTIDISC, P337; Richerson PJ, 2010, P NATL ACAD SCI USA, V107, P8985, DOI 10.1073/pnas.0914631107; Romero-Hidalgo S, 2012, J NUTR, V142, P278, DOI 10.3945/jn.111.152421; Rowley-Conwy P, 2011, PHILOS T R SOC B, V366, P849, DOI 10.1098/rstb.2010.0307; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schroeder KB, 2009, MOL BIOL EVOL, V26, P995, DOI 10.1093/molbev/msp024; Schwarcz H, 2006, HIST MAIZE MULTIDISC, P315; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; Steckel RH, 2002, EVOL ANTHROPOL, V11, P142, DOI 10.1002/evan.10030; Tarazona-Santos E, 2001, AM J HUM GENET, V68, P1485, DOI 10.1086/320601; Tian F, 2009, P NATL ACAD SCI USA, V106, P9979, DOI 10.1073/pnas.0901122106; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Tovo-Rodrigues L, 2010, AM J PHYS ANTHROPOL, V143, P458, DOI 10.1002/ajpa.21358; Tykot RH, 2006, HIST MAIZE MULTIDISC, P187; van Heerwaarden J, 2011, P NATL ACAD SCI USA, V108, P1088, DOI 10.1073/pnas.1013011108; Vargas-Alarcon G, 2007, MOL IMMUNOL, V44, P747, DOI 10.1016/j.molimm.2006.04.014; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Wegmann D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-116; Zarrillo S, 2009, P NATL ACAD SCI USA, V106, P9979	74	29	31	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38862	10.1371/journal.pone.0038862	http://dx.doi.org/10.1371/journal.pone.0038862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22768049	Green Published, gold			2022-12-27	WOS:000305695100021
J	Imbeault, P; Findlay, CS; Robidoux, MA; Haman, F; Blais, JM; Tremblay, A; Springthorpe, S; Pal, S; Seabert, T; Krummel, EM; Maal-Bared, R; Tetro, JA; Pandey, S; Sattar, SA; Filion, LG				Imbeault, Pascal; Findlay, C. Scott; Robidoux, Michael A.; Haman, Francois; Blais, Jules M.; Tremblay, Angelo; Springthorpe, Susan; Pal, Shinjini; Seabert, Tim; Kruemmel, Eva M.; Maal-Bared, Rasha; Tetro, Jason A.; Pandey, Sunita; Sattar, Syed A.; Filion, Lionel G.			Dysregulation of Cytokine Response in Canadian First Nations Communities: Is There an Association with Persistent Organic Pollutant Levels?	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ADIPOSE-TISSUE; ENVIRONMENTAL CONTAMINANTS; POLYCHLORINATED-BIPHENYLS; SERUM CONCENTRATIONS; INSULIN-RESISTANCE; DIABETES-MELLITUS; HUMAN HEALTH; WEIGHT-LOSS; IN-VIVO	In vitro and animal studies report that some persistent organic pollutants (POPs) trigger the secretion of proinflammatory cytokines. Whether POP exposure is associated with a dysregulation of cytokine response remains to be investigated in humans. We studied the strength of association between plasma POP levels and circulating cytokines as immune activation markers. Plasma levels of fourteen POPs and thirteen cytokines were measured in 39 Caucasians from a comparator sample in Quebec City (Canada) and 72 First Nations individuals from two northern communities of Ontario (Canada). Caucasians showed significantly higher levels of organochlorine insecticides (beta-HCH, p,p'-DDE and HCB) compared to First Nations. Conversely, First Nations showed higher levels of Mirex, Aroclor 1260, PCB 153, PCB 170, PCB 180 and PCB 187 compared to Caucasians. While there was no difference in cytokine levels of IL-4, IL-6, IL-10 and IL-22 between groups, First Nations had significantly greater average levels of IFN gamma, IL-1 beta, IL-2, IL-5, IL-8, IL-12p70, IL-17A, TNF alpha and TNF beta levels compared to Caucasians. Among candidate predictor variables (age, body mass index, insulin resistance and POP levels), high levels of PCBs were the only predictor accounting for a small but significant effect of observed variance (similar to 7%) in cytokine levels. Overall, a weak but significant association is detected between persistent organochlorine pollutant exposure and elevated cytokine levels. This finding augments the already existing information that environmental pollution is related to inflammation, a common feature of several metabolic disorders that are known to be especially prevalent in Canada's remote First Nations communities.	[Imbeault, Pascal] Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, Behav & Metab Res Unit, Ottawa, ON, Canada; [Imbeault, Pascal; Robidoux, Michael A.; Haman, Francois] Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, Indigenous Hlth Grp, Ottawa, ON, Canada; [Findlay, C. Scott; Blais, Jules M.; Pal, Shinjini; Seabert, Tim; Kruemmel, Eva M.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Findlay, C. Scott; Blais, Jules M.; Pal, Shinjini; Seabert, Tim; Kruemmel, Eva M.] Univ Ottawa, Inst Environm, Ottawa, ON, Canada; [Tremblay, Angelo] Univ Laval, Fac Med, Div Kinesiol, Quebec City, PQ G1K 7P4, Canada; [Springthorpe, Susan; Maal-Bared, Rasha; Tetro, Jason A.; Sattar, Syed A.; Filion, Lionel G.] Univ Ottawa, Ctr Res Environm Microbiol, Ottawa, ON, Canada; [Springthorpe, Susan; Maal-Bared, Rasha; Tetro, Jason A.; Pandey, Sunita; Sattar, Syed A.; Filion, Lionel G.] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1N 6N5, Canada; [Findlay, C. Scott; Blais, Jules M.; Pal, Shinjini; Seabert, Tim; Kruemmel, Eva M.] Ottawa Hosp, Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; Laval University; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Imbeault, P (corresponding author), Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, Behav & Metab Res Unit, Ottawa, ON, Canada.	imbeault@uottawa.ca	Blais, Jules/AAV-2321-2020	Blais, Jules/0000-0002-7188-3598; Maal-Bared, Rasha/0000-0001-9488-8124; Tetro, Jason/0000-0001-8759-7281	National First Nations Environmental Contaminant Program (NFCECP); Canadian Institutes for Health Research (CIHR); Natural Sciences and Engineering Research Council (NSERC) of Canada	National First Nations Environmental Contaminant Program (NFCECP); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The National First Nations Environmental Contaminant Program (NFCECP), the Canadian Institutes for Health Research (CIHR) and the Natural Sciences and Engineering Research Council (NSERC) of Canada provided financial support for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenescu V, 2008, ENVIRON HEALTH PERSP, V116, P761, DOI 10.1289/ehp.10554; BARRIE LA, 1992, SCI TOTAL ENVIRON, V122, P1, DOI 10.1016/0048-9697(92)90245-N; Bastard JP, 2002, J CLIN ENDOCR METAB, V87, P2084, DOI 10.1210/jc.87.5.2084; Beard J, 2003, ENVIRON HEALTH PERSP, V111, P724, DOI 10.1289/ehp.5885; Bertazzi PA, 2001, AM J EPIDEMIOL, V153, P1031, DOI 10.1093/aje/153.11.1031; Calvert GM, 1999, OCCUP ENVIRON MED, V56, P270, DOI 10.1136/oem.56.4.270; Cowan J, 2012, CLIN EXP IMMUNOL, V167, P317, DOI 10.1111/j.1365-2249.2011.04520.x; Dewailly E, 1999, ENVIRON HEALTH PERSP, V107, P823, DOI 10.2307/3454581; Dirinck E, 2011, OBESITY, V19, P709, DOI 10.1038/oby.2010.133; Donaldson SG, 2010, SCI TOTAL ENVIRON, V408, P5165, DOI 10.1016/j.scitotenv.2010.04.059; El-Ansary AK, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-142; Elobeid MA, 2010, INT J ENV RES PUB HE, V7, P2988, DOI 10.3390/ijerph7072988; First Nations Centre, 2005, 1 NAT REG LONG HLTH; Green C, 2003, DIABETES CARE, V26, P1993, DOI 10.2337/diacare.26.7.1993; Haman F, 2010, INT J OBESITY, V34, pS24, DOI 10.1038/ijo.2010.236; Health Canada, 2003, CANADIAN GUIDELINES; Hennig B, 2002, TOXICOL APPL PHARM, V181, P174, DOI 10.1006/taap.2002.9408; Henriksen GL, 1997, EPIDEMIOLOGY, V8, P252, DOI 10.1097/00001648-199705000-00005; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Humblet O, 2008, ENVIRON HEALTH PERSP, V116, P1443, DOI 10.1289/ehp.11579; Imbeault P, 2002, AM J PHYSIOL-ENDOC M, V282, pE574, DOI 10.1152/ajpendo.00394.2001; Imbeault P, 2011, J OBES, V2011, DOI 10.1155/2011/267509; Imbeault P, 2009, METABOLISM, V58, P552, DOI 10.1016/j.metabol.2008.11.017; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; KERN PA, 1995, J CLIN INVEST, V95, P2111, DOI 10.1172/JCI117899; Lee DH, 2007, DIABETOLOGIA, V50, P1841, DOI 10.1007/s00125-007-0755-4; Lee DH, 2011, ENV INT; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Macdonald RW, 2005, SCI TOTAL ENVIRON, V342, P5, DOI 10.1016/j.scitotenv.2004.12.059; MacDonald RW, 2000, SCI TOTAL ENVIRON, V254, P234; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MCFARLAND VA, 1989, ENVIRON HEALTH PERSP, V81, P225, DOI 10.2307/3430833; Neel BA, 2011, DIABETES, V60, P1838, DOI 10.2337/db11-0153; Oades RD, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-32; Porta M, 2010, ENVIRON INT, V36, P655, DOI 10.1016/j.envint.2010.04.013; Reading C. L., 2009, HLTH INEQUALITIES SO; Receveur O, 1998, Int J Circumpolar Health, V57 Suppl 1, P219; Rhainds M, 1999, ARCH ENVIRON HEALTH, V54, P40, DOI 10.1080/00039899909602235; Robidoux M. A., 2012, CANADIAN J NATIVE ST, V32; SAFE SH, 1994, CRIT REV TOXICOL, V24, P87, DOI 10.3109/10408449409049308; Sandau CD, 2002, ENVIRON HEALTH PERSP, V110, P411, DOI 10.1289/ehp.02110411; Semeena VS, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022229; Turyk M, 2009, ENVIRON HEALTH PERSP, V117, P1076, DOI 10.1289/ehp.0800281; Vallack HW, 1998, ENVIRON TOXICOL PHAR, V6, P143, DOI 10.1016/S1382-6689(98)00036-2; Van Oostdam J, 2005, SCI TOTAL ENVIRON, V351, P165, DOI 10.1016/j.scitotenv.2005.03.034; Van Oostdam JC, 2004, SCI TOTAL ENVIRON, V330, P55, DOI 10.1016/j.scitotenv.2004.02.028; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vozarova B, 2001, OBES RES, V9, P414, DOI 10.1038/oby.2001.54; Wang SL, 2008, DIABETES CARE, V31, P1574, DOI 10.2337/dc07-2449	50	25	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39931	10.1371/journal.pone.0039931	http://dx.doi.org/10.1371/journal.pone.0039931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768323	Green Submitted, Green Published, gold			2022-12-27	WOS:000305966500036
J	Di Camillo, CG; Luna, GM; Bo, M; Giordano, G; Corinaldesi, C; Bavestrello, G				Di Camillo, Cristina Gioia; Luna, Gian Marco; Bo, Marzia; Giordano, Giuseppe; Corinaldesi, Cinzia; Bavestrello, Giorgio			Biodiversity of Prokaryotic Communities Associated with the Ectoderm of Ectopleura crocea (Cnidaria, Hydrozoa)	PLOS ONE			English	Article							MICROBIAL DIVERSITY; GEN. NOV.; BACTERIA; HYDRA; ALGAE; SEA	The surface of many marine organisms is colonized by complex communities of microbes, yet our understanding of the diversity and role of host-associated microbes is still limited. We investigated the association between Ectopleura crocea (a colonial hydroid distributed worldwide in temperate waters) and prokaryotic assemblages colonizing the hydranth surface. We used, for the first time on a marine hydroid, a combination of electron and epifluorescence microscopy and 16S rDNA tag pyrosequencing to investigate the associated prokaryotic diversity. Dense assemblages of prokaryotes were associated with the hydrant surface. Two microbial morphotypes were observed: one horseshoe-shaped and one fusiform, worm-like. These prokaryotes were observed on the hydrozoan epidermis, but not in the portions covered by the perisarcal exoskeleton, and their abundance was higher in March while decreased in late spring. Molecular analyses showed that assemblages were dominated by Bacteria rather than Archaea. Bacterial assemblages were highly diversified, with up to 113 genera and 570 Operational Taxonomic Units (OTUs), many of which were rare and contributed to <0.4%. The two most abundant OTUs, likely corresponding to the two morphotypes present on the epidermis, were distantly related to Comamonadaceae (genus Delftia) and to Flavobacteriaceae (genus Polaribacter). Epibiontic bacteria were found on E. crocea from different geographic areas but not in other hydroid species in the same areas, suggesting that the host-microbe association is species-specific. This is the first detailed report of bacteria living on the hydrozoan epidermis, and indeed the first study reporting bacteria associated with the epithelium of E. crocea. Our results provide a starting point for future studies aiming at clarifying the role of this peculiar hydrozoan-bacterial association.	[Di Camillo, Cristina Gioia; Giordano, Giuseppe; Corinaldesi, Cinzia] Polytech Univ Marche, Dept Life & Environm Sci, Ancona, Italy; [Luna, Gian Marco] Natl Res Council CNR, Inst Marine Sci, Venice, Italy; [Bo, Marzia; Bavestrello, Giorgio] Univ Genoa, Dept Study Land & Resources, Genoa, Italy	Marche Polytechnic University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); University of Genoa	Di Camillo, CG (corresponding author), Polytech Univ Marche, Dept Life & Environm Sci, Ancona, Italy.	c.dicamillo@univpm.it	Luna, Gian Marco/G-9129-2012; Luna, Gian Marco/AAY-5262-2020; Di Camillo, Cristina/AAI-5960-2021	Di Camillo, Cristina/0000-0002-4031-8158; Bavestrello, Giorgio/0000-0002-5428-2344; Bo, Marzia/0000-0001-8400-6722; LUNA, GIAN MARCO/0000-0002-8303-3400	programme FIRB Futuro in ricerca; MIUR [I31J10000060001]	programme FIRB Futuro in ricerca; MIUR(Ministry of Education, Universities and Research (MIUR))	This work was partly supported by the programme FIRB Futuro in ricerca 2008 funded by the MIUR (contract n. I31J10000060001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Altincicek B, 2009, ISJ-INVERT SURVIV J, V6, P106; Barott KL, 2011, ENVIRON MICROBIOL, V13, P1192, DOI 10.1111/j.1462-2920.2010.02419.x; Bavestrello G, 2008, J MAR BIOL ASSOC UK, V88, P1611, DOI 10.1017/S0025315408001665; Bowman JP, 1998, MICROBIOL-UK, V144, P1601, DOI 10.1099/00221287-144-6-1601; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collins AG, 2005, ZOOL SCR, V34, P91, DOI 10.1111/j.1463-6409.2005.00172.x; Di Camillo C, 2008, J MAR BIOL ASSOC UK, V88, P485, DOI 10.1017/S0025315408001045; Di Camillo C, 2005, J MAR BIOL ASSOC UK, V85, P1373, DOI 10.1017/S0025315405012555; Di Camillo CG, MAR ECOL; Di Camillo C, 2006, J MAR BIOL ASSOC UK, V86, P1285, DOI 10.1017/S0025315406014305; Dobretsov S, 2004, J EXP MAR BIOL ECOL, V299, P35, DOI 10.1016/j.jembe.2003.08.011; DUCKLOW HW, 1979, LIMNOL OCEANOGR, V24, P715, DOI 10.4319/lo.1979.24.4.0715; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Gnanambal KME, 2005, INDIAN J MAR SCI, V34, P316; Gorelova O.A., 2009, MOSC U BIOL SCI B, V64, P16, DOI [10.3103/S0096392509010040, DOI 10.3103/S0096392509010040]; Gravili C, 2011, J MAR BIOL IN PRESS; HUFNAGEL LA, 1977, T AM MICROSC SOC, V96, P406, DOI 10.2307/3225874; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; MARGULIS L, 1978, CURR MICROBIOL, V1, P227, DOI 10.1007/BF02602848; Neave MJ, 2012, MICROB ECOL, V63, P639, DOI 10.1007/s00248-011-9966-9; Nedashkovskaya OI, 2005, CURR MICROBIOL, V51, P408, DOI 10.1007/s00284-005-0105-z; Ostman C, 2000, SCI MAR, V64, P31; Proksch P, 2002, APPL MICROBIOL BIOT, V59, P125, DOI 10.1007/s00253-002-1006-8; RAHAT M, 1982, SCIENCE, V216, P67, DOI 10.1126/science.7063873; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Romagnoli T, 2007, MAR BIOL, V151, P537, DOI 10.1007/s00227-006-0487-x; Santiago-Vazquez LZ, 2007, ISME J, V1, P654, DOI 10.1038/ismej.2007.77; Schuett C, 2010, HELGOLAND MAR RES, V64, P205, DOI 10.1007/s10152-009-0179-2; Sharon G, 2008, CURR MICROBIOL, V56, P481, DOI 10.1007/s00284-008-9100-5; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stabili L, 2008, MICROB ECOL, V56, P625, DOI 10.1007/s00248-008-9382-y; Stabili L, 2006, MICROB ECOL, V52, P603, DOI 10.1007/s00248-006-9010-7; Stachowicz JJ, 2000, OECOLOGIA, V124, P280, DOI 10.1007/s004420000372; SVOBODA A, 1991, ZOOLOGISCHE VERHANDE, V274, P1; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Wen AM, 1999, INT J SYST BACTERIOL, V49, P567, DOI 10.1099/00207713-49-2-567; WILKERSON FP, 1980, MICROB ECOL, V6, P85, DOI 10.1007/BF02020377	37	20	22	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39926	10.1371/journal.pone.0039926	http://dx.doi.org/10.1371/journal.pone.0039926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768172	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100142
J	Idh, J; Mekonnen, M; Abate, E; Wedajo, W; Werngren, J; Angeby, K; Lerm, M; Elias, D; Sundqvist, T; Aseffa, A; Stendahl, O; Schon, T				Idh, Jonna; Mekonnen, Mekidim; Abate, Ebba; Wedajo, Wassihun; Werngren, Jim; Angeby, Kristian; Lerm, Maria; Elias, Daniel; Sundqvist, Tommy; Aseffa, Abraham; Stendahl, Olle; Schon, Thomas			Resistance to First-Line Anti-TB Drugs Is Associated with Reduced Nitric Oxide Susceptibility in Mycobacterium tuberculosis	PLOS ONE			English	Article							INTERMEDIATES IN-VITRO; REACTIVE NITROGEN; PULMONARY TUBERCULOSIS; ALVEOLAR MACROPHAGES; GENETIC DIVERSITY; HOST-DEFENSE; STRAINS; SYNTHASE; COMPLEX; EPIDEMIOLOGY	Background and Objective: The relative contribution of nitric oxide (NO) to the killing of Mycobacterium tuberculosis in human tuberculosis (TB) is controversial, although this has been firmly established in rodents. Studies have demonstrated that clinical strains of M. tuberculosis differ in susceptibility to NO, but how this correlates to drug susceptibility and clinical outcome is not known. Methods: In this study, 50 sputum smear-and culture-positive patients with pulmonary TB in Gondar, Ethiopia were included. Clinical parameters were recorded and drug susceptibility profile and spoligotyping patterns were investigated. NO susceptibility was studied by exposing the strains to the NO donor DETA/NO. Results: Clinical isolates of M. tuberculosis showed a dose-and time-dependent response when exposed to NO. The most frequent spoligotypes found were CAS1-Delhi and T3_ETH in a total of nine known spoligotypes and four orphan patterns. There was a significant association between reduced susceptibility to NO (>10% survival after exposure to 1 mM DETA/NO) and resistance against first-line anti-TB drugs, in particular isoniazid (INH). Patients infected with strains of M. tuberculosis with reduced susceptibility to NO showed no difference in cure rate or other clinical parameters but a tendency towards lower rate of weight gain after two months of treatment, independent of antibiotic resistance. Conclusion:: There is a correlation between resistance to first-line anti-TB drugs and reduced NO susceptibility in clinical strains of M. tuberculosis. Further studies including the mechanisms of reduced NO susceptibility are warranted and could identify targets for new therapeutic interventions.	[Idh, Jonna; Abate, Ebba; Lerm, Maria; Sundqvist, Tommy; Stendahl, Olle] Linkoping Univ, Fac Hlth Sci, Div Microbiol & Mol Med, Linkoping, Sweden; [Mekonnen, Mekidim] Univ Addis Ababa, Dept Microbiol Immunol & Parasitol, Debre Zeit, Ethiopia; [Mekonnen, Mekidim; Abate, Ebba; Wedajo, Wassihun; Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Abate, Ebba] Gondar Univ Hosp, Dept Microbiol & Parasitol, Gondar, Ethiopia; [Werngren, Jim] Swedish Inst Communicable Dis Control, Dept Preparedness, Unit Highly Pathogen Microorganisms, Solna, Sweden; [Angeby, Kristian] Karolinska Univ Hosp, Karolinska Inst, MTC, Stockholm, Sweden; [Elias, Daniel] Univ So Denmark, Inst Mol Med, Dept Canc & Inflammat, Odense, Denmark; [Schon, Thomas] Kalmar Cty Hosp, Dept Infect Dis, Kalmar, Sweden; [Schon, Thomas] Kalmar Cty Hosp, Dept Clin Microbiol, Kalmar, Sweden	Linkoping University; Addis Ababa University; Swedish Institute for Infectious Disease Control; Karolinska Institutet; Karolinska University Hospital; University of Southern Denmark	Idh, J (corresponding author), Linkoping Univ, Fac Hlth Sci, Div Microbiol & Mol Med, Linkoping, Sweden.	jonna.idh@liu.se	Aseffa, Abraham/J-3248-2016; Lerm, Maria/AAA-1780-2020; Lerm, Maria/AAM-8705-2020	Aseffa, Abraham/0000-0002-8028-1150; Lerm, Maria/0000-0002-5092-9892; Aragaw, Wassihun/0000-0002-4199-2224	Swedish Research Council; Swedish International Development Agency (Sida); Swedish Heart-Lung Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Agency (Sida); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation)	The study was supported by grants from the Swedish Research Council, Swedish International Development Agency (Sida) and the Swedish Heart-Lung Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate G, 2001, EUR J CLIN MICROBIOL, V20, P329, DOI 10.1007/PL00011272; American ST, 1961, NAT TUB ASS US DIAGN; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Chan ED, 2001, AM J RESP CELL MOL, V25, P606, DOI 10.1165/ajrcmb.25.5.4487; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; Choi HS, 2002, AM J RESP CRIT CARE, V166, P178, DOI 10.1164/rccm.2201023; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; DOI T, 1993, INFECT IMMUN, V61, P1980, DOI 10.1128/IAI.61.5.1980-1989.1993; Firmani MA, 2002, INFECT IMMUN, V70, P3965, DOI 10.1128/IAI.70.7.3965-3968.2002; Friedman CR, 1997, J INFECT DIS, V176, P478, DOI 10.1086/514067; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gumbo T, 2007, ANTIMICROB AGENTS CH, V51, P2329, DOI 10.1128/AAC.00185-07; Gurumurthy M, 2012, FEBS J, V279, P113, DOI 10.1111/j.1742-4658.2011.08404.x; (HPA). HPA, 2003, STAND OP PROC INV SP; Idh J, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-146; Institut GldP, 2011, SITVITWEB; Inumaru VTG, 2009, INT J TUBERC LUNG D, V13, P665; JACKETT PS, 1978, J GEN MICROBIOL, V104, P37, DOI 10.1099/00221287-104-1-37; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Keefer LK, 1996, METHOD ENZYMOL, V268, P281; Liu PT, 2008, CURR OPIN IMMUNOL, V20, P371, DOI 10.1016/j.coi.2008.05.014; Macallan DC, 1999, DIAGN MICR INFEC DIS, V34, P153, DOI 10.1016/S0732-8893(99)00007-3; Manjunatha Ujjini, 2009, Commun Integr Biol, V2, P215; Mekonen Mekdem, 2010, Ethiop Med J, V48, P203; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nathan C, 2008, SCIENCE, V322, P1337, DOI 10.1126/science.1167452; NCCLS NCfCLS, 2000, M24T2 NCCLS NCFCLS; Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293; OBRIEN L, 1994, INFECT IMMUN, V62, P5187, DOI 10.1128/IAI.62.11.5187-5190.1994; Parsons LM, 2002, J CLIN MICROBIOL, V40, P2339, DOI 10.1128/JCM.40.7.2339-2345.2002; Rhoades ER, 1997, INFECT IMMUN, V65, P1189, DOI 10.1128/IAI.65.4.1189-1195.1997; Rich EA, 1997, TUBERCLE LUNG DIS, V78, P247, DOI 10.1016/S0962-8479(97)90005-8; Rockett KA, 1998, INFECT IMMUN, V66, P5314, DOI 10.1128/IAI.66.11.5314-5321.1998; Scanga CA, 2001, INFECT IMMUN, V69, P7711, DOI 10.1128/IAI.69.12.7711-7717.2001; Schon T, 2004, INT J TUBERC LUNG D, V8, P1134; Schon T, 2011, TUBERCULOSIS, V91, P370, DOI 10.1016/j.tube.2011.06.002; Schon T, 2003, EUR RESPIR J, V21, P483, DOI 10.1183/09031936.03.00090702; Sherman DR, 1999, BIOFACTORS, V10, P211, DOI 10.1002/biof.5520100219; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Timmins GS, 2006, MOL MICROBIOL, V62, P1220, DOI 10.1111/j.1365-2958.2006.05467.x; Timmins GS, 2004, ANTIMICROB AGENTS CH, V48, P3006, DOI 10.1128/AAC.48.8.3006-3009.2004; VERDON CP, 1995, ANAL BIOCHEM, V224, P502, DOI 10.1006/abio.1995.1079; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205	47	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39891	10.1371/journal.pone.0039891	http://dx.doi.org/10.1371/journal.pone.0039891			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768155	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100124
J	Kumar, A; Zhang, M; Zhu, LY; Liao, RLP; Mutai, C; Hafsat, S; Sherman, DR; Wang, MW				Kumar, Anuradha; Zhang, Meng; Zhu, Linyun; Liao, Reiling P.; Mutai, Charles; Hafsat, Shittu; Sherman, David R.; Wang, Ming-Wei			High-throughput Screening and Sensitized Bacteria Identify an M. tuberculosis Dihydrofolate Reductase Inhibitor with Whole Cell Activity	PLOS ONE			English	Article							EXPRESSION; TARGETS; DESIGN; DNA	Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, is a bacterial pathogen that claims roughly 1.4 million lives every year. Current drug regimens are inefficient at clearing infection, requiring at least 6 months of chemotherapy, and resistance to existing agents is rising. There is an urgent need for new drugs that are more effective and faster acting. The folate pathway has been successfully targeted in other pathogens and diseases, but has not yielded a lead drug against tuberculosis. We developed a high-throughput screening assay against Mtb dihydrofolate reductase (DHFR), a critical enzyme in the folate pathway, and screened a library consisting of 32,000 synthetic and natural product-derived compounds. One potent inhibitor containing a quinazoline ring was identified. This compound was active against the wildtype laboratory strain H37Rv (MIC99 = 207 mu M). In addition, an Mtb strain with artificially lowered DHFR levels showed increased sensitivity to this compound (MIC99 = 70.7 mu M), supporting that the inhibition was target-specific. Our results demonstrate the potential to identify Mtb DHFR inhibitors with activity against whole cells, and indicate the power of using a recombinant strain of Mtb expressing lower levels of DHFR to facilitate the discovery of antimycobacterial agents. With these new tools, we highlight the folate pathway as a potential target for new drugs to combat the tuberculosis epidemic.	[Kumar, Anuradha; Liao, Reiling P.; Sherman, David R.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Zhang, Meng; Zhu, Linyun; Mutai, Charles; Hafsat, Shittu; Wang, Ming-Wei] Chinese Acad Sci, Natl Ctr Drug Screening, Shanghai, Peoples R China; [Zhang, Meng; Zhu, Linyun; Mutai, Charles; Hafsat, Shittu; Wang, Ming-Wei] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China	Center for Infectious Disease Research; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Kumar, A (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	david.sherman@seattlebiomed.org; wangmw@mail.shcnc.ac.cn	Mutai, Prof. Charles/GNH-5259-2022; Mutai, Prof. Charles/AAP-1084-2021	Mutai, Prof. Charles/0000-0002-9354-006X	World Health Organization [A80533]; Ministry of Science and Technology of China [2009ZX09302-001, 2010DFB73280, 2012ZX09304-011]; Novo Nordisk-CAS Research Fund; Paul G. Allen Family Foundation	World Health Organization(World Health Organization); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Novo Nordisk-CAS Research Fund; Paul G. Allen Family Foundation	This study was supported in part by grants from World Health Organization (A80533), the Ministry of Science and Technology of China (2009ZX09302-001, 2010DFB73280 and 2012ZX09304-011), Novo Nordisk-CAS Research Fund, and the Paul G. Allen Family Foundation. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	[Anonymous], 2011, 2011 TB ALL ANN REP; Argyrou A, 2006, NAT STRUCT MOL BIOL, V13, P408, DOI 10.1038/nsmb1089; BUSHBY SRM, 1968, BRIT J PHARMACOL, V33, P72, DOI 10.1111/j.1476-5381.1968.tb00475.x; Dhople AM, 2002, INT J ANTIMICROB AG, V19, P71, DOI 10.1016/S0924-8579(01)00470-8; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; El-Hamamsy MHRI, 2007, BIOORGAN MED CHEM, V15, P4552, DOI 10.1016/j.bmc.2007.04.011; Gangjee A, 2001, BIOORGAN MED CHEM, V9, P2929, DOI 10.1016/S0968-0896(01)00223-1; Gerum AB, 2002, ANTIMICROB AGENTS CH, V46, P3362, DOI 10.1128/AAC.46.11.3362-3369.2002; Hawser S, 2006, BIOCHEM PHARMACOL, V71, P941, DOI 10.1016/j.bcp.2005.10.052; Hitchings G H, 1980, Adv Enzyme Regul, V18, P349, DOI 10.1016/0065-2571(80)90025-4; Kompis IM, 2005, CHEM REV, V105, P593, DOI 10.1021/cr0301144; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Li RB, 2000, J MOL BIOL, V295, P307, DOI 10.1006/jmbi.1999.3328; Nerlich AG, 1997, LANCET, V350, P1404, DOI 10.1016/S0140-6736(05)65185-9; ROSOWSKY A, 1995, ANTIMICROB AGENTS CH, V39, P79, DOI 10.1128/AAC.39.1.79; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Wang F, 2010, ANTIMICROB AGENTS CH, V54, P3776, DOI 10.1128/AAC.00453-10; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Wei JR, 2011, P NATL ACAD SCI USA, V108, P4176, DOI 10.1073/pnas.1018301108; White EL, 2004, FEMS MICROBIOL LETT, V232, P101, DOI 10.1016/S0378-1097(04)00038-2; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; World Health Organization, 2011, GLOB TUB CONTR REP 2; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	25	39	39	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39961	10.1371/journal.pone.0039961	http://dx.doi.org/10.1371/journal.pone.0039961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768185	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100157
J	Podhajska, A; Musso, A; Trancikova, A; Stafa, K; Moser, R; Sonnay, S; Glauser, L; Moore, DJ				Podhajska, Agata; Musso, Alessandra; Trancikova, Alzbeta; Stafa, Klodjan; Moser, Roger; Sonnay, Sarah; Glauser, Liliane; Moore, Darren J.			Common Pathogenic Effects of Missense Mutations in the P-Type ATPase ATP13A2 (PARK9) Associated with Early-Onset Parkinsonism	PLOS ONE			English	Article							KUFOR-RAKEB SYNDROME; ALPHA-SYNUCLEIN; PROTEINS; DISEASE; CELLS; DEGRADATION; HOMEOSTASIS; TRANSPORT	Mutations in the ATP13A2 gene (PARK9) cause autosomal recessive, juvenile-onset Kufor-Rakeb syndrome (KRS), a neurodegenerative disease characterized by parkinsonism. KRS mutations produce truncated forms of ATP13A2 with impaired protein stability resulting in a loss-of-function. Recently, homozygous and heterozygous missense mutations in ATP13A2 have been identified in subjects with early-onset parkinsonism. The mechanism(s) by which missense mutations potentially cause parkinsonism are not understood at present. Here, we demonstrate that homozygous F182L, G504R and G877R missense mutations commonly impair the protein stability of ATP13A2 leading to its enhanced degradation by the proteasome. ATP13A2 normally localizes to endosomal and lysosomal membranes in neurons and the F182L and G504R mutations disrupt this vesicular localization and promote the mislocalization of ATP13A2 to the endoplasmic reticulum. Heterozygous T12M, G533R and A746T mutations do not obviously alter protein stability or subcellular localization but instead impair the ATPase activity of microsomal ATP13A2 whereas homozygous missense mutations disrupt the microsomal localization of ATP13A2. The overexpression of ATP13A2 missense mutants in SH-SY5Y neural cells does not compromise cellular viability suggesting that these mutant proteins lack intrinsic toxicity. However, the overexpression of wild-type ATP13A2 may impair neuronal integrity as it causes a trend of reduced neurite outgrowth of primary cortical neurons, whereas the majority of disease-associated missense mutations lack this ability. Finally, ATP13A2 overexpression sensitizes cortical neurons to neurite shortening induced by exposure to cadmium or nickel ions, supporting a functional interaction between ATP13A2 and heavy metals in post-mitotic neurons, whereas missense mutations influence this sensitizing effect. Collectively, our study provides support for common loss-of-function effects of homozygous and heterozygous missense mutations in ATP13A2 associated with early-onset forms of parkinsonism.	[Podhajska, Agata; Musso, Alessandra; Trancikova, Alzbeta; Stafa, Klodjan; Moser, Roger; Sonnay, Sarah; Glauser, Liliane; Moore, Darren J.] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Mol Neurodegenerat Res, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Podhajska, A (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Mol Neurodegenerat Res, CH-1015 Lausanne, Switzerland.	darren.moore@epfl.ch	Trancikova, Alzbeta Kralova/X-7402-2018	Trancikova, Alzbeta Kralova/0000-0002-4743-4952; Moore, Darren/0000-0003-2359-5679	Michael J. Fox Foundation for Parkinson's Research; Swiss National Science Foundation [310030_127478]; Ecole Polytechnique Federale de Lausanne	Michael J. Fox Foundation for Parkinson's Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ecole Polytechnique Federale de Lausanne	This work was supported by funding from the Michael J. Fox Foundation for Parkinson's Research (D. J. M.), Swiss National Science Foundation (grant no. 310030_127478 to D. J. M.), and the Ecole Polytechnique Federale de Lausanne (D. J. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDIN ASN, 1994, ACTA NEUROL SCAND, V89, P347; Behrens MI, 2010, MOVEMENT DISORD, V25, P1929, DOI 10.1002/mds.22996; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Crosiers D, 2011, PARKINSONISM RELAT D, V17, P135, DOI 10.1016/j.parkreldis.2010.10.011; Di Fonzo A, 2007, NEUROLOGY, V68, P1557, DOI 10.1212/01.wnl.0000260963.08711.08; Gasser T, 2009, BBA-MOL BASIS DIS, V1792, P587, DOI 10.1016/j.bbadis.2008.12.007; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Grunewald A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.035; Gusdon AM, 2012, NEUROBIOL DIS, V45, P962, DOI 10.1016/j.nbd.2011.12.015; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Leitch S, 2011, BIOMETALS, V24, P159, DOI 10.1007/s10534-010-9384-3; Lin CH, 2008, NEUROLOGY, V71, P1727, DOI 10.1212/01.wnl.0000335167.72412.68; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Missiaen L, 2004, BIOCHEM BIOPH RES CO, V322, P1204, DOI 10.1016/j.bbrc.2004.07.128; Moore DJ, 2008, J NEUROCHEM, V105, P1806, DOI 10.1111/j.1471-4159.2008.05261.x; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Moore DJ, 2005, HUM MOL GENET, V14, P71, DOI 10.1093/hmg/ddi007; Mukhopadhyay S, 2011, P NATL ACAD SCI USA, V108, P858, DOI 10.1073/pnas.1013642108; Ning YP, 2008, NEUROLOGY, V70, P1491, DOI 10.1212/01.wnl.0000310427.72236.68; Park JS, 2011, HUM MUTAT, V32, P956, DOI 10.1002/humu.21527; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Ramonet D, 2012, HUM MOL GENET, V21, P1725, DOI 10.1093/hmg/ddr606; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; Santoro L, 2011, NEUROGENETICS, V12, P33, DOI 10.1007/s10048-010-0259-0; Schmidt K, 2009, BIOCHEM BIOPH RES CO, V383, P198, DOI 10.1016/j.bbrc.2009.03.151; Schneider SA, 2010, MOVEMENT DISORD, V25, P979, DOI 10.1002/mds.22947; Schultheis PJ, 2004, BIOCHEM BIOPH RES CO, V323, P731, DOI 10.1016/j.bbrc.2004.08.156; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Tan JQ, 2011, J BIOL CHEM, V286, P29654, DOI 10.1074/jbc.M111.233874; Ton VK, 2004, AM J PHYSIOL-CELL PH, V287, pC580, DOI 10.1152/ajpcell.00135.2004; Ugolino J, 2011, HUM MOL GENET, V20, P3565, DOI 10.1093/hmg/ddr274; Usenovic M, 2012, J NEUROSCI, V32, P4240, DOI 10.1523/JNEUROSCI.5575-11.2012; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Williams DR, 2005, MOVEMENT DISORD, V20, P1264, DOI 10.1002/mds.20511	36	40	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39942	10.1371/journal.pone.0039942	http://dx.doi.org/10.1371/journal.pone.0039942			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768177	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100147
J	Tamura, H; Ohgami, N; Yajima, I; Iida, M; Ohgami, K; Fujii, N; Itabe, H; Kusudo, T; Yamashita, H; Kato, M				Tamura, Haruka; Ohgami, Nobutaka; Yajima, Ichiro; Iida, Machiko; Ohgami, Kyoko; Fujii, Noriko; Itabe, Hiroyuki; Kusudo, Tastuya; Yamashita, Hitoshi; Kato, Masashi			Chronic Exposure to Low Frequency Noise at Moderate Levels Causes Impaired Balance in Mice	PLOS ONE			English	Article							OXIDATIVE STRESS; HEARING; BRAIN; CELLS; LIPOPROTEIN; PERFORMANCE; DEPRESSION; AUTOPHAGY	We are routinely exposed to low frequency noise (LFN; below 0.5 kHz) at moderate levels of 60-70 dB sound pressure level (SPL) generated from various sources in occupational and daily environments. LFN has been reported to affect balance in humans. However, there is limited information about the influence of chronic exposure to LFN at moderate levels for balance. In this study, we investigated whether chronic exposure to LFN at a moderate level of 70 dB SPL affects the vestibule, which is one of the organs responsible for balance in mice. Wild-type ICR mice were exposed for 1 month to LFN (0.1 kHz) and high frequency noise (HFN; 16 kHz) at 70 dB SPL at a distance of approximately 10-20 cm. Behavior analyses including rotarod, beam-crossing and footprint analyses showed impairments of balance in LFN-exposed mice but not in non-exposed mice or HFN-exposed mice. Immunohistochemical analysis showed a decreased number of vestibular hair cells and increased levels of oxidative stress in LFN-exposed mice compared to those in non-exposed mice. Our results suggest that chronic exposure to LFN at moderate levels causes impaired balance involving morphological impairments of the vestibule with enhanced levels of oxidative stress. Thus, the results of this study indicate the importance of considering the risk of chronic exposure to LFN at a moderate level for imbalance.	[Tamura, Haruka; Ohgami, Nobutaka; Yajima, Ichiro; Iida, Machiko; Ohgami, Kyoko; Kato, Masashi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Unit Environm Hlth Sci, Kasugai, Aichi 487, Japan; [Fujii, Noriko] Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 59004, Japan; [Itabe, Hiroyuki] Showa Univ, Sch Pharm, Dept Biol Chem, Shinagawa Ku, Tokyo, Japan; [Kusudo, Tastuya; Yamashita, Hitoshi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Mol Biol Unit, Kasugai, Aichi 487, Japan	Chubu University; Kyoto University; Showa University; Chubu University	Tamura, H (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Unit Environm Hlth Sci, Kasugai, Aichi 487, Japan.	katomasa@isc.chubu.ac.jp	KATO, Masashi/I-7250-2014; YAJIMA, Ichiro/I-7467-2014; Ohgami, Nobutaka/I-4572-2014; 板部板部, 洋之/ABC-7746-2020	Yamashita, Hitoshi/0000-0002-5785-5208	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [19390168, 20406003, 23650241, 18790738]; Center of Excellence (COE) Project; MEXT; Chubu University [S0801055]; Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency; AA Science Platform Program from the Japan Society for the Promotion of Science (JSPS); Mitsui Co., Ltd. [R08-C097]; Tokyo Biochemical Research Foundation (TBRF); Research Foundation from the Institute of Science and Technology Research in Chubu University; Chubu University	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Center of Excellence (COE) Project; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Chubu University; Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency; AA Science Platform Program from the Japan Society for the Promotion of Science (JSPS); Mitsui Co., Ltd.(Mitsui & Co., LTD.); Tokyo Biochemical Research Foundation (TBRF); Research Foundation from the Institute of Science and Technology Research in Chubu University; Chubu University	This study was supported in part by Grants-in-Aid for Scientific Research (B) (No. 19390168 and 20406003), Grant-in-Aid for Challenging Exploratory Research (No. 23650241), Grants-in-Aid for Young Scientists (B) (No. 18790738) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Center of Excellence (COE) Project (Health Science Hills) for Private Universities form MEXT and Chubu University (No. S0801055), Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency, AA Science Platform Program from the Japan Society for the Promotion of Science (JSPS), Mitsui & Co., Ltd. Environment Fund (No. R08-C097), Research Grant from the Tokyo Biochemical Research Foundation (TBRF), Research Foundation from the Institute of Science and Technology Research in Chubu University and Chubu University grants A, B and CG. The authors also declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akishima Y, 2005, MODERN PATHOL, V18, P365, DOI 10.1038/modpathol.3800249; Al Deeb S, 2000, NEUROTOXICOL TERATOL, V22, P213, DOI 10.1016/S0892-0362(99)00075-6; Bartolami S, 2011, J NEUROSCI, V31, P16541, DOI 10.1523/JNEUROSCI.2430-11.2011; DANIELSSON A, 1985, ACTA MED SCAND, V217, P531; Doroshenko PN, 1983, NOISE VIBRATION  NOV, P192; DOUGHERTY JD, 1966, NEW ENGL J MED, V275, P759, DOI 10.1056/NEJM196610062751405; Fujii N, 2002, BIOCHEM BIOPH RES CO, V294, P1047, DOI 10.1016/S0006-291X(02)00597-1; Gerhardt KJ, 1996, SEMIN PERINATOL, V20, P11, DOI 10.1016/S0146-0005(96)80053-X; Guthrie OW, 2008, TOXICOLOGY, V249, P91, DOI 10.1016/j.tox.2008.04.015; Heffner HE, 2007, J AM ASSOC LAB ANIM, V46, P20; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Ising Hartmut, 2002, Noise Health, V4, P13; ITABE H, 1994, J BIOL CHEM, V269, P15274; Karpova N., 1970, NOISE VIBRATION B, V11, P100; Kaur G, 2002, BRAIN RES, V943, P206, DOI 10.1016/S0006-8993(02)02624-0; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Kuo AD, 2010, PHYS THER, V90, P157, DOI 10.2522/ptj.20090125; Lalwani A. K., 2008, CURRENT DIAGNOSIS TR, P683; Landstrom U, 1983, J LOW FREQ NOISE VIB, V2, P1; Leventhall Geoff, 2003, REV PUBLISHED RES LO; Marino G, 2010, J CLIN INVEST, V120, P2331, DOI 10.1172/JCI42601; Matsumura BA, 2006, CLIN GERIATR MED, V22, P395, DOI 10.1016/j.cger.2005.12.007; Miller LJ, 2009, WOMENS HEALTH, V5, P577, DOI 10.2217/WHE.09.44; Ohgami N, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.04.002; Ohgami N, 2011, TOXICOL IND HEALTH, V27, P143, DOI 10.1177/0748233710382539; Ohgami N, 2010, P NATL ACAD SCI USA, V107, P13051, DOI 10.1073/pnas.1004520107; Patel RS, 2012, TOXICOLOGY, V293, P41, DOI 10.1016/j.tox.2011.12.005; Pei ZH, 2007, ENVIRON TOXICOL, V22, P169, DOI 10.1002/tox.20244; Pienkowski M, 2012, EAR HEAR IN PRESS; Prasher D, 2009, NOISE HEALTH, V11, P141, DOI 10.4103/1463-1741.53358; PRIEVE BA, 1984, ACTA OTO-LARYNGOL, V98, P428, DOI 10.3109/00016488409107584; ROTHENBERG SJ, 1994, NEUROTOXICOLOGY, V15, P695; Samson J, 2007, NEUROSCI RES, V57, P143, DOI 10.1016/j.neures.2006.09.019; Samson J, 2007, NEUROTOXICOLOGY, V28, P679, DOI 10.1016/j.neuro.2007.02.011; Schust M, 2004, Noise Health, V6, P73; Takigawa H., 1988, Journal of Low Frequency Noise & Vibration, V7, P66; Wallenius MA, 2004, J ENVIRON PSYCHOL, V24, P167, DOI 10.1016/j.jenvp.2003.12.002; Waye KP, 2002, LIFE SCI, V70, P745, DOI 10.1016/S0024-3205(01)01450-3; Wijayanto Titis, 2009, Journal of Physiological Anthropology, V28, P253, DOI 10.2114/jpa2.28.253; Yamauchi Daisuke, 2010, BMC Physiology, V10, P1, DOI 10.1186/1472-6793-10-1; Zakon H, 1998, J NEUROSCI, V18, P2581; Zhao X, 2008, NEUROSCIENCE, V153, P289, DOI 10.1016/j.neuroscience.2008.01.055	42	38	39	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39807	10.1371/journal.pone.0039807	http://dx.doi.org/10.1371/journal.pone.0039807			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768129	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100099
J	Lee, KM; Ahn, KH; Keller, EL				Lee, Kyoung-Min; Ahn, Kyung-Ha; Keller, Edward L.			Saccade Generation by the Frontal Eye Fields in Rhesus Monkeys Is Separable from Visual Detection and Bottom-Up Attention Shift	PLOS ONE			English	Article							SPATIAL ATTENTION; NEURAL ACTIVITY; MOVEMENTS; INACTIVATION; SEARCH; RESPONSES; SELECTION; NEURONS; LESIONS; CHOICE	The frontal eye fields (FEF), originally identified as an oculomotor cortex, have also been implicated in perceptual functions, such as constructing a visual saliency map and shifting visual attention. Further dissecting the area's role in the transformation from visual input to oculomotor command has been difficult because of spatial confounding between stimuli and responses and consequently between intermediate cognitive processes, such as attention shift and saccade preparation. Here we developed two tasks in which the visual stimulus and the saccade response were dissociated in space (the extended memory-guided saccade task), and bottom-up attention shift and saccade target selection were independent (the four-alternative delayed saccade task). Reversible inactivation of the FEF in rhesus monkeys disrupted, as expected, contralateral memory-guided saccades, but visual detection was demonstrated to be intact at the same field. Moreover, saccade behavior was impaired when a bottom-up shift of attention was not a prerequisite for saccade target selection, indicating that the inactivation effect was independent of the previously reported dysfunctions in bottom-up attention control. These findings underscore the motor aspect of the area's functions, especially in situations where saccades are generated by internal cognitive processes, including visual short-term memory and long-term associative memory.	[Lee, Kyoung-Min; Ahn, Kyung-Ha] Seoul Natl Univ, Dept Neurol, Seoul, South Korea; [Lee, Kyoung-Min; Keller, Edward L.] Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	Seoul National University (SNU); The Smith-Kettlewell Eye Research Institute	Lee, KM (corresponding author), Seoul Natl Univ, Dept Neurol, Seoul, South Korea.	kminlee@snu.ac.kr	Lee, Kyoung Min/J-2775-2012		National Research Foundation of Korea; Korean Government (MEST) (Global Research Network Project) [2008-H00004]; Smith-Kettlewell Eye Research Foundation	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government (MEST) (Global Research Network Project); Smith-Kettlewell Eye Research Foundation	This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (MEST) (Global Research Network Project, 2008-H00004 to KML) and by the Smith-Kettlewell Eye Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; BIZZI E, 1967, SCIENCE, V157, P1588, DOI 10.1126/science.157.3796.1588; BRUCE CJ, 1984, TRENDS NEUROSCI, V7, P436, DOI 10.1016/S0166-2236(84)80149-6; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Buschman TJ, 2009, NEURON, V63, P386, DOI 10.1016/j.neuron.2009.06.020; Deng S.-Y., 1986, ADAPTIVE PROCESSES V, P201; Dias EC, 1995, J NEUROPHYSIOL, V74, P2744, DOI 10.1152/jn.1995.74.6.2744; Dias EC, 1999, J NEUROPHYSIOL, V81, P2191, DOI 10.1152/jn.1999.81.5.2191; Gregoriou GG, 2012, NEURON, V73, P581, DOI 10.1016/j.neuron.2011.12.019; Karnath HO, 2003, NEUROREPORT, V14, P437, DOI 10.1097/01.wnr.0000059778.23521.88; Keller EL, 2008, J NEUROPHYSIOL, V100, P2726, DOI 10.1152/jn.90673.2008; LATTO R, 1971, BRAIN RES, V30, P1, DOI 10.1016/0006-8993(71)90002-3; Lee KM, 2008, J NEUROSCI, V28, P2242, DOI 10.1523/JNEUROSCI.3596-07.2008; Monosov IE, 2009, J NEUROPHYSIOL, V102, P3656, DOI 10.1152/jn.00750.2009; Moore T, 2004, J NEUROPHYSIOL, V91, P152, DOI 10.1152/jn.00741.2002; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; Schiller PH, 1998, NAT NEUROSCI, V1, P248, DOI 10.1038/693; SCHILLER PH, 1979, SCIENCE, V206, P590, DOI 10.1126/science.115091; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Sommer MA, 1997, EXP BRAIN RES, V116, P229, DOI 10.1007/PL00005752; Thompson KG, 2005, PROG BRAIN RES, V147, P251, DOI 10.1016/S0079-6123(04)47019-8; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; Umeno MM, 2001, J NEUROPHYSIOL, V86, P2344, DOI 10.1152/jn.2001.86.5.2344; Wardak C, 2006, J NEUROSCI, V26, P4228, DOI 10.1523/JNEUROSCI.3336-05.2006; WYSZECKI G, 1982, COLOR SCI CONCEPTS M, P164; Zhou HH, 2011, NEURON, V70, P1205, DOI 10.1016/j.neuron.2011.04.032	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39886	10.1371/journal.pone.0039886	http://dx.doi.org/10.1371/journal.pone.0039886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761923	Green Published, gold, Green Submitted			2022-12-27	WOS:000305825800078
J	Dean, ED; Mexas, LM; Capiro, NL; McKeon, JE; DeLong, MR; Pennell, KD; Doorn, JA; Tangpricha, V; Miller, GW; Evatt, ML				Dean, E. Danielle; Mexas, Lydia M.; Capiro, Natalie L.; McKeon, Jeanne E.; DeLong, Mahlon R.; Pennell, Kurt D.; Doorn, Jonathan A.; Tangpricha, Vin; Miller, Gary W.; Evatt, Marian L.			25-Hydroxyvitamin D Depletion Does Not Exacerbate MPTP-Induced Dopamine Neuron Damage in Mice	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; D-RECEPTOR GENE; PARKINSONS-DISEASE; 1,25-DIHYDROXYVITAMIN D-3; HIGH PREVALENCE; ANIMAL-MODEL; ADULT-RAT; D HORMONE; EXPRESSION; BRAIN	Recent clinical evidence supports a link between 25-hydroxyvitamin D insufficiency (serum 25-hydroxyvitamin D [25(OH)D] levels <30 ng/mL) and Parkinson's disease. To investigate the effect of 25(OH)D depletion on neuronal susceptibility to toxic insult, we induced a state of 25(OH)D deficiency in mice and then challenged them with the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). We found there was no significant difference between control and 25(OH)D-deficient animals in striatal dopamine levels or dopamine transporter and tyrosine hydroxylase expression after lesioning with MPTP. Additionally, we found no difference in tyrosine hydroxylase expression in the substantia nigra pars compacta. Our data suggest that reducing 25(OH)D serum levels in mice has no effect on the vulnerability of nigral dopaminergic neurons in vivo in this model system of parkinsonism.	[Dean, E. Danielle; Miller, Gary W.] Emory Univ, Dept Environm Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Dean, E. Danielle; DeLong, Mahlon R.; Miller, Gary W.; Evatt, Marian L.] Emory Univ, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Mexas, Lydia M.; Doorn, Jonathan A.] Univ Iowa, Coll Pharm, Div Med & Nat Prod Chem, Iowa City, IA 52242 USA; [Capiro, Natalie L.; Pennell, Kurt D.] Tufts Univ, Dept Civil & Environm Engn, Medford, MA 02155 USA; [McKeon, Jeanne E.; DeLong, Mahlon R.] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [DeLong, Mahlon R.; Evatt, Marian L.] Dept Vet Affairs Med Ctr, Neurol Serv, Atlanta Vet Adm, Atlanta, GA USA; [Tangpricha, Vin] Dept Vet Affairs Med Ctr, Serv Endocrinol, Atlanta Vet Adm, Atlanta, GA USA; [Tangpricha, Vin] Emory Univ, Dept Med, Div Endocrinol Diabet & Lipids, Atlanta, GA 30322 USA; [Evatt, Marian L.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Evatt, Marian L.] Emory Univ, Div Movement Disorders, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; Emory University; University of Iowa; Tufts University; Emory University; Emory University; Emory University; Emory University	Dean, ED (corresponding author), Vanderbilt Univ, Med Ctr, Div Diabet Endocrinol & Metab, Nashville, TN 37203 USA.	mevatt@emory.edu	Capiro, Natalie/G-5955-2010; Pennell, Kurt/ABD-8337-2020; Tangpricha, Vin/A-8645-2009; Pennell, Kurt D/F-6862-2010	Capiro, Natalie/0000-0002-8125-1658; Tangpricha, Vin/0000-0002-4021-5853; Pennell, Kurt D/0000-0002-5788-6397; Miller, Gary/0000-0001-8984-1284	Atlanta Veterans Affairs Medical Center; National Institutes of Health [P01 ES 016731, T32 ES 012870, K23 AR054334]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR054334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016731, T32ES012870] Funding Source: NIH RePORTER	Atlanta Veterans Affairs Medical Center(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This material is the result of work supported with resources and the use of facilities at the Atlanta Veterans Affairs Medical Center. Drs. Evatt and Tangpricha receive salary support from Atlanta Veterans Affairs Medical Center. This study was funded by grants from the National Institutes of Health (P01 ES 016731 and T32 ES 012870). Dr. Tangpricha is supported by grant K23 AR054334 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.	BALLARD PA, 1985, NEUROLOGY, V35, P949, DOI 10.1212/WNL.35.7.949; Brewer LD, 2001, J NEUROSCI, V21, P98, DOI 10.1523/JNEUROSCI.21-01-00098.2001; Butler MW, 2011, ANN HUM GENET, V75, P201, DOI 10.1111/j.1469-1809.2010.00631.x; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Cekic M, 2009, FRONT NEUROENDOCRIN, V30, P158, DOI 10.1016/j.yfrne.2009.04.002; Chesselet MF, 2008, EXP NEUROL, V209, P22, DOI 10.1016/j.expneurol.2007.08.006; Evatt ML, 2008, ARCH NEUROL-CHICAGO, V65, P1348, DOI 10.1001/archneur.65.10.1348; Evatt ML, 2011, ARCH NEUROL-CHICAGO, V68, P314, DOI 10.1001/archneurol.2011.30; Evatt ML, 2010, ARCH NEUROL-CHICAGO, V67, P795, DOI 10.1001/archneurol.2010.123; Eyles D.W., 2009, PSYCHNEURO S1, V34, pS247, DOI [10.1016/B978-0-12-381978-9.10032-0, DOI 10.1016/J.PSYNEUEN.2009.04.015]; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Guillot TS, 2008, J MOTOR BEHAV, V40, P568, DOI 10.3200/JMBR.40.6.568-577; Hindle JV, 2010, AGE AGEING, V39, P156, DOI 10.1093/ageing/afp223; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; Kesby JP, 2006, BIOL PSYCHIAT, V60, P591, DOI 10.1016/j.biopsych.2006.02.033; Kesby JP, 2010, PSYCHOPHARMACOLOGY, V208, P159, DOI 10.1007/s00213-009-1717-y; Kim JS, 2005, J KOREAN MED SCI, V20, P495, DOI 10.3346/jkms.2005.20.3.495; Knekt P, 2010, ARCH NEUROL-CHICAGO, V67, P808, DOI 10.1001/archneurol.2010.120; Lim LS, 2005, AGE AGEING, V34, P504, DOI 10.1093/ageing/afi133; Lin AMY, 2005, ANN NY ACAD SCI, V1053, P319, DOI 10.1196/annals.1344.028; Masoumi A, 2009, J ALZHEIMERS DIS, V17, P703, DOI 10.3233/JAD-2009-1080; Miller GW, 1997, ANN NEUROL, V41, P530, DOI 10.1002/ana.410410417; Misharin A, 2009, ENDOCRINOLOGY, V150, P1051, DOI 10.1210/en.2008-1191; Mooslehner KA, 2001, MOL CELL BIOL, V21, P5321, DOI 10.1128/MCB.21.16.5321-5331.2001; Newmark HL, 2007, MOVEMENT DISORD, V22, P461, DOI 10.1002/mds.21317; Richardson JR, 2008, NEUROTOXICOLOGY, V29, P855, DOI 10.1016/j.neuro.2008.05.007; Richardson JR, 2006, FASEB J, V20, P1695, DOI 10.1096/fj.06-5864fje; Sanchez B, 2009, J NEUROSCI RES, V87, P723, DOI 10.1002/jnr.21878; Sato Y, 2005, MOVEMENT DISORD, V20, P1598, DOI 10.1002/mds.20658; Sato Y, 1997, NEUROLOGY, V49, P1273, DOI 10.1212/WNL.49.5.1273; Shinpo K, 2000, J NEUROSCI RES, V62, P374, DOI 10.1002/1097-4547(20001101)62:3<374::AID-JNR7>3.0.CO;2-7; Solomon JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029354; Spach KM, 2005, J IMMUNOL, V175, P4119, DOI 10.4049/jimmunol.175.6.4119; Tangpricha V, 2005, J NUTR, V135, P2350, DOI 10.1093/jn/135.10.2350; Tekes K, 2009, HORM METAB RES, V41, P277, DOI 10.1055/s-0028-1103287; Tekes K, 2009, BRAIN DEV-JPN, V31, P666, DOI 10.1016/j.braindev.2008.10.007; Tillerson JL, 2002, EXP NEUROL, V178, P80, DOI 10.1006/exnr.2002.8021; Wang JY, 2001, BRAIN RES, V904, P67, DOI 10.1016/S0006-8993(01)02450-7; Wergeland S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026262; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6	40	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39227	10.1371/journal.pone.0039227	http://dx.doi.org/10.1371/journal.pone.0039227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768297	Green Published, gold, Green Submitted			2022-12-27	WOS:000305966500010
J	Kroes, T; Post, FH; Botha, CP				Kroes, Thomas; Post, Frits H.; Botha, Charl P.			Exposure Render: An Interactive Photo-Realistic Volume Rendering Framework	PLOS ONE			English	Article							OCCLUSION SHADING MODEL; AMBIENT OCCLUSION; ILLUMINATION	The field of volume visualization has undergone rapid development during the past years, both due to advances in suitable computing hardware and due to the increasing availability of large volume datasets. Recent work has focused on increasing the visual realism in Direct Volume Rendering (DVR) by integrating a number of visually plausible but often effect-specific rendering techniques, for instance modeling of light occlusion and depth of field. Besides yielding more attractive renderings, especially the more realistic lighting has a positive effect on perceptual tasks. Although these new rendering techniques yield impressive results, they exhibit limitations in terms of their exibility and their performance. Monte Carlo ray tracing (MCRT), coupled with physically based light transport, is the de-facto standard for synthesizing highly realistic images in the graphics domain, although usually not from volumetric data. Due to the stochastic sampling of MCRT algorithms, numerous effects can be achieved in a relatively straight-forward fashion. For this reason, we have developed a practical framework that applies MCRT techniques also to direct volume rendering (DVR). With this work, we demonstrate that a host of realistic effects, including physically based lighting, can be simulated in a generic and flexible fashion, leading to interactive DVR with improved realism. In the hope that this improved approach to DVR will see more use in practice, we have made available our framework under a permissive open source license.	[Kroes, Thomas; Post, Frits H.; Botha, Charl P.] Delft Univ Technol, Dept Intelligent Syst, Delft, Netherlands; [Kroes, Thomas] Leiden Univ, Med Ctr, Dept Orthopaed, NL-2300 RA Leiden, Netherlands; [Botha, Charl P.] Leiden Univ, Med Ctr, Dept Radiol, LKEB, NL-2300 RA Leiden, Netherlands	Delft University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kroes, T (corresponding author), Delft Univ Technol, Dept Intelligent Syst, Delft, Netherlands.	t.kroes@tudelft.nl	Botha, Charl P./E-9506-2010		Dutch Technology Foundation project [10812]	Dutch Technology Foundation project	This work was partly supported by the Dutch Technology Foundation project 10812 Novel pre-operative planning and intra-operative guidance system for shoulder replacement surgery. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikhmin M, 2000, COMP GRAPH, P65, DOI 10.1145/344779.344814; Banks DC, 2009, IEEE T VIS COMPUT GR, V15, P1595, DOI 10.1109/TVCG.2009.137; Barsky B, 2003, COMPUTATIONAL SCI IT, P983; Beason K., 2006, P SOC PHOTO-OPT INS, P98; Behrens U, 1998, IEEE SYMPOSIUM ON VOLUME VISUALIZATION, P39, DOI 10.1109/SVV.1998.729583; Blasi P., 1993, Computer Graphics Forum, V12, pC201, DOI 10.1111/1467-8659.1230201; Blinn J F, 1977, ACM SIGGRAPH COMPUTE, V11, P192, DOI DOI 10.1145/563858.563893; Buades A, 2006, IEEE T IMAGE PROCESS, V15, P1499, DOI 10.1109/TIP.2006.871137; Csebfalvi B, 2003, P 14 IEEE VIS 2003 V, P59; Hadwiger M., 2006, P 21 ACM SIGGRAPHEUR, P49, DOI [10.1145/1283900.1283908, DOI 10.1145/1283900.1283908]; Kniss J, 2003, IEEE T VIS COMPUT GR, V9, P150, DOI 10.1109/TVCG.2003.1196003; Kniss J, 2002, IEEE T VIS COMPUT GR, V8, P270, DOI 10.1109/TVCG.2002.1021579; Knuth D.E., 1997, FUNDAMENTAL ALGORITH, VI; Kontkanen J, 2006, MONTE CARLO AND QUASI-MONTE CARLO METHODS 2004, P259, DOI 10.1007/3-540-31186-6_16; Kronander J., 2011, IEEE T VISUALIZATION, V99; Lindemann F., 2010, IEEE EG INT S VOL GR, P101; Lindemann F, 2011, IEEE T VIS COMPUT GR, V17, P1922, DOI 10.1109/TVCG.2011.161; Lokovic T, 2000, COMP GRAPH, P385, DOI 10.1145/344779.344958; MAX N, 1995, IEEE T VIS COMPUT GR, V1, P99, DOI 10.1109/2945.468400; McCool MD, 1999, ACM T GRAPHIC, V18, P171, DOI 10.1145/318009.318015; Mendez-Feliu A, 2009, VISUAL COMPUT, V25, P181, DOI 10.1007/s00371-008-0213-4; Novak J., 2010, P EUROGRAPHICS; Penner E., 2008, P 5 EUR IEEE VGTC C, P57, DOI [10.2312/VG/VG-PBG08/057-064, DOI 10.2312/VG/VG-PBG08/057-064]; Ritschel T., 2007, P EUR, P17; Ropinski T, 2008, COMPUT GRAPH FORUM, V27, P567, DOI 10.1111/j.1467-8659.2008.01154.x; Ropinski T, 2010, IEEE PAC VIS SYMP, P169, DOI 10.1109/PACIFICVIS.2010.5429594; Ropinski T, 2008, WSCG 2008, FULL PAPERS, P17; Salama CR, 2007, PACIFIC GRAPHICS 2007: 15TH PACIFIC CONFERENCE ON COMPUTER GRAPHICS AND APPLICATIONS, P411, DOI 10.1109/PG.2007.27; Schlegel P, 2011, IEEE T VIS COMPUT GR, V17, P1795, DOI 10.1109/TVCG.2011.198; Schott M, 2011, COMPUT GRAPH FORUM, V30, P941, DOI 10.1111/j.1467-8659.2011.01943.x; Schott M, 2009, COMPUT GRAPH FORUM, V28, P855, DOI 10.1111/j.1467-8659.2009.01464.x; Solteszova V, 2010, COMPUT GRAPH FORUM, V29, P883, DOI 10.1111/j.1467-8659.2009.01695.x; Stewart A. J., 2003, P 2003 IEEE S VIS I, P47; Suykens F., 2000, WSCG 2000 C P; Szirmay-Kalos L, 2011, COMPUT GRAPH FORUM, V30, P85, DOI 10.1111/j.1467-8659.2010.01831.x; van Antwerpen D, 2011, P HIGH PERF GRAPH 20; Veach E, 1997, THESIS CITESEER; WANGER LR, 1992, IEEE COMPUT GRAPH, V12, P44, DOI 10.1109/38.135913; Woodcock E, 1965, P C APPL COMP METH R, P557; Wyman C, 2006, IEEE T VIS COMPUT GR, V12, P186, DOI 10.1109/TVCG.2006.33; Xu RF, 2005, IEEE COMPUT GRAPH, V25, P31, DOI 10.1109/MCG.2005.31; Zhukov S., 1998, Rendering Techniques '98. Proceedings of the Eurographics Workshop, P45	42	70	78	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e38586	10.1371/journal.pone.0038586	http://dx.doi.org/10.1371/journal.pone.0038586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768292	gold, Green Published			2022-12-27	WOS:000305966500005
J	Miedel, MT; Graf, NJ; Stephen, KE; Long, OS; Pak, SC; Perlmutter, DH; Silverman, GA; Luke, CJ				Miedel, Mark T.; Graf, Nathan J.; Stephen, Kate E.; Long, Olivia S.; Pak, Stephen C.; Perlmutter, David H.; Silverman, Gary A.; Luke, Cliff J.			A Pro-Cathepsin L Mutant Is a Luminal Substrate for Endoplasmic-Reticulum-Associated Degradation in C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PROTEIN-DEGRADATION; RETRO-TRANSLOCATION; MEMBRANE-PROTEIN; PROTEASOME; ERAD; PROTEOSTASIS; EXPRESSION; DISEASE; EMBRYOGENESIS	Endoplasmic-reticulum associated degradation (ERAD) is a major cellular misfolded protein disposal pathway that is well conserved from yeast to mammals. In yeast, a mutant of carboxypeptidase Y (CPY*) was found to be a luminal ER substrate and has served as a useful marker to help identify modifiers of the ERAD pathway. Due to its ease of genetic manipulation and the ability to conduct a genome wide screen for modifiers of molecular pathways, C. elegans has become one of the preferred metazoans for studying cell biological processes, such as ERAD. However, a marker of ERAD activity comparable to CPY* has not been developed for this model system. We describe a mutant of pro-cathepsin L fused to YFP that no longer targets to the lysosome, but is efficiently eliminated by the ERAD pathway. Using this mutant pro-cathepsin L, we found that components of the mammalian ERAD system that participate in the degradation of ER luminal substrates were conserved in C. elegans. This transgenic line will facilitate high-throughput genetic or pharmacological screens for ERAD modifiers using widefield epifluorescence microscopy.	[Miedel, Mark T.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat Cell Biol & Physiol,UPMC, Pittsburgh, PA 15260 USA; UPMC, Magee Womens Hosp, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Miedel, MT (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat Cell Biol & Physiol,UPMC, Pittsburgh, PA 15260 USA.	cliff.luke@chp.edu	Silverman, Gary/AAJ-1269-2020	Miedel, Mark/0000-0002-0132-6032; Pak, Stephen/0000-0002-8089-3237	National Institutes of Health [F32DK086112, DK0854512, DK076918, DK079806, DK081422]; Hartwell Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076918, R01DK079806, F32DK086112, R01DK081422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (F32DK086112 to MTM, DK0854512 and DK076918 to DHP, DK079806 and DK081422 to GAS) (http://www.nih.gov) and The Hartwell Foundation (http://www.thehartwellfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bhatia SR, 2011, METHOD ENZYMOL, V499, P283, DOI 10.1016/B978-0-12-386471-0.00014-6; Britton C, 2004, J CELL SCI, V117, P5133, DOI 10.1242/jcs.01387; Campbell EM, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-40; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chapman RL, 1997, J BIOL CHEM, V272, P8808, DOI 10.1074/jbc.272.13.8808; Chi Woo, 2006, Development, V133, P3147, DOI 10.1242/dev.02490; Dafforn TR, 1999, J BIOL CHEM, V274, P9548, DOI 10.1074/jbc.274.14.9548; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Davy A, 2001, EMBO REP, V2, P821, DOI 10.1093/embo-reports/kve184; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Gosai SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015460; Hashmi S, 2002, J BIOL CHEM, V277, P3477, DOI 10.1074/jbc.M106117200; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Hiraiwa M, 1999, CELL MOL LIFE SCI, V56, P894, DOI 10.1007/s000180050482; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Ishida Y, 2009, AUTOPHAGY, V5, P1217, DOI 10.4161/auto.5.8.10168; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Khan LA, 2006, J NEUROCHEM, V98, P576, DOI 10.1111/j.1471-4159.2006.03895.x; Kipreos E. T., 2005, WORMBOOK, V1, P24, DOI [10.1895/wormbook.1.36.1, DOI 10.1895/WORMBOOK.1.7.1]; Kreusch S, 2000, EUR J BIOCHEM, V267, P2965; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lipson C, 2008, J BIOL CHEM, V283, P7166, DOI 10.1074/jbc.M705893200; Luke CJ, 2007, CELL, V130, P1108, DOI 10.1016/j.cell.2007.07.013; Mailhes John B, 2002, Cell Chromosome, V1, P2, DOI 10.1186/1475-9268-1-2; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Melendez Alicia, 2009, WormBook, P1, DOI 10.1895/wormbook.1.147.1; Mello C, 1995, METHOD CELL BIOL, V48, P451; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mouysset J, 2006, J STRUCT BIOL, V156, P41, DOI 10.1016/j.jsb.2006.02.015; Naganawa Y, 1999, BIOCHEM J, V340, P467, DOI 10.1042/0264-6021:3400467; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nehrke K, 2002, J BIOL CHEM, V277, P29036, DOI 10.1074/jbc.M203200200; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Roth DM, 2011, CURR OPIN CELL BIOL, V23, P126, DOI 10.1016/j.ceb.2010.11.001; Sasagawa Y, 2007, GENES CELLS, V12, P1063, DOI 10.1111/j.1365-2443.2007.01108.x; Sasagawa Y, 2007, BIOCHEM BIOPH RES CO, V358, P920, DOI 10.1016/j.bbrc.2007.05.022; Schaheen B, 2009, J CELL SCI, V122, P2228, DOI 10.1242/jcs.048892; Segref A, 2011, GENETICS, V187, P1235, DOI 10.1534/genetics.111.126797; Silverman GA, 2009, PEDIATR RES, V65, P10, DOI 10.1203/PDR.0b013e31819009b0; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; TAO K, 1994, ARCH BIOCHEM BIOPHYS, V311, P19, DOI 10.1006/abbi.1994.1203; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Yamamoto M, 2010, BIOCHEM BIOPH RES CO, V393, P384, DOI 10.1016/j.bbrc.2010.02.001; Yamauchi S, 2006, BIOCHEM BIOPH RES CO, V345, P746, DOI 10.1016/j.bbrc.2006.04.160; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	55	33	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40145	10.1371/journal.pone.0040145	http://dx.doi.org/10.1371/journal.pone.0040145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768338	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000305966500051
J	Ahn, HJ; Cha, Y; Moon, SH; Jung, JE; Park, KS				Ahn, Hee-Jin; Cha, Young; Moon, Seok-Ho; Jung, Jee-Eun; Park, Kyung-Soon			Ell3 Enhances Differentiation of Mouse Embryonic Stem Cells by Regulating Epithelial-Mesenchymal Transition and Apoptosis	PLOS ONE			English	Article							DEVELOPMENTAL REGULATORS; EXPRESSION; P53; GENE; IDENTIFICATION; SPECIFICATION; POLYCOMB; MAINTAIN; CANCER; STAT3	Ell3 is a testis-specific RNA polymerase II elongation factor whose cellular function is not clear. The present study shows that Ell3 is activated during the differentiation of mouse embryonic stem cells (mESCs). Furthermore, Ell3 plays a critical role in stimulating lineage differentiation of mESCs by promoting epithelial-mesenchymal transition (EMT) and suppressing apoptosis. Mouse ESCs engineered to stably express Ell3 were rapidly differentiated compared with control cells either under spontaneous differentiation or neural lineage-specific differentiation conditions. Gene expression profile and quantitative RT-PCR analysis showed that the expression of EMT markers, such as Zeb1 and Zeb2, two major genes that regulate EMT, was upregulated in Ell3-overexpressing mESCs. Remarkably, knockdown of Zeb1 attenuated the enhanced differentiation capacity of Ell3-overexpressing mESCs, which indicates that Ell3 plays a role in the induction of mESC differentiation by inducing EMT. In contrast to Ell3-overexpressing mESCs, Ell3-knock down mESCs could not differentiate under differentiation conditions and, instead, underwent caspase-dependent apoptosis. In addition, apoptosis of differentiating Ell3-knock out mESCs was associated with enhanced expression of p53. The present results suggest that Ell3 promotes the differentiation of mESCs by activating the expression of EMT-related genes and by suppressing p53 expression.	[Ahn, Hee-Jin; Cha, Young; Moon, Seok-Ho; Jung, Jee-Eun; Park, Kyung-Soon] CHA Univ, Coll Life Sci, Dept Biomed Sci, Seoul, South Korea	Pochon Cha University	Ahn, HJ (corresponding author), CHA Univ, Coll Life Sci, Dept Biomed Sci, Seoul, South Korea.	kspark@cha.ac.kr	Cha, Young/AAI-3460-2020	Cha, Young/0000-0001-7647-0699	Korea Science and Engineering Foundation (KOSEF) of the Korean government (MOST) [2010-0003254, 2011-0014084]; Ministry of Health Welfare [A091087-0911-0000200]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2009-0093821]	Korea Science and Engineering Foundation (KOSEF) of the Korean government (MOST)(Korea Science and Engineering Foundation); Ministry of Health Welfare; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Korea Science and Engineering Foundation (KOSEF) of the Korean government (MOST) (2010-0003254, 2011-0014084) and Korea Health Technology R&D project, Ministry of Health & Welfare (A091087-0911-0000200). This work was also supported by Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0093821). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cha Y, FEBS LETT, V584, P4241; Cha Y, 2010, STEM CELLS, V28, P1476, DOI 10.1002/stem.470; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Guo Y, 2008, STEM CELLS, V26, P30, DOI 10.1634/stemcells.2007-0401; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Jirmanova L, 2002, ONCOGENE, V21, P5515, DOI 10.1038/sj.onc.1205728; Johnstone RW, 2001, MOL CELL BIOL, V21, P1672, DOI 10.1128/MCB.21.5.1672-1681.2001; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kim NH, 2011, J CELL BIOL, V195, P417, DOI 10.1083/jcb.201103097; Lee KH, 2010, P NATL ACAD SCI USA, V107, P69, DOI 10.1073/pnas.0909734107; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li XA, 2011, CELL STEM CELL, V8, P46, DOI 10.1016/j.stem.2010.11.027; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Miller T, 2000, J BIOL CHEM, V275, P32052, DOI 10.1074/jbc.M005175200; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Sabapathy K, 1997, EMBO J, V16, P6217, DOI 10.1093/emboj/16.20.6217; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Shinobu N, 1999, J BIOL CHEM, V274, P17003, DOI 10.1074/jbc.274.24.17003; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Solozobova V, 2010, EXP CELL RES, V316, P2434, DOI 10.1016/j.yexcr.2010.06.006; Tanaka H, NAT MED, V16, P1414; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yamada Y, CELL STEM CELL, V6, P10; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoon SJ, 2005, FERTIL STERIL, V83, P1293, DOI 10.1016/j.fertnstert.2004.09.037	34	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40293	10.1371/journal.pone.0040293	http://dx.doi.org/10.1371/journal.pone.0040293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768269	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100243
J	Bakst, RL; Lee, N; He, SB; Chernichenko, N; Chen, CH; Linkov, G; Le, HC; Koutcher, J; Vakiani, E; Wong, RJ				Bakst, Richard L.; Lee, Nancy; He, Shuangba; Chernichenko, Natalya; Chen, Chun-Hao; Linkov, Gary; Le, H. Carl; Koutcher, Jason; Vakiani, Efsevia; Wong, Richard J.			Radiation Impairs Perineural Invasion by Modulating the Nerve Microenvironment	PLOS ONE			English	Article							ADENOID CYSTIC CARCINOMA; SQUAMOUS-CELL CARCINOMA; NEUROTROPHIC FACTOR; PANCREATIC-CANCER; PROSTATE-CANCER; RET PROTOONCOGENE; SALIVARY-GLANDS; AXON GUIDANCE; HEAD; NECK	Purpose: Perineural invasion (PNI) by cancer cells is an ominous clinical event that is associated with increased local recurrence and poor prognosis. Although radiation therapy (RT) may be delivered along the course of an invaded nerve, the mechanisms through which radiation may potentially control PNI remain undefined. Experimental Design: An in vitro co-culture system of dorsal root ganglia (DRG) and pancreatic cancer cells was used as a model of PNI. An in vivo murine sciatic nerve model was used to study how RT to nerve or cancer affects nerve invasion by cancer. Results: Cancer cell invasion of the DRG was partially dependent on DRG secretion of glial-derived neurotrophic factor (GDNF). A single 4 Gy dose of radiation to the DRG alone, cultured with non-radiated cancer cells, significantly inhibited PNI and was associated with decreased GDNF secretion but intact DRG viability. Radiation of cancer cells alone, co-cultured with non-radiated nerves, inhibited PNI through predominantly compromised cancer cell viability. In a murine model of PNI, a single 8 Gy dose of radiation to the sciatic nerve prior to implantation of non-radiated cancer cells resulted in decreased GDNF expression, decreased PNI by imaging and histology, and preservation of sciatic nerve motor function. Conclusions: Radiation may impair PNI through not only direct effects on cancer cell viability, but also an independent interruption of paracrine mechanisms underlying PNI. RT modulation of the nerve microenvironment may decrease PNI, and hold significant therapeutic implications for RT dosing and field design for patients with cancers exhibiting PNI.	[Bakst, Richard L.; Lee, Nancy] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; [He, Shuangba; Chernichenko, Natalya; Chen, Chun-Hao; Linkov, Gary; Wong, Richard J.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Le, H. Carl; Koutcher, Jason] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Koutcher, Jason] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Vakiani, Efsevia] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Bakst, RL (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA.	wongr@mskcc.org		He, Shuangba/0000-0002-5171-8819; Linkov, Gary/0000-0001-8584-5851	National Cancer Institute from National Institutes of Health [1R01CA157686-01]; NATIONAL CANCER INSTITUTE [R01CA157686, T32CA009685] Funding Source: NIH RePORTER	National Cancer Institute from National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Richard J. Wong is funded by National Cancer Institute, from the National Institutes of Health grant no. 1R01CA157686-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERT K, 1976, CELL TISSUE RES, V165, P281; Ayala GE, 2001, PROSTATE, V49, P213, DOI 10.1002/pros.1137; Bapat AA, 2011, NAT REV CANCER, V11, P695, DOI 10.1038/nrc3131; Batchelor PE, 1999, J NEUROSCI, V19, P1708; BATSAKIS JG, 1985, ANN OTO RHINOL LARYN, V94, P426; Chedotal A, 2005, CELL DEATH DIFFER, V12, P1044, DOI 10.1038/sj.cdd.4401707; Chen AM, 2007, INT J RADIAT ONCOL, V67, P982, DOI 10.1016/j.ijrobp.2006.10.043; Chilton JK, 2006, DEV BIOL, V292, P13, DOI 10.1016/j.ydbio.2005.12.048; Cornell RJ, 2003, UROLOGY, V61, P870, DOI 10.1016/S0090-4295(02)02426-3; Dawson DM, 1998, J NATL CANCER I, V90, P519, DOI 10.1093/jnci/90.7.519; Fagan JJ, 1998, ARCH OTOLARYNGOL, V124, P637, DOI 10.1001/archotol.124.6.637; GARDEN AS, 1995, INT J RADIAT ONCOL, V32, P619, DOI 10.1016/0360-3016(95)00122-F; GARDEN AS, 1994, CANCER, V73, P2563, DOI 10.1002/1097-0142(19940515)73:10<2563::AID-CNCR2820731018>3.0.CO;2-X; Gil Z, 2010, J NATL CANCER I, V102, P107, DOI 10.1093/jnci/djp456; GOEPFERT H, 1984, AM J SURG, V148, P542, DOI 10.1016/0002-9610(84)90385-4; Gomez DR, 2008, INT J RADIAT ONCOL, V70, P1365, DOI 10.1016/j.ijrobp.2007.08.008; Ito Y, 2005, SURGERY, V138, P788, DOI 10.1016/j.surg.2005.07.007; LARSON DL, 1966, AM J SURG, V112, P488, DOI 10.1016/0002-9610(66)90309-6; Liebig C, 2009, CANCER-AM CANCER SOC, V115, P3379, DOI 10.1002/cncr.24396; Okada Y, 1999, INT J CANCER, V81, P67, DOI 10.1002/(SICI)1097-0215(19990331)81:1<67::AID-IJC13>3.0.CO;2-V; Sawai H, 2005, CANCER RES, V65, P11536, DOI 10.1158/0008-5472.CAN-05-2843; Singh B, 2001, CANCER RES, V61, P4506; SOO KC, 1986, LARYNGOSCOPE, V96, P1145; Walsh GS, 2004, J NEUROSCI, V24, P9638, DOI 10.1523/JNEUROSCI.1299-04.2004	24	38	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39925	10.1371/journal.pone.0039925	http://dx.doi.org/10.1371/journal.pone.0039925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768171	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100141
J	Botha, H; Ackerman, C; Candy, S; Carr, JA; Griffith-Richards, S; Bateman, KJ				Botha, Hugo; Ackerman, Christelle; Candy, Sally; Carr, Jonathan A.; Griffith-Richards, Stephanie; Bateman, Kathleen J.			Reliability and Diagnostic Performance of CT Imaging Criteria in the Diagnosis of Tuberculous Meningitis	PLOS ONE			English	Article							PREDICTORS; ENHANCEMENT; PREVALENCE; FEATURES; CHILDREN	Introduction: Abnormalities on CT imaging may contribute to the diagnosis of tuberculous meningitis (TBM). Recently, an expert consensus case definition (CCD) and set of imaging criteria for diagnosing basal meningeal enhancement (BME) have been proposed. This study aimed to evaluate the sensitivity, specificity and reliability of these in a prospective cohort of adult meningitis patients. Methods: Initial diagnoses were based on the CCD, classifying patients into: 'Definite TBM' (microbiological confirmation), 'Probable TBM' (diagnostic score >= 10), 'Possible TBM' (diagnostic score 6-9), 'Not TBM' (confirmation of an alternative diagnosis) or 'Uncertain' (diagnostic score of,6). CT images were evaluated independently on two occasions by four experienced reviewers. Intra-rater and inter-rater agreement were calculated using the kappa statistic. Sensitivities and specificities were calculated using both 'Definite TBM' and either 'Definite TBM' or 'Probable TBM' as gold standards. Results: CT scan criteria for BME had good intra-rater agreement (kappa range 0.35-0.78) and fair to moderate inter-rater agreement (kappa range 0.20-0.52). Intra-and inter-rater agreement on the CCD components were good to fair (kappa = ranges 0.47-0.81 and 0.21-0.63). Using 'Definite TBM' as a gold standard, the criteria for BME were very specific (61.5%-100%), but insensitive (5.9%-29.4%). Similarly, the imaging components of the CCD were highly specific (69.2-100%) but lacked sensitivity (0-56.7%). Similar values were found when using 'Definite TBM' or 'Probable TBM' as a gold standard. Discussion: The fair to moderate inter-rater agreement and poor sensitivities of the criteria for BME suggest that little reliance should be placed in these features in isolation. While the presence of the CCD criteria of acute infarction or tuberculoma(s) appears useful as rule-in criteria, their absence is of little help in excluding TBM. The CCD and criteria for BME, as well as any new criteria, need to be standardized and validated in prospective cohort studies.	[Botha, Hugo; Carr, Jonathan A.; Bateman, Kathleen J.] Univ Stellenbosch, Tygerberg Hosp, Div Neurol, Cape Town, Western Cape, South Africa; [Ackerman, Christelle; Griffith-Richards, Stephanie] Univ Stellenbosch, Tygerberg Hosp, Dept Radiodiagnost, Cape Town, Western Cape, South Africa; [Candy, Sally] Univ Cape Town, Groote Schuur Hosp, Dept Radiol, ZA-7925 Cape Town, Western Cape, South Africa	Stellenbosch University; Tygerberg Hospital; Stellenbosch University; Tygerberg Hospital; University of Cape Town	Botha, H (corresponding author), Univ Stellenbosch, Tygerberg Hosp, Div Neurol, Cape Town, Western Cape, South Africa.	kathbateman@gmail.com	Botha, Hugo/W-2909-2019	Botha, Hugo/0000-0003-4390-685X; Carr, Jonathan/0000-0002-7677-426X; Bateman, Kathleen/0000-0002-0213-7102	Discovery Foundation; College of Neurology of South Africa; University of Stellenbosch	Discovery Foundation; College of Neurology of South Africa; University of Stellenbosch	KB received funding from the Discovery Foundation (Academic Fellowship Award; http://www.discovery.co.za/portal/loggedout-individual/discovery-community-about), College of Neurology of South Africa (K. M. Browse Award; http://www.collegemedsa.ac.za/Default.aspx) and the University of Stellenbosch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1; Altman D.G., 1991, PRACTICAL STATISTIC; Andronikou S, 2004, PEDIATR RADIOL, V34, P876, DOI 10.1007/s00247-004-1237-1; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; Chapp-Jumbo Emmanuel N, 2006, Afr Health Sci, V6, P55; Christensen ASH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-47; DUNN G, 1992, DESIGN ANAL RELIABIL; Hosoglu S, 2002, INT J TUBERC LUNG D, V6, P64; Jarvis JN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-67; Kalita J, 2007, EUR J NEUROL, V14, P33, DOI 10.1111/j.1468-1331.2006.01534.x; Katrak SM, 2000, J NEUROL SCI, V181, P118, DOI 10.1016/S0022-510X(00)00440-8; Kumar R, 1996, Indian Pediatr, V33, P465; Marais S, 2010, LANCET INFECT DIS, V3099, P1; Marais S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020077; Ozates M, 2000, ACTA RADIOL, V41, P13; Przybojewski S, 2006, PEDIATR RADIOL, V36, P687, DOI 10.1007/s00247-006-0160-z; Reichenheim ME, 2004, STATA J, P2004; Sheu JJ, 2009, AM J MED SCI, V338, P134, DOI 10.1097/MAJ.0b013e3181a590f1; Theron S, 2006, PEDIATR RADIOL, V36, P1182, DOI 10.1007/s00247-006-0312-1; Thwaites GE, 2004, J CLIN MICROBIOL, V42, P378, DOI 10.1128/JCM.42.1.378-379.2004; Thwaites GE, 2005, LANCET NEUROL, V4, P160, DOI 10.1016/S1474-4422(05)01013-6; Thwaites GE, 2002, LANCET, V360, P1287, DOI 10.1016/S0140-6736(02)11318-3; Thwaites G, 2009, J INFECTION, V59, P167, DOI 10.1016/j.jinf.2009.06.011; Thwaites GE, 2009, CLIN CHEST MED, V30, P745, DOI 10.1016/j.ccm.2009.08.018; Torok ME, 2007, AM J TROP MED HYG, V77, P555, DOI 10.4269/ajtmh.2007.77.555	25	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38982	10.1371/journal.pone.0038982	http://dx.doi.org/10.1371/journal.pone.0038982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768055	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100025
J	Champiat, S; Raposo, RAS; Maness, NJ; Lehman, JL; Purtell, SE; Hasenkrug, AM; Miller, JC; Dean, H; Koff, WC; Hong, MA; Martin, JN; Deeks, SG; Spotts, GE; Pilcher, CD; Hecht, FM; Kallas, EG; Garrison, KE; Nixon, DF				Champiat, Stephane; Raposo, Rui Andre Saraiva; Maness, Nicholas J.; Lehman, John L.; Purtell, Sean E.; Hasenkrug, Aaron M.; Miller, Jacob C.; Dean, Hansi; Koff, Wayne C.; Hong, Marisa Ailin; Martin, Jeffrey N.; Deeks, Steven G.; Spotts, Gerald E.; Pilcher, Christopher D.; Hecht, Fredrick M.; Kallas, Esper G.; Garrison, Keith E.; Nixon, Douglas F.			Influence of HAART on Alternative Reading Frame Immune Responses over the Course of HIV-1 Infection	PLOS ONE			English	Article							T-CELL RESPONSES; VIRUS TYPE-1 PROTEASE; VIRAL LOAD; CTL EPITOPES; TRANSLATION INITIATION; SELECTION PRESSURE; SUBTYPE-C; LYMPHOCYTES; GENE; RNA	Background: Translational errors can result in bypassing of the main viral protein reading frames and the production of alternate reading frame (ARF) or cryptic peptides. Within HIV, there are many such ARFs in both sense and the antisense directions of transcription. These ARFs have the potential to generate immunogenic peptides called cryptic epitopes (CE). Both antiretroviral drug therapy and the immune system exert a mutational pressure on HIV-1. Immune pressure exerted by ARF CD8(+) T cells on the virus has already been observed in vitro. HAART has also been described to select HIV-1 variants for drug escape mutations. Since the mutational pressure exerted on one location of the HIV-1 genome can potentially affect the 3 reading frames, we hypothesized that ARF responses would be affected by this drug pressure in vivo. Methodology/Principal findings: In this study we identified new ARFs derived from sense and antisense transcription of HIV-1. Many of these ARFs are detectable in circulating viral proteins. They are predominantly found in the HIV-1 env nucleotide region. We measured T cell responses to 199 HIV-1 CE encoded within 13 sense and 34 antisense HIV-1 ARFs. We were able to observe that these ARF responses are more frequent and of greater magnitude in chronically infected individuals compared to acutely infected patients, and in patients on HAART, the breadth of ARF responses increased. Conclusions/Significance: These results have implications for vaccine design and unveil the existence of potential new epitopes that could be included as vaccine targets.	[Champiat, Stephane; Raposo, Rui Andre Saraiva; Lehman, John L.; Hasenkrug, Aaron M.; Miller, Jacob C.; Nixon, Douglas F.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA; [Maness, Nicholas J.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Dean, Hansi; Koff, Wayne C.] Int AIDS Vaccine Initiat, New York, NY USA; [Hong, Marisa Ailin; Kallas, Esper G.] Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Hong, Marisa Ailin] Adolfo Lutz Inst, Sao Paulo, Brazil; [Martin, Jeffrey N.] Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA USA; [Deeks, Steven G.; Spotts, Gerald E.; Pilcher, Christopher D.; Hecht, Fredrick M.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Posit Hlth Program, San Francisco, CA USA; [Lehman, John L.; Purtell, Sean E.; Garrison, Keith E.] St Marys Coll Calif, Dept Biol, Moraga, CA USA	University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison; International AIDS Vaccine Initiative; Universidade de Sao Paulo; Instituto Adolfo Lutz; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Saint Mary's College of California	Champiat, S (corresponding author), Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA.	douglas.nixon@ucsf.edu	Nixon, Douglas/AAU-5734-2020; Champiat, Stephane/O-4780-2014	Nixon, Douglas/0000-0002-2801-1786; Raposo, R. Andre/0000-0001-5435-0290; Champiat, Stephane/0000-0002-0741-2118; Hecht, Frederick/0000-0002-5782-1171; Kallas, Esper/0000-0003-2026-6925	International AIDS Vaccine Initiative (IAVI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, K24AI069994] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative (IAVI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by the International AIDS Vaccine Initiative (IAVI), a not for profit organization focused on helping facilitate the discovery of an effective AIDS vaccine. Two scientists from IAVI were involved in the design, analysis and writing of the paper and are included as co-authors. The funders had no role in data collection or decision to publish the manuscript.	Addo MM, 2001, P NATL ACAD SCI USA, V98, P1781, DOI 10.1073/pnas.98.4.1781; Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Altfeld M, 2001, J IMMUNOL, V167, P2743, DOI 10.4049/jimmunol.167.5.2743; Bansal A, 2010, J EXP MED, V207, P51, DOI 10.1084/jem.20092060; Berger CT, 2010, J EXP MED, V207, P61, DOI 10.1084/jem.20091808; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; BRUCE AG, 1986, P NATL ACAD SCI USA, V83, P5062, DOI 10.1073/pnas.83.14.5062; Bullock TNJ, 1996, J EXP MED, V184, P1319, DOI 10.1084/jem.184.4.1319; Bullock TNJ, 1997, J EXP MED, V186, P1051, DOI 10.1084/jem.186.7.1051; Cardinaud S, 2004, J EXP MED, V199, P1053, DOI 10.1084/jem.20031869; FETTEN JV, 1991, J IMMUNOL, V147, P2697; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Garrison KE, 2009, CLIN VACCINE IMMUNOL, V16, P1369, DOI 10.1128/CVI.00410-08; Gatanaga H, 2010, AIDS, V24, pF15, DOI 10.1097/QAD.0b013e328337b010; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Ho O, 2006, J IMMUNOL, V176, P2470, DOI 10.4049/jimmunol.176.4.2470; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; John M, 2005, ANTIVIR THER, V10, P551; Karlsson AC, 2003, J VIROL, V77, P6743, DOI 10.1128/JVI.77.12.6743-6752.2003; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Landry S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-71; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Ludwig LB, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-80; Mahnke Lisa, 2006, AIDS Res Ther, V3, P21, DOI 10.1186/1742-6405-3-21; Malarkannan S, 1999, IMMUNITY, V10, P681, DOI 10.1016/S1074-7613(00)80067-9; Maness NJ, 2007, J EXP MED, V204, P2505, DOI 10.1084/jem.20071261; Maness NJ, 2010, J IMMUNOL, V184, P67, DOI 10.4049/jimmunol.0903118; Maness NJ, 2009, J VIROL, V83, P10280, DOI 10.1128/JVI.00138-09; Manosuthi W, 2010, AIDS, V24, P411, DOI 10.1097/QAD.0b013e3283350eef; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; Mason RA, 2004, J IMMUNOL, V172, P7212, DOI 10.4049/jimmunol.172.11.7212; Mayrand SM, 1998, IMMUNOL TODAY, V19, P551, DOI 10.1016/S0167-5699(98)01342-5; McBratney S, 1993, CURR OPIN CELL BIOL, V5, P961, DOI 10.1016/0955-0674(93)90077-4; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Meiklejohn DA, 2004, J IMMUNOL METHODS, V288, P135, DOI 10.1016/j.jim.2004.03.006; MICHAEL NL, 1994, J VIROL, V68, P979, DOI 10.1128/JVI.68.2.979-987.1994; Mueller SM, 2007, J VIROL, V81, P2887, DOI 10.1128/JVI.01547-06; Mueller SM, 2011, JAIDS-J ACQ IMM DEF, V56, P109, DOI 10.1097/QAI.0b013e3181fe946e; Novitsky V, 2002, J VIROL, V76, P10155, DOI 10.1128/JVI.76.20.10155-10168.2002; Probst-Kepper M, 2001, J EXP MED, V193, P1189, DOI 10.1084/jem.193.10.1189; Rimoldi D, 2000, J IMMUNOL, V165, P7253, DOI 10.4049/jimmunol.165.12.7253; Saeterdal I, 2001, P NATL ACAD SCI USA, V98, P13255, DOI 10.1073/pnas.231326898; Samri A, 2000, J VIROL, V74, P9306, DOI 10.1128/JVI.74.19.9306-9312.2000; Saulquin X, 2002, J EXP MED, V195, P353, DOI 10.1084/jem.20011399; Schmitt M, 2000, AIDS, V14, P653, DOI 10.1097/00002030-200004140-00004; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schwab SR, 2004, PLOS BIOL, V2, P1774, DOI 10.1371/journal.pbio.0020366; Wang RF, 1996, J EXP MED, V183, P1131, DOI 10.1084/jem.183.3.1131; WEISS RB, 1987, COLD SPRING HARB SYM, V52, P687, DOI 10.1101/SQB.1987.052.01.078; Yu XG, 2002, J VIROL, V76, P8690, DOI 10.1128/JVI.76.17.8690-8701.2002	51	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39311	10.1371/journal.pone.0039311	http://dx.doi.org/10.1371/journal.pone.0039311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768072	Green Published, gold			2022-12-27	WOS:000305892100043
J	Kirchhoff, T; Gaudet, MM; Antoniou, AC; McGuffog, L; Humphreys, MK; Dunning, AM; Bojesen, SE; Nordestgaard, BG; Flyger, H; Kang, D; Yoo, KY; Noh, DY; Ahn, SH; Dork, T; Schurmann, P; Karstens, JH; Hillemanns, P; Couch, FJ; Olson, J; Vachon, C; Wang, XS; Cox, A; Brock, I; Elliott, G; Reed, MWR; Burwinkel, B; Meindl, A; Brauch, H; Hamann, U; Ko, YD; Broeks, A; Schmidt, MK; van 't Veer, LJ; Braaf, LM; Johnson, N; Fletcher, O; Gibson, L; Peto, J; Turnbull, C; Seal, S; Renwick, A; Rahman, N; Wu, PE; Yu, JC; Hsiung, CN; Shen, CY; Southey, MC; Hopper, JL; Hammet, F; Van Dorpe, T; Dieudonne, AS; Hatse, S; Lambrechts, D; Andrulis, IL; Bogdanova, N; Antonenkova, N; Rogov, JI; Prokofieva, D; Bermisheva, M; Khusnutdinova, E; van Asperen, CJ; Tollenaar, RAEM; Hooning, MJ; Devilee, P; Margolin, S; Lindblom, A; Milne, RL; Arias, JI; Zamora, MP; Benitez, J; Severi, G; Baglietto, L; Giles, GG; Spurdle, AB; Beesley, J; Chen, XQ; Holland, H; Healey, S; Wang-Gohrke, S; Chang-Claude, J; Mannermaa, A; Kosma, VM; Kauppinen, J; Kataja, V; Agnarsson, BA; Caligo, MA; Godwin, AK; Nevanlinna, H; Heikkinen, T; Fredericksen, Z; Lindor, N; Nathanson, KL; Domchek, SM; Loman, N; Karlsson, P; Askmalm, MS; Melin, B; von Wachenfeldt, A; Hogervorst, FBL; Verheus, M; Rookus, MA; Seynaeve, C; Oldenburg, RA; Ligtenberg, MJ; Ausems, MGEM; Aalfs, CM; Gille, HJP; Wijnen, JT; Garcia, EBG; Peock, S; Cook, M; Oliver, CT; Frost, D; Luccarini, C; Pichert, G; Davidson, R; Chu, C; Eccles, D; Ong, KR; Cook, J; Douglas, F; Hodgson, S; Evans, DG; Eeles, R; Gold, B; Pharoah, PDP; Offit, K; Chenevix-Trench, G; Easton, DF				Kirchhoff, Tomas; Gaudet, Mia M.; Antoniou, Antonis C.; McGuffog, Lesley; Humphreys, Manjeet K.; Dunning, Alison M.; Bojesen, Stig E.; Nordestgaard, Borge G.; Flyger, Henrik; Kang, Daehee; Yoo, Keun-Young; Noh, Dong-Young; Ahn, Sei-Hyun; Dork, Thilo; Schuermann, Peter; Karstens, Johann H.; Hillemanns, Peter; Couch, Fergus J.; Olson, Janet; Vachon, Celine; Wang, Xianshu; Cox, Angela; Brock, Ian; Elliott, Graeme; Reed, Malcolm W. R.; Burwinkel, Barbara; Meindl, Alfons; Brauch, Hiltrud; Hamann, Ute; Ko, Yon-Dschun; Broeks, Annegien; Schmidt, Marjanka K.; Van 't Veer, Laura J.; Braaf, Linde M.; Johnson, Nichola; Fletcher, Olivia; Gibson, Lorna; Peto, Julian; Turnbull, Clare; Seal, Sheila; Renwick, Anthony; Rahman, Nazneen; Wu, Pei-Ei; Yu, Jyh-Cherng; Hsiung, Chia-Ni; Shen, Chen-Yang; Southey, Melissa C.; Hopper, John L.; Hammet, Fleur; Van Dorpe, Thijs; Dieudonne, Anne-Sophie; Hatse, Sigrid; Lambrechts, Diether; Andrulis, Irene L.; Bogdanova, Natalia; Antonenkova, Natalia; Rogov, Juri I.; Prokofieva, Daria; Bermisheva, Marina; Khusnutdinova, Elza; van Asperen, Christi J.; Tollenaar, Robert A. E. M.; Hooning, Maartje J.; Devilee, Peter; Margolin, Sara; Lindblom, Annika; Milne, Roger L.; Ignacio Arias, Jose; Pilar Zamora, M.; Benitez, Javier; Severi, Gianluca; Baglietto, Laura; Giles, Graham G.; Spurdle, Amanda B.; Beesley, Jonathan; Chen, Xiaoqing; Holland, Helene; Healey, Sue; Wang-Gohrke, Shan; Chang-Claude, Jenny; Mannermaa, Arto; Kosma, Veli-Matti; Kauppinen, Jaana; Kataja, Vesa; Agnarsson, Bjarni A.; Caligo, Maria A.; Godwin, Andrew K.; Nevanlinna, Heli; Heikkinen, Tuomas; Fredericksen, Zachary; Lindor, Noralane; Nathanson, Katherine L.; Domchek, Susan M.; Loman, Niklas; Karlsson, Per; Askmalm, Marie Stenmark; Melin, Beatrice; von Wachenfeldt, Anna; Hogervorst, Frans B. L.; Verheus, Martijn; Rookus, Matti A.; Seynaeve, Caroline; Oldenburg, Rogier A.; Ligtenberg, Marjolijn J.; Ausems, Margreet G. E. M.; Aalfs, Cora M.; Gille, Hans J. P.; Wijnen, Juul T.; Garcia, Encarna B. Gomez; Peock, Susan; Cook, Margaret; Oliver, Clare T.; Frost, Debra; Luccarini, Craig; Pichert, Gabriella; Davidson, Rosemarie; Chu, Carol; Eccles, Diana; Ong, Kai-Ren; Cook, Jackie; Douglas, Fiona; Hodgson, Shirley; Evans, D. Gareth; Eeles, Rosalind; Gold, Bert; Pharoah, Paul D. P.; Offit, Kenneth; Chenevix-Trench, Georgia; Easton, Douglas F.		GENICA Network; kConFab; AOCS Study Grp; SWE-BRCA; HEBON; EMBRACE; BCAC-CIMBA	Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; VARIANTS; ALLELES; FGFR2; GENE	Recently, a locus on chromosome 6q22.33 (rs2180341) was reported to be associated with increased breast cancer risk in the Ashkenazi Jewish (AJ) population, and this association was also observed in populations of non-AJ European ancestry. In the present study, we performed a large replication analysis of rs2180341 using data from 31,428 invasive breast cancer cases and 34,700 controls collected from 25 studies in the Breast Cancer Association Consortium (BCAC). In addition, we evaluated whether rs2180341 modifies breast cancer risk in 3,361 BRCA1 and 2,020 BRCA2 carriers from 11 centers in the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Based on the BCAC data from women of European ancestry, we found evidence for a weak association with breast cancer risk for rs2180341 (per-allele odds ratio (OR) = 1.03, 95% CI 1.00-1.06, p = 0.023). There was evidence for heterogeneity in the ORs among studies (I-2 = 49.3%; p = <0.004). In CIMBA, we observed an inverse association with the minor allele of rs2180341 and breast cancer risk in BRCA1 mutation carriers (per-allele OR = 0.89, 95% CI 0.80-1.00, p = 0.048), indicating a potential protective effect of this allele. These data suggest that that 6q22.33 confers a weak effect on breast cancer risk.	[Kirchhoff, Tomas; Gaudet, Mia M.; Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Clin Genet Serv, New York, NY 10021 USA; [Kirchhoff, Tomas] NYU, Inst Canc, Dept Environm Med, New York, NY USA; [Gaudet, Mia M.] Amer Canc Soc, Atlanta, GA 30329 USA; [Antoniou, Antonis C.; McGuffog, Lesley; Humphreys, Manjeet K.; Dunning, Alison M.; Pharoah, Paul D. P.; Easton, Douglas F.] Univ Cambridge, Studies Epidemiol & Risk Factors Canc Hered SEARC, Dept Oncol, Cambridge, England; [Antoniou, Antonis C.; McGuffog, Lesley; Humphreys, Manjeet K.; Dunning, Alison M.; Pharoah, Paul D. P.; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Bojesen, Stig E.; Nordestgaard, Borge G.] Univ Copenhagen, Dept Clin Biochem, Copenhagen Breast Canc Study, DK-1168 Copenhagen, Denmark; [Bojesen, Stig E.; Nordestgaard, Borge G.] Univ Copenhagen, Dept Clin Biochem, Copenhagen Gen Populat Study, DK-1168 Copenhagen, Denmark; [Flyger, Henrik] Univ Copenhagen, Copenhagen Univ Hosp, Herlev Hosp, Dept Breast Surg, DK-1168 Copenhagen, Denmark; [Kang, Daehee; Yoo, Keun-Young; Noh, Dong-Young; Ahn, Sei-Hyun] Seoul Natl Univ, Coll Med, Seoul Breast Canc Study SEBCS, Seoul, South Korea; [Kang, Daehee; Yoo, Keun-Young; Noh, Dong-Young; Ahn, Sei-Hyun] Natl Canc Ctr, Seoul, South Korea; [Kang, Daehee; Yoo, Keun-Young; Noh, Dong-Young; Ahn, Sei-Hyun] Univ Ulsan, Coll Med, Dept Surg, Ulsan 680749, South Korea; [Dork, Thilo; Schuermann, Peter; Karstens, Johann H.; Hillemanns, Peter] Hannover Med Sch, Hannover Breast Canc Study HABCS, Clin Obstet & Gynecol, D-3000 Hannover, Germany; [Dork, Thilo; Schuermann, Peter; Karstens, Johann H.; Hillemanns, Peter] Hannover Med Sch, Hannover Breast Canc Study HABCS, Clin Radiat Oncol, D-3000 Hannover, Germany; [Couch, Fergus J.; Olson, Janet; Vachon, Celine; Wang, Xianshu] Mayo Clin, MCBCS, Rochester, MN USA; [Cox, Angela; Brock, Ian; Elliott, Graeme; Reed, Malcolm W. R.] Univ Sheffield, Sch Med, Dept Oncol, SBCS, Sheffield, S Yorkshire, England; [Burwinkel, Barbara] German Canc Res Ctr, Inst Human Genet, GC HBOC, D-6900 Heidelberg, Germany; [Meindl, Alfons] Tech Univ Munich, Div Tumor Genet, Dept Obstet & Gynecol, Munich, Germany; [Brauch, Hiltrud] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Gene Environm Interact & Breast Canc Germany GENI, D-7000 Stuttgart, Germany; [Brauch, Hiltrud] Univ Tubingen, Stuttgart, Germany; [Brauch, Hiltrud] Univ Tubingen, Tubingen, Germany; [Hamann, Ute] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany; [Ko, Yon-Dschun] Evangel Kliniken Bonn gGmbH, Johanniter Krankenhaus, Dept Internal Med, Bonn, Germany; Univ Bonn, Fac Med, Inst Pathol, Bonn, Germany; German Social Accid Insurance, Inst Prevent & Occupat Med, Bochum, Germany; [Broeks, Annegien; Schmidt, Marjanka K.; Van 't Veer, Laura J.; Braaf, Linde M.] Netherlands Canc Inst, ABCS, Dept Expt Therapy, Amsterdam, Netherlands; [Broeks, Annegien; Schmidt, Marjanka K.; Van 't Veer, Laura J.; Braaf, Linde M.] Netherlands Canc Inst, ABCS, Dept Epidemiol, Amsterdam, Netherlands; [Broeks, Annegien; Schmidt, Marjanka K.; Van 't Veer, Laura J.; Braaf, Linde M.] Netherlands Canc Inst, ABCS, Dept Mol Pathol, Amsterdam, Netherlands; [Johnson, Nichola; Fletcher, Olivia] Inst Canc Res, Breakthrough Breast Canc Res Ctr, BBCS, London SW3 6JB, England; [Gibson, Lorna; Peto, Julian] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Turnbull, Clare; Seal, Sheila; Renwick, Anthony; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, ICR Familial Breast Canc Study FBCS, Sutton, Surrey, England; [Hsiung, Chia-Ni; Shen, Chen-Yang] Acad Sinica, Inst Biomed Sci, Taiwanese Breast Canc Study TWBCS, Taipei, Taiwan; [Wu, Pei-Ei] Acad Sinica, Taiwan Biobank, Taipei, Taiwan; [Yu, Jyh-Cherng] Tri Serv Gen Hosp, Dept Surg, Taipei, Taiwan; [Southey, Melissa C.; Hammet, Fleur] Univ Melbourne, Genet Epidemiol Lab, Dept Pathol, ABCFS, Melbourne, Vic 3010, Australia; [Hopper, John L.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3010, Australia; [Van Dorpe, Thijs; Dieudonne, Anne-Sophie; Hatse, Sigrid] Katholieke Univ Leuven, Multidisciplinary Breast Clin, LMBC, Louvain, Belgium; [Lambrechts, Diether] Vesalius Res Ctr, Louvain, Belgium; [Andrulis, Irene L.] Canc Care Ontario, Ontario Canc Genet Network, OFBCR, Toronto, ON, Canada; [Andrulis, Irene L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred A Litwin Ctr Canc Genet, Toronto, ON, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Bogdanova, Natalia; Antonenkova, Natalia; Rogov, Juri I.] NN Alexandrov Res Inst Oncol & Med Radiol, HMBCS, Minsk, BELARUS; [Prokofieva, Daria; Bermisheva, Marina; Khusnutdinova, Elza] Russian Acad Sci, Ufa Sci Ctr, Inst Biochem & Genet, HUBCS, Ufa, Russia; [Hooning, Maartje J.] Erasmus MC, Dept Med Oncol, Leiden Univ Med Ctr Breast Canc Study ORIGO, Rotterdam, Netherlands; [Tollenaar, Robert A. E. M.] Leiden Univ, Med Ctr, Dept Surg Oncol, Leiden, Netherlands; [van Asperen, Christi J.] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet & Pathol, Leiden, Netherlands; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, Karolinska Breast Canc Study KARBAC, S-10401 Stockholm, Sweden; [Margolin, Sara] Karolinska Inst, Dept Oncol Pathol, S-10401 Stockholm, Sweden; [Margolin, Sara] Karolinska Univ, Stockholm, Sweden; [Milne, Roger L.] Spanish Natl Canc Ctr, Genet & Mol Epidemiol Grp, Spanish Natl Canc Ctr Breast Canc Study CNIO BCS, Madrid, Spain; [Benitez, Javier] Spanish Natl Canc Ctr, Human Genet Grp, Madrid, Spain; [Benitez, Javier] Ctr Invest Biomed Red Enfermedades Rares, Valencia, Spain; [Ignacio Arias, Jose] Monte Naranco Hosp, Oviedo, Spain; [Pilar Zamora, M.] La Paz Univ Hosp, Madrid, Spain; [Southey, Melissa C.; Severi, Gianluca; Baglietto, Laura; Giles, Graham G.] Canc Council, Canc Epidemiol Ctr, MCCS, Melbourne, Vic, Australia; [Southey, Melissa C.; Severi, Gianluca; Baglietto, Laura; Giles, Graham G.] Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3010, Australia; [Spurdle, Amanda B.; Beesley, Jonathan; Chen, Xiaoqing; Holland, Helene; Healey, Sue; Chenevix-Trench, Georgia] Queensland Inst Med Res, Kathleen Cuningham Fdn Consortium Res Familial Br, Brisbane, Qld 4006, Australia; [Spurdle, Amanda B.; Beesley, Jonathan; Chen, Xiaoqing; Holland, Helene; Healey, Sue; Chenevix-Trench, Georgia] Peter MacCallum Canc Ctr, Australian Ovarian Canc Study Grp, Melbourne, Vic, Australia; [Chang-Claude, Jenny] German Canc Res Ctr DFKZ, Div Canc Epidemiol, Genet Epidemiol Study Breast Canc Age 50 GESBC, Heidelberg, Germany; [Wang-Gohrke, Shan] Univ Ulm, Dept Gynecol & Obstet, Mol Biol Lab, Ulm, Germany; [Mannermaa, Arto; Kosma, Veli-Matti; Kauppinen, Jaana] Univ Eastern Finland, Dept Pathol, Inst Clin Med, KBCP, Kuopio, Finland; [Mannermaa, Arto; Kosma, Veli-Matti; Kauppinen, Jaana] Kuopio Univ Hosp, Bioctr Kuopio, SF-70210 Kuopio, Finland; [Kataja, Vesa] Vaasa Cent Hosp, Dept Oncol, Vaasa, Finland; [Kataja, Vesa] Kuopio Univ Hosp, Dept Oncol, SF-70210 Kuopio, Finland; [Agnarsson, Bjarni A.] Landspitali Univ Hosp, Dept Pathol, ILUH, Reykjavik, Iceland; [Agnarsson, Bjarni A.] Univ Iceland, Sch Med, Reykjavik, Iceland; [Caligo, Maria A.] Univ Pisa, Dept Oncol, Div Surg Mol & Ultrastruct Pathol, Pisa, Italy; [Caligo, Maria A.] Pisa Univ Hosp, Pisa, Italy; [Godwin, Andrew K.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Nevanlinna, Heli; Heikkinen, Tuomas] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, Helsinki Breast Canc Study HEBCS, FIN-00290 Helsinki, Finland; [Couch, Fergus J.; Fredericksen, Zachary; Lindor, Noralane] Mayo Clin, Mayo Clin Familial Breast & Ovarian Canc Study MA, Rochester, MN USA; [Nathanson, Katherine L.; Domchek, Susan M.] Univ Penn, Dept Med, Univ Penn UPENN, Philadelphia, PA 19104 USA; [Nathanson, Katherine L.; Domchek, Susan M.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Loman, Niklas] Univ Lund Hosp, Dept Oncol, Swedish BRCA1 & BRCA2 Study Collaborators SWE BRC, S-22185 Lund, Sweden; [Karlsson, Per] Sahlgrens Univ Hosp, Dept Oncol, Gothenburg, Sweden; [Askmalm, Marie Stenmark] Linkoping Univ Hosp, Dept Oncol, S-58185 Linkoping, Sweden; [Melin, Beatrice] Umea Univ, Dept Radiat Sci, Umea, Sweden; [von Wachenfeldt, Anna] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden; [Hogervorst, Frans B. L.; Verheus, Martijn; Rookus, Matti A.] Netherlands Canc Inst, Coordinating Ctr, Hereditary Breast & Ovarian Canc Res Grp Netherla, Amsterdam, Netherlands; [Seynaeve, Caroline; Oldenburg, Rogier A.] Erasmus MC, Rotterdam, Netherlands; [Ligtenberg, Marjolijn J.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Ausems, Margreet G. E. M.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Aalfs, Cora M.] Amsterdam Med Ctr, Amsterdam, Netherlands; [Gille, Hans J. P.] Vrije Univ, Univ Med Ctr, Amsterdam, Netherlands; [Garcia, Encarna B. Gomez] Univ Hosp Maastricht, Maastricht, Netherlands; [Peock, Susan; Cook, Margaret; Oliver, Clare T.; Frost, Debra; Luccarini, Craig] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Epidemiol Study BRCA1 & BRCA2 Mutat Carriers EMBR, Cambridge, England; [Evans, D. Gareth] Cent Manchester Univ Hosp Natl Hlth Serv NHS Fdn, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Eeles, Rosalind] Inst Canc Res, Oncogenet Team, London SW3 6JB, England; [Eeles, Rosalind] Royal Marsden NHS Fdn Trust, London, England; [Pichert, Gabriella] Guys & St Thomas NHS Fdn Trust, London, England; [Davidson, Rosemarie] Yorkhill Hosp, Ferguson Smith Ctr Clin Genet, Glasgow, Lanark, Scotland; [Chu, Carol] Yorkshire Reg Genet Serv, Leeds, W Yorkshire, England; [Eccles, Diana] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Ong, Kai-Ren] Birmingham Womens Hosp Healthcare NHS Trust, W Midlands Reg Genet Serv, Birmingham, W Midlands, England; [Cook, Jackie] Sheffield Childrens Hosp, Sheffield Clin Genet Serv, Sheffield, S Yorkshire, England; [Douglas, Fiona] Newcastle Tyne Hosp NHS Trust, Ctr Life, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Hodgson, Shirley] Univ London, St Georges Hosp, Dept Clin Genet, London, England; [Gold, Bert] NCI, Clin Genet Branch, Rockville, MD USA	Memorial Sloan Kettering Cancer Center; New York University; American Cancer Society; University of Cambridge; University of Cambridge; University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Seoul National University (SNU); National Cancer Center - Korea (NCC); University of Ulsan; Hannover Medical School; Hannover Medical School; Mayo Clinic; University of Sheffield; Helmholtz Association; German Cancer Research Center (DKFZ); Technical University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); University of Bonn; Ruhr University Bochum; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine; University of London; Institute of Cancer Research - UK; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Tri-Service General Hospital; University of Melbourne; University of Melbourne; KU Leuven; Cancer Care Ontario; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario La Paz; University of Melbourne; QIMR Berghofer Medical Research Institute; Peter Maccallum Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Vaasa Central Hospital; Kuopio University Hospital; University of Eastern Finland; Landspitali National University Hospital; University of Iceland; University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Fox Chase Cancer Center; University of Helsinki; Helsinki University Central Hospital; Mayo Clinic; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Lund University; Skane University Hospital; Sahlgrenska University Hospital; Linkoping University; Umea University; Karolinska Institutet; Karolinska University Hospital; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Maastricht University; Maastricht University Medical Centre (MUMC); University of Cambridge; University of Manchester; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Birmingham Women's Hospital; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; St Georges University London; University of London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kirchhoff, T (corresponding author), Mem Sloan Kettering Canc Ctr, Clin Genet Serv, 1275 York Ave, New York, NY 10021 USA.	offitk@mskcc.org	Haviv, Izhak/E-3782-2015; Bowtell, David/H-1007-2016; Flyger, Henrik/AAM-6494-2021; Spurdle, Amanda B/A-4978-2011; Caligo, Adelaide Maria/K-4289-2018; Eccles, Diana/K-6327-2019; Bogdanova, Natalia V./Y-2205-2019; Schmidt, Marjanka K/G-9058-2011; Brüning, Thomas/G-8120-2015; Nordestgaard, Borge Gronne/ABF-1310-2020; Hartikainen, Jaana M/E-6256-2015; Oosterwijk, Jan C./G-5770-2011; Baglietto, Laura/AAB-9051-2019; Shen, CY/F-6271-2010; Evans, D Gareth/AAB-4308-2022; Tobias, Edward/D-4246-2009; Devilee, Peter/GXV-8005-2022; Margolin, Sara/AAX-9034-2020; Dörk, Thilo/J-8620-2012; Ligtenberg, Marjolijn/N-9666-2013; Khusnutdinova, Elza Kamilevna/A-4810-2013; Pharoah, Paul/V-6658-2019; van Asperen, Christi J/D-3970-2012; Chenevix-Trench, Georgia/AAV-2014-2020; Severi, Gianluca/H-3774-2018; Reed, Malcolm Walter/AAG-9219-2020; Ehrencrona, Hans/Q-4621-2019; Verdrengh, Evelien/H-4571-2012; Zeps, Nikolajs/C-4180-2013; Yoo, Keun-Young/J-5548-2012; friedlander, michael l/G-3490-2013; Hoogerbrugge, Nicoline/O-1016-2013; DEVILEE, PETER/ABR-2140-2022; Ehrencrona, Hans/M-5619-2014; Noh, Dong-Young/G-5531-2011; Severi, Gianluca/Q-1824-2019; Lambrechts, Diether/AAJ-3167-2020; Turnbull, Clare/AAA-6596-2019; Lucassen, Anneke/D-7764-2017; Rahman, Nazneen/D-2802-2013; Wyld, David/B-8893-2015	Haviv, Izhak/0000-0002-0837-5005; Bowtell, David/0000-0001-9089-7525; Spurdle, Amanda B/0000-0003-1337-7897; Caligo, Adelaide Maria/0000-0003-0589-1829; Eccles, Diana/0000-0002-9935-3169; Schmidt, Marjanka K/0000-0002-2228-429X; Brüning, Thomas/0000-0001-9560-5464; Hartikainen, Jaana M/0000-0001-8267-1905; Evans, D Gareth/0000-0002-8482-5784; Tobias, Edward/0000-0003-2649-7695; Dörk, Thilo/0000-0002-9458-0282; Ligtenberg, Marjolijn/0000-0003-1290-1474; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Pharoah, Paul/0000-0001-8494-732X; van Asperen, Christi J/0000-0002-1436-7650; Chenevix-Trench, Georgia/0000-0002-1878-2587; Severi, Gianluca/0000-0001-7157-419X; Reed, Malcolm Walter/0000-0001-7442-2132; Ehrencrona, Hans/0000-0002-5589-3622; Zeps, Nikolajs/0000-0002-6404-6839; friedlander, michael l/0000-0002-6488-0604; Hoogerbrugge, Nicoline/0000-0003-2393-8141; Ehrencrona, Hans/0000-0002-5589-3622; Severi, Gianluca/0000-0001-7157-419X; Lambrechts, Diether/0000-0002-3429-302X; Kirchhoff, Tomas/0000-0002-9055-2364; Kang, Daehee/0000-0003-4031-5878; Turnbull, Clare/0000-0002-1734-5772; Southey, Melissa/0000-0002-6313-9005; Nordling, Margareta/0000-0002-4047-4994; Cox, Angela/0000-0002-5138-1099; Beesley, Jonathan/0000-0003-1942-325X; Thorne, Heather/0000-0003-3610-2511; Lucassen, Anneke/0000-0003-3324-4338; Gomez-Garcia, Encarna/0000-0003-4999-8847; Dunning, Alison Margaret/0000-0001-6651-7166; Nevanlinna, Heli/0000-0002-0916-2976; Brauch, Hiltrud/0000-0001-7531-2736; Nordestgaard, Borge/0000-0002-1954-7220; Heikkinen, Tuomas/0000-0003-1154-6204; Rahman, Nazneen/0000-0003-4376-0440; van der Luijt, Rob/0000-0002-0018-1089; Margolin, Sara/0000-0002-5526-5570; Eeles, Rosalind/0000-0002-3698-6241; Wyld, David/0000-0001-9523-4333; Nathanson, Katherine/0000-0002-6740-0901; Gille, Johan/0000-0003-4526-298X; Kataja, Vesa/0000-0003-4846-4843; Baglietto, Laura/0000-0002-8193-7529; Jacobs, Chris/0000-0002-9557-9080; Bancroft, Elizabeth/0000-0002-5482-5660; Giles, Graham/0000-0003-4946-9099; Vasen, Hans/0000-0003-2682-2603; Bojesen, Stig/0000-0002-4061-4133	Cancer Research UK [10124, 11022, 10118, 11174] Funding Source: Medline; Medical Research Council [G0700491] Funding Source: Medline; MRC [G0700491] Funding Source: UKRI; Cancer Research UK [15106, 15007] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); The Francis Crick Institute		Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Antoniou AC, 2005, GENET EPIDEMIOL, V29, P1, DOI 10.1002/gepi.20074; Broeks A, 2011, HUM MOL GENET, V20, P3289, DOI 10.1093/hmg/ddr228; Callow MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022595; Dai JC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3101; Dizin E, 2010, INT J BIOCHEM CELL B, V42, P693, DOI 10.1016/j.biocel.2009.12.025; Dunning AM, 2009, HUM MOL GENET, V18, P1131, DOI 10.1093/hmg/ddn429; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Gaudet MM, 2009, CANCER EPIDEM BIOMAR, V18, P1610, DOI 10.1158/1055-9965.EPI-08-0745; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Hemminki K, 2010, INT J CANCER, V126, P2858, DOI 10.1002/ijc.24986; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kirchhoff T, 2009, CANCER EPIDEM BIOMAR, V18, P2468, DOI 10.1158/1055-9965.EPI-09-0151; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Ma YX, 2010, MOL ENDOCRINOL, V24, P76, DOI 10.1210/me.2009-0218; Milne RL, 2009, JNCI-J NATL CANCER I, V101, P1012, DOI 10.1093/jnci/djp167; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang Z, 2012, GENES DEV; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	24	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e35706	10.1371/journal.pone.0035706	http://dx.doi.org/10.1371/journal.pone.0035706			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768030	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305892100001
J	Lizier, NF; Kerkis, A; Gomes, CM; Hebling, J; Oliveira, CF; Caplan, AI; Kerkis, I				Lizier, Nelson F.; Kerkis, Alexandre; Gomes, Cicera M.; Hebling, Josimeri; Oliveira, Camila F.; Caplan, Arnold I.; Kerkis, Irina			Scaling-Up of Dental Pulp Stem Cells Isolated from Multiple Niches	PLOS ONE			English	Article							IN-VITRO; POPULATION; TEETH; DIFFERENTIATION; EXPRESSION; DPSCS	Dental pulp (DP) can be extracted from child's primary teeth (deciduous), whose loss occurs spontaneously by about 5 to 12 years. Thus, DP presents an easy accessible source of stem cells without ethical concerns. Substantial quantities of stem cells of an excellent quality and at early (2-5) passages are necessary for clinical use, which currently is a problem for use of adult stem cells. Herein, DPs were cultured generating stem cells at least during six months through multiple mechanical transfers into a new culture dish every 3-4 days. We compared stem cells isolated from the same DP before (early population, EP) and six months after several mechanical transfers (late population, LP). No changes, in both EP and LP, were observed in morphology, expression of stem cells markers (nestin, vimentin, fibronectin, SH2, SH3 and Oct3/4), chondrogenic and myogenic differentiation potential, even after cryopreservation. Six hours after DP extraction and in vitro plating, rare 5-bromo-2'-deoxyuridine (BrdU) positive cells were observed in pulp central part. After 72 hours, BrdU positive cells increased in number and were found in DP periphery, thus originating a multicellular population of stem cells of high purity. Multiple stem cell niches were identified in different zones of DP, because abundant expression of nestin, vimentin and Oct3/4 proteins was observed, while STRO-1 protein localization was restricted to perivascular niche. Our finding is of importance for the future of stem cell therapies, providing scaling-up of stem cells at early passages with minimum risk of losing their "stemness".	[Lizier, Nelson F.; Kerkis, Alexandre; Gomes, Cicera M.; Oliveira, Camila F.; Kerkis, Irina] Butantan Inst, Genet Lab, Sao Paulo, Brazil; [Lizier, Nelson F.; Kerkis, Irina] Fed Univ Sao Paulo UNIFESP, Dept Morphol, Sao Paulo, Brazil; [Hebling, Josimeri] State Univ Sao Paulo UNESP, Dept Orthodont & Pediat Dent, Araraquara, SP, Brazil; [Caplan, Arnold I.] Case Western Reserve Univ, Dept Biol, Skeletal Res Ctr, Cleveland, OH 44106 USA	Instituto Butantan; Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual Paulista; Case Western Reserve University	Lizier, NF (corresponding author), Butantan Inst, Genet Lab, Sao Paulo, Brazil.	nelson_lizier@yahoo.com.br	Kerkis, Irina/AAD-1006-2019; Hebling, Josimeri/C-7738-2012; Hebling, Josimeri/AAH-1737-2019	Hebling, Josimeri/0000-0002-2846-2325; Caplan, Arnold/0000-0002-8677-6621	FAPESP (Sao Paulo Research Foundation) [2010/51051-6]	FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grant 2010/51051-6 from FAPESP (Sao Paulo Research Foundation). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2007, J BIOL CHEM, V282, P7339, DOI 10.1074/jbc.M607530200; About I, 2000, AM J PATHOL, V157, P287, DOI 10.1016/S0002-9440(10)64539-7; Arora V, 2009, J CLIN PEDIATR DENT, V33, P289, DOI 10.17796/jcpd.33.4.y887672r0j703654; Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675; Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Costa AD, 2008, J CRANIOFAC SURG, V19, P204, DOI 10.1097/scs.0b013e31815c8a54; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; De Bari C, 2006, CURR OPIN ORTHOP, V17, P398; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Huang AHC, 2008, J ORAL PATHOL MED, V37, P571, DOI 10.1111/j.1600-0714.2008.00654.x; Jo YY, 2007, TISSUE ENG, V13, P767, DOI 10.1089/ten.2006.0192; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kerkis I., 2009, STEM CELLS BASIC APP, P426; Kerkis I, 2011, TISSUE ENG B    1228; Kerkis I, 2006, CELLS TISSUES ORGANS, V184, P105, DOI 10.1159/000099617; Kerkis I, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-35; Laino G, 2005, J BONE MINER RES, V20, P1394, DOI 10.1359/JBMR.050325; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mitsiadis TA, 2007, EXP CELL RES, V313, P3377, DOI 10.1016/j.yexcr.2007.07.027; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Nam H, 2009, BIOCHEM BIOPH RES CO, V386, P135, DOI 10.1016/j.bbrc.2009.05.141; Pal R, 2009, J TISSUE ENG REGEN M, V3, P163, DOI 10.1002/term.143; Papaccio G, 2006, J CELL PHYSIOL, V208, P319, DOI 10.1002/jcp.20667; Gomes JAP, 2010, INVEST OPHTH VIS SCI, V51, P1408, DOI 10.1167/iovs.09-4029; Pierdomenico L, 2005, TRANSPLANTATION, V80, P836, DOI 10.1097/01.tp.0000173794.72151.88; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; da Fonseca SAS, 2009, CELL PROLIFERAT, V42, P132, DOI 10.1111/j.1365-2184.2008.00578.x; Spath L, 2010, J CELL MOL MED, V14, P1635, DOI 10.1111/j.1582-4934.2009.00848.x; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Waddington RJ, 2009, CELLS TISSUES ORGANS, V189, P268, DOI 10.1159/000151447; Wagner J, 2009, CURR OPIN BIOTECH, V20, P531, DOI 10.1016/j.copbio.2009.08.009; Wang Y, 2005, CYTOTHERAPY, V7, P509, DOI 10.1080/14653240500363216; Yan X, 2010, STEM CELLS DEV, V19, P469, DOI 10.1089/scd.2009.0314; Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004; Zhang WB, 2006, TISSUE ENG, V12, P2813, DOI 10.1089/ten.2006.12.2813	39	74	80	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39885	10.1371/journal.pone.0039885	http://dx.doi.org/10.1371/journal.pone.0039885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768154	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100123
J	Piana, S; Lindorff-Larsen, K; Dirks, RM; Salmon, JK; Dror, RO; Shaw, DE				Piana, Stefano; Lindorff-Larsen, Kresten; Dirks, Robert M.; Salmon, John K.; Dror, Ron O.; Shaw, David E.			Evaluating the Effects of Cutoffs and Treatment of Long-range Electrostatics in Protein Folding Simulations	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; FORCE-FIELD; FORMULATION; TRUNCATION; EWALD	The use of molecular dynamics simulations to provide atomic-level descriptions of biological processes tends to be computationally demanding, and a number of approximations are thus commonly employed to improve computational efficiency. In the past, the effect of these approximations on macromolecular structure and stability has been evaluated mostly through quantitative studies of small-molecule systems or qualitative observations of short-timescale simulations of biological macromolecules. Here we present a quantitative evaluation of two commonly employed approximations, using a test system that has been the subject of a number of previous protein folding studies-the villin headpiece. In particular, we examined the effect of (i) the use of a cutoff-based force-shifting technique rather than an Ewald summation for the treatment of electrostatic interactions, and (ii) the length of the cutoff used to determine how many pairwise interactions are included in the calculation of both electrostatic and van der Waals forces. Our results show that the free energy of folding is relatively insensitive to the choice of cutoff beyond 9 angstrom, and to whether an Ewald method is used to account for long-range electrostatic interactions. In contrast, we find that the structural properties of the unfolded state depend more strongly on the two approximations examined here.	[Piana, Stefano; Lindorff-Larsen, Kresten; Dirks, Robert M.; Salmon, John K.; Dror, Ron O.; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Shaw, David E.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY USA	D. E. Shaw Research; Columbia University	Piana, S (corresponding author), DE Shaw Res, New York, NY 10036 USA.	Stefano.Piana-Agostinetti@DEShawResearch.com; David.Shaw@DEShawResearch.com	Lindorff-Larsen, Kresten/K-6469-2014	Lindorff-Larsen, Kresten/0000-0002-4750-6039; Dror, Ron/0000-0002-6418-2793	D.E. Shaw Research	D.E. Shaw Research	All the authors are affiliated with D.E. Shaw Research, the funder of this study. This research was conducted within D. E. Shaw Research, of which DES is the sole beneficial owner and Chief Scientist. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Beauchamp KA, 2011, P NATL ACAD SCI USA, V108, P12734, DOI 10.1073/pnas.1010880108; Beck DAC, 2005, BIOCHEMISTRY-US, V44, P609, DOI 10.1021/bi0486381; Bowman GR, 2011, J AM CHEM SOC, V133, P664, DOI 10.1021/ja106936n; Buchete NV, 2008, J PHYS CHEM B, V112, P6057, DOI 10.1021/jp0761665; Dror RO, 2010, J GEN PHYSIOL, V135, P555, DOI 10.1085/jgp.200910373; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ensign DL, 2007, J MOL BIOL, V374, P806, DOI 10.1016/j.jmb.2007.09.069; Feller SE, 1996, J PHYS CHEM-US, V100, P17011, DOI 10.1021/jp9614658; Fennell CJ, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2206581; FLYVBJERG H, 1989, J CHEM PHYS, V91, P461, DOI 10.1063/1.457480; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; KARASAWA N, 1989, J PHYS CHEM-US, V93, P7320, DOI 10.1021/j100358a012; Klauda JB, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2354486; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; Kubelka J, 2006, J MOL BIOL, V359, P546, DOI 10.1016/j.jmb.2006.03.034; Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131; Lindorff-Larsen K, 2012, J AM CHEM SOC, V134, P3787, DOI 10.1021/ja209931w; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Lippert RA, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2431176; Maritan A, 2000, NATURE, V406, P287, DOI 10.1038/35018538; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mobley DL, 2012, J COMPUT AID MOL DES, V26, P93, DOI 10.1007/s10822-011-9497-y; NORTHRUP SH, 1980, J CHEM PHYS, V73, P2700, DOI 10.1063/1.440484; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Patra M, 2003, BIOPHYS J, V84, P3636, DOI 10.1016/S0006-3495(03)75094-2; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Pronk S, 2011, P INT C HIGH PERF CO; Robertson A, 2008, J COMPUT CHEM, V29, P694, DOI 10.1002/jcc.20828; Sagui C, 1999, ANNU REV BIOPH BIOM, V28, P155, DOI 10.1146/annurev.biophys.28.1.155; Shan YB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839571; Shaw D. E, 2009, P ACM IEEE C SUP SC0; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Shirts MR, 2007, J PHYS CHEM B, V111, P13052, DOI 10.1021/jp0735987; STEINBACH PJ, 1994, J COMPUT CHEM, V15, P667, DOI 10.1002/jcc.540150702; Stone JE, 2010, J MOL GRAPH MODEL, V29, P116, DOI 10.1016/j.jmgm.2010.06.010; Toxvaerd S, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3558787; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137	39	64	64	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39918	10.1371/journal.pone.0039918	http://dx.doi.org/10.1371/journal.pone.0039918			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768169	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100138
J	Schoville, SD; Flowers, JM; Burton, RS				Schoville, Sean D.; Flowers, Jonathan M.; Burton, Ronald S.			Diversifying Selection Underlies the Origin of Allozyme Polymorphism at the Phosphoglucose Isomerase Locus in Tigriopus californicus	PLOS ONE			English	Article							CODON-SUBSTITUTION MODELS; POPULATION-STRUCTURE; BALANCING SELECTION; STATISTICAL TESTS; GENETIC-VARIATION; RECOMBINATION; EVOLUTIONARY; ADAPTATION; DIFFERENTIATION; FITNESS	The marine copepod Tigriopus californicus lives in intertidal rock pools along the Pacific coast, where it exhibits strong, temporally stable population genetic structure. Previous allozyme surveys have found high frequency private alleles among neighboring subpopulations, indicating that there is limited genetic exchange between populations. Here we evaluate the factors responsible for the diversification and maintenance of alleles at the phosphoglucose isomerase (Pgi) locus by evaluating patterns of nucleotide variation underlying previously identified allozyme polymorphism. Copepods were sampled from eleven sites throughout California and Baja California, revealing deep genetic structure among populations as well as genetic variability within populations. Evidence of recombination is limited to the sample from Pescadero and there is no support for linkage disequilibrium across the Pgi locus. Neutrality tests and codon-based models of substitution suggest the action of natural selection due to elevated non-synonymous substitutions at a small number of sites in Pgi. Two sites are identified as the charge-changing residues underlying allozyme polymorphisms in T. californicus. A reanalysis of allozyme variation at several focal populations, spanning a period of 26 years and over 200 generations, shows that Pgi alleles are maintained without notable frequency changes. Our data suggest that diversifying selection accounted for the origin of Pgi allozymes, while McDonald-Kreitman tests and the temporal stability of private allozyme alleles suggests that balancing selection may be involved in the maintenance of amino acid polymorphisms within populations.	[Schoville, Sean D.; Flowers, Jonathan M.; Burton, Ronald S.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Schoville, SD (corresponding author), Univ Grenoble 1, CNRS, Equipe Biol Computat & Math, Grenoble, France.	sschoville@ucsd.edu	Schoville, Sean D./J-8061-2012; Schoville, Sean D./AAY-5324-2020; Burton, R/F-7694-2010	Schoville, Sean D./0000-0001-7364-434X; Schoville, Sean D./0000-0001-7364-434X; Burton, R/0000-0002-6995-5329	National Science Foundation [DEB 0521176, DEB 0717178]; Direct For Biological Sciences [1051057] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors gratefully acknowledge financial support from National Science Foundation grants to R.S.B. (DEB 0521176 and DEB 0717178). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2003, GENETICS, V164, P1229; Beaumont MA, 2003, GENETICS, V164, P1139; BURTON RS, 1984, OECOLOGIA, V65, P108, DOI 10.1007/BF00384471; BURTON RS, 1990, EVOLUTION, V44, P1814, DOI 10.1111/j.1558-5646.1990.tb05252.x; Burton RS, 1997, EVOLUTION, V51, P993, DOI 10.1111/j.1558-5646.1997.tb03681.x; BURTON RS, 1981, EVOLUTION, V35, P1192, DOI 10.1111/j.1558-5646.1981.tb04989.x; BURTON RS, 1994, P NATL ACAD SCI USA, V91, P5197, DOI 10.1073/pnas.91.11.5197; BURTON RS, 1979, MAR ECOL PROG SER, V1, P29, DOI 10.3354/meps001029; Dahlhoff EP, 2000, P NATL ACAD SCI USA, V97, P10056, DOI 10.1073/pnas.160277697; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; DYBDAHL MF, 1994, EVOL ECOL, V8, P113, DOI 10.1007/BF01238245; Edmands S, 2001, MOL ECOL, V10, P1743, DOI 10.1046/j.0962-1083.2001.01306.x; Ellegren H, 2008, NATURE, V452, P169, DOI 10.1038/nature06737; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; FU YX, 1993, GENETICS, V133, P693; GANZ HH, 1995, MAR BIOL, V123, P821, DOI 10.1007/BF00349126; GILLESPIE JH, 1978, THEOR POPUL BIOL, V14, P1, DOI 10.1016/0040-5809(78)90002-3; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; HUDSON RR, 1985, GENETICS, V111, P147; JUKES T H, 1969, P21; Katz LA, 1997, GENETICS, V147, P609; Kelly JK, 1997, GENETICS, V146, P1197; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; MORGAN K, 1979, NATURE, V277, P383, DOI 10.1038/277383a0; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Nylander J. A. A., 2004, MRMODELTEST V2; PATARNELLO T, 1992, EVOLUTION, V46, P1568, DOI 10.1111/j.1558-5646.1992.tb01148.x; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; R Development Core Team, 2011, R VERS 2 13 2; Rambaut A., 2009, TRACER MCMC TRACE AN; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2001, GENETICS, V158, P1147; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; Storz JF, 2010, EVOLUTION, V64, P2489, DOI 10.1111/j.1558-5646.2010.01044.x; TAJIMA F, 1989, GENETICS, V123, P585; Vittor B.A, 1971, EFFECTS ENV FITNESS; Wakeley J, 2001, THEOR POPUL BIOL, V59, P133, DOI 10.1006/tpbi.2000.1495; Wall JD, 1999, GENET RES, V74, P65, DOI 10.1017/S0016672399003870; Wang B., 2012, J MOL EVOL; WATT WB, 1983, GENETICS, V103, P691; Wheat CW, 2010, CONSERV GENET, V11, P387, DOI 10.1007/s10592-009-0042-7; Wheat CW, 2010, MOL BIOL EVOL, V27, P267, DOI 10.1093/molbev/msp227; Willett CS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-139; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431	52	11	11	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40035	10.1371/journal.pone.0040035	http://dx.doi.org/10.1371/journal.pone.0040035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768211	Green Submitted, gold, Green Published			2022-12-27	WOS:000305892100183
J	Sheik, CS; Mitchell, TW; Rizvi, FZ; Rehman, Y; Faisal, M; Hasnain, S; McInerney, MJ; Krumholz, LR				Sheik, Cody S.; Mitchell, Tyler W.; Rizvi, Fariha Z.; Rehman, Yasir; Faisal, Muhammad; Hasnain, Shahida; McInerney, Michael J.; Krumholz, Lee R.			Exposure of Soil Microbial Communities to Chromium and Arsenic Alters Their Diversity and Structure	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; BACTERIAL COMMUNITY; CHROMATE-RESISTANT; REDUCTION; PATTERNS; PROTEIN; GENES; ACR3; MICROORGANISMS; POPULATIONS	Extensive use of chromium (Cr) and arsenic (As) based preservatives from the leather tanning industry in Pakistan has had a deleterious effect on the soils surrounding production facilities. Bacteria have been shown to be an active component in the geochemical cycling of both Cr and As, but it is unknown how these compounds affect microbial community composition or the prevalence and form of metal resistance. Therefore, we sought to understand the effects that long-term exposure to As and Cr had on the diversity and structure of soil microbial communities. Soils from three spatially isolated tanning facilities in the Punjab province of Pakistan were analyzed. The structure, diversity and abundance of microbial 16S rRNA genes were highly influenced by the concentration and presence of hexavalent chromium (Cr (VI)) and arsenic. When compared to control soils, contaminated soils were dominated by Proteobacteria while Actinobacteria and Acidobacteria (which are generally abundant in pristine soils) were minor components of the bacterial community. Shifts in community composition were significant and revealed that Cr (VI)-containing soils were more similar to each other than to As contaminated soils lacking Cr (VI). Diversity of the arsenic resistance genes, arsB and ACR3 were also determined. Results showed that ACR3 becomes less diverse as arsenic concentrations increase with a single OTU dominating at the highest concentration. Chronic exposure to either Cr or As not only alters the composition of the soil bacterial community in general, but affects the arsenic resistant individuals in different ways.	[Sheik, Cody S.; Mitchell, Tyler W.; McInerney, Michael J.; Krumholz, Lee R.] Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA; [Sheik, Cody S.; Mitchell, Tyler W.; Krumholz, Lee R.] Univ Oklahoma, Inst Energy & Environm, Norman, OK 73019 USA; [Rizvi, Fariha Z.; Rehman, Yasir; Faisal, Muhammad; Hasnain, Shahida] Univ Punjab, Dept Microbiol & Mol Genet, Lahore, Pakistan	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University of Punjab	Sheik, CS (corresponding author), Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA.	krumholz@ou.edu	Hasnain, Shahida/I-6924-2015; Rehman, Yasir/Y-8730-2019	Hasnain, Shahida/0000-0002-5916-7759; Rehman, Yasir/0000-0002-4787-275X; Sheik, Cody/0000-0003-0413-1924	National Academy of Sciences, USA [PGA-P280292]	National Academy of Sciences, USA	Funding was from the National Academy of Sciences, USA under grant # PGA-P280292. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour-Rokbani A, 2010, APPL ENVIRON MICROB, V76, P948, DOI 10.1128/AEM.01738-09; Agency EP, 1998, IN ARS; Aguilar-Barajas E, 2008, FEMS MICROBIOL LETT, V285, P97, DOI 10.1111/j.1574-6968.2008.01220.x; Alvarez AH, 1999, J BACTERIOL, V181, P7398, DOI 10.1128/JB.181.23.7398-7400.1999; Atlas RM., 2004, HDB MICROBIOLOGICAL; BAATH E, 1989, WATER AIR SOIL POLL, V47, P335, DOI 10.1007/BF00279331; Badar U, 2000, BIOTECHNOL LETT, V22, P829, DOI 10.1023/A:1005649113190; Bell T, 2010, ISME J, V4, P1357, DOI 10.1038/ismej.2010.77; Bobrowicz P, 1997, YEAST, V13, P819, DOI 10.1002/(SICI)1097-0061(199707)13:9<819::AID-YEA142>3.0.CO;2-Y; Bouskill NJ, 2010, ECOTOXICOLOGY, V19, P317, DOI 10.1007/s10646-009-0414-2; Cai L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-4; CAMPOS J, 1995, ANTON LEEUW INT J G, V68, P203, DOI 10.1007/BF00871816; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DEY S, 1995, J BACTERIOL, V177, P385, DOI 10.1128/jb.177.2.385-389.1995; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elshahed MS, 2008, APPL ENVIRON MICROB, V74, P5422, DOI 10.1128/AEM.00410-08; Faith DP, 2009, INT J MOL SCI, V10, P4723, DOI 10.3390/ijms10114723; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fu HL, 2009, J BIOL CHEM, V284, P19887, DOI 10.1074/jbc.M109.011882; Fulthorpe RR, 2008, ISME J, V2, P901, DOI 10.1038/ismej.2008.55; Giller KE, 1997, APPL SOIL ECOL, V6, P3, DOI 10.1016/S0929-1393(96)00149-7; Giller KE, 2009, SOIL BIOL BIOCHEM, V41, P2031, DOI 10.1016/j.soilbio.2009.04.026; Girvan MS, 2005, ENVIRON MICROBIOL, V7, P301, DOI 10.1111/j.1462-2920.2005.00695.x; GOODFELLOW M, 1983, ANNU REV MICROBIOL, V37, P189, DOI 10.1146/annurev.mi.37.100183.001201; Gough HL, 2011, ISME J, V5, P543, DOI 10.1038/ismej.2010.132; Gough HL, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000566; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; He MY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-221; Hugenholtz P, 2002, GENOME BIOL, V3; JI GY, 1992, J BACTERIOL, V174, P3684, DOI 10.1128/JB.174.11.3684-3694.1992; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Kamaludeen SPB, 2003, REV ENVIRON CONTAM T, V178, P93, DOI 10.1007/0-387-21728-2_4; Knight BP, 1997, APPL ENVIRON MICROB, V63, P39, DOI 10.1128/AEM.63.1.39-43.1997; Kothe E, 2010, SOIL BIOL, V19, P225, DOI 10.1007/978-3-642-02436-8_10; Kourtev PS, 2006, APPL ENVIRON MICROB, V72, P628, DOI 10.1128/AEM.72.1.628-637.2006; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Li XK, 2007, J BACTERIOL, V189, P3705, DOI 10.1128/JB.01913-06; Liu CR, 2007, POPUL ECOL, V49, P89, DOI 10.1007/s10144-006-0026-0; Lloyd JR, 2001, CURR OPIN BIOTECH, V12, P248, DOI 10.1016/S0958-1669(00)00207-X; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Margesin R, 2011, CHEMOSPHERE, V82, P1583, DOI 10.1016/j.chemosphere.2010.11.056; Marsh TL, 2001, APPL ENVIRON MICROB, V67, P1517, DOI 10.1128/AEM.67.4.1517-1521.2001; MCCARTHY AJ, 1992, GENE, V115, P189, DOI 10.1016/0378-1119(92)90558-7; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; Okansen J, 2011, VEGAN COMMUNITY ECOL; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Oremland RS, 2004, FEMS MICROBIOL ECOL, V48, P15, DOI 10.1016/j.femsec.2003.12.016; Oremland RS, 2005, TRENDS MICROBIOL, V13, P45, DOI 10.1016/j.tim.2004.12.002; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Roesch LFW, 2007, ISME J; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sheik CS, 2011, ISME J; Sokal RR, 2003, BIOMETRY; Spain AM, 2009, ISME J, V3, P992, DOI 10.1038/ismej.2009.43; Tamura K., 2011, MOL BIOL EVOL, DOI [10.1093/molbev/msr121, DOI 10.1093/MOLBEV/MSR121]; URONE PF, 1955, ANAL CHEM, V27, P1354, DOI 10.1021/ac60104a048; USEPA, 1998, TOX REV HEX CHROM; Ward NL, 2009, APPL ENVIRON MICROB, V75, P2046, DOI 10.1128/AEM.02294-08; WU JH, 1992, J BIOL CHEM, V267, P12570; Wysocki R, 1997, J BIOL CHEM, V272, P30061, DOI 10.1074/jbc.272.48.30061; Youssef NH, 2009, ISME J, V3, P305, DOI 10.1038/ismej.2008.106	70	178	202	14	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40059	10.1371/journal.pone.0040059	http://dx.doi.org/10.1371/journal.pone.0040059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768219	gold, Green Published			2022-12-27	WOS:000305892100191
J	Voges, M; Bachmann, V; Naujoks, J; Kopp, K; Hauck, CR				Voges, Maike; Bachmann, Verena; Naujoks, Jan; Kopp, Kathrin; Hauck, Christof R.			Extracellular Ig(C2) Constant Domains of CEACAMs Mediate PI3K Sensitivity during Uptake of Pathogens	PLOS ONE			English	Article							CARCINOEMBRYONIC ANTIGEN FAMILY; NEISSERIA-GONORRHOEAE; ADHESION MOLECULE; CELL-ADHESION; PHOSPHOINOSITIDE 3-KINASE; DIFFERENTIAL RECOGNITION; BACTERIAL PATHOGENS; SIGNAL-TRANSDUCTION; OPA PROTEINS; N-DOMAIN	Background: Several pathogenic bacteria utilize receptors of the CEACAM family to attach to human cells. Binding to different members of this receptor family can result in uptake of the bacteria. Uptake of Neisseria gonorrhoeae, a Gram-negative human pathogen, via CEACAMs found on epithelial cells, such as CEACAM1, CEA or CEACAM6, differs mechanistically from phagocytosis mediated by CEACAM3, a CEACAM family member expressed selectively by human granulocytes. Principal Findings: We find that CEACAM1- as well as CEACAM3-mediated bacterial internalization are accompanied by a rapid increase in phosphatidylinositol-3,4,5 phosphate (PI(3,4,5) P) at the site of bacterial entry. However, pharmacological inhibition of phosphatidylinositol-3' kinase (PI3K) selectively affects CEACAM1-mediated uptake of Neisseria gonorrhoeae. Accordingly, overexpression of the PI(3,4,5) P phosphatase SHIP diminishes and expression of a constitutive active PI3K increases CEACAM1-mediated internalization of gonococci, without influencing uptake by CEACAM3. Furthermore, bacterial uptake by GPI-linked members of the CEACAM family (CEA and CEACAM6) and CEACAM1-mediated internalization of N. meningitidis by endothelial cells require PI3K activity. Sensitivity of CEACAM1-mediated uptake toward PI3K inhibition is independent of receptor localization in cholesterol-rich membrane microdomains and does not require the cytoplasmic or the transmembrane domain of CEACAM1. However, PI3K inhibitor sensitivity requires the Ig(C2)-like domains of CEACAM1, which are also present in CEA and CEACAM6, but which are absent from CEACAM3. Accordingly, overexpression of CEACAM1 Ig(C2) domains blocks CEACAM1-mediated internalization. Conclusions: Our results provide novel mechanistic insight into CEACAM1-mediated endocytosis and suggest that epithelial CEACAMs associate in cis with other membrane receptor(s) via their extracellular domains to trigger bacterial uptake in a PI3K-dependent manner.	[Voges, Maike; Bachmann, Verena; Naujoks, Jan; Kopp, Kathrin; Hauck, Christof R.] Univ Konstanz, Lehrstuhl Zellbiol, Constance, Germany; [Voges, Maike; Hauck, Christof R.] Univ Konstanz, Konstanz Res Sch Chem Biol, Constance, Germany	University of Konstanz; University of Konstanz	Voges, M (corresponding author), Univ Konstanz, Lehrstuhl Zellbiol, Constance, Germany.	christof.hauck@uni-konstanz.de			DFG (Deutsche Forschungsgemeinschaft) [Ha2856/6-1]; Ministry of Science, Research and Arts of Baden-Wurttemberg	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Ministry of Science, Research and Arts of Baden-Wurttemberg	This study was supported by funds from the DFG (Deutsche Forschungsgemeinschaft),(Ha2856/6-1) and by a grant from the Ministry of Science, Research and the Arts of Baden-Wurttemberg to C. R. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2009, J BIOL CHEM, V284, P19427, DOI 10.1074/jbc.M109.003442; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Balla Tamas, 2002, Sci STKE, V2002, ppl3, DOI 10.1126/stke.2002.125.pl3; Barclay AN, 2003, SEMIN IMMUNOL, V15, P215, DOI 10.1016/S1044-5323(03)00047-2; Berger CN, 2004, MOL MICROBIOL, V52, P963, DOI 10.1111/j.1365-2958.2004.04033.x; Billker O, 2002, EMBO J, V21, P560, DOI 10.1093/emboj/21.4.560; Bos MP, 1997, INFECT IMMUN, V65, P2353, DOI 10.1128/IAI.65.6.2353-2361.1997; Brumell JH, 2003, CELL MICROBIOL, V5, P287, DOI 10.1046/j.1462-5822.2003.00273.x; Buntru A, 2012, ARCH BIOCHEM BIOPHYS, V524, P77, DOI 10.1016/j.abb.2012.03.020; Buntru A, 2011, J BIOL CHEM, V286, P9555, DOI 10.1074/jbc.M110.216085; Buntru A, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-81; Chen T, 1997, J EXP MED, V185, P1557, DOI 10.1084/jem.185.9.1557; Chen T, 1996, P NATL ACAD SCI USA, V93, P14851, DOI 10.1073/pnas.93.25.14851; Choice CV, 1998, J BIOL CHEM, V273, P22194, DOI 10.1074/jbc.273.35.22194; Cossart P, 2011, P NATL ACAD SCI USA, V108, P19484, DOI 10.1073/pnas.1112371108; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; FORMISANO P, 1995, J BIOL CHEM, V270, P24073, DOI 10.1074/jbc.270.41.24073; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Gray-Owen SD, 1997, MOL MICROBIOL, V26, P971, DOI 10.1046/j.1365-2958.1997.6342006.x; Hauck CR, 1998, EMBO J, V17, P443, DOI 10.1093/emboj/17.2.443; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hill DJ, 2003, MOL MICROBIOL, V48, P117, DOI 10.1046/j.1365-2958.2003.03433.x; INDIK ZK, 1995, BLOOD, V86, P4389, DOI 10.1182/blood.V86.12.4389.bloodjournal86124389; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; Kuespert K, 2007, J MICROBIOL METH, V68, P478, DOI 10.1016/j.mimet.2006.10.003; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Kuespert K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014609; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; McCaw SE, 2004, INFECT IMMUN, V72, P2742, DOI 10.1128/IAI.72.5.2742-2752.2004; McCaw SE, 2003, MOL MICROBIOL, V49, P623, DOI 10.1046/j.1365-2958.2003.03591.x; Muenzner P, 2005, J CELL BIOL, V170, P825, DOI 10.1083/jcb.200412151; Muenzner P, 2000, INFECT IMMUN, V68, P3601, DOI 10.1128/IAI.68.6.3601-3607.2000; Muenzner P, 2001, J BIOL CHEM, V276, P24331, DOI 10.1074/jbc.M006883200; Muenzner P, 2008, CELL MICROBIOL, V10, P1074, DOI 10.1111/j.1462-5822.2007.01106.x; Muenzner P, 2010, SCIENCE, V329, P1197, DOI 10.1126/science.1190892; Pils S, 2008, INT J MED MICROBIOL, V298, P553, DOI 10.1016/j.ijmm.2008.04.005; Pils S, 2006, J MICROBIOL METH, V65, P301, DOI 10.1016/j.mimet.2005.08.013; Pils S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032808; Popp A, 1999, CELL MICROBIOL, V1, P169, DOI 10.1046/j.1462-5822.1999.00017.x; Poy MN, 2002, NAT GENET, V30, P270, DOI 10.1038/ng840; Prasadarao NV, 2003, INFECT IMMUN, V71, P1680, DOI 10.1128/IAI.71.4.1680-1688.2003; Reddy MA, 2000, J BIOL CHEM, V275, P36769, DOI 10.1074/jbc.M007382200; Robert J, 1999, J IMMUNOL, V163, P4133; Rojas R, 2002, NAT REV MOL CELL BIO, V3, P944, DOI 10.1038/nrm972; Rowe HA, 2007, CELL MICROBIOL, V9, P154, DOI 10.1111/j.1462-5822.2006.00775.x; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sarantis H, 2012, CELL HOST MICROBE, V11, P117, DOI 10.1016/j.chom.2012.01.010; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; Schmitter T, 2004, J EXP MED, V199, P35, DOI 10.1084/jem.20030204; Schmitter T, 2007, INFECT IMMUN, V75, P4116, DOI 10.1128/IAI.01835-06; Schmitter T, 2007, J IMMUNOL, V178, P3797, DOI 10.4049/jimmunol.178.6.3797; Slanina H, 2010, INFECT IMMUN, V78, P1905, DOI 10.1128/IAI.01267-09; Soni P, 2000, MOL CELL BIOL, V20, P3896, DOI 10.1128/MCB.20.11.3896-3905.2000; Toleman M, 2001, CELL MICROBIOL, V3, P33, DOI 10.1046/j.1462-5822.2001.00089.x; Umlauf E, 2006, J BIOL CHEM, V281, P23349, DOI 10.1074/jbc.M513720200; Virji M, 1996, MOL MICROBIOL, V22, P929, DOI 10.1046/j.1365-2958.1996.01548.x; Voges M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-117; Wang J, 1998, MOL MICROBIOL, V30, P657, DOI 10.1046/j.1365-2958.1998.01102.x; Wang JA, 2008, INT J MED MICROBIOL, V298, P209, DOI 10.1016/j.ijmm.2007.05.004; Wu S, 2012, J BIOL CHEM, V287, P6735, DOI 10.1074/jbc.M111.309526; Zebhauser R, 2005, GENOMICS, V86, P566, DOI 10.1016/j.ygeno.2005.07.008; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	64	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39908	10.1371/journal.pone.0039908	http://dx.doi.org/10.1371/journal.pone.0039908			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768164	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100133
J	Wernike, K; Hoffmann, B; Dauber, M; Lange, E; Schirrmeier, H; Beer, M				Wernike, Kerstin; Hoffmann, Bernd; Dauber, Malte; Lange, Elke; Schirrmeier, Horst; Beer, Martin			Detection and Typing of Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus by Multiplex Real-Time RT-PCR	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE-PCR; MOUTH-DISEASE VIRUS; NORTH-AMERICAN; RAPID DETECTION; LELYSTAD VIRUS; UNITED-STATES; CHINA; PRRSV; ASSAY; DIFFERENTIATION	Porcine reproductive and respiratory syndrome (PRRS) causes economic losses in the pig industry worldwide, and PRRS viruses (PRRSV) are classified into the two distinct genotypes "North American (NA, type 2)" and "European (EU, type 1)". In 2006, a highly pathogenic NA strain of PRRSV (HP-PRRSV), characterized by high fever as well as high morbidity and mortality, emerged in swine farms in China. Therefore, a real-time reverse transcription polymerase chain reaction (RT-qPCR) assay specific for HP-PRRSV was developed and combined with type 1- and type 2-specific RT-qPCR systems. Furthermore, an internal control, based on a heterologous RNA, was successfully introduced. This final multiplex PRRSV RT-qPCR, detecting and typing PRRSV, had an analytical sensitivity of less than 200 copies per mu l for the type 1-assay and 20 copies per mu l for the type 2- and HP assays and a high diagnostic sensitivity. A panel of reference strains and field isolates was reliably detected and samples from an animal trial with a Chinese HP-PRRS strain were used for test validation. The new multiplex PRRSV RT-qPCR system allows for the first time the highly sensitive detection and rapid differentiation of PRRSV of both genotypes as well as the direct detection of HP-PRRSV.	[Wernike, Kerstin; Hoffmann, Bernd; Schirrmeier, Horst; Beer, Martin] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany; [Dauber, Malte; Lange, Elke] Friedrich Loeffler Inst, Dept Expt Anim Facil & Biorisk Management, Greifswald, Germany	Friedrich Loeffler Institute; Friedrich Loeffler Institute	Wernike, K (corresponding author), Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany.	martin.beer@fli.bund.de			SAB, Sachsische Aufbaubank - Forderbank; SAB	SAB, Sachsische Aufbaubank - Forderbank; SAB	The authros have read the journal's policy and have the following conflicts: MB is a PLoS ONE Editorial Board member (Academic Editor). The study was funded by the SAB, Sachsische Aufbaubank - Forderbank, as a collaboration project with the company Labor Diagnostik Leipzig. KW was funded by the SAB. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cavanagh D, 1997, ARCH VIROL, V142, P629; Chen NH, 2009, J VIROL METHODS, V161, P192, DOI 10.1016/j.jviromet.2009.06.007; Darwich L, 2011, VET MICROBIOLOGY; Egli C, 2001, J VIROL METHODS, V98, P63, DOI 10.1016/S0166-0934(01)00358-5; Fang Y, 2004, VIRUS RES, V100, P229, DOI 10.1016/j.virusres.2003.12.026; Feng YJ, 2008, EMERG INFECT DIS, V14, P1774, DOI 10.3201/eid1411.071676; Gao ZQ, 2004, ARCH VIROL, V149, P1341, DOI 10.1007/s00705-004-0292-0; Hoffmann B, 2006, J VIROL METHODS, V136, P200, DOI 10.1016/j.jviromet.2006.05.020; Hoffmann B, 2005, J VIROL METHODS, V130, P36, DOI 10.1016/j.jviromet.2005.05.030; Karniychuk UU, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-30; Key KF, 2001, VET MICROBIOL, V83, P249, DOI 10.1016/S0378-1135(01)00427-8; Kleiboeker SB, 2005, J VET DIAGN INVEST, V17, P165, DOI 10.1177/104063870501700211; Li YF, 2007, VET J, V174, P577, DOI 10.1016/j.tvjl.2007.07.032; Lurchachaiwong W, 2008, LETT APPL MICROBIOL, V46, P55, DOI 10.1111/j.1472-765X.2007.02259.x; Lv J, 2008, J GEN VIROL, V89, P2075, DOI 10.1099/vir.0.2008/001529-0; MEULENBERG JJM, 1993, VIROLOGY, V192, P62, DOI 10.1006/viro.1993.1008; Moniwa M, 2007, J VET DIAGN INVEST, V19, P9, DOI 10.1177/104063870701900103; Nelsen CJ, 1999, J VIROL, V73, P270, DOI 10.1128/JVI.73.1.270-280.1999; Normile D, 2007, SCIENCE, V317, P1017, DOI 10.1126/science.317.5841.1017; Oleksiewicz MB, 1998, VET MICROBIOL, V64, P7, DOI 10.1016/S0378-1135(98)00254-5; Oleksiewicz MB, 2001, J VIROL METHODS, V92, P23, DOI 10.1016/S0166-0934(00)00265-2; Pesch S, 2005, VET MICROBIOL, V107, P31, DOI 10.1016/j.vetmic.2005.01.028; R Core Team, 2020, R LANG ENV STAT COMP; Ropp SL, 2004, J VIROL, V78, P3684, DOI 10.1128/JVI.78.7.3684-3703.2004; Rossow KD, 1998, VET PATHOL, V35, P1, DOI 10.1177/030098589803500101; Shi M, 2010, J VIROL, V84, P8700, DOI 10.1128/JVI.02551-09; Stadejek T, 2006, J GEN VIROL, V87, P1835, DOI 10.1099/vir.0.81782-0; Stadejek T, 2008, ARCH VIROL, V153, P1479, DOI 10.1007/s00705-008-0146-2; Thanawongnuwech R, 2004, VET MICROBIOL, V101, P9, DOI 10.1016/j.vetmic.2004.03.005; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Tong GZ, 2007, EMERG INFECT DIS, V13, P1434, DOI 10.3201/eid1309.070399; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Wakeley PR, 2005, J CLIN MICROBIOL, V43, P2786, DOI 10.1128/JCM.43.6.2786-2792.2005; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Xiao XL, 2008, J VIROL METHODS, V149, P49, DOI 10.1016/j.jviromet.2008.01.009; Zhou L, 2009, J VIROL, V83, P5156, DOI 10.1128/JVI.02678-08; Zhou YJ, 2008, TRANSBOUND EMERG DIS, V55, P152, DOI 10.1111/j.1865-1682.2008.01020.x	38	36	43	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38251	10.1371/journal.pone.0038251	http://dx.doi.org/10.1371/journal.pone.0038251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768042	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100013
J	Lorist, MM; Jolij, J				Lorist, Monicque M.; Jolij, Jacob			Trial History Effects in Stroop Task Performance Are Independent of Top-Down Control	PLOS ONE			English	Article							CONFLICT ADAPTATION; ANTERIOR CINGULATE; COGNITIVE CONTROL; MENTAL FATIGUE; FLANKER TASK; ATTENTION; INTERFERENCE; IMPACT; ERP	In this study we sought to elucidate what mechanisms underlie the effects of trial history on information processing. We explicitly focused on the contribution of conflict control and S-R binding to sequential trial effects. Performance and brain activity were measured during two hours of continuous Stroop task performance. Mental fatigue, known to influence top-down processing, was used to elucidate separate effects via top-down and bottom-up mechanisms. Here we confirm that performance in the Stroop task is indeed strongly modulated by stimulus history. Performance was affected by the kind of advance information available; dependent on this information adjustments were made, resulting in differential effects of cognitive conflict, and S-R binding on subsequent performance. The influence of mental fatigue on information processing was mainly related to general effects on attention.	[Lorist, Monicque M.; Jolij, Jacob] Univ Groningen, Dept Expt Psychol, Groningen, Netherlands; [Lorist, Monicque M.] Univ Groningen, BCN NeuroImaging Ctr, Univ Med Ctr Groningen, Groningen, Netherlands	University of Groningen; University of Groningen	Lorist, MM (corresponding author), Univ Groningen, Dept Expt Psychol, Groningen, Netherlands.	M.M.Lorist@rug.nl	Jolij, Jacob/A-9560-2009	Jolij, Jacob/0000-0002-9137-052X; Lorist, Monicque M./0000-0002-7361-093X	University of Groningen	University of Groningen	This study was funded by the University of Groningen. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Electroencephalographic Society, 1994, J CLIN NEUROPHYSIOL, V11, P30; Badzakova-Trajkov G, 2009, BRAIN RES, V1253, P139, DOI 10.1016/j.brainres.2008.11.069; Bekker EM, 2004, CLIN NEUROPHYSIOL, V115, P2001, DOI 10.1016/j.clinph.2004.04.008; Boksem MAS, 2006, BIOL PSYCHOL, V72, P123, DOI 10.1016/j.biopsycho.2005.08.007; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Chen SF, 2009, BRAIN RES, V1297, P89, DOI 10.1016/j.brainres.2009.08.003; Clayson PE, 2011, PSYCHOPHYSIOLOGY, V48, P1621, DOI 10.1111/j.1469-8986.2011.01265.x; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dutzi IB, 2009, PSYCHOL RES-PSYCH FO, V73, P425, DOI 10.1007/s00426-008-0161-7; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Holding D. H., 1983, STRESS FATIGUE HUMAN; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; Lorist M. M., 2011, COGNITIVE FATIGUE, P105, DOI [10.1037/12343-005, DOI 10.1037/12343-005]; Lorist MM, 2000, PSYCHOPHYSIOLOGY, V37, P614, DOI 10.1111/1469-8986.3750614; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Lorist MM, 2008, BRAIN RES, V1232, P113, DOI 10.1016/j.brainres.2008.07.053; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Nieuwenhuis S, 2006, MEM COGNITION, V34, P1260, DOI 10.3758/BF03193270; Notebaert W, 2006, PSYCHON B REV, V13, P112, DOI 10.3758/BF03193821; QUINTANA SM, 1994, J EDUC STAT, V19, P57, DOI 10.2307/1165177; Ridderinkhof KR, 1997, ADV PSYCHOL, V118, P119; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Szucs D, 2010, BRAIN RES, V1325, P63, DOI 10.1016/j.brainres.2010.02.011; van der Linden D, 2006, PSYCHOL RES-PSYCH FO, V70, P395, DOI 10.1007/s00426-005-0228-7; van Veen V, 2005, NEUROIMAGE, V27, P497, DOI 10.1016/j.neuroimage.2005.04.042; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; West R, 2000, BRAIN RES, V873, P102, DOI 10.1016/S0006-8993(00)02530-0; West R, 2003, NEUROPSYCHOLOGIA, V41, P1122, DOI 10.1016/S0028-3932(02)00297-X; Yeung N, 2006, PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-9280.2006.01680.x	41	16	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39802	10.1371/journal.pone.0039802	http://dx.doi.org/10.1371/journal.pone.0039802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966GL	22761907	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800072
J	Kim, H; Casta, A; Tang, XW; Luke, CT; Kim, AL; Bickers, DR; Athar, M; Christiano, AM				Kim, Hyunmi; Casta, Alexandre; Tang, Xiuwei; Luke, Courtney T.; Kim, Arianna L.; Bickers, David R.; Athar, Mohammad; Christiano, Angela M.			Loss of Hairless Confers Susceptibility to UVB-Induced Tumorigenesis via Disruption of NF-kappaB Signaling	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; HR GENE; TRANSCRIPTIONAL REGULATION; NONSENSE MUTATION; MOLECULAR-BASIS; B-CELL; MOUSE; SKIN; MICE	In order to model squamous cell carcinoma development in vivo, researchers have long preferred hairless mouse models such as SKH-1 mice that have traditionally been classified as 'wild-type' mice irrespective of the genetic factors underlying their hairless phenotype. The work presented here shows that mutations in the Hairless (Hr) gene not only result in the hairless phenotype of the SKH-1 and Hr(-/-) mouse lines but also cause aberrant activation of NF kappa B and its downstream effectors. We show that in the epidermis, Hr is an early UVB response gene that regulates NF kappa B activation and thereby controls cellular responses to irradiation. Therefore, when Hr expression is decreased in Hr mutant animals there is a corresponding increase in NF kappa B activity that is augmented by UVB irradiation. This constitutive activation of NF kappa B in the Hr mutant epidermis leads to the stimulation a large variety of downstream effectors including the cell cycle regulators cyclin D1 and cyclin E, the anti-apoptosis protein Bcl-2, and the pro-inflammatory protein Cox-2. Therefore, Hr loss results in a state of uncontrolled epidermal proliferation that promotes tumor development, and Hr mutant mice should no longer be considered merely hairless 'wild-type' mice. Instead, Hr is a crucial UVB response gene and its loss creates a permissive environment that potentiates increased tumorigenesis.	[Kim, Hyunmi; Christiano, Angela M.] Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; [Casta, Alexandre] Columbia Univ Coll Phys & Surg, Inst Human Nutr, New York, NY 10032 USA; [Kim, Hyunmi; Tang, Xiuwei; Luke, Courtney T.; Kim, Arianna L.; Bickers, David R.; Athar, Mohammad; Christiano, Angela M.] Columbia Univ Coll Phys & Surg, Dept Dermatol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Kim, H (corresponding author), Columbia Univ Coll Phys & Surg, Dept Genet & Dev, 701 W 168th St, New York, NY 10032 USA.	amc65@columbia.edu			National Institutes of Health [R01AR47338, T32AR007605, P30AR044535, R01ES015323]; NATIONAL CANCER INSTITUTE [R01CA138998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047338, P30AR050948, P30AR044535, T32AR007605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The following National Institutes of Health grants supported this work: R01AR47338 (AMC), T32AR007605 (HK and CTL), Research Supplement for Underrepresented Minorities (CTL), P30AR044535 (Columbia University SDRC and R01ES015323 (MA). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbassi MS, 2008, INT J ANTIMICROB AG, V32, P308, DOI 10.1016/j.ijantimicag.2008.04.009; Ahmad W, 1998, GENOMICS, V53, P383, DOI 10.1006/geno.1998.5495; Ahmad W, 1998, EXP DERMATOL, V7, P298; Brooke HC, 1926, J HERED, V17, P173, DOI 10.1093/oxfordjournals.jhered.a102700; CACHONGONZALEZ MB, 1994, P NATL ACAD SCI USA, V91, P7717, DOI 10.1073/pnas.91.16.7717; Casta A, 2012, PHOTOCHEM PHOTOBIOL; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Chen H, 2007, J CELL BIOCHEM, V102, P1281, DOI 10.1002/jcb.21358; Crew FAE, 1931, J GENET, V25, P17; Deckbar D, 2011, CRIT REV BIOCHEM MOL, V46, P271, DOI 10.3109/10409238.2011.575764; Falvo JV, 2010, CURR DIR AUTOIMMUN, V11, P27, DOI 10.1159/000289196; Feng B, 2004, CELL IMMUNOL, V232, P9, DOI 10.1016/j.cellimm.2005.01.006; FORBES PD, 1981, PHOTOCHEM PHOTOBIOL, V34, P361, DOI 10.1111/j.1751-1097.1981.tb09371.x; Green CL, 2004, SEMIN CANCER BIOL, V14, P63, DOI 10.1016/j.semcancer.2003.11.007; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Howard A, 1940, J HERED, V31, P467, DOI 10.1093/oxfordjournals.jhered.a104815; Hudson LG, 2010, MOL CARCINOGEN, V49, P619, DOI 10.1002/mc.20636; IVERSEN U, 1976, CANCER RES, V36, P1238; Kanoh M, 2008, EUR J DERMATOL, V18, P518, DOI 10.1684/ejd.2008.0485; Kaur G, 2010, MOL CARCINOGEN, V49, P290, DOI 10.1002/mc.20601; Kim AL, 2002, PHOTOCHEM PHOTOBIOL, V75, P58, DOI 10.1562/0031-8655(2002)075<0058:SSAOCE>2.0.CO;2; LAN R, 1994, PHOTOCHEM PHOTOBIOL, V59, P356, DOI 10.1111/j.1751-1097.1994.tb05047.x; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Loercher A, 2004, CANCER RES, V64, P6511, DOI 10.1158/0008-5472.CAN-04-0852; Muthusamy V, 2010, ARCH DERMATOL RES, V302, P5, DOI 10.1007/s00403-009-0994-y; Panteleyev AA, 2000, AM J PATHOL, V157, P1071, DOI 10.1016/S0002-9440(10)64621-4; Panteleyev AA, 1999, AM J PATHOL, V155, P159, DOI 10.1016/S0002-9440(10)65110-3; Panteleyev AA, 1998, EXP DERMATOL, V7, P249, DOI 10.1111/j.1600-0625.1998.tb00295.x-i1; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Qin JZ, 2001, J INVEST DERMATOL, V117, P898, DOI 10.1046/j.0022-202x.2001.01477.x; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Schaffer BS, 2010, MOL CANCER THER, V9, P2354, DOI 10.1158/1535-7163.MCT-10-0207; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Snell GD, 1931, GENETICS, V16, P0042; STEINEL HH, 1988, CANCER LETT, V41, P63, DOI 10.1016/0304-3835(88)90055-9; STOYE JP, 1988, CELL, V54, P383, DOI 10.1016/0092-8674(88)90201-2; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Sur I, 2008, INT REV IMMUNOL, V27, P205, DOI 10.1080/08830180802130319; Tang XW, 2008, PHOTOCHEM PHOTOBIOL, V84, P522, DOI 10.1111/j.1751-1097.2008.00303.x; Thompson Catherine C, 2009, Nucl Recept Signal, V7, pe010, DOI 10.1621/nrs.07010; Tracey L, 2005, J PATHOL, V206, P123, DOI 10.1002/path.1768; VANLAETHEM A, 2009, PHOTOCH PHOTOBIO SCI, V8, P299, DOI DOI 10.1039/B813346H; Weinberg AS, 2007, DERMATOL SURG, V33, P885, DOI 10.1111/j.1524-4725.2007.33190.x; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999; Yan M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-437; Zarach JM, 2004, DEVELOPMENT, V131, P4189, DOI 10.1242/dev.01303; Zhan H, 2007, AM J CLIN DERMATOL, V8, P195, DOI 10.2165/00128071-200708040-00002; Zhao JF, 1999, PHOTOCHEM PHOTOBIOL, V70, P637, DOI 10.1111/j.1751-1097.1999.tb08263.x	50	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39691	10.1371/journal.pone.0039691	http://dx.doi.org/10.1371/journal.pone.0039691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761871	Green Submitted, gold, Green Published			2022-12-27	WOS:000305781700058
J	van't Hoog, AH; Meme, HK; Laserson, KF; Agaya, JA; Muchiri, BG; Githui, WA; Odeny, LO; Marston, BJ; Borgdorff, MW				van't Hoog, Anna H.; Meme, Helen K.; Laserson, Kayla F.; Agaya, Janet A.; Muchiri, Benson G.; Githui, Willie A.; Odeny, Lazarus O.; Marston, Barbara J.; Borgdorff, Martien W.			Screening Strategies for Tuberculosis Prevalence Surveys: The Value of Chest Radiography and Symptoms	PLOS ONE			English	Article							INFECTIOUS TUBERCULOSIS; PULMONARY TUBERCULOSIS; TRIBAL POPULATION; BURDEN; HIV; COMMUNITY; DIAGNOSIS; HARARE; YIELD; INDIA	Background: We conducted a tuberculosis (TB) prevalence survey and evaluated the screening methods used in our survey, to assess if screening in TB prevalence surveys could be simplified, and to assess the accuracy of screening algorithms that may be applicable for active case finding. Methods: All participants with a positive screen on either a symptom questionnaire, chest radiography (CXR) and/or sputum smear microscopy submitted sputum for culture. HIV status was obtained from prevalent cases. We estimated the accuracy of modified screening strategies with bacteriologically confirmed TB as the gold standard, and compared these with other survey reports. We also assessed whether sequential rather than parallel application of symptom, CXR and HIV screening would substantially reduce the number of participants requiring CXR and/or sputum culture. Results: Presence of any abnormality on CXR had 94% (95%CI 88-98) sensitivity (92% in HIV-infected and 100% in HIV-uninfected) and 73% (95%CI 68-77) specificity. Symptom screening combinations had significantly lower sensitivity than CXR except for 'any TB symptom' which had 90% (95%CI 84-95) sensitivity (96% in HIV-infected and 82% in HIV-uninfected) and 32% (95%CI 30-34) specificity. Smear microscopy did not yield additional suspects, thus the combined symptom/CXR screen applied in the survey had 100% (95%CI 97-100) sensitivity. Specificity was 65% (95%CI 61-68). Sequential application of first a symptom screen for 'any symptom', followed by CXR-evaluation and different suspect criteria depending on HIV status would result in the largest reduction of the need for CXR and sputum culture, approximately 36%, but would underestimate prevalence by 11%. Conclusion: CXR screening alone had higher accuracy compared to symptom screening alone. Combined CXR and symptom screening had the highest sensitivity and remains important for suspect identification in TB prevalence surveys in settings where bacteriological sputum examination of all participants is not feasible.	[van't Hoog, Anna H.; Laserson, Kayla F.; Agaya, Janet A.; Muchiri, Benson G.; Odeny, Lazarus O.] Kenya Govt Med Res Ctr, Ctr Dis Control Res & Publ Hlth Collaborat, Kisumu, Kenya; [van't Hoog, Anna H.; Borgdorff, Martien W.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Meme, Helen K.; Githui, Willie A.] Kenya Govt Med Res Ctr, Ctr Resp Dis Res, Nairobi, Kenya; [Laserson, Kayla F.; Marston, Barbara J.] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA	Kenya Medical Research Institute; University of Amsterdam; Academic Medical Center Amsterdam; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA	van't Hoog, AH (corresponding author), Kenya Govt Med Res Ctr, Ctr Dis Control Res & Publ Hlth Collaborat, Kisumu, Kenya.	a.h.vanthoog@amc.uva.nl	Odeny, Lazarus/CAF-6591-2022		US President's Emergency Plan For AIDS Relief; United States Agency for International Development through John's Hopkins University; Gates Foundation	US President's Emergency Plan For AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States Agency for International Development through John's Hopkins University(United States Agency for International Development (USAID)); Gates Foundation(Bill & Melinda Gates Foundation)	Support provided by The US President's Emergency Plan For AIDS Relief; www.pepfar.gov, United States Agency for International Development through John's Hopkins University and protocol development was also supported by the Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Borgdorff MW, 2002, B WORLD HEALTH ORGAN, V80, P217; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Churchyard GJ, 2010, AIDS, V24, pS19, DOI 10.1097/01.aids.0000391018.72542.46; Corbett EL, 2009, INT J TUBERC LUNG D, V13, P1231; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Corbett EL, 2010, B WORLD HEALTH ORGAN, V88, P13, DOI 10.2471/BLT.08.055467; Datta M, 2001, INT J TUBERC LUNG D, V5, P240; Davis JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009859; den Boon S, 2006, INT J TUBERC LUNG D, V10, P876; Den Boon S, 2005, INT J TUBERC LUNG D, V9, P1088; Glaziou P, 2008, INT J TUBERC LUNG D, V12, P1003; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Gopi PG, 2006, INT J TUBERC LUNG D, V10, P343; Gopi PG, 2003, INT J TUBERC LUNG D, V7, P1154; Guwatudde D, 2003, B WORLD HEALTH ORGAN, V81, P799; Lewis JJ, 2009, AM J RESP CRIT CARE, V180, P1271, DOI 10.1164/rccm.200806-846OC; Marciniuk DD, 1999, CHEST, V115, P445, DOI 10.1378/chest.115.2.445; Ministry of Health Kingdom of Cambodia, 2002, REP NAT TB PREV SURV; Ministry of Health of the People's Republic of China, 2004, REP NAT RAND SURV EP; Monkongdee P, 2009, AM J RESP CRIT CARE, V180, P903, DOI 10.1164/rccm.200905-0692OC; Mtei L, 2005, CLIN INFECT DIS, V40, P1500, DOI 10.1086/429825; Murhekar MV, 2004, B WORLD HEALTH ORGAN, V82, P836; National AIDS/STI Control Programme (NASCOP) Kenya, 2009, 2007 KEN AIDS IND SU; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; OCONNOR GT, 1994, AM J RESP CRIT CARE, V149, pS21, DOI 10.1164/ajrccm/149.2_Pt_2.S21; Pronyk PM, 2001, INT J TUBERC LUNG D, V5, P611; Salim MAH, 2004, INT J TUBERC LUNG D, V8, P952; Sebhatu M, 2007, B WORLD HEALTH ORGAN, V85, P593, DOI 10.2471/BLT.06.038604; Shargie EB, 2006, INT J TUBERC LUNG D, V10, P87; Soemantri S, 2007, INT J TUBERC LUNG D, V11, P398; Tupasi TE, 2009, INT J TUBERC LUNG D, V13, P1224; van der Werf MJ, 2008, INT J TUBERC LUNG D, V12, P1255; van Ginneken B, 2009, EUR J RADIOL, V72, P226, DOI 10.1016/j.ejrad.2009.05.061; van Leth F, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P58, DOI 10.5588/ijtld.10.0417; van't Hoog AH, 2011, INT J TUBERC LUNG D, V15, P1308, DOI 10.5588/ijtld.11.0004; van't Hoog AH, 2011, AM J RESP CRIT CARE, V183, P1245, DOI 10.1164/rccm.201008-1269OC; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; World Health Organization, 1998, LAB SERV TUB CONTR 3; World Health Organization, 2007, ASS TB PREV POP BAS; World Health Organization, 2009, WHOHTMTB2009419, P2; World Health Organization (WHO), 2009, WHOHTMTB2009426; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	44	71	71	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e38691	10.1371/journal.pone.0038691	http://dx.doi.org/10.1371/journal.pone.0038691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792158	Green Submitted, Green Published, gold			2022-12-27	WOS:000306461800004
J	Cruz-Machado, SD; Pinato, L; Tamura, EK; Carvalho-Sousa, CE; Markus, RP				Cruz-Machado, Sanseray da Silveira; Pinato, Luciana; Tamura, Eduardo Koji; Carvalho-Sousa, Claudia Emanuele; Markus, Regina P.			Glia-Pinealocyte Network: The Paracrine Modulation of Melatonin Synthesis by Tumor Necrosis Factor (TNF)	PLOS ONE			English	Article							NF-KAPPA-B; INNATE IMMUNE-RESPONSE; CELL-WALL COMPONENTS; TOLL-LIKE RECEPTOR-4; GLAND; RAT; SYSTEM; LIPOPOLYSACCHARIDE; ACTIVATION; INCREASE	The pineal gland, a circumventricular organ, plays an integrative role in defense responses. The injury-induced suppression of the pineal gland hormone, melatonin, which is triggered by darkness, allows the mounting of innate immune responses. We have previously shown that cultured pineal glands, which express toll-like receptor 4 (TLR4) and tumor necrosis factor receptor 1 (TNFR1), produce TNF when challenged with lipopolysaccharide (LPS). Here our aim was to evaluate which cells present in the pineal gland, astrocytes, microglia or pinealocytes produced TNF, in order to understand the interaction between pineal activity, melatonin production and immune function. Cultured pineal glands or pinealocytes were stimulated with LPS. TNF content was measured using an enzyme-linked immunosorbent assay. TLR4 and TNFR1 expression were analyzed by confocal microscopy. Microglial morphology was analyzed by immunohistochemistry. In the present study, we show that although the main cell types of the pineal gland (pinealocytes, astrocytes and microglia) express TLR4, the production of TNF induced by LPS is mediated by microglia. This effect is due to activation of the nuclear factor kappa B (NF-kB) pathway. In addition, we observed that LPS activates microglia and modulates the expression of TNFR1 in pinealocytes. As TNF has been shown to amplify and prolong inflammatory responses, its production by pineal microglia suggests a glia-pinealocyte network that regulates melatonin output. The current study demonstrates the molecular and cellular basis for understanding how melatonin synthesis is regulated during an innate immune response, thus our results reinforce the role of the pineal gland as sensor of immune status.	[Cruz-Machado, Sanseray da Silveira; Tamura, Eduardo Koji; Carvalho-Sousa, Claudia Emanuele; Markus, Regina P.] Univ Sao Paulo, Inst Biosci, Lab Chronopharmacol, Sao Paulo, Brazil; [Pinato, Luciana] Univ Estadual Paulista UNESP, Dept Speech Language & Hearing Therapy, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista	Cruz-Machado, SD (corresponding author), Univ Sao Paulo, Inst Biosci, Lab Chronopharmacol, Sao Paulo, Brazil.	rpmarkus@usp.br	Tamura, Eduardo Koji/F-7068-2012; Markus, Regina P./AAC-1505-2021; Tamura, Eduardo Koji/L-4360-2019; Markus, Regina P/K-2954-2012; Pinato, luciana/A-8314-2018	Tamura, Eduardo Koji/0000-0002-6105-7452; Markus, Regina P./0000-0003-4606-6120; Tamura, Eduardo Koji/0000-0002-6105-7452; Markus, Regina P/0000-0003-4606-6120; da Silveira Cruz-Machado, Sanseray/0000-0002-6937-7207; Pinato, luciana/0000-0001-7788-9205	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [07/07871-6]; Conselho Nacional de Pesquisa - CNPq [305378/2009-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding for this study was provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP - (07/07871-6) to RPM; Conselho Nacional de Pesquisa - CNPq - 305378/2009-0 - to RPM; and RPM senior fellow CNPq, LP and EKT - post-doc fellows FAPESP, and SSCM and CECS - PhD fellows FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORJIGIN J, 1995, NATURE, V378, P783, DOI 10.1038/378783a0; Bubenik GA, 2002, DIGEST DIS SCI, V47, P2336, DOI 10.1023/A:1020107915919; Carrillo-Vico A, 2004, FASEB J, V18, P537, DOI 10.1096/fj.03-0694fje; CARVALHOSOUSA CE, 2011, FR ENDOCRINOL, V2, P1, DOI DOI 10.3389/FENDO.2011.00010; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Cruz-Machado SD, 2010, J PINEAL RES, V49, P183, DOI 10.1111/j.1600-079X.2010.00785.x; Fernandes PACM, 2006, J PINEAL RES, V41, P344, DOI 10.1111/j.1600-079X.2006.00373.x; Ferreira ZS, 2003, PHARMACOLOGY, V69, P33, DOI 10.1159/000071264; FERREIRA ZS, 1994, BRIT J PHARMACOL, V112, P107, DOI 10.1111/j.1476-5381.1994.tb13037.x; Ganguly S, 2001, P NATL ACAD SCI USA, V98, P8083, DOI 10.1073/pnas.141118798; Gomez-Corvera A, 2009, J PINEAL RES, V47, P15, DOI 10.1111/j.1600-079X.2009.00683.x; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Ho AK, 2006, MOL CELL ENDOCRINOL, V252, P34, DOI 10.1016/j.mce.2006.03.022; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Jiang-Shieh YF, 2005, J PINEAL RES, V38, P17, DOI 10.1111/j.1600-079X.2004.00170.x; Kaltschmidt B, 2000, EXP BRAIN RES, V130, P100, DOI 10.1007/s002210050011; Konturek SJ, 2007, J PHYSIOL PHARMACOL, V58, P23; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Laflamme N, 2001, FASEB J, V15, P155, DOI 10.1096/fj.00-0339com; Lardone PJ, 2006, J CELL PHYSIOL, V206, P273, DOI 10.1002/jcp.20461; Liu YJ, 2007, J PINEAL RES, V43, P232, DOI 10.1111/j.1600-079X.2007.00466.x; Lotufo CMC, 2006, EUR J PHARMACOL, V534, P258, DOI 10.1016/j.ejphar.2006.01.050; Lotufo CMC, 2001, EUR J PHARMACOL, V430, P351, DOI 10.1016/S0014-2999(01)01369-3; Majewski P, 2005, J PINEAL RES, V39, P66, DOI 10.1111/j.1600-079X.2005.00214.x; Maldonado MD, 2010, PHARMACOL RES, V62, P282, DOI 10.1016/j.phrs.2009.11.014; Markus RP, 2007, NEUROIMMUNOMODULAT, V14, P126, DOI 10.1159/000110635; Markus RP, 2011, ADV NEUROIMMUNE BIOL, V1, P95, DOI 10.3233/NIB-2011-009; Moller M, 2002, CELL TISSUE RES, V309, P139, DOI 10.1007/s00441-002-0580-5; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; PAULSEN RE, 1987, J NEUROCHEM, V48, P1377, DOI 10.1111/j.1471-4159.1987.tb05674.x; Pedron T, 2003, J BIOL CHEM, V278, P20555, DOI 10.1074/jbc.M203551200; Perras B, 2006, INTENS CARE MED, V32, P624, DOI 10.1007/s00134-006-0069-x; Pontes GN, 2007, J PINEAL RES, V43, P365, DOI 10.1111/j.1600-079X.2007.00487.x; Pontes GN, 2006, J PINEAL RES, V41, P136, DOI 10.1111/j.1600-079X.2006.00345.x; Roseboom PH, 1996, ENDOCRINOLOGY, V137, P3033, DOI 10.1210/en.137.7.3033; Skwarlo-Sonta K, 2003, CAN J PHYSIOL PHARM, V81, P342, DOI 10.1139/Y03-026; Srinivasan V, 2010, J PINEAL RES, V48, P1, DOI 10.1111/j.1600-079X.2009.00728.x; Tamura EK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013958; Tsai SY, 2001, HISTOL HISTOPATHOL, V16, P1135, DOI 10.14670/HH-16.1135; Tsai SY, 2001, CELL TISSUE RES, V303, P423, DOI 10.1007/s004410000330; Tsai SY, 1999, J PINEAL RES, V27, P42, DOI 10.1111/j.1600-079X.1999.tb00595.x; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Venegas C, 2012, J PINEAL RES, V52, P217, DOI 10.1111/j.1600-079X.2011.00931.x; Wong ET, 2009, CLIN SCI, V116, P451, DOI 10.1042/CS20080502; Wuchert F, 2008, J NEUROIMMUNOL, V204, P66, DOI 10.1016/j.jneuroim.2008.07.017; Zhou H, 2009, J IMMUNOL, V183, P5244, DOI 10.4049/jimmunol.0901309	46	48	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40142	10.1371/journal.pone.0040142	http://dx.doi.org/10.1371/journal.pone.0040142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768337	gold, Green Published, Green Submitted			2022-12-27	WOS:000305966500050
J	Homolka, S; Projahn, M; Feuerriegel, S; Ubben, T; Diel, R; Nubel, U; Niemann, S				Homolka, Susanne; Projahn, Michaela; Feuerriegel, Silke; Ubben, Tanja; Diel, Roland; Nuebel, Ulrich; Niemann, Stefan			High Resolution Discrimination of Clinical Mycobacterium tuberculosis Complex Strains Based on Single Nucleotide Polymorphisms	PLOS ONE			English	Article							ETHAMBUTOL RESISTANCE; VARIABLE-NUMBER; MIRU-VNTRPLUS; LINEAGE; GENE; RECOMMENDATIONS; PHYLOGEOGRAPHY; IDENTIFICATION; DIVERSITY; EVOLUTION	Recently, the diversity of the Mycobacterium tuberculosis complex (MTBC) population structure has been described in detail. Based on geographical separation and specific host pathogen co-evolution shaping MTBC virulence traits, at least 20 major lineages/genotypes have evolved finally leading to a clear influence of strain genetic background on transmissibility, clinical presentation/outcome, and resistance development. Therefore, high resolution genotyping for characterization of strains in larger studies is mandatory for understanding mechanisms of host-pathogen-interaction and to improve tuberculosis (TB) control. Single nucleotide polymorphisms (SNPs) represent the most reliable markers for lineage classification of clinical isolates due to the low levels of homoplasy, however their use is hampered either by low discriminatory power or by the need to analyze a large number of genes to achieve higher resolution. Therefore, we carried out de novo sequencing of 26 genes (approx. 20000 bp per strain) in a reference collection of MTBC strains including all major genotypes to define a highly discriminatory gene set. Overall, 161 polymorphisms were detected of which 59 are genotype-specific, while 13 define deeper branches such as the Euro-American lineage. Unbiased investigation of the most variable set of 11 genes in a population based strain collection (one year, city of Hamburg, Germany) confirmed the validity of SNP analysis as all strains were classified with high accuracy. Taken together, we defined a diagnostic algorithm which allows the identification of 17 MTBC phylogenetic lineages with high confidence for the first time by sequencing analysis of just five genes. In conclusion, the diagnostic algorithm developed in our study is likely to open the door for a low cost high resolution sequence/SNP based differentiation of the MTBC with a very high specificity. High throughput assays can be established which will be needed for large association studies that are mandatory for detailed investigation of host-pathogen-interaction during TB infection.	[Homolka, Susanne; Projahn, Michaela; Feuerriegel, Silke; Ubben, Tanja; Niemann, Stefan] Res Ctr Borstel, Borstel, Germany; [Diel, Roland] Med Sch Hannover MHH, Dept Pneumol, Hannover, Germany; [Nuebel, Ulrich] Robert Koch Inst, Wernigerrode, Germany	Forschungszentrum Borstel; Hannover Medical School; Robert Koch Institute	Homolka, S (corresponding author), Res Ctr Borstel, Borstel, Germany.	sniemann@fz-borstel.de	Projahn, Michaela/O-7430-2018; Projahn, Michaela/GSD-6357-2022; Niemann, Stefan/C-9327-2011	Projahn, Michaela/0000-0002-3896-3561; Niemann, Stefan/0000-0002-6604-0684	Germany Ministry of Health; German Federal Ministry for Education and Research (BMBF) within the PathoGenomikPlus network [0313801J]; German Federal Ministry for Education and Research (BMBF) within the "TB or not TB'' network [01KI0784]; European Union TB-PAN-NET [FP7-223681]	Germany Ministry of Health; German Federal Ministry for Education and Research (BMBF) within the PathoGenomikPlus network; German Federal Ministry for Education and Research (BMBF) within the "TB or not TB'' network; European Union TB-PAN-NET	Parts of this work were were supported by the Germany Ministry of Health and the German Federal Ministry for Education and Research (BMBF) within the PathoGenomikPlus (0313801J) and "TB or not TB'' (01KI0784) networks and by the European Union TB-PAN-NET (FP7-223681) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; [Anonymous], 2011, GLOB TUB CONTR; Baker S, 2010, CURR OPIN MICROBIOL, V13, P640, DOI 10.1016/j.mib.2010.08.002; Beisiegel M, 2009, EUR J IMMUNOL, V39, P3369, DOI 10.1002/eji.200939615; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Choi GE, 2011, KOREAN J LAB MED, V31, P37, DOI 10.3343/kjlm.2011.31.1.37; Chuang PC, 2010, J CLIN MICROBIOL, V48, P4245, DOI 10.1128/JCM.00970-10; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Cox HS, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-134; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; Douglas JT, 2003, J CLIN MICROBIOL, V41, P2723, DOI 10.1128/JCM.41.6.2723-2726.2003; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kaufmann SHE, 2006, NAT REV IMMUNOL, V6, P699, DOI 10.1038/nri1920; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Plinke C, 2006, ANTIMICROB AGENTS CH, V50, P1900, DOI 10.1128/AAC.50.5.1900-1902.2006; Ramaswamy SV, 2000, ANTIMICROB AGENTS CH, V44, P326, DOI 10.1128/AAC.44.2.326-336.2000; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Thye T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020908; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160	38	86	87	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39855	10.1371/journal.pone.0039855	http://dx.doi.org/10.1371/journal.pone.0039855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768315	gold, Green Published			2022-12-27	WOS:000305966500028
J	Chang, YH; Lee, CP; Su, MT; Wang, JT; Chen, JY; Lin, SF; Tsai, CH; Hsieh, MJ; Takada, K; Chen, MR				Chang, Yu-Hsin; Lee, Chung-Pei; Su, Mei-Tzu; Wang, Jiin-Tarng; Chen, Jen-Yang; Lin, Su-Fang; Tsai, Ching-Hwa; Hsieh, Min-Jei; Takada, Kenzo; Chen, Mei-Ru			Epstein-Barr Virus BGLF4 Kinase Retards Cellular S-Phase Progression and Induces Chromosomal Abnormality	PLOS ONE			English	Article							RETINOBLASTOMA GENE-PRODUCT; CONSERVED PROTEIN-KINASES; DNA-DAMAGE RESPONSE; LYTIC REPLICATION; PHOSPHORYLATION; CYCLE; INHIBITION; EXPRESSION; TARGET; COMPLEX	Epstein-Barr virus (EBV) induces an uncoordinated S-phase-like cellular environment coupled with multiple prophase-like events in cells replicating the virus. The EBV encoded Ser/Thr kinase BGLF4 has been shown to induce premature chromosome condensation through activation of condensin and topoisomerase II and reorganization of the nuclear lamina to facilitate the nuclear egress of nucleocapsids in a pathway mimicking Cdk1. However, the observation that RB is hyperphosphorylated in the presence of BGLF4 raised the possibility that BGLF4 may have a Cdk2-like activity to promote S-phase progression. Here, we investigated the regulatory effects of BGLF4 on cell cycle progression and found that S-phase progression and DNA synthesis were interrupted by BGLF4 in mammalian cells. Expression of BGLF4 did not compensate Cdk1 defects for DNA replication in S. cerevisiae. Using time-lapse microscopy, we found the fate of individual HeLa cells was determined by the expression level of BGLF4. In addition to slight cell growth retardation, BGLF4 elicits abnormal chromosomal structure and micronucleus formation in 293 and NCP-TW01 cells. In Saos-2 cells, BGLF4 induced the hyperphosphorylation of co-transfected RB, while E2F1 was not released from RB-E2F1 complexes. The E2F1 regulated activities of the cyclin D1 and ZBRK1 promoters were suppressed by BGLF4 in a dose dependent manner. Detection with phosphoamino acid specific antibodies revealed that, in addition to Ser780, phosphorylation of the DNA damage-responsive Ser612 on RB was enhanced by BGLF4. Taken together, our study indicates that BGLF4 may directly or indirectly induce a DNA damage signal that eventually interferes with host DNA synthesis and delays S-phase progression.	[Chang, Yu-Hsin; Lee, Chung-Pei; Su, Mei-Tzu; Wang, Jiin-Tarng; Chen, Jen-Yang; Tsai, Ching-Hwa; Chen, Mei-Ru] Natl Taiwan Univ, Coll Med, Grad Inst, Taipei 10764, Taiwan; [Chang, Yu-Hsin; Lee, Chung-Pei; Su, Mei-Tzu; Wang, Jiin-Tarng; Chen, Jen-Yang; Tsai, Ching-Hwa; Chen, Mei-Ru] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan; [Lee, Chung-Pei] Natl Taipei Univ Nursing & Hlth Sci, Gen Educ Ctr, Taipei, Taiwan; [Chen, Jen-Yang; Lin, Su-Fang; Hsieh, Min-Jei] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan, Taiwan; [Takada, Kenzo] Hokkaido Univ, Inst Genet Med, Dept Tumor Virol, Sapporo, Hokkaido, Japan	National Taiwan University; National Taiwan University; National Taipei University of Nursing & Health Science (NTUNHS); National Health Research Institutes - Taiwan; Hokkaido University	Chang, YH (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst, Taipei 10764, Taiwan.	mrc@ntu.edu.tw	Chen, Jen-Yang/D-2085-2010; Lin, Su-Fang/B-2666-2010	CHEN, MEI-RU/0000-0002-7007-8036; Lin, Su-Fang/0000-0001-8706-2439	National Health Research Institute [NHRI-EX100-9928BI]; National Science National Science Council [NSC98-2320B002-54 MY3]; National Taiwan University, Taiwan [99R71423]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science National Science Council; National Taiwan University, Taiwan(National Taiwan University)	This study was supported by National Health Research Institute, (NHRI-EX100-9928BI, http://www.nhri.org.tw/) and partially supported by National Science National Science Council (NSC98-2320B002-54 MY3, http://web1.nsc.gov.tw/) and National Taiwan University, Taiwan (99R71423, http://www.ntu.edu.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplan PD, 1996, BLOOD, V87, P2649, DOI 10.1182/blood.V87.7.2649.bloodjournal8772649; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Chang Y, 1999, J VIROL, V73, P8857, DOI 10.1128/JVI.73.10.8857-8866.1999; Chen KC, 2000, MOL BIOL CELL, V11, P369, DOI 10.1091/mbc.11.1.369; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; Depowski PL, 2000, MODERN PATHOL, V13, P542, DOI 10.1038/modpathol.3880094; El Achkar E, 2005, P NATL ACAD SCI USA, V102, P18069, DOI 10.1073/pnas.0506497102; Fang CY, 2009, INT J CANCER, V124, P2016, DOI 10.1002/ijc.24179; Gershburg E, 2008, BBA-PROTEINS PROTEOM, V1784, P203, DOI 10.1016/j.bbapap.2007.08.009; GOODRICH DW, 1991, CELL, V67, P293, DOI 10.1016/0092-8674(91)90181-W; HEDDLE JA, 1991, ENVIRON MOL MUTAGEN, V18, P277, DOI 10.1002/em.2850180414; HIEBERT SW, 1992, GENE DEV, V6, P177, DOI 10.1101/gad.6.2.177; Hume AJ, 2008, SCIENCE, V320, P797, DOI 10.1126/science.1152095; Inoue Y, 2007, EMBO J, V26, P2083, DOI 10.1038/sj.emboj.7601652; Iwahori S, 2009, J BIOL CHEM, V284, P18923, DOI 10.1074/jbc.M109.015123; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kato K, 2001, J GEN VIROL, V82, P1457, DOI 10.1099/0022-1317-82-6-1457; Kawaguchi Y, 2003, J VIROL, V77, P2359, DOI 10.1128/JVI.77.4.2359-2368.2003; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Knudsen ES, 1998, GENE DEV, V12, P2278, DOI 10.1101/gad.12.15.2278; Knudsen ES, 1997, MOL CELL BIOL, V17, P5771, DOI 10.1128/MCB.17.10.5771; Kudoh A, 2005, J BIOL CHEM, V280, P8156, DOI 10.1074/jbc.M411405200; Kudoh A, 2004, J VIROL, V78, P104, DOI 10.1128/JVI.78.1.104-115.2004; Kudoh A, 2003, J VIROL, V77, P851, DOI 10.1128/JVI.77.2.851-861.2003; Kudoh A, 2006, J VIROL, V80, P10064, DOI 10.1128/JVI.00678-06; Kuny CV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001092; Lee CP, 2007, J VIROL, V81, P5166, DOI 10.1128/JVI.00120-07; Lee CP, 2008, J VIROL, V82, P11913, DOI 10.1128/JVI.01100-08; Li RF, 2011, CELL HOST MICROBE, V10, P390, DOI 10.1016/j.chom.2011.08.013; Liao CC, 2010, J BIOL CHEM, V285, P33134, DOI 10.1074/jbc.M110.143461; LIN CT, 1990, LAB INVEST, V62, P713; LORINCZ AT, 1986, MOL CELL BIOL, V6, P4099; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Maruo S, 2001, J GEN VIROL, V82, P2373, DOI 10.1099/0022-1317-82-10-2373; Mauser A, 2002, J VIROL, V76, P12543, DOI 10.1128/JVI.76.24.12543-12552.2002; McClendon H, 2007, DIMENS CRIT CARE NUR, V26, P199, DOI 10.1097/01.DCC.0000286824.11861.74; Mekhail K, 2010, NAT REV MOL CELL BIO, V11, P317, DOI 10.1038/nrm2894; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Ou YH, 2007, EMBO J, V26, P3968, DOI 10.1038/sj.emboj.7601825; SUPER HJG, 1993, BLOOD, V82, P3705; Tarakanova VL, 2007, CELL HOST MICROBE, V1, P275, DOI 10.1016/j.chom.2007.05.008; Tsai CH, 1997, J BIOMED SCI, V4, P69, DOI 10.1007/BF02255596; Wang JT, 2005, J GEN VIROL, V86, P3215, DOI 10.1099/vir.0.81313-0; Yang PW, 2008, J GEN VIROL, V89, P884, DOI 10.1099/vir.0.83546-0; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhu J, 2009, J VIROL, V83, P5219, DOI 10.1128/JVI.02378-08	50	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39217	10.1371/journal.pone.0039217	http://dx.doi.org/10.1371/journal.pone.0039217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768064	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100034
J	Heller, EA; Zhang, WZ; Selimi, F; Earnheart, JC; Slimak, MA; Santos-Torres, J; Ibanez-Tallon, I; Aoki, C; Chait, BT; Heintz, N				Heller, Elizabeth A.; Zhang, Wenzhu; Selimi, Fekrije; Earnheart, John C.; Slimak, Marta A.; Santos-Torres, Julio; Ibanez-Tallon, Ines; Aoki, Chiye; Chait, Brian T.; Heintz, Nathaniel			The Biochemical Anatomy of Cortical Inhibitory Synapses	PLOS ONE			English	Article							POSTSYNAPTIC DENSITY FRACTION; GABA(A) RECEPTOR TRAFFICKING; ADULT-RAT BRAIN; GLUTAMATERGIC SYNAPSES; SIGNALING COMPLEXES; GABAERGIC SYNAPSES; MASS-SPECTROMETRY; ADHESION PROTEIN; GAMMA-2 SUBUNIT; CEREBRAL-CORTEX	Classical electron microscopic studies of the mammalian brain revealed two major classes of synapses, distinguished by the presence of a large postsynaptic density (PSD) exclusively at type 1, excitatory synapses. Biochemical studies of the PSD have established the paradigm of the synapse as a complex signal-processing machine that controls synaptic plasticity. We report here the results of a proteomic analysis of type 2, inhibitory synaptic complexes isolated by affinity purification from the cerebral cortex. We show that these synaptic complexes contain a variety of neurotransmitter receptors, neural cell-scaffolding and adhesion molecules, but that they are entirely lacking in cell signaling proteins. This fundamental distinction between the functions of type 1 and type 2 synapses in the nervous system has far reaching implications for models of synaptic plasticity, rapid adaptations in neural circuits, and homeostatic mechanisms controlling the balance of excitation and inhibition in the mature brain.	[Heller, Elizabeth A.; Earnheart, John C.; Heintz, Nathaniel] Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10021 USA; [Zhang, Wenzhu; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA; [Selimi, Fekrije] Coll France, CIRB, Paris, France; [Slimak, Marta A.; Santos-Torres, Julio; Ibanez-Tallon, Ines] Max Delbruck Ctr Mol Med, Mol Neurobiol Grp, Berlin, Germany; [Aoki, Chiye] NYU, Ctr Neural Sci, New York, NY 10003 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; UDICE-French Research Universities; PSL Research University Paris; College de France; Helmholtz Association; Max Delbruck Center for Molecular Medicine; New York University	Heller, EA (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10021 USA.	heintz@rockefeller.edu	Aoki, Chiye/T-9405-2019	Aoki, Chiye/0000-0003-4010-9425; Slimak-Mastrobuoni, Marta/0000-0003-3203-2309; Heller, Elizabeth A/0000-0002-2984-8705	Irma L. & Abram S. Croll Charitable Trust; Simons Foundation; Howard Hughes Medical Institute; National Eye Institute [EY13079]; National Institutes of Health (NIH) [5 R01 DA009618-09, RR00862, RR022220]; Klarman Family Foundation; NYU Research Challenge Fund; Helmholtz Association [31-002];  [MH091445-01];  [Sonderforschungsbereich SFB 665]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862, U54RR022220] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY013079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH091445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009618] Funding Source: NIH RePORTER	Irma L. & Abram S. Croll Charitable Trust; Simons Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klarman Family Foundation; NYU Research Challenge Fund; Helmholtz Association(Helmholtz Association); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by Irma L. & Abram S. Croll Charitable Trust, Simons Foundation and Howard Hughes Medical Institute to NH; National Eye Institute Core grant EY13079, National Institutes of Health (NIH) 5 R01 DA009618-09, Klarman Family Foundation grant, NYU Research Challenge Fund Grant, and MH091445-01 to CA; NIH RR00862 and NIH RR022220 to WZ and BTC; Helmholtz Association 31-002 and Sonderforschungsbereich SFB 665 to IIT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki C, 2000, METH MOL B, V136, P535; Arancibia-Carcamo IL, 2009, P NATL ACAD SCI USA, V106, P17552, DOI 10.1073/pnas.0905502106; Auer S, 2010, NAT METHODS, V7, P229, DOI [10.1038/NMETH.1425, 10.1038/nmeth.1425]; Bayes A, 2009, NAT REV NEUROSCI, V10, P635, DOI 10.1038/nrn2701; Beavis Ronald C., 2006, V328, P217; Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; BLOMBERG F, 1977, J CELL BIOL, V74, P204, DOI 10.1083/jcb.74.1.204; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Burli T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011507; Chen XB, 2005, P NATL ACAD SCI USA, V102, P11551, DOI 10.1073/pnas.0505359102; Chen ZW, 2007, J NEUROSCI, V27, P6655, DOI 10.1523/JNEUROSCI.0919-07.2007; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Delint-Ramirez I, 2010, J NEUROSCI, V30, P8162, DOI 10.1523/JNEUROSCI.1792-10.2010; DUNKLEY PR, 1988, BRAIN RES, V441, P59, DOI 10.1016/0006-8993(88)91383-2; Earnheart JC, 2007, J NEUROSCI, V27, P3845, DOI 10.1523/JNEUROSCI.3609-06.2007; ECCLES JC, 1958, PROC R SOC SER B-BIO, V148, P38, DOI 10.1098/rspb.1958.0003; ECCLES JC, 1959, ANN NY ACAD SCI, V81, P247, DOI 10.1111/j.1749-6632.1959.tb49312.x; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Fritschy JM, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.005.2008; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Gasser EMS, 2006, NAT PROTOC, V1, P1887, DOI 10.1038/nprot.2006.265; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; GRAY EG, 1959, J ANAT, V93, P420; Hjelmeland LM, 1990, METHOD ENZYMOL, P253; Huang ZJ, 2008, CURR OPIN NEUROBIOL, V18, P77, DOI 10.1016/j.conb.2008.05.008; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Hutcheon B, 2004, EUR J NEUROSCI, V19, P2475, DOI 10.1111/j.0953-816X.2004.03349.x; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; KELLY PT, 1978, J CELL BIOL, V79, P173, DOI 10.1083/jcb.79.1.173; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Levinson JN, 2010, NEUROSCIENCE, V165, P782, DOI 10.1016/j.neuroscience.2009.11.016; Li X, 2007, J NEUROCHEM, V102, P1329, DOI 10.1111/j.1471-4159.2007.04635.x; Li XJ, 2009, J BIOL CHEM, V284, P17253, DOI 10.1074/jbc.M109.008870; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; McBain CJ, 2009, CURR OPIN NEUROBIOL, V19, P254, DOI 10.1016/j.conb.2009.05.008; MCKERNAN RM, 1991, NEURON, V7, P667, DOI 10.1016/0896-6273(91)90379-E; Medrihan L, 2009, J PHYSIOL-LONDON, V587, P5095, DOI 10.1113/jphysiol.2009.178236; Merchan-Perez A, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.018.2009; Muir J, 2010, P NATL ACAD SCI USA, V107, P16679, DOI 10.1073/pnas.1000589107; Nusser Z, 1998, J NEUROSCI, V18, P1693; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Papadopoulos T, 2008, MOL CELL NEUROSCI, V39, P161, DOI 10.1016/j.mcn.2008.06.006; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Saiepour L., 2010, J BIOL CHEM; Selimi F, 2009, PLOS BIOL, V7, P948, DOI 10.1371/journal.pbio.1000083; Shen H, 2010, SCIENCE, V327, P1515, DOI 10.1126/science.1184245; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; SIEKEVITZ P, 1985, P NATL ACAD SCI USA, V82, P3494, DOI 10.1073/pnas.82.10.3494; Sturzebecher AS, 2010, J PHYSIOL-LONDON, V588, P1695, DOI 10.1113/jphysiol.2010.187112; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Szabadits E, 2011, J NEUROSCI, V31, P5893, DOI 10.1523/JNEUROSCI.5938-10.2011; Thomson AM, 2010, EUR J NEUROSCI, V31, P2193, DOI 10.1111/j.1460-9568.2010.07252.x; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Tyagarajan SK, 2010, J PHYSIOL-LONDON, V588, P101, DOI 10.1113/jphysiol.2009.178517; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Wang XL, 2000, J NEUROSCI, V20, P8551; WEHNER JM, 1993, PHARMACOL BIOCHEM BE, V44, P133, DOI 10.1016/0091-3057(93)90290-A; Wisniewski, 2009, NAT METH, V6, P1	73	42	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39572	10.1371/journal.pone.0039572	http://dx.doi.org/10.1371/journal.pone.0039572			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768092	gold, Green Published, Green Accepted			2022-12-27	WOS:000305892100062
J	Kaundun, SS; Hutchings, SJ; Dale, RP; McIndoe, E				Kaundun, Shiv Shankhar; Hutchings, Sarah-Jane; Dale, Richard Paul; McIndoe, Eddie			Broad Resistance to ACCase Inhibiting Herbicides in a Ryegrass Population Is Due Only to a Cysteine to Arginine Mutation in the Target Enzyme	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; COENZYME-A CARBOXYLASE; LOLIUM-RIGIDUM; ACETOLACTATE-SYNTHASE; CARBOXYLTRANSFERASE DOMAIN; MULTIPLE-RESISTANCE; RAPID EVOLUTION; ENDOWING RESISTANCE; MOLECULAR-BASIS; GENETIC-CONTROL	Background: The design of sustainable weed management strategies requires a good understanding of the mechanisms by which weeds evolve resistance to herbicides. Here we have conducted a study on the mechanism of resistance to ACCase inhibiting herbicides in a Lolium multiflorum population (RG3) from the UK. Methodology/Principal Findings: Analysis of plant phenotypes and genotypes showed that all the RG3 plants (72%) that contained the cysteine to arginine mutation at ACCase codon position 2088 were resistant to ACCase inhibiting herbicides. Whole plant dose response tests on predetermined wild and mutant 2088 genotypes from RG3 and a standard sensitive population indicated that the C2088R mutation is the only factor conferring resistance to all ten ACCase herbicides tested. The associated resistance indices ranged from 13 for clethodim to over 358 for diclofop-methyl. Clethodim, the most potent herbicide was significantly affected even when applied on small mutant plants at the peri-emergence and one leaf stages. Conclusion/Significance: This study establishes the clear and unambiguous importance of the C2088R target site mutation in conferring broad resistance to ten commonly used ACCase inhibiting herbicides. It also demonstrates that low levels "creeping", multigenic, non target site resistance, is not always selected before single gene target site resistance appears in grass weed populations subjected to herbicide selection pressure.	[Kaundun, Shiv Shankhar; Hutchings, Sarah-Jane; Dale, Richard Paul; McIndoe, Eddie] Syngenta, Jealotts Hill Int Res Ctr, Bracknell, Berks, England	Syngenta	Kaundun, SS (corresponding author), Syngenta, Jealotts Hill Int Res Ctr, Bracknell, Berks, England.	deepak.kaundun@syngenta.com	Kaundun, Shiv/AIB-0473-2022					Beckie HJ, 2004, WEED TECHNOL, V18, P853, DOI 10.1614/WT-03-124R; BURNET MWM, 1994, WEED SCI, V42, P369, DOI 10.1017/S0043174500076645; Busi R, 2011, HEREDITY, V106, P817, DOI 10.1038/hdy.2010.124; Cocker KM, 2001, PEST MANAG SCI, V57, P587, DOI 10.1002/ps.330; de Prado JL, 2005, J AGR FOOD CHEM, V53, P2185, DOI 10.1021/jf049481m; Delye C, 2005, WEED SCI, V53, P728, DOI 10.1614/WS-04-203R.1; Delye C, 2005, WEED RES, V45, P323, DOI 10.1111/j.1365-3180.2005.00467.x; Delye C, 2011, WEED RES, V51, P353, DOI 10.1111/j.1365-3180.2011.00852.x; Delye C, 2009, WEED RES, V49, P326, DOI 10.1111/j.1365-3180.2009.00700.x; Delye C, 2011, PLANT SCI, V180, P333, DOI 10.1016/j.plantsci.2010.10.007; Heap I., 2021, INT SURVEY HERBICIDE, DOI DOI 10.1002/ps.3790; HEAP J, 1982, J AUST I AGR SCI, V48, P156; Hofer U, 2006, J PLANT DIS PROTECT, P989; Kaundun SS, 2010, PEST MANAG SCI, V66, P1249, DOI 10.1002/ps.2003; KONISHI T, 1994, P NATL ACAD SCI USA, V91, P3598, DOI 10.1073/pnas.91.9.3598; Kotoula-Syka E, 2000, PEST MANAG SCI, V56, P1054, DOI 10.1002/1526-4998(200012)56:12<1054::AID-PS267>3.0.CO;2-M; Kuk YI, 2008, WEED SCI, V56, P614, DOI 10.1614/WS-08-003.1; Manalil S, 2011, WEED SCI, V59, P210, DOI 10.1614/WS-D-10-00111.1; Maxwell Bruce D., 1994, P1; Neve P, 2005, THEOR APPL GENET, V110, P1154, DOI 10.1007/s00122-005-1947-2; Owen MJ, 2007, AUST J AGR RES, V58, P711, DOI 10.1071/AR06283; Petit C, 2010, PLANT SCI, V178, P501, DOI 10.1016/j.plantsci.2010.03.007; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; RENDINA AR, 1990, J AGR FOOD CHEM, V38, P1282, DOI 10.1021/jf00095a029; Ruegg WT, 2007, WEED RES, V47, P271, DOI 10.1111/j.1365-3180.2007.00572.x; Sammons RD, 2007, WEED TECHNOL, V21, P347, DOI 10.1614/WT-04-150.1; Sasaki Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1175, DOI 10.1271/bbb.68.1175; Scarabel L, 2011, PEST MANAG SCI, V67, P932, DOI 10.1002/ps.2133; SECOR J, 1988, PLANT PHYSIOL, V86, P10, DOI 10.1104/pp.86.1.10; Tan MK, 2007, WEED RES, V47, P534, DOI 10.1111/j.1365-3180.2007.00591.x; TARDIF FJ, 1994, PHYSIOL PLANTARUM, V91, P488, DOI 10.1111/j.1399-3054.1994.tb02978.x; WRUBEL RP, 1994, WEED TECHNOL, V8, P635, DOI 10.1017/S0890037X00039828; Xiang S, 2009, P NATL ACAD SCI USA, V106, P20723, DOI 10.1073/pnas.0908431106; Yu LPC, 2010, P NATL ACAD SCI USA, V107, P22072, DOI 10.1073/pnas.1012039107; Yu Q, 2008, PEST MANAG SCI, V64, P1229, DOI 10.1002/ps.1624; Yu Q, 2007, PLANT PHYSIOL, V145, P547, DOI 10.1104/pp.107.105262; Zhang HL, 2004, P NATL ACAD SCI USA, V101, P5910, DOI 10.1073/pnas.0400891101; Zhang XQ, 2006, PLANTA, V223, P550, DOI 10.1007/s00425-005-0095-x	38	31	33	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39759	10.1371/journal.pone.0039759	http://dx.doi.org/10.1371/journal.pone.0039759			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768118	gold, Green Submitted, Green Published			2022-12-27	WOS:000305892100088
J	Kroidl, I; Clowes, P; Mwalongo, W; Maganga, L; Maboko, L; Kroidl, AL; Geldmacher, C; Machibya, H; Hoelscher, M; Saathoff, E				Kroidl, Inge; Clowes, Petra; Mwalongo, Wolfram; Maganga, Lucas; Maboko, Leonard; Kroidl, Arne L.; Geldmacher, Christof; Machibya, Harun; Hoelscher, Michael; Saathoff, Elmar			Low Specificity of Determine HIV1/2 RDT Using Whole Blood in South West Tanzania	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TESTING ALGORITHMS; ASSAYS; AFRICA; IMMUNOASSAYS; DISEASES; UGANDA; CAPE	Objective: To evaluate the diagnostic performance of two rapid detection tests (RDTs) for HIV 1/2 in plasma and in whole blood samples. Methods: More than 15,000 study subjects above the age of two years participated in two rounds of a cohort study to determine the prevalence of HIV. HIV testing was performed using the Determine HIV 1/2 test (Abbott) in the first (2006/2007) and the HIV 1/2 STAT-PAK Dipstick Assay (Chembio) in the second round (2007/2008) of the survey. Positive results were classified into faint and strong bands depending on the visual appearance of the test strip and confirmed by ELISA and Western blot. Results: The sensitivity and specificity of the Determine RDT were 100% (95% confidence interval = 86.8 to 100%) and 96.8% (95.9 to 97.6%) in whole blood and 100% (99.7 to 100%) and 97.9% (97.6 to 98.1%) in plasma respectively. Specificity was highly dependent on the tested sample type: when using whole blood, 67.1% of positive results were false positive, as opposed to 17.4% in plasma. Test strips with only faint positive bands were more often false positive than strips showing strong bands and were more common in whole blood than in plasma. Evaluation of the STAT-PAK RDT in plasma during the second year resulted in a sensitivity of 99.7% (99.1 to 99.9%) and a specificity of 99.3% (99.1 to 99.4%) with 6.9% of the positive results being false. Conclusions: Our study shows that the Determine HIV 1/2 strip test with its high sensitivity is an excellent tool to screen for HIV infection, but that - at least in our setting - it can not be recommended as a confirmatory test in VCT campaigns where whole blood is used.	[Kroidl, Inge; Kroidl, Arne L.; Geldmacher, Christof; Hoelscher, Michael; Saathoff, Elmar] Univ Munich LMU, Div Infect Dis & Trop Med, Med Ctr, Munich, Germany; [Clowes, Petra; Mwalongo, Wolfram; Maganga, Lucas; Maboko, Leonard; Kroidl, Arne L.] NIMR Mbeya Med Res Programme, Mbeya, Tanzania; [Kroidl, Arne L.; Geldmacher, Christof; Hoelscher, Michael; Saathoff, Elmar] LMU, German Ctr Infect Res, Munich, Germany; [Machibya, Harun] Mbeya Reg Med Off, Mbeya, Tanzania	University of Munich; German Center for Infection Research; University of Munich	Kroidl, I (corresponding author), Univ Munich LMU, Div Infect Dis & Trop Med, Med Ctr, Munich, Germany.	ikroidl@lrz.uni-muenchen.de	Hoelscher, Michael/D-3436-2012		European Commission as part of EuropAid [SANTE/2004/078-545, SANTE/2006/129-931]	European Commission as part of EuropAid	This study was funded by the European Commission as part of EuropAid (SANTE/2004/078-545 and SANTE/2006/129-931). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, Wkly Epidemiol Rec, V67, P145; [Anonymous], 2010, CLEARVIEW HIV1 2 STA; [Anonymous], 2009, DETERMINE HIV 1 2 PR; Claassen M, 2006, J CLIN VIROL, V37, P68, DOI 10.1016/j.jcv.2006.06.008; Dax EM, 1999, J VIROL METHODS, V82, P113, DOI 10.1016/S0166-0934(99)00082-8; Eller LA, 2007, J CLIN MICROBIOL, V45, P3281, DOI 10.1128/JCM.00894-07; Everett DB, 2010, J CLIN MICROBIOL, V48, P1570, DOI 10.1128/JCM.02264-09; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025; Granade TC, 2005, CLIN DIAGN LAB IMMUN, V12, P855, DOI 10.1128/CDLI.12.7.855-860.2005; Gray RH, 2007, BRIT MED J, V335, P188, DOI 10.1136/bmj.39210.582801.BE; Halkin A, 1998, QJM-INT J MED, V91, P247, DOI 10.1093/qjmed/91.4.247; Heinrich N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001557; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hutchinson PL, 2006, AIDS CARE, V18, P446, DOI 10.1080/09540120500213511; Koblavi-Deme S, 2001, J CLIN MICROBIOL, V39, P1808, DOI 10.1128/JCM.39.5.1808-1812.2001; Lyamuya EF, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-19; Mayhood MK, 2008, J CLIN MICROBIOL, V46, P3946, DOI 10.1128/JCM.01045-08; McKenna SL, 1997, AIDS, V11, pS103; Menard D, 2005, J VIROL METHODS, V126, P75, DOI 10.1016/j.jviromet.2005.01.023; National AIDS Control Program website. Standard Operating Procedures for HIV testing and counselling (HTC) services, STAND OP PROC HIV TE; Respess RA, 2001, AIDS, V15, pS49, DOI 10.1097/00002030-200104003-00007; SELLERS RF, 1980, J HYG-CAMBRIDGE, V85, P65, DOI 10.1017/S0022172400027108; Singer DE, 2005, J CLIN MICROBIOL, V43, P5312, DOI 10.1128/JCM.43.10.5312-5315.2005; van den Berk GEL, 2003, J CLIN MICROBIOL, V41, P3868, DOI 10.1128/JCM.41.8.3868-3869.2003; World Health Organization Dept. of essential health technologies, 2002, 12 WHO DEP ESS HLTH; 1998, WKLY EPIDEMIOL REC, V73, P321	27	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39529	10.1371/journal.pone.0039529	http://dx.doi.org/10.1371/journal.pone.0039529			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768086	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100057
J	Nam, D; Mau, E; Wang, YF; Wright, D; Silkstone, D; Whetstone, H; Whyne, C; Alman, B				Nam, Diane; Mau, Elaine; Wang, Yufa; Wright, David; Silkstone, David; Whetstone, Heather; Whyne, Cari; Alman, Benjamin			T-Lymphocytes Enable Osteoblast Maturation via IL-17F during the Early Phase of Fracture Repair	PLOS ONE			English	Article							TNF-ALPHA; BONE; DIFFERENTIATION; INTERLEUKIN-6; CELLS; SYSTEM; MICE	While it is well known that the presence of lymphocytes and cytokines are important for fracture healing, the exact role of the various cytokines expressed by cells of the immune system on osteoblast biology remains unclear. To study the role of inflammatory cytokines in fracture repair, we studied tibial bone healing in wild-type and Rag1(-/-) mice. Histological analysis, mu CT stereology, biomechanical testing, calcein staining and quantitative RNA gene expression studies were performed on healing tibial fractures. These data provide support for Rag1(-/-) mice as a model of impaired fracture healing compared to wild-type. Moreover, the pro-inflammatory cytokine, IL-17F, was found to be a key mediator in the cellular response of the immune system in osteogenesis. In vitro studies showed that IL-17F alone stimulated osteoblast maturation. We propose a model in which the Th17 subset of T-lymphocytes produces IL-17F to stimulate bone healing. This is a pivotal link in advancing our current understanding of the molecular and cellular basis of fracture healing, which in turn may aid in optimizing fracture management and in the treatment of impaired bone healing.	[Nam, Diane; Mau, Elaine; Wang, Yufa; Wright, David; Whyne, Cari] Univ Toronto, Sunnybrook Res Inst, Dept Surg, Div Orthopaed Surg, Toronto, ON, Canada; [Silkstone, David; Whetstone, Heather; Alman, Benjamin] Univ Toronto, Hosp Sick Children, Dept Dev Biol, Toronto, ON M5G 1X8, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Nam, D (corresponding author), Univ Toronto, Sunnybrook Res Inst, Dept Surg, Div Orthopaed Surg, Toronto, ON, Canada.	diane.nam@sunnybrook.ca			Holland Musculoskeletal Program, Sunnybrook Research Institute; Department of Surgery, University of Toronto; Division of Orthopaedic Surgery, Department of Surgery, University of Toronto [489200]; Canadian Institutes of Health Research	Holland Musculoskeletal Program, Sunnybrook Research Institute; Department of Surgery, University of Toronto(University of Toronto); Division of Orthopaedic Surgery, Department of Surgery, University of Toronto; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This project was generously supported by the Holland Musculoskeletal Program, Sunnybrook Research Institute (Internal funding sources); Roscoe Reid Surgical Science Scholarship Award (scholarship), Department of Surgery, University of Toronto; Division of Orthopaedic Surgery, Department of Surgery, University of Toronto (489200) (http://www.medresearch.utoronto.ca/fmro_deans_fund.html) and Canadian Institutes of Health Research (http://www.cihrirsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW JG, 1994, ACTA ORTHOP SCAND, V65, P462, DOI 10.3109/17453679408995493; ASKALONOV AA, 1981, J HYG EPID MICROB IM, V25, P307; Bastian O, 2011, J LEUKOCYTE BIOL, V89, P669, DOI 10.1189/jlb.0810446; Boyce BF, 2009, CRIT REV EUKAR GENE, V19, P171, DOI 10.1615/CritRevEukarGeneExpr.v19.i3.10; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Cheon SS, 2006, FASEB J, V20, P692, DOI 10.1096/fj.05-4759com; Cho TJ, 2001, CURR OPIN ORTHOP, V12, P403; Colburn NT, 2009, ARTHRITIS RHEUM-US, V60, P1694, DOI 10.1002/art.24520; Entezari V, 2011, J BIOMECH, V44, P552, DOI 10.1016/j.jbiomech.2010.09.022; Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401; Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584; Glass GE, 2011, P NATL ACAD SCI USA, V108, P1585, DOI 10.1073/pnas.1018501108; Hauser CJ, 1997, J TRAUMA, V42, P895, DOI 10.1097/00005373-199705000-00021; HILTUNEN A, 1993, J ORTHOP RES, V11, P305, DOI 10.1002/jor.1100110219; Hu Y, 2011, ANN NY ACAD SCI, V1217, P60, DOI 10.1111/j.1749-6632.2010.05825.x; Huang H, 2009, CELL DEATH DIFFER, V16, P1332, DOI 10.1038/cdd.2009.74; Itoh S, 2006, BONE, V39, P505, DOI 10.1016/j.bone.2006.02.074; Kabelitz D, 2011, CELL MOL LIFE SCI, V68, P2331, DOI 10.1007/s00018-011-0696-4; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kitami S, 2010, BIOCHIMIE, V92, P398, DOI 10.1016/j.biochi.2009.12.011; Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI 10.1089/ten.TEB.2009.0687; Lange J, 2010, J ORTHOP RES, V28, P778, DOI 10.1002/jor.21061; Le AX, 2001, J ORTHOPAED RES, V19, P78, DOI 10.1016/S0736-0266(00)00006-1; Le Goff B, 2010, JOINT BONE SPINE, V77, P201, DOI 10.1016/j.jbspin.2010.03.002; Lorenzo J, 2011, OSTEOIMMUNOLOGY: INTERACTIONS OF THE IMMUNE AND SKELETAL SYSTEMS, P1; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; MARVEL J, 1988, EUR J IMMUNOL, V18, P825, DOI 10.1002/eji.1830180526; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mountziaris PM, 2008, TISSUE ENG PART B-RE, V14, P179, DOI 10.1089/ten.teb.2008.0038; Nakashima T, 2009, J CLIN IMMUNOL, V29, P555, DOI 10.1007/s10875-009-9316-6; Nazarian A, 2010, CALCIFIED TISSUE INT, V86, P397, DOI 10.1007/s00223-010-9353-4; Nepal RM, 2008, ONCOGENE, V27, P4752, DOI 10.1038/onc.2008.111; Neve A, 2011, CELL TISSUE RES, V343, P289, DOI 10.1007/s00441-010-1086-1; Pacifici R, 2010, ARCH BIOCHEM BIOPHYS, V503, P41, DOI 10.1016/j.abb.2010.05.027; Pape HC, 2010, J ORTHOP TRAUMA, V24, P522, DOI 10.1097/BOT.0b013e3181ed1361; Pappu R, 2011, IMMUNOLOGY, V134, P8, DOI 10.1111/j.1365-2567.2011.03465.x; Richardson J, 2008, J BONE JOINT SURG BR, V90B, P988, DOI 10.1302/0301-620X.90B8.20861; Shoji K, 2008, OSTEOPOROSIS INT, V19, P1193, DOI 10.1007/s00198-007-0558-y; Terpos Evangelos, 2008, Pediatr Endocrinol Rev, V6 Suppl 1, P94; Toben D, 2011, J BONE MINER RES, V26, P113, DOI 10.1002/jbmr.185; van Gaalen SM, 2010, TISSUE ENG PART B-RE, V16, P209, DOI [10.1089/ten.teb.2009.0503, 10.1089/ten.TEB.2009.0503]; Wallace A, 2011, J ORTHOP RES, V29, P1437, DOI 10.1002/jor.21367; Xing ZQ, 2010, J ORTHOP RES, V28, P1000, DOI 10.1002/jor.21087; Yago T, 2009, J CELL BIOCHEM, V108, P947, DOI 10.1002/jcb.22326; Yang X, 2007, BONE, V41, P928, DOI 10.1016/j.bone.2007.07.022	46	117	119	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40044	10.1371/journal.pone.0040044	http://dx.doi.org/10.1371/journal.pone.0040044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768215	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100187
J	Papa, E; Docktor, M; Smillie, C; Weber, S; Preheim, SP; Gevers, D; Giannoukos, G; Ciulla, D; Tabbaa, D; Ingram, J; Schauer, DB; Ward, DV; Korzenik, JR; Xavier, RJ; Bousvaros, A; Alm, EJ				Papa, Eliseo; Docktor, Michael; Smillie, Christopher; Weber, Sarah; Preheim, Sarah P.; Gevers, Dirk; Giannoukos, Georgia; Ciulla, Dawn; Tabbaa, Diana; Ingram, Jay; Schauer, David B.; Ward, Doyle V.; Korzenik, Joshua R.; Xavier, Ramnik J.; Bousvaros, Athos; Alm, Eric J.			Non-Invasive Mapping of the Gastrointestinal Microbiota Identifies Children with Inflammatory Bowel Disease	PLOS ONE			English	Article							DIAGNOSTIC-VALUE; ACTIVITY INDEX; MANAGEMENT; APPRAISAL; THERAPY; UTILITY; TWINS	Background: Pediatric inflammatory bowel disease (IBD) is challenging to diagnose because of the non-specificity of symptoms; an unequivocal diagnosis can only be made using colonoscopy, which clinicians are reluctant to recommend for children. Diagnosis of pediatric IBD is therefore frequently delayed, leading to inappropriate treatment plans and poor outcomes. We investigated the use of 16S rRNA sequencing of fecal samples and new analytical methods to assess differences in the microbiota of children with IBD and other gastrointestinal disorders. Methodology/Principal Findings: We applied synthetic learning in microbial ecology (SLiME) analysis to 16S sequencing data obtained from i) published surveys of microbiota diversity in IBD and ii) fecal samples from 91 children and young adults who were treated in the gastroenterology program of Children's Hospital (Boston, USA). The developed method accurately distinguished control samples from those of patients with IBD; the area under the receiver-operating-characteristic curve (AUC) value was 0.83 (corresponding to 80.3% sensitivity and 69.7% specificity at a set threshold). The accuracy was maintained among data sets collected by different sampling and sequencing methods. The method identified taxa associated with disease states and distinguished patients with Crohn's disease from those with ulcerative colitis with reasonable accuracy. The findings were validated using samples from an additional group of 68 patients; the validation test identified patients with IBD with an AUC value of 0.84 (e. g. 92% sensitivity, 58.5% specificity). Conclusions/Significance: Microbiome-based diagnostics can distinguish pediatric patients with IBD from patients with similar symptoms. Although this test can not replace endoscopy and histological examination as diagnostic tools, classification based on microbial diversity is an effective complementary technique for IBD detection in pediatric patients.	[Papa, Eliseo] Harvard MIT Hlth Sci & Technol Inst, Cambridge, MA USA; [Docktor, Michael; Weber, Sarah; Ingram, Jay; Bousvaros, Athos] Childrens Hosp Boston, Ctr Inflammatory Bowel Dis, Boston, MA USA; [Smillie, Christopher] MIT, Computat & Syst Biol Initiat, Cambridge, MA 02139 USA; [Preheim, Sarah P.; Alm, Eric J.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Gevers, Dirk; Giannoukos, Georgia; Ciulla, Dawn; Tabbaa, Diana; Ward, Doyle V.; Xavier, Ramnik J.; Alm, Eric J.] 7 Cambridge Ctr, Broad Inst, Cambridge, MA USA; [Schauer, David B.; Alm, Eric J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Schauer, David B.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Korzenik, Joshua R.; Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit,Ctr Inflammatory Bowel Dis, Boston, MA USA; [Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA USA	Harvard University; Harvard University; Boston Children's Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Papa, E (corresponding author), Harvard MIT Hlth Sci & Technol Inst, Cambridge, MA USA.	athos.bousvaros@childrens.harvard.edu; ejalm@mit.edu	Preheim, Sarah P/B-3432-2010; Gevers, Dirk/C-1451-2009	Preheim, Sarah P/0000-0001-7365-2382; Papa, Eliseo/0000-0002-2467-7759; Smillie, Chris/0000-0002-7606-3433	NSERC PGS D award; NIH [1-R21-A1084032-01A1]; MacInnes Friends and Family Fund; Rasmussen Family Fund; NCBI BioProject [82109]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092405, P30DK043351] Funding Source: NIH RePORTER	NSERC PGS D award(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MacInnes Friends and Family Fund; Rasmussen Family Fund; NCBI BioProject; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by philantropic donations from the MacInnes Friends and Family Fund and by the Rasmussen Family Fund. EP was supported by a NSERC PGS D award. EJA was supported by the NIH award 1-R21-A1084032-01A1. ALPCO diagnostics/Buhlmann laboratories kindly provided calprotectin kits. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sequencing data is publicly available as a NCBI BioProject, with BioProjectID 82109.	Andersen K, 2006, EUR J RADIOL, V58, P140, DOI 10.1016/j.ejrad.2005.11.004; Arseneau Kristen O, 2007, Curr Gastroenterol Rep, V9, P508, DOI 10.1007/s11894-007-0067-3; Austin GL, 2007, CLIN GASTROENTEROL H, V5, P545, DOI 10.1016/j.cgh.2007.03.006; BALDI P, 2001, BIOINFORMATICS MACHI; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Bernstein CN, 2008, GUT, V57, P1185, DOI 10.1136/gut.2007.122143; Bohm SK, 2006, ANN NY ACAD SCI, V1072, P339, DOI 10.1196/annals.1326.005; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cabrera-Abreu JC, 2004, ARCH DIS CHILD, V89, P69; Carter MJ, 2004, GUT, V53, DOI 10.1136/gut.2004.043372; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DEVROEDE GJ, 1971, NEW ENGL J MED, V285, P17, DOI 10.1056/NEJM197107012850103; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Dubinsky MC, 2001, AM J GASTROENTEROL, V96, P758; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Griffiths AM, 2005, INFLAMM BOWEL DIS, V11, P185, DOI 10.1097/00054725-200502000-00013; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Heikenen JB, 1999, INFLAMM BOWEL DIS, V5, P158, DOI 10.1097/00054725-199908000-00002; Kappelman MD, 2008, MOL NUTR FOOD RES, V52, P867, DOI 10.1002/mnfr.200700156; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Knights D, 2010, FEMS MICROBIOLOGY RE, P1; Lewis JD, 2011, GASTROENTEROLOGY, V140, P1817, DOI 10.1053/j.gastro.2010.11.058; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Loffler M, 2006, ANN NY ACAD SCI, V1072, P379, DOI 10.1196/annals.1326.014; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peeters M, 2001, AM J GASTROENTEROL, V96, P730, DOI 10.1111/j.1572-0241.2001.03613.x; Ruemmele FM, 1998, GASTROENTEROLOGY, V115, P822, DOI 10.1016/S0016-5085(98)70252-5; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sartor R Balfour, 2007, Curr Gastroenterol Rep, V9, P497; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schloss PD, 2008, ISME J, V2, P265, DOI 10.1038/ismej.2008.5; Selby W, 2007, GASTROENTEROLOGY, V132, P2313, DOI 10.1053/j.gastro.2007.03.031; Sepehri S, 2007, INFLAMM BOWEL DIS, V13, P675, DOI 10.1002/ibd.20101; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Spray C, 2001, ACTA PAEDIATR, V90, P400, DOI 10.1080/080352501750126230; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; Team R. D. C, 2011, R LANG ENV STAT COMP; Tomas G, 2012, ONCOGENE; Turner D, 2010, AM J GASTROENTEROL, V105, P2085, DOI 10.1038/ajg.2010.143; Turner D, 2009, INFLAMM BOWEL DIS, V15, P1218, DOI 10.1002/ibd.20867; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Yantiss RK, 2006, HISTOPATHOLOGY, V48, P116, DOI 10.1111/j.1365-2559.2005.02248.x	49	191	209	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39242	10.1371/journal.pone.0039242	http://dx.doi.org/10.1371/journal.pone.0039242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768065	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100036
J	Tamura, M; Moriguchi, Y; Higuchi, S; Hida, A; Enomoto, M; Umezawa, J; Mishima, K				Tamura, Miyuki; Moriguchi, Yoshiya; Higuchi, Shigekazu; Hida, Akiko; Enomoto, Minori; Umezawa, Jun; Mishima, Kazuo			Neural Network Development in Late Adolescents during Observation of Risk-Taking Action	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; POSTERIOR CINGULATE CORTEX; SOCIAL-ANXIETY-DISORDER; AGE-RELATED-CHANGES; BRAIN-DEVELOPMENT; PHYSIOLOGICAL CONDITION; REJECTION SENSITIVITY; DEPRESSIVE-DISORDERS; PERSONALITY-FACTORS; FACIAL EXPRESSIONS	Emotional maturity and social awareness are important for adolescents, particularly college students beginning to face the challenges and risks of the adult world. However, there has been relatively little research into personality maturation and psychological development during late adolescence and the neural changes underlying this development. We investigated the correlation between psychological properties (neuroticism, extraversion, anxiety, and depression) and age among late adolescents (n = 25, from 18 years and 1 month to 22 years and 8 months). The results revealed that late adolescents became less neurotic, less anxious, less depressive and more extraverted as they aged. Participants then observed video clips depicting hand movements with and without a risk of harm (risk-taking or safe actions) during functional magnetic resonance imaging (fMRI). The results revealed that risk-taking actions elicited significantly stronger activation in the bilateral inferior parietal lobule, temporal visual regions (superior/middle temporal areas), and parieto-occipital visual areas (cuneus, middle occipital gyri, precuneus). We found positive correlations of age and extraversion with neural activation in the insula, middle temporal gyrus, lingual gyrus, and precuneus. We also found a negative correlation of age and anxiety with activation in the angular gyrus, precentral gyrus, and red nucleus/substantia nigra. Moreover, we found that insula activation mediated the relationship between age and extraversion. Overall, our results indicate that late adolescents become less anxious and more extraverted with age, a process involving functional neural changes in brain networks related to social cognition and emotional processing. The possible neural mechanisms of psychological and social maturation during late adolescence are discussed.	[Tamura, Miyuki] Univ Human Arts & Sci, Fac Human Arts & Sci, Saitama, Japan; [Tamura, Miyuki; Moriguchi, Yoshiya; Higuchi, Shigekazu; Hida, Akiko; Enomoto, Minori; Mishima, Kazuo] Natl Ctr Neurol & Psychiat, Dept Psychophysiol, Natl Inst Mental Hlth, Tokyo, Japan; [Moriguchi, Yoshiya; Mishima, Kazuo] Natl Ctr Neurol & Psychiat, Dept Clin Neuroimaging, Integrat Brain Imaging Ctr, Tokyo, Japan; [Higuchi, Shigekazu] Kyushu Univ, Fac Design, Fukuoka 812, Japan; [Umezawa, Jun] Natl Canc Ctr, Epidemiol & Prevent Div, Res Ctr Canc Prevent & Screening, Tokyo 104, Japan	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; Kyushu University; National Cancer Center - Japan	Tamura, M (corresponding author), Univ Human Arts & Sci, Fac Human Arts & Sci, Saitama, Japan.	m-tamura@human.ac.jp	HIGUCHI, Shigekazu/AAM-5800-2020	MISHIMA, KAZUO/0000-0003-1182-1181; higuchi, shigekazu/0000-0001-7131-0792	KAKENHI [21770269]; Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant-in-Aid for Young Scientists (B), KAKENHI (21770269) (http://www.jsps.go.jp/english/e-grants/index.html). This study was supported in part by a Research Grant for a Health Science Grant from the Ministry of Health, Labor and Welfare of Japan, and the Strategic Research Program for Brain Sciences from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2010, CORTEX, V46, P425, DOI 10.1016/j.cortex.2009.04.011; Arnett J., 2004, EMERGING ADULTHOOD W; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Azmitia M, 2008, NEW DIR CHILD ADOLES, V120, P1, DOI 10.1002/cd.212; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Beesdo K, 2007, ARCH GEN PSYCHIAT, V64, P903, DOI 10.1001/archpsyc.64.8.903; Berthoz S, 2006, NEUROIMAGE, V31, P945, DOI 10.1016/j.neuroimage.2005.12.039; Bienvenu OJ, 2007, AM J PSYCHIAT, V164, P1714, DOI 10.1176/appi.ajp.2007.06101667; Bienvenu OJ, 2001, J NERV MENT DIS, V189, P154, DOI 10.1097/00005053-200103000-00003; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blakemore SJ, 2010, NEURON, V65, P744, DOI 10.1016/j.neuron.2010.03.004; Blum RW, 2004, J ADOLESCENT HEALTH, V35, P402, DOI [10.1016/j.jadohealth.2003.10.007, 10.1016/S1054-139X(03)00537-8]; Boecker H, 2008, NEUROIMAGE, V39, P1356, DOI 10.1016/j.neuroimage.2007.09.069; Branje SJT, 2007, EUR J PERSONALITY, V21, P45, DOI 10.1002/per.596; Braun AR, 1997, BRAIN, V120, P761, DOI 10.1093/brain/120.5.761; Brown S, 2005, HUM BRAIN MAPP, V25, P105, DOI 10.1002/hbm.20140; Buchweitz Augusto, 2009, Psychol. Neurosci., V2, P111, DOI 10.3922/j.psns.2009.2.003; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Burnett S, 2010, COGNITIVE DEV, V25, P183, DOI 10.1016/j.cogdev.2009.11.003; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Butler T, 2007, NEUROSCIENCE, V150, P1, DOI 10.1016/j.neuroscience.2007.09.048; Canli T, 2001, BEHAV NEUROSCI, V115, P33, DOI 10.1037//0735-7044.115.1.33; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Cheng YW, 2007, CEREB CORTEX, V17, P1979, DOI 10.1093/cercor/bhl107; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; Chumbley JR, 2009, NEUROIMAGE, V44, P62, DOI 10.1016/j.neuroimage.2008.05.021; Cohen JD, 2010, J PSYCHIATR RES, V44, P81, DOI 10.1016/j.jpsychires.2009.07.001; Corfield DR, 1999, J APPL PHYSIOL, V86, P1468, DOI 10.1152/jappl.1999.86.5.1468; Costa PT, 2007, REVISED NEO PERSONAL; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Damier P, 1999, BRAIN, V122, P1421, DOI 10.1093/brain/122.8.1421; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Davis N, 2009, MAGN RESON IMAGING, V27, P1187, DOI 10.1016/j.mri.2009.05.010; De Moor MHM, 2006, PREV MED, V42, P273, DOI 10.1016/j.ypmed.2005.12.002; den Ouden HEM, 2005, NEUROIMAGE, V28, P787, DOI 10.1016/j.neuroimage.2005.05.001; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; Dumontheil I, 2010, DEVELOPMENTAL SCI, V13, P331, DOI 10.1111/j.1467-7687.2009.00888.x; Eccles J, 2003, CROSS CONT, P383; Erikson E. H., 1994, IDENTITY YOUTH CRISI; Erikson Erik, 1994, IDENTITY LIFE CYCLE; Eysenk HansJ., 1967, BIOL BASIS PERSONALI; Eysenk HJ, 1959, MANUAL MAUDSLEY PERS; Eysenk HJ, 1990, BIOL DIMENSIONS PERS; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; Farrow TFD, 2001, NEUROREPORT, V12, P2433, DOI 10.1097/00001756-200108080-00029; Feinstein JS, 2002, NEUROREPORT, V13, P1255, DOI 10.1097/00001756-200207190-00007; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox PT, 2001, NEUROIMAGE, V13, P196, DOI 10.1006/nimg.2000.0659; French SE, 2000, J ADOLESCENT RES, V15, P587, DOI 10.1177/0743558400155004; Fukuda K, 1983, SDS SELF RATING DEPR; Gamma A, 2000, NEUROPSYCHOPHARMACOL, V23, P388, DOI 10.1016/S0893-133X(00)00130-5; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giedd JN, 1996, CEREB CORTEX, V6, P551, DOI 10.1093/cercor/6.4.551; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goodwin RD, 2004, PSYCHIAT RES, V126, P135, DOI 10.1016/j.psychres.2003.12.024; Haas BW, 2007, BEHAV NEUROSCI, V121, P249, DOI 10.1037/0735-7044.121.2.249; Hanby MS, 2012, J INTERPERS VIOLENCE; Harper MS, 2006, J YOUTH ADOLESCENCE, V35, P459, DOI 10.1007/s10964-006-9048-3; Hurtado Aida., 2003, VOICING CHICANA FEMI; Iwawaki S, 1969, MAUDSLEY PERSONALITY; John Oliver P., 1999, BIG 5 TRAIT TAXONOMY; Johnson DL, 1999, AM J PSYCHIAT, V156, P252; Johnson MK, 2006, SOC COGN AFFECT NEUR, V1, P56, DOI 10.1093/scan/nsl004; Jolliffe D, 2006, J ADOLESCENCE, V29, P589, DOI 10.1016/j.adolescence.2005.08.010; Jylha P, 2006, DEPRESS ANXIETY, V23, P281, DOI 10.1002/da.20167; Keltner D, 1998, REV GEN PSYCHOL, V2, P320, DOI [10.1037/1089-2680.2.3.320, DOI 10.1037/1089-2680.2.3.320]; Kilner JM, 2011, TRENDS COGN SCI, V15, P352, DOI 10.1016/j.tics.2011.06.005; Kim SH, 2008, NEUROREPORT, V19, P883, DOI 10.1097/WNR.0b013e328300080f; Kobayashi C, 2007, NEUROPSYCHOLOGIA, V45, P1522, DOI 10.1016/j.neuropsychologia.2006.11.017; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lee TMC, 2008, SOC COGN AFFECT NEUR, V3, P7, DOI 10.1093/scan/nsm033; Lieb R, 2000, ACTA PSYCHIAT SCAND, V101, P194, DOI 10.1034/j.1600-0447.2000.101003194.x; Lieb R, 2007, PSYCHOSOM MED, V69, P860, DOI 10.1097/PSY.0b013e31815b0103; Ludtke O, 2011, J PERS SOC PSYCHOL, V101, P620, DOI 10.1037/a0023743; Maddock RF, 2001, NEUROSCIENCE, V104, P667, DOI 10.1016/S0306-4522(01)00108-7; Marston EG, 2010, J RES ADOLESCENCE, V20, P959, DOI 10.1111/j.1532-7795.2010.00675.x; Mason MJ, 2009, J CLIN PSYCHOL MED S, V16, P346, DOI 10.1007/s10880-009-9169-4; Matthews G, 1999, PERS INDIV DIFFER, V26, P583, DOI 10.1016/S0191-8869(98)00158-5; Mayer EA, 2006, GASTROENTEROLOGY, V131, P1925, DOI 10.1053/j.gastro.2006.10.026; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; McCrae RR, 1999, DEV PSYCHOL, V35, P466, DOI 10.1037/0012-1649.35.2.466; Mizuguchi T, 1982, STATE TRAIT ANXIETY; Monk CS, 2003, NEUROIMAGE, V20, P420, DOI 10.1016/S1053-8119(03)00355-0; Moriguchi Y, 2011, J COGNITIVE NEUROSCI, V23, P1027, DOI 10.1162/jocn.2010.21527; Newman B., 2009, DEV LIFE PSYCHOSOCIA; Newman B. M., 2016, THEORIES HUMAN DEV; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Okonogi K, 1981, HUMAN MORATORIUM PER; Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Omura K, 2005, COGN AFFECT BEHAV NE, V5, P252, DOI 10.3758/CABN.5.2.252; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Pearson JM, 2011, TRENDS COGN SCI, V15, P143, DOI 10.1016/j.tics.2011.02.002; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Pfeifer JH, 2007, J COGNITIVE NEUROSCI, V19, P1323, DOI 10.1162/jocn.2007.19.8.1323; Phillips ML, 2004, NEUROIMAGE, V21, P1484, DOI 10.1016/j.neuroimage.2003.12.013; Poropat AE, 2011, BRIT J EDUC PSYCHOL, V81, P41, DOI 10.1348/000709910X497671; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RAUCH SL, 1995, ARCH GEN PSYCHIAT, V52, P20; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; Sakurai Y, 2010, J NEUROL SCI, V288, P25, DOI 10.1016/j.jns.2009.10.015; Schulenberg JE, 2004, DEV PSYCHOPATHOL, V16, P1119, DOI 10.1017/S0954579404040167; Shaver Phillip, 1985, UNDERSTANDING PERSON, P193; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Simmons A, 2006, BIOL PSYCHIAT, V60, P402, DOI 10.1016/j.biopsych.2006.04.038; Smoller JW, 2008, ARCH GEN PSYCHIAT, V65, P298, DOI 10.1001/archgenpsychiatry.2007.48; Sollberger M, 2009, NEUROPSYCHOLOGIA, V47, P2812, DOI 10.1016/j.neuropsychologia.2009.06.006; Sowell ER, 1999, NEUROIMAGE, V9, P587, DOI 10.1006/nimg.1999.0436; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Stein MB, 2001, ARCH GEN PSYCHIAT, V58, P251, DOI 10.1001/archpsyc.58.3.251; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Tabachnik SE, 2006, USING MULTIVARIATE S; TALAIRACH J, 1988, COPLANAR STEREOAXIC; Tanaka E, 1998, J CLIN PSYCHOL, V54, P1043, DOI 10.1002/(SICI)1097-4679(199812)54:8<1043::AID-JCLP4>3.0.CO;2-A; Tanum L, 2001, J PSYCHOSOM RES, V50, P139, DOI 10.1016/S0022-3999(00)00219-1; Terracciano A, 2005, PSYCHOL AGING, V20, P493, DOI 10.1037/0882-7974.20.3.493; Tsujimoto S, 2011, TRENDS COGN SCI, V15, P169, DOI 10.1016/j.tics.2011.02.001; Uddin LQ, 2010, CEREB CORTEX, V20, P2636, DOI 10.1093/cercor/bhq011; Vaidya JG, 2002, J PERS SOC PSYCHOL, V83, P1469, DOI 10.1037//0022-3514.83.6.1469; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Watkins KE, 2008, BRAIN, V131, P50, DOI 10.1093/brain/awm241; Watson KK, 2008, ANN NY ACAD SCI, V1128, P8, DOI 10.1196/annals.1399.002; Williams PG, 2002, J CONSULT CLIN PSYCH, V70, P828, DOI 10.1037//0022-006X.70.3.828; Wright CI, 2007, NEUROIMAGE, V35, P263, DOI 10.1016/j.neuroimage.2006.11.039; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118; Zald DH, 2002, NEUROIMAGE, V16, P746, DOI 10.1006/nimg.2002.1115; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	142	14	14	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39527	10.1371/journal.pone.0039527	http://dx.doi.org/10.1371/journal.pone.0039527			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768085	gold, Green Published			2022-12-27	WOS:000305892100056
J	Tomlinson, GS; Booth, H; Petit, SJ; Potton, E; Towers, GJ; Miller, RF; Chain, BM; Noursadeghi, M				Tomlinson, Gillian S.; Booth, Helen; Petit, Sarah J.; Potton, Elspeth; Towers, Greg J.; Miller, Robert F.; Chain, Benjamin M.; Noursadeghi, Mahdad			Adherent Human Alveolar Macrophages Exhibit a Transient Pro-Inflammatory Profile That Confounds Responses to Innate Immune Stimulation	PLOS ONE			English	Article							MONOCYTE-DERIVED MACROPHAGES; ACTIVATION; EXPRESSION; RECEPTOR; DIFFERENTIATION; SARCOIDOSIS; INFECTION; SUPPRESS; BINDING; ALPHA	Alveolar macrophages (AM) are thought to have a key role in the immunopathogenesis of respiratory diseases. We sought to test the hypothesis that human AM exhibit an anti-inflammatory bias by making genome-wide comparisons with monocyte derived macrophages (MDM). Adherent AM obtained by bronchoalveolar lavage of patients under investigation for haemoptysis, but found to have no respiratory pathology, were compared to MDM from healthy volunteers by whole genome transcriptional profiling before and after innate immune stimulation. We found that freshly isolated AM exhibited a marked pro-inflammatory transcriptional signature. High levels of basal pro-inflammatory gene expression gave the impression of attenuated responses to lipopolysaccharide (LPS) and the RNA analogue, poly IC, but in rested cells pro-inflammatory gene expression declined and transcriptional responsiveness to these stimuli was restored. In comparison to MDM, both freshly isolated and rested AM showed upregulation of MHC class II molecules. In most experimental paradigms ex vivo adherent AM are used immediately after isolation. Therefore, the confounding effects of their pro-inflammatory profile at baseline need careful consideration. Moreover, despite the prevailing view that AM have an anti-inflammatory bias, our data clearly show that they can adopt a striking pro-inflammatory phenotype, and may have greater capacity for presentation of exogenous antigens than MDM.	[Tomlinson, Gillian S.] UCL, Ctr Resp Res, London, England; [Booth, Helen] Univ Coll London Hosp NHS Trust, Dept Thorac Med, London, England; [Miller, Robert F.] UCL, Res Dept Infect & Populat Hlth, London, England	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London	Tomlinson, GS (corresponding author), UCL, Ctr Resp Res, London, England.	m.noursadeghi@ucl.ac.uk	Towers, Greg J/H-8892-2012	Tomlinson, Gillian/0000-0003-4342-3161; Towers, Gregory/0000-0002-7707-0264; Miller, Robert/0000-0003-2067-4291; Chain, Benny/0000-0002-7417-3970; Noursadeghi, Mahdad/0000-0002-4774-0853	UK Medical Research Council [G0700569]; Wellcome Trust [WT077161, WT090940]; UK NIHR Comprehensive Biomedical Research Centre; Medical Research Council [G0801172, G0900950B, G9721629, G0700569, G0900950] Funding Source: researchfish; MRC [G0700569, G0900950, G0801172, G9721629] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); UK NIHR Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a UK Medical Research Council fellowship to GT (G0700569), Wellcome Trust fellowships to MN (WT077161) and to GJT (WT090940), and UK NIHR Comprehensive Biomedical Research Centre funding to UCLH/UCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagawa KS, 2006, RESPIROLOGY, V11, pS32, DOI 10.1111/j.1440-1843.2006.00805.x; ANDREESEN R, 1990, J LEUKOCYTE BIOL, V47, P490, DOI 10.1002/jlb.47.6.490; Armstrong L, 1996, THORAX, V51, P143, DOI 10.1136/thx.51.2.143; Bonfield TL, 2003, AM J PHYSIOL-LUNG C, V285, pL1132, DOI 10.1152/ajplung.00216.2003; Carey B, 2010, CLIN IMMUNOL, V135, P223, DOI 10.1016/j.clim.2010.02.017; Chain B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-344; Chain BM, 2011, PLOS ONE, V6; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Davies John Q, 2005, Methods Mol Biol, V290, P105; Garcia JEL, 1999, MEDIAT INFLAMM, V8, P43, DOI 10.1080/09629359990711; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Hamilton JA, 2004, GROWTH FACTORS, V22, P225, DOI 10.1080/08977190412331279881; Hoppstadter J, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-124; Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008; Lambrecht BN, 2006, IMMUNITY, V24, P366, DOI 10.1016/j.immuni.2006.03.008; Li JN, 2007, J LEUKOCYTE BIOL, V81, P328, DOI 10.1189/jlb.0206124; LIPSCOMB MF, 1986, J IMMUNOL, V136, P497; Palecanda A, 1999, J EXP MED, V189, P1497, DOI 10.1084/jem.189.9.1497; Prior C, 1996, EUR RESPIR J, V9, P47, DOI 10.1183/09031936.96.09010047; ROTH MD, 1993, J LEUKOCYTE BIOL, V53, P366, DOI 10.1002/jlb.53.4.366; Schwander S, 2011, AM J RESP CRIT CARE, V183, P696, DOI 10.1164/rccm.201006-0963PP; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; STANDIFORD TJ, 1991, AM J RESP CELL MOL, V5, P579, DOI 10.1165/ajrcmb/5.6.579; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Tazelaar HD, 2011, HISTOPATHOLOGY, V58, P509, DOI 10.1111/j.1365-2559.2010.03649.x; Thirumaran M, 2009, THORAX, V64, P854, DOI 10.1136/thx.2008.108795; Tsang J, 2009, AIDS, V23, P2255, DOI 10.1097/QAD.0b013e328331a4ce; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Xu F, 2008, AM J RESP CELL MOL, V39, P522, DOI 10.1165/rcmb.2007-0328OC; Zissel G, 2010, SEMIN RESP CRIT CARE, V31, P390, DOI 10.1055/s-0030-1262208	30	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40348	10.1371/journal.pone.0040348	http://dx.doi.org/10.1371/journal.pone.0040348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768282	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100256
J	Tzertzinis, G; Schildkraut, E; Schildkraut, I				Tzertzinis, George; Schildkraut, Ezra; Schildkraut, Ira			Substrate Cooperativity in Marine Luciferases	PLOS ONE			English	Article							RENILLA-RENIFORMIS LUCIFERASE; COPEPOD METRIDIA-LONGA; GAUSSIA-PRINCEPS; CDNA; BIOLUMINESCENCE; EXPRESSION; DOMAINS; NOCTILUCA; CLONING; GENE	Marine luciferases are increasingly used as reporters to study gene regulation. These luciferases have utility in bioluminescent assay development, although little has been reported on their catalytic properties in response to substrate concentration. Here, we report that the two marine luciferases from the copepods, Gaussia princeps (GLuc) and Metridia longa (MLuc) were found, surprisingly, to produce light in a cooperative manner with respect to their luciferin substrate concentration; as the substrate concentration was decreased 10 fold the rate of light production decreased 1000 fold. This positive cooperative effect is likely a result of allostery between the two proposed catalytic domains found in Gaussia and Metridia. In contrast, the marine luciferases from Renilla reniformis (RLuc) and Cypridina noctiluca (CLuc) demonstrate a linear relationship between the concentration of their respective luciferin and the rate of light produced. The consequences of these enzyme responses are discussed.	[Tzertzinis, George] New England Biolabs Inc, Ipswich, MA USA; [Schildkraut, Ezra; Schildkraut, Ira] CerroSci LLC, Ipswich, MA USA	New England Biolabs	Tzertzinis, G (corresponding author), New England Biolabs Inc, Ipswich, MA USA.	schildkraut@neb.com			New England Biolabs; CerroSci	New England Biolabs; CerroSci	George Tzertzinis was employed by New England Biolabs, Inc. and Ezra Schildkraut and Ira Schildkraut by CerroSci LLC while performing this research. New England Biolabs and CerroSci funded this work. Coelenterazine, cypridina luciferin and Biolux GLuc Flex Assay Buffer were obtained from New England Biolabs. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Anderson J, 1978, METHOD ENZYMOL, V55, P244; Bryan B., 2001, United States Patent, Patent No. 6232107; Goerke AR, 2008, METAB ENG, V10, P187, DOI 10.1016/j.ymben.2008.04.001; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; Inouye S, 2008, BIOCHEM BIOPH RES CO, V365, P96, DOI 10.1016/j.bbrc.2007.10.152; Li LM, 2001, BIOCHEMISTRY-US, V40, P1844, DOI 10.1021/bi002094v; Liu L, 2004, PNAS, V101; Liu LY, 2007, P NATL ACAD SCI USA, V104, P696, DOI 10.1073/pnas.0607816103; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; Loening AM, 2007, J MOL BIOL, V374, P1017, DOI 10.1016/j.jmb.2007.09.078; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; LORENZ WW, 1991, P NATL ACAD SCI USA, V88, P4438, DOI 10.1073/pnas.88.10.4438; Maguire CA, 2009, ANAL CHEM, V81, P7102, DOI 10.1021/ac901234r; Markova SV, 2004, J BIOL CHEM, V279, P3212, DOI 10.1074/jbc.M309639200; Markova SV, 2012, BIOCHEM BIOPH RES CO, V417, P98, DOI 10.1016/j.bbrc.2011.11.063; MATTHEWS JC, 1977, BIOCHEMISTRY-US, V16, P85, DOI 10.1021/bi00620a014; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nakajima Y, 2004, BIOSCI BIOTECH BIOCH, V68, P565, DOI 10.1271/bbb.68.565; Rathnayaka T, 2010, BBA-PROTEINS PROTEOM, V1804, P1902, DOI 10.1016/j.bbapap.2010.04.014; Segel IH., 1993, ENZYME KINETICS BEHA; STANLEY PE, 1975, ANAL BIOCHEM, V67, P540, DOI 10.1016/0003-2697(75)90330-9; Szent-Gyorgyi C, 1999, P SPIE; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Welsh JP, 2009, BIOCHEM BIOPH RES CO, V389, P563, DOI 10.1016/j.bbrc.2009.09.006; Woo J, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-23	25	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40099	10.1371/journal.pone.0040099	http://dx.doi.org/10.1371/journal.pone.0040099			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768230	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100202
J	Banki, NF; Ver, A; Wagner, LJ; Vannay, A; Degrell, P; Prokai, A; Gellai, R; Lenart, L; Szakal, DN; Kenesei, E; Rosta, K; Reusz, G; Szabo, AJ; Tulassay, T; Baylis, C; Fekete, A				Banki, Nora F.; Ver, Agota; Wagner, Laszlo J.; Vannay, Adam; Degrell, Peter; Prokai, Agnes; Gellai, Renata; Lenart, Lilla; Szakal, Dorottya-Nagy; Kenesei, Eva; Rosta, Klara; Reusz, Gyorgy; Szabo, Attila J.; Tulassay, Tivadar; Baylis, Chris; Fekete, Andrea			Aldosterone Antagonists in Monotherapy Are Protective against Streptozotocin-Induced Diabetic Nephropathy in Rats	PLOS ONE			English	Article							MINERALOCORTICOID RECEPTOR BLOCKADE; ANGIOTENSIN-II; KIDNEY; HEART; SPIRONOLACTONE; GLUCOSE; SYSTEM; ATPASE; NA+,K+-ATPASE; METABOLISM	Angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) are the standard clinical therapy of diabetic nephropathy (DN), while aldosterone antagonists are only used as adjuncts. Previously in experimental DN we showed that Na/K ATPase (NKA) is mislocated and angiotensin II leads to superimposed renal progression. Here we investigated the monotherapeutic effect of aldosterone blockers on the progression of DN and renal NKA alteration in comparison to ACEi and ARBs. Streptozotocin-diabetic rats developing DN were treated with aldosterone antagonists; ACEi and ARB. Renal function, morphology, protein level and tubular localization of NKA were analyzed. To evaluate the effect of high glucose per se; HK-2 proximal tubular cells were cultured in normal or high concentration of glucose and treated with the same agents. Aldosterone antagonists were the most effective in ameliorating functional and structural kidney damage and they normalized diabetes induced bradycardia and weight loss. Aldosterone blockers also prevented hyperglycemia and diabetes induced increase in NKA protein level and enzyme mislocation. A monotherapy with aldosterone antagonists might be as, or more effective than ACEi or ARBs in the prevention of STZ-induced DN. Furthermore the alteration of the NKA could represent a novel pathophysiological feature of DN and might serve as an additional target of aldosterone blockers.	[Banki, Nora F.; Prokai, Agnes; Gellai, Renata; Lenart, Lilla; Szakal, Dorottya-Nagy; Kenesei, Eva; Reusz, Gyorgy; Szabo, Attila J.; Tulassay, Tivadar; Fekete, Andrea] Semmelweis Univ, Dept Pediat 1, H-1085 Budapest, Hungary; [Banki, Nora F.; Gellai, Renata; Lenart, Lilla; Fekete, Andrea] Hungarian Acad Sci, SE MTA Lendulet Diabet Res Grp, Budapest, Hungary; [Ver, Agota; Rosta, Klara] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary; [Wagner, Laszlo J.] Semmelweis Univ, Dept Transplantat & Surg, H-1085 Budapest, Hungary; [Vannay, Adam; Tulassay, Tivadar] Hungarian Acad Sci, Res Lab Pediat & Nephrol, Budapest, Hungary; [Degrell, Peter] Dept Med 2, Pecs, Hungary; [Degrell, Peter] Ctr Nephrol Res & Training, Pecs, Hungary; [Baylis, Chris] Univ Florida, Dept Physiol, Gainesville, FL USA; [Baylis, Chris] Univ Florida, Dept Funct Genom & Med, Gainesville, FL USA	Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; Semmelweis University; Hungarian Academy of Sciences; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Banki, NF (corresponding author), Semmelweis Univ, Dept Pediat 1, H-1085 Budapest, Hungary.	fekete.andrea@med.semmelweis-univ.hu	Reusz, George S/N-7918-2017	Reusz, George S/0000-0003-0396-043X; Vannay, Adam/0000-0001-7412-4733; Rosta, Klara/0000-0002-3502-3734	Lendulet Research Grant [LP2011-008/2011]; NIH [R01 DK56843]; Pfizer; TAMOP [TAMOP-4.2.3-08/1/KMR-2008-0003];  [OTKA PD83431-84087-T71730];  [ETT 05-180-06-066-057-123/2009];  [REG_KM_09-1-2009-0016]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056843] Funding Source: NIH RePORTER	Lendulet Research Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); TAMOP; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by LP2011-008/2011 Lendulet Research Grant; NIH grant R01 DK56843 and a Pfizer Scholarship for Young investigators. It was also supported by grants of OTKA PD83431-84087-T71730, ETT 05-180-06-066-057-123/2009, REG_KM_09-1-2009-0016 and TAMOP (TAMOP-4.2.3-08/1/KMR-2008-0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Achi A, 2001, DRUG DEV IND PHARM, V27, P465, DOI 10.1081/DDC-100104322; ANDERSON S, 1993, AM J PHYSIOL, V265, pF477, DOI 10.1152/ajprenal.1993.265.4.F477; Attman PO, 1998, NEPHROL DIAL TRANSPL, V13, P2833, DOI 10.1093/ndt/13.11.2833; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; BELL RC, 1994, ENDOCRINOLOGY, V135, P2681, DOI 10.1210/en.135.6.2681; Bomback AS, 2012, BLOOD PURIFICAT, V33, P119, DOI 10.1159/000334161; BURNS KD, 1993, SEMIN NEPHROL, V13, P13; Coppey LJ, 2006, DIABETES, V55, P341, DOI 10.2337/diabetes.55.02.06.db05-0885; De Angelis K, 2009, AUTON NEUROSCI-BASIC, V145, P3, DOI 10.1016/j.autneu.2008.10.013; Degrell P, 2009, LIFE SCI, V84, P389, DOI 10.1016/j.lfs.2009.01.007; EWING DJ, 1981, LANCET, V1, P183; Failli P, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-32; Fekete A, 2008, J PHYSIOL-LONDON, V586, P5337, DOI 10.1113/jphysiol.2008.156703; Galuska D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028294; Giacchetti G, 2005, TRENDS ENDOCRIN MET, V16, P120, DOI 10.1016/j.tem.2005.02.003; Goyal BR, 2009, J CARDIOVASC PHARM, V54, P502, DOI 10.1097/FJC.0b013e3181be75cc; Guo C, 2008, CIRCULATION, V117, P2253, DOI 10.1161/CIRCULATIONAHA.107.748640; Harris KPG, 2006, DIABETIC MED, V23, P13, DOI 10.1111/j.1464-5491.2006.1930_4.x; Hashimoto M, 2001, J ELECTROCARDIOL, V34, P243, DOI 10.1054/jelc.2001.25130; Isenovic ER, 2004, INT J MOL MED, V13, P915; Izuhara Y, 2005, J AM SOC NEPHROL, V16, P3631, DOI 10.1681/ASN.2005050522; Jarman PR, 2003, BRIT MED J, V327, P812, DOI 10.1136/bmj.327.7418.812; Karnib HH, 2010, DIABETES RES CLIN PR, V89, P201, DOI 10.1016/j.diabres.2010.05.022; Kurtz TW, 2005, HYPERTENSION, V45, P299, DOI 10.1161/01.HYP.0000150857.39919.cb; Mather A, 2011, KIDNEY INT, V79, pS1, DOI 10.1038/ki.2010.509; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; Nangaku M, 2004, INTERNAL MED, V43, P9, DOI 10.2169/internalmedicine.43.9; National Institutes of Heath National Institute of Diabetes and Digestive and Kidney Diseases, 2010, US REN DAT SYST USRD; Navar LG, 1999, J AM SOC NEPHROL, V10, pS189; NAVAR LG, 1994, J AM SOC NEPHROL, V5, P1153; Neeli H, 2009, CURR DIABETES REP, V9, P11, DOI 10.1007/s11892-009-0004-y; Ohtomo S, 2010, J OBES, V2010, DOI 10.1155/2010/136502; Ottlecz A, 1996, INVEST OPHTH VIS SCI, V37, P1633; Ribeiro-Oliveira A, 2008, VASC HEALTH RISK MAN, V4, P787; Rosta K, 2009, ACTA PHARMACOL SIN, V30, P1616, DOI 10.1038/aps.2009.162; SEIKALY MG, 1990, J CLIN INVEST, V86, P1352, DOI 10.1172/JCI114846; Setacci C, 2009, J CARDIOVASC SURG, V50, P263; Taira M, 2008, EUR J PHARMACOL, V589, P264, DOI 10.1016/j.ejphar.2008.06.019; Titan SM, 2011, CLIN NEPHROL, V76, P273, DOI 10.5414/CN107013; Ueno H, 2010, INT J CARDIOL, V138, P174, DOI 10.1016/j.ijcard.2008.08.011; Wada T, 2010, ENDOCRINOLOGY, V151, P2040, DOI 10.1210/en.2009-0869; WANG W, 1994, HYPERTENSION, V24, P571, DOI 10.1161/01.HYP.24.5.571; Woroniecki R, 2003, AM J PHYSIOL-RENAL, V284, pF358, DOI 10.1152/ajprenal.00100.2002; Zimpelmann J, 2000, KIDNEY INT, V58, P2320, DOI 10.1046/j.1523-1755.2000.00416.x	44	17	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39938	10.1371/journal.pone.0039938	http://dx.doi.org/10.1371/journal.pone.0039938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761931	Green Published, Green Submitted, gold			2022-12-27	WOS:000305826400047
J	Greenberg, AK; Lu, F; Goldberg, JD; Eylers, E; Tsay, JC; Yie, TA; Naidich, D; McGuinness, G; Pass, H; Tchou-Wong, KM; Addrizzo-Harris, D; Chachoua, A; Crawford, B; Rom, WN				Greenberg, Alissa K.; Lu, Feng; Goldberg, Judith D.; Eylers, Ellen; Tsay, Jun-Chieh; Yie, Ting-An; Naidich, David; McGuinness, Georgeann; Pass, Harvey; Tchou-Wong, Kam-Meng; Addrizzo-Harris, Doreen; Chachoua, Abraham; Crawford, Bernard; Rom, William N.			CT Scan Screening for Lung Cancer: Risk Factors for Nodules and Malignancy in a High-Risk Urban Cohort	PLOS ONE			English	Article							SPIRAL COMPUTED-TOMOGRAPHY; AIR-FLOW OBSTRUCTION; ACTION PROJECT; FOLLOW-UP; DOSE CT; EMPHYSEMA; MANAGEMENT; SMOKERS; VOLUME; SIZE	Background: Low-dose computed tomography (CT) for lung cancer screening can reduce lung cancer mortality. The National Lung Screening Trial reported a 20% reduction in lung cancer mortality in high-risk smokers. However, CT scanning is extremely sensitive and detects non-calcified nodules (NCNs) in 24-50% of subjects, suggesting an unacceptably high false-positive rate. We hypothesized that by reviewing demographic, clinical and nodule characteristics, we could identify risk factors associated with the presence of nodules on screening CT, and with the probability that a NCN was malignant. Methods: We performed a longitudinal lung cancer biomarker discovery trial (NYU LCBC) that included low-dose CT-screening of high-risk individuals over 50 years of age, with more than 20 pack-year smoking histories, living in an urban setting, and with a potential for asbestos exposure. We used case-control studies to identify risk factors associated with the presence of nodules (n = 625) versus no nodules (n = 557), and lung cancer patients (n = 30) versus benign nodules (n = 128). Results: The NYU LCBC followed 1182 study subjects prospectively over a 10-year period. We found 52% to have NCNs>4 mm on their baseline screen. Most of the nodules were stable, and 9.7% of solid and 26.2% of sub-solid nodules resolved. We diagnosed 30 lung cancers, 26 stage I. Three patients had synchronous primary lung cancers or multifocal disease. Thus, there were 33 lung cancers: 10 incident, and 23 prevalent. A sub-group of the prevalent group were stable for a prolonged period prior to diagnosis. These were all stage I at diagnosis and 12/13 were adenocarcinomas. Conclusions: NCNs are common among CT-screened high-risk subjects and can often be managed conservatively. Risk factors for malignancy included increasing age, size and number of nodules, reduced FEV1 and FVC, and increased pack-years smoking. A sub-group of screen-detected cancers are slow-growing and may contribute to over-diagnosis and lead-time biases.	[Greenberg, Alissa K.; Eylers, Ellen; Tsay, Jun-Chieh; Yie, Ting-An; Tchou-Wong, Kam-Meng; Addrizzo-Harris, Doreen; Rom, William N.] NYU, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY 10012 USA; [Lu, Feng; Goldberg, Judith D.] NYU, Sch Med, Div Biostat, Dept Environm Med, New York, NY USA; [Naidich, David; McGuinness, Georgeann] NYU, Sch Med, Dept Radiol, Div Thorac Imagining, New York, NY USA; [Pass, Harvey; Crawford, Bernard] NYU, Sch Med, Dept Cardiothorac Surg, Div Thorac Surg, New York, NY USA; [Chachoua, Abraham] NYU, Sch Med, Dept Med, Div Med Oncol, New York, NY USA	New York University; New York University; New York University; New York University; New York University	Greenberg, AK (corresponding author), NYU, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY 10012 USA.	alissa.greenberg@nyumc.org		McGuinness, Georgeann/0000-0002-5326-9180; Goldberg, Judith D./0000-0003-3758-6976; Pass, Harvey/0000-0003-3222-3471; Addrizzo-Harris, Doreen/0000-0002-4831-8101; Rom, William/0000-0002-8793-7028; naidich, david/0000-0003-3751-5836; Tsay, Jun-Chieh/0000-0002-2282-2510	NCI [2UO1CA086137-12, T32 ES007267, 2 P30 CA16087]; NATIONAL CANCER INSTITUTE [U01CA086137, P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007267] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Sources of funding: NCI 2UO1CA086137-12, T32 ES007267 and NCI 2 P30 CA16087. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; [Anonymous], 1984, AM REV RESPIR DIS, V130, P565; Bach PB, 2007, JAMA-J AM MED ASSOC, V297, P953, DOI 10.1001/jama.297.9.953; Bastarrika G, 2005, AM J RESP CRIT CARE, V171, P1378, DOI 10.1164/rccm.200411-1479OC; Blanchon T, 2007, LUNG CANCER, V58, P50, DOI 10.1016/j.lungcan.2007.05.009; Croswell JM, 2010, ANN INTERN MED, V152, P505, DOI 10.7326/0003-4819-152-8-201004200-00007; de Torres JP, 2007, CHEST, V132, P1932, DOI 10.1378/chest.07-1490; Diederich S, 2004, EUR RADIOL, V14, P691, DOI 10.1007/s00330-003-2200-5; Fasola G, 2007, ONCOLOGIST, V12, P1215, DOI 10.1634/theoncologist.12-10-1215; FONTANA RS, 1991, CANCER-AM CANCER SOC, V67, P1155, DOI 10.1002/1097-0142(19910215)67:4+<1155::AID-CNCR2820671509>3.0.CO;2-0; Ford JG, 2008, CANCER, P1097; Goldberg SW, 2010, POPUL HEALTH MANAG, V13, P33, DOI 10.1089/pop.2009.0010; Henschke CI, 2001, CANCER, V92, P153, DOI 10.1002/1097-0142(20010701)92:1<153::AID-CNCR1303>3.0.CO;2-S; Henschke CI, 2004, RADIOLOGY, V231, P164, DOI 10.1148/radiol.2311030634; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Hiramatsu M, 2008, J THORAC ONCOL, V3, P1245, DOI 10.1097/JTO.0b013e318189f526; Infante M, 2009, AM J RESP CRIT CARE, V180, P445, DOI 10.1164/rccm.200901-0076OC; Jett JR, 2011, ANN INTERN MED, V155, P540, DOI 10.7326/0003-4819-155-8-201110180-00367; Kaneko M, 1996, RADIOLOGY, V201, P798, DOI 10.1148/radiology.201.3.8939234; Lindell RM, 2007, RADIOLOGY, V242, P555, DOI 10.1148/radiol.2422052090; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Maisonneuve P, 2011, CANCER PREV RES, V4, P1778, DOI 10.1158/1940-6207.CAPR-11-0026; Maldonado F, 2010, CHEST, V138, P1295, DOI 10.1378/chest.09-2567; Marcus PM, 2000, J NATL CANCER I, V92, P1308, DOI 10.1093/jnci/92.16.1308; Marcus PM, 2006, J NATL CANCER I, V98, P748, DOI 10.1093/jnci/djj207; Markowitz SB, 2007, CHEST, V131, P1028, DOI 10.1378/chest.05-3014; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Mountain CF, 2002, CLIN CHEST MED, V23, P103, DOI 10.1016/S0272-5231(03)00063-7; Mulshine JL, 2005, NEW ENGL J MED, V352, P2714, DOI 10.1056/NEJMcp042630; Oh JY, 2007, LUNG CANCER, V55, P67, DOI 10.1016/j.lungcan.2006.09.009; Ost DE, 2012, AM J RESP CRIT CARE, V185, P363, DOI 10.1164/rccm.201104-0679CI; Pastorino U, 2003, LANCET, V362, P593, DOI 10.1016/S0140-6736(03)14188-8; Patz EF, 2000, NEW ENGL J MED, V343, P1627, DOI 10.1056/NEJM200011303432208; Saghir Z, 2012, THORAX, V67, P296, DOI 10.1136/thoraxjnl-2011-200736; Smith BM, 2012, LUNG CANCER, V77, P58, DOI 10.1016/j.lungcan.2012.02.019; Sone S, 2001, BRIT J CANCER, V84, P25, DOI 10.1054/bjoc.2000.1531; Spivack SD, 2010, EVOLVING EARLY DETEC; Swensen SJ, 2003, RADIOLOGY, V226, P756, DOI 10.1148/radiol.2263020036; Swensen SJ, 2002, AM J RESP CRIT CARE, V165, P508, DOI 10.1164/ajrccm.165.4.2107006; Swensen SJ, 2005, RADIOLOGY, V235, P259, DOI 10.1148/radiol.2351041662; Syamlal Girija, 2011, Morbidity and Mortality Weekly Report, V60, P1305; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085; Wasswa-Kintu S, 2005, THORAX, V60, P570, DOI 10.1136/thx.2004.037135; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P956, DOI 10.1164/rccm.200802-336OC; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P738, DOI 10.1164/rccm.200803-435OC; Wilson DO, 2012, AM J RESP CRIT CARE, V185, P85, DOI 10.1164/rccm.201107-1223OC; Yoon HE, 2005, GEN THORAC CARDIOVAS, V53, P22; Yu YY, 2008, ARCH INTERN MED, V168, P2326, DOI 10.1001/archinte.168.21.2326	50	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39403	10.1371/journal.pone.0039403	http://dx.doi.org/10.1371/journal.pone.0039403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768300	gold, Green Published, Green Submitted			2022-12-27	WOS:000305966500013
J	Bian, MJ; Liu, J; Hong, XQ; Yu, M; Huang, YF; Sheng, ZJ; Fei, J; Huang, F				Bian, Minjuan; Liu, Jie; Hong, Xiaoqi; Yu, Mei; Huang, Yufang; Sheng, Zhejin; Fei, Jian; Huang, Fang			Overexpression of Parkin Ameliorates Dopaminergic Neurodegeneration Induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in Mice	PLOS ONE			English	Article							ALPHA-SYNUCLEIN AGGREGATION; UBIQUITIN-PROTEIN LIGASE; CELL-DEATH; RAT MODEL; MITOCHONDRIAL DYSFUNCTION; NEURONAL DEGENERATION; PINK1/PARKIN PATHWAY; OXIDATIVE DAMAGE; MOTOR DEFICITS; MOUSE MODEL	Mutations in the parkin gene are currently thought to be the most common cause of recessive familial Parkinsonism. Parkin functions as an E3 ligase to regulate protein turnover, and its function in mitochondrial quality control has been reported recently. Overexpression of parkin has been found to prevent neuronal degeneration under various conditions both in vivo and in vitro. Here, we generated a transgenic mouse model in which expression of wild type parkin was driven by neuron-specific enolase (NSE) promoter. We reported that both young and old parkin transgenic mice exhibited less reduction of striatal TH protein and number of TH positive neurons in the substantia nigra induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP), compared to wild type littermates. MPTP-induced mitochondrial impairment in the substantia nigra was improved in young parkin transgenic mice. Decreased striatal alpha-synuclein was demonstrated in old parkin transgenic mice. These results provide reliable evidence from the transgenic mouse model for parkin that overexpression of parkin may attenuate dopaminergic neurodegeneration induced by MPTP through protection of mitochondria and reduction of alpha-synuclein in the nigrostriatal pathway.	[Bian, Minjuan; Liu, Jie; Hong, Xiaoqi; Yu, Mei; Huang, Yufang; Huang, Fang] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Sheng, Zhejin; Fei, Jian] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Huang, Fang] Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China	Fudan University; Tongji University; Fudan University	Bian, MJ (corresponding author), Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China.	huangf@shmu.edu.cn			National Natural Science Foundation of China [90919004, 81171188]; Specialized Research Fund for the Doctoral Program of Higher Education [20110071110039]; Ministry of Science and Technology of China [2012CB966300, 2010CB945501, 2011CB965103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by National Natural Science Foundation of China (90919004, 81171188); Specialized Research Fund for the Doctoral Program of Higher Education (20110071110039) and grants from the Ministry of Science and Technology of China (2012CB966300, 2010CB945501, 2011CB965103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Beal MF, 2003, ANN NY ACAD SCI, V991, P120; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Bian MJ, 2008, ACTA BIOCH BIOPH SIN, V40, P505, DOI 10.1111/j.1745-7270.2008.00423.x; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Burke RE, 2004, NEUROLOGIST, V10, P75, DOI 10.1097/01.nrl.0000117822.90759.83; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Choi P, 2003, MOL BRAIN RES, V117, P179, DOI 10.1016/S0169-328X(03)00318-8; Chu YP, 2007, NEUROBIOL DIS, V25, P134, DOI 10.1016/j.nbd.2006.08.021; Chung YC, 2010, J IMMUNOL, V185, P1230, DOI 10.4049/jimmunol.1000208; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Duvoisin R C, 1999, Adv Neurol, V80, P161; Dzaman-Serafin Sylwia, 2005, Pol Merkur Lekarski, V19, P215; Fleming Sheila M, 2005, NeuroRx, V2, P495, DOI 10.1602/neurorx.2.3.495; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; Gandhi S, 2005, HUM MOL GENET, V14, P2749, DOI 10.1093/hmg/ddi308; Gegg ME, 2011, AUTOPHAGY, V7, P243, DOI 10.4161/auto.7.2.14332; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gibrat C, 2009, J NEUROCHEM, V109, P1469, DOI 10.1111/j.1471-4159.2009.06072.x; Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Henn IH, 2007, J NEUROSCI, V27, P1868, DOI 10.1523/JNEUROSCI.5537-06.2007; Hu JH, 2003, J NEUROSCI RES, V74, P614, DOI 10.1002/jnr.10780; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Ko HS, 2006, J BIOL CHEM, V281, P16193, DOI 10.1074/jbc.C600041200; Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2172-05.2005; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Le Couteur David G, 2002, Rev Environ Health, V17, P51; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Liberatore GT, 1999, NAT MED, V5, P1403; Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101; Lu XH, 2009, J NEUROSCI, V29, P1962, DOI 10.1523/JNEUROSCI.5351-08.2009; Manfredsson FP, 2007, EXP NEUROL, V207, P289, DOI 10.1016/j.expneurol.2007.06.019; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McLean PJ, 2004, BIOCHEM BIOPH RES CO, V321, P665, DOI 10.1016/j.bbrc.2004.07.021; Mizuno Y, 1999, Adv Neurol, V80, P171; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Offen D, 1998, P NATL ACAD SCI USA, V95, P5789, DOI 10.1073/pnas.95.10.5789; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Paterna JC, 2007, MOL THER, V15, P698, DOI 10.1038/sj.mt.6300067; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Ulusoy A, 2008, EXP NEUROL, V212, P258, DOI 10.1016/j.expneurol.2008.04.026; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; van Noort JM, 2008, J PATHOL, V214, P267, DOI 10.1002/path.2273; Vercammen L, 2006, MOL THER, V14, P716, DOI 10.1016/j.ymthe.2006.06.009; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Whitworth AJ, 2009, J BIOENERG BIOMEMBR, V41, P499, DOI 10.1007/s10863-009-9253-3; Xuan Q, 2011, J NEURAL TRANSM, V118, P1575, DOI 10.1007/s00702-011-0636-3; Yang LC, 1998, J NEUROSCI, V18, P8145; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yasuda T, 2011, J NEUROPATH EXP NEUR, V70, P686, DOI 10.1097/NEN.0b013e3182269ecd; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang W, 2005, J CEREBR BLOOD F MET, V25, P30, DOI 10.1038/sj.jcbfm.9600004; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	80	53	55	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39953	10.1371/journal.pone.0039953	http://dx.doi.org/10.1371/journal.pone.0039953			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22792139	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100151
J	Chen, YL; Wu, XM; Yu, SS; Lin, XM; Wu, JX; Li, L; Zhao, J; Zhao, Y				Chen, Yanlin; Wu, Xuemei; Yu, Shanshan; Lin, Xuemei; Wu, Jingxian; Li, Lan; Zhao, Jing; Zhao, Yong			Neuroprotection of Tanshinone IIA against Cerebral Ischemia/Reperfusion Injury through Inhibition of Macrophage Migration Inhibitory Factor in Rats	PLOS ONE			English	Article							NF-KAPPA-B; ARTERY OCCLUSION; ISCHEMIA; INFLAMMATION; ACTIVATION; STROKE	Background: Ischemia/reperfusion (I/R) injury is associated with systemic inflammatory response. Macrophage migration inhibitory factor (MIF) has been implicated in many inflammatory processes. Tanshinone IIA (TSA) is one of the active ingredients in danshen, which derived from the dried root or rhizome of Salviae miltiorrhizae Bge. Recent studies have demonstrated that TSA has protective effects against focal cerebral I/R injury. However, little is known about the underlying mechanisms. Here we put forward the hypothesis that TSA acts through inhibition of MIF expression during focal cerebral I/R injury in rats. Methodology/Principal Findings: Rats were subjected to middle cerebral artery occlusion (MCAO) for 2 hours. This was followed by reperfusion. We measured neurological deficits, brain water content, and infarct volume, and found that neurological dysfunction, brain edema, and brain infarction were significantly attenuated by TSA 6 hours after reperfusion. We also measured myeloperoxidase (MPO) activity at 6 and 24 hours, and found that neutrophil infiltration was significantly higher in the vehicle+I/R group than in the TSA+I/R group. ELISA demonstrated that TSA could inhibit MIF expression and the release of TNF-alpha and IL-6 induced by I/R injury. Western blot analysis and immunofluorescence staining showed that MIF expression was significantly lower in the TSA+I/R group than in the vehicle+I/R group. MIF was found almost all located in neurons and hardly any located in astrocytes in the cerebral cortex. Western blot analysis and EMSA demonstrated that NF-kappa B expression and activity were significantly increased in the vehicle+I/R group. However, these changes were attenuated by TSA. Conclusion/Significance: Our results suggest that TSA helps alleviate the proinflammatory responses associated with I/R-induced injury and that this neuroprotective effect may occur through down-regulation of MIF expression in neurons.	[Chen, Yanlin; Wu, Xuemei; Yu, Shanshan; Lin, Xuemei; Wu, Jingxian; Zhao, Yong] Chongqing Med Univ, Dept Pathol, Chongqing, Peoples R China; [Li, Lan; Zhao, Jing] Chongqing Med Univ, Dept Pathophysiol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Chen, YL (corresponding author), Chongqing Med Univ, Dept Pathol, Chongqing, Peoples R China.	yangyang741022@sina.com; blys01@163.com			National Nature Science Foundation of China [30900457, 81070917]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Nature Science Foundation of China (No. 30900457 and No. 81070917). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams James David, 2006, Chin Med, V1, P3, DOI 10.1186/1749-8546-1-3; Amin MA, 2006, BLOOD, V107, P2252, DOI 10.1182/blood-2005-05-2011; [Anonymous], 1977, CHINESE MED J-PEKING, V3, P224; Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; Berti R, 2002, J CEREBR BLOOD F MET, V22, P1068, DOI 10.1097/00004647-200209000-00004; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Chamorro A, 2006, STROKE, V37, P291, DOI 10.1161/01.STR.0000200561.69611.f8; Chen YL, 2012, BIOL PHARM BULL, V35, P164, DOI 10.1248/bpb.35.164; Choe CU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019046; Clemens JA, 1998, STROKE, V29, P677, DOI 10.1161/01.STR.29.3.677; Dong KN, 2009, PHYTOTHER RES, V23, P608, DOI 10.1002/ptr.2615; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Elango C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-97; Gao XM, 2011, J MOL CELL CARDIOL, V50, P991, DOI 10.1016/j.yjmcc.2010.12.022; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hoffman GE, 2006, ENDOCRINE, V29, P217, DOI 10.1385/ENDO:29:2:217; Inacio AR, 2011, NEUROBIOL DIS, V41, P270, DOI 10.1016/j.nbd.2010.09.015; Jang SI, 2006, EUR J PHARMACOL, V542, P1, DOI 10.1016/j.ejphar.2006.04.044; Jin W, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/725174; Kim JS, 1996, J NEUROL SCI, V137, P69, DOI 10.1016/0022-510X(95)00338-3; Lam BYH, 2003, PHYTOMEDICINE, V10, P286, DOI 10.1078/094471103322004776; Liesz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021312; Liu LL, 2010, BRAIN RES BULL, V82, P228, DOI 10.1016/j.brainresbull.2010.04.005; Liu Y, 2009, BRAIN RES, V1268, P174, DOI 10.1016/j.brainres.2009.02.069; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Phillips JB, 2000, STROKE, V31, P1686, DOI 10.1161/01.STR.31.7.1686; Tang C, 2010, PHYTOMEDICINE, V17, P1145, DOI 10.1016/j.phymed.2010.03.017; Tripathy D, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-10; Wang LJ, 2009, STROKE, V40, P973, DOI 10.1161/STROKEAHA.108.530535; Yu SS, 2010, BRAIN RES, V1308, P167, DOI 10.1016/j.brainres.2009.10.037; Zhang Y, 2011, BIOL PHARM BULL, V34, P1052, DOI 10.1248/bpb.34.1052; Zhao J, 2008, BRAIN RES, V1229, P224, DOI 10.1016/j.brainres.2008.06.117; Zhao J, 2010, NEUROCHEM RES, V35, P374, DOI 10.1007/s11064-009-0065-y; Zhou ML, 2007, J SURG RES, V137, P103, DOI 10.1016/j.jss.2006.06.023	34	68	77	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40165	10.1371/journal.pone.0040165	http://dx.doi.org/10.1371/journal.pone.0040165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768247	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100220
J	Hakanson, M; Kobel, S; Lutolf, MP; Textor, M; Cukierman, E; Charnley, M				Hakanson, Maria; Kobel, Stefan; Lutolf, Matthias P.; Textor, Marcus; Cukierman, Edna; Charnley, Mirren			Controlled Breast Cancer Microarrays for the Deconvolution of Cellular Multilayering and Density Effects upon Drug Responses	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; BETA(1) INTEGRIN; PROGNOSTIC MARKER; RESISTANCE; TISSUE; APOPTOSIS; ADHESION; GROWTH; MICROENVIRONMENT; INHIBITOR	Background: Increasing evidence shows that the cancer microenvironment affects both tumorigenesis and the response of cancer to drug treatment. Therefore in vitro models that selectively reflect characteristics of the in vivo environment are greatly needed. Current methods allow us to screen the effect of extrinsic parameters such as matrix composition and to model the complex and three-dimensional (3D) cancer environment. However, 3D models that reflect characteristics of the in vivo environment are typically too complex and do not allow the separation of discrete extrinsic parameters. Methodology/Principal Findings: In this study we used a poly(ethylene glycol) (PEG) hydrogel-based microwell array to model breast cancer cell behavior in multilayer cell clusters that allows a rigorous control of the environment. The innovative array fabrication enables different matrix proteins to be integrated into the bottom surface of microwells. Thereby, extrinsic parameters including dimensionality, type of matrix coating and the extent of cell-cell adhesion could be independently studied. Our results suggest that cell to matrix interactions and increased cell-cell adhesion, at high cell density, induce independent effects on the response to Taxol in multilayer breast cancer cell clusters. In addition, comparing the levels of apoptosis and proliferation revealed that drug resistance mediated by cell-cell adhesion can be related to altered cell cycle regulation. Conversely, the matrix-dependent response to Taxol did not correlate with proliferation changes suggesting that cell death inhibition may be responsible for this effect. Conclusions/Significance: The application of the PEG hydrogel platform provided novel insight into the independent role of extrinsic parameters controlling drug response. The presented platform may not only become a useful tool for basic research related to the role of the cancer microenvironment but could also serve as a complementary platform for in vitro drug development.	[Hakanson, Maria; Textor, Marcus; Charnley, Mirren] Swiss Fed Inst Technol, Lab Surface Sci & Technol, BioInterface Grp, Zurich, Switzerland; [Kobel, Stefan; Lutolf, Matthias P.] EPF Lausanne, Lab Stem Cell Bioengn, Lausanne, Switzerland; [Cukierman, Edna] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Fox Chase Cancer Center	Hakanson, M (corresponding author), Swiss Fed Inst Technol, Lab Surface Sci & Technol, BioInterface Grp, Zurich, Switzerland.	edna.cukierman@fccc.edu; mirren.charnley@mat.ethz.ch	Textor, Marcus/A-6200-2012; Lutolf, Matthias P/E-5914-2010; Cukierman, Edna/A-3951-2013; cukierman, edna/AAU-8932-2020	Textor, Marcus/0000-0002-0178-1801; cukierman, edna/0000-0002-1452-9576; Charnley, Mirren/0000-0003-3845-9290	Competence Centre for Materials Science and Technoloy (CCMX); Swiss National Science Foundation (SNSF) [CR23I2_125290/1]; National Centers for Competence in Research (NCCR); National Institutes of Health/National Cancer Institute [CA113451]; NATIONAL CANCER INSTITUTE [R01CA113451] Funding Source: NIH RePORTER	Competence Centre for Materials Science and Technoloy (CCMX); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Centers for Competence in Research (NCCR)(Swiss National Science Foundation (SNSF)); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank the Competence Centre for Materials Science and Technoloy (CCMX; www.ccmx.ch), the Swiss National Science Foundation (SNSF; www.snf.ch; grant number CR23I2_125290/1) and the National Centers for Competence in Research (NCCR; www.nccr.ch; Nano-P5, project 03) for their financial support of this work. The authors also acknowledge funds from National Institutes of Health/National Cancer Institute grant CA113451 (to EC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas T, 2003, EUR J CANCER, V39, P438, DOI 10.1016/S0959-8049(02)00732-3; AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; Aoudjit F, 2001, ONCOGENE, V20, P4995, DOI 10.1038/sj.onc.1204554; Beacham DA, 2005, SEMIN CANCER BIOL, V15, P329, DOI 10.1016/j.semcancer.2005.05.003; Benton G, 2009, FASEB J, V23, P3884, DOI 10.1096/fj.08-128702; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Campbell JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025661; Castello-Cros R, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-94; Charnley M, 2009, INTEGR BIOL-UK, V1, P625, DOI 10.1039/b918172p; Cukierman E, 2012, CELL ADHESION MIGRAT, V6, px; Cukierman E, 2010, SEMIN CANCER BIOL, V20, P139, DOI 10.1016/j.semcancer.2010.04.004; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Denys H, 2009, CURR PHARM DESIGN, V15, P1373, DOI 10.2174/138161209787846711; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dhiman HK, 2005, BIOMATERIALS, V26, P979, DOI 10.1016/j.biomaterials.2004.04.012; Erkan M, 2008, CLIN GASTROENTEROL H, V6, P1155, DOI 10.1016/j.cgh.2008.05.006; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Folgiero V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001592; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Goicoechea SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010347; Grantab R, 2006, CANCER RES, V66, P1033, DOI 10.1158/0008-5472.CAN-05-3077; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Gudjonsson T, 2003, METHODS, V30, P247, DOI 10.1016/S1046-2023(03)00031-8; Gupta V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021494; Hakanson M., 2011, INTEGR BIOL, P1; Hazlehurst LA, 2003, ONCOGENE, V22, P7396, DOI 10.1038/sj.onc.1206943; Heino J, 2000, MATRIX BIOL, V19, P319, DOI 10.1016/S0945-053X(00)00076-7; Hirtenlehner K, 2002, EUR CYTOKINE NETW, V13, P234; Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Kim JH, 2009, P NATL ACAD SCI USA, V106, P11149, DOI 10.1073/pnas.0812651106; Lang P, 2006, NAT REV DRUG DISCOV, V5, P343, DOI 10.1038/nrd2008; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee HO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-245; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Naumov GN, 2003, BREAST CANCER RES TR, V82, P199, DOI 10.1023/B:BREA.0000004377.12288.3c; Ochsner M, 2007, LAB CHIP, V7, P1074, DOI 10.1039/b704449f; Ohbayashi M., 2008, Experimental Oncology, V30, P276; Park CC, 2008, CANCER RES, V68, P4398, DOI 10.1158/0008-5472.CAN-07-6390; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Pasche S, 2003, LANGMUIR, V19, P9216, DOI 10.1021/la034111y; Patel SR, 2001, CANCER, V92, P1347, DOI 10.1002/1097-0142(20010901)92:5<1347::AID-CNCR1456>3.0.CO;2-0; Serebriiskii I, 2008, MATRIX BIOL, V27, P573, DOI 10.1016/j.matbio.2008.02.008; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sherman-Baust CA, 2003, CANCER CELL, V3, P377, DOI 10.1016/S1535-6108(03)00058-8; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; StCroix B, 1996, NAT MED, V2, P1204; Teicher BA, 2009, BIOCHEM PHARMACOL, V77, P1665, DOI 10.1016/j.bcp.2009.01.006; Vargas GA, 2009, BIOMARK MED, V3, P701, DOI 10.2217/BMM.09.74; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Xu R, 2009, CANCER METAST REV, V28, P167, DOI 10.1007/s10555-008-9178-z; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yao CC, 1996, J BIOL CHEM, V271, P25598, DOI 10.1074/jbc.271.41.25598; Yao ES, 2007, CANCER RES, V67, P659, DOI 10.1158/0008-5472.CAN-06-2768; Zahir N, 2004, CURR OPIN GENET DEV, V14, P71, DOI 10.1016/j.gde.2003.12.005; Zutter MM, 2007, ADV EXP MED BIOL, V608, P87	59	21	21	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40141	10.1371/journal.pone.0040141	http://dx.doi.org/10.1371/journal.pone.0040141			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22792141	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100215
J	Marsh, AK; Willer, DO; Skokovets, O; Iwajomo, OH; Chan, JK; MacDonald, KS				Marsh, Angie K.; Willer, David O.; Skokovets, Olena; Iwajomo, Oluwadamilola H.; Chan, Jacqueline K.; MacDonald, Kelly S.			Evaluation of Cynomolgus Macaque (Macaca fascicularis) Endogenous Retrovirus Expression Following Simian Immunodeficiency Virus Infection	PLOS ONE			English	Article							HERV-K; RHESUS-MONKEYS; CHINESE RHESUS; RNA TITERS; HIV; SEQUENCES; GENOME; VACCINE; INDIVIDUALS; PRIMATES	Human endogenous retrovirus type K (HERV-K) transcripts are upregulated in the plasma of HIV-infected individuals and have been considered as targets for an HIV vaccine. We evaluated cynomolgus macaque endogenous retrovirus (CyERV) mRNA expression by RT-qPCR in PBMCs isolated from a cohort of animals previously utilized in a live attenuated SIV vaccine trial. CyERV env transcript levels decreased following vaccination (control and vaccine groups) and CyERV env and gag mRNA expression was decreased following acute SIV-infection, whereas during chronic SIV infection, CyERV transcript levels were indistinguishable from baseline. Reduced susceptibility to initial SIV infection, as measured by the number of SIV challenges required for infection, was associated with increased CyERV transcript levels in PBMCs. In vitro analysis revealed that SIV infection of purified CD4(+) T-cells did not alter CyERV gene expression. This study represents the first evaluation of ERV expression in cynomolgus macaques following SIV infection, in an effort to assess the utility of cynomolgus macaques as an animal model to evaluate ERVs as a target for an HIV/SIV vaccine. This non-human primate model system does not recapitulate what has been observed to date in the plasma of HIV-infected humans suggesting that further investigation at the cellular level is required to elucidate the impact of HIV/SIV infection on endogenous retrovirus expression.	[Marsh, Angie K.; MacDonald, Kelly S.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Willer, David O.; Skokovets, Olena; Iwajomo, Oluwadamilola H.; Chan, Jacqueline K.; MacDonald, Kelly S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Marsh, Angie K.; Willer, David O.; Iwajomo, Oluwadamilola H.; Chan, Jacqueline K.; MacDonald, Kelly S.] Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Marsh, AK (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	kmacdonald@mtsinai.on.ca	MacDonald, Kelly S/L-3315-2019		OHTN [JIDA109, SCI G654]; CIHR [HOP90180, VSR-107743]	OHTN; CIHR(Canadian Institutes of Health Research (CIHR))	OHTN (#JIDA109, #SCI G654; www.ohtn.on.ca), CIHR (#HOP90180, #VSR-107743; http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Contreras-Galindo R, 2007, AIDS RES HUM RETROV, V23, P1083, DOI 10.1089/aid.2007.0054; Contreras-Galindo R, 2006, AIDS RES HUM RETROV, V22, P979, DOI 10.1089/aid.2006.22.979; Contreras-Galindo R, 2006, J VIROL METHODS, V136, P51, DOI 10.1016/j.jviromet.2006.03.029; Denner J, 1995, J CANC RES CLIN ONCO, P121; Drummond A., 2011, GENEIOUS V5 5; Ebeling M, 2011, GENOME RES, V21, P1746, DOI 10.1101/gr.123117.111; Garrison KE, 2007, PLOS PATHOG, V3, P1617, DOI 10.1371/journal.ppat.0030165; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Greenwood AD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-44; Guan YJ, 2000, J VIROL, V74, P8854, DOI 10.1128/JVI.74.19.8854-8860.2000; Han K, 2007, SCIENCE, V316, P238, DOI 10.1126/science.1139462; Hu Shiu-Lok, 2005, Current Drug Targets - Infectious Disorders, V5, P193, DOI 10.2174/1568005054201508; Johnson WE, 2002, ANNU REV MED, V53, P499, DOI 10.1146/annurev.med.53.082901.104053; Katzourakis A, 2005, MOL B INT U, P186; KESTLER H, 1990, SCIENCE, V248, P1109, DOI 10.1126/science.2160735; Kurth R, 2010, INT J CANCER, V126, P306, DOI 10.1002/ijc.24902; Lefebvre G, 2011, J VIROL, V85, P6205, DOI 10.1128/JVI.00252-11; Lower R, 1996, P NATL ACAD SCI USA, V93, P5177, DOI 10.1073/pnas.93.11.5177; Mayer J, 1998, J VIROL, V72, P1870, DOI 10.1128/JVI.72.3.1870-1875.1998; MEDSTRAND P, 1992, J GEN VIROL, V73, P2463, DOI 10.1099/0022-1317-73-9-2463; Nelson PN, 2003, J CLIN PATHOL-MOL PA, V56, P11, DOI 10.1136/mp.56.1.11; O'Connor DH, 2006, FUTURE VIROL, V1, P165, DOI 10.2217/17460794.1.2.165; Romano CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001026; Sacha JB, 2010, NAT PROTOC, V5, P239, DOI 10.1038/nprot.2009.227; SenGupta D, 2011, J VIROL, V85, P6977, DOI 10.1128/JVI.00179-11; STEINHUBER S, 1995, HUM GENET, V96, P188, DOI 10.1007/BF00207377; Tonjes RR, 1999, J VIROL, V73, P9187; van der Kuyl AC, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-6; Vogt P. K., 1997, P1; Willer DO, 2010, J VIROL, V84, P2304, DOI 10.1128/JVI.01995-09; Yan GM, 2011, NAT BIOTECHNOL, V29, P1019, DOI 10.1038/nbt.1992	31	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40158	10.1371/journal.pone.0040158	http://dx.doi.org/10.1371/journal.pone.0040158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768246	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100219
J	Noor, S; Taylor, MC; Russell, RJ; Jermiin, LS; Jackson, CJ; Oakeshott, JG; Scott, C				Noor, Sajid; Taylor, Matthew C.; Russell, Robyn J.; Jermiin, Lars S.; Jackson, Colin J.; Oakeshott, John G.; Scott, Colin			Intramolecular Epistasis and the Evolution of a New Enzymatic Function	PLOS ONE			English	Article							ATRAZINE CHLOROHYDROLASE; PSEUDOMONAS SP; PROTEIN; ENZYMES	Atrazine chlorohydrolase (AtzA) and its close relative melamine deaminase (TriA) differ by just nine amino acid substitutions but have distinct catalytic activities. Together, they offer an informative model system to study the molecular processes that underpin the emergence of new enzymatic function. Here we have constructed the potential evolutionary trajectories between AtzA and TriA, and characterized the catalytic activities and biophysical properties of the intermediates along those trajectories. The order in which the nine amino acid substitutions that separate the enzymes could be introduced to either enzyme, while maintaining significant catalytic activity, was dictated by epistatic interactions, principally between three amino acids within the active site: namely, S331C, N328D and F84L. The mechanistic basis for the epistatic relationships is consistent with a model for the catalytic mechanisms in which protonation is required for hydrolysis of melamine, but not atrazine.	[Noor, Sajid; Taylor, Matthew C.; Russell, Robyn J.; Jermiin, Lars S.; Oakeshott, John G.; Scott, Colin] Commonwealth Sci & Ind Res Org, Ecosyst Sci, Canberra, ACT, Australia; [Jermiin, Lars S.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Jermiin, Lars S.] Univ Roma La Sapienza, Dept Biochem Sci Rossi Fanelli, Rome, Italy; [Noor, Sajid; Jackson, Colin J.] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Sydney; Sapienza University Rome; Australian National University	Noor, S (corresponding author), Commonwealth Sci & Ind Res Org, Ecosyst Sci, Canberra, ACT, Australia.	colin.scott@csiro.au	Jackson, Colin J/C-1500-2008; Taylor, Matthew/B-5903-2009; Jermiin, Lars Sommer/AAQ-7033-2020; Russell, Robyn/C-5449-2008; Oakeshott, John G/B-5365-2009; Jermiin, Lars Sommer/C-2458-2009; Scott, Colin/A-4682-2009	Jackson, Colin J/0000-0001-6150-3822; Taylor, Matthew/0000-0001-9576-1555; Jermiin, Lars Sommer/0000-0002-9619-3809; Russell, Robyn/0000-0001-5600-3305; Oakeshott, John G/0000-0001-8324-7874; Jermiin, Lars Sommer/0000-0002-9619-3809; Scott, Colin/0000-0001-6110-6982	Australian National University; CSIRO's Synthetic Enzymes Emerging Science Initiative	Australian National University(Australian National University); CSIRO's Synthetic Enzymes Emerging Science Initiative	SN was supported by an Australian National University Postgraduate Scholarship and CSIRO's Synthetic Enzymes Emerging Science Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; COOK AM, 1981, J AGR FOOD CHEM, V29, P1135, DOI 10.1021/jf00108a009; Copley SD, 2009, NAT CHEM BIOL, V5, P560, DOI 10.1038/nchembio.197; Costanzo MS, 2011, J GENET, V90, P187, DOI 10.1007/s12041-011-0072-z; Costanzo MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019636; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; deSouza ML, 1996, J BACTERIOL, V178, P4894, DOI 10.1128/jb.178.16.4894-4900.1996; EATON RW, 1991, J BACTERIOL, V173, P1215, DOI 10.1128/jb.173.3.1215-1222.1991; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; LENNOX ES, 1955, VIROLOGY, V1, P190, DOI 10.1016/0042-6822(55)90016-7; MANDELBAUM RT, 1995, APPL ENVIRON MICROB, V61, P1451, DOI 10.1128/AEM.61.4.1451-1457.1995; Peisajovich SG, 2007, NAT METHODS, V4, P991, DOI 10.1038/nmeth1207-991; Raillard S, 2001, CHEM BIOL, V8, P891, DOI 10.1016/S1074-5521(01)00061-8; Russell RJ, 2011, EVOL APPL, V4, P225, DOI 10.1111/j.1752-4571.2010.00175.x; Salverda MLM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001321; Scott C, 2009, APPL ENVIRON MICROB, V75, P2184, DOI 10.1128/AEM.02634-08; Seffernick JL, 2001, J BACTERIOL, V183, P2405, DOI 10.1128/JB.183.8.2405-2410.2001; Seffernick JL, 2001, BIOCHEMISTRY-US, V40, P12747, DOI 10.1021/bi011293r; SHOICHET BK, 1995, P NATL ACAD SCI USA, V92, P452, DOI 10.1073/pnas.92.2.452; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tracewell CA, 2009, CURR OPIN CHEM BIOL, V13, P3, DOI 10.1016/j.cbpa.2009.01.017; Wackett LP, 2009, CURR OPIN MICROBIOL, V12, P244, DOI 10.1016/j.mib.2009.05.001; Wackett LP, 2004, J BIOL CHEM, V279, P41259, DOI 10.1074/jbc.R400014200; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539	28	38	39	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39822	10.1371/journal.pone.0039822	http://dx.doi.org/10.1371/journal.pone.0039822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768133	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100103
J	Pfeifer, M; Burgess, ND; Swetnam, RD; Platts, PJ; Willcock, S; Marchant, R				Pfeifer, Marion; Burgess, Neil D.; Swetnam, Ruth D.; Platts, Philip J.; Willcock, Simon; Marchant, Robert			Protected Areas: Mixed Success in Conserving East Africa's Evergreen Forests	PLOS ONE			English	Article							TROPICAL FORESTS; LAND-COVER; CONSERVATION; BIODIVERSITY; DEFORESTATION; DEGRADATION; TANZANIA; LOCATION; POVERTY; GROWTH	In East Africa, human population growth and demands for natural resources cause forest loss contributing to increased carbon emissions and reduced biodiversity. Protected Areas (PAs) are intended to conserve habitats and species. Variability in PA effectiveness and 'leakage' (here defined as displacement of deforestation) may lead to different trends in forest loss within, and adjacent to, existing PAs. Here, we quantify spatial variation in trends of evergreen forest coverage in East Africa between 2001 and 2009, and test for correlations with forest accessibility and environmental drivers. We investigate PA effectiveness at local, landscape and national scales, comparing rates of deforestation within park boundaries with those detected in park buffer zones and in unprotected land more generally. Background forest loss (BFL) was estimated at -9.3% (17,167 km(2)), but varied between countries (range: -0.9% to -85.7%; note: no BFL in South Sudan). We document high variability in PA effectiveness within and between PA categories. The most successful PAs were National Parks, although only 26 out of 48 parks increased or maintained their forest area (i.e. Effective parks). Forest Reserves (Ineffective parks, i.e. parks that lose forest from within boundaries: 204 out of 337), Nature Reserves (six out of 12) and Game Parks (24 out of 26) were more likely to lose forest cover. Forest loss in buffer zones around PAs exceeded background forest loss, in some areas indicating leakage driven by Effective National Parks. Human pressure, forest accessibility, protection status, distance to fires and long-term annual rainfall were highly significant drivers of forest loss in East Africa. Some of these factors can be addressed by adjusting park management. However, addressing close links between livelihoods, natural capital and poverty remains a fundamental challenge in East Africa's forest conservation efforts.	[Pfeifer, Marion; Marchant, Robert] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; [Burgess, Neil D.] Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Burgess, Neil D.] WWF US Conservat Sci, Washington, DC USA; [Swetnam, Ruth D.; Platts, Philip J.] Univ Cambridge, Dept Zool, Cambridge, England; [Willcock, Simon] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England	University of York - UK; University of Copenhagen; World Wildlife Fund; University of Cambridge; University of Leeds	Pfeifer, M (corresponding author), Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England.	marion.pfeifer@googlemail.com	Platts, Philip J./C-2002-2009; Swetnam, Ruth D/I-2848-2017	Platts, Philip J./0000-0002-0153-0121; Swetnam, Ruth D/0000-0002-5199-9622; Marchant, Robert/0000-0001-5013-4056; Pfeifer, Marion/0000-0002-6775-3141	Marie Curie Intra-European fellowship IEF Programme (EU FP7-People-IEF) [234394]; Leverthulme Trust through the Valuing the Arc Programme	Marie Curie Intra-European fellowship IEF Programme (EU FP7-People-IEF); Leverthulme Trust through the Valuing the Arc Programme	Marion Pfeifer was supported by the Marie Curie Intra-European fellowship IEF Programme (EU FP7-People-IEF-2008 Grant Agreement no234394). Ruth Swetnam, Philip Platts and Simon Willcock were funded by the Leverthulme Trust through the Valuing the Arc Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrends A, 2010, P NATL ACAD SCI USA, V107, P14556, DOI 10.1073/pnas.0914471107; Andrew G., 2010, Journal of Sustainable Development in Africa, V12, P122; [Anonymous], 2007, FORESTRY GOVERNANCE; Balmford A, 2001, SCIENCE, V291, P2616, DOI 10.1126/science.291.5513.2616; Baranga D, 2009, AFR J ECOL, V47, P664, DOI 10.1111/j.1365-2028.2009.01037.x; Blomley T., 2009, PARTICIPATORY FOREST; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Burgess N, 2005, BIODIVERS CONSERV, V14, P1877, DOI 10.1007/s10531-004-1299-2; Burgess ND, 2007, BIOL CONSERV, V134, P209, DOI 10.1016/j.biocon.2006.08.015; Caro T, 2009, DIVERS DISTRIB, V15, P178, DOI 10.1111/j.1472-4642.2008.00522.x; Cotula Lorenzo., 2009, LAND GRAB DEV OPPORT; Cropper M, 2001, LAND ECON, V77, P172, DOI 10.2307/3147088; Davis A., 2011, Conservation and Society, V9, P25, DOI 10.4103/0972-4923.79184; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; DeFries R, 2010, P NATL ACAD SCI USA, V107, P19627, DOI 10.1073/pnas.1011163107; Enawgaw AC, 2011, EXISTING CHALLENGES; Ewers RM, 2008, TRENDS ECOL EVOL, V23, P113, DOI 10.1016/j.tree.2007.11.008; Ewers RM, 2006, BIOL CONSERV, V133, P312, DOI 10.1016/j.biocon.2006.06.018; FAO, 2005, STAT WORLDS FOR 2005; Fearnside PM, 2009, MITIG ADAPT STRAT GL, V14, P557, DOI 10.1007/s11027-009-9174-9; Ferraro PJ, 2011, P NATL ACAD SCI USA, V108, P13913, DOI 10.1073/pnas.1011529108; Fisher B, 2011, NAT CLIM CHANGE, V1, P161, DOI 10.1038/NCLIMATE1119; Freitas SR, 2010, FOREST ECOL MANAG, V259, P410, DOI 10.1016/j.foreco.2009.10.036; Gardner TA, 2007, CONSERV BIOL, V21, P1516, DOI 10.1111/j.1523-1739.2007.00794.x; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Gaveau DLA, 2007, BIOL CONSERV, V134, P495, DOI 10.1016/j.biocon.2006.08.035; Goldewijk KK, 2001, GLOBAL BIOGEOCHEM CY, V15, P417, DOI 10.1029/1999GB001232; Hall J, 2009, BIOL CONSERV, V142, P2510, DOI 10.1016/j.biocon.2009.05.028; Harris Dan, 2011, POLITICAL EC SOCIAL; IUCN UNEP, 2009, WORLD DAT PROT AR WD; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Koenig WD, 1999, TRENDS ECOL EVOL, V14, P22, DOI 10.1016/S0169-5347(98)01533-X; Leverington F, 2010, ENVIRON MANAGE, V46, P685, DOI 10.1007/s00267-010-9564-5; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lilieholm RJ, 2010, CONSERV BIOL, V24, P924, DOI 10.1111/j.1523-1739.2010.01527.x; Linkie M, 2004, BIODIVERS CONSERV, V13, P1809, DOI 10.1023/B:BIOC.0000035867.90891.ea; Lovejoy TE, 2006, TRENDS ECOL EVOL, V21, P329, DOI 10.1016/j.tree.2006.04.005; Lung T, 2010, ENVIRON MONIT ASSESS, V161, P531, DOI 10.1007/s10661-009-0766-3; Masozera MK, 2004, SCAND J FOREST RES, V19, P85, DOI 10.1080/14004080410034164; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Naidoo R, 2006, PLOS BIOL, V4, P2153, DOI 10.1371/journal.pbio.0040360; Naughton-Treves L, 2011, P NATL ACAD SCI USA, V108, P13919, DOI 10.1073/pnas.1013332108; Nelson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022722; Oliveira PJC, 2007, SCIENCE, V317, P1233, DOI 10.1126/science.1146324; Pfeifer M, 2012, GLOBAL ECOL BIOGEOGR, V21, P603, DOI 10.1111/j.1466-8238.2011.00712.x; Pfund JL, 2011, ENVIRON MANAGE, V48, P334, DOI 10.1007/s00267-011-9689-1; Rutagarama E, 2006, GEOGR J, V172, P291, DOI 10.1111/j.1475-4959.2006.00217.x; Swetnam RD, 2011, J ENVIRON MANAGE, V92, P563, DOI 10.1016/j.jenvman.2010.09.007; Tabor Karyn, 2010, Journal of East African Natural History, V99, P19, DOI 10.2982/028.099.0102; Tallis H, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P278; Tatem AJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001298; Timberlake J, 2011, PLANT ECOL EVOL, V144, P126, DOI 10.5091/plecevo.2011.539; Tumusiime DM, 2011, FOREST POLICY ECON, V13, P273, DOI 10.1016/j.forpol.2011.02.001; United Nations, 2011, WORLD POP PROSP 2010; Wass P, 1995, KENYAS INDIGENEOUS F; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; Wunder S, 2001, WORLD DEV, V29, P1817, DOI 10.1016/S0305-750X(01)00070-5	59	87	90	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39337	10.1371/journal.pone.0039337	http://dx.doi.org/10.1371/journal.pone.0039337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768074	gold, Green Published, Green Accepted			2022-12-27	WOS:000305892100045
J	Stone, W; Bousema, T; Jones, S; Gesase, S; Hashim, R; Gosling, R; Carneiro, I; Chandramohan, D; Theander, T; Ronca, R; Modiano, D; Arca, B; Drakeley, C				Stone, Will; Bousema, Teun; Jones, Sophie; Gesase, Samwel; Hashim, Rhamadhan; Gosling, Roly; Carneiro, Ilona; Chandramohan, Daniel; Theander, Thor; Ronca, Raffaele; Modiano, David; Arca, Bruno; Drakeley, Chris			IgG Responses to Anopheles gambiae Salivary Antigen gSG6 Detect Variation in Exposure to Malaria Vectors and Disease Risk	PLOS ONE			English	Article							ANTIBODY-RESPONSE; EPIDEMIOLOGIC TOOL; INOCULATION RATES; TRANSMISSION; MOSQUITO; MARKER; CHILDREN; PROTEIN; HETEROGENEITY; IMMUNITY	Assessment of exposure to malaria vectors is important to our understanding of spatial and temporal variations in disease transmission and facilitates the targeting and evaluation of control efforts. Recently, an immunogenic Anopheles gambiae salivary protein (gSG6) was identified and proposed as the basis of an immuno-assay determining exposure to Afrotropical malaria vectors. In the present study, IgG responses to gSG6 and 6 malaria antigens (CSP, AMA-1, MSP-1, MSP-3, GLURP R1, and GLURP R2) were compared to Anopheles exposure and malaria incidence in a cohort of children from Korogwe district, Tanzania, an area of moderate and heterogeneous malaria transmission. Anti-gSG6 responses above the threshold for seropositivity were detected in 15% (96/636) of the children, and were positively associated with geographical variations in Anopheles exposure (OR 1.25, CI 1.01-1.54, p = 0.04). Additionally, IgG responses to gSG6 in individual children showed a strong positive association with household level mosquito exposure. IgG levels for all antigens except AMA-1 were associated with the frequency of malaria episodes following sampling. gSG6 seropositivity was strongly positively associated with subsequent malaria incidence (test for trend p = 0.004), comparable to malaria antigens MSP-1 and GLURP R2. Our results show that the gSG6 assay is sensitive to micro-epidemiological variations in exposure to Anopheles mosquitoes, and provides a correlate of malaria risk that is unrelated to immune protection. While the technique requires further evaluation in a range of malaria endemic settings, our findings suggest that the gSG6 assay may have a role in the evaluation and planning of targeted and preventative anti-malaria interventions.	[Stone, Will; Bousema, Teun; Jones, Sophie; Carneiro, Ilona; Chandramohan, Daniel; Drakeley, Chris] London Sch Hyg & Trop Med, Dept Immun & Infect, London WC1, England; [Stone, Will; Bousema, Teun] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Gesase, Samwel; Hashim, Rhamadhan] Natl Inst Med Res, Tanga, Tanzania; [Gosling, Roly] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Theander, Thor] Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Theander, Thor] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen, Denmark; [Ronca, Raffaele; Arca, Bruno] Univ Federico II, Dept Struct & Funct Biol, Naples, Italy; [Modiano, David; Arca, Bruno] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Parasitol Sect, Rome, Italy	University of London; London School of Hygiene & Tropical Medicine; Radboud University Nijmegen; University of California System; University of California San Francisco; University of Copenhagen; University of Copenhagen; University of Naples Federico II; Sapienza University Rome	Stone, W (corresponding author), London Sch Hyg & Trop Med, Dept Immun & Infect, London WC1, England.	chris.drakeley@lshtm.ac.uk	Bousema, Teun/N-3574-2014; Stone, Will/F-9416-2016; Theander, Thor/F-6714-2015; Arca, Bruno/C-8383-2012	Bousema, Teun/0000-0003-2666-094X; Theander, Thor/0000-0002-3509-7514; Ronca, Raffaele/0000-0003-2217-3378; Arca, Bruno/0000-0002-4029-0984; Stone, William/0000-0002-6647-0166	Intermittent Preventive Treatment in Infants (IPTi) Consortium by the Bill and Melinda Gates Foundation; Gates Malaria Partnership by the Bill and Melinda Gates Foundation; Gates Grand Challenges Exploration Grant [51991]; Wellcome Trust [078925]	Intermittent Preventive Treatment in Infants (IPTi) Consortium by the Bill and Melinda Gates Foundation; Gates Malaria Partnership by the Bill and Melinda Gates Foundation; Gates Grand Challenges Exploration Grant; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Intermittent Preventive Treatment in Infants (IPTi) Consortium and the Gates Malaria Partnership, both of which are supported by the Bill and Melinda Gates Foundation. T. B. is supported by a Gates Grand Challenges Exploration Grant (grant 51991); C. D. is supported by a grant from the Wellcome Trust (grant 078925). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Barral A, 2000, AM J TROP MED HYG, V62, P740, DOI 10.4269/ajtmh.2000.62.740; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Bejon P, 2011, J INFECT DIS, V204, P9, DOI 10.1093/infdis/jir222; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bejon P, 2009, INFECT IMMUN, V77, P1917, DOI 10.1128/IAI.01358-08; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2011, J INFECT DIS, V204, P1, DOI 10.1093/infdis/jir225; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Bousema T, 2010, EMERG INFECT DIS, V16, P392, DOI 10.3201/eid1603.090732; BRUMMERKORVENKONTIO H, 1994, J ALLERGY CLIN IMMUN, V93, P551, DOI 10.1016/S0091-6749(94)70066-4; Cham GKK, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-108; Clark TD, 2008, J INFECT DIS, V198, P393, DOI 10.1086/589778; Clarke SE, 2002, T ROY SOC TROP MED H, V96, P499, DOI 10.1016/S0035-9203(02)90419-0; Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137; Cornelie S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-75; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Das P, 2010, LANCET, V376, P1515, DOI 10.1016/S0140-6736(10)61551-6; Drakeley C, 2003, TROP MED INT HEALTH, V8, P767, DOI 10.1046/j.1365-3156.2003.01100.x; Drakeley C, 2009, ADV PARASIT, V69, P299, DOI 10.1016/S0065-308X(09)69005-9; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Drame PM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-72; Drame PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015596; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Gosling RD, 2009, LANCET, V374, P1521, DOI 10.1016/S0140-6736(09)60997-1; Greenhouse B, 2011, J INFECT DIS, V204, P19, DOI 10.1093/infdis/jir223; GREENWOOD BM, 1990, B WORLD HEALTH ORGAN, V68, P184; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Hii JLK, 2000, B ENTOMOL RES, V90, P211, DOI 10.1017/S000748530000033X; Hommel M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S1; King JG, 2011, J BIOL CHEM, V286, P40824, DOI 10.1074/jbc.M111.280552; Kinyanjui SM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-242; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; Lanfrancotti A, 2002, FEBS LETT, V517, P67, DOI 10.1016/S0014-5793(02)02578-4; Marzouki S, 2011, AM J TROP MED HYG, V84, P653, DOI 10.4269/ajtmh.2011.10-0598; Matsuoka H, 2002, PARASITOL INT, V51, P17, DOI 10.1016/S1383-5769(01)00095-2; MBOGO CNM, 1993, J AM MOSQUITO CONTR, V9, P260; Medica DL, 2005, INFECT IMMUN, V73, P4363, DOI 10.1128/IAI.73.7.4363-4369.2005; MENDIS C, 1992, PARASITE IMMUNOL, V14, P75, DOI 10.1111/j.1365-3024.1992.tb00007.x; Mmbando BP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-216; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Oesterholt MJAM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-98; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Orlandi-Pradines E, 2007, MICROBES INFECT, V9, P1454, DOI 10.1016/j.micinf.2007.07.012; Palosuo K, 1997, INT ARCH ALLERGY IMM, V114, P367, DOI 10.1159/000237696; Peng ZK, 2007, CURR OPIN ALLERGY CL, V7, P350, DOI 10.1097/ACI.0b013e328259c313; Poinsignon A, 2008, AM J TROP MED HYG, V78, P750, DOI 10.4269/ajtmh.2008.78.750; Poinsignon A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-198; Poinsignon A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002472; Proietti C, 2011, AM J TROP MED HYG, V84, P830, DOI 10.4269/ajtmh.2011.10-0498; Remoue F, 2006, T ROY SOC TROP MED H, V100, P363, DOI 10.1016/j.trstmh.2005.06.032; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Rizzo C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-206; Rizzo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017980; ROSENBERG R, 1990, T ROY SOC TROP MED H, V84, P209, DOI 10.1016/0035-9203(90)90258-G; Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274; SCHWARTZ BS, 1990, AM J EPIDEMIOL, V132, P58, DOI 10.1093/oxfordjournals.aje.a115643; SCHWARTZ BS, 1991, AM J EPIDEMIOL, V134, P86, DOI 10.1093/oxfordjournals.aje.a115996; Schwarz A, 2009, INT J PARASITOL, V39, P1021, DOI 10.1016/j.ijpara.2009.01.010; Smith DL, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1107; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Theisen M, 2004, VACCINE, V22, P1188, DOI 10.1016/j.vaccine.2003.09.017; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; World Health Organization, 2007, MAL EL FIELD MAN LOW	70	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40170	10.1371/journal.pone.0040170	http://dx.doi.org/10.1371/journal.pone.0040170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768250	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305892100223
J	Teng, L; Kerbiriou, M; Taiya, M; Le Hir, S; Mignen, O; Benz, N; Trouve, P; Ferec, C				Teng, Ling; Kerbiriou, Mathieu; Taiya, Mehdi; Le Hir, Sophie; Mignen, Olivier; Benz, Nathalie; Trouve, Pascal; Ferec, Claude			Proteomic Identification of Calumenin as a G551D-CFTR Associated Protein	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR CHLORIDE CHANNELS; CYSTIC-FIBROSIS GENE; KINASE-A; ANNEXIN A5; ATP; EXPRESSION; DOMAIN; MECHANISMS; MUTATIONS	Cystic fibrosis (CF) is the most common lethal autosomal recessive disease in the Caucasian population. It is due to mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. To date, over 1910 mutations have been identified in the CFTR gene. Among these mutations, the CF-causing missense mutation G551D-CFTR (approx. 5% of cases) encodes for a CFTR chloride channel with normal expression on the cell surface. Nevertheless, it is associated with severe disease due to its altered channel activation. The aim of the present study was to identify specific interacting proteins of G551D-CFTR. Co-immunoprecipitated proteins with G551D-CFTR were resolved by 2D-gel electrophoresis (2-DE). Mass Spectrometry revealed that calumenin was present in the protein complex linked to G551D-CFTR. Despite its basal expression was not modified in G551D-CFTR expressing cells when compared to Wt-CFTR expressing cells, it was more abundant in the G551D-CFTR complex detected by immunoprecipitation. The calumenin-CFTR interaction was also shown by Surface Plasmon Resonance and further confirmed by computational analysis of the predicted calumenin's partners. Because in our cellular model calumenin was found in the endoplasmic reticulum (ER) by immunofluorescence experiments, we suggest that calumenin is likely involved in the mutated CFTR's maturation. In conclusion, we showed for the first time that calumenin binds to CFTR and that it is increased in the G551D-CFTR complex. We suggest that it may be involved in the physiopathology of G551D-CFTR and that G551D-CFTR may follow a specific maturation and trafficking pathway. We also hypothesize that UPR may be triggered independently of the retention of G551D-CFTR in the ER because Grp78/Bip expression is increased in the cells. Finally, we propose here that Calumenin is a new CFTR chaperone.	[Teng, Ling; Kerbiriou, Mathieu; Le Hir, Sophie; Mignen, Olivier; Benz, Nathalie; Trouve, Pascal; Ferec, Claude] Inserm, UMR1078, Brest, France; [Teng, Ling; Kerbiriou, Mathieu; Mignen, Olivier; Trouve, Pascal; Ferec, Claude] Univ Bretagne Occidentale, Fac Med & Sci Sante, Brest, France; [Taiya, Mehdi] Univ Bretagne Occidentale, Serv Commun Spectrometrie Masse, Brest, France; [Le Hir, Sophie; Ferec, Claude] CHRU Morvan, Genet Mol Lab, Brest, France; [Ferec, Claude] Etab Francais Sang, Brest, France; [Benz, Nathalie] Assoc Biogenet Gaetan Salaun, Brest, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; CHU Brest	Teng, L (corresponding author), Inserm, UMR1078, Brest, France.	pascal.trouve@univ-brest.fr; claude.ferec@univ-brest.fr	Ferec, Claude/ABG-9699-2020; MIGNEN, Olivier/M-3258-2019	Ferec, Claude/0000-0002-2325-0710; MIGNEN, Olivier/0000-0001-7913-6119	association Gaetan Salaun; Etablissement Francais du Sang; French CF foundation "Vaincre la Mucoviscidose"	association Gaetan Salaun; Etablissement Francais du Sang; French CF foundation "Vaincre la Mucoviscidose"	This work was supported by grants from the association Gaetan Salaun, the "Etablissement Francais du Sang'' and the French CF foundation "Vaincre la Mucoviscidose''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MP, 1992, SCIENCE, V257, P1701, DOI 10.1126/science.1382316; ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; Bompadre SG, 2008, J BIOL CHEM, V283, P5364, DOI 10.1074/jbc.M709417200; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Caputo A, 2009, J PHARMACOL EXP THER, V330, P783, DOI 10.1124/jpet.109.154146; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; Gomes-Alves P, 2010, BBA-PROTEINS PROTEOM, V1804, P856, DOI 10.1016/j.bbapap.2009.12.013; GREGORY RJ, 1991, MOL CELL BIOL, V11, P3886, DOI 10.1128/MCB.11.8.3886; Honore B, 2009, BIOESSAYS, V31, P262, DOI 10.1002/bies.200800186; Howell LD, 2004, BIOCHEM J, V378, P151, DOI 10.1042/BJ20021428; Kerbiriou M, 2007, BBA-MOL BASIS DIS, V1772, P1236, DOI 10.1016/j.bbadis.2007.10.004; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Le Drevo MA, 2008, BBA-MOL BASIS DIS, V1782, P605, DOI 10.1016/j.bbadis.2008.08.002; Leblais V, 1999, J BIOL CHEM, V274, P6107, DOI 10.1074/jbc.274.10.6107; Naren AP, 1999, SCIENCE, V286, P544, DOI 10.1126/science.286.5439.544; Naren AP, 1998, P NATL ACAD SCI USA, V95, P10972, DOI 10.1073/pnas.95.18.10972; Naren AP, 2000, NEWS PHYSIOL SCI, V15, P57; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; Pasyk S, 2009, BIOCHEM J, V418, P185, DOI 10.1042/BJ20081424; QUINTON PM, 1992, NATURE, V360, P79, DOI 10.1038/360079a0; Ramjeesingh M, 2003, BIOCHEM J, V375, P633, DOI 10.1042/BJ20030774; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sahoo SK, 2008, MOL CELLS, V26, P265; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Szellas T, 2003, FEBS LETT, V535, P141, DOI 10.1016/S0014-5793(02)03892-9; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Trouve P, 2007, BBA-MOL BASIS DIS, V1772, P1121, DOI 10.1016/j.bbadis.2007.06.006; Trouve P, 2012, TALANTA, V93, P219, DOI 10.1016/j.talanta.2012.02.017; Vorum H, 1999, EXP CELL RES, V248, P473, DOI 10.1006/excr.1999.4431; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Welsh MJ, 1995, METABOLIC MOL BASES, V3, P3799; YANG YP, 1993, HUM MOL GENET, V2, P1253, DOI 10.1093/hmg/2.8.1253	37	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40173	10.1371/journal.pone.0040173	http://dx.doi.org/10.1371/journal.pone.0040173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768251	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100224
J	Torcia, MG; Nencioni, L; Clemente, AM; Civitelli, L; Celestino, I; Limongi, D; Fadigati, G; Perissi, E; Cozzolino, F; Garaci, E; Palamara, AT				Torcia, Maria Gabriella; Nencioni, Lucia; Clemente, Ann Maria; Civitelli, Livia; Celestino, Ignacio; Limongi, Dolores; Fadigati, Giulia; Perissi, Eloisa; Cozzolino, Federico; Garaci, Enrico; Palamara, Anna Teresa			Sex Differences in the Response to Viral Infections: TLR8 and TLR9 Ligand Stimulation Induce Higher IL10 Production in Males	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; H1N1 VIRUS-INFECTION; IFN-ALPHA PRODUCTION; REGULATORY T-CELLS; INFLUENZA-VIRUS; DENDRITIC CELLS; GENERAL-POPULATION; HEPATITIS-C; INTERLEUKIN-10; GENDER	Background: Susceptibility to viral infections as well as their severity are higher in men than in women. Heightened antiviral responses typical of women are effective for rapid virus clearance, but if excessively high or prolonged, can result in chronic/inflammatory pathologies. We investigated whether this variability could be in part attributable to differences in the response to the Toll-Like Receptors (TLR) more involved in the virus recognition. Methods: Cytokine production by peripheral blood mononuclear cells (PBMCs) from male and female healthy donors after stimulation with Toll-like receptors (TLR) 3, 7, 8, 9 ligands or with viruses (influenza and Herpes-simplex-1) was evaluated. Results: Compared to females, PBMCs from males produced not only lower amounts of IFN-alpha in response to TLR7 ligands but also higher amounts of the immunosuppressive cytokine IL10 after stimulation with TLR8 and TLR9 ligands or viruses. IL10 production after TLR9 ligands or HSV-1 stimulation was significantly related with plasma levels of sex hormones in both groups, whereas no correlation was found in cytokines produced following TLR7 and TLR8 stimulation. Conclusions: Given the role of an early production of IL10 by cells of innate immunity in modulating innate and adaptive immune response to viruses, we suggest that sex-related difference in its production following viral nucleic acid stimulation of TLRs may be involved in the sex-related variability in response to viral infections.	[Torcia, Maria Gabriella; Clemente, Ann Maria; Fadigati, Giulia; Perissi, Eloisa; Cozzolino, Federico] Univ Florence, Dept Clin Physiopathol, Florence, Italy; [Limongi, Dolores; Garaci, Enrico] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy; [Palamara, Anna Teresa] Sapienza Univ Rome, Inst Pasteur Cenci Bolognetti Fdn, Dept Publ Hlth & Infect Dis, Rome, Italy; [Palamara, Anna Teresa] San Raffaele Pisana Sci Inst Res Hospitalizat & H, Rome, Italy	University of Florence; University of Rome Tor Vergata; Sapienza University Rome; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Torcia, MG (corresponding author), Univ Florence, Dept Clin Physiopathol, Florence, Italy.	g.torcia@dfc.unifi.it	Nencioni, Lucia/K-5988-2016; Limongi, Dolores/F-7296-2010; GARACI, ENRICO/AAB-3349-2021; Limongi, Dolores/O-9189-2019; Torcia, Maria Gabriella G/K-1840-2018	Nencioni, Lucia/0000-0003-4427-4823; Limongi, Dolores/0000-0003-2095-8112; Limongi, Dolores/0000-0003-2095-8112; Torcia, Maria Gabriella G/0000-0003-4740-4646; Civitelli, Livia/0000-0003-2399-1436; PALAMARA, ANNA TERESA/0000-0001-8330-4381; Cozzolino, Federico/0000-0002-2800-640X	Italian Ministry of Health; Italian Ministry of Instruction, University, and Research; Istituto Superiore di Sanita; University of Roma "Sapienza"; University of Firenze	Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Instruction, University, and Research(Ministry of Education, Universities and Research (MIUR)); Istituto Superiore di Sanita; University of Roma "Sapienza"; University of Firenze	This work was supported by: Italian Ministry of Health (Progetto donna); Italian Ministry of Instruction, University, and Research (Progetto PON); grants from Istituto Superiore di Sanita -2012; grants from University of Roma "Sapienza" (Progetto Ateneo); and grants from University of Firenze. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arankalle VA, 2010, PLOS ONE, V1, ppii; Barchet W, 2005, EUR J IMMUNOL, V35, P236, DOI 10.1002/eji.200425583; Barton GM, 2007, SEMIN IMMUNOL, V19, P33, DOI 10.1016/j.smim.2007.01.003; Berghofer B, 2006, J IMMUNOL, V177, P2088, DOI 10.4049/jimmunol.177.4.2088; Bouman A, 2004, AM J REPROD IMMUNOL, V52, P19, DOI 10.1111/j.1600-0897.2004.00177.x; Brady MT, 2003, EUR J IMMUNOL, V33, P3448, DOI 10.1002/eji.200324251; Brooks DG, 2008, P NATL ACAD SCI USA, V105, P20428, DOI 10.1073/pnas.0811139106; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Chang ZL, 2010, INFLAMM RES, V59, P791, DOI 10.1007/s00011-010-0208-2; Choi Won-Il, 2011, BMC Res Notes, V4, P351, DOI 10.1186/1756-0500-4-351; GAUSH CR, 1968, APPL MICROBIOL, V16, P588, DOI 10.1128/AEM.16.4.588-594.1968; Guo YQ, 2011, J EXP MED, V208, P2083, DOI 10.1084/jem.20101568; Han X, 2001, J VIROL, V75, P3048, DOI 10.1128/JVI.75.6.3048-3052.2001; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Hyodo N, 2004, CLIN EXP IMMUNOL, V135, P462, DOI 10.1111/j.1365-2249.2003.02376.x; Ichinohe T, 2010, EXPERT REV VACCINES, V9, P1315, DOI 10.1586/ERV.10.118; Iwashiro M, 2001, P NATL ACAD SCI USA, V98, P9226, DOI 10.1073/pnas.151174198; Jukkola-Vuorinen A, 2009, J INNATE IMMUN, V1, P59, DOI 10.1159/000151602; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Khan N, 2010, HUM IMMUNOL, V71, P372, DOI 10.1016/j.humimm.2010.01.018; Khandaker G, 2011, INFLUENZA OTHER RESP, V5, P148, DOI 10.1111/j.1750-2659.2011.00199.x; Killington R, 1991, GROWTH ASSAY PURIFIC, P212; Klein S., 2010, SEX GENDER INFLUENZA, P1; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Koyama S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000759; Larange A, 2009, J LEUKOCYTE BIOL, V85, P673, DOI 10.1189/jlb.0808504; Ru A, 2010, VACCINE, V28, P3661, DOI 10.1016/j.vaccine.2010.03.029; Li XQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-272; Libert C, 2010, NAT REV IMMUNOL, V10, P594, DOI 10.1038/nri2815; Ling LM, 2010, CLIN INFECT DIS, V50, P963, DOI 10.1086/651083; Liva SM, 2001, J IMMUNOL, V167, P2060, DOI 10.4049/jimmunol.167.4.2060; Lorenzo ME, 2011, VACCINE, V29, P9246, DOI 10.1016/j.vaccine.2011.09.110; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; McClelland EE, 2011, ARCH IMMUNOL THER EX, V59, P203, DOI 10.1007/s00005-011-0124-3; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Panchanadeswaran S, 2006, SEX TRANSM INFECT, V82, P491, DOI 10.1136/sti.2006.020768; Puchhammer-Stockl E, 2012, J CLIN VIROL, V53, P356, DOI 10.1016/j.jcv.2011.12.015; Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697; Robinson DP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002149; Roriz-Cruz M, 2010, J AM GERIATR SOC, V58, P1813, DOI 10.1111/j.1532-5415.2010.03045.x; Sarangi PP, 2008, J IMMUNOL, V180, P6297, DOI 10.4049/jimmunol.180.9.6297; Schmidt A, 2012, EUR J CELL BIOL, V91, P78, DOI 10.1016/j.ejcb.2011.01.015; Siegel AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000039; Sloan DD, 2007, J VIROL, V81, P12504, DOI 10.1128/JVI.01111-07; Solomon L, 2003, SEX TRANSM INFECT, V79, P456, DOI 10.1136/sti.79.6.456; Sousa H, 2011, ACTA MEDICA PORT, V 24, P707; Stepanova M, 2012, J VIRAL HEPATITIS, V19, P341, DOI 10.1111/j.1365-2893.2011.01554.x; Sun K, 2010, J VIROL, V84, P5007, DOI 10.1128/JVI.02408-09; Wolfle SJ, 2011, EUR J IMMUNOL, V41, P413, DOI 10.1002/eji.201040979; Xiao H, 2010, CHINESE MED J-PEKING, V123, P401, DOI 10.3760/cma.j.issn.0366-6999.2010.04.004; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	53	88	89	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39853	10.1371/journal.pone.0039853	http://dx.doi.org/10.1371/journal.pone.0039853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768144	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100113
J	Li, ZR; Ptak, D; Zhang, LY; Walls, EK; Zhong, WX; Leung, YF				Li, Zeran; Ptak, Devon; Zhang, Liyun; Walls, Elwood K.; Zhong, Wenxuan; Leung, Yuk Fai			Phenylthiourea Specifically Reduces Zebrafish Eye Size	PLOS ONE			English	Article							GENE-EXPRESSION; THYROID PEROXIDASE; IN-VIVO; SODIUM/IODIDE SYMPORTER; EMBRYONIC-DEVELOPMENT; TRANSGENIC ZEBRAFISH; DANIO-RERIO; CELL FATE; TYROSINASE; MELANOGENESIS	Phenylthiourea (PTU) is commonly used for inhibiting melanization of zebrafish embryos. In this study, the standard treatment with 0.2 mM PTU was demonstrated to specifically reduce eye size in larval fish starting at three days postfertilization. This effect is likely the result of a reduction in retinal and lens size of PTU-treated eyes and is not related to melanization inhibition. This is because the eye size of tyr, a genetic mutant of tyrosinase whose activity is inhibited in PTU treatment, was not reduced. As PTU contains a thiocarbamide group which is presented in many goitrogens, suppressing thyroid hormone production is a possible mechanism by which PTU treatment may reduce eye size. Despite the fact that thyroxine level was found to be reduced in PTU-treated larvae, thyroid hormone supplements did not rescue the eye size reduction. Instead, treating embryos with six goitrogens, including inhibitors of thyroid peroxidase (TPO) and sodium-iodide symporter (NIS), suggested an alternative possibility. Specifically, three TPO inhibitors, including those that do not possess thiocarbamide, specifically reduced eye size; whereas none of the NIS inhibitors could elicit this effect. These observations indicate that TPO inhibition rather than a general suppression of thyroid hormone synthesis is likely the underlying cause of PTU-induced eye size reduction. Furthermore, the tissue-specific effect of PTU treatment might be mediated by an eye-specific TPO expression. Compared with treatment with other tyrosinase inhibitors or bleaching to remove melanization, PTU treatment remains the most effective approach. Thus, one should use caution when interpreting results that are obtained from PTU-treated embryos.	[Li, Zeran; Ptak, Devon; Zhang, Liyun; Walls, Elwood K.; Leung, Yuk Fai] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Li, Zeran] Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA; [Walls, Elwood K.] Indiana Univ Sch Med Lafayette, Dept Cellular & Integrat Physiol, W Lafayette, IN USA; [Zhong, Wenxuan] Univ Illinois, Dept Stat, Champaign, IL USA; [Leung, Yuk Fai] Indiana Univ Sch Med Lafayette, Dept Biochem & Mol Biol, W Lafayette, IN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Washington University (WUSTL); University of Illinois System; University of Illinois Urbana-Champaign	Li, ZR (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	yfleung@purdue.edu	Zhang, Liyun/F-6193-2016; Ptak, Devon/A-5699-2013; Li, Zeran/AAZ-5312-2020	Li, Zeran/0000-0002-7434-6499	Sigma Xi; Zippy Ostroy Research Experience for Undergraduates award; Phillips Undergraduate Research Internship; Knights Templar Eye Foundation; Charles D. Kelman, MD Scholar award; office of Science (BER), U.S. Department of Energy and an NSF [DMS 1120256]; Indiana Academy of Science; Hope for Vision & Showalter Research Trust	Sigma Xi; Zippy Ostroy Research Experience for Undergraduates award; Phillips Undergraduate Research Internship; Knights Templar Eye Foundation; Charles D. Kelman, MD Scholar award; office of Science (BER), U.S. Department of Energy and an NSF; Indiana Academy of Science; Hope for Vision & Showalter Research Trust	This work was supported by Sigma Xi Grant-in-Aid awards for vision-related research to Z.L. and D. P., a Sandy and Zippy Ostroy Research Experience for Undergraduates award and a Dr. William H. Phillips Undergraduate Research Internship to Z.L., a Pediatric Ophthalmology Research Grant from Knights Templar Eye Foundation and a Charles D. Kelman, MD Scholar award to L.Z., a grant from the office of Science (BER), U.S. Department of Energy and an NSF grant DMS 1120256 to WZ, and a Senior Research Grant from Indiana Academy of Science and awards from Hope for Vision & Showalter Research Trust to Y.F.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariga Junko, 2010, J Vis Exp, DOI 10.3791/2093; BELL LGE, 1955, NATURE, V175, P1001, DOI 10.1038/1751001a0; Bentley PJ, 1980, ENDOCRINE PHARM PHYS, Vxvi; Bernardos RL, 2006, GENE EXPR PATTERNS, V6, P1007, DOI 10.1016/j.modgep.2006.04.006; Bohnsack BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022991; BYWATER WG, 1945, J PHARMACOL EXP THER, V85, P14; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chang TS, 2009, INT J MOL SCI, V10, P2440, DOI 10.3390/ijms10062440; Chen QX, 2003, J PROTEIN CHEM, V22, P481, DOI 10.1023/B:JOPC.0000005464.36961.9c; Choi TY, 2007, PIGM CELL RES, V20, P120, DOI 10.1111/j.1600-0749.2007.00365.x; Criton M, 2008, BIOORG MED CHEM LETT, V18, P3607, DOI 10.1016/j.bmcl.2008.04.079; Das T, 2003, NEURON, V37, P597, DOI 10.1016/S0896-6273(03)00066-7; DE la Vieja A, 2000, PHYSIOL REV, V80, P1083, DOI 10.1152/physrev.2000.80.3.1083; delMarmol V, 1996, FEBS LETT, V381, P165, DOI 10.1016/0014-5793(96)00109-3; DIEKE SH, 1947, ENDOCRINOLOGY, V40, P123, DOI 10.1210/endo-40-3-123; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Draelos ZD, 2007, DERMATOL THER, V20, P308, DOI 10.1111/j.1529-8019.2007.00144.x; Easter SS, 1996, DEV BIOL, V180, P646; Elsalini OA, 2003, DEV GENES EVOL, V212, P593, DOI 10.1007/s00427-002-0279-3; FRIEDERS F., 1954, CATHOLIC UNIV AMER BIOL STUD, V31, P1; Gaitan E., 1989, ENV GOITROGENESIS; Halfter W, 2006, INVEST OPHTH VIS SCI, V47, P3586, DOI 10.1167/iovs.05-1480; HARBOTTLE R, 1984, BIOCHEM J, V217, P485, DOI 10.1042/bj2170485; Hensley MR, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-45; Hensley MR, 2010, ZEBRAFISH, V7, P219, DOI 10.1089/zeb.2010.0652; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Hornung MW, 2011, 7 INT S AMPH END NEU; JENKINS MM, 1959, BIOL BULL, V116, P106, DOI 10.2307/1539160; Karlsson J, 2001, MAR BIOTECHNOL, V3, P522, DOI 10.1007/s1012601-0053-4; Kelsh RN, 1996, DEVELOPMENT, V123, P369; KIRSCHBAUM F, 1975, ROUX ARCH DEV BIOL, V177, P129; Klabunde T, 1998, NAT STRUCT BIOL, V5, P1084, DOI 10.1038/4193; Kuliawat R, 2005, J BIOL CHEM, V280, P27713, DOI 10.1074/jbc.M503804200; Lawrence C, 2011, METHOD CELL BIOL, V104, P431, DOI 10.1016/B978-0-12-374814-0.00023-9; Leung YF, 2008, P NATL ACAD SCI USA, V105, P12909, DOI 10.1073/pnas.0806038105; Leung YF, 2005, ZEBRAFISH, V2, P269, DOI 10.1089/zeb.2005.2.269; Leung YF, 2007, INVEST OPHTH VIS SCI, V48, P881, DOI 10.1167/iovs.06-0723; Lister JA, 1999, DEVELOPMENT, V126, P3757; Liu SH, 2007, BIOL PHARM BULL, V30, P1135, DOI 10.1248/bpb.30.1135; Liu YH, 2001, INVEST OPHTH VIS SCI, V42, P481; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYNN WG, 1957, BIOL BULL-US, V113, P160, DOI 10.2307/1538810; LYNN WG, 1947, BIOL BULL, V93, P199; LYNN WG, 1948, BIOL BULL-US, V94, P1, DOI 10.2307/1538202; MELIUS ME, 1969, J MORPHOL, V129, P1, DOI 10.1002/jmor.1051290102; Messier N, 2001, MOL CELL ENDOCRINOL, V174, P59, DOI 10.1016/S0303-7207(00)00446-9; MILLOT N, 1966, NATURE, V209, P99, DOI 10.1038/209099b0; MINGANTI A, 1957, ACTA EMBRYOL MORPHOL, V1, P37; Neter J, 1996, APPL LINEAR STAT MOD, Vxv; Neuhauss SCF, 1999, J NEUROSCI, V19, P8603; Nusslein-Volhard C, 2002, ZEBRAFISH PRACTICAL, Vxviii, P303; Ohtaki S, 1996, ENDOCR J, V43, P1, DOI 10.1507/endocrj.43.1; Patton EE, 2001, NAT REV GENET, V2, P956, DOI 10.1038/35103567; Pinazo-Duran MD, 2011, BRAIN RES, V1392, P16, DOI 10.1016/j.brainres.2011.04.005; Piotrowski T, 1996, DEVELOPMENT, V123, P345; Rees MD, 2008, FREE RADICAL BIO MED, V44, P1973, DOI 10.1016/j.freeradbiomed.2008.03.016; Richter CP, 1942, ARCH PATHOL, V33, P46; Richter CP, 1941, P SOC EXP BIOL MED, V48, P684; SIMS RT, 1962, Q J MICROSC SCI, V103, P439; Stenkamp D L, 1998, Mol Vis, V4, P26; Takabayashi S, 2006, MOL ENDOCRINOL, V20, P2584, DOI 10.1210/me.2006-0099; Tingaud-Sequeira A, 2006, DEV DYNAM, V235, P3071, DOI 10.1002/dvdy.20921; VanDunk C, 2011, J NEUROSCI, V31, P6457, DOI 10.1523/JNEUROSCI.5385-10.2011; Walpita CN, 2007, GEN COMP ENDOCR, V152, P206, DOI 10.1016/j.ygcen.2007.02.020; Wang WD, 2004, BIOCHEM PHARMACOL, V68, P63, DOI 10.1016/j.bcp.2004.03.010; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; WHITTAKE.JR, 1966, DEV BIOL, V14, P1, DOI 10.1016/0012-1606(66)90003-0; WINKLER AW, 1946, YALE J BIOL MED, V18, P527; Wojciechowski R, 2011, CLIN GENET, V79, P301, DOI 10.1111/j.1399-0004.2010.01592.x	70	45	47	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e40132	10.1371/journal.pone.0040132	http://dx.doi.org/10.1371/journal.pone.0040132			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761952	Green Submitted, Green Published, gold			2022-12-27	WOS:000305825800089
J	Jang, YJ; Soekmadji, C; Mitchell, JM; Thomas, WG; Thorn, P				Jang, Yujin; Soekmadji, Carolina; Mitchell, Justin M.; Thomas, Walter G.; Thorn, Peter			Real-Time Measurement of F-Actin Remodelling during Exocytosis Using Lifeact-EGFP Transgenic Animals	PLOS ONE			English	Article							PANCREATIC ACINAR-CELLS; FUSION PORE; COMPENSATORY ENDOCYTOSIS; ZYMOGEN GRANULES; DYNAMICS; RELEASE; BODIES; COAT	F-actin remodelling is essential for a wide variety of cell processes. It is important in exocytosis, where F-actin coats fusing exocytic granules. The purpose of these F-actin coats is unknown. They may be important in stabilizing the fused granules, they may play a contractile role and promote expulsion of granule content and finally may be important in endocytosis. To elucidate these functions of F-actin remodelling requires a reliable method to visualize F-actin dynamics in living cells. The recent development of Lifeact-EGFP transgenic animals offers such an opportunity. Here, we studied the characteristics of exocytosis in pancreatic acinar cells obtained from the Lifeact-EGFP transgenic mice. We show that the time-course of agonist-evoked exocytic events and the kinetics of each single exocytic event are the same for wild type and Lifeact-EGFP transgenic animals. We conclude that Lifeact-EGFP animals are a good model to study of exocytosis and reveal that F-actin coating is dependent on the de novo synthesis of F-actin and that development of actin polymerization occurs simultaneously in all regions of the granule. Our insights using the Lifeact-EGFP mice demonstrate that F-actin coating occurs after granule fusion and is a granule-wide event.	[Jang, Yujin; Mitchell, Justin M.; Thomas, Walter G.; Thorn, Peter] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Soekmadji, Carolina] Princess Alexandra Hosp, Australian Prostate Res Ctr Queensland, Buranda, Qld, Australia	University of Queensland	Jang, YJ (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	p.thorn@uq.edu.au	Thorn, Peter/F-7030-2010; Mitchell, justin M/D-2061-2017; Soekmadji, Carolina/M-2757-2016; Thomas, Walter/I-2208-2015	Thorn, Peter/0000-0002-3228-770X; Mitchell, justin M/0000-0001-8391-5959; Soekmadji, Carolina/0000-0002-6920-6627; Thomas, Walter/0000-0003-0685-2952	Australian Research Council [DP110100642]; National Health and Medical Research Council [APP1021764]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an Australian Research Council Grant DP110100642 to PT and WGT, and a National Health and Medical Research Council Grant APP1021764 to PT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrendorff N, 2011, J BIOL CHEM, V286, P29627, DOI 10.1074/jbc.M111.265199; Bhat P, 2009, MOL BIOL CELL, V20, P1795, DOI 10.1091/mbc.E08-10-1048; BURGOYNE RD, 1987, BIOSCIENCE REP, V7, P281, DOI 10.1007/BF01121449; Deibler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022941; Larina O, 2005, J CELL SCI, V118, P4131, DOI 10.1242/jcs.02533; Larina O, 2007, MOL BIOL CELL, V18, P3502, DOI 10.1091/mbc.E07-01-0024; Masedunskas A, 2011, P NATL ACAD SCI USA, V108, P13552, DOI 10.1073/pnas.1016778108; Miklavc P, 2009, ANN NY ACAD SCI, V1152, P43, DOI 10.1111/j.1749-6632.2008.03989.x; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Nemoto T, 2004, J BIOL CHEM, V279, P37544, DOI 10.1074/jbc.M403976200; Nemoto T, 2001, NAT CELL BIOL, V3, P253, DOI 10.1038/35060042; Nightingale TD, 2011, J CELL BIOL, V194, P613, DOI 10.1083/jcb.201011119; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Riedl J, 2010, NAT METHODS, V7, P168, DOI 10.1038/nmeth0310-168; Rindler MJ, 2007, J PROTEOME RES, V6, P2978, DOI 10.1021/pr0607029; Schell MJ, 2006, EUR J NEUROSCI, V24, P2491, DOI 10.1111/j.1460-9568.2006.05125.x; Sokac AM, 2006, MOL BIOL CELL, V17, P1495, DOI 10.1091/mbc.E05-10-0908; Sokac AM, 2003, NAT CELL BIOL, V5, P727, DOI 10.1038/ncb1025; Thorn P, 2005, J PHYSIOL-LONDON, V563, P433, DOI 10.1113/jphysiol.2004.077230; Thorn P, 2004, P NATL ACAD SCI USA, V101, P6774, DOI 10.1073/pnas.0400336101; THORN P, 1993, CELL, V74, P661, DOI 10.1016/0092-8674(93)90513-P; Turvey MR, 2005, J CELL SCI, V118, P971, DOI 10.1242/jcs.01693; Turvey MR, 2004, PFLUG ARCH EUR J PHY, V448, P552, DOI 10.1007/s00424-004-1288-z; Valentijn JA, 2000, P NATL ACAD SCI USA, V97, P1091, DOI 10.1073/pnas.97.3.1091; Yu HYE, 2007, MOL BIOL CELL, V18, P4096, DOI 10.1091/mbc.E06-11-0993; Yu HYE, 2007, NAT CELL BIOL, V9, P149, DOI 10.1038/ncb1527	26	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39815	10.1371/journal.pone.0039815	http://dx.doi.org/10.1371/journal.pone.0039815			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768313	Green Published, Green Submitted, gold			2022-12-27	WOS:000305966500026
J	Kim, J; Di Vizio, D; Kim, TK; Kim, J; Kim, M; Pelton, K; Clinton, SK; Hai, T; Hwang, D; Solomon, KR; Freeman, MR				Kim, Jayoung; Di Vizio, Dolores; Kim, Taek-Kyun; Kim, Jonghwan; Kim, Minjung; Pelton, Kristine; Clinton, Steven K.; Hai, Tsonwin; Hwang, Daehee; Solomon, Keith R.; Freeman, Michael R.			The Response of the Prostate to Circulating Cholesterol: Activating Transcription Factor 3 (ATF3) as a Prominent Node in a Cholesterol-Sensing Network	PLOS ONE			English	Article							STRESS-INDUCIBLE GENE; EPITHELIAL-CELLS; GROWTH-FACTOR; NEGATIVE REGULATOR; SYSTEMS BIOLOGY; CANCER; HYPERPLASIA; INFLAMMATION; EXPRESSION; RISK	Elevated circulating cholesterol is a systemic risk factor for cardiovascular disease and metabolic syndrome, however the manner in which the normal prostate responds to variations in cholesterol levels is poorly understood. In this study we addressed the molecular and cellular effects of elevated and suppressed levels of circulating cholesterol on the normal prostate. Integrated bioinformatic analysis was performed using DNA microarray data from two experimental formats: (1) ventral prostate from male mice with chronically elevated circulating cholesterol and (2) human prostate cells exposed acutely to cholesterol depletion. A cholesterol-sensitive gene expression network was constructed from these data and the transcription factor ATF3 was identified as a prominent node in the network. Validation experiments confirmed that elevated cholesterol reduced ATF3 expression and enhanced proliferation of prostate cells, while cholesterol depletion increased ATF3 levels and inhibited proliferation. Cholesterol reduction in vivo alleviated dense lymphomononuclear infiltrates in the periprostatic adipose tissue, which were closely associated with nerve tracts and blood vessels. These findings open new perspectives on the role of cholesterol in prostate health, and provide a novel role for ATF3, and associated proteins within a large signaling network, as a cholesterol-sensing mechanism.	[Kim, Jayoung; Di Vizio, Dolores; Freeman, Michael R.] Cedars Sinai Med Ctr, Dept Surg, Div Canc Biol & Therapeut, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Kim, Jayoung; Di Vizio, Dolores; Freeman, Michael R.] Cedars Sinai Med Ctr, Dept Biomed Sci, Div Canc Biol & Therapeut, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Kim, Jayoung; Di Vizio, Dolores; Solomon, Keith R.; Freeman, Michael R.] Childrens Hosp, Urol Dis Res Ctr, Boston, MA 02115 USA; [Kim, Jayoung; Di Vizio, Dolores; Freeman, Michael R.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kim, Jayoung; Di Vizio, Dolores; Freeman, Michael R.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Kim, Taek-Kyun; Hwang, Daehee] Pohang Univ Sci & Technol, Dept Chem Engn, Pohang, South Korea; [Kim, Taek-Kyun; Hwang, Daehee] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Kim, Jonghwan] Univ Texas Austin, Austin, TX 78712 USA; [Kim, Minjung] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Mol Oncol Dept, Tampa, FL 33682 USA; [Pelton, Kristine; Solomon, Keith R.] Harvard Univ, Dept Orthopaed Surg, Sch Med, Childrens Hosp Boston, Boston, MA USA; [Clinton, Steven K.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Hai, Tsonwin] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); University of Texas System; University of Texas Austin; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Harvard University; Boston Children's Hospital; Harvard Medical School; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kim, J (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Canc Biol & Therapeut, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA.	Jayoung.Kim@cshs.org; Jayoung.Kim@cshs.org; Michael.Freeman@cshs.org	Hai, Tsonwin/H-4480-2011; Kim, Jonghwan/AAR-2815-2021; Kim, Taekkyun/A-9810-2017; Hai, Tsonwin/E-3185-2011	Hai, Tsonwin/0000-0003-4510-0315; Kim, Taekkyun/0000-0002-3703-6790; Hai, Tsonwin/0000-0003-4510-0315; Kim, Minjung/0000-0002-5682-6640; Kim, Jonghwan/0000-0002-9919-9843	National Institutes of Health [R01 DK087806, R01 CA143777, P50 DK65298, R01 CA101046, NCI K99 CA131472]; Fishbein Family IC Research Foundation/Interstitial Cystitis Association (ICA); Pilot Research Program/ICA; New York Academy of Medicine; Children's Hospital Boston Faculty Development; NATIONAL CANCER INSTITUTE [R01CA143777, K99CA131472, R01CA101046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087806, P50DK065298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fishbein Family IC Research Foundation/Interstitial Cystitis Association (ICA); Pilot Research Program/ICA; New York Academy of Medicine; Children's Hospital Boston Faculty Development; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the following funding sources: National Institutes of Health grants R01 DK087806, R01 CA143777 and P50 DK65298 (to MRF); R01 CA101046 (to KRS); and NCI K99 CA131472 (to DDV); the Fishbein Family IC Research Foundation/Interstitial Cystitis Association (ICA), Pilot Research Program/ICA, New York Academy of Medicine, and Children's Hospital Boston Faculty Development (to Jayoung Kim). Jayoung Kim is an American Urological Association Foundation Research Scholar and a Harvard Medical School Eleanor and Miles Shore Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RM, 2003, CANCER RES, V63, P484; Adam RM, 2007, CANCER RES, V67, P6238, DOI 10.1158/0008-5472.CAN-07-0288; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Castro P, 2004, PROSTATE, V60, P153, DOI 10.1002/pros.20051; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; de Ferranti S, 2008, CLIN CHEM, V54, P945, DOI 10.1373/clinchem.2007.100156; Dong P, 2010, J CELL BIOCH; Fibbi B, 2010, INT J ANDROL, V33, P475, DOI 10.1111/j.1365-2605.2009.00972.x; Flick ED, 2007, CANCER EPIDEM BIOMAR, V16, P2218, DOI 10.1158/1055-9965.EPI-07-0197; Freeman MR, 2004, J CELL BIOCHEM, V91, P54, DOI 10.1002/jcb.10724; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gilchrist M, 2008, J EXP MED, V205, P2349, DOI 10.1084/jem.20072254; Graaf MR, 2004, J CLIN ONCOL, V22, P2388, DOI 10.1200/JCO.2004.02.027; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Hashimoto Y, 2002, NUCLEIC ACIDS RES, V30, P2398, DOI 10.1093/nar/30.11.2398; Hua B, 2006, J BIOL CHEM, V281, P1620, DOI 10.1074/jbc.M508471200; Hwang D, 2005, P NATL ACAD SCI USA, V102, P17296, DOI 10.1073/pnas.0508647102; Ishiguro T, 2000, ONCOL RES, V12, P343, DOI 10.3727/096504001108747792; James CG, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-30; Junker BH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-219; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kashiwakura Y, 2008, CANCER RES, V68, P8333, DOI 10.1158/0008-5472.CAN-08-0080; Kim J, 2005, CANCER RES, V65, P8242, DOI 10.1158/0008-5472.CAN-05-0942; Kim J, 2007, CANCER RES, V67, P9229, DOI 10.1158/0008-5472.CAN-07-1333; Kim J, 2009, ENDOCRINOLOGY, V150, P3576, DOI 10.1210/en.2008-1782; Konig JE, 2004, PROSTATE, V58, P121, DOI 10.1002/pros.10317; Kramer G, 2006, CURR OPIN UROL, V16, P25; Lempicki RA, 2006, J INFECT DIS, V193, P1172, DOI 10.1086/501365; Li D, 2008, DIABETES, V57, P635, DOI 10.2337/db07-0717; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Marcovecchio M, 2005, J ENDOCRINOL INVEST, V28, P853, DOI 10.1007/BF03347581; Morote J, 2000, EUR UROL, V37, P537, DOI 10.1159/000020190; Mostaghel EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030062; Moyad MA, 2008, AM J MED, V121, pS34, DOI 10.1016/j.amjmed.2008.05.025; Murtola TJ, 2007, CANCER EPIDEM BIOMAR, V16, P2226, DOI 10.1158/1055-9965.EPI-07-0599; Nickel JC, 2008, UROL CLIN N AM, V35, P109, DOI 10.1016/j.ucl.2007.09.012; Nickel JC, 2005, BJU INT, V95, P571, DOI 10.1111/j.1464-410X.2005.05341.x; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Parsons JK, 2008, BJU INT, V101, P313, DOI 10.1111/j.1464-410X.2007.07332.x; Pelton K, 2010, J UROLOGY, V184, P1555, DOI 10.1016/j.juro.2010.05.083; Pelzer AE, 2006, J UROLOGY, V175, P1517, DOI 10.1016/S0022-5347(05)00651-8; Penna G, 2009, J IMMUNOL, V182, P4056, DOI 10.4049/jimmunol.0801875; Platz EA, 2008, INT J CANCER, V123, P1693, DOI 10.1002/ijc.23715; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Rosen R, 2003, EUR UROL, V44, P637, DOI 10.1016/j.eururo.2003.08.015; Rosenberger CM, 2008, P NATL ACAD SCI USA, V105, P2544, DOI 10.1073/pnas.0712182105; Saslowsky DE, 2003, J MEMBRANE BIOL, V194, P153, DOI 10.1007/s00232-003-2035-7; Solomon KR, 2009, AM J PATHOL, V174, P1017, DOI 10.2353/ajpath.2009.080551; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Suganami T, 2009, CIRC RES, V105, P25, DOI 10.1161/CIRCRESAHA.109.196261; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Wang J, 2003, J BIOL CHEM, V278, P32899, DOI 10.1074/jbc.M305456200; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861; Zhuang LY, 2005, J CLIN INVEST, V115, P959	56	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39448	10.1371/journal.pone.0039448	http://dx.doi.org/10.1371/journal.pone.0039448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768301	Green Published, gold, Green Submitted			2022-12-27	WOS:000305966500014
J	Aguilar, LF; Pino, JA; Soto-Arriaza, MA; Cuevas, FJ; Sanchez, S; Sotomayor, CP				Aguilar, Luis F.; Pino, Jose A.; Soto-Arriaza, Marco A.; Cuevas, Francisco J.; Sanchez, Susana; Sotomayor, Carlos P.			Differential Dynamic and Structural Behavior of Lipid-Cholesterol Domains in Model Membranes	PLOS ONE			English	Article							GIANT UNILAMELLAR VESICLES; SPIN-LABELED LIPIDS; WATER-PENETRATION; FLUORESCENCE; PHASE; POLARIZATION; MICROSCOPY; PRESSURE; BILAYERS; RAFTS	Changes in the cholesterol (Chol) content of biological membranes are known to alter the physicochemical properties of the lipid lamella and consequently the function of membrane-associated enzymes. To characterize these changes, we used steady-state and time resolved fluorescence spectroscopy and two photon-excitation microscopy techniques. The membrane systems were chosen according to the techniques that were used: large unilamellar vesicles (LUVs) for cuvette and giant unilamellar vesicles (GUVs) for microscopy measurements; they were prepared from dipalmitoyl phosphatidylcholine (DPPC) and dioctadecyl phosphatidylcholine (DOPC) in mixtures that are well known to form lipid domains. Two fluorescent probes, which insert into different regions of the bilayer, were selected: 1,6-diphenyl-1,3,5-hexatriene (DPH) was located at the deep hydrophobic core of the acyl chain regions and 2-dimethylamino-6-lauroylnaphthalene (Laurdan) at the hydrophilic-hydrophobic membrane interface. Our spectroscopy results show that (i) the changes induced by cholesterol in the deep hydrophobic phospholipid acyl chain domain are different from the ones observed in the superficial region of the hydrophilic-hydrophobic interface, and these changes depend on the state of the lamella and (ii) the incorporation of cholesterol into the lamella induces an increase in the orientation dynamics in the deep region of the phospholipid acyl chains with a corresponding decrease in the orientation at the region close to the polar lipid headgroups. The microscopy data from DOPC/DPPC/Chol GUVs using Laurdan generalized polarization (Laurdan GP) suggest that a high cholesterol content in the bilayer weakens the stability of the water hydrogen bond network and hence the stability of the liquid-ordered phase (Lo).	[Aguilar, Luis F.; Pino, Jose A.; Sotomayor, Carlos P.] Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile; [Soto-Arriaza, Marco A.] Pontificia Univ Catolica Chile, Fac Quim, Santiago, Chile; [Cuevas, Francisco J.] Univ Santo Tomas, Dept Ciencias Basicas, Vina Del Mar, Chile; [Sanchez, Susana] Natl Ctr Cardiovasc Res CNIC, Microscopy & Dynam Imaging Unit, Madrid, Spain; [Sanchez, Susana] Univ Calif Irvine, Dept Biomed Engn, Fluorescence Dynam Lab, Irvine, CA USA	Pontificia Universidad Catolica de Valparaiso; Pontificia Universidad Catolica de Chile; Universidad Santo Tomas; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of California System; University of California Irvine	Aguilar, LF (corresponding author), Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile.	luis.aguilar@ucv.cl	Cuevas, Francisco/AAE-2898-2021; Sánchez, Susana/HII-3113-2022; Pino, José/AAF-4359-2021; Soto-Arriaza, Marco/J-8918-2017	Pino, José/0000-0002-1542-0660; Aguilar, Luis/0000-0002-6038-3475; Cuevas, Francisco/0000-0002-0863-4652; Soto-Arriaza, Marco/0000-0003-4502-6960	Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile [1070320]	Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile, grant no 1070320. Also acknowledged are Vicerrectoria de Investigacion y Estudios Avanzados and Direccion de Investigacion, Pontificia Universidad Catolica de Valparaiso. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCALA JR, 1987, BIOPHYS J, V51, P587, DOI 10.1016/S0006-3495(87)83383-0; ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Bagatolli LA, 2000, BIOPHYS J, V78, P290, DOI 10.1016/S0006-3495(00)76592-1; Barenholz Y, 2002, PROG LIPID RES, V41, P1, DOI 10.1016/S0163-7827(01)00016-9; Bartucci R, 2006, CHEM PHYS LIPIDS, V141, P142, DOI 10.1016/j.chemphyslip.2006.02.009; Bernsdorff C, 1995, BER BUNSEN PHYS CHEM, V99, P1479, DOI 10.1002/bbpc.199500112; Bernsdorff C, 1997, BIOPHYS J, V72, P1264, DOI 10.1016/S0006-3495(97)78773-3; Bhattacharya S, 2000, BBA-BIOMEMBRANES, V1467, P39, DOI 10.1016/S0005-2736(00)00196-6; Chong PLG, 2009, BBA-BIOMEMBRANES, V1788, P2, DOI 10.1016/j.bbamem.2008.10.010; de Almeida RFM, 2007, BIOPHYS J, V93, P539, DOI 10.1529/biophysj.106.098822; de la Serna JB, 2004, J BIOL CHEM, V279, P40715, DOI 10.1074/jbc.M404648200; Erilov DA, 2004, BIOPHYS J, V87, P3873, DOI 10.1529/biophysj.104.046631; GRATTON E, 1984, ANNU REV BIOPHYS BIO, V13, P105; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; HO C, 1992, BIOPHYS J, V63, P897, DOI 10.1016/S0006-3495(92)81671-5; IPSEN JH, 1987, BIOCHIM BIOPHYS ACTA, V905, P162; Isaev NP, 2010, APPL MAGN RESON, V37, P405, DOI 10.1007/s00723-009-0096-1; KINOSITA K, 1977, BIOPHYS J, V20, P289, DOI 10.1016/S0006-3495(77)85550-1; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; LENTZ BR, 1980, BIOCHEMISTRY-US, V19, P1943, DOI 10.1021/bi00550a034; LEVI M, 1990, J CLIN INVEST, V85, P231, DOI 10.1172/JCI114417; Marsh D, 2002, EUR BIOPHYS J BIOPHY, V31, P559, DOI 10.1007/s00249-002-0245-z; Martinez-Cabrera H. I., 2014, PLOS ONE, V9, DOI [10.1371/journal.pone, DOI 10.1371/journal.pone.0011162]; MCELHANEY RN, 1982, CHEM PHYS LIPIDS, V30, P229, DOI 10.1016/0009-3084(82)90053-6; McIntosh TJ, 2006, ANNU REV BIOPH BIOM, V35, P177, DOI 10.1146/annurev.biophys.35.040405.102022; Nielsen M, 1999, PHYS REV E, V59, P5790, DOI 10.1103/PhysRevE.59.5790; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; PARASASSI T, 1994, BIOPHYS J, V66, P763, DOI 10.1016/S0006-3495(94)80852-5; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; Pasenkiewicz-Gierula M, 2000, BIOPHYS J, V78, P1376, DOI 10.1016/S0006-3495(00)76691-4; PASENKIEWICZGIERULA M, 1990, BIOCHEMISTRY-US, V29, P4059, DOI 10.1021/bi00469a006; Rigaud JL, 1997, J STRUCT BIOL, V118, P226, DOI 10.1006/jsbi.1997.3848; ROBINSON AJ, 1995, BIOPHYS J, V68, P164, DOI 10.1016/S0006-3495(95)80171-2; Sanchez S.A., 2007, APPL PHYS CHEM SCI, P1007; Sanchez SA, 2002, BIOPHYS J, V82, P2232, DOI 10.1016/S0006-3495(02)75569-0; Sanchez SA, 2007, J LIPID RES, V48, P1689, DOI 10.1194/jlr.M600457-JLR200; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SPENCER RD, 1969, ANN NY ACAD SCI, V158, P361, DOI 10.1111/j.1749-6632.1969.tb56231.x; Tu KC, 1998, BIOPHYS J, V75, P2147, DOI 10.1016/S0006-3495(98)77657-X; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; YEAGLE PL, 1989, FASEB J, V3, P1833, DOI 10.1096/fasebj.3.7.2469614; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; Yu WM, 1996, BIOPHYS J, V70, P626, DOI 10.1016/S0006-3495(96)79646-7; ZANNONI C, 1983, CHEM PHYS LIPIDS, V32, P179, DOI 10.1016/0009-3084(83)90037-3	45	39	39	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40254	10.1371/journal.pone.0040254	http://dx.doi.org/10.1371/journal.pone.0040254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768264	Green Published, gold			2022-12-27	WOS:000305892100238
J	Ammosova, T; Platonov, M; Yedavalli, VRK; Obukhov, Y; Gordeuk, VR; Jeang, KT; Kovalskyy, D; Nekhai, S				Ammosova, Tatiana; Platonov, Maxim; Yedavalli, Venkat R. K.; Obukhov, Yuri; Gordeuk, Victor R.; Jeang, Kuan-Teh; Kovalskyy, Dmytro; Nekhai, Sergei			Small Molecules Targeted to a Non-Catalytic "RVxF" Binding Site of Protein Phosphatase-1 Inhibit HIV-1	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; P-TEFB; DEPENDENT TRANSACTIVATION; TAT; TRANSCRIPTION; TYPE-1; PHOSPHORYLATION; ACTIVATION; MACHINERY; COMPLEX	HIV-1 Tat protein recruits host cell factors including CDK9/cyclin T1 to HIV-1 TAR RNA and thereby induces HIV-1 transcription. An interaction with host Ser/Thr protein phosphatase-1 (PP1) is critical for this function of Tat. PP1 binds to a Tat sequence, Q(35)VCF(38), which resembles the PP1-binding "RVxF" motif present on PP1-binding regulatory subunits. We showed that expression of PP1 binding peptide, a central domain of Nuclear Inhibitor of PP1, disrupted the interaction of HIV-1 Tat with PP1 and inhibited HIV-1 transcription and replication. Here, we report small molecule compounds that target the "RVxF"-binding cavity of PP1 to disrupt the interaction of PP1 with Tat and inhibit HIV-1 replication. Using the crystal structure of PP1, we virtually screened 300,000 compounds and identified 262 small molecules that were predicted to bind the "RVxF"-accommodating cavity of PP1. These compounds were then assayed for inhibition of HIV-1 transcription in CEM T cells. One of the compounds, 1H4, inhibited HIV-1 transcription and replication at non-cytotoxic concentrations. 1H4 prevented PP1-mediated dephosphorylation of a substrate peptide containing an RVxF sequence in vitro. 1H4 also disrupted the association of PP1 with Tat in cultured cells without having an effect on the interaction of PP1 with the cellular regulators, NIPP1 and PNUTS, or on the cellular proteome. Finally, 1H4 prevented the translocation of PP1 to the nucleus. Taken together, our study shows that HIV-inhibition can be achieved through using small molecules to target a non-catalytic site of PP1. This proof-of-principle study can serve as a starting point for the development of novel antiviral drugs that target the interface of HIV-1 viral proteins with their host partners.	[Ammosova, Tatiana; Gordeuk, Victor R.; Nekhai, Sergei] Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20059 USA; [Ammosova, Tatiana; Obukhov, Yuri; Nekhai, Sergei] Howard Univ, RCMI Prote Core Facil, Washington, DC 20059 USA; [Ammosova, Tatiana; Nekhai, Sergei] Howard Univ, Dept Med, Washington, DC 20059 USA; [Platonov, Maxim; Kovalskyy, Dmytro] Natl Taras Shevchenko Univ, ChemBio Ctr, Kiev, Ukraine; [Platonov, Maxim; Kovalskyy, Dmytro] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Kiev, Ukraine; [Yedavalli, Venkat R. K.; Jeang, Kuan-Teh] NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Gordeuk, Victor R.] Univ Illinois, Sickle Cell Ctr, Chicago, IL USA	Howard University; Howard University; Howard University; Ministry of Education & Science of Ukraine; Taras Shevchenko National University Kiev; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Ammosova, T (corresponding author), Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20059 USA.	snekhai@howard.edu	Ammosova, Tatiana/HIA-0704-2022; Gordeuk, Victor/AAG-6577-2019; Platonov, Maxim/D-3238-2015; , nekhai/AFO-2652-2022; Ammosova, Tatiana/J-7564-2018; , nekhai/AAW-3105-2021	Platonov, Maxim/0000-0002-3205-3305; Ammosova, Tatiana/0000-0001-8777-1032; 	Civilian Research and Development Foundation [UKB2-2927-KV-07]; National Institutes of Health (NIH) [2 R25 HL003679-08]; Office of Research on Minority Health [2MO1 RR10284, 1SC1GM082325-01, K25GM097501]; Howard University; RCMI-NIH from the Research Centers in Minority Institutions (RCMI) Program (Division of Research Infrastructure, National Center for Research Resources, NIH) [RCMI-NIH 2G12RR003048]; National Heart, Lung, and Blood Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR010284, G12RR003048] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL003679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM082325, K25GM097501] Funding Source: NIH RePORTER	Civilian Research and Development Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research on Minority Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Howard University; RCMI-NIH from the Research Centers in Minority Institutions (RCMI) Program (Division of Research Infrastructure, National Center for Research Resources, NIH); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by Civilian Research and Development Foundation [Grant UKB2-2927-KV-07] (to SN and DK), National Institutes of Health (NIH) Research grants [Grant 2 R25 HL003679-08] (to VRG) funded by the National Heart, Lung, and Blood Institute and The Office of Research on Minority Health [Grant 2MO1 RR10284] (to VRG), [Grant 1SC1GM082325-01] (to SN); [Grant K25GM097501] (to YO); by Howard University Seed Grant (to SN) and RCMI-NIH grant [Grant RCMI-NIH 2G12RR003048] (to SN) from the Research Centers in Minority Institutions (RCMI) Program (Division of Research Infrastructure, National Center for Research Resources, NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammosova T, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-47; Ammosova T, 2005, J BIOL CHEM, V280, P36364, DOI 10.1074/jbc.M503673200; Ammosova T, 2005, VIROLOGY, V341, P171, DOI 10.1016/j.virol.2005.06.041; Ammosova T, 2003, J BIOL CHEM, V278, P32189, DOI 10.1074/jbc.M300521200; Ammosova Tatiana, 2011, PLoS One, V6, pe18985, DOI 10.1371/journal.pone.0018985; Ammosova T, 2011, J BIOL CHEM, V286, P3798, DOI 10.1074/jbc.M110.196493; Ammosova T, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-78; Barboric M, 2009, P NATL ACAD SCI USA, V106, P7798, DOI 10.1073/pnas.0903188106; BERKHOUT B, 1989, CELL, V59, P273, DOI 10.1016/0092-8674(89)90289-4; Bollen M, 2002, TRENDS CELL BIOL, V12, P138, DOI 10.1016/S0962-8924(01)02247-4; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Chelius D, 2002, J PROTEOME RES, V1, P317, DOI 10.1021/pr025517j; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Chun RF, 1998, J VIROL, V72, P2615, DOI 10.1128/JVI.72.4.2615-2629.1998; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; He MZ, 2005, BIOORG MED CHEM LETT, V15, P3978, DOI 10.1016/j.bmcl.2005.01.068; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Huang C C, 1998, Pac Symp Biocomput, P349; Iguchi Takashi, 2005, Nucleic Acids Symp Ser (Oxf), P169; Ivanova G, 2007, OLIGONUCLEOTIDES, V17, P54, DOI 10.1089/oli.2006.0046; Jerebtsova M, 2011, MOL CELL BIOCHEM, V347, P79, DOI 10.1007/s11010-010-0614-3; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Jochmann R, 2009, J VIROL, V83, P3704, DOI 10.1128/JVI.01384-08; Lesage B, 2007, BIOCHEMISTRY-US, V46, P8909, DOI 10.1021/bi7003119; Massari S, 2010, J MED CHEM, V53, P641, DOI 10.1021/jm901211d; McMartin C, 1997, J COMPUT AID MOL DES, V11, P333, DOI 10.1023/A:1007907728892; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Nekhai S, 2007, ONCOGENE, V26, P3899, DOI 10.1038/sj.onc.1210158; Nekhai S, 2009, HUMAN IMMUNODEFICIEN; Nekhai S, 2006, FUTURE MICROBIOL, V1, P417, DOI 10.2217/17460913.1.4.417; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Okamoto H, 2000, VIROLOGY, V272, P402, DOI 10.1006/viro.2000.0396; Pan CF, 2007, J MED CHEM, V50, P2285, DOI 10.1021/jm070014g; Parolin C, 2003, ANTIMICROB AGENTS CH, V47, P889, DOI 10.1128/AAC.47.3.889-896.2003; Ragusa MJ, 2010, NAT STRUCT MOL BIOL, V17, P459, DOI 10.1038/nsmb.1786; Richter S, 2004, ANTIMICROB AGENTS CH, V48, P1895, DOI 10.1128/AAC.48.5.1895-1899.2004; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Stevens M, 2007, VIROLOGY, V365, P220, DOI 10.1016/j.virol.2007.03.036; Washington K, 2002, J BIOL CHEM, V277, P40442, DOI 10.1074/jbc.M205687200; Woldehawariat G, 1999, MOL CELL BIOCHEM, V198, P7, DOI 10.1023/A:1006978622240; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yedavalli VSRK, 2003, J BIOL CHEM, V278, P6404, DOI 10.1074/jbc.M209162200; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Yuan DK, 2007, BIOORGAN MED CHEM, V15, P265, DOI 10.1016/j.bmc.2006.09.062; Zeng L, 2005, J AM CHEM SOC, V127, P2376, DOI 10.1021/ja044885g; Zhang Y, 2008, PEPTIDES, V29, P465, DOI 10.1016/j.peptides.2007.07.015	46	27	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39481	10.1371/journal.pone.0039481	http://dx.doi.org/10.1371/journal.pone.0039481			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768081	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100052
J	Bagamian, KH; Douglass, RJ; Alvarado, A; Kuenzi, AJ; Amman, BR; Waller, LA; Mills, JN				Bagamian, Karoun H.; Douglass, Richard J.; Alvarado, Arlene; Kuenzi, Amy J.; Amman, Brian R.; Waller, Lance A.; Mills, James N.			Population Density and Seasonality Effects on Sin Nombre Virus Transmission in North American Deermice (Peromyscus maniculatus) in Outdoor Enclosures	PLOS ONE			English	Article							CREEK CANAL VIRUS; PUUMALA-HANTAVIRUS; TEMPORAL DYNAMICS; BANK VOLES; CLETHRIONOMYS-GLAREOLUS; NEPHROPATHIA-EPIDEMICA; DEPENDENT PREVALENCE; INFECTIOUS-DISEASES; ANTIBODY PREVALENCE; HEMORRHAGIC-FEVER	Surveys of wildlife host-pathogen systems often document clear seasonal variation in transmission; conclusions concerning the relationship between host population density and transmission vary. In the field, effects of seasonality and population density on natural disease cycles are challenging to measure independently, but laboratory experiments may poorly reflect what happens in nature. Outdoor manipulative experiments are an alternative that controls for some variables in a relatively natural environment. Using outdoor enclosures, we tested effects of North American deermouse (Peromyscus maniculatus) population density and season on transmission dynamics of Sin Nombre hantavirus. In early summer, mid-summer, late summer, and fall 2007-2008, predetermined numbers of infected and uninfected adult wild deermice were released into enclosures and trapped weekly or bi-weekly. We documented 18 transmission events and observed significant seasonal effects on transmission, wounding frequency, and host breeding condition. Apparent differences in transmission incidence or wounding frequency between high-and low-density treatments were not statistically significant. However, high host density was associated with a lower proportion of males with scrotal testes. Seasonality may have a stronger influence on disease transmission dynamics than host population density, and density effects cannot be considered independent of seasonality.	[Bagamian, Karoun H.; Mills, James N.] Emory Univ, Populat Biol Ecol & Evolut Program, Atlanta, GA 30322 USA; [Bagamian, Karoun H.; Amman, Brian R.; Mills, James N.] US Ctr Dis Control & Prevent, Med Ecol Unit, Viral Special Pathogens Branch, Atlanta, GA USA; [Bagamian, Karoun H.; Douglass, Richard J.; Kuenzi, Amy J.] Univ Montana, Montana Tech, Dept Biol, Butte, MT USA; [Alvarado, Arlene] Univ Montana, Montana Tech, Inst Educ Opportun, Cfwep Org, Butte, MT USA; [Waller, Lance A.] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA	Emory University; Centers for Disease Control & Prevention - USA; University of Montana System; Montana Technological University; University of Montana; University of Montana System; Montana Technological University; University of Montana; Emory University; Rollins School Public Health	Bagamian, KH (corresponding author), Emory Univ, Populat Biol Ecol & Evolut Program, Atlanta, GA 30322 USA.	karoun11@gmail.com	Waller, Lance A./AAA-1012-2021		NIH-CDC [R-36]; NIH from the INBRE-BRIN program of the National Center for Research Resources [P20RR16455-06, P20RR16455-07]; CDC Medical Ecology Unit; Viral Special Pathogens Branch; Montana Tech, University of Montana; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015525] Funding Source: NIH RePORTER	NIH-CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institutes of Health (NIH) - USA); NIH from the INBRE-BRIN program of the National Center for Research Resources; CDC Medical Ecology Unit; Viral Special Pathogens Branch; Montana Tech, University of Montana; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was funded by the NIH-CDC Public Health Dissertation Research Grant R-36, NIH Grant P20RR16455-06,07 from the INBRE-BRIN program of the National Center for Research Resources, CDC Medical Ecology Unit, Viral Special Pathogens Branch, and Montana Tech, University of Montana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler FR, 2008, B MATH BIOL, V70, P236, DOI 10.1007/s11538-007-9251-8; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Begon M, 1999, P ROY SOC B-BIOL SCI, V266, P1939, DOI 10.1098/rspb.1999.0870; Begon M, 2009, P ROY SOC B-BIOL SCI, V276, P1603, DOI 10.1098/rspb.2008.1732; Botten J, 2003, J VIROL, V77, P1540, DOI 10.1128/JVI.77.2.1540-1550.2002; Botten J, 2002, J VIROL, V76, P7587, DOI 10.1128/JVI.76.15.7587-7594.2002; Burthe S, 2006, J ANIM ECOL, V75, P1416, DOI 10.1111/j.1365-2656.2006.01166.x; Calisher CH, 2007, J WILDLIFE DIS, V43, P1, DOI 10.7589/0090-3558-43.1.1; Cantoni G, 2001, TROP MED INT HEALTH, V6, P811, DOI 10.1046/j.1365-3156.2001.00788.x; Carver S, 2011, J WILDLIFE DIS, V47, P56, DOI 10.7589/0090-3558-47.1.56; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; CHRISTIAN J, 1961, P NATL ACAD SCI USA, V47, P428, DOI 10.1073/pnas.47.4.428; Clay CA, 2009, P R SOC B, V276, P1305, DOI 10.1098/rspb.2008.1693; Dearing MD, 2009, J WILDLIFE DIS, V45, P430, DOI 10.7589/0090-3558-45.2.430; Dobson A., 1995, ECOLOGY INFECT DIS N; Douglass RJ, 2007, J WILDLIFE DIS, V43, P12, DOI 10.7589/0090-3558-43.1.12; Douglass RJ, 2001, AM J TROP MED HYG, V65, P33, DOI 10.4269/ajtmh.2001.65.33; Escutenaire S, 2000, VIRUS RES, V67, P91, DOI 10.1016/S0168-1702(00)00136-2; FELDMANN H, 1993, VIRUS RES, V30, P351, DOI 10.1016/0168-1702(93)90101-R; Fichet-Calvet E, 2007, VECTOR-BORNE ZOONOT, V7, P119, DOI 10.1089/vbz.2006.0520; Fuller CA, 1996, ECOLOGY, V77, P2196, DOI 10.2307/2265712; GLASS GE, 1988, EPIDEMIOL INFECT, V101, P459, DOI 10.1017/S0950268800054418; Hamede RK, 2008, AUSTRAL ECOL, V33, P614, DOI 10.1111/j.1442-9993.2007.01827.x; Hardestam J, 2008, EMERG INFECT DIS, V14, P1209, DOI 10.3201/eid1408.080221; Hinson ER, 2004, AM J TROP MED HYG, V70, P310, DOI 10.4269/ajtmh.2004.70.310; Hutchinson KL, 2000, J MED VIROL, V60, P70, DOI 10.1002/(SICI)1096-9071(200001)60:1<70::AID-JMV12>3.0.CO;2-1; Hutchinson KL, 1998, AM J TROP MED HYG, V59, P58, DOI 10.4269/ajtmh.1998.59.58; Kallio ER, 2006, J GEN VIROL, V87, P2127, DOI 10.1099/vir.0.81643-0; KAUFMAN GA, 1989, J MAMMAL, V70, P656, DOI 10.2307/1381445; Kuenzi AJ, 2005, J WILDLIFE DIS, V41, P473, DOI 10.7589/0090-3558-41.3.473; Kuenzi AJ, 2001, AM J TROP MED HYG, V64, P137, DOI 10.4269/ajtmh.2001.64.137; LEE HW, 1981, AM J TROP MED HYG, V30, P1106, DOI 10.4269/ajtmh.1981.30.1106; Lonner BN, 2008, VECTOR-BORNE ZOONOT, V8, P433, DOI 10.1089/vbz.2007.0232; Madhav NK, 2007, VECTOR-BORNE ZOONOT, V7, P353, DOI 10.1089/vbz.2006.0605; Millar J.S., 1989, P169; Mills J.N., 1995, METHODS TRAPPING SAM, P61; Mills JN, 2010, VECTOR-BORNE ZOONOT, V10, P563, DOI 10.1089/vbz.2009.0018; Mills JN, 1999, EMERG INFECT DIS, V5, P135, DOI 10.3201/eid0501.990116; MILLS JN, 1992, AM J TROP MED HYG, V47, P749, DOI 10.4269/ajtmh.1992.47.749; NIKLASSON B, 1995, AM J TROP MED HYG, V53, P134, DOI 10.4269/ajtmh.1995.53.134; Pearce-Duvet JMC, 2006, J WILDLIFE DIS, V42, P819, DOI 10.7589/0090-3558-42.4.819; PETERS C. J., 2006, TROPICAL INFECT DIS, P762; Sauvage F, 2003, J ANIM ECOL, V72, P1, DOI 10.1046/j.1365-2656.2003.00675.x; Schauber EM, 1997, ECOL APPL, V7, P143, DOI 10.1890/1051-0761(1997)007[0143:IEOSMI]2.0.CO;2; Schountz T, 2007, EMERG INFECT DIS, V13, P1604, DOI 10.3201/eid1310.070383; Smith MJ, 2009, P NATL ACAD SCI USA, V106, P7905, DOI 10.1073/pnas.0809145106; Tagliapietra V, 2009, EMERG INFECT DIS, V15, P1019, DOI 10.3201/eid1507.081524; YANAGIHARA R, 1985, J VIROL, V55, P34, DOI 10.1128/JVI.55.1.34-38.1985; YIN Z, 1995, FISH SHELLFISH IMMUN, V5, P519, DOI 10.1016/S1050-4648(95)80052-2	50	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e37254	10.1371/journal.pone.0037254	http://dx.doi.org/10.1371/journal.pone.0037254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768034	Green Submitted, gold, Green Published			2022-12-27	WOS:000305892100005
J	Fu, SB; Yang, Y; Tirtha, D; Yen, Y; Zhou, BS; Zhou, MM; Ohlmeyer, M; Ko, EC; Cagan, R; Rosenstein, BS; Chen, SH; Kao, J				Fu, Shibo; Yang, Ying; Tirtha, Das; Yen, Yun; Zhou, Bing-sen; Zhou, Ming-Ming; Ohlmeyer, Michael; Ko, Eric C.; Cagan, Ross; Rosenstein, Barry S.; Chen, Shu-hsia; Kao, Johnny			gamma-H2AX Kinetics as a Novel Approach to High Content Screening for Small Molecule Radiosensitizers	PLOS ONE			English	Article							HISTONE H2AX PHOSPHORYLATION; DNA-DAMAGE RESPONSE; TARGET; ACTIVATION; EFFICACY; ATM	Background: Persistence of gamma-H2AX after ionizing radiation (IR) or drug therapy is a robust reporter of unrepaired DNA double strand breaks in treated cells. Methods: DU-145 prostate cancer cells were treated with a chemical library +/- IR and assayed for persistence of gamma-H2AX using an automated 96-well immunocytochemistry assay at 4 hours after treatment. Hits that resulted in persistence of gamma-H2AX foci were tested for effects on cell survival. The molecular targets of hits were validated by molecular, genetic and biochemical assays and in vivo activity was tested in a validated Drosophila cancer model. Results: We identified 2 compounds, MS0019266 and MS0017509, which markedly increased persistence of gamma-H2AX, apoptosis and radiosensitization in DU-145 cells. Chemical evaluation demonstrated that both compounds exhibited structurally similar and biochemical assays confirmed that these compounds inhibit ribonucleotide reductase. DNA microarray analysis and immunoblotting demonstrates that MS0019266 significantly decreased polo-like kinase 1 gene and protein expression. MS0019266 demonstrated in vivo antitumor activity without significant whole organism toxicity. Conclusions: MS0019266 and MS0017509 are promising compounds that may be candidates for further development as radiosensitizing compounds as inhibitors of ribonucleotide reductase.	[Fu, Shibo; Ko, Eric C.; Rosenstein, Barry S.; Kao, Johnny] Mt Sinai Sch Med, Dept Radiat Oncol, New York, NY 10029 USA; [Fu, Shibo] Jilin Univ, Sch Publ Hlth, Dept Radiat Biol, Changchun 130023, Peoples R China; [Yang, Ying] Columbia Univ, Dept Dermatol, New York, NY 10027 USA; [Tirtha, Das; Cagan, Ross] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY USA; [Yen, Yun; Zhou, Bing-sen] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA; [Zhou, Ming-Ming; Ohlmeyer, Michael] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY USA; [Chen, Shu-hsia] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA; [Kao, Johnny] Good Samaritan Hosp Med Ctr, Dept Radiat Oncol, W Islip, NY USA	Icahn School of Medicine at Mount Sinai; Jilin University; Columbia University; Icahn School of Medicine at Mount Sinai; City of Hope; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Fu, SB (corresponding author), Mt Sinai Sch Med, Dept Radiat Oncol, New York, NY 10029 USA.	Johnny.kao@chsli.org	Ko, Eric/AAB-7870-2019; Fu, Shi-bo/ABE-1277-2020; Cagan, Ross Leigh/AAV-9528-2021	Ko, Eric/0000-0003-2308-115X; Cagan, Ross/0000-0001-5297-450X	DOD [W81XWH-05-1-0199]; National Center for Minority Health and Health Disparities Scholar; Katz Foundation; William Harris Research Fellowship; NATIONAL CANCER INSTITUTE [R01CA109322, R01CA127483] Funding Source: NIH RePORTER	DOD(United States Department of Defense); National Center for Minority Health and Health Disparities Scholar; Katz Foundation; William Harris Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research is supported by DOD grant W81XWH-05-1-0199, National Center for Minority Health and Health Disparities Scholar, Katz Foundation Award, and William Harris Research Fellowship to J.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banath JP, 2003, CANCER RES, V63, P4347; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Connell PP, 2004, DNA REPAIR, V3, P1245, DOI 10.1016/j.dnarep.2004.04.004; CORY JG, 1994, ANTICANCER RES, V14, P875; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Easmon J, 1997, J MED CHEM, V40, P4420, DOI 10.1021/jm970255w; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Gerster K, 2010, INT J RADIAT ONCOL, V77, P253, DOI 10.1016/j.ijrobp.2009.11.027; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Hou YN, 2009, RADIAT RES, V171, P360, DOI 10.1667/RR1349.1; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Janzen WP, 2001, HIGH THROUGHPUT SCRE, pix; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kainkaryam RM, 2009, CURR OPIN DRUG DISC, V12, P339; Kao J, 2006, CURR CANCER DRUG TAR, V6, P197, DOI 10.2174/156800906776842957; Kao J, 2005, ANN NY ACAD SCI, V1066, P243, DOI 10.1196/annals.1363.012; Katz D, 2008, BIOTECHNIQUES, V44, pIX, DOI 10.2144/000112757; Katz D, 2009, INT J RADIAT ONCOL, V73, P988, DOI 10.1016/j.ijrobp.2008.12.002; Kunos CA, 2009, RADIAT RES, V172, P666, DOI 10.1667/RR1858.1; Lally BE, 2007, CANCER RES, V67, P8791, DOI 10.1158/0008-5472.CAN-07-0477; Lang P, 2006, NAT REV DRUG DISCOV, V5, P343, DOI 10.1038/nrd2008; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sarkaria JN, 2001, SEMIN RADIAT ONCOL, V11, P316, DOI 10.1053/srao.2001.26030; Seiwert TY, 2007, NAT CLIN PRACT ONCOL, V4, P86, DOI 10.1038/ncponc0714; Shiloh Y, 2004, NAT CELL BIOL, V6, P923, DOI 10.1038/ncb1004-923; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Stucki M, 2004, NAT CELL BIOL, V6, P1150, DOI 10.1038/ncb1204-1150; Taneja N, 2004, J BIOL CHEM, V279, P2273, DOI 10.1074/jbc.M310030200; Tannock IF, 1998, LANCET, V351, P9; Taylor DL, 2006, HIGH CONTENT SCREENI; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Vidal M, 2005, CANCER RES, V65, P3538, DOI 10.1158/0008-5472.CAN-04-4561; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Yu Y, 2009, J MED CHEM, V52, P5271, DOI 10.1021/jm900552r	38	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38465	10.1371/journal.pone.0038465	http://dx.doi.org/10.1371/journal.pone.0038465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768044	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100015
J	Goossens, GH; Moors, CCM; van der Zijl, NJ; Venteclef, N; Alili, R; Jocken, JWE; Essers, Y; Cleutjens, JP; Clement, K; Diamant, M; Blaak, EE				Goossens, Gijs H.; Moors, Chantalle C. M.; van der Zijl, Nynke J.; Venteclef, Nicolas; Alili, Rohia; Jocken, Johan W. E.; Essers, Yvonne; Cleutjens, Jack P.; Clement, Karine; Diamant, Michaela; Blaak, Ellen E.			Valsartan Improves Adipose Tissue Function in Humans with Impaired Glucose Metabolism: A Randomized Placebo-Controlled Double-Blind Trial	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; DECREASES ADIPOCYTE SIZE; INSULIN SENSITIVITY; BLOOD-FLOW; TRIGLYCERIDE LIPASE; RECEPTOR BLOCKADE; RESISTANCE; OBESITY; DIFFERENTIATION; INFLAMMATION	Background: Blockade of the renin-angiotensin system (RAS) reduces the incidence of type 2 diabetes mellitus. In rodents, it has been demonstrated that RAS blockade improved adipose tissue (AT) function and glucose homeostasis. However, the effects of long-term RAS blockade on AT function have not been investigated in humans. Therefore, we examined whether 26-wks treatment with the angiotensin II type 1 receptor blocker valsartan affects AT function in humans with impaired glucose metabolism (IGM). Methodology/Principal Findings: We performed a randomized, double-blind, placebo-controlled parallel-group study, in which 38 subjects with IGM were treated with valsartan (VAL, 320 mg/d) or placebo (PLB) for 26 weeks. Before and after treatment, an abdominal subcutaneous AT biopsy was collected for measurement of adipocyte size and AT gene/protein expression of angiogenesis/capillarization, adipogenesis, lipolytic and inflammatory cell markers. Furthermore, we evaluated fasting and postprandial AT blood flow (ATBF) (Xe-133 wash-out), systemic inflammation and insulin sensitivity (hyperinsulinemic-euglycemic clamp). VAL treatment markedly reduced adipocyte size (P < 0.001), with a shift toward a higher proportion of small adipocytes. In addition, fasting (P = 0.043) and postprandial ATBF (P = 0.049) were increased, whereas gene expression of angiogenesis/capillarization, adipogenesis and macrophage infiltration markers in AT was significantly decreased after VAL compared with PLB treatment. Interestingly, the change in adipocyte size was associated with alterations in insulin sensitivity and reduced AT gene expression of macrophage infiltration markers. VAL did not alter plasma monocyte-chemoattractant protein (MCP)-1, TNF-alpha, adiponectin and leptin concentrations. Conclusions/Significance: 26-wks VAL treatment markedly reduced abdominal subcutaneous adipocyte size and AT macrophage infiltration markers, and increased ATBF in IGM subjects. The VAL-induced decrease in adipocyte size was associated with reduced expression of macrophage infiltration markers in AT. Our findings suggest that interventions targeting the RAS may improve AT function, thereby contributing to a reduced risk of developing cardiovascular disease and type 2 diabetes. Trial Registration: Trialregister.nlNTR721 (ISRCTN Registry: ISRCTN42786336)	[Goossens, Gijs H.; Moors, Chantalle C. M.; Jocken, Johan W. E.; Essers, Yvonne; Blaak, Ellen E.] Maastricht Univ, Med Ctr, Dept Human Biol, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [van der Zijl, Nynke J.; Diamant, Michaela] Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Ctr Diabet, Amsterdam, Netherlands; [Venteclef, Nicolas; Alili, Rohia; Clement, Karine] Univ Paris 06, Cordelier Res Ctr, Human Nutr Res Ctr, INSERM,Nutriom U872 Eq 7, Paris, France; [Venteclef, Nicolas; Alili, Rohia; Clement, Karine] Hop La Pitie Salpetriere, AP HP, Paris, France; [Cleutjens, Jack P.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Pathol, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Vrije Universiteit Amsterdam; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Maastricht University	Goossens, GH (corresponding author), Maastricht Univ, Med Ctr, Dept Human Biol, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands.	G.Goossens@maastrichtuniversity.nl	Venteclef, Nicolas/K-8484-2017; Clément, karine/R-1120-2017; Cleutjens, Jack P.M./F-6242-2012; Blaak, Ellen/E-3459-2015	Cleutjens, Jack P.M./0000-0002-4346-1785; Blaak, Ellen/0000-0002-2496-3464; Venteclef, Nicolas/0000-0002-6313-1214; Goossens, Gijs/0000-0002-2092-3019	Novartis Pharma; European Commission [HEALTH-F2-2008-201100]	Novartis Pharma; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by an investigator-initiated study grant from Novartis Pharma. KC thanks the European Commission (Collaborative Project ADAPT, contract number HEALTH-F2-2008-201100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksnes TA, 2007, METABOLISM, V56, P1470, DOI 10.1016/j.metabol.2007.06.012; Chu KY, 2006, DIABETES, V55, P367, DOI 10.2337/diabetes.55.02.06.db05-1022; Cole BK, 2010, HYPERTENSION, V55, P715, DOI 10.1161/HYPERTENSIONAHA.109.148049; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; EDENS NK, 1990, J LIPID RES, V31, P1423; Fliser D, 2004, CIRCULATION, V110, P1103, DOI 10.1161/01.CIR.0000140265.21608.8E; Furuhashi M, 2004, J HYPERTENS, V22, P1977, DOI 10.1097/00004872-200410000-00021; Gillespie EL, 2005, DIABETES CARE, V28, P2261, DOI 10.2337/diacare.28.9.2261; Goossens GH, 2006, DIABETOLOGIA, V49, P3009, DOI 10.1007/s00125-006-0458-2; Goossens G H, 2003, Obes Rev, V4, P43; Goossens GH, 2006, J PHYSIOL-LONDON, V571, P451, DOI 10.1113/jphysiol.2005.101352; Goossens GH, 2004, J CLIN ENDOCR METAB, V89, P2690, DOI 10.1210/jc.2003-032053; Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010; Goossens GH, 2007, HYPERTENSION, V49, P542, DOI 10.1161/01.HYP.0000256091.55393.92; Goossens GH, 2011, CIRCULATION, V124, P67, DOI 10.1161/CIRCULATIONAHA.111.027813; Hausman GJ, 2004, J ANIM SCI, V82, P925; Henriksen EJ, 2007, AM J PHYSIOL-REG I, V293, pR974, DOI 10.1152/ajpregu.00147.2007; Janke J, 2002, DIABETES, V51, P1699, DOI 10.2337/diabetes.51.6.1699; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Jocken JWE, 2007, J CLIN ENDOCR METAB, V92, P2292, DOI 10.1210/jc.2006-1318; Jones BH, 1997, ENDOCRINOLOGY, V138, P1512, DOI 10.1210/en.138.4.1512; Karpe F, 2002, DIABETES, V51, P2467, DOI 10.2337/diabetes.51.8.2467; Kurata A, 2006, KIDNEY INT, V70, P1717, DOI 10.1038/sj.ki.5001810; Leung PS, 2007, DIABETIC MED, V24, P110, DOI 10.1111/j.1464-5491.2007.02072.x; Lundgren M, 2007, DIABETOLOGIA, V50, P625, DOI 10.1007/s00125-006-0572-1; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; McMurray JJ, 2010, NEW ENGL J MED, V362, P1477, DOI 10.1056/NEJMoa1001121; Munoz MC, 2009, J HYPERTENS, V27, P2409, DOI 10.1097/HJH.0b013e3283310e1b; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Olivares-Reyes JA, 2009, MOL CELL ENDOCRINOL, V302, P128, DOI 10.1016/j.mce.2008.12.011; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Pscherer S, 2010, DIABETES CARE, V33, P914, DOI 10.2337/dc09-1381; Samra JS, 1996, AM J PHYSIOL-ENDOC M, V271, pE834, DOI 10.1152/ajpendo.1996.271.5.E834; SAMRA JS, 1995, CLIN PHYSIOL, V15, P241, DOI 10.1111/j.1475-097X.1995.tb00515.x; Taleb S, 2007, CLIN CHEM LAB MED, V45, P328, DOI 10.1515/CCLM.2007.083; Tomono Y, 2008, AM J HYPERTENS, V21, P206, DOI 10.1038/ajh.2007.50; van der Zijl NJ, 2011, DIABETES CARE, V34, P845, DOI 10.2337/dc10-2224; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636	39	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39930	10.1371/journal.pone.0039930	http://dx.doi.org/10.1371/journal.pone.0039930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768174	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100144
J	Jensen, GS; Haswell, ES				Jensen, Gregory S.; Haswell, Elizabeth S.			Functional Analysis of Conserved Motifs in the Mechanosensitive Channel Homolog MscS-Like2 from Arabidopsis thaliana	PLOS ONE			English	Article							SENSITIVE ION-CHANNEL; ESCHERICHIA-COLI MSCS; HYPOOSMOTIC STRESS; BACILLUS-SUBTILIS; PATCH-CLAMP; IDENTIFICATION; MEMBRANE; TENSION; DOMAIN; ACTIVATION	The Mechanosensitive channel of Small conductance (MscS) of Escherichia coli has become an excellent model system for the structural, biophysical, and functional study of mechanosensitive ion channels. MscS, a complex channel with multiple states, contributes to protection against lysis upon osmotic downshock. MscS homologs are widely and abundantly dispersed among the bacterial and plant lineages, but are not found in animals. Investigation into the eukaryotic branch of the MscS family is in the beginning stages, and it remains unclear how much MscS homologs from eukaryotes resemble E. coli MscS with respect to structure, function, and regulation. Here we test the effect of mutating three conserved motifs on the function of MscS-Like (MSL) 2, a MscS homolog localized to the plastids of Arabidopsis thaliana. We show that 1) a motif at the top of the cytoplasmic domain, referred to here as the PN(X)(9)N motif, is essential for MSL2 function and for its proper intraplastidic localization; 2) substituting polar residues for two large hydrophobic residues located in the predicted pore-lining transmembrane helix of MSL2 produces a likely gain-of-function allele, as previously shown for MscS; and 3) mis-expression of this allele causes severe defects in leaf growth, loss of chloroplast integrity, and abnormal starch accumulation. Thus, two of the three conserved motifs we analyzed are critical for MSL2 function, consistent with the conservation of structure and function between MscS family members in bacteria and plants. These results underscore the importance of plastidic mechanosensitive channels in the maintenance of normal plastid and leaf morphology.	[Jensen, Gregory S.; Haswell, Elizabeth S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Jensen, GS (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	ehaswell@wustl.edu	Haswell, Elizabeth/AAE-9370-2021	Haswell, Elizabeth/0000-0002-4246-065X	National Science Foundation [MCB0816627]; National Institutes of Health [R01GM084211-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084211] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation (MCB0816627) and the National Institutes of Health (R01GM084211-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akitake B, 2007, NAT STRUCT MOL BIOL, V14, P1141, DOI 10.1038/nsmb1341; Anishkin A, 2004, BIOPHYS J, V86, P2883, DOI 10.1016/S0006-3495(04)74340-4; Anishkin A, 2008, J GEN PHYSIOL, V132, P67, DOI 10.1085/jgp.200810000; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Balleza D, 2009, EUR BIOPHYS J BIOPHY, V38, P1013, DOI 10.1007/s00249-009-0460-y; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Belyy V, 2010, NAT STRUCT MOL BIOL, V17, P451, DOI 10.1038/nsmb.1775; Bent A, 2006, METH MOL B, V343, P87; Berrier C, 1996, J MEMBRANE BIOL, V151, P175, DOI 10.1007/s002329900068; BERRIER C, 1989, FEBS LETT, V259, P27, DOI 10.1016/0014-5793(89)81486-3; Booth IR, 2011, BIOCHEM SOC T, V39, P733, DOI 10.1042/BST0390733; Booth IR, 1999, CURR OPIN MICROBIOL, V2, P166, DOI 10.1016/S1369-5274(99)80029-0; Booth IR, 2007, MECHANOSENSITIVE I A; CUI C, 1995, J MEMBRANE BIOL, V144, P31; DELCOUR AH, 1989, J MEMBRANE BIOL, V112, P267, DOI 10.1007/BF01870957; Edwards MD, 2005, NAT STRUCT MOL BIOL, V12, P113, DOI 10.1038/nsmb895; Folgering JHA, 2005, J BIOL CHEM, V280, P8784, DOI 10.1074/jbc.M411732200; Grajkowski W, 2005, BIOPHYS J, V88, P3050, DOI 10.1529/biophysj.104.053546; Haswell ES, 2008, CURR BIOL, V18, P730, DOI 10.1016/j.cub.2008.04.039; Haswell ES, 2011, STRUCTURE, V19, P1356, DOI 10.1016/j.str.2011.09.005; Haswell ES, 2006, CURR BIOL, V16, P1, DOI 10.1016/j.cub.2005.11.044; Haswell ES, 2007, MECHANOSENSITIVE I A; Hoffmann T, 2008, APPL ENVIRON MICROB, V74, P2454, DOI 10.1128/AEM.01573-07; Kloda A, 2001, BIOPHYS J, V80, P229, DOI 10.1016/S0006-3495(01)76009-2; Kloda Anna, 2002, Archaea, V1, P35, DOI 10.1155/2002/419261; Koprowski P, 2003, J BIOL CHEM, V278, P11237, DOI 10.1074/jbc.M212073200; Koprowski P, 2001, BIOESSAYS, V23, P1148, DOI 10.1002/bies.10017; Koprowski P, 2011, J BIOL CHEM, V286, P877, DOI 10.1074/jbc.M110.176131; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Kung C, 2010, ANNU REV MICROBIOL, V64, P313, DOI 10.1146/annurev.micro.112408.134106; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Li C, 2007, MOL MICROBIOL, V64, P560, DOI 10.1111/j.1365-2958.2007.05672.x; Li YZ, 2002, EMBO J, V21, P5323, DOI 10.1093/emboj/cdf537; Machiyama H, 2009, BIOPHYS J, V97, P1048, DOI 10.1016/j.bpj.2009.05.021; Malcolm HR, 2012, BIOCHEM BIOPH RES CO, V417, P972, DOI 10.1016/j.bbrc.2011.12.049; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; McLaggan D, 2002, MOL MICROBIOL, V43, P521, DOI 10.1046/j.1365-2958.2002.02764.x; Miller S, 2003, J BIOL CHEM, V278, P32246, DOI 10.1074/jbc.M303188200; Miller S, 2003, EMBO J, V22, P36, DOI 10.1093/emboj/cdg011; Nomura T, 2008, BIOPHYS J, V94, P1638, DOI 10.1529/biophysj.107.114785; Nottebrock D, 2003, FEMS MICROBIOL LETT, V218, P305, DOI 10.1111/j.1574-6968.2003.tb11533.x; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Okada K, 2002, J BIOL CHEM, V277, P27682, DOI 10.1074/jbc.M202497200; Osanai T, 2005, J BIOL CHEM, V280, P34684, DOI 10.1074/jbc.M507489200; Peyronnet R, 2008, PLANT SIGNAL BEHAV, V3, P726, DOI 10.4161/psb.3.9.6487; Pivetti CD, 2003, MICROBIOL MOL BIOL R, V67, P66, DOI 10.1128/MMBR.67.1.66-85.2003; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Sachs F, 2010, PHYSIOLOGY, V25, P50, DOI 10.1152/physiol.00042.2009; Schumann U, 2004, FEBS LETT, V572, P233, DOI 10.1016/j.febslet.2004.07.045; Schumann U, 2010, P NATL ACAD SCI USA, V107, P12664, DOI 10.1073/pnas.1001405107; Sotomayor M, 2004, BIOPHYS J, V87, P3050, DOI 10.1529/biophysj.104.046045; Steinbacker S, 2007, MECHANOSENSITIVE I A; Sukharev S, 2002, BIOPHYS J, V83, P290, DOI 10.1016/S0006-3495(02)75169-2; SUKHAREV SI, 1993, BIOPHYS J, V65, P177, DOI 10.1016/S0006-3495(93)81044-0; Vasquez V, 2008, SCIENCE, V321, P1210, DOI 10.1126/science.1159674; Veley KM, 2012, CURR BIOL, V22, P408, DOI 10.1016/j.cub.2012.01.027; Wahome PG, 2008, ARCH MICROBIOL, V189, P49, DOI 10.1007/s00203-007-0292-z; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; Weber APM, 2011, ANNU REV PLANT BIOL, V62, P53, DOI 10.1146/annurev-arplant-042110-103903; Wilson M, 2012, PLANT SIGNAL BEHAV, V7; Wilson ME, 2011, PLANT CELL, V23, P2939, DOI 10.1105/tpc.111.088112; Zhang M, 2009, CELL RES, V19, P877, DOI 10.1038/cr.2009.78	63	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40336	10.1371/journal.pone.0040336	http://dx.doi.org/10.1371/journal.pone.0040336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768278	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100252
J	Pilbrow, AP; Folkersen, L; Pearson, JF; Brown, CM; McNoe, L; Wang, NM; Sweet, WE; Tang, WHW; Black, MA; Troughton, RW; Richards, AM; Franco-Cereceda, A; Gabrielsen, A; Eriksson, P; Moravec, CS; Cameron, VA				Pilbrow, Anna P.; Folkersen, Lasse; Pearson, John F.; Brown, Chris M.; McNoe, Les; Wang, Nancy M.; Sweet, Wendy E.; Tang, W. H. Wilson; Black, Michael A.; Troughton, Richard W.; Richards, A. Mark; Franco-Cereceda, Anders; Gabrielsen, Anders; Eriksson, Per; Moravec, Christine S.; Cameron, Vicky A.			The Chromosome 9p21.3 Coronary Heart Disease Risk Allele Is Associated with Altered Gene Expression in Normal Heart and Vascular Tissues	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; ARTERY-DISEASE; 4 SNPS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; SUSCEPTIBILITY LOCI; COMMON VARIANT; NONCODING RNA	Genome-wide association studies have identified a coronary artery disease (CAD) risk locus in a non-coding region at 9p21.3, the nearest genes being CDKN2A and CDKN2B. To understand the pathways by which this locus might influence CAD susceptibility, we investigated associations between the 9p21.3 risk genotype and global gene expression in heart tissue from donors with no diagnosed heart disease (n = 108, predominant cause of death, cerebral vascular accident) and in carotid plaque (n = 106), aorta (n = 104) and mammary artery (n = 88) tissues from heart valve and carotid endarterectomy patients. Genotyping was performed with Taqman assays and Illumina arrays, and gene expression profiles generated with Affymetrix microarrays. Associations were analyzed with an additive genetic model. In heart tissue, 46 genes were putatively altered in association with the 9p21.3 risk allele (70% down-regulated, fold-change >1.1 per allele, p<0.05 adjusted for age, gender, ethnicity, cause of death). These genes were enriched for biomarkers of myocardial infarction (p = 1.53x10(-9)), response to wounding (p = 2.65x10(-10)) and inflammatory processes (p<1.97x10(-7)). Among the top 10 most down-regulated genes, 7 genes shared a set of transcription factor binding sites within conserved promoter regions (p<1.14x10(-5)), suggesting they may be co-regulated. Canonical pathway modelling of the most differentially expressed transcripts across all tissues (154 genes, 60% down-regulated, fold-change > 1.1 per allele, p < 0.01) showed that 75% of the genes could be transcriptionally regulated through the cell cycle G1 phase progression pathway (p < 1.08x10(-258)), in which CDKN2A and CDKN2B play a regulatory role. These data suggest that the cell cycle G1 phase progression pathway is activated in individuals with the 9p21.3 risk allele. This may contribute to a proliferative phenotype that promotes adverse cardiac hypertrophy and vascular remodeling, leading to an increased CAD risk.	[Pilbrow, Anna P.; Troughton, Richard W.; Richards, A. Mark; Cameron, Vicky A.] Univ Otago, Christchurch Cardioendocrine Res Grp, Dept Med, Christchurch, New Zealand; [Folkersen, Lasse; Gabrielsen, Anders; Eriksson, Per] Karolinska Inst, Dept Med, Stockholm, Sweden; [Pearson, John F.] Univ Otago, Dept Publ Hlth & Gen Practice, Christchurch, New Zealand; [Brown, Chris M.; McNoe, Les; Black, Michael A.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Sweet, Wendy E.; Tang, W. H. Wilson; Moravec, Christine S.] Cleveland Clin, Dept Cardiovasc Med, Kaufman Ctr Heart Failure, Cleveland, OH 44106 USA; [Franco-Cereceda, Anders] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	University of Otago; Karolinska Institutet; University of Otago; University of Otago; Cleveland Clinic Foundation; Karolinska Institutet	Pilbrow, AP (corresponding author), Univ Otago, Christchurch Cardioendocrine Res Grp, Dept Med, Christchurch, New Zealand.	anna.pilbrow@otago.ac.nz	Pearson, John F/D-7428-2012; Pilbrow, Anna P/B-9969-2011; Cameron, Vicky A/L-4046-2019; Black, Michael/F-1484-2010; Tang, Wai Hong Wilson/I-1238-2013	Pearson, John F/0000-0001-5607-4517; Pilbrow, Anna P/0000-0003-1949-9449; Folkersen, Lasse/0000-0003-0708-9530; Brown, Chris M/0000-0003-0079-7067; Cameron, Vicky/0000-0003-3147-683X; Tang, W. H. Wilson/0000-0002-8335-735X; Troughton, Richard/0000-0001-7484-4036; Eriksson, Per/0000-0002-5635-2692; Black, Michael/0000-0003-1174-6054	Cleveland Clinic Foundation; Heart Foundation of New Zealand; Ministry of Science and Innovation; Health Research Council of New Zealand; Maurice and Phyllis Paykel Trust; Lotteries Health New Zealand; Swedish Research Council; Swedish Heart-Lung Foundation; European Commission; Danish Agency for Science, Technology and Innovation	Cleveland Clinic Foundation; Heart Foundation of New Zealand; Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Health Research Council of New Zealand(Health Research Council of New Zealand); Maurice and Phyllis Paykel Trust; Lotteries Health New Zealand; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Agency for Science, Technology and Innovation	This work was funded by the Cleveland Clinic Foundation (www.clevelandclinic.org), the Heart Foundation of New Zealand (www.heartfoundation.org.nz), the New Zealand Foundation of Research, Science and Technology (now the Ministry of Science and Innovation, www.msi.govt.nz), the Health Research Council of New Zealand (www.hrc.govt.nz), the Maurice and Phyllis Paykel Trust (www.paykeltrust.co.nz), Lotteries Health New Zealand (www.dia.govt.nz/Services-Lottery-Grants-Health-Research), the Swedish Research Council (www.vr.se), the Swedish Heart-Lung Foundation (www.hjart-lungfonden.se), the European Commission (www.ec.europa.eu), the Danish Agency for Science, Technology and Innovation (en.fi.dk) and a donation by Fredrik Lundberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah KG, 2008, ANN HUM GENET, V72, P654, DOI 10.1111/j.1469-1809.2008.00454.x; Almontashiri N, 2011, AM HEART ASS SCI SES; Assimes TL, 2008, HUM MOL GENET, V17, P2320, DOI 10.1093/hmg/ddn132; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Brautbar A, 2009, CIRC-CARDIOVASC GENE, V2, P279, DOI 10.1161/CIRCGENETICS.108.817338; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen JY, 2007, CLIN CANCER RES, V13, P3100, DOI 10.1158/1078-0432.CCR-06-2319; Chen M, 2002, CIRCULATION, V106, P2707, DOI 10.1161/01.CIR.0000038706.30661.86; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cunnington MS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000899; Debniak T, 2005, J MED GENET, V42, P763, DOI 10.1136/jmg.2005.031476; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Driver KE, 2008, CARCINOGENESIS, V29, P333, DOI 10.1093/carcin/bgm284; Ellmers LJ, 2007, J MOL ENDOCRINOL, V38, P245, DOI 10.1677/jme.1.02138; Folkersen L, 2010, CIRC-CARDIOVASC GENE, V3, P365, DOI 10.1161/CIRCGENETICS.110.948935; Folkersen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007677; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Gayther SA, 2007, CANCER RES, V67, P3027, DOI 10.1158/0008-5472.CAN-06-3261; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gschwendtner A, 2009, ANN NEUROL, V65, P531, DOI 10.1002/ana.21590; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Healy J, 2007, BLOOD, V109, P683, DOI 10.1182/blood-2006-02-003236; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hinohara K, 2008, J HUM GENET, V53, P357, DOI 10.1007/s10038-008-0248-4; Holdt LM, 2010, ARTERIOSCL THROM VAS, V30, P620, DOI 10.1161/ATVBAHA.109.196832; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Isumi Y, 2011, BIOCHEM BIOPH RES CO, V405, P216, DOI 10.1016/j.bbrc.2011.01.012; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Kumar R, 2001, INT J CANCER, V95, P388, DOI 10.1002/1097-0215(20011120)95:6<388::AID-IJC1069>3.0.CO;2-6; Larson MG, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S5; Liu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005027; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Matarin M, 2008, STROKE, V39, P1586, DOI 10.1161/STROKEAHA.107.502963; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Melzer D, 2007, MECH AGEING DEV, V128, P370, DOI 10.1016/j.mad.2007.03.005; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Pilbrow AP, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-64; Robinson MD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-449; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shen GQ, 2008, J HUM GENET, V53, P144, DOI 10.1007/s10038-007-0230-6; Shen GQ, 2008, ARTERIOSCL THROM VAS, V28, P360, DOI 10.1161/ATVBAHA.107.157248; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Talmud PJ, 2008, CLIN CHEM, V54, P467, DOI 10.1373/clinchem.2007.095489; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	59	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39574	10.1371/journal.pone.0039574	http://dx.doi.org/10.1371/journal.pone.0039574			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768093	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100063
J	Song, JP; Sun, RJ; Li, DZ; Tan, FJ; Li, X; Jiang, PP; Huang, XJ; Lin, L; Deng, ZI; Zhang, Y				Song, Jiaping; Sun, Renjie; Li, Dazhi; Tan, Fengji; Li, Xin; Jiang, Pingping; Huang, Xinjie; Lin, Liang; Deng, Ziniu; Zhang, Yong			An Improvement of Shotgun Proteomics Analysis by Adding Next-Generation Sequencing Transcriptome Data in Orange	PLOS ONE			English	Article							PROTEIN; IDENTIFICATION; MAP	Background: Shotgun proteomics data analysis usually relies on database search. Because commonly employed protein sequence databases of most species do not contain sufficient protein information, the application of shotgun proteomics to the research of protein sequence profile remains a big challenge, especially to the species whose genome has not been sequenced yet. Methodology/Principal Findings: In this paper, we present a workflow with integrated database to partly address this problem. First, we downloaded the homologous species database. Next, we identified the transcriptome of the sample, created a protein sequence database based on the transcriptome data, and integtrated it with homologous species database. Lastly, we developed a workflow for identifying peptides simultaneously from shotgun proteomics data. Conclusions/Significance: We used datasets from orange leaves samples to demonstrate our workflow. The results showed that the integrated database had great advantage on orange shotgun proteomics data analysis compared to the homologous species database, an 18.5% increase in number of proteins identification.	[Song, Jiaping; Sun, Renjie; Tan, Fengji; Li, Xin; Jiang, Pingping; Huang, Xinjie; Lin, Liang; Zhang, Yong] BGI Shenzhen, Shenzhen Proteome Engn Lab, Shenzhen, Peoples R China; [Li, Dazhi; Deng, Ziniu] Hunan Agr Univ, Natl Ctr Citrus Improvement, Changsha, Hunan, Peoples R China	Beijing Genomics Institute (BGI); Hunan Agricultural University	Song, JP (corresponding author), BGI Shenzhen, Shenzhen Proteome Engn Lab, Shenzhen, Peoples R China.	zhangy@genomics.org.cn						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Brechenmacher L, 2009, PLANT PHYSIOL, V149, P670, DOI 10.1104/pp.108.131649; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; Hughes MA, 2006, J PROTEOME RES, V5, P54, DOI 10.1021/pr050248t; Katz E, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-68; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lucker J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-50; Ma W, 2010, J PROTEOME RES, V9, P2968, DOI 10.1021/pr901168v; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Shen Z, 2009, MOL CELL PROTEOMICS, V8, P2443, DOI 10.1074/mcp.M900187-MCP200; Sigdel TK, 2010, PROTEOM CLIN APPL, V4, P32, DOI 10.1002/prca.200900124; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	19	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39494	10.1371/journal.pone.0039494	http://dx.doi.org/10.1371/journal.pone.0039494			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768084	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100055
J	Wood, JR; Wilmshurst, JM; Wagstaff, SJ; Worthy, TH; Rawlence, NJ; Cooper, A				Wood, Jamie R.; Wilmshurst, Janet M.; Wagstaff, Steven J.; Worthy, Trevor H.; Rawlence, Nicolas J.; Cooper, Alan			High-Resolution Coproecology: Using Coprolites to Reconstruct the Habits and Habitats of New Zealand's Extinct Upland Moa (Megalapteryx didinus)	PLOS ONE			English	Article							CLOVIS HUMAN COPROLITES; ANCIENT DNA; SOUTH ISLAND; HOLOCENE VEGETATION; POLLEN CONTENT; DIET; ECOLOGY; CLIMATE; RATITE; AVES	Knowledge about the diet and ecology of extinct herbivores has important implications for understanding the evolution of plant defence structures, establishing the influences of herbivory on past plant community structure and composition, and identifying pollination and seed dispersal syndromes. The flightless ratite moa (Aves: Dinornithiformes) were New Zealand's largest herbivores prior to their extinction soon after initial human settlement. Here we contribute to the knowledge of moa diet and ecology by reporting the results of a multidisciplinary study of 35 coprolites from a subalpine cave (Euphrates Cave) on the South Island of New Zealand. Ancient DNA analysis and radiocarbon dating revealed the coprolites were deposited by the extinct upland moa (Megalapteryx didinus), and span from at least 6,368 +/- 31 until 694 +/- 30 C-14 years BP; the approximate time of their extinction. Using pollen, plant macrofossil, and ancient DNA analyses, we identified at least 67 plant taxa from the coprolites, including the first evidence that moa fed on the nectar-rich flowers of New Zealand flax (Phormium) and tree fuchsia (Fuchsia excorticata). The plant assemblage from the coprolites reflects a highly-generalist feeding ecology for upland moa, including browsing and grazing across the full range of locally available habitats (spanning southern beech (Nothofagus) forest to tussock (Chionochloa) grassland). Intact seeds in the coprolites indicate that upland moa may have been important dispersal agents for several plant taxa. Plant taxa with putative anti-browse adaptations were also identified in the coprolites. Clusters of coprolites (based on pollen assemblages, moa haplotypes, and radiocarbon dates), probably reflect specimens deposited at the same time by individual birds, and reveal the necessity of suitably large sample sizes in coprolite studies to overcome potential biases in diet interpretation.	[Wood, Jamie R.; Wilmshurst, Janet M.; Wagstaff, Steven J.] Landcare Res, Canterbury, New Zealand; [Worthy, Trevor H.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Rawlence, Nicolas J.; Cooper, Alan] Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Ancient DNA, Adelaide, SA, Australia	Landcare Research - New Zealand; University of New South Wales Sydney; University of Adelaide	Wood, JR (corresponding author), Landcare Res, Canterbury, New Zealand.	woodj@landcareresearch.co.nz	Wood, Jamie/A-9393-2008; Wilmshurst, Janet/O-8611-2019; Cooper, Alan/E-8171-2012; Wagstaff, Steven J./E-3847-2014; Wilmshurst, Janet M/C-2209-2009; Wood, Jamie/AAU-5530-2021; Worthy, Trevor/B-3781-2012	Wood, Jamie/0000-0001-8008-6083; Wilmshurst, Janet/0000-0002-4474-8569; Cooper, Alan/0000-0002-7738-7851; Wagstaff, Steven J./0000-0002-9066-8869; Wilmshurst, Janet M/0000-0002-4474-8569; Worthy, Trevor/0000-0001-7047-4680	Royal Society of New Zealand [08-LCR-012]	Royal Society of New Zealand(Royal Society of New Zealand)	This research was funded by the Royal Society of New Zealand Marsden Fund (08-LCR-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allentoft ME, 2012, ANN ANAT, V194, P36, DOI 10.1016/j.aanat.2011.04.002; Alloway BV, 2007, J QUATERNARY SCI, V22, P9, DOI 10.1002/jqs.1079; Antonelli A., 2010, P ROYAL SOC B, V278, P662; ATKINSON IAE, 1989, NEW ZEAL J ECOL, V12, P67; Baker AJ, 2005, P NATL ACAD SCI USA, V102, P8257, DOI 10.1073/pnas.0409435102; BATCHELER CL, 1989, NEW ZEAL J ECOL, V12, P57; Bengtsson L, 1986, HDB HOLOCENE PALAEOE, P423, DOI DOI 10.1016/0277-3791(85)90013-7; Bjune AE, 2005, GRANA, V44, P45, DOI 10.1080/00173130410005564; Bond WJ, 2004, OIKOS, V104, P500, DOI 10.1111/j.0030-1299.2004.12720.x; Bunce M, 2009, P NATL ACAD SCI USA, V106, P20646, DOI 10.1073/pnas.0906660106; BURROWS C J, 1981, Records of the Canterbury Museum, V9, P309; Cochrane CH, 2003, NEW ZEAL J ECOL, V27, P61; Cooper A, 2000, SCIENCE, V289, P1139; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; Day JS, 1998, NEW ZEAL J ECOL, V22, P43; DRUCE AP, 1987, NEW ZEAL J BOT, V25, P41, DOI 10.1080/0028825X.1987.10409956; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eisen M, 1998, GENE CLUSTER; Flannery TF, 1990, FUTURE EATERS ECOLOG; Forsyth DM, 2010, NEW ZEAL J ECOL, V34, P48; Forsyth DM, 2002, NEW ZEAL J ZOOL, V29, P323, DOI 10.1080/03014223.2002.9518316; Gilbert MTP, 2008, SCIENCE, V320, P786, DOI 10.1126/science.1154116; Gill B.J., 2010, CHECKLIST BIRDS NZ N, V4th edition; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; GREGG D, 1972, Records of the Canterbury Museum, V9, P151; Hansen DM, 2009, SCIENCE, V324, P42, DOI 10.1126/science.1172393; Hester Alison J., 2006, Conservation Biology Series (Cambridge), V11, P97; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; HOLECHEK JL, 1985, J RANGE MANAGE, V38, P350, DOI 10.2307/3899420; Horrocks M, 2004, EMU, V104, P149, DOI 10.1071/MU03019; Howell CJ, 2002, FUNCT ECOL, V16, P232, DOI 10.1046/j.1365-2435.2002.00613.x; Janis C.M., 1990, P241; JANZEN DH, 1982, SCIENCE, V215, P19, DOI 10.1126/science.215.4528.19; JANZEN DH, 1984, AM NAT, V123, P338, DOI 10.1086/284208; Johnson CN, 2009, P ROY SOC B-BIOL SCI, V276, P2509, DOI 10.1098/rspb.2008.1921; Jorgensen T, 2012, MOL ECOL, V21, P1989, DOI 10.1111/j.1365-294X.2011.05287.x; Kelso GK, 2006, PALAEOGEOGR PALAEOCL, V237, P80, DOI 10.1016/j.palaeo.2005.11.036; Koch PL, 1998, CHEM GEOL, V152, P119, DOI 10.1016/S0009-2541(98)00101-6; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lee WG, 2010, NEW ZEAL J ECOL, V34, P28; MacFadden BJ, 1997, PALEOBIOLOGY, V23, P77, DOI 10.1017/S0094837300016651; McCormac FG, 2004, RADIOCARBON, V46, P1087, DOI 10.1017/S0033822200033014; McGlone M.S., 1993, Tuatara, V32, P1; McGlone MS, 2004, QUATERNARY RES, V62, P267, DOI 10.1016/j.yqres.2004.09.003; McGlone MS, 1999, J QUATERNARY SCI, V14, P239, DOI 10.1002/(SICI)1099-1417(199905)14:3<239::AID-JQS438>3.0.CO;2-9; MILLS JA, 1977, J ANIM ECOL, V46, P939, DOI 10.2307/3651; Moar NT, 2011, NEW ZEAL J BOT, V49, P201, DOI 10.1080/0028825X.2010.526617; Poinar H, 2009, SCIENCE, V325, DOI [10.1126/science.1167531, 10.1126/science.1168182]; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Pollock ML, 2007, NEW ZEAL J ECOL, V31, P68; Rambaut A, 2010, FIGTREE V131; Rambaut A., 2007, TRACER V1 5; Rambaut A, 2009, MOL BIOL EVOL, V26, P245, DOI 10.1093/molbev/msn256; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rawlence NJ, 2011, J ROY SOC NEW ZEAL, V41, P217, DOI 10.1080/03036758.2011.559663; Rawlence NJ, 2009, P ROY SOC B-BIOL SCI, V276, P3395, DOI 10.1098/rspb.2009.0755; Rowe P, 1994, NZ SPELEOL B, V9, P271; Rule S, 2012, SCIENCE, V335, P1483, DOI 10.1126/science.1214261; Shulmeister J, 2003, NEW ZEAL J BOT, V41, P503, DOI 10.1080/0028825X.2003.9512867; SLATER J, 1971, J AUST I AGR SCI, V37, P238; STEVENS EJ, 1987, J RANGE MANAGE, V40, P187, DOI 10.2307/3899218; Tennyson A.J.D., 2006, EXTINCT BIRDS NZ; Urlich SC, 2005, NEW ZEAL J ECOL, V29, P299; Webb C. J., 2001, SEEDS NZ GYMNOSPERMS; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Wilmshurst J. M., 2003, Science for Conservation; Wilmshurst JM, 2002, J QUATERNARY SCI, V17, P653, DOI 10.1002/jqs.689; Wood Jamie R., 2007, Records of the Canterbury Museum, V21, P27; Wood JR, 2012, NEW ZEAL J ECOL, V36, P164; Wood JR, 2008, QUATERNARY SCI REV, V27, P2593, DOI 10.1016/j.quascirev.2008.09.019; Wood JR, 2008, THESIS U OTAGO DUNED; WORTHY TH, 2002, LOST WORLD MOA	73	69	71	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40025	10.1371/journal.pone.0040025	http://dx.doi.org/10.1371/journal.pone.0040025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768206	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100178
J	Zhan, HY; Moore, CS; Chen, BJ; Zhou, X; Ma, XM; Ijichi, K; Bennett, MVL; Li, XJ; Crocker, SJ; Wang, ZW				Zhan, Haiying; Moore, Craig S.; Chen, Bojun; Zhou, Xin; Ma, Xin-Ming; Ijichi, Kumiko; Bennett, Michael V. L.; Li, Xue-Jun; Crocker, Stephen J.; Wang, Zhao-Wen			Stomatin Inhibits Pannexin-1-Mediated Whole-Cell Currents by Interacting with Its Carboxyl Terminal	PLOS ONE			English	Article							GAP-JUNCTION HEMICHANNELS; CAENORHABDITIS-ELEGANS; PANNEXIN 1; ATP RELEASE; VOLATILE ANESTHETICS; GENETIC-ANALYSIS; NERVOUS-SYSTEM; ION CHANNELS; ACTIVATION; SENSITIVITY	The pannexin-1 (Panx1) channel (often referred to as the Panx1 hemichannel) is a large-conductance channel in the plasma membrane of many mammalian cells. While opening of the channel is potentially detrimental to the cell, little is known about how it is regulated under physiological conditions. Here we show that stomatin inhibited Panx1 channel activity. In transfected HEK-293 cells, stomatin reduced Panx1-mediated whole-cell currents without altering either the total or membrane surface Panx1 protein expression. Stomatin coimmunoprecipitated with full-length Panx1 as well as a Panx1 fragment containing the fourth membrane-spanning domain and the cytosolic carboxyl terminal. The inhibitory effect of stomatin on Panx1-mediated whole-cell currents was abolished by truncating Panx1 at a site in the cytosolic carboxyl terminal. In primary culture of mouse astrocytes, inhibition of endogenous stomatin expression by small interfering RNA enhanced Panx1-mediated outward whole-cell currents. These observations suggest that stomatin may play important roles in astrocytes and other cells by interacting with Panx1 carboxyl terminal to limit channel opening.	[Zhan, Haiying; Moore, Craig S.; Chen, Bojun; Ma, Xin-Ming; Ijichi, Kumiko; Li, Xue-Jun; Crocker, Stephen J.; Wang, Zhao-Wen] Univ Connecticut Hlth Ctr, Dept Neurosci, Farmington, CT 06032 USA; [Zhou, Xin] Univ Connecticut Hlth Ctr, Ctr Aging, Farmington, CT USA; [Bennett, Michael V. L.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA	University of Connecticut; University of Connecticut; Yeshiva University; Albert Einstein College of Medicine	Zhan, HY (corresponding author), Univ Connecticut Hlth Ctr, Dept Neurosci, Farmington, CT 06032 USA.	zwwang@uchc.edu	Moore, Craig/I-9205-2014	Moore, Craig/0000-0003-3333-435X; LI, XUEJUN/0000-0003-1899-9134	National Institutes of Health [5R01GM083049, 1R01MH085927]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health (5R01GM083049, ZWW and 1R01MH085927) (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; BRENNER S, 1974, GENETICS, V77, P71; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Bunse S, 2009, FEBS J, V276, P6258, DOI 10.1111/j.1742-4658.2009.07334.x; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen BJ, 2007, CURR BIOL, V17, P1334, DOI 10.1016/j.cub.2007.06.060; Dando R, 2009, J PHYSIOL-LONDON, V587, P5899, DOI 10.1113/jphysiol.2009.180083; DAVIDSON JS, 1988, J PHARMACOL EXP THER, V246, P1104; GALLAGHER PG, 1995, J BIOL CHEM, V270, P26358, DOI 10.1074/jbc.270.44.26358; Garre JM, 2010, P NATL ACAD SCI US; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Huang Y, 2007, GLIA, V55, P46, DOI 10.1002/glia.20435; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Iwabuchi S, 2011, NEUROCHEM INT, V58, P376, DOI 10.1016/j.neuint.2010.12.013; Kim JE, 2011, J CLIN INVEST, V121, P2037, DOI 10.1172/JCI44818; Lapatsina L, 2011, EUR J CELL BIOL; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Mairhofer M, 2009, J BIOL CHEM, V284, P29218, DOI 10.1074/jbc.M109.014993; Mannsfeldt AG, 1999, MOL CELL NEUROSCI, V13, P391, DOI 10.1006/mcne.1999.0761; Montel-Hagen A, 2008, CELL, V132, P1039, DOI 10.1016/j.cell.2008.01.042; MORGAN PG, 1990, P NATL ACAD SCI USA, V87, P2965, DOI 10.1073/pnas.87.8.2965; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; PARK EC, 1986, GENETICS, V113, P821; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Price MP, 2004, J BIOL CHEM, V279, P53886, DOI 10.1074/jbc.M407708200; Qiu F, 2011, PURINERGIC SIGNAL; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Rajaram S, 1998, P NATL ACAD SCI USA, V95, P8761, DOI 10.1073/pnas.95.15.8761; Ray A, 2005, EUR J NEUROSCI, V21, P3277, DOI 10.1111/j.1460-9568.2005.04139.x; SEDENSKY MM, 1987, SCIENCE, V236, P952, DOI 10.1126/science.3576211; Sedensky MM, 2001, AM J PHYSIOL-CELL PH, V280, pC1340, DOI 10.1152/ajpcell.2001.280.5.C1340; Shestopalov VI, 2008, CELL MOL LIFE SCI, V65, P376, DOI 10.1007/s00018-007-7200-1; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Sridharan M, 2010, AM J PHYSIOL-HEART C, V299, pH1146, DOI 10.1152/ajpheart.00301.2010; STARICH TA, 1993, GENETICS, V133, P527; STEWART GW, 1993, BIOCHIM BIOPHYS ACTA, V1225, P15, DOI 10.1016/0925-4439(93)90116-I; STEWART GW, 2003, NEPHRON PHYSIOL, V93, P29; Suadicani SO, 2012, GLIA; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; VEENSTRA RD, 1995, CIRC RES, V77, P1156, DOI 10.1161/01.RES.77.6.1156; Veenstra RD, 1996, J BIOENERG BIOMEMBR, V28, P327, DOI 10.1007/BF02110109; Wang Y, 2011, J NEUROCHEM, V116, P374, DOI 10.1111/j.1471-4159.2010.07117.x; Weber PA, 2004, BIOPHYS J, V87, P958, DOI 10.1529/biophysj.103.036350; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; Woehrle T, 2010, BLOOD, V116, P3475, DOI 10.1182/blood-2010-04-277707	52	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39489	10.1371/journal.pone.0039489	http://dx.doi.org/10.1371/journal.pone.0039489			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768083	Green Submitted, gold, Green Published			2022-12-27	WOS:000305892100054
J	Zhang, ZH; Ma, XT; Zhang, MQ				Zhang, Zhihua; Ma, Xiaotu; Zhang, Michael Q.			Bivalent-Like Chromatin Markers Are Predictive for Transcription Start Site Distribution in Human	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; NUCLEOSOME ORGANIZATION; HUMAN-CELLS; IN-VIVO; DNA HYPERMETHYLATION; SILENT CHROMATIN; HISTONE H4; CHIP-SEQ; INITIATION; PROMOTERS	Deep sequencing of 5' capped transcripts has revealed a variety of transcription initiation patterns, from narrow, focused promoters to wide, broad promoters. Attempts have already been made to model empirically classified patterns, but virtually no quantitative models for transcription initiation have been reported. Even though both genetic and epigenetic elements have been associated with such patterns, the organization of regulatory elements is largely unknown. Here, linear regression models were derived from a pool of regulatory elements, including genomic DNA features, nucleosome organization, and histone modifications, to predict the distribution of transcription start sites (TSS). Importantly, models including both active and repressive histone modification markers, e. g. H3K4me3 and H4K20me1, were consistently found to be much more predictive than models with only single-type histone modification markers, indicating the possibility of "bivalent-like" epigenetic control of transcription initiation. The nucleosome positions are proposed to be coded in the active component of such bivalent-like histone modification markers. Finally, we demonstrated that models trained on one cell type could successfully predict TSS distribution in other cell types, suggesting that these models may have a broader application range.	[Zhang, Zhihua; Ma, Xiaotu; Zhang, Michael Q.] Univ Texas Dallas, Ctr Syst Biol, Dept Mol Cell Biol, Richardson, TX 75083 USA; [Zhang, Zhihua] Chinese Acad Sci, Beijing Inst Genom, Ctr Computat Biol, Beijing, Peoples R China; [Zhang, Zhihua] Chinese Acad Sci, Beijing Inst Genom, Lab Dis Genom & Personalized Med, Beijing, Peoples R China; [Zhang, Michael Q.] Tsinghua Univ, TNLIST, Ctr Synthet & Syst Biol, Bioinformat Div, Beijing 100084, Peoples R China	University of Texas System; University of Texas Dallas; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Tsinghua University	Zhang, ZH (corresponding author), Univ Texas Dallas, Ctr Syst Biol, Dept Mol Cell Biol, Richardson, TX 75083 USA.	michael.zhang@utdallas.edu			National Institutes of Health [HG001696]; National Natural Science Foundation of China [91131012]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001696] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by a National Institutes of Health R01 grant (HG001696) to MQZ (http://www.ncbi.nlm.nih.gov) and a National Natural Science Foundation of China grant (91131012) to ZZ (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allis CD., 2007, EPIGENETICS 2007 COL; Antos A, 2001, RANDOM STRUCT ALGOR, V19, P163, DOI 10.1002/rsa.10019; Balakrishnan L, 2010, CRIT REV BIOCHEM MOL, V45, P440, DOI 10.3109/10409238.2010.504700; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cayrou C, 2010, CHROMOSOME RES, V18, P137, DOI 10.1007/s10577-009-9105-3; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Jensen ST, 2008, J AM STAT ASSOC, V103, P188, DOI 10.1198/016214507000000365; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kawaji H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r118; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Koh KM, 2007, J MACH LEARN RES, V8, P1519; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Megraw M, 2009, GENOME RES, V19, P644, DOI 10.1101/gr.085449.108; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Rach EA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001274; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sanz LA, 2008, EMBO J, V27, P2523, DOI 10.1038/emboj.2008.142; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schones DE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-19; Schurmann T, 2004, J PHYS A-MATH GEN, V37, pL295, DOI 10.1088/0305-4470/37/27/L02; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Sims JK, 2006, J BIOL CHEM, V281, P12760, DOI 10.1074/jbc.M513462200; Spektor TM, 2009, P NATL ACAD SCI USA, V106, P14808, DOI 10.1073/pnas.0907799106; Sun JL, 2010, J BIOL CHEM, V285, P6443, DOI 10.1074/jbc.M109.084285; Svejstrup JQ, 2004, BBA-GENE STRUCT EXPR, V1677, P64, DOI 10.1016/j.bbaexp.2003.10.012; Valen E, 2009, GENOME RES, V19, P255, DOI 10.1101/gr.084541.108; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Wang XW, 2009, GENOME RES, V19, P266, DOI 10.1101/gr.081638.108; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Xu H, 2010, BIOINFORMATICS, V26, P1199, DOI 10.1093/bioinformatics/btq128; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-537; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508; Zhang ZH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-155	53	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38112	10.1371/journal.pone.0038112	http://dx.doi.org/10.1371/journal.pone.0038112			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768038	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100009
J	Preobrazhenska, O; Wright, JL; Churg, A				Preobrazhenska, Olena; Wright, Joanne L.; Churg, Andrew			Regional Heterogeneity in Murine Lung Fibroblasts from Normal Mice or Mice Exposed Once to Cigarette Smoke	PLOS ONE			English	Article							TGF-BETA; EXPRESSION; DECORIN; EMPHYSEMA; DIFFERENTIATION; SURVIVAL; DISEASE	Chronic obstructive lung disease (COPD) is characterized by matrix deposition in the small airways but matrix loss from the parenchyma, phenomena which must depend on the ability of local fibroblasts to produce matrix after smoke exposure. To investigate this idea, we exposed C57Bl/6 mice once to cigarette smoke or to air (control) and prepared primary cultures of lung fibroblasts by microdissecting large airways (trachea, LAF), medium size airways (major bronchi, MAF) and parenchyma (PF). Control PF showed the lowest rate of wound closure and wound closure was depressed in all lines by a single in vivo smoke exposure. Gene expression of matrix proteins differed considerably among the sites; decorin, which may sequester TGF beta, was markedly higher in PF. PF showed higher intrinsic ratios of pSmad2/Smad2. Smoke caused much greater increases in secreted and matrix deposited collagens 1 and 3 in PF than in LAF or MAF. Expression of Thy-1, a gene that suppresses myofibroblast differentiation, was increased by smoke in PF. We conclude that there is considerable regional heterogeneity in murine lung fibroblasts in terms of matrix production, either basally or after in vivo smoke exposure; that PF have lower ability to repair wounds and higher intrinsic TGF beta signaling; and that a single exposure to smoke produces lasting changes in the pattern of matrix production and wound repair, changes that may be mediated in part by smoke-induced release of TGF beta. However, PF still retain the ability to repair by producing new matrix after a single in vivo smoke exposure.	[Preobrazhenska, Olena; Wright, Joanne L.; Churg, Andrew] Univ British Columbia, Dept Pathol, Vancouver, BC, Canada	University of British Columbia	Preobrazhenska, O (corresponding author), Univ British Columbia, Dept Pathol, Vancouver, BC, Canada.	achurg@interchange.ubc.ca			Canadian Institutes of Health Research [42539]; AstraZeneca RD	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); AstraZeneca RD(AstraZeneca)	Supported in part by grant 42539 from the Canadian Institutes of Health Research. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AC and JLW have received grants from AstraZeneca R&D, but they were not specific to this particular study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Churg A, 2003, AM J RESP CRIT CARE, V168, P199, DOI 10.1164/rccm.200302-203OC; HAUSSER H, 1994, FEBS LETT, V353, P243, DOI 10.1016/0014-5793(94)01044-7; Kis K, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001967; Koenders MMJF, 2009, J PATHOL, V218, P446, DOI 10.1002/path.2548; Kolb M, 2001, AM J PHYSIOL-LUNG C, V280, pL1327, DOI 10.1152/ajplung.2001.280.6.L1327; Kolb M, 2001, AM J RESP CRIT CARE, V163, P770, DOI 10.1164/ajrccm.163.3.2006084; Kotaru C, 2006, AM J RESP CRIT CARE, V173, P1208, DOI 10.1164/rccm.200508-1218OC; Markmann A, 2000, MATRIX BIOL, V19, P631, DOI 10.1016/S0945-053X(00)00097-4; Nihlberg K, 2010, THORAX, V65, P670, DOI 10.1136/thx.2009.129320; Noordhoek Jacobien A, 2005, COPD, V2, P17; Pechkovsky DV, 2010, AM J RESP CELL MOL, V43, P641, DOI 10.1165/rcmb.2009-0318OC; Rennard Stephen I, 2011, Proc Am Thorac Soc, V8, P368, DOI 10.1513/pats.201102-019RM; Robbesom AA, 2008, MODERN PATHOL, V21, P297, DOI 10.1038/modpathol.3801004; Sanders YY, 2008, AM J RESP CELL MOL, V39, P610, DOI 10.1165/rcmb.2007-0322OC; Sanders YY, 2007, AM J RESP CELL MOL, V36, P226, DOI 10.1165/rcmb.2006-0178OC; Sugiura H, 2007, AM J RESP CELL MOL, V37, P424, DOI 10.1165/rcmb.2007-0089OC; Wang RD, 2005, AM J RESP CELL MOL, V33, P387, DOI 10.1165/rcmb.2005-0203OC; Zhou XX, 2011, AM J RESP CELL MOL, V45, P1256, DOI 10.1165/rcmb.2011-0065OC	18	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39761	10.1371/journal.pone.0039761	http://dx.doi.org/10.1371/journal.pone.0039761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761892	Green Published, Green Submitted, gold			2022-12-27	WOS:000305826400037
J	Salazar, E; Bank, EM; Ramsey, N; Hess, KC; Deitsch, KW; Levin, LR; Buck, J				Salazar, Eric; Bank, Erin M.; Ramsey, Nicole; Hess, Kenneth C.; Deitsch, Kirk W.; Levin, Lonny R.; Buck, Jochen			Characterization of Plasmodium falciparum Adenylyl Cyclase-beta and Its Role in Erythrocytic Stage Parasites	PLOS ONE			English	Article							MALARIA PARASITE; V-ATPASE; CYCLIC-AMP; BICARBONATE; PH; CALCIUM; EXPRESSION; EXTRUSION; SENSOR; DIFFER	The most severe form of human malaria is caused by the parasite Plasmodium falciparum. The second messenger cAMP has been shown to be important for the parasite's ability to infect the host's liver, but its role during parasite growth inside erythrocytes, the stage responsible for symptomatic malaria, is less clear. The P. falciparum genome encodes two adenylyl cyclases, the enzymes that synthesize cAMP, PfAC alpha and PfAC beta. We now show that one of these, PfAC beta, plays an important role during the erythrocytic stage of the P. falciparum life cycle. Biochemical characterization of PfAC beta revealed a marked pH dependence, and sensitivity to a number of small molecule inhibitors. These inhibitors kill parasites growing inside red blood cells. One particular inhibitor is selective for PfAC beta relative to its human ortholog, soluble adenylyl cyclase (sAC); thus, PfAC beta represents a potential target for development of safe and effective antimalarial therapeutics.	[Salazar, Eric; Ramsey, Nicole] Cornell Univ, Weill Med Coll, Triinst MD PhD Program, New York, NY 10021 USA; [Salazar, Eric; Bank, Erin M.; Ramsey, Nicole; Hess, Kenneth C.; Deitsch, Kirk W.; Levin, Lonny R.; Buck, Jochen] Cornell Univ, Grad Sch Med Sci, New York, NY 10021 USA; [Salazar, Eric; Bank, Erin M.; Ramsey, Nicole; Hess, Kenneth C.; Levin, Lonny R.; Buck, Jochen] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Deitsch, Kirk W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University; Cornell University	Salazar, E (corresponding author), Cornell Univ, Weill Med Coll, Triinst MD PhD Program, New York, NY 10021 USA.	llevin@med.cornell.edu	Hess, Kenneth/K-6546-2019	Hess, Kenneth/0000-0003-1377-6070; Levin, Lonny/0000-0002-5204-6356	National Institutes of Health [AI064842, AI052390]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064842, R01AI052390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM073546, T32GM007739, R01GM062328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health to LRL & JB (AI064842) and to KWD (AI052390). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; ALEY SB, 1984, J EXP MED, V160, P1585, DOI 10.1084/jem.160.5.1585; Beraldo FH, 2005, J CELL BIOL, V170, P551, DOI 10.1083/jcb.200505117; Boron WF, 2010, BBA-PROTEINS PROTEOM, V1804, P410, DOI 10.1016/j.bbapap.2009.10.021; BOSIA A, 1993, J CELL PHYSIOL, V154, P527, DOI 10.1002/jcp.1041540311; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; BRAUN T, 1975, P NATL ACAD SCI USA, V72, P1097, DOI 10.1073/pnas.72.3.1097; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Cann MJ, 2003, J BIOL CHEM, V278, P35033, DOI 10.1074/jbc.M303025200; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Epp C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-86; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Jaiswal BS, 2003, P NATL ACAD SCI USA, V100, P10676, DOI 10.1073/pnas.1831008100; JENSEN MD, 1983, J PARASITOL, V69, P1060, DOI 10.2307/3280864; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Kobayashi M, 2004, DEV GENES EVOL, V214, P503, DOI 10.1007/s00427-004-0432-2; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lee YS, 2011, J BIOL CHEM, V286, P41353, DOI 10.1074/jbc.M111.284679; Linder JU, 2003, CELL SIGNAL, V15, P1081, DOI 10.1016/S0898-6568(03)00130-X; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Merckx A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040019; Muhia DK, 2003, J BIOL CHEM, V278, P22014, DOI 10.1074/jbc.M301639200; Ono T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000008; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; Paunescu TG, 2008, AM J PHYSIOL-RENAL, V294, pF130, DOI 10.1152/ajprenal.00406.2007; Paunescu TG, 2010, AM J PHYSIOL-RENAL, V298, pF643, DOI 10.1152/ajprenal.00584.2009; READ LK, 1991, MOL BIOCHEM PARASIT, V45, P109, DOI 10.1016/0166-6851(91)90032-2; Saliba KJ, 1999, J BIOL CHEM, V274, P33213, DOI 10.1074/jbc.274.47.33213; Salomon Y, 1979, Adv Cyclic Nucleotide Res, V10, P35; Schmid A, 2007, J GEN PHYSIOL, V130, P99, DOI 10.1085/jgp.200709784; Steegborn C, 2005, J BIOL CHEM, V280, P31754, DOI 10.1074/jbc.M507144200; Stessin AM, 2006, J BIOL CHEM, V281, P17253, DOI 10.1074/jbc.M603500200; Syin C, 2001, EUR J BIOCHEM, V268, P4842, DOI 10.1046/j.1432-1327.2001.02403.x; Taussig Ronald, 2003, V237, P77; Tresguerres M, 2011, KIDNEY INT, V79, P1277, DOI 10.1038/ki.2011.95; Tresguerres M, 2010, PFLUG ARCH EUR J PHY, V460, P953, DOI 10.1007/s00424-010-0865-6; Tresguerres M, 2010, AM J PHYSIOL-REG I, V299, pR62, DOI 10.1152/ajpregu.00761.2009; Tresguerres M, 2010, P NATL ACAD SCI USA, V107, P442, DOI 10.1073/pnas.0911790107; Weber JH, 2004, CELL SIGNAL, V16, P115, DOI 10.1016/S0898-6568(03)00129-3; Wu KY, 2006, NAT NEUROSCI, V9, P1257, DOI 10.1038/nn1767; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973	46	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39769	10.1371/journal.pone.0039769	http://dx.doi.org/10.1371/journal.pone.0039769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761895	Green Published, gold			2022-12-27	WOS:000305808700047
J	Liu, KN; Meng, HX; Hou, JX				Liu, Kaining; Meng, Huanxin; Hou, Jianxia			Characterization of the Autocrine/Paracrine Function of Vitamin D in Human Gingival Fibroblasts and Periodontal Ligament Cells	PLOS ONE			English	Article							D HYDROXYLASE EXPRESSION; D ENDOCRINE SYSTEM; AGGRESSIVE PERIODONTITIS; 25-HYDROXYVITAMIN D-3; SERUM CONCENTRATIONS; PARATHYROID-HORMONE; MEDIATED INDUCTION; GENE-EXPRESSION; D-RECEPTOR; IN-VITRO	Background: We previously demonstrated that 25-hydroxyvitamin D-3, the precursor of 1 alpha,25-dihydroxyvitamin D-3, is abundant around periodontal soft tissues. Here we investigate whether 25-hydroxyvitamin D-3 is converted to 1 alpha,25-dihydroxyvitamin D-3 in periodontal soft tissue cells and explore the possibility of an autocrine/paracrine function of 1 alpha,25-dihydroxyvitamin D-3 in periodontal soft tissue cells. Methodology/Principal Findings: We established primary cultures of human gingival fibroblasts and human periodontal ligament cells from 5 individual donors. We demonstrated that 1 alpha-hydroxylase was expressed in human gingival fibroblasts and periodontal ligament cells, as was cubilin. After incubation with the 1 alpha-hydroxylase substrate 25-hydroxyvitamin D-3, human gingival fibroblasts and periodontal ligament cells generated detectable 1 alpha,25-dihydroxyvitamin D-3 that resulted in an up-regulation of CYP24A1 and RANKL mRNA. A specific knockdown of 1 alpha-hydroxylase in human gingival fibroblasts and periodontal ligament cells using siRNA resulted in a significant reduction in both 1 alpha, 25-dihydroxyvitamin D-3 production and mRNA expression of CYP24A1 and RANKL. The classical renal regulators of 1 alpha-hydroxylase (parathyroid hormone, calcium and 1 alpha,25-dihydroxyvitamin D-3) and Porphyromonas gingivalis lipopolysaccharide did not influence 1 alpha-hydroxylase expression significantly, however, interleukin-1 beta and sodium butyrate strongly induced 1 alpha-hydroxylase expression in human gingival fibroblasts and periodontal ligament cells. Conclusions/Significance: In this study, the expression, activity and functionality of 1 alpha-hydroxylase were detected in human gingival fibroblasts and periodontal ligament cells, raising the possibility that vitamin D acts in an autocrine/paracrine manner in these cells.	[Liu, Kaining] Peking Univ, Sch Stomatol, Dept Periodontol, Beijing 100871, Peoples R China; Peking Univ, Hosp Stomatol, Dept Periodontol, Beijing 100871, Peoples R China	Peking University; Peking University	Liu, KN (corresponding author), Peking Univ, Sch Stomatol, Dept Periodontol, Beijing 100871, Peoples R China.	kqhxmeng@bjmu.edu.cn	hou, joye/AAT-9545-2020		National Natural Science Foundations of China [30772420, 81100749]; Beijing Natural Science Foundation [7102164]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This research was funded by National Natural Science Foundations of China (http://www.nsfc.gov.cn/Portal0/default152.htm) (30772420, 81100749) and Beijing Natural Science Foundation (http://www.bjkw.gov.cn/n1143/n1240/n1465/n2276/index.html) (7102164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins GJ, 2007, BONE, V40, P1517, DOI 10.1016/j.bone.2007.02.024; Bashutski JD, 2011, J DENT RES, V90, P1007, DOI 10.1177/0022034511407771; Bland R, 1999, ENDOCRINOLOGY, V140, P2027, DOI 10.1210/en.140.5.2027; Bland R, 2001, KIDNEY INT, V60, P1277, DOI 10.1046/j.1523-1755.2001.00966.x; BOUILLON R, 1995, ENDOCR REV, V16, P200, DOI 10.1210/er.16.2.200; CHEN KS, 1995, BBA-GENE STRUCT EXPR, V1263, P1, DOI 10.1016/0167-4781(95)00060-T; Christakos S, 2003, J CELL BIOCHEM, V88, P695, DOI 10.1002/jcb.10423; Cross HS, 2007, NUTR REV, V65, pS108, DOI 10.1111/j.1753-4887.2007.tb00334.x; Dietrich T, 2005, AM J CLIN NUTR, V82, P575, DOI 10.1093/ajcn/82.3.575; Dietrich T, 2004, AM J CLIN NUTR, V80, P108; Fujiki R, 2005, EMBO J, V24, P3881, DOI 10.1038/sj.emboj.7600853; Garcia MN, 2011, J PERIODONTOL, V82, P25, DOI 10.1902/jop.2010.100207; HADDAD JG, 1995, J STEROID BIOCHEM, V53, P579, DOI 10.1016/0960-0760(95)00104-8; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; HENRY HL, 1985, ENDOCRINOLOGY, V116, P503, DOI 10.1210/endo-116-2-503; Hewison M, 2000, J MOL ENDOCRINOL, V25, P141, DOI 10.1677/jme.0.0250141; Huang DC, 2002, MOL CANCER RES, V1, P56; Ivanovski S, 2001, J PERIODONTAL RES, V36, P131, DOI 10.1034/j.1600-0765.2001.360301.x; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Khorchide M, 2005, J STEROID BIOCHEM, V93, P167, DOI 10.1016/j.jsbmb.2004.12.022; Kitazawa S, 2003, J CELL BIOCHEM, V89, P771, DOI 10.1002/jcb.10567; Kramer C, 2009, J STEROID BIOCHEM, V113, P9, DOI 10.1016/j.jsbmb.2008.10.010; Kurita-Ochiai T, 2002, INFECT IMMUN, V70, P2361, DOI 10.1128/IAI.70.5.2361-2367.2002; Lehmann B, 1997, J INVEST DERMATOL, V108, P78, DOI 10.1111/1523-1747.ep12285640; Li Qi-qiang, 2005, Zhonghua Kou Qiang Yi Xue Za Zhi, V40, P208; Liu KN, 2010, J PERIODONTOL, V81, P260, DOI 10.1902/jop.2009.090355; Liu KN, 2009, J PERIODONTOL, V80, P1114, DOI 10.1902/jop.2009.080675; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Rui-fang, 2008, Zhonghua Kou Qiang Yi Xue Za Zhi, V43, P664; McMahon L, 2011, INFECT IMMUN, V79, P2250, DOI 10.1128/IAI.00099-11; Murayama A, 2004, EMBO J, V23, P1598, DOI 10.1038/sj.emboj.7600157; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Nykjaer A, 2001, P NATL ACAD SCI USA, V98, P13895, DOI 10.1073/pnas.241516998; Overbergh L, 2006, J CLIN ENDOCR METAB, V91, P3566, DOI 10.1210/jc.2006-0678; Rachez C, 2000, GENE, V246, P9, DOI 10.1016/S0378-1119(00)00052-4; ROST CR, 1981, ENDOCRINOLOGY, V108, P1002, DOI 10.1210/endo-108-3-1002; SOMERMAN MJ, 1988, J DENT RES, V67, P66, DOI 10.1177/00220345880670011301; Takeyama K, 1997, SCIENCE, V277, P1827, DOI 10.1126/science.277.5333.1827; Tang X, 2008, J PERIODONTAL RES, V43, P311, DOI 10.1111/j.1600-0765.2007.01031.x; Tang XL, 2009, ARCH ORAL BIOL, V54, P625, DOI 10.1016/j.archoralbio.2009.04.009; van Driel M, 2006, FASEB J, V20, P2417, DOI 10.1096/fj.06-6374fje; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Xu Yan, 2006, Zhonghua Kou Qiang Yi Xue Za Zhi, V41, P743; Zhang MYH, 2002, ENDOCRINOLOGY, V143, P587, DOI 10.1210/en.143.2.587	44	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39878	10.1371/journal.pone.0039878	http://dx.doi.org/10.1371/journal.pone.0039878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761920	Green Published, Green Submitted, gold			2022-12-27	WOS:000305781700070
J	Dehmer, M; Grabner, M; Furtula, B				Dehmer, Matthias; Grabner, Martin; Furtula, Boris			Structural Discrimination of Networks by Using Distance, Degree and Eigenvalue-Based Measures	PLOS ONE			English	Article							INFORMATION; INDEXES; GRAPHS; COMPLEXITY	In chemistry and computational biology, structural graph descriptors have been proven essential for characterizing the structure of chemical and biological networks. It has also been demonstrated that they are useful to derive empirical models for structure-oriented drug design. However, from a more general (complex network-oriented) point of view, investigating mathematical properties of structural descriptors, such as their uniqueness and structural interpretation, is also important for an in-depth understanding of the underlying methods. In this paper, we emphasize the evaluation of the uniqueness of distance, degree and eigenvalue-based measures. Among these are measures that have been recently investigated extensively. We report numerical results using chemical and exhaustively generated graphs and also investigate correlations between the measures.	[Dehmer, Matthias; Grabner, Martin] UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria; [Furtula, Boris] Univ Kragujevac, Fac Sci, Kragujevac, Serbia	University of Kragujevac	Dehmer, M (corresponding author), UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria.	matthias.dehmer@umit.at	Furtula, Boris/B-8767-2008	Furtula, Boris/0000-0002-5056-6892	Austrian Science Funds; Standortagentur Tirol [P22029-N13]; Serbian Ministry of Education and Science [174033]; Austrian Science Fund (FWF) [P 22029] Funding Source: researchfish	Austrian Science Funds(Austrian Science Fund (FWF)); Standortagentur Tirol; Serbian Ministry of Education and Science(Ministry of Education, Science & Technological Development, Serbia); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	MD and MG thank the Austrian Science Funds and the Standortagentur Tirol for supporting this work (project P22029-N13). The authors are also grateful to `Zentraler Informatikdienst' of the Technical University of Vienna for providing computing resources to perform large scale computations on the Phoenix Cluster. BF thanks the Serbian Ministry of Education and Science for partial support of this work (project 174033) and Ivan Gutman for valuable discussions and suggestions concerning this paper. The authors thank Kurt Varmuza for fruitful discussions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, MATH MODELING BIOL S; Backhaus K., 2003, MULTIVARIATE ANALYSE; Balaban AT, 2006, SAR QSAR ENVIRON RES, V17, P429, DOI 10.1080/10629360600884421; Balaban AT, 2005, J COMPUT AID MOL DES, V19, P651, DOI 10.1007/s10822-005-9010-6; BALABAN AT, 1982, CHEM PHYS LETT, V89, P399, DOI 10.1016/0009-2614(82)80009-2; Balaban AT, 1987, GRAPH THEORY TOPOLOG, P159; BONCHEV D, 1981, J COMPUT CHEM, V2, P127, DOI 10.1002/jcc.540020202; BONCHEV D, 1989, THEOCHEM-J MOL STRUC, V54, P155, DOI 10.1016/0166-1280(89)85011-0; Bonchev D, 1983, INFORM THEORETIC IND; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Cvetkovic D., 1980, SPECTRA GRAPHS THEOR; Das KC, 2011, MATCH-COMMUN MATH CO, V65, P595; Dehmer M, 2011, STRUCTURAL ANALYSIS OF COMPLEX NETWORKS, P1, DOI 10.1007/978-0-8176-4789-6; Dehmer M, 2011, QUANTUM FRONTIERS AT, P479; Dehmer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031214; Dehmer M, 2011, INFORM SCIENCES, V181, P57, DOI 10.1016/j.ins.2010.08.041; Dehmer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011393; Devillers J., 1999, TOPOLOGICAL INDICES; Diudea M.V., 2001, MOL TOPOLOGY; Diudea MV, 2011, COMPLEXITY, V16, P32, DOI 10.1002/cplx.20363; Emmert-Streib F, 2011, IET SYST BIOL, V5, P185, DOI 10.1049/iet-syb.2010.0025; Estrada E, 1998, INDIAN J CHEM A, V37, P849; Estrada E, 2002, BIOINFORMATICS, V18, P697, DOI 10.1093/bioinformatics/18.5.697; Fath-Tabar G.H., 2009, NOTE ESTRADA L ESTRA, VCXXXIX; Fath-Tabar G, 2010, J MATH CHEM, V47, P477, DOI 10.1007/s10910-009-9584-7; Furtula B, 2010, J MATH CHEM, V48, P370, DOI 10.1007/s10910-010-9677-3; Gutman I, 2006, LINEAR ALGEBRA APPL, V414, P29, DOI 10.1016/j.laa.2005.09.008; Harary F., 1969, GRAPH THEORY; Hu CY, 1996, J CHEM INF COMP SCI, V36, P82, DOI 10.1021/ci9501150; Ivanciuc O., 1999, ROUM CHEM Q REV, V7, P41; Janezic D, 2007, MATH CHEM MONOGRAPHS; Kim J, 2008, PHYSICA A, V387, P2637, DOI 10.1016/j.physa.2008.01.015; Konstantinova EV, 2006, LECT NOTES COMPUT SC, V4123, P831; Konstantinova EV, 1996, J CHEM INF COMP SCI, V36, P54, DOI 10.1021/ci9502461; Kuratowski K., 1930, FUND MATH, V15, P271, DOI DOI 10.1007/S10623-014-9982-0; Milicevic A, 2004, CROAT CHEM ACTA, V77, P97; Miljkovic O, 2009, MATCH-COMMUN MATH CO, V61, P451; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; Mueller LAJ, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-53; Narumi H., 1984, MEM FAC ENG HOKKAIDO, V16, P209; Newman, 2006, STRUCTURE DYNAMICS N; Nikolic S, 2003, CROAT CHEM ACTA, V76, P113; Randic M., 2001, QSPR QSAR STUDIES MO QSPR QSAR STUDIES MO, P93; RAYCHAUDHURY C, 1984, J COMPUT CHEM, V5, P581, DOI 10.1002/jcc.540050612; Thurner S., 2009, ANAL COMPLEX NETWORK; Todeschini R., 2002, HDB MOL DESCRIPTORS; Vukicevic D, 2009, J MATH CHEM, V46, P1369, DOI 10.1007/s10910-009-9520-x; Wilhelm T, 2007, PHYSICA A, V385, P385, DOI 10.1016/j.physa.2007.06.029; Zhou B, 2009, CHEM PHYS LETT, V482, P153, DOI 10.1016/j.cplett.2009.09.102	50	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e38564	10.1371/journal.pone.0038564	http://dx.doi.org/10.1371/journal.pone.0038564			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792157	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800003
J	Jarajapu, YPR; Cai, J; Yan, YQ; Calzi, SL; Kielczewski, JL; Hu, P; Shaw, LC; Firth, SM; Chan-Ling, T; Boulton, ME; Baxter, RC; Grant, MB				Jarajapu, Yagna P. R.; Cai, Jun; Yan, Yuanqing; Calzi, Sergio Li; Kielczewski, Jennifer L.; Hu, Ping; Shaw, Lynn C.; Firth, Sue M.; Chan-Ling, Tailoi; Boulton, Michael E.; Baxter, Robert C.; Grant, Maria B.			Protection of Blood Retinal Barrier and Systemic Vasculature by Insulin-Like Growth Factor Binding Protein-3	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; BREAST-CANCER CELLS; SCAVENGER RECEPTOR; ENDOTHELIAL-CELLS; SHEAR-STRESS; IGFBP-3; ACTIVATION; EXPRESSION; APOPTOSIS; PATHWAYS	Previously, we showed that insulin growth factor (IGF)-1 binding protein-3 (IGFBP-3), independent of IGF-1, reduces pathological angiogenesis in a mouse model of the oxygen-induced retinopathy (OIR). The current study evaluates novel endothelium-dependent functions of IGFBP-3 including blood retinal barrier (BRB) integrity and vasorelaxation. To evaluate vascular barrier function, either plasmid expressing IGFBP-3 under the regulation of an endothelial-specific promoter or a control plasmid was injected into the vitreous humor of mouse pups (P1) and compared to the non-injected eyes of the same pups undergoing standard OIR protocol. Prior to sacrifice, the mice were given an injection of horseradish peroxidase (HRP). IGFBP-3 plasmid-injected eyes displayed near-normal vessel morphology and enhanced vascular barrier function. Further, in vitro IGFBP-3 protects retinal endothelial cells from VEGF-induced loss of junctional integrity by antagonizing the dissociation of the junctional complexes. To assess the vasodilatory effects of IGFBP-3, rat posterior cerebral arteries were examined in vitro. Intraluminal IGFBP-3 decreased both pressure- and serotonin-induced constrictions by stimulating nitric oxide ( NO) release that were blocked by L-NAME or scavenger receptor-B1 neutralizing antibody (SRB1-Ab). Both wild-type and IGF-1-nonbinding mutant IGFBP-3 (IGFBP-3NB) stimulated eNOS activity/NO release to a similar extent in human microvascular endothelial cells (HMVECs). NO release was neither associated with an increase in intracellular calcium nor decreased by Ca2+/calmodulin-dependent protein kinase II (CamKII) blockade; however, dephosphorylation of eNOS-Thr(495) was observed. Phosphatidylinositol 3-kinase (PI3K) activity and Akt-Ser(473) phosphorylation were both increased by IGFBP-3 and selectively blocked by the SRB1-Ab or PI3K blocker LY294002. In conclusion, IGFBP-3 mediates protective effects on BRB integrity and mediates robust NO release to stimulate vasorelaxation via activation of SRB1. This response is IGF-1- and calcium-independent, but requires PI3K/Akt activation, suggesting that IGFBP-3 has novel protective effects on retinal and systemic vasculature and may be a therapeutic candidate for ocular complications such as diabetic retinopathy.	[Jarajapu, Yagna P. R.; Yan, Yuanqing; Calzi, Sergio Li; Kielczewski, Jennifer L.; Shaw, Lynn C.; Grant, Maria B.] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Cai, Jun; Boulton, Michael E.] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Hu, Ping; Chan-Ling, Tailoi] Univ Sydney, Bosch Inst, Discipline Anat, Sydney, NSW 2006, Australia; [Firth, Sue M.; Baxter, Robert C.] Univ Sydney, Kolling Inst Med Res, St Leonards, NSW, Australia	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Sydney; University of Sydney; Kolling Institute of Medical Research	Jarajapu, YPR (corresponding author), Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA.	grantma@ufl.edu	Baxter, Robert C/F-3927-2012; Chan-Ling, Tailoi/X-2718-2019; Chan-Ling, Tailoi/A-2177-2008	Baxter, Robert C/0000-0001-5061-2142; Chan-Ling, Tailoi/0000-0002-8225-3671	National Institutes of Health (NIH) [EY007739, EY012601, U01 HL087366, RO1 EY018358]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R29EY007739, R01EY007739, R01EY018358, R01EY012601] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087366] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (NIH) grants EY007739, EY012601 and U01 HL087366 to Dr. Grant and RO1 EY018358 to Dr. Boulton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Butler AA, 2001, ENDOCRINOLOGY, V142, P1685, DOI 10.1210/en.142.5.1685; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Carmo A, 2000, NITRIC OXIDE-BIOL CH, V4, P590, DOI 10.1006/niox.2000.0312; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; ChanLing T, 1997, MICROSC RES TECHNIQ, V36, P1; Domene H M, 2005, J Endocrinol Invest, V28, P43; El-Remessy AB, 2003, AM J PATHOL, V162, P1995, DOI 10.1016/S0002-9440(10)64332-5; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fleming I, 1998, CIRC RES, V82, P686, DOI 10.1161/01.RES.82.6.686; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fu P, 2007, J BIOL CHEM, V282, P22298, DOI 10.1074/jbc.M703066200; Granata R, 2007, J THROMB HAEMOST, V5, P835, DOI 10.1111/j.1538-7836.2007.02431.x; Granata R, 2004, FASEB J, V18, P1456, DOI 10.1096/fj.04-1618fje; Grimberg A, 2000, J CELL PHYSIOL, V183, P1, DOI 10.1002/(SICI)1097-4652(200004)183:1<1::AID-JCP1>3.0.CO;2-J; Haynes MP, 2003, J BIOL CHEM, V278, P2118, DOI 10.1074/jbc.M210828200; Heidary G, 2009, SEMIN OPHTHALMOL, V24, P77, DOI 10.1080/08820530902800314; HIRATA K, 1995, HYPERTENSION, V25, P180, DOI 10.1161/01.HYP.25.2.180; Hwa V, 1999, ACTA PAEDIATR, V88, P37, DOI 10.1111/j.1651-2227.1999.tb14349.x; Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100; Ingermann AR, 2010, J BIOL CHEM, V285, P30233, DOI 10.1074/jbc.M110.122226; Jarajapu YPR, 2002, AM J PHYSIOL-HEART C, V283, pH2234, DOI 10.1152/ajpheart.00624.2002; JOHNSON PC, 1986, CIRC RES, V59, P483, DOI 10.1161/01.RES.59.5.483; Ju WK, 2001, NEUROREPORT, V12, P2405, DOI 10.1097/00001756-200108080-00024; Kacimi R, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-7; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Kielczewski JL, 2011, AM J PATHOL, V178, P1517, DOI 10.1016/j.ajpath.2010.12.031; Kielczewski JL, 2009, CIRC RES, V105, P897, DOI 10.1161/CIRCRESAHA.109.199059; Kohler R, 2006, ARTERIOSCL THROM VAS, V26, P1495, DOI 10.1161/01.ATV.0000225698.36212.6a; Koga T, 2008, CANCER LETT, V268, P82, DOI 10.1016/j.canlet.2008.03.030; Le Jan S, 2006, FEBS LETT, V580, P3395, DOI 10.1016/j.febslet.2006.05.011; Leal EC, 2007, INVEST OPHTH VIS SCI, V48, P5257, DOI 10.1167/iovs.07-0112; Lee KW, 2005, J BIOL CHEM, V280, P16942, DOI 10.1074/jbc.M412757200; Lee KW, 2004, J BIOL CHEM, V279, P469, DOI 10.1074/jbc.M307316200; Lee WH, 1999, ENDOCRINE, V11, P181, DOI 10.1385/ENDO:11:2:181; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Lu LJ, 2009, BRAIN RES, V1264, P104, DOI 10.1016/j.brainres.2009.01.043; Mishra S, 2004, CANCER RES, V64, P2516, DOI 10.1158/0008-5472.CAN-03-2877; Mohanraj LOY, 2010, ENDOCR REV, pS1035; OH Y, 1993, GROWTH REGULAT, V3, P84; Phillips LS, 1998, PROG NUCLEIC ACID RE, V60, P195, DOI 10.1016/S0079-6603(08)60894-6; Rosenfeld RG, 2000, GROWTH HORM IGF RES, V10, pS16, DOI 10.1016/S1096-6374(00)90007-8; Schedlich LJ, 2007, ARCH BIOCHEM BIOPHYS, V465, P359, DOI 10.1016/j.abb.2007.06.013; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; Shaw LC, 2006, GENE THER, V13, P752, DOI 10.1038/sj.gt.3302718; Spoerri PE, 2006, MOL VIS, V12, P32; TAILOI CL, 1992, INVEST OPHTH VIS SCI, V33, P2128; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Weinzimer SA, 2001, J CLIN ENDOCR METAB, V86, P1806, DOI 10.1210/jc.86.4.1806; Xu HS, 2003, J BIOL CHEM, V278, P11520, DOI 10.1074/jbc.M211061200; Yamanaka Y, 1999, ENDOCRINOLOGY, V140, P1319, DOI 10.1210/en.140.3.1319; Yan XL, 2004, J BIOL CHEM, V279, P53232, DOI 10.1074/jbc.M409345200; Zhu WD, 2008, NATURE, V454, P345, DOI 10.1038/nature07027	53	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39398	10.1371/journal.pone.0039398	http://dx.doi.org/10.1371/journal.pone.0039398			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792172	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800010
J	Butte, MJ; Lee, SJ; Jesneck, J; Keir, ME; Haining, WN; Sharpe, AH				Butte, Manish J.; Lee, Sun Jung; Jesneck, Jonathan; Keir, Mary E.; Haining, W. Nicholas; Sharpe, Arlene H.			CD28 Costimulation Regulates Genome-Wide Effects on Alternative Splicing	PLOS ONE			English	Article							T-CELLS; EXON ARRAYS; EXPRESSION; CTLA-4; RIBONUCLEOPROTEIN; NAIVE; CD45; AGE	CD28 is the major costimulatory receptor required for activation of naive T cells, yet CD28 costimulation affects the expression level of surprisingly few genes over those altered by TCR stimulation alone. Alternate splicing of genes adds diversity to the proteome and contributes to tissue-specific regulation of genes. Here we demonstrate that CD28 costimulation leads to major changes in alternative splicing during activation of naive T cells, beyond the effects of TCR alone. CD28 costimulation affected many more genes through modulation of alternate splicing than by modulation of transcription. Different families of biological processes are over-represented among genes alternatively spliced in response to CD28 costimulation compared to those genes whose transcription is altered, suggesting that alternative splicing regulates distinct biological effects. Moreover, genes dependent upon hnRNPLL, a global regulator of splicing in activated T cells, were enriched in T cells activated through TCR plus CD28 as compared to TCR alone. We show that hnRNPLL expression is dependent on CD28 signaling, providing a mechanism by which CD28 can regulate splicing in T cells and insight into how hnRNPLL can influence signal-induced alternative splicing in T cells. The effects of CD28 on alternative splicing provide a newly appreciated means by which CD28 can regulate T cell responses.	[Butte, Manish J.; Lee, Sun Jung; Keir, Mary E.; Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Jesneck, Jonathan; Haining, W. Nicholas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Jesneck, Jonathan; Haining, W. Nicholas] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Sharpe, Arlene H.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital	Butte, MJ (corresponding author), Stanford Univ, Dept Pediat, Div Immunol & Allergy, Stanford, CA 94305 USA.	arlene_sharpe@hms.harvard.edu	Butte, Manish/AAM-8604-2020; Butte, Manish/T-8860-2019	Butte, Manish/0000-0002-4490-5595; Butte, Manish/0000-0002-4490-5595	NIH [BAA-05-011, P01 AI39671, P01 AI065687]; NIAID/NIH [K08AI079268];  [R01 AI091493]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI079268, P01AI065687, P01AI039671, R01AI091493] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH BAA-05-011, P01 AI39671 and P01 AI065687 to AHS, K08AI079268 from the NIAID/NIH to MJB, and R01 AI091493 to WNH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Chang SY, 2007, NEUROSCIENCE, V145, P1026, DOI 10.1016/j.neuroscience.2006.12.054; DELLAVEDOVA F, 1992, MOL BRAIN RES, V12, P357, DOI 10.1016/0169-328X(92)90140-7; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Freeburn RW, 2002, J IMMUNOL, V169, P5441, DOI 10.4049/jimmunol.169.10.5441; Fury Wen, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5531; Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ip JY, 2007, RNA, V13, P563, DOI 10.1261/rna.457207; Ishunina TA, 2005, J CLIN ENDOCR METAB, V90, P3757, DOI 10.1210/jc.2004-1858; Kapur K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r82; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; Lin L, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp420; Linton PJ, 1997, IMMUNOL REV, V160, P9, DOI 10.1111/j.1600-065X.1997.tb01023.x; Linton PJ, 1996, J EXP MED, V184, P1891, DOI 10.1084/jem.184.5.1891; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Meshorer E, 2002, AGING CELL, V1, P10, DOI 10.1046/j.1474-9728.2002.00005.x; Oaks MK, 2000, J IMMUNOL, V164, P5015, DOI 10.4049/jimmunol.164.10.5015; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Riley JL, 2002, P NATL ACAD SCI USA, V99, P11790, DOI 10.1073/pnas.162359999; Salomonis N, 2010, P NATL ACAD SCI USA, V107, P10514, DOI 10.1073/pnas.0912260107; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vijayakrishnan L, 2004, IMMUNITY, V20, P563, DOI 10.1016/S1074-7613(04)00110-4; Wu Z, 2008, IMMUNITY, V29, P863, DOI 10.1016/j.immuni.2008.11.004; Xing Y, 2008, RNA, V14, P1470, DOI 10.1261/rna.1070208; Xing Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000088; Yabas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026440; Zikherman J, 2008, IMMUNITY, V29, P839, DOI 10.1016/j.immuni.2008.12.005	36	26	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40032	10.1371/journal.pone.0040032	http://dx.doi.org/10.1371/journal.pone.0040032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768209	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100181
J	Ge, XL; Lv, X; Feng, LL; Liu, XQ; Gao, JM; Chen, N; Wang, X				Ge, Xueling; Lv, Xiao; Feng, Lili; Liu, Xiaoqian; Gao, Junming; Chen, Na; Wang, Xin			Metadherin Contributes to the Pathogenesis of Diffuse Large B-cell Lymphoma	PLOS ONE			English	Article							ASTROCYTE-ELEVATED GENE-1; FLOW-CYTOMETRIC DETECTION; NON-HODGKINS-LYMPHOMA; BREAST-CANCER; PHOSPHATIDYLSERINE EXPRESSION; CLINICAL-SIGNIFICANCE; SIGNALING PATHWAYS; BETA-CATENIN; ANNEXIN-V; IN-VITRO	Background: Metadherin (MTDH) has been demonstrated as a potentially crucial mediator of various types of human malignancies. However, the expression and role of MTDH in diffuse large-B-cell lymphoma (DLBCL) have not been reported yet. This study aimed to illuminate the role of MTDH in the pathogenesis of DLBCL. Methodology/Principal Findings: A remarkable elevation of MTDH on mRNA level was detected in DLBCL tissues by quantitative polymerase chain reaction (PCR). Using Western-blot analysis we found that the expression of MTDH protein was significantly upregulated in DLBCL cell lines and DLBCL tissues compared with peripheral blood mononuclear cells (PBMCs) from healthy samples and tissues from patients of reactive hyperplasia of lymph node. The results showed high expression of MTDH in 23 of 30 (76.67%) DLBCL tissues by using immunohistochemical analysis and the over expression of MTDH was strongly correlated to the clinical staging of patients with DLBCL (P<0.05). Furthermore, the finding suggested that the increase of MTDH in DLBCL cells could distinctly enhance cell proliferation and inhibit cell apoptosis; meanwhile, inhibition of MTDH expression by specific siRNA clearly enhanced LY8 cell apoptosis. Upregulation of MTDH elevated the protein level of total beta-catenin and translocation of beta-catenin to the nucleus directly or indirectly. Knockdown of MTDH decreased the level of total, cytoplasmic beta-catenin and reduced nuclear accumulation of beta-catenin protein. This indicated that the function of MTDH on the development of DLBCL was mediated through regulation of Wnt/beta-catenin signaling pathway. Conclusions/Significance: Our results suggest that MTDH contributes to the pathogenesis of DLBCL mediated by activation of Wnt/beta-catenin pathway. This novel study may contribute to further investigation on the useful biomarkers and potential therapeutic target in the DLBCL patients.	[Ge, Xueling; Lv, Xiao; Feng, Lili; Chen, Na; Wang, Xin] Shandong Univ, Dept Hematol, Prov Hosp, Jinan 250100, Peoples R China; [Liu, Xiaoqian] Qingdao Univ, Dept Hematol, Yantai Yuhuangding Hosp, Affiliated Hosp Med Coll, Yantai, Peoples R China; [Gao, Junming] Shandong Police Officer Gen Hosp, Dept Internal Med, Jinan, Peoples R China; [Wang, Xin] Shandong Univ, Inst Diagnost, Jinan 250100, Peoples R China	Shandong University; Qingdao University; Shandong University	Ge, XL (corresponding author), Shandong Univ, Dept Hematol, Prov Hosp, Jinan 250100, Peoples R China.	xinwang55@yahoo.com.cn			Natural Science Foundation of Shandong Province, China [Y2007C053, ZR2009CM059]; Project of Scientific and Technological Development of Shandong Province, China [2007GG10002008]	Natural Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province); Project of Scientific and Technological Development of Shandong Province, China	This study was supported by the grants from the Natural Science Foundation of Shandong Province, China (No. Y2007C053 and No. ZR2009CM059) and the Project of Scientific and Technological Development of Shandong Province, China (No. 2007GG10002008) to Prof. Xin Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid Muhammad Bilal, 2005, Asian Pac J Cancer Prev, V6, P531; Amin HM, 2003, ARCH PATHOL LAB MED, V127, P424; Bellei B, 2004, MODERN PATHOL, V17, P1275, DOI 10.1038/modpathol.3800181; Britt DE, 2004, EXP CELL RES, V300, P134, DOI 10.1016/j.yexcr.2004.06.026; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Chan WC, 1997, BLOOD, V89, P3909; Chen W, 2010, NEOPLASMA, V57, P522, DOI 10.4149/neo_2010_06_522; Chung R, 2010, INT J CLIN EXP PATHO, V3, P244; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coiffier B, 2007, ONCOGENE, V26, P3603, DOI 10.1038/sj.onc.1210376; Coiffier B, 2005, J CLIN ONCOL, V23, P6387, DOI 10.1200/JCO.2005.05.015; Coiffier B, 2001, CURR OPIN ONCOL, V13, P325, DOI 10.1097/00001622-200109000-00003; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; Everly DN, 2004, J VIROL, V78, P11648, DOI 10.1128/JVI.78.21.11648-11655.2004; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Flowers CR, 2010, CA-CANCER J CLIN, V60, P393, DOI 10.3322/caac.20087; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Ge XL, 2012, MOL MED REP IN PRESS; Gelebart P, 2008, BLOOD, V112, P5171, DOI 10.1182/blood-2008-02-139212; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Jaffe E.S., 2001, PATHOLOGY GENETICS T, VVolume 3; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; Kawahara T, 2009, ANTICANCER RES, V29, P4629; Kikuno N, 2007, ONCOGENE, V26, P7647, DOI 10.1038/sj.onc.1210572; Koivula S, 2011, ONCOL REP, V25, P1183, DOI 10.3892/or.2011.1179; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Lee SG, 2008, ONCOGENE, V27, P1114, DOI 10.1038/sj.onc.1210713; Lee SG, 2009, ONCOGENE, V28, P2476, DOI 10.1038/onc.2009.93; Lee SG, 2006, P NATL ACAD SCI USA, V103, P17390, DOI 10.1073/pnas.0608386103; Li C, 2011, J SURG ONCOL, V103, P184, DOI 10.1002/jso.21788; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Liu HY, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-19; Lu YR, 2008, CANCER BIOL THER, V7, P245, DOI 10.4161/cbt.7.2.5296; Meng FL, 2011, INT J GYNECOL PATHOL, V30, P145, DOI 10.1097/PGP.0b013e3181ffd2f7; Meng XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020920; Moon R.T., 2005, SCI SIGNAL, V2005, pCM1, DOI [10.1126/stke.2712005cm1, DOI 10.1126/STKE.2712005CM1]; Muris JJF, 2005, BLOOD, V105, P2916, DOI 10.1182/blood-2004-07-2716; Sarkar D, 2008, CANCER RES, V68, P1478, DOI 10.1158/0008-5472.CAN-07-6164; Sarkar D, 2009, CANCER RES, V69, P8529, DOI 10.1158/0008-5472.CAN-09-1846; Schmidt M, 2009, BRIT J HAEMATOL, V144, P796, DOI 10.1111/j.1365-2141.2008.07503.x; Sehn LH, 2007, BLOOD, V109, P1857, DOI 10.1182/blood-2006-08-038257; Stein H, 2008, WHO CLASSIFICATION T, P233; Su ZZ, 2002, ONCOGENE, V21, P3592, DOI 10.1038/sj.onc.1205445; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Xu JB, 2011, MED ONCOL, V28, P455, DOI 10.1007/s12032-010-9475-6; Xueling GE, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-33; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460; Yu CP, 2009, CARCINOGENESIS, V30, P894, DOI 10.1093/carcin/bgp064; Zhang D, 2010, LEUKEMIA LYMPHOMA, V51, P906, DOI 10.3109/10428191003695645	51	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39449	10.1371/journal.pone.0039449	http://dx.doi.org/10.1371/journal.pone.0039449			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768080	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100051
J	Kreft, ME; Robenek, H				Kreft, Mateja Erdani; Robenek, Horst			Freeze-Fracture Replica Immunolabelling Reveals Urothelial Plaques in Cultured Urothelial Cells	PLOS ONE			English	Article							PRIMARY EXPLANT OUTGROWTHS; RAT URINARY-BLADDER; TRANSITIONAL EPITHELIUM; MEMBRANE-STRUCTURE; LUMINAL MEMBRANE; BARRIER FUNCTION; GOLGI-APPARATUS; UROPLAKIN-I; DIFFERENTIATION; MECHANISM	The primary function of the urothelium is to provide the tightest and most impermeable barrier in the body, i.e. the blood-urine barrier. Urothelial plaques are formed and inserted into the apical plasma membrane during advanced stages of urothelial cell differentiation. Currently, it is supposed that differentiation with the final formation of urothelial plaques is hindered in cultured urothelial cells. With the aid of the high-resolution imaging technique of freeze-fracture replica immunolabelling, we here provide evidence that urothelial cells in vitro form uroplakin-positive urothelial plaques, localized in fusiform-shaped vesicles and apical plasma membranes. With the establishment of such an in vitro model of urothelial cells with fully developed urothelial plaques and functional properties equivalent to normal bladder urothelium, new perspectives have emerged which challenge prevailing concepts of apical plasma membrane biogenesis and blood-urine barrier development. This may hopefully provide a timely impulse for many ongoing studies and open up new questions for future research.	[Kreft, Mateja Erdani] Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia; [Robenek, Horst] Univ Munster, Leibniz Inst Arteriosclerosis Res, Munster, Germany	University of Ljubljana; University of Munster	Kreft, ME (corresponding author), Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia.	mateja.erdani@mf.uni-lj.si		Kreft, Mateja Erdani/0000-0001-6486-165X	Slovenian Ministry of Higher Education, Science and Technology [P3-0108]; Deutsche Forschungsgemeinschaft [SFB 492]	Slovenian Ministry of Higher Education, Science and Technology; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by the Slovenian Ministry of Higher Education, Science and Technology (grant number P3-0108) and Deutsche Forschungsgemeinschaft, SFB 492. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	FROMTER E, 1972, NATURE-NEW BIOL, V235, P9, DOI 10.1038/newbio235009a0; Hu P, 2002, AM J PHYSIOL-RENAL, V283, pF1200, DOI 10.1152/ajprenal.00043.2002; Hudoklin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023636; Kachar B, 1999, J MOL BIOL, V285, P595, DOI 10.1006/jmbi.1998.2304; KOSS LG, 1969, LAB INVEST, V21, P154; Kreft ME, 2010, BIOL CELL, V102, P593, DOI 10.1042/BC20100024; Kreft ME, 2009, DIFFERENTIATION, V77, P48, DOI 10.1016/j.diff.2008.09.011; Kreft ME, 2006, HISTOCHEM CELL BIOL, V125, P475, DOI 10.1007/s00418-005-0104-y; Kreft ME, 2005, HISTOCHEM CELL BIOL, V123, P529, DOI 10.1007/s00418-005-0770-9; Kreft ME, 2002, CELL BIOL INT, V26, P63, DOI 10.1006/cbir.2001.0829; Liang FX, 2001, BIOCHEM J, V355, P13, DOI 10.1042/0264-6021:3550013; Robenek H, 2009, J CELL MOL MED, V13, P1381, DOI 10.1111/j.1582-4934.2008.00407.x; Romih R, 2005, CELL TISSUE RES, V320, P259, DOI 10.1007/s00441-004-1005-4; Severs NJ, 2008, METHOD CELL BIOL, V88, P181, DOI 10.1016/S0091-679X(08)00411-1; SEVERS NJ, 1978, J ULTRA MOL STRUCT R, V64, P124, DOI 10.1016/S0022-5320(78)80031-8; SEVERS NJ, 1979, J ULTRA MOL STRUCT R, V69, P279, DOI 10.1016/S0022-5320(79)90117-5; Sun TT, 2006, AM J PHYSIOL-RENAL, V291, pF9, DOI 10.1152/ajprenal.00035.2006; SURYA B, 1990, J CELL SCI, V97, P419; Truschel ST, 1999, J BIOL CHEM, V274, P15020, DOI 10.1074/jbc.274.21.15020; Turner AM, 2008, EUR UROL, V54, P1423, DOI 10.1016/j.eururo.2008.03.068; Visnjar T, 2012, HISTOCHEM CELL BIOL, V137, P177, DOI 10.1007/s00418-011-0893-0; WU XR, 1990, J BIOL CHEM, V265, P19170	22	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38509	10.1371/journal.pone.0038509	http://dx.doi.org/10.1371/journal.pone.0038509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768045	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100016
J	Ma, WX; Gutierrez, A; Goff, DJ; Geron, I; Sadarangani, A; Jamieson, CAM; Court, AC; Shih, AY; Jiang, QF; Wu, CC; Li, K; Smith, KM; Crews, LA; Gibson, NW; Deichaite, I; Morris, SR; Wei, P; Carson, DA; Look, AT; Jamieson, CHM				Ma, Wenxue; Gutierrez, Alejandro; Goff, Daniel J.; Geron, Ifat; Sadarangani, Anil; Jamieson, Christina A. M.; Court, Angela C.; Shih, Alice Y.; Jiang, Qingfei; Wu, Christina C.; Li, Kang; Smith, Kristen M.; Crews, Leslie A.; Gibson, Neil W.; Deichaite, Ida; Morris, Sheldon R.; Wei, Ping; Carson, Dennis A.; Look, A. Thomas; Jamieson, Catriona H. M.			NOTCH1 Signaling Promotes Human T-Cell Acute Lymphoblastic Leukemia Initiating Cell Regeneration in Supportive Niches	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; PROGENITOR CELLS; SELF-RENEWAL; CORD BLOOD; MUTATIONS; MAINTENANCE; EXPRESSION; DIFFERENTIATION; INACTIVATION	Background: Leukemia initiating cells (LIC) contribute to therapeutic resistance through acquisition of mutations in signaling pathways, such as NOTCH1, that promote self-renewal and survival within supportive niches. Activating mutations in NOTCH1 occur commonly in T cell acute lymphoblastic leukemia (T-ALL) and have been implicated in therapeutic resistance. However, the cell type and context specific consequences of NOTCH1 activation, its role in human LIC regeneration, and sensitivity to NOTCH1 inhibition in hematopoietic microenvironments had not been elucidated. Methodology and Principal Findings: We established humanized bioluminescent T-ALL LIC mouse models transplanted with pediatric T-ALL samples that were sequenced for NOTCH1 and other common T-ALL mutations. In this study, CD34(+) cells from NOTCH1(Mutated) T-ALL samples had higher leukemic engraftment and serial transplantation capacity than NOTCH1(Wild-type) CD34(+) cells in hematopoietic niches, suggesting that self-renewing LIC were enriched within the NOTCH1(Mutated) CD34(+) fraction. Humanized NOTCH1 monoclonal antibody treatment reduced LIC survival and self-renewal in NOTCH1(Mutated) T-ALL LIC-engrafted mice and resulted in depletion of CD34(+)CD2(+)CD7(+) cells that harbor serial transplantation capacity. Conclusions: These results reveal a functional hierarchy within the LIC population based on NOTCH1 activation, which renders LIC susceptible to targeted NOTCH1 inhibition and highlights the utility of NOTCH1 antibody targeting as a key component of malignant stem cell eradication strategies.	[Ma, Wenxue; Goff, Daniel J.; Geron, Ifat; Sadarangani, Anil; Jamieson, Christina A. M.; Court, Angela C.; Shih, Alice Y.; Jiang, Qingfei; Wu, Christina C.; Smith, Kristen M.; Crews, Leslie A.; Deichaite, Ida; Morris, Sheldon R.; Carson, Dennis A.; Jamieson, Catriona H. M.] Univ Calif San Diego, Dept Med, Stem Cell Program, La Jolla, CA 92093 USA; [Ma, Wenxue; Goff, Daniel J.; Geron, Ifat; Sadarangani, Anil; Jamieson, Christina A. M.; Court, Angela C.; Shih, Alice Y.; Jiang, Qingfei; Wu, Christina C.; Smith, Kristen M.; Crews, Leslie A.; Deichaite, Ida; Morris, Sheldon R.; Carson, Dennis A.; Jamieson, Catriona H. M.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Gutierrez, Alejandro; Look, A. Thomas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Gutierrez, Alejandro; Look, A. Thomas] Childrens Hosp, Boston, MA 02115 USA; [Li, Kang; Gibson, Neil W.; Wei, Ping] La Jolla Labs, Pfizer Global Res & Dev, Oncol Res Unit, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Pfizer	Ma, WX (corresponding author), Univ Calif San Diego, Dept Med, Stem Cell Program, La Jolla, CA 92093 USA.	cjamieson@ucsd.edu	Ma, Wenxue/D-5383-2019; JIANG, QINGFEI/K-3492-2012; Ma, Wenxue/A-6344-2012; Crews, Leslie/B-7584-2014	Ma, Wenxue/0000-0001-9228-6162; Ma, Wenxue/0000-0001-9228-6162; Crews, Leslie/0000-0003-0704-0067; Gutierrez, Alejandro/0000-0002-0249-9007; Goff, Daniel/0000-0003-2109-1696; Deichaite, Ida/0000-0001-8839-0573; Smith, Kristen/0000-0003-0960-0937; JIANG, QINGFEI/0000-0002-9072-8032	Ratner Family Foundation; Leichtag Family Foundation; Moores Cancer Center; NIH [1K08CA133103, 5P01CA68484]; William Lawrence Foundation; American Society of Hematology-Amos Medical Faculty Development program; California Institute for Regenerative Medicine (CIRM) Scientific Excellence through Exploration and Development (SEED) program; CIRM New Faculty Award; CIRM; CIRM Early Translational II grants; Pfizer [Pfizer/28-1076]; NATIONAL CANCER INSTITUTE [K08CA133103, P01CA068484] Funding Source: NIH RePORTER	Ratner Family Foundation; Leichtag Family Foundation; Moores Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Lawrence Foundation; American Society of Hematology-Amos Medical Faculty Development program; California Institute for Regenerative Medicine (CIRM) Scientific Excellence through Exploration and Development (SEED) program; CIRM New Faculty Award; CIRM(California Institute for Regenerative Medicine); CIRM Early Translational II grants; Pfizer(Pfizer); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Ratner Family Foundation, the Leichtag Family Foundation, and Moores Cancer Center Donor Funds. Dr. Gutierrez's work is supported by the NIH (grant 1K08CA133103), the William Lawrence Foundation, and the American Society of Hematology-Amos Medical Faculty Development program. Dr. Look's work was funded by the NIH (grant 5P01CA68484). Dr. Jamieson's work was supported by the California Institute for Regenerative Medicine (CIRM) Scientific Excellence through Exploration and Development (SEED) program, a CIRM New Faculty Award, and CIRM Disease Team and CIRM Early Translational II grants. A portion of this research study was funded by a sponsored research agreement with Pfizer (Pfizer/28-1076), and the antibody utilized in this study was provided by Pfizer. Authors Li, Gibson, and Wei were employees of Pfizer during the study, and these authors provided reagents for use in this study and contributed to data collection and analysis for antibody validation experiments.	Abrahamsson AE, 2009, P NATL ACAD SCI USA, V106, P3925, DOI 10.1073/pnas.0900189106; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Chessells JM, 2003, BRIT J HAEMATOL, V123, P396, DOI 10.1046/j.1365-2141.2003.04584.x; Chiu PPL, 2010, BLOOD, V116, P5268, DOI 10.1182/blood-2010-06-292300; Clappier E, 2010, LEUKEMIA, V24, P2023, DOI 10.1038/leu.2010.205; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cox CV, 2007, BLOOD, V109, P674, DOI 10.1182/blood-2006-06-030445; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Feng H, 2010, CANCER CELL, V18, P353, DOI 10.1016/j.ccr.2010.09.009; Ferrando A, 2010, LEUKEMIA, V24, P2003, DOI 10.1038/leu.2010.237; Gerby B, 2011, LEUKEMIA, V25, P1249, DOI 10.1038/leu.2011.93; Geron I, 2008, CANCER CELL, V13, P321, DOI 10.1016/j.ccr.2008.02.017; Gutierrez A, 2010, J CLIN ONCOL, V28, P3816, DOI 10.1200/JCO.2010.28.3390; Gutierrez A, 2010, BLOOD, V115, P2845, DOI 10.1182/blood-2009-07-234377; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Haddad R, 2004, BLOOD, V104, P3918, DOI 10.1182/blood-2004-05-1845; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Liu JN, 2010, CURR TOP DEV BIOL, V92, P367, DOI [10.1016/S0070-2153(10)92012-7, 10.1016/S0070-2153(10)91012-7]; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Medyouf H, 2011, J EXP MED, V208, P1809, DOI 10.1084/jem.20110121; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Sanda T, 2010, BLOOD, V115, P1735, DOI 10.1182/blood-2009-07-235143; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; van Delft FW, 2011, BLOOD; Varnum-Finney B, 2011, J CLIN INVEST, V121, P1207, DOI 10.1172/JCI43868; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	43	25	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39725	10.1371/journal.pone.0039725	http://dx.doi.org/10.1371/journal.pone.0039725			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768113	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100083
J	Mijaljica, D; Prescott, M; Devenish, RJ				Mijaljica, Dalibor; Prescott, Mark; Devenish, Rodney J.			A Late Form of Nucleophagy in Saccharomyces cerevisiae	PLOS ONE			English	Article							NUCLEUS-VACUOLE JUNCTIONS; PIECEMEAL MICROAUTOPHAGY; AUTOPHAGOSOME FORMATION; SELECTIVE AUTOPHAGY; FLUORESCENT PROTEIN; BUDDING YEAST; MEMBRANE; COMPLEX; ATG9; DEGRADATION	Autophagy encompasses several processes by which cytosol and organelles can be delivered to the vacuole/lysosome for breakdown and recycling. We sought to investigate autophagy of the nucleus (nucleophagy) in the yeast Saccharomyces cerevisiae by employing genetically encoded fluorescent reporters. The use of such a nuclear reporter, n-Rosella, proved the basis of robust assays based on either following its accumulation (by confocal microscopy), or degradation (by immunoblotting), within the vacuole. We observed the delivery of n-Rosella to the vacuole only after prolonged periods of nitrogen starvation. Dual labeling of cells with Nvj1p-EYFP, a nuclear membrane reporter of piecemeal micronucleophagy of the nucleus (PMN), and the nucleoplasm-targeted NAB35-DsRed. T3 allowed us to detect PMN soon after the commencement of nitrogen starvation whilst delivery to the vacuole of the nucleoplasm reporter was observed only after prolonged periods of nitrogen starvation. This later delivery of nuclear components to the vacuole has been designated LN (late nucleophagy). Only a very few cells showed simultaneous accumulation of both reporters (Nvj1p-EYFP and NAB35-DsRed.T3) in the vacuole. We determined, therefore, that delivery of the two respective nuclear reporters to the vacuole is temporally and spatially separated. Furthermore, our data suggest that LN is mechanistically distinct from PMN because it can occur in nvj1 Delta and vac8 Delta cells, and does not require ATG11. Nevertheless, a subset of the components of the core macroautophagic machinery is required for LN as it is efficiently inhibited in null mutants of several autophagy-related genes (ATG) specifying such components. Moreover, the inhibition of LN in some mutants is accompanied by alterations in nuclear morphology.	[Mijaljica, Dalibor; Prescott, Mark; Devenish, Rodney J.] Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Fac Med Nursing & Hlth Sci, Clayton, Vic 3800, Australia	Monash University	Mijaljica, D (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Fac Med Nursing & Hlth Sci, Clayton, Vic 3800, Australia.	Rodney.Devenish@monash.edu		MIJALJICA, DALIBOR/0000-0002-8519-286X	Australian Research Council [DP0986937]	Australian Research Council(Australian Research Council)	This work was supported by Australian Research Council Grant DP0986937. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer C, 2001, MICROSC MICROANAL, V7, P530, DOI 10.1007/s10005-001-0020-4; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Devenish RJ, 2008, METHOD ENZYMOL, V451, P109, DOI 10.1016/S0076-6879(08)03209-6; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Epple UD, 2003, J BIOL CHEM, V278, P7810, DOI 10.1074/jbc.M209309200; Farre JC, 2009, CURR OPIN CELL BIOL, V21, P522, DOI 10.1016/j.ceb.2009.04.015; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; He CC, 2006, J CELL BIOL, V175, P925, DOI 10.1083/jcb.200606084; KEAN LS, 1993, J CELL BIOL, V123, P1403, DOI 10.1083/jcb.123.6.1403; Kiel JAKW, 2010, PHILOS T R SOC B, V365, P819, DOI 10.1098/rstb.2009.0237; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Klionsky DJ, 2007, AUTOPHAGY, V3, P413, DOI 10.4161/auto.4377; Kraft C, 2009, BBA-MOL CELL RES, V1793, P1404, DOI 10.1016/j.bbamcr.2009.02.006; Krick R, 2008, MOL BIOL CELL, V19, P4492, DOI 10.1091/mbc.E08-04-0363; Krick R, 2009, AUTOPHAGY, V5, P270, DOI 10.4161/auto.5.2.7639; Kvam E, 2005, MOL BIOL CELL, V16, P3987, DOI 10.1091/mbc.e05-04-0290; Kvam E, 2004, J CELL SCI, V117, P4959, DOI 10.1242/jcs.01372; Kvam E, 2007, AUTOPHAGY, V3, P85, DOI 10.4161/auto.3586; Legakis JE, 2007, AUTOPHAGY, V3, P422, DOI 10.4161/auto.4129; Mijaljica D, 2010, NUCLEUS-PHILA, V1, P213, DOI 10.4161/nucl.1.3.11738; Millen JI, 2009, AUTOPHAGY, V5, P75, DOI 10.4161/auto.5.1.7181; Muller O, 2003, J CELL SCI, V116, P1107, DOI 10.1242/jcs.00328; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Olkkonen VM, 2004, BIOCHEM CELL BIOL, V82, P87, DOI 10.1139/o03-088; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Pereira C, 2010, MOL MICROBIOL, V76, P1398, DOI 10.1111/j.1365-2958.2010.07122.x; PRESCOTT M, 1995, BIOCHEM BIOPH RES CO, V207, P943, DOI 10.1006/bbrc.1995.1276; Reggiori F, 2004, MOL BIOL CELL, V15, P2189, DOI 10.1091/mbc.E03-07-0479; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Rosado CJ, 2008, AUTOPHAGY, V4, P205, DOI 10.4161/auto.5331; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sattler T, 2000, J CELL BIOL, V151, P529, DOI 10.1083/jcb.151.3.529; Sekito T, 2009, GENES CELLS, V14, P525, DOI 10.1111/j.1365-2443.2009.01299.x; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Siniossoglou S, 2009, TRAFFIC, V10, P1181, DOI 10.1111/j.1600-0854.2009.00923.x; Subramani S, 2007, CELL, V130, P18, DOI 10.1016/j.cell.2007.06.041; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Tang FS, 2006, TRAFFIC, V7, P1368, DOI 10.1111/j.1600-0854.2006.00458.x; Teter SA, 2001, J BIOL CHEM, V276, P2083, DOI 10.1074/jbc.C000739200; Uttenweiler Andreas, 2008, V445, P245, DOI 10.1007/978-1-59745-157-4_16; Uttenweiler A, 2007, MOL BIOL CELL, V18, P166, DOI 10.1091/mbc.E06-08-0664; van der Vaart A, 2008, TRAFFIC, V9, P281, DOI 10.1111/j.1600-0854.2007.00674.x; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang ZF, 2006, MOL BIOL CELL, V17, P5094, DOI 10.1091/mbc.E06-06-0479; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Yen WL, 2007, MOL BIOL CELL, V18, P581, DOI 10.1091/mbc.E06-07-0612	50	39	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40013	10.1371/journal.pone.0040013	http://dx.doi.org/10.1371/journal.pone.0040013			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768199	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100171
J	Neant-Fery, M; Peres, E; Nasrallah, C; Kessner, M; Gribaudo, S; Greer, C; Didier, A; Trembleau, A; Caille, I				Neant-Fery, Marie; Peres, Eleonore; Nasrallah, Carole; Kessner, Monica; Gribaudo, Simona; Greer, Charles; Didier, Anne; Trembleau, Alain; Caille, Isabelle			A Role for Dendritic Translation of CaMKII alpha mRNA in Olfactory Plasticity	PLOS ONE			English	Article							PROTEIN-KINASE-II; MENTAL-RETARDATION PROTEIN; LONG-TERM POTENTIATION; CYTOPLASMIC POLYADENYLATION; DEPENDENT TRANSLATION; SYNAPTIC PLASTICITY; MOUSE MODEL; BULB; MEMORY; STIMULATION	Local protein synthesis in dendrites contributes to the synaptic modifications underlying learning and memory. The mRNA encoding the alpha subunit of the calcium/calmodulin dependent Kinase II (CaMKII alpha) is dendritically localized and locally translated. A role for CaMKII alpha local translation in hippocampus-dependent memory has been demonstrated in mice with disrupted CaMKII alpha dendritic translation, through deletion of CaMKII alpha 3'UTR. We studied the dendritic localization and local translation of CaMKII alpha in the mouse olfactory bulb (OB), the first relay of the olfactory pathway, which exhibits a high level of plasticity in response to olfactory experience. CaMKII alpha is expressed by granule cells (GCs) of the OB. Through in situ hybridization and synaptosome preparation, we show that CaMKII alpha mRNA is transported in GC dendrites, synaptically localized and might be locally translated at GC synapses. Increases in the synaptic localization of CaMKII alpha mRNA and protein in response to brief exposure to new odors demonstrate that they are activity-dependent processes. The activity-induced dendritic transport of CaMKII alpha mRNA can be inhibited by an NMDA receptor antagonist and mimicked by an NMDA receptor agonist. Finally, in mice devoid of CaMKII alpha 3'UTR, the dendritic localization of CaMKII alpha mRNA is disrupted in the OB and olfactory associative learning is severely impaired. Our studies thus reveal a new functional modality for CaMKII alpha local translation, as an essential determinant of olfactory plasticity.	[Neant-Fery, Marie; Nasrallah, Carole; Kessner, Monica; Gribaudo, Simona; Trembleau, Alain; Caille, Isabelle] UPMC Univ Paris 06, CNRS, UMR 7102, Team Dev & Plast Neural Networks, Paris, France; [Peres, Eleonore; Didier, Anne] Univ Lyon 1, Neuroplast & Neuropathol Olfactory Percept Team, Lyon Neurosci Res Ctr, F-69365 Lyon, France; [Peres, Eleonore; Didier, Anne] INSERM, UMR 1028, F-69008 Lyon, France; [Peres, Eleonore; Didier, Anne] CNRS, UMR5292, Lyon, France; [Greer, Charles] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA; [Caille, Isabelle] Univ Paris Diderot, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Yale University; UDICE-French Research Universities; Universite Paris Cite	Neant-Fery, M (corresponding author), UPMC Univ Paris 06, CNRS, UMR 7102, Team Dev & Plast Neural Networks, Paris, France.	isabelle.caille@snv.jussieu.fr	Caillé, Isabelle/AAC-9575-2021; DIDIER, Anne/H-4413-2017	DIDIER, Anne/0000-0003-3118-9961; Caille, Isabelle/0000-0002-9054-2641; Gribaudo, Simona/0000-0002-9361-3855; Trembleau, Alain/0000-0002-8290-0795	Centre National de la Recherche Scientifique, UPMC; Institut National Scientifique d'Etudes et de Recherches Medicales [R06496DS]; ANR [06-NEUR-039-01]; FRM [INE20071110908, DEQ20071210561]; Fondation Lejeune; Region I le de France (DIM Stem-Pole and NeRF)	Centre National de la Recherche Scientifique, UPMC(Centre National de la Recherche Scientifique (CNRS)); Institut National Scientifique d'Etudes et de Recherches Medicales; ANR(French National Research Agency (ANR)); FRM(Fondation pour la Recherche Medicale); Fondation Lejeune; Region I le de France (DIM Stem-Pole and NeRF)	This work was supported by Centre National de la Recherche Scientifique, UPMC, Institut National Scientifique d'Etudes et de Recherches Medicales Avenir program (R06496DS), ANR (06-NEUR-039-01), FRM (INE20071110908 & DEQ20071210561) and Fondation Lejeune Grants. The "Development and Plasticity of Neural Networks'' team is affiliated with the Paris School of Neuroscience. MNF and SG were supported by fellowships from Region I le de France (DIM Stem-Pole and NeRF respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Alves-Sampaio A, 2010, J NEUROSCI, V30, P13537, DOI 10.1523/JNEUROSCI.3457-10.2010; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Bagni C, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0004.2000; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Burton S, 2000, J NEUROSCI, V20, P5468, DOI 10.1523/JNEUROSCI.20-14-05468.2000; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Doucette W, 2011, NEURON, V69, P1176, DOI 10.1016/j.neuron.2011.02.024; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Havik B, 2003, EUR J NEUROSCI, V17, P2679, DOI 10.1046/j.1460-9568.2003.02712.x; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Jonasson Z, 2004, HIPPOCAMPUS, V14, P28, DOI 10.1002/hipo.10146; Jourdain P, 2003, J NEUROSCI, V23, P10645; Kao DI, 2010, P NATL ACAD SCI USA, V107, P15601, DOI 10.1073/pnas.1010564107; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; Kermen F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012118; Mandairon N, 2009, J NEUROSCI METH, V180, P296, DOI 10.1016/j.jneumeth.2009.04.008; Mandairon N, 2009, J NEUROPHYSIOL, V101, P2204, DOI 10.1152/jn.00076.2009; Martin C, 2004, J NEUROSCI, V24, P389, DOI 10.1523/JNEUROSCI.3433-03.2004; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Moreno MM, 2009, P NATL ACAD SCI USA, V106, P17980, DOI 10.1073/pnas.0907063106; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Ouyang Y, 1999, J NEUROSCI, V19, P7823; Paradies MA, 1997, J NEUROBIOL, V33, P473, DOI 10.1002/(SICI)1097-4695(199710)33:4<473::AID-NEU10>3.0.CO;2-D; Pi HJ, 2010, P NATL ACAD SCI USA, V107, P14437, DOI 10.1073/pnas.1009268107; Richard MB, 2010, P NATL ACAD SCI USA, V107, P15613, DOI 10.1073/pnas.1007931107; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Scotto-Lomassese S, 2011, J NEUROSCI, V31, P2205, DOI 10.1523/JNEUROSCI.5514-10.2011; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; STEWARD O, 1982, J NEUROSCI, V2, P284; Sultan S, 2010, FASEB J, V24, P2355, DOI 10.1096/fj.09-151456; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; THOMAS KL, 1994, NEURON, V13, P737, DOI 10.1016/0896-6273(94)90040-X; Wells DG, 2001, J NEUROSCI, V21, P9541, DOI 10.1523/JNEUROSCI.21-24-09541.2001; WHITTAKER VP, 1959, BIOCHEM J, V72, P694, DOI 10.1042/bj0720694; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Yamagata Y, 2009, J NEUROSCI, V29, P7607, DOI 10.1523/JNEUROSCI.0707-09.2009; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zou DJ, 2002, J COMP NEUROL, V443, P226, DOI 10.1002/cne.10125	48	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40133	10.1371/journal.pone.0040133	http://dx.doi.org/10.1371/journal.pone.0040133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768241	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100213
J	Ravin, R; Blank, PS; Steinkamp, A; Rappaport, SM; Ravin, N; Bezrukov, L; Guerrero-Cazares, H; Quinones-Hinojosa, A; Bezrukov, SM; Zimmerberg, J				Ravin, Rea; Blank, Paul S.; Steinkamp, Alex; Rappaport, Shay M.; Ravin, Nitay; Bezrukov, Ludmila; Guerrero-Cazares, Hugo; Quinones-Hinojosa, Alfredo; Bezrukov, Sergey M.; Zimmerberg, Joshua			Shear Forces during Blast, Not Abrupt Changes in Pressure Alone, Generate Calcium Activity in Human Brain Cells	PLOS ONE			English	Article							IN-VITRO; INJURY; MECHANISMS; MODEL; WAVE; RESPONSES	Blast-Induced Traumatic Brain Injury (bTBI) describes a spectrum of injuries caused by an explosive force that results in changes in brain function. The mechanism responsible for primary bTBI following a blast shockwave remains unknown. We have developed a pneumatic device that delivers shockwaves, similar to those known to induce bTBI, within a chamber optimal for fluorescence microscopy. Abrupt changes in pressure can be created with and without the presence of shear forces at the surface of cells. In primary cultures of human central nervous system cells, the cellular calcium response to shockwaves alone was negligible. Even when the applied pressure reached 15 atm, there was no damage or excitation, unless concomitant shear forces, peaking between 0.3 to 0.7 Pa, were present at the cell surface. The probability of cellular injury in response to a shockwave was low and cell survival was unaffected 20 hours after shockwave exposure.	[Ravin, Rea; Blank, Paul S.; Steinkamp, Alex; Rappaport, Shay M.; Ravin, Nitay; Bezrukov, Ludmila; Bezrukov, Sergey M.; Zimmerberg, Joshua] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD USA; [Blank, Paul S.; Rappaport, Shay M.; Bezrukov, Sergey M.; Zimmerberg, Joshua] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Guerrero-Cazares, Hugo; Quinones-Hinojosa, Alfredo] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Uniformed Services University of the Health Sciences - USA; Johns Hopkins University	Ravin, R (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD USA.	zimmerbj@mail.nih.gov	Blank, Paul/Q-9673-2019	Guerrero-Cazares, Hugo/0000-0003-1307-719X	Department of Defense in the Center for Neuroscience and Regenerative Medicine (CNRM); Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001409, ZIAHD000072] Funding Source: NIH RePORTER	Department of Defense in the Center for Neuroscience and Regenerative Medicine (CNRM); Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Support for this work included funding from Department of Defense in the Center for Neuroscience and Regenerative Medicine (CNRM) and the Intramural Program of the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; BOWEN IG, 1968, ANN NY ACAD SCI, V152, P122, DOI 10.1111/j.1749-6632.1968.tb11971.x; BRODE HL, 1959, PHYS FLUIDS, V2, P217, DOI 10.1063/1.1705911; Center DaVBI, 2011, DEP DEF NUMB TRAUM B; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howard D, 1997, ULTRASOUND MED BIOL, V23, P1107, DOI 10.1016/S0301-5629(97)00081-1; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; LaPlaca MC, 2006, 2006 28TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-15, P5882; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Prado GR, 2005, J NEURAL ENG, V2, P148, DOI 10.1088/1741-2560/2/4/011; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Shin HS, 2009, J NANOSCI NANOTECHNO, V9, P7330, DOI 10.1166/jnn.2009.1769; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; WHITTAKER VP, 1993, J NEUROCYTOL, V22, P735, DOI 10.1007/BF01181319; Zhang JY, 2009, STAPP CAR CRASH JO, V53, P215	27	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39421	10.1371/journal.pone.0039421	http://dx.doi.org/10.1371/journal.pone.0039421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768078	gold, Green Published			2022-12-27	WOS:000305892100049
J	Simonsen, TG; Gaustad, JV; Leinaas, MN; Rofstad, EK				Simonsen, Trude G.; Gaustad, Jon-Vidar; Leinaas, Marit N.; Rofstad, Einar K.			High Interstitial Fluid Pressure Is Associated with Tumor-Line Specific Vascular Abnormalities in Human Melanoma Xenografts	PLOS ONE			English	Article							SOLID TUMORS; CANCER-THERAPY; BLOOD-FLOW; ANGIOGENESIS; HYPERTENSION; METASTASIS; MACROMOLECULES; HETEROGENEITY; CARCINOMA; DELIVERY	Purpose: Interstitial fluid pressure (IFP) is highly elevated in many solid tumors. High IFP has been associated with low radiocurability and high metastatic frequency in human melanoma xenografts and with poor survival after radiation therapy in cervical cancer patients. Abnormalities in tumor vascular networks have been identified as an important cause of elevated tumor IFP. The aim of this study was to investigate the relationship between tumor IFP and the functional and morphological properties of tumor vascular networks. Materials and Methods: A-07-GFP and R-18-GFP human melanomas growing in dorsal window chambers in BALB/c nu/nu mice were used as preclinical tumor models. Functional and morphological parameters of the vascular network were assessed from first-pass imaging movies and vascular maps recorded after intravenous bolus injection of 155-kDa tetramethylrhodamine isothiocyanate-labeled dextran. IFP was measured in the center of the tumors using a Millar catheter. Angiogenic profiles of A-07-GFP and R-18-GFP cells were obtained with a quantitative PCR array. Results: High IFP was associated with low growth rate and low vascular density in A-07-GFP tumors, and with high growth rate and high vascular density in R-18-GFP tumors. A-07-GFP tumors showed chaotic and highly disorganized vascular networks, while R-18-GFP tumors showed more organized vascular networks with supplying arterioles in the tumor center and draining venules in the tumor periphery. Furthermore, A-07-GFP and R-18-GFP cells differed substantially in angiogenic profiles. A-07-GFP tumors with high IFP showed high geometric resistance to blood flow due to high vessel tortuosity. R-18-GFP tumors with high IFP showed high geometric resistance to blood flow due to a large number of narrow tumor capillaries. Conclusions: High IFP in A-07-GFP and R-18-GFP human melanoma xenografts was primarily a consequence of high blood flow resistance caused by tumor-line specific vascular abnormalities.	[Simonsen, Trude G.; Gaustad, Jon-Vidar; Leinaas, Marit N.; Rofstad, Einar K.] Oslo Univ Hosp, Inst Canc Res, Dept Radiat Biol, Grp Radiat Biol & Tumor Physiol, Oslo, Norway	University of Oslo	Simonsen, TG (corresponding author), Oslo Univ Hosp, Inst Canc Res, Dept Radiat Biol, Grp Radiat Biol & Tumor Physiol, Oslo, Norway.	Trude.Golimo.Simonsen@rr-research.no			Norwegian Cancer Society; South-Eastern Norway Regional Health Authority	Norwegian Cancer Society(Norwegian Cancer Society); South-Eastern Norway Regional Health Authority	This work was supported by the Norwegian Cancer Society and the South-Eastern Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Olama M, 2011, ACTA ONCOL, V50, P1098, DOI 10.3109/0284186X.2011.562240; BAXTER LT, 1989, MICROVASC RES, V37, P77, DOI 10.1016/0026-2862(89)90074-5; Bjornaes I, 2001, MAGN RESON IMAGING, V19, P723, DOI 10.1016/S0730-725X(01)00377-0; BOUCHER Y, 1990, CANCER RES, V50, P4478; BOUCHER Y, 1991, CANCER RES, V51, P6691; BOUCHER Y, 1992, CANCER RES, V52, P5110; Boucher Y, 1996, CANCER RES, V56, P4264; Brown JM, 1998, CANCER RES, V58, P1408; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; CURTI BD, 1993, CANCER RES, V53, P2204; Ferretti S, 2009, NEOPLASIA, V11, P874, DOI 10.1593/neo.09554; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gaustad JV, 2008, NEOPLASIA, V10, P354, DOI 10.1593/neo.08162; Gaustad JV, 2009, NEOPLASIA, V11, P277, DOI 10.1593/neo.81400; Gulliksrud K, 2009, RADIOTHER ONCOL, V91, P107, DOI 10.1016/j.radonc.2008.08.015; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; JAIN RK, 1987, CANCER METAST REV, V6, P559, DOI 10.1007/BF00047468; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; JAIN RK, 1988, CANCER RES, V48, P2641; Klosowska-Wardega A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008149; Less JR, 1997, MICROCIRCULATION-LON, V4, P25, DOI 10.3109/10739689709148315; LESS JR, 1992, CANCER RES, V52, P6371; Lunt SJ, 2008, FUTURE ONCOL, V4, P793, DOI 10.2217/14796694.4.6.793; Milosevic M, 2001, CANCER RES, V61, P6400; Milosevic MF, 1998, CANCER, V82, P2418, DOI 10.1002/(SICI)1097-0142(19980615)82:12<2418::AID-CNCR16>3.0.CO;2-S; NETTI PA, 1995, CANCER RES, V55, P5451; Netti PA, 1999, P NATL ACAD SCI USA, V96, P3137, DOI 10.1073/pnas.96.6.3137; Oye KS, 2008, MICROVASC RES, V75, P179, DOI 10.1016/j.mvr.2007.06.009; Ozerdem U, 2005, MICROVASC RES, V70, P116, DOI 10.1016/j.mvr.2005.07.003; Padera TP, 2002, SCIENCE, V296, P1883, DOI 10.1126/science.1071420; Rofstad EK, 2010, NEOPLASIA, V12, P889, DOI 10.1593/neo.10712; Rofstad EK, 2010, CLIN CANCER RES, V16, P936, DOI 10.1158/1078-0432.CCR-09-2718; Rofstad EK, 2009, NEOPLASIA, V11, P1243, DOI 10.1593/neo.91152; ROFSTAD EK, 1986, CELL TISSUE KINET, V19, P205, DOI 10.1111/j.1365-2184.1986.tb00731.x; Rofstad EK, 2000, CANCER RES, V60, P4932; Rofstad EK, 1999, INT J RADIAT BIOL, V75, P1377; Rofstad EK, 2002, CANCER RES, V62, P661; ROFSTAD EK, 1994, BRIT J CANCER, V70, P804, DOI 10.1038/bjc.1994.403; Salnikov AV, 2003, FASEB J, V17, P1756, DOI 10.1096/fj.02-1201fje; Sen A, 2011, CANCER RES, V71, P3872, DOI 10.1158/0008-5472.CAN-10-4482; SEVICK EM, 1991, CANCER RES, V51, P1352; Tailor TD, 2010, MOL CANCER THER, V9, P1798, DOI 10.1158/1535-7163.MCT-09-0856; Tozer GM, 2005, ADV DRUG DELIVER REV, V57, P135, DOI 10.1016/j.addr.2004.07.015; Tufto I, 1998, CANCER LETT, V123, P159, DOI 10.1016/S0304-3835(97)00424-2; Vajkoczy P, 2000, NEOPLASIA, V2, P53, DOI 10.1038/sj.neo.7900062; VAUPEL P, 1989, CANCER RES, V49, P6449; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Yeo SG, 2009, CLIN CANCER RES, V15, P6201, DOI 10.1158/1078-0432.CCR-09-0560	48	51	52	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40006	10.1371/journal.pone.0040006	http://dx.doi.org/10.1371/journal.pone.0040006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768196	Green Submitted, gold, Green Published			2022-12-27	WOS:000305892100168
J	Su, HL; Liu, XY; Yan, WC; Shi, TY; Zhao, XX; Blake, DP; Tomley, FM; Suo, X				Su, Huali; Liu, Xianyong; Yan, Wenchao; Shi, Tuanyuan; Zhao, Xinxin; Blake, Damer P.; Tomley, Fiona M.; Suo, Xun			piggyBac Transposon-Mediated Transgenesis in the Apicomplexan Parasite Eimeria tenella	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS VIRUSES; STABLE TRANSFECTION; FLUORESCENT PROTEIN; BACULOVIRUS GENOME; IN-VITRO; TRANSFORMATION; EXPRESSION; SEQUENCES; SPOROZOITES; MUTAGENESIS	piggyBac, a type II transposon that is useful for efficient transgenesis and insertional mutagenesis, has been used for effective and stable transfection in a wide variety of organisms. In this study we investigate the potential use of the piggyBac transposon system for forward genetics studies in the apicomplexan parasite Eimeria tenella. Using the restriction enzyme-mediated integration (REMI) method, E. tenella sporozoites were electroporated with a donor plasmid containing the enhanced yellow fluorescent protein (EYFP) gene flanked by piggyBac inverted terminal repeats (ITRs), an Asc I-linearized helper plasmid containing the transposase gene and the restriction enzyme Asc I. Subsequently, electroporated sporozoites were inoculated into chickens via the cloacal route and transfected progeny oocysts expressing EYFP were sorted by flow cytometry. A transgenic E. tenella population was selected by successive in vivo passage. Southern-blotting analysis showed that exogenous DNA containing the EYFP gene was integrated into the parasite genome at a limited number of integration sites and that the inserted part of the donor plasmid was the fragment located between the 5' and 3' ITRs as indicated by primer-specific PCR screening. Genome walking revealed that the insertion sites were TTAA-specific, which is consistent with the transposition characteristics of piggyBac.	[Su, Huali; Liu, Xianyong; Yan, Wenchao; Shi, Tuanyuan; Zhao, Xinxin; Suo, Xun] China Agr Univ, Natl Anim Protozoa Lab, Beijing 100094, Peoples R China; [Su, Huali; Liu, Xianyong; Yan, Wenchao; Shi, Tuanyuan; Zhao, Xinxin; Suo, Xun] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Blake, Damer P.; Tomley, Fiona M.] Inst Anim Hlth, Compton, Berks, England; [Blake, Damer P.; Tomley, Fiona M.] Royal Vet Coll, N Mymms, Herts, England	China Agricultural University; China Agricultural University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of London; University of London Royal Veterinary College	Su, HL (corresponding author), China Agr Univ, Natl Anim Protozoa Lab, Beijing 100094, Peoples R China.	suoxun@cau.edu.cn	Tomley, Fiona/GWM-9070-2022; Su, Huali/AAD-3755-2021; Yan, Wenchao/R-1234-2019	Tomley, Fiona/0000-0003-2188-8013; Zhao, Xin-Xin/0000-0002-1901-1784; LIU, XIANYONG/0000-0001-9425-6784; Blake, Damer/0000-0003-1077-2306	Ministry of Education Academic Awards for Excellent PhD Students in China; National Key Programs of China [2009ZX08009-152B]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001142] Funding Source: researchfish	Ministry of Education Academic Awards for Excellent PhD Students in China; National Key Programs of China; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by the Ministry of Education Academic Awards for Excellent PhD Students in China and the National Key Programs of China (Project Nos. 2009ZX08009-152B). Interactions between the authors' laboratories have been facilitated by BBSRC China Partnering Award 1340. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balu B, 2005, P NATL ACAD SCI USA, V102, P16391, DOI 10.1073/pnas.0504679102; Black M, 1995, MOL BIOCHEM PARASIT, V74, P55, DOI 10.1016/0166-6851(95)02483-2; Blake DP, 2006, INT J PARASITOL, V36, P97, DOI 10.1016/j.ijpara.2005.09.011; Bromley E, 2003, PROTEOMICS, V3, P1553, DOI 10.1002/pmic.200300479; CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7; Clark JD, 2008, MOL BIOCHEM PARASIT, V162, P77, DOI 10.1016/j.molbiopara.2008.07.006; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Fonager J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-155; FRASER MJ, 1983, J VIROL, V47, P287, DOI 10.1128/JVI.47.2.287-300.1983; FRASER MJ, 1995, VIROLOGY, V211, P397, DOI 10.1006/viro.1995.1422; Fraser MJ, 1996, INSECT MOL BIOL, V5, P141, DOI 10.1111/j.1365-2583.1996.tb00048.x; Hao LL, 2007, MOL BIOCHEM PARASIT, V153, P213, DOI 10.1016/j.molbiopara.2007.02.005; Kelleher M, 1998, MOL BIOCHEM PARASIT, V97, P21, DOI 10.1016/S0166-6851(98)00128-5; Kurth M, 2009, PARASITOL RES, V104, P303, DOI 10.1007/s00436-008-1192-0; Li X, 2005, INSECT MOL BIOL, V14, P17, DOI 10.1111/j.1365-2583.2004.00525.x; Ling KH, 2007, GENOME RES, V17, P311, DOI 10.1101/gr.5823007; Liu XY, 2008, MOL BIOCHEM PARASIT, V161, P72, DOI 10.1016/j.molbiopara.2008.06.006; LONG P L, 1976, Folia Veterinaria Latina, V6, P201; SCHMATZ DM, 1984, J PROTOZOOL, V31, P181, DOI 10.1111/j.1550-7408.1984.tb04314.x; Shi TY, 2008, J PARASITOL, V94, P978, DOI 10.1645/GE-1412.1; Shi TY, 2009, PARASITOL RES, V104, P315, DOI 10.1007/s00436-008-1194-y; Shirley MW, 2005, ADV PARASIT, V60, P285, DOI 10.1016/S0065-308X(05)60005-X; Shirley MW, 2004, TRENDS PARASITOL, V20, P199, DOI 10.1016/j.pt.2004.02.005; Suo X, 2006, VET PARASITOL, V142, P63, DOI 10.1016/j.vetpar.2006.06.020; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Williams RB, 1998, INT J PARASITOL, V28, P1089, DOI 10.1016/S0020-7519(98)00066-6; Yan WC, 2009, INT J PARASITOL, V39, P109, DOI 10.1016/j.ijpara.2008.06.013	27	12	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40075	10.1371/journal.pone.0040075	http://dx.doi.org/10.1371/journal.pone.0040075			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768223	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100195
J	Taya, S; Windridge, D; Osman, M				Taya, Shuichiro; Windridge, David; Osman, Magda			Looking to Score: The Dissociation of Goal Influence on Eye Movement and Meta-Attentional Allocation in a Complex Dynamic Natural Scene	PLOS ONE			English	Article							SALIENCY; TASK; OVERT; STRATEGIES; DIRECTION; MEMORY; SHIFTS	Several studies have reported that task instructions influence eye-movement behavior during static image observation. In contrast, during dynamic scene observation we show that while the specificity of the goal of a task influences observers' beliefs about where they look, the goal does not in turn influence eye-movement patterns. In our study observers watched short video clips of a single tennis match and were asked to make subjective judgments about the allocation of visual attention to the items presented in the clip (e. g., ball, players, court lines, and umpire). However, before attending to the clips, observers were either told to simply watch clips (non-specific goal), or they were told to watch the clips with a view to judging which of the two tennis players was awarded the point (specific goal). The results of subjective reports suggest that observers believed that they allocated their attention more to goal-related items (e. g. court lines) if they performed the goal-specific task. However, we did not find the effect of goal specificity on major eye-movement parameters (i.e., saccadic amplitudes, inter-saccadic intervals, and gaze coherence). We conclude that the specificity of a task goal can alter observer's beliefs about their attention allocation strategy, but such task-driven meta-attentional modulation does not necessarily correlate with eye-movement behavior.	[Taya, Shuichiro; Osman, Magda] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Taya, Shuichiro; Windridge, David; Osman, Magda] Univ Surrey, Ctr Vis Speech & Signal Proc, Guildford GU2 5XH, Surrey, England	University of London; Queen Mary University London; University of Surrey	Taya, S (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England.	m.osman@qmul.ac.uk		osman, magda/0000-0003-1480-6657; Windridge, David/0000-0001-5507-8516	Engineering and Physical Sciences Research Council [EP/F069626/1]; EPSRC [EP/F069421/1, EP/F069626/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F069421/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study is supported by grants from the Engineering and Physical Sciences Research Council (EP/F069626/1; http://www.epsrc.ac.uk/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awh E, 2006, TRENDS COGN SCI, V10, P124, DOI 10.1016/j.tics.2006.01.001; Betz T, 2010, J VISION, V10, DOI 10.1167/10.3.15; Buswell Guy Thomas, 1935, PEOPLE LOOK PICTURES; Carmi R, 2006, J VISION, V6, P898, DOI 10.1167/6.9.4; Castelhano MS, 2009, J VISION, V9, DOI 10.1167/9.3.6; Chun MM, 2000, VIS COGN, V7, P65, DOI 10.1080/135062800394685; Dorr M, 2010, J VISION, V10, DOI 10.1167/10.10.28; Foulsham T, 2007, PERCEPTION, V36, P1123, DOI 10.1068/p5659; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Hayhoe M, 2000, VIS COGN, V7, P43, DOI 10.1080/135062800394676; Hegarty M, 2010, J EXP PSYCHOL LEARN, V36, P37, DOI 10.1037/a0017683; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Henderson John M., 2007, P537, DOI 10.1016/B978-008044980-7/50027-6; Henderson JM, 2007, CURR DIR PSYCHOL SCI, V16, P219, DOI 10.1111/j.1467-8721.2007.00507.x; Henderson JM, 2009, PSYCHON B REV, V16, P850, DOI 10.3758/PBR.16.5.850; Itti L, 2005, VIS COGN, V12, P1093, DOI 10.1080/13506280444000661; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kawahara J, 2010, CONSCIOUS COGN, V19, P107, DOI 10.1016/j.concog.2009.10.004; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Land MF, 2001, CURR BIOL, V11, P1215, DOI 10.1016/S0960-9822(01)00351-7; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Land MF, 1997, PHILOS T ROY SOC B, V352, P1231, DOI 10.1098/rstb.1997.0105; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; Levin DT, 2000, VIS COGN, V7, P397, DOI 10.1080/135062800394865; Lippert M, 2007, BRAIN RES, V1173, P102, DOI 10.1016/j.brainres.2007.07.050; Lleras A, 2004, SPATIAL VISION, V17, P465, DOI 10.1163/1568568041920113; Malcolm GL, 2010, J VISION, V10, DOI 10.1167/10.2.4; Marat S, 2009, INT J COMPUT VISION, V82, P231, DOI 10.1007/s11263-009-0215-3; Mills M, 2011, J VISION, V11, DOI 10.1167/11.8.17; Mital PK, 2011, COGN COMPUT, V3, P5, DOI 10.1007/s12559-010-9074-z; Navalpakkam V, 2005, VISION RES, V45, P205, DOI 10.1016/j.visres.2004.07.042; Noesselt T, 2008, BRAIN RES, V1220, P157, DOI 10.1016/j.brainres.2007.12.060; Nuthmann A, 2010, J VISION, V10, DOI 10.1167/10.8.20; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Peters RJ, 2005, VISION RES, V45, P2397, DOI 10.1016/j.visres.2005.03.019; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Shinoda H, 2001, VISION RES, V41, P3535, DOI 10.1016/S0042-6989(01)00199-7; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; Turano KA, 2003, VISION RES, V43, P333, DOI 10.1016/S0042-6989(02)00498-4; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; van der Burg E, 2008, J VISION, V8, DOI 10.1167/8.5.2; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Welchman AE, 2003, J VISION, V3, P817, DOI 10.1167/3.11.15; Wolfe JM, 1999, MIT BRAD COGN PSYCH, P71; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	46	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39060	10.1371/journal.pone.0039060	http://dx.doi.org/10.1371/journal.pone.0039060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768058	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100028
J	Xie, X; Ma, YT; Yang, YN; Li, XM; Fu, ZY; Zheng, YY; Ma, X; Chen, BD; Liu, F; Huang, Y; Yu, ZX; Chen, Y				Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Li, Xiao-Mei; Fu, Zhen-Yan; Zheng, Ying-Ying; Ma, Xiang; Chen, Bang-Dang; Liu, Fen; Huang, Ying; Yu, Zi-Xiang; Chen, You			Serum Uric Acid Levels Are Associated with Polymorphism in the SAA1 Gene in Chinese Subjects	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; HEALTHY-SUBJECTS; HYPERTENSION; DISEASE; INFLAMMATION; MECHANISMS; PROTEINS; OBESITY; CELLS; RISK	Objective: Serum uric acid (SUA) is a cardiovascular risk marker associated with inflammation. The serum amyloid A protein (SAA) is an inflammatory factor and is associated with cardiovascular disease (CVD). However, the relationship between genetic polymorphisms of SAA and SUA levels has not been studied. The objective of this study was to investigate the association between SUA levels and SAA genetic polymorphisms. Methods: All participants were selected from subjects participating in the Cardiovascular Risk Survey (CRS) study. The single nucleotide polymorphism (SNP) rs12218 of the SAA1 gene was genotyped by using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The association of SUA levels with genotypes was assessed by using the general liner mode. Results: The SNP rs12218 was associated with SUA levels by analyses of a dominate model (P = 0.002) and additive model (P = 0.005), and the difference remained significant after adjustment of sex, age, obesity, ethnicity, HDL-C, alcohol intake, smoking, and creatinine (P = 0.006 and P = 0.023, respectively). The TT genotype was associated with an increased SUA concentration of 39.34 mmol/L (95% confidence interval [CI], 3.61-75.06, P = 0.031) compared with the CC genotype, and the TT genotype was associated with an increased SUA concentration of 2.48 mmol/L (95% CI, 6.86-38.10; P = 0.005) compared with the CT genotype. Conclusions: The rs12218 SNP in the SAA1 gene was associated with SUA levels in Chinese subjects, indicating that carriers of the T allele of rs12218 have a high risk of hyperuricemia.	[Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Li, Xiao-Mei; Fu, Zhen-Yan; Zheng, Ying-Ying; Ma, Xiang; Huang, Ying; Yu, Zi-Xiang; Chen, You] Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China; [Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Li, Xiao-Mei; Fu, Zhen-Yan; Zheng, Ying-Ying; Ma, Xiang; Chen, Bang-Dang; Liu, Fen; Huang, Ying; Yu, Zi-Xiang; Chen, You] Xinjiang Key Lab Cardiovasc Dis Res, Urumqi, Peoples R China	Xinjiang Medical University	Ma, YT (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China.	myt-xj@163.com	xie, xiang/AAG-2128-2021		Xinjiang Medical University [2010YFY08]; National Natural Science Foundation of China [81160017]; Natural Science Foundation of Xinjiang [2011211D32]	Xinjiang Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Xinjiang	Encouraged Fund for Research of Xinjiang Medical University (2010YFY08) on the basis of the National Natural Science Foundation of China (81160017) and Natural Science Foundation of Xinjiang (2011211D32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman MH, 1999, HYPERTENSION, V34, P144, DOI 10.1161/01.HYP.34.1.144; Alper AB, 2005, HYPERTENSION, V45, P34, DOI 10.1161/01.HYP.0000150783.79172.bb; BENDITT EP, 1971, FEBS LETT, V19, P169, DOI 10.1016/0014-5793(71)80506-9; Bonora E, 1996, INT J OBESITY, V20, P975; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Johnson RJ, 2005, AM J HYPERTENS, V18, P431, DOI 10.1016/j.amjhyper.2004.08.035; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; KIRWAN J, 1993, BRIT J RHEUMATOL, V32, P729; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; LEVIN M, 1972, J CLIN INVEST, V51, P2773, DOI 10.1172/JCI107098; Leyva F, 1998, EUR HEART J, V19, P1814, DOI 10.1053/euhj.1998.1188; Manzato E, 2007, INTERN EMERG MED, V2, P1, DOI 10.1007/s11739-007-0001-6; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Montalcini T, 2007, INTERN EMERG MED, V2, P19, DOI 10.1007/s11739-007-0004-3; Nakanishi N, 2003, EUR J EPIDEMIOL, V18, P523, DOI 10.1023/A:1024600905574; Ogura T, 2004, METABOLISM, V53, P448, DOI 10.1016/j.metabol.2003.11.017; Patel S, 2008, EUR HEART J, V29, P386, DOI 10.1093/eurheartj/ehm526; Ruggiero C, 2006, EUR HEART J, V27, P1174, DOI 10.1093/eurheatj/ehi879; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shi Y, 2010, J CLIN INVEST, V120, P1809, DOI 10.1172/JCI43132; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; van der Harst P, 2010, HUM MOL GENET, V19, P387, DOI 10.1093/hmg/ddp489; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Xie X, 2011, BLOOD PRESSURE, V20, P232, DOI 10.3109/08037051.2011.566244; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013997; Xie Xiang, 2010, Zhonghua Yi Xue Za Zhi, V90, P1824; Xie X, 2009, CLIN APPL THROMB-HEM, V15, P574, DOI 10.1177/1076029608329581; Xie X, 2009, CLIN CHEM LAB MED, V47, P347, DOI 10.1515/CCLM.2009.078; Yamada T, 1999, AMYLOID, V6, P199, DOI 10.3109/13506129909007327	31	11	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40263	10.1371/journal.pone.0040263	http://dx.doi.org/10.1371/journal.pone.0040263			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768267	Green Submitted, gold, Green Published			2022-12-27	WOS:000305892100241
J	Zhang, SL; Wang, YC; Mao, JH; Hsieh, D; Kim, IJ; Hu, LM; Xu, ZD; Long, H; Jablons, DM; You, L				Zhang, Shulin; Wang, Yucheng; Mao, Jian-Hua; Hsieh, David; Kim, Il-Jin; Hu, Li-Min; Xu, Zhidong; Long, Hao; Jablons, David M.; You, Liang			Inhibition of CK2 alpha Down-Regulates Hedgehog/Gli Signaling Leading to a Reduction of a Stem-Like Side Population in Human Lung Cancer Cells	PLOS ONE			English	Article							PROTEIN-KINASE CK2; PROSTATE-CANCER; THERAPEUTIC INHIBITION; PATHWAY; TARGET; ABCG2; WNT; DIVERGENCE; CARCINOMAS; SUPPRESSOR	Protein kinase CK2 is frequently elevated in a variety of human cancers. The Hedgehog (Hh) signaling pathway has been implicated in stem cell maintenance, and its aberrant activation has been indicated in several types of cancer, including lung cancer. In this study, we show that CK2 is positively involved in Hh/Gli signaling in lung cancer cell lines A549 and H1299. First, we found a correlation between CK2 alpha and Gli1 mRNA levels in 100 primary lung cancer tissues. Down-regulation of Gli1 expression and transcriptional activity were demonstrated after the silencing of CK2 alpha in lung cancer cells. In addition, CK2 alpha siRNA down-regulated the expression of Hh target genes. Furthermore, two small-molecule CK2 alpha inhibitors led to a dose-dependent inhibition of Gli1 expression and transcriptional activity in lung cancer cells. Reversely, forced overexpression of CK2 alpha resulted in an increase both in Gli1 expression and transcriptional activity in A549 cells. Finally, the inhibition of Hh/Gli by CK2 alpha siRNA led to a reduction of a cancer stem cell-like side population that shows higher ABCG2 expression level. Thus, we report that the inhibition of CK2 alpha down-regulates Hh/Gli signaling and subsequently reduces stem-like side population in human lung cancer cells.	[Zhang, Shulin; Hsieh, David; Kim, Il-Jin; Xu, Zhidong; Long, Hao; Jablons, David M.; You, Liang] Univ Calif San Francisco, Dept Surg, Helen Diller Family Comprehens Canc Ctr, Thorac Oncol Lab, San Francisco, CA 94143 USA; [Zhang, Shulin] Sun Yat Sen Univ, Lung Canc Inst, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Shulin] Guangzhou Med Univ, Affiliated Hosp 3, Dept Surg Oncol, Guangzhou, Guangdong, Peoples R China; [Mao, Jian-Hua] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Hu, Li-Min] Univ Calif San Francisco, Dept Obstet & Gynecol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Sun Yat Sen University; Guangzhou Medical University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Zhang, SL (corresponding author), Univ Calif San Francisco, Dept Surg, Helen Diller Family Comprehens Canc Ctr, Thorac Oncol Lab, San Francisco, CA 94143 USA.	longhao@mail.sysu.edu.cn; Liang.You@ucsfmedctr.org	Mao, Jian-Hua/EIZ-8595-2022	Mao, Jian-Hua/0000-0001-9320-6021	National Institutes of Health [R01 CA140654-01A1]; Natural Science Foundation of Guangdong Province, P.R.C. [9451008901003072]; Kazan, McClain, Abrams, Fernandez, Lyons, Greenwood, Harley & Oberman Foundation, Inc; Estate of Robert Griffiths; Jeffrey and Karen Peterson Family Foundation; Paul and Michelle Zygielbaum; Estate of Norman Mancini; Barbara Isackson Lung Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA140654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of Guangdong Province, P.R.C.; Kazan, McClain, Abrams, Fernandez, Lyons, Greenwood, Harley & Oberman Foundation, Inc; Estate of Robert Griffiths; Jeffrey and Karen Peterson Family Foundation; Paul and Michelle Zygielbaum; Estate of Norman Mancini; Barbara Isackson Lung Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The present work was supported by National Institutes of Health grant R01 CA140654-01A1 (LY) and Natural Science Foundation of Guangdong Province, P.R.C. 2009 (9451008901003072). We are also grateful for support from the Kazan, McClain, Abrams, Fernandez, Lyons, Greenwood, Harley & Oberman Foundation, Inc; the Estate of Robert Griffiths; the Jeffrey and Karen Peterson Family Foundation; Paul and Michelle Zygielbaum; the Estate of Norman Mancini; and the Barbara Isackson Lung Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KA, 2008, ADV ENZYME REGUL, V48, P179, DOI 10.1016/j.advenzreg.2008.04.002; Altaba ARI, 2008, CANCER CELL, V14, P281, DOI 10.1016/j.ccr.2008.09.007; Balbuena J, 2011, CYTOM PART A, V79A, P672, DOI 10.1002/cyto.a.21103; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Buchou T, 2003, MOL CELL BIOL, V23, P908, DOI 10.1128/MCB.23.3.908-915.2003; Chen YB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001083; Cozza G, 2011, CURR MED CHEM, V18, P2867, DOI 10.2174/092986711796150423; Cozza G, 2010, MED RES REV, V30, P419, DOI 10.1002/med.20164; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dominguez I, 2009, CELL MOL LIFE SCI, V66, P1850, DOI 10.1007/s00018-009-9153-z; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Duncan JS, 2008, BBA-PROTEINS PROTEOM, V1784, P33, DOI 10.1016/j.bbapap.2007.08.017; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Gao Y, 2006, J BIOL CHEM, V281, P18394, DOI 10.1074/jbc.M601112200; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Guerra B, 2006, INT J ONCOL, V28, P685; Guo CH, 1999, CANCER RES, V59, P1146; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Hung MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011418; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia HG, 2010, J BIOL CHEM, V285, P37218, DOI 10.1074/jbc.M110.174565; Kim JS, 2007, CLIN CANCER RES, V13, P1019, DOI 10.1158/1078-0432.CCR-06-1602; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Laramas M, 2007, EUR J CANCER, V43, P928, DOI 10.1016/j.ejca.2006.11.021; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin KY, 2010, ANN SURG ONCOL, V17, P1695, DOI 10.1245/s10434-010-0911-9; Martins LR, 2010, BLOOD, V116, P2724, DOI 10.1182/blood-2010-04-277947; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mizuarai S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-44; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Niemann C, 2003, P NATL ACAD SCI USA, V100, P11873, DOI 10.1073/pnas.1834202100; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Perea SE, 2011, MOL CELL BIOCHEM, V356, P45, DOI 10.1007/s11010-011-0950-y; Piazza FA, 2006, BLOOD, V108, P1698, DOI 10.1182/blood-2005-11-013672; Pierre F, 2011, MOL CELL BIOCHEM, V356, P37, DOI 10.1007/s11010-011-0956-5; Pierre F, 2011, J MED CHEM, V54, P635, DOI 10.1021/jm101251q; Raaf J, 2011, BIOCHEMISTRY-US, V50, P512, DOI 10.1021/bi1013563; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Sarno S, 2008, MOL BIOSYST, V4, P889, DOI 10.1039/b805534c; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; Shi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033358; Singh RR, 2011, ONCOGENE, V30, P4874, DOI 10.1038/onc.2011.195; Song DH, 2000, J BIOL CHEM, V275, P23790, DOI 10.1074/jbc.M909107199; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Tian F, 2012, CLIN EXP MED, V12, P25, DOI 10.1007/s10238-011-0135-8; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Wang GX, 2008, MOL CELL BIOCHEM, V316, P91, DOI 10.1007/s11010-008-9810-9; Yuan Z, 2007, ONCOGENE, V26, P1046, DOI 10.1038/sj.onc.1209860	58	51	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38996	10.1371/journal.pone.0038996	http://dx.doi.org/10.1371/journal.pone.0038996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768056	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100026
J	Gangwar, SP; Dey, S; Saxena, AK				Gangwar, Shanti P.; Dey, Sharmistha; Saxena, Ajay K.			Structural Modeling and DNA Binding Autoinhibition Analysis of Ergp55, a Critical Transcription Factor in Prostate Cancer	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; ETS-DOMAIN; STRUCTURE PREDICTION; CRYSTAL-STRUCTURE; COMPLEX; FAMILY; RECOGNITION; PEA3; TRANSACTIVATION; EXPRESSION	Background: The Ergp55 protein belongs to Ets family of transcription factor. The Ets proteins are highly conserved in their DNA binding domain and involved in various development processes and regulation of cancer metabolism. To study the structure and DNA binding autoinhibition mechanism of Ergp55 protein, we have produced full length and smaller polypeptides of Ergp55 protein in E. coli and characterized using various biophysical techniques. Results: The Ergp55 polypeptides contain large amount of alpha-helix and random coil structures as measured by circular dichorism spectroscopy. The full length Ergp55 forms a flexible and elongated molecule as revealed by molecular modeling, dynamics simulation and structural prediction algorithms. The binding analyses of Ergp55 polypeptides with target DNA sequences of E74 and cfos promoters indicate that longer fragments of Ergp55 (beyond the Ets domain) showed the evidence of auto-inhibition. This study also revealed the parts of Ergp55 protein that mediate auto-inhibition. Significance: The current study will aid in designing the compounds that stabilize the inhibited form of Ergp55 and inhibit its binding to promoter DNA. It will contribute in the development of drugs targeting Ergp55 for the prostate cancer treatment.	[Gangwar, Shanti P.; Saxena, Ajay K.] Jawaharlal Nehru Univ, Sch Life Sci, Struct Biol Lab, New Delhi 110067, India; [Dey, Sharmistha] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India	Jawaharlal Nehru University, New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Gangwar, SP (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Struct Biol Lab, New Delhi 110067, India.	ajaysaxena@mail.jnu.ac.in	Gangwar, Shanti Pal/AAE-8163-2021	Gangwar, Shanti Pal/0000-0003-1024-7608	Department of Science and Technology (DST) New Delhi, India [No-SR/SO/HS-05/2009]	Department of Science and Technology (DST) New Delhi, India(Department of Science & Technology (India))	The work was supported by grant from the Department of Science and Technology (DST) New Delhi, India (No-SR/SO/HS-05/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarkar VB, 2010, J MOL BIOL, V397, P278, DOI 10.1016/j.jmb.2010.01.017; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Bojovic BB, 2001, J BIOL CHEM, V276, P4509, DOI 10.1074/jbc.M005509200; Brown LA, 1998, ONCOGENE, V17, P93, DOI 10.1038/sj.onc.1201911; Carrere S, 1998, ONCOGENE, V16, P3261, DOI 10.1038/sj.onc.1201868; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Greenall A, 2001, J BIOL CHEM, V276, P16207, DOI 10.1074/jbc.M011582200; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; Laget MP, 1996, ONCOGENE, V12, P1325; Lamber EP, 2008, EMBO J, V27, P2006, DOI 10.1038/emboj.2008.117; LIANG H, 1994, NAT STRUCT BIOL, V1, P871, DOI 10.1038/nsb1294-871; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Loughran SJ, 2008, NAT IMMUNOL, V9, P810, DOI 10.1038/ni.1617; Mackereth CD, 2004, J MOL BIOL, V342, P1249, DOI 10.1016/j.jmb.2004.07.094; Mauen S, 2006, BBA-GEN SUBJECTS, V1760, P1192, DOI 10.1016/j.bbagen.2006.03.007; Mo Y, 1998, MOL CELL, V2, P201, DOI 10.1016/S1097-2765(00)80130-6; Mo Y, 2000, NAT STRUCT BIOL, V7, P292; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; Pio F, 1996, J BIOL CHEM, V271, P23329, DOI 10.1074/jbc.271.38.23329; PRASAD DDK, 1992, CANCER RES, V52, P5833; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; SHIMIZU K, 1993, P NATL ACAD SCI USA, V90, P10280, DOI 10.1073/pnas.90.21.10280; SIDDIQUE HR, 1993, ONCOGENE, V8, P1751; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Verger A, 2001, J BIOL CHEM, V276, P17181, DOI 10.1074/jbc.M010208200; Wang YZ, 2005, BIOCHEMISTRY-US, V44, P7095, DOI 10.1021/bi047352t; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251	41	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39850	10.1371/journal.pone.0039850	http://dx.doi.org/10.1371/journal.pone.0039850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761914	gold, Green Submitted, Green Published			2022-12-27	WOS:000305826400042
J	Rutgen, BC; Willenbrock, S; Reimann-Berg, N; Walter, I; Fuchs-Baumgartinger, A; Wagner, S; Kovacic, B; Essler, SE; Schwendenwein, I; Nolte, I; Saalmuller, A; Escobar, HM				Ruetgen, Barbara C.; Willenbrock, Saskia; Reimann-Berg, Nicola; Walter, Ingrid; Fuchs-Baumgartinger, Andrea; Wagner, Siegfried; Kovacic, Boris; Essler, Sabine E.; Schwendenwein, Ilse; Nolte, Ingo; Saalmueller, Armin; Escobar, Hugo Murua			Authentication of Primordial Characteristics of the CLBL-1 Cell Line Prove the Integrity of a Canine B-Cell Lymphoma in a Murine In Vivo Model	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMAS; MALIGNANT-LYMPHOMA; CHROMOSOMAL-ABERRATIONS; DOGS; RECEPTOR; CANCER; TUMORS; CLASSIFICATION; ABNORMALITIES; EXPRESSION	Cell lines are key tools in cancer research allowing the generation of neoplasias in animal models resembling the initial tumours able to mimic the original neoplasias closely in vivo. Canine lymphoma is the major hematopoietic malignancy in dogs and considered as a valuable spontaneous large animal model for human Non-Hodgkin's Lymphoma (NHL). Herein we describe the establishment and characterisation of an in vivo model using the canine B-cell lymphoma cell line CLBL-1 analysing the stability of the induced tumours and the ability to resemble the original material. CLBL-1 was injected into Rag2(-/-)gamma(-/-)(c) mice. The generated tumor material was analysed by immunophenotyping and histopathology and used to establish the cell line CLBL-1M. Both cell lines were karyotyped for detection of chromosomal aberrations. Additionally, CLBL-1 was stimulated with IL-2 and DSP30 as described for primary canine B-cell lymphomas and NHL to examine the stimulatory effect on cell proliferation. CLBL-1 in vivo application resulted in lymphoma-like disease and tumor formation. Immunophenotypic analysis of tumorous material showed expression of CD45(+), MHCII+, CD11a(+) and CD79 alpha cy(+). PARR analysis showed positivity for IgH indicating a monoclonal character. These cytogenetic, molecular, immunophenotypical and histological characterisations of the in vivo model reveal that the induced tumours and thereof generated cell line resemble closely the original material. After DSP30 and IL-2 stimulation, CLBL-1 showed to respond in the same way as primary material. The herein described CLBL-1 in vivo model provides a highly stable tool for B-cell lymphoma research in veterinary and human medicine allowing various further in vivo studies.	[Ruetgen, Barbara C.; Schwendenwein, Ilse] Univ Vet Med Vienna, Dept Pathobiol, Cent Lab, Vienna, Austria; [Willenbrock, Saskia; Reimann-Berg, Nicola; Wagner, Siegfried; Nolte, Ingo; Escobar, Hugo Murua] Univ Vet Med Hannover, Small Anim Clin & Res Cluster Excellence REBIRTH, Hannover, Lower Saxony, Germany; [Walter, Ingrid] Univ Vet Med Vienna, VetCore Facil Res, VetBioBank, Vienna, Austria; [Fuchs-Baumgartinger, Andrea] Univ Vet Med Vienna, Dept Pathobiol, Inst Pathol, Vienna, Austria; [Kovacic, Boris] Univ Vet Med Vienna, Inst Anim Breeding & Genet, Dept Biomed Sci, Vienna, Austria; [Essler, Sabine E.; Saalmueller, Armin] Univ Vet Med Vienna, Inst Immunol, Dept Pathobiol, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Rutgen, BC (corresponding author), Univ Vet Med Vienna, Dept Pathobiol, Cent Lab, Vienna, Austria.	hescobar@tiho-hannover.de	Kovacic, Boris/J-1871-2016; Saalmüller, Armin/AAN-9058-2020; Rütgen, Barbara/ADM-6510-2022	Kovacic, Boris/0000-0002-1148-4149; Saalmuller, Armin/0000-0002-7703-3252	German Research Foundation within the excellence cluster REBIRTH; collaborative research cluster Transregio 37 'Micro- und Nanosysteme in der Medizin'	German Research Foundation within the excellence cluster REBIRTH; collaborative research cluster Transregio 37 'Micro- und Nanosysteme in der Medizin'	The work was funded in part by the German Research Foundation within the excellence cluster REBIRTH. Further parts were funded by the collaborative research cluster Transregio 37 'Micro- und Nanosysteme in der Medizin'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTNITZKE S, 1992, CYTOGENET CELL GENET, V60, P135, DOI 10.1159/000133323; BLOOMFIELD CD, 1983, CANCER RES, V43, P2975; Breen M, 2008, CHROMOSOME RES, V16, P145, DOI 10.1007/s10577-007-1212-4; Burnett RC, 2003, VET PATHOL, V40, P32, DOI 10.1354/vp.40-1-32; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Decker T, 2000, EXP HEMATOL, V28, P558, DOI 10.1016/S0301-472X(00)00144-2; Devitt JJ, 2009, CYTOGENET GENOME RES, V124, P12, DOI 10.1159/000200083; Fosmire SP, 2007, VET PATHOL, V44, P467, DOI 10.1354/vp.44-4-467; FournelFleury C, 1997, J COMP PATHOL, V117, P35, DOI 10.1016/S0021-9975(97)80065-5; GREENLEE PG, 1990, CANCER-AM CANCER SOC, V66, P480, DOI 10.1002/1097-0142(19900801)66:3&lt;480::AID-CNCR2820660314&gt;3.0.CO;2-X; Haferlach C, 2007, LEUKEMIA, V21, P2442, DOI 10.1038/sj.leu.2404935; HAHN KA, 1994, VET PATHOL, V31, P528, DOI 10.1177/030098589403100504; Joetzke AE, 2010, VET COMP ONCOL, V8, P87, DOI 10.1111/j.1476-5829.2010.00207.x; JOHNSON RE, 1969, RADIOLOGY, V93, P395, DOI 10.1148/93.2.395; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Kisseberth WC, 2007, LEUKEMIA RES, V31, P1709, DOI 10.1016/j.leukres.2007.04.003; MACEWEN EG, 1990, CANCER METAST REV, V9, P125, DOI 10.1007/BF00046339; Milner RJ, 1996, ONDERSTEPOORT J VET, V63, P309; Mitsiades CS, 2003, CANCER RES, V63, P6689; Pastor M, 2009, J VET INTERN MED, V23, P301, DOI 10.1111/j.1939-1676.2008.0255.x; Reimann N, 1996, CYTOGENET CELL GENET, V73, P140, DOI 10.1159/000134326; Reimann-Berg N, 2011, CYTOGENET GENOME RES, V135, P79, DOI 10.1159/000330126; Rutgen BC, 2010, LEUKEMIA RES, V34, P932, DOI 10.1016/j.leukres.2010.01.021; Rutgen BC, 2011, TUMORGENICITY GROWTH, P56; Saalmuller A, 2005, CELL IMMUNOL, V236, P51, DOI 10.1016/j.cellimm.2005.08.009; Starkey Mike P., 2005, Briefings in Functional Genomics & Proteomics, V4, P112; Sterenczak KA, 2010, ANTICANCER RES, V30, P5043; Struski S, 2009, LEUKEMIA, V23, P617, DOI 10.1038/leu.2008.252; TESKE E, 1994, VET QUART, V16, P209, DOI 10.1080/01652176.1994.9694451; Thomas R, 2003, BRIT J CANCER, V89, P1530, DOI 10.1038/sj.bjc.6601275; Upanal N, 2011, AUST NZ J OBSTET GYN, V51, P559, DOI 10.1111/j.1479-828X.2011.01365.x; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Vang R, 2000, MODERN PATHOL, V13, P19, DOI 10.1038/modpathol.3880005; Winkler S, 2005, ANTICANCER RES, V25, P3995; Withrow SJ, 2001, SMALL ANIMAL CLIN ON, V3rd	36	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e40078	10.1371/journal.pone.0040078	http://dx.doi.org/10.1371/journal.pone.0040078			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761949	Green Submitted, Green Published, gold			2022-12-27	WOS:000305826400054
J	Artal, P; Schwarz, C; Canovas, C; Mira-Agudelo, A				Artal, Pablo; Schwarz, Christina; Canovas, Carmen; Mira-Agudelo, Alejandro			Night Myopia Studied with an Adaptive Optics Visual Analyzer	PLOS ONE			English	Article							WAVE-FRONT SENSOR; HUMAN EYE; OCULAR ABERRATIONS; ACCOMMODATION; COMPENSATION; PERFORMANCE	Purpose: Eyes with distant objects in focus in daylight are thought to become myopic in dim light. This phenomenon, often called "night myopia" has been studied extensively for several decades. However, despite its general acceptance, its magnitude and causes are still controversial. A series of experiments were performed to understand night myopia in greater detail. Methods: We used an adaptive optics instrument operating in invisible infrared light to elucidate the actual magnitude of night myopia and its main causes. The experimental setup allowed the manipulation of the eye's aberrations (and particularly spherical aberration) as well as the use of monochromatic and polychromatic stimuli. Eight subjects with normal vision monocularly determined their best focus position subjectively for a Maltese cross stimulus at different levels of luminance, from the baseline condition of 20 cd/m(2) to the lowest luminance of 22 x 10(-6) cd/m(2). While subjects performed the focusing tasks, their eye's defocus and aberrations were continuously measured with the 1050-nm Hartmann-Shack sensor incorporated in the adaptive optics instrument. The experiment was repeated for a variety of controlled conditions incorporating specific aberrations of the eye and chromatic content of the stimuli. Results: We found large inter-subject variability and an average of -0.8 D myopic shift for low light conditions. The main cause responsible for night myopia was the accommodation shift occurring at low light levels. Other factors, traditionally suggested to explain night myopia, such as chromatic and spherical aberrations, have a much smaller effect in this mechanism. Conclusions: An adaptive optics visual analyzer was applied to study the phenomenon of night myopia. We found that the defocus shift occurring in dim light is mainly due to accommodation errors.	[Artal, Pablo; Schwarz, Christina; Canovas, Carmen; Mira-Agudelo, Alejandro] Univ Murcia, Lab Opt, Murcia, Spain	University of Murcia	Artal, P (corresponding author), Univ Murcia, Lab Opt, Murcia, Spain.	pablo@um.es	Artal, Pablo/AAG-4485-2020; Mira-Agudelo, Alejandro/B-2755-2008; Artal, Pablo/D-7423-2012; Artal, Pablo/AGV-7547-2022	Artal, Pablo/0000-0003-1284-6591; Mira-Agudelo, Alejandro/0000-0002-7747-9465; Artal, Pablo/0000-0003-1284-6591; Artal, Pablo/0000-0003-1284-6591; Schwarz, Christina/0000-0003-0796-9773	Ministerio de Ciencia e Innovacion, Spain [FIS2010-14926, CSD2007-00013]; Fundacion Seneca (Region de Murcia, Spain) [4524/GERM/06]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Seneca (Region de Murcia, Spain)(Fundacion Seneca)	This work was supported by the Ministerio de Ciencia e Innovacion, Spain (grants FIS2010-14926 and CSD2007-00013) and Fundacion Seneca (Region de Murcia, Spain), grant 4524/GERM/06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artal P, 2004, J VISION, V4, P281, DOI 10.1167/4.4.4; Artal P, 2002, J OPT SOC AM A, V19, P137, DOI 10.1364/JOSAA.19.000137; Artal P, 2001, J VISION, V1, DOI 10.1167/1.1.1; BEDFORD RE, 1957, J OPT SOC AM, V47, P564; Charman WN, 1996, OPHTHAL PHYSL OPT, V16, P474, DOI 10.1016/0275-5408(96)00024-5; Fernandez EJ, 2001, OPT LETT, V26, P746, DOI 10.1364/OL.26.000746; Fernandez EJ, 2008, OPT EXPRESS, V16, P21199, DOI 10.1364/OE.16.021199; Hofer H, 2001, OPT EXPRESS, V8, P631, DOI 10.1364/OE.8.000631; Jaeken B, 2011, OPT EXPRESS, V19, P7903, DOI 10.1364/OE.19.007903; KOOMEN M, 1949, J OPT SOC AM, V39, P370, DOI 10.1364/JOSA.39.000370; KOOMEN M, 1951, J OPT SOC AM, V41, P80, DOI 10.1364/JOSA.41.000080; LEIBOWITZ HW, 1975, SCIENCE, V189, P646, DOI 10.1126/science.1162349; Levene JR, 1965, NOTES RECORDS ROYAL, V20, P100, DOI DOI 10.1098/RSNR.1965.0006; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; Manzanera S, 2008, OPT EXPRESS, V16, P7748, DOI 10.1364/OE.16.007748; OTERO JM, 1951, J OPT SOC AM, V41, P942, DOI 10.1364/JOSA.41.000942; Otero JM, 1941, ANAL FIS QUIM, V37, P459; OWENS DA, 1975, VISION RES, V15, P1161, DOI 10.1016/0042-6989(75)90016-4; Prieto PM, 2000, J OPT SOC AM A, V17, P1388, DOI 10.1364/JOSAA.17.001388; Rayleigh Lord, 1883, P CAMB PHILOS SOC, V4, P324; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; SCHOBER H, 1954, OPTIK, V11, P282; Schober H, 1947, GRAEFES ARCHIV, V148, P171; Vargas-Martin F, 1998, J OPT SOC AM A, V15, P2552, DOI 10.1364/JOSAA.15.002552; WALD G, 1947, J OPT SOC AM, V37, P321, DOI 10.1364/JOSA.37.000321	25	14	15	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40239	10.1371/journal.pone.0040239	http://dx.doi.org/10.1371/journal.pone.0040239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768343	Green Submitted, Green Published, gold			2022-12-27	WOS:000305966500056
J	Bouthoorn, SH; van Lenthe, FJ; Hokken-Koelega, ACS; Moll, HA; Tiemeier, H; Hofman, A; Mackenbach, JP; Jaddoe, VWV; Raat, H				Bouthoorn, Selma H.; van Lenthe, Frank J.; Hokken-Koelega, Anita C. S.; Moll, Henriette A.; Tiemeier, Henning; Hofman, Albert; Mackenbach, Johan P.; Jaddoe, Vincent W. V.; Raat, Hein			Head Circumference of Infants Born to Mothers with Different Educational Levels; The Generation R Study	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; BODY-MASS INDEX; SOCIOECONOMIC-STATUS; NUTRITIONAL-STATUS; BRAIN-DEVELOPMENT; BIRTH COHORT; FETAL-GROWTH; CHILDREN; SIZE; HEIGHT	Objective: Head circumference (HC) reflect growth and development of the brain in early childhood. It is unknown whether socioeconomic differences in HC are present in early childhood. Therefore, we investigated the association between socioeconomic position (SEP) and HC in early childhood, and potential underlying factors. Methods: The study focused on Dutch children born between April 2002 and January 2006 who participated in The Generation R Study, a population-based prospective cohort study in Rotterdam, the Netherlands. Maternal educational level was used as indicator of SEP. HC measures were concentrated around 1, 3, 6 and 11 months. Associations and explanatory factors were investigated using linear regression analysis, adjusted for potential mediators. Results: The study included 3383 children. At 1, 3 and 6 months of age, children of mothers with a low education had a smaller HC than those with a high education (difference at 1 month: -0.42 SD; 95% CI: -0.54,-0.30; at 3 months: -0.27 SD; 95% CI -0.40,-0.15; and at 6 months: -0.13 SD; 95% CI -0.24,-0.02). Child's length and weight could only partially explain the smaller HC at 1 and 3 months of age. At 6 months, birth weight, gestational age and parental height explained the HC differences. At 11 months, no HC differences were found. Conclusion: Educational inequalities in HC in the first 6 months of life can be mainly explained by pregnancy-related factors, such as birth weight and gestational age. These findings further support public health policies to prevent negative birth outcomes in lower socioeconomic groups.	[Bouthoorn, Selma H.; Hofman, Albert; Jaddoe, Vincent W. V.] Erasmus MC, Generat Study Grp R, Rotterdam, Netherlands; [Bouthoorn, Selma H.; van Lenthe, Frank J.; Mackenbach, Johan P.; Raat, Hein] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Hokken-Koelega, Anita C. S.; Moll, Henriette A.; Jaddoe, Vincent W. V.] Erasmus MC, Dept Pediat, Rotterdam, Netherlands; [Tiemeier, Henning; Hofman, Albert; Jaddoe, Vincent W. V.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Tiemeier, Henning] Erasmus MC, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Bouthoorn, SH (corresponding author), Erasmus MC, Generat Study Grp R, Rotterdam, Netherlands.	h.raat@erasmusmc.nl	Tiemeier, Henning/H-6534-2019	Tiemeier, Henning/0000-0002-4395-1397	Erasmus Medical Centre, Rotterdam, Erasmus University Rotterdam; Netherlands Organization for Health Research and Development [2100.0074]	Erasmus Medical Centre, Rotterdam, Erasmus University Rotterdam; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	The first phase of the Generation R Study is made possible by financial support from: Erasmus Medical Centre, Rotterdam, Erasmus University Rotterdam and the Netherlands Organization for Health Research and Development. The present study was supported by an additional grant from the Netherlands Organization for Health Research and Development (grant No. 2100.0074). URL: http://www.zonmw.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, GROWTH AN 3 0; Atrash H, 2008, CURR OPIN OBSTET GYN, V20, P581, DOI 10.1097/GCO.0b013e328317a27c; Bartholomeusz HH, 2002, NEUROPEDIATRICS, V33, P239, DOI 10.1055/s-2002-36735; Basso O, 2006, JAMA-J AM MED ASSOC, V296, P1357, DOI 10.1001/jama.296.11.1357; Bauman AE, 2002, AM J PREV MED, V23, P5, DOI 10.1016/S0749-3797(02)00469-5; BOBAK M, 1994, AM J PUBLIC HEALTH, V84, P1167, DOI 10.2105/AJPH.84.7.1167; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Cecil JE, 2005, INT J OBESITY, V29, P1199, DOI 10.1038/sj.ijo.0803055; du Prel X, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-312; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Fredriks AM, 2004, ACTA PAEDIATR, V93, P817, DOI 10.1111/j.1651-2227.2004.tb03024.x; Fredriks AM, 2003, EUR J PEDIATR, V162, P788, DOI 10.1007/s00431-003-1292-x; Gale CR, 2004, BRAIN, V127, P321, DOI 10.1093/brain/awh034; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P7, DOI 10.1136/jech.2004.023531; Galobardes B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029118; Geraedts EJ, 2011, HORM RES PAEDIAT, V75, P213, DOI 10.1159/000321192; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Hindmarsh PC, 2008, PEDIATR RES, V63, P99, DOI 10.1203/PDR.0b013e31815b8e8f; HOKKENKOELEGA ACS, 1995, PEDIATR RES, V38, P267, DOI 10.1203/00006450-199508000-00022; Ivanovic DM, 2004, NEUROPSYCHOLOGIA, V42, P1118, DOI 10.1016/j.neuropsychologia.2003.11.022; Ivanovic DM, 2002, BRIT J NUTR, V87, P81, DOI 10.1079/BJN2001485; Jaddoe VWV, 2006, EUR J EPIDEMIOL, V21, P475, DOI 10.1007/s10654-006-9022-0; Jaddoe VWV, 2010, EUR J EPIDEMIOL, V25, P823, DOI 10.1007/s10654-010-9516-7; Jansen PW, 2009, ARCH DIS CHILD-FETAL, V94, pF28, DOI 10.1136/adc.2007.136945; Jansen PW, 2009, PAEDIATR PERINAT EP, V23, P216, DOI 10.1111/j.1365-3016.2009.01023.x; Jokela M, 2009, PEDIATRICS, V124, pE380, DOI 10.1542/peds.2009-0334; Kramer MS, 2004, J PEDIATR-US, V145, P600, DOI 10.1016/j.jpeds.2004.06.069; Larroque B, 2001, PEDIATRICS, V108, P111, DOI 10.1542/peds.108.1.111; Lynch JW., 2000, SOCIAL EPIDEMIOLOGY, P13; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; MALINA RM, 1975, AM J CLIN NUTR, V28, P1061, DOI 10.1093/ajcn/28.9.1061; Martyn CN, 1996, LANCET, V348, P1264, DOI 10.1016/S0140-6736(96)04257-2; McNamee R, 2003, OCCUP ENVIRON MED, V60, P227, DOI 10.1136/oem.60.3.227; NAGRA SA, 1984, ARCH LATINOAM NUTR, V34, P308; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; Parker Jennifer D., 1994, Annals of Epidemiology, V4, P271; RONA RJ, 1985, INT J EPIDEMIOL, V14, P402, DOI 10.1093/ije/14.3.402; Silva LM, 2010, INT J EPIDEMIOL, V39, P1250, DOI 10.1093/ije/dyq069; Smit DJA, 2010, TWIN RES HUM GENET, V13, P370, DOI 10.1375/twin.13.4.370; Statistics Netherlands, 2004, ALL NED 2004; TANNER JM, 1992, HORM RES, V38, P106, DOI 10.1159/000182580; Tisserand DJ, 2001, NEUROLOGY, V56, P969, DOI 10.1212/WNL.56.7.969; Van de Mheen H, 1994, RELATIE TUSSEN SOCIA; Voigt M, 2010, J PERINAT MED, V38, P425, DOI [10.1515/JPM.2010.059, 10.1515/jpm.2010.059]; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; Yu CKH, 2006, BJOG-INT J OBSTET GY, V113, P1117, DOI 10.1111/j.1471-0528.2006.00991.x	46	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39798	10.1371/journal.pone.0039798	http://dx.doi.org/10.1371/journal.pone.0039798			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768125	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100095
J	Bulus, N; Feral, C; Pozzi, A; Zent, R				Bulus, Nada; Feral, Chloe; Pozzi, Ambra; Zent, Roy			CD98 Increases Renal Epithelial Cell Proliferation by Activating MAPKs	PLOS ONE			English	Article							AMINO-ACID TRANSPORTER; 4F2 HEAVY-CHAIN; CYCLIN D1 EXPRESSION; LUNG-CANCER; PROGNOSTIC-SIGNIFICANCE; SUBSTRATE SELECTIVITY; SLC3A2 INTERACTION; MEMBRANE-PROTEIN; CO-EXPRESSES; IDENTIFICATION	CD98 heavy chain (CD98hc) is a multifunctional transmembrane spanning scaffolding protein whose extracellular domain binds with light chain amino acid transporters (Lats) to form the heterodimeric amino acid transporters (HATs). It also interacts with beta 1 and beta 3 integrins by its transmembrane and cytoplasmic domains. This interaction is proposed to be the mechanism whereby CD98 mediates cell survival and growth via currently undefined signaling pathways. In this study, we determined whether the critical function of CD98-dependent amino acid transport also plays a role in cell proliferation and defined the signaling pathways that mediate CD98-dependent proliferation of murine renal inner medullary collecting duct (IMCD) cells. We demonstrate that downregulating CD98hc expression resulted in IMCD cell death. Utilizing overexpression studies of CD98hc mutants that either lacked a cytoplasmic tail or were unable to bind to Lats we showed that CD98 increases serum-dependent cell proliferation by a mechanism that requires the CD98hc cytoplasmic tail. We further demonstrated that CD98-dependent amino acid transport increased renal tubular epithelial cell proliferation by a mechanism that does not require the CD98hc cytoplasmic tail. Both these mechanisms of increased renal tubular epithelial cell proliferation are mediated by Erk and p38 MAPK signaling. Although increased amino transport markedly activated mTor signaling, this pathway did not alter cell proliferation. Thus, these studies demonstrate that in IMCD cells, the cytoplasmic and extracellular domains of CD98hc regulate cell proliferation by distinct mechanisms that are mediated by common MAPK signaling pathways.	[Bulus, Nada; Pozzi, Ambra; Zent, Roy] Vanderbilt Univ, Med Ctr, Div Nephrol, Dept Med, Nashville, TN 37235 USA; [Pozzi, Ambra; Zent, Roy] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37235 USA; [Zent, Roy] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37235 USA; [Pozzi, Ambra; Zent, Roy] Vet Affairs Hosp, Dept Med, Nashville, TN USA; [Feral, Chloe] Univ Nice Sophia Antipolis, Ctr Antoine Lacassagne, Inst Res Canc & Aging, Nice, France	Vanderbilt University; Vanderbilt University; Vanderbilt University; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne	Bulus, N (corresponding author), Vanderbilt Univ, Med Ctr, Div Nephrol, Dept Med, Nashville, TN 37235 USA.	roy.zent@vanderbilt.edu	FERAL, Chloe/AAB-6111-2020; Feral, Chloe C/O-5781-2016	FERAL, Chloe/0000-0001-9756-2082; Feral, Chloe C/0000-0001-9756-2082	Department of Veterans Affairs	Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averous J, 2008, ONCOGENE, V27, P1106, DOI 10.1038/sj.onc.1210715; Ballou LM, 2007, J BIOL CHEM, V282, P24463, DOI 10.1074/jbc.M704741200; Bassi MT, 2001, PFLUG ARCH EUR J PHY, V442, P286, DOI 10.1007/s004240100537; BERTRAN J, 1992, P NATL ACAD SCI USA, V89, P5601, DOI 10.1073/pnas.89.12.5601; Cai S, 2005, J CELL SCI, V118, P889, DOI 10.1242/jcs.01674; Cantor J, 2011, J IMMUNOL, V187, P851, DOI 10.4049/jimmunol.1100002; Cantor J, 2009, NAT IMMUNOL, V10, P412, DOI 10.1038/ni.1712; Cantor JM, 2008, IMMUNOL REV, V223, P236, DOI 10.1111/j.1600-065X.2008.00640.x; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Casas-Terradellas E, 2008, BBA-MOL CELL RES, V1783, P2241, DOI 10.1016/j.bbamcr.2008.08.011; Chairoungdua A, 2001, J BIOL CHEM, V276, P49390, DOI 10.1074/jbc.M107517200; Chen XW, 2010, MOL CELL BIOL, V30, P3048, DOI 10.1128/MCB.00892-09; Chrostowski MK, 2010, PLACENTA, V31, P528, DOI 10.1016/j.placenta.2009.12.010; Eskelinen EL, 2002, TRAFFIC, V3, P878, DOI 10.1034/j.1600-0854.2002.31204.x; Estevez R, 1998, FASEB J, V12, P1319, DOI 10.1096/fasebj.12.13.1319; Fenczik CA, 1997, NATURE, V390, P81, DOI 10.1038/36349; Fenczik CA, 2001, J BIOL CHEM, V276, P8746, DOI 10.1074/jbc.M011239200; Feral CC, 2005, P NATL ACAD SCI USA, V102, P355, DOI 10.1073/pnas.0404852102; Feral CC, 2007, J CELL BIOL, V178, P701, DOI 10.1083/jcb.200705090; Fogelstrand P, 2009, J EXP MED, V206, P2397, DOI 10.1084/jem.20082845; Fukasawa Y, 2000, J BIOL CHEM, V275, P9690, DOI 10.1074/jbc.275.13.9690; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Hang TTN, 2011, J CLIN INVEST, V121, P1733, DOI 10.1172/JCI44631; Hara K, 2000, ONCOGENE, V19, P6209, DOI 10.1038/sj.onc.1204019; Henderson NC, 2004, J BIOL CHEM, V279, P54731, DOI 10.1074/jbc.M408700200; HUSTED RF, 1988, AM J PHYSIOL, V255, pF1160, DOI 10.1152/ajprenal.1988.255.6.F1160; Imai H, 2009, HISTOPATHOLOGY, V54, P804, DOI 10.1111/j.1365-2559.2009.03300.x; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Kaira K, 2008, BRIT J CANCER, V98, P742, DOI 10.1038/sj.bjc.6604235; Kaira K, 2008, PATHOL RES PRACT, V204, P553, DOI 10.1016/j.prp.2008.02.003; Kaira K, 2009, ANN SURG ONCOL, V16, P3473, DOI 10.1245/s10434-009-0685-0; Kaira K, 2009, LUNG CANCER, V66, P120, DOI 10.1016/j.lungcan.2008.12.015; Kaira K, 2009, CANCER SCI, V100, P249, DOI 10.1111/j.1349-7006.2008.01029.x; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Kolesnikova TV, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-10; Kozar K, 2005, CELL CYCLE, V4, P388, DOI 10.4161/cc.4.3.1551; Leung-Pineda V, 2004, BIOCHEM J, V379, P79, DOI 10.1042/BJ20031383; Liu Y, 2001, J BIOL CHEM, V276, P40156, DOI 10.1074/jbc.M104138200; Mastroberardino L, 1998, NATURE, V395, P288, DOI 10.1038/26246; Nelsen CJ, 2003, J BIOL CHEM, V278, P25853, DOI 10.1074/jbc.M302360200; Pfeiffer R, 1999, EMBO J, V18, P49, DOI 10.1093/emboj/18.1.49; Pineda M, 1999, J BIOL CHEM, V274, P19738, DOI 10.1074/jbc.274.28.19738; Prager GW, 2007, J BIOL CHEM, V282, P24477, DOI 10.1074/jbc.M702877200; Prasad PD, 1999, BIOCHEM BIOPH RES CO, V255, P283, DOI 10.1006/bbrc.1999.0206; QUACKENBUSH E, 1987, P NATL ACAD SCI USA, V84, P8618; RAUCHMAN MI, 1993, AM J PHYSIOL, V265, pF416, DOI 10.1152/ajprenal.1993.265.3.F416; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Rossier G, 1999, J BIOL CHEM, V274, P34948, DOI 10.1074/jbc.274.49.34948; Sato Y, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-7; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; Tapon N, 2001, CURR OPIN CELL BIOL, V13, P731, DOI 10.1016/S0955-0674(00)00284-2; Tato I, 2011, J BIOL CHEM, V286, P6128, DOI 10.1074/jbc.M110.166991; Tomiya T, 2004, HEPATOL RES, V30, pS14, DOI 10.1016/j.hepres.2004.08.010; Torrents D, 1998, J BIOL CHEM, V273, P32437, DOI 10.1074/jbc.273.49.32437; Tsumura H, 2003, BIOCHEM BIOPH RES CO, V308, P847, DOI 10.1016/S0006-291X(03)01473-6; Verrey F, 2000, PFLUG ARCH EUR J PHY, V440, P503, DOI 10.1007/s004240050001; Verrey F, 1999, J MEMBRANE BIOL, V172, P181, DOI 10.1007/s002329900595; Villanueva J, 2007, MOL BIOL CELL, V18, P1457, DOI 10.1091/mbc.E06-10-0908; Wagner CA, 2001, AM J PHYSIOL-CELL PH, V281, pC1077, DOI 10.1152/ajpcell.2001.281.4.C1077; WELLS RG, 1992, J BIOL CHEM, V267, P15285; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Zent R, 2000, J BIOL CHEM, V275, P5059, DOI 10.1074/jbc.275.7.5059; Zhang X, 2009, DEVELOPMENT, V136, P3357, DOI 10.1242/dev.036269	65	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40026	10.1371/journal.pone.0040026	http://dx.doi.org/10.1371/journal.pone.0040026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768207	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100179
J	Cheong, D; Zubieta, JK; Liu, J				Cheong, Daniel; Zubieta, Jon-Kar; Liu, Jing			Neural Correlates of Visual Motion Prediction	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; POSTERIOR PARIETAL CORTEX; CORTICAL AREA MT; ANTERIOR CINGULATE; WORKING-MEMORY; PREFRONTAL CORTEX; MENTAL ROTATION; FMRI ACTIVATION; DEFAULT-MODE	Predicting the trajectories of moving objects in our surroundings is important for many life scenarios, such as driving, walking, reaching, hunting and combat. We determined human subjects' performance and task-related brain activity in a motion trajectory prediction task. The task required spatial and motion working memory as well as the ability to extrapolate motion information in time to predict future object locations. We showed that the neural circuits associated with motion prediction included frontal, parietal and insular cortex, as well as the thalamus and the visual cortex. Interestingly, deactivation of many of these regions seemed to be more closely related to task performance. The differential activity during motion prediction vs. direct observation was also correlated with task performance. The neural networks involved in our visual motion prediction task are significantly different from those that underlie visual motion memory and imagery. Our results set the stage for the examination of the effects of deficiencies in these networks, such as those caused by aging and mental disorders, on visual motion prediction and its consequences on mobility related daily activities.	[Cheong, Daniel] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Cheong, Daniel; Zubieta, Jon-Kar; Liu, Jing] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Zubieta, Jon-Kar; Liu, Jing] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Zubieta, Jon-Kar] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Cheong, D (corresponding author), Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA.	ljing@umich.edu	Zubieta, Jon-Kar/AAB-5565-2022	Liu, Jing/0000-0003-3688-3194				ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; Amedi A, 2005, NEURON, V48, P859, DOI 10.1016/j.neuron.2005.10.032; Anguera JA, 2010, J COGNITIVE NEUROSCI, V22, P1917, DOI 10.1162/jocn.2009.21351; Barkley RA, 2007, J SAFETY RES, V38, P113, DOI 10.1016/j.jsr.2006.09.004; BECKERS G, 1995, BRAIN, V118, P49, DOI 10.1093/brain/118.1.49; BECKERS G, 1992, P ROY SOC B-BIOL SCI, V249, P173, DOI 10.1098/rspb.1992.0100; Benguigui N, 2004, NEUROSCI LETT, V369, P197, DOI 10.1016/j.neulet.2004.07.051; Bisley JW, 2000, CEREB CORTEX, V10, P1053, DOI 10.1093/cercor/10.11.1053; Bisley JW, 2004, J NEUROPHYSIOL, V91, P286, DOI 10.1152/jn.00870.2003; Bisley JW, 2001, J NEUROPHYSIOL, V85, P187, DOI 10.1152/jn.2001.85.1.187; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; BRITTEN K, 2003, VISUAL NEUROSCIENCES; Brown SM, 2006, EMOTION, V6, P239, DOI 10.1037/1528-3542.6.2.239; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Casey BJ, 2001, HUM BRAIN MAPP, V13, P26, DOI 10.1002/hbm.1022; Chau W, 2004, NEUROIMAGE, V23, P983, DOI 10.1016/j.neuroimage.2004.07.007; CHENG K, 1994, J NEUROPHYSIOL, V71, P2269, DOI 10.1152/jn.1994.71.6.2269; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Cowey A, 2006, EXP BRAIN RES, V171, P558, DOI 10.1007/s00221-006-0479-6; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8; Daselaar SM, 2010, NEUROIMAGE, V52, P677, DOI 10.1016/j.neuroimage.2010.04.239; Davidson MC, 2004, NEUROIMAGE, V23, P1039, DOI 10.1016/j.neuroimage.2004.07.049; De Las Cuevas Carlos, 2008, Prim Care Companion J Clin Psychiatry, V10, P384; DeLucia PR, 2006, HUM FACTORS, V48, P666, DOI 10.1518/001872006779166352; Edwards JD, 2009, GERONTOLOGIST, V49, P485, DOI 10.1093/geront/gnp042; FELLEMAN DJ, 1987, J NEUROPHYSIOL, V57, P889, DOI 10.1152/jn.1987.57.4.889; Fincham JM, 2002, P NATL ACAD SCI USA, V99, P3346, DOI 10.1073/pnas.052703399; Fink GR, 1999, BRAIN, V122, P497, DOI 10.1093/brain/122.3.497; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Goldstein RZ, 2009, P NATL ACAD SCI USA, V106, P9453, DOI 10.1073/pnas.0900491106; Hartley T, 2003, NEURON, V37, P877, DOI 10.1016/S0896-6273(03)00095-3; Hester R, 2009, NEUROPSYCHOPHARMACOL, V34, P2450, DOI 10.1038/npp.2009.67; Howe PD, 2009, J VISION, V9, DOI 10.1167/9.4.10; Huk AC, 2000, J NEUROPHYSIOL, V83, P3525, DOI 10.1152/jn.2000.83.6.3525; Hussar CR, 2009, NEURON, V64, P730, DOI 10.1016/j.neuron.2009.11.018; Iaria G, 2003, J NEUROSCI, V23, P5945; Ishai A, 2010, F1000 BIOL REP, V2; Isomura Y, 2004, REV NEUROSCIENCE, V15, P279; Jerome L, 2006, J CAN ACAD CHILD ADO, V15, P105; Kaas A, 2010, NEUROIMAGE, V49, P794, DOI 10.1016/j.neuroimage.2009.07.055; Kaufman JN, 2003, J NEUROSCI, V23, P7839; Kawasaki M, 2008, BRAIN RES, V1213, P91, DOI 10.1016/j.brainres.2008.03.037; Kiehl KA, 2000, PSYCHOPHYSIOLOGY, V37, P216, DOI 10.1111/1469-8986.3720216; Kirschen MP, 2010, BEHAV NEUROL, V23, P51, DOI [10.3233/BEN-2010-0266, 10.1155/2010/587450]; Koshino H, 2005, COGN AFFECT BEHAV NE, V5, P54, DOI 10.3758/CABN.5.1.54; Kubler A, 2006, J COGNITIVE NEUROSCI, V18, P1331, DOI 10.1162/jocn.2006.18.8.1331; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Lencer R, 2008, BRAIN COGNITION, V68, P219, DOI 10.1016/j.bandc.2008.08.013; Lewald J, 2011, NEUROPSYCHOLOGIA, V49, P209, DOI 10.1016/j.neuropsychologia.2010.11.038; Lewis JW, 2000, CEREB CORTEX, V10, P873, DOI 10.1093/cercor/10.9.873; Liston C, 2006, NEURON, V50, P643, DOI 10.1016/j.neuron.2006.04.015; Liu J, 2005, J NEUROSCI, V25, P711, DOI 10.1523/JNEUROSCI.4034-04.2005; Liu J, 2003, J NEUROPHYSIOL, V89, P246, DOI 10.1152/jn.00097.2002; Lloyd D, 2006, J NEUROPHYSIOL, V95, P205, DOI 10.1152/jn.00614.2005; MacDonald SWS, 2008, J COGNITIVE NEUROSCI, V20, P779, DOI 10.1162/jocn.2008.20502; Maguire EA, 2003, HIPPOCAMPUS, V13, P250, DOI 10.1002/hipo.10087; Matthews N, 2001, EXP BRAIN RES, V140, P397, DOI 10.1007/s002210100837; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Mayer JS, 2010, HUM BRAIN MAPP, V31, P126, DOI 10.1002/hbm.20850; McKeefry DJ, 2008, J NEUROSCI, V28, P6848, DOI 10.1523/JNEUROSCI.1287-08.2008; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Mechelli A, 2004, CEREB CORTEX, V14, P1256, DOI 10.1093/cercor/bhh087; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mozolic JL, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-35; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Orban GA, 2003, NEUROPSYCHOLOGIA, V41, P1757, DOI 10.1016/S0028-3932(03)00177-5; Park SW, 2011, PM&R, V3, P198, DOI 10.1016/j.pmrj.2010.12.008; Podzebenko K, 2002, NEUROIMAGE, V15, P547, DOI 10.1006/nimg.2001.0999; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rama P, 2001, NEUROIMAGE, V13, P1090, DOI 10.1006/nimg.2001.0777; Rangaswamy M, 2004, NEUROIMAGE, V21, P329, DOI 10.1016/j.neuroimage.2003.09.018; Richards E, 2006, VISION RES, V46, P4217, DOI 10.1016/j.visres.2006.08.011; RODMAN HR, 1987, VISION RES, V27, P2035, DOI 10.1016/0042-6989(87)90118-0; Sack AT, 2005, SCIENCE, V308, P702, DOI 10.1126/science.1107784; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Schicke T, 2006, EUR J NEUROSCI, V23, P1910, DOI 10.1111/j.1460-9568.2006.04720.x; Seiffert AE, 2003, CEREB CORTEX, V13, P340, DOI 10.1093/cercor/13.4.340; Serences JT, 2007, J NEUROSCI, V27, P12893, DOI 10.1523/JNEUROSCI.4021-07.2007; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Singh KD, 2008, NEUROIMAGE, V41, P100, DOI 10.1016/j.neuroimage.2008.01.051; Slotnick SD, 2011, NEUROIMAGE, V55, P794, DOI 10.1016/j.neuroimage.2010.11.077; Smith AT, 1998, J NEUROSCI, V18, P3816; Sweeney JA, 2007, NEUROIMAGE, V36, pT54, DOI 10.1016/j.neuroimage.2007.03.018; Taylor JG, 2000, NEUROIMAGE, V11, P257, DOI 10.1006/nimg.1999.0529; Thakral PP, 2009, BRAIN RES, V1302, P157, DOI 10.1016/j.brainres.2009.09.031; Tomasi D, 2006, HUM BRAIN MAPP, V27, P694, DOI 10.1002/hbm.20211; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Umla-Runge K, 2011, BRAIN RES, V1382, P206, DOI 10.1016/j.brainres.2011.01.052; Vaidya JG, 2007, NEUROIMAGE, V37, P1346, DOI 10.1016/j.neuroimage.2007.06.015; Vance A, 2007, MOL PSYCHIATR, V12, P826, DOI 10.1038/sj.mp.4001999; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006; Zaksas D, 2006, J NEUROSCI, V26, P11726, DOI 10.1523/JNEUROSCI.3420-06.2006; Zar JH, 1999, BIOSTATISTICAL ANAL	99	9	10	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39854	10.1371/journal.pone.0039854	http://dx.doi.org/10.1371/journal.pone.0039854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768145	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100114
J	Duca, FA; Swartz, TD; Sakar, Y; Covasa, M				Duca, Frank A.; Swartz, Timothy D.; Sakar, Yassine; Covasa, Mihai			Increased Oral Detection, but Decreased Intestinal Signaling for Fats in Mice Lacking Gut Microbiota	PLOS ONE			English	Article							FLAVOR PREFERENCES; TASTE; OBESITY; ACIDS; CD36; ABSORPTION; ADIPOSITY; SECRETION; GERMFREE; RECEPTOR	Germ-free (GF) mice lacking intestinal microbiota are significantly leaner than normal (NORM) control mice despite consuming more calories. The contribution of microbiota on the recognition and intake of fats is not known. Thus, we investigated the preference for, and acceptance of, fat emulsions in GF and NORM mice, and associated changes in lingual and intestinal fatty acid receptors, intestinal peptide content, and plasma levels of gut peptides. GF and NORM C57Bl/6J mice were given 48-h two-bottle access to water and increasing concentrations of intralipid emulsions. Gene expression of the lingual fatty acid translocase CD36 and protein expression of intestinal satiety peptides and fatty-acid receptors from isolated intestinal epithelial cells were determined. Differences in intestinal enteroendocrine cells along the length of the GI tract were quantified. Circulating plasma satiety peptides reflecting adiposity and biochemical parameters of fat metabolism were also examined. GF mice had an increased preference and intake of intralipid relative to NORM mice. This was associated with increased lingual CD36 (P<0.05) and decreased intestinal expression of fatty acid receptors GPR40 (P<0.0001), GPR41 (P<0.0001), GPR43 (P<0.05), and GPR120 (P<0.0001) and satiety peptides CCK (P<0.0001), PYY (P<0.001), and GLP-1 (P<0.001). GF mice had fewer enteroendocrine cells in the ileum (P<0.05), and more in the colon (P<0.05), relative to NORM controls. Finally, GF mice had lower levels of circulating leptin and ghrelin (P<0.001), and altered plasma lipid metabolic markers indicative of energy deficits. Increased preference and caloric intake from fats in GF mice are associated with increased oral receptors for fats coupled with broad and marked decreases in expression of intestinal satiety peptides and fatty-acid receptors.	[Duca, Frank A.; Swartz, Timothy D.; Sakar, Yassine; Covasa, Mihai] MICALIS, UMR 1319, Ctr Rech Jouy En Josas, Inst Natl Rech Agron, Jouy En Josas, France; [Duca, Frank A.; Swartz, Timothy D.] Univ Paris 06, Paris, France; [Covasa, Mihai] Western Univ Hlth Sci, Coll Osteopath Med, Basic Med Sci Dept, Pomona, CA USA	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Western University of Health Sciences	Duca, FA (corresponding author), MICALIS, UMR 1319, Ctr Rech Jouy En Josas, Inst Natl Rech Agron, Jouy En Josas, France.	mcovasa@jouy.inra.fr		Swartz, Timothy/0000-0002-9801-8756	institution (INRA, French National Institute for Agricultural Research)	institution (INRA, French National Institute for Agricultural Research)	The study was supported by the institution (INRA, French National Institute for Agricultural Research) scientific package awarded to Mihai Covasa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKROFF K, 1991, PHYSIOL BEHAV, V50, P815, DOI 10.1016/0031-9384(91)90023-H; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Cherbut C, 1998, AM J PHYSIOL-GASTR L, V275, pG1415, DOI 10.1152/ajpgi.1998.275.6.G1415; Cherbuy C, 2010, AM J PHYSIOL-GASTR L, V299, pG348, DOI 10.1152/ajpgi.00384.2009; Degrace-Passilly P, 2012, CURR OPIN CLIN NUTR, V15, P107, DOI 10.1097/MCO.0b013e32834ff19c; Delzenne NM, 2005, BRIT J NUTR, V93, pS157, DOI 10.1079/BJN20041342; DEMARNE Y, 1972, ANN BIOL ANIM BIOCH, V12, P509, DOI 10.1051/rnd:19720313; DEMARNE Y, 1982, GUT, V23, P49, DOI 10.1136/gut.23.1.49; Engelstoft MS, 2008, CELL METAB, V8, P447, DOI 10.1016/j.cmet.2008.11.004; Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303; Gilbertson TA, 1998, ANN NY ACAD SCI, V855, P165, DOI 10.1111/j.1749-6632.1998.tb10560.x; Gilbertson TA, 2005, PHYSIOL BEHAV, V86, P681, DOI 10.1016/j.physbeh.2005.08.057; Glendinning JI, 2010, AM J PHYSIOL-REG I, V299, pR1333, DOI 10.1152/ajpregu.00331.2010; GOODLAD RA, 1989, Q J EXP PHYSIOL CMS, V74, P437, DOI 10.1113/expphysiol.1989.sp003291; Goudriaan JR, 2002, MOL CELL BIOCHEM, V239, P199, DOI 10.1023/A:1020575412789; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Liou AP, 2011, GASTROENTEROLOGY, V140, P903, DOI 10.1053/j.gastro.2010.10.012; Lucas F, 1996, PHYSIOL BEHAV, V60, P1151, DOI 10.1016/0031-9384(96)00136-9; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Martin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024014; MINDELL S, 1990, PHYSIOL BEHAV, V48, P283, DOI 10.1016/0031-9384(90)90314-T; Rabot S, 2010, FASEB J; REED DR, 1991, AM J PHYSIOL, V261, pR1084, DOI 10.1152/ajpregu.1991.261.5.R1084; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Sclafani A, 2007, AM J PHYSIOL-REG I, V293, pR1823, DOI 10.1152/ajpregu.00211.2007; Sclafani A, 2005, AM J PHYSIOL-REG I, V289, pR712, DOI 10.1152/ajpregu.00176.2005; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Swartz TD, 2010, PHYSIOL BEHAV, V99, P109, DOI 10.1016/j.physbeh.2009.10.016; Swartz T. D., 2011, BR J NUTR, P1; Tanaka T, 2008, N-S ARCH PHARMACOL, V377, P523, DOI 10.1007/s00210-007-0200-8; Theodorakis MJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE550, DOI 10.1152/ajpendo.00326.2004; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; WOSTMANN BS, 1964, J NUTR, V84, P277, DOI 10.1093/jn/84.3.277; Zhang XJ, 2011, ACTA HISTOCHEM, V113, P663, DOI 10.1016/j.acthis.2010.09.007	40	111	120	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39748	10.1371/journal.pone.0039748	http://dx.doi.org/10.1371/journal.pone.0039748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768116	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100086
J	Orekhova, EV; Tsetlin, MM; Butorina, AV; Novikova, SI; Gratchev, VV; Sokolov, PA; Elam, M; Stroganova, TA				Orekhova, Elena V.; Tsetlin, Marina M.; Butorina, Anna V.; Novikova, Svetlana I.; Gratchev, Vitaliy V.; Sokolov, Pavel A.; Elam, Mikael; Stroganova, Tatiana A.			Auditory Cortex Responses to Clicks and Sensory Modulation Difficulties in Children with Autism Spectrum Disorders (ASD)	PLOS ONE			English	Article							SUPERIOR TEMPORAL GYRUS; REDUCED THALAMIC VOLUME; EVOKED MAGNETIC-FIELDS; SURFACE-BASED ANALYSIS; YOUNG-CHILDREN; FUNCTIONAL NEUROANATOMY; INFANTILE-AUTISM; BRAIN SIZE; MEG; ABNORMALITIES	Auditory sensory modulation difficulties are common in autism spectrum disorders (ASD) and may stem from a faulty arousal system that compromises the ability to regulate an optimal response. To study neurophysiological correlates of the sensory modulation difficulties, we recorded magnetic field responses to clicks in 14 ASD and 15 typically developing (TD) children. We further analyzed the P100m, which is the most prominent component of the auditory magnetic field response in children and may reflect preattentive arousal processes. The P100m was rightward lateralized in the TD, but not in the ASD children, who showed a tendency toward P100m reduction in the right hemisphere (RH). The atypical P100m lateralization in the ASD subjects was associated with greater severity of sensory abnormalities assessed by Short Sensory Profile, as well as with auditory hypersensitivity during the first two years of life. The absence of right-hemispheric predominance of the P100m and a tendency for its right-hemispheric reduction in the ASD children suggests disturbance of the RH ascending reticular brainstem pathways and/or their thalamic and cortical projections, which in turn may contribute to abnormal arousal and attention. The correlation of sensory abnormalities with atypical, more leftward, P100m lateralization suggests that reduced preattentive processing in the right hemisphere and/or its shift to the left hemisphere may contribute to abnormal sensory behavior in ASD.	[Orekhova, Elena V.; Elam, Mikael] Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden; [Tsetlin, Marina M.; Butorina, Anna V.; Novikova, Svetlana I.; Stroganova, Tatiana A.] Moscow State Univ Psychol & Educ, Moscow, Russia; [Gratchev, Vitaliy V.] Moscow Pediat Ctr, Moscow, Russia; [Sokolov, Pavel A.] Acad Med Sci, Mental Hlth Res Ctr Russian, Clin Dept Study Adolescent Psychiat, Moscow, Russia	University of Gothenburg; Moscow State University of Psychology & Education; Russian Academy of Medical Sciences	Orekhova, EV (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden.	Elena.orekhova@neuro.gu.se	Stroganova, Tatiana T.A./C-5773-2014; Orekhova, Elena V/S-9043-2018; Butorina, Anna/V-6995-2018	Orekhova, Elena V/0000-0003-0950-1613; Stroganova, Tatiana/0000-0003-3750-9890	Swedish Research Council [2009-3765]; Russian Ministry of Science and Education [16.518.11.7088]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Russian Ministry of Science and Education(Ministry of Education and Science, Russian Federation)	This research was supported by grant # 2009-3765 from the Swedish Research Council and by grant # 16.518.11.7088 from the Russian Ministry of Science and Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auyeung B, 2008, J AUTISM DEV DISORD, V38, P1230, DOI 10.1007/s10803-007-0504-z; Ben-Sasson A, 2008, J CHILD PSYCHOL PSYC, V49, P817, DOI 10.1111/j.1469-7610.2008.01899.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Berument SK, 1999, BRIT J PSYCHIAT, V175, P444, DOI 10.1192/bjp.175.5.444; Bishop DVM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018993; Blumenfeld LD, 2001, CLIN NEUROPHYSIOL, V112, P1650, DOI 10.1016/S1388-2457(01)00604-6; Boutros NN, 2011, BIOL PSYCHIAT, V69, P883, DOI 10.1016/j.biopsych.2010.12.011; Brugge JF, 2008, HEARING RES, V238, P12, DOI 10.1016/j.heares.2007.11.012; BUCHWALD JS, 1991, ELECTROEN CLIN NEURO, V80, P303, DOI 10.1016/0168-5597(91)90114-D; BUCHWALD JS, 1992, ELECTROEN CLIN NEURO, V84, P164, DOI 10.1016/0168-5597(92)90021-3; Budinger E, 2006, NEUROSCIENCE, V143, P1065, DOI 10.1016/j.neuroscience.2006.08.035; Cardy JEO, 2008, INT J PSYCHOPHYSIOL, V68, P170, DOI 10.1016/j.ijpsycho.2007.10.015; Cardy JEO, 2004, NEUROREPORT, V15, P1867, DOI 10.1097/00001756-200408260-00006; Cheon KA, 2011, BRAIN RES, V1417, P77, DOI 10.1016/j.brainres.2011.08.020; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Crane L, 2009, AUTISM, V13, P215, DOI 10.1177/1362361309103794; DAHLGREN SO, 1989, EUR ARCH PSY CLIN N, V238, P169; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dunn W, 1999, SENSORY PROFILE USER, Vxiv; Eggermont JJ, 2003, ACTA OTO-LARYNGOL, V123, P249, DOI 10.1080/0036554021000028098; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Friedman SD, 2003, NEUROLOGY, V60, P100, DOI 10.1212/WNL.60.1.100; Fujioka T, 2006, BRAIN, V129, P2593, DOI 10.1093/brain/awl247; Hackett TA, 1998, J COMP NEUROL, V400, P271, DOI 10.1002/(SICI)1096-9861(19981019)400:2<271::AID-CNE8>3.0.CO;2-6; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hardan AY, 2008, PSYCHIAT RES-NEUROIM, V163, P97, DOI 10.1016/j.pscychresns.2007.12.002; Hardan AY, 2008, J AUTISM DEV DISORD, V38, P390, DOI 10.1007/s10803-007-0385-1; Hardan AY, 2006, PSYCHIAT RES-NEUROIM, V147, P145, DOI 10.1016/j.pscychresns.2005.12.009; Harrison J, 2004, J AUTISM DEV DISORD, V34, P727, DOI 10.1007/s10803-004-5293-z; HARRISON JB, 1990, BRAIN RES, V520, P43, DOI 10.1016/0006-8993(90)91690-I; Hauk O, 2011, NEUROIMAGE, V54, P1966, DOI 10.1016/j.neuroimage.2010.09.053; Haznedar MM, 2006, AM J PSYCHIAT, V163, P1252, DOI 10.1176/appi.ajp.163.7.1252; Hine J, 2007, CLIN NEUROPHYSIOL, V118, P1274, DOI 10.1016/j.clinph.2007.03.012; Howard MA, 2000, J COMP NEUROL, V416, P79, DOI 10.1002/(SICI)1096-9861(20000103)416:1<79::AID-CNE6>3.0.CO;2-2; Howard MF, 2009, HEARING RES, V257, P41, DOI 10.1016/j.heares.2009.07.010; Huang MX, 2003, CLIN NEUROPHYSIOL, V114, P835, DOI 10.1016/S1388-2457(03)00041-5; Jou RJ, 2009, PSYCHOL MED, V39, P1347, DOI 10.1017/S0033291708004376; Kern JK, 2006, AUTISM, V10, P480, DOI 10.1177/1362361306066564; Kotecha R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004811; Kral A, 2007, BRAIN RES REV, V56, P259, DOI 10.1016/j.brainresrev.2007.07.021; Leekam SR, 2007, J AUTISM DEV DISORD, V37, P894, DOI 10.1007/s10803-006-0218-7; Lin FH, 2006, NEUROIMAGE, V31, P160, DOI 10.1016/j.neuroimage.2005.11.054; Lin FH, 2006, HUM BRAIN MAPP, V27, P1, DOI 10.1002/hbm.20155; Liss M, 2006, AUTISM, V10, P155, DOI 10.1177/1362361306062021; Moore JK, 2007, INT J AUDIOL, V46, P460, DOI 10.1080/14992020701383019; Moore JK, 2001, JARO-J ASSOC RES OTO, V2, P297, DOI 10.1007/s101620010052; Okon-Singer N, 2011, NEUROIMAGE, V54, P3010, DOI 10.1016/j.neuroimage.2010.10.078; Orekhova EV, 2009, CLIN NEUROPHYSIOL, V120, P520, DOI 10.1016/j.clinph.2008.12.034; ORNITZ EM, 1983, INT J NEUROSCI, V19, P85, DOI 10.3109/00207458309148648; PAETAU R, 1995, J CLIN NEUROPHYSIOL, V12, P177, DOI 10.1097/00004691-199503000-00008; Ponton C, 2002, CLIN NEUROPHYSIOL, V113, P407, DOI 10.1016/S1388-2457(01)00733-7; Ray MA, 2005, NEUROBIOL DIS, V19, P366, DOI 10.1016/j.nbd.2005.01.017; Rogers SJ, 2003, J AUTISM DEV DISORD, V33, P631, DOI 10.1023/B:JADD.0000006000.38991.a7; Romanski LM, 1997, J COMP NEUROL, V379, P313; Ruhnau P, 2011, NEUROIMAGE, V58, P630, DOI 10.1016/j.neuroimage.2011.06.050; Spencer MD, 2006, NEUROIMAGE, V33, P1136, DOI 10.1016/j.neuroimage.2006.08.011; Stiegler LN, 2010, FOCUS AUTISM DEV DIS, V25, P67, DOI 10.1177/1088357610364530; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Sussman E, 2008, HEARING RES, V236, P61, DOI 10.1016/j.heares.2007.12.001; Tamura R, 2010, PSYCHIAT RES-NEUROIM, V184, P186, DOI 10.1016/j.pscychresns.2010.07.001; Thoma RJ, 2003, AM J PSYCHIAT, V160, P1595, DOI 10.1176/appi.ajp.160.9.1595; Tomchek SD, 2007, AM J OCCUP THER, V61, P190, DOI 10.5014/ajot.61.2.190; Tsatsanis KD, 2003, BIOL PSYCHIAT, V53, P121, DOI 10.1016/S0006-3223(02)01530-5; VANENGELAND H, 1984, J AUTISM DEV DISORD, V14, P261, DOI 10.1007/BF02409578; Waiter GD, 2004, NEUROIMAGE, V22, P619, DOI 10.1016/j.neuroimage.2004.02.029; Weiland BJ, 2008, NEUROIMAGE, V42, P827, DOI 10.1016/j.neuroimage.2008.05.042; Wiggins LD, 2009, J AUTISM DEV DISORD, V39, P1087, DOI 10.1007/s10803-009-0711-x; Zilbovicius M, 2000, AM J PSYCHIAT, V157, P1988, DOI 10.1176/appi.ajp.157.12.1988	70	37	38	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39906	10.1371/journal.pone.0039906	http://dx.doi.org/10.1371/journal.pone.0039906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768163	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100132
J	Scali, J; Gandubert, C; Ritchie, K; Soulier, M; Ancelin, ML; Chaudieu, I				Scali, Jacqueline; Gandubert, Catherine; Ritchie, Karen; Soulier, Maryvonne; Ancelin, Marie-Laure; Chaudieu, Isabelle			Measuring Resilience in Adult Women Using the 10-Items Connor-Davidson Resilience Scale (CD-RISC). Role of Trauma Exposure and Anxiety Disorders	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; HUMAN CAPACITY; BREAST-CANCER; CD-RISC; GROWTH; RELIABILITY; VALIDITY; VULNERABILITY; EPIDEMIOLOGY; PERSONALITY	Purpose: Resilience is the ability of individuals to adapt positively in the face of trauma. Little is known, however, about lifetime factors affecting resilience. Methods: We assessed the effects of psychiatric disorder and lifetime trauma history on the resilience self-evaluation using the Connor-Davidson Resilience Scale (CD-RISC-10) in a high-risk-women sample. Two hundred and thirty eight community-dwelling women, including 122 participants in a study of breast cancer survivors and 116 participants without previous history of cancer completed the CD-RISC-10. Lifetime psychiatric symptoms were assessed retrospectively using two standardized psychiatric examinations (Mini International Neuropsychiatric Interview and Watson's Post-Traumatic Stress Disorder Inventory). Results: Multivariate logistic regression adjusted for age, education, trauma history, cancer, current psychiatric diagnoses, and psychoactive treatment indicated a negative association between current psychiatric disorder and high resilience compared to low resilience level (OR = 0.44, 95% CI [0.21-0.93]). This was related to anxiety and not mood disorder. A positive and independent association with a trauma history was also observed (OR = 3.18, 95% CI [1.44-7.01]). Conclusion: Self-evaluation of resilience is influenced by both current anxiety disorder and trauma history. The independent positive association between resilience and trauma exposure may indicate a "vaccination" effect. This finding need to be taken into account in future studies evaluating resilience in general or clinical populations.	[Scali, Jacqueline; Gandubert, Catherine; Ritchie, Karen; Ancelin, Marie-Laure; Chaudieu, Isabelle] INSERM, U1061, Montpellier, France; [Scali, Jacqueline; Gandubert, Catherine; Ritchie, Karen; Ancelin, Marie-Laure; Chaudieu, Isabelle] Univ Montpellier I, Montpellier, France; [Ritchie, Karen] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Soulier, Maryvonne] CRLC Val Aurelle Paul Lamarque, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Imperial College London; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM)	Scali, J (corresponding author), INSERM, U1061, Montpellier, France.	isabelle.chaudieu@inserm.fr	Ritchie, Karen/G-3571-2013; Ancelin, Marie-Laure/F-3079-2013; Chaudieu, Isabelle/B-8084-2008; Ancelin, Marie-Laure/L-1198-2019	Ritchie, Karen/0000-0002-0688-8982; Ancelin, Marie-Laure/0000-0002-1149-4320; Chaudieu, Isabelle/0000-0003-0587-4842; Ancelin, Marie-Laure/0000-0002-1149-4320; scali, jacqueline/0000-0003-2844-7499	Fondation de France (France Fundation); Institut National de la Sante et de la Recherche Medicale (INSERM; National Institut of Health and Medical Research)	Fondation de France (France Fundation); Institut National de la Sante et de la Recherche Medicale (INSERM; National Institut of Health and Medical Research)	Sources of funding: The "Fondation de France (France Fundation)" and the "Institut National de la Sante et de la Recherche Medicale (INSERM; National Institut of Health and Medical Research)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Joint Committee on Cancer, 1989, MAN STAG BREAST CARC; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Bonanno GA, 2008, PEDIATRICS, V121, P369, DOI 10.1542/peds.2007-1648; Bonanno GA, 2007, J CONSULT CLIN PSYCH, V75, P671, DOI 10.1037/0022-006X.75.5.671; Brunet A, 1995, P 4 EUR C TRAUM STRE; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Campbell-Sills L, 2009, J PSYCHIATR RES, V43, P1007, DOI 10.1016/j.jpsychires.2009.01.013; CARLIER IVE, 1995, J NERV MENT DIS, V183, P107, DOI 10.1097/00005053-199502000-00008; Charney DS, 2004, AM J PSYCHIAT, V161, P195, DOI 10.1176/appi.ajp.161.2.195; Chaudieu I, 2011, J CLIN PSYCHIAT, V72, P929, DOI 10.4088/JCP.10m06230; Connor KM, 2006, CNS SPECTRUMS, V11, P5, DOI 10.1017/S1092852900025797; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Cordova MJ, 2001, HEALTH PSYCHOL, V20, P176, DOI 10.1037//0278-6133.20.3.176; Davidson J, 2008, INT CLIN PSYCHOPHARM, V23, P299, DOI 10.1097/YIC.0b013e32830c202d; Davidson JRT, 2005, INT CLIN PSYCHOPHARM, V20, P43, DOI 10.1097/00004850-200501000-00009; Davydov DM, 2010, CLIN PSYCHOL REV, V30, P479, DOI 10.1016/j.cpr.2010.03.003; Duncko R, 2006, PROG NEURO-PSYCHOPH, V30, P1058, DOI 10.1016/j.pnpbp.2006.04.002; Gandubert C, 2009, PSYCHO-ONCOLOGY, V18, P1029, DOI 10.1002/pon.1469; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Jehel L, 1999, REV FRANCAISE PSYCHI, V24, P203; Jorgensen Ivar Elvik, 2008, Int J Adolesc Med Health, V20, P23; Joseph S, 2006, CLIN PSYCHOL REV, V26, P1041, DOI 10.1016/j.cpr.2005.12.006; Karairmak O, 2010, PSYCHIAT RES, V179, P350, DOI 10.1016/j.psychres.2009.09.012; Keane TM, 2006, ANNU REV CLIN PSYCHO, V2, P161, DOI 10.1146/annurev.clinpsy.2.022305.095305; Lamond AJ, 2008, J PSYCHIATR RES, V43, P148, DOI 10.1016/j.jpsychires.2008.03.007; Lavretsky H, 2010, AM J GERIAT PSYCHIAT, V18, P154, DOI 10.1097/JGP.0b013e3181beab1e; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Luthar S.S., 2003, RESILIENCE VULNERABI, P510, DOI [DOI 10.1017/CBO9780511615788, 10.1017/CBO9780511615788]; McLean CP, 2009, CLIN PSYCHOL REV, V29, P496, DOI 10.1016/j.cpr.2009.05.003; Notario-Pacheco B, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-63; Ramanaiah NV, 1999, PSYCHOL REP, V84, P497, DOI 10.2466/PR0.84.2.497-500; Ritchie K, 2011, INT J GERIATR PSYCH, V26, P503, DOI 10.1002/gps.2553; Ritchie K, 2009, J CLIN PSYCHIAT, V70, P1281, DOI 10.4088/JCP.08m04510; Rutter M, 2006, ANN NY ACAD SCI, V1094, P1, DOI 10.1196/annals.1376.002; Seery MD, 2010, J PERS SOC PSYCHOL, V99, P1025, DOI 10.1037/a0021344; Sexton MB, 2010, J PSYCHIATR RES, V44, P236, DOI 10.1016/j.jpsychires.2009.06.007; Simeon D, 2007, PSYCHONEUROENDOCRINO, V32, P1149, DOI 10.1016/j.psyneuen.2007.08.005; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Wang L, 2010, PSYCHIAT CLIN NEUROS, V64, P499, DOI 10.1111/j.1440-1819.2010.02130.x; WATSON CG, 1991, J CLIN PSYCHOL, V47, P179, DOI 10.1002/1097-4679(199103)47:2<179::AID-JCLP2270470202>3.0.CO;2-P; Weisberg RB, 2009, J CLIN PSYCHIAT, V70, P4, DOI 10.4088/JCP.s.7002.01; Weiss T, 2002, J PSYCHOSOC ONCOL, V20, P65, DOI 10.1300/J077v20n02_04; Wingo AP, 2010, J AFFECT DISORDERS, V126, P411, DOI 10.1016/j.jad.2010.04.009; Yu XN, 2011, COMPR PSYCHIAT, V52, P218, DOI 10.1016/j.comppsych.2010.05.010	45	116	119	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39879	10.1371/journal.pone.0039879	http://dx.doi.org/10.1371/journal.pone.0039879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768152	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100121
J	Tsukuda, Y; Iwasaki, N; Seito, N; Kanayama, M; Fujitani, N; Shinohara, Y; Kasahara, Y; Onodera, T; Suzuki, K; Asano, T; Minami, A; Yamashita, T				Tsukuda, Yukinori; Iwasaki, Norimasa; Seito, Naoki; Kanayama, Masashi; Fujitani, Naoki; Shinohara, Yasuro; Kasahara, Yasuhiko; Onodera, Tomohiro; Suzuki, Koji; Asano, Tsuyoshi; Minami, Akio; Yamashita, Tadashi			Ganglioside GM3 Has an Essential Role in the Pathogenesis and Progression of Rheumatoid Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; PROINFLAMMATORY CYTOKINES; MONOCYTE MIGRATION; IMMUNE-RESPONSE; C57BL/6 MICE; T-CELLS; INTERLEUKIN-17; INFLAMMATION; IL-17; DESTRUCTION	Rheumatoid arthritis (RA), a chronic systemic inflammatory disorder that principally attacks synovial joints, afflicts over 2 million people in the United States. Interleukin (IL)-17 is considered to be a master cytokine in chronic, destructive arthritis. Levels of the ganglioside GM3, one of the most primitive glycosphingolipids containing a sialic acid in the structure, are remarkably decreased in the synovium of patients with RA. Based on the increased cytokine secretions observed in in vitro experiments, GM3 might have an immunologic role. Here, to clarify the association between RA and GM3, we established a collagen-induced arthritis mouse model using the null mutation of the ganglioside GM3 synthase gene. GM3 deficiency exacerbated inflammatory arthritis in the mouse model of RA. In addition, disrupting GM3 induced T cell activation in vivo and promoted overproduction of the cytokines involved in RA. In contrast, the amount of the GM3 synthase gene transcript in the synovium was higher in patients with RA than in those with osteoarthritis. These findings indicate a crucial role for GM3 in the pathogenesis and progression of RA. Control of glycosphingolipids such as GM3 might therefore provide a novel therapeutic strategy for RA.	[Tsukuda, Yukinori; Iwasaki, Norimasa; Seito, Naoki; Kasahara, Yasuhiko; Onodera, Tomohiro; Asano, Tsuyoshi; Minami, Akio] Hokkaido Univ, Grad Sch Med, Dept Orthopaed Surg, Sapporo, Hokkaido, Japan; Hokkaido Univ, Inst Med Genet, Div Mol Immunol, Sapporo, Hokkaido, Japan; [Fujitani, Naoki; Shinohara, Yasuro] Hokkaido Univ, Grad Sch Adv Life Sci, Lab Med & Funct Glyc, Sapporo, Hokkaido, Japan; [Suzuki, Koji] Hokkaido Orthopaed Mem Hosp, Sapporo, Hokkaido, Japan; [Yamashita, Tadashi] Hokkaido Univ, Frontier Res Ctr Postgenom Sci & Technol, Fac Adv Life Sci, Sapporo, Hokkaido, Japan; [Yamashita, Tadashi] Kyungpook Natl Univ, Sch Med, World Class Univ Program, Taegu, South Korea	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Kyungpook National University	Tsukuda, Y (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Orthopaed Surg, Sapporo, Hokkaido, Japan.	niwasaki@med.hokudai.ac.jp; ty11106@sci.hokudai.ac.jp	Fujitani, Naoki/A-4072-2012; Onodera, Tomohiro/G-1686-2012	Fujitani, Naoki/0000-0002-4035-7317; Kanayama, Masashi/0000-0001-8366-5275	Ministry of Health, Labor, and Welfare in Japan [7263000119]; Uehara Memorial Foundation; World Class University through the National Research Foundation of Korea; Ministry of Education, Science, and Technology of Korea [R32-10064]	Ministry of Health, Labor, and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Uehara Memorial Foundation(Uehara Memorial Foundation); World Class University through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Health and Labor Sciences Research Grants "Comprehensive Research on Aging and Health" (7263000119) from the Ministry of Health, Labor, and Welfare in Japan (http://www.mhlw.go.jp/english/) and the Uehara Memorial Foundation (http://www.ueharazaidan.com/) to N.I., and the World Class University program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology of Korea (R32-10064) (http://wcu.nrf.go.kr/english/e_about/about_5.jsp) to T.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AREND WP, 1990, ARTHRITIS RHEUM-US, V33, P305, DOI 10.1002/art.1780330302; Awasthi A, 2009, NAT IMMUNOL, V10, P568, DOI 10.1038/ni0609-568; Bankhurst Arthur D, 2008, Arthritis Rheum, V58, pS58, DOI 10.1002/art.23359; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Drolet AM, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/913802; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697; Geboes L, 2009, ARTHRITIS RHEUM-US, V60, P390, DOI 10.1002/art.24220; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; Hashiramoto A, 2006, ONCOGENE, V25, P3948, DOI 10.1038/sj.onc.1209416; IKEDA T, 1992, LIFE SCI, V51, P847, DOI 10.1016/0024-3205(92)90612-S; ITO M, 1989, J BIOL CHEM, V264, P9510; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Katz Y, 2001, ARTHRITIS RHEUM-US, V44, P2176, DOI 10.1002/1529-0131(200109)44:9<2176::AID-ART371>3.0.CO;2-4; Kelchtermans H, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2787; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; LADISCH S, 1992, BIOCHIM BIOPHYS ACTA, V1125, P180, DOI 10.1016/0005-2760(92)90043-U; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Niimi K, 2011, BIOCHEM BIOPH RES CO, V406, P524, DOI 10.1016/j.bbrc.2011.02.071; Okuzawa C, 2008, BIOCHEM BIOPH RES CO, V371, P561, DOI 10.1016/j.bbrc.2008.04.124; Pan M, 2004, J CLIN IMMUNOL, V24, P481, DOI 10.1023/B:JOCI.0000040919.16739.44; Rampersad RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025833; Saouaf SJ, 2009, EXP MOL PATHOL, V87, P99, DOI 10.1016/j.yexmp.2009.06.003; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Shahrara S, 2010, J IMMUNOL, V184, P4479, DOI 10.4049/jimmunol.0901942; Shahrara S, 2009, J IMMUNOL, V182, P3884, DOI 10.4049/jimmunol.0802246; Shevchuk NA, 2007, BBA-MOL CELL BIOL L, V1771, P1226, DOI 10.1016/j.bbalip.2007.05.008; Shu LM, 2002, J BIOL CHEM, V277, P18447, DOI 10.1074/jbc.M111363200; Toledo MS, 2005, J BIOL CHEM, V280, P16227, DOI 10.1074/jbc.M413713200; Toledo MS, 2004, J BIOL CHEM, V279, P34655, DOI 10.1074/jbc.M403857200; Tran CN, 2007, AM J PATHOL, V171, P1588, DOI 10.2353/ajpath.2007.070004; TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857; van Hamburg JP, 2011, ARTHRITIS RHEUM-US, V63, P73, DOI 10.1002/art.30093; Yamashita T, 2005, P NATL ACAD SCI USA, V102, P2725, DOI 10.1073/pnas.0407785102; Zhu YX, 2011, J BIOL CHEM, V286, P14787, DOI 10.1074/jbc.M111.218610	38	25	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40136	10.1371/journal.pone.0040136	http://dx.doi.org/10.1371/journal.pone.0040136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768242	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100214
J	Wang, ZX; Cao, Y; Jiang, CP; Yang, G; Wu, JH; Ding, YT				Wang, Zhongxia; Cao, Yin; Jiang, Chunping; Yang, Guang; Wu, Junhua; Ding, Yitao			Lack of Association of Two Common Polymorphisms rs2910164 and rs11614913 with Susceptibility to Hepatocellular Carcinoma: A Meta-Analysis	PLOS ONE			English	Article							PRE-MICRORNAS; FUNCTIONAL POLYMORPHISM; TURKISH POPULATION; GENETIC-VARIANTS; CANCER-RISK; EXPRESSION; BREAST	Background: Single nucleotide polymorphisms (SNPs) in microRNA-coding genes may participate in the process of carcinogenesis by altering the expression of tumor-related microRNAs. It has been suggested that two common SNPs rs2910164 in miR-146a and rs11614913 in miR-196a2 are associated with susceptibility to hepatocellular carcinoma (HCC). However, published results are inconsistent and inconclusive. In the present study, we performed a meta-analysis to systematically summarize the possible association between the two SNPs and the risk for HCC. Methodology/Principal Findings: We conducted a search of case-control studies on the associations of SNPs rs2910164 and/or rs11614913 with susceptibility to HCC in PubMed, EMBASE, ISI Web of Science, Cochrane Central Register of Controlled Trials, ScienceDirect, Wiley Online Library and Chinese National Knowledge Infrastructure databases. Data from eligible studies were extracted for meta-analysis. HCC risk associated with the two polymorphisms was estimated by pooled odds ratios (ORs) and 95% confidence intervals (95% CIs). 5 studies on rs2910164 and 4 studies on rs11614913 were included in our meta-analysis. Our results showed that neither allele frequency nor genotype distribution of the two polymorphisms was associated with risk for HCC in all genetic models. Similarly, subgroup analysis in Chinese population showed no association between the two SNPs and the susceptibility to HCC. Conclusions/Significance: This meta-analysis suggests that two common SNPs rs2910164 and rs11614913 are not associated with the risk of HCC. Well-designed studies with larger sample size and more ethnic groups are required to further validate the results.	[Wang, Zhongxia; Cao, Yin; Jiang, Chunping; Yang, Guang; Ding, Yitao] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Hepatobiliary Surg, Nanjing, Jiangsu, Peoples R China; [Wang, Zhongxia; Cao, Yin; Jiang, Chunping; Yang, Guang; Ding, Yitao] Jiangsu Prov Key Med Ctr Hepatobiliary Surg, Nanjing, Jiangsu, Peoples R China	Nanjing University	Wang, ZX (corresponding author), Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Hepatobiliary Surg, Nanjing, Jiangsu, Peoples R China.	dingyitao@yahoo.com.cn		Wu, Junhua/0000-0003-4753-2648	Jiangsu Province's Key Medical Center [ZX201105]; Research Foundation of Ministry of Health of China [LW201008]	Jiangsu Province's Key Medical Center; Research Foundation of Ministry of Health of China	This study was supported by Jiangsu Province's Key Medical Center (ZX201105) and the Research Foundation of Ministry of Health of China (LW201008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkiz H, 2011, J VIRAL HEPATITIS, V18, pE399, DOI 10.1111/j.1365-2893.2010.01414.x; Akkiz H, 2011, GENE, V486, P104, DOI 10.1016/j.gene.2011.07.006; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Braconi C, 2011, SEMIN ONCOL, V38, P752, DOI 10.1053/j.seminoncol.2011.08.001; Chu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018108; Damazo AS, 2008, INFLAMM RES, V57, P97, DOI 10.1007/s00011-007-7114-2; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Gao LB, 2011, BREAST CANCER RES TR, V125, P571, DOI 10.1007/s10549-010-0993-x; Guo J, 2012, PLOS ONE, P7; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kanai M, 2010, ONCOL REP, V23, P843, DOI 10.3892/or_00000706; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Law PTY, 2011, J GASTROEN HEPATOL, V26, P437, DOI 10.1111/j.1440-1746.2010.06512.x; Li XD, 2010, PATHOLOGY, V42, P669, DOI 10.3109/00313025.2010.522175; Lian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031615; Lovat F, 2011, SEMIN ONCOL, V38, P724, DOI 10.1053/j.seminoncol.2011.08.006; MANTEL N, 1959, J NATL CANCER I, V22, P719; Masaki T, 1996, HEPATOLOGY, V24, P72, DOI 10.1053/jhep.1996.v24.pm0008707286; Maschler S, 2010, EMBO MOL MED, V2, P401, DOI 10.1002/emmm.201000095; Mittal RD, 2011, DNA CELL BIOL, V30, P401, DOI 10.1089/dna.2010.1159; Okubo M, 2010, HELICOBACTER, V15, P524, DOI 10.1111/j.1523-5378.2010.00806.x; Owens BM, 2002, STEM CELLS, V20, P364, DOI 10.1634/stemcells.20-5-364; Pastrello C, 2010, CARCINOGENESIS, V31, P2124, DOI 10.1093/carcin/bgq184; Perretti M, 2009, BRIT J PHARMACOL, V158, P936, DOI 10.1111/j.1476-5381.2009.00483.x; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Pogribny IP, 2012, CANC LETT; Qi P, 2010, HUM IMMUNOL, V71, P621, DOI 10.1016/j.humimm.2010.02.017; Qiu LX, 2011, CYTOKINE, V56, P695, DOI 10.1016/j.cyto.2011.09.001; Qiu LX, 2011, CYTOKINE, V56, P589, DOI 10.1016/j.cyto.2011.08.019; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Srivastava K, 2010, J HUM GENET, V55, P495, DOI 10.1038/jhg.2010.54; Tian T, 2010, INT J MOL EPIDEMIOL, V1, P358; Wang J, 2012, MOL BIOL REP, V39, P4571, DOI 10.1007/s11033-011-1247-7; Wang PY, 2012, EXP THER MED, V3, P324, DOI 10.3892/etm.2011.399; Xiang Y, 2012, MOL BIOL REP; Xu T, 2008, CARCINOGENESIS, V29, P2126, DOI 10.1093/carcin/bgn195; Xu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020471; Yom CK, 2011, J BREAST CANCER, V14, P262, DOI 10.4048/jbc.2011.14.4.262; [张新伟 Zhang Xinwei], 2011, [中华预防医学杂志, Chinese Journal of Preventive Medicine], V45, P239; Zhou B, 2011, MOL CARCINOGEN, V50, P499, DOI 10.1002/mc.20740; Zhou J, 2011, DNA CELL BIOL	45	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40039	10.1371/journal.pone.0040039	http://dx.doi.org/10.1371/journal.pone.0040039			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768213	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100185
J	Xiao, R; Teng, M; Zhang, Q; Shi, XH; Huang, YS				Xiao, Rong; Teng, Miao; Zhang, Qiong; Shi, Xiao-hua; Huang, Yue-sheng			Myocardial Autophagy after Severe Burn in Rats	PLOS ONE			English	Article							ANGIOTENSIN-II TYPE-1; CELL-DEATH; CARDIAC MYOCYTES; ISCHEMIA/REPERFUSION INJURY; CARDIOMYOCYTE AUTOPHAGY; REPERFUSION; APOPTOSIS; ISCHEMIA; HEART; PATHOGENESIS	Background: Autophagy plays a major role in myocardial ischemia and hypoxia injury. The present study investigated the effects of autophagy on cardiac dysfunction in rats after severe burn. Methods: Protein expression of the autophagy markers LC3 and Beclin 1 were determined at 0, 1, 3, 6, and 12 h post-burn in Sprague Dawley rats subjected to 30% total body surface area 3rd degree burns. Autophagic, apoptotic, and oncotic cell death were evaluated in the myocardium at each time point by immunofluorescence. Changes of cardiac function were measured in a Langendorff model of isolated heart at 6 h post-burn, and the autophagic response was measured following activation by Rapamycin and inhibition by 3-methyladenine (3-MA). The angiotensin converting enzyme inhibitor enalaprilat, the angiotensin receptor I blocker losartan, and the reactive oxygen species inhibitor diphenylene iodonium (DPI) were also applied to the ex vivo heart model to examine the roles of these factors in post-burn cardiac function. Results: Autophagic cell death was first observed in the myocardium at 3 h post-burn, occurring in 0.008 +/- 0.001% of total cardiomyocytes, and continued to increase to a level of 0.022 +/- 0.005% by 12 h post-burn. No autophagic cell death was observed in control hearts. Compared with apoptosis, autophagic cell death occurred earlier and in larger quantities. Rapamycin enhanced autophagy and decreased cardiac function in isolated hearts 6 h post-burn, while 3-MA exerted the opposite response. Enalaprilat, losartan, and DPI all inhibited autophagy and enhanced heart function. Conclusion: Myocardial autophagy is enhanced in severe burns and autophagic cell death occurred early at 3 h post-burn, which may contribute to post-burn cardiac dysfunction. Angiotensin II and reactive oxygen species may play important roles in this process by regulating cell signaling transduction.	[Xiao, Rong; Teng, Miao; Zhang, Qiong; Shi, Xiao-hua; Huang, Yue-sheng] Third Mil Med Univ, Inst Burn Res, State Key Lab Trauma Burns & Combined Injury, Southwest Hosp, Chongqing, Peoples R China	Army Medical University	Xiao, R (corresponding author), Third Mil Med Univ, Inst Burn Res, State Key Lab Trauma Burns & Combined Injury, Southwest Hosp, Chongqing, Peoples R China.	yshuang.tmmu@gmail.com			State Key Laboratory of Trauma, Burns and Combined injury [SKLZZ200806]; National Key Technology Research and Development Program [2009BAI87B03]; Key Project of China National Basic Research and Development Program [2012CB518101]; National Natural Science Foundation of China [81071547]	State Key Laboratory of Trauma, Burns and Combined injury; National Key Technology Research and Development Program(National Key Technology R&D Program); Key Project of China National Basic Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a Key Grant from the State Key Laboratory of Trauma, Burns and Combined injury (SKLZZ200806), National Key Technology Research and Development Program (2009BAI87B03), Key Project of China National Basic Research and Development Program (2012CB518101), and National Natural Science Foundation of China (81071547). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki T, 2003, ONCOGENE, V22, P8529, DOI 10.1038/sj.onc.1207197; Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Blommaart EFC, 1997, HISTOCHEM J, V29, P365, DOI 10.1023/A:1026486801018; Dong Y, 2010, J CARDIOVASC PHARM T, V15, P220, DOI 10.1177/1074248410370327; Ferreira MAS, 1998, J CLIN PATHOL, V51, P548, DOI 10.1136/jcp.51.7.548; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Hu JY, 2010, CELL MOL LIFE SCI, V67, P321, DOI 10.1007/s00018-009-0187-z; Huang YS, 1998, BURNS, V24, P706, DOI 10.1016/S0305-4179(98)00123-5; Jin Yulan, 2010, Front Biosci (Elite Ed), V2, P1147; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Knaapen MWM, 2001, CARDIOVASC RES, V51, P304, DOI 10.1016/S0008-6363(01)00290-5; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Matsui Y, 2008, AUTOPHAGY, V4, P409, DOI 10.4161/auto.5638; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mazure NM, 2010, CURR OPIN CELL BIOL, V22, P177, DOI 10.1016/j.ceb.2009.11.015; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Narula Jagat, 2001, Cardiology Clinics, V19, P113, DOI 10.1016/S0733-8651(05)70198-3; OLIVETTI G, 1995, J AM COLL CARDIOL, V26, P1068, DOI 10.1016/0735-1097(95)00282-8; Porrello ER, 2009, AUTOPHAGY, V5, P1215, DOI 10.4161/auto.5.8.10153; Porrello ER, 2009, HYPERTENSION, V53, P1032, DOI 10.1161/HYPERTENSIONAHA.108.128488; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Sheng Zhiyong, 2002, Chin J Traumatol, V5, P195; Valentim L, 2006, J MOL CELL CARDIOL, V40, P846, DOI 10.1016/j.yjmcc.2006.03.428; Wang GQ, 2001, BURNS, V27, P250, DOI 10.1016/S0305-4179(00)00105-4; Xiang F, 2010, FEBS J, V277, P1929, DOI 10.1111/j.1742-4658.2010.07615.x; Xiao R, 2011, J TRAUMA, V71, P663, DOI 10.1097/TA.0b013e31822175f6; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Yang J, 1999, Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi, V15, P102; Yin Ze-gang, 2010, Zhonghua Shao Shang Za Zhi, V26, P10; Zhang JP, 2008, J TRAUMA, V65, P401, DOI 10.1097/TA.0b013e31817cf732	35	29	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39488	10.1371/journal.pone.0039488	http://dx.doi.org/10.1371/journal.pone.0039488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768082	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100053
J	van Oosterhout, F; Lucassen, EA; Houben, T; vanderLeest, HT; Antle, MC; Meijer, JH				van Oosterhout, Floor; Lucassen, Eliane A.; Houben, Thijs; vanderLeest, Henk Tjebbe; Antle, Michael C.; Meijer, Johanna H.			Amplitude of the SCN Clock Enhanced by the Behavioral Activity Rhythm	PLOS ONE			English	Article							HAMSTER SUPRACHIASMATIC NUCLEUS; HUMAN CIRCADIAN-RHYTHMS; PHASE DELAYS; NOCTURNAL EXERCISE; PHYSICAL-EXERCISE; MELATONIN RHYTHM; BODY-TEMPERATURE; CONTROLLED-TRIAL; RESPONSE CURVES; SYRIAN-HAMSTERS	Circadian rhythms are regulated by the suprachiasmatic nucleus (SCN), a small structure at the base of the hypothalamus. While light effects on the SCN are well established, little is known of behavioral effects. This study elucidates direct modulating action of behavioral activity on the SCN by use of in vivo electrophysiology recordings, assessments of general locomotor behavior, and video-tracking of mice. The results show suppression of SCN neuronal activity by spontaneous behavior, the magnitude being dependent on the intensity, duration and type of behavioral activity. The suppression was moderate (32% of circadian amplitude) for low-intensity behavior and considerable (59%) for locomotor activity. Mild manipulation of the animals had reversed effects on the SCN indicating that different mechanisms are involved in the regulatory effect of spontaneous versus induced activity. The results indicate that exercise at the proper time of the cycle can boost the amplitude of the rhythm of the SCN clock itself. This has potentially beneficial effects for other rhythmic functions that are under the control of the SCN.	[van Oosterhout, Floor; Lucassen, Eliane A.; Houben, Thijs; vanderLeest, Henk Tjebbe; Antle, Michael C.; Meijer, Johanna H.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Neurophysiol Lab, Leiden, Netherlands; [Antle, Michael C.] Univ Calgary, Dept Psychol, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Calgary	van Oosterhout, F (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Neurophysiol Lab, Leiden, Netherlands.	J.H.Meijer@lumc.nl		Antle, Michael/0000-0001-5178-4683	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [425-20-403]; EU [018741]; CONACYT (Consejo Nacional de Ciencia y Tecnologia) [91984]; FONCICYT (Fondo de Cooperacion Internacional para el fomento de la investigacion cientifica y tecnologica), Mexico	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); EU(European Commission); CONACYT (Consejo Nacional de Ciencia y Tecnologia)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); FONCICYT (Fondo de Cooperacion Internacional para el fomento de la investigacion cientifica y tecnologica), Mexico	This research was supported by Nederlandse Organisatie voor Wetenschappelijk Onderzoek (425-20-403), the EU-funded "Entrainment of the circadian clock"-EUCLOCK (018741), and grant #91984 from CONACYT (Consejo Nacional de Ciencia y Tecnologia) and FONCICYT (Fondo de Cooperacion Internacional para el fomento de la investigacion cientifica y tecnologica), Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antle MC, 2000, J NEUROSCI, V20, P9326; Atkinson G, 2007, EUR J APPL PHYSIOL, V99, P331, DOI 10.1007/s00421-006-0361-z; Barger LK, 2004, AM J PHYSIOL-REG I, V286, pR1077, DOI 10.1152/ajpregu.00397.2003; BINA KG, 1993, J COMP NEUROL, V335, P295, DOI 10.1002/cne.903350212; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; Bobrzynska KJ, 1998, J COMP PHYSIOL A, V182, P251, DOI 10.1007/s003590050175; Brown TM, 2008, NEUROSCI LETT, V448, P273, DOI 10.1016/j.neulet.2008.10.058; Brown TM, 2011, J PHYSIOL-LONDON, V589, P1173, DOI 10.1113/jphysiol.2010.199877; Buxton OM, 1997, AM J PHYSIOL-ENDOC M, V273, pE536, DOI 10.1152/ajpendo.1997.273.3.E536; Challet E, 2007, ENDOCRINOLOGY, V148, P5648, DOI 10.1210/en.2007-0804; Deboer T, 2000, J COMP PHYSIOL A, V186, P969, DOI 10.1007/s003590000150; Deboer T, 2003, NAT NEUROSCI, V6, P1086, DOI 10.1038/nn1122; Dudley TE, 1998, J NEUROSCI, V18, P5045; EDGAR DM, 1991, J BIOL RHYTHM, V6, P185, DOI 10.1177/074873049100600301; Ehlen JC, 2006, EUR J NEUROSCI, V23, P3328, DOI 10.1111/j.1460-9568.2006.04857.x; Foster RG, 2008, CURR BIOL, V18, pR784, DOI 10.1016/j.cub.2008.07.003; Glass JD, 2010, EUR J NEUROSCI, V31, P1117, DOI 10.1111/j.1460-9568.2010.07139.x; Kalsbeek A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003194; Kas MJH, 2001, J BIOL RHYTHM, V16, P66, DOI 10.1177/074873040101600108; Klein D.C., 1991, SUPRACHIASMATIC NUCL; McCurry SM, 2005, J AM GERIATR SOC, V53, P793, DOI 10.1111/j.1532-5415.2005.53252.x; Meerlo P, 1997, J BIOL RHYTHM, V12, P80, DOI 10.1177/074873049701200109; Meijer JH, 1997, BRAIN RES, V753, P322, DOI 10.1016/S0006-8993(97)00150-9; Mistlberger RE, 2005, J BIOL RHYTHM, V20, P339, DOI 10.1177/0748730405277982; Mistlberger RE, 2003, AM J PHYSIOL-REG I, V285, pR917, DOI 10.1152/ajpregu.00222.2003; Miyazaki T, 2001, AM J PHYSIOL-REG I, V281, pR197; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; MROSOVSKY N, 1988, J COMP PHYSIOL A, V162, P35, DOI 10.1007/BF01342701; Mrosovsky N, 1996, BIOL REV, V71, P343, DOI 10.1111/j.1469-185X.1996.tb01278.x; Power A, 2010, J BIOL RHYTHM, V25, P235, DOI 10.1177/0748730410374446; REEBS SG, 1989, J COMP PHYSIOL A, V165, P811, DOI 10.1007/BF00610879; REEBS SG, 1989, J BIOL RHYTHM, V4, P39, DOI 10.1177/074873048900400103; ROSENFELD P, 1988, DEV BRAIN RES, V42, P119, DOI 10.1016/0165-3806(88)90207-6; Rosenwasser AM, 2009, BRAIN RES REV, V61, P281, DOI 10.1016/j.brainresrev.2009.08.001; Schaap J, 2001, EUR J NEUROSCI, V13, P1955, DOI 10.1046/j.0953-816x.2001.01561.x; SHIOIRI T, 1991, PHYSIOL BEHAV, V49, P779, DOI 10.1016/0031-9384(91)90318-I; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Teri L, 2003, JAMA-J AM MED ASSOC, V290, P2015, DOI 10.1001/jama.290.15.2015; Teri L, 2011, J AM GERIATR SOC, V59, P1188, DOI 10.1111/j.1532-5415.2011.03454.x; van Oosterhout F, 2008, ANN NEUROL, V64, P315, DOI 10.1002/ana.21418; VanderLeest HT, 2007, CURR BIOL, V17, P468, DOI 10.1016/j.cub.2007.01.048; VANEEKELEN JAM, 1987, BRAIN RES, V436, P120, DOI 10.1016/0006-8993(87)91563-0; VANREETH O, 1989, NATURE, V339, P49, DOI 10.1038/339049a0; VANREETH O, 1994, AM J PHYSIOL, V266, pE964, DOI 10.1152/ajpendo.1994.266.6.E964; VanSomeren EJW, 1997, J BIOL RHYTHM, V12, P146, DOI 10.1177/074873049701200206; Webb IC, 2008, EUR J NEUROSCI, V27, P828, DOI 10.1111/j.1460-9568.2008.06074.x; Yamakawa GR, 2010, EUR J NEUROSCI, V31, P1974, DOI 10.1111/j.1460-9568.2010.07228.x; Yamanaka Y, 2010, AM J PHYSIOL-REG I, V298, pR681, DOI 10.1152/ajpregu.00345.2009; Yamazaki S, 1998, J NEUROSCI, V18, P10709; Youngstedt SD, 2005, CLIN SPORT MED, V24, P355, DOI 10.1016/j.csm.2004.12.003	51	63	63	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39693	10.1371/journal.pone.0039693	http://dx.doi.org/10.1371/journal.pone.0039693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761873	Green Submitted, gold, Green Published			2022-12-27	WOS:000305826400028
J	Deharvengt, S; Marmarelis, M; Korc, M				Deharvengt, Sophie; Marmarelis, Melina; Korc, Murray			Concomitant Targeting of EGF Receptor, TGF-beta and Src Points to a Novel Therapeutic Approach in Pancreatic Cancer	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; KINASE SIGNALING PATHWAYS; ONCOGENE ADDICTION; FACTOR-ALPHA; CELL-LINE; EXPRESSION; METASTASIS; PROLIFERATION; ANGIOGENESIS; ADENOCARCINOMA	To test the hypothesis that concomitant targeting of the epidermal growth factor receptor (EGFR) and transforming growth factor-beta (TGF-beta) may offer a novel therapeutic approach in pancreatic cancer, EGFR silencing by RNA interference (shEGFR) was combined with TGF-beta sequestration by soluble TGF-beta receptor II (sT beta RII). Effects on colony formation in 3-dimensional culture, tumor formation in nude mice, and downstream signaling were monitored. In both ASPC-1 and T3M4 cells, either shEGFR or sT beta RII significantly inhibited colony formation. However, in ASPC-1 cells, combining shEGFR with sT beta RII reduced colony formation more efficiently than either approach alone, whereas in T3M4 cells, shEGFR-mediated inhibition of colony formation was reversed by sT beta RII. Similarly, in vivo growth of ASPC-1-derived tumors was attenuated by either shEGFR or sT beta RII, and was markedly suppressed by both vectors. By contrast, T3M4-derived tumors either failed to form or were very small when EGFR alone was silenced, and these effects were reversed by sT beta RII due to increased cancer cell proliferation. The combination of shEGFR and sT beta RII decreased phospho-HER2, phospho-HER3, phoshpo-ERK and phospho-src (Tyr416) levels in ASPC-1 cells but increased their levels in T3M4 cells. Moreover, inhibition of both EGFR and HER2 by lapatinib or of src by SSKI-606, PP2, or dasatinib, blocked the sT beta RII-mediated antagonism of colony formation in T3M4 cells. Together, these observations suggest that concomitantly targeting EGFR, TGF-beta, and src may constitute a novel therapeutic approach in PDAC that prevents deleterious cross-talk between EGFR family members and TGF-beta-dependent pathways.	[Deharvengt, Sophie; Marmarelis, Melina] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, Hanover, NH 03756 USA; [Korc, Murray] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Melvin & Bren Simon Canc Ctr, Indianapolis, IN USA; [Korc, Murray] Indiana Univ Sch Med, Dept Med, Melvin & Bren Simon Canc Ctr, Indianapolis, IN USA; [Korc, Murray] Pancreat Canc Signature Ctr, Indianapolis, IN USA	Dartmouth College; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Deharvengt, S (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, Hanover, NH 03756 USA.	mkorc@iupui.edu			National Cancer Institute (NCI) [CA-R37-075059]; NATIONAL CANCER INSTITUTE [R37CA075059, R01CA075059] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute (NCI) grant CA-R37-075059 (M.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN RL, 1993, GROWTH FACTORS, V8, P23, DOI 10.3109/08977199309029131; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; EBERT M, 1994, CANCER RES, V54, P3959; Felsher Dean W., 2008, Lymphatic Research and Biology, V6, P149, DOI 10.1089/lrb.2008.63403; Folkman J, 2005, COLD SH Q B, V70, P389, DOI 10.1101/sqb.2005.70.042; Fukasawa M, 2004, CLIN CANCER RES, V10, P3327, DOI 10.1158/1078-0432.CCR-03-0820; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; HALL PA, 1990, J PATHOL, V161, P195, DOI 10.1002/path.1711610305; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hruban RH, 2000, AM J PATHOL, V156, P1821, DOI 10.1016/S0002-9440(10)65054-7; Innocenti F, 2012, CLIN CANCER RES, V18, P577, DOI 10.1158/1078-0432.CCR-11-1387; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Kern SE, 2000, MED CLIN N AM, V84, P691, DOI 10.1016/S0025-7125(05)70251-0; Kleeff J, 1999, ONCOGENE, V18, P5363, DOI 10.1038/sj.onc.1202909; Kolb A, 2007, INT J CANCER, V120, P514, DOI 10.1002/ijc.22360; Kolch W, 2010, NAT REV CANCER, V10, P618, DOI 10.1038/nrc2900; KORC M, 1992, J CLIN INVEST, V90, P1352, DOI 10.1172/JCI116001; Korc M, 1998, Surg Oncol Clin N Am, V7, P25; KORC M, 1986, P NATL ACAD SCI USA, V83, P5141, DOI 10.1073/pnas.83.14.5141; Korc M, 2007, AM J SURG, V194, pS84, DOI 10.1016/j.amjsurg.2007.05.004; Lim JE, 2003, ANN SURG, V237, P74, DOI 10.1097/00000658-200301000-00011; Ma YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033414; Matsuda K, 2002, CANCER RES, V62, P5611; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Mimeault M, 2010, PHARMACOL REV, V62, P497, DOI 10.1124/pr.109.002329; MORGAN RT, 1980, INT J CANCER, V25, P591, DOI 10.1002/ijc.2910250507; Mueller KL, 2008, CANCER RES, V68, P3314, DOI 10.1158/0008-5472.CAN-08-0132; Nagaraj NS, 2011, CLIN CANCER RES, V17, P483, DOI 10.1158/1078-0432.CCR-10-1670; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; OKABE T, 1983, CANCER, V51, P662, DOI 10.1002/1097-0142(19830215)51:4<662::AID-CNCR2820510419>3.0.CO;2-X; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Park SS, 2004, ONCOGENE, V23, P6272, DOI 10.1038/sj.onc.1207856; Preis M, 2010, CANCER BIOL THER, V9, P754, DOI 10.4161/cbt.9.10.11534; Rowland-Goldsmith MA, 2002, MOL CANCER THER, V1, P161; Rowland-Goldsmith MA, 2001, CLIN CANCER RES, V7, P2931; Schutte M, 1997, CANCER RES, V57, P3126; Schutte M, 1996, CANCER RES, V56, P2527; Sempere LF, 2011, CANCER BIOL THER, V12, P198, DOI 10.4161/cbt.12.3.15979; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SMITH JJ, 1987, P NATL ACAD SCI USA, V84, P7567, DOI 10.1073/pnas.84.21.7567; van Meeteren LA, 2011, CURR PHARM BIOTECHNO, V12, P2108; Wagner M, 1998, INT J CANCER, V78, P255, DOI 10.1002/(SICI)1097-0215(19981005)78:2<255::AID-IJC21>3.0.CO;2-8; Wang SE, 2009, CANCER RES, V69, P475, DOI 10.1158/0008-5472.CAN-08-2649; Whipple CA, 2012, ONCOGENE, V31, P2535, DOI 10.1038/onc.2011.430; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4; Xiong HQ, 2006, DRUGS, V66, P1059, DOI 10.2165/00003495-200666080-00003; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yokoyama M, 1996, INT J ONCOL, V8, P289; Zhang Q, 2004, CANCER RES, V64, P6166, DOI 10.1158/0008-5472.CAN-04-0504	52	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39684	10.1371/journal.pone.0039684	http://dx.doi.org/10.1371/journal.pone.0039684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761868	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800062
J	Wang, L; Liu, J; Zhang, AS; Cheng, P; Zhang, X; Lv, S; Wu, L; Yu, J; Di, WJ; Zha, JM; Kong, XC; Qi, HM; Zhong, Y; Ding, GX				Wang, Long; Liu, Juan; Zhang, Aisen; Cheng, Peng; Zhang, Xiao; Lv, Shan; Wu, Lin; Yu, Jing; Di, Wenjuan; Zha, Juanmin; Kong, Xiaocen; Qi, Hanmei; Zhong, Yi; Ding, Guoxian			BVT.2733, a Selective 11 beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Attenuates Obesity and Inflammation in Diet-Induced Obese Mice	PLOS ONE			English	Article							ADIPOSE-TISSUE; CORTISOL METABOLISM; VISCERAL OBESITY; FATTY-ACIDS; GLUCOCORTICOIDS; MACROPHAGE; EXPRESSION; HYPERGLYCEMIA; SENSITIVITY; ADIPOCYTES	Background: Inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) is being pursued as a new therapeutic approach for the treatment of obesity and metabolic syndrome. Therefore, there is an urgent need to determine the effect of 11 beta-HSD1 inhibitor, which suppresses glucocorticoid action, on adipose tissue inflammation. The purpose of the present study was to examine the effect of BVT.2733, a selective 11 beta-HSD1 inhibitor, on expression of pro-inflammatory mediators and macrophage infiltration in adipose tissue in C57BL/6J mice. Methodology/Principal Findings: C57BL/6J mice were fed with a normal chow diet (NC) or high fat diet (HFD). HFD treated mice were then administrated with BVT.2733 (HFD+BVT) or vehicle (HFD) for four weeks. Mice receiving BVT.2733 treatment exhibited decreased body weight and enhanced glucose tolerance and insulin sensitivity compared to control mice. BVT.2733 also down-regulated the expression of inflammation-related genes including monocyte chemoattractant protein 1 (MCP-1), tumor necrosis factor alpha (TNF-alpha) and the number of infiltrated macrophages within the adipose tissue in vivo. Pharmacological inhibition of 11 beta-HSD1 and RNA interference against 11 beta-HSD1 reduced the mRNA levels of MCP-1 and interleukin-6 (IL-6) in cultured J774A.1 macrophages and 3T3-L1 preadipocyte in vitro. Conclusions/Significance: These results suggest that BVT.2733 treatment could not only decrease body weight and improve metabolic homeostasis, but also suppress the inflammation of adipose tissue in diet-induced obese mice. 11 beta-HSD1 may be a very promising therapeutic target for obesity and associated disease.	[Wang, Long; Liu, Juan; Zhang, Aisen; Cheng, Peng; Lv, Shan; Wu, Lin; Yu, Jing; Di, Wenjuan; Zha, Juanmin; Kong, Xiaocen; Qi, Hanmei; Ding, Guoxian] Nanjing Med Univ, Affiliated Hosp 1, Dept Geratol, Nanjing, Jiangsu, Peoples R China; [Zhang, Xiao] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Zhong, Yi] China Pharmaceut Univ, Dept Pharmaceut Chem, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Northwestern University; Feinberg School of Medicine; China Pharmaceutical University	Wang, L (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Geratol, Nanjing, Jiangsu, Peoples R China.	dinggx@njmu.edu.cn	zhang, xiao/B-3947-2010; Yu, Jing/AAL-5498-2021	Yu, Jing/0000-0002-5062-7069	First Affiliated Hospital of Nanjing Medical University; National Natural Science Foundation of China [3057087]; National Natural Science Youth Foundation of China [30900506]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	First Affiliated Hospital of Nanjing Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Youth Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University, grants from the National Natural Science Foundation of China (3057087) to Guoxian Ding, grants from the National Natural Science Youth Foundation of China (30900506) to Juan Liu and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Alberts P, 2002, DIABETOLOGIA, V45, P1528, DOI 10.1007/s00125-002-0959-6; Charriere G, 2003, J BIOL CHEM, V278, P9850, DOI 10.1074/jbc.M210811200; Erridge C, 2009, ARTERIOSCL THROM VAS, V29, P1944, DOI 10.1161/ATVBAHA.109.194050; Fain JN, 2004, INT J OBESITY, V28, P616, DOI 10.1038/sj.ijo.0802594; Gilmour JS, 2006, J IMMUNOL, V176, P7605, DOI 10.4049/jimmunol.176.12.7605; Hara Y, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001227; Hauner H, 2005, P NUTR SOC, V64, P163, DOI 10.1079/PNS2005428; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Ishii-Yonemoto T, 2010, AM J PHYSIOL-ENDOC M, V298, pE930, DOI 10.1152/ajpendo.00320.2009; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; Lenz A, 2008, CURR OPIN ENDOCRINOL, V15, P9, DOI 10.1097/MED.0b013e3282f43a5b; Lim HY, 2007, IMMUNOLOGY, V122, P47, DOI 10.1111/j.1365-2567.2007.02611.x; Livingstone DEW, 2000, ENDOCRINOLOGY, V141, P560, DOI 10.1210/en.141.2.560; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931; Morton NM, 2001, J BIOL CHEM, V276, P41293, DOI 10.1074/jbc.M103676200; Napolitano A, 1998, J STEROID BIOCHEM, V64, P251, DOI 10.1016/S0960-0760(97)00200-8; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Paulmyer-Lacroix O, 2002, J CLIN ENDOCR METAB, V87, P2701, DOI 10.1210/jc.87.6.2701; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Rask E, 2002, J CLIN ENDOCR METAB, V87, P3330, DOI 10.1210/jc.87.7.3330; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rosenstock J, 2010, DIABETES CARE, V33, P1516, DOI 10.2337/dc09-2315; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schwartz EA, 2010, ARTERIOSCL THROM VAS, V30, P802, DOI 10.1161/ATVBAHA.109.201681; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Staab CA, 2010, J STEROID BIOCHEM, V119, P56, DOI 10.1016/j.jsbmb.2009.12.013; Stewart PM, 2009, DIABETES, V58, P14, DOI 10.2337/db08-1404; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; Tomlinson JW, 2001, ENDOCRINOLOGY, V142, P1982, DOI 10.1210/en.142.5.1982; Wamil M, 2011, DIABETES, V60, P1158, DOI 10.2337/db10-0830; Wang SJY, 2006, DIABETOLOGIA, V49, P1333, DOI 10.1007/s00125-006-0239-y; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang TY, 2007, J IMMUNOL, V179, P6325, DOI 10.4049/jimmunol.179.9.6325	37	20	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40056	10.1371/journal.pone.0040056	http://dx.doi.org/10.1371/journal.pone.0040056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768329	gold, Green Published, Green Submitted			2022-12-27	WOS:000305966500042
J	Wei, J; Cheng, JM; Li, WJ; Liu, WG				Wei, Jie; Cheng, Jimin; Li, Weijun; Liu, Weiguo			Comparing the Effect of Naturally Restored Forest and Grassland on Carbon Sequestration and Its Vertical Distribution in the Chinese Loess Plateau	PLOS ONE			English	Article							SOIL ORGANIC-CARBON; LAND-USE CHANGE; ISOTOPE FRACTIONATION; CLIMATE-CHANGE; DYNAMICS; VEGETATION; MATTER; DECOMPOSITION; NITROGEN; STORAGE	Vegetation restoration has been conducted in the Chinese Loess Plateau (CLP) since the 1950s, and large areas of farmland have been converted to forest and grassland, which largely results in SOC change. However, there has been little comparative research on SOC sequestration and distribution between secondary forest and restored grassland. Therefore, we selected typical secondary forest (SF-1 and SF-2) and restored grassland (RG-1 and RG-2) sites and determined the SOC storage. Moreover, to illustrate the factors resulting in possible variance in SOC sequestration, we measured the soil delta C-13 value. The average SOC content was 6.8, 9.9, 17.9 and 20.4 g kg(-1) at sites SF-1, SF-2, RG-1 and RG-2, respectively. Compared with 0-100 cm depth, the percentage of SOC content in the top 20 cm was 55.1%, 55.3%, 23.1%, and 30.6% at sites SF-1, SF-2, RG-1 and RG-2, suggesting a higher SOC content in shallow layers in secondary forest and in deeper layers in restored grassland. The variation of soil delta C-13 values with depth in this study might be attributed to the mixing of new and old carbon and kinetic fractionation during the decomposition of SOM by microbes, whereas the impact of the Suess effect (the decline of C-13 atmospheric CO2 values with the burning of fossil fuel since the Industrial Revolution) was minimal. The soil delta C-13 value increased sharply in the top 20 cm, which then increased slightly in deeper layers in secondary forest, indicating a main carbon source of surface litter. However the soil delta C-13 values exhibited slow increases in the whole profile in the restored grasslands, suggesting that the contribution of roots to soil carbon in deeper layers played an important role. We suggest that naturally restored grassland would be a more effective vegetation type for SOC sequestration due to higher carbon input from roots in the CLP.	[Wei, Jie; Liu, Weiguo] Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary, Xian, Shaanxi, Peoples R China; [Wei, Jie] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Cheng, Jimin] Chinese Acad Sci, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China; [Cheng, Jimin] Minist Water Resources, Yangling, Shaanxi, Peoples R China; [Li, Weijun] Adm Off Yunwu Mt, Ningxia, Peoples R China; [Liu, Weiguo] Xi An Jiao Tong Univ, Sch Human Settlement & Civil Engn, Xian 710049, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Earth Environment, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Xi'an Jiaotong University	Wei, J (corresponding author), Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary, Xian, Shaanxi, Peoples R China.	liuwg@loess.llqg.ac.cn	Liu, Weiguo/J-1824-2014		Chinese Academy of Science [kzcx2-yw-149]; National Natural Science Foundation of China [40673012]	Chinese Academy of Science(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was co-funded by the Knowledge Innovation Program of the Chinese Academy of Science (kzcx2-yw-149) (URL: http://www.cas.cn/) and the National Natural Science Foundation of China (40673012)(URL: http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alewell C, 2011, BIOGEOSCIENCES, V8, P1769, DOI 10.5194/bg-8-1769-2011; Amundson R, 2000, METHODS IN ECOSYSTEM SCIENCE, P117; An SS, 2010, CATENA, V81, P226, DOI 10.1016/j.catena.2010.04.002; Arai H, 2010, GEODERMA, V159, P425, DOI 10.1016/j.geoderma.2010.09.009; BALDOCK JA, 1992, BIOGEOCHEMISTRY, V16, P1, DOI 10.1007/BF02402261; Bostrom B, 2007, OECOLOGIA, V153, P89, DOI 10.1007/s00442-007-0700-8; Chen LD, 2010, FOREST ECOL MANAG, V259, P1291, DOI 10.1016/j.foreco.2009.10.025; Chen QQ, 2005, PLANT SOIL, V273, P115, DOI 10.1007/s11104-004-7245-y; DeGryze S, 2004, GLOBAL CHANGE BIOL, V10, P1120, DOI 10.1111/j.1529-8817.2003.00786.x; Dirnbock T, 2002, APPL VEG SCI, V5, P147, DOI 10.1111/j.1654-109X.2002.tb00544.x; Dube F, 2009, FOREST ECOL MANAG, V257, P1695, DOI 10.1016/j.foreco.2009.01.044; Ehleringer JR, 2000, ECOL APPL, V10, P412, DOI 10.1890/1051-0761(2000)010[0412:CIRIBC]2.0.CO;2; Fearnside Philip M., 1998, Forest Ecology and Management, V108, P147, DOI 10.1016/S0378-1127(98)00222-9; FRIEDLI H, 1986, NATURE, V324, P237, DOI 10.1038/324237a0; Fu B.J., 2002, LAND USE STRUCTURE E, P1; Garten CT, 2009, ACTA OECOL, V35, P218, DOI 10.1016/j.actao.2008.10.004; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Han FP, 2010, GEODERMA, V154, P261, DOI 10.1016/j.geoderma.2009.10.011; Hobbie EA, 2004, PLANT SOIL, V259, P331, DOI 10.1023/B:PLSO.0000020975.75850.ca; Huygens D, 2005, BIOGEOSCIENCES, V2, P159, DOI 10.5194/bg-2-159-2005; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Katterer T, 2011, AGR ECOSYST ENVIRON, V141, P184, DOI 10.1016/j.agee.2011.02.029; Lal R, 2008, ENERG ENVIRON SCI, V1, P86, DOI 10.1039/b809492f; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2002, LAND DEGRAD DEV, V13, P469, DOI 10.1002/ldr.531; Li JF, 2009, CONTENT DISTRIBUTION; Li YY, 2006, J ARID ENVIRON, V64, P77, DOI 10.1016/j.jaridenv.2005.04.005; Liu WG, 2005, GLOBAL CHANGE BIOL, V11, P1094, DOI 10.1111/j.1365-2486.2005.00969.x; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031782; Maia SMF, 2010, GLOBAL CHANGE BIOL, V16, P2775, DOI 10.1111/j.1365-2486.2009.02105.x; Marin-Spiotta E, 2009, GLOBAL CHANGE BIOL, V15, P1584, DOI 10.1111/j.1365-2486.2008.01805.x; Matamala R, 2008, ECOL APPL, V18, P1470, DOI 10.1890/07-1609.1; McLauchlan KK, 2006, GEODERMA, V136, P289, DOI 10.1016/j.geoderma.2006.03.053; Meier CL, 2008, P NATL ACAD SCI USA, V105, P19780, DOI 10.1073/pnas.0805600105; O'Brien SL, 2010, GLOBAL CHANGE BIOL, V16, P2573, DOI 10.1111/j.1365-2486.2009.02114.x; Parfitt RL, 1997, PLANT SOIL, V191, P279, DOI 10.1023/A:1004266000509; Porporato A, 2002, ADV WATER RESOUR, V25, P1335, DOI 10.1016/S0309-1708(02)00058-1; Post WM, 2000, GLOBAL CHANGE BIOL, V6, P317, DOI 10.1046/j.1365-2486.2000.00308.x; Ruiz-Navarro A, 2009, GEODERMA, V153, P353, DOI 10.1016/j.geoderma.2009.08.024; Schweizer M, 1999, RAPID COMMUN MASS SP, V13, P1284, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1284::AID-RCM578>3.0.CO;2-0; Steinbeiss S, 2008, GLOBAL CHANGE BIOL, V14, P2937, DOI 10.1111/j.1365-2486.2008.01697.x; Tate KR, 2000, AUST J SOIL RES, V38, P685, DOI 10.1071/SR99092; Wang G.A., 2008, BIOGEOSCIENCES DISCU, V5, P1795; Wang SP, 2011, AGR ECOSYST ENVIRON, V142, P329, DOI 10.1016/j.agee.2011.06.002; Wang YF, 2011, CATENA, V85, P58, DOI 10.1016/j.catena.2010.12.003; Wang YF, 2010, QUATERNARY RES, V73, P70, DOI 10.1016/j.yqres.2008.11.006; Wei J, 2011, ACTA ECOL SINICA, V31, P271, DOI DOI 10.1016/j.chnaes.2011.06.009; Wynn JG, 2006, GEODERMA, V131, P89, DOI 10.1016/j.geoderma.2005.03.005; Wynn JG, 2005, GEOCHIM COSMOCHIM AC, V69, P1961, DOI 10.1016/j.gca.2004.09.003; Wynn JG, 2007, PALAEOGEOGR PALAEOCL, V251, P437, DOI 10.1016/j.palaeo.2007.04.009; Zhang X.B., 1994, B SOIL WATER CONSERV, V14, P1, DOI DOI 10.13961/JI.CNKI.STBCTB.1994.06.001	52	37	42	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40123	10.1371/journal.pone.0040123	http://dx.doi.org/10.1371/journal.pone.0040123			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768335	Green Published, gold, Green Submitted			2022-12-27	WOS:000305966500048
J	An, SJ; Chen, ZH; Su, J; Zhang, XC; Zhong, WZ; Yang, JJ; Zhou, Q; Yang, XN; Huang, L; Guan, JL; Nie, Q; Yan, HH; Mok, TS; Wu, YL				An, She-Juan; Chen, Zhi-Hong; Su, Jian; Zhang, Xu-Chao; Zhong, Wen-Zhao; Yang, Jin-Ji; Zhou, Qing; Yang, Xue-Ning; Huang, Ling; Guan, Ji-Lin; Nie, Qiang; Yan, Hong-Hong; Mok, Tony S.; Wu, Yi-Long			Identification of Enriched Driver Gene Alterations in Subgroups of Non-Small Cell Lung Cancer Patients Based on Histology and Smoking Status	PLOS ONE			English	Article							JAPANESE PATIENTS; MUTATIONS; EGFR; ADENOCARCINOMA; THERAPY; KRAS; BRAF; GEFITINIB	Background: Appropriate patient selection is needed for targeted therapies that are efficacious only in patients with specific genetic alterations. We aimed to define subgroups of patients with candidate driver genes in patients with non-small cell lung cancer. Methods: Patients with primary lung cancer who underwent clinical genetic tests at Guangdong General Hospital were enrolled. Driver genes were detected by sequencing, high-resolution melt analysis, qPCR, or multiple PCR and RACE methods. Results: 524 patients were enrolled in this study, and the differences in driver gene alterations among subgroups were analyzed based on histology and smoking status. In a subgroup of non-smokers with adenocarcinoma, EGFR was the most frequently altered gene, with a mutation rate of 49.8%, followed by EML4-ALK (9.3%), PTEN (9.1%), PIK3CA (5.2%), c-Met (4.8%), KRAS (4.5%), STK11 (2.7%), and BRAF (1.9%). The three most frequently altered genes in a subgroup of smokers with adenocarcinoma were EGFR (22.0%), STK11 (19.0%), and KRAS (12.0%). We only found EGFR (8.0%), c-Met (2.8%), and PIK3CA (2.6%) alterations in the non-smoker with squamous cell carcinoma (SCC) subgroup. PTEN (16.1%), STK11 (8.3%), and PIK3CA (7.2%) were the three most frequently enriched genes in smokers with SCC. DDR2 and FGFR2 only presented in smokers with SCC (4.4% and 2.2%, respectively). Among these four subgroups, the differences in EGFR, KRAS, and PTEN mutations were statistically significant. Conclusion: The distinct features of driver gene alterations in different subgroups based on histology and smoking status were helpful in defining patients for future clinical trials that target these genes. This study also suggests that we may consider patients with infrequent alterations of driver genes as having rare or orphan diseases that should be managed with special molecularly targeted therapies.	[An, She-Juan; Chen, Zhi-Hong; Su, Jian; Zhang, Xu-Chao; Huang, Ling; Guan, Ji-Lin; Yan, Hong-Hong; Wu, Yi-Long] Guangdong Acad Med Sci, Guangdong Gen Hosp, Med Res Ctr, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China; [Zhong, Wen-Zhao; Yang, Jin-Ji; Zhou, Qing; Yang, Xue-Ning; Huang, Ling; Guan, Ji-Lin; Nie, Qiang; Wu, Yi-Long] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Lung Canc Inst, Div Pulm Oncol, Guangzhou, Guangdong, Peoples R China; [Mok, Tony S.] Chinese Univ Hong Kong, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China; [Mok, Tony S.] Prince Wales Hosp, Shatin, Hong Kong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital	An, SJ (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Med Res Ctr, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China.	tony@clo.cuhk.edu.hk; syylwu@live.cn	Wu, Yi-Long/GRJ-9238-2022; Wu, Yi-Long/AAB-9137-2022; Mok, Tony Shu Kam/B-2310-2019; Wu, Yi-Long/AAW-9832-2020; Wu, Yi-Long/C-3396-2008	Wu, Yi-Long/0000-0002-3611-0258; Mok, Tony Shu Kam/0000-0002-8251-0551; Wu, Yi-Long/0000-0002-3611-0258	National Natural Science Foundation of China [30772531, 81071699, 30871126, 81172090, 81001031, 81101549]; Foundation of Guangdong Science and Technology Department [2006B60101010, 2007A032000002]; Chinese Lung Cancer Research Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Guangdong Science and Technology Department; Chinese Lung Cancer Research Foundation	This work was supported by grants from the National Natural Science Foundation of China (Nos. 30772531, 81071699, 30871126, 81172090, 81001031, and 81101549), Foundation of Guangdong Science and Technology Department (2006B60101010 and 2007A032000002), and the Chinese Lung Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bronte G, 2010, CANCER TREAT REV, V36, pS21, DOI 10.1016/S0305-7372(10)70016-5; Cadranel J, 2011, EUR RESPIR J, V37, P183, DOI 10.1183/09031936.00179409; Chen HJ, 2009, PATHOL ONCOL RES, V15, P651, DOI 10.1007/s12253-009-9167-8; Gao YJ, 2011, PROTEIN CELL, V2, P99, DOI 10.1007/s13238-011-1021-6; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Hata A, 2010, J THORAC ONCOL, V5, P1197, DOI 10.1097/JTO.0b013e3181e2a2bc; Inamura K, 2008, J THORAC ONCOL, V3, P13, DOI 10.1097/JTO.0b013e31815e8b60; Kalikaki A, 2010, LUNG CANCER, V69, P110, DOI 10.1016/j.lungcan.2009.09.010; Kris MG, 2011, J CLIN ONCOL, V29; Loriot Y, 2009, NAT REV CLIN ONCOL, V6, P528, DOI 10.1038/nrclinonc.2009.106; Mao C, 2010, LUNG CANCER, V69, P272, DOI 10.1016/j.lungcan.2009.11.020; Mitsudomi T, 2010, JPN J CLIN ONCOL, V40, P101, DOI 10.1093/jjco/hyp174; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; O'Byrne KJ, 2011, LANCET ONCOL, V12, P795, DOI 10.1016/S1470-2045(11)70189-9; Paik PK, 2011, J CLIN ONCOL, V29, P2046, DOI 10.1200/JCO.2010.33.1280; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Sanchez-Cespedes M, 2011, FAM CANCER, V10, P447, DOI 10.1007/s10689-011-9443-0; Sasaki H, 2006, J SURG RES, V133, P203, DOI 10.1016/j.jss.2005.10.022; Scagliotti GV, 2009, CURR OPIN ONCOL, V21, P99, DOI 10.1097/CCO.0b013e328321049e; Shepherd FA, 2011, J CLIN ONCOL, V29, P2843, DOI 10.1200/JCO.2011.35.9208; Simi L, 2008, AM J CLIN PATHOL, V130, P247, DOI 10.1309/LWDY1AXHXUULNVHQ; Sonobe M, 2007, J SURG ONCOL, V95, P63, DOI 10.1002/jso.20547; Sun YH, 2010, J CLIN ONCOL, V28, P4616, DOI 10.1200/JCO.2010.29.6038; Takahashi T, 2010, ANN SURG ONCOL, V17, P889, DOI 10.1245/s10434-009-0808-7; Thunnissen FB, 2012, LUNG CANCER, V75, P156, DOI 10.1016/j.lungcan.2011.07.013; Vakiani E, 2011, J PATHOL, V223, P219, DOI 10.1002/path.2796; Ware Kathryn E, 2010, PLoS One, V5, pe14117, DOI 10.1371/journal.pone.0014117; West H, 2009, CHEST, V136, P1112, DOI 10.1378/chest.08-2484; Youn A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/bioinformatics/btq630; Zhang XC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-188; Zhou Q, 2011, J CLIN ONCOL, V29, P3316, DOI 10.1200/JCO.2010.33.3757; Zhou Wei, 2011, Chin J Cancer, V30, P287	32	114	131	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40109	10.1371/journal.pone.0040109	http://dx.doi.org/10.1371/journal.pone.0040109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768234	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100206
J	Carriere, Y; Goodell, PB; Ellers-Kirk, C; Larocque, G; Dutilleul, P; Naranjo, SE; Ellsworth, PC				Carriere, Yves; Goodell, Peter B.; Ellers-Kirk, Christa; Larocque, Guillaume; Dutilleul, Pierre; Naranjo, Steven E.; Ellsworth, Peter C.			Effects of Local and Landscape Factors on Population Dynamics of a Cotton Pest	PLOS ONE			English	Article							HEMIPTERA-MIRIDAE; HOST PLANTS; LYGUS; ALFALFA; MODELS; SAFFLOWER; STRATEGY; SCALE; SINKS; CROP	Background: Many polyphagous pests sequentially use crops and uncultivated habitats in landscapes dominated by annual crops. As these habitats may contribute in increasing or decreasing pest density in fields of a specific crop, understanding the scale and temporal variability of source and sink effects is critical for managing landscapes to enhance pest control. Methodology/Principal Findings: We evaluated how local and landscape characteristics affect population density of the western tarnished plant bug, Lygus hesperus (Knight), in cotton fields of the San Joaquin Valley in California. During two periods covering the main window of cotton vulnerability to Lygus attack over three years, we examined the associations between abundance of six common Lygus crops, uncultivated habitats and Lygus population density in these cotton fields. We also investigated impacts of insecticide applications in cotton fields and cotton flowering date. Consistent associations observed across periods and years involved abundances of cotton and uncultivated habitats that were negatively associated with Lygus density, and abundance of seed alfalfa and cotton flowering date that were positively associated with Lygus density. Safflower and forage alfalfa had variable effects, possibly reflecting among-year variation in crop management practices, and tomato, sugar beet and insecticide applications were rarely associated with Lygus density. Using data from the first two years, a multiple regression model including the four consistent factors successfully predicted Lygus density across cotton fields in the last year of the study. Conclusions/Significance: Our results show that the approach developed here is appropriate to characterize and test the source and sink effects of various habitats on pest dynamics and improve the design of landscape-level pest management strategies.	[Carriere, Yves; Ellers-Kirk, Christa; Ellsworth, Peter C.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Goodell, Peter B.] Univ Calif Cooperat Extens, Kearney Agr Ctr, Parlier, CA USA; [Larocque, Guillaume; Dutilleul, Pierre] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada; [Naranjo, Steven E.] USDA ARS, Arid Land Agr Res Ctr, Maricopa, AZ USA	University of Arizona; University of California System; McGill University; United States Department of Agriculture (USDA)	Carriere, Y (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.	ycarrier@ag.arizona.edu	Ellsworth, Peter C./I-2524-2019	Ellsworth, Peter C./0000-0002-2485-0830; Larocque, Guillaume/0000-0002-5967-9156	USDA-CSREES RAMP [0207436]	USDA-CSREES RAMP(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was funded by USDA-CSREES RAMP, Developing and Implementing Field and Landscape Level Reduced-Risk Management Strategies for Lygus in Western Cropping Systems (Project #0207436). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpargu G, 2006, COMMUN STAT-SIMUL C, V35, P79, DOI 10.1080/03610910500416082; [Anonymous], 2008, JMP 8 0; Barman AK, 2010, INSECT SCI, V17, P542, DOI 10.1111/j.1744-7917.2010.01334.x; Bianchi FJJA, 2010, ECOL APPL, V20, P2322, DOI 10.1890/09-1278.1; Bommarco R, 2003, OIKOS, V102, P440, DOI 10.1034/j.1600-0579.2003.12578.x; Brodt SB, 2007, CALIF AGR, V61, P24, DOI 10.3733/ca.v061n01p24; Carriere Y, 2006, ENTOMOL EXP APPL, V118, P203, DOI 10.1111/j.1570-7458.2006.00384.x; Carriere Y, 2004, ECOL APPL, V14, P1615, DOI 10.1890/03-5268; Carriere Y, 2012, P NATL ACAD SCI USA, V109, P775, DOI 10.1073/pnas.1117851109; Dutilleul P, 2008, J STAT PLAN INFER, V138, P1402, DOI 10.1016/j.jspi.2007.06.022; Dutilleul PRL., 2011, SPATIO TEMPORAL HETE; ESRI, 2011, ARCGIS DESKT REL 10; Gardiner MM, 2009, ECOL APPL, V19, P143, DOI 10.1890/07-1265.1; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; GODFREY LD, 1994, ENVIRON ENTOMOL, V23, P1106, DOI 10.1093/ee/23.5.1106; Goodell P.B., 2006, Proceedings Beltwide Cotton Conferences, V2006, P1375; Goodell PB, 2002, P BELT COTT PROD RES; Goodell PB, 2010, P CAL PLANT SOIL C V, P26; Goodell PB, 2009, PEST MANAG SCI, V65, P1293, DOI 10.1002/ps.1859; [Google Earth web site http://earth.google.com], GOOGL EARTH VERS 6; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hagler JR, 2006, ANN APPL BIOL, V149, P153, DOI 10.1111/j.1744-7348.2006.00076.x; Hanski I., 1999, METAPOPULATION ECOLO; Hunter MD, 2002, AGR FOREST ENTOMOL, V4, P159, DOI 10.1046/j.1461-9563.2002.00152.x; Jonsson M, 2010, BIOL INVASIONS, V12, P2933, DOI 10.1007/s10530-010-9737-4; Kennedy GG, 2000, ANNU REV ENTOMOL, V45, P467, DOI 10.1146/annurev.ento.45.1.467; Layton MB, 2000, SOUTHWEST ENTOMOL, P7; Letourneau DK, 2011, ECOL APPL, V21, P9, DOI 10.1890/09-2026.1; Meehan TD, 2011, P NATL ACAD SCI USA, V108, P11500, DOI 10.1073/pnas.1100751108; MUELLER AJ, 1974, J ECON ENTOMOL, V67, P77, DOI 10.1093/jee/67.1.77; Pickett CH, 2009, BIOL CONTROL, V49, P27, DOI 10.1016/j.biocontrol.2008.09.009; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Ruberson JR, 2000, SOUTHWEST ENTOMOL, P96; Rykiel EJ, 1996, ECOL MODEL, V90, P229, DOI 10.1016/0304-3800(95)00152-2; SEVACHERIAN V, 1977, J ECON ENTOMOL, V70, P399, DOI 10.1093/jee/70.4.399; SEVACHERIAN V, 1975, ENVIRON ENTOMOL, V4, P163, DOI 10.1093/ee/4.1.163; Snodgrass GL, 2006, ENVIRON ENTOMOL, V35, P1417, DOI 10.1603/0046-225X(2006)35[1417:SOTPBH]2.0.CO;2; STERN VM, 1969, CALIF AGR, V23, P8; The Mathworks Inc, 2008, MATLAB VERS R2008A; Thomas CD, 1999, J ANIM ECOL, V68, P647, DOI 10.1046/j.1365-2656.1999.00330.x; Tscharntke T, 2004, ANNU REV ENTOMOL, V49, P405, DOI 10.1146/annurev.ento.49.061802.123339; UC IPM Online website, STAT INT PEST MAN PR; University of CA Cotton Web Site, COTT GUID HEAT UN AV; USDA Farm Service Agency website. Aerial Photography Field Office, AER PHOT FIELD OFF I; WILSON LT, 1984, J ECON ENTOMOL, V77, P1313, DOI 10.1093/jee/77.5.1313; Zaller JG, 2008, BASIC APPL ECOL, V9, P682, DOI 10.1016/j.baae.2007.10.004; Zink AG, 2008, ENTOMOL EXP APPL, V126, P61, DOI 10.1111/j.1570-7458.2007.00634.x; [No title captured]	48	45	45	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39862	10.1371/journal.pone.0039862	http://dx.doi.org/10.1371/journal.pone.0039862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768147	Green Published, gold			2022-12-27	WOS:000305892100116
J	Linder, K; Wagner, R; Hatziagelaki, E; Ketterer, C; Heni, M; Machicao, F; Stefan, N; Staiger, H; Haring, HU; Fritsche, A				Linder, Katarzyna; Wagner, Robert; Hatziagelaki, Erifili; Ketterer, Caroline; Heni, Martin; Machicao, Fausto; Stefan, Norbert; Staiger, Harald; Haering, Hans-Ulrich; Fritsche, Andreas			Allele Summation of Diabetes Risk Genes Predicts Impaired Glucose Tolerance in Female and Obese Individuals	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; INSULIN-SECRETION; TYPE-2; ASSOCIATION; POLYMORPHISMS; SENSITIVITY; WOMEN; METAANALYSIS; DETERMINES; DEFINITION	Introduction: Single nucleotide polymorphisms (SNPs) in approximately 40 genes have been associated with an increased risk for type 2 diabetes (T2D) in genome-wide association studies. It is not known whether a similar genetic impact on the risk of prediabetes (impaired glucose tolerance [IGT] or impaired fasting glycemia [IFG]) exists. Methods: In our cohort of 1442 non-diabetic subjects of European origin (normal glucose tolerance [NGT] n = 1046, isolated IFG n = 142, isolated IGT n = 140, IFG+IGT n = 114), an impact on glucose homeostasis has been shown for 9 SNPs in previous studies in this specific cohort. We analyzed these SNPs (within or in the vicinity of the genes TCF7L2, KCNJ11, HHEX, SLC30A8, WFS1, KCNQ1, MTNR1B, FTO, PPARG) for association with prediabetes. Results: The genetic risk load was significantly associated with the risk for IGT (p = 0.0006) in a model including gender, age, BMI and insulin sensitivity. To further evaluate potential confounding effects, we stratified the population on gender, BMI and insulin sensitivity. The association of the risk score with IGT was present in female participants (p = 0.008), but not in male participants. The risk score was significantly associated with IGT (p = 0.008) in subjects with a body mass index higher than 30 kg/m(2) but not in non-obese individuals. Furthermore, only in insulin resistant subjects a significant association between the genetic load and the risk for IGT (p = 0.01) was found. Discussion: We found that T2D genetic risk alleles cause an increased risk for IGT. This effect was not present in male, lean and insulin sensitive subjects, suggesting a protective role of beneficial environmental factors on the genetic risk.	[Linder, Katarzyna; Wagner, Robert; Ketterer, Caroline; Heni, Martin; Machicao, Fausto; Stefan, Norbert; Staiger, Harald; Haering, Hans-Ulrich; Fritsche, Andreas] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Nephrol Vasc Dis & Clin C, D-7400 Tubingen, Germany; [Hatziagelaki, Erifili] Univ Athens, Sch Med, Attikon Univ Hosp, Dept Internal Med 2,Res Inst, GR-11527 Athens, Greece; [Hatziagelaki, Erifili] Univ Athens, Sch Med, Attikon Univ Hosp, Ctr Diabet, GR-11527 Athens, Greece; [Fritsche, Andreas] Univ Hosp Tubingen, Div Nutr & Prevent Med, Dept Internal Med, Tubingen, Germany	Eberhard Karls University of Tubingen; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Linder, K (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Nephrol Vasc Dis & Clin C, D-7400 Tubingen, Germany.	Andreas.Fritsche@med.uni-tuebingen.de	Wagner, Robert/B-3689-2012; Staiger, Harald/N-5871-2014	Wagner, Robert/0000-0002-6120-0191; Stefan, Norbert/0000-0002-2186-9595; Staiger, Harald/0000-0002-9507-5333; Heni, Martin/0000-0002-8462-3832	German Federal Ministry of Education and Research; German Research Foundation [FR 1561/5-1]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG))	This study was supported in part by a grant from the German Federal Ministry of Education and Research to the German Center for Diabetes Research (DZD e.V.) and by a grant from the German Research Foundation to AF (FR 1561/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Billings LK, 2010, ANN NY ACAD SCI, V1212, P59, DOI 10.1111/j.1749-6632.2010.05838.x; Brochu M, 2001, J CLIN ENDOCR METAB, V86, P1020, DOI 10.1210/jc.86.3.1020; Cauchi S, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-45; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; DeFronzo RA, 2011, DIABETES CARE, V34, pS202, DOI 10.2337/dc11-s221; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Ding EL, 2009, NEW ENGL J MED, V361, P1152, DOI 10.1056/NEJMoa0804381; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Ershow Abby G, 2009, J Diabetes Sci Technol, V3, P727; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; Haupt A, 2009, EXP CLIN ENDOCR DIAB, V117, P194, DOI 10.1055/s-0028-1087176; Haupt A, 2009, J CLIN ENDOCR METAB, V94, P1775, DOI 10.1210/jc.2008-1876; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Heni M, 2010, DIABETES, V59, P3247, DOI 10.2337/db10-0674; Hivert MF, 2011, DIABETES, V60, P1340, DOI 10.2337/db10-1119; Kirchhoff K, 2008, DIABETOLOGIA, V51, P597, DOI 10.1007/s00125-008-0926-y; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Mussig K, 2009, DIABETES, V58, P1715, DOI 10.2337/db08-1589; MYKKANEN L, 1990, DIABETES CARE, V13, P1099, DOI 10.2337/diacare.13.11.1099; Perry JRB, 2010, HUM MOL GENET, V19, P535, DOI 10.1093/hmg/ddp522; Peter A, 2010, DIABETES, V59, P3167, DOI 10.2337/db10-0179; Qiao Q, 2003, DIABETES CARE, V26, P688; Reiling E, 2009, DIABETOLOGIA, V52, P1866, DOI 10.1007/s00125-009-1413-9; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Schafer SA, 2009, DIABETOLOGIA, V52, P1075, DOI 10.1007/s00125-009-1344-5; Sims EAH, 2001, METABOLISM, V50, P1499, DOI 10.1053/meta.2001.27213; Staiger H, 2008, DIABETES, V57, P514, DOI 10.2337/db07-1254; Staiger H, 2009, ENDOCR REV, V30, P557, DOI 10.1210/er.2009-0017; Staiger H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003962; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16	37	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38224	10.1371/journal.pone.0038224	http://dx.doi.org/10.1371/journal.pone.0038224			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768041	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100012
J	Roy, A; Lara, A; Guimaraes, D; Pires, R; Gomes, ER; Carter, DE; Gomez, MV; Guatimosim, S; Prado, VF; Prado, MAM; Gros, R				Roy, Ashbeel; Lara, Aline; Guimaraes, Diogo; Pires, Rita; Gomes, Eneas R.; Carter, David E.; Gomez, Marcus V.; Guatimosim, Silvia; Prado, Vania F.; Prado, Marco A. M.; Gros, Robert			An Analysis of the Myocardial Transcriptome in a Mouse Model of Cardiac Dysfunction with Decreased Cholinergic Neurotransmission	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; FATTY-ACID OXIDATION; METABOLISM; REPERFUSION; XANTHINE; STRESS; ACETYLCHOLINE; ENDOTHELIUM; TRANSPORTER; EXPRESSION	Autonomic dysfunction is observed in many cardiovascular diseases and contributes to cardiac remodeling and heart disease. We previously reported that a decrease in the expression levels of the vesicular acetylcholine transporter (VAChT) in genetically-modified homozygous mice (VAChT KDHOM) leads to decreased cholinergic tone, autonomic imbalance and a phenotype resembling cardiac dysfunction. In order to further understand the molecular changes resulting from chronic long-term decrease in parasympathetic tone, we undertook a transcriptome-based, microarray-driven approach to analyze gene expression changes in ventricular tissue from VAChT KDHOM mice. We demonstrate that a decrease in cholinergic tone is associated with alterations in gene expression in mutant hearts, which might contribute to increased ROS levels observed in these cardiomyocytes. In contrast, in another model of cardiac remodeling and autonomic imbalance, induced through chronic isoproterenol treatment to increase sympathetic drive, these genes did not appear to be altered in a pattern similar to that observed in VAChT KDHOM hearts. These data suggest the importance of maintaining a fine balance between the two branches of the autonomic nervous system and the significance of absolute levels of cholinergic tone in proper cardiac function.	[Roy, Ashbeel; Pires, Rita; Carter, David E.; Prado, Vania F.; Prado, Marco A. M.; Gros, Robert] Western Univ, Schulich Sch Med & Dent, Robarts Res Inst, London, ON, Canada; [Roy, Ashbeel; Prado, Vania F.; Prado, Marco A. M.; Gros, Robert] Western Univ, Schulich Sch Med & Dent, Dept Physiol, London, ON, Canada; [Roy, Ashbeel; Prado, Vania F.; Prado, Marco A. M.; Gros, Robert] Western Univ, Schulich Sch Med & Dent, Dept Pharmacol, London, ON, Canada; [Prado, Vania F.; Prado, Marco A. M.] Western Univ, Schulich Sch Med & Dent, Dept Anat, London, ON, Canada; [Prado, Vania F.; Prado, Marco A. M.] Western Univ, Schulich Sch Med & Dent, Dept Cell Biol, London, ON, Canada; [Gros, Robert] Western Univ, Schulich Sch Med & Dent, Dept Med Clin Pharmacol, London, ON, Canada; [Lara, Aline; Gomes, Eneas R.; Guatimosim, Silvia] Univ Fed Minas Gerais, Inst Biol Sci, Dept Physiol, Belo Horizonte, MG, Brazil; [Lara, Aline; Gomes, Eneas R.; Guatimosim, Silvia] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biophys, Belo Horizonte, MG, Brazil; [Guimaraes, Diogo; Gomez, Marcus V.] Grad Program Santa Casa, Belo Horizonte, MG, Brazil	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Roy, A (corresponding author), Western Univ, Schulich Sch Med & Dent, Robarts Res Inst, London, ON, Canada.	rgros@robarts.ca	Gros, Robert/AAV-2237-2020; Gomez, Marcus Vinicius/I-4081-2012; Guatimosim, Silvia/AAN-7441-2021; Gomes, Eneas RM/G-3153-2010; Prado, Marco Antonio Maximo/K-7638-2013; Gros, Robert/A-3010-2009; Prado, Vania Ferreira/K-7630-2013	Gros, Robert/0000-0002-3667-8011; Gomez, Marcus Vinicius/0000-0002-6082-930X; Guatimosim, Silvia/0000-0001-8386-3722; Gomes, Eneas RM/0000-0001-8528-8741; Prado, Marco Antonio Maximo/0000-0002-3028-5778; Gros, Robert/0000-0002-3667-8011; Prado, Vania Ferreira/0000-0003-4994-6393	Heart and Stroke Foundation of Ontario [NA 6656]; Canadian Institutes for Health Research [MOP-82756, MOP-89919]; Canadian Foundation for Innovation (CFI); Ontario Research Fund (ORF); NIH from Fogarty International Center [R03TW008425]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Programa de Apoio a Nucleos de Excelencia [PRONEX-CBB APQ-04334-10, APQ-00746-09]; Queen Elizabeth II Graduate Scholarship in Science and Technology (QEIIGSST); CNPq; Heart and Stroke Foundation of Canada; FOGARTY INTERNATIONAL CENTER [R03TW008425] Funding Source: NIH RePORTER	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Research Fund (ORF); NIH from Fogarty International Center; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa de Apoio a Nucleos de Excelencia; Queen Elizabeth II Graduate Scholarship in Science and Technology (QEIIGSST); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Heart and Stroke Foundation of Ontario (Grant NA 6656), Canadian Institutes for Health Research (Grant MOP-82756 and MOP-89919), Canadian Foundation for Innovation (CFI), and the Ontario Research Fund (ORF), NIH R03TW008425 from the Fogarty International Center (SG), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (SG) and Programa de Apoio a Nucleos de Excelencia (PRONEX-CBB APQ-04334-10 and APQ-00746-09). AR is supported by the Queen Elizabeth II Graduate Scholarship in Science and Technology (QEIIGSST). AL is a recipient of the CNPq PhD fellowship at the Post-graduation Program in Biological Science: Physiology and Pharmacology at UFMG. D G is a PhD student at the Graduate Program Santa Casa, Belo Horizonte, MG, Brazil. RG is supported by a New Investigator Award from the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELFATTAH AS, 1988, CIRCULATION, V78, P224; Arch J R, 1978, Essays Biochem, V14, P82; Beetsch JW, 1998, BRAIN RES, V786, P89, DOI 10.1016/S0006-8993(97)01407-8; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Bone DBJ, 2010, AM J PHYSIOL-HEART C, V299, pH847, DOI 10.1152/ajpheart.00018.2010; Chesley A, 2000, CIRC RES, V87, P1172, DOI 10.1161/01.RES.87.12.1172; Davila-Roman VG, 2002, J AM COLL CARDIOL, V40, P271, DOI 10.1016/S0735-1097(02)01967-8; DEUTICKE B, 1966, PFLUG ARCH GES PHYS, V292, P239, DOI 10.1007/BF00362739; FLORAS JS, 1993, J AM COLL CARDIOL, V22, pA72, DOI 10.1016/0735-1097(93)90466-E; GERLACH E, 1985, BASIC RES CARDIOL, V80, P459, DOI 10.1007/BF01907911; Guatimosim S, 2001, AM J PHYSIOL-CELL PH, V280, pC1327, DOI 10.1152/ajpcell.2001.280.5.C1327; Handa T, 2009, J CARD FAIL, V15, P805, DOI 10.1016/j.cardfail.2009.05.008; HASKING GJ, 1986, CIRCULATION, V73, P615, DOI 10.1161/01.CIR.73.4.615; Hunt MJ, 2002, AM J PHYSIOL-LUNG C, V283, pL239, DOI 10.1152/ajplung.00001.2002; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kakinuma Y, 2009, FEBS J, V276, P5111, DOI 10.1111/j.1742-4658.2009.07208.x; Kanazawa H, 2010, J CLIN INVEST, V120, P408, DOI 10.1172/JCI39778; KATZ AM, 1993, CARDIOSCIENCE, V4, P199; Katz Arnold M., 1998, Cardiology Clinics, V16, P633, DOI 10.1016/S0733-8651(05)70040-0; Kinugasa Y, 2003, CIRC J, V67, P781; Lara A, 2010, MOL CELL BIOL, V30, P1746, DOI 10.1128/MCB.00996-09; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; NEES S, 1985, BASIC RES CARDIOL, V80, P515, DOI 10.1007/BF01907915; NOLAN J, 1992, BRIT HEART J, V67, P482; Okazaki Y, 2010, J PHYSIOL SCI, V60, P67, DOI 10.1007/s12576-009-0071-5; Olshansky B, 2008, CIRCULATION, V118, P863, DOI 10.1161/CIRCULATIONAHA.107.760405; OLSON RE, 1951, MEDICINE, V30, P21, DOI 10.1097/00005792-195102000-00002; Osorio JC, 2002, CIRCULATION, V106, P606, DOI 10.1161/01.CIR.0000023531.22727.C1; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Rana OR, 2010, AUTON NEUROSCI-BASIC, V156, P82, DOI 10.1016/j.autneu.2010.04.011; Rocha-Resende C, 2012, J MOL CELL CARDIOL; Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837; Shizukuda Y, 2002, AM J PHYSIOL-LUNG C, V283, pL237, DOI 10.1152/ajplung.00111.2002; Singal PK, 1998, CARDIOVASC RES, V40, P426, DOI 10.1016/S0008-6363(98)00244-2; Sommerschild HT, 2000, ACTA ANAESTH SCAND, V44, P1038, DOI 10.1034/j.1399-6576.2000.440903.x; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; van Bilsen M, 2004, CARDIOVASC RES, V61, P218, DOI 10.1016/j.cardiores.2003.11.014; Ward JL, 2000, J BIOL CHEM, V275, P8375, DOI 10.1074/jbc.275.12.8375; YAMAMOTO M, 1978, JPN CIRC J, V42, P1385; Zhang JY, 2000, J CARDIOVASC MAGN R, V2, P23, DOI 10.3109/10976640009148670; ZIMMERMAN TP, 1970, P AM ASSOC CANC RES, V11, P87	41	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39997	10.1371/journal.pone.0039997	http://dx.doi.org/10.1371/journal.pone.0039997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768193	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100165
J	Sun, YE; Peng, LY; Sun, XF; Bo, JH; Yang, D; Zheng, YG; Liu, CL; Zhu, BB; Ma, ZL; Gu, XP				Sun, Yu-e; Peng, Liangyu; Sun, Xiaofeng; Bo, Jinhua; Yang, Dong; Zheng, Yaguo; Liu, Chenglong; Zhu, Beibei; Ma, Zhengliang; Gu, Xiaoping			Intrathecal Injection of Spironolactone Attenuates Radicular Pain by Inhibition of Spinal Microglia Activation in a Rat Model	PLOS ONE			English	Article							PERIPHERAL-NERVE INJURY; CENTRAL GLUCOCORTICOID-RECEPTORS; BLOOD MONONUCLEAR-CELLS; NECROSIS-FACTOR-ALPHA; DORSAL-ROOT GANGLION; KAPPA-B-ALPHA; PROINFLAMMATORY CYTOKINES; CHRONIC COMPRESSION; NEUROPATHIC PAIN; MINERALOCORTICOID RECEPTOR	Background: Microglia might play an important role in nociceptive processing and hyperalgesia by neuroinflammatory process. Mineralocorticoid receptor (MR) expressed on microglia might play a central role in the modulation of microglia activity. However the roles of microglia and MR in radicular pain were not well understood. This study sought to investigate whether selective MR antagonist spironolactone develop antinociceptive effects on radicular pain by inhibition neuroinflammation induced by spinal microglia activation. Results: Radicular pain was produced by chronic compression of the dorsal root ganglia with SURGIFLO (TM). The expression of microglia, interleukin beta (IL-1 beta), interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha), NR1 subunit of the NMDA receptor (t-NR1), and NR1 subunit phosphorylated at Ser896 (p-NR1) were also markedly up-regulated. Intrathecal injection of spironolactone significantly attenuated pain behaviors as well as the expression of microglia, IL-1 beta, TNF-alpha, t-NR1, and p-NR1, whereas the production of IL-6 wasn't affected. Conclusion: These results suggest that intrathecal delivery spironolactone has therapeutic effects on radicular pain in rats. Decreasing the activation of glial cells, the production of proinflammatory cytokines and down-regulating the expression and phosphorylation of NMDA receptors in the spinal dorsal horn and dorsal root ganglia are the main mechanisms contributing to its beneficial effects.	[Sun, Yu-e; Peng, Liangyu; Sun, Xiaofeng; Bo, Jinhua; Yang, Dong; Zheng, Yaguo; Liu, Chenglong; Zhu, Beibei; Ma, Zhengliang; Gu, Xiaoping] Nanjing Univ, Coll Med, Drum Tower Hosp, Dept Anaesthesiol, Nanjing, Jiangsu, Peoples R China	Nanjing University	Sun, YE (corresponding author), Nanjing Univ, Coll Med, Drum Tower Hosp, Dept Anaesthesiol, Nanjing, Jiangsu, Peoples R China.	mazhengliang1964@yahoo.com.cn; xiaopinggu1@gmail.com			National Natural Foundation of China [30872439/C16060202, 81171047/H0903]; National Natural Foundation of Jiangsu Province, China [BK2010105, 2010117, RC2011006, H200943]	National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Foundation of Jiangsu Province, China	This research was supported by the National Natural Foundation of China (30872439/C16060202, 81171047/H0903) and the National Natural Foundation of Jiangsu Province, China (BK2010105, 2010117, RC2011006, H200943). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Salam OME, 2010, EXCLI J, V9; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Avital A, 2006, J NEUROSCI, V26, P9130, DOI 10.1523/JNEUROSCI.1628-06.2006; Bendtzen K, 2003, CLIN EXP IMMUNOL, V134, P151, DOI 10.1046/j.1365-2249.2003.02249.x; Bursztajn S, 2004, NEUROSCIENCE, V125, P269, DOI 10.1016/j.neuroscience.2004.01.024; Doggrell SA, 2001, EXPERT OPIN INV DRUG, V10, P943, DOI 10.1517/13543784.10.5.943; Frieler RA, 2011, STROKE, V42, P179, DOI 10.1161/STROKEAHA.110.598441; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; Gu XP, 2008, ANESTHESIOLOGY, V108, P113, DOI 10.1097/01.anes.0000296073.16972.13; Gu XP, 2011, BRAIN RES, V1396, P88, DOI 10.1016/j.brainres.2011.04.012; Gu XP, 2010, EUR J PAIN, V14, P496, DOI 10.1016/j.ejpain.2009.09.001; Gu XP, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-76; Guo W, 2007, J NEUROSCI, V27, P6006, DOI 10.1523/JNEUROSCI.0176-07.2007; Hansen PR, 2004, IMMUNOL LETT, V91, P87, DOI 10.1016/j.imlet.2003.11.008; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Jaggi AS, 2010, EUR J PHARMACOL, V648, P102, DOI 10.1016/j.ejphar.2010.08.050; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Laflamme N, 1999, J NEUROCHEM, V73, P309, DOI 10.1046/j.1471-4159.1999.0730309.x; Leroy V, 2009, J AM SOC NEPHROL, V20, P131, DOI 10.1681/ASN.2008020232; Liou JT, 2011, ANESTHESIOLOGY, V114, P660, DOI 10.1097/ALN.0b013e31820b8b1e; Ma ZL, 2007, ANN CLIN LAB SCI, V37, P349; MAO J, 1992, BRAIN RES, V576, P254, DOI 10.1016/0006-8993(92)90688-6; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Miura R, 2006, J PHARMACOL SCI, V101, P256, DOI 10.1254/jphs.SC0060049; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Pedersen LM, 2008, ACTA PHYSIOL, V192, P421, DOI 10.1111/j.1748-1716.2007.01756.x; Quan N, 1997, P NATL ACAD SCI USA, V94, P10985, DOI 10.1073/pnas.94.20.10985; Reeve AJ, 2000, EUR J PAIN-LONDON, V4, P247, DOI 10.1053/eujp.2000.0177; Sierra A, 2008, GLIA, V56, P659, DOI 10.1002/glia.20644; Sonder SUS, 2006, APOPTOSIS, V11, P2159, DOI 10.1007/s10495-006-0286-3; Sonder SUS, 2006, BRIT J PHARMACOL, V148, P46, DOI 10.1038/sj.bjp.0706700; Su DS, 2010, ANESTH ANALG, V111, P768, DOI 10.1213/ANE.0b013e3181e9e897; Syngle A, 2009, SCAND J RHEUMATOL, V38, P15, DOI 10.1080/03009740802279709; TAL M, 1994, PAIN, V57, P375, DOI 10.1016/0304-3959(94)90013-2; Tanaka J, 1997, GLIA, V20, P23, DOI 10.1002/(SICI)1098-1136(199705)20:1<23::AID-GLIA3>3.3.CO;2-U; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; Ultenius C, 2006, NEUROSCI LETT, V399, P85, DOI 10.1016/j.neulet.2006.01.018; Viviani B, 2003, J NEUROSCI, V23, P8692; Wang SX, 2006, PAIN, V120, P78, DOI 10.1016/j.pain.2005.10.015; Wang SX, 2005, J NEUROSCI, V25, P488, DOI 10.1523/JNEUROSCI.4127-04.2005; Wang SX, 2004, J NEUROSCI, V24, P8595, DOI 10.1523/JNEUROSCI.3058-04.2004; Wang X, 2004, MOL PSYCHIATR, V9, P65, DOI 10.1038/sj.mp.4001339; Wheeler D, 2009, J NEUROCHEM, V109, P1237, DOI 10.1111/j.1471-4159.2009.06038.x; Woods AG, 1999, NEUROSCIENCE, V91, P1277, DOI 10.1016/S0306-4522(98)00685-X; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; YAMAMOTO T, 1992, PAIN, V49, P121, DOI 10.1016/0304-3959(92)90198-K; Zhang RX, 2008, NEUROSCIENCE, V154, P1533, DOI 10.1016/j.neuroscience.2008.04.072; Zhang RX, 2008, PAIN, V135, P232, DOI 10.1016/j.pain.2007.05.023; Zhang W, 2009, ANESTH ANALG, V108, P1015, DOI 10.1213/ane.0b013e318193ffd2	50	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39897	10.1371/journal.pone.0039897	http://dx.doi.org/10.1371/journal.pone.0039897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768159	gold, Green Submitted, Green Published			2022-12-27	WOS:000305892100128
J	van Winden, JF; Reichart, GJ; McNamara, NP; Benthien, A; Damste, JSS				van Winden, Julia F.; Reichart, Gert-Jan; McNamara, Niall P.; Benthien, Albert; Damste, Jaap S. Sinninghe			Temperature-Induced Increase in Methane Release from Peat Bogs: A Mesocosm Experiment	PLOS ONE			English	Article							CARBON; PEATLANDS; CH4	Peat bogs are primarily situated at mid to high latitudes and future climatic change projections indicate that these areas may become increasingly wetter and warmer. Methane emissions from peat bogs are reduced by symbiotic methane oxidizing bacteria (methanotrophs). Higher temperatures and increasing water levels will enhance methane production, but also methane oxidation. To unravel the temperature effect on methane and carbon cycling, a set of mesocosm experiments were executed, where intact peat cores containing actively growing Sphagnum were incubated at 5, 10, 15, 20, and 25 degrees C. After two months of incubation, methane flux measurements indicated that, at increasing temperatures, methanotrophs are not able to fully compensate for the increasing methane production by methanogens. Net methane fluxes showed a strong temperature-dependence, with higher methane fluxes at higher temperatures. After removal of Sphagnum, methane fluxes were higher, increasing with increasing temperature. This indicates that the methanotrophs associated with Sphagnum plants play an important role in limiting the net methane flux from peat. Methanotrophs appear to consume almost all methane transported through diffusion between 5 and 15 degrees C. Still, even though methane consumption increased with increasing temperature, the higher fluxes from the methane producing microbes could not be balanced by methanotrophic activity. The efficiency of the Sphagnum-methanotroph consortium as a filter for methane escape thus decreases with increasing temperature. Whereas 98% of the produced methane is retained at 5 degrees C, this drops to approximately 50% at 25 degrees C. This implies that warming at the mid to high latitudes may be enhanced through increased methane release from peat bogs.	[van Winden, Julia F.; Reichart, Gert-Jan; Damste, Jaap S. Sinninghe] Univ Utrecht, Dept Geosci, Utrecht, Netherlands; [Reichart, Gert-Jan; Benthien, Albert] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [McNamara, Niall P.] Lancaster Environm Ctr, Ctr Ecol & Hydrol, Lancaster, England; [Damste, Jaap S. Sinninghe] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Organ Biogeochem, Den Burg, Netherlands	Utrecht University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Lancaster University; UK Centre for Ecology & Hydrology (UKCEH); Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	van Winden, JF (corresponding author), Univ Utrecht, Dept Geosci, Utrecht, Netherlands.	damste@nioz.nl	Reichart, Gert-Jan/N-6308-2018; Damste, Jaap S Sinninghe/F-6128-2011; McNamara, Niall P/B-4907-2008	Reichart, Gert-Jan/0000-0002-7256-2243; Damste, Jaap S Sinninghe/0000-0002-8683-1854; McNamara, Niall P/0000-0002-5143-5819; Benthien, Albert/0000-0002-9159-3109	Darwin Centre for Biogeosciences [142.16.1062]; Natural Environment Research Council [ceh010023] Funding Source: researchfish	Darwin Centre for Biogeosciences; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was partially supported by the Darwin Centre for Biogeosciences (grant no. 142.16.1062). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basiliko N, 2004, WETLANDS, V24, P178, DOI 10.1672/0277-5212(2004)024[0178:ROMSAH]2.0.CO;2; Bloom AA, 2010, SCIENCE, V327, P322, DOI 10.1126/science.1175176; Bohn TJ, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045015; Borren W, 2007, THESIS UTRECHT U NET; Boucher O, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044007; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Frenzel P, 2000, BIOGEOCHEMISTRY, V51, P91, DOI 10.1023/A:1006351118347; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Kip N, 2010, NAT GEOSCI, V3, P617, DOI 10.1038/NGEO939; Larmola T, 2010, ECOLOGY, V91, P2356, DOI 10.1890/09-1343.1; McNamara NP, 2008, SCI TOTAL ENVIRON, V404, P354, DOI 10.1016/j.scitotenv.2008.03.015; Raghoebarsing AA, 2005, NATURE, V436, P1153, DOI 10.1038/nature03802; Rigby M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036037; Smith A.J.E., 2004, MOSS FLORA BRITAIN I, DOI [10.1017/cbo9780511541858, DOI 10.1017/CBO9780511541858]; Smith LC, 2004, SCIENCE, V303, P353, DOI 10.1126/science.1090553; WILLIAMS RT, 1984, APPL ENVIRON MICROB, V47, P1266, DOI 10.1128/AEM.47.6.1266-1271.1984	17	48	51	5	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39614	10.1371/journal.pone.0039614	http://dx.doi.org/10.1371/journal.pone.0039614			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768100	Green Published, Green Accepted, gold			2022-12-27	WOS:000305892100070
J	Wang, CH; Hung, CP; Chen, MT; Shih, YH; Lin, YY				Wang, Chi-Han; Hung, Chou P.; Chen, Ming-Teh; Shih, Yang-Hsin; Lin, Yung-Yang			Hippocampal Desynchronization of Functional Connectivity Prior to the Onset of Status Epilepticus in Pilocarpine-Treated Rats	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; PRIMARY VISUAL-CORTEX; IN-VIVO; NEURONAL CORRELATION; SPONTANEOUS SEIZURES; ENTORHINAL CORTEX; CROSS-CORRELATION; EPILEPTOGENESIS; DISCHARGES; MODEL	Status epilepticus (SE), a pro-epileptogenic brain insult in rodent models of temporal lobe epilepsy, is successfully induced by pilocarpine in some, but not all, rats. This study aimed to identify characteristic alterations within the hippocampal neural network prior to the onset of SE. Sixteen microwire electrodes were implanted into the left hippocampus of male Sprague-Dawley rats. After a 7-day recovery period, animal behavior, hippocampal neuronal ensemble activities, and local field potentials (LFP) were recorded before and after an intra-peritoneal injection of pilocarpine (350 mg/kg). The single-neuron firing, population neuronal correlation, and coincident firing between neurons were compared between SE (n = 9) and nonSE rats (n = 12). A significant decrease in the strength of functional connectivity prior to the onset of SE, as measured by changes in coincident spike timing between pairs of hippocampal neurons, was exclusively found in SE rats. However, single-neuron firing and LFP profiles did not show a significant difference between SE and nonSE rats. These results suggest that desynchronization in the functional circuitry of the hippocampus, likely associated with a change in synaptic strength, may serve as an electrophysiological marker prior to SE in pilocarpine-treated rats.	[Wang, Chi-Han; Lin, Yung-Yang] Natl Yang Ming Univ, Inst Physiol, Taipei 112, Taiwan; [Wang, Chi-Han] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Hung, Chou P.; Lin, Yung-Yang] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Hung, Chou P.; Lin, Yung-Yang] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Hung, Chou P.] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Chen, Ming-Teh] Natl Yang Ming Univ, Dept Neurosurg, Taipei 112, Taiwan; [Hung, Chou P.] Georgetown Univ, Dept Neurosci, Washington, DC USA; [Wang, Chi-Han; Lin, Yung-Yang] Taipei Vet Gen Hosp, Neurophysiol Lab, Taipei, Taiwan; [Chen, Ming-Teh; Shih, Yang-Hsin] Taipei Vet Gen Hosp, Dept Neurosurg, Taipei, Taiwan; [Lin, Yung-Yang] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Georgetown University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Wang, CH (corresponding author), Natl Yang Ming Univ, Inst Physiol, Taipei 112, Taiwan.	g2000kev@gmail.com			Taipei Veterans General Hospital [V96C1-123, V96ER3-004, V96S4-010, V97C1-034, V97ER3-006, V97S4-011, VGHUST97-P6-24, V98C1-095, V98ER3-002, V98S4-001, V98S4-006, V98S4-018, V99C1-156, V99ER3-006, V99S4-004, V101C-023, V100C-146, V100E6-003]; National Science Council [NSC-95-2314-B-010-030-MY3, NSC-96-2628-B-010-030-MY3, NSC98-2321-B-010-007, NSC-99-2321-B-010-004, NSC-99-2628-B-010-011-MY3, NSC 100-2321-B-010 -004]; Ministry of Education (Aim for the Top University Plan), Taipei, Taiwan	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education (Aim for the Top University Plan), Taipei, Taiwan	The study was supported in part by research grants from the Taipei Veterans General Hospital (V96C1-123, V96ER3-004, V96S4-010, V97C1-034, V97ER3-006, V97S4-011, V97S4-011, VGHUST97-P6-24, V98C1-095, V98ER3-002, V98S4-001, V98S4-006, V98S4-018, V99C1-156, V99ER3-006, V99S4-004, V101C-023, V100C-146, V100E6-003), the National Science Council (NSC-95-2314-B-010-030-MY3; NSC-96-2628-B-010-030-MY3; NSC98-2321-B-010-007; NSC-99-2321-B-010-004, NSC-99-2628-B-010-011-MY3, NSC 100-2321-B-010 -004), and the Ministry of Education (Aim for the Top University Plan), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolomei F, 2005, EPILEPSIA, V46, P677, DOI 10.1111/j.1528-1167.2005.43804.x; Bower MR, 2008, J NEUROPHYSIOL, V99, P2431, DOI 10.1152/jn.01369.2007; Chang BS, 2003, NEW ENGL J MED, V349, P1257, DOI 10.1056/NEJMra022308; Chen MT, 2001, EXP NEUROL, V171, P72, DOI 10.1006/exnr.2001.7730; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Costa RM, 2006, NEURON, V52, P359, DOI 10.1016/j.neuron.2006.07.030; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Cymerblit-Sabba A, 2010, J NEUROSCI, V30, P1619, DOI 10.1523/JNEUROSCI.5078-09.2010; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Goldberg JA, 2003, J NEUROSCI, V23, P10058; Gorter JA, 2001, EUR J NEUROSCI, V13, P657, DOI 10.1046/j.1460-9568.2001.01428.x; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Huberfeld G, 2011, NAT NEUROSCI, V14, P627, DOI 10.1038/nn.2790; Hung CP, 2007, NAT NEUROSCI, V10, P1185, DOI 10.1038/nn1948; Hung YW, 2012, EPILEPSY RES, V98, P206, DOI 10.1016/j.eplepsyres.2011.09.015; Klitgaard H, 2002, EPILEPSY RES, V51, P93, DOI 10.1016/S0920-1211(02)00099-2; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; LEMOS T, 1995, EXP BRAIN RES, V102, P423; Litt B, 2002, LANCET NEUROL, V1, P22, DOI 10.1016/S1474-4422(02)00003-0; Liu XZ, 2003, J NEUROSCI, V23, P11505; LIU Z, 1994, EPILEPSY RES, V17, P237; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mora GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005759; NELSON JI, 1992, VISUAL NEUROSCI, V9, P21, DOI 10.1017/S0952523800006349; Popova IY, 2008, NEUROSCI LETT, V442, P228, DOI 10.1016/j.neulet.2008.07.016; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Scharfman HE, 2001, NEUROSCIENCE, V104, P741, DOI 10.1016/S0306-4522(01)00132-4; Shi LH, 2007, EPILEPSY RES, V73, P85, DOI 10.1016/j.eplepsyres.2006.08.008; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; SPENCER SS, 1994, EPILEPSIA, V35, P721, DOI 10.1111/j.1528-1157.1994.tb02502.x; Stoop R, 2000, EUR J NEUROSCI, V12, P3651, DOI 10.1046/j.1460-9568.2000.00253.x; Swanson L.W, 2004, BRAIN MAPS; Truccolo W, 2011, NAT NEUROSCI, V14, P635, DOI 10.1038/nn.2782; Tsai ML, 2003, J NEUROSCI METH, V131, P107, DOI 10.1016/S0165-0270(03)00235-8; TSO DY, 1986, J NEUROSCI, V6, P1160; TURSKI WA, 1984, BRAIN RES, V321, P237, DOI 10.1016/0006-8993(84)90177-X; TURSKI WA, 1983, BEHAV BRAIN RES, V9, P315, DOI 10.1016/0166-4328(83)90136-5; Warren CP, 2010, J NEUROPHYSIOL, V104, P3530, DOI 10.1152/jn.00368.2010; Wennberg R, 2002, EPILEPSIA, V43, P716, DOI 10.1046/j.1528-1157.2002.31101.x; Williams PA, 2002, J NEUROPHYSIOL, V88, P2075, DOI 10.1152/jn.2002.88.4.2075; Zhou JL, 2007, EPILEPSIA, V48, P720, DOI 10.1111/j.1528-1167.2006.00972.x	41	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39763	10.1371/journal.pone.0039763	http://dx.doi.org/10.1371/journal.pone.0039763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768120	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100090
J	Quitschke, WW				Quitschke, Wolfgang W.			Curcuminoid Binding to Embryonal Carcinoma Cells: Reductive Metabolism, Induction of Apoptosis, Senescence, and Inhibition of Cell Proliferation	PLOS ONE			English	Article							GROWTH SUPPRESSIVE ACTIVITY; HUMAN SERUM-ALBUMIN; VITAMIN-D-RECEPTOR; IN-VITRO; SIGNALING PATHWAYS; DNA FRAGMENTATION; COLORECTAL-CARCINOMA; GENE-EXPRESSION; AGENT CURCUMIN; MELANOMA-CELLS	Curcumin preparations typically contain a mixture of polyphenols, collectively referred to as curcuminoids. In addition to the primary component curcumin, they also contain smaller amounts of the co-extracted derivatives demethoxycurcumin and bisdemethoxycurcumin. Curcuminoids can be differentially solubilized in serum, which allows for the systematic analysis of concentration-dependent cellular binding, biological effects, and metabolism. Technical grade curcumin was solubilized in fetal calf serum by two alternative methods yielding saturated preparations containing either predominantly curcumin (60%) or bisdemethoxycurcumin (55%). Continual exposure of NT2/D1 cells for 4-6 days to either preparation in cell culture media reduced cell division (1-5 mu M), induced senescence (6-7 mu M) or comprehensive cell death (8-10 mu M) in a concentration-dependent manner. Some of these effects could also be elicited in cells transiently exposed to higher concentrations of curcuminoids (47 mu M) for 0.5-4 h. Curcuminoids induced apoptosis by generalized activation of caspases but without nucleosomal fragmentation. The equilibrium binding of serum-solubilized curcuminoids to NT2/D1 cells incubated with increasing amounts of curcuminoid-saturated serum occurred with apparent overall dissociation constants in the 6-10 mu M range. However, the presence of excess free serum decreased cellular binding in a hyperbolic manner. Cellular binding was overwhelmingly associated with membrane fractions and bound curcuminoids were metabolized in NT2/D1 cells via a previously unidentified reduction pathway. Both the binding affinities for curcuminoids and their reductive metabolic pathways varied in other cell lines. These results suggest that curcuminoids interact with cellular binding sites, thereby activating signal transduction pathways that initiate a variety of biological responses. The dose-dependent effects of these responses further imply that distinct cellular pathways are sequentially activated and that this activation is dependent on the affinity of curcuminoids for the respective binding sites. Defined serum-solubilized curcuminoids used in cell culture media are thus suitable for further investigating the differential activation of signal transduction pathways.	SUNY Stony Brook, Dept Psychiat & Behav Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Quitschke, WW (corresponding author), SUNY Stony Brook, Dept Psychiat & Behav Sci, Stony Brook, NY 11794 USA.	wolfgang.quitschke@sbumed.org			American Health Assistance Foundation [A2009342]; National Institutes of Health/National Center for Research Resources (NIH/NCRR) through the Proteomics Center of the State University of New York at Stony Brook [1 S10 RR023680-1]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023680] Funding Source: NIH RePORTER	American Health Assistance Foundation(BrightFocus Foundation); National Institutes of Health/National Center for Research Resources (NIH/NCRR) through the Proteomics Center of the State University of New York at Stony Brook; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by grant A2009342 from the American Health Assistance Foundation (http://www.ahaf.org/). Additionally, support for mass spectrometry was provided by the shared instrumentation grant National Institutes of Health/National Center for Research Resources (NIH/NCRR) 1 S10 RR023680-1 through the Proteomics Center of the State University of New York at Stony Brook. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abas F, 2006, Z NATURFORSCH C, V61, P625; Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1; Aggarwal BB, 2010, ANNU REV NUTR, V30, P173, DOI 10.1146/annurev.nutr.012809.104755; Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Anand P, 2010, BIOCHEM PHARMACOL, V79, P330, DOI 10.1016/j.bcp.2009.09.003; Andrews PW, 1998, APMIS, V106, P158, DOI 10.1111/j.1699-0463.1998.tb01331.x; ANDREWS PW, 1984, LAB INVEST, V50, P147; Anuchapreeda S, 2006, ACTA PHARMACOL SIN, V27, P360, DOI 10.1111/j.1745-7254.2006.00291.x; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Aouida M, 2010, J BIOL CHEM, V285, P6275, DOI 10.1074/jbc.M109.046151; Balstad TR, 2011, MOL NUTR FOOD RES, V55, P185, DOI 10.1002/mnfr.201000204; Bangaru MLY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009893; Bartik L, 2010, J NUTR BIOCHEM, V21, P1153, DOI 10.1016/j.jnutbio.2009.09.012; BAYREUTHER K, 1988, P NATL ACAD SCI USA, V85, P5112, DOI 10.1073/pnas.85.14.5112; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Besancenot R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000476; Bielak-Zmijewska A, 2010, CELL PROLIFERAT, V43, P354, DOI 10.1111/j.1365-2184.2010.00684.x; Blasius R, 2004, ANN NY ACAD SCI, V1030, P442, DOI 10.1196/annals.1329.055; Braga MEM, 2003, J AGR FOOD CHEM, V51, P6604, DOI 10.1021/jf0345550; Cen L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-99; Charoensuk L, 2011, INT J PARASITOL; Chen CC, 2010, INT J MOL SCI, V11, P2839, DOI 10.3390/ijms11082839; CRISTOFALO VJ, 1993, PHYSIOL REV, V73, P617, DOI 10.1152/physrev.1993.73.3.617; Delmas D, 2011, MOL NUTR FOOD RES, V55, P1142, DOI 10.1002/mnfr.201100065; Demirovic D, 2011, BIOGERONTOLOGY; Dempe JS, 2008, MOL NUTR FOOD RES, V52, P1074, DOI 10.1002/mnfr.200800029; Deters M, 2008, PHARM RES-DORDR, V25, P1822, DOI 10.1007/s11095-008-9579-2; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ding ZS, 2008, MOLECULES, V13, P220, DOI 10.3390/molecules13020220; Dormeyer W, 2008, J PROTEOME RES, V7, P2936, DOI 10.1021/pr800056j; Dujic J, 2007, J INVEST DERMATOL, V127, P1992, DOI 10.1038/sj.jid.5700801; Epstein J, 2010, BRIT J NUTR, V103, P1545, DOI 10.1017/S0007114509993667; Friedman L, 2009, ANTI-CANCER DRUG, V20, P444, DOI 10.1097/CAD.0b013e32832afc04; Gautam SC, 1998, BIOCHEM PHARMACOL, V55, P1333, DOI 10.1016/S0006-2952(98)00019-7; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Heng MCY, 2010, INT J DERMATOL, V49, P608, DOI 10.1111/j.1365-4632.2010.04468.x; Hiserodt R, 1996, J CHROMATOGR A, V740, P51, DOI 10.1016/0021-9673(96)00103-3; Hoehle SI, 2006, J AGR FOOD CHEM, V54, P756, DOI 10.1021/jf058146a; HUANG MT, 1995, CARCINOGENESIS, V16, P2493, DOI 10.1093/carcin/16.10.2493; Huang TY, 2010, J AGR FOOD CHEM, V58, P10639, DOI 10.1021/jf1016303; Ireson CR, 2002, CANCER EPIDEM BIOMAR, V11, P105; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Jaruga E, 1998, FEBS LETT, V433, P287, DOI 10.1016/S0014-5793(98)00919-3; Jayaprakasha GK, 2002, J AGR FOOD CHEM, V50, P3668, DOI 10.1021/jf025506a; Johnson SM, 2009, ANTICANCER RES, V29, P3185; Kim AN, 2010, FREE RADICAL BIO MED, V49, P323, DOI 10.1016/j.freeradbiomed.2010.04.015; Kitazumi I, 2011, FEBS J, V278, P427, DOI 10.1111/j.1742-4658.2010.07975.x; Knower KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017751; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Kunwar A, 2008, BBA-GEN SUBJECTS, V1780, P673, DOI 10.1016/j.bbagen.2007.11.016; Kurz DJ, 2000, J CELL SCI, V113, P3613; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Leung MHM, 2009, LANGMUIR, V25, P5773, DOI 10.1021/la804215v; Li L, 2005, CANCER-AM CANCER SOC, V104, P1322, DOI 10.1002/cncr.21300; Lin L, 2011, BIOCHEM BIOPH RES CO, V416, P246, DOI 10.1016/j.bbrc.2011.10.112; Liu HL, 2005, ACTA PHARMACOL SIN, V26, P603, DOI 10.1111/j.1745-7254.2005.00081.x; Liu Q, 2009, PHYTOMEDICINE, V16, P916, DOI 10.1016/j.phymed.2009.04.008; LoTempio MM, 2005, CLIN CANCER RES, V11, P6994, DOI 10.1158/1078-0432.CCR-05-0301; Lu CW, 2010, CURR EYE RES, V35, P352, DOI 10.3109/02713680903521944; Lu JJ, 2012, MOL CELL BIOCHEM, V360, P253, DOI 10.1007/s11010-011-1064-2; Lunenburger H, 2010, ANTI-CANCER DRUG, V21, P514, DOI 10.1097/CAD.0b013e3283375d5c; Magalska A, 2006, ACTA BIOCHIM POL, V53, P531; Malik M, 2009, FERTIL STERIL, V91, P2177, DOI 10.1016/j.fertnstert.2008.03.045; Marczylo TH, 2007, CANCER CHEMOTH PHARM, V60, P171, DOI 10.1007/s00280-006-0355-x; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Moiseeva EP, 2007, MOL CANCER THER, V6, P3071, DOI 10.1158/1535-7163.MCT-07-0117; Nangia AK, 2007, J UROLOGY, V178, P1092, DOI 10.1016/j.juro.2007.05.009; Natarajan VT, 2010, J INVEST DERMATOL; Norman AW, 2004, NAT REV DRUG DISCOV, V3, P27, DOI 10.1038/nrd1283; O'Sullivan-Coyne G, 2009, BRIT J CANCER, V101, P1585, DOI 10.1038/sj.bjc.6605308; Ohtani Naoko, 2004, J Med Invest, V51, P146, DOI 10.2152/jmi.51.146; Peret-Almeida L, 2005, FOOD RES INT, V38, P1039, DOI 10.1016/j.foodres.2005.02.021; Philip S, 2003, J BIOL CHEM, V278, P14487, DOI 10.1074/jbc.M207309200; Piwocka K, 1999, EXP CELL RES, V249, P299, DOI 10.1006/excr.1999.4480; Premanand C, 2006, INVEST OPHTH VIS SCI, V47, P2179, DOI 10.1167/iovs.05-0580; Purkayastha S, 2009, BRAIN RES; Quitschke WW, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-84; Ravindran J, 2009, AAPS J, V11, P495, DOI 10.1208/s12248-009-9128-x; Reddy ACP, 1999, LIPIDS, V34, P1025, DOI 10.1007/s11745-999-0453-x; Sahu A, 2008, ACTA BIOMATER, V4, P1752, DOI 10.1016/j.actbio.2008.04.021; Sandur SK, 2007, CARCINOGENESIS, V28, P1765, DOI 10.1093/carcin/bgm123; Sarkar FH, 2009, CELL SIGNAL, V21, P1541, DOI 10.1016/j.cellsig.2009.03.009; Scapagnini G, 2011, MOL NEUROBIOL; Schaaf C, 2010, NEUROENDOCRINOLOGY, V91, P200, DOI 10.1159/000287236; Shen GX, 2006, MOL CANCER THER, V5, P39, DOI 10.1158/1535-7163.MCT-05-0293; Shinojima N, 2007, AUTOPHAGY, V3, P635, DOI 10.4161/auto.4916; Shishodia S, 2005, BIOCHEM PHARMACOL, V70, P700, DOI 10.1016/j.bcp.2005.04.043; Shu JC, 2009, BRAZ J MED BIOL RES, V42, P1173, DOI 10.1590/S0100-879X2009005000041; Sikora E, 2006, MOL CANCER THER, V5, P927, DOI 10.1158/1535-7163.MCT-05-0360; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Singh M, 2010, MED ONCOL, V27, P1096, DOI 10.1007/s12032-009-9341-6; Siwak DR, 2005, CANCER-AM CANCER SOC, V104, P879, DOI 10.1002/cncr.21216; Skommer J, 2006, EXP HEMATOL, V34, P463, DOI 10.1016/j.exphem.2005.12.015; Staal J, 2011, CELL RES, V21, P40, DOI 10.1038/cr.2010.168; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Tayyem RR, 2006, NUTR CANCER, V55, P126, DOI 10.1207/s15327914nc5502_2; Teiten MH, 2011, INT J ONCOL, V38, P603, DOI 10.3892/ijo.2011.905; Thangapazham RL, 2006, AAPS J, V8, pE443, DOI 10.1208/aapsj080352; Tripathi R, 2011, MOL CANCER THER, V10, P255, DOI 10.1158/1535-7163.MCT-10-0606; Verghese J., 1993, Flavour and Fragrance Journal, V8, P315, DOI 10.1002/ffj.2730080605; Villegas I, 2008, MOL NUTR FOOD RES, V52, P1040, DOI 10.1002/mnfr.200700280; Walters DK, 2008, INVEST NEW DRUG, V26, P289, DOI 10.1007/s10637-007-9099-7; Wang YJ, 1997, J PHARMACEUT BIOMED, V15, P1867, DOI 10.1016/S0731-7085(96)02024-9; Wilken R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-12; Wu JY, 2007, BIOL PHARM BULL, V30, P1336, DOI 10.1248/bpb.30.1336; Youn HS, 2006, BIOCHEM PHARMACOL, V72, P62, DOI 10.1016/j.bcp.2006.03.022; Yue GGL, 2010, FOOD CHEM TOXICOL, V48, P2011, DOI 10.1016/j.fct.2010.04.039; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356; Zhou QM, 2011, ACTA PHARMACOL SIN, V32, P1402, DOI 10.1038/aps.2011.97	112	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39568	10.1371/journal.pone.0039568	http://dx.doi.org/10.1371/journal.pone.0039568			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22768090	Green Published, Green Submitted, gold			2022-12-27	WOS:000305808700035
J	Guo, SJ; Li, XB; Gao, M; Kong, H; Li, YQ; Gu, ML; Dong, XQ; Niu, WQ				Guo, Shujie; Li, Xiaobo; Gao, Min; Kong, Hong; Li, Yuqiong; Gu, Mingliang; Dong, Xiaoqun; Niu, Wenquan			Synergistic Association of PTGS2 and CYP2E1 Genetic Polymorphisms with Lung Cancer Risk in Northeastern Chinese	PLOS ONE			English	Article							MULTIFACTOR DIMENSIONALITY REDUCTION; INCREASED EXPRESSION; CYCLOOXYGENASE-2; SURVIVAL; ASIANS	Background: Lung cancer is the most common cause of cancer-related deaths worldwide. The aim of this study was to investigate the association of five extensively-studied polymorphisms in PTGS2 (rs689466, rs5275, rs20417) and CYP2E1 (rs2031920, rs6413432) genes with lung cancer risk in a large northeastern Chinese population. Methodology/Principal Findings: This is a hospital-based case-control study involving 684 patients with lung cancer and 604 cancer-free controls. Genotyping was performed using the PCR-LDR method. Data were analyzed using Haplo.stats and MDR programs. There were significant differences between patients and controls in allele/genotype distributions of rs5275 (P = 0.002/0.003) and rs6413432 (P = 0.037/0.044), as well as in genotype distributions of rs689466 (P = 0.02). The risk for lung cancer associated with the rs5275-C mutant allele was decreased by 60% (95% CI [confidence interval]: 0.21-0.74; P = 0.004) under the recessive model. Carriers of rs689466-G mutant allele had a 28% (95% CI: 0.57-0.92; P = 0.008) reduced risk of developing lung cancer relative to the AA genotype carriers. In haplotype analysis, haplotype G-C-C-T (in order of rs689466, rs5275, rs2031920 and rs6413432) decreased the odds of lung cancer by 28% (95% CI: 0.51-0.93; P = 0.019) after adjusting for confounding factors, whereas haplotype A-T-T-T had 1.49-fold (95% CI: 1.21-1.79; P = 0.012) increased risk for lung cancer. Using MDR method, the overall best model including rs5275, rs689466 and rs6413432 polymorphisms was identified with a maximal testing accuracy of 66.1% and a maximal cross-validation consistency of 10 out of 10 (P = 0.003). Conclusions/Significance: Our findings demonstrated a potentially synergistic association of PTGS2 and CYP2E1 polymorphisms with the underlying cause of lung cancer in northeastern Chinese.	[Guo, Shujie; Li, Xiaobo; Kong, Hong; Li, Yuqiong; Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Gao, Min] Harbin Med Univ, Affiliated Hosp 1, Dept Resp Med, Harbin, Heilongjiang, Peoples R China; [Gu, Mingliang] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Gu, Mingliang] Chinese Acad Sci, Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Dong, Xiaoqun] Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA	Chinese Academy of Sciences; Shanghai Jiao Tong University; Harbin Medical University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Rhode Island	Guo, SJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China.	xiaoqun_dong@mail.uri.edu; niuwenquan@yahoo.cn			Shanghai Rising Star Program [11QA1405500]; National Natural Science Foundation of China [30900808]	Shanghai Rising Star Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Shanghai Rising Star Program (11QA1405500), and the National Natural Science Foundation of China (30900808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan P, 2011, LANCET ONCOL, V12, P399, DOI 10.1016/S1470-2045(10)70126-1; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Haque AK, 2004, APPL IMMUNOHISTO M M, V12, P315, DOI 10.1097/00129039-200412000-00005; Hida T, 1998, CANCER RES, V58, P3761; Koch A, 2011, DIAGN CYTOPATHOL, V39, P188, DOI 10.1002/dc.21366; Liao Zhongxing, 2004, Expert Rev Anticancer Ther, V4, P543, DOI 10.1586/14737140.4.4.543; Liu F, 2010, ASIAN PAC J CANCER P, V11, P1257; Michaud V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015666; Micu AL, 2003, J PHARMACOL EXP THER, V306, P941, DOI 10.1124/jpet.103.052183; Mineo TC, 2010, EUR J CARDIO-THORAC, V38, P245, DOI 10.1016/j.ejcts.2010.02.012; Moore JH, 2010, ADV GENET, V72, P101, DOI [10.1016/B978-0-12-380862-2.00005-9, 10.1016/S0065-2660(10)72005-8]; Neafsey P, 2009, J TOXICOL ENV HEAL B, V12, P362, DOI 10.1080/10937400903158359; Niu WQ, 2010, CLIN CHIM ACTA, V411, P1491, DOI 10.1016/j.cca.2010.06.004; Pankratz VS, 2011, J THORAC ONCOL, V6, P1488, DOI 10.1097/JTO.0b013e318223bf05; Pattin KA, 2009, GENET EPIDEMIOL, V33, P87, DOI 10.1002/gepi.20360; Peng WJ, 2011, MOL BIOL REP; Salgia R, 2011, SEMIN ONCOL, V38, P274, DOI 10.1053/j.seminoncol.2011.01.012; Salmenkivi K, 2001, J CLIN ENDOCR METAB, V86, P5615, DOI 10.1210/jc.86.11.5615; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Subramanian J, 2008, LANCET ONCOL, V9, P676, DOI 10.1016/S1470-2045(08)70174-8; Tang KF, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-575; Thun MJ, 2008, PLOS MED, V5, P1357, DOI 10.1371/journal.pmed.0050185; Wang YD, 2010, EUR J CANCER, V46, P758, DOI 10.1016/j.ejca.2009.12.010; Wolff H, 1998, CANCER RES, V58, P4997; Zhan P, 2010, LUNG CANCER, V69, P19, DOI 10.1016/j.lungcan.2009.09.001	27	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39814	10.1371/journal.pone.0039814	http://dx.doi.org/10.1371/journal.pone.0039814			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761909	Green Published, gold			2022-12-27	WOS:000305781700069
J	Feng, Y; Ma, ZZ				Feng, Yun; Ma, Zhizhong			Transscleral Diode Photocoagulation of Large Retinal and Choroidal Vascular Lesions	PLOS ONE			English	Article							COATS-DISEASE; THRESHOLD RETINOPATHY; LASER; MANAGEMENT	Background: Transscleral retinal photocoagulation with a diode laser is used in glaucoma refractory to medical and surgical treatment. Our main research question was how the technique performed in large vascular lesions associated with hemangiomas of the retina and choroid. Methodology/Clinical Findings: Patient charts were retrieved from the hospital files for patients who underwent the procedure and were followed for at least 24 months. Five patients (6 eyes) fit the criteria. Cases included Von Hippel's disease (2 eyes), Coats' disease (1 eye) and choroidal hemangioma (3 cases). Transscleral diode laser treatment was performed under retrobulbar and topical anesthesia with a retinopexy probe (IRIS DioPexy, IRIS Medical Instruments, Mountain View, CA) applied transsclerally under indirect ophthalmoscope visualization. We found an improvement in best-corrected visual acuity at 24 months postoperatively. Conclusions/Significance: Transscleral photocoagulation may have a clinical application in these diseases as an alternate to the high cost of photodynamic therapy with photosensitizing agents.	[Feng, Yun] Peking Univ, Dept Ophthalmol, Hosp 3, Ctr Eye, Beijing 100871, Peoples R China; Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China	Peking University	Feng, Y (corresponding author), Peking Univ, Dept Ophthalmol, Hosp 3, Ctr Eye, Beijing 100871, Peoples R China.	puh3_yk@bjmu.edu.cn	Feng, Yun/L-7476-2019					Abramson DH, 1998, AM J OPHTHALMOL, V126, P733, DOI 10.1016/S0002-9394(98)00142-1; JACCOMA EH, 1985, ARCH OPHTHALMOL-CHIC, V103, P1728, DOI 10.1001/archopht.1985.01050110124039; Jones JH, 2001, INT OPHTHALMOL CLIN, V41, P189, DOI 10.1097/00004397-200110000-00017; McHugh DA, 1995, BRIT J OPHTHALMOL, V79, P1083, DOI 10.1136/bjo.79.12.1083; MCHUGH JDA, 1989, EYE, V3, P516, DOI 10.1038/eye.1989.83; Parvaresh MM, 2009, J AAPOS, V13, P535, DOI 10.1016/j.jaapos.2009.09.018; Paysse EA, 2002, OPHTHALMOLOGY, V109, P1662, DOI 10.1016/S0161-6420(02)01169-7; Schefler AC, 2008, RETINA-J RET VIT DIS, V28, pS38, DOI 10.1097/IAE.0b013e318163cd7c; Seiberth V, 1999, OPHTHALMOLOGY, V106, P1828, DOI 10.1016/S0161-6420(99)90367-6; Shapiro MJ, 2011, AM J OPHTHALMOL, V151, P725, DOI 10.1016/j.ajo.2010.10.024; Shields JA, 2002, RETINA-J RET VIT DIS, V22, P80, DOI 10.1097/00006982-200202000-00014; Shields JA, 2001, AM J OPHTHALMOL, V131, P572, DOI 10.1016/S0002-9394(01)00896-0; TARKKANEN A, 1983, BRIT J OPHTHALMOL, V67, P766, DOI 10.1136/bjo.67.11.766; Turell ME, 2010, MIDDLE EAST AFR J OP, V17, P191, DOI 10.4103/0974-9233.65486	14	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39340	10.1371/journal.pone.0039340	http://dx.doi.org/10.1371/journal.pone.0039340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792170	Green Submitted, Green Published, gold			2022-12-27	WOS:000306354700009
J	Shutters, ST; Muneepeerakul, R				Shutters, Shade T.; Muneepeerakul, Rachata			Agricultural Trade Networks and Patterns of Economic Development	PLOS ONE			English	Article							SOCIOMETRIC DATA; WORLD CITIES; EVOLUTION	International trade networks are manifestations of a complex combination of diverse underlying factors, both natural and social. Here we apply social network analytics to the international trade network of agricultural products to better understand the nature of this network and its relation to patterns of international development. Using a network tool known as triadic analysis we develop triad significance profiles for a series of agricultural commodities traded among countries. Results reveal a novel network "superfamily" combining properties of biological information processing networks and human social networks. To better understand this unique network signature, we examine in more detail the degree and triadic distributions within the trade network by country and commodity. Our results show that countries fall into two very distinct classes based on their triadic frequencies. Roughly 165 countries fall into one class while 18, all highly isolated with respect to international agricultural trade, fall into the other. Only Vietnam stands out as a unique case. Finally, we show that as a country becomes less isolated with respect to number of trading partners, the country's triadic signature follows a predictable trajectory that may correspond to a trajectory of development.	[Shutters, Shade T.; Muneepeerakul, Rachata] Arizona State Univ, Sch Sustainabil, Tempe, AZ 85287 USA; [Shutters, Shade T.] Arizona State Univ, Ctr Social Dynam & Complex, Tempe, AZ USA; [Muneepeerakul, Rachata] Arizona State Univ, Math Computat & Modeling Sci Ctr, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Shutters, ST (corresponding author), Arizona State Univ, Sch Sustainabil, Tempe, AZ 85287 USA.	shade.shutters@asu.edu	Shutters, Shade/B-9807-2013	Shutters, Shade T./0000-0002-8072-4134				Athukorala PC, 2006, WORLD ECON, V29, P161, DOI 10.1111/j.1467-9701.2006.00776.x; Derudder B, 2005, GLOBAL NETW, V5, P71, DOI 10.1111/j.1471-0374.2005.00108.x; Derudder B, 2010, GLOBAL NETW, V10, P1, DOI 10.1111/j.1471-0374.2010.00271.x; Facchetti G, 2011, P NATL ACAD SCI USA, V108, P20953, DOI 10.1073/pnas.1109521108; Garlaschelli D, 2005, PHYSICA A, V355, P138, DOI 10.1016/j.physa.2005.02.075; Heider F, 1946, J PSYCHOL, V21, P107, DOI 10.1080/00223980.1946.9917275; Hoekstra AY, 2012, P NATL ACAD SCI USA, V109, P3232, DOI 10.1073/pnas.1109936109; HOLLAND PW, 1970, AM J SOCIOL, V76, P492, DOI 10.1086/224954; Kaluza P, 2010, J R SOC INTERFACE, V7, P1093, DOI 10.1098/rsif.2009.0495; Kaluza P, 2008, CHAOS, V18, DOI 10.1063/1.2945228; Konar M, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010307; MACRAE D, 1960, SOCIOMETRY, V23, P360, DOI 10.2307/2785690; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Pennock DM, 2002, P NATL ACAD SCI USA, V99, P5207, DOI 10.1073/pnas.032085699; Serrano MA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.015101; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Suweis S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046837; van Duijn MAJ, 2003, J MATH SOCIOL, V27, P153, DOI 10.1080/00222500305889; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478	19	29	31	9	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39756	10.1371/journal.pone.0039756	http://dx.doi.org/10.1371/journal.pone.0039756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	968GX	22768310	Green Submitted, Green Published, gold			2022-12-27	WOS:000305966500023
J	Ayna, G; Krysko, DV; Kaczmarek, A; Petrovski, G; Vandenabeele, P; Fesus, L				Ayna, Gizem; Krysko, Dmitri V.; Kaczmarek, Agnieszka; Petrovski, Goran; Vandenabeele, Peter; Fesues, Laszlo			ATP Release from Dying Autophagic Cells and Their Phagocytosis Are Crucial for Inflammasome Activation in Macrophages	PLOS ONE			English	Article							CALRETICULIN EXPOSURE; NALP3 INFLAMMASOME; IMMUNE-RESPONSES; P2X(7) RECEPTOR; MECHANISMS; IL-1-BETA; APOPTOSIS; DANGER; DEATH; RECOGNITION	Pathogen-activated and damage-associated molecular patterns activate the inflammasome in macrophages. We report that mouse macrophages release IL-1 beta while co-incubated with pro-B (Ba/F3) cells dying, as a result of IL-3 withdrawal, by apoptosis with autophagy, but not when they are co-incubated with living, apoptotic, necrotic or necrostatin-1 treated cells. NALP3-deficient macrophages display reduced IL-1b secretion, which is also inhibited in macrophages deficient in caspase-1 or pre-treated with its inhibitor. This finding demonstrates that the inflammasome is activated during phagocytosis of dying autophagic cells. We show that activation of NALP3 depends on phagocytosis of dying cells, ATP release through pannexin-1 channels of dying autophagic cells, P2X7 purinergic receptor activation, and on consequent potassium efflux. Dying autophagic Ba/F3 cells injected intraperitoneally in mice recruit neutrophils and thereby induce acute inflammation. These findings demonstrate that NALP3 performs key upstream functions in inflammasome activation in mouse macrophages engulfing dying autophagic cells, and that these functions lead to pro-inflammatory responses.	[Ayna, Gizem; Vandenabeele, Peter; Fesues, Laszlo] Univ Debrecen, Med & Hlth Sci Ctr, Dept Biochem & Mol Biol, Debrecen, Hungary; [Krysko, Dmitri V.; Kaczmarek, Agnieszka; Vandenabeele, Peter] VIB, Dept Mol Biomed Res, Mol Signalling & Cell Death Unit, Ghent, Belgium; [Krysko, Dmitri V.; Kaczmarek, Agnieszka; Vandenabeele, Peter] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Fesues, Laszlo] Univ Debrecen, Hungarian Acad Sci, Med & Hlth Sci Ctr, Apoptosis & Genom Res Grp, Debrecen, Hungary	University of Debrecen; Flanders Institute for Biotechnology (VIB); Ghent University; Hungarian Academy of Sciences; University of Debrecen	Ayna, G (corresponding author), Univ Debrecen, Med & Hlth Sci Ctr, Dept Biochem & Mol Biol, Debrecen, Hungary.	fesus@med.unideb.hu	Krysko, Dmitri V./AAE-9368-2019; Vandenabeele, Peter/AAD-5793-2022; Vandenabeele, Peter/C-8597-2009	Krysko, Dmitri V./0000-0002-9692-2047; Vandenabeele, Peter/0000-0002-6669-8822; Ayna Duran, Assist. Prof. Dr. Gizem/0000-0002-2168-753X; Petrovski, Goran/0000-0003-2905-9252	Hungarian Scientific Research Fund [OTKA NI 67877, K 61868]; European Social Fund [TAMOP-4.2.2-08/1/2008-0015, TAMOP 4.2.1./B-09/1/KONV-2010-0007]; ETT (Egeszsegugyi Tudomanyos Tanacs) from Hungarian Ministry of Health; EU [MRTNCT-2006-036032, MRTN-CT 2006-035624]; Fund for Scientific Research Flanders (FWO [Het Fonds Wetenschappelijk Onderzoek - Vlaanderen]-Vlaanderen) [3G072810]; FWO-Vlaanderen [31507110]; VIB; Ghent University (GROUP-ID consortium of the UGent MRP initiative); FWO Vlaanderen [G.0875.11, G.0973.11]; Federal Research Program [IAP 6/18]; European Research Program [MRTN-CT-035624, Apo-Sys 200767]; Euregional PACTII (Euregional PACT II - Euregional Platform for Advancing Cancer Treatment II); Flemish Government [BOF09/01M00709]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Social Fund(European Social Fund (ESF)); ETT (Egeszsegugyi Tudomanyos Tanacs) from Hungarian Ministry of Health; EU(European Commission); Fund for Scientific Research Flanders (FWO [Het Fonds Wetenschappelijk Onderzoek - Vlaanderen]-Vlaanderen)(FWO); FWO-Vlaanderen(FWO); VIB; Ghent University (GROUP-ID consortium of the UGent MRP initiative); FWO Vlaanderen(FWO); Federal Research Program; European Research Program(European Commission); Euregional PACTII (Euregional PACT II - Euregional Platform for Advancing Cancer Treatment II); Flemish Government(European Commission)	This work has been supported by grants from the Hungarian Scientific Research Fund (OTKA NI 67877, K 61868), TAMOP-4.2.2-08/1/2008-0015 and TAMOP 4.2.1./B-09/1/KONV-2010-0007 project implemented through the New Hungary Development Plan, co-financed by the European Social Fund, an ETT (Egeszsegugyi Tudomanyos Tanacs) grant from the Hungarian Ministry of Health, EU MRTNCT-2006-036032 and MRTN-CT 2006-035624, Fund for Scientific Research Flanders (FWO [Het Fonds Wetenschappelijk Onderzoek - Vlaanderen]-Vlaanderen, 3G072810 to D.V.K.) and by an individual research grant from FWO-Vlaanderen (31507110 to D.V.K.). D.V.K. is a postdoctoral fellow and A.K. is a doctoral fellow, both paid by fellowships from FWO-Vlaanderen. Peter Vandenabeele's group is supported by VIB, Ghent University (GROUP-ID consortium of the UGent MRP initiative), FWO Vlaanderen (G.0875.11 and G.0973.11), Federal Research Program (IAP 6/18), European Research Program FP6 ApopTrain (MRTN-CT-035624), FP7 Apo-Sys 200767, and the Euregional PACTII (Euregional PACT II - Euregional Platform for Advancing Cancer Treatment II). P.V. holds a Methusalem grant (BOF09/01M00709) from the Flemish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman BJ, 2009, MOL BIOL CELL, V20, P1180, DOI 10.1091/mbc.E08-08-0829; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chu CT, 2006, J NEUROPATH EXP NEUR, V65, P423, DOI 10.1097/01.jnen.0000229233.75253.be; Cvetanovic M, 2006, J BIOL CHEM, V281, P20055, DOI 10.1074/jbc.M603920200; D'hondt C, 2011, CELL SIGNAL, V23, P305, DOI 10.1016/j.cellsig.2010.07.018; ELLIOTT JA, 1986, INFECT IMMUN, V51, P31, DOI 10.1128/IAI.51.1.31-36.1986; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fesus L, 2011, ANTIOXID REDOX SIGN, V14, P2233, DOI 10.1089/ars.2010.3485; Franc NC, 1999, CURR OPIN IMMUNOL, V11, P47, DOI 10.1016/S0952-7915(99)80009-0; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Garg AD, 2010, BBA-REV CANCER, V1805, P53, DOI 10.1016/j.bbcan.2009.08.003; Geng Y, 2010, NEURO-ONCOLOGY, V12, P473, DOI 10.1093/neuonc/nop048; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gozuacik D, 2008, CELL DEATH DIFFER, V15, P1875, DOI 10.1038/cdd.2008.121; Grimsley C, 2003, TRENDS CELL BIOL, V13, P648, DOI 10.1016/j.tcb.2003.10.004; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kersse K, 2011, CYTOKINE GROWTH F R, V22, P257, DOI 10.1016/j.cytogfr.2011.09.003; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Krysko DV, 2011, CELL DEATH DIFFER, V18, P1316, DOI 10.1038/cdd.2011.4; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005; Krysko DV, 2010, APOPTOSIS, V15, P995, DOI 10.1007/s10495-010-0524-6; Krysko O, 2010, APOPTOSIS, V15, P1137, DOI 10.1007/s10495-010-0504-x; Majai G, 2006, IMMUNOL LETT, V104, P94, DOI 10.1016/j.imlet.2005.11.016; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; McDonald B, 2011, SCIENCE, V331, P1517; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Petrilli V, 2007, SWISS MED WKLY, V137, p28S; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Petrovski G, 2007, CELL DEATH DIFFER, V14, P1117, DOI 10.1038/sj.cdd.4402112; Petrovski G, 2011, AUTOPHAGY, V7, P321, DOI 10.4161/auto.7.3.14583; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Prietzsch H, 2002, CELL SIGNAL, V14, P751, DOI 10.1016/S0898-6568(02)00023-2; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Uhl M, 2009, CELL DEATH DIFFER, V16, P991, DOI 10.1038/cdd.2009.8; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Zitvogel L, 2010, CLIN CANCER RES, V16, P3100, DOI 10.1158/1078-0432.CCR-09-2891	56	88	92	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40069	10.1371/journal.pone.0040069	http://dx.doi.org/10.1371/journal.pone.0040069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768222	Green Published, gold			2022-12-27	WOS:000305892100194
J	Hejda, M				Hejda, Martin			What Is the Impact of Impatiens parviflora on Diversity and Composition of Herbal Layer Communities of Temperate Forests?	PLOS ONE			English	Article							SPECIES RICHNESS; INVASION; VEGETATION; PLANTS; SIZE; DC.	The aim was to estimate the impacts of invasive Impatiens parviflora on forests' herbal layer communities. A replicated Before-After-Control-Impact field experiment and comparisons with adjacent uninvaded plots were used. The alien's impact on species richness was tested using hierarchical generalized mixed effect models with Poisson error structure. Impact on species composition was tested using multivariate models (DCA, CCA, RDA) and Monte-Carlo permutation tests. Removal plots did not differ in native species richness from neither invaded nor adjacent uninvaded plots, both when the treatment's main effect or its interaction with sampling time was tested (Chi(2) = 0.4757, DF = 2, p = 0.7883; Chi(2) = 7.229, DF = 8, p = 0.5121 respectively). On the contrary, ordination models revealed differences in the development of plots following the treatments (p = 0.034) with the invaded plots differing from the adjacent uninvaded (p = 0.002). Impatiens parviflora is highly unlikely to impact native species richness of invaded communities, which may be associated with its limited ability to create a dense canopy, a modest root system or the fact the I. parviflora does not represent a novel and distinctive dominant to the invaded communities. Concerning its potential impacts on species composition, the presence of native clonal species (Athyrium filix-femina, Dryopteris filix-mas, Fragaria moschata, Luzula luzuloides, Poa nemoralis) on the adjacent uninvaded plots likely makes them different from the invaded plots. However, these competitive and strong species are more likely to prevent the invasion of I. parviflora on the adjacent uninvaded plots rather than being themselves eliminated from the invaded communities.	Acad Sci Czech Republic, Dept Invas Ecol, Inst Bot, Pruhonice, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Hejda, M (corresponding author), Acad Sci Czech Republic, Dept Invas Ecol, Inst Bot, Pruhonice, Czech Republic.	martinhejda@seznam.cz	Hejda, Martin/H-1589-2014		Grant Agency of the Czech Republic [P505/11/1112, 206/070668]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	The work on this manuscript was funded by grants no. P505/11/1112 and 206/070668 from the Grant Agency of the Czech Republic (www.gacr.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chmura D, 2007, FOREST ECOL MANAG, V242, P487, DOI 10.1016/j.foreco.2007.01.083; Chmura D, 2006, POL J ECOL, V54, P417; Crawley M.J., 2007, R BOOK; CSONTOS P, 1986, Studia Botanica Hungarica, V19, P115; ELIAS P, 1992, EKOL CSFR, V11, P299; Godefroid S, 2010, PLANT ECOL EVOL, V143, P119, DOI 10.5091/plecevo.2010.397; Hejda M, 2006, BIOL CONSERV, V132, P143, DOI 10.1016/j.biocon.2006.03.025; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; Hughes AP, 1964, NEW PHYTOL, V64, P48; Klimko Malgorzata, 2003, Ecological Questions, V3, P63; Kwiatkowska AJ, 1997, PLANT ECOL, V129, P1, DOI 10.1023/A:1009708317294; Leps J., 2000, MULTIVARIATE ANAL EC; Obidzinski T, 2000, ACTA SOC BOT POL, V69, P311, DOI 10.5586/asbp.2000.041; PEACE WJH, 1982, NEW PHYTOL, V90, P127, DOI 10.1111/j.1469-8137.1982.tb03247.x; PERRINS J, 1993, J BIOGEOGR, V20, P33, DOI 10.2307/2845737; Piskorz R, 2006, ACTA SOC BOT POL, V75, P51; Piskorz R, 2007, SYLWAN, V151, P43; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Sadlo J, 2007, PRESLIA, V79, P303; Schmitz G, 1998, PLANT INVASIONS: ECOLOGICAL MECHANISMS AND HUMAN RESPONSES, P335; Schmitz Gregor, 1999, Zeitschrift fuer Oekologie und Naturschutz, V7, P193; Swies F, 1982, BIOLOGIA, V37, P351; Ter Braak C.J.F., 1998, CANOCO RELEASE 4 REF; Trepl L, 1982, DISSERTATIONES BOT, V73; UHERCIKOVA E, 1991, Preslia (Prague), V63, P227	25	35	39	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39571	10.1371/journal.pone.0039571	http://dx.doi.org/10.1371/journal.pone.0039571			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768091	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100061
J	Keating, MA; Hamela, G; Miller, WC; Moses, A; Hoffman, IF; Hosseinipour, MC				Keating, Maria A.; Hamela, Gloria; Miller, William C.; Moses, Agnes; Hoffman, Irving F.; Hosseinipour, Mina C.			High HIV Incidence and Sexual Behavior Change among Pregnant Women in Lilongwe, Malawi: Implications for the Risk of HIV Acquisition	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; INFECTION; ZIMBABWE; PREVENTION; PREVALENCE; ABSTINENCE; EXPRESSION; INSIGHTS; AFRICA; PERIOD	Background: HIV incidence is higher among pregnant women than their non-pregnant counterparts in some sub-Saharan African settings. Our aims were (1) to estimate HIV incidence during pregnancy and (2) to compare sexual activity between pregnant, postpartum, and non-pregnant women. Methods: We examined a retrospective cohort of 1087 women to identify seroconverters using antenatal and labor ward HIV test results. We also conducted a cross-sectional survey, including a quantitative questionnaire (n = 200) and in-depth interviews (n = 20) among women in early pregnancy, late pregnancy, postpartum, and non-pregnancy. Outcomes included measures of sexual activity, reported spouse's risky behavior, and beliefs about abstinence. Results: 11 of 1087 women seroconverted during pregnancy yielding a 1% seroconversion risk and an incidence rate of 4.0/100 person years (95% CI 2.2-7.2). The reported sexual activity of the early pregnancy and non-pregnancy groups was similar, but significantly higher than the late pregnancy and postpartum groups (p < 0.001). During pregnancy, sex acts decreased as gestation increased (p = 0.001). There was no reported difference in the spouse's risky behavior. Most women believed that sex should cease between the 6th and 8th month of pregnancy and should not resume until 6 months postpartum. Some talked about conflict between their cultural obligation to abstain and fear of HIV infection if their spouses find other partners. Conclusions: HIV incidence is high among pregnant women in Malawi, and sexual activity decreases during pregnancy and postpartum. Pregnant women need to be informed of their increased risk for HIV and the importance of using condoms throughout pregnancy and the postpartum period.	[Keating, Maria A.; Hamela, Gloria; Moses, Agnes; Hosseinipour, Mina C.] Univ N Carolina Project, Lilongwe, Malawi; [Keating, Maria A.] Drexel Univ, Coll Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Miller, William C.; Hoffman, Irving F.; Hosseinipour, Mina C.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA	Drexel University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Keating, MA (corresponding author), Univ N Carolina Project, Lilongwe, Malawi.	mina_hosseinipour@med.unc.edu	Miller, William C/H-4800-2014	Miller, William C/0000-0002-1934-7827	Doris Duke Charitable Foundation through the University of North Carolina; Elizabeth Glaser Pediatric AIDS Foundation [MQ-00-9-200-01205-0-00]; University of North Carolina at Chapel Hill Center for AIDS Research (CFAR), an National Institutes of Health [P30 AI50410]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation through the University of North Carolina; Elizabeth Glaser Pediatric AIDS Foundation; University of North Carolina at Chapel Hill Center for AIDS Research (CFAR), an National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was upported by (1) the Doris Duke Charitable Foundation through the University of North Carolina to fund Clinical Research Fellow Maria Keating, (2) the Elizabeth Glaser Pediatric AIDS Foundation Operation Research Grant #MQ-00-9-200-01205-0-00, and (3) the University of North Carolina at Chapel Hill Center for AIDS Research (CFAR), an National Institutes of Health funded program #P30 AI50410. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDER EM, 1989, BAILLIERE CLIN OB GY, V3, P805, DOI 10.1016/S0950-3552(89)80066-5; Awusabo-Asare K, 1997, Health Transit Rev, V7 Suppl, P257; Chakraborty H, 2001, AIDS, V15, P621, DOI 10.1097/00002030-200103300-00012; Cleland JG, 1999, AIDS, V13, P125, DOI 10.1097/00002030-199901140-00017; Dube S, 2008, JAIDS-J ACQ IMM DEF, V48, P72, DOI 10.1097/QAI.0b013e31816bcdbb; Government of Malawi Ministry of Health, 2007, PREV MOTH CHILD TRAN; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; Kieffer MP, 2011, JAIDS-J ACQ IMM DEF, V57, pE85, DOI 10.1097/QAI.0b013e31821acc6e; Kinuthia J, 2010, CURR HIV RES, V8, P510, DOI 10.2174/157016210793499213; Lawoyin TO, 2002, J BIOSOC SCI, V34, P51, DOI 10.1017/S0021932002000512; Makanani B, 2010, INT J GYNECOL OBSTET, V108, P26, DOI 10.1016/j.ijgo.2009.08.014; Moodley D, 2011, J INFECT DIS, V203, P1231, DOI 10.1093/infdis/jir017; Moodley D, 2009, AIDS, V23, P1255, DOI 10.1097/QAD.0b013e32832a5934; Morrison CS, 2007, AIDS, V21, P1027, DOI 10.1097/QAD.0b013e3280f00fc4; Munjoma MW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-668; Patterson BK, 1998, AM J PATHOL, V153, P481, DOI 10.1016/S0002-9440(10)65591-5; PIWOWARMANNING EM, 2010, AIDS CARE, V9, P170; Rehle T, 2007, SAMJ S AFR MED J, V97, P194; Reid SE, 2010, JAIDS-J ACQ IMM DEF, V53, P606, DOI 10.1097/QAI.0b013e3181bc4869; Sheffield JS, 2009, REPROD SCI, V16, P20, DOI 10.1177/1933719108325510; Taha TE, 1998, AIDS, V12, P197, DOI 10.1097/00002030-199802000-00010; Tavengwa NV, 2007, TROP MED INT HEALTH, V12, P97, DOI 10.1111/j.1365-3156.2006.01758.x; UNAIDS, 2010, GLOB REP UNAIDS REP; Urassa W, 2006, SCAND J PUBLIC HEALT, V34, P272, DOI 10.1080/14034940500434871	25	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39109	10.1371/journal.pone.0039109	http://dx.doi.org/10.1371/journal.pone.0039109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768063	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100033
J	Libeu, CAP; Descamps, O; Zhang, Q; John, V; Bredesen, DE				Libeu, Clare A. Peters; Descamps, Olivier; Zhang, Qiang; John, Varghese; Bredesen, Dale E.			Altering APP Proteolysis: Increasing sAPPalpha Production by Targeting Dimerization of the APP Ectodomain	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; BOVINE SERUM ALBUMIN; A-BETA; EXTRACELLULAR DOMAIN; SIGNAL-TRANSDUCTION; ALZHEIMER-DISEASE; ALPHA-SECRETASE; BINDING; CLEAVAGE; COMMON	One of the events associated with Alzheimer's disease is the dysregulation of alpha- versus beta-cleavage of the amyloid precursor protein (APP). The product of a-cleavage (sAPP alpha) has neuroprotective properties, while A beta 1-42 peptide, a product of beta-cleavage, is neurotoxic. Dimerization of APP has been shown to influence the relative rate of alpha- and beta-cleavage of APP. Thus finding compounds that interfere with dimerization of the APP ectodomain and increase the alpha-cleavage of APP could lead to the development of new therapies for Alzheimer's disease. Examining the intrinsic fluorescence of a fragment of the ectodomain of APP, which dimerizes through the E2 and A beta-cognate domains, revealed significant changes in the fluorescence of the fragment upon binding of A beta oligomers-which bind to dimers of the ectodomain- and A beta fragments-which destabilize dimers of the ectodomain. This technique was extended to show that RERMS-containing peptides (APP(695) 328-332), disulfiram, and sulfiram also inhibit dimerization of the ectodomain fragment. This activity was confirmed with small angle x-ray scattering. Analysis of the activity of disulfiram and sulfiram in an AlphaLISA assay indicated that both compounds significantly enhance the production of sAPP alpha by 7W-CHO and B103 neuroblastoma cells. These observations demonstrate that there is a class of compounds that modulates the conformation of the APP ectodomain and influences the ratio of alpha- to beta-cleavage of APP. These compounds provide a rationale for the development of a new class of therapeutics for Alzheimer's disease.	[Libeu, Clare A. Peters; Descamps, Olivier; Zhang, Qiang; John, Varghese; Bredesen, Dale E.] Buck Inst Res Aging, Novato, CA USA	Buck Institute for Research on Aging	Libeu, CAP (corresponding author), Buck Inst Res Aging, Novato, CA USA.	clibeu@buckinstitute.org	Zhang, Qiang/C-3317-2018	Zhang, Qiang/0000-0002-4746-0392	Stephen D. Bechtel, Jr. Foundation; Joseph Drown Foundation; Douglas and Ellen Rosenberg Foundation; National Institutes of Health [AG034427]; NATIONAL INSTITUTE ON AGING [R01AG034427] Funding Source: NIH RePORTER	Stephen D. Bechtel, Jr. Foundation; Joseph Drown Foundation; Douglas and Ellen Rosenberg Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Stephen D. Bechtel, Jr. Foundation, the Joseph Drown Foundation, the Douglas and Ellen Rosenberg Foundation, and the National Institutes of Health (AG034427- D. Bredesen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Bredesen DE, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-27; Butterfield DA, 2003, CURR MED CHEM, V10, P2651, DOI 10.2174/0929867033456422; Chen CD, 2006, J NEUROCHEM, V97, P30, DOI 10.1111/j.1471-4159.2006.03705.x; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Dahms SO, 2010, P NATL ACAD SCI USA, V107, P5381, DOI 10.1073/pnas.0911326107; DANIEL E, 1966, BIOCHEMISTRY-US, V5, P1893, DOI 10.1021/bi00870a016; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Ferrao-Gonzales AD, 2005, J BIOL CHEM, V280, P34747, DOI 10.1074/jbc.M501651200; Fombonne J, 2009, ANN NEUROL, V65, P294, DOI 10.1002/ana.21578; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Glabe C, 2001, J MOL NEUROSCI, V17, P137, DOI 10.1385/JMN:17:2:137; Gralle M, 2006, J MOL BIOL, V357, P493, DOI 10.1016/j.jmb.2005.12.053; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; Haas C, 1997, BIOCHEM J, V325, P169, DOI 10.1042/bj3250169; Hass S, 1998, J BIOL CHEM, V273, P13892; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; JIN LW, 1994, J NEUROSCI, V14, P5461; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Kaden D, 2012, EUR J CELL BIOL, V91, P234, DOI 10.1016/j.ejcb.2011.01.017; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; Libeu CP, 2011, J ALZHEIMERS DIS, V25, P547, DOI 10.3233/JAD-2011-101938; Lourenco FC, 2009, CELL DEATH DIFFER, V16, P655, DOI 10.1038/cdd.2008.191; Lu DC, 2003, J NEUROCHEM, V87, P733, DOI 10.1046/j.1471-4159.2003.02059.x; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; Matsuda S, 2005, J BIOL CHEM, V280, P28912, DOI 10.1074/jbc.C500217200; Matsuda S, 2009, J BIOL CHEM, V284, P15815, DOI 10.1074/jbc.M109.006403; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; MULTHAUP G, 1994, BIOCHIMIE, V76, P304, DOI 10.1016/0300-9084(94)90163-5; Multhaup G, 2006, NEURODEGENER DIS, V3, P270, DOI 10.1159/000095266; Neve RL, 2008, AMYLOID, V15, P1, DOI 10.1080/13506120701814608; Nguyen TVV, 2008, J NEUROCHEM, V104, P1065, DOI 10.1111/j.1471-4159.2007.05031.x; Nichols MR, 2005, J BIOL CHEM, V280, P2471, DOI 10.1074/jbc.M410553200; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; NINOMIYA H, 1993, J CELL BIOL, V121, P879, DOI 10.1083/jcb.121.4.879; Oh SY, 2005, J NEUROSCI RES, V82, P32, DOI 10.1002/jnr.20625; Parvathy S, 1999, BIOCHEMISTRY-US, V38, P9728, DOI 10.1021/bi9906827; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Shaked GM, 2006, FASEB J, V20, P1254, DOI 10.1096/fj.05-5032fje; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; WEBER G, 1966, BIOCHEMISTRY-US, V5, P1900, DOI 10.1021/bi00870a017; WETLAUFER DB, 1962, ADV PROTEIN CHEM, V17, P303; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630	56	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40027	10.1371/journal.pone.0040027	http://dx.doi.org/10.1371/journal.pone.0040027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768208	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100180
J	Overman, EL; Rivier, JE; Moeser, AJ				Overman, Elizabeth L.; Rivier, Jean E.; Moeser, Adam J.			CRF Induces Intestinal Epithelial Barrier Injury via the Release of Mast Cell Proteases and TNF-alpha	PLOS ONE			English	Article							INDUCED VISCERAL HYPERSENSITIVITY; NEONATAL MATERNAL SEPARATION; STRESS-RELATED ALTERATIONS; PARACELLULAR PERMEABILITY; SIGNALING PATHWAYS; COLONIC DISTENSION; RECTAL DISTENSION; SUBSTANCE-P; DYSFUNCTION; TIGHT	Background and Aims: Psychological stress is a predisposing factor in the onset and exacerbation of important gastrointestinal diseases including irritable bowel syndrome (IBS) and the inflammatory bowel diseases (IBD). The pathophysiology of stress-induced intestinal disturbances is known to be mediated by corticotropin releasing factor (CRF) but the precise signaling pathways remain poorly understood. Utilizing a porcine ex vivo intestinal model, the aim of this study was to investigate the mechanisms by which CRF mediates intestinal epithelial barrier disturbances. Methodology: Ileum was harvested from 6-8 week-old pigs, mounted on Ussing Chambers, and exposed to CRF in the presence or absence of various pharmacologic inhibitors of CRF-mediated signaling pathways. Mucosal-to-serosal flux of 4 kDa-FITC dextran (FD4) and transepithelial electrical resistance (TER) were recorded as indices of intestinal epithelial barrier function. Results: Exposure of porcine ileum to 0.05-0.5 mu M CRF increased (p < 0.05) paracellular flux compared with vehicle controls. CRF treatment had no deleterious effects on ileal TER. The effects of CRF on FD4 flux were inhibited with pre-treatment of tissue with the non-selective CRF1/2 receptor antagonist Astressin B and the mast cell stabilizer sodium cromolyn (10(-4) M). Furthermore, anti-TNF-alpha neutralizing antibody (p < 0.01), protease inhibitors (p < 0.01) and the neural blocker tetrodotoxin (TTX) inhibited CRF-mediated intestinal barrier dysfunction. Conclusion: These data demonstrate that CRF triggers increases in intestinal paracellular permeability via mast cell dependent release of TNF-alpha and proteases. Furthermore, CRF-mast cell signaling pathways and increases in intestinal permeability require critical input from the enteric nervous system. Therefore, blocking the deleterious effects of CRF may address the enteric signaling of mast cell degranulation, TNF alpha release, and protease secretion, hallmarks of IBS and IBD.	[Overman, Elizabeth L.; Moeser, Adam J.] N Carolina State Univ, Coll Vet Med, Raleigh, NC 27695 USA; [Rivier, Jean E.] Salk Inst Biol Studies, La Jolla, CA USA	University of North Carolina; North Carolina State University; Salk Institute	Overman, EL (corresponding author), N Carolina State Univ, Coll Vet Med, Raleigh, NC 27695 USA.	ajmoeser@ncsu.edu		Moeser, Adam/0000-0003-3068-627X	National Institutes of Health [NIH P30 DK34987, K08 DK084313, DKPO1026741]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK084313, P30DK034987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health grant NIH P30 DK34987 (UNC Chapel Hill Center for Gastrointestinal Biology and Disease) and K08 DK084313 (AJM) and DKPO1026741 (JER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Agelaki S, 2002, INFECT IMMUN, V70, P6068, DOI 10.1128/IAI.70.11.6068-6074.2002; AGGARWAL A, 1994, GASTROENTEROLOGY, V106, P945, DOI 10.1016/0016-5085(94)90753-6; Ait-Belgnaoui A, 2005, PAIN, V113, P141, DOI 10.1016/j.pain.2004.10.002; ARGENZIO RA, 1990, AM J VET RES, V51, P747; ARGENZIO RA, 1988, AM J PHYSIOL, V255, pG62, DOI 10.1152/ajpgi.1988.255.1.G62; Asadi S, 2012, J INVEST DERMATOL, V132, P324, DOI 10.1038/jid.2011.334; Bennett EJ, 1998, GUT, V43, P256, DOI 10.1136/gut.43.2.256; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Buhner S, 2011, BIOCH BIOPHYS ACTA; Cao J, 2006, MOL PHARMACOL, V69, P998, DOI 10.1124/mol.105.019539; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Delvaux M M, 1999, Can J Gastroenterol, V13 Suppl A, p32A; Farhadi A, 2005, AM J GASTROENTEROL, V100, P1796, DOI 10.1111/j.1572-0241.2005.50071.x; Gareau MG, 2007, AM J PHYSIOL-GASTR L, V293, pG198, DOI 10.1152/ajpgi.00392.2006; Gareau MG, 2006, PEDIATR RES, V59, P83, DOI 10.1203/01.pdr.0000190577.62426.45; Gebhardt T, 2005, EUR J IMMUNOL, V35, P1124, DOI 10.1002/eji.200425869; Gourcerol G, 2011, GASTROENTEROLOGY, V140, P1586, DOI 10.1053/j.gastro.2011.01.039; Groschwitz KR, 2009, P NATL ACAD SCI USA, V106, P22381, DOI 10.1073/pnas.0906372106; Gue M, 1997, NEUROGASTROENT MOTIL, V9, P271, DOI 10.1046/j.1365-2982.1997.d01-63.x; Hart A, 2002, ALIMENT PHARM THER, V16, P2017, DOI 10.1046/j.1365-2036.2002.01359.x; Jacob C, 2005, J BIOL CHEM, V280, P31936, DOI 10.1074/jbc.M506338200; Johnson David A, 2006, Methods Mol Biol, V315, P193; Keita A V, 2010, Neurogastroenterol Motil, V22, P770, DOI 10.1111/j.1365-2982.2010.01471.x; Kulka M, 2008, IMMUNOLOGY, V123, P398, DOI 10.1111/j.1365-2567.2007.02705.x; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V293, pG413, DOI 10.1152/ajpgi.00304.2006; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V292, pG173, DOI 10.1152/ajpgi.00197.2006; Nozu T, 2006, J GASTROENTEROL, V41, P740, DOI 10.1007/s00535-006-1848-4; Park CH, 2003, J KOREAN MED SCI, V18, P204, DOI 10.3346/jkms.2003.18.2.204; Raithel M, 1999, SCAND J GASTROENTERO, V34, P496, DOI 10.1080/003655299750026236; Santos J, 1999, AM J PHYSIOL-GASTR L, V277, pG391, DOI 10.1152/ajpgi.1999.277.2.G391; Santos J, 2001, GUT, V48, P630, DOI 10.1136/gut.48.5.630; Santos J, 2000, AM J PHYSIOL-GASTR L, V278, pG847, DOI 10.1152/ajpgi.2000.278.6.G847; Santos J, 2008, PSYCHONEUROENDOCRINO, V33, P1248, DOI 10.1016/j.psyneuen.2008.07.002; Saunders PR, 2002, DIGEST DIS SCI, V47, P208, DOI 10.1023/A:1013204612762; SAUNDERS PR, 1994, AM J PHYSIOL-GASTR L, V267, pG794, DOI 10.1152/ajpgi.1994.267.5.G794; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Smith F, 2010, AM J PHYSIOL-GASTR L, V298, pG352, DOI 10.1152/ajpgi.00081.2009; Tache Y, 2004, NEUROGASTROENT MOTIL, V16, P137, DOI 10.1111/j.1743-3150.2004.00490.x; Tache Y, 2004, BRIT J PHARMACOL, V141, P1321, DOI 10.1038/sj.bjp.0705760; Teitelbaum AA, 2008, AM J PHYSIOL-GASTR L, V295, pG452, DOI 10.1152/ajpgi.90210.2008; Theoharides TC, 2004, TRENDS PHARMACOL SCI, V25, P563, DOI 10.1016/j.tips.2004.09.007; Tjong YW, 2010, NEUROENDOCRINOL LETT, V31, P215; Venihaki M, 1997, ENDOCRINOLOGY, V138, P698, DOI 10.1210/en.138.2.698; Wallon C, 2008, GUT, V57, P50, DOI 10.1136/gut.2006.117549; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; Yuan PQ, 2007, NEUROGASTROENT MOTIL, V19, P923, DOI 10.1111/j.1365-2982.2007.00978.x; Zhao JH, 2011, EUR J PHARMACOL, V654, P289, DOI 10.1016/j.ejphar.2010.12.032; Zoumakis E, 2001, GYNECOL ENDOCRINOL, V15, P98, DOI 10.1080/713602800	51	138	146	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39935	10.1371/journal.pone.0039935	http://dx.doi.org/10.1371/journal.pone.0039935			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768175	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100145
J	Schuch, AP; Lago, JC; Yagura, T; Menck, CFM				Schuch, Andre Passaglia; Lago, Juliana Carvalhaes; Yagura, Teiti; Martins Menck, Carlos Frederico			DNA Dosimetry Assessment for Sunscreen Genotoxic Photoprotection	PLOS ONE			English	Article							CYCLOBUTANE PYRIMIDINE DIMERS; SUN PROTECTION FACTOR; HUMAN SKIN; ULTRAVIOLET-RADIATION; HUMAN KERATINOCYTES; UVA RADIATION; DAMAGE; CELLS; REPAIR; PHOTOCARCINOGENESIS	Background: Due to the increase of solar ultraviolet radiation (UV) incidence over the last few decades, the use of sunscreen has been widely adopted for skin protection. However, considering the high efficiency of sunlight-induced DNA lesions, it is critical to improve upon the current approaches that are used to evaluate protection factors. An alternative approach to evaluate the photoprotection provided by sunscreens against daily UV radiation-induced DNA damage is provided by the systematic use of a DNA dosimeter. Methodology/Principal Findings: The Sun Protection Factor for DNA (DNA-SPF) is calculated by using specific DNA repair enzymes, and it is defined as the capacity for inhibiting the generation of cyclobutane pyrimidine dimers (CPD) and oxidised DNA bases compared with unprotected control samples. Five different commercial brands of sunscreen were initially evaluated, and further studies extended the analysis to include 17 other products representing various formulations and Sun Protection Factors (SPF). Overall, all of the commercial brands of SPF 30 sunscreens provided sufficient protection against simulated sunlight genotoxicity. In addition, this DNA biosensor was useful for rapidly screening the biological protection properties of the various sunscreen formulations. Conclusions/Significance: The application of the DNA dosimeter is demonstrated as an alternative, complementary, and reliable method for the quantification of sunscreen photoprotection at the level of DNA damage.	[Schuch, Andre Passaglia; Yagura, Teiti; Martins Menck, Carlos Frederico] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil; [Lago, Juliana Carvalhaes] Nat Inovacao & Tecnol Prod LTDA, Sao Paulo, Brazil	Universidade de Sao Paulo	Schuch, AP (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil.	cfmmenck@usp.br	Schuch, André/AAY-8946-2020; Menck, Carlos FM/G-6321-2011	Menck, Carlos FM/0000-0003-1941-0694	Natura Inovacao e Tecnologia de Produtos LTDA (Sao Paulo, Brazil); FAPESP (Sao Paulo, Brazil); CNPq (Brasilia, Brazil); Natura Inovacao e Tecnologia de Produtos LTDA	Natura Inovacao e Tecnologia de Produtos LTDA (Sao Paulo, Brazil); FAPESP (Sao Paulo, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Brasilia, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Natura Inovacao e Tecnologia de Produtos LTDA	This work was funded by Natura Inovacao e Tecnologia de Produtos LTDA (Sao Paulo, Brazil), FAPESP (Sao Paulo, Brazil), and CNPq (Brasilia, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; One of the authors, Juliana Carvalhaes Lago, is a researcher at the company Natura Inovacao e Tecnologia de Produtos LTDA, a funder of this research. However, he confirms that this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Agar NS, 2004, P NATL ACAD SCI USA, V101, P4954, DOI 10.1073/pnas.0401141101; Bernerd F, 2003, EUR J DERMATOL, V13, P242; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Cadet J, 2011, J INVEST DERMATOL, V131, P1005, DOI 10.1038/jid.2011.51; COLIPA, 2006, INT SUN PROT FACT SP; Courdavault S, 2005, DNA REPAIR, V4, P836, DOI 10.1016/j.dnarep.2005.05.001; Dahle J, 2008, CANCER LETT, V267, P18, DOI 10.1016/j.canlet.2008.03.002; De Fabo EC, 2004, CANCER RES, V64, P6372, DOI 10.1158/0008-5472.CAN-04-1454; de Gruijl FR, 2000, METHOD ENZYMOL, V319, P359; Douki T, 2003, BIOCHEMISTRY-US, V42, P9221, DOI 10.1021/bi034593c; Duale N, 2010, TOXICOL SCI, V114, P272, DOI 10.1093/toxsci/kfq005; Goulart JM, 2010, PHOTOCH PHOTOBIO SCI, V9, P432, DOI 10.1039/b9pp00122k; Gulston M, 1999, MUTAT RES-GEN TOX EN, V444, P49, DOI 10.1016/S1383-5718(99)00091-1; Horiki S, 2000, ARCH DERMATOL RES, V292, P511, DOI 10.1007/s004030000164; Kozmin S, 2005, P NATL ACAD SCI USA, V102, P13538, DOI 10.1073/pnas.0504497102; Lejeune F, 2008, PHOTODERMATOL PHOTO, V24, P249, DOI 10.1111/j.1600-0781.2008.00370.x; Liardet S, 2001, J INVEST DERMATOL, V117, P1437, DOI 10.1046/j.0022-202x.2001.01580.x; Marrot L, 2008, J AM ACAD DERMATOL, V58, pS139, DOI 10.1016/j.jaad.2007.12.007; Mouret S, 2008, DNA REPAIR, V7, P704, DOI 10.1016/j.dnarep.2008.01.005; Mouret S, 2006, P NATL ACAD SCI USA, V103, P13765, DOI 10.1073/pnas.0604213103; Mouret S, 2011, PHOTOCHEM PHOTOBIOL, V87, P109, DOI 10.1111/j.1751-1097.2010.00834.x; PIETTE J, 1986, PHOTOCHEM PHOTOBIOL, V44, P793, DOI 10.1111/j.1751-1097.1986.tb05539.x; RIBEIRO DT, 1992, PHOTOCHEM PHOTOBIOL, V55, P39, DOI 10.1111/j.1751-1097.1992.tb04207.x; Runger TM, 2007, J INVEST DERMATOL, V127, P2103, DOI 10.1038/sj.jid.5700988; Schuch AP, 2012, ENVIRON MOL MUTAGEN, V53, P198, DOI 10.1002/em.21678; Schuch AP, 2010, J PHOTOCH PHOTOBIO B, V99, P111, DOI 10.1016/j.jphotobiol.2010.03.004; Schuch AP, 2009, PHOTOCH PHOTOBIO SCI, V8, P111, DOI 10.1039/b810085c; Tewari A, 2011, J INVEST DERMATOL, V131, pS103; Yagura T, 2011, SENSORS-BASEL, V11, P4277, DOI 10.3390/s110404277; Young AR, 2010, J INVEST DERMATOL, V130, P2457, DOI 10.1038/jid.2010.144	30	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40344	10.1371/journal.pone.0040344	http://dx.doi.org/10.1371/journal.pone.0040344			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768281	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100255
J	Thomas, CM; Wood, RC; Wyatt, JE; Pendleton, MH; Torrenegra, RD; Rodriguez, OE; Harirforoosh, S; Ballester, M; Lightner, J; Krishnan, K; Ramsauer, VP				Thomas, Christan M.; Wood, Robert C., III; Wyatt, Jarrett E.; Pendleton, Morgan H.; Torrenegra, Ruben D.; Rodriguez, Oscar E.; Harirforoosh, Sam; Ballester, Maria; Lightner, Janet; Krishnan, Koyamangalath; Ramsauer, Victoria P.			Anti-Neoplastic Activity of Two Flavone Isomers Derived from Gnaphalium elegans and Achyrocline bogotensis	PLOS ONE			English	Article							CANCER STEM-CELLS; IN-VITRO; APOPTOSIS; ESTABLISHMENT; APIGENIN; PLANTS; LINE	Over 4000 flavonoids have been identified so far and among these, many are known to have antitumor activities. The basis of the relationships between chemical structures, type and position of substituent groups and the effects these compounds exert specifically on cancer cells are not completely elucidated. Here we report the differential cytotoxic effects of two flavone isomers on human cancer cells from breast (MCF7, SK-BR-3), colon (Caco-2, HCT116), pancreas (MIA PaCa, Panc 28), and prostate (PC3, LNCaP) that vary in differentiation status and tumorigenic potential. These flavones are derived from plants of the family Asteraceae, genera Gnaphalium and Achyrocline reputed to have anti-cancer properties. Our studies indicate that 5,7-dihydroxy-3,6,8-trimethoxy-2-phenyl-4H-chromen-4-one (5,7-dihydroxy-3,6,8-trimethoxy flavone) displays potent activity against more differentiated carcinomas of the colon (Caco-2), and pancreas (Panc28), whereas 3,5-dihydroxy-6,7,8-trimethoxy-2-phenyl-4H-chromen-4-one (3,5-dihydroxy-6,7,8-trimethoxy flavone) cytototoxic action is observed on poorly differentiated carcinomas of the colon (HCT116), pancreas (Mia PaCa), and breast (SK-BR3). Both flavones induced cell death (>50%) as proven by MTT cell viability assay in these cancer cell lines, all of which are regarded as highly tumorigenic. At the concentrations studied (5-80 mu M), neither flavone demonstrated activity against the less tumorigenic cell lines, breast cancer MCF-7 cells, androgen-responsive LNCaP human prostate cancer line, and androgen-unresponsive PC3 prostate cancer cells. 5,7-dihydroxy-3,6,8-trimethoxy-2-phenyl-4H-chromen-4-one (5,7-dihydroxy-3,6,8-trimethoxy flavone) displays activity against more differentiated carcinomas of the colon and pancreas, but minimal cytotoxicity on poorly differentiated carcinomas of these organs. On the contrary, 3,5-dihydroxy-6,7,8-trimethoxy-2-phenyl-4H-chromen-4-one (3,5-dihydroxy-6,7,8-trimethoxy flavone) is highly cytotoxic to poorly differentiated carcinomas of the colon, pancreas, and breast with minimal activity against more differentiated carcinomas of the same organs. These differential effects suggest activation of distinct apoptotic pathways. In conclusion, the specific chemical properties of these two flavone isomers dictate mechanistic properties which may be relevant when evaluating biological responses to flavones.	[Harirforoosh, Sam; Ramsauer, Victoria P.] E Tennessee State Univ, Bill Gatton Coll Pharm, Dept Pharmaceut Sci, Johnson City, TN 37614 USA; [Torrenegra, Ruben D.; Rodriguez, Oscar E.] Univ Ciencias Aplicadas & Ambientales, Bogota, Colombia; [Ballester, Maria] Nova SE Univ, Farquhar Coll Arts & Sci, Div Math Sci & Technol, Ft Lauderdale, FL 33314 USA; [Lightner, Janet; Krishnan, Koyamangalath; Ramsauer, Victoria P.] E Tennessee State Univ, James Quillen Coll Med, Dept Internal Med, Div Hematol Oncol, Johnson City, TN 37614 USA	East Tennessee State University; Nova Southeastern University; East Tennessee State University	Thomas, CM (corresponding author), E Tennessee State Univ, Bill Gatton Coll Pharm, Dept Pharmaceut Sci, Johnson City, TN 37614 USA.	ramsauer@mail.etsu.edu	GUERRERO, RUBEN D TORRENEGRA/W-9018-2019; Palau, Victoria E/F-3520-2012; Harirforoosh, Sam/J-9493-2013; RODRIGUEZ AGUIRRE, OSCAR EDUARDO/A-2907-2015	Palau, Victoria E/0000-0003-2761-7003; Harirforoosh, Sam/0000-0002-2631-3756; U.D.C.A, Universidad de Ciencias Aplicadas y Ambientales/0000-0002-2291-5354; RODRIGUEZ AGUIRRE, OSCAR EDUARDO/0000-0002-5934-0451; Torrenegra G., Ruben Dario/0000-0002-5473-5315	Department of Pharmaceutical Sciences at East Tennessee State University Gatton College of Pharmacy; Chemistry Department at Universidad de Ciencias Aplicadas y Ambientales	Department of Pharmaceutical Sciences at East Tennessee State University Gatton College of Pharmacy; Chemistry Department at Universidad de Ciencias Aplicadas y Ambientales	Funds were provided by the Department of Pharmaceutical Sciences at East Tennessee State University Gatton College of Pharmacy, and the Chemistry Department at Universidad de Ciencias Aplicadas y Ambientales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi EJ, 2009, ONCOL REP, V22, P1533, DOI 10.3892/or_00000598; Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002; Dandawate PR, 2012, PHARM RES; Erhart LM, 2005, APOPTOSIS, V10, P611, DOI 10.1007/s10495-005-1895-y; Fiamegos YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018127; Garca-Barriga H, 1975, FLORA MED COLOMBIA B; Garcia-Lafuente A, 2009, INFLAMM RES, V58, P537, DOI 10.1007/s00011-009-0037-3; HANSEL R, 1972, PHYTOCHEMISTRY, V11, P2632, DOI 10.1016/S0031-9422(00)88566-0; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; Javed H, 2012, NEUROSCIENCE; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kale A, 2008, PHYTOTHER RES, V22, P567, DOI 10.1002/ptr.2283; Kanadaswami C, 2005, IN VIVO, V19, P895; Karna P, 2011, CARCINOGENESIS, V32, P1872, DOI 10.1093/carcin/bgr215; Le Marchand L, 2002, BIOMED PHARMACOTHER, V56, P296, DOI 10.1016/S0753-3322(02)00186-5; Lee SH, 2008, CANCER LETT, V259, P39, DOI 10.1016/j.canlet.2007.09.015; LIM DJ, 1993, PROSTATE, V22, P109, DOI 10.1002/pros.2990220203; Lin L, 2011, BRIT J CANCER, V105, P212, DOI 10.1038/bjc.2011.200; Liu HL, 2010, RECENT PAT ANTI-CANC, V5, P152, DOI 10.2174/157489210790936261; Lopez-Lazaro M, 2002, Curr Med Chem Anticancer Agents, V2, P691; Menter DG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028813; Middleton E, 2000, PHARMACOL REV, V52, P673; Middleton ET, 2000, CHEST, V117, P758, DOI 10.1378/chest.117.3.758; Moghaddam G, 2011, PHYTOTHER RES; Neumeister V, 2010, AM J PATHOL, V176, P2131, DOI 10.2353/ajpath.2010.090712; Perez-Vizcaino F, 2009, PHARMACOL REP, V61, P67, DOI 10.1016/S1734-1140(09)70008-8; Schumacher M, 2011, CANCER INVEST, V29, P396, DOI 10.3109/07357907.2011.587071; Sclabas Guido M, 2003, Int J Gastrointest Cancer, V33, P15, DOI 10.1385/IJGC:33:1:15; Shin SY, 2011, TOXICOL APPL PHARM, V254, P288, DOI 10.1016/j.taap.2011.05.003; Singh M, 2011, J BIOMED NANOTECHNOL, V7, P202, DOI 10.1166/jbn.2011.1268; Sipos B, 2003, VIRCHOWS ARCH, V442, P444, DOI 10.1007/s00428-003-0784-4; Suzgec S, 2005, FITOTERAPIA, V76, P269, DOI 10.1016/j.fitote.2004.12.006; TOMASLORENTE F, 1989, PHYTOCHEMISTRY, V28, P1613, DOI 10.1016/S0031-9422(00)97809-9; TORRENEGRA RD, 1980, PHYTOCHEMISTRY, V19, P2795, DOI 10.1016/S0031-9422(00)83978-3; Torrenegra RD, 1982, REV LATINOAM QUIM, V13, P75; Torrenegra RD, 1987, REV LATINOAMERICANA, V18, P116; Torres F, 2010, MOL CARCINOGEN, V49, P464, DOI 10.1002/mc.20619; Tseng Tsui-Hwa, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P347, DOI 10.2174/187152006777698150; VANPUYVELDE L, 1989, J NAT PROD, V52, P629, DOI 10.1021/np50063a025; Visus C, 2011, CLIN CANCER RES, V17, P6174, DOI 10.1158/1078-0432.CCR-11-1111; Wang HK, 2000, EXPERT OPIN INV DRUG, V9, P2103, DOI 10.1517/13543784.9.9.2103; Wang S, 2009, EUR J PHARMACOL, V624, P31, DOI 10.1016/j.ejphar.2009.10.001; Xiong HP, 2009, ACTA CRYSTALLOGR E, V65, pO3277, DOI 10.1107/S1600536809050715	43	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39806	10.1371/journal.pone.0039806	http://dx.doi.org/10.1371/journal.pone.0039806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768128	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100098
J	Zhang, CZ; Pan, YH; Cao, Y; Lai, PBS; Liu, LL; Chen, GG; Yun, JP				Zhang, Chris Zhiyi; Pan, Yinghua; Cao, Yun; Lai, Paul B. S.; Liu, Lili; Chen, George Gong; Yun, Jingping			Histone Deacetylase Inhibitors Facilitate Dihydroartemisinin-Induced Apoptosis in Liver Cancer In Vitro and In Vivo	PLOS ONE			English	Article							SIGNALING PATHWAY; PHASE-II; C-MYC; CELLS; PROTEIN; ERK; DEGRADATION; VORINOSTAT; ACTIVATION; EXPRESSION	Liver cancer ranks in prevalence and mortality among top five cancers worldwide. Accumulating interests have been focused in developing new strategies for liver cancer treatment. We have previously showed that dihydroartemisinin (DHA) exhibited antitumor activity towards liver cancer. In this study, we demonstrated that histone deacetylase inhibitors (HDACi) significantly augmented the antineoplastic effect of DHA via increasing apoptosis in vitro and in vivo. Inhibition of ERK phosphorylation contributed to DHA-induced apoptosis, due to the fact that inhibitor of ERK phosphorylation (PD98059) increased DHA-induced apoptosis. Compared with DHA alone, the combined treatment with DHA and HDACi reduced mitochondria membrane potential, released cytochrome c into cytoplasm, increased p53 and Bak, decreased Mcl-1 and p-ERK, activated caspase 3 and PARP, and induced apoptotic cells. Furthermore, we showed that HDACi pretreatment facilitated DHA-induced apoptosis. In Hep G2-xenograft carrying nude mice, the intraperitoneal injection of DHA and SAHA resulted in significant inhibition of xenograft tumors. Results of TUNEL and H&E staining showed more apoptosis induced by combined treatment. Immunohistochemistry data revealed the activation of PARP, and the decrease of Ki-67, p-ERK and Mcl-1. Taken together, our data suggest that the combination of HDACi and DHA offers an antitumor effect on liver cancer, and this combination treatment should be considered as a promising strategy for chemotherapy.	[Zhang, Chris Zhiyi; Cao, Yun; Liu, Lili; Yun, Jingping] Sun Yat Sen Univ, State Key Lab Oncol So China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Chris Zhiyi; Cao, Yun; Liu, Lili; Yun, Jingping] Sun Yat Sen Univ, Dept Pathol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Pan, Yinghua] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Rheumatol & Immunol, Guangzhou 510275, Guangdong, Peoples R China; [Lai, Paul B. S.; Chen, George Gong] Chinese Univ Hong Kong, Dept Surg, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Chinese University of Hong Kong; Prince of Wales Hospital	Zhang, CZ (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol So China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	gchen@cuhk.edu.hk; yunjp@mail.sysu.edu.cn	Liu, Lili/HHC-6357-2022; Chen, George Gong/I-2757-2016; Lai, Paul BS/K-8556-2015; Zhang, Chris Zhiyi/F-9862-2013	Lai, Paul BS/0000-0002-9469-6728; 	National Natural Science Foundation of China [81172345, 30973506]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81172345 and No. 30973506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilano K, 2009, BIOCHEM PHARMACOL, V77, P337, DOI 10.1016/j.bcp.2008.10.034; Bommi PV, 2010, CELL CYCLE, V9, P2663, DOI 10.4161/cc.9.13.12147; Booy EP, 2011, ONCOGENE, V30, P2367, DOI 10.1038/onc.2010.616; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Breous E, 2011, J HEPATOL, V54, P830, DOI 10.1016/j.jhep.2010.10.013; Calvino E, 2011, BIOCHEM PHARMACOL, V82, P1619, DOI 10.1016/j.bcp.2011.08.017; Chen T, 2009, J CELL MOL MED, V13, P1358, DOI 10.1111/j.1582-4934.2008.00360.x; Dalgard CL, 2008, CLIN CANCER RES, V14, P3113, DOI 10.1158/1078-0432.CCR-07-4836; Ehses JA, 2002, J BIOL CHEM, V277, P37088, DOI 10.1074/jbc.M205055200; Erichsen R, 2008, EUR J GASTROEN HEPAT, V20, P104, DOI 10.1097/MEG.0b013e3282f17517; Gould JJ, 2010, J UROLOGY, V183, P2395, DOI 10.1016/j.juro.2010.02.004; Jazirehi AR, 2004, CANCER RES, V64, P7117, DOI 10.1158/0008-5472.CAN-03-3500; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim HM, 2011, BREAST CANCER RES TR, V130, P365, DOI 10.1007/s10549-010-1310-4; Konopleva M, 2011, LEUKEMIA; Kretzner L, 2011, CANCER RES, V71, P3912, DOI 10.1158/0008-5472.CAN-10-2259; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Li D, 2011, CELL DEATH DIFFER, V18, P1904, DOI 10.1038/cdd.2011.71; Lu JJ, 2010, BIOCHEM PHARMACOL, V80, P22, DOI 10.1016/j.bcp.2010.02.016; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Molife LR, 2010, ANN ONCOL, V21, P109, DOI 10.1093/annonc/mdp270; Munster PN, 2011, BRIT J CANCER, V104, P1828, DOI 10.1038/bjc.2011.156; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Rahbari NN, 2011, ANN SURG, V253, P453, DOI 10.1097/SLA.0b013e31820d944f; Rahman MS, 2006, J IMMUNOL, V177, P4064, DOI 10.4049/jimmunol.177.6.4064; Reeves MB, 2012, P NATL ACAD SCI USA, V109, P588, DOI 10.1073/pnas.1114966108; Rosato RR, 2008, MOL CANCER THER, V7, P3285, DOI 10.1158/1535-7163.MCT-08-0385; Sawatzky DA, 2006, AM J PATHOL, V168, P33, DOI 10.2353/ajpath.2006.050058; Sun HL, 2009, CLIN CANCER RES, V15, P4904, DOI 10.1158/1078-0432.CCR-09-0269; Nguyen T, 2011, CLIN CANCER RES, V17, P3219, DOI 10.1158/1078-0432.CCR-11-0234; Tsochatzis EA, 2010, SEMIN ONCOL, V37, P89, DOI 10.1053/j.seminoncol.2010.03.007; Wagner S, 2005, BIOCHEM PHARMACOL, V69, P1059, DOI 10.1016/j.bcp.2004.12.017; Willoughby JA, 2009, J BIOL CHEM, V284, P2203, DOI 10.1074/jbc.M804491200; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yuen HF, 2012, CLIN CANCER RES, V18, P380, DOI 10.1158/1078-0432.CCR-11-2035; Zhang CZY, 2012, CELL CYCLE, V11, P322, DOI 10.4161/cc.11.2.18758; Zhang CZY, 2011, APOPTOSIS, V16, P683, DOI 10.1007/s10495-011-0597-x; Zhang CZ, BIOCH PHARM	38	30	35	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39870	10.1371/journal.pone.0039870	http://dx.doi.org/10.1371/journal.pone.0039870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761917	gold, Green Published, Green Submitted			2022-12-27	WOS:000305826400043
J	Yang, CH; Liu, XM; Si, JJ; Shi, HS; Xue, YX; Liu, JF; Luo, YX; Chen, C; Li, P; Yang, JL; Wu, P; Lu, L				Yang, Cheng-Hao; Liu, Xiang-Ming; Si, Ji-Jian; Shi, Hai-Shui; Xue, Yan-Xue; Liu, Jian-Feng; Luo, Yi-Xiao; Chen, Chen; Li, Peng; Yang, Jian-Li; Wu, Ping; Lu, Lin			Role of IKK/NF-kappa B Signaling in Extinction of Conditioned Place Aversion Memory in Rats	PLOS ONE			English	Article							LONG-TERM-MEMORY; ANTAGONIST MK-801 BLOCKS; TRANSCRIPTION FACTOR; BASOLATERAL AMYGDALA; SODIUM-BUTYRATE; IMPAIRS RECONSOLIDATION; HISTONE MODIFICATION; SYNAPTIC PLASTICITY; FEAR EXTINCTION; SPATIAL MEMORY	The inhibitor kB protein kinase/nuclear factor kB (IKK/NF-kB) signaling pathway is critical for synaptic plasticity. However, the role of IKK/NF-kB in drug withdrawal-associated conditioned place aversion (CPA) memory is unknown. Here, we showed that inhibition of IKK/NF-kB by sulphasalazine (SSZ; 10 mM, i.c.v.) selectively blocked the extinction but not acquisition or expression of morphine-induced CPA in rats. The blockade of CPA extinction induced by SSZ was abolished by sodium butyrate, an inhibitor of histone deacetylase. Thus, the IKK/NF-kB signaling pathway might play a critical role in the extinction of morphine-induced CPA in rats and might be a potential pharmacotherapy target for opiate addiction.	[Yang, Cheng-Hao; Si, Ji-Jian] Tianjin Med Univ, Tianjin, Peoples R China; [Liu, Xiang-Ming] Tianjin Med Univ, Dept Thorac Oncol, Tianjin Canc Inst & Hosp, Tianjin, Peoples R China; [Shi, Hai-Shui; Xue, Yan-Xue; Liu, Jian-Feng; Luo, Yi-Xiao; Chen, Chen; Li, Peng; Wu, Ping; Lu, Lin] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China; [Yang, Cheng-Hao; Si, Ji-Jian; Yang, Jian-Li] Tianjin Mental Hlth Ctr, Tianjin Inst Mental Hlth, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Peking University	Yang, CH (corresponding author), Tianjin Med Univ, Tianjin, Peoples R China.	yangjianli0722@sohu.com; wuping@bjmu.edu.cn		Yang, Chenghao/0000-0002-3424-6004; Liu, Jianfeng/0000-0002-3464-6462	National Natural Science Foundation of China [30870895, 81071085]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 30870895 and and No. 81071085 to JLY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2008, LEARN MEMORY, V15, P539, DOI 10.1101/lm.866408; Azar MR, 2003, PSYCHOPHARMACOLOGY, V170, P42, DOI 10.1007/s00213-003-1514-y; Baker JD, 1996, BEHAV NEUROSCI, V110, P618, DOI 10.1037/0735-7044.110.3.618; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Boccia M, 2007, J NEUROSCI, V27, P13436, DOI 10.1523/JNEUROSCI.4430-07.2007; COX J, 1994, Q J EXP PSYCHOL-B, V47, P187; Dash PK, 2005, J NEUROCHEM, V93, P269, DOI 10.1111/j.1471-4159.2004.03016.x; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; de la Fuente V, 2011, J NEUROSCI, V31, P5562, DOI 10.1523/JNEUROSCI.6066-10.2011; De Vries TJ, 2002, J NEUROSCI, V22, P3321; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Ear T, 2005, J IMMUNOL, V175, P1834, DOI 10.4049/jimmunol.175.3.1834; Federman N, 2009, LEARN MEMORY, V16, P600, DOI 10.1101/lm.1537009; Freudenthal R, 2005, EUR J NEUROSCI, V21, P2845, DOI 10.1111/j.1460-9568.2005.04126.x; Glezer I, 2003, NEUROPHARMACOLOGY, V45, P1120, DOI 10.1016/S0028-3908(03)00279-X; GUERRINI L, 1995, P NATL ACAD SCI USA, V92, P9077, DOI 10.1073/pnas.92.20.9077; Gundersen BB, 2009, NEUROPHARMACOLOGY, V57, P67, DOI 10.1016/j.neuropharm.2009.04.008; He YY, 2011, NEUROPSYCHOPHARMACOL, V36, P1972, DOI 10.1038/npp.2011.63; Hou YY, 2009, J NEUROSCI, V29, P12244, DOI 10.1523/JNEUROSCI.1970-09.2009; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; KALTSCHMIDT C, 1995, P NATL ACAD SCI USA, V92, P9618, DOI 10.1073/pnas.92.21.9618; Koo JW, 2010, P NATL ACAD SCI USA, V107, P2669, DOI 10.1073/pnas.0910658107; Koob GF, 2009, NEUROPHARMACOLOGY, V56, P18, DOI 10.1016/j.neuropharm.2008.07.043; Lattal KM, 2006, BIOL PSYCHIAT, V60, P344, DOI 10.1016/j.biopsych.2006.05.038; Li FQ, 2010, J NEUROSCI, V30, P10351, DOI 10.1523/JNEUROSCI.2112-10.2010; Li YQ, 2011, J NEUROSCI, V31, P5436, DOI 10.1523/JNEUROSCI.5884-10.2011; Liou HC, 2003, BIOESSAYS, V25, P767, DOI 10.1002/bies.10306; Lu L, 2005, PSYCHOPHARMACOLOGY, V181, P90, DOI 10.1007/s00213-005-2207-5; Lubin FD, 2007, NEURON, V55, P942, DOI 10.1016/j.neuron.2007.07.039; Lubin FD, 2011, NEUROSCIENTIST, V17, P616, DOI 10.1177/1073858411386967; Madrigal JLM, 2001, J NEUROCHEM, V76, P532, DOI 10.1046/j.1471-4159.2001.00108.x; Massa PE, 2005, J BIOL CHEM, V280, P14057, DOI 10.1074/jbc.M414401200; Meffert MK, 2005, TRENDS NEUROSCI, V28, P37, DOI 10.1016/j.tins.2004.11.002; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Merlo E, 2005, LEARN MEMORY, V12, P23, DOI 10.1101/lm.82705; Merlo E, 2002, NEUROSCIENCE, V112, P161, DOI 10.1016/S0306-4522(02)00049-0; Merlo E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003687; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Nestler H P, 2001, IDrugs, V4, P1365; PRASAD KN, 1976, IN VITRO CELL DEV B, V12, P125; RIGGS MG, 1977, NATURE, V268, P462, DOI 10.1038/268462a0; Robbins TW, 2008, ANN NY ACAD SCI, V1141, P1, DOI 10.1196/annals.1441.020; Russo SJ, 2009, J NEUROSCI, V29, P3529, DOI 10.1523/JNEUROSCI.6173-08.2009; Santini E, 2001, J NEUROSCI, V21, P9009, DOI 10.1523/JNEUROSCI.21-22-09009.2001; SEALY L, 1978, CELL, V14, P115, DOI 10.1016/0092-8674(78)90306-9; Stafford JM, 2012, BIOL PSYCHIAT; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992; Wang XY, 2008, J NEUROSCI, V28, P5602, DOI 10.1523/JNEUROSCI.0750-08.2008; Weber CK, 2000, GASTROENTEROLOGY, V119, P1209, DOI 10.1053/gast.2000.19458; White DA, 2005, PHARMACOL BIOCHEM BE, V81, P451, DOI 10.1016/j.pbb.2005.04.002; Yang JL, 2011, BEHAV BRAIN RES, V216, P592, DOI 10.1016/j.bbr.2010.08.047; Yeh SH, 2004, MOL PHARMACOL, V65, P1286, DOI 10.1124/mol.65.5.1286; Yeh SH, 2002, J BIOL CHEM, V277, P46720, DOI 10.1074/jbc.M206258200; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zhai HF, 2008, BEHAV PHARMACOL, V19, P211, DOI 10.1097/FBP.0b013e3282fe88a0	58	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39696	10.1371/journal.pone.0039696	http://dx.doi.org/10.1371/journal.pone.0039696			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761874	gold, Green Published, Green Submitted			2022-12-27	WOS:000305808700045
J	Paul, D; Busireddy, A; Nagaraja, SB; Satyanarayana, S; Dewan, PK; Nair, SA; Sarkar, S; Ahmed, QT; Sarkar, S; Shamrao, SRM; Harries, AD; Oeltmann, JE				Paul, Durba; Busireddy, Arundhathi; Nagaraja, Sharath Burugina; Satyanarayana, Srinath; Dewan, Puneet Kumar; Nair, Sreenivas Achutan; Sarkar, Silajit; Ahmed, Quazi Toufique; Sarkar, Shakuntala; Shamrao, Sreenivas Rao Motta; Harries, Anthony David; Oeltmann, John Ethan			Factors Associated with Delays in Treatment Initiation after Tuberculosis Diagnosis in Two Districts of India	PLOS ONE			English	Article								Background: Excessive time between diagnosis and initiation of tuberculosis (TB) treatment contributes to ongoing TB transmission and should be minimized. In India, Revised National TB Control Programme (RNTCP) focuses on indicator start of treatment within 7 days of diagnosis for patients with sputum smear-positive PTB for monitoring DOTS implementation. Objectives: To determine length of time between diagnosis and initiation of treatment and factors associated with delays of more than 7 days in smear-positive pulmonary TB. Methods: Using existing programme records such as the TB Register, treatment cards, and the laboratory register, we conducted a retrospective cohort study of all patients with smear-positive pulmonary TB registered from July-September 2010 in two districts in India. A random sample of patients with pulmonary TB who experienced treatment delay of more than 7 days was interviewed using structured questionnaire. Results: 2027 of 3411 patients registered with pulmonary TB were smear-positive. 711(35%) patients had >7 days between diagnosis and treatment and 262(13%) had delays >15 days. Mean duration between TB diagnosis and treatment initiation was 8 days (range = 0-128 days). Odds of treatment delay >7 days was 1.8 times more likely among those who had been previously treated (95% confidence interval [CI] 1.5-2.3) and 1.6 (95% CI 1.3-1.8) times more likely among those diagnosed in health facilities without microscopy centers. The main factors associated with a delay >7 days were: patient reluctance to start a re-treatment regimen, patients seeking second opinions, delay in transportation of drugs to the DOT centers and delay in initial home visits. To conclude, treatment delay >7 days was associated with a number of factors that included history of previous treatment and absence of TB diagnostic services in the local health facility. Decentralized diagnostic facilities and improved referral procedures may reduce such treatment delays.	[Paul, Durba; Nagaraja, Sharath Burugina; Dewan, Puneet Kumar; Sarkar, Silajit; Ahmed, Quazi Toufique] WHO, Off WHO Representat India, New Delhi, India; [Busireddy, Arundhathi] Dist TB Off, Nalgonda, Andhra Pradesh, India; [Satyanarayana, Srinath; Nair, Sreenivas Achutan] Int Union TB & Lung Dis, SE Asia Off, New Delhi, India; [Sarkar, Shakuntala] Dist TB Ctr, Bardhaman, W Bengal, India; [Harries, Anthony David] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony David] London Sch Hyg & Trop Med, London WC1, England; [Oeltmann, John Ethan] US Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA	World Health Organization; University of London; London School of Hygiene & Tropical Medicine; Centers for Disease Control & Prevention - USA	Paul, D (corresponding author), WHO, Off WHO Representat India, New Delhi, India.	pauld@rntcp.org	Nagaraja, Sharath Burugina/ABD-7748-2021; Nagaraja, Sharath Burugina/ABD-7238-2021	Nagaraja, Sharath Burugina/0000-0002-6599-5753; Nagaraja, Sharath Burugina/0000-0002-6599-5753; Satyanarayana, Srinath/0000-0002-5420-2551; Nair, Sreenivas/0000-0002-2586-6797	Union from Global Fund Round 9 India TB Project funds; World Health Organization WHO-India from United States Agency for International Development (USAID)	Union from Global Fund Round 9 India TB Project funds; World Health Organization WHO-India from United States Agency for International Development (USAID)(United States Agency for International Development (USAID)World Health Organization)	Funding support was provided by The Union from Global Fund Round 9 India TB Project funds and by World Health Organization WHO-India from United States Agency for International Development (USAID) funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Central Tuberculosis Division, 2005, STRAT DOC SUP MON RE; Central Tuberculosis Division, 2005, TECHN OP GUID TUB CO; Central Tuberculosis Division, 2011, TUB IND 2011 ANN REP; Charles N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012379; FAO, 2022, GLOB STRAT DIG HLTH; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; [Stop TB Partnership World Health Organization], 2006, GLOB PLAN STOP TB 20; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1	9	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39040	10.1371/journal.pone.0039040	http://dx.doi.org/10.1371/journal.pone.0039040			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792161	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000306354700006
J	Chen, TJ; Wang, JQ; Zeng, LL; Li, RZ; Li, JC; Chen, YL; Lin, ZL				Chen, Tingjian; Wang, Jianqing; Zeng, Lingli; Li, Rizong; Li, Jicong; Chen, Yilu; Lin, Zhanglin			Significant Rewiring of the Transcriptome and Proteome of an Escherichia coli Strain Harboring a Tailored Exogenous Global Regulator IrrE	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; DEINOCOCCUS-RADIODURANS; OUTER-MEMBRANE; SMALL RNAS; CLOSTRIDIUM-ACETOBUTYLICUM; NITROSATIVE STRESS; NITRIC-OXIDE; TOLERANCE; BACTERIA; RESISTANCE	Cell reprogramming for microorganisms via engineered or artificial transcription factors and RNA polymerase mutants has presented a powerful tool for eliciting complex traits that are practically useful particularly for industrial strains, and for understanding at the global level the regulatory network of gene transcription. We previously further showed that an exogenous global regulator IrrE (derived from the extreme radiation-resistant bacterium Deinococcus radiodurans) can be tailored to confer Escherichia coli (E. coli) with significantly enhanced tolerances to different stresses. In this work, based on comparative transcriptomic and proteomic analyses of the representative strains E1 and E0, harboring the ethanol-tolerant IrrE mutant E1 and the ethanol-intolerant wild type IrrE, respectively, we found that the transcriptome and proteome of E. coli were extensively rewired by the tailored IrrE protein. Overall, 1196 genes (or approximately 27% of E. coli genes) were significantly altered at the transcriptomic level, including notably genes in the nitrate-nitrite-nitric oxide (NO) pathway, and genes for non-coding RNAs. The proteomic profile revealed significant up-or downregulation of several proteins associated with syntheses of the cell membrane and cell wall. Analyses of the intracellular NO level and cell growth under reduced temperature supported a close correlation between NO and ethanol tolerance, and also suggests a role for membrane fluidity. The significantly different omic profiles of strain E1 indicate that IrrE functions as a global regulator in E. coli, and that IrrE may be evolved for other cellular tolerances. In this sense, it will provide synthetic biology with a practical and evolvable regulatory "part" that operates at a higher level of complexity than local regulators. This work also suggests a possibility of introducing and engineering other exogenous global regulators to rewire the genomes of microorganism cells.	[Chen, Tingjian; Wang, Jianqing; Zeng, Lingli; Li, Rizong; Li, Jicong; Lin, Zhanglin] Tsinghua Univ, Dept Chem Engn, Beijing 100084, Peoples R China; [Chen, Yilu] Nanjing Univ Technol, Coll Biotechnol & Pharmaceut Engn, Nanjing 210009, Peoples R China	Tsinghua University; Nanjing Tech University	Chen, TJ (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	zhanglinlin@mail.tsinghua.edu.cn	Chen, Tingjian/L-2659-2013; Lin, Zhanglin/A-7232-2011	Chen, Tingjian/0000-0002-4458-4269; 	National Basic Research (973) program of China [2009CB724704, 2011CBA00800]	National Basic Research (973) program of China(National Basic Research Program of China)	This work was supported by grants from the National Basic Research (973) program of China (No. 2009CB724704 and No. 2011CBA00800). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldor IS, 2005, APPL ENVIRON MICROB, V71, P1717, DOI 10.1128/AEM.71.4.1717-1728.2005; Alper H, 2007, METAB ENG, V9, P258, DOI 10.1016/j.ymben.2006.12.002; Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; Alsaker KV, 2010, BIOTECHNOL BIOENG, V105, P1131, DOI 10.1002/bit.22628; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Arguelles JC, 2000, ARCH MICROBIOL, V174, P217, DOI 10.1007/s002030000192; Atsumi S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.98; BAER SH, 1987, APPL ENVIRON MICROB, V53, P2854, DOI 10.1128/AEM.53.12.2854-2861.1987; Bauermeister A, 2009, ARCH MICROBIOL, V191, P913, DOI 10.1007/s00203-009-0522-7; Chen TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016228; Conrad TM, 2010, P NATL ACAD SCI USA, V107, P20500, DOI 10.1073/pnas.0911253107; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; Delihas N, 2001, J MOL BIOL, V313, P1, DOI 10.1006/jmbi.2001.5029; Earl AM, 2002, J BACTERIOL, V184, P6216, DOI 10.1128/JB.184.22.6216-6224.2002; Frey AD, 2002, APPL ENVIRON MICROB, V68, P4835, DOI 10.1128/AEM.68.10.4835-4840.2002; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; Gao GJ, 2003, DNA REPAIR, V2, P1419, DOI 10.1016/j.dnarep.2003.08.012; Guillier M, 2006, MOL MICROBIOL, V59, P231, DOI 10.1111/j.1365-2958.2005.04929.x; Guillier M, 2006, GENE DEV, V20, P2338, DOI 10.1101/gad.1457506; Hayashi S, 2003, J BIOSCI BIOENG, V95, P379, DOI 10.1263/jbb.95.379; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Hobbs EC, 2010, J BACTERIOL, V192, P59, DOI 10.1128/JB.00873-09; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; Horinouchi T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-579; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kaino T, 2008, APPL MICROBIOL BIOT, V79, P273, DOI 10.1007/s00253-008-1431-4; Knoshaug EP, 2009, APPL BIOCHEM BIOTECH, V153, P13, DOI 10.1007/s12010-008-8460-4; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Lease RA, 2004, J BACTERIOL, V186, P6179, DOI 10.1128/JB.186.18.6179-6185.2004; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Lee JY, 2011, BIOTECHNOL BIOENG, V108, P742, DOI 10.1002/bit.22989; Lee JY, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn449; Li ZL, 2005, ANAL BIOCHEM, V343, P35, DOI 10.1016/j.ab.2005.04.021; Lu HM, 2009, MOL CELL PROTEOMICS, V8, P481, DOI 10.1074/mcp.M800123-MCP200; Ma RQ, 2011, CURR MICROBIOL, V62, P659, DOI 10.1007/s00284-010-9759-2; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masse E, 2003, CURR OPIN MICROBIOL, V6, P120, DOI 10.1016/S1369-5274(03)00027-4; Nicolaou SA, 2010, METAB ENG, V12, P307, DOI 10.1016/j.ymben.2010.03.004; Pan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004422; Patridge EV, 2006, J BACTERIOL, V188, P3498, DOI 10.1128/JB.188.10.3498-3506.2006; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; Purvis JE, 2005, APPL ENVIRON MICROB, V71, P3761, DOI 10.1128/AEM.71.7.3761-3769.2005; Reyes LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017678; Rutherford BJ, 2010, APPL ENVIRON MICROB, V76, P1935, DOI 10.1128/AEM.02323-09; Satoh K, 2006, MICROBIOL-SGM, V152, P3217, DOI 10.1099/mic.0.29139-0; SIKKEMA J, 1995, MICROBIOL REV, V59, P201, DOI 10.1128/MMBR.59.2.201-222.1995; STROM AR, 1993, MOL MICROBIOL, V8, P205, DOI 10.1111/j.1365-2958.1993.tb01564.x; Tucker NP, 2010, TRENDS MICROBIOL, V18, P149, DOI 10.1016/j.tim.2009.12.009; Vujicic-Zagar A, 2009, J MOL BIOL, V386, P704, DOI 10.1016/j.jmb.2008.12.062; Wassarman KM, 2002, CELL, V109, P141, DOI 10.1016/S0092-8674(02)00717-1; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Weiner JH, 2008, BBA-BIOMEMBRANES, V1778, P1698, DOI 10.1016/j.bbamem.2007.07.020; Xu CX, 2006, PROTEOMICS, V6, P462, DOI 10.1002/pmic.200500219; Yoon SH, 2003, BIOTECHNOL BIOENG, V81, P753, DOI 10.1002/bit.10626; Zhou ZF, 2011, MOL BIOSYST, V7, P1613, DOI 10.1039/c0mb00336k	58	19	22	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e37126	10.1371/journal.pone.0037126	http://dx.doi.org/10.1371/journal.pone.0037126			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792156	gold, Green Published, Green Submitted			2022-12-27	WOS:000306436300003
J	Boncompagni, S; Thomas, M; Lopez, JR; Allen, PD; Yuan, QY; Kranias, EG; Franzini-Armstrong, C; Perez, CF				Boncompagni, Simona; Thomas, Monique; Lopez, Jose R.; Allen, Paul D.; Yuan, Qunying; Kranias, Evangelia G.; Franzini-Armstrong, Clara; Perez, Claudio F.			Triadin/Junctin Double Null Mouse Reveals a Differential Role for Triadin and Junctin in Anchoring CASQ to the jSR and Regulating Ca2+ Homeostasis	PLOS ONE			English	Article							RABBIT SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM VESICLES; CALCIUM-BINDING PROTEIN; RYANODINE RECEPTOR; MOLECULAR-CLONING; STORE DEPLETION; CARDIAC-MUSCLE; RELEASE UNITS; CALSEQUESTRIN; MEMBRANE	Triadin (Tdn) and Junctin (Jct) are structurally related transmembrane proteins thought to be key mediators of structural and functional interactions between calsequestrin (CASQ) and ryanodine receptor (RyRs) at the junctional sarcoplasmic reticulum (jSR). However, the specific contribution of each protein to the jSR architecture and to excitation-contraction (e-c) coupling has not been fully established. Here, using mouse models lacking either Tdn (Tdn-null), Jct (Jct-null) or both (Tdn/Jct-null), we identify Tdn as the main component of periodically located anchors connecting CASQ to the RyR-bearing jSR membrane. Both proteins proved to be important for the structural organization of jSR cisternae and retention of CASQ within them, but with different degrees of impact. Our results also suggest that the presence of CASQ is responsible for the wide lumen of the jSR cisternae. Using Ca2+ imaging and Ca2+ selective microelectrodes we found that changes in e-c coupling, SR Ca2+ content and resting [Ca2+] in Jct, Tdn and Tdn/Jct-null muscles are directly correlated to the effect of each deletion on CASQ content and its organization within the jSR. These data suggest that in skeletal muscle the disruption of Tdn/CASQ link has a more profound effect on jSR architecture and myoplasmic Ca2+ regulation than Jct/CASQ association.	[Boncompagni, Simona] Univ G DAnnunzio, CeSI Ctr Res Ageing, DNI Dept Neurosci & Imaging, Chieti, Italy; [Boncompagni, Simona; Franzini-Armstrong, Clara] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Yuan, Qunying; Kranias, Evangelia G.] Acad Athens, Biomed Res Fdn, Div Mol Biol, Athens, Greece; [Kranias, Evangelia G.] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA; [Thomas, Monique; Lopez, Jose R.; Allen, Paul D.; Perez, Claudio F.] Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, Boston, MA 02115 USA	G d'Annunzio University of Chieti-Pescara; University of Pennsylvania; Academy of Athens; University System of Ohio; University of Cincinnati; Harvard University; Brigham & Women's Hospital	Boncompagni, S (corresponding author), Univ G DAnnunzio, CeSI Ctr Res Ageing, DNI Dept Neurosci & Imaging, Chieti, Italy.	s.boncompagni@unich.it			National Institutes of Health [5K01AR054818, P01AR052354, P01AR47605, AR055104, HL26057, HL64018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL026057, R01HL026057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR054818, R03AR047605, P01AR052354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health, Grants 5K01AR054818 to Dr. Perez, P01AR052354 to Dr. Allen and Dr. Franzini-Armstrong, P01AR47605 to Dr. Allen, AR055104 KG Beam subcontract to Dr. Franzini-Armstrong and HL26057, HL64018 to Dr. Kranias. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augusto V, 2004, BRAZ J MORPHOL SCIS, V21, P89; Avila G, 2003, J BIOL CHEM, V278, P22600, DOI 10.1074/jbc.M205866200; Beard NA, 2002, BIOPHYS J, V82, P310, DOI 10.1016/S0006-3495(02)75396-4; Boncompagni S, 2011, AGE DORDR; Boncompagni S, 2007, P NATL ACAD SCI USA, V104, P19339, DOI 10.1073/pnas.0709061104; CAMPBELL KP, 1980, BIOCHIM BIOPHYS ACTA, V602, P97, DOI 10.1016/0005-2736(80)90293-X; CASWELL AH, 1991, BIOCHEMISTRY-US, V30, P7507, DOI 10.1021/bi00244a020; Cherednichenko G, 2004, P NATL ACAD SCI USA, V101, P15793, DOI 10.1073/pnas.0403485101; Chopra N, 2009, P NATL ACAD SCI USA, V106, P7636, DOI 10.1073/pnas.0902919106; Danieli-Betto D, 2005, AM J PHYSIOL-REG I, V289, pR1328, DOI 10.1152/ajpregu.00673.2004; Dinchuk JE, 2000, J BIOL CHEM, V275, P39543, DOI 10.1074/jbc.M006753200; Divet A, 2007, J CELL PHYSIOL, V213, P464, DOI 10.1002/jcp.21121; Eltit JM, 2011, CELL CALCIUM, V49, P128, DOI 10.1016/j.ceca.2011.01.005; Eltit JM, 2010, J BIOL CHEM, V285, P38453, DOI 10.1074/jbc.M110.164525; ENGEL AG, 2004, MYOLOGY, P749; FAN HR, 1995, BIOCHEMISTRY-US, V34, P14902, DOI 10.1021/bi00045a035; Fodor J, 2008, J PHYSIOL-LONDON, V586, P5803, DOI 10.1113/jphysiol.2008.160457; FRANZINI.C, 1970, J CELL BIOL, V47, P488, DOI 10.1083/jcb.47.2.488; FRANZINIARMSTRONG C, 1987, J CELL BIOL, V105, P49, DOI 10.1083/jcb.105.1.49; Froemming GR, 1999, BBA-BIOMEMBRANES, V1418, P197, DOI 10.1016/S0005-2736(99)00024-3; Gergs U, 2007, AM J PHYSIOL-HEART C, V293, pH728, DOI 10.1152/ajpheart.01187.2006; Gu W, 1996, SOC GEN PHY, V51, P19; Guido AN, 2010, ANAT REC, V293, P1722, DOI 10.1002/ar.21224; GUO W, 1995, J BIOL CHEM, V270, P9027, DOI 10.1074/jbc.270.16.9027; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Hong CS, 2002, FASEB J, V16, P1310, DOI 10.1096/fj.01-0908fje; Hurne AM, 2005, J BIOL CHEM, V280, P36994, DOI 10.1074/jbc.M506441200; Jones LR, 1998, J CLIN INVEST, V101, P1385, DOI 10.1172/JCI1362; Jones LR, 1995, J BIOL CHEM, V270, P30787, DOI 10.1074/jbc.270.51.30787; JORGENSEN AO, 1984, J CELL BIOL, V98, P1597, DOI 10.1083/jcb.98.4.1597; Kirchhefer U, 2006, CELL CALCIUM, V39, P131, DOI 10.1016/j.ceca.2005.10.004; Knollmann BC, 2009, J PHYSIOL-LONDON, V587, P3081, DOI 10.1113/jphysiol.2009.172098; KNUDSON CM, 1993, J BIOL CHEM, V268, P12646; Kobayashi YM, 1999, J BIOL CHEM, V274, P28660, DOI 10.1074/jbc.274.40.28660; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Lee KW, 2012, J BIOL CHEM, V287, P1679, DOI 10.1074/jbc.M111.254045; MACLENNAN DH, 1971, P NATL ACAD SCI USA, V68, P1231, DOI 10.1073/pnas.68.6.1231; MARTY I, 1995, BIOCHEM J, V307, P769, DOI 10.1042/bj3070769; McFarland TP, 2010, J MOL CELL CARDIOL, V49, P556, DOI 10.1016/j.yjmcc.2010.05.012; MEISSNER G, 1973, BIOCHIM BIOPHYS ACTA, V298, P246, DOI 10.1016/0005-2736(73)90355-6; MEISSNER G, 1975, BIOCHIM BIOPHYS ACTA, V389, P51, DOI 10.1016/0005-2736(75)90385-5; Milstein ML, 2009, EXP CELL RES, V315, P523, DOI 10.1016/j.yexcr.2008.11.006; MITCHELL RD, 1988, J BIOL CHEM, V263, P1376; O'Reilly FM, 2002, BIOPHYS J, V82, P145, DOI 10.1016/S0006-3495(02)75381-2; Oddoux S, 2009, J BIOL CHEM, V284, P34918, DOI 10.1074/jbc.M109.022442; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; Perez CF, 2005, AM J PHYSIOL-CELL PH, V288, pC640, DOI 10.1152/ajpcell.00407.2004; PORTER KR, 1957, J BIOPHYS BIOCHEM CY, V3, P269, DOI 10.1083/jcb.3.2.269; Royer L, 2009, J PHYSIOL-LONDON, V587, P3101, DOI 10.1113/jphysiol.2009.171934; Samso M, 2006, J MOL BIOL, V356, P917, DOI 10.1016/j.jmb.2005.12.023; Shen XH, 2007, J BIOL CHEM, V282, P37864, DOI 10.1074/jbc.M705702200; Takekura H, 1996, J MUSCLE RES CELL M, V17, P391, DOI 10.1007/BF00123356; TAKEKURA H, 1995, P NATL ACAD SCI USA, V92, P3381, DOI 10.1073/pnas.92.8.3381; Tijskens P, 2003, J MOL CELL CARDIOL, V35, P961, DOI 10.1016/S0022-2828(03)00181-0; Treves S, 2004, J CELL BIOL, V166, P537, DOI 10.1083/jcb.200404079; Treves S, 2000, J BIOL CHEM, V275, P39555, DOI 10.1074/jbc.M005473200; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476; Wang Y, 2009, CELL CALCIUM, V45, P29, DOI 10.1016/j.ceca.2008.05.006; Wei L, 2009, INT J BIOCHEM CELL B, V41, P2214, DOI 10.1016/j.biocel.2009.04.017; Wetzel GT, 2000, MOL GENET METAB, V69, P252, DOI 10.1006/mgme.2000.2966; Yuan QQ, 2007, CIRCULATION, V115, P300, DOI 10.1161/CIRCULATIONAHA.106.654699; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389; Zhang L, 2001, J MOL CELL CARDIOL, V33, P233, DOI 10.1006/jmcc.2000.1295	64	44	46	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39962	10.1371/journal.pone.0039962	http://dx.doi.org/10.1371/journal.pone.0039962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768324	Green Published, gold, Green Submitted			2022-12-27	WOS:000305966500037
J	Perise-Barrios, AJ; Munoz-Fernandez, MA; Pion, M				Judith Perise-Barrios, Ana; Angeles Munoz-Fernandez, Maria; Pion, Marjorie			Direct Phenotypical and Functional Dysregulation of Primary Human B Cells by Human Immunodeficiency Virus (HIV) Type 1 In Vitro	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; POLYCLONAL ACTIVATION; CD40 LIGAND; T-CELLS; MEMORY; INFECTION; LYMPHOCYTES; HYPERGAMMAGLOBULINEMIA; DIFFERENTIATION; MAINTENANCE	Background: Human immunodeficiency virus type 1 (HIV-1) induces a general dysregulation of immune system. Dysregulation of B cell compartment is generally thought to be induced by HIV-related immune activation and lymphopenia. However, a direct influence of HIV-1 particles on B cells was recently proposed as the third pathway of B cells dysregulation. Methods/Principal Findings: We evaluated the direct and specific consequences of HIV-1 contact on activation, survival, proliferation and phenotype of primary B cells in vitro. Moreover, we examined expression of activation-induced cytidine deaminase (AID) mRNA that is responsible for class switch recombination (CSR) and somatic hypermutation (SHM). Here, we report that changes observed in cellular proliferation, phenotypes and activation of B cells could be caused by direct contact between HIV-1 particles and primary B cells in vitro. Finally, direct HIV-1-derived B cells activation led to the increase of AID mRNA expression and its subsequent CSR function was detected in vitro. Conclusion/Significance: We showed that HIV-1 could directly induce primary B cells dysregulation triggering phenotypical and functional abilities of B cells in vitro that could explain in some extent early B-cell abnormalities in HIV disease.	[Judith Perise-Barrios, Ana; Angeles Munoz-Fernandez, Maria; Pion, Marjorie] Hosp Gen Univ Gregorio Maranon, Lab Inmunobiol Mol, Madrid, Spain; [Angeles Munoz-Fernandez, Maria] Red Temat Invest Cooperat Sanitaria Inst Salud Ca, HIV Vaccine Grp, Madrid, Spain	General University Gregorio Maranon Hospital	Perise-Barrios, AJ (corresponding author), Hosp Gen Univ Gregorio Maranon, Lab Inmunobiol Mol, Madrid, Spain.	marjorie.pion@salud.madrid.org	Barrios, Ana Judith Perisé/AAY-5670-2020; Pion, Marjorie/AAB-5812-2022; Pion, Marjorie/D-8139-2012; Barrios, Ana Judith Perisé/A-4007-2019; Pion, Marjorie/D-8139-2012	Barrios, Ana Judith Perisé/0000-0002-0136-3968; Pion, Marjorie/0000-0003-1828-4745; Barrios, Ana Judith Perisé/0000-0002-0136-3968; Munoz-Fernandez/0000-0002-0813-4500; Pion, Marjorie/0000-0002-6406-747X	Fondos de Investigacion Sanitaria [FIS PS09/02523]; Subprogramma Ramon y Cajal [RYC-2009-05486]; Red Tematica de Investigacion Cooperativa Sanitaria ISCIII [RETIC RD06/0006/0035]; Fundacion para la Investigacion y Prevencion del SIDA en Espana [FIPSE 240800/09]; INTRASALUD [PI09/02029]; Fondo de Investigacion Sanitaria [CP07/00117]	Fondos de Investigacion Sanitaria(Instituto de Salud Carlos III); Subprogramma Ramon y Cajal; Red Tematica de Investigacion Cooperativa Sanitaria ISCIII; Fundacion para la Investigacion y Prevencion del SIDA en Espana; INTRASALUD; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	This work was supported by Fondos de Investigacion Sanitaria (FIS PS09/02523), Subprogramma Ramon y Cajal (RYC-2009-05486), Red Tematica de Investigacion Cooperativa Sanitaria ISCIII (RETIC RD06/0006/0035), Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE 240800/09). AJPB was supported by INTRASALUD (PI09/02029). The authors thank Dr. Rafael Correa Rocha (Fondo de Investigacion Sanitaria (CP07/00117)) who provided statistical analysis support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Agematsu K, 2000, HISTOL HISTOPATHOL, V15, P573, DOI 10.14670/HH-15.573; Baenziger S, 2009, BLOOD, V113, P377, DOI 10.1182/blood-2008-04-151712; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Cagigi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005427; Cerutti A, 1998, J IMMUNOL, V160, P2145; Chong Y, 2004, AIDS RES HUM RETROV, V20, P621, DOI 10.1089/0889222041217455; Chong Y, 2004, AIDS RES HUM RETROV, V20, P219, DOI 10.1089/088922204773004941; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; De Milito A, 2004, CURR HIV RES, V2, P11, DOI 10.2174/1570162043485068; De Milito A, 2001, AIDS, V15, P957, DOI 10.1097/00002030-200105250-00003; Epeldegui M, 2010, IMMUNOL RES; Epeldegui M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011448; French MA, 2007, HIV MED, V8, P148, DOI 10.1111/j.1468-1293.2007.00445.x; Garcia-Merino I, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-27; HAERTLE T, 1988, J BIOL CHEM, V263, P5870; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Imbeault M, 2011, J VIROL, V85, P2189, DOI 10.1128/JVI.01993-10; Jacobson MA, 2002, JAIDS, V31, P472, DOI 10.1097/00126334-200212150-00003; Jakubik JJ, 2000, J VIROL, V74, P552, DOI 10.1128/JVI.74.1.552-555.2000; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Maddaly R, 2010, FEBS LETT, V584, P4883, DOI 10.1016/j.febslet.2010.08.022; Malaspina A, 2005, J INFECT DIS, V191, P1442, DOI 10.1086/429298; Malaspina A, 2002, J VIROL, V76, P8855, DOI 10.1128/JVI.76.17.8855-8863.2002; Martin G, 2007, J VIROL, V81, P5872, DOI 10.1128/JVI.02542-06; Martinez-Maza O, 2002, CURR OPIN ONCOL, V14, P528, DOI 10.1097/00001622-200209000-00009; Moir S, 2000, J EXP MED, V192, P637, DOI 10.1084/jem.192.5.637; Moir S, 2001, P NATL ACAD SCI USA, V98, P10362, DOI 10.1073/pnas.181347898; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Racanelli V, 2006, J VIROL, V80, P3923, DOI 10.1128/JVI.80.8.3923-3934.2006; Redgrave BE, 2005, HIV MED, V6, P307, DOI 10.1111/j.1468-1293.2005.00312.x; SCHMID I, 1994, CYTOMETRY, V15, P12, DOI 10.1002/cyto.990150104; SCHNITTMAN SM, 1986, SCIENCE, V233, P1084, DOI 10.1126/science.3016902; Seidl T, 2011, IMMUNOLOGY; Shen Xiaoying, 2011, Curr HIV/AIDS Rep, V8, P23, DOI 10.1007/s11904-010-0064-2; Stevenson PG, 1999, J VIROL, V73, P1075, DOI 10.1128/JVI.73.2.1075-1079.1999; STRONG DM, 1974, J IMMUNOL, V113, P1429; Swingler S, 2008, CELL HOST MICROBE, V4, P63, DOI 10.1016/j.chom.2008.05.015; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; VUJCIC LK, 1995, AIDS RES HUM RETROV, V11, P783, DOI 10.1089/aid.1995.11.783; WRIGHT DN, 1990, J ALLERGY CLIN IMMUN, V85, P445, DOI 10.1016/0091-6749(90)90154-V	44	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39472	10.1371/journal.pone.0039472	http://dx.doi.org/10.1371/journal.pone.0039472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768302	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000305966500015
J	Tsvirkun, D; Bourreau, J; Mieuset, A; Garo, F; Vinogradova, O; Larina, I; Navasiolava, N; Gauquelin-Koch, G; Gharib, C; Custaud, MA				Tsvirkun, Darya; Bourreau, Jennifer; Mieuset, Aurelie; Garo, Florian; Vinogradova, Olga; Larina, Irina; Navasiolava, Nastassia; Gauquelin-Koch, Guillemette; Gharib, Claude; Custaud, Marc-Antoine			Contribution of Social Isolation, Restraint, and Hindlimb Unloading to Changes in Hemodynamic Parameters and Motion Activity in Rats	PLOS ONE			English	Article							NERVOUS-SYSTEM; BLOOD-PRESSURE; ANTIORTHOSTATIC RESTRAINT; CARDIOVASCULAR CHANGES; CIRCADIAN-RHYTHMS; HEART-RATE; MICROGRAVITY; HYPERTENSION; RECOVERY; EXERCISE	The most accepted animal model for simulation of the physiological and morphological consequences of microgravity on the cardiovascular system is one of head-down hindlimb unloading. Experimental conditions surrounding this model include not only head-down tilting of rats, but also social and restraint stresses that have their own influences on cardiovascular system function. Here, we studied levels of spontaneous locomotor activity, blood pressure, and heart rate during 14 days under the following experimental conditions: cage control, social isolation in standard rat housing, social isolation in special cages for hindlimb unloading, horizontal attachment (restraint), and head-down hindlimb unloading. General activity and hemodynamic parameters were continuously monitored in conscious rats by telemetry. Heart rate and blood pressure were both evaluated during treadmill running to reveal cardiovascular deconditioning development as a result of unloading. The main findings of our work are that: social isolation and restraint induced persistent physical inactivity, while unloading in rats resulted in initial inactivity followed by normalization and increased locomotion after one week. Moreover, 14 days of hindlimb unloading showed significant elevation of blood pressure and slight elevation of heart rate. Hemodynamic changes in isolated and restrained rats largely reproduced the trends observed during unloading. Finally, we detected no augmentation of tachycardia during moderate exercise in rats after 14 days of unloading. Thus, we concluded that both social isolation and restraint, as an integral part of the model conditions, contribute essentially to cardiovascular reactions during head-down hindlimb unloading, compared to the little changes in the hydrostatic gradient.	[Tsvirkun, Darya; Bourreau, Jennifer; Mieuset, Aurelie; Garo, Florian; Custaud, Marc-Antoine] Univ Angers, CNRS, INSERM 1083, Fac Med Angers,UMR 6214, Angers, France; [Tsvirkun, Darya] Moscow MV Lomonosov State Univ, Dept Human & Anim Physiol, Moscow, Russia; [Gauquelin-Koch, Guillemette] Ctr Natl Etud Spatiales, Paris, France; [Gharib, Claude] ISOSTEO LYON Inst Super Osteopathie, Limonest, France; [Gharib, Claude] Fac Med Lyon Est, Lyon, France; [Larina, Irina; Navasiolava, Nastassia; Custaud, Marc-Antoine] Associated French Russia Lab CaDyWEC, Angers, France; [Vinogradova, Olga; Larina, Irina; Navasiolava, Nastassia] Russian Acad Sci SSC, Inst Biomed Problems, Moscow, Russia; [Custaud, Marc-Antoine] CHU Angers, Angers, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Lomonosov Moscow State University; Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Tsvirkun, D (corresponding author), Univ Angers, CNRS, INSERM 1083, Fac Med Angers,UMR 6214, Angers, France.	macustaud@chu-angers.fr	Navasiolava, Nastassia/AAU-8149-2020; Custaud, Marc-Antoine/K-1376-2015; Tsvirkun, Darya/AAH-7043-2020; Vinogradova, Olga/E-6494-2014	Tsvirkun, Darya/0000-0002-6599-6844; Vinogradova, Olga/0000-0002-4622-0522	Centre National d'Etudes Spatiales (CNES); Centre National de la Recherche Scientifique (CNRS); Region des Pays de la Loire; French Embassy in Russia	Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Region des Pays de la Loire(Region Pays de la Loire); French Embassy in Russia	This work was supported by the Centre National d'Etudes Spatiales (CNES, www.cnes.fr), the Centre National de la Recherche Scientifique (CNRS, www.cnrs.fr, LIA CaDyWEC), and the Region des Pays de la Loire (www.paysdelaloire.fr, project DCVACE). Post-doctoral study grants are from the French Embassy in Russia and CNES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SH, 1995, PSYCHOPHARMACOLOGY, V117, P116, DOI 10.1007/BF02245106; Assenmacher I, 1995, ACTA ASTRONAUT, V36, P545, DOI 10.1016/0094-5765(95)00141-7; Barrot M, 2005, P NATL ACAD SCI USA, V102, P8357, DOI 10.1073/pnas.0500587102; Basset A, 2004, J HYPERTENS, V22, P727, DOI 10.1097/00004872-200404000-00015; BENNETT T, 1979, BRIT J PHARMACOL, V65, P205, DOI 10.1111/j.1476-5381.1979.tb07820.x; Bouzeghrane F, 1996, J APPL PHYSIOL, V80, P1993, DOI 10.1152/jappl.1996.80.6.1993; CARLIER PG, 1988, J HYPERTENS, V6, pS112, DOI 10.1097/00004872-198812040-00032; Dehority W, 1999, AM J PHYSIOL-ENDOC M, V276, pE62; DELP MD, 1995, J APPL PHYSIOL, V78, P2079, DOI 10.1152/jappl.1995.78.6.2079; Dupont E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017564; FELL RD, 1985, AM J PHYSIOL, V249, pR308, DOI 10.1152/ajpregu.1985.249.3.R308; Fluckey JD, 2002, ACTA PHYSIOL SCAND, V176, P293, DOI 10.1046/j.1365-201X.2002.01040.x; Fujita N, 2009, ARCH HISTOL CYTOL, V72, P151, DOI 10.1679/aohc.72.151; GARDINER SM, 1977, MED BIOL, V55, P325; GAUQUELIN G, 1987, BIOCHEM BIOPH RES CO, V148, P582, DOI 10.1016/0006-291X(87)90916-8; Greene Adrianne N., 2007, Journal of Pharmacological and Toxicological Methods, V56, P218, DOI 10.1016/j.vascn.2007.04.006; Grippo AJ, 2003, PHYSIOL BEHAV, V78, P703, DOI 10.1016/S0031-9384(03)00050-7; Hall FS, 1998, CRIT REV NEUROBIOL, V12, P129, DOI 10.1615/CritRevNeurobiol.v12.i1-2.50; Hargens AR., 1984, PHYSIOLOGIST, V27, pS37; Hasser EM, 2001, ANN NY ACAD SCI, V940, P454; Henze M, 2008, AM J PHYSIOL-HEART C, V295, pH29, DOI 10.1152/ajpheart.01373.2007; Itai Y, 2004, ACTA PHYSIOL SCAND, V181, P217, DOI 10.1111/j.1365-201X.2004.01271.x; JANKOWSKA E, 1991, BEHAV BRAIN RES, V43, P155, DOI 10.1016/S0166-4328(05)80065-8; Makino M, 1997, CIRCULATION, V96, P1667, DOI 10.1161/01.CIR.96.5.1667; Maurel D, 1996, BRAIN RES, V736, P165, DOI 10.1016/0006-8993(96)00676-2; MCDONALD KS, 1992, J APPL PHYSIOL, V72, P2210, DOI 10.1152/jappl.1992.72.6.2210; Moffitt JA, 2008, J APPL PHYSIOL, V105, P1049, DOI 10.1152/japplphysiol.90535.2008; Momken I, 2011, FASEB J, V25, P3646, DOI 10.1096/fj.10-177295; Morey E R, 1979, Physiologist, V22, pS23; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Mueller PJ, 2008, AM J PHYSIOL-REG I, V295, pR727, DOI 10.1152/ajpregu.00144.2008; Mueller PJ, 2010, AM J PHYSIOL-REG I, V298, pR1468, DOI 10.1152/ajpregu.00101.2010; Musacchia X J, 1997, J Gravit Physiol, V4, P49; Narayanan R, 2004, BONE, V35, P134, DOI 10.1016/j.bone.2004.02.014; Navasiolava NM, 2011, EUR J APPL PHYSIOL, V111, P1235, DOI 10.1007/s00421-010-1750-x; Ohira T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021044; OVERTON JM, 1989, J APPL PHYSIOL, V66, P653, DOI 10.1152/jappl.1989.66.2.653; Raffai G, 2009, PHYSIOL RES, V58, P57, DOI 10.33549/physiolres.931264; Ray CA, 2001, J APPL PHYSIOL, V91, P1207, DOI 10.1152/jappl.2001.91.3.1207; Sabban EL, 2009, NEUROENDOCRINOLOGY, V89, P98, DOI 10.1159/000150099; Schuenke MD, 2009, EUR J APPL PHYSIOL, V106, P885, DOI 10.1007/s00421-009-1091-9; SHELLOCK FG, 1985, AVIAT SPACE ENVIR MD, V56, P791; Shen S, 1999, CLIN EXP HYPERTENS, V21, P275, DOI 10.3109/10641969909068667; Shibata S, 2010, J APPL PHYSIOL, V108, P1177, DOI 10.1152/japplphysiol.01408.2009; Wallace DL, 2009, NAT NEUROSCI, V12, P200, DOI 10.1038/nn.2257; Watenpaugh DE, 2000, J APPL PHYSIOL, V89, P218, DOI 10.1152/jappl.2000.89.1.218; Wright RC, 2003, NEUROPEPTIDES, V37, P127, DOI 10.1016/S0143-4179(03)00024-6; Xue JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019775; Zhang LF, 2001, J APPL PHYSIOL, V91, P2415, DOI 10.1152/jappl.2001.91.6.2415; Zhang LF, 2008, J APPL PHYSIOL, V105, P1134, DOI 10.1152/japplphysiol.00184.2008	50	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39923	10.1371/journal.pone.0039923	http://dx.doi.org/10.1371/journal.pone.0039923			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768322	Green Published, gold			2022-12-27	WOS:000305966500035
J	Assefa, N; Berhane, Y; Worku, A				Assefa, Nega; Berhane, Yemane; Worku, Alemayehu			Wealth Status, Mid Upper Arm Circumference (MUAC) and Ante Natal Care (ANC) Are Determinants for Low Birth Weight in Kersa, Ethiopia	PLOS ONE			English	Article							PREGNANCY	Background: Low Birth Weight (LBW) is one of the major risk factor for death in early life. However, little is known about predictors of LBW in sub-Saharan Africa. Therefore, the aim of this study was to measure the incidence and determinants of LBW in a rural population of Ethiopia. Methods: An observational cohort study on pregnant women was conducted from December 2009 to November 2010. During the study period 1295 live birth were registered and the weights of 956 children were measured within 24 hours after birth. Socio-demographic, economic, maternal and organizational factors were considered as a predicators of LBW, defined as birth weight below 2500g. Logistic regression was used to analyze the data, odds ratio (OR) and confidence intervals (CI) are reported. Result: The incidence of LBW was 28.3%. It is significantly associated with poverty [OR 2.1; 95% CI: 1.42, 3.05], maternal Mid Upper Arm Circumference (MUAC) less than 23 cm [OR 1.6; 95% CI: 1.19, 2.19], not attending ANC [OR 1.6; 95% CI: 1.12, 2.28], mother's experience of physical violence during pregnancy [OR 1.7; 95% CI: 1.12, 2.48], and longer time to walk to health facility [OR 1.6; 95% CI: 1.11, 2.40]. Conclusion and Recommendation: The incidence of LBW was high in Kersa. Babies born to women who were poor, undernourished, experienced physical violence during pregnancy and who had poor access to health services were more likely to be LBW in this part of the country. In this largely poor community where ANC coverage is low, to reduce the incidence of LBW, it is essential to improve access for maternal health care. The involvement of husbands and the community at large to seek collective action on LBW is essential.	[Assefa, Nega] Haramaya Univ, Coll Hlth Sci, Harar, Ethiopia; [Berhane, Yemane; Worku, Alemayehu] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia; [Worku, Alemayehu] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia	Haramaya University; Addis Continental Institute of Public Health; Addis Ababa University	Assefa, N (corresponding author), Haramaya Univ, Coll Hlth Sci, Harar, Ethiopia.	negaassefa@yahoo.com	Berhane, Yemane/ABB-8154-2020	Assefa, Nega/0000-0003-0341-2329; Berhane, Yemane/0000-0002-2527-1339	Haramaya University, Ethiopia	Haramaya University, Ethiopia	This work was funded by Haramaya University, Ethiopia, as part of Ph.D work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arokiasamy P, 2010, HLTH POLICY PLANNING, P1; Asefa M, 2004, ETHIOP J HLTH SCI, V14, P13; Assefa N, 2011, PREGNANCY R IN PRESS; Badshah S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-197; Basso O, 2000, INT J EPIDEMIOL, V29, P856, DOI 10.1093/ije/29.5.856; Dey AC, 2007, BANGLADISH J CHILD H, V31, P1; Dubois L, 2006, PEDIATR INT, V48, P470, DOI 10.1111/j.1442-200X.2006.02256.x; Enquoselassie F., 2000, Ethiopian Journal of Health Development, V14, P169; EpiDataAss, 2010, EPIDATA STAT APPL; Ethiopia CSA, 2006, DEM HLTH SURV 2005; Feresu SA, 2004, PAEDIATR PERINAT EP, V18, P154, DOI 10.1111/j.1365-3016.2003.00539.x; FMOH, 2007, HLTH EXT PROGR ETH P; FMOH, 2007, HLTH HLTH REL IND; Gelman A, 2007, STAT SCI, V22, P153, DOI 10.1214/088342306000000691; Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2; Janjua ZN, 2008, DETEMINATS LOW BIRTH; Kersa DHO, 2011, HLTH SERVICE COVERAG; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Leal M, 2006, PARENTAL CHILDBIRTH, P40; Lemons JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.1.e1; Macro O, 2002, UTILIZATION MATERNAL; Mbuagbaw LCE, 2011, MATERN CHILD HLTH J, V15, P1427, DOI 10.1007/s10995-010-0707-3; Mohanty C, 2006, J TROP PEDIATRICS, V52, P24, DOI 10.1093/tropej/fmi059; Mohanty C, 2005, MATERNAL ANTHROPOMET; Moss William, 2002, J Perinatol, V22, P484; Neeti R, 2011, ASIA PAC J PUBLIC HL; Nobile CGA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-192; OHLSSON A, 2008, DETERMINANTS PREVENT; PETHYBRIDGE RJ, 1974, BRIT J PREV SOC MED, V28, P10; Ricalde AE, 1998, REV SAUDE PUBL, V32, P112, DOI 10.1590/S0034-89101998000200002; Rosen D, 2007, J INTERPERS VIOLENCE, V22, P1305, DOI 10.1177/0886260507304551; Sarkar NN, 2008, J OBSTET GYNAECOL, V28, P266, DOI 10.1080/01443610802042415; Sellstrom E, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-267; Sen J, 2010, J TROP PEDIATRICS, V56, P254, DOI 10.1093/tropej/fmp102; Shah PS, 2011, MATERN CHILD HLTH J, V15, P205, DOI 10.1007/s10995-009-0546-2; StataCorp, 2009, STAT STAT SOFTW REL; Tuniseranee P, 1999, WHO J EPIDEMIOLOGY C, V53, P624; Vahdaninia M, 2008, BMC PREGNANCY CHILDB, V8; Vyas S, 2006, CONSTRUCTING SOCIOEC; World Health Organization, 2005, RES VIOLENCE WOMEN P	41	78	78	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39957	10.1371/journal.pone.0039957	http://dx.doi.org/10.1371/journal.pone.0039957			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22792140	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100154
J	Hees, HL; Nieuwenhuijsen, K; Koeter, MWJ; Bultmann, U; Schene, AH				Hees, Hiske L.; Nieuwenhuijsen, Karen; Koeter, Maarten W. J.; Bultmann, Ute; Schene, Aart H.			Towards a New Definition of Return-to-Work Outcomes in Common Mental Disorders from a Multi-Stakeholder Perspective	PLOS ONE			English	Article							TERM SICKNESS ABSENCE; RANDOMIZED CONTROLLED-TRIAL; DISABILITY; DEPRESSION; EMPLOYEES; INTERVENTIONS; PREVENTION; MANAGEMENT; THERAPY; DESIGN	Objectives: To examine the perspectives of key stakeholders involved in the return-to-work (RTW) process regarding the definition of successful RTW outcome after sickness absence related to common mental disorders (CMD's). Methods: A mixed-method design was used: First, we used qualitative methods (focus groups, interviews) to identify a broad range of criteria important for the definition of successful RTW (N = 57). Criteria were grouped into content-related clusters. Second, we used a quantitative approach (online questionnaire) to identify, among a larger stakeholder sample (N = 178), the clusters and criteria most important for successful RTW. Results: A total of 11 clusters, consisting of 52 unique criteria, were identified. In defining successful RTW, supervisors and occupational physicians regarded "Sustainability'' and "At-work functioning" most important, while employees regarded "Sustainability," "Job satisfaction," "Work-home balance,'' and " Mental Functioning" most important. Despite agreement on the importance of certain criteria, considerable differences among stakeholders were observed. Conclusions: Key stakeholders vary in the aspects and criteria they regard as important when defining successful RTW after CMD-related sickness absence. Current definitions of RTW outcomes used in scientific research may not accurately reflect these key stakeholder perspectives. Future studies should be more aware of the perspective from which they aim to evaluate the effectiveness of a RTW intervention, and define their RTW outcomes accordingly.	[Hees, Hiske L.; Koeter, Maarten W. J.; Schene, Aart H.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Program Mood Disorders, NL-1105 AZ Amsterdam, Netherlands; [Nieuwenhuijsen, Karen] Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, NL-1105 AZ Amsterdam, Netherlands; [Bultmann, Ute] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Med, Groningen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen	Hees, HL (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Program Mood Disorders, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	H.L.Hees@amc.uva.nl	Schene, A.H./H-8085-2014	Schene, A.H./0000-0002-1756-3235; Bultmann, Ute/0000-0001-9589-9220	Netherlands Foundation for Mental Health (Fonds Psychische Gezondheid) [20035713]; National Institute for Employee Benefit Schemes (UWV) [5002002]	Netherlands Foundation for Mental Health (Fonds Psychische Gezondheid); National Institute for Employee Benefit Schemes (UWV)	This study was financially supported by the Netherlands Foundation for Mental Health (Fonds Psychische Gezondheid; grant no. 20035713) and the National Institute for Employee Benefit Schemes (UWV; grant no. 5002002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman B. M., 2001, HDB DISABILITY STUDI, P97, DOI DOI 10.4135/9781412976251.N4; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arends I, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-132; Blonk RWB, 2006, WORK STRESS, V20, P129, DOI 10.1080/02678370600856615; de Vries G, 2012, J AFFECT DISORDERS, V136, P1017, DOI 10.1016/j.jad.2011.06.035; Franche RL, 2005, J OCCUP REHABIL, V15, P525, DOI 10.1007/s10926-005-8032-1; Gupta M, 2003, J EVAL CLIN PRACT, V9, P111, DOI 10.1046/j.1365-2753.2003.00382.x; Hees HL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-558; Henderson M, 2005, BMJ-BRIT MED J, V330, P802, DOI 10.1136/bmj.330.7495.802; JOHNSON R. B., 2004, EDUC RESEARCHER, V33, P14, DOI 10.3102/0013189X033007014; Josephson M, 2008, SCAND J WORK ENV HEA, V34, P430, DOI 10.5271/sjweh.1289; Koopmans PC, 2011, INT ARCH OCC ENV HEA, V84, P193, DOI 10.1007/s00420-010-0540-4; Lander F, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-372; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; Loisel P, 2001, DIS MANAG HEALTH OUT, V9, P351, DOI 10.2165/00115677-200109070-00001; Lysaght RM, 2008, WORK, V30, P255; Moffitt TE, 2010, PSYCHOL MED, V40, P899, DOI 10.1017/S0033291709991036; Mykletun A, 2006, AM J PSYCHIAT, V163, P1412, DOI 10.1176/appi.ajp.163.8.1412; Nieuwenhuijsen K, 2004, OCCUP ENVIRON MED, V61, P817, DOI 10.1136/oem.2003.009688; Noordik E, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-140; Post M, 2005, DISABIL REHABIL, V27, P481, DOI 10.1080/09638280400018601; Pransky G, 2005, J OCCUP REHABIL, V15, P453, DOI 10.1007/s10926-005-8027-y; Rauscher L, 2009, PHYS THER, V89, P91, DOI 10.2522/ptj.20070236; Rebergen DS, 2009, J OCCUP ENVIRON MED, V51, P305, DOI 10.1097/JOM.0b013e3181990d32; Schene AH, 2007, PSYCHOL MED, V37, P351, DOI 10.1017/S0033291706009366; Schoenbaum M, 2002, HEALTH SERV RES, V37, P1145, DOI 10.1111/1475-6773.01086; Stewart WF, 2003, JAMA-J AM MED ASSOC, V289, P3135, DOI 10.1001/jama.289.23.3135; Tjulin A, 2010, J OCCUP REHABIL, V20, P311, DOI 10.1007/s10926-009-9209-9; van der Klink JJL, 2003, OCCUP ENVIRON MED, V60, P429, DOI 10.1136/oem.60.6.429; Wang PS, 2007, JAMA-J AM MED ASSOC, V298, P1401, DOI 10.1001/jama.298.12.1401; Westmorland Muriel G, 2002, Work, V18, P29; Young AE, 2005, J OCCUP REHABIL, V15, P543, DOI 10.1007/s10926-005-8033-0	32	37	39	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39947	10.1371/journal.pone.0039947	http://dx.doi.org/10.1371/journal.pone.0039947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768180	gold, Green Submitted, Green Published			2022-12-27	WOS:000305892100150
J	Hosoi, T; Korematsu, K; Horie, N; Suezawa, T; Okuma, Y; Nomura, Y; Ozawa, K				Hosoi, Toru; Korematsu, Kenta; Horie, Naohiro; Suezawa, Takahiro; Okuma, Yasunobu; Nomura, Yasuyuki; Ozawa, Koichiro			Inhibition of Casein Kinase 2 Modulates XBP1-GRP78 Arm of Unfolded Protein Responses in Cultured Glial Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER STRESS; TRANSCRIPTION FACTOR; CANCER-THERAPY; MESSENGER-RNA; CK2; XBP-1; TRANSLATION; ACTIVATION; EXPRESSION	Stress signals cause abnormal proteins to accumulate in the endoplasmic reticulum (ER). Such stress is known as ER stress, which has been suggested to be involved in neurodegenerative diseases, diabetes, obesity and cancer. ER stress activates the unfolded protein response (UPR) to reduce levels of abnormal proteins by inducing the production of chaperon proteins such as GRP78, and to attenuate translation through the phosphorylation of eIF2 alpha. However, excessive stress leads to apoptosis by generating transcription factors such as CHOP. Casein kinase 2 (CK2) is a serine/threonine kinase involved in regulating neoplasia, cell survival and viral infections. In the present study, we investigated a possible linkage between CK2 and ER stress using mouse primary cultured glial cells. 4,5,6,7-tetrabromobenzotriazole (TBB), a CK2-specific inhibitor, attenuated ER stress-induced XBP-1 splicing and subsequent induction of GRP78 expression, but was ineffective against ER stress-induced eIF2 alpha phosphorylation and CHOP expression. Similar results were obtained when endogenous CK2 expression was knocked-down by siRNA. Immunohistochemical analysis suggested that CK2 was present at the ER. These results indicate CK2 to be linked with UPR and to resist ER stress by activating the XBP-1-GRP78 arm of UPR.	[Hosoi, Toru; Korematsu, Kenta; Suezawa, Takahiro; Ozawa, Koichiro] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmacotherapy, Hiroshima, Japan; [Horie, Naohiro] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sapporo, Hokkaido, Japan; [Okuma, Yasunobu] Chiba Inst Sci, Fac Pharmaceut Sci, Dept Pharmacol, Choshi, Chiba, Japan; [Nomura, Yasuyuki] Yokohama Coll Pharm, Dept Pharmacotherapeut, Yokohama, Kanagawa, Japan	Hiroshima University; Hokkaido University	Hosoi, T (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmacotherapy, Hiroshima, Japan.	toruh@hiroshima-u.ac.jp; ozawak@hiroshima-u.ac.jp	Hosoi, Toru/A-7954-2018	Hosoi, Toru/0000-0003-4831-487X	Ministry of Education, Culture, Sports, Science, and Technology, Japan [23790088]; Takeda Science Foundation; Tokyo Biochemical Research Foundation; Suzuken Memorial Foundation; Nakajima Foundation	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Tokyo Biochemical Research Foundation; Suzuken Memorial Foundation; Nakajima Foundation	This research was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (23790088); Takeda Science Foundation; Tokyo Biochemical Research Foundation; Suzuken Memorial Foundation; and The Nakajima Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KA, 2005, ANTI-CANCER DRUG, V16, P1037, DOI 10.1097/00001813-200511000-00001; Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; Blaydes JP, 1998, ONCOGENE, V17, P1045, DOI 10.1038/sj.onc.1202014; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CHAUHAN A, 1993, BRAIN RES, V629, P47, DOI 10.1016/0006-8993(93)90479-7; Faust M, 2001, MOL CELL BIOCHEM, V227, P73, DOI 10.1023/A:1013129410551; Gerber DA, 2000, J BIOL CHEM, V275, P23919, DOI 10.1074/jbc.M002697200; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hosoi T, 2000, BIOCHEM BIOPH RES CO, V273, P312, DOI 10.1006/bbrc.2000.2937; Hosoi T, 2008, MOL PHARMACOL, V74, P1610, DOI 10.1124/mol.108.050070; Hosoi T, 2007, BRAIN RES, V1152, P27, DOI 10.1016/j.brainres.2007.03.052; Hosoi T, 2010, J PHARMACOL SCI, V114, P230, DOI 10.1254/jphs.10082SC; Hosoi T, 2010, BRIT J PHARMACOL, V159, P428, DOI 10.1111/j.1476-5381.2009.00544.x; Hosoi T, 2010, CLIN SCI, V118, P19, DOI 10.1042/CS20080680; Hosoi T, 2009, NEUROCHEM INT, V54, P1, DOI 10.1016/j.neuint.2008.09.017; IIMOTO DS, 1990, BRAIN RES, V507, P273, DOI 10.1016/0006-8993(90)90282-G; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee J, 2011, NAT MED, V17, P1251, DOI 10.1038/nm.2449; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Sayed M, 2000, J BIOL CHEM, V275, P16569, DOI 10.1074/jbc.M000312200; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Trembley JH, 2010, BIOFACTORS, V36, P187, DOI 10.1002/biof.96; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	34	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40144	10.1371/journal.pone.0040144	http://dx.doi.org/10.1371/journal.pone.0040144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768244	gold, Green Published			2022-12-27	WOS:000305892100217
J	Ibrahim, F; Dosoo, D; Kronmann, KC; Ouedraogo, I; Anyorigiya, T; Abdul, H; Sodiomon, S; Owusu-Agyei, S; Koram, K				Ibrahim, Faisal; Dosoo, David; Kronmann, Karl C.; Ouedraogo, Issa; Anyorigiya, Thomas; Abdul, Haruna; Sodiomon, Sirima; Owusu-Agyei, Seth; Koram, Kwadwo			Good Clinical Laboratory Practices Improved Proficiency Testing Performance at Clinical Trials Centers in Ghana and Burkina Faso	PLOS ONE			English	Article							QUALITY	Background: The recent drive towards accreditation of clinical laboratories in Africa by the World Health Organization Regional Office for Africa (WHO-AFRO) and the U. S Government is a historic step to strengthen health systems, provide better results for patients and an improved quality of results for clinical trials. Enrollment in approved proficiency testing (PT) programs and maintenance of satisfactory performance is vital in the process of accreditation. Passing proficiency testing surveys has posed a great challenge to many laboratories across sub-Saharan Africa. Our study was aimed at identifying the causes of unsatisfactory PT results in clinical research laboratories conducting or planning to conduct malaria vaccine trials sponsored by the National Institutes of Health (NIH). Methodology: PT reports for 2009 and 2010 from the College of American Pathologists (CAP) for the laboratories were reviewed as part of the process. Errors accounting for unsatisfactory results were classified into clerical, methodological, technical, problem with PT materials, and random errors. A training program on good clinical laboratory practices (GCLP) was developed for each center to address areas for improvement. Results: The major cause of PT failure in the four centers was methodological. The application of GCLP improved the success rate in the PT surveys from 58% in 2009 to 88% in 2010. It also decreased the error rate on PT by 35%. Conclusion: A previous report from the CAP-PT participating laboratories indicated that the major causes of error were clerical. These types of errors were predominantly made in laboratories in the US, with much more experience in quality control, and varied significantly from what we found. In our centers in sub-Saharan Africa, methodological errors, and not clerical errors, accounted for the vast majority of errors. A process was started for continuous improvement which has decreased methodological errors by 35%, but more improvement is needed.	[Ibrahim, Faisal; Kronmann, Karl C.] US Naval Med Res Unit 3 Ghana Detachment, Accra, Ghana; [Dosoo, David; Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Kintampo, Ghana; [Ouedraogo, Issa; Sodiomon, Sirima] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Anyorigiya, Thomas] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Abdul, Haruna; Koram, Kwadwo] Noguchi Mem Inst Med Res, Legon, Ghana	Kintampo Health Research Centre; Navrongo Health Research Center; University of Ghana	Ibrahim, F (corresponding author), US Naval Med Res Unit 3 Ghana Detachment, Accra, Ghana.	faisali40@hotmail.com		Kronmann, Karl/0000-0003-1783-7061; Owusu-Agyei, Seth/0000-0002-0807-1781	United States National Institutes of Health	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the United States National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal SK, 2004, AAPS PHARMSCITECH, V5; Clinical and Laboratory Standards Institute (CLSI), 2007, GP26A3 CLSI; CLSI, 2007, CLSI DOCUMENT GP27 A, V2nd; CLSI, 2006, C24A3 CLSI, V3rd; College of American Pathologists, 2010, CHEM TOX CHECKL; College of American Pathologists, 2011, RES INT APPL; College of American Pathologists, 2010, HEM COAG CHECKL; Crucitti T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013592; Ezzelle J, 2008, J PHARMACEUT BIOMED, V46, P18, DOI 10.1016/j.jpba.2007.10.010; Gershy-Damet GM, 2010, AM J CLIN PATHOL, V134, P393, DOI 10.1309/AJCPTUUC2V1WJQBM; Harrison C, 2007, GETTING MOST OUT YOU; Laboratory General Checklist, 2010, LAB GEN CHECKL; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Polage CR, 2006, AM J TROP MED HYG, V75, P526, DOI 10.4269/ajtmh.2006.75.526; Sciacovelli L, 2010, BIOCHEM MEDICA, V20, P160; Simon J, 2000, BRIT MED J, V321, P816; Sitti-amorn C, 2000, BRIT MED J, V321; Stevens W, 2003, Qual Assur, V10, P83; Wertheim HFL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000231	19	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39098	10.1371/journal.pone.0039098	http://dx.doi.org/10.1371/journal.pone.0039098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768062	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000305892100032
J	Jia, KZ; Zhang, YP; Li, Y				Jia, Kaizhi; Zhang, Yanping; Li, Yin			Identification and Characterization of Two Functionally Unknown Genes Involved in Butanol Tolerance of Clostridium acetobutylicum	PLOS ONE			English	Article							PROTEIN-KINASE-C; INCREASED SOLVENT PRODUCTION; TRANSCRIPTIONAL ANALYSIS; ESCHERICHIA-COLI; ATCC 824; DSM 1731; ALCOHOLS; MOTILITY; STRAIN; OVEREXPRESSION	Solvents toxicity is a major limiting factor hampering the cost-effective biotechnological production of chemicals. In Clostridium acetobutylicum, a functionally unknown protein (encoded by SMB_G1518) with a hypothetical alcohol interacting domain was identified. Disruption of SMB_G1518 and/or its downstream gene SMB_G1519 resulted in increased butanol tolerance, while overexpression of SMB_G1518-1519 decreased butanol tolerance. In addition, SMB_G1518-1519 also influences the production of pyruvate: ferredoxin oxidoreductase (PFOR) and flagellar protein hag, the maintenance of cell motility. We conclude that the system of SMB_G1518-1519 protein plays a role in the butanol sensitivity/tolerance phenotype of C. acetobutylicum, and can be considered as potential targets for engineering alcohol tolerance.	[Jia, Kaizhi; Zhang, Yanping; Li, Yin] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS	Jia, KZ (corresponding author), Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China.	yli@im.ac.cn	Zhang, Yanping/C-7114-2009; Li, Yin/C-6644-2009	Li, Yin/0000-0003-0995-3070	National Science Foundation of China [31000024]; National Basic Research Program of China (973 Project) [2011CBA00807]; Chinese Academy of Sciences	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Project)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Science Foundation of China (31000024), National Basic Research Program of China (973 Project, 2011CBA00807), and Hundreds Talents Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaker KV, 2004, J BACTERIOL, V186, P1959, DOI 10.1128/JB.186.7.1959-1971.2004; Bao GH, 2011, J BACTERIOL, V193, P5007, DOI 10.1128/JB.05596-11; Borden JR, 2007, APPL ENVIRON MICROB, V73, P3061, DOI 10.1128/AEM.02296-06; Bouhouche N, 2000, TRENDS MICROBIOL, V8, P77, DOI 10.1016/S0966-842X(99)01679-0; BOWLES LK, 1985, APPL ENVIRON MICROB, V50, P1165, DOI 10.1128/AEM.50.5.1165-1170.1985; Butler MT, 2010, P NATL ACAD SCI USA, V107, P3776, DOI 10.1073/pnas.0910934107; Das J, 2006, PROTEIN SCI, V15, P2107, DOI 10.1110/ps.062237606; Dong HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009038; Ezeji TC, 2005, BIOPROC BIOSYST ENG, V27, P207, DOI 10.1007/s00449-005-0403-7; Ezeji T, 2010, APPL MICROBIOL BIOT, V85, P1697, DOI 10.1007/s00253-009-2390-0; Ezeji TC, 2007, CURR OPIN BIOTECH, V18, P220, DOI 10.1016/j.copbio.2007.04.002; Faulds-Pain A, 2011, J BACTERIOL, V193, P2695, DOI 10.1128/JB.01172-10; FRANKS NP, 1982, NATURE, V300, P487, DOI 10.1038/300487a0; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; INGRAM LO, 1986, TRENDS BIOTECHNOL, V4, P40, DOI 10.1016/0167-7799(86)90152-6; Isken S, 1998, EXTREMOPHILES, V2, P229, DOI 10.1007/s007920050065; Jia KZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016693; Jia KZ, 2010, ENG LIFE SCI, V10, P422, DOI 10.1002/elsc.201000076; Lai S, 2009, ENVIRON MICROBIOL, V11, P126, DOI 10.1111/j.1462-2920.2008.01747.x; Lee SY, 2008, BIOTECHNOL BIOENG, V101, P209, DOI 10.1002/bit.22003; LIN YL, 1983, APPL ENVIRON MICROB, V45, P966, DOI 10.1128/AEM.45.3.966-973.1983; Mao SM, 2010, J PROTEOME RES, V9, P3046, DOI 10.1021/pr9012078; Mendez M, 2008, J BACTERIOL, V190, P48, DOI 10.1128/JB.01407-07; MERMELSTEIN LD, 1992, BIO-TECHNOL, V10, P190, DOI 10.1038/nbt0292-190; Nicolaou SA, 2010, METAB ENG, V12, P307, DOI 10.1016/j.ymben.2010.03.004; Ricci JCD, 2000, CRIT REV BIOTECHNOL, V20, P79, DOI 10.1080/07388550008984167; RICHARDS CD, 1978, NATURE, V276, P775, DOI 10.1038/276775a0; Sengupta S, 2008, NUCLEIC ACIDS RES, V36, P4310, DOI 10.1093/nar/gkn355; Shi Z, 2008, APPL ENVIRON MICROB, V74, P7709, DOI 10.1128/AEM.01948-08; Slater SJ, 1997, J BIOL CHEM, V272, P6167, DOI 10.1074/jbc.272.10.6167; SLATER SJ, 1993, NATURE, V364, P82, DOI 10.1038/364082a0; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Tang Y, 2004, MOL MICROBIOL, V51, P1817, DOI 10.1111/j.1365-2958.2003.03954.x; Tomas CA, 2004, J BACTERIOL, V186, P2006, DOI 10.1128/JB.186.7.2006-2018.2004; Tomas CA, 2003, APPL ENVIRON MICROB, V69, P4951, DOI 10.1128/AEM.69.8.4951-4965.2003; Wong J, 1996, CURR MICROBIOL, V32, P349, DOI 10.1007/s002849900062; Yakhnin H, 2007, MOL MICROBIOL, V64, P1605, DOI 10.1111/j.1365-2958.2007.05765.x; Zhao YS, 2003, APPL ENVIRON MICROB, V69, P2831, DOI 10.1128/AEM.69.5.2831-2841.2003	38	24	26	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38815	10.1371/journal.pone.0038815	http://dx.doi.org/10.1371/journal.pone.0038815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768047	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100018
J	Koga, H; Tsedensodnom, O; Tomimaru, Y; Walker, EJ; Lee, HC; Kim, KM; Yano, H; Wands, JR; Kim, M				Koga, Hironori; Tsedensodnom, Orkhontuya; Tomimaru, Yoshito; Walker, Evan J.; Lee, Han Chu; Kim, Kang Mo; Yano, Hirohisa; Wands, Jack R.; Kim, Miran			Loss of the SxxSS Motif in a Human T-Cell Factor-4 Isoform Confers Hypoxia Resistance to Liver Cancer: An Oncogenic Switch in Wnt Signaling	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; BETA-CATENIN; COLORECTAL-CANCER; INDUCIBLE FACTORS; TUMOR HYPOXIA; GROWTH-FACTOR; C-MYC; IDENTIFICATION; TRANSCRIPTION; ACTIVATION	Purpose: Aberrantly activated Wnt/beta-catenin signaling is important in hepatocellular carcinoma (HCC) development. Downstream gene expressions involving the Wnt/b-catenin cascade occur through T-cell factor (TCF) proteins. Here, we show the oncogenic potential of human TCF-4 isoforms based on the expression of a single conserved SxxSS motif. Methods: We investigated the TCF-4J and K isoform pair characterized by the presence (K) or absence (J) of the SxxSS motif. The mRNA expression profiles were examined in 47 pairs of human HCCs and adjacent non-cancerous liver tissues by RT-PCR. Proliferation, sphere assays and immunoblot analysis were performed under normoxia and hypoxia conditions. The ability of HCC cells overexpressing TCF-4J (J cells) and K (K cells) to grow as solid tumors in nude mice was explored. Results: TCF-4J expression was significantly upregulated in HCC tumors compared to corresponding peritumor and normal liver and was preferentially expressed in poorly differentiated HCCs. In contrast, TCF-4K was downregulated in those same HCC tumors. TCF-4J-overexpressing HCC cells (J cells) revealed a survival advantage under hypoxic conditions, high proliferation rate and formation of aggregates/spheres compared to overexpression of TCF-4K (K cells). The hypoxic J cells had high expression levels of HIF-2 alpha and EGFR as possible mechanisms to promote tumorigenesis. Increased stability of HIF-2 alpha under hypoxia in J cells was associated with a decreased level of von Hippel-Lindau (VHL) protein, a known E3 ligase for HIF-alpha s. In a xenograft model, the J cells rapidly developed tumors compared to K cells. Tumor tissues derived from J cells exhibited high expression levels of HIF-2 alpha and EGFR compared to the slow developing and small K cell derived tumors. Conclusions: Our results suggest that the specific TCF-4J isoform, which lacks a regulatory SxxSS motif, has robust tumor-initiating potential under hypoxic conditions.	[Koga, Hironori; Tsedensodnom, Orkhontuya; Tomimaru, Yoshito; Walker, Evan J.; Wands, Jack R.; Kim, Miran] Rhode Isl Hosp, Liver Res Ctr, Providence, RI 02903 USA; [Koga, Hironori; Tsedensodnom, Orkhontuya; Tomimaru, Yoshito; Walker, Evan J.; Wands, Jack R.; Kim, Miran] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Lee, Han Chu; Kim, Kang Mo] Univ Ulsan, Coll Med, Dept Internal Med, Asan Med Ctr, Seoul, South Korea; [Yano, Hirohisa] Kurume Univ, Dept Pathol, Kurume, Fukuoka 830, Japan	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; University of Ulsan; Kurume University	Koga, H (corresponding author), Rhode Isl Hosp, Liver Res Ctr, Providence, RI 02903 USA.	Miran_Kim@brown.edu		Walker, Evan/0000-0002-3081-190X	National Institutes of Health [CA-123544]; NATIONAL CANCER INSTITUTE [R01CA123544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (CA-123544 to JRW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengochea A, 2008, BRIT J CANCER, V99, P143, DOI 10.1038/sj.bjc.6604422; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Choi H, 2010, CANCER RES, V70, P10101, DOI 10.1158/0008-5472.CAN-10-0505; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Deng Y, 2010, J CANCER RES CLIN, V136, P1161, DOI 10.1007/s00432-010-0763-5; Duval A, 2000, CANCER RES, V60, P3872; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Franovic A, 2007, P NATL ACAD SCI USA, V104, P13092, DOI 10.1073/pnas.0702387104; Franovic A, 2009, P NATL ACAD SCI USA, V106, P21306, DOI 10.1073/pnas.0906432106; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HE L, 1984, IN VITRO CELL DEV B, V20, P493, DOI 10.1007/BF02619623; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hecht A, 2003, J BIOL CHEM, V278, P3776, DOI 10.1074/jbc.M210081200; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kim M, 2008, J HEPATOL, V48, P780, DOI 10.1016/j.jhep.2007.12.020; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kojiro M, 2004, INTERVIROLOGY, V47, P179, DOI 10.1159/000078470; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liebner S, 2004, J CELL BIOL, V166, P359, DOI 10.1083/jcb.200403050; Maeyama M, 2008, CANCER, V113, P2823, DOI 10.1002/cncr.23900; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Merle P, 2004, GASTROENTEROLOGY, V127, P1110, DOI 10.1053/j.gastro.2004.07.009; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nakamura K, 2007, HUM PATHOL, V38, P1532, DOI 10.1016/j.humpath.2007.03.002; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Pukrop T, 2001, J BIOL CHEM, V276, P8968, DOI 10.1074/jbc.M007533200; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tsedensodnom O, 2011, EXP CELL RES, V317, P920, DOI 10.1016/j.yexcr.2011.01.015; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Weise A, 2010, NUCLEIC ACIDS RES, V38, P1964, DOI 10.1093/nar/gkp1197; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang XR, 2008, CLIN CANCER RES, V14, P3850, DOI 10.1158/1078-0432.CCR-07-4338; YANO H, 1993, HEPATOLOGY, V18, P320, DOI 10.1016/0270-9139(93)90015-F; Ying Y, 2009, EPIGENETICS-US, V4, P307, DOI 10.4161/epi.4.5.9371; Yoneda N, 2011, LAB INVEST, V91, P262, DOI 10.1038/labinvest.2010.161	45	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39981	10.1371/journal.pone.0039981	http://dx.doi.org/10.1371/journal.pone.0039981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768190	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100162
J	Kuhns, M; Zautner, AE; Rabsch, W; Zimmermann, O; Weig, M; Bader, O; Gross, U				Kuhns, Martin; Zautner, Andreas E.; Rabsch, Wolfgang; Zimmermann, Ortrud; Weig, Michael; Bader, Oliver; Gross, Uwe			Rapid Discrimination of Salmonella enterica Serovar Typhi from Other Serovars by MALDI-TOF Mass Spectrometry	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; BLOOD-STREAM INFECTIONS; BACTEREMIA; FEVER; IDENTIFICATION; EPIDEMIOLOGY; RESISTANCE; CHILDREN; KENYA; ADMISSIONS	Systemic infections caused by Salmonella enterica are an ongoing public health problem especially in Sub-Saharan Africa. Essentially typhoid fever is associated with high mortality particularly because of the increasing prevalence of multidrug-resistant strains. Thus, a rapid blood-culture based bacterial species diagnosis including an immediate sub-differentiation of the various serovars is mandatory. At present, MALDI-TOF based intact cell mass spectrometry (ICMS) advances to a widely used routine identification tool for bacteria and fungi. In this study, we investigated the appropriateness of ICMS to identify pathogenic bacteria derived from Sub-Saharan Africa and tested the potential of this technology to discriminate S. enterica subsp. enterica serovar Typhi (S. Typhi) from other serovars. Among blood culture isolates obtained from a study population suffering from febrile illness in Ghana, no major misidentifications were observed for the species identification process, but serovars of Salmonella enterica could not be distinguished using the commercially available Biotyper database. However, a detailed analysis of the mass spectra revealed several serovar-specific biomarker ions, allowing the discrimination of S. Typhi from others. In conclusion, ICMS is able to identify isolates from a sub-Saharan context and may facilitate the rapid discrimination of the clinically and epidemiologically important serovar S. Typhi and other non-S. Typhi serovars in future implementations.	[Kuhns, Martin; Zautner, Andreas E.; Zimmermann, Ortrud; Weig, Michael; Bader, Oliver; Gross, Uwe] Univ Med Ctr Gottingen, Inst Med Microbiol, Gottingen, Germany; [Kuhns, Martin; Zautner, Andreas E.; Zimmermann, Ortrud; Weig, Michael; Bader, Oliver; Gross, Uwe] Univ Med Ctr Gottingen, Int Hlth Network Gottingen, Gottingen, Germany; [Rabsch, Wolfgang] Robert Koch Inst, German Natl Reference Ctr Salmonella & Enter Path, Wernigerode, Germany	University of Gottingen; University of Gottingen; Robert Koch Institute	Kuhns, M (corresponding author), Univ Med Ctr Gottingen, Inst Med Microbiol, Gottingen, Germany.	obader@medizin.uni-goettingen.de	Zautner, Andreas Erich/AAE-7425-2019; Bader, Oliver/C-7650-2015; Zautner, Andreas Erich/ABA-9655-2020	Zautner, Andreas Erich/0000-0003-0984-013X; Bader, Oliver/0000-0002-1534-440X; Zautner, Andreas Erich/0000-0003-0984-013X	German Research Foundation; University of Gottingen Publication Foundation	German Research Foundation(German Research Foundation (DFG)); University of Gottingen Publication Foundation	Publication costs were covered by the open-access support program of the German Research Foundation and the University of Gottingen Publication Foundation.	Akinyemi KO, 2005, PUBLIC HEALTH, V119, P321, DOI 10.1016/j.puhe.2004.04.009; Archibald LK, 2003, J INFECT DIS, V188, P202, DOI 10.1086/376507; Bader O, 2011, CLIN MICROBIOL INFEC, V17, P1359, DOI 10.1111/j.1469-0691.2010.03398.x; Bahwere P, 2001, Int J Infect Dis, V5, P180, DOI 10.1016/S1201-9712(01)90067-0; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Browne NK, 2010, J APPL MICROBIOL, V108, P1828, DOI 10.1111/j.1365-2672.2009.04588.x; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; Conway GC, 2001, J MOL MICROB BIOTECH, V3, P103; Cooke VM, 1999, APPL ENVIRON MICROB, V65, P807; Dieckmann R, 2008, APPL ENVIRON MICROB, V74, P7767, DOI 10.1128/AEM.01402-08; Dieckmann R, 2011, APPL ENVIRON MICROB, V77, P4136, DOI 10.1128/AEM.02418-10; English M, 2003, B WORLD HEALTH ORGAN, V81, P166; Gordon MA, 2001, J INFECTION, V42, P44, DOI 10.1053/jinf.2000.0779; Gross U, 2011, EMERG INFECT DIS, V17, P1879, DOI [10.3201/edi1710.110327, 10.3201/eid1710.110327]; Guibourdenche M, 2010, RES MICROBIOL, V161, P26, DOI 10.1016/j.resmic.2009.10.002; Kariuki S, 2010, J CLIN MICROBIOL, V48, P2171, DOI 10.1128/JCM.01983-09; Kodaka H, 2000, J FOOD PROTECT, V63, P1643, DOI 10.4315/0362-028X-63.12.1643; Kothari A, 2008, J INFECT DEV COUNTR, V2, P253; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Marks F, 2010, EMERG INFECT DIS, V16, P1796, DOI 10.3201/eid1611.100388; Mengo DM, 2010, J INFECT DEV COUNTR, V4, P393, DOI 10.3855/jidc.503; Perkins BA, 1997, B WORLD HEALTH ORGAN, V75, P33; Peters RPH, 2004, TROP MED INT HEALTH, V9, P928, DOI 10.1111/j.1365-3156.2004.01288.x; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Pien BC, 2010, AM J MED, V123, P819, DOI 10.1016/j.amjmed.2010.03.021; Rabsch W, 2011, SALMONELLA: FROM GENOME TO FUNCTION, P25; Rabsch Wolfgang, 2007, V394, P177, DOI 10.1007/978-1-59745-512-1_10; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Shears P, 2001, T ROY SOC TROP MED H, V95, P127, DOI 10.1016/S0035-9203(01)90134-8; Sparbier K, 2012, EUR J CLIN MICROBIOL, V31, P767, DOI 10.1007/s10096-011-1373-0; Tran VTN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-125; Wain J, 2008, J INFECT DEV COUNTR, V2, P421, DOI 10.3855/jidc.164; Weinstein MP, 1997, CLIN INFECT DIS, V24, P584, DOI 10.1093/clind/24.4.584; Zaki SA, 2011, J INFECT DEV COUNTR, V5, P324, DOI 10.3855/jidc.1405	35	66	70	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40004	10.1371/journal.pone.0040004	http://dx.doi.org/10.1371/journal.pone.0040004			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768195	Green Published, gold			2022-12-27	WOS:000305892100167
J	Menezes, SP; dos Santos, JL; Cardoso, THS; Pirovani, CP; Micheli, F; Noronha, FSM; Alves, AC; Faria, AMC; Gesteira, AD				Menezes, Sara Pereira; dos Santos, Jane Lima; Santana Cardoso, Thyago Hermylly; Pirovani, Carlos Priminho; Micheli, Fabienne; Motta Noronha, Fatima Soares; Alves, Andrea Catao; Caetano Faria, Ana Maria; Gesteira, Abelmon da Silva			Evaluation of the Allergenicity Potential of TcPR-10 Protein from Theobroma cacao	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEIN; MAJOR CHERRY ALLERGEN; BET V 1; MUTATIONAL EPITOPE ANALYSIS; SITE-DIRECTED MUTAGENESIS; PLANT FOOD ALLERGENS; CROSS-REACTIVITY; BIRCH POLLEN; PRU AV-1; MOLECULAR-CLONING	Background: The pathogenesis related protein PR10 (TcPR-10), obtained from the Theobroma cacao-Moniliophthora perniciosa interaction library, presents antifungal activity against M. perniciosa and acts in vitro as a ribonuclease. However, despite its biotechnological potential, the TcPR-10 has the P-loop motif similar to those of some allergenic proteins such as Bet v 1 (Betula verrucosa) and Pru av 1 (Prunus avium). The insertion of mutations in this motif can produce proteins with reduced allergenic power. The objective of the present work was to evaluate the allergenic potential of the wild type and mutant recombinant TcPR-10 using bioinformatics tools and immunological assays. Methodology/Principal Findings: Mutant substitutions (T10P, I30V, H45S) were inserted in the TcPR-10 gene by site-directed mutagenesis, cloned into pET28a and expressed in Escherichia coli BL21(DE3) cells. Changes in molecular surface caused by the mutant substitutions was evaluated by comparative protein modeling using the three-dimensional structure of the major cherry allergen, Pru av 1 as a template. The immunological assays were carried out in 8-12 week old female BALB/c mice. The mice were sensitized with the proteins (wild type and mutants) via subcutaneous and challenged intranasal for induction of allergic airway inflammation. Conclusions/Significance: We showed that the wild TcPR-10 protein has allergenic potential, whereas the insertion of mutations produced proteins with reduced capacity of IgE production and cellular infiltration in the lungs. On the other hand, in vitro assays show that the TcPR-10 mutants still present antifungal and ribonuclease activity against M. perniciosa RNA. In conclusion, the mutant proteins present less allergenic potential than the wild TcPR-10, without the loss of interesting biotechnological properties.	[Menezes, Sara Pereira; Santana Cardoso, Thyago Hermylly; Pirovani, Carlos Priminho; Micheli, Fabienne] Univ Estadual Santa Cruz, Ctr Biotecnol & Genet, Ilheus, BA, Brazil; [dos Santos, Jane Lima] Univ Estadual Santa Cruz, Ctr Microscopia Eletron, Ilheus, BA, Brazil; [Micheli, Fabienne] CIRAD, UMAR AGAP, Montpellier, France; [Motta Noronha, Fatima Soares; Alves, Andrea Catao; Caetano Faria, Ana Maria] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Gesteira, Abelmon da Silva] Embrapa Mandioca & Fruticultura, Cruz Das Almas, BA, Brazil	Universidade Estadual de Santa Cruz; Universidade Estadual de Santa Cruz; CIRAD; Universidade Federal de Minas Gerais; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Menezes, SP (corresponding author), Univ Estadual Santa Cruz, Ctr Biotecnol & Genet, Ilheus, BA, Brazil.	Abelmon.Gesteira@embrapa.br	Pirovani, Carlos Priminho/N-1153-2019; Faria, Ana Maria/AAK-8688-2021; Micheli, Fabienne/AAL-9895-2021; Pirovani, Carlos P/J-3426-2017; da Silva Gesteira, Abelmon/I-2136-2013	Pirovani, Carlos Priminho/0000-0002-6176-4069; Pirovani, Carlos P/0000-0002-6176-4069; da Silva Gesteira, Abelmon/0000-0002-7590-0455; Micheli, Fabienne/0000-0002-9031-362X; Faria, Ana Maria/0000-0002-0604-8510	Research Support Foundation of the State of Bahia (FAPESB); FAPESB; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [471849/2004-9]	Research Support Foundation of the State of Bahia (FAPESB); FAPESB(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work of SPM was supported by the Research Support Foundation of the State of Bahia (FAPESB). This research was supported by FAPESB and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - 471849/2004-9, http://www.cnpq.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2001, EV ALL GEN MOD FOODS; Asensio T, 2004, J ALLERGY CLIN IMMUN, V114, P896, DOI 10.1016/j.jaci.2004.06.014; AYRES M, 2005, BIOESTAT APLICACOES; Bahramnejad B, 2010, PLANT CELL REP, V29, P1235, DOI 10.1007/s00299-010-0909-6; Bantignies B, 2000, PLANT MOL BIOL, V42, P871, DOI 10.1023/A:1006475303115; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breiteneder H, 2000, J ALLERGY CLIN IMMUN, V106, P27, DOI 10.1067/mai.2000.106929; Breiteneder H, 2005, BIOTECHNOL ADV, V23, P395, DOI 10.1016/j.biotechadv.2005.05.004; Chapman HD, 2000, WORLD POULTRY SCI J, V56, P7, DOI 10.1079/WPS20000002; Chapman JA, 2006, ANN ALLERG ASTHMA IM, V96, pS1, DOI 10.1016/S1081-1206(10)60926-X; Cressman RF, 2009, REGUL TOXICOL PHARM, V54, pS20, DOI 10.1016/j.yrtph.2008.11.006; Dearman RJ, 2003, FOOD CHEM TOXICOL, V41, P1509, DOI 10.1016/S0278-6915(03)00167-4; Ebner C, 2001, ALLERGY, V56, P43, DOI 10.1034/j.1398-9995.2001.00913.x; Fernandes H, 2009, FEBS J, V276, P1596, DOI 10.1111/j.1742-4658.2009.06892.x; Ferreira F, 1998, FASEB J, V12, P231, DOI 10.1096/fasebj.12.2.231; Filho DF, 2006, CURR MICROBIOL, V52, P407, DOI 10.1007/s00284-005-0405-3; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Gallo M, 2009, CURR OPIN BIOTECH, V20, P191, DOI 10.1016/j.copbio.2009.03.005; Gesteira AS, 2007, ANN BOT-LONDON, V100, P129, DOI 10.1093/aob/mcm092; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hoffmann-Sommergruber K, 2002, BIOCHEM SOC T, V30, P930, DOI 10.1042/BST0300930; Ivanciuc O, 2003, NUCLEIC ACIDS RES, V31, P359, DOI 10.1093/nar/gkg010; Ivanciuc O, 2002, BIOINFORMATICS, V18, P1358, DOI 10.1093/bioinformatics/18.10.1358; Ivanciuc O, 2009, MOL IMMUNOL, V46, P559, DOI 10.1016/j.molimm.2008.07.034; Ivanciuc O, 2009, REGUL TOXICOL PHARM, V54, pS11, DOI 10.1016/j.yrtph.2008.11.007; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Lebel S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-184; Liu JJ, 2005, PLANTA, V221, P159, DOI 10.1007/s00425-004-1428-x; Ma Y, 2006, INT ARCH ALLERGY IMM, V139, P53, DOI 10.1159/000089756; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Midoro-Horiuti T, 2001, ANN ALLERG ASTHMA IM, V87, P261, DOI 10.1016/S1081-1206(10)62238-7; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Motulsky H.J., 2003, PRISM 4 STAT GUIDE S; Neudecker P, 2000, J BIOMOL NMR, V18, P71, DOI 10.1023/A:1008357100592; Neudecker P, 2003, BIOCHEM J, V376, P97, DOI 10.1042/BJ20031057; Neudecker P, 2001, J BIOL CHEM, V276, P22756, DOI 10.1074/jbc.M101657200; Peters S, 2011, TRANSGENIC RES, V20, P547, DOI 10.1007/s11248-010-9435-0; Puehringer HM, 2003, GENE, V321, P173, DOI 10.1016/S0378-1119(03)00822-9; Schenk MF, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-168; Scheurer S, 1999, MOL IMMUNOL, V36, P155, DOI 10.1016/S0161-5890(99)00033-4; Selgrade MK, 2009, TOXICOL SCI, V110, P31, DOI 10.1093/toxsci/kfp075; Silvanovich A, 2009, REGUL TOXICOL PHARM, V54, pS26, DOI 10.1016/j.yrtph.2009.02.004; Son DY, 1999, EUR J NUTR, V38, P201, DOI 10.1007/s003940050063; Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084; SWOBODA I, 1995, PLANT CELL ENVIRON, V18, P865, DOI 10.1111/j.1365-3040.1995.tb00595.x; Thomas K, 2008, FOOD CHEM TOXICOL, V46, P3219, DOI 10.1016/j.fct.2008.06.078; Thomas WR, 2011, J ALLERGY CLIN IMMUN, V127, P855, DOI 10.1016/j.jaci.2010.12.1084; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Montagu M, 2011, ANNU REV PLANT BIOL, V62, P1, DOI 10.1146/annurev-arplant-042110-103906; Veluthakkal R, 2010, TREES-STRUCT FUNCT, V24, P993, DOI 10.1007/s00468-010-0489-7; Venkatarajan MS, 2001, J MOL MODEL, V7, P445, DOI 10.1007/s00894-001-0058-5; Walter MH, 1996, EUR J BIOCHEM, V239, P281, DOI 10.1111/j.1432-1033.1996.0281u.x; Wangorsch A, 2007, MOL IMMUNOL, V44, P2518, DOI 10.1016/j.molimm.2006.12.023; Wiche R, 2005, BIOCHEM J, V385, P319, DOI 10.1042/BJ20040842; Xie YR, 2010, J PLANT PHYSIOL, V167, P121, DOI 10.1016/j.jplph.2009.07.004; Zubini P, 2009, PLANT PHYSIOL, V150, P1235, DOI 10.1104/pp.109.139543	63	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e37969	10.1371/journal.pone.0037969	http://dx.doi.org/10.1371/journal.pone.0037969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768037	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100008
J	Perot, G; Croce, S; Ribeiro, A; Lagarde, P; Velasco, V; Neuville, A; Coindre, JM; Stoeckle, E; Floquet, A; MacGrogan, G; Chibon, F				Perot, Gaelle; Croce, Sabrina; Ribeiro, Agnes; Lagarde, Pauline; Velasco, Valerie; Neuville, Agnes; Coindre, Jean-Michel; Stoeckle, Eberhard; Floquet, Anne; MacGrogan, Gaetan; Chibon, Frederic			MED12 Alterations in Both Human Benign and Malignant Uterine Soft Tissue Tumors	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; X-CHROMOSOME INACTIVATION; BETA-CATENIN EXPRESSION; BROAD LIGAMENT; CLONAL ORIGINS; LEIOMYOSARCOMA; LEIOMYOMA; ABERRATIONS; NEOPLASMS; MEDIATOR	The relationship between benign uterine leiomyomas and their malignant counterparts, i.e. leiomyosarcomas and smooth muscle tumors of uncertain malignant potential (STUMP), is still poorly understood. The idea that a leiomyosarcoma could derive from a leiomyoma is still controversial. Recently MED12 mutations have been reported in uterine leiomyomas. In this study we asked whether such mutations could also be involved in leiomyosarcomas and STUMP oncogenesis. For this purpose we examined 33 uterine mesenchymal tumors by sequencing the hot-spot mutation region of MED12. We determined that MED12 is altered in 66.6% of typical leiomyomas as previously reported but also in 11% of STUMP and 20% of leiomyosarcomas. The mutated allele is predominantly expressed in leiomyomas and STUMP. Interestingly all classical leiomyomas exhibit MED12 protein expression while 40% of atypical leiomyomas, 50% of STUMP and 80% of leiomyosarcomas (among them the two mutated ones) do not express MED12. All these tumors without protein expression exhibit complex genomic profiles. No mutations and no expression loss were identified in an additional series of 38 non-uterine leiomyosarcomas. MED12 mutations are not exclusive to leiomyomas but seem to be specific to uterine malignancies. A previous study has suggested that MED12 mutations in leiomyomas could lead to Wnt/beta-catenin pathway activation however our immunohistochemistry results show that there is no association between MED12 status and beta-catenin nuclear/cytoplasmic localization. Collectively, our results show that subgroups of benign and malignant tumors share a common genetics. We propose here that MED12 alterations could be implicated in the development of smooth muscle tumor and that its expression could be inhibited in malignant tumors.	[Perot, Gaelle; Lagarde, Pauline; Coindre, Jean-Michel; MacGrogan, Gaetan; Chibon, Frederic] Inst Bergonie, Inst Canc, INSERM U916, Bordeaux, France; [Croce, Sabrina; Ribeiro, Agnes; Velasco, Valerie; Neuville, Agnes; Coindre, Jean-Michel; MacGrogan, Gaetan; Chibon, Frederic] Inst Bergonie, Inst Canc, Dept Pathol, Bordeaux, France; [Ribeiro, Agnes; Velasco, Valerie; Chibon, Frederic] Inst Bergonie, Inst Canc, Dept Mol Pathol, Bordeaux, France; [Coindre, Jean-Michel] Univ Victor Segalen, Bordeaux, France; [Stoeckle, Eberhard] Inst Bergonie, Inst Canc, Dept Surg, Bordeaux, France; [Floquet, Anne] Inst Bergonie, Inst Canc, Dept Med Oncol, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; UNICANCER; Institut Bergonie; UNICANCER; Institut Bergonie; UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; UNICANCER; Institut Bergonie	Perot, G (corresponding author), Inst Bergonie, Inst Canc, INSERM U916, Bordeaux, France.	f.chibon@bordeaux.unicancer.fr	Pérot, Gaëlle/W-8038-2019; chibon, frederic/A-2651-2013; Pérot, Gaëlle/J-3912-2014	chibon, Frederic/0000-0002-6548-2181; MacGrogan, Gaetan/0000-0002-3483-9758	Institut National Du Cancer (INCa); La Ligue Nationale Contre le Cancer; Institut Bergonie	Institut National Du Cancer (INCa)(Institut National du Cancer (INCA) France); La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Institut Bergonie	Institut National Du Cancer (INCa): http://www.e-cancer.fr/; La Ligue Nationale Contre le Cancer: http://www.ligue-cancer.net/; and Institut Bergonie:http://www.bergonie.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL SW, 1994, AM J SURG PATHOL, V18, P535, DOI 10.1097/00000478-199406000-00001; Canevari RA, 2005, AM J OBSTET GYNECOL, V193, P1395, DOI 10.1016/j.ajog.2005.02.097; Chibon F, 2010, NAT MED, V16, P781, DOI 10.1038/nm.2174; Cho YL, 2005, GYNECOL ONCOL, V99, P545, DOI 10.1016/j.ygyno.2005.07.017; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; D'Angelo E, 2011, GYNECOL ONCOL, V121, P328, DOI 10.1016/j.ygyno.2011.01.022; Doring B, 2006, J CELL SCI, V119, P1715, DOI 10.1242/jcs.02892; Fletcher CDM, 2002, WHO CLASSIFICATION T; HAN KJ, 1994, CANCER GENET CYTOGEN, V74, P19, DOI 10.1016/0165-4608(94)90023-X; HART WR, 1978, CANCER, V41, P1902, DOI 10.1002/1097-0142(197805)41:5<1902::AID-CNCR2820410535>3.0.CO;2-K; HASHIMOTO K, 1995, GYNECOL OBSTET INVES, V40, P204, DOI 10.1159/000292336; HERBOLD DR, 1983, AM J SURG PATHOL, V7, P285, DOI 10.1097/00000478-198304000-00007; Hodge JC, 2007, HUM MOL GENET, V16, pR7, DOI 10.1093/hmg/ddm043; Hostetter G, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp881; Je EM, 2012, INT J CANCER, V131, pE1044, DOI 10.1002/ijc.27610; Jung CK, 2008, MODERN PATHOL, V21, P756, DOI 10.1038/modpathol.2008.53; Kildal W, 2009, EUR J CANCER, V45, P2412, DOI 10.1016/j.ejca.2009.06.017; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Kir G, 2003, EUR J GYNAECOL ONCOL, V24, P505; Lagarde P, 2012, CLIN CANCER RES, V18, P826, DOI 10.1158/1078-0432.CCR-11-1610; LEIBSOHN S, 1990, AM J OBSTET GYNECOL, V162, P968, DOI 10.1016/0002-9378(90)91298-Q; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; LOWELL DM, 1968, OBSTET GYNECOL, V32, P107; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Markowski DN, 2012, INT J CANCER, V131, P1528, DOI 10.1002/ijc.27424; MASHAL RD, 1994, GENE CHROMOSOME CANC, V11, P1, DOI 10.1002/gcc.2870110102; McGuire MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033251; Mittal K, 2000, HUM PATHOL, V31, P398, DOI 10.1016/S0046-8177(00)80258-0; Mittal K, 2007, GYNECOL ONCOL, V104, P362, DOI 10.1016/j.ygyno.2006.08.034; Mittal KR, 2009, MODERN PATHOL, V22, P1303, DOI 10.1038/modpathol.2009.96; Morey C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002212; Ng TL, 2005, MODERN PATHOL, V18, P68, DOI 10.1038/modpathol.3800272; Okolo S, 2008, BEST PRACT RES CL OB, V22, P571, DOI 10.1016/j.bpobgyn.2008.04.002; Oliva E., 2009, GYNECOLOGIC PATHOLOG, V1st; Pelmus M, 2009, INT J GYNECOL CANCER, V19, P385, DOI 10.1111/IGC.0b013e3181a1bfbc; Qiao QL, 2001, INT J CANCER, V95, P194, DOI 10.1002/1097-0215(20010520)95:3<194::AID-IJC1033>3.3.CO;2-D; Robboy SJ, 2000, ENVIRON HEALTH PERSP, V108, P779, DOI 10.2307/3454306; Rocha PP, 2010, DEVELOPMENT, V137, P2723, DOI 10.1242/dev.053660; Salas S, 2010, GENE CHROMOSOME CANC, V49, P560, DOI 10.1002/gcc.20766; SCURRY J, 1990, GYNECOL ONCOL, V39, P381, DOI 10.1016/0090-8258(90)90271-L; Szymanska J, 1997, CANCER GENET CYTOGEN, V99, P14, DOI 10.1016/S0165-4608(96)00436-0; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tavassoli F, 2003, WHO CLASSIFICATION T, V5, P223; Uchida M, 2010, J PATHOL, V221, P96, DOI 10.1002/path.2686; Yanai H, 2010, PATHOL INT, V60, P506, DOI 10.1111/j.1440-1827.2010.02549.x; Zavadil J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012362; Zhang P, 2006, HUM PATHOL, V37, P1350, DOI 10.1016/j.humpath.2006.05.005	48	100	103	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40015	10.1371/journal.pone.0040015	http://dx.doi.org/10.1371/journal.pone.0040015			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768200	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100172
J	Reinders, AATS; Willemsen, ATM; Vos, HPJ; den Boer, JA; Nijenhuis, ERS				Reinders, A. A. T. Simone; Willemsen, Antoon T. M.; Vos, Herry P. J.; den Boer, Johan A.; Nijenhuis, Ellert R. S.			Fact or Factitious? A Psychobiological Study of Authentic and Simulated Dissociative Identity States	PLOS ONE			English	Article							ANIMAL DEFENSIVE REACTIONS; FANTASY PRONENESS; MULTIPLE PERSONALITY; COGNITIVE-PROCESSES; SOMATOFORM DISSOCIATION; SOCIOCOGNITIVE MODEL; DISORDER; PERSISTENCE; TRAUMA; BRAIN	Background: Dissociative identity disorder (DID) is a disputed psychiatric disorder. Research findings and clinical observations suggest that DID involves an authentic mental disorder related to factors such as traumatization and disrupted attachment. A competing view indicates that DID is due to fantasy proneness, suggestibility, suggestion, and role-playing. Here we examine whether dissociative identity state-dependent psychobiological features in DID can be induced in high or low fantasy prone individuals by instructed and motivated role-playing, and suggestion. Methodology/Principal Findings: DID patients, high fantasy prone and low fantasy prone controls were studied in two different types of identity states (neutral and trauma-related) in an autobiographical memory script-driven (neutral or trauma-related) imagery paradigm. The controls were instructed to enact the two DID identity states. Twenty-nine subjects participated in the study: 11 patients with DID, 10 high fantasy prone DID simulating controls, and 8 low fantasy prone DID simulating controls. Autonomic and subjective reactions were obtained. Differences in psychophysiological and neural activation patterns were found between the DID patients and both high and low fantasy prone controls. That is, the identity states in DID were not convincingly enacted by DID simulating controls. Thus, important differences regarding regional cerebral bloodflow and psychophysiological responses for different types of identity states in patients with DID were upheld after controlling for DID simulation. Conclusions/Significance: The findings are at odds with the idea that differences among different types of dissociative identity states in DID can be explained by high fantasy proneness, motivated role-enactment, and suggestion. They indicate that DID does not have a sociocultural (e. g., iatrogenic) origin.	[Reinders, A. A. T. Simone] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London WC2R 2LS, England; [Reinders, A. A. T. Simone] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Reinders, A. A. T. Simone] Univ Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands; [Willemsen, Antoon T. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands; [den Boer, Johan A.] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat, Groningen, Netherlands; [Nijenhuis, Ellert R. S.] Top Referent Trauma Ctr Mental Hlth Care Drenthe, Assen, Netherlands	University of London; King's College London; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Reinders, AATS (corresponding author), Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London WC2R 2LS, England.	a.a.t.s.reinders@gmail.com		Nijenhuis, Ellert/0000-0003-4710-474X	Netherlands Organization for Scientific Research, NWO-VENI [451-07-009]	Netherlands Organization for Scientific Research, NWO-VENI(Netherlands Organization for Scientific Research (NWO))	AATSR is supported by the Netherlands Organization for Scientific Research (www.nwo.nl), NWO-VENI grant no. 451-07-009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Armony JL, 1997, ANN NY ACAD SCI, V821, P259, DOI 10.1111/j.1749-6632.1997.tb48285.x; Association AP DSM- IV APATF, 2000, DIAGN STAT MAN MENT; Braffman W, 1999, J PERS SOC PSYCHOL, V77, P578, DOI 10.1037/0022-3514.77.3.578; Bremner JD, 2010, PSYCHOL BULL, V136, P1, DOI 10.1037/a0018021; Brett M., 2006, MNI BRAIN TALAIRACH; Brown D., 1998, MEMORY TRAUMA TREATM; Brown D, 1999, J PSYCHIAT LAW, V27, P549, DOI DOI 10.1177/009318539902700308; Camm AJ, 1996, EUR HEART J, V17, P354; Casada JH, 1998, BIOL PSYCHIAT, V44, P1037, DOI 10.1016/S0006-3223(98)00182-6; Coons PM, 2005, CAN J PSYCHIAT, V50, P813, DOI 10.1177/070674370505001217; Draijer N, 1999, J PSYCHIAT L, V27, P423; Driver J, 2001, COGNITION, V79, P39, DOI 10.1016/S0010-0277(00)00124-4; Elzinga BM, 2003, J ABNORM PSYCHOL, V112, P237, DOI 10.1037/0021-843X.112.2.237; Elzinga BM, 1998, CLIN PSYCHOL PSYCHOT, V5, P13, DOI 10.1002/(SICI)1099-0879(199803)5:1<13::AID-CPP148>3.0.CO;2-J; Friston KJ, 1997, TRENDS COGN SCI, V1, P21, DOI 10.1016/S1364-6613(97)01001-2; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Friston KJ, 1996, NEUROIMAGE, V4, P97, DOI 10.1006/nimg.1996.0033; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Giesbrecht T, 2008, E COMMUNICATION 0211; Giesbrecht T, 2008, PSYCHOL BULL, V134, P617, DOI 10.1037/0033-2909.134.5.617; Giesbrecht T, 2007, J NERV MENT DIS, V195, P812, DOI 10.1097/NMD.0b013e3181568137; Giesbrecht T, 2006, PERS INDIV DIFFER, V41, P697, DOI 10.1016/j.paid.2006.02.015; Giesbrecht T, 2010, PSYCHOL BULL, V136, P7, DOI 10.1037/a0018068; Gleaves DH, 1996, PSYCHOL BULL, V120, P42, DOI 10.1037/0033-2909.120.1.42; Goebel R, 2011, BRAIN INNOVATION HOM; Haaksma J, 1994, HEART RATE DEPENDENT, P45; Hamilton JP, 2008, BIOL PSYCHIAT, V63, P1155, DOI 10.1016/j.biopsych.2007.12.015; Huntjens RJC, 2007, BEHAV RES THER, V45, P775, DOI 10.1016/j.brat.2006.07.001; Huntjens RJC, 2006, PSYCHOL MED, V36, P857, DOI 10.1017/S0033291706007100; Huntjens RJC, 2005, CONSCIOUS COGN, V14, P377, DOI 10.1016/j.concog.2004.10.001; Huntjens RJC, 2005, BEHAV RES THER, V43, P243, DOI 10.1016/j.brat.2004.01.007; Huntjens RJC, 2003, J ABNORM PSYCHOL, V112, P290, DOI 10.1037/0021-843X.112.2.290; Huntjens RJC, 2002, MEM COGNITION, V30, P1033, DOI 10.3758/BF03194321; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lanius RA, 2004, AM J PSYCHIAT, V161, P36, DOI 10.1176/appi.ajp.161.1.36; Lanius RA, 2010, AM J PSYCHIAT, V167, P640, DOI 10.1176/appi.ajp.2009.09081168; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Levin R, 2004, ASSESSMENT, V11, P160, DOI 10.1177/1073191103256377; Lilienfeld SO, 1999, PSYCHOL BULL, V125, P507, DOI 10.1037/0033-2909.125.5.507; Loewenstein RJ., 2007, TRAUMATIC DISSOCIATI, P275; Mai J.K., 1997, ATLAS HUMAN BRAIN; Merckelbach H, 2000, J NERV MENT DIS, V188, P428, DOI 10.1097/00005053-200007000-00006; Merckelbach H, 2006, PERS INDIV DIFFER, V40, P365, DOI 10.1016/j.paid.2005.07.007; Merckelbach H, 2001, PERS INDIV DIFFER, V31, P987, DOI 10.1016/S0191-8869(00)00201-4; Merckelbach H, 2002, CLIN PSYCHOL REV, V22, P481, DOI 10.1016/S0272-7358(01)00115-5; Merckelbach H, 2001, BEHAV RES THER, V39, P245, DOI 10.1016/S0005-7967(99)00181-3; Merskey H, 2009, REMOVING DID MPD DSM; Nijenhuis ERS, 2011, DISSOCIATION AND THE DISSOCIATIVE DISORDERS: DSM-V AND BEYOND, P337; Nijenhuis ERS, 2011, J TRAUMA DISSOCIATIO, V12, P416, DOI 10.1080/15299732.2011.570592; Nijenhuis ERS, 1998, J TRAUMA STRESS, V11, P243, DOI 10.1023/A:1024447003022; Nijenhuis ERS, 1996, J NERV MENT DIS, V184, P688, DOI 10.1097/00005053-199611000-00006; Nijenhuis ERS, 1998, J ABNORM PSYCHOL, V107, P63, DOI 10.1037/0021-843X.107.1.63; Nijenhuis ERS, 2004, AUST NZ J PSYCHIAT, V38, P678, DOI 10.1080/j.1440-1614.2004.01441.x; Nijenhuis ERS, 2002, CLIN PSYCHOL PSYCHOT, V9, P200, DOI 10.1002/cpp.332; Nijenhuis ERS, 1997, ACTA PSYCHIAT SCAND, V96, P311, DOI 10.1111/j.1600-0447.1997.tb09922.x; O'Neil, 2009, DISSOCIATION DISSOCI; Pavani F, 2003, TRENDS COGN SCI, V7, P407, DOI 10.1016/S1364-6613(03)00189-X; Piper A, 2005, CAN J PSYCHIAT, V50, P814, DOI 10.1177/070674370505001220; Piper A, 2004, CAN J PSYCHIAT, V49, P678, DOI 10.1177/070674370404901005; Piper A, 2004, CAN J PSYCHIAT, V49, P592, DOI 10.1177/070674370404900904; Pope HG, 2006, PSYCHOTHER PSYCHOSOM, V75, P19, DOI 10.1159/000089223; Poulsen B. C., 2003, CONT HYPNOSIS, V20, P198, DOI DOI 10.1002/CH.278; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Price CJ, 1997, HUM BRAIN MAPP, V5, P264, DOI 10.1002/(SICI)1097-0193(1997)5:4<264::AID-HBM11>3.0.CO;2-E; PUTNAM FW, 1992, BRIT J PSYCHIAT, V161, P415, DOI 10.1192/bjp.161.3.415b; Rassin E, 2001, J NERV MENT DIS, V189, P478, DOI 10.1097/00005053-200107000-00010; RAUSCHENBERGER SL, 1995, J ABNORM PSYCHOL, V104, P373, DOI 10.1037/0021-843X.104.2.373; Reinders AATS, 2008, NEUROCASE, V14, P44, DOI 10.1080/13554790801992768; Reinders AATS, 2006, BIOL PSYCHIAT, V60, P730, DOI 10.1016/j.biopsych.2005.12.019; Reinders AATS, 2005, EUR J NEUROSCI, V22, P524, DOI 10.1111/j.1460-9568.2005.04212.x; Reinders AATS, 2003, NEUROIMAGE, V20, P2119, DOI 10.1016/j.neuroimage.2003.08.021; Reinders AATS, 2002, NEUROIMAGE, V17, P1844, DOI 10.1006/nimg.2002.1318; Sar V, 2001, J TRAUMA DISSOCIATIO, V1, P67, DOI DOI 10.1300/J229v01n04_04; Sar V, 2005, CAN J PSYCHIAT, V50, P813, DOI 10.1177/070674370505001218; Schwabe L, 2008, NEUROBIOL LEARN MEM, V90, P495, DOI 10.1016/j.nlm.2008.07.015; SILVA CE, 1992, J PERS SOC PSYCHOL, V63, P847, DOI 10.1037/0022-3514.63.5.847; Simeon D, 2000, AM J PSYCHIAT, V157, P1782, DOI 10.1176/appi.ajp.157.11.1782; Spanos N.P., 1996, MULTIPLE IDENTITIES; SPANOS NP, 1994, PSYCHOL BULL, V116, P143, DOI 10.1037/0033-2909.116.1.143; Spiegel D, 2006, AM J PSYCHIAT, V163, P566, DOI 10.1176/appi.ajp.163.4.566; SPIEGEL D, 1984, PSYCHIAT CLIN N AM, V7, P101; Steinberg M, 1993, STRUCTURED CLIN INTE; Talairach J., 1988, COPLANAR STEREOTAXIC; van der Hart O, 2006, HAUNTED SELF STRUCTU; White NM, 2009, BEHAV BRAIN RES, V199, P3, DOI 10.1016/j.bbr.2008.12.003; Xiao ZP, 2006, AM J PSYCHIAT, V163, P1388, DOI 10.1176/appi.ajp.163.8.1388; [No title captured]	91	54	54	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39279	10.1371/journal.pone.0039279	http://dx.doi.org/10.1371/journal.pone.0039279			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768068	Green Published, gold			2022-12-27	WOS:000305892100039
J	Sawitzky, M; Zeissler, A; Langhammer, M; Bielohuby, M; Stock, P; Hammon, HM; Gors, S; Metges, CC; Stoehr, BJM; Bidlingmaier, M; Fromm-Dornieden, C; Baumgartner, BG; Christ, B; Brenig, B; Binder, G; Metzger, F; Renne, U; Hoeflich, A				Sawitzky, Mandy; Zeissler, Anja; Langhammer, Martina; Bielohuby, Maximilian; Stock, Peggy; Hammon, Harald M.; Goers, Solvig; Metges, Cornelia C.; Stoehr, Barbara J. M.; Bidlingmaier, Martin; Fromm-Dornieden, Carolin; Baumgartner, Bernhard G.; Christ, Bruno; Brenig, Bertram; Binder, Gerhard; Metzger, Friedrich; Renne, Ulla; Hoeflich, Andreas			Phenotype Selection Reveals Coevolution of Muscle Glycogen and Protein and PTEN as a Gate Keeper for the Accretion of Muscle Mass in Adult Female Mice	PLOS ONE			English	Article							LONG-TERM SELECTION; BREAST-CANCER CELLS; GROWTH FACTOR-I; STRAIN FZT-DU; KINASE-B; SYNTHASE KINASE-3; IGF-II; MYOTUBE HYPERTROPHY; SKELETAL; AKT	We have investigated molecular mechanisms for muscle mass accretion in a non-inbred mouse model (DU6P mice) characterized by extreme muscle mass. This extreme muscle mass was developed during 138 generations of phenotype selection for high protein content. Due to the repeated trait selection a complex setting of different mechanisms was expected to be enriched during the selection experiment. In muscle from 29-week female DU6P mice we have identified robust increases of protein kinase B activation (AKT, Ser-473, up to 2-fold) if compared to 11- and 54-week DU6P mice or controls. While a number of accepted effectors of AKT activation, including IGF-I, IGF-II, insulin/IGF-receptor, myostatin or integrin-linked kinase (ILK), were not correlated with this increase, phosphatase and tensin homologue deleted on chromosome 10 (PTEN) was down-regulated in 29-week female DU6P mice. In addition, higher levels of PTEN phosphorylation were found identifying a second mechanism of PTEN inhibition. Inhibition of PTEN and activation of AKT correlated with specific activation of p70S6 kinase and ribosomal protein S6, reduced phosphorylation of eukaryotic initiation factor 2 alpha (eIF2 alpha) and higher rates of protein synthesis in 29-week female DU6P mice. On the other hand, AKT activation also translated into specific inactivation of glycogen synthase kinase 3 beta (GSK3 beta) and an increase of muscular glycogen. In muscles from 29-week female DU6P mice a significant increase of protein/DNA was identified, which was not due to a reduction of protein breakdown or to specific increases of translation initiation. Instead our data support the conclusion that a higher rate of protein translation is contributing to the higher muscle mass in mid-aged female DU6P mice. Our results further reveal coevolution of high protein and high glycogen content during the selection experiment and identify PTEN as gate keeper for muscle mass in mid-aged female DU6P mice.	[Sawitzky, Mandy; Zeissler, Anja; Langhammer, Martina; Renne, Ulla; Hoeflich, Andreas] Leibniz Inst Farm Anim Biol FBN, Lab Mouse Genet Res Unit Genet & Biometry, Dummerstorf, Germany; [Bielohuby, Maximilian; Stoehr, Barbara J. M.; Bidlingmaier, Martin] Univ Munich, Endocrine Res Unit, Med Klin, Munich, Germany; [Bielohuby, Maximilian; Stoehr, Barbara J. M.; Bidlingmaier, Martin] Univ Munich, Poliklin 4, Munich, Germany; [Stock, Peggy; Christ, Bruno] Univ Halle Wittenberg, ZAMED, Halle, Germany; [Hammon, Harald M.; Goers, Solvig; Metges, Cornelia C.] Leibniz Inst Farm Anim Biol FBN, Res Unit Nutr Physiol, Dummerstorf, Germany; [Fromm-Dornieden, Carolin; Baumgartner, Bernhard G.; Brenig, Bertram] Inst Vet Med, Gottingen, Germany; [Binder, Gerhard] Univ Childrens Hosp, Tubingen, Germany; [Metzger, Friedrich] F Hoffmann La Roche Ltd, CNS Discovery Res, Basel, Switzerland	Forschungsinstitut fur Nutztierbiologie (FBN); University of Munich; University of Munich; Martin Luther University Halle Wittenberg; Forschungsinstitut fur Nutztierbiologie (FBN); Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; Roche Holding	Sawitzky, M (corresponding author), Leibniz Inst Farm Anim Biol FBN, Lab Mouse Genet Res Unit Genet & Biometry, Dummerstorf, Germany.	hoeflich@fbn-dummerstorf.de	Hammon, Harald/AAD-9990-2020; Bielohuby, Maximilian/A-2304-2015	Bielohuby, Maximilian/0000-0002-9859-8156; Christ, Bruno/0000-0001-8213-9548; Brenig, Bertram/0000-0002-7635-9656; Hoeflich, Andreas/0000-0003-2018-2836; Bidlingmaier, Martin/0000-0002-4681-6668; Stock, Peggy/0000-0002-9208-8411	H. Wilhelm Schaumann Foundation; Eli Lilly Foundation; German Research Council (DFG)	H. Wilhelm Schaumann Foundation; Eli Lilly Foundation(Eli Lilly); German Research Council (DFG)(German Research Foundation (DFG))	This work was supported by grants from the H. Wilhelm Schaumann Foundation, Eli Lilly Foundation, and by the German Research Council (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Bielohuby M, 2009, ENDOCRINOLOGY, V150, P1269, DOI 10.1210/en.2008-1055; Binder G, 2006, J CLIN ENDOCR METAB, V91, P4709, DOI 10.1210/jc.2006-1127; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Boppart MD, 2011, BBA-MOL BASIS DIS, V1812, P439, DOI 10.1016/j.bbadis.2011.01.002; Bunger L, 1998, GENET RES, V72, P93, DOI 10.1017/S0016672398003401; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cassano M, 2009, J MUSCLE RES CELL M, V30, P243, DOI 10.1007/s10974-010-9204-y; Cid VJ, 2008, ONCOGENE, V27, P5431, DOI 10.1038/onc.2008.240; Cleasby ME, 2007, MOL ENDOCRINOL, V21, P215, DOI 10.1210/me.2006-0154; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Dietl G, 2004, ARCH TIERZUCHT, V47, P595, DOI 10.5194/aab-47-595-2004; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Gardner S, 2011, MOL ENDOCRINOL, V25, P128, DOI 10.1210/me.2010-0292; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Hamilton DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011624; Hoeflich A, 2002, FEBS LETT, V523, P63, DOI 10.1016/S0014-5793(02)02935-6; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jeon JT, 1999, NAT GENET, V21, P157, DOI 10.1038/5938; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Kimball SR, 1999, INT J BIOCHEM CELL B, V31, P25, DOI 10.1016/S1357-2725(98)00128-9; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Kromer JO, 2005, ANAL BIOCHEM, V340, P171, DOI 10.1016/j.ab.2005.01.027; Kuhla B, 2010, PROTEOMICS, V10, P2573, DOI 10.1002/pmic.200900789; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Liao Y, 2010, AM J TRANSL RES, V2, P19; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MATHEWS LS, 1988, ENDOCRINOLOGY, V123, P433, DOI 10.1210/endo-123-1-433; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mendez R, 1996, FASEB J, V10, P1378; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Morissette MR, 2009, AM J PHYSIOL-CELL PH, V297, pC1124, DOI 10.1152/ajpcell.00043.2009; Morris DR, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-215; Motti ML, 2005, AM J PATHOL, V166, P737, DOI 10.1016/S0002-9440(10)62295-X; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Parent R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r19; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Perks CM, 2007, ONCOGENE, V26, P5966, DOI 10.1038/sj.onc.1210397; REHFELDT C, 1990, ARCH TIERZUCHT, V33, P507; Renne U, 2003, J EXP ANIM SCI, V42, P218, DOI 10.1016/S0939-8600(03)80004-4; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rotwein P, 2009, J CELL PHYSIOL, V219, P503, DOI 10.1002/jcp.21692; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SCHULER L, 1985, ARCH TIERZUCHT, V28, P357; Spangenburg EE, 2008, J PHYSIOL-LONDON, V586, P283, DOI 10.1113/jphysiol.2007.141507; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Troussard AA, 2006, CANCER RES, V66, P393, DOI 10.1158/0008-5472.CAN-05-2304; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wan XL, 2003, ONCOGENE, V22, P8205, DOI 10.1038/sj.onc.1206878; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Wang XJ, 2008, BIOCHEM J, V414, P221, DOI 10.1042/BJ20080674; WELSH GI, 1993, BIOCHEM J, V294, P625, DOI 10.1042/bj2940625; Wilson EM, 2007, J BIOL CHEM, V282, P5106, DOI 10.1074/jbc.C600315200; Xu Z, 2003, BIOCHEM BIOPH RES CO, V312, P388, DOI 10.1016/j.bbrc.2003.10.130; Zhang Y, 2010, DEV GROWTH DIFFER, V52, P725, DOI 10.1111/j.1440-169X.2010.01209.x	63	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39711	10.1371/journal.pone.0039711	http://dx.doi.org/10.1371/journal.pone.0039711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768110	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100080
J	Strasser, K; Bloomfield, G; MacWilliams, A; Ceccarelli, A; MacWilliams, H; Tsang, A				Strasser, Kimchi; Bloomfield, Gareth; MacWilliams, Asa; Ceccarelli, Adriano; MacWilliams, Harry; Tsang, Adrian			A Retinoblastoma Orthologue Is a Major Regulator of S-Phase, Mitotic, and Developmental Gene Expression in Dictyostelium	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; DNA-REPLICATION; TRANSCRIPTIONAL REPRESSION; PHYSARUM POLYCEPHALUM; SLIME MOLD; DISCOIDEUM; CANCER; DIFFERENTIATION; PROTEINS; E2F	Background: The retinoblastoma tumour suppressor, Rb, has two major functions. First, it represses genes whose products are required for S-phase entry and progression thus stabilizing cells in G1. Second, Rb interacts with factors that induce cell-cycle exit and terminal differentiation. Dictyostelium lacks a G1 phase in its cell cycle but it has a retinoblastoma orthologue, rblA. Methodology/Principal Findings: Using microarray analysis and mRNA-Seq transcriptional profiling, we show that RblA strongly represses genes whose products are involved in S phase and mitosis. Both S-phase and mitotic genes are upregulated at a single point in late G2 and again in mid-development, near the time when cell cycling is reactivated. RblA also activates a set of genes unique to slime moulds that function in terminal differentiation. Conclusions: Like its mammalian counterpart Dictyostelium, RblA plays a dual role, regulating cell-cycle progression and transcriptional events leading to terminal differentiation. In the absence of a G1 phase, however, RblA functions in late G2 controlling the expression of both S-phase and mitotic genes.	[Strasser, Kimchi; Tsang, Adrian] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada; [Strasser, Kimchi; Tsang, Adrian] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada; [Bloomfield, Gareth] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Bloomfield, Gareth] Wellcome Trust Sanger Inst, Hinxton, S Cambs, England; [MacWilliams, Asa] Siemens Corp Technol, Munich, Germany; [Ceccarelli, Adriano] Univ Turin, Neurosci Inst Cavalieri Ottolenghi, Turin, Italy; [MacWilliams, Harry] Univ Munich, Biozentrum, Munich, Germany	Concordia University - Canada; Concordia University - Canada; MRC Laboratory Molecular Biology; Wellcome Trust Sanger Institute; Siemens AG; Siemens Germany; University of Turin; University of Munich	Strasser, K (corresponding author), Concordia Univ, Dept Biol, 1455 De Maisonneuve Blvd W, Montreal, PQ H3G 1M8, Canada.	kimchi@gene.concordia.ca		Bloomfield, Gareth/0000-0003-4269-8059	Natural Sciences and Engineering Research Council of Canada; MRC	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Charles David, John Bonner, Richard Kessin, and John Stiller for helpful comments on the manuscript, and are especially grateful to the DictyBase team for support in all aspects of this project. HKM thanks his colleagues Angelika Boettger and Heinrich Leonhardt for encouragement and Dietfried Molter for IT expertise; he is particularly indebted to Barbara Goldstein-Muller whose intervention at a crucial juncture made it possible for him to complete this work. KS thanks Vineet Dua for preparing RNA from the cell-cycle experiment, Nadeeza Ismael for coordinating sample shipment, Marc Champagne for sharing his knowledge on qPCR, and Ian Reid for handling the sequence submission. GB wishes to thank Rob Kay and Al Ivens for their support, and Jason Skelton and the rest of the Sanger Pathogen Microarrays group for help with the array experiment.; This work was supported by a Discovery grant from the Natural Sciences and Engineering Research Council of Canada, http://NSERC.ca. GB was supported by MRC core funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAND RN, 1973, J PROTOZOOL, V20, P654, DOI 10.1111/j.1550-7408.1973.tb03592.x; Bloomfield G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r75; Bonner JT, 1952, J EXPT ZOOLOGY, P561; BRAUN R, 1965, P NATL ACAD SCI USA, V53, P924, DOI 10.1073/pnas.53.5.924; Chen GK, 2004, DEVELOPMENT, V131, P2619, DOI 10.1242/dev.01151; Ciemerych MA, 2005, ONCOGENE, V24, P2877, DOI 10.1038/sj.onc.1208608; Date DA, 2007, CELL BIOL INT, V31, P1470, DOI 10.1016/j.cellbi.2007.06.013; de Jager SM, 2009, PLANT MOL BIOL, V71, P345, DOI 10.1007/s11103-009-9527-5; Dimova DK, 2003, GENE DEV, V17, P2308, DOI 10.1101/gad.1116703; DURSTON AJ, 1978, EXP CELL RES, V115, P454, DOI 10.1016/0014-4827(78)90308-7; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Escalante R, 2004, EUKARYOT CELL, V3, P564, DOI 10.1128/EC.3.2.564-566.2004; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Fortin A, 2004, J BIOL CHEM, V279, P28706, DOI 10.1074/jbc.M400376200; Gasior SL, 2006, J MOL BIOL, V357, P1383, DOI 10.1016/j.jmb.2006.01.089; Gaudet P, 2011, NUCLEIC ACIDS RES, V39, pD620, DOI 10.1093/nar/gkq1103; Hallows JL, 1998, J NEUROSCI, V18, P5682; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; He GG, 2005, ONCOGENE, V24, P2929, DOI 10.1038/sj.onc.1208474; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Jackson MW, 2005, J CELL SCI, V118, P1821, DOI 10.1242/jcs.02307; JANTZEN H, 1988, J CELL SCI, V91, P389; Jung CR, 2006, NAT MED, V12, P809, DOI 10.1038/nm1440; Kadri Z, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000123; KESSLER D, 1967, EXP CELL RES, V45, P676, DOI 10.1016/0014-4827(67)90170-X; Khidr L, 2006, ONCOGENE, V25, P5210, DOI 10.1038/sj.onc.1209612; Kisseleva-Romanova E, 2006, EMBO J, V25, P3576, DOI 10.1038/sj.emboj.7601235; Kollmar M, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-47; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Li H, 2008, EUKARYOT CELL, V7, P894, DOI 10.1128/EC.00422-07; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; MacWilliams H, 2006, DEVELOPMENT, V133, P1287, DOI 10.1242/dev.02287; MacWilliams H, 2001, DIFFERENTIATION, V67, P12, DOI 10.1046/j.1432-0436.2001.067001012.x; Maeda Y, 1986, J GEN MICROBIOL, P1189; Magyar Z, 2000, FEBS LETT, V486, P79, DOI 10.1016/S0014-5793(00)02238-9; Markey MP, 2002, CANCER RES, V62, P6587; Miyagishima SY, 2008, P NATL ACAD SCI USA, V105, P15202, DOI 10.1073/pnas.0802412105; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Muramoto T, 2008, DEVELOPMENT, V135, P1647, DOI 10.1242/dev.020115; Nag Dilip K, 2008, BMC Cell Biol, V9, P21, DOI 10.1186/1471-2121-9-21; NYGAARD OF, 1960, BIOCHIM BIOPHYS ACTA, V38, P298, DOI 10.1016/0006-3002(60)91245-2; Parikh A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r35; Polager S, 2002, ONCOGENE, V21, P437, DOI 10.1038/sj.onc.1205102; Ramirez-Parra E, 2003, PLANT J, V33, P801, DOI 10.1046/j.1365-313X.2003.01662.x; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saeki M, 2006, BIOCHEM BIOPH RES CO, V342, P568, DOI 10.1016/j.bbrc.2006.02.009; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Schmit F, 2007, CELL CYCLE, V6, P1903, DOI 10.4161/cc.6.15.4512; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Urushihara H, 2004, NUCLEIC ACIDS RES, V32, P1647, DOI 10.1093/nar/gkh262; Vicente JJ, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-1; WEIJER CJ, 1984, J CELL SCI, V70, P111; White RJ, 2004, ONCOGENE, V23, P3208, DOI 10.1038/sj.onc.1207547; ZADAHAMES IM, 1978, J CELL SCI, V32, P1; ZADAHAMES IM, 1978, DEV BIOL, V63, P307, DOI 10.1016/0012-1606(78)90136-7; ZIMMERMAN W, 1993, DEV BIOL, V160, P178, DOI 10.1006/dbio.1993.1296	64	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39914	10.1371/journal.pone.0039914	http://dx.doi.org/10.1371/journal.pone.0039914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768168	Green Submitted, gold, Green Published			2022-12-27	WOS:000305892100137
J	Uhalte, EC; Kirchner, M; Hellwig, N; Allen, JJ; Donat, S; Shokat, KM; Selbach, M; Abdelilah-Seyfried, S				Uhalte, Elena Cibrian; Kirchner, Marieluise; Hellwig, Nicole; Allen, Jasmina J.; Donat, Stefan; Shokat, Kevan M.; Selbach, Matthias; Abdelilah-Seyfried, Salim			In Vivo Conditions to Identify Prkci Phosphorylation Targets Using the Analog-Sensitive Kinase Method in Zebrafish	PLOS ONE			English	Article							CELL POLARITY; EPITHELIAL POLARITY; APKC; COMPLEX; MORPHOGENESIS; HEART; PAR-3; MECHANISMS; DIVISION; POSITION	Protein kinase C iota is required for various cell biological processes including epithelial tissue polarity and organ morphogenesis. To gain mechanistic insight into different roles of this kinase, it is essential to identify specific substrate proteins in their cellular context. The analog-sensitive kinase method provides a powerful tool for the identification of kinase substrates under in vivo conditions. However, it has remained a major challenge to establish screens based on this method in multicellular model organisms. Here, we report the methodology for in vivo conditions using the analog-sensitive kinase method in a genetically-tractable vertebrate model organism, the zebrafish. With this approach, kinase substrates can uniquely be labeled in the developing zebrafish embryo using bulky ATP gamma S analogs which results in the thiophosphorylation of substrates. The labeling of kinase substrates with a thiophosphoester epitope differs from phosphoesters that are generated by all other kinases and allows for an enrichment of thiophosphopeptides by immunoaffinity purification. This study provides the foundation for using the analog-sensitive kinase method in the context of complex vertebrate development, physiology, or disease.	[Uhalte, Elena Cibrian; Kirchner, Marieluise; Hellwig, Nicole; Donat, Stefan; Selbach, Matthias; Abdelilah-Seyfried, Salim] Max Delbruck Ctr Mol Med, Berlin, Germany; [Allen, Jasmina J.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Allen, Jasmina J.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Uhalte, EC (corresponding author), European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge, England.	seyfried@mdc-berlin.de	Selbach, Matthias/C-5988-2008	Donat, Stefan/0000-0003-3901-3733; Cibrian Uhalte, Elena/0000-0002-0987-9862	Deutsche Forschungsgemeinschaft (DFG) [SE106/5-1]; Helmholtz Society	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Helmholtz Society(Helmholtz Association)	S.A.-S. is supported by a Heisenberg fellowship of the Deutsche Forschungsgemeinschaft (DFG). This work was supported by DFG grant SE106/5-1 and a Helmholtz Society re-entry grant to N.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Allen JJ, 2005, J AM CHEM SOC, V127, P5288, DOI 10.1021/ja050727t; Atwood SX, 2009, CURR BIOL, V19, P723, DOI 10.1016/j.cub.2009.03.056; Bakkers J, 2009, DEV BIOL, V330, P213, DOI 10.1016/j.ydbio.2009.04.011; Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; Betschinger J, 2005, CURR BIOL, V15, P276, DOI 10.1016/j.cub.2005.01.012; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Cravatt BF, 2005, NAT METHODS, V2, P411, DOI 10.1038/nmeth0605-411; Djiane A, 2005, CELL, V121, P621, DOI 10.1016/j.cell.2005.03.014; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Galli M, 2011, NAT CELL BIOL, V13, P1132, DOI 10.1038/ncb2315; Hao Y, 2010, CURR BIOL, V20, P1809, DOI 10.1016/j.cub.2010.09.032; Hindley AD, 2004, FEBS LETT, V556, P26, DOI 10.1016/S0014-5793(03)01352-8; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Horne-Badovinac S, 2003, SCIENCE, V302, P662, DOI 10.1126/science.1085397; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Liu Y, 1998, CHEM BIOL, V5, P91, DOI 10.1016/S1074-5521(98)90143-0; Morais-de-Sa E, 2010, CELL, V141, P509, DOI 10.1016/j.cell.2010.02.040; Murray NR, 2011, J CELL PHYSIOL, V226, P879, DOI 10.1002/jcp.22463; Nagai-Tamai Y, 2002, GENES CELLS, V7, P1161, DOI 10.1046/j.1365-2443.2002.00590.x; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Peterson RT, 2001, CURR BIOL, V11, P1481, DOI 10.1016/S0960-9822(01)00482-1; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Rohr S, 2006, DEVELOPMENT, V133, P107, DOI 10.1242/dev.02182; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; St Johnston D, 2011, CURR OPIN CELL BIOL, V23, P540, DOI 10.1016/j.ceb.2011.07.005; Suzuki A, 2003, J BIOCHEM, V133, P9, DOI 10.1093/jb/mvg018; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Westerfield M, 1994, ZEBRAFISH BOOK; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6	36	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40000	10.1371/journal.pone.0040000	http://dx.doi.org/10.1371/journal.pone.0040000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768194	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100166
J	Wada, M; Takano, K; Ikegami, S; Ora, H; Spence, C; Kansaku, K				Wada, Makoto; Takano, Kouji; Ikegami, Shiro; Ora, Hiroki; Spence, Charles; Kansaku, Kenji			Spatio-Temporal Updating in the Left Posterior Parietal Cortex	PLOS ONE			English	Article							TEMPORAL-ORDER JUDGMENT; EVENT-RELATED FMRI; PERCEPTION; HANDEDNESS; LOBE; HAND; JUNCTION; PATHWAY; POSTURE; BODY	Adopting an unusual posture can sometimes give rise to paradoxical experiences. For example, the subjective ordering of successive unseen tactile stimuli delivered to the two arms can be affected when people cross them. A growing body of evidence now highlights the role played by the parietal cortex in spatio-temporal information processing when sensory stimuli are delivered to the body or when actions are executed; however, little is known about the neural basis of such paradoxical feelings resulting from such unusual limb positions. Here, we demonstrate increased fMRI activation in the left posterior parietal cortex when human participants adopted a crossed hands posture with their eyes closed. Furthermore, by assessing tactile temporal order judgments (TOJs) in the same individuals, we observed a positive association between activity in this area and the degree of reversal in TOJs resulting from crossing arms. The strongest positive association was observed in the left intraparietal sulcus. This result implies that the left posterior parietal cortex may be critically involved in monitoring limb position and in spatio-temporal binding when serial events are delivered to the limbs.	[Wada, Makoto; Takano, Kouji; Ikegami, Shiro; Ora, Hiroki; Kansaku, Kenji] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Brain Funct, Syst Neurosci Sect, Tokorozawa, Saitama, Japan; [Spence, Charles] Univ Oxford, Dept Expt Psychol, Crossmodal Res Lab, Oxford OX1 3UD, England	University of Oxford	Wada, M (corresponding author), Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Brain Funct, Syst Neurosci Sect, Tokorozawa, Saitama, Japan.	kansaku-kenji@rehab.go.jp	Ora, Hiroki/B-2407-2008; Ikegami, Shiro/GLS-7614-2022	Ora, Hiroki/0000-0001-8393-8982; 	Ministry of Education, Culture, Sports Science and Technology (MEXT) [21650062, 23300151]	Ministry of Education, Culture, Sports Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partly supported by Ministry of Education, Culture, Sports Science and Technology (MEXT) grants (#21650062 and #23300151) to K.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Azanon E, 2010, CURR BIOL, V20, P1304, DOI 10.1016/j.cub.2010.05.063; Battelli L, 2007, TRENDS COGN SCI, V11, P204, DOI 10.1016/j.tics.2007.03.001; Bohlhalter S, 2009, CEREB CORTEX, V19, P1256, DOI 10.1093/cercor/bhn168; Bushara KO, 2003, NAT NEUROSCI, V6, P190, DOI 10.1038/nn993; Cadieux ML, 2010, EXP BRAIN RES, V204, P431, DOI 10.1007/s00221-010-2268-5; Davis B, 2009, J NEUROSCI, V29, P3182, DOI 10.1523/JNEUROSCI.5793-08.2009; Desmurget M, 2001, J NEUROSCI, V21, P2919, DOI 10.1523/JNEUROSCI.21-08-02919.2001; EFRON R, 1963, BRAIN, V86, P261, DOI 10.1093/brain/86.2.261; Fridman EA, 2006, NEUROIMAGE, V29, P417, DOI 10.1016/j.neuroimage.2005.07.026; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; HYVARINEN J, 1982, PHYSIOL REV, V62, P1060, DOI 10.1152/physrev.1982.62.3.1060; Jacquin-Ciourtois S, 2011, SYSTEMS NEUROSCIENCE AND REHABILITATION, P81, DOI 10.1007/978-4-431-54008-3_6; Kitazawa S, 2007, REVERSAL SUBJECTIVE; Kroliczak G, 2009, CEREB CORTEX, V19, P2396, DOI 10.1093/cercor/bhn261; Lloyd DM, 2003, NAT NEUROSCI, V6, P17, DOI 10.1038/nn991; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pellijeff A, 2006, NEUROPSYCHOLOGIA, V44, P2685, DOI 10.1016/j.neuropsychologia.2006.01.009; Roder B, 2004, CURR BIOL, V14, P121, DOI 10.1016/j.cub.2003.12.054; Rusconi E, 2010, BRAIN, V133, P320, DOI 10.1093/brain/awp281; Rusconi E, 2009, ANN NEUROL, V66, P654, DOI 10.1002/ana.21776; Shore DI, 2002, COGNITIVE BRAIN RES, V14, P153, DOI 10.1016/S0926-6410(02)00070-8; SIRIGU A, 1995, CORTEX, V31, P41, DOI 10.1016/S0010-9452(13)80104-9; Sirigu A, 1999, BRAIN, V122, P1867, DOI 10.1093/brain/122.10.1867; Spierer L, 2009, J NEUROSCI, V29, P8630, DOI 10.1523/JNEUROSCI.2111-09.2009; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P2740, DOI 10.1016/j.neuropsychologia.2010.05.021; Wada M, 2004, NEUROPSYCHOLOGIA, V42, P1887, DOI 10.1016/j.neuropsychologia.2004.05.009; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Woo SH, 2009, BRAIN COGNITION, V69, P337, DOI 10.1016/j.bandc.2008.08.006; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559	30	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39800	10.1371/journal.pone.0039800	http://dx.doi.org/10.1371/journal.pone.0039800			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768126	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100096
J	Karan, R; DeLeon, T; Biradar, H; Subudhi, PK				Karan, Ratna; DeLeon, Teresa; Biradar, Hanamareddy; Subudhi, Prasanta K.			Salt Stress Induced Variation in DNA Methylation Pattern and Its Influence on Gene Expression in Contrasting Rice Genotypes	PLOS ONE			English	Article							ORYZA-SATIVA L.; CYTOSINE METHYLATION; ARABIDOPSIS-THALIANA; ENVIRONMENTAL-STRESS; PLANTS; TOLERANCE; STAGE; POLYMORPHISMS; DEMETHYLATION; TRANSCRIPTION	Background: Salinity is a major environmental factor limiting productivity of crop plants including rice in which wide range of natural variability exists. Although recent evidences implicate epigenetic mechanisms for modulating the gene expression in plants under environmental stresses, epigenetic changes and their functional consequences under salinity stress in rice are underexplored. DNA methylation is one of the epigenetic mechanisms regulating gene expression in plant's responses to environmental stresses. Better understanding of epigenetic regulation of plant growth and response to environmental stresses may create novel heritable variation for crop improvement. Methodology/Principal Findings: Methylation sensitive amplification polymorphism (MSAP) technique was used to assess the effect of salt stress on extent and patterns of DNA methylation in four genotypes of rice differing in the degree of salinity tolerance. Overall, the amount of DNA methylation was more in shoot compared to root and the contribution of fully methylated loci was always more than hemi-methylated loci. Sequencing of ten randomly selected MSAP fragments indicated gene-body specific DNA methylation of retrotransposons, stress responsive genes, and chromatin modification genes, distributed on different rice chromosomes. Bisulphite sequencing and quantitative RT-PCR analysis of selected MSAP loci showed that cytosine methylation changes under salinity as well as gene expression varied with genotypes and tissue types irrespective of the level of salinity tolerance of rice genotypes. Conclusions/Significance: The gene body methylation may have an important role in regulating gene expression in organ and genotype specific manner under salinity stress. Association between salt tolerance and methylation changes observed in some cases suggested that many methylation changes are not "directed''. The natural genetic variation for salt tolerance observed in rice germplasm may be independent of the extent and pattern of DNA methylation which may have been induced by abiotic stress followed by accumulation through the natural selection process.	[Karan, Ratna; DeLeon, Teresa; Biradar, Hanamareddy; Subudhi, Prasanta K.] Louisiana State Univ, Ctr Agr, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Karan, R (corresponding author), Louisiana State Univ, Ctr Agr, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA.	psubudhi@agcenter.lsu.edu		Karan, Ratna/0000-0002-1737-2682	United States Department of Agriculture-CSREES; Louisiana Rice Research Board	United States Department of Agriculture-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Louisiana Rice Research Board	United States Department of Agriculture-CSREES and Louisiana Rice Research Board funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikawa I, 2001, PLANT MOL BIOL, V45, P31, DOI 10.1023/A:1006457321781; Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; Berken A, 2006, CELL MOL LIFE SCI, V63, P2446, DOI 10.1007/s00018-006-6197-1; Berr A, 2009, PLANT PHYSIOL, V151, P1476, DOI 10.1104/pp.109.143941; Bilichak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030515; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Boyko A, 2011, CURR OPIN PLANT BIOL, V14, P260, DOI 10.1016/j.pbi.2011.03.003; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Hashida S, 2003, PLANT PHYSIOL, V132, P1207, DOI 10.1104/pp.102.017533; Hetzl J, 2007, PLANT J, V51, P526, DOI 10.1111/j.1365-313X.2007.03152.x; Ismail AM, 2007, PLANT MOL BIOL, V65, P547, DOI 10.1007/s11103-007-9215-2; Kakutani T, 2002, PLANT CELL PHYSIOL, V43, P1106, DOI 10.1093/pcp/pcf131; Karan R, 2009, FUNCT INTEGR GENOMIC, V9, P411, DOI 10.1007/s10142-009-0119-x; Kashkush K, 2007, GENETICS, V177, P1975, DOI 10.1534/genetics.107.080234; Kim J, 2002, PLANT PHYSIOL, V128, P95, DOI 10.1104/pp.101801; Kou HP, 2011, J PLANT PHYSIOL, V168, P1685, DOI 10.1016/j.jplph.2011.03.017; Kurek I, 1999, PLANT PHYSIOL, V119, P693, DOI 10.1104/pp.119.2.693; Labra M, 2002, PLANT BIOLOGY, V4, P694, DOI 10.1055/s-2002-37398; Lee KS, 2003, PLANTA, V216, P1043, DOI 10.1007/s00425-002-0958-3; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Lukens LN, 2007, CURR OPIN PLANT BIOL, V10, P317, DOI 10.1016/j.pbi.2007.04.012; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; MURRAY HG, 1980, NUCLEIC ACIDS RES, V8, P4321; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Pandey GK, 2004, PLANT CELL, V16, P1912, DOI 10.1105/tpc.021311; Rabinowicz PD, 2003, GENOME RES, V13, P2658, DOI 10.1101/gr.1784803; Reinders J, 2009, GENE DEV, V23, P939, DOI 10.1101/gad.524609; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Subudhi PK, 1998, THEOR APPL GENET, V96, P941, DOI 10.1007/s001220050824; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takata M, 2005, BREEDING SCI, V55, P57, DOI 10.1270/jsbbs.55.57; Takuno S, 2012, MOL BIOL EVOL, V29, P219, DOI 10.1093/molbev/msr188; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; Vaillant I, 2006, EMBO REP, V7, P1273, DOI 10.1038/sj.embor.7400791; Walia H, 2005, PLANT PHYSIOL, V139, P822, DOI 10.1104/pp.105.065961; Walia H, 2007, PLANT MOL BIOL, V63, P609, DOI 10.1007/s11103-006-9112-0; Wang WS, 2011, J EXP BOT, V62, P1951, DOI 10.1093/jxb/erq391; Wang WS, 2011, J GENET GENOMICS, V38, P419, DOI 10.1016/j.jgg.2011.07.006; Yan HH, 2010, PLANT J, V63, P353, DOI 10.1111/j.1365-313X.2010.04246.x; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61; Zemach A, 2007, TRENDS PLANT SCI, V12, P80, DOI 10.1016/j.tplants.2006.12.004; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang MS, 2011, PLANT PHYSIOL, V156, P1955, DOI 10.1104/pp.111.176842; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhong L, 2009, AFR J BIOTECHNOL, V8, P6201; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	51	185	204	11	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e40203	10.1371/journal.pone.0040203	http://dx.doi.org/10.1371/journal.pone.0040203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761959	Green Submitted, gold, Green Published			2022-12-27	WOS:000305826400060
J	Sanz-Ramos, M; Rodriguez-Calvo, T; Sevilla, N				Sanz-Ramos, Marta; Rodriguez-Calvo, Teresa; Sevilla, Noemi			Mutagenesis-Mediated Decrease of Pathogenicity as a Feature of the Mutant Spectrum of a Viral Population	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NUCLEOTIDE-SEQUENCE HETEROGENEITY; DEPENDENT RNA-POLYMERASE; LETHAL MUTAGENESIS; ERROR CATASTROPHE; RIBAVIRIN; FITNESS; REPLICATION; POLIOVIRUS	Background: RNA virus populations are heterogeneous ensembles of closely related genomes termed quasispecies. This highly complex distribution of variants confers important properties to RNA viruses and influences their pathogenic behavior. It has been hypothesized that increased mutagenesis of viral populations, by treatment with mutagenic agents, can induce alterations in the pathogenic potential of a virus population. In this work we investigate whether mutagenized foot-and-mouth disease virus (FMDV) populations display changes in their virulence in mice. Methodology and Principal Findings: FMDV C-S8c1 was passaged in BHK cells in the presence of the mutagenic agent ribavirin. Decline in viral titer and viral RNA progeny was observed in the first passage, fluctuating around a constant value thereafter. Hence, the specific infectivity remained stable during the passages. The viral population harvested from passage 9 (P9 R) showed decreased virulence in mice, with a lethal dose 50 (LD50) > 10(4) PFU, as compared with LD50 of 50 PFU of the parental population FMDV C-S8c1. This decrease in virulence was associated to a 20-fold increase in the mutation frequency of the P9 R population with respect to C-S8c1. Interestingly, individual biological clones isolated from the attenuated population P9 R were as virulent as the parental virus C-S8c1. Furthermore, a mixed population of C-S8c1 and P9 R was inoculated into mice and showed decreased virulence as compared to C-S8c1, suggesting that population P9 R is able to suppress the virulent phenotype of C-S8c1. Conclusion: Ribavirin-mediated mutagenesis of an FMDV population resulted in attenuation in vivo, albeit a large proportion of its biological clones displayed a highly virulent phenotype. These results, together with the suppression of C-S8c1 by mutagenized P9 R population, document a suppressive effect of mutagenized viral quasispecies in vivo, and suggest novel approaches to the treatment and prevention of viral diseases.	[Sanz-Ramos, Marta; Rodriguez-Calvo, Teresa; Sevilla, Noemi] INIA, CISA, Madrid, Spain; [Sanz-Ramos, Marta] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Sanz-Ramos, M (corresponding author), Natl Inst Med Res, Div Virol, London NW7 1AA, England.	sevilla@inia.es	Sevilla, Noemi/K-8648-2014; Rodriguez-Calvo, Teresa/AAH-2365-2019	Sevilla, Noemi/0000-0003-0118-0376; 	CISA-INIA Centro de Investigacion en Sanidad Animal from Ministerio de Ciencia e Innovacion (MCINN) [AGL2007-61374, AGL2009-07353]; Activities 7th EU program [228394-NADIR-Integrating]; CBMSO Centro de Biologia Molecular from Ministerio de Ciencia e Innovacion and Fundacion R. Areces [BFU2008-02816/BMC]	CISA-INIA Centro de Investigacion en Sanidad Animal from Ministerio de Ciencia e Innovacion (MCINN); Activities 7th EU program; CBMSO Centro de Biologia Molecular from Ministerio de Ciencia e Innovacion and Fundacion R. Areces	Work at CISA-INIA Centro de Investigacion en Sanidad Animal was supported by grants AGL2007-61374 and AGL2009-07353 from Ministerio de Ciencia e Innovacion (MCINN) and 228394-NADIR-Integrating Activities 7th EU program. Work at CBMSO Centro de Biologia Molecular was supported by grants BFU2008-02816/BMC from Ministerio de Ciencia e Innovacion and Fundacion R. Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001072; Airaksinen A, 2003, VIROLOGY, V311, P339, DOI 10.1016/S0042-6822(03)00144-2; Anderson JP, 2004, ANNU REV MICROBIOL, V58, P183, DOI 10.1146/annurev.micro.58.030603.123649; Arezi B, 2003, ANAL BIOCHEM, V321, P226, DOI 10.1016/S0003-2697(03)00465-2; Arias A, 2005, J MOL BIOL, V353, P1021, DOI 10.1016/j.jmb.2005.09.022; Arias A, 2001, J GEN VIROL, V82, P1049, DOI 10.1099/0022-1317-82-5-1049; Arias A, 2008, J VIROL, V82, P12346, DOI 10.1128/JVI.01297-08; BORREGO B, 1993, J VIROL, V67, P6071, DOI 10.1128/JVI.67.10.6071-6079.1993; CHUMAKOV KM, 1991, P NATL ACAD SCI USA, V88, P199, DOI 10.1073/pnas.88.1.199; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; Coffey LL, 2011, P NATL ACAD SCI USA, V108, P16038, DOI 10.1073/pnas.1111650108; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; Crowder S, 2005, NAT GENET, V37, P701, DOI 10.1038/ng1583; DELATORRE JC, 1990, J VIROL, V64, P6278, DOI 10.1128/JVI.64.12.6278-6281.1990; Domingo E, 2005, VIRUS RES, V107, P115, DOI 10.1016/j.virusres.2004.11.001; DOMINGO E, 1978, CELL, V13, P735, DOI 10.1016/0092-8674(78)90223-4; DOMINGO E, 1980, GENE, V11, P333, DOI 10.1016/0378-1119(80)90073-6; Domingo E, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P87, DOI 10.1016/B978-0-12-374153-0.00004-7; DUARTE EA, 1994, J VIROL, V68, P4295, DOI 10.1128/JVI.68.7.4295-4301.1994; EIGEN M, 1988, J PHYS CHEM-US, V92, P6881, DOI 10.1021/j100335a010; Eigen M, 1988, RNA GENETICS, V3; Eigen M, 1979, THE HYPERCYCLE, P60; Escarmis C, 1999, J MOL BIOL, V285, P495, DOI 10.1006/jmbi.1998.2366; Escarmis C, 2008, J MOL BIOL, V376, P367, DOI 10.1016/j.jmb.2007.11.042; Ferrer-Orta C, 2010, J VIROL, V84, P6188, DOI 10.1128/JVI.02420-09; Garcia-Arriaza J, 2004, J VIROL, V78, P11678, DOI 10.1128/JVI.78.21.11678-11685.2004; Gonzalez-Lopez C, 2004, J VIROL, V78, P3319, DOI 10.1128/JVI.78.7.3319-3324.2004; Gonzalez-Lopez Claudia, 2005, Infection Genetics and Evolution, V5, P366, DOI 10.1016/j.meegid.2005.05.001; Graci JD, 2002, VIROLOGY, V298, P175, DOI 10.1006/viro.2002.1487; Grande-Perez A, 2005, J VIROL, V79, P10451, DOI 10.1128/JVI.79.16.10451-10459.2005; Grande-Perez A, 2005, P NATL ACAD SCI USA, V102, P4448, DOI 10.1073/pnas.0408871102; Harris KS, 2005, ANTIVIR RES, V67, P1, DOI 10.1016/j.antiviral.2005.03.004; Lancaster KZ, 2011, J VIROL, V85, P9778, DOI 10.1128/JVI.00355-11; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Loeb LA, 1999, P NATL ACAD SCI USA, V96, P1492, DOI 10.1073/pnas.96.4.1492; Mahy BWJ, 2005, CURR TOP MICROBIOL, V288, P1; Martin V, 2010, J GEN VIROL, V91, P990, DOI 10.1099/vir.0.017053-0; Mas A, 2010, J MOL BIOL, V397, P865, DOI 10.1016/j.jmb.2010.02.005; Moreno H, 2011, J VIROL, V85, P7246, DOI 10.1128/JVI.00614-11; Ojosnegros S, 2010, P NATL ACAD SCI USA, V107, P2108, DOI 10.1073/pnas.0909787107; Ojosnegros S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-207; Pariente N, 2001, J VIROL, V75, P9723, DOI 10.1128/JVI.75.20.9723-9730.2001; Pawlotsky JM, 1998, J MED VIROL, V54, P256, DOI 10.1002/(SICI)1096-9071(199804)54:4<256::AID-JMV4>3.3.CO;2-K; Perales C, 2007, J MOL BIOL, V369, P985, DOI 10.1016/j.jmb.2007.03.074; Perales C, 2010, FUTURE VIROL, V5, P679, DOI 10.2217/FVL.10.61; Perales C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000658; Perales C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005554; Pfeiffer JK, 2006, P NATL ACAD SCI USA, V103, P5520, DOI 10.1073/pnas.0600834103; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Pfeiffer JK, 2005, PLOS PATHOG, V1, P102, DOI 10.1371/journal.ppat.0010011; Rowlands DJ, 2003, VIRUS RES, V91, P1, DOI 10.1016/S0168-1702(02)00264-2; Salguero FJ, 2005, VIROLOGY, V332, P384, DOI 10.1016/j.virol.2004.11.005; Sanz-Ramos M, 2008, J VIROL, V82, P10465, DOI 10.1128/JVI.00825-08; Sierra M, 2007, J VIROL, V81, P2012, DOI 10.1128/JVI.01606-06; Sierra S, 2000, J VIROL, V74, P8316, DOI 10.1128/JVI.74.18.8316-8323.2000; SOBRINO F, 1983, VIROLOGY, V128, P310, DOI 10.1016/0042-6822(83)90258-1; SOBRINO F, 2004, FOOT AND MOUTH DIS C; Teng MN, 1996, J VIROL, V70, P8438, DOI 10.1128/JVI.70.12.8438-8443.1996; Toja M, 1999, VIRUS RES, V64, P161, DOI 10.1016/S0168-1702(99)00089-1; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vignuzzi M, 2005, VIRUS RES, V107, P173, DOI 10.1016/j.virusres.2004.11.007; Vignuzzi M, 2010, PICORNAVIRU IN PRESS; Vignuzzi M, 2008, NAT MED, V14, P154, DOI 10.1038/nm1726; Volkenstein MV., 1994, PHYS APPROACHES BIOL, DOI [10.1007/978-3-642-78788-1, DOI 10.1007/978-3-642-78788-1]	64	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39941	10.1371/journal.pone.0039941	http://dx.doi.org/10.1371/journal.pone.0039941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761933	Green Submitted, Green Published, gold			2022-12-27	WOS:000305826400049
J	Zhang, DL; Xiong, W; Chu, S; Sun, C; Albensi, BC; Parkinson, FE				Zhang, Dali; Xiong, Wei; Chu, Stephanie; Sun, Chao; Albensi, Benedict C.; Parkinson, Fiona E.			Inhibition of Hippocampal Synaptic Activity by ATP, Hypoxia or Oxygen-Glucose Deprivation Does Not Require CD73	PLOS ONE			English	Article							ADENOSINE A(1) RECEPTORS; NUCLEOSIDE TRANSPORTER 1; RAT HIPPOCAMPUS; ADENINE-NUCLEOTIDES; ISCHEMIC CONDITIONS; MOUSE NEURONS; AREA CA1; TRANSMISSION; RELEASE; ECTO-5'-NUCLEOTIDASE	Adenosine, through activation of its A(1) receptors, has neuroprotective effects during hypoxia and ischemia. Recently, using transgenic mice with neuronal expression of human equilibrative nucleoside transporter 1 (hENT1), we reported that nucleoside transporter-mediated release of adenosine from neurons was not a key mechanism facilitating the actions of adenosine at A(1) receptors during hypoxia/ischemia. The present study was performed to test the importance of CD73 (ecto-5'-nucleotidase) for basal and hypoxic/ischemic adenosine production. Hippocampal slice electrophysiology was performed with CD73(+/+) and CD73(-/-) mice. Adenosine and ATP had similar inhibitory effects in both genotypes, with IC50 values of approximately 25 mu M. In contrast, ATP was a less potent inhibitor (IC50 = 100 mu M) in slices from mice expressing hENT1 in neurons. The inhibitory effects of ATP in CD73(+/+) and CD73(-/-) slices were blocked by the adenosine A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) and were enhanced by the nucleoside transport inhibitor S-(4-nitrobenzyl)-6-thioinosine (NBTI), consistent with effects that are mediated by adenosine after metabolism of ATP. AMP showed a similar inhibitory effect to ATP and adenosine, indicating that the response to ATP was not mediated by P2 receptors. In comparing CD73(-/-) and CD73(+/+) slices, hypoxia and oxygen-glucose deprivation produced similar depression of synaptic transmission in both genotypes. An inhibitor of tissue non-specific alkaline phosphatase (TNAP) was found to attenuate the inhibitory effects of AMP and ATP, increase basal synaptic activity and reduce responses to oxygen-glucose deprivation selectively in slices from CD73(-/-) mice. These results do not support an important role for CD73 in the formation of adenosine in the CA1 area of the hippocampus during basal, hypoxic or ischemic conditions, but instead point to TNAP as a potential source of extracellular adenosine when CD73 is absent.	[Zhang, Dali; Xiong, Wei; Chu, Stephanie; Sun, Chao; Albensi, Benedict C.; Parkinson, Fiona E.] Univ Manitoba, Dept Pharmacol & Therapeut, Winnipeg, MB, Canada; [Zhang, Dali; Albensi, Benedict C.] St Boniface Gen Hosp, Res Ctr, Div Neurodegenerat Disorders, Winnipeg, MB R2H 2A6, Canada	University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Zhang, DL (corresponding author), Univ Manitoba, Dept Pharmacol & Therapeut, Winnipeg, MB, Canada.	parkins@cc.umanitoba.ca	Albensi, Benedict Charles/AAJ-2359-2021	Albensi, Benedict Charles/0000-0002-7884-9261	Canadian Institutes for Health Research; Heart and Stroke Foundation of Manitoba; St. Boniface General Hospital Research Foundation	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Manitoba; St. Boniface General Hospital Research Foundation	This research was funded by the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca/e/193.html), the Heart and Stroke Foundation of Manitoba (http://www.heartandstroke.mb.ca/site/c.lgLSIVOyGpF/b.4951313/k.F6E0/Heart_Disease_Stroke_and_Healthy_Living.htm), and the St. Boniface General Hospital Research Foundation (http://www.stbhf.org/english/index.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann HS, 2003, PHARMACOGENETICS, V13, P759, DOI 10.1097/00008571-200312000-00006; Brust TB, 2006, J NEUROSCI, V26, P12427, DOI 10.1523/JNEUROSCI.4052-06.2006; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Coppi E, 2007, PURINERG SIGNAL, V3, P203, DOI 10.1007/s11302-006-9049-4; Cunha RA, 1996, BRIT J PHARMACOL, V119, P253, DOI 10.1111/j.1476-5381.1996.tb15979.x; Cunha RA, 1998, J NEUROSCI, V18, P1987; CUNHA RA, 1992, J NEUROCHEM, V59, P657, DOI 10.1111/j.1471-4159.1992.tb09420.x; Dahl R, 2009, J MED CHEM, V52, P6919, DOI 10.1021/jm900383s; Diez-Zaera M, 2011, MOL BIOL CELL, V22, P1014, DOI 10.1091/mbc.E10-09-0740; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; Frenguelli BG, 2007, J NEUROCHEM, V101, P1400, DOI 10.1111/j.1471-4159.2006.04425.x; GRIBKOFF VK, 1992, J NEUROPHYSIOL, V68, P620, DOI 10.1152/jn.1992.68.2.620; Klyuch BP, 2012, J NEUROSCI, V32, P3842, DOI 10.1523/JNEUROSCI.6052-11.2012; Klyuch BP, 2011, J PHYSIOL-LONDON, V589, P283, DOI 10.1113/jphysiol.2010.198986; Koszalka P, 2004, CIRC RES, V95, P814, DOI 10.1161/01.RES.0000144796.82787.6f; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovatt D, 2012, P NATL ACAD SCI USA, V109, P6265, DOI 10.1073/pnas.1120997109; Lucchi R, 1996, BRAIN RES, V732, P261, DOI 10.1016/0006-8993(96)00748-2; Martin ED, 2007, GLIA, V55, P36, DOI 10.1002/glia.20431; Masino SA, 2002, J PHARMACOL EXP THER, V303, P356, DOI 10.1124/jpet.102.036731; Parkinson FE, 2005, NEUROL RES, V27, P153, DOI 10.1179/016164105X21878; Parkinson FE, 2009, J NEUROCHEM, V109, P562, DOI 10.1111/j.1471-4159.2009.05991.x; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pearson T, 2000, EUR J NEUROSCI, V12, P3064, DOI 10.1046/j.1460-9568.2000.00201.x; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; SCHRADER J, 1976, PFLUG ARCH EUR J PHY, V367, P129, DOI 10.1007/BF00585148; Sowa NA, 2010, J NEUROSCI, V30, P2235, DOI 10.1523/JNEUROSCI.5324-09.2010; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Zamzow CR, 2008, J NEUROSCI RES, V86, P2641, DOI 10.1002/jnr.21718; Zernecke A, 2006, CIRCULATION, V113, P2120, DOI 10.1161/CIRCULATIONAHA.105.595249; Zhang DL, 2011, J NEUROCHEM, V118, P4, DOI 10.1111/j.1471-4159.2011.07242.x; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	32	65	67	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39772	10.1371/journal.pone.0039772	http://dx.doi.org/10.1371/journal.pone.0039772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761898	Green Published, Green Submitted, gold			2022-12-27	WOS:000305781700065
J	Heikkila, K; Nyberg, ST; Fransson, EI; Alfredsson, L; De Bacquer, D; Bjorner, JB; Bonenfant, S; Borritz, M; Burr, H; Clays, E; Casini, A; Dragano, N; Erbel, R; Geuskens, GA; Goldberg, M; Hooftman, WE; Houtman, IL; Joensuu, M; Jockel, KH; Kittel, F; Knutsson, A; Koskenvuo, M; Koskinen, A; Kouvonen, A; Leineweber, C; Lunau, T; Madsen, IEH; Hanson, LLM; Marmot, MG; Nielsen, ML; Nordin, M; Pentti, J; Salo, P; Rugulies, R; Steptoe, A; Siegrist, J; Suominen, S; Vahtera, J; Virtanen, M; Vaananen, A; Westerholm, P; Westerlund, H; Zins, M; Theorell, T; Hamer, M; Ferrie, JE; Singh-Manoux, A; Batty, GD; Kivimaki, M				Heikkila, Katriina; Nyberg, Solja T.; Fransson, Eleonor I.; Alfredsson, Lars; De Bacquer, Dirk; Bjorner, Jakob B.; Bonenfant, Sebastien; Borritz, Marianne; Burr, Hermann; Clays, Els; Casini, Annalisa; Dragano, Nico; Erbel, Raimund; Geuskens, Goedele A.; Goldberg, Marcel; Hooftman, Wendela E.; Houtman, Irene L.; Joensuu, Matti; Joeckel, Karl-Heinz; Kittel, France; Knutsson, Anders; Koskenvuo, Markku; Koskinen, Aki; Kouvonen, Anne; Leineweber, Constanze; Lunau, Thorsten; Madsen, Ida E. H.; Hanson, Linda L. Magnusson; Marmot, Michael G.; Nielsen, Martin L.; Nordin, Maria; Pentti, Jaana; Salo, Paula; Rugulies, Reiner; Steptoe, Andrew; Siegrist, Johannes; Suominen, Sakari; Vahtera, Jussi; Virtanen, Marianna; Vaananen, Ari; Westerholm, Peter; Westerlund, Hugo; Zins, Marie; Theorell, Tores; Hamer, Mark; Ferrie, Jane E.; Singh-Manoux, Archana; Batty, G. David; Kivimaeki, Mika		IPD-Work Consortium	Job Strain and Tobacco Smoking: An Individual-Participant Data Meta-Analysis of 166 130 Adults in 15 European Studies	PLOS ONE			English	Article							ADVERSE HEALTH BEHAVIORS; WHITEHALL-II; PATIENT DATA; WORK STRESS; RISK; ASSOCIATIONS; OVERTIME; TRIALS	Background: Tobacco smoking is a major contributor to the public health burden and healthcare costs worldwide, but the determinants of smoking behaviours are poorly understood. We conducted a large individual-participant meta-analysis to examine the extent to which work-related stress, operationalised as job strain, is associated with tobacco smoking in working adults. Methodology and Principal Findings: We analysed cross-sectional data from 15 European studies comprising 166 130 participants. Longitudinal data from six studies were used. Job strain and smoking were self-reported. Smoking was harmonised into three categories never, ex- and current. We modelled the cross-sectional associations using logistic regression and the results pooled in random effects meta-analyses. Mixed effects logistic regression was used to examine longitudinal associations. Of the 166 130 participants, 17% reported job strain, 42% were never smokers, 33% ex-smokers and 25% current smokers. In the analyses of the cross-sectional data, current smokers had higher odds of job strain than never-smokers (age, sex and socioeconomic position-adjusted odds ratio: 1.11, 95% confidence interval: 1.03, 1.18). Current smokers with job strain smoked, on average, three cigarettes per week more than current smokers without job strain. In the analyses of longitudinal data (1 to 9 years of follow-up), there was no clear evidence for longitudinal associations between job strain and taking up or quitting smoking. Conclusions: Our findings show that smokers are slightly more likely than non-smokers to report work-related stress. In addition, smokers who reported work stress smoked, on average, slightly more cigarettes than stress-free smokers.	[Heikkila, Katriina; Nyberg, Solja T.; Joensuu, Matti; Koskinen, Aki; Virtanen, Marianna; Vaananen, Ari; Kivimaeki, Mika] Finnish Inst Occupat Hlth, Helsinki, Finland; [Fransson, Eleonor I.; Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Fransson, Eleonor I.] Jonkoping Univ, Sch Hlth Sci, Jonkoping, Sweden; [De Bacquer, Dirk; Clays, Els] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Bjorner, Jakob B.; Madsen, Ida E. H.; Rugulies, Reiner] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Bonenfant, Sebastien; Goldberg, Marcel; Zins, Marie; Singh-Manoux, Archana] INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Bonenfant, Sebastien; Goldberg, Marcel; Zins, Marie] Versailles St Quentin Univ, Versailles, France; [Borritz, Marianne] Bispebjerg Hosp, Dept Occupat Med, Copenhagen, Denmark; [Burr, Hermann] Ctr Maritime Hlth & Safety, Esbjerg, Denmark; [Casini, Annalisa; Kittel, France] Univ Libre Bruxelles, Sch Publ Hlth, Brussels, Belgium; [Dragano, Nico; Joeckel, Karl-Heinz; Lunau, Thorsten] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Erbel, Raimund] Univ Duisburg Essen, W German Heart Ctr Essen, Dept Cardiol, Essen, Germany; [Geuskens, Goedele A.; Hooftman, Wendela E.; Houtman, Irene L.] TNO, Hoofddorp, Netherlands; [Knutsson, Anders] Mid Sweden Univ, Dept Hlth Sci, Sundsvall, Sweden; [Koskenvuo, Markku] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Kouvonen, Anne] Wroclaw Fac, Warsaw Sch Social Sci & Humanities, Wroclaw, Poland; [Leineweber, Constanze; Hanson, Linda L. Magnusson; Westerlund, Hugo; Theorell, Tores] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Marmot, Michael G.; Steptoe, Andrew; Westerlund, Hugo; Hamer, Mark; Ferrie, Jane E.; Singh-Manoux, Archana; Batty, G. David; Kivimaeki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Nielsen, Martin L.] Bispebjerg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark; [Nordin, Maria] Umea Univ, Dept Publ Hlth & Clin Med Occupat & Environm Med, Umea, Sweden; [Pentti, Jaana; Salo, Paula; Vahtera, Jussi] Finnish Inst Occupat Hlth, Turku, Finland; [Rugulies, Reiner] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Rugulies, Reiner] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Siegrist, Johannes] Univ Dusseldorf, Dept Med Sociol, D-40225 Dusseldorf, Germany; [Suominen, Sakari] Folkhalsan Res Ctr, Helsinki, Finland; [Suominen, Sakari; Vahtera, Jussi] Univ Turku, Dept Publ Hlth, Turku, Finland; [Vahtera, Jussi] Turku Univ Hosp, FIN-20520 Turku, Finland; [Westerholm, Peter] Uppsala Univ, Uppsala, Sweden; [Ferrie, Jane E.] Univ Bristol, Sch Community & Social Med, Bristol, Avon, England	Finnish Institute of Occupational Health; Karolinska Institutet; Jonkoping University; Ghent University; National Research Centre for the Working Environment; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Copenhagen; Bispebjerg Hospital; Universite Libre de Bruxelles; University of Duisburg Essen; University of Duisburg Essen; Netherlands Organization Applied Science Research; Mid-Sweden University; University of Helsinki; SWPS University of Social Sciences & Humanities; Stockholm University; University of London; University College London; Aarhus University; University of Copenhagen; Bispebjerg Hospital; Umea University; Finnish Institute of Occupational Health; University of Copenhagen; University of Copenhagen; Heinrich Heine University Dusseldorf; Folkhalsan Research Center; University of Turku; University of Turku; Uppsala University; University of Bristol	Heikkila, K (corresponding author), Finnish Inst Occupat Hlth, Helsinki, Finland.	katriina.heikkila@ttl.fi	Marmot, M G/Y-3920-2019; Singh-Manoux, Archana/F-6804-2013; Fransson, Eleonor I/J-7792-2013; Leineweber, Constanze/G-7052-2012; Alfredsson, Lars/AAC-9007-2019; Westerlund, Hugo/A-3049-2012; Leineweber, Constanze/Z-1330-2019; Rugulies, Reiner/E-8140-2010; Casini, Annalisa/ABG-2250-2020; Hanson, Linda L Magnusson/D-2435-2017; Hamer, Mark/AAJ-6814-2021; Goldberg, Marcel/I-7834-2012; Siegrist, Johannes/AAL-6814-2021; Hamer, Mark/C-1602-2008; Nielsen, Martin Lindhardt/E-3071-2012; De Bacquer, Dirk/HGU-3191-2022; Steptoe, Andrew/Y-2440-2019; Salo, Paula/D-6649-2013; Vahtera, Jussi/J-3271-2013; Batty, GD/Y-4401-2018; Kivimaki, Mika/B-3607-2012; Ferrie, Jane/AAZ-2009-2020; Zins, Marie/AAX-6551-2021	Marmot, M G/0000-0002-2431-6419; Singh-Manoux, Archana/0000-0002-1244-5037; Fransson, Eleonor I/0000-0001-9042-4832; Leineweber, Constanze/0000-0001-8433-2405; Alfredsson, Lars/0000-0003-1688-6697; Westerlund, Hugo/0000-0002-8806-5698; Rugulies, Reiner/0000-0002-7752-131X; Casini, Annalisa/0000-0002-3539-4500; Hanson, Linda L Magnusson/0000-0002-2908-1903; Hamer, Mark/0000-0002-8726-7992; Goldberg, Marcel/0000-0002-6161-5880; Siegrist, Johannes/0000-0002-7530-4178; Hamer, Mark/0000-0002-8726-7992; Nielsen, Martin Lindhardt/0000-0002-1523-0453; Salo, Paula/0000-0002-0812-277X; Batty, GD/0000-0003-1822-5753; Kivimaki, Mika/0000-0002-4699-5627; Steptoe, Andrew/0000-0001-7808-4943; Vahtera, Jussi/0000-0002-6036-061X; Heikkila, Katriina/0000-0001-6269-6881; Clays, Els/0000-0002-1092-945X; Kouvonen, Anne/0000-0001-6997-8312; Madsen, Ida/0000-0003-3635-3900; Burr, Hermann/0000-0002-3864-6347; Suominen, Sakari B./0000-0001-6648-603X; Theorell, Tores/0000-0003-1956-7931; De Bacquer, Dirk/0000-0002-3202-7238	EU New OSH ERA research programme; Finnish Work Environment Fund, Finland; Swedish Research Council for Working Life and Social Research, Sweden; German Social Accident Insurance, Germany; Danish Work Environment Research Fund, Denmark; Academy of Finland [132944]; BUPA Foundation [22094477]; Heinz Nixdorf Foundation, Germany; German Ministry of Education and Science (BMBF); German Research Foundation (DFG); German Social Accident Insurance (DGUV); Ministry of Social Affairs and Employment, The Netherlands; MRC [G0902037] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G19/35, G0100222, G8802774, G0902037] Funding Source: researchfish	EU New OSH ERA research programme; Finnish Work Environment Fund, Finland; Swedish Research Council for Working Life and Social Research, Sweden; German Social Accident Insurance, Germany; Danish Work Environment Research Fund, Denmark; Academy of Finland(Academy of Finland); BUPA Foundation; Heinz Nixdorf Foundation, Germany; German Ministry of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); German Social Accident Insurance (DGUV); Ministry of Social Affairs and Employment, The Netherlands(Netherlands Government); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The IPD work consortium is supported by the EU New OSH ERA research programme (funded by the Finnish Work Environment Fund, Finland, the Swedish Research Council for Working Life and Social Research, Sweden, the German Social Accident Insurance, Germany, the Danish Work Environment Research Fund, Denmark), the Academy of Finland (grant # 132944), and the BUPA Foundation (grant 22094477). The HNR was funded by the Heinz Nixdorf Foundation, Germany, German Ministry of Education and Science (BMBF) and the German Research Foundation (DFG). The German Social Accident Insurance (DGUV) supports analyses in the frame of the OSH ERA project. POLS was funded by the Ministry of Social Affairs and Employment, The Netherlands. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Doll R, 1986, IARC Sci Publ, P11; Egger M, 2003, SYSTEMATIC REV HLTH; Forey BA, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-36; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; International Agency for Research on Cancer, 2004, IARC MON EV CARC RIS, V88; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Karasek R, 1990, HLTH WORK STRESS PRO; Kassel JD, 2003, PSYCHOL BULL, V129, P270, DOI 10.1037/0033-2909.129.2.270; Kivimaki M, 2010, AM J EPIDEMIOL, V172, P167, DOI 10.1093/aje/kwq094; Kouvonen A, 2005, J EPIDEMIOL COMMUN H, V59, P63, DOI 10.1136/jech.2004.019752; Kouvonen A, 2009, TOB CONTROL, V18, P108, DOI 10.1136/tc.2008.025411; Kouvonen A, 2007, J OCCUP ENVIRON MED, V49, P68, DOI 10.1097/JOM.0b013e31802db54a; Lallukka T, 2008, SOC SCI MED, V66, P1681, DOI 10.1016/j.socscimed.2007.12.027; MCCRAE RR, 1990, STRESS MEDICINE, V6, P237, DOI 10.1002/smi.2460060309; Nyberg ST, 2011, J INTERN MED; Paterniti S, 2002, BRIT J PSYCHIAT, V181, P111; Perdikaris P, 2010, INT J ENV RES PUB HE, V7, P2362, DOI 10.3390/ijerph7052362; Radi S, 2007, AM J IND MED, V50, P584, DOI 10.1002/ajim.20492; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Riley RD, 2010, INT J EPIDEMIOL, V39, P1359, DOI 10.1093/ije/dyq129; Rugulies R, 2008, INT J BEHAV MED, V15, P34, DOI [10.1007/BF03003072, 10.1080/10705500701783900]; Salo P, 2011, SLEEP IN PRESS; Siegrist J, 2006, SCAND J WORK ENV HEA, V32, P473, DOI 10.5271/sjweh.1052; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Sinha R, 2001, PSYCHOPHARMACOLOGY, V158, P343, DOI 10.1007/s002130100917; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; Thompson S, 2010, INT J EPIDEMIOL, V39, P1345, DOI 10.1093/ije/dyq063; Turner RM, 2000, STAT MED, V19, P3417, DOI 10.1002/1097-0258(20001230)19:24<3417::AID-SIM614>3.0.CO;2-L; Vartiainen E, 2002, J EPIDEMIOL COMMUN H, V56, P167, DOI 10.1136/jech.56.3.167; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; Vinjar B, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006687.pub2; Virtanen M, 2010, EUR HEART J, V31, P1737, DOI 10.1093/eurheartj/ehq124; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	33	85	87	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e35463	10.1371/journal.pone.0035463	http://dx.doi.org/10.1371/journal.pone.0035463			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974UB	22792154	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000306461800002
J	Schallenberg, M; Prokosch, V; Thanos, S				Schallenberg, Maurice; Prokosch, Verena; Thanos, Solon			Regulation of Retinal Proteome by Topical Antiglaucomatous Eye Drops in an Inherited Glaucoma Rat Model	PLOS ONE			English	Article							GANGLION-CELL DEATH; INTRAOCULAR-PRESSURE; INHIBITS APOPTOSIS; AXONAL-TRANSPORT; IN-VITRO; HEAT-SHOCK-PROTEIN-70; SURVIVAL; BDNF; CALCIUM/CALMODULIN; PHARMACOLOGY	Examination of the response of the retinal proteome to elevated intraocular pressure (IOP) and to the pharmacological normalization of IOP is crucial, in order to develop drugs with neuroptorective potential. We used a hereditary rat model of ocular hypertension to lower IOP with travaprost and dorzolamide applied topically on the eye surface, and examine changes of the retinal proteome. Our data demonstrate that elevated IOP causes alterations in the retinal protein profile, in particular in high-mobility-group-protein B1 (HMGB1), calmodulin, heat-shock-protein (HSP) 70 and carbonic anhydrase II expression. The changes of the retinal proteome by dorzolamide or travoprost are different and independent of the IOP lowering effect. This fact suggests that the eye drops exert a direct IOP-independent effect on retinal metabolism. Further investigations are required to elucidate the potential neuroprotective mechanisms signaled through changes of HMGB1, calmodulin, HSP70 and carbonic anhydrase II expression in glaucoma. The data may facilitate development of eye drops that exert neuroprotection through direct pharmacological effect.	[Schallenberg, Maurice; Prokosch, Verena; Thanos, Solon] Univ Clin Munster, Sch Med, Inst Expt Ophthalmol, Munster, Germany; [Schallenberg, Maurice; Prokosch, Verena; Thanos, Solon] Interdisciplinary Ctr Clin Res IZKF, Munster, Germany; [Schallenberg, Maurice] Univ Duisburg Essen, Univ Hosp Essen, Dept Ophthalmol, Essen, Germany	University of Munster; University of Duisburg Essen	Schallenberg, M (corresponding author), Univ Clin Munster, Sch Med, Inst Expt Ophthalmol, Munster, Germany.	solon@uni-muenster.de			Deutsche Forschungsgemeinschaft (DFG) [Th386/16-1, Th386/16-2]; IMF-Munster [NA 110503]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); IMF-Munster	This work was supported by the Deutsche Forschungsgemeinschaft (DFG Grants Th386/16-1 and Th386/16-2 to Dr. Thanos) and the IMF-Munster (Grant NA 110503 to Dr. Thanos). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Beere HM, 2001, TRENDS CELL BIOL, V11, P6, DOI 10.1016/S0962-8924(00)01874-2; Caprioli J, 1996, INVEST OPHTH VIS SCI, V37, P2376; Caprioli Joseph, 2003, Trans Am Ophthalmol Soc, V101, P39; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Davis TL, 1999, J OCUL PHARMACOL TH, V15, P323, DOI 10.1089/jop.1999.15.323; Drago F, 2001, EXP EYE RES, V72, P479, DOI 10.1006/exer.2000.0975; Egea J, 2001, J CELL BIOL, V154, P585, DOI 10.1083/jcb.200101023; Fan W, 2007, INVEST OPHTH VIS SCI, V48, P3854, DOI 10.1167/iovs.06-1382; Faraco G, 2007, J NEUROCHEM, V103, P590, DOI 10.1111/j.1471-4159.2007.04788.x; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Hitchings R A, 1995, Curr Opin Ophthalmol, V6, P67; Joachim SC, 2007, CURR EYE RES, V32, P501, DOI 10.1080/02713680701375183; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Kniep EM, 2006, INVEST OPHTH VIS SCI, V47, P1185, DOI 10.1167/iovs.05-0555; Kokubo M, 2009, J NEUROSCI, V29, P8901, DOI 10.1523/JNEUROSCI.0040-09.2009; Levin LA, 2003, SURV OPHTHALMOL, V48, pS21, DOI 10.1016/S0039-6257(03)00007-9; Limana F, 2005, CIRC RES, V97, pE73, DOI 10.1161/01.RES.0000186276.06104.04; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Martinez A, 2009, J OCUL PHARMACOL TH, V25, P239, DOI 10.1089/jop.2008.0114; Naskar R, 2006, MOL VIS, V12, P1199; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Osborne NN, 2004, EYE, V18, P1075, DOI 10.1038/sj.eye.6701588; Park HY, 2008, J OCUL PHARMACOL TH, V24, P563, DOI 10.1089/jop.2008.0039; Park KH, 2001, INVEST OPHTH VIS SCI, V42, P1522; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Pedrazzi M, 2006, J NEUROCHEM, V99, P827, DOI 10.1111/j.1471-4159.2006.04120.x; Perez-Garcia MJ, 2004, J BIOL CHEM, V279, P6132, DOI 10.1074/jbc.M308367200; Qu J, 2010, EXP EYE RES, V91, P48, DOI 10.1016/j.exer.2010.04.002; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; See V, 2001, FASEB J, V15, P134, DOI 10.1096/fj.00-0106com; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Sugrue MF, 1996, J OCUL PHARMACOL TH, V12, P363, DOI 10.1089/jop.1996.12.363; Tezel G, 2000, J NEUROSCI, V20, P3552, DOI 10.1523/JNEUROSCI.20-10-03552.2000; Thanos S, 2004, EXP EYE RES, V79, P119, DOI 10.1016/j.exer.2004.02.005; Toris CB, 2008, SURV OPHTHALMOL, V53, pS107, DOI 10.1016/j.survophthal.2008.08.010; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Yamagishi R, 2011, EXP EYE RES, V93, P265, DOI 10.1016/j.exer.2011.06.022; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147	43	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e33593	10.1371/journal.pone.0033593	http://dx.doi.org/10.1371/journal.pone.0033593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792152	gold, Green Published, Green Submitted			2022-12-27	WOS:000306436300001
J	Ahn, M; Ghaemmaghami, S; Huang, Y; Phuan, PW; May, BCH; Giles, K; DeArmond, SJ; Prusiner, SB				Ahn, Misol; Ghaemmaghami, Sina; Huang, Yong; Phuan, Puay-Wah; May, Barnaby C. H.; Giles, Kurt; DeArmond, Stephen J.; Prusiner, Stanley B.			Pharmacokinetics of Quinacrine Efflux from Mouse Brain via the P-glycoprotein Efflux Transporter	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; PRION DISEASES; CELL-DEATH; ACCUMULATION; BARRIER; DRUGS; P53; DERIVATIVES; INHIBITOR; ACRIDINE	The lipophilic cationic compound quinacrine has been used as an antimalarial drug for over 75 years but its pharmacokinetic profile is limited. Here, we report on the pharmacokinetic properties of quinacrine in mice. Following an oral dose of 40 mg/kg/day for 30 days, quinacrine concentration in the brain of wild-type mice was maintained at a concentration of similar to 1 mu M. As a substrate of the P-glycoprotein (P-gp) efflux transporter, quinacrine is actively exported from the brain, preventing its accumulation to levels that may show efficacy in some disease models. In the brains of P-gp-deficient Mdr1(0/0) mice, we found quinacrine reached concentrations of similar to 80 mu M without any signs of acute toxicity. Additionally, we examined the distribution and metabolism of quinacrine in the wild-type and Mdr1(0/0) brains. In wild-type mice, the co-administration of cyclosporin A, a known P-gp inhibitor, resulted in a 6-fold increase in the accumulation of quinacrine in the brain. Our findings argue that the inhibition of the P-gp efflux transporter should improve the poor pharmacokinetic properties of quinacrine in the CNS.	[Ahn, Misol; Ghaemmaghami, Sina; May, Barnaby C. H.; Giles, Kurt; DeArmond, Stephen J.; Prusiner, Stanley B.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; [Huang, Yong] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA; [Ahn, Misol; DeArmond, Stephen J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Phuan, Puay-Wah] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Ghaemmaghami, Sina; May, Barnaby C. H.; Giles, Kurt; Prusiner, Stanley B.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ahn, M (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.	stanley@ind.ucsf.edu		Ghaemmaghami, Sina/0000-0002-8696-2950; May, Barnaby/0000-0001-9855-018X; Ahn, Misol/0000-0002-6088-8481	National Institutes of Health [AG021601, AG031220]; NATIONAL INSTITUTE ON AGING [R37AG031220, P01AG021601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health (AG021601 and AG031220) as well as by gifts from the Sherman Fairchild Foundation, Fight for Mike Homer Program, Schott Foundation for Public Education, and Lincy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benito-Leon J, 2004, CLIN NEUROPHARMACOL, V27, P201, DOI 10.1097/01.wnf.0000134853.36429.0e; BERMAN JD, 1983, AM J TROP MED HYG, V32, P947, DOI 10.4269/ajtmh.1983.32.947; Collins SJ, 2002, ANN NEUROL, V52, P503, DOI 10.1002/ana.10336; CONNELLY MC, 1984, BIOCHEM BIOPH RES CO, V121, P931, DOI 10.1016/0006-291X(84)90766-6; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; Doh-Ura K, 2004, J VIROL, V78, P4999, DOI 10.1128/JVI.78.10.4999-5006.2004; Dohgu S, 2004, CELL MOL NEUROBIOL, V24, P205, DOI 10.1023/B:CEMN.0000018617.21378.95; Dolphin GT, 2008, CHEMBIOCHEM, V9, P952, DOI 10.1002/cbic.200700602; Fromm MF, 2004, TRENDS PHARMACOL SCI, V25, P423, DOI 10.1016/j.tips.2004.06.002; Gao JT, 2009, CELL BIOL INT, V33, P874, DOI 10.1016/j.cellbi.2009.04.021; Gayrard V, 2005, BRIT J PHARMACOL, V144, P386, DOI 10.1038/sj.bjp.0706072; Geng Y, 2010, NEURO-ONCOLOGY, V12, P473, DOI 10.1093/neuonc/nop048; Ghaemmaghami S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000673; Goodman L., 1975, PHARM BASIS THERAPEU; Gorbachev AV, 2007, EUR J IMMUNOL, V37, P2257, DOI 10.1002/eji.200636708; Guo C, 2009, ONCOGENE, V28, P1151, DOI 10.1038/onc.2008.460; Huang Y, 2006, DRUG METAB DISPOS, V34, P1136, DOI 10.1124/dmd.105.008664; Jonker JW, 1999, BRIT J PHARMACOL, V127, P43, DOI 10.1038/sj.bjp.0702497; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Nakajima M, 2004, DEMENT GERIATR COGN, V17, P158, DOI 10.1159/000076350; Neznanov N, 2009, CELL CYCLE, V8, P3960, DOI 10.4161/cc.8.23.10179; Pardridge William M, 2005, NeuroRx, V2, P3; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Spilman P, 2008, P NATL ACAD SCI USA, V105, P10595, DOI 10.1073/pnas.0803671105; WALLACE DJ, 1989, SEMIN ARTHRITIS RHEU, V18, P282, DOI 10.1016/0049-0172(89)90050-4; Wang WG, 2005, CANCER BIOL THER, V4, P893, DOI 10.4161/cbt.4.8.2134; Yung L, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-53; Zipper J, 2003, INT J GYNECOL OBSTET, V83, pS7, DOI 10.1016/S0020-7292(03)90084-1	29	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39112	10.1371/journal.pone.0039112	http://dx.doi.org/10.1371/journal.pone.0039112			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768295	Green Submitted, Green Published, gold			2022-12-27	WOS:000305966500008
J	El Emam, K; Samet, S; Hu, J; Peyton, L; Earle, C; Jayaraman, GC; Wong, T; Kantarcioglu, M; Dankar, F; Essex, A				El Emam, Khaled; Samet, Saeed; Hu, Jun; Peyton, Liam; Earle, Craig; Jayaraman, Gayatri C.; Wong, Tom; Kantarcioglu, Murat; Dankar, Fida; Essex, Aleksander			A Protocol for the Secure Linking of Registries for HPV Surveillance	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINES; PRIVATE RECORD LINKAGE; PUBLIC-HEALTH; MEDICAL-RECORDS; INFORMATION; CONSENT; HIPAA	Introduction: In order to monitor the effectiveness of HPV vaccination in Canada the linkage of multiple data registries may be required. These registries may not always be managed by the same organization and, furthermore, privacy legislation or practices may restrict any data linkages of records that can actually be done among registries. The objective of this study was to develop a secure protocol for linking data from different registries and to allow on-going monitoring of HPV vaccine effectiveness. Methods: A secure linking protocol, using commutative hash functions and secure multi-party computation techniques was developed. This protocol allows for the exact matching of records among registries and the computation of statistics on the linked data while meeting five practical requirements to ensure patient confidentiality and privacy. The statistics considered were: odds ratio and its confidence interval, chi-square test, and relative risk and its confidence interval. Additional statistics on contingency tables, such as other measures of association, can be added using the same principles presented. The computation time performance of this protocol was evaluated. Results: The protocol has acceptable computation time and scales linearly with the size of the data set and the size of the contingency table. The worse case computation time for up to 100,000 patients returned by each query and a 16 cell contingency table is less than 4 hours for basic statistics, and the best case is under 3 hours. Discussion: A computationally practical protocol for the secure linking of data from multiple registries has been demonstrated in the context of HPV vaccine initiative impact assessment. The basic protocol can be generalized to the surveillance of other conditions, diseases, or vaccination programs.	[El Emam, Khaled; Samet, Saeed; Dankar, Fida; Essex, Aleksander] Childrens Hosp Eastern Ontario, Res Inst, Elect Hlth Informat Lab, Ottawa, ON K1H 8L1, Canada; [Hu, Jun; Peyton, Liam] Univ Ottawa, Sch Elect Engn & Comp Sci, Ottawa, ON, Canada; [Earle, Craig] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Jayaraman, Gayatri C.; Wong, Tom] Publ Hlth Agcy Canada, Ottawa, ON, Canada; [Kantarcioglu, Murat] Univ Texas Dallas, Dallas, TX 75230 USA; [Jayaraman, Gayatri C.] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Wong, Tom] Univ Ottawa, Div Infect Dis, Ottawa, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Toronto; Public Health Agency of Canada; University of Texas System; University of Texas Dallas; University of Ottawa; University of Ottawa	El Emam, K (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, Elect Hlth Informat Lab, Ottawa, ON K1H 8L1, Canada.	kelemam@uottawa.ca	Dankar, Fida/AAR-7015-2020	Dankar, Fida/0000-0002-1248-3295; Samet, Saeed/0000-0002-5116-5484	Canada Research Chairs program; Ontario Institute for Cancer Research; Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council; National Institutes of Health [1R01LM009989]; National Science Foundation (NSF) [Career-CNS-0845803, CNS-0964350, CNS-1016343]; Division Of Computer and Network Systems [1016343] Funding Source: National Science Foundation; NATIONAL LIBRARY OF MEDICINE [R01LM009989] Funding Source: NIH RePORTER	Canada Research Chairs program(Canada Research Chairs); Ontario Institute for Cancer Research; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was funded by the Canada Research Chairs program, the Ontario Institute for Cancer Research, a Collaborative Health Research Project grant from the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council, an operating grant from CIHR, National Institutes of Health Grant 1R01LM009989, National Science Foundation (NSF) Grant Career-CNS-0845803, and NSF Grants CNS-0964350 and CNS-1016343. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2000, SIGMOD REC, V29, P439, DOI 10.1145/335191.335438; Agrawal R., 2004, P 2004 ACM SIGMOD IN, P873; Agrawal R., 2003, P 2003 ACM SIGMOD IN, P86, DOI [DOI 10.1145/872757.872771, 10.1145/872757.872771]; Ainsworth J, 2009, 22 IEEE INT S COMP B, P1; Al-Lawati A, 2005, P 2 INT WORKSHOP INF, P59; [Anonymous], 2009, HIPAA PRIVACY RULE E; ATALLAH M. J., 2003, P 2003 ACM WORKSH PR, P39; Baker DB, 2006, ANN COMPUT SECURITY, P3, DOI 10.1145/1185657.1185757; Berman JJ, 2004, ARCH PATHOL LAB MED, V128, P344; Birtwhistle R, 2009, J AM BOARD FAM MED, V22, P412, DOI 10.3122/jabfm.2009.04.090081; Broome CV, 2003, J URBAN HEALTH, V80, pI14; Buzzigoli L, 2006, J SYMBOLIC DATA ANAL, V4, P1; Chang YL, 2009, VACCINE, V27, P4355, DOI 10.1016/j.vaccine.2009.03.008; Christine M.O., 2004, P 2004 ACM WORKSH PR, P94, DOI DOI 10.1145/1029179.1029203; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Dankar F.K., 2010, P 2010 EDBT ICDT WOR; Dawar M, 2007, CAN MED ASSOC J, V177, P456, DOI 10.1503/cmaj.070771; Denning D. E., 1979, ACM Transactions on Database Systems, V4, P76, DOI 10.1145/320064.320069; Department of Health and Human Services, DISCL EM PREP DEC TO; Department of Health and Human Services, 2004, GUID RES INV COD PRI; Department of Health and Human Services, 2008, OHRP GUID RES INV CO; Dillner J, 2011, CLIN EXP IMMUNOL, V163, P17, DOI 10.1111/j.1365-2249.2010.04268.x; Durham Elizabeth, 2010, AMIA Annu Symp Proc, V2010, P182; El Emam K, 2011, CASE DEIDENTIFYING P; El Emam K, 2009, RISK ASSESSMENT DISC; El Emam K, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-46; El Emam K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-454; El Emam K, 2011, J AM MED INFORM ASSN, V18, P212, DOI 10.1136/amiajnl-2011-000100; El Emam K, 2009, J AM MED INFORM ASSN, V16, P670, DOI 10.1197/jamia.M3144; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Gostin L, 2008, PUBLIC HLTH LAW; GPC Alberta, 2003, OIPC STAK SURV 2003; GREENFIELD CC, 1975, J ROY STAT SOC A STA, V138, P51, DOI 10.2307/2345249; He XY, 2011, J COMPUT SECUR, V19, P453, DOI 10.3233/JCS-2010-0417; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; Inan A, 2007, DATA KNOWL ENG, V63, P646, DOI 10.1016/j.datak.2007.03.015; Inan A, 2008, PROC INT CONF DATA, P496, DOI 10.1109/ICDE.2008.4497458; Karakasidis A, 2009, PROCEEDINGS OF THE 2009 FOURTH BALKAN CONFERENCE IN INFORMATICS, P101, DOI 10.1109/BCI.2009.29; Kass NE, 2003, J LAW MED ETHICS, V31, P429, DOI 10.1111/j.1748-720X.2003.tb00105.x; Kho ME, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b866; Li YZ, 2005, CHEM PHYS LETT, V404, P25, DOI 10.1016/j.cplett.2005.01.062; Lindell Y, 2000, LECT NOTES COMPUT SC, V1880, P36; Lindell Y., 2008, J PRIVACY CONFIDENT, V2008, P197, DOI DOI 10.29012/JPC.V1I1.566; Lu HB, 2008, LECT NOTES COMPUT SC, V5094, P144; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Medeiros LR, 2009, INT J GYNECOL CANCER, V19, P1166, DOI 10.1111/IGC.0b013e3181a3d100; Nair Kalpana, 2004, J Health Serv Res Policy, V9, P22, DOI 10.1258/135581904322716076; National Institutes of Health, 2005, HLTH SERV RES HIPAA; Oechslin P, 2003, LECT NOTES COMPUT SC, V2729, P617; OTIS DL, 1978, WILDLIFE MONOGR, P1; Paillier P, 1999, LECT NOTES COMPUT SC, V1592, P223; Pritts J, 2008, IMP VAL PROT PRIV HL; Pullman D, 2006, E HLTH 2006 C VICT B; Rothstein MA, 2005, J LAW MED ETHICS, V33, P154, DOI 10.1111/j.1748-720X.2005.tb00217.x; Rothstein MA, 2010, AM J BIOETHICS, V10, P3, DOI 10.1080/15265161.2010.494215; Samet Saeed, 2009, 2009 International Conference on Computational Science and Engineering (CSE), P9, DOI 10.1109/CSE.2009.94; Schadow G, 2002, P IEEE ICDM WORKSH P, V14, P55; Schnell R, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-41; Sengupta S, 2008, J AM MED INFORM ASSN, V15, P569, DOI 10.1197/jamia.M2207; Stolba N., 2006, Proceedings. The First International Conference on Availability, Reliability and Security, DOI 10.1002/9780470510544.ch2; Swire P, 2009, RES REPORT APPL IBM; U.S. Department of Health and Human Services, 2022, HIPAA PRIV RUL; Vaidya J, 2005, J COMPUT SECUR, V13, P593, DOI 10.3233/JCS-2005-13401; Van Eycken E., 2000, ARCH PUBLIC HEALTH, V50, P281; Whiddett R, 2006, INT J MED INFORM, V75, P530, DOI 10.1016/j.ijmedinf.2005.08.009; White G.C., 1982, LA8787NERP; Willison DJ, 2007, J AM MED INFORM ASSN, V14, P706, DOI 10.1197/jamia.M2457; WOJCIK R, 2007, DIS SURVEILLANCE PUB, P91; Wong J, 2010, 14 INT C INF DIS ICI; Wong T, 2009, RAPID REAL TIME SURV; Xiaoyun He, 2010, International Journal of Computational Models and Algorithms in Medicine, V1, P22, DOI 10.4018/jcmam.2010040102; Yakout M, 2009, PROC INT CONF DATA, P1283	73	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39915	10.1371/journal.pone.0039915	http://dx.doi.org/10.1371/journal.pone.0039915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	968GX	22768321	Green Published, Green Submitted, gold			2022-12-27	WOS:000305966500034
J	Goldschmidt, P; Degorge, S; Sarria, PC; Benallaoua, D; Semoun, O; Borderie, V; Laroche, L; Chaumeil, C				Goldschmidt, Pablo; Degorge, Sandrine; Sarria, Patricia Che; Benallaoua, Djida; Semoun, Oudy; Borderie, Vincent; Laroche, Laurent; Chaumeil, Christine			New Strategy for Rapid Diagnosis and Characterization of Fungal Infections: The Example of Corneal Scrapings	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CLINICAL-SAMPLES; BROAD-RANGE; PCR ASSAY; CANDIDA; DNA; IDENTIFICATION; ASPERGILLUS; DIFFERENTIATION; AMPLIFICATION	Purpose: The prognosis of people infected with Fungi especially immunocompromised depends on rapid and accurate diagnosis to capitalize on time administration of specific treatments. However, cultures produce false negative results and nucleic-acid amplification techniques require complex post-amplification procedures to differentiate relevant fungal types. The objective of this work was to develop a new diagnostic strategy based on real-time polymerase-chain reaction high-resolution melting analysis (PCR-HRM) that a) detects yeasts and filamentous Fungi, b) differentiates yeasts from filamentous Fungi, and c) discriminates among relevant species of yeasts. Methods: PCR-HRM detection limits and specificity were assessed with a) isolated strains; b) human blood samples experimentally infected with Fungi; c) blood experimentally infected with other infectious agents; d) corneal scrapings from patients with suspected fungal keratitis (culture positive and negative) and e) scrapings from patients with suspected bacterial, viral or Acanthamoeba infections. The DNAs were extracted and mixed with primers diluted in the MeltDoctor (R) HRM Master Mix in 2 tubes, the first for yeasts, containing the forward primer CandUn (5'CATGCCTGTTTGAGCGTC) and the reverse primer FungUn (5'TCCTCCGCTT ATTGATATGCT) and the second for filamentous Fungi, containing the forward primer FilamUn (5'TGCCTGTCCGAGCGTCAT) and FungUn. Molecular probes were not necessary. The yields of DNA extraction and the PCR inhibitors were systematically monitored. Results: PCR-HRM detected 0.1 Colony Forming Units (CFU)/mu l of yeasts and filamentous Fungi, differentiated filamentous Fungi from yeasts and discriminated among relevant species of yeasts. PCR-HRM performances were higher than haemoculture and sensitivity and specificity was 100% for culture positive samples, detecting and characterizing Fungi in 7 out 10 culture negative suspected fungal keratitis. Conclusions: PCR-HRM appears as a new, sensitive, specific and inexpensive test that detects Fungi and differentiates filamentous Fungi from yeasts. It allows direct fungal detection from clinical samples and experimentally infected blood in less than 2.30 h after DNA extraction.	[Goldschmidt, Pablo; Degorge, Sandrine; Benallaoua, Djida; Semoun, Oudy; Borderie, Vincent; Laroche, Laurent; Chaumeil, Christine] Ctr Hosp Natl Ophtalmol Quinze Vingts, Paris, France; [Sarria, Patricia Che] Hop St Louis, Lab Jean Dausset, Paris, France	CHNO des Quinze-Vingts; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Goldschmidt, P (corresponding author), Ctr Hosp Natl Ophtalmol Quinze Vingts, Paris, France.	pablogol@aol.com	Borderie, Vincent/AAT-1092-2021; Ghoubay, Djida/AAE-3971-2022	Borderie, Vincent/0000-0002-1395-8483; 	Laboratoire du Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Ministry of Public Health, Paris, France	Laboratoire du Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Ministry of Public Health, Paris, France	This work was funded by the Laboratoire du Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Ministry of Public Health, Paris, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan EK, 2005, BRIT J HAEMATOL, V128, P578, DOI 10.1111/j.1365-2141.2004.05333.x; Arancia S, 2006, MOL CELL PROBE, V20, P263, DOI 10.1016/j.mcp.2006.01.006; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Baskova L, 2007, J MED MICROBIOL, V56, P1167, DOI 10.1099/jmm.0.47212-0; Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; Fidel PL, 1999, CLIN MICROBIOL REV, V12, P80, DOI 10.1128/CMR.12.1.80; Goldschmidt P, 2006, BRIT J OPHTHALMOL, V90, P1354, DOI 10.1136/bjo.2006.098830; Gomez-Lopez A, 2006, DIAGN MICR INFEC DIS, V56, P387, DOI 10.1016/j.diagmicrobio.2006.06.010; Hall BJ, 2010, EYE CONTACT LENS, V36, P101, DOI 10.1097/ICL.0b013e3181d05555; Horvath LL, 2004, J CLIN MICROBIOL, V42, P115, DOI 10.1128/JCM.42.1.115-118.2004; Hsu MC, 2003, J MED MICROBIOL, V52, P1071, DOI 10.1099/jmm.0.05302-0; Innings A, 2007, J CLIN MICROBIOL, V45, P874, DOI 10.1128/JCM.01556-06; Jordanides NE, 2005, BONE MARROW TRANSPL, V35, P389, DOI 10.1038/sj.bmt.1704768; Klingspor L, 2006, CLIN MICROBIOL INFEC, V12, P745, DOI 10.1111/j.1469-0691.2006.01498.x; Loeffler J, 2000, DIAGN MICR INFEC DIS, V38, P207, DOI 10.1016/S0732-8893(00)00201-7; Maertens J, 2001, BLOOD, V97, P1604, DOI 10.1182/blood.V97.6.1604; Mandviwala T, 2010, J MOL DIAGN, V12, P91, DOI 10.2353/jmoldx.2010.090085; Marr KA, 2002, CLIN INFECT DIS, V34, P909, DOI 10.1086/339202; Monis PT, 2005, ANAL BIOCHEM, V340, P24, DOI 10.1016/j.ab.2005.01.046; Obara H, 2011, J INFECT CHEMOTHER, V17, P327, DOI 10.1007/s10156-010-0168-z; Ostrosky-Zeichner L, 2003, ANTIMICROB AGENTS CH, V47, P3149, DOI 10.1128/AAC.47.10.3149-3154.2003; Pagano L, 2006, HAEMATOLOGICA, V91, P1068; Rakeman JL, 2005, J CLIN MICROBIOL, V43, P3324, DOI 10.1128/JCM.43.7.3324-3333.2005; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Rosa C, 2011, J MED MICROBIOL, V60, P1467, DOI 10.1099/jmm.0.030601-0; Schabereiter-Gurtner C, 2007, J CLIN MICROBIOL, V45, P906, DOI 10.1128/JCM.01344-06; Selvarangan R, 2003, J CLIN MICROBIOL, V41, P5660, DOI 10.1128/JCM.41.12.5660-5664.2003; Spiess B, 2003, J CLIN MICROBIOL, V41, P1811, DOI 10.1128/JCM.41.5.1811-1818.2003; Srinivasan M, 2004, Curr Opin Ophthalmol, V15, P321, DOI 10.1097/00055735-200408000-00008; Sullivan D, 1997, J CLIN MICROBIOL, V35, P960, DOI 10.1128/JCM.35.4.960-964.1997; Szczotka-Flynn LB, 2010, EYE CONTACT LENS, V36, P116, DOI 10.1097/ICL.0b013e3181d20cae; van Doornum GJJ, 2003, J CLIN MICROBIOL, V41, P576, DOI 10.1128/JCM.41.2.576-580.2003; Vanden Bossche H, 1998, MED MYCOL, V36, P119; Vollmer T, 2008, J CLIN MICROBIOL, V46, P1919, DOI 10.1128/JCM.02178-07; Wellinghausen N, 2009, J MED MICROBIOL, V58, P1106, DOI 10.1099/jmm.0.007906-0; White PL, 2005, J CLIN MICROBIOL, V43, P2181, DOI 10.1128/JCM.43.5.2181-2187.2005	37	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e37660	10.1371/journal.pone.0037660	http://dx.doi.org/10.1371/journal.pone.0037660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768289	Green Published, gold, Green Submitted			2022-12-27	WOS:000305966500002
J	Knight, AJ; Johnson, NM; Behm, CA				Knight, Alison J.; Johnson, Nicholas M.; Behm, Carolyn A.			VHA-19 Is Essential in Caenorhabditis elegans Oocytes for Embryogenesis and Is Involved in Trafficking in Oocytes	PLOS ONE			English	Article							C-ELEGANS; GERM-LINE; CHONDROITIN PROTEOGLYCANS; MEIOTIC MATURATION; CELL-DIVISION; GENE; EXPRESSION; PROTEIN; IDENTIFICATION; REQUIREMENT	There is an urgent need to develop new drugs against parasitic nematodes, which are a significant burden on human health and agriculture. Information about the function of essential nematode-specific genes provides insight to key nematode-specific processes that could be targeted with drugs. We have characterized the function of a novel, nematode-specific Caenorhabditis elegans protein, VHA-19, and show that VHA-19 is essential in the germline and, specifically, the oocytes, for the completion of embryogenesis. VHA-19 is also involved in trafficking the oocyte receptor RME-2 to the oocyte plasma membrane and is essential for osmoregulation in the embryo, probably because VHA-19 is required for proper eggshell formation via exocytosis of cortical granules or other essential components of the eggshell. VHA-19 may also have a role in cytokinesis, either directly or as an indirect effect of its role in osmoregulation. Critically, VHA-19 is expressed in the excretory cell in both larvae and adults, suggesting that it may have a role in osmoregulation in C. elegans more generally, probably in trafficking or secretion pathways. This is the first time a role for VHA-19 has been described.	[Knight, Alison J.; Johnson, Nicholas M.; Behm, Carolyn A.] Australian Natl Univ, Res Sch Biol, Coll Med Biol & Environm, Canberra, ACT, Australia	Australian National University	Knight, AJ (corresponding author), Australian Natl Univ, Res Sch Biol, Coll Med Biol & Environm, Canberra, ACT, Australia.	Carolyn.Behm@anu.edu.au	Behm, Carolyn A/A-2102-2008	Behm, Carolyn A/0000-0002-0603-221X	Meat and Livestock Australia; Australian Government; NIH National Center for Research Resources (NCRR)	Meat and Livestock Australia(Meat and Livestock Australia); Australian Government(Australian GovernmentCGIAR); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	AK was supported in part by a Junior Research Fellowship from Meat and Livestock Australia and by an Australian Government Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Nicole Norris for critical reading of this manuscript and Daryl Webb from the Centre for Advanced Microscopy (Australian National University) for assistance with confocal microscopy. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; Bembenek JN, 2007, DEVELOPMENT, V134, P3837, DOI 10.1242/dev.011361; BRENNER S, 1974, GENETICS, V77, P71; Carvalho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024656; Choe KP, 2007, AM J PHYSIOL-CELL PH, V293, pC915, DOI 10.1152/ajpcell.00126.2007; Choi KY, 2003, GENE, V311, P13, DOI 10.1016/S0378-1119(03)00561-4; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; Edgar LG, 1995, METHOD CELL BIOL, V48, P303; Feng HT, 2008, J BIOL CHEM, V283, P13194, DOI 10.1074/jbc.M709712200; Fritz JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005117; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Hall DH, 1999, DEV BIOL, V212, P101, DOI 10.1006/dbio.1999.9356; Hall DH., 2008, C ELEGANS ATLAS; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Iwasaki K, 1996, J CELL BIOL, V134, P699, DOI 10.1083/jcb.134.3.699; Jantsch-Plunger V, 1999, CURR BIOL, V9, P738, DOI 10.1016/S0960-9822(99)80333-9; Johnston WL, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-35; Johnston WL, 2012, GENESIS, V50, P333, DOI 10.1002/dvg.20823; Kaitna S, 2002, J CELL SCI, V115, P2293; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kelly WG, 1998, DEVELOPMENT, V125, P2451; Kelly WG, 1997, GENETICS, V146, P227; Koenning SR, 1999, J NEMATOL, V31, P587; Kosinski M, 2005, DEVELOPMENT, V132, P3357, DOI 10.1242/dev.01916; Kuwabara PE, 2000, GENE DEV, V14, P1933; LAMUNYON CW, 1995, EXPERIENTIA, V51, P817, DOI 10.1007/BF01922436; Miller MA, 2001, SCIENCE, V291, P2144, DOI 10.1126/science.1057586; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Oka T, 2000, J BIOL CHEM, V275, P29556, DOI 10.1074/jbc.M002756200; Olson SK, 2006, J CELL BIOL, V173, P985, DOI 10.1083/jcb.200603003; Rappleye CA, 1999, GENE DEV, V13, P2838, DOI 10.1101/gad.13.21.2838; Rappleye Chad A, 2003, BMC Dev Biol, V3, P8, DOI 10.1186/1471-213X-3-8; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; SCHEDL T, 1988, GENETICS, V119, P43; SHARROCK WJ, 1990, J BIOL CHEM, V265, P14422; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Skop AR, 2001, CURR BIOL, V11, P735, DOI 10.1016/S0960-9822(01)00231-7; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Spencer WC, 2011, GENOME RES, V21, P325, DOI 10.1101/gr.114595.110; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Wang X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-213; WARD S, 1979, DEV BIOL, V73, P304, DOI 10.1016/0012-1606(79)90069-1; Xu XZ, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-114	50	2	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40317	10.1371/journal.pone.0040317	http://dx.doi.org/10.1371/journal.pone.0040317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768351	Green Published, Green Submitted, gold			2022-12-27	WOS:000305966500064
J	Mellone, U; Klaassen, RHG; Garcia-Ripolles, C; Liminana, R; Lopez-Lopez, P; Pavon, D; Strandberg, R; Urios, V; Vardakis, M; Alerstam, T				Mellone, Ugo; Klaassen, Raymond H. G.; Garcia-Ripolles, Clara; Liminana, Ruben; Lopez-Lopez, Pascual; Pavon, Diego; Strandberg, Roine; Urios, Vicente; Vardakis, Michalis; Alerstam, Thomas			Interspecific Comparison of the Performance of Soaring Migrants in Relation to Morphology, Meteorological Conditions and Migration Strategies	PLOS ONE			English	Article							CIRCUS-AERUGINOSUS MIGRATION; FLIGHT STRATEGIES; EAGLES; SPEED; MARSH; WIND; FLEXIBILITY; RAPTORS; SAHARA; RADAR	Background: Performance of migrating birds can be affected by a number of intrinsic and extrinsic factors like morphology, meteorological conditions and migration strategies. We compared travel speeds of four raptor species during their crossing of the Sahara desert. Focusing the analyses on this region allows us to compare different species under equivalent conditions in order to disentangle which factors affect migratory performance. Methodology/Principal Finding: We tracked raptors using GPS satellite transmitters from Sweden, Spain and Italy, and evaluated their migratory performance at both an hourly and a daily scale. Hourly data (flight speed and altitude for intervals of two hours) were analyzed in relation to time of day, species and season, and daily data (distance between roosting sites) in relation to species, season, day length and tailwind support. Conclusions/Significance: Despite a clear variation in morphology, interspecific differences were generally very small, and did only arise in spring, with long-distance migrants (>5000 km: osprey and Western marsh-harrier) being faster than species that migrate shorter distances (Egyptian vulture and short-toed eagle). Our results suggest that the most important factor explaining hourly variation in flight speed is time of day, while at a daily scale, tailwind support is the most important factor explaining variation in daily distance, raising new questions about the consequences of possible future changes in worldwide wind patterns.	[Mellone, Ugo; Garcia-Ripolles, Clara; Liminana, Ruben; Lopez-Lopez, Pascual; Urios, Vicente] Univ Alicante, CIBIO, Vertebrates Zool Res Grp, Estn Biol Terra Nat, E-03080 Alicante, Spain; [Klaassen, Raymond H. G.; Strandberg, Roine; Vardakis, Michalis; Alerstam, Thomas] Lund Univ, Dept Biol, Lund, Sweden; [Liminana, Ruben] CSIC UCLM JCCM, Inst Invest Recursos Cineget IREC, Ciudad Real, Spain; [Pavon, Diego] Univ Helsinki, Bird Ecol Unit, Dept Biosci, Helsinki, Finland	Universitat d'Alacant; Lund University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; University of Helsinki	Mellone, U (corresponding author), Univ Alicante, CIBIO, Vertebrates Zool Res Grp, Estn Biol Terra Nat, E-03080 Alicante, Spain.	ugomellone@libero.it	Klaassen, Raymond/K-3027-2013; López-López, Pascual/C-1039-2011; Urios, Vicente/AAD-4800-2022	López-López, Pascual/0000-0001-5269-652X; Liminana, Ruben/0000-0001-8152-3644; Pavon-Jordan, Diego/0000-0001-5105-3426	Swedish Research Council; Terra Natura Foundation; Diputacion de Alicante; Parco Gallipoli Cognato Piccole Dolomiti Lucane; FPU grant of the Spanish Ministerio de Educacion [AP2008-0947]; "Consejeria de Educacion y Ciencia" (JCCM); European Social Fund; Spanish Ministry of Economy and Competitiveness [JCI-2011-09588]; Research Foundation of The University of Helsinki;  [10/12-C]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Terra Natura Foundation; Diputacion de Alicante; Parco Gallipoli Cognato Piccole Dolomiti Lucane; FPU grant of the Spanish Ministerio de Educacion(German Research Foundation (DFG)); "Consejeria de Educacion y Ciencia" (JCCM); European Social Fund(European Social Fund (ESF)); Spanish Ministry of Economy and Competitiveness(Spanish Government); Research Foundation of The University of Helsinki; 	Satellite tracking studies were supported by the Swedish Research Council (Swedish birds, grant to TA), Terra Natura Foundation and Diputacion de Alicante (Spanish birds), and Parco Gallipoli Cognato Piccole Dolomiti Lucane (Italian birds). UM is supported by a FPU grant of the Spanish Ministerio de Educacion (reference AP2008-0947) and carried out this research during a stay at the Department of Biology and Centre for Animal Movement Research (Lund University, Sweden). RHGK was supported by a postdoctoral grant from the Swedish Research Council. RL has a postdoctoral grant (reference 10/12-C) co-funded by "Consejeria de Educacion y Ciencia" (JCCM) and the European Social Fund. PLL is supported by a "Juan de la Cierva" postdoctoral grant of the Spanish Ministry of Economy and Competitiveness (reference JCI-2011-09588). DP is awarded with a grant from the Research Foundation of The University of Helsinki. This paper is part of the Ph.D. dissertation of UM at the University of Alicante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini N, 2010, J RAPTOR RES, V44, P136, DOI 10.3356/JRR-09-48.1; Alerstam T, 2006, ANIM BEHAV, V71, P555, DOI 10.1016/j.anbehav.2005.05.016; Alerstam T, 2003, AVIAN MIGRATION, P253; Alerstam T, 1998, J AVIAN BIOL, V29, P343, DOI 10.2307/3677155; Alerstam T, 2006, ARDEA, V94, P347; Alerstam T, 2007, PLOS BIOL, V5, P1656, DOI 10.1371/journal.pbio.0050197; Bauchinger U, 2005, J AVIAN BIOL, V36, P3, DOI 10.1111/j.0908-8857.2005.03444.x; Bildstein K. L., 2006, MIGRATING RAPTORS WO; Bohrer G, 2012, ECOL LETT, V15, P96, DOI 10.1111/j.1461-0248.2011.01713.x; Bruderer B, 2001, IBIS, V143, P178, DOI 10.1111/j.1474-919X.2001.tb04475.x; Chevallier D, 2010, P ROY SOC B-BIOL SCI, V277, P2755, DOI 10.1098/rspb.2010.0422; Garcia-Ripolles C, 2010, BIRD STUDY, V57, P261, DOI 10.1080/00063650903505762; Goudie A.S., 2006, DESERT DUST GLOBAL S; HEDENSTROM A, 1993, PHILOS T ROY SOC B, V342, P353, DOI 10.1098/rstb.1993.0164; Kemp MU, 2012, METHODS ECOL EVOL, V3, P65, DOI 10.1111/j.2041-210X.2011.00138.x; Kerlinger P., 1989, FLIGHT STRATEGIES MI; Klaassen RHG, 2008, BEHAV ECOL SOCIOBIOL, V62, P1427, DOI 10.1007/s00265-008-0572-x; Klaassen RHG, 2012, BEHAV ECOL, V23, P58, DOI 10.1093/beheco/arr150; Klaassen RHG, 2011, P ROY SOC B-BIOL SCI, V278, P1339, DOI 10.1098/rspb.2010.2106; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; Kvist A, 2000, PHYSIOL BIOCHEM ZOOL, V73, P30, DOI 10.1086/316719; Liminana R, 2012, IBIS, V154, P389, DOI 10.1111/j.1474-919X.2011.01210.x; Lopez-Lopez P, 2010, LANDSCAPE ECOL, V25, P803, DOI 10.1007/s10980-010-9460-7; Mandel JT, 2008, P NATL ACAD SCI USA, V105, P19102, DOI 10.1073/pnas.0801789105; Mandel JT, 2011, ECOL APPL, V21, P2258, DOI 10.1890/10-1651.1; Mellone U, 2011, J AVIAN BIOL, V42, P468, DOI 10.1111/j.1600-048X.2011.05454.x; Mellone U, 2011, BIRD STUDY, V58, P516, DOI 10.1080/00063657.2011.598914; Mellone U, 2011, INT J BIOMETEOROL, V55, P463, DOI 10.1007/s00484-010-0368-3; Pavon D, 2010, ARDEA, V98, P113, DOI 10.5253/078.098.0114; PENNYCUICK CJ, 1979, ORNIS SCAND, V10, P241, DOI 10.2307/3676068; PENNYCUICK CJ, 1978, OIKOS, V30, P165, DOI 10.2307/3543476; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Schmaljohann H, 2007, P R SOC B, V274, P735, DOI 10.1098/rspb.2006.0011; Shamoun-Baranes J, 2003, J AVIAN BIOL, V34, P97, DOI 10.1034/j.1600-048X.2003.03079.x; Shamoun-Baranes J, 2011, IBIS, V153, P411, DOI 10.1111/j.1474-919X.2010.01096.x; Spaar R, 1997, IBIS, V139, P523, DOI 10.1111/j.1474-919X.1997.tb04669.x; Spaar R, 1997, CONDOR, V99, P458, DOI 10.2307/1369952; Strandberg R, 2010, BIOL LETTERS, V6, P297, DOI 10.1098/rsbl.2009.0785; Strandberg R, 2009, ARDEA, V97, P287, DOI 10.5253/078.097.0304; Strandberg R, 2008, ARDEA, V96, P159, DOI 10.5253/078.096.0202; Strandberg R, 2009, IBIS, V151, P200, DOI 10.1111/j.1474-919X.2008.00890.x; Thorup K, 2003, P ROY SOC B-BIOL SCI, V270, pS8, DOI 10.1098/rsbl.2003.0014; TUCKER CJ, 1991, SCIENCE, V253, P299, DOI 10.1126/science.253.5017.299; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270	44	68	71	0	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39833	10.1371/journal.pone.0039833	http://dx.doi.org/10.1371/journal.pone.0039833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768314	Green Published, gold			2022-12-27	WOS:000305966500027
J	Anel, JA; Blanco-Duran, M; Gimeno, L; de la Torre, L				Anel, Juan A.; Blanco-Duran, Marcos; Gimeno, Luis; de la Torre, Laura			Recovery of Meteorological Data for the Observatory of A Guarda, Spain	PLOS ONE			English	Article							SURFACE OZONE; PRECIPITATION; ATLANTIC; 20TH-CENTURY; WIND	We herein describe the recovery of a series of data on temperature, humidity, precipitation, evaporation, wind, and local weather conditions from documentary sources obtained from the Jesuit observatory of A Guarda (Galicia, Spain) for the period 1881-1896. The data were digitized and made available in accessible electronic formats. Comparisons were made with present-day meteorological data obtained from two nearby stations. We further believe that the discovery of some new complementary documentary sources made during the present research could be a basis for future data recovery efforts. Among these new results, early ozone data from the period are of outstanding importance to meteorologists.	[Anel, Juan A.] Univ Oxford, Smith Sch Enterprise & Environm, Oxford, England; [Anel, Juan A.; Blanco-Duran, Marcos; Gimeno, Luis; de la Torre, Laura] Univ Vigo, Fac Ciencias, EPhysLab, Orense, Galicia, Spain	University of Oxford; Universidade de Vigo	Anel, JA (corresponding author), Univ Oxford, Smith Sch Enterprise & Environm, Oxford, England.	juan.anel@smithschool.ox.ac.uk	, Juan Antonio Añel Cabanelas/N-1866-2019; de la Torre, Laura/Y-3723-2019; GIMENO, LUIS/B-8137-2008	, Juan Antonio Añel Cabanelas/0000-0003-2448-4647; de la Torre, Laura/0000-0001-5305-6946; GIMENO, LUIS/0000-0002-0778-3605	Ministerio de Medio Ambiente y Medio Rural y Marino (Spanish Ministry of Environment and Rural and Marine Areas) through the Salva-Sinobas Project [20080050083542]; European Regional Development Fund	Ministerio de Medio Ambiente y Medio Rural y Marino (Spanish Ministry of Environment and Rural and Marine Areas) through the Salva-Sinobas Project; European Regional Development Fund(European Commission)	This study was partially funded by the Ministerio de Medio Ambiente y Medio Rural y Marino (Spanish Ministry of Environment and Rural and Marine Areas) through the Salva-Sinobas Project (Ref. 20080050083542) and the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ACRE, 2010, ACRE IN INT ATM CIRC; Blanco-Duran M, 2008, HIST METEROLOXIA CLI; Bronnimann S, 2006, CLIM PAST, V2, P137; CARTALIS C, 1994, ATMOS ENVIRON, V28, P3, DOI 10.1016/1352-2310(94)90018-3; Eisenberg JD, 2005, OASIS OPENDOCUMENT E; Garcia NO, 2005, ATMOSFERA, V18, P25; Herrera RG, 2003, B AM METEOROL SOC, V84, P1025, DOI 10.1175/BAMS-84-8-1025; Hurrell J, 2003, CLIMATE VARIABILITY, V2, P439; Iribarne JV, 1996, TERMODINAMICA ATMOSF, P296; Jones PD, 1997, INT J CLIMATOL, V17, P1433, DOI 10.1002/(SICI)1097-0088(19971115)17:13<1433::AID-JOC203>3.0.CO;2-P; LINVILL DE, 1980, MON WEATHER REV, V108, P1883, DOI 10.1175/1520-0493(1980)108<1883:OIME>2.0.CO;2; Merino B, 1897, OBSERVATORIO METEORO; Merino B, 1894, OBSERVATORIO METEORO; Merino B, 1893, ESTUDIO BORRASCAS CO, V65; Merino Baltasar, 1891, RESUMEN OBSERVACIONE; OASIS, 2005, OP DOC FORM OFF APPL; Rodrigo FS, 2008, GLOBAL PLANET CHANGE, V63, P243, DOI 10.1016/j.gloplacha.2007.09.004; Servicio Meteorologico Nacional, 1943, SER MAS LARG OBS P D; Tank AMGK, 2002, INT J CLIMATOL, V22, P1441, DOI 10.1002/joc.773; Trigo RM, 2008, ANN NY ACAD SCI, V1146, P212, DOI 10.1196/annals.1446.014; Trigo RM, 2004, INT J CLIMATOL, V24, P925, DOI 10.1002/joc.1048; Udias A, 2003, SEARCHING HEAVENS EA, P369; Udias A, 1996, B AM METEOROL SOC, V7, P2307; VAROTSOS C, 1994, TOXICOL ENVIRON CHEM, V44, P233, DOI 10.1080/02772249409358062; WMO, 2008, MEDARE P INT WORKSH; WMO, 2004, 1210 WMOTD, V1210, P1210	26	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39281	10.1371/journal.pone.0039281	http://dx.doi.org/10.1371/journal.pone.0039281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768069	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100040
J	Hussain, AR; Ahmed, SO; Ahmed, M; Khan, OS; Al AbdulMohsen, S; Platanias, LC; Al-Kuraya, KS; Uddin, S				Hussain, Azhar R.; Ahmed, Saeeda O.; Ahmed, Maqbool; Khan, Omar S.; Al AbdulMohsen, Sally; Platanias, Leonidas C.; Al-Kuraya, Khawla S.; Uddin, Shahab			Cross-Talk between NFkB and the PI3-Kinase/AKT Pathway Can Be Targeted in Primary Effusion Lymphoma (PEL) Cell Lines for Efficient Apoptosis	PLOS ONE			English	Article							KAPPA-B ACTIVATION; SARCOMA-ASSOCIATED HERPESVIRUS; KINASE PROTEIN-2 DEGRADATION; FATTY-ACID SYNTHASE; CONSTITUTIVE ACTIVATION; EXPRESSION; INHIBITION; BAX; PROLIFERATION; SUPPRESSION	Background: A number of constitutively activated signaling pathways play critical roles in the survival and growth of primary effusion lymphoma cells (PELs) including NFkB and PI3/AKT kinase cascades. NFkB is constitutively activated in a number of malignancies, including multiple myeloma, Burkitt's lymphoma and diffuse large cell B-cell lymphoma. However, its role in primary effusion lymphoma has not been fully explored. Methodology/Principal Findings: We used pharmacological inhibition and gene silencing to define the role of NFkB in growth and survival of PEL cells. Inhibition of NFkB activity by Bay11-7085 resulted in decreased expression of p65 in the nuclear compartment as detected by EMSA assays. In addition, Bay11-7085 treatment caused de-phosphorylation of AKT and its downstream targets suggesting a cross-talk between NFkB and the PI3-kinase/AKT pathway. Importantly, treatment of PEL cells with Bay11-7085 led to inhibition of cell viability and induced apoptosis in a dose dependent manner. Similar apoptotic effects were found when p65 was knocked down using specific small interference RNA. Finally, co-treatment of PEL cells with suboptimal doses of Bay11-7085 and LY294002 led to synergistic apoptotic responses in PEL cells. Conclusion/Significance: These data support a strong biological-link between NFkB and the PI3-kinase/AKT pathway in the modulation of anti-apoptotic effects in PEL cells. Synergistic targeting of these pathways using NFKB- and PI3-kinase/AKT-inhibitors may have a therapeutic potential for the treatment of PEL and possibly other malignancies with constitutive activation of these pathways.	[Hussain, Azhar R.; Ahmed, Saeeda O.; Ahmed, Maqbool; Khan, Omar S.; Al AbdulMohsen, Sally; Al-Kuraya, Khawla S.; Uddin, Shahab] King Faisal Specialist Hosp & Res Ctr, Res Ctr, Riyadh 11211, Saudi Arabia; [Platanias, Leonidas C.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA	King Faisal Specialist Hospital & Research Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Hussain, AR (corresponding author), King Faisal Specialist Hosp & Res Ctr, Res Ctr, Riyadh 11211, Saudi Arabia.	Shahab@kfshrc.edu.sa		Khan, Omar/0000-0002-4998-1693; Uddin, Shahab/0000-0003-1886-6710				An J, 2004, LEUKEMIA, V18, P1699, DOI 10.1038/sj.leu.2403460; Ansari MQ, 1996, AM J CLIN PATHOL, V105, P221; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Aoki Y, 2001, BLOOD, V97, P2173, DOI 10.1182/blood.V97.7.2173; Arora Anita, 2007, Cancer Treat Res, V133, P21; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Boulanger E, 2008, AM J TRANSPLANT, V8, P707, DOI 10.1111/j.1600-6143.2007.02110.x; Brimo F, 2007, CANCER CYTOPATHOL, V111, P224, DOI 10.1002/cncr.22691; Carbone A, 2008, BRIT J HAEMATOL, V140, P13, DOI 10.1111/j.1365-2141.2007.06879.x; Chen JH, 2004, BIOCHEM PHARMACOL, V67, P1337, DOI 10.1016/j.bcp.2003.12.015; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cras A, 2011, CLIN CANC RES; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Fisher RI, 2003, LEUKEMIA, V17, P1948, DOI 10.1038/sj.leu.2403096; Ganem D, 2007, KSHV INDUCED ONCOGEN; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Ghosh-Choudhury N, 2010, CELL SIGNAL, V22, P749, DOI 10.1016/j.cellsig.2009.12.010; Gogvadze V, 2001, J BIOL CHEM, V276, P19066, DOI 10.1074/jbc.M100614200; Grossmann C, 2008, VIROLOGY, V375, P94, DOI 10.1016/j.virol.2007.12.044; Han SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-97; Hussain AR, 2006, APOPTOSIS, V11, P245, DOI 10.1007/s10495-006-3392-3; Hussain AR, 2008, MOL CANCER THER, V7, P3318, DOI 10.1158/1535-7163.MCT-08-0541; Hussain AR, 2007, CANCER RES, V67, P3888, DOI 10.1158/0008-5472.CAN-06-3764; Hussain AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024703; Hussain AR, 2009, LEUKEMIA LYMPHOMA, V50, P1204, DOI 10.1080/10428190902951799; Jones KD, 1999, BLOOD, V94, P2871; Joseph B, 2002, ONCOGENE, V21, P65, DOI 10.1038/sj/onc/1205018; Keller SA, 2000, BLOOD, V96, P2537; Kim SW, 2008, BLOOD, V111, P1644, DOI 10.1182/blood-2007-05-088591; Melo NCV, 2008, AM J TRANSPLANT, V8, P906, DOI 10.1111/j.1600-6143.2008.02156.x; Rahman MA, 2010, NUTR CANCER, V62, P973, DOI 10.1080/01635581.2010.509538; Raskatov JA, 2011, P NATL ACAD SCI US; Rossi D, 2003, HAEMATOLOGICA, V88, P212; Scheid MP, 2000, CURR BIOL, V10, pR191, DOI 10.1016/S0960-9822(00)00349-3; Sethi G, 2008, MOL CANCER RES, V6, P1059, DOI 10.1158/1541-7786.MCR-07-2088; Shishodia S, 2005, BIOCHEM PHARMACOL, V70, P700, DOI 10.1016/j.bcp.2005.04.043; Smolewski P, 2011, CURR MOL MED, V11, P633, DOI 10.2174/156652411797536723; Uddin S, 2005, ONCOGENE, V24, P7022, DOI 10.1038/sj.onc.1208864; Uddin S, 2005, CLIN CANCER RES, V11, P3102, DOI 10.1158/1078-0432.CCR-04-1857; Uddin S, 2004, P NATL ACAD SCI USA, V101, P147, DOI 10.1073/pnas.0307075101; Uddin S, 2008, J CLIN ENDOCR METAB, V93, P4088, DOI 10.1210/jc.2008-0503; Uddin S, 2008, CANCER RES, V68, P3379, DOI 10.1158/0008-5472.CAN-07-6109; Uddin S, 2009, AM J GASTROENTEROL, V104, P1790, DOI 10.1038/ajg.2009.230; Wu SJ, 2009, J CLIN VIROL, V44, P81, DOI 10.1016/j.jcv.2008.08.015; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	49	114	120	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39945	10.1371/journal.pone.0039945	http://dx.doi.org/10.1371/journal.pone.0039945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768179	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100149
J	Julien, C; Marcouiller, F; Bretteville, A; El Khoury, NB; Baillargeon, J; Hebart, SS; Planel, E				Julien, Carl; Marcouiller, Francois; Bretteville, Alexis; El Khoury, Noura B.; Baillargeon, Joanie; Hebart, Sebastien S.; Planel, Emmanuel			Dimethyl Sulfoxide Induces Both Direct and Indirect Tau Hyperphosphorylation	PLOS ONE			English	Article							NEURONAL CELL-DEATH; COLD-WATER STRESS; ALZHEIMERS-DISEASE; IN-VIVO; NEUROFIBRILLARY PATHOLOGY; PROTEIN PHOSPHATASE-2A; PHOSPHORYLATION SITES; INHIBITION; HYPOTHERMIA; KINASE	Dimethyl sulfoxide (DMSO) is widely used as a solvent or vehicle for biological studies, and for treatment of specific disorders, including traumatic brain injury and several forms of amyloidosis. As Alzheimer's disease (AD) brains are characterized by deposits of beta-amyloid peptides, it has been suggested that DMSO could be used as a treatment for this devastating disease. AD brains are also characterized by aggregates of hyperphosphorylated tau protein, but the effect of DMSO on tau phosphorylation is unknown. We thus investigated the impact of DMSO on tau phosphorylation in vitro and in vivo. One hour following intraperitoneal administration of 1 or 2 ml/kg DMSO in mice, no change was observed in tau phosphorylation. However, at 4 ml/kg, tau was hyperphosphorylated at AT8 (Ser(202)/Thr(205)), PHF-1 (Ser(396)/Ser(404)) and AT180 (Thr(231)) epitopes. At this dose, we also noticed that the animals were hypothermic. When the mice were maintained normothermic, the effect of 4 ml/kg DMSO on tau hyperphosphorylation was prevented. On the other hand, in SH-SY5Y cells, 0.1% DMSO induced tau hyperphosphorylation at AT8 and AT180 phosphoepitopes in normothermic conditions. Globally, these findings demonstrate that DMSO can induce tau hyperphosphorylation indirectly via hypothermia in vivo, and directly in vitro. These data should caution researchers working with DMSO as it can induce artifactual results both in vivo and in vitro.	[Julien, Carl; Marcouiller, Francois; Bretteville, Alexis; El Khoury, Noura B.; Baillargeon, Joanie; Hebart, Sebastien S.; Planel, Emmanuel] Univ Laval, Fac Med, Dept Neurosci & Psychiat, Quebec City, PQ G1K 7P4, Canada; [Julien, Carl; Marcouiller, Francois; Bretteville, Alexis; El Khoury, Noura B.; Baillargeon, Joanie; Hebart, Sebastien S.; Planel, Emmanuel] Univ Quebec, Ctr Hosp, Ctr Rech, Axe Neurosci, Quebec City, PQ, Canada	Laval University; Laval University; University of Quebec	Julien, C (corresponding author), Univ Laval, Fac Med, Dept Neurosci & Psychiat, Quebec City, PQ G1K 7P4, Canada.	carl.julien@crchul.ulaval.ca; emmanuel@planel.org	Hébert, Sébastien S./Q-2729-2017; Julien, Carl/AAU-5309-2021	Planel, Emmanuel/0000-0001-5128-0565; Hebert, Sebastien/0000-0002-0391-9325	Canadian Institute of Health Research [MOP-106423, PCN-102993]; Natural Sciences and Engineering Research Council of Canada [354722]; Fonds de la recherche en sante du Quebec [16205, 20048]; Alzheimer Society of Canada; Alzheimer Society of Saskatchewan	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Alzheimer Society of Canada; Alzheimer Society of Saskatchewan	This work was supported by grants to EP from the Canadian Institute of Health Research (MOP-106423, PCN-102993) (www.cihr-irsc.gc.ca), the Natural Sciences and Engineering Research Council of Canada (354722) (www.nserc-crsng.gc.ca), the Fonds de la recherche en sante du Quebec (16205, 20048) (www.frsq.gouv.qc.ca). CJ was supported by Postdoctoral Awards from the Alzheimer Society of Canada and the Alzheimer Society of Saskatchewan (www.alzheimer.ca). NBEK was supported by a Doctoral Award from the Alzheimer Society of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTLAND PD, 1966, P SOC EXP BIOL MED, V123, P853; ASHWOODS.MJ, 1967, ANN NY ACAD SCI, V141, P45, DOI 10.1111/j.1749-6632.1967.tb34865.x; Balakin KV, 2006, CURR MED CHEM, V13, P223, DOI 10.2174/092986706775197917; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BROADWELL RD, 1982, SCIENCE, V217, P164, DOI 10.1126/science.7089551; CAUJOLLE F, 1964, CR HEBD ACAD SCI, V258, P2224; de Oliveira ACP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-2; Delobel P, 2002, J NEUROCHEM, V83, P412, DOI 10.1046/j.1471-4159.2002.01143.x; Dugo L, 2005, CRIT CARE MED, V33, P1903, DOI 10.1097/01.CCM.0000178350.21839.44; FARRANT J, 1964, J PHARM PHARMACOL, V16, P472, DOI 10.1111/j.2042-7158.1964.tb07496.x; Feng Q, 2005, NEUROSCI LETT, V388, P13, DOI 10.1016/j.neulet.2005.06.022; Goedert M, 1996, ANN NY ACAD SCI, V777, P121, DOI 10.1111/j.1749-6632.1996.tb34410.x; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; GOEDERT M, 1992, FEBS LETT, V312, P95, DOI 10.1016/0014-5793(92)81418-L; Goldbaum O, 2002, GLIA, V40, P271, DOI 10.1002/glia.10119; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; Hamdane M, 2005, J CELL SCI, V118, P1291, DOI 10.1242/jcs.01724; Hamdane M, 2003, J BIOL CHEM, V278, P34026, DOI 10.1074/jbc.M302872200; Jacob SW, 2009, PHARMACOL REP, V61, P225, DOI 10.1016/S1734-1140(09)70026-X; KORNEYEV A, 1995, NEUROSCI LETT, V191, P19, DOI 10.1016/0304-3940(95)11546-3; LOVELOCK JE, 1959, NATURE, V183, P1394, DOI 10.1038/1831394a0; Mailliot C, 2000, ANN NY ACAD SCI, V920, P107; Martins DF, 2011, J PAIN, V12, P315, DOI 10.1016/j.jpain.2010.06.007; Okawa Y, 2003, FEBS LETT, V535, P183, DOI 10.1016/S0014-5793(02)03883-8; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Paquet D, 2009, J CLIN INVEST, V119, P1382, DOI 10.1172/JCI37537; Patel SJ, 2012, NAT BIOTECHNOL, V30, P179, DOI 10.1038/nbt.2089; Pegg David E, 2007, Methods Mol Biol, V368, P39; Planel E, 2001, J BIOL CHEM, V276, P34298, DOI 10.1074/jbc.M102780200; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; Planel E, 2007, J NEUROSCI, V27, P13635, DOI 10.1523/JNEUROSCI.3949-07.2007; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Planel E, 2009, FASEB J, V23, P2595, DOI 10.1096/fj.08-122424; Pohjanvirta R, 2002, FOOD CHEM TOXICOL, V40, P1023, DOI 10.1016/S0278-6915(02)00067-4; Porzig R, 2007, BIOCHEM BIOPH RES CO, V358, P644, DOI 10.1016/j.bbrc.2007.04.187; Qian W, 2010, J ALZHEIMERS DIS, V19, P1221, DOI [10.3233/JAD-2009-1317, 10.3233/JAD-2010-1317]; Regelson W, 1997, ANN NY ACAD SCI, V826, P348, DOI 10.1111/j.1749-6632.1997.tb48485.x; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Roller J, 2010, LANGENBECK ARCH SURG, V395, P387, DOI 10.1007/s00423-010-0603-8; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; Selenica ML, 2007, BRIT J PHARMACOL, V152, P959, DOI 10.1038/sj.bjp.0707471; SU JH, 1994, NEUROREPORT, V5, P2358, DOI 10.1097/00001756-199411000-00037; Villarreal JS, 2006, NEUROBIOL LEARN MEM, V85, P44, DOI 10.1016/j.nlm.2005.08.005; Wang JZ, 1996, MOL BRAIN RES, V38, P200, DOI 10.1016/0169-328X(95)00316-K; Watanabe E, 2000, BIOL PHARM BULL, V23, P838; Whittington RA, 2010, CURR ALZHEIMER RES, V7, P717; Whittington RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016648; WOOD DC, 1975, ANN NY ACAD SCI, V243, P7, DOI 10.1111/j.1749-6632.1975.tb25339.x; Zhu GC, 2006, TRANSPLANT P, V38, P3307, DOI 10.1016/j.transproceed.2006.10.114	50	22	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40020	10.1371/journal.pone.0040020	http://dx.doi.org/10.1371/journal.pone.0040020			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768202	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100174
J	Liu, ZJ; Kumari, S; Zhang, LF; Zheng, YL; Ware, D				Liu, Zhijie; Kumari, Sunita; Zhang, Lifang; Zheng, Yonglian; Ware, Doreen			Characterization of miRNAs in Response to Short-Term Waterlogging in Three Inbred Lines of Zea mays	PLOS ONE			English	Article							STRESS-REGULATED MICRORNAS; DNA-BINDING SPECIFICITY; ZINC-FINGER PROTEIN; LOOP RT-PCR; TRANSCRIPTION FACTORS; ABSCISIC-ACID; SMALL RNAS; MOLECULAR CHARACTERIZATION; AERENCHYMA FORMATION; ENDOGENOUS SIRNAS	Waterlogging of plants leads to low oxygen levels (hypoxia) in the roots and causes a metabolic switch from aerobic respiration to anaerobic fermentation that results in rapid changes in gene transcription and protein synthesis. Our research seeks to characterize the microRNA-mediated gene regulatory networks associated with short-term waterlogging. MicroRNAs (miRNAs) are small non-coding RNAs that regulate many genes involved in growth, development and various biotic and abiotic stress responses. To characterize the involvement of miRNAs and their targets in response to short-term hypoxia conditions, a quantitative real time PCR (qRT-PCR) assay was used to quantify the expression of the 24 candidate mature miRNA signatures (22 known and 2 novel mature miRNAs, representing 66 miRNA loci) and their 92 predicted targets in three inbred Zea mays lines (waterlogging tolerant Hz32, mid-tolerant B73, and sensitive Mo17). Based on our studies, miR159, miR164, miR167, miR393, miR408 and miR528, which are mainly involved in root development and stress responses, were found to be key regulators in the post-transcriptional regulatory mechanisms under short-term waterlogging conditions in three inbred lines. Further, computational approaches were used to predict the stress and development related cis-regulatory elements on the promoters of these miRNAs; and a probable miRNA-mediated gene regulatory network in response to short-term waterlogging stress was constructed. The differential expression patterns of miRNAs and their targets in these three inbred lines suggest that the miRNAs are active participants in the signal transduction at the early stage of hypoxia conditions via a gene regulatory network; and crosstalk occurs between different biochemical pathways.	[Liu, Zhijie; Zheng, Yonglian] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [Liu, Zhijie; Kumari, Sunita; Zhang, Lifang; Ware, Doreen] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Ware, Doreen] USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA	Huazhong Agricultural University; Cold Spring Harbor Laboratory; United States Department of Agriculture (USDA)	Liu, ZJ (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	yonglianzheng@gmail.com; ware@cshl.edu			USDA [1907-21000-030]; project 111, Ministry of Education of China and State Administration of Foreign Experts Affairs of China [B07041]	USDA(United States Department of Agriculture (USDA)); project 111, Ministry of Education of China and State Administration of Foreign Experts Affairs of China	This work was supported by a USDA grant (1907-21000-030, www.usda.gov), and project 111 (B07041, Ministry of Education of China and State Administration of Foreign Experts Affairs of China) (http://www.moe.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Hernandez GJ, 2005, PLANT J, V43, P506, DOI 10.1111/j.1365-313X.2005.02468.x; Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; ADMAN ET, 1991, ADV PROTEIN CHEM, V42, P145; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Bracht J, 2004, RNA, V10, P1586, DOI 10.1261/rna.7122604; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Cardon G, 1999, GENE, V237, P91, DOI 10.1016/S0378-1119(99)00308-X; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Colasanti J, 2000, TRENDS BIOCHEM SCI, V25, P236, DOI 10.1016/S0968-0004(00)01542-5; Colasanti J, 1998, CELL, V93, P593, DOI 10.1016/S0092-8674(00)81188-5; Colmer TD, 2006, NEW PHYTOL, V170, P767, DOI 10.1111/j.1469-8137.2006.01725.x; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Dennis ES, 2000, J EXP BOT, V51, P89, DOI 10.1093/jexbot/51.342.89; DENNIS ES, 1988, J MOL BIOL, V202, P759, DOI 10.1016/0022-2836(88)90556-6; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Feng JL, 2009, GENE, V437, P14, DOI 10.1016/j.gene.2009.01.017; Gao P, 2011, MOL BIOL REP, V38, P237, DOI 10.1007/s11033-010-0100-8; Gomez-Cadenas A, 2001, PLANT CELL, V13, P667, DOI 10.1105/tpc.13.3.667; GUAN LQ, 1993, PLANT J, V3, P527, DOI 10.1046/j.1365-313X.1993.03040527.x; Gubler F, 1999, PLANT J, V17, P1, DOI 10.1046/j.1365-313X.1999.00346.x; GUILTINAN MJ, 1990, SCIENCE, V250, P267, DOI 10.1126/science.2145628; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; He CJ, 1996, PLANT PHYSIOL, V112, P1679, DOI 10.1104/pp.112.4.1679; Henriksson E, 2005, PLANT PHYSIOL, V139, P509, DOI 10.1104/pp.105.063461; Hosoda K, 2002, PLANT CELL, V14, P2015, DOI 10.1105/tpc.002733; HUANG H, 1995, PLANT MOL BIOL, V28, P549, DOI 10.1007/BF00020401; HUANG H, 1993, NUCLEIC ACIDS RES, V21, P4769, DOI 10.1093/nar/21.20.4769; Jackson MB, 2008, ANN BOT-LONDON, V101, P229, DOI 10.1093/aob/mcm237; Jia H, 2007, CROP SCI, V47, pS45, DOI 10.2135/cropsci2006-00025tpg; Johannesson H, 2001, PLANT MOL BIOL, V45, P63, DOI 10.1023/A:1006423324025; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Katiyar-Agarwal S, 2007, METHOD ENZYMOL, V427, P215, DOI 10.1016/S0076-6879(07)27012-0; Kim JH, 2003, PLANT J, V36, P94, DOI 10.1046/j.1365-313X.2003.01862.x; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kozaki A, 2004, NUCLEIC ACIDS RES, V32, P1710, DOI 10.1093/nar/gkh337; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee TG, 2007, PHYSIOL PLANTARUM, V129, P375, DOI 10.1111/j.1399-3054.2006.00828.x; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lelandais-Briere C, 2010, CURR GENOMICS, V11, P14, DOI 10.2174/138920210790217918; Li HM, 2007, PLANT MOL BIOL, V65, P655, DOI 10.1007/s11103-007-9230-3; Li Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-122; Liu FL, 2005, PLANT PHYSIOL, V137, P1115, DOI 10.1104/pp.104.055475; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu YZ, 2010, AGR SCI CHINA, V9, P362, DOI 10.1016/S1671-2927(09)60105-X; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Maltby E, 1991, PLANT LIFE OXYGEN DE, P3; Marin E, 2010, PLANT CELL, V22, P1104, DOI 10.1105/tpc.109.072553; Martinez-Garcia JF, 1998, PLANT J, V13, P489, DOI 10.1046/j.1365-313X.1998.00050.x; Meng YJ, 2010, BIOCHEM BIOPH RES CO, V393, P345, DOI 10.1016/j.bbrc.2010.01.129; MEYER WS, 1987, IRRIGATION SCI, V8, P257, DOI 10.1007/BF00257510; Moldovan D, 2010, J EXP BOT, V61, P165, DOI 10.1093/jxb/erp296; Muhlenbock P, 2007, PLANT CELL, V19, P3819, DOI 10.1105/tpc.106.048843; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Niu XP, 2002, PLANT CELL, V14, P2565, DOI 10.1105/tpc.003400; Niu XP, 1999, PLANT MOL BIOL, V41, P1, DOI 10.1023/A:1006206011502; Nobuta K, 2008, P NATL ACAD SCI USA, V105, P14958, DOI 10.1073/pnas.0808066105; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Olsson ASB, 2004, PLANT MOL BIOL, V55, P663, DOI 10.1007/s11103-004-1581-4; Qiu DY, 2009, GENE, V436, P37, DOI 10.1016/j.gene.2009.01.006; Qiu FZ, 2007, ANN BOT-LONDON, V99, P1067, DOI 10.1093/aob/mcm055; Raman S, 2008, PLANT J, V55, P65, DOI 10.1111/j.1365-313X.2008.03483.x; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Ritter W, 1969, ASAE T, V12, P46; SACHS MM, 1980, CELL, V20, P761, DOI 10.1016/0092-8674(80)90322-0; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sato N, 1998, PLANT CELL, V10, P859, DOI 10.1105/tpc.10.5.859; Savelieff MG, 2008, P NATL ACAD SCI USA, V105, P7919, DOI 10.1073/pnas.0711316105; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schones DE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-19; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; SESSA G, 1993, EMBO J, V12, P3507, DOI 10.1002/j.1460-2075.1993.tb06025.x; SHEN QX, 1995, PLANT CELL, V7, P295, DOI 10.1105/tpc.7.3.295; Shigyo M, 2006, GENE, V366, P256, DOI 10.1016/j.gene.2005.08.009; Sieber P, 2007, DEVELOPMENT, V134, P1051, DOI 10.1242/dev.02817; Smith AD, 2006, P NATL ACAD SCI USA, V103, P6275, DOI 10.1073/pnas.0508169103; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; SOLANO R, 1995, EMBO J, V14, P1773, DOI 10.1002/j.1460-2075.1995.tb07166.x; Steemers FJ, 2005, PHARMACOGENOMICS, V6, P777, DOI 10.2217/14622416.6.7.777; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tang WH, 2005, SCI CHINA SER C, V48, P337, DOI 10.1360/062004-27; Tree JJ, 2007, ENVIRON MICROBIOL, V9, P2110, DOI 10.1111/j.1462-2920.2007.01320.x; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; URAO T, 1993, PLANT CELL, V5, P1529, DOI 10.1105/tpc.5.11.1529; vanderZaal BJ, 1996, PLANT PHYSIOL, V110, P79, DOI 10.1104/pp.110.1.79; Varkonyi-Gasic E, 2011, METHODS MOL BIOL, V744, P145, DOI 10.1007/978-1-61779-123-9_10; Vidal EA, 2010, P NATL ACAD SCI USA, V107, P4477, DOI 10.1073/pnas.0909571107; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang L, 2011, J EXP BOT, V62, P761, DOI 10.1093/jxb/erq307; Waypa GB, 2005, J APPL PHYSIOL, V98, P404, DOI 10.1152/japplphysiol.00722.2004; Webster CI, 1997, PLANT J, V11, P703, DOI 10.1046/j.1365-313X.1997.11040703.x; Webster CI, 2001, EUR J BIOCHEM, V268, P3154, DOI 10.1046/j.1432-1327.2001.02191.x; West AG, 1998, NUCLEIC ACIDS RES, V26, P5277, DOI 10.1093/nar/26.23.5277; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Yanagisawa S, 1999, PLANT J, V17, P209, DOI 10.1046/j.1365-313X.1999.00363.x; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P1892, DOI 10.1093/nar/gkl118; Yang YZ, 2003, PLANT J, V33, P47, DOI 10.1046/j.0960-7412.2003.01473.x; Yao XZ, 2009, FEBS LETT, V583, P3711, DOI 10.1016/j.febslet.2009.10.076; Yokoyama A, 2007, PLANT CELL PHYSIOL, V48, P84, DOI 10.1093/pcp/pcl040; Zentella R, 2002, PLANT CELL, V14, P2289, DOI 10.1105/tpc.003376; Zhai L, 2012, PHYSL PLANTARUM, P9999; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang ZX, 2008, ANN BOT-LONDON, V102, P509, DOI 10.1093/aob/mcn129; Zhong Ke-Ya, 2006, Yichuan, V28, P249; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005	122	59	61	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39786	10.1371/journal.pone.0039786	http://dx.doi.org/10.1371/journal.pone.0039786			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768123	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305892100093
J	Singh, S; Chitkara, D; Mehrazin, R; Behrman, SW; Wake, RW; Mahato, RI				Singh, Saurabh; Chitkara, Deepak; Mehrazin, Reza; Behrman, Stephen W.; Wake, Robert W.; Mahato, Ram I.			Chemoresistance in Prostate Cancer Cells Is Regulated by miRNAs and Hedgehog Pathway	PLOS ONE			English	Article							P-GLYCOPROTEIN ABCB1; STEM-LIKE CELLS; SIDE POPULATION; MULTIDRUG-RESISTANCE; LUNG-CANCER; LINES; CYCLOPAMINE; METASTASIS; EXPRESSION; DOCETAXEL	Many prostate cancers relapse due to the generation of chemoresistance rendering first-line treatment drugs like paclitaxel (PTX) ineffective. The present study aims to determine the role of miRNAs and Hedgehog (Hh) pathway in chemoresistant prostate cancer and to evaluate the combination therapy using Hh inhibitor cyclopamine (CYA). Studies were conducted on PTX resistant DU145-TXR and PC3-TXR cell lines and clinical prostate tissues. Drug sensitivity and apoptosis assays showed significantly improved cytotoxicity with combination of PTX and CYA. To distinguish the presence of cancer stem cell like side populations (SP), Hoechst 33342 flow cytometry method was used. PTX resistant DU145 and PC3 cells, as well as human prostate cancer tissue possess a distinct SP fraction. Nearly 75% of the SP cells are in the G0/G1 phase compared to 62% for non-SP cells and have higher expression of stem cell markers as well. SP cell fraction was increased following PTX monotherapy and treatment with CYA or CYA plus PTX effectively reduced their numbers suggesting the effectiveness of combination therapy. SP fraction cells were allowed to differentiate and reanalyzed by Hoechst staining and gene expression analysis. Post differentiation, SP cells constitute 15.8% of total viable cells which decreases to 0.6% on treatment with CYA. The expression levels of P-gp efflux protein were also significantly decreased on treatment with PTX and CYA combination. MicroRNA profiling of DU145-TXR and PC3-TXR cells and prostate cancer tissue from the patients showed decreased expression of tumor suppressor miRNAs such as miR34a and miR200c. Treatment with PTX and CYA combination restored the expression of miR200c and 34a, confirming their role in modulating chemoresistance. We have shown that supplementing mitotic stabilizer drugs such as PTX with Hh-inhibitor CYA can reverse PTX chemoresistance and eliminate SP fraction in androgen independent, metastatic prostate cancer cell lines.	[Singh, Saurabh; Chitkara, Deepak; Mahato, Ram I.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Chitkara, Deepak] Natl Inst Pharmaceut Educ & Res, Dept Pharmaceut, Sas Nagar, Punjab, India; [Mehrazin, Reza; Wake, Robert W.] Univ Tennessee, Ctr Hlth Sci, Dept Urol, Memphis, TN 38163 USA; [Behrman, Stephen W.] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali); University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Singh, S (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA.	rmahato@uthsc.edu	Jackson, Benjamin L/C-4297-2012; Chitkara, Deepak/K-5545-2017		Idea Award from Department of Defense Prostate Cancer Research Program [W81XWH-10-1-0969]; Kosten Foundation	Idea Award from Department of Defense Prostate Cancer Research Program; Kosten Foundation	This work is supported by an Idea Award (W81XWH-10-1-0969) from the Department of Defense Prostate Cancer Research Program. Financial support by Kosten Foundation (www.kostenfoundation.com) is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Baumert C, 2009, ANTI-CANCER AGENT ME, V9, P415, DOI 10.2174/1871520610909040415; Ceppi P, 2010, MOL CANCER RES, V8, P1207, DOI 10.1158/1541-7786.MCR-10-0052; Chearwae W, 2004, BIOCHEM PHARMACOL, V68, P2043, DOI 10.1016/j.bcp.2004.07.009; Chen MQ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-89; Chung MK, 2010, CLIN EXP MED, V10, P51, DOI 10.1007/s10238-009-0068-7; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; Colabufo NA, 2011, TOXICOL IN VITRO, V25, P222, DOI 10.1016/j.tiv.2010.11.004; Coley HM, 2010, METHODS MOL BIOL, V596, P341, DOI 10.1007/978-1-60761-416-6_15; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Danquah M, 2009, PHARM RES-DORDR, V26, P2081, DOI 10.1007/s11095-009-9903-5; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Gandellini P, 2010, DISCOV MED, V9, P212; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Han J, 2012, CANC LETT; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Komuro H, 2007, J PEDIATR SURG, V42, P2040, DOI 10.1016/j.jpedsurg.2007.08.026; Li F, 2011, DRUG DELIV TRANSL RE, V1, P420, DOI 10.1007/s13346-011-0042-2; Limtrakul P, 2007, MOL CELL BIOCHEM, V296, P85, DOI 10.1007/s11010-006-9302-8; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu T, 2010, MOL CELL BIOCHEM, V340, P265, DOI 10.1007/s11010-010-0426-5; Mimeault M, 2010, MOL CANCER THER, V9, P617, DOI 10.1158/1535-7163.MCT-09-1013; Nadendla SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020271; Nguyen NP, 2010, CANCER TREAT REV, V36, P485, DOI 10.1016/j.ctrv.2010.02.016; PAZDUR R, 1993, CANCER TREAT REV, V19, P351, DOI 10.1016/0305-7372(93)90010-O; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Ruiz IAA, 2011, SCI SIGNAL, V4, ppt9; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Shaw G, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-3; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Shukla S, 2010, CURR DRUG TARGETS; Singh BN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027306; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Takubo K, 2008, CELL STEM CELL, V2, P170, DOI 10.1016/j.stem.2007.10.023; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; van Brussel JR, 2003, ONKOLOGIE, V26, P175, DOI 10.1159/000071510; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yao J, 2010, ONCOL REP, V23, P1375, DOI 10.3892/or_00000774; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang WY, 2007, AM J PATHOL, V171, P728, DOI 10.2353/ajpath.2007.070070; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337; Zhou Y, 2012, BIOMATERIALS, V33, P1863, DOI 10.1016/j.biomaterials.2011.11.029	52	82	87	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40021	10.1371/journal.pone.0040021	http://dx.doi.org/10.1371/journal.pone.0040021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768203	gold, Green Published			2022-12-27	WOS:000305892100175
J	Wei, CC; Chen, YW; Powell, LC; Zheng, JY; Shi, K; Bradley, WE; Powell, PC; Ahmad, S; Ferrario, CM; Dell'Italia, LJ				Wei, Chih-Chang; Chen, Yuanwen; Powell, Lindsay C.; Zheng, Junying; Shi, Ke; Bradley, Wayne E.; Powell, Pamela C.; Ahmad, Sarfaraz; Ferrario, Carlos M.; Dell'Italia, Louis J.			Cardiac Kallikrein-Kinin System Is Upregulated in Chronic Volume Overload and Mediates an Inflammatory Induced Collagen Loss	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE; PLASMINOGEN-ACTIVATOR; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; MAST-CELLS; BRADYKININ; HEART; RECEPTOR; RATS; HYPERTROPHY	Background: The clinical problem of a "pure volume overload'' as in isolated mitral or aortic regurgitation currently has no documented medical therapy that attenuates collagen loss and the resultant left ventricular (LV) dilatation and failure. Here, we identify a potential mechanism related to upregulation of the kallikrein - kinin system in the volume overload of aortocaval fistula (ACF) in the rat. Methodology/Principal Findings: LV interstitial fluid (ISF) collection, hemodynamics, and echocardiography were performed in age - matched shams and 4 and 15 wk ACF rats. ACF rats had LV dilatation and a 2 - fold increase in LV end-diastolic pressure, along with increases in LV ISF bradykinin, myocardial kallikrein and bradykinin type - 2 receptor (BK2R) mRNA expression. Mast cell numbers were increased and interstitial collagen was decreased at 4 and 15 wk ACF, despite increases in LV ACE and chymase activities. Treatment with the kallikrein inhibitor aprotinin preserved interstitial collagen, prevented the increase in mast cells, and improved LV systolic function at 4 wk ACF. To establish a cause and effect between ISF bradykinin and mast cell - mediated collagen loss, direct LV interstitial bradykinin infusion in vivo for 24 hrs produced a 2 - fold increase in mast cell numbers and a 30% decrease in interstitial collagen, which were prevented by BK2R antagonist. To further connect myocardial stretch with cellular kallikrein - kinin system upregulation, 24 hrs cyclic stretch of adult cardiomyocytes and fibroblasts produced increased kallikrein, BK2R mRNA expressions, bradykinin protein and gelatinase activity, which were all decreased by the kallikrein inhibitor - aprotinin. Conclusions/Significance: A pure volume overload is associated with upregulation of the kallikrein - kinin system and ISF bradykinin, which mediates mast cell infiltration, extracellular matrix loss, and LV dysfunction - all of which are improved by kallikrein inhibition. The current investigation provides important new insights into future potential medical therapies for the volume overload of aortic and mitral regurgitation.	[Wei, Chih-Chang; Dell'Italia, Louis J.] Univ Alabama Birmingham, Birmingham Vet Affairs Med Ctr, Birmingham, AL USA; [Wei, Chih-Chang; Powell, Lindsay C.; Zheng, Junying; Shi, Ke; Bradley, Wayne E.; Powell, Pamela C.; Dell'Italia, Louis J.] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Dell'Italia, Louis J.] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Chen, Yuanwen] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai 200030, Peoples R China; [Ahmad, Sarfaraz; Ferrario, Carlos M.] Wake Forest Univ, Sch Med, Hypertens & Vasc Dis Ctr, Winston Salem, NC 27109 USA	University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Shanghai Jiao Tong University; Wake Forest University	Wei, CC (corresponding author), Univ Alabama Birmingham, Birmingham Vet Affairs Med Ctr, Birmingham, AL USA.	chih@uab.edu	Ferrario, Carlos/ABB-4165-2021; Ferrario, Carlos/ABD-2791-2020; Chen, Yuanwen/AAL-6421-2020	Ferrario, Carlos/0000-0003-0792-6239; 	American Heart Association [0130306N]; Department of Veteran Affairs [84781]; National Institutes of Health for the SCCOR (Specialized Centers of Clinically Oriented Research) in Cardiac Dysfunction [P50-HL077100]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051952, P50HL077100] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Department of Veteran Affairs(US Department of Veterans Affairs); National Institutes of Health for the SCCOR (Specialized Centers of Clinically Oriented Research) in Cardiac Dysfunction; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the American Heart Association for National Scientist Development Grant Program [Grant 0130306N to CCW], by the Department of Veteran Affairs for Merit Review [Grant 84781 to CCW], and by the National Institutes of Health for the SCCOR (Specialized Centers of Clinically Oriented Research) in Cardiac Dysfunction [Grant P50-HL077100 to LJD]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bax JJ, 2006, J AM COLL CARDIOL, V48, P754, DOI 10.1016/j.jacc.2006.04.077; Behr TM, 2000, CIRCULATION, V102, P1315, DOI 10.1161/01.CIR.102.11.1315; Bledsoe G, 2003, AM J PHYSIOL-HEART C, V285, pH1479, DOI 10.1152/ajpheart.01129.2002; Boluyt MO, 2004, J APPL PHYSIOL, V96, P822, DOI 10.1152/japplphysiol.01026.2003; Borer JS, 2003, CIRCULATION, V108, P2432, DOI 10.1161/01.CIR.0000096400.00562.A3; Brower GL, 2002, AM J PHYSIOL-HEART C, V283, pH518, DOI 10.1152/ajpheart.00218.2000; Caughey GH, 2000, BBA-PROTEIN STRUCT M, V1480, P245, DOI 10.1016/S0167-4838(00)00076-5; Chandrashekhar Y, 2007, J AM COLL CARDIOL, V49, P822, DOI 10.1016/j.jacc.2006.11.025; CHAO J, 1988, BIOCHIM BIOPHYS ACTA, V964, P329, DOI 10.1016/0304-4165(88)90033-5; Chen YW, 2011, AM J PHYSIOL-HEART C, V300, pH2251, DOI 10.1152/ajpheart.01104.2010; Cross LJM, 1997, INFLAMM RES, V46, P306, DOI 10.1007/s000110050192; Dolgilevich SM, 2001, AM J PHYSIOL-HEART C, V281, pH207, DOI 10.1152/ajpheart.2001.281.1.H207; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461; Forteza R, 1999, AM J RESP CELL MOL, V21, P666, DOI 10.1165/ajrcmb.21.6.3651; Hsieh HL, 2004, CELL SIGNAL, V16, P1163, DOI 10.1016/j.cellsig.2004.03.021; Kim NN, 1999, J MOL CELL CARDIOL, V31, P457, DOI 10.1006/jmcc.1998.0887; Li HJ, 2007, CARDIOVASC RES, V73, P130, DOI 10.1016/j.cardiores.2006.10.014; Li P, 1997, HYPERTENSION, V29, P394, DOI 10.1161/01.HYP.29.1.394; Lopez B, 2006, J AM COLL CARDIOL, V48, P89, DOI 10.1016/j.jacc.2006.01.077; Nolly H, 1997, IMMUNOPHARMACOLOGY, V36, P185, DOI 10.1016/S0162-3109(97)00020-9; Okada H, 2004, J AM SOC NEPHROL, V15, P2404, DOI 10.1097/01.ASN.0000136132.20189.95; Pat B, 2010, J CARD FAIL, V16, P769, DOI 10.1016/j.cardfail.2010.05.005; Ryan TD, 2007, J AM COLL CARDIOL, V49, P811, DOI 10.1016/j.jacc.2006.06.083; Sancho-Bru P, 2007, GASTROENTEROLOGY, V133, P2019, DOI 10.1053/j.gastro.2007.09.023; Santos DR, 2003, BRIT J PHARMACOL, V139, P271, DOI 10.1038/sj.bjp.0705236; Shigematsu S, 2002, AM J PHYSIOL-HEART C, V283, pH2676, DOI 10.1152/ajpheart.00538.2002; Tchougounova E, 2005, J BIOL CHEM, V280, P9291, DOI 10.1074/jbc.M410396200; Tyagi SC, 1998, J CELL PHYSIOL, V176, P374, DOI 10.1002/(SICI)1097-4652(199808)176:2<374::AID-JCP16>3.0.CO;2-3; Wang M, 2011, PLOS ONE, V6; Wei CC, 2003, AM J PHYSIOL-HEART C, V285, pH784, DOI 10.1152/ajpheart.00793.2001; Wei CC, 2010, J CLIN INVEST, V120, P1229, DOI 10.1172/JCI39345; Yayama K, 2003, BIOCHEM PHARMACOL, V65, P1017, DOI 10.1016/S0006-2952(03)00008-X; Yayama K, 2000, BBA-MOL CELL RES, V1495, P69, DOI 10.1016/S0167-4889(99)00154-8; Zaczynska E, 2003, INFLAMMATION, V27, P307, DOI 10.1023/A:1026080527573	35	51	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40110	10.1371/journal.pone.0040110	http://dx.doi.org/10.1371/journal.pone.0040110			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768235	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100207
J	Zhang, WS; Edwards, A; Fan, W; Flemington, EK; Zhang, K				Zhang, Wensheng; Edwards, Andrea; Fan, Wei; Flemington, Erik K.; Zhang, Kun			miRNA-mRNA Correlation-Network Modules in Human Prostate Cancer and the Differences between Primary and Metastatic Tumor Subtypes	PLOS ONE			English	Article							SINGULAR-VALUE DECOMPOSITION; HUMAN BRAIN-CELLS; REGULATORY MODULES; EXPRESSION PROFILES; MICRORNA EXPRESSION; IDENTIFICATION; ACTIVATION; GENOMICS; TOOLS	Recent studies have shown the contribution of miRNAs to cancer pathogenesis. Prostate cancer is the most commonly diagnosed cancer in men. Unlike other major types of cancer, no single gene has been identified as being mutated in the majority of prostate tumors. This implies that the expression profiling of genes, including the non-coding miRNAs, may substantially vary across individual cases of this cancer. The within-class variability makes it possible to reconstruct or infer disease-specific miRNA-mRNA correlation and regulatory modular networks using high-dimensional microarray data of prostate tumor samples. Furthermore, since miRNAs and tumor suppressor genes are usually tissue specific, miRNA-mRNA modules could potentially differ between primary prostate cancer (PPC) and metastatic prostate cancer (MPC). We herein performed an in silico analysis to explore the miRNA-mRNA correlation network modules in the two tumor subtypes. Our analysis identified 5 miRNA-mRNA module pairs (MPs) for PPC and MPC, respectively. Each MP includes one positive-connection (correlation) module and one negative-connection (correlation) module. The number of miRNAs or mRNAs (genes) in each module varies from 2 to 8 or from 6 to 622. The modules discovered for PPC are more informative than those for MPC in terms of the implicated biological insights. In particular, one negative-connection module in PPC fits well with the popularly recognized miRNA-mediated post-transcriptional regulation theory. That is, the 3'UTR sequences of the involved mRNAs (similar to 620) are enriched with the target site motifs of the 7 modular miRNAs, has-miR-106b, -191, -19b, -92a, -92b, -93, and -141. About 330 GO terms and KEGG pathways, including TGF-beta signaling pathway that maintains tissue homeostasis and plays a crucial role in the suppression of the proliferation of cancer cells, are over-represented (adj. p<0.05) in the modular gene list. These computationally identified modules provide remarkable biological evidence for the interference of miRNAs in the development of prostate cancers and warrant additional follow-up in independent laboratory studies.	[Zhang, Wensheng; Edwards, Andrea; Zhang, Kun] Xavier Univ Louisiana, Dept Comp Sci, New Orleans, LA USA; [Fan, Wei] IBM TJ Watson Res, Hawthorne, NY USA; [Flemington, Erik K.] Tulane Univ, Hlth Sci Ctr, Dept Pathol, New Orleans, LA 70118 USA; [Flemington, Erik K.] Tulane Canc Ctr, New Orleans, LA USA	Xavier University of Louisiana; International Business Machines (IBM); Tulane University; Tulane University	Zhang, WS (corresponding author), Xavier Univ Louisiana, Dept Comp Sci, New Orleans, LA USA.	kzhang@xula.edu	Jackson, Benjamin L/C-4297-2012		National Institutes of Health [NIGMS P20GM103424, NCRR-RCMI 5G12RR026260-03]; Louisiana BOR award [LEQSF(2008-11)-RD-A-32]; US Department of Army [W911NF-12-1-0066]; NSF [EPS-1006891]; NATIONAL CANCER INSTITUTE [R01CA138268] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR026260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana BOR award; US Department of Army; NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by National Institutes of Health grants (NIGMS P20GM103424, NCRR-RCMI 5G12RR026260-03), a Louisiana BOR award (LEQSF(2008-11)-RD-A-32), an US Department of Army grant (W911NF-12-1-0066) and an NSF grant (EPS-1006891). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bonnet E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010162; Bueno MJ, 2010, MOL CELL BIOL, V30, P2983, DOI 10.1128/MCB.01372-09; Bunz F., 2008, PRINCIPLES CANC GENE; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; Dong JT, 2006, J CELL BIOCHEM, V97, P433, DOI 10.1002/jcb.20696; Figel S, 2011, ANTICANCER AGENTS ME; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hill JM, 2009, NEUROREPORT, V20, P1500, DOI 10.1097/WNR.0b013e3283329c05; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ji XL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-426; Joshi A, 2009, BIOINFORMATICS, V25, P490, DOI 10.1093/bioinformatics/btn658; Kulp DC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-125; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liu B, 2010, BIOINFORMATICS, V26, P3105, DOI 10.1093/bioinformatics/btq576; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Michoel T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-49; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tran DH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S5; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Wall ME, 2001, BIOINFORMATICS, V17, P566, DOI 10.1093/bioinformatics/17.6.566; Wang D., 2010, PLOS ONE, V5; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Wu MQ, 2008, CARCINOGENESIS, V29, P1710, DOI 10.1093/carcin/bgn073; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031429; Zhang WS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-338	39	31	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40130	10.1371/journal.pone.0040130	http://dx.doi.org/10.1371/journal.pone.0040130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768240	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100212
J	Kenney, JW; Poole, RL; Adoff, MD; Logue, SF; Gould, TJ				Kenney, Justin W.; Poole, Rachel L.; Adoff, Michael D.; Logue, Sheree F.; Gould, Thomas J.			Learning and Nicotine Interact to Increase CREB Phosphorylation at the jnk1 Promoter in the Hippocampus	PLOS ONE			English	Article							LONG-TERM-MEMORY; ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR CREB; SYNAPTIC PLASTICITY; C57BL/6J MICE; HISTONE ACETYLTRANSFERASE; ACETYLCHOLINE-RECEPTOR; GLUTAMATE RECEPTORS; CBP; NEURONS	Nicotine is known to enhance long-term hippocampus dependent learning and memory in both rodents and humans via its activity at nicotinic acetylcholinergic receptors (nAChRs). However, the molecular basis for the nicotinic modulation of learning is incompletely understood. Both the mitogen activated protein kinases (MAPKs) and cAMP response element binding protein (CREB) are known to be integral to the consolidation of long-term memory and the disruption of MAPKs and CREB are known to abrogate some of the cognitive effects of nicotine. In addition, the acquisition of contextual fear conditioning in the presence of nicotine is associated with a beta 2-subunit containing nAChR-dependent increase in jnk1 (mapk8) transcription in the hippocampus. In the present study, chromatin immunoprecipitation (ChIP) was used to examine whether learning and nicotine interact to alter transcription factor binding or histone acetylation at the jnk1 promoter region. The acquisition of contextual fear conditioning in the presence of nicotine resulted in an increase in phosphorylated CREB (pCREB) binding to the jnk1 promoter in the hippocampus in a beta 2-subunit containing nAChR dependent manner, but had no effect on CREB binding; neither fear conditioning alone nor nicotine administration alone altered transcription factor binding to the jnk1 promoter. In addition, there were no changes in histone H3 or H4 acetylation at the jnk1 promoter following fear conditioning in the presence of nicotine. These results suggest that contextual fear learning and nicotine administration act synergistically to produce a unique pattern of protein activation and gene transcription in the hippocampus that is not individually generated by fear conditioning or nicotine administration alone.	[Kenney, Justin W.; Poole, Rachel L.; Adoff, Michael D.; Logue, Sheree F.; Gould, Thomas J.] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Kenney, JW (corresponding author), Univ Southampton, Ctr Biol Sci, Southampton, Hants, England.	tgould@temple.edu	Kenney, Justin/AAG-8291-2020	Kenney, Justin/0000-0001-8790-5184	National Institutes of Health [DA017949, DA024787, DA07237, CA143187]; Temple University; NATIONAL CANCER INSTITUTE [P50CA143187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024787, R01DA017949, T32DA007237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Temple University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health (DA017949, DA024787, TJG; DA07237, JWK; CA143187, PI Caryn Lerman) and the Temple University Thomas E. Shipley Jr. Memorial Award (Justin W. Kenney). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Andre JM, 2011, NEUROPHARMACOLOGY, V60, P617, DOI 10.1016/j.neuropharm.2010.12.004; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; Bailey DJ, 1999, BEHAV NEUROSCI, V113, P276, DOI 10.1037/0735-7044.113.2.276; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Barrett RM, 2008, LEARN MEMORY, V15, P460, DOI 10.1101/lm.917508; Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brunzell DH, 2009, NEUROPSYCHOPHARMACOL, V34, P1993, DOI 10.1038/npp.2009.11; Brunzell DH, 2003, J NEUROCHEM, V84, P1431, DOI 10.1046/j.1471-4159.2003.01640.x; Cammarota M, 2000, MOL BRAIN RES, V76, P36, DOI 10.1016/S0169-328X(99)00329-0; Chang KT, 2001, NEURON, V32, P855, DOI 10.1016/S0896-6273(01)00516-5; Craig JC, 2001, J BIOL CHEM, V276, P11719, DOI 10.1074/jbc.M010263200; Dajas-Bailador FA, 2002, J NEUROCHEM, V80, P520, DOI 10.1046/j.0022-3042.2001.00725.x; Davis JA, 2006, NEUROSCI LETT, V394, P202, DOI 10.1016/j.neulet.2005.10.026; Davis JA, 2007, J NEUROSCI, V27, P10870, DOI 10.1523/JNEUROSCI.3242-07.2007; Davis JA, 2007, PSYCHOPHARMACOLOGY, V190, P343, DOI 10.1007/s00213-006-0624-8; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Fujii S, 1999, BRAIN RES, V846, P137, DOI 10.1016/S0006-8993(99)01982-4; Gass P, 1998, LEARN MEMORY, V5, P274; Gould TJ, 2003, NEUROBIOL LEARN MEM, V80, P147, DOI 10.1016/S1074-7427(03)00057-1; Graves L, 2002, HIPPOCAMPUS, V12, P18, DOI 10.1002/hipo.10003; Haettig J, 2011, LEARN MEMORY, V18, P71, DOI 10.1101/lm.1986911; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; Heishman SJ, 2010, PSYCHOPHARMACOLOGY, V210, P453, DOI 10.1007/s00213-010-1848-1; Herman AI, 2010, ADDICT BIOL, V15, P250, DOI 10.1111/j.1369-1600.2010.00213.x; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Ito T, 2007, J BIOCHEM, V141, P609, DOI 10.1093/jb/mvm091; Kenney JW, 2008, BEHAV NEUROSCI, V122, P1158, DOI 10.1037/a0012807; Kenney JW, 2008, MOL NEUROBIOL, V38, P101, DOI 10.1007/s12035-008-8037-9; Kenney JW, 2011, PSYCHOPHARMACOLOGY, V217, P353, DOI 10.1007/s00213-011-2283-7; Kenney JW, 2010, NEUROPSYCHOPHARMACOL, V35, P483, DOI 10.1038/npp.2009.153; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; KURINO M, 1995, J NEUROCHEM, V65, P1282; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Levin ED, 2006, PSYCHOPHARMACOLOGY, V184, P523, DOI 10.1007/s00213-005-0164-7; Mao LM, 2004, EUR J NEUROSCI, V19, P1207, DOI 10.1111/j.1460-9568.2004.03223.x; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Mayall TP, 1997, GENE DEV, V11, P887, DOI 10.1101/gad.11.7.887; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Melichercik AM, 2012, NEUROPHARMACOLOGY, V62, P2096, DOI 10.1016/j.neuropharm.2012.01.008; Nakayama H, 2001, J NEUROCHEM, V79, P489, DOI 10.1046/j.1471-4159.2001.00602.x; NICHOLS M, 1992, EMBO J, V11, P3337, DOI 10.1002/j.1460-2075.1992.tb05412.x; Oliveira AMM, 2011, LEARN MEMORY, V18, P161, DOI 10.1101/lm.1939811; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Picciotto MR, 2008, FRONT BIOSCI-LANDMRK, V13, P492, DOI 10.2741/2695; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Portugal GS, 2012, BEHAV GENET, V42, P133, DOI 10.1007/s10519-011-9489-7; Quinn JJ, 2005, HIPPOCAMPUS, V15, P665, DOI 10.1002/hipo.20088; Raybuck JD, 2010, NEUROBIOL LEARN MEM, V94, P353, DOI 10.1016/j.nlm.2010.08.001; Raybuck JD, 2007, BEHAV NEUROSCI, V121, P1119, DOI 10.1037/0735-7044.121.5.1119; Satoh Y, 2007, J NEUROSCI, V27, P10765, DOI 10.1523/JNEUROSCI.0117-07.2007; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Steiner RC, 2007, J NEUROCHEM, V103, P666, DOI 10.1111/j.1471-4159.2007.04799.x; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Trifilieff P, 2006, LEARN MEMORY, V13, P349, DOI 10.1101/lm.80206; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; WADA E, 1989, J COMP NEUROL, V284, P314, DOI 10.1002/cne.902840212; Walters CL, 2005, NEURON, V46, P933, DOI 10.1016/j.neuron.2005.05.005; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wehner JM, 2004, NEUROSCIENCE, V129, P11, DOI 10.1016/j.neuroscience.2004.07.016; Woodruff-Pak Diana S, 2002, Behav Cogn Neurosci Rev, V1, P5, DOI 10.1177/1534582302001001002; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	69	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39939	10.1371/journal.pone.0039939	http://dx.doi.org/10.1371/journal.pone.0039939			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761932	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000305826400048
J	Khemiri, L; Guterstam, J; Franck, J; Jayaram-Lindstrom, N				Khemiri, Lotfi; Guterstam, Joar; Franck, Johan; Jayaram-Lindstrom, Nitya			Alcohol Dependence Associated with Increased Utilitarian Moral Judgment: A Case Control Study	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; EMOTIONAL FACIAL EXPRESSION; DECISION-MAKING; PERSONAL/IMPERSONAL DISTINCTION; PROBLEM GAMBLERS; DEFICITS; ADDICTION; INDIVIDUALS; IMPULSIVITY; COGNITION	Recent studies indicate that emotional processes, mediated by the ventromedial prefrontal cortex (VMPC), are of great importance for moral judgment. Neurological patients with VMPC dysfunction have been shown to generate increased utilitarian moral judgments, i.e. are more likely to endorse emotionally aversive actions in order to maximize aggregate welfare, when faced with emotionally salient personal moral dilemmas. Patients with alcohol dependence (AD) also exhibit impairments in functions mediated by the prefrontal cortex, but whether they exhibit increased utilitarian moral reasoning has not previously been investigated. The aim of this study was to investigate moral judgment in AD patients (n = 20) compared to healthy controls (n = 20) matched by sex, age and education years. Each subject responded to a battery of 50 hypothetical dilemmas categorized as non-moral, moral impersonal and moral personal. They also responded to a questionnaire evaluating explicit knowledge of social and moral norms. Results confirmed our hypothesis that AD patients generated increased utilitarian moral judgment compared to controls when faced with moral personal dilemmas. Crucially, there was no difference in their responses to non-moral or impersonal moral dilemmas, nor knowledge of explicit social and moral norms. One possible explanation is that damage to the VMPC, caused by long term repeated exposure to alcohol results in emotional dysfunction, predisposing to utilitarian moral judgment. This work elucidates a novel aspect of the neuropsychological profile of AD patients, namely a tendency to generate utilitarian moral judgment when faced with emotionally salient moral personal dilemmas.	[Khemiri, Lotfi; Guterstam, Joar; Franck, Johan; Jayaram-Lindstrom, Nitya] Karolinska Inst, Div Psychiat, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet	Khemiri, L (corresponding author), Karolinska Inst, Div Psychiat, Dept Clin Neurosci, Stockholm, Sweden.	lotfi.khemiri@stud.ki.se	Jayaram-Lindström, Nitya/AAQ-4268-2021; Guterstam, Joar/T-8883-2019	Jayaram-Lindström, Nitya/0000-0002-2678-3782; Guterstam, Joar/0000-0002-2643-4291	Swedish Science Research Council (VR)	Swedish Science Research Council (VR)(Swedish Research Council)	The study was supported by a public grant from the Swedish Science Research Council (VR). This grant was given to support research on alcoholism. None of the authors are in any way affiliated or employed by the funder. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTERMAN AI, 1978, J CLIN PSYCHOL, V34, P790, DOI 10.1002/1097-4679(197807)34:3<790::AID-JCLP2270340346>3.0.CO;2-P; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1675, DOI 10.1016/S0028-3932(02)00015-5; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1690, DOI 10.1016/S0028-3932(02)00016-7; Bentham J, 2007, INTRO PRINCIPLES MOR; CERMAK LS, 1989, ALCOHOL CLIN EXP RES, V13, P611, DOI 10.1111/j.1530-0277.1989.tb00391.x; Ciaramelli E, 2007, SOC COGN AFFECT NEUR, V2, P84, DOI 10.1093/scan/nsm001; Clark US, 2007, NEUROPSYCHOLOGY, V21, P346, DOI 10.1037/0894-4105.21.3.346; Crews FT, 2009, PHARMACOL BIOCHEM BE, V93, P237, DOI 10.1016/j.pbb.2009.04.018; Damasio AR., 2005, DESCARTES ERROR EMOT; Darwin Charles, 1998, DESCENT MAN; Foisy ML, 2007, ALCOHOL CLIN EXP RES, V31, P404, DOI 10.1111/j.1530-0277.2006.00321.x; Foot, 1967, OXFORD REV, V5, P5, DOI DOI 10.1093/0199252866.003.0002; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene JD, 2009, J EXP SOC PSYCHOL, V45, P581, DOI 10.1016/j.jesp.2009.01.003; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; HARPER CG, 1987, BRIT J ADDICT, V82, P1349; Heekeren HR, 2003, NEUROREPORT, V14, P1215, DOI 10.1097/00001756-200307010-00005; Kant I., 2005, FUNDAMENTAL PRINCIPL; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Kohlberg L., 1973, J PHILOS, V70, P630, DOI [10.2307/2025030, DOI 10.2307/2025030]; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Koob GF, 2011, CURR TOP BEHAV NEURO; Kril JJ, 1999, PROG NEUROBIOL, V58, P381, DOI 10.1016/S0301-0082(98)00091-4; Lawrence AJ, 2009, ADDICTION, V104, P1006, DOI 10.1111/j.1360-0443.2009.02533.x; MANN K, 1995, J NEURAL TRANSM-GEN, V99, P145, DOI 10.1007/BF01271475; McGuire J, 2009, J EXP SOC PSYCHOL, V45, P577, DOI 10.1016/j.jesp.2009.01.002; Mendez MF, 2005, COGN BEHAV NEUROL, V18, P193, DOI 10.1097/01.wnn.0000191292.17964.bb; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Monnot M, 2001, ALCOHOL CLIN EXP RES, V25, P362, DOI 10.1111/j.1530-0277.2001.tb02222.x; Moselhy HF, 2001, ALCOHOL ALCOHOLISM, V36, P357, DOI 10.1093/alcalc/36.5.357; Philippot P, 1999, ALCOHOL CLIN EXP RES, V23, P1031, DOI 10.1097/00000374-199906000-00010; Thomson Judith J, 1976, Monist, V59, P204; Uekermann J, 2007, ADDICTION, V102, P232, DOI 10.1111/j.1360-0443.2006.01656.x; Uekermann J, 2008, ADDICTION, V103, P726, DOI 10.1111/j.1360-0443.2008.02157.x; Valdesolo P, 2006, PSYCHOL SCI, V17, P476, DOI 10.1111/j.1467-9280.2006.01731.x; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Verdejo-Garcia A, 2009, NEUROPHARMACOLOGY, V56, P48, DOI 10.1016/j.neuropharm.2008.07.035; Waal F, 2009, PRIMATES PHILOS MORA; Young L, 2007, BRIT MED BULL, V84, P69, DOI 10.1093/bmb/ldm031	43	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39882	10.1371/journal.pone.0039882	http://dx.doi.org/10.1371/journal.pone.0039882			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966GR	22761922	Green Published, gold, Green Submitted			2022-12-27	WOS:000305826400044
J	Cevik, MO; Erden, A				Cevik, Munire Ozlem; Erden, Ahmet			The Course of Habituation of the Proboscis Extension Reflex Can Be Predicted by Sucrose Responsiveness in Drosophila	PLOS ONE			English	Article							TASTE; BEHAVIOR; FLY; DISHABITUATION; MUTATIONS; LABELLAR	The proboscis extension reflex (PER) is triggered when insects' gustatory receptors contact appetitive stimuli, so it provides a behavioral readout for perceptual encoding of tastants. Research on the experience dependent modulation of PER in Drosophila has been hindered by the difficulty of obtaining reliable measures of memory-driven change in PER probability in the background of larger changes induced by physiological state. In this study, we showed that the course of PER habituation can be predicted by the degree of sucrose responsiveness in Drosophila. We assessed early response parameters, including the number of proboscis extensions and labellar movements in the first five trials, the trial to start responding, and the trial to make the first stop to quantify responsiveness, which predicted the upcoming pattern of both the short-term and 1 hour memory of PER habituation for individual flies. The cAMP signaling pathway mutant rutabaga displayed deficits in attunement of perceptual salience of sucrose to physiological demands and stimulus-driven sensitization.	[Cevik, Munire Ozlem; Erden, Ahmet] Abant Izzet Baysal Univ, Bolu, Turkey	Abant Izzet Baysal University	Cevik, MO (corresponding author), Dogus Univ, Istanbul, Turkey.	mcevik@dogus.edu.tr	Cevik, Munire Ozlem/O-7757-2019	Cevik, Munire Ozlem/0000-0002-7151-9630	Turkish Institute of Scientific and Technological Research [TUBITAK-SBAG 2534]; Turkish Academy of Science Young Investigator Award (TUBA-GEBIP); Abant Izzet Baysal Universitesi Scientific Research Grants (AIBU-BAP)	Turkish Institute of Scientific and Technological Research(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Turkish Academy of Science Young Investigator Award (TUBA-GEBIP)(Turkish Academy of Sciences); Abant Izzet Baysal Universitesi Scientific Research Grants (AIBU-BAP)(Abant Izzet Baysal University)	This research was supported by research grants to Munire Ozlem Cevik from the following institutions: The Turkish Institute of Scientific and Technological Research (TUBITAK-SBAG 2534), www.tubitak.gov.tr, The Turkish Academy of Science Young Investigator Award (TUBA-GEBIP), www.tuba.gov.tr, and Abant Izzet Baysal Universitesi Scientific Research Grants (AIBU-BAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo SF, 2007, LEARN MEMORY, V14, P376, DOI 10.1101/lm.566007; Bullock TH, 1959, INTRO NERVOUS SYSTEM; Bullock TH, 1957, PHYSL TRIGGERS DISCO; Chabaud MA, 2006, J COMP PHYSIOL A, V192, P1335, DOI 10.1007/s00359-006-0160-3; CORFAS G, 1990, J NEUROSCI, V10, P491; CORFAS G, 1989, J NEUROSCI, V9, P56; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Dethier V, 1974, EXPT ANAL INSECT BEH; DETHIER VG, 1952, BIOL BULL, V103, P178, DOI 10.2307/1538444; Dethier VG, 1976, HUNGRY FLY; DOMJAN M, 1980, LEARN MOTIV, V11, P522, DOI 10.1016/0023-9690(80)90031-4; DUERR JS, 1982, P NATL ACAD SCI-BIOL, V79, P3646, DOI 10.1073/pnas.79.11.3646; EDGECOMB RS, 1987, J EXP BIOL, V127, P79; Engel JE, 2009, NEUROBIOL LEARN MEM, V92, P166, DOI 10.1016/j.nlm.2008.08.003; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Inagaki HK, 2012, CELL, V148, P583, DOI 10.1016/j.cell.2011.12.022; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; LUBOW RE, 1959, J COMP PHYSIOL PSYCH, V52, P415, DOI 10.1037/h0046700; Marella S, 2012, NEURON, V73, P941, DOI 10.1016/j.neuron.2011.12.032; Martin F, 2001, J COMP PHYSIOL A, V187, P359, DOI 10.1007/s003590100208; Masek P, 2010, P NATL ACAD SCI USA, V107, P14833, DOI 10.1073/pnas.1009318107; Motosaka K, 2007, J COMP PHYSIOL A, V193, P279, DOI 10.1007/s00359-006-0200-z; Muller U, 2002, J NEUROSCI, V22, P8739; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; POLLACK GS, 1977, J COMP PHYSIOL, V121, P115, DOI 10.1007/BF00614184; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Riemensperger T, 2011, P NATL ACAD SCI USA, V108, P834, DOI 10.1073/pnas.1010930108; Scheiner R, 2004, LEARN MEMORY, V11, P303, DOI 10.1101/lm.71604; Srivastava DP, 2005, J NEUROSCI, V25, P6145, DOI 10.1523/JNEUROSCI.1005-05.2005; SUDLOW LC, 1987, J EXP BIOL, V130, P219; TULLY T, 1983, BEHAV NEUROSCI, V97, P146, DOI 10.1037/0735-7044.97.1.146; Ueda A, 2009, J NEUROGENET, V23, P185, DOI 10.1080/01677060802471726; van Swinderen B, 2007, SCIENCE, V315, P1590, DOI 10.1126/science.1137931; VARGO M, 1982, J COMP PHYSIOL PSYCH, V96, P452, DOI 10.1037/h0077899; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001	35	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39863	10.1371/journal.pone.0039863	http://dx.doi.org/10.1371/journal.pone.0039863			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761915	Green Submitted, gold, Green Published			2022-12-27	WOS:000305808700051
J	Lausberg, F; Fleckenstein, S; Kreutzenbeck, P; Frobel, J; Rose, P; Muller, M; Freudl, R				Lausberg, Frank; Fleckenstein, Stefan; Kreutzenbeck, Peter; Froebel, Julia; Rose, Patrick; Mueller, Matthias; Freudl, Roland			Genetic Evidence for a Tight Cooperation of TatB and TatC during Productive Recognition of Twin-Arginine (Tat) Signal Peptides in Escherichia coli	PLOS ONE			English	Article							PRECURSOR PROTEINS BIND; TRANSLOCATION PATHWAY; SUBSTRATE-BINDING; SECRETION; MEMBRANE; TRANSPORT; COMPLEX; SYSTEM; EXPORT; MOTIF	The twin arginine translocation (Tat) pathway transports folded proteins across the cytoplasmic membrane of bacteria. Tat signal peptides contain a consensus motif (S/T-R-R-X-F-L-K) that is thought to play a crucial role in substrate recognition by the Tat translocase. Replacement of the phenylalanine at the +2 consensus position in the signal peptide of a Tat-specific reporter protein (TorA-MalE) by aspartate blocked export of the corresponding TorA(D+2)-MalE precursor, indicating that this mutation prevents a productive binding of the TorA(D+2) signal peptide to the Tat translocase. Mutations were identified in the extreme amino-terminal regions of TatB and TatC that synergistically suppressed the export defect of TorA(D+2)-MalE when present in pairwise or triple combinations. The observed synergistic suppression activities were even more pronounced in the restoration of membrane translocation of another export-defective precursor, TorA(KQ)-MalE, in which the conserved twin arginine residues had been replaced by lysine-glutamine. Collectively, these findings indicate that the extreme amino-terminal regions of TatB and TatC cooperate tightly during recognition and productive binding of Tat-dependent precursor proteins and, furthermore, that TatB and TatC are both involved in the formation of a specific signal peptide binding site that reaches out as far as the end of the TatB transmembrane segment.	[Lausberg, Frank; Fleckenstein, Stefan; Kreutzenbeck, Peter; Freudl, Roland] Forschungszentrum Julich, Inst Bio & Geowissensch 1, D-52425 Julich, Germany; [Froebel, Julia; Rose, Patrick; Mueller, Matthias] Univ Freiburg, Inst Biochem & Mol Biol, Zentrum Biochem & Mol Zellforsch, D-79106 Freiburg, Germany; [Froebel, Julia; Rose, Patrick] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany	Helmholtz Association; Research Center Julich; University of Freiburg; University of Freiburg	Freudl, R (corresponding author), Forschungszentrum Julich, Inst Bio & Geowissensch 1, D-52425 Julich, Germany.	r.freudl@fz-juelich.de	Freudl, Roland/N-4179-2017	Freudl, Roland/0000-0003-0743-1279	Commission of the European Union (CEU) [LSHG-CT-2004-005257]	Commission of the European Union (CEU)(European Commission)	This research was supported by the Commission of the European Union (CEU) project LSHG-CT-2004-005257. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Bageshwar UK, 2009, MOL MICROBIOL, V74, P209, DOI 10.1111/j.1365-2958.2009.06862.x; Berks BC, 2003, ADV MICROB PHYSIOL, V47, P187, DOI 10.1016/S0065-2911(03)47004-5; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Blaudeck N, 2003, J BACTERIOL, V185, P2811, DOI 10.1128/JB.185.9.2811-2819.2003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Fincher V, 1998, FEBS LETT, V423, P66, DOI 10.1016/S0014-5793(98)00066-0; Gerard F, 2007, J BIOL CHEM, V282, P5263, DOI 10.1074/jbc.M610337200; Halbig D, 1999, EUR J BIOCHEM, V263, P543, DOI 10.1046/j.1432-1327.1999.00536.x; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Hou B, 2006, J MOL BIOL, V355, P957, DOI 10.1016/j.jmb.2005.11.029; Jaeger KE, 2001, APPL MICROBIOL BIOT, V55, P519, DOI 10.1007/s002530100643; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; KNECHT DA, 1984, ANAL BIOCHEM, V136, P180, DOI 10.1016/0003-2697(84)90321-X; Kostecki JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009225; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Lee PA, 2006, ANNU REV MICROBIOL, V60, P373, DOI 10.1146/annurev.micro.60.080805.142212; Li HM, 2006, FEMS MICROBIOL LETT, V255, P268, DOI 10.1111/j.1574-6968.2005.00081.x; Ma XY, 2010, EMBO J, V29, P1477, DOI 10.1038/emboj.2010.44; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; McDevitt CA, 2006, FEBS J, V273, P5656, DOI 10.1111/j.1742-4658.2006.05554.x; Meissner D, 2007, APPL MICROBIOL BIOT, V76, P633, DOI 10.1007/s00253-007-0934-8; Mendel S, 2008, J MOL BIOL, V375, P661, DOI 10.1016/j.jmb.2007.09.087; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Rusch SL, 2007, BIOCHEMISTRY-US, V46, P9665, DOI 10.1021/bi7010064; Sambrook J., 2001, MOL CLONING LAB MANU; Sargent F, 2006, FEMS MICROBIOL LETT, V254, P198, DOI 10.1111/j.1574-6968.2005.00049.x; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Shanmugham A, 2006, BIOCHEMISTRY-US, V45, P2243, DOI 10.1021/bi052188a; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Strauch EM, 2007, J MOL BIOL, V374, P283, DOI 10.1016/j.jmb.2007.09.050; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; TANAKA S, 1967, J BACTERIOL, V93, P642, DOI 10.1128/JB.93.2.642-648.1967; Tarry MJ, 2009, P NATL ACAD SCI USA, V106, P13284, DOI 10.1073/pnas.0901566106; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Zoufaly S, 2012, J BIOL CHEM IN PRESS	44	37	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39867	10.1371/journal.pone.0039867	http://dx.doi.org/10.1371/journal.pone.0039867			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761916	Green Submitted, gold, Green Published			2022-12-27	WOS:000305808700052
J	Tanaka, M; Mroz, P; Dai, TH; Huang, LY; Morimoto, Y; Kinoshita, M; Yoshihara, Y; Nemoto, K; Shinomiya, N; Seki, S; Hamblin, MR				Tanaka, Masamitsu; Mroz, Pawel; Dai, Tianhong; Huang, Liyi; Morimoto, Yuji; Kinoshita, Manabu; Yoshihara, Yasuo; Nemoto, Koichi; Shinomiya, Nariyoshi; Seki, Suhji; Hamblin, Michael R.			Photodynamic Therapy Can Induce a Protective Innate Immune Response against Murine Bacterial Arthritis via Neutrophil Accumulation	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; KAPPA-B ACTIVATION; IN-VIVO; CHOROIDAL NEOVASCULARIZATION; ANTITUMOR IMMUNITY; INFECTIONS; CELLS; VITRO; MICE; PHOTOSENSITIZER	Background: Local microbial infections induced by multiple-drug-resistant bacteria in the orthopedic field can be intractable, therefore development of new therapeutic modalities is needed. Photodynamic therapy (PDT) is a promising alternative modality to antibiotics for intractable microbial infections, and we recently reported that PDT has the potential to accumulate neutrophils into the infected site which leads to resolution of the infection. PDT for cancer has long been known to be able to stimulate the innate and adaptive arms of the immune system. Methodology/Principal Findings: In the present study, a murine methicillin-resistant Staphylococcus aureus (MRSA) arthritis model using bioluminescent MRSA and polystyrene microparticles was established, and both the therapeutic (Th-PDT) and preventive (Pre-PDT) effects of PDT using methylene blue as photosensitizer were examined. Although Th-PDT could not demonstrate direct bacterial killing, neutrophils were accumulated into the infectious joint space after PDT and MRSA arthritis was reduced. With the preconditioning Pre-PDT regimen, neutrophils were quickly accumulated into the joint immediately after bacterial inoculation and bacterial growth was suppressed and the establishment of infection was inhibited. Conclusions/Significance: This is the first demonstration of a protective innate immune response against a bacterial pathogen produced by PDT.	[Tanaka, Masamitsu; Mroz, Pawel; Dai, Tianhong; Huang, Liyi; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Tanaka, Masamitsu; Mroz, Pawel; Dai, Tianhong; Huang, Liyi; Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Tanaka, Masamitsu; Yoshihara, Yasuo; Nemoto, Koichi] Natl Def Med Coll, Dept Orthoped Surg, Tokorozawa, Saitama 359, Japan; [Morimoto, Yuji; Shinomiya, Nariyoshi] Natl Def Med Coll, Dept Integrated Physiol & Bionano Med, Tokorozawa, Saitama 359, Japan; [Kinoshita, Manabu; Seki, Suhji] Natl Def Med Coll, Dept Immunol & Microbiol, Tokorozawa, Saitama 359, Japan; [Hamblin, Michael R.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Defense Medical College - Japan; National Defense Medical College - Japan; National Defense Medical College - Japan; Harvard University; Massachusetts Institute of Technology (MIT)	Tanaka, M (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA.	moyan@ndmc.ac.jp; hamblin@helix.mgh.harvard.edu	Hamblin, Michael R/H-2758-2019; Dai, Tianhong/P-5961-2018; Shinomiya, Nariyoshi/I-9666-2014; Mroz, Pawel/P-1258-2019; Hamblin, Mike/AAB-2511-2022; MORIMOTO, YUJI/F-2912-2019	Hamblin, Michael R/0000-0001-6431-4605; Dai, Tianhong/0000-0001-8960-8896; Mroz, Pawel/0000-0003-3838-4743; MORIMOTO, YUJI/0000-0001-6494-413X	Ministry of Education, Culture, Sports, Science and Technology of Japan [23659628]; U.S. National Institutes of Health [R01AI050875]; Airlift Research Foundation Extremity Trauma Research Grant [109421]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050875] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Airlift Research Foundation Extremity Trauma Research Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Grant-in-Aid for Challenging Exploratory Research (23659628) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to Yuji Morimoto. Liyi Huang and Michael R. Hamblin were supported by U.S. National Institutes of Health grant R01AI050875 to Michael R. Hamblin, and Tianhong Dai by an Airlift Research Foundation Extremity Trauma Research Grant (grant 109421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTHIAUME F, 1994, BIO-TECHNOL, V12, P703, DOI 10.1038/nbt0794-703; Biel MA, 2010, METHODS MOL BIOL, V635, P175, DOI 10.1007/978-1-60761-697-9_13; Bisland SK, 2006, PHOTOCH PHOTOBIO SCI, V5, P31, DOI 10.1039/b507082a; Castano AP, 2008, P NATL ACAD SCI USA, V105, P5495, DOI 10.1073/pnas.0709256105; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Cecic I, 2002, CANCER LETT, V183, P43, DOI 10.1016/S0304-3835(02)00092-7; Cecic I, 2001, PHOTOCHEM PHOTOBIOL, V74, P712, DOI 10.1562/0031-8655(2001)074<0712:IOSNRI>2.0.CO;2; Chang CJ, 1999, LASER SURG MED, V24, P178, DOI 10.1002/(SICI)1096-9101(1999)24:3<178::AID-LSM2>3.3.CO;2-N; Dai TH, 2010, LASER SURG MED, V42, P38, DOI 10.1002/lsm.20887; deVree WJA, 1996, CANCER RES, V56, P2908; Di Poto A, 2009, BIOMATERIALS, V30, P3158, DOI 10.1016/j.biomaterials.2009.02.038; DRISCOLL KE, 1993, AM J RESP CELL MOL, V8, P311, DOI 10.1165/ajrcmb/8.3.311; Fontana CR, 2009, J PERIODONTAL RES, V44, P751, DOI 10.1111/j.1600-0765.2008.01187.x; Gad F, 2004, PHOTOCH PHOTOBIO SCI, V3, P451, DOI 10.1039/b311901g; Gallo Jiri, 2003, Biomedical Papers (Olomouc), V147, P27; Garg AD, 2011, PHOTOCH PHOTOBIO SCI, V10, P670, DOI 10.1039/c0pp00294a; Gollnick SO, 2003, BRIT J CANCER, V88, P1772, DOI 10.1038/sj.bjc.6600864; Granville DJ, 2000, BLOOD, V95, P256; Hamblin MR, 2002, PHOTOCHEM PHOTOBIOL, V75, P51, DOI 10.1562/0031-8655(2002)075<0051:RCOWIB>2.0.CO;2; HAYATA Y, 1982, CHEST, V81, P269, DOI 10.1378/chest.81.3.269; HENDERSON BW, 1992, PHOTOCHEM PHOTOBIOL, V55, P145, DOI 10.1111/j.1751-1097.1992.tb04222.x; HSIANG YN, 1994, CAN J SURG, V37, P148; Kielian T, 2000, AM J PATHOL, V157, P647, DOI 10.1016/S0002-9440(10)64575-0; Kinoshita M, 2011, INFECT IMMUN, V79, P2670, DOI 10.1128/IAI.01298-10; KONIG K, 1987, J CANCER RES CLIN, V113, P301, DOI 10.1007/BF00396390; Korbelik M, 1999, CANCER RES, V59, P1941; Kousis PC, 2007, CANCER RES, V67, P10501, DOI 10.1158/0008-5472.CAN-07-1778; Kramer M, 1996, OPHTHALMOLOGY, V103, P427; Lambrechts SAG, 2005, PHOTOCH PHOTOBIO SCI, V4, P503, DOI 10.1039/b502125a; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; MacDonald IJ, 2001, J PORPHYR PHTHALOCYA, V5, P105, DOI 10.1002/jpp.328; Massey E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005341.pub2; MONTEFORT S, 1994, J CLIN INVEST, V93, P1411, DOI 10.1172/JCI117118; Mroz P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015194; NAKAGAWA Y, 1993, CANCER IMMUNOL IMMUN, V37, P157, DOI 10.1007/BF01525429; Neut D, 2007, ACTA ORTHOP, V78, P299, DOI 10.1080/17453670710013843; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; Obana A, 1999, LASER SURG MED, V24, P209, DOI 10.1002/(SICI)1096-9101(1999)24:3<209::AID-LSM6>3.0.CO;2-L; Oleinick NL, 1998, RADIAT RES, V150, pS146, DOI 10.2307/3579816; Patel A, 2008, J BONE JOINT SURG BR, V90B, P1401, DOI 10.1302/0301-620X.90B11.20771; Peng Q, 1997, PHOTOCHEM PHOTOBIOL, V65, P235, DOI 10.1111/j.1751-1097.1997.tb08549.x; Preise D, 2009, CANCER IMMUNOL IMMUN, V58, P71, DOI 10.1007/s00262-008-0527-0; RYTER SW, 1993, PHOTOCHEM PHOTOBIOL, V58, P753, DOI 10.1111/j.1751-1097.1993.tb04964.x; Street CN, 2010, PHOTOMED LASER SURG, V28, pS61, DOI 10.1089/pho.2009.2622; Tanaka M, 2012, PHOTOCHEM PHOTOBIOL, V88, P227, DOI 10.1111/j.1751-1097.2011.01005.x; Tanaka M, 2011, LASER SURG MED, V43, P221, DOI 10.1002/lsm.21037; Tanaka M, 2010, PHOTOCHEM PHOTOBIOL, V86, P403, DOI 10.1111/j.1751-1097.2009.00658.x; TANG G, 1993, NEUROSURGERY, V32, P438, DOI 10.1227/00006123-199303000-00016; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006; Verdrengh M, 1997, INFECT IMMUN, V65, P2517, DOI 10.1128/IAI.65.7.2517-2521.1997; Volanti C, 2002, PHOTOCHEM PHOTOBIOL, V75, P36, DOI 10.1562/0031-8655(2002)075<0036:IOOSIN>2.0.CO;2; Zolfaghari PS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-27	52	44	44	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39823	10.1371/journal.pone.0039823	http://dx.doi.org/10.1371/journal.pone.0039823			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761911	Green Published, Green Submitted, gold			2022-12-27	WOS:000305808700049
J	Yao, YF; Li, X; Jiang, HE; Ferguson, DK; Hueber, F; Ghosh, R; Bera, S; Li, CS				Yao, Yi-Feng; Li, Xiao; Jiang, Hong-En; Ferguson, David K.; Hueber, Francis; Ghosh, Ruby; Bera, Subir; Li, Cheng-Sen			Pollen and Phytoliths from Fired Ancient Potsherds as Potential Indicators for Deciphering Past Vegetation and Climate in Turpan, Xinjiang, NW China	PLOS ONE			English	Article							YANGHAI TOMBS; PALEOENVIRONMENTAL INDICATORS; ENVIRONMENTAL-CONDITIONS; QUANTITATIVE INDICATORS; GRASSES; L.; RECONSTRUCTION; ASSEMBLAGES; CANNABIS; HISTORY	It is demonstrated that palynomorphs can occur in fired ancient potsherds when the firing temperature was under 350 degrees C. Pollen and phytoliths recovered from incompletely fired and fully fired potsherds (ca. 2700 yrs BP) from the Yanghai Tombs, Turpan, Xinjiang, NW China can be used as potential indicators for reconstructing past vegetation and corresponding climate in the area. The results show a higher rate of recovery of pollen and phytoliths from incompletely fired potsherds than from fully fired ones. Charred phytoliths recovered from both fully fired and incompletely fired potsherds prove that degree and condition of firing result in a permanent change in phytolith color. The palynological data, together with previous data of macrobotanical remains from the Yanghai Tombs, suggest that temperate vegetation and arid climatic conditions dominated in the area ca. 2700 yrs BP.	[Yao, Yi-Feng; Li, Cheng-Sen] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Li, Xiao] Renmin Univ China, Sch Guoxue, Beijing, Peoples R China; [Jiang, Hong-En] Chinese Acad Sci, Grad Univ, Dept Sci Hist & Archaeometry, Beijing, Peoples R China; [Ferguson, David K.] Univ Vienna, Dept Paleontol, Vienna, Austria; [Hueber, Francis] US Natl Museum, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC USA; [Ghosh, Ruby] Birbal Sahni Inst Paleobot, Lucknow, Uttar Pradesh, India; [Ghosh, Ruby; Bera, Subir] Univ Calcutta, Dept Bot, Kolkata, India	Chinese Academy of Sciences; Institute of Botany, CAS; Renmin University of China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Vienna; Smithsonian Institution; Smithsonian National Museum of Natural History; Department of Science & Technology (India); Birbal Sahni Institute of Palaeobotany (BSIP); University of Calcutta	Yao, YF (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	lics@ibcas.ac.cn		Bera, Subir/0000-0002-1075-7846	National Natural Science Foundation of China [30990241, 40701191, 41102114]; Graduate University of Chinese Academy of Sciences [Y05101PY00]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate University of Chinese Academy of Sciences(Chinese Academy of Sciences)	This study is financially supported by the National Natural Science Foundation of China (Nos. 30990241, 40701191, 41102114) and the Presidential Fund of the Graduate University of Chinese Academy of Sciences (Y05101PY00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[阿布都热合曼·哈力克 Abdirahman·Halik], 2009, [水文, Hydrology], V29, P50; [Anonymous], [No title captured]; Barboni D, 1999, PALAEOGEOGR PALAEOCL, V152, P87, DOI 10.1016/S0031-0182(99)00045-0; Boyd M, 2005, J ARID ENVIRON, V61, P357, DOI 10.1016/j.jaridenv.2004.09.015; BROWN DA, 1984, J ARCHAEOL SCI, V11, P345, DOI 10.1016/0305-4403(84)90016-5; Bryant VM, 2003, SCIENCE, V299, P1029, DOI 10.1126/science.1081624; Comprehensive Expedition of Xinjiang Chinese Academy of Sciences Institute of Botany CAS (CEXCAS IBCAS), 1978, XINJ VEG ITS UT; Elbaum R, 2003, J ARCHAEOL SCI, V30, P217, DOI 10.1006/jasc.2002.0828; Erdtman G., 1952, INTRO PALYNOLOGY, VI; Faegri K, 1975, TXB POLLEN ANAL; Fici S, 2004, PLANT BIOSYST, V138, P125, DOI 10.1080/11263500412331283753; FREDLUND GG, 1994, J BIOGEOGR, V21, P321, DOI 10.2307/2845533; Ghosh R, 2006, J ARCHAEOL SCI, V33, P1445, DOI 10.1016/j.jas.2006.01.015; Gu YS, 2008, J BIOGEOGR, V35, P325, DOI 10.1111/j.1365-2699.2007.01763.x; Hu YQ, 2007, J ARCHAEOL SCI, V34, P1153, DOI 10.1016/j.jas.2006.10.026; IBCAS (Institute of Botany Chinese Academy of Sciences), 1976, SPOR PTER SIN; IBSCIBCAS (Institute of Botany and South China Institute of Botany Chinese Academy of Sciences), 1982, ANG POLL FLOR TROP S; JACOBS M., 1965, Blumea, V12, P385; Jiang H, 2007, J PALAEOGEOGR, V5, P551; Jiang HE, 2006, THESIS CHINESE ACAD; Jiang HE, 2007, J ETHNOPHARMACOL, V113, P409, DOI 10.1016/j.jep.2007.06.020; Jiang HE, 2006, J ETHNOPHARMACOL, V108, P414, DOI 10.1016/j.jep.2006.05.034; Jiang HE, 2007, J ARCHAEOL SCI, V34, P167, DOI 10.1016/j.jas.2006.04.003; Jiang HE, 2009, J ARCHAEOL SCI, V36, P1458, DOI 10.1016/j.jas.2009.02.010; Kenny JB, 1976, COMPLETE BOOK POTTER; KONDO R, 1981, Research Bulletin of Obihiro University Series I, V12, P217; Kondo R, 1978, SOIL SCI PLANT NUTR, V49, P138; Kondo R., 1994, OPAL PHYTOLITHS NZ; Lu HY, 2007, QUATERNARY SCI REV, V26, P759, DOI 10.1016/j.quascirev.2006.10.006; Lu HY, 2006, QUATERNARY SCI REV, V25, P945, DOI 10.1016/j.quascirev.2005.07.014; Lu HY, 2005, HOLOCENE, V15, P965, DOI 10.1191/0959683605hl870ra; Lu HY, 2003, DIVERS DISTRIB, V9, P73, DOI 10.1046/j.1472-4642.2003.00166.x; Mabberley D. J., 1997, PLANT BOOK PORTABLE; Mulholland S. C., 1992, PHYTOLITH SYSTEMATIC, P65; MULHOLLAND SC, 1989, J ARCHAEOL SCI, V16, P489, DOI 10.1016/0305-4403(89)90070-8; Parr JF, 2006, GEOARCHAEOLOGY, V21, P171, DOI 10.1002/gea.20102; Pearsall DM., 2015, PALEOETHNOBOTANY HDB; Piperno D.R., 1988, PHYTOLITH ANAL ARCHA; Piperno D.R., 2006, PHYTOLITH COMPREHENS; Piperno D.R., 1998, SMITHSONIAN CONTRIBU, P1, DOI [10.5479/si.0081024X.85, DOI 10.5479/SI.0081024X.85]; Russo EB, 2008, J EXP BOT, V59, P4171, DOI 10.1093/jxb/ern260; SASE T, 1974, Research Bulletin of Obihiro University Series I, V8, P465; SENGUPTA S, 1977, REV PALAEOBOT PALYNO, V24, P239, DOI 10.1016/0034-6667(77)90037-9; TWISS PC, 1969, SOIL SCI SOC AM PRO, V33, P109, DOI 10.2136/sssaj1969.03615995003300010030x; Wallis LA, 2001, QUATERN INT, V83-5, P103, DOI 10.1016/S1040-6182(01)00033-7; Wang FX, 1995, POLLEN FLORA CHINA; Wang YJ, 1993, STUDY PHYTOLITHS THE; Xi YZ, 1994, YUSHANIA, V11, P119; XICRA-BCRTP (Xinjiang Institute of Cultural Relics and Archaeology Bureau of Cultural Relics of Turpan Prefecture), 2004, TURFANOLOGICAL RES, V1, P1	49	10	10	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39780	10.1371/journal.pone.0039780	http://dx.doi.org/10.1371/journal.pone.0039780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761901	Green Published, Green Submitted, gold			2022-12-27	WOS:000305781700067
J	Xu, L; Wang, YX; Guo, Y; You, QS; Jonas, JB				Xu, Liang; Wang, Ya Xing; Guo, Yin; You, Qi Sheng; Jonas, Jost B.		Beijing Eye Study Grp	Prevalence and Associations of Steep Cornea/Keratoconus in Greater Beijing. The Beijing Eye Study	PLOS ONE			English	Article							KERATOCONUS; KERATOPLASTY; POPULATION	Purpose: To evaluate the prevalence and associated factors of steep cornea/keratoconus in the adult Chinese population. Methods: The population-based Beijing Eye Study 2011 included 3468 individuals with a mean age of 64.6 +/- 9.8 years (range: 50-93 years). A detailed ophthalmic examination was performed including optical low-coherence reflectometry. Steep cornea/keratoconus were defined as an anterior corneal refractive power exceeding 48 diopters. Results: Mean refractive power of the cornea was 43.16 +/- 1.45 diopters (range: 36.51 to 48.46 diopters; flattest meridian) and 43.98 +/- 1.52 diopters (range: 37.00 to 52.88 diopters; steepest meridian). A steep cornea/keratoconus defined as corneal refractive power of >= 48 diopters and >= 49 diopters was detected in 27 subjects (prevalence rate: 0.9 +/- 0.2%) and 6 (0.2 +/- 0.1%) subjects, respectively. Presence of steep cornea/keratoconus was associated with shorter axial length (P<0.001), smaller interpupillary distance (P=0.038), lower best corrected visual acuity (P=0.021), higher cylindrical refractive error (P<0.001) and more myopic refractive error (P<0.001). It was not significantly associated with gender, body height, psychic depression, cognitive function, blood concentrations of glucose, lipids, creatinine and C-reactive protein, blood pressure and quality of life score, nor with intraocular pressure, dry eye feeling, and lens thickness. Conclusions: A steep cornea/keratoconus defined as corneal refractive power of 48+ diopters has a prevalence of 0.9 +/- 0.2% among Chinese aged 50 years and above. Its prevalence was significantly associated with the ocular parameters of shorter axial length, smaller interpupillary distance, higher cylindrical and myopic refractive error and lower best corrected visual acuity, however, with none of the systemic parameters tested.	[Xu, Liang; Wang, Ya Xing; Guo, Yin; You, Qi Sheng; Jonas, Jost B.; Beijing Eye Study Grp] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Univ Heidelberg, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Xu, L (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China.	xlbio1@163.com	You, Qisheng/AAG-7153-2020; You, Qisheng/A-3619-2014; Guo, Yin/ABC-2134-2020; wang, YA XING/K-9671-2016	You, Qisheng/0000-0003-0743-7320; You, Qisheng/0000-0003-0743-7320; Guo, Yin/0000-0003-3806-3771; wang, YA XING/0000-0003-2749-7793	National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Towerki AE, 2004, CORNEA, V23, P584, DOI 10.1097/01.ico.0000121708.58571.5b; Assiri AA, 2005, BRIT J OPHTHALMOL, V89, P1403, DOI 10.1136/bjo.2005.074955; Claesson M, 2004, BRIT J OPHTHALMOL, V88, P858, DOI 10.1136/bjo.2003.035758; Dandona Lalit, 1997, Indian Journal of Ophthalmology, V45, P163; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ghosheh Faris R., 2008, International Ophthalmology, V28, P147, DOI 10.1007/s10792-007-9177-z; Jonas JB, 2009, AM J OPHTHALMOL, V148, P760, DOI 10.1016/j.ajo.2009.06.024; LAWLESS M, 1989, AUST NZ J OPHTHALMOL, V17, P33; McMonnies Charles W, 2007, Eye Contact Lens, V33, P265, DOI 10.1097/ICL.0b013e31814fb64b; MCNAB AA, 1993, AUST NZ J OPHTHALMOL, V21, P1; Nielsen K, 2007, ACTA OPHTHALMOL SCAN, V85, P890, DOI 10.1111/j.1600-0420.2007.00981.x; OLSEN T, 1986, BRIT J OPHTHALMOL, V70, P152, DOI 10.1136/bjo.70.2.152; Poinard C, 2003, J FR OPHTALMOL, V26, P911; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Reeves SW, 2009, CORNEA, V28, P40, DOI 10.1097/ICO.0b013e3181839b06; Spoerl E, 2008, J REFRACT SURG, V24, pS737, DOI 10.3928/1081597X-20080901-18; Xu L, 2006, BRIT J OPHTHALMOL, V90, P1087, DOI 10.1136/bjo.2006.096123; Xu L, 2008, AM J OPHTHALMOL, V145, P929, DOI 10.1016/j.ajo.2008.01.004	18	42	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39313	10.1371/journal.pone.0039313	http://dx.doi.org/10.1371/journal.pone.0039313			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792169	Green Submitted, Green Published, gold			2022-12-27	WOS:000306461800008
J	Groeneveld, LF; Atencia, R; Garriga, RM; Vigilant, L				Groeneveld, Linn Fenna; Atencia, Rebeca; Garriga, Rosa M.; Vigilant, Linda			High Diversity at PRDM9 in Chimpanzees and Bonobos	PLOS ONE			English	Article							AMINO-ACID SITES; MEIOTIC RECOMBINATION HOTSPOTS; HISTONE H3 METHYLTRANSFERASE; POLYMERASE-CHAIN-REACTION; HOT-SPOTS; NUCLEOTIDE SUBSTITUTION; MOLECULAR EVOLUTION; POSITIVE SELECTION; MALE-STERILITY; GENE	Background: The PRDM9 locus in mammals has increasingly attracted research attention due to its role in mediating chromosomal recombination and possible involvement in hybrid sterility and hence speciation processes. The aim of this study was to characterize sequence variation at the PRDM9 locus in a sample of our closest living relatives, the chimpanzees and bonobos. Methodology/Principal Findings: PRDM9 contains a highly variable and repetitive zinc finger array. We amplified this domain using long-range PCR and determined the DNA sequences using conventional Sanger sequencing. From 17 chimpanzees representing three subspecies and five bonobos we obtained a total of 12 alleles differing at the nucleotide level. Based on a data set consisting of our data and recently published Pan PRDM9 sequences, we found that at the subspecies level, diversity levels did not differ among chimpanzee subspecies or between chimpanzee subspecies and bonobos. In contrast, the sample of chimpanzees harbors significantly more diversity at PRDM9 than samples of humans. Pan PRDM9 shows signs of rapid evolution including no alleles or ZnFs in common with humans as well as signals of positive selection in the residues responsible for DNA binding. Conclusions and Significance: The high number of alleles specific to the genus Pan, signs of positive selection in the DNA binding residues, and reported lack of conservation of recombination hotspots between chimpanzees and humans suggest that PRDM9 could be active in hotspot recruitment in the genus Pan. Chimpanzees and bonobos are considered separate species and do not have overlapping ranges in the wild, making the presence of shared alleles at the amino acid level between the chimpanzee and bonobo species interesting in view of the hypothesis that PRDM9 plays a universal role in interspecific hybrid sterility.	[Groeneveld, Linn Fenna; Vigilant, Linda] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Garriga, Rosa M.] Tacugama Chimpanzee Sanctuary, Freetown, Sierra Leone; [Atencia, Rebeca] Jane Goodall Inst, Pointe Noire, Rep Congo	Max Planck Society	Groeneveld, LF (corresponding author), Univ Gottingen, Courant Res Ctr Geobiol, Gottingen, Germany.	linn.groeneveld@geo.uni-goettingen.de; vigilant@eva.mpg.de		Groeneveld, Linn Fenna/0000-0002-1290-9436; Garriga, Rosa M./0000-0002-5442-7523	Max Planck Society; Ministry of Forest of the Republic of Congo	Max Planck Society(Max Planck Society); Ministry of Forest of the Republic of Congo	This project was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank Roger Mundry for help with the permutation tests, Kathrin Kohler for preparing DNA extracts and the MPI-EVA Sequencing Group for sequencing services and Kay Prufer and Svante Paabo for helpful discussions. We are grateful to Ngamba Island Chimpanzee Sanctuary/Chimpanzee Sanctuary & Wildlife Conservation Trust, Uganda and Lola ya Bonobo Sanctuary, Democratic Republic of Congo for granting access to samples, as well as A. Fischer and M. Halbwax for sample acquisition efforts. The Ministry of Forest of the Republic of Congo is thanked for their authorization and support of this study.	Adams DC, 1996, ANIM BEHAV, V51, P733, DOI 10.1006/anbe.1996.0077; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; [Anonymous], 2006, THESIS U TEXAS AUSTI; Arnheim N, 2007, ANNU REV GENET, V41, P369, DOI 10.1146/annurev.genet.41.110306.130301; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Axelsson E, 2012, GENOME RES, V22, P51, DOI 10.1101/gr.124123.111; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2011, P NATL ACAD SCI USA, V108, P12378, DOI 10.1073/pnas.1109531108; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Birtle Z, 2006, BIOINFORMATICS, V22, P2841, DOI 10.1093/bioinformatics/btl498; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; Cheung VG, 2010, SCIENCE, V327, P791, DOI 10.1126/science.1187155; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; ENNIS PD, 1990, P NATL ACAD SCI USA, V87, P2833, DOI 10.1073/pnas.87.7.2833; Fischer A, 2006, CURR BIOL, V16, P1133, DOI 10.1016/j.cub.2006.04.033; Fischer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021605; Fledel-Alon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020321; FOREJT J, 1974, GENET RES, V24, P189, DOI 10.1017/S0016672300015214; Forejt J, 1996, TRENDS GENET, V12, P412, DOI 10.1016/0168-9525(96)10040-8; Fumasoni I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-187; Goldman N, 2002, MOL BIOL EVOL, V19, P1821, DOI 10.1093/oxfordjournals.molbev.a004007; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Good JM, 2008, EVOLUTION, V62, P50, DOI 10.1111/j.1558-5646.2007.00257.x; Goodstadt L, 2011, HEREDITY, V106, P710, DOI 10.1038/hdy.2010.88; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grey C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001176; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Hochwagen A, 2010, CURR BIOL, V20, pR271, DOI 10.1016/j.cub.2010.01.048; Irie S, 2009, J ANDROL, V30, P426, DOI 10.2164/jandrol.108.006262; Jeffreys AJ, 2009, NAT GENET, V41, P625, DOI 10.1038/ng.346; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; LABBE D, 1992, IMMUNOGENETICS, V35, P395; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; Longeri M, 2002, EUR J IMMUNOGENET, V29, P517, DOI 10.1046/j.1365-2370.2002.00356.x; Manly BFJ, 1997, RANDOMIZATION BOOTST; Massingham T, 2005, GENETICS, V169, P1753, DOI 10.1534/genetics.104.032144; McVean G, 2010, NAT GENET, V42, P821, DOI 10.1038/ng1010-821; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Munoz-Fuentes V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025498; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Nielsen R, 1998, GENETICS, V148, P929; ODELBERG SJ, 1995, NUCLEIC ACIDS RES, V23, P2049, DOI 10.1093/nar/23.11.2049; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; PAABO S, 1990, J BIOL CHEM, V265, P4718; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Ponting CP, 2011, TRENDS GENET, V27, P165, DOI 10.1016/j.tig.2011.02.001; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Sandovici Ionel, 2010, F1000 Biol Rep, V2, DOI 10.3410/B2-37; Segurel L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001211; Thomas JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008505; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zylstra P, 1998, IMMUNOL CELL BIOL, V76, P395, DOI 10.1046/j.1440-1711.1998.00772.x	61	29	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39064	10.1371/journal.pone.0039064	http://dx.doi.org/10.1371/journal.pone.0039064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768294	Green Published, Green Submitted, gold			2022-12-27	WOS:000305966500007
J	Trindade-Silva, AE; Rua, C; Silva, GGZ; Dutilh, BE; Moreira, APB; Edwards, RA; Hajdu, E; Lobo-Hajdu, G; Vasconcelos, AT; Berlinck, RGS; Thompson, FL				Trindade-Silva, Amaro E.; Rua, Cintia; Silva, Genivaldo G. Z.; Dutilh, Bas E.; Moreira, Ana Paula B.; Edwards, Robert A.; Hajdu, Eduardo; Lobo-Hajdu, Gisele; Vasconcelos, Ana Tereza; Berlinck, Roberto G. S.; Thompson, Fabiano L.			Taxonomic and Functional Microbial Signatures of the Endemic Marine Sponge Arenosclera brasiliensis	PLOS ONE			English	Article							TRIPARTITE TRICARBOXYLATE TRANSPORTER; ELECTRON-MICROSCOPE; GENOME; BACTERIA; DIVERSITY; SEQUENCE; DEHYDROGENASE; BIOSYNTHESIS; METAGENOMES; ASSOCIATION	The endemic marine sponge Arenosclera brasiliensis (Porifera, Demospongiae, Haplosclerida) is a known source of secondary metabolites such as arenosclerins A-C. In the present study, we established the composition of the A. brasiliensis microbiome and the metabolic pathways associated with this community. We used 454 shotgun pyrosequencing to generate approximately 640,000 high-quality sponge-derived sequences (similar to 150 Mb). Clustering analysis including sponge, seawater and twenty-three other metagenomes derived from marine animal microbiomes shows that A. brasiliensis contains a specific microbiome. Fourteen bacterial phyla (including Proteobacteria, Cyanobacteria, Actinobacteria, Bacteroidetes, Firmicutes and Cloroflexi) were consistently found in the A. brasiliensis metagenomes. The A. brasiliensis microbiome is enriched for Betaproteobacteria (e.g., Burkholderia) and Gammaproteobacteria (e.g., Pseudomonas and Alteromonas) compared with the surrounding planktonic microbial communities. Functional analysis based on Rapid Annotation using Subsystem Technology (RAST) indicated that the A. brasiliensis microbiome is enriched for sequences associated with membrane transport and one-carbon metabolism. In addition, there was an overrepresentation of sequences associated with aerobic and anaerobic metabolism as well as the synthesis and degradation of secondary metabolites. This study represents the first analysis of sponge-associated microbial communities via shotgun pyrosequencing, a strategy commonly applied in similar analyses in other marine invertebrate hosts, such as corals and algae. We demonstrate that A. brasiliensis has a unique microbiome that is distinct from that of the surrounding planktonic microbes and from other marine organisms, indicating a species-specific microbiome.	[Trindade-Silva, Amaro E.; Berlinck, Roberto G. S.] Univ Sao Paulo, Inst Quim Sao Carlos, Sao Carlos, SP, Brazil; [Trindade-Silva, Amaro E.; Rua, Cintia; Moreira, Ana Paula B.; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Silva, Genivaldo G. Z.; Dutilh, Bas E.; Edwards, Robert A.] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Dutilh, Bas E.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Edwards, Robert A.] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA; [Hajdu, Eduardo] Univ Fed Rio de Janeiro, Museu Nacl, Dept Invertebrados, Rio De Janeiro, Brazil; [Lobo-Hajdu, Gisele] Univ Estado Rio de Janeiro, Inst Biol Roberto Alcantara Gomes, BR-20550011 Rio De Janeiro, Brazil; [Vasconcelos, Ana Tereza] Lab Nacl Comp Cient, Petropolis, Brazil	Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; California State University System; San Diego State University; Radboud University Nijmegen; United States Department of Energy (DOE); Argonne National Laboratory; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Laboratorio Nacional de Computacao Cientifica (LNCC)	Trindade-Silva, AE (corresponding author), Univ Sao Paulo, Inst Quim Sao Carlos, Sao Carlos, SP, Brazil.	fabiano.thompson@biologia.ufrj.br	Vasconcelos, Ana Tereza R/I-1011-2012; Moreira, Ana Paula B./J-8442-2013; Dutilh, Bas E./B-9719-2011; Trindade-Silva, Amaro/AAO-5685-2020; Edwards, Robert/Q-1691-2019; Lobo-Hajdu, Gisele/A-6709-2008; Berlinck, Roberto G. S./G-4756-2010; Moreira, Ana Paula B./ABE-5912-2020; Hajdu, Eduardo/C-3863-2009; Fapesp, Biota/F-8655-2017; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022	Vasconcelos, Ana Tereza R/0000-0002-4632-2086; Moreira, Ana Paula B./0000-0001-9757-1317; Dutilh, Bas E./0000-0003-2329-7890; Trindade-Silva, Amaro/0000-0003-4321-065X; Edwards, Robert/0000-0001-8383-8949; Lobo-Hajdu, Gisele/0000-0001-7792-9609; Berlinck, Roberto G. S./0000-0003-0118-2523; Moreira, Ana Paula B./0000-0001-9757-1317; Hajdu, Eduardo/0000-0002-8760-9403; Fapesp, Biota/0000-0002-9887-8449; Thompson, Fabiano/0000-0002-7562-1683; Rua, Cintia/0000-0002-1872-2963	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); FAPESP [2009/11612-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Dutch Science foundation (NWO) Veni grant [016.111.075]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Dutch Science foundation (NWO) Veni grant	The authors thank the financial support provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) to RGSB, by FAPESP scholarship 2009/11612-1 to AETS, by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) to FLT, and by Dutch Science foundation (NWO) Veni grant: 016.111.075 to BED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antoine R, 2005, J MOL BIOL, V351, P799, DOI 10.1016/j.jmb.2005.05.071; Antoine R, 2003, J BACTERIOL, V185, P1470, DOI 10.1128/JB.185.4.1470-1474.2003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg IA, 2010, NAT REV MICROBIOL, V8, P447, DOI 10.1038/nrmicro2365; Bluman AG., 2007, ELEMENTARY STAT STEP; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; de Oliveira JHHL, 2007, J NAT PROD, V70, P538, DOI 10.1021/np060450q; Drennan CL, 2001, P NATL ACAD SCI USA, V98, P11973, DOI 10.1073/pnas.211429998; Dutilh BE, 2007, BIOINFORMATICS, V23, P815, DOI 10.1093/bioinformatics/btm015; Dutilh BE, 2004, J MOL EVOL, V58, P527, DOI 10.1007/s00239-003-2575-6; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fieseler L, 2004, APPL ENVIRON MICROB, V70, P3724, DOI 10.1128/aem.70.6.3724-3732.2004; Fontana A., 2006, MOLLUSCS CHEMOECOLOG, P304; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Korbel JO, 2002, TRENDS GENET, V18, P158, DOI 10.1016/S0168-9525(01)02597-5; Kristiansson E, 2009, BIOINFORMATICS, V25, P2737, DOI 10.1093/bioinformatics/btp508; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Lobo-Hadju G., 2004, B MUS I BIOL U GEN, V68, P413; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; Mahenthiralingam E, 2011, CHEM BIOL, V18, P665, DOI 10.1016/j.chembiol.2011.01.020; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Muricy Guilherme, 1999, Beaufortia, V49, P83; Nguyen T, 2008, NAT BIOTECHNOL, V26, P225, DOI 10.1038/nbt1379; O'Sullivan LA, 2007, ENVIRON MICROBIOL, V9, P1017, DOI 10.1111/j.1462-2920.2006.01228.x; Ollagnier-de Choudens S, 2005, FEBS LETT, V579, P3737, DOI 10.1016/j.febslet.2005.05.065; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Partida-Martinez LP, 2007, CHEMBIOCHEM, V8, P41, DOI 10.1002/cbic.200600393; Partida-Martinez LP, 2005, NATURE, V437, P884, DOI 10.1038/nature03997; Pierce E, 2008, ENVIRON MICROBIOL, V10, P2550, DOI 10.1111/j.1462-2920.2008.01679.x; Raaijmakers H, 2002, STRUCTURE, V10, P1261, DOI 10.1016/S0969-2126(02)00826-2; Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012; Rohm B, 2010, ORG BIOMOL CHEM, V8, P1520, DOI 10.1039/b925483h; Schmitt S, 2012, HYDROBIOLOGIA, V687, P341, DOI 10.1007/s10750-011-0799-9; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Sipkema D, 2009, MICROB ECOL, V58, P903, DOI 10.1007/s00248-009-9534-8; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stankevicins L, 2008, TOXICOL IN VITRO, V22, P1869, DOI 10.1016/j.tiv.2008.09.003; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Thomas T, 2010, ISME J, V4, P1557, DOI 10.1038/ismej.2010.74; Thompson FL, 2011, ARCH MICROBIOL, V193, P105, DOI 10.1007/s00203-010-0644-y; Torres YR, 2002, TOXICON, V40, P885, DOI 10.1016/S0041-0101(01)00286-0; Torres YR, 2000, J NAT PROD, V63, P1098, DOI 10.1021/np9905618; Turque AS, 2008, MAR BIOL, V155, P135, DOI 10.1007/s00227-008-1008-x; Turque AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015774; VACELET J, 1975, J MICROSC BIOL CELL, V23, P271; VACELET J, 1977, J EXP MAR BIOL ECOL, V30, P301, DOI 10.1016/0022-0981(77)90038-7; Vial L, 2011, ENVIRON MICROBIOL, V13, P1, DOI 10.1111/j.1462-2920.2010.02343.x; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Winnen B, 2003, RES MICROBIOL, V154, P457, DOI 10.1016/S0923-2508(03)00126-8; WOOTTERS WK, 1981, PHYS REV D, V23, P357, DOI 10.1103/PhysRevD.23.357	57	43	43	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39905	10.1371/journal.pone.0039905	http://dx.doi.org/10.1371/journal.pone.0039905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768320	Green Published, Green Submitted, gold			2022-12-27	WOS:000305966500033
J	Bowlby, SC; Thomas, MJ; D'Agostino, RB; Kridel, SJ				Bowlby, Sarah C.; Thomas, Michael J.; D'Agostino, Ralph B., Jr.; Kridel, Steven J.			Nicotinamide Phosphoribosyl Transferase (Nampt) Is Required for De Novo Lipogenesis in Tumor Cells	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; PROSTATE-CANCER; LIFE-SPAN; PHASE-I; SIRT1; INHIBITION; PHOSPHORYLATION; OVEREXPRESSION; ACETYLATION; CHS-828	Tumor cells have increased metabolic requirements to maintain rapid growth. In particular, a highly lipogenic phenotype is a hallmark of many tumor types, including prostate. Cancer cells also have increased turnover of nicotinamide adenine dinucleotide (NAD(+)), a coenzyme involved in multiple metabolic pathways. However, a specific role for NAD(+) in tumor cell lipogenesis has yet to be described. Our studies demonstrate a novel role for the NAD(+)-biosynthetic enzyme Nicotinamide phosphoribosyltransferase (Nampt) in maintaining de novo lipogenesis in prostate cancer (PCa) cells. Inhibition of Nampt reduces fatty acid and phospholipid synthesis. In particular, short chain saturated fatty acids and the phosphatidylcholine (PC) lipids into which these fatty acids are incorporated were specifically reduced by Nampt inhibition. Nampt blockade resulted in reduced ATP levels and concomitant activation of AMP-activated protein kinase (AMPK) and phosphorylation of acetyl-CoA carboxylase (ACC). In spite of this, pharmacological inhibition of AMPK was not sufficient to fully restore fatty acid synthesis. Rather, Nampt blockade also induced protein hyperacetylation in PC-3, DU145, and LNCaP cells, which correlated with the observed decreases in lipid synthesis. Moreover, the sirtuin inhibitor Sirtinol, and the simultaneous knockdown of SIRT1 and SIRT3, phenocopied the effects of Nampt inhibition on fatty acid synthesis. Altogether, these data reveal a novel role for Nampt in the regulation of de novo lipogenesis through the modulation of sirtuin activity in PCa cells.	[Bowlby, Sarah C.; Kridel, Steven J.] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27106 USA; [Thomas, Michael J.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27103 USA; [D'Agostino, Ralph B., Jr.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Thomas, Michael J.; D'Agostino, Ralph B., Jr.; Kridel, Steven J.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Comprehens Canc, Winston Salem, NC USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Bowlby, SC (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27106 USA.	skridel@wakehealth.edu	Dagostino, Ralph/C-4060-2017	Dagostino, Ralph/0000-0002-3550-8395	National Institutes of Health/National Cancer Institute (NIH/NCI) [T32 CA079448-10, CA114104]; Department of Defense Prostate Cancer Research Program [W81XWH-10-1-0538, W81XWH-11-1-0168]; NATIONAL CANCER INSTITUTE [R01CA114104, T32CA079448] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Prostate Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health/National Cancer Institute (NIH/NCI) T32 CA079448-10; Department of Defense Prostate Cancer Research Program W81XWH-10-1-0538, W81XWH-11-1-0168; and National Institutes of Health/National Cancer Institute (NIH/NCI) CA114104. The Nampt inhibitor FK866 was provided by the National Institute of Mental Health Chemical Synthesis and Drug Supply Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZB, 2007, J BIOL CHEM, V282, P26793, DOI 10.1074/jbc.M703701200; Bae SK, 2006, FEBS LETT, V580, P4105, DOI 10.1016/j.febslet.2006.06.052; Bao JJ, 2010, CELL MOL LIFE SCI, V67, P3073, DOI 10.1007/s00018-010-0402-y; Bi TQ, 2011, ONCOL REP, V26, P1251, DOI 10.3892/or.2011.1378; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borradaile NM, 2009, AGING CELL, V8, P100, DOI 10.1111/j.1474-9726.2009.00453.x; Chalkiadaki A, 2012, NAT REV ENDOCRINOL A; DeLong CJ, 2001, J LIPID RES, V42, P1959; Fleischer TC, 2010, CHEM BIOL, V17, P659, DOI 10.1016/j.chembiol.2010.05.008; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Hasmann M, 2003, CANCER RES, V63, P7436; Hirschey MD, 2011, COLD SPRING HARBOR S; Ho C, 2009, FEBS LETT, V583, P3081, DOI 10.1016/j.febslet.2009.08.031; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Hovstadius P, 2002, CLIN CANCER RES, V8, P2843; Jung-Hynes B, 2009, J BIOL CHEM, V284, P3823, DOI 10.1074/jbc.M807869200; Kim DH, 2011, J NUTR BIOCH; Kim GW, 2011, TRENDS BIOCHEM SCI, V36, P211, DOI 10.1016/j.tibs.2010.10.001; Kojima K, 2008, BIOCHEM BIOPH RES CO, V373, P423, DOI 10.1016/j.bbrc.2008.06.045; KOSAKA A, 1971, J BIOL CHEM, V246, P3277; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; Kridel SJ, 2007, EXPERT OPIN INV DRUG, V16, P1817, DOI 10.1517/13543784.16.11.1817; Lara E, 2009, ONCOGENE, V28, P781, DOI 10.1038/onc.2008.436; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Lewis EM, 2011, BIOCHEMISTRY-US, V50, P11084, DOI 10.1021/bi201483g; Little JL, 2007, CANCER RES, V67, P1262, DOI 10.1158/0008-5472.CAN-06-1794; MUNDAY MR, 1988, EUR J BIOCHEM, V175, P331, DOI 10.1111/j.1432-1033.1988.tb14201.x; Muruganandham M, 2005, CLIN CANCER RES, V11, P3503, DOI 10.1158/1078-0432.CCR-04-1399; Nakane K, 2012, INT J UROL, V19, P71, DOI 10.1111/j.1442-2042.2011.02888.x; Narala SR, 2008, MOL BIOL CELL, V19, P1210, DOI 10.1091/mbc.E07-09-0965; Olesen UH, 2008, BIOCHEM BIOPH RES CO, V367, P799, DOI 10.1016/j.bbrc.2008.01.019; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Pittelli M, 2010, J BIOL CHEM; Pizer ES, 1998, CANCER RES, V58, P4611; PREISS J, 1957, J BIOL CHEM, V225, P759; Rajendran R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/368276; Ravaud A, 2005, EUR J CANCER, V41, P702, DOI 10.1016/j.ejca.2004.12.023; Reddy PS, 2008, CANCER BIOL THER, V7, P663, DOI 10.4161/cbt.7.5.5663; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Rysman E, 2010, CANCER RES, V70, P8117, DOI 10.1158/0008-5472.CAN-09-3871; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Scott KEN, 2012, PLOS ONE IN PRESS; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Shah US, 2006, HUM PATHOL, V37, P401, DOI 10.1016/j.humpath.2005.11.022; Taylor DM, 2008, CELL MOL LIFE SCI, V65, P4000, DOI 10.1007/s00018-008-8357-y; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang B, 2011, ONCOGENE, V30, P907, DOI 10.1038/onc.2010.468; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09; WITTERS LA, 1990, BIOCHEM BIOPH RES CO, V169, P369, DOI 10.1016/0006-291X(90)90341-J; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	60	44	46	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40195	10.1371/journal.pone.0040195	http://dx.doi.org/10.1371/journal.pone.0040195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768255	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100228
J	Chanvillard, C; Millward, JM; Lozano, M; Hamann, I; Paul, F; Zipp, F; Dorr, J; Infante-Duarte, C				Chanvillard, Coralie; Millward, Jason M.; Lozano, Marta; Hamann, Isabell; Paul, Friedemann; Zipp, Frauke; Doerr, Jan; Infante-Duarte, Carmen			Mitoxantrone Induces Natural Killer Cell Maturation in Patients with Secondary Progressive Multiple Sclerosis	PLOS ONE			English	Article							CD8 T-CELLS; INDUCED CARDIOTOXICITY; PHENOTYPE; DIFFERENTIATION; NEUTROPHILS; CYTOKINES; THERAPY	Mitoxantrone is one of the few drugs approved for the treatment of progressive multiple sclerosis (MS). However, the prolonged use of this potent immunosuppressive agent is limited by the appearance of severe side effects. Apart from its general cytotoxic effect, the mode of action of mitoxantrone on the immune system is poorly understood. Thus, to develop safe therapeutic approaches for patients with progressive MS, it is essential to elucidate how mitoxantrone exerts it benefits. Accordingly, we initiated a prospective single-arm open-label study with 19 secondary progressive MS patients. We investigated long-term effects of mitoxantrone on patient peripheral immune subsets using flow cytometry. While we corroborate that mitoxantrone persistently suppresses B cells in vivo, we show for the first time that treatment led to an enrichment of neutrophils and immunomodulatory CD8(low) T cells. Moreover, sustained mitoxantrone applications promoted not only persistent NK cell enrichment but also NK cell maturation. Importantly, this mitoxantrone-induced NK cell maturation was seen only in patients that showed a clinical response to treatment. Our data emphasize the complex immunomodulatory role of mitoxantrone, which may account for its benefit in MS. In particular, these results highlight the contribution of NK cells to mitoxantrone efficacy in progressive MS.	[Chanvillard, Coralie; Millward, Jason M.; Lozano, Marta; Hamann, Isabell; Paul, Friedemann; Infante-Duarte, Carmen] Fac Med Charite, Expt & Clin Res Ctr, Berlin, Germany; [Chanvillard, Coralie; Millward, Jason M.; Lozano, Marta; Hamann, Isabell; Paul, Friedemann; Infante-Duarte, Carmen] Max Delbruck Ctr Mol Med, Berlin, Germany; [Chanvillard, Coralie; Millward, Jason M.; Lozano, Marta; Hamann, Isabell; Paul, Friedemann; Doerr, Jan; Infante-Duarte, Carmen] Charite Univ Med Berlin, Clin & Expt Multiple Sclerosis Res Ctr, Berlin, Germany; [Paul, Friedemann; Doerr, Jan] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Zipp, Frauke] Univ Med Mainz, Dept Neurol, Mainz, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Johannes Gutenberg University of Mainz	Chanvillard, C (corresponding author), Fac Med Charite, Expt & Clin Res Ctr, Berlin, Germany.	carmen.infante@charite.de	Zipp, Frauke/C-9968-2015; Paul, Friedemann/ABF-9415-2020	Zipp, Frauke/0000-0002-1231-1928; Infante Duarte, Carmen/0000-0003-3005-351X; Millward, Jason/0000-0003-4484-2798; paul, friedemann/0000-0002-6378-0070	European Community (UEPHA*MS) [212877]; German Research Council -DFG [KFO 213, Exc 257]; Novartis Pharma	European Community (UEPHA*MS); German Research Council -DFG(German Research Foundation (DFG)); Novartis Pharma	The work was supported by grants to CID from the European Community's Seventh Framework Programme (UEPHA*MS, Grant agreement # 212877) from the German Research Council -DFG- (KFO 213) and from Novartis Pharma and by a DFG grant to FP (Exc 257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas O, 2007, ARCH NEUROL-CHICAGO, V64, P185, DOI 10.1001/archneur.64.2.185; Angelucci F, 2006, NEUROIMMUNOMODULAT, V13, P76, DOI 10.1159/000095762; Avasarala JR, 2003, MULT SCLER, V9, P59, DOI 10.1191/1352458503ms896oa; BENCZUR M, 1980, CLIN EXP IMMUNOL, V39, P657; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Bjorkstrom NK, 2010, BLOOD, V116, P3853, DOI 10.1182/blood-2010-04-281675; Chan A, 2005, CLIN EXP IMMUNOL, V139, P152, DOI 10.1111/j.1365-2249.2005.02653.x; Dale DC, 2008, BLOOD, V112, P935, DOI 10.1182/blood-2007-12-077917; De Jager PL, 2008, BRAIN, V131, P1701, DOI 10.1093/brain/awn118; Dorr J, 2009, NEUROLOGY, V73, P991, DOI 10.1212/WNL.0b013e3181b878f6; DURR FE, 1983, CANCER TREAT REV, V10, P3, DOI 10.1016/0305-7372(83)90016-6; FIDLER JM, 1986, J IMMUNOL, V137, P727; Fox EJ, 2004, NEUROLOGY, V63, pS15, DOI 10.1212/WNL.63.12_suppl_6.S15; Franzen D, 2010, MULT SCLER INT, V2010, DOI 10.1155/2010/351045; Gbadamosi J, 2003, EUR NEUROL, V49, P137, DOI 10.1159/000069082; Goodin DS, 2003, NEUROLOGY, V61, P1332, DOI 10.1212/01.WNL.0000095425.84407.39; Hamann I, 2011, IMMUNOLOGY, V133, P62, DOI 10.1111/j.1365-2567.2011.03409.x; Hartung HP, 2002, LANCET, V360, P2018, DOI 10.1016/S0140-6736(02)12023-X; HIRSCH RL, 1985, CLIN IMMUNOL IMMUNOP, V37, P236, DOI 10.1016/0090-1229(85)90155-2; Infante-Duarte C, 2008, J MOL MED, V86, P975, DOI 10.1007/s00109-007-0292-0; Infante-Duarte C, 2005, FASEB J, V19, P1902, DOI 10.1096/fj.05-3832fje; Juelke K, 2010, BLOOD, V116, P1299, DOI 10.1182/blood-2009-11-253286; Kastrukoff LF, 1999, NEUROLOGY, V52, P351, DOI 10.1212/WNL.52.2.351; Kienzle N, 2004, IMMUNOL CELL BIOL, V82, P75, DOI 10.1111/j.1440-1711.2004.01210.x; Kitajima M, 2011, CANCER RES, V71, P4790, DOI 10.1158/0008-5472.CAN-10-1572; Le Page E, 2011, MULT SCLER J, V17, P867, DOI 10.1177/1352458511398371; Martinez-Rodriguez JE, 2011, CLIN IMMUNOL, V141, P348, DOI 10.1016/j.clim.2011.09.006; MUNSCHAUER FE, 1995, J NEUROIMMUNOL, V62, P177, DOI 10.1016/0165-5728(95)00115-9; Naegele M, 2012, J NEUROIMMUNOL, V242, P60, DOI 10.1016/j.jneuroim.2011.11.009; Neuhaus O, 2005, J NEUROIMMUNOL, V168, P128, DOI 10.1016/j.jneuroim.2005.01.024; Pascual AM, 2009, MULT SCLER J, V15, P1303, DOI 10.1177/1352458509107015; Paul F, 2007, J NEUROL NEUROSUR PS, V78, P198, DOI 10.1136/jnnp.2006.091033; Sand KL, 2009, CELL MOL LIFE SCI, V66, P1446, DOI 10.1007/s00018-009-8726-1; Soulika AM, 2009, J NEUROSCI, V29, P14965, DOI 10.1523/JNEUROSCI.3794-09.2009; Trautmann A, 2003, IMMUNOLOGY, V108, P305, DOI 10.1046/j.1365-2567.2003.01590.x; Vogelgesang A, 2010, ACTA NEUROL SCAND, V122, P237, DOI 10.1111/j.1600-0404.2009.01295.x; Vollmer T, 2010, NEUROLOGY, V74, pS41, DOI 10.1212/WNL.0b013e3181c97f5a; Vossen MTM, 2008, J IMMUNOL, V180, P3739, DOI 10.4049/jimmunol.180.6.3739; VRANES Z, 1989, J NEUROL SCI, V94, P115, DOI 10.1016/0022-510X(89)90222-0; WANG BS, 1986, INT J IMMUNOPHARMACO, V8, P967, DOI 10.1016/0192-0561(86)90099-8; Wu FL, 2010, HISTOCHEM CELL BIOL, V133, P313, DOI 10.1007/s00418-009-0673-2	41	23	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39625	10.1371/journal.pone.0039625	http://dx.doi.org/10.1371/journal.pone.0039625			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768101	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000305892100071
J	Oh, JH; Wong, HP; Wang, XW; Deasy, JO				Oh, Jung Hun; Wong, Harry P.; Wang, Xiaowei; Deasy, Joseph O.			A Bioinformatics Filtering Strategy for Identifying Radiation Response Biomarker Candidates	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; BREAST-CANCER PATIENTS; SQUAMOUS-CELL CARCINOMA; DNA-REPAIR GENES; DIFFERENTIALLY EXPRESSED GENES; ADENOVIRUS-MEDIATED EXPRESSION; THERAPY FOLLOWING LUMPECTOMY; NORMAL TISSUE COMPLICATIONS; HUMAN TUMOR-CELLS; QUALITY-OF-LIFE	The number of biomarker candidates is often much larger than the number of clinical patient data points available, which motivates the use of a rational candidate variable filtering methodology. The goal of this paper is to apply such a bioinformatics filtering process to isolate a modest number (<10) of key interacting genes and their associated single nucleotide polymorphisms involved in radiation response, and to ultimately serve as a basis for using clinical datasets to identify new biomarkers. In step 1, we surveyed the literature on genetic and protein correlates to radiation response, in vivo or in vitro, across cellular, animal, and human studies. In step 2, we analyzed two publicly available microarray datasets and identified genes in which mRNA expression changed in response to radiation. Combining results from Step 1 and Step 2, we identified 20 genes that were common to all three sources. As a final step, a curated database of protein interactions was used to generate the most statistically reliable protein interaction network among any subset of the 20 genes resulting from Steps 1 and 2, resulting in identification of a small, tightly interacting network with 7 out of 20 input genes. We further ranked the genes in terms of likely importance, based on their location within the network using a graph-based scoring function. The resulting core interacting network provides an attractive set of genes likely to be important to radiation response.	[Oh, Jung Hun; Deasy, Joseph O.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Wong, Harry P.] Washington Univ, Sch Med, Dept Infect Dis, St Louis, MO USA; [Wang, Xiaowei] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO USA	Memorial Sloan Kettering Cancer Center; Washington University (WUSTL); Washington University (WUSTL)	Oh, JH (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA.	deasyj@mskcc.org	Wang, Xiaowei/T-7452-2019	Oh, Jung Hun/0000-0001-8791-2755; Deasy, Joseph/0000-0002-9437-266X	Memorial Sloan-Kettering Cancer Center	Memorial Sloan-Kettering Cancer Center	The research did not receive any external funding. This work was funded by an internal grant from Memorial Sloan-Kettering Cancer Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaszadeh F, 2010, J MED GENET, V47, P176, DOI 10.1136/jmg.2009.068866; Abbott DW, 1999, J BIOL CHEM, V274, P18808, DOI 10.1074/jbc.274.26.18808; Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Ahn J, 2006, CLIN CANCER RES, V12, P7063, DOI 10.1158/1078-0432.CCR-06-0039; Alsbeih G, 2010, RADIAT RES, V173, P505, DOI 10.1667/RR1769.1; Ambrosone CB, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1526; Andreassen CN, 2006, INT J RADIAT BIOL, V82, P577, DOI 10.1080/09553000600876637; Andreassen CN, 2009, RADIOTHER ONCOL, V92, P299, DOI 10.1016/j.radonc.2009.06.015; Andreassen CN, 2003, RADIOTHER ONCOL, V69, P127, DOI 10.1016/j.radonc.2003.09.010; Andreassen CN, 2005, RADIOTHER ONCOL, V75, P18, DOI 10.1016/j.radonc.2004.12.012; Appleby JM, 1997, BRIT J CANCER, V76, P1546, DOI 10.1038/bjc.1997.593; Azria D, 2008, CLIN CANCER RES, V14, P6284, DOI 10.1158/1078-0432.CCR-08-0700; Badie C, 2008, BRIT J CANCER, V98, P1845, DOI 10.1038/sj.bjc.6604381; Barahmani N, 2009, NEURO-ONCOLOGY, V11, P292, DOI 10.1215/15228517-2008-089; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Blalock EM, 2005, AGEING RES REV, V4, P481, DOI 10.1016/j.arr.2005.06.006; Bonner JA, 2009, RADIOTHER ONCOL, V92, P339, DOI 10.1016/j.radonc.2009.06.022; Borgmann K, 2002, RADIOTHER ONCOL, V64, P141, DOI 10.1016/S0167-8140(02)00167-6; Brem R, 2006, CARCINOGENESIS, V27, P2469, DOI 10.1093/carcin/bgl114; Brigl B, 2006, METHOD INFORM MED, V45, P216; Brunner TB, 2005, CANCER RES, V65, P8433, DOI 10.1158/0008-5472.CAN-05-0158; Burns TF, 2001, ONCOGENE, V20, P4601, DOI 10.1038/sj.onc.1204484; Burri RJ, 2008, RADIAT RES, V170, P49, DOI 10.1667/RR1219.1; Cao Y, 2009, FREE RADICAL BIO MED, V47, P1057, DOI 10.1016/j.freeradbiomed.2009.07.017; Cecchin E, 2011, PHARMACOGENOMICS J, V11, P214, DOI 10.1038/tpj.2010.25; Cengel KA, 2005, CRIT REV ONCOL HEMAT, V55, P103, DOI 10.1016/j.critrevonc.2005.02.001; Chang CJ, 2009, BIOCHEM BIOPH RES CO, V380, P236, DOI 10.1016/j.bbrc.2009.01.040; Chang JTC, 2007, MOL CANCER THER, V6, P2271, DOI 10.1158/1535-7163.MCT-06-0801; Chang-Claude J, 2005, CLIN CANCER RES, V11, P4802, DOI 10.1158/1078-0432.CCR-04-2657; Chen T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S20; Chen WS, 2010, INT J RADIAT ONCOL, V77, P566, DOI 10.1016/j.ijrobp.2009.12.013; Chetty C, 2009, INT J CANCER, V124, P2468, DOI 10.1002/ijc.24209; Chiani F, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap007; Chiou SH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002090; Chorna IV, 2005, EXP ONCOL, V27, P196; Chung HJ, 2006, J CELL PHYSIOL, V209, P131, DOI 10.1002/jcp.20714; Clark AJ, 2007, J NEURO-ONCOL, V83, P163, DOI 10.1007/s11060-006-9317-8; Clarke R A, 2002, Australas Radiol, V46, P329, DOI 10.1046/j.1440-1673.2002.01072.x; Correa CR, 2004, AM J HUM GENET, V75, P885, DOI 10.1086/425221; Damaraju S, 2006, CLIN CANCER RES, V12, P2545, DOI 10.1158/1078-0432.CCR-05-2703; Das A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703343200; De Ruyck K, 2005, RADIAT RES, V164, P237, DOI 10.1667/RR3417.1; De Ruyck K, 2005, INT J RADIAT ONCOL, V62, P1140, DOI 10.1016/j.ijrobp.2004.12.027; Demizu Y, 2008, ANTIOXID REDOX SIGN, V10, P951, DOI 10.1089/ars.2007.1871; Dexter TJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-127; Ding KK, 2009, RADIAT ENVIRON BIOPH, V48, P205, DOI 10.1007/s00411-009-0213-4; Dittmann K, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-69; Djuzenova C, 2004, BRIT J CANCER, V90, P2356, DOI 10.1038/sj.bjc.6601878; Du XL, 2009, CROAT MED J, V50, P143, DOI 10.3325/cmj.2009.50.143; Edvardsen H, 2007, INT J RADIAT ONCOL, V67, P1163, DOI 10.1016/j.ijrobp.2006.11.009; Eke I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006434; Ernestos B, 2010, INT J RADIAT ONCOL, V76, P1199, DOI 10.1016/j.ijrobp.2009.10.020; Eschrich S, 2009, INT J RADIAT ONCOL, V75, P497, DOI 10.1016/j.ijrobp.2009.05.056; Fernet M, 2004, DNA REPAIR, V3, P1237, DOI 10.1016/j.dnarep.2004.03.019; Fernet M, 2000, INT J RADIAT BIOL, V76, P1621, DOI 10.1080/09553000050201118; Firat E, 2009, CANCER RES, V69, P3325, DOI 10.1158/0008-5472.CAN-08-3269; Fogarty GB, 2010, INT J RADIAT ONCOL, V77, P1486, DOI 10.1016/j.ijrobp.2009.07.1690; Gaffney DK, 1998, RADIOTHER ONCOL, V47, P129, DOI 10.1016/S0167-8140(98)00023-1; Giagkousiklidis S, 2007, ONCOGENE, V26, P7006, DOI 10.1038/sj.onc.1210502; Giotopoulos G, 2007, BRIT J CANCER, V96, P1001, DOI 10.1038/sj.bjc.6603637; Guo WF, 2007, INT J ONCOL, V30, P1447; Guo WF, 2005, RADIAT RES, V164, P27, DOI 10.1667/RR3401; Hadchity E, 2009, MOL THER, V17, P1387, DOI 10.1038/mt.2009.90; Haffty BG, 2003, ONCOGENE, V22, P5915, DOI 10.1038/sj.onc.1206704; Guan HT, 2006, WORLD J GASTROENTERO, V12, P2901, DOI 10.3748/wjg.v12.i18.2901; Hall EJ, 1998, CANCER J, V4, P385; Hamilton J, 2009, CANCER BIOL THER, V8, P1577, DOI 10.4161/cbt.8.16.8962; Hehlgans S, 2009, RADIOTHER ONCOL, V92, P362, DOI 10.1016/j.radonc.2009.07.004; Hendry JH, 2002, INT J RADIAT BIOL, V78, P559, DOI 10.1080/09553000210132333; Higgins GS, 2010, CANCER RES, V70, P2984, DOI 10.1158/0008-5472.CAN-09-4040; Higuchi Y, 2002, J RADIAT RES, V43, pS219; Hixon JA, 2001, BIOL BLOOD MARROW TR, V7, P136, DOI 10.1053/bbmt.2001.v7.pm11302547; Hui ZG, 2009, INT J RADIAT ONCOL, V73, P288, DOI 10.1016/j.ijrobp.2008.08.043; Iannuzzi CM, 2002, INT J RADIAT ONCOL, V52, P606, DOI 10.1016/S0360-3016(01)02684-0; Ishigami T, 2008, BRIT J CANCER, V98, P1357, DOI 10.1038/sj.bjc.6604290; Isomura M, 2008, CLIN CANCER RES, V14, P6683, DOI 10.1158/1078-0432.CCR-07-4389; Javvadi P, 2010, CANCER RES, V70, P1941, DOI 10.1158/0008-5472.CAN-09-3025; Jen KY, 2003, GENOME RES, V13, P2092, DOI 10.1101/gr.1240103; Jia LJ, 2010, CLIN CANCER RES, V16, P814, DOI 10.1158/1078-0432.CCR-09-1592; Kabacik S, 2011, INT J RADIAT BIOL, V87, P115, DOI 10.3109/09553002.2010.519424; Kassem HS, 2002, INT J CANCER, V101, P454, DOI 10.1002/ijc.10631; Kim DW, 2007, J ORTHOP RES, V25, P820, DOI 10.1002/jor.20377; Kim D, 2010, CYTOKINE, V50, P37, DOI 10.1016/j.cyto.2009.12.013; Kim JS, 2010, PROTEOMICS, V10, P2589, DOI 10.1002/pmic.200900523; Kim KW, 2010, ONCOGENE, V29, P3241, DOI 10.1038/onc.2010.74; Kool J, 2003, ONCOGENE, V22, P4235, DOI 10.1038/sj.onc.1206611; Kornguth DG, 2005, INT J RADIAT ONCOL, V62, P665, DOI 10.1016/j.ijrobp.2004.11.026; Kuo ML, 2003, CANCER J, V9, P277, DOI 10.1097/00130404-200307000-00010; Kuptsova N, 2008, INT J CANCER, V122, P1333, DOI 10.1002/ijc.23138; Langsenlehner T, 2008, INT J RADIAT ONCOL, V71, P960, DOI 10.1016/j.ijrobp.2008.02.029; Larsson O, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-129; Lee C, 2004, CANCER RES, V64, P6906, DOI 10.1158/0008-5472.CAN-04-1767; Leong T, 2000, INT J RADIAT ONCOL, V48, P959, DOI 10.1016/S0360-3016(00)00728-8; Li SY, 2009, NUCLEIC ACIDS RES, V37, P6746, DOI 10.1093/nar/gkp741; Li XM, 2010, ONCOL REP, V23, P345, DOI 10.3892/or_00000642; Li XL, 2009, ACTA PHARMACOL SIN, V30, P458, DOI 10.1038/aps.2009.18; Liu Li, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P1551; Lu HR, 2006, CELL CYCLE, V5, P2364, DOI 10.4161/cc.5.20.3355; Mao JH, 2008, ONCOGENE, V27, P6596, DOI 10.1038/onc.2008.280; Merbl Y, 2009, P NATL ACAD SCI USA, V106, P2543, DOI 10.1073/pnas.0812892106; Meyer A, 2009, WORLD J UROL, V27, P371, DOI 10.1007/s00345-008-0354-0; Mi J, 2007, CANCER RES, V67, P1082, DOI 10.1158/0008-5472.CAN-06-3071; Milliat F, 2008, AM J PATHOL, V172, P691, DOI 10.2353/ajpath.2008.070930; Mirzayans R, 2006, INT J RADIAT ONCOL, V66, P1498, DOI 10.1016/j.ijrobp.2006.08.064; Moore J, 2007, INT J RADIAT ONCOL, V69, pS7, DOI 10.1016/j.ijrobp.2007.07.014; Moretti L, 2007, AUTOPHAGY, V3, P142, DOI 10.4161/auto.3607; Moullan N, 2003, CANCER EPIDEM BIOMAR, V12, P1168; Moussavi-Harami F, 2006, BIOCHEM BIOPH RES CO, V346, P379, DOI 10.1016/j.bbrc.2006.05.158; Moussay E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-115; Munshi A, 2005, CLIN CANCER RES, V11, P4912, DOI 10.1158/1078-0432.CCR-04-2088; Negroni A, 2008, INT J RADIAT BIOL, V84, P265, DOI 10.1080/09553000801953318; O'Malley BW, 2003, LARYNGOSCOPE, V113, P1588, DOI 10.1097/00005537-200309000-00034; Ogawa K, 2007, CANCER RES, V67, P4016, DOI 10.1158/0008-5472.CAN-06-4498; Oh JH, 2011, J PROTEOME RES, V10, P1406, DOI 10.1021/pr101226q; Park JJ, 2009, INT J RADIAT ONCOL, V73, P1196, DOI 10.1016/j.ijrobp.2008.10.070; Park S, 2010, J MOL MED, V88, P807, DOI 10.1007/s00109-010-0622-5; PATERSON MC, 1979, CANCER RES, V39, P3725; Paul S, 2008, INT J RADIAT ONCOL, V71, P1236, DOI 10.1016/j.ijrobp.2008.03.043; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Pazzaglia S, 2006, ONCOGENE, V25, P1165, DOI 10.1038/sj.onc.1209032; Pena LA, 2000, CANCER RES, V60, P321; Peng YL, 2002, CANCER RES, V62, P6400; Peter Y, 2001, EMBO J, V20, P1538, DOI 10.1093/emboj/20.7.1538; Pierce LJ, 2000, J CLIN ONCOL, V18, P3360, DOI 10.1200/JCO.2000.18.19.3360; Pietras RJ, 1999, CANCER RES, V59, P1347; Popanda O, 2006, CANCER EPIDEM BIOMAR, V15, P1048, DOI 10.1158/1055-9965.EPI-06-0046; Popanda O, 2009, MUTAT RES-FUND MOL M, V667, P58, DOI 10.1016/j.mrfmmm.2008.10.014; Prevo R, 2008, CANCER RES, V68, P5915, DOI 10.1158/0008-5472.CAN-08-0757; Price EA, 1997, SOMAT CELL MOLEC GEN, V23, P237, DOI 10.1007/BF02674415; Pugh TJ, 2009, CLIN CANCER RES, V15, P5008, DOI 10.1158/1078-0432.CCR-08-3357; Raaphorst GP, 2005, ANTICANCER RES, V25, P53; Reap EA, 1997, P NATL ACAD SCI USA, V94, P5750, DOI 10.1073/pnas.94.11.5750; Riballo E, 2001, J BIOL CHEM, V276, P31124, DOI 10.1074/jbc.M103866200; Rieger KE, 2004, NUCLEIC ACIDS RES, V32, P4786, DOI 10.1093/nar/gkh783; Rieger KE, 2004, P NATL ACAD SCI USA, V101, P6635, DOI 10.1073/pnas.0307761101; Rossi M, 2008, NUCLEIC ACIDS RES, V36, P7168, DOI 10.1093/nar/gkn888; Sak SC, 2005, CLIN CANCER RES, V11, P6205, DOI 10.1158/1078-0432.CCR-05-0045; Sakata Koh-Ichi, 2007, Radiat Med, V25, P433, DOI 10.1007/s11604-007-0161-3; Severin DM, 2001, INT J RADIAT ONCOL, V50, P1323, DOI 10.1016/S0360-3016(01)01608-X; Shan B, 2003, J BIOL CHEM, V278, P44009, DOI 10.1074/jbc.M302671200; Shankar S, 2004, INT J ONCOL, V24, P1133; Shanley S, 2006, CLIN CANCER RES, V12, P7025, DOI 10.1158/1078-0432.CCR-06-1244; Sheen JH, 2002, MOL CELL BIOL, V22, P1819, DOI 10.1128/MCB.22.6.1819-1833.2002; Shi Hua-Shan, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P1977; Singhal SS, 2010, INT J CANCER, V126, P1327, DOI 10.1002/ijc.24767; Singhal SS, 2009, BIOCHEM PHARMACOL, V77, P1074, DOI 10.1016/j.bcp.2008.11.013; Snyder AR, 2004, CANCER METAST REV, V23, P259, DOI 10.1023/B:CANC.0000031765.17886.fa; Sterpone S, 2010, MUTAT RES-FUND MOL M, V684, P43, DOI 10.1016/j.mrfmmm.2009.11.009; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Suga T, 2008, INT J RADIAT ONCOL, V72, P808, DOI 10.1016/j.ijrobp.2008.01.029; Suga T, 2007, INT J RADIAT ONCOL, V69, P685, DOI 10.1016/j.ijrobp.2007.06.021; Tan WH, 2006, J IMMUNOL, V176, P6186, DOI 10.4049/jimmunol.176.10.6186; Taniguchi K, 2008, ANTICANCER RES, V28, P1559; Templin T, 2011, INT J RADIAT ONCOL, V80, P549, DOI 10.1016/j.ijrobp.2010.12.061; Terry SYA, 2009, MUTAT RES-FUND MOL M, V663, P40, DOI 10.1016/j.mrfmmm.2009.01.003; Thurfjell N, 2005, INT J MOL MED, V16, P1065; Toulany M, 2008, MOL CANCER THER, V7, P1772, DOI 10.1158/1535-7163.MCT-07-2200; Turtoi A, 2009, INT J RADIAT BIOL, V85, P403, DOI 10.1080/09553000902838541; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Urano M, 2010, INT J RADIAT ONCOL, V77, P877, DOI 10.1016/j.ijrobp.2009.12.062; Valdagni R, 2009, INT J RADIAT ONCOL, V74, P1431, DOI 10.1016/j.ijrobp.2008.10.021; Vandersickel V, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-30; Vandersickel V, 2010, INT J RADIAT BIOL, V86, P114, DOI 10.3109/09553000903419940; Vens C, 2002, NUCLEIC ACIDS RES, V30, P2995, DOI 10.1093/nar/gkf403; Wachsberger PR, 1999, RADIAT RES, V151, P398, DOI 10.2307/3579826; Wang R, 2009, AURIS NASUS LARYNX, V36, P332, DOI 10.1016/j.anl.2008.08.006; Wang X, 2006, ONCOGENE, V25, P1980, DOI 10.1038/sj.onc.1209212; Wang Y, 2004, CANCER RES, V64, P6240, DOI 10.1158/0008-5472.CAN-04-0591; Welsh JW, 2009, INT J RADIAT ONCOL, V74, P1251, DOI 10.1016/j.ijrobp.2009.03.018; Werbrouck J, 2009, INT J RADIAT ONCOL, V73, P1187, DOI 10.1016/j.ijrobp.2008.08.073; Wiebalk K, 2007, INT J CANCER, V121, P2340, DOI 10.1002/ijc.22981; Wischhusen J, 2002, CANCER RES, V62, P2592; Worgul BV, 2002, P NATL ACAD SCI USA, V99, P9836, DOI 10.1073/pnas.162349699; Xiang DB, 2008, CANCER GENE THER, V15, P625, DOI 10.1038/cgt.2008.30; Xiang GA, 2010, SURGERY, V147, P553, DOI 10.1016/j.surg.2009.10.033; Xiao Z, 2005, ONCOGENE, V24, P1403, DOI 10.1038/sj.onc.1208309; Xu QY, 2008, CHINESE MED J-PEKING, V121, P1830, DOI 10.1097/00029330-200809020-00014; Xu W, 2010, ANTI-CANCER AGENT ME, V10, P152, DOI 10.2174/187152010790909362; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Jiao Y, 2007, ACTA PHARMACOL SIN, V28, P1628, DOI 10.1111/j.1745-7254.2007.00647.x; Yavari K, 2010, ACTA ONCOL, V49, P70, DOI 10.3109/02841860903334429; Yokomakura N, 2007, ONCOL REP, V18, P561; Yoshida K, 2004, CANCER RES, V64, P4131, DOI 10.1158/0008-5472.CAN-03-2566; Yuan XL, 2009, J CLIN ONCOL, V27, P3370, DOI 10.1200/JCO.2008.20.6763; Zhang B, 2010, MED ONCOL; Zhang B, 2008, BIOCHEM PHARMACOL, V75, P660, DOI 10.1016/j.bcp.2007.09.016; Zhang M, 2008, CLIN CANCER RES, V14, P1868, DOI 10.1158/1078-0432.CCR-07-1894; Zheng M, 2008, CANCER RES, V68, P7570, DOI 10.1158/0008-5472.CAN-08-0632; Zhou T, 2006, ENVIRON HEALTH PERSP, V114, P553, DOI 10.1289/ehp.8026; Zschenker O, 2010, RADIOTHER ONCOL, V97, P26, DOI 10.1016/j.radonc.2010.01.016	190	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38870	10.1371/journal.pone.0038870	http://dx.doi.org/10.1371/journal.pone.0038870			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768051	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100021
J	Ringler, E; Ringler, M; Jehle, R; Hodl, W				Ringler, Eva; Ringler, Max; Jehle, Robert; Hoedl, Walter			The Female Perspective of Mating in A. femoralis, a Territorial Frog with Paternal Care - A Spatial and Genetic Analysis	PLOS ONE			English	Article							DART-POISON FROG; MATE CHOICE; KIN RECOGNITION; INBREEDING AVOIDANCE; EPIPEDOBATES-FEMORALIS; SEQUENTIAL POLYANDRY; SEXUAL SELECTION; BEHAVIOR; WILD; RELATEDNESS	The adaptive significance of sequential polyandry is a challenging question in evolutionary and behavioral biology. Costs and benefits of different mating patterns are shaped by the spatial distribution of individuals and by genetic parameters such as the pairwise relatedness between potential mating partners. Thus, females should become less choosy as costs of mating and searching for mates increase. We used parentage assignments to investigate spatial and genetic patterns of mating across a natural population of the Neotropical frog Allobates femoralis, a species characterized by male territoriality and care and female iteroparity. There was no correlation between genetic and spatial distances between adult individuals across the population. In 72% of cases, females mated with males available within a radius of 20 m. Mean pairwise relatedness coefficients of successful reproducers did not differ from random mating but had a lower variance than expected by chance, suggesting maximal reproductive output at intermediate genetic divergence. We also found evidence for selection in favor of more heterozygous individuals between the embryo and adult stage. The level of sequential polyandry significantly increased with the number of spatially available males. Females that had more candidate males also produced more adult progeny. We hypothesize that the benefits associated with female multiple mating outweigh the costs of in-and outbreeding depression, and consequently precluded the evolution of 'choosy' mate selection in this species.	[Ringler, Eva; Ringler, Max; Hoedl, Walter] Univ Vienna, Dept Evolutionary Biol, Vienna, Austria; [Jehle, Robert] Univ Salford, Ctr Environm Syst & Wildlife Res, Sch Environm & Life Sci, Salford M5 4WT, Lancs, England	University of Vienna; University of Salford	Ringler, E (corresponding author), Univ Vienna, Dept Evolutionary Biol, Vienna, Austria.	eva.ringler@univie.ac.at	Ringler, Max/J-4821-2012; , Eva/F-9064-2014	Ringler, Max/0000-0002-4530-4919; , Eva/0000-0003-3273-6568	University of Vienna; French Centre National de la Recherche Scientifique (CNRS); Austrian Science Fund (FWF) [P18811]; DOC-fFORTE scholarship; Austrian Academy of Sciences	University of Vienna; French Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); DOC-fFORTE scholarship; Austrian Academy of Sciences	This work was supported by the University of Vienna ('Forschungsstipendium' and 'Forderstipendium', http://www.univie.ac.at), the 'Nouragues Grant 2009' (PI Max Ringler) from the French Centre National de la Recherche Scientifique (CNRS, http://www.guyane.cnrs.fr), and the Austrian Science Fund (FWF): P18811 (PI Walter Hodl, http://www.fwf.ac.at). Eva Ringler was supported by a DOC-fFORTE scholarship and a L'OREAL Austria fellowship 'For Women in Science' from the Austrian Academy of Sciences (http://www.oeaw.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amezquita A, 2009, BIOL J LINN SOC, V98, P826, DOI 10.1111/j.1095-8312.2009.01324.x; Anderson MJ, 1999, J STAT COMPUT SIM, V62, P271, DOI 10.1080/00949659908811936; [Anonymous], 2010, R LANG ENV STAT COMP; Arct A, 2010, BIOL LETTERS, V6, P762, DOI 10.1098/rsbl.2010.0417; BLAUSTEIN AR, 1992, ANIM BEHAV, V44, P207, DOI 10.1016/0003-3472(92)90027-7; Bleu J, 2012, ANIM BEHAV, V83, P131, DOI 10.1016/j.anbehav.2011.10.017; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; Blouin MS, 1996, MOL ECOL, V5, P393, DOI 10.1111/j.1365-294X.1996.tb00329.x; Bonachea LA, 2011, ETHOLOGY, V117, P56, DOI 10.1111/j.1439-0310.2010.01843.x; Brown JL, 2010, AM NAT, V175, P436, DOI 10.1086/650727; Byrne PG, 2012, BIOL REV, V87, P209, DOI 10.1111/j.1469-185X.2011.00191.x; Byrne PG, 2009, P R SOC B, V276, P115, DOI 10.1098/rspb.2008.0794; Clutton-Brock T, 2009, Q REV BIOL, V84, P3, DOI 10.1086/596461; Colegrave N, 2002, EVOL ECOL RES, V4, P911; CORNELL TJ, 1989, OECOLOGIA, V78, P312, DOI 10.1007/BF00379103; Crnokrak P, 2002, EVOLUTION, V56, P2347, DOI 10.1111/j.0014-3820.2002.tb00160.x; Data East, 2021, XTOOLS PRO ARCGIS DE; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Evans JP, 2000, P NATL ACAD SCI USA, V97, P10074, DOI 10.1073/pnas.180207297; Ficetola GF, 2011, EVOL APPL, V4, P30, DOI 10.1111/j.1752-4571.2010.00130.x; Frere CH, 2010, P ROY SOC B-BIOL SCI, V277, P2667, DOI 10.1098/rspb.2010.0039; Gottsberger B, 2004, J TROP ECOL, V20, P271, DOI 10.1017/S0266467403001172; HALLIDAY TR, 1988, J HERPETOL, V22, P253, DOI 10.2307/1564148; Halverson MA, 2006, J HERED, V97, P499, DOI 10.1093/jhered/esl019; Hettyey A, 2010, ETHOLOGY, V116, P1, DOI 10.1111/j.1439-0310.2009.01704.x; Hodl W, 2004, J COMP PHYSIOL A, V190, P823, DOI 10.1007/s00359-004-0536-1; Jamieson IG, 2009, BEHAV ECOL, V20, P575, DOI 10.1093/beheco/arp034; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kempenaers B, 2007, ADV STUD BEHAV, V37, P189, DOI 10.1016/S0065-3454(07)37005-8; Kokko H, 2006, EVOLUTION, V60, P467, DOI 10.1554/05-613.1; Kokko H, 2002, AM NAT, V160, P468, DOI 10.1086/342074; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Konovalov DA, 2008, MOL ECOL RESOUR, V8, P256, DOI 10.1111/j.1471-8286.2007.01940.x; Lampert KP, 2006, BEHAV ECOL SOCIOBIOL, V59, P796, DOI 10.1007/s00265-005-0125-5; Lotters S., 2007, POISON FROGS BIOL SP; MANTEL N, 1967, CANCER RES, V27, P209; Mays HL, 2008, GENETICA, V134, P147, DOI 10.1007/s10709-007-9219-5; Milinski M, 2003, J FISH BIOL, V63, P1, DOI 10.1111/j.1095-8649.2003.00215.x; Montanarin A, 2011, ETHOL ECOL EVOL, V23, P141, DOI 10.1080/03949370.2011.554884; Narins PM, 2003, P NATL ACAD SCI USA, V100, P577, DOI 10.1073/pnas.0237165100; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; Neff BD, 2004, P NATL ACAD SCI USA, V101, P2381, DOI 10.1073/pnas.0307522100; Part T, 1996, EVOLUTION, V50, P1625, DOI 10.1111/j.1558-5646.1996.tb03934.x; Prohl H, 2005, J HERPETOL, V39, P354, DOI 10.1670/162-04A.1; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Richard M, 2009, P ROY SOC B-BIOL SCI, V276, P2779, DOI 10.1098/rspb.2009.0319; Ringler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025844; Ringler M, 2009, BEHAV ECOL SOCIOBIOL, V63, P1281, DOI 10.1007/s00265-009-0793-7; Rioux-Paquette E, 2010, ANIM BEHAV, V80, P865, DOI 10.1016/j.anbehav.2010.08.006; Roberts SC, 2003, NAT GENET, V35, P103, DOI 10.1038/ng1231; ROITHMAIR ME, 1994, HERPETOL J, V4, P77; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Summers K, 1997, BEHAV ECOL, V8, P260, DOI 10.1093/beheco/8.3.260; Thunken T, 2007, CURR BIOL, V17, P225, DOI 10.1016/j.cub.2006.11.053; TOFT CA, 1980, OECOLOGIA, V45, P131, DOI 10.1007/BF00346717; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Ursprung E, 2011, HERPETOL J, V21, P83; Ursprung E, 2011, MOL ECOL, V20, P1759, DOI 10.1111/j.1365-294X.2011.05056.x; Vonesh JR, 2002, OECOLOGIA, V133, P325, DOI 10.1007/s00442-002-1039-9; Voronoi G., 1907, J REINE ANGEW MATH, V133, P97, DOI DOI 10.1515/CRLL.1908.133.97; Wagner AP, 2007, MOL ECOL, V16, P4356, DOI 10.1111/j.1365-294X.2007.03470.x; WALDMAN B, 1992, AM ZOOL, V32, P18; Wang JL, 2009, MOL ECOL, V18, P2148, DOI 10.1111/j.1365-294X.2009.04175.x; Weygoldt P., 1980, Salamandra, V16, P215; [No title captured]	68	37	37	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40237	10.1371/journal.pone.0040237	http://dx.doi.org/10.1371/journal.pone.0040237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768260	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000305892100233
J	Taqi, MM; Warmlander, SKTS; Yamskova, O; Madani, F; Bazov, I; Luo, JH; Zubarev, R; Verbeek, D; Graslund, A; Bakalkin, G				Taqi, Malik Mumtaz; Warmlander, Sebastian K. T. S.; Yamskova, Olga; Madani, Fatemeh; Bazov, Igor; Luo, Jinghui; Zubarev, Roman; Verbeek, Dineke; Graslund, Astrid; Bakalkin, Georgy			Conformation Effects of CpG Methylation on Single-Stranded DNA Oligonucleotides: Analysis of the Opioid Peptide Dynorphin-Coding Sequences	PLOS ONE			English	Article							GEL-ELECTROPHORESIS; IN-VIVO; CYTOSINE METHYLATION; HAIRPIN CONFORMATION; DYNAMIC IMPACT; G-QUADRUPLEX; TRANSCRIPTION; RECOMBINATION; RECOGNITION; GUANINE	Single-stranded DNA (ssDNA) is characterized by high conformational flexibility that allows these molecules to adopt a variety of conformations. Here we used native polyacrylamide gel electrophoresis (PAGE), circular dichroism (CD) spectroscopy and nuclear magnetic resonance (NMR) spectroscopy to show that cytosine methylation at CpG sites affects the conformational flexibility of short ssDNA molecules. The CpG containing 37-nucleotide PDYN (prodynorphin) fragments were used as model molecules. The presence of secondary DNA structures was evident from differences in oligonucleotide mobilities on PAGE, from CD spectra, and from formation of A-T, G-C, and non-canonical G-T base pairs observed by NMR spectroscopy. The oligonucleotides displayed secondary structures at 4 degrees C, and some also at 37 degrees C. Methylation at CpG sites prompted sequence-dependent formation of novel conformations, or shifted the equilibrium between different existing ssDNA conformations. The effects of methylation on gel mobility and base pairing were comparable in strength to the effects induced by point mutations in the DNA sequences. The conformational effects of methylation may be relevant for epigenetic regulatory events in a chromatin context, including DNA-protein or DNA-DNA recognition in the course of gene transcription, and DNA replication and recombination when double-stranded DNA is unwinded to ssDNA.	[Warmlander, Sebastian K. T. S.; Madani, Fatemeh; Luo, Jinghui; Graslund, Astrid] Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden; [Zubarev, Roman] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Verbeek, Dineke] Univ Groningen, Dept Genet, Univ Med Ctr Groningen, Groningen, Netherlands; [Taqi, Malik Mumtaz; Yamskova, Olga; Bazov, Igor; Bakalkin, Georgy] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden	Stockholm University; Karolinska Institutet; University of Groningen; Uppsala University	Taqi, MM (corresponding author), Quaid I Azam Univ, Dept Pharm, Islamabad, Pakistan.	Georgy.Bakalkin@farmbio.uu.se	Zubarev, Roman A/W-7891-2018	Zubarev, Roman A/0000-0001-9839-2089; Bazov, Igor/0000-0003-4388-1656; Luo, Jinghui/0000-0002-7014-8153; Bakalkin, Georgy/0000-0002-8074-9833	Swedish Science Research Council; Swedish Council for Working Life and Social Research	Swedish Science Research Council; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This work was supported by grants from the Swedish Science Research Council, and Swedish Council for Working Life and Social Research to GB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Silva C, 2010, J PHYS CHEM B, V114, P10217, DOI 10.1021/jp103850h; Bakalkin G, 2010, 2010 NEUR M PLANN; Bakalkin G, 2010, AM J HUM GENET, V87, P593, DOI 10.1016/j.ajhg.2010.10.001; Ballestar E, 2001, EUR J BIOCHEM, V268, P1, DOI 10.1046/j.1432-1327.2001.01869.x; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Biyani M, 2005, J BIOCHEM, V138, P363, DOI 10.1093/jb/mvi149; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Derreumaux S, 2001, NUCLEIC ACIDS RES, V29, P2314, DOI 10.1093/nar/29.11.2314; DIEKMANN S, 1987, NUCLEIC ACIDS RES, V15, P5765, DOI 10.1093/nar/15.14.5765; Faruqi AF, 2000, MOL CELL BIOL, V20, P990, DOI 10.1128/MCB.20.3.990-1000.2000; Geahigan KB, 2000, BIOCHEMISTRY-US, V39, P4939, DOI 10.1021/bi9917636; Gohler T, 2002, J BIOL CHEM, V277, P41192, DOI 10.1074/jbc.M202344200; Han HY, 2001, J AM CHEM SOC, V123, P8902, DOI 10.1021/ja002179j; Hernandez M, 2007, BIOCHEM BIOPH RES CO, V355, P1075, DOI 10.1016/j.bbrc.2007.02.079; HODGESGARCIA Y, 1992, BIOCHEMISTRY-US, V31, P7595, DOI 10.1021/bi00148a022; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Krasilnikov AS, 1999, J MOL BIOL, V292, P1149, DOI 10.1006/jmbi.1999.3117; Lada AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024848; Laporte L, 1998, J MOL BIOL, V281, P261, DOI 10.1006/jmbi.1998.1938; Liang XG, 2006, BIOPHYS J, V90, P2877, DOI 10.1529/biophysj.105.074104; Masai H, 1997, CELL, V89, P897, DOI 10.1016/S0092-8674(00)80275-5; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Mayer-Jung C, 1998, EMBO J, V17, P2709, DOI 10.1093/emboj/17.9.2709; Meints GA, 2001, BIOCHEMISTRY-US, V40, P12436, DOI 10.1021/bi0102555; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; Napierala M, 2002, J BIOL CHEM, V277, P34087, DOI 10.1074/jbc.M202128200; Nathan D, 2002, J MOL BIOL, V316, P7, DOI 10.1006/jmbi.2001.5247; NISHIGAKI K, 1986, J BIOCHEM-TOKYO, V99, P663, DOI 10.1093/oxfordjournals.jbchem.a135525; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; Patel SS, 2011, CURR OPIN CHEM BIOL; Pearson CE, 1996, J CELL BIOCHEM, V63, P1; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; Severin P, 2011, NUCL ACIDS RES; SHEA RG, 1990, NUCLEIC ACIDS RES, V18, P4859, DOI 10.1093/nar/18.16.4859; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Skolakova P, 2010, BIOCHEM BIOPH RES CO, V399, P203, DOI 10.1016/j.bbrc.2010.07.055; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Swamynathan SK, 1998, FASEB J, V12, P515, DOI 10.1096/fasebj.12.7.515; Tomasko M, 2009, BIOCHIMIE, V91, P171, DOI 10.1016/j.biochi.2008.07.012; Vondruskova J, 2008, INT J BIOL MACROMOL, V43, P463, DOI 10.1016/j.ijbiomac.2008.08.013; Warmlander S, 2000, BIOCHEMISTRY-US, V39, P607, DOI 10.1021/bi991863b; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003; Wright BE, 2011, CARCINOGENESIS, V32, P1559, DOI 10.1093/carcin/bgr177; YU AD, 1995, NUCLEIC ACIDS RES, V23, P2706, DOI 10.1093/nar/23.14.2706; ZACHARIAS W, 1990, J BACTERIOL, V172, P3278, DOI 10.1128/jb.172.6.3278-3283.1990; Zhuang XY, 2007, J MOL RECOGNIT, V20, P386, DOI 10.1002/jmr.847; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	51	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39605	10.1371/journal.pone.0039605	http://dx.doi.org/10.1371/journal.pone.0039605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768096	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100066
J	Zhou, Y; Fang, L; Jiang, L; Wen, P; Cao, HD; He, WC; Dai, CS; Yang, JW				Zhou, Yang; Fang, Li; Jiang, Lei; Wen, Ping; Cao, Hongdi; He, Weichun; Dai, Chunsun; Yang, Junwei			Uric Acid Induces Renal Inflammation via Activating Tubular NF-kappa B Signaling Pathway	PLOS ONE			English	Article							CELL-PROLIFERATION; EPITHELIAL-CELLS; URATE CRYSTALS; KIDNEY-DISEASE; EXPRESSION; MICE; HYPERTENSION; INCREASES; FIBROSIS	Inflammation is a pathologic feature of hyperuricemia in clinical settings. However, the underlying mechanism remains unknown. Here, infiltration of T cells and macrophages were significantly increased in hyperuricemia mice kidneys. This infiltration of inflammatory cells was accompanied by an up-regulation of TNF-alpha, MCP-1 and RANTES expression. Further, infiltration was largely located in tubular interstitial spaces, suggesting a role for tubular cells in hyperuricemia-induced inflammation. In cultured tubular epithelial cells (NRK-52E), uric acid, probably transported via urate transporter, induced TNF-alpha, MCP-1 and RANTES mRNA as well as RANTES protein expression. Culture media of NRK-52E cells incubated with uric acid showed a chemo-attractive ability to recruit macrophage. Moreover uric acid activated NF-kappa B signaling. The uric acid-induced up-regulation of RANTES was blocked by SN 50, a specific NF-kappa B inhibitor. Activation of NF-kappa B signaling was also observed in tubule of hyperuricemia mice. These results suggest that uric acid induces renal inflammation via activation of NF-kappa B signaling.	[Zhou, Yang; Fang, Li; Jiang, Lei; Wen, Ping; Cao, Hongdi; He, Weichun; Dai, Chunsun; Yang, Junwei] Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Zhou, Y (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China.	jwyang@njmu.edu.cn			National Science Foundation of China [30871201/31171093]; Ministry of Science and Technology, China [2011CB504005]; Jiangsu Province's Outstanding Medical Academic Leader Program [SWKJ 2006-50]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology, China(Ministry of Science and Technology, China); Jiangsu Province's Outstanding Medical Academic Leader Program	This work was supported by National Science Foundation of China Grants 30871201/31171093, "973'' Science Program of the Ministry of Science and Technology, China (2011CB504005), and Jiangsu Province's Outstanding Medical Academic Leader Program (SWKJ 2006-50) to JY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker SD, 2003, CIRCULATION, V107, P1991, DOI 10.1161/01.CIR.0000065637.10517.A0; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Chen GL, 2006, AM J CHINESE MED, V34, P77, DOI 10.1142/S0192415X06003655; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Cirillo P, 2009, J AM SOC NEPHROL, V20, P545, DOI 10.1681/ASN.2008060576; DIGIOVINE FS, 1991, J CLIN INVEST, V87, P1375, DOI 10.1172/JCI115142; Guijarro C, 2001, KIDNEY INT, V59, P415, DOI 10.1046/j.1523-1755.2001.059002415.x; Han HJ, 2007, AM J PHYSIOL-RENAL, V292, pF373, DOI 10.1152/ajprenal.00104.2006; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124; Kosugi T, 2009, AM J PHYSIOL-RENAL, V297, pF481, DOI 10.1152/ajprenal.00092.2009; Krensky AM, 2007, NAT CLIN PRACT NEPHR, V3, P164, DOI 10.1038/ncpneph0418; Lai KN, 2007, KIDNEY INT, V71, P526, DOI 10.1038/sj.ki.5002091; Livolsi A, 2001, EUR J BIOCHEM, V268, P1508, DOI 10.1046/j.1432-1327.2001.02028.x; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Mene P, 2008, J HYPERTENS, V26, P2085, DOI 10.1097/HJH.0b013e32830e4945; Obermayr RP, 2008, J AM SOC NEPHROL, V19, P2407, DOI 10.1681/ASN.2008010080; Roson MI, 2006, KIDNEY INT, V70, P1439, DOI 10.1038/sj.ki.5001831; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; Shi Y, 2010, J CLIN INVEST, V120, P1809, DOI 10.1172/JCI43132; Tan XY, 2008, J AM SOC NEPHROL, V19, P1741, DOI 10.1681/ASN.2007060666; Vielhauer V, 2001, J AM SOC NEPHROL, V12, P1173, DOI 10.1681/ASN.V1261173; Wang Y, 2004, BASIC CLIN PHARMACOL, V94, P232, DOI 10.1111/j.1742-7843.2004.pto940506.x; Weiner DE, 2008, J AM SOC NEPHROL, V19, P1204, DOI 10.1681/ASN.2007101075; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Zhou Y, 2010, AM J PHYSIOL-RENAL, V299, pF336, DOI 10.1152/ajprenal.00053.2010; Zoccali C, 2006, J AM SOC NEPHROL, V17, P1466, DOI 10.1681/ASN.2005090949	28	131	143	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39738	10.1371/journal.pone.0039738	http://dx.doi.org/10.1371/journal.pone.0039738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761883	Green Submitted, gold, Green Published			2022-12-27	WOS:000305781700061
J	Catena, A; Perales, JC; Megias, A; Candido, A; Jara, E; Maldonado, A				Catena, Andres; Perales, Jose C.; Megias, Alberto; Candido, Antonio; Jara, Elvia; Maldonado, Antonio			The Brain Network of Expectancy and Uncertainty Processing	PLOS ONE			English	Article							STIMULUS-PRECEDING NEGATIVITY; DECISION-MAKING; ELECTROMAGNETIC TOMOGRAPHY; LEARNED IRRELEVANCE; INSULAR CORTEX; DOPAMINE; REWARD; COVARIATION; RESPONSES; PREDICTION	Background: The Stimulus Preceding Negativity (SPN) is a non-motor slow cortical potential elicited by temporally predictable stimuli, customarily interpreted as a physiological index of expectancy. Its origin would be the brain activity responsible for generating the anticipatory mental representation of an expected upcoming event. The SPN manifests itself as a slow cortical potential with negative slope, growing in amplitude as the stimulus approximates. The uncertainty hypothesis we present here postulates that the SPN is linked to control-related areas in the prefrontal cortex that become more active before the occurrence of an upcoming outcome perceived as uncertain. Methods/Findings: We tested the uncertainty hypothesis by using a repeated measures design in a Human Contingency Learning task with two levels of uncertainty. In the high uncertainty condition, the outcome is unpredictable. In the mid uncertainty condition, the outcome can be learnt to be predicted in 75% of the trials. Our experiment shows that the Stimulus Preceding Negativity is larger for probabilistically unpredictable (uncertain) outcomes than for probabilistically predictable ones. sLoreta estimations of the brain activity preceding the outcome suggest that prefrontal and parietal areas can be involved in its generation. Prefrontal sites activation (Anterior Cingulate and Dorsolateral Prefrontal Cortex) seems to be related to the degree of uncertainty. Activation in posterior parietal areas, however, does not correlates with uncertainty. Conclusions/Significance: We suggest that the Stimulus Preceding Negativity reflects the attempt to predict the outcome, when posterior brain areas fail to generate a stable expectancy. Uncertainty is thus conceptualized, not just as the absence of learned expectancy, but as a state with psychological and physiological entity.	[Catena, Andres; Perales, Jose C.; Megias, Alberto; Candido, Antonio; Jara, Elvia; Maldonado, Antonio] Univ Granada, Dept Psicol Expt, Granada, Spain	University of Granada	Catena, A (corresponding author), Univ Granada, Dept Psicol Expt, Granada, Spain.	acatena@ugr.es	Ortíz, Antonio Cándido/AAB-5339-2019; Cándido, antonio/G-7309-2015; Megías-Robles, Alberto/AAA-7458-2020; Catena, Andres/I-2159-2015; Maldonado, Antonio/E-9540-2018	Ortíz, Antonio Cándido/0000-0002-3973-8219; Cándido, antonio/0000-0002-3973-8219; Megías-Robles, Alberto/0000-0002-4563-7465; Catena, Andres/0000-0002-0775-5751; Maldonado, Antonio/0000-0001-5903-3833; Perales, Jose C./0000-0001-5163-8811	CONSOLIDER-INGENIO [CSD2007-00012]; Spanish Ministry of Science and Innovation (MICINN) [PSI2009-13133, PSI2009-12217]; Junta de Andalucia grant [P09/SEJ-4752]	CONSOLIDER-INGENIO(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia grant(Junta de Andalucia)	Research by A. Catena is funded by CONSOLIDER-INGENIO CSD2007-00012 (http://www.bcbl.eu/consolider/index.php). Research by J.C. Perales is founded by a Spanish Ministry of Science and Innovation (MICINN) grant (Direccion General de Programas y Transferencia de Conocimiento, Ref. PSI2009-13133, http://www.micinn.es/). Research by A. Catena, A. Candido, and A. Maldonado is founded by a Spanish Ministry of Science and Innovation (MICINN) grant (Direccion General de Programas y Transferencia de Conocimiento, Ref. PSI2009-12217, http://www.micinn.es/). Research was also founded by a Junta de Andalucia grant (Reference P09/SEJ-4752, http://www.juntadeandalucia.es/servicios/ayudas/detalle/69962.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER AG, 1976, J EXP PSYCHOL ANIM B, V2, P130, DOI 10.1037/0097-7403.2.2.130; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; BENNETT CH, 1995, Q J EXP PSYCHOL-B, V48, P117; BIRBAUMER N, 1990, PHYSIOL REV, V70, P1, DOI 10.1152/physrev.1990.70.1.1; Bocker KBE, 2001, INT J PSYCHOPHYSIOL, V43, P77, DOI 10.1016/S0167-8760(01)00180-5; Bocker Koen B. E., 1994, Brain Topography, V7, P71, DOI 10.1007/BF01184839; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Brunia CHM, 1999, ACTA PSYCHOL, V101, P213, DOI 10.1016/S0001-6918(99)00006-2; Buehner MJ, 2005, LEARN BEHAV, V33, P230; Butz MV, 2003, LECT NOTES ARTIF INT, V2684, P1; CHENG PW, 1990, J PERS SOC PSYCHOL, V58, P545, DOI 10.1037/0022-3514.58.4.545; CHWILLA DJ, 1991, PSYCHOPHYSIOLOGY, V28, P123, DOI 10.1111/j.1469-8986.1991.tb00400.x; Corlett PR, 2006, ARCH GEN PSYCHIAT, V63, P611, DOI 10.1001/archpsyc.63.6.611; Corlett PR, 2004, NEURON, V44, P877, DOI 10.1016/j.neuron.2004.11.022; Coull JT, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000166; DAMEN EJP, 1994, PSYCHOPHYSIOLOGY, V31, P129, DOI 10.1111/j.1469-8986.1994.tb01033.x; Donkers FCL, 2005, COGNITIVE BRAIN RES, V25, P777, DOI 10.1016/j.cogbrainres.2005.09.007; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fletcher PC, 2001, NAT NEUROSCI, V4, P1043, DOI 10.1038/nn733; Gilbert DT, 2007, SCIENCE, V317, P1351, DOI 10.1126/science.1144161; Gracian B, 1892, ART WORLDLY WISDOM; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Jaccard J., 1996, LISREL APPROACHES IN, DOI DOI 10.4135/9781412984782; Kline RB., 2015, METHODOLOGY SOCIAL S, V4th ed; Kotani Y, 1999, BIOL PSYCHOL, V50, P1, DOI 10.1016/S0301-0511(98)00047-7; Kotani Y, 2003, PSYCHOPHYSIOLOGY, V40, P818, DOI 10.1111/1469-8986.00082; Kotani Y, 2009, NEUROSCI LETT, V450, P75, DOI 10.1016/j.neulet.2008.11.032; Maldonado A, 2006, Q J EXP PSYCHOL, V59, P457, DOI 10.1080/02724980443000854; Maldonado A, 1999, ANIM LEARN BEHAV, V27, P168, DOI 10.3758/BF03199673; Masaki H, 2006, BRAIN RES, V1105, P110, DOI 10.1016/j.brainres.2006.01.022; Masaki H, 2010, NEUROREPORT, V21, P277, DOI 10.1097/WNR.0b013e3283360bc3; Mattox ST, 2006, CLIN NEUROPHYSIOL, V117, P2144, DOI 10.1016/j.clinph.2006.05.026; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Ochsner KN, 2009, J COGNITIVE NEUROSCI, V21, P1841, DOI 10.1162/jocn.2009.21129; Ohgami Y, 2006, PSYCHOPHYSIOLOGY, V43, P227, DOI 10.1111/j.1469-8986.2006.00396.x; Ohgami Y, 2004, PSYCHOPHYSIOLOGY, V41, P729, DOI 10.1111/j.1469-8986.2004.00203.x; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Perales JC, 2005, J EXP PSYCHOL LEARN, V31, P1105, DOI 10.1037/0278-7393.31.5.1105; Perales JC, 2007, PSYCHON B REV, V14, P577, DOI 10.3758/BF03196807; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; QUINTANA J, 1992, NEUROREPORT, V3, P721, DOI 10.1097/00001756-199208000-00018; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rogers RD, 2011, NEUROPSYCHOPHARMACOL, V36, P114, DOI 10.1038/npp.2010.165; Schlosser RGM, 2009, SYNAPSE, V63, P429, DOI 10.1002/syn.20621; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Silton RL, 2010, NEUROIMAGE, V50, P1292, DOI 10.1016/j.neuroimage.2009.12.061; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tsukamoto T, 2006, NEUROSCI LETT, V399, P39, DOI 10.1016/j.neulet.2006.01.061; Ture U, 1999, J NEUROSURG, V90, P720, DOI 10.3171/jns.1999.90.4.0720; Uncapher MR, 2009, NEUROBIOL LEARN MEM, V91, P139, DOI 10.1016/j.nlm.2008.10.011; van Boxtel GJM, 2004, J PSYCHOPHYSIOL, V18, P61, DOI 10.1027/0269-8803.18.23.61; VANBOXTEL GJM, 1994, BIOL PSYCHOL, V38, P37, DOI 10.1016/0301-0511(94)90048-5; VASEY MW, 1987, PSYCHOPHYSIOLOGY, V24, P479, DOI 10.1111/j.1469-8986.1987.tb00324.x; Vogt BA, 2005, J COMP NEUROL, V485, P218, DOI 10.1002/cne.20512; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500	59	39	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40252	10.1371/journal.pone.0040252	http://dx.doi.org/10.1371/journal.pone.0040252			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	968GX	22768344	Green Submitted, Green Published, gold			2022-12-27	WOS:000305966500057
J	Falcone, R; Brunamonti, E; Genovesio, A				Falcone, Rossella; Brunamonti, Emiliano; Genovesio, Aldo			Vicarious Learning from Human Models in Monkeys	PLOS ONE			English	Article							RHESUS-MONKEYS; IMITATION	We examined whether monkeys can learn by observing a human model, through vicarious learning. Two monkeys observed a human model demonstrating an object-reward association and consuming food found underneath an object. The monkeys observed human models as they solved more than 30 learning problems. For each problem, the human models made a choice between two objects, one of which concealed a piece of apple. In the test phase afterwards, the monkeys made a choice of their own. Learning was apparent from the first trial of the test phase, confirming the ability of monkeys to learn by vicarious observation of human models.	[Falcone, Rossella; Brunamonti, Emiliano; Genovesio, Aldo] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy	Sapienza University Rome	Falcone, R (corresponding author), Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy.	aldo.genovesio@uniroma1.it		FALCONE, ROSSELLA/0000-0001-5068-2984; Genovesio, Aldo/0000-0003-2521-143X; Brunamonti, Emiliano/0000-0002-5119-6950	'Sapienza' University of Rome, Ricerca dell'Ateneo Federato di Scienze delle Politiche Pubbliche e Sanitarie [P288/09]	'Sapienza' University of Rome, Ricerca dell'Ateneo Federato di Scienze delle Politiche Pubbliche e Sanitarie	This work was supported by the 'Sapienza' University of Rome, Ricerca dell'Ateneo Federato di Scienze delle Politiche Pubbliche e Sanitarie (Protocol number: P288/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandura Albert, 1977, SOCIAL LEARNING THEO; Bonnie KE, 2007, ANIM COGN, V10, P283, DOI 10.1007/s10071-006-0069-9; Brosnan SF, 2004, J COMP PSYCHOL, V118, P133, DOI 10.1037/0735-7036.118.2.133; Burke CJ, 2010, P NATL ACAD SCI USA, V107, P14431, DOI 10.1073/pnas.1003111107; Chang SWC, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00027; DARBY CL, 1959, J COMP PHYSIOL PSYCH, V52, P94, DOI 10.1037/h0046068; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Falcone R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032209; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Flombaum JI, 2005, CURR BIOL, V15, P447, DOI 10.1016/j.cub.2004.12.076; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Fujii N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000397; HEYES CM, 1993, ANIM LEARN BEHAV, V21, P221, DOI 10.3758/BF03197985; Kumashiro M, 2003, INT J PSYCHOPHYSIOL, V50, P81, DOI 10.1016/S0167-8760(03)00126-0; Meunier M, 2007, NEUROBIOL LEARN MEM, V88, P243, DOI 10.1016/j.nlm.2007.04.015; Miklosi A, 1999, BIOL REV, V74, P347, DOI 10.1017/S000632319900537X; Mobbs D, 2009, SCIENCE, V324, P900, DOI 10.1126/science.1170539; Monfardini E, 2008, NEUROIMAGE, V42, P1207, DOI 10.1016/j.neuroimage.2008.05.043; MYERS WA, 1970, J EXP ANAL BEHAV, V14, P225, DOI 10.1901/jeab.1970.14-225; Paukner A, 2005, BIOL LETTERS, V1, P219, DOI 10.1098/rsbl.2004.0291; Snowdon CT, 2003, J COMP PSYCHOL, V117, P142, DOI 10.1037/0735-7036.117.2.142; Subiaul F, 2007, ANIM COGN, V10, P369, DOI 10.1007/s10071-006-0070-3; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; Yoshida K, 2011, CURR BIOL, V21, P249, DOI 10.1016/j.cub.2011.01.004	25	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40283	10.1371/journal.pone.0040283	http://dx.doi.org/10.1371/journal.pone.0040283			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768347	Green Submitted, Green Published, gold			2022-12-27	WOS:000305966500060
J	Jordan, F; Gjata, N; Mei, S; Yule, CM				Jordan, Ferenc; Gjata, Nerta; Mei, Shu; Yule, Catherine M.			Simulating Food Web Dynamics along a Gradient: Quantifying Human Influence	PLOS ONE			English	Article							ECOLOGY; CONSERVATION; CHALLENGES; COMPLEXITY; KEYSTONES; STREAMS; INDEX; QUEST	Realistically parameterized and dynamically simulated food-webs are useful tool to explore the importance of the functional diversity of ecosystems, and in particular relations between the dynamics of species and the whole community. We present a stochastic dynamical food web simulation for the Kelian River (Borneo). The food web was constructed for six different locations, arrayed along a gradient of increasing human perturbation (mostly resulting from gold mining activities) along the river. Along the river, the relative importance of grazers, filterers and shredders decreases with increasing disturbance downstream, while predators become more dominant in governing eco-dynamics. Human activity led to increased turbidity and sedimentation which adversely impacts primary productivity. Since the main difference between the study sites was not the composition of the food webs (structure is quite similar) but the strengths of interactions and the abundance of the trophic groups, a dynamical simulation approach seemed to be useful to better explain human influence. In the pristine river (study site 1), when comparing a structural version of our model with the dynamical model we found that structurally central groups such as omnivores and carnivores were not the most important ones dynamically. Instead, primary consumers such as invertebrate grazers and shredders generated a greater dynamical response. Based on the dynamically most important groups, bottom-up control is replaced by the predominant top-down control regime as distance downstream and human disturbance increased. An important finding, potentially explaining the poor structure to dynamics relationship, is that indirect effects are at least as important as direct ones during the simulations. We suggest that our approach and this simulation framework could serve systems-based conservation efforts. Quantitative indicators on the relative importance of trophic groups and the mechanistic modeling of eco-dynamics could greatly contribute to understanding various aspects of functional diversity.	[Jordan, Ferenc; Gjata, Nerta] Univ Trent, Ctr Computat & Syst Biol, Microsoft Res, Trento, Italy; [Mei, Shu; Yule, Catherine M.] Monash Univ, Sch Sci, Selangor Darulehsan, Malaysia	University of Trento	Jordan, F (corresponding author), Univ Trent, Ctr Computat & Syst Biol, Microsoft Res, Trento, Italy.	jordan.ferenc@gmail.com	Jordan, Ferenc/A-9940-2009; YULE, Catherine/F-9733-2015	Jordan, Ferenc/0000-0002-0224-6472; YULE, CATHERINE/0000-0002-1085-2798				Abrams Peter A., 1996, P371; Baptista DF, 2007, HYDROBIOLOGIA, V575, P83, DOI 10.1007/s10750-006-0286-x; Boyero L, 2012, GLOBAL ECOL BIOGEOGR, V21, P134, DOI 10.1111/j.1466-8238.2011.00673.x; Dematte L, 2008, THEOR COMPUT SCI, V408, P83, DOI 10.1016/j.tcs.2008.07.013; Dudgeon D, 2010, CURRENT OPINION ENV, V2, P1; Feest A, 2010, ECOL INDIC, V10, P1077, DOI 10.1016/j.ecolind.2010.04.002; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gotelli NJ, 2006, PLOS BIOL, V4, P1869, DOI 10.1371/journal.pbio.0040324; Green JL, 2005, BIOSCIENCE, V55, P501, DOI 10.1641/0006-3568(2005)055[0501:CIEACM]2.0.CO;2; Guariento RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022205; Harary F., 1961, GEN SYST, V6, P41; Hurlbert SH, 1997, AUST J ECOL, V22, P369, DOI 10.1111/j.1442-9993.1997.tb00687.x; Jordan F, 2006, COMMUNITY ECOL, V7, P81, DOI 10.1556/ComEc.7.2006.1.8; Jordan F., 2004, Physics of Life Reviews, V1, DOI 10.1016/j.plrev.2004.08.001; Jordan F, 2003, COMMUNITY ECOL, V4, P79, DOI 10.1556/ComEc.4.2003.1.12; Jordan F, 1999, OIKOS, V86, P453, DOI 10.2307/3546650; Jordan F, 2011, ECOL COMPLEX, V8, P357, DOI 10.1016/j.ecocom.2011.07.006; Jordan F, 2009, PHILOS T R SOC B, V364, P1733, DOI 10.1098/rstb.2008.0335; KERANS BL, 1994, ECOL APPL, V4, P768, DOI 10.2307/1942007; Livi CM, 2011, ECOL MODEL, V222, P2542, DOI 10.1016/j.ecolmodel.2010.09.025; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; MENGE BA, 1995, ECOL MONOGR, V65, P21, DOI 10.2307/2937158; MILLS LS, 1993, BIOSCIENCE, V43, P219, DOI 10.2307/1312122; O'Connor MI, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000178; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Pascual M, 2005, PLOS COMPUT BIOL, V1, P101, DOI 10.1371/journal.pcbi.0010018; PATTEN BC, 1991, THEORETICAL STUDIES, P117; Pimm SL, 1991, BALANCE NATURE ECOLO; Powell CR, 2009, J THEOR BIOL, V257, P170, DOI 10.1016/j.jtbi.2008.11.006; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; Priami C, 2009, COMMUN ACM, V52, P80, DOI 10.1145/1506409.1506427; Seth AK, 2007, PHILOS T R SOC B, V362, P1545, DOI 10.1098/rstb.2007.2052; Valentini R, 2010, ENVIRON MODELL SOFTW, V25, P886, DOI 10.1016/j.envsoft.2010.02.001; Wassermann S., 1994, SOCIAL NETWORK ANAL, Vfirst; Wilson E.O., 1987, Conservation Biology, V1, P344, DOI 10.1111/j.1523-1739.1987.tb00055.x; WOOTTON JT, 1994, ANNU REV ECOL SYST, V25, P443, DOI 10.1146/annurev.es.25.110194.002303; Yule C.M., 1995, TROPICAL LIMNOLOGY, V3, P61; Yule CM, 2010, MAR FRESHWATER RES, V61, P204, DOI 10.1071/MF09065; Yule CM, 2009, J N AM BENTHOL SOC, V28, P404, DOI 10.1899/07-161.1	39	9	9	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40280	10.1371/journal.pone.0040280	http://dx.doi.org/10.1371/journal.pone.0040280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768346	Green Published, Green Submitted, gold			2022-12-27	WOS:000305966500059
J	Ke, LP; Liu, RE; Chu, BJ; Yu, XS; Sun, J; Jones, B; Pan, G; Cheng, XF; Wang, HZ; Zhu, SJ; Sun, YQ				Ke, Liping; Liu, RuiE; Chu, Bijue; Yu, Xiushuang; Sun, Jie; Jones, Brian; Pan, Gang; Cheng, Xiaofei; Wang, Huizhong; Zhu, Shuijin; Sun, Yuqiang			Cell Suspension Culture-Mediated Incorporation of the Rice Bel Gene into Transgenic Cotton	PLOS ONE			English	Article							PLANT CYTOCHROME-P450; GOSSYPIUM-HIRSUTUM; SOMATIC HYBRIDS; METABOLISM; TOBACCO; HYDROXYLATION; RESISTANCE; BENTAZON; CLONING; YEAST	Cotton plants engineered for resistance to the herbicides, glyphosate or glufosinate have made a considerable impact on the production of the crop worldwide. In this work, embryogenic cell cultures derived from Gossypium hirsutum L. cv Coker 312 hypocotyl callus were transformed via Agrobacterium tumefaciens with the rice cytochrome P450 gene, CYP81A6 (bel). In rice, bel has been shown to confer resistance to both bentazon and sulfanylurea herbicides. Transformed cells were selected on a liquid medium supplemented alternately or simultaneously with kanamycin (50mg/L) and bentazon (4.2 mu mol). A total of 17 transgenic cotton lines were recovered, based on the initial resistance to bentazon and on PCR detection of the bel transgene. Bel integration into the cotton genome was confirmed by Southern blot and expression of the transgene was verified by RT-PCR. In greenhouse and experimental plot trials, herbicide (bentazon) tolerance of up to 1250mg/L was demonstrated in the transgenic plants. Transgenic lines with a single copy of the bel gene showed normal Mendelian inheritance of the characteristic. Importantly, resistance to bentazon was shown to be stably incorporated in the T1, T2 and T3 generations of self-fertilised descendents and in plants outcrossed to another upland cotton cultivar. Engineering resistance to bentazon in cotton through the heterologous expression of bel opens the possibility of incorporating this trait into elite cultivars, a strategy that would give growers a more flexible alternative to weed management in cotton crops.	[Ke, Liping; Liu, RuiE; Chu, Bijue; Yu, Xiushuang; Cheng, Xiaofei; Wang, Huizhong; Sun, Yuqiang] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Sun, Jie] Shihezi Univ, Coll Agron, Shihezi, Xinjiang, Peoples R China; [Jones, Brian] Univ Sydney, Fac Agr Food & Nat Resources, Sydney, NSW 2006, Australia; [Pan, Gang; Zhu, Shuijin] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Hangzhou Normal University; Shihezi University; University of Sydney; Zhejiang University	Sun, YQ (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	yqsun@hznu.edu.cn	Cheng, Xiaofei/AAT-2600-2020; Jones, Brian m/E-8848-2016; Cheng, Xiaofei/M-6239-2014	Cheng, Xiaofei/0000-0002-9771-9059; Sun, Jie/0000-0002-8068-8102	Foundation for the Author of National Excellent Doctoral Dissertation of People's Republic of China (FANEDD) [201175]; National Natural Science foundation of China [31101417]; National Program on Research and Development of Transgenic Plants	Foundation for the Author of National Excellent Doctoral Dissertation of People's Republic of China (FANEDD)(Foundation for the Author of National Excellent Doctoral Dissertation of China); National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); National Program on Research and Development of Transgenic Plants	This research was funded by a Foundation for the Author of National Excellent Doctoral Dissertation of People's Republic of China (FANEDD, 201175), the National Natural Science foundation of China (Grant No. 31101417) and the National Program on Research and Development of Transgenic Plants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYLEY C, 1992, THEOR APPL GENET, V83, P645, DOI 10.1007/BF00226910; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BOLWELL GP, 1994, PHYTOCHEMISTRY, V37, P1491, DOI 10.1016/S0031-9422(00)89567-9; Bowyer P., 2001, MOL CELLULAR BIOL FI, P33; BROWN HM, 1990, PESTIC SCI, V29, P263, DOI 10.1002/ps.2780290304; BURTON JD, 1992, PESTIC BIOCHEM PHYS, V44, P40, DOI 10.1016/0048-3575(92)90007-M; Cabello-Hurtado F, 1998, J BIOL CHEM, V273, P7260, DOI 10.1074/jbc.273.13.7260; Chapple C, 1998, ANNU REV PLANT PHYS, V49, P311, DOI 10.1146/annurev.arplant.49.1.311; Chou WM, 1998, PLANT J, V15, P289, DOI 10.1046/j.1365-313X.1998.00220.x; Deng F, 2002, PESTIC BIOCHEM PHYS, V74, P102, DOI 10.1016/S0048-3575(02)00151-7; Didierjean L, 2002, PLANT PHYSIOL, V130, P179, DOI 10.1104/pp.005801; Durst Francis, 1995, Drug Metabolism and Drug Interactions, V12, P171; FIROOZABADY E, 1987, PLANT MOL BIOL, V10, P105, DOI 10.1007/BF00016148; Forthoffer N, 2001, EUR J DRUG METAB PH, V26, P9, DOI 10.1007/BF03190370; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Hooykaas PJJ, 1988, PLANT MOL BIOL MANUA, pA4; Keller G, 1997, TRANSGENIC RES, V6, P385, DOI 10.1023/A:1018483300902; KOEPPE MK, 1995, AGRO FOOD IND HI TEC, V6, P9; Lamb SB, 1998, FEBS LETT, V431, P343, DOI 10.1016/S0014-5793(98)00771-6; LEAH JM, 1991, PESTIC BIOCHEM PHYS, V39, P232, DOI 10.1016/0048-3575(91)90118-6; MCFADDEN JJ, 1990, BIOCHEM BIOPH RES CO, V168, P206, DOI 10.1016/0006-291X(90)91695-O; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Pan G, 2006, PLANT MOL BIOL, V61, P933, DOI 10.1007/s11103-006-0058-z; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; PIERREL MA, 1994, EUR J BIOCHEM, V224, P835, DOI 10.1111/j.1432-1033.1994.00835.x; Robineau T, 1998, PLANT PHYSIOL, V118, P1049, DOI 10.1104/pp.118.3.1049; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SAWAHEL WA, 1992, BIOTECHNOL ADV, V10, P393, DOI 10.1016/0734-9750(92)90302-P; Schuler MA, 1996, PLANT PHYSIOL, V112, P1411, DOI 10.1104/pp.112.4.1411; Siminszky B, 1999, P NATL ACAD SCI USA, V96, P1750, DOI 10.1073/pnas.96.4.1750; Stalker David M., 1996, P93; Sun YQ, 2005, PLANT CELL TISS ORG, V83, P303, DOI 10.1007/s11240-005-7770-2; Sun YQ, 2005, PLANT CELL TISS ORG, V82, P309, DOI 10.1007/s11240-005-1837-y; Sun YQ, 2004, THEOR APPL GENET, V109, P472, DOI 10.1007/s00122-004-1663-3; Wilkins TA, 2000, CRIT REV PLANT SCI, V19, P511, DOI 10.1016/S0735-2689(01)80007-1; Wilkins TA, 2004, J FOOD AGRIC ENVIRON, V2, P179; Yamada T, 2000, PESTIC BIOCHEM PHYS, V68, P11, DOI 10.1006/pest.2000.2496	37	5	5	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39974	10.1371/journal.pone.0039974	http://dx.doi.org/10.1371/journal.pone.0039974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768325	Green Submitted, Green Published, gold			2022-12-27	WOS:000305966500038
J	Bendezu, FO; Vincenzetti, V; Martin, SG				Bendezu, Felipe O.; Vincenzetti, Vincent; Martin, Sophie G.			Fission Yeast Sec3 and Exo70 Are Transported on Actin Cables and Localize the Exocyst Complex to Cell Poles	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; FORMIN FOR3P; POLARIZED SECRETION; SUBUNIT SEC3; GTPASE RHO3; V MYOSINS; IN-VIVO; EXOCYTOSIS	The exocyst complex is essential for many exocytic events, by tethering vesicles at the plasma membrane for fusion. In fission yeast, polarized exocytosis for growth relies on the combined action of the exocyst at cell poles and myosin-driven transport along actin cables. We report here the identification of fission yeast Schizosaccharomyces pombe Sec3 protein, which we identified through sequence homology of its PH-like domain. Like other exocyst subunits, sec3 is required for secretion and cell division. Cells deleted for sec3 are only conditionally lethal and can proliferate when osmotically stabilized. Sec3 is redundant with Exo70 for viability and for the localization of other exocyst subunits, suggesting these components act as exocyst tethers at the plasma membrane. Consistently, Sec3 localizes to zones of growth independently of other exocyst subunits but depends on PIP2 and functional Cdc42. FRAP analysis shows that Sec3, like all other exocyst subunits, localizes to cell poles largely independently of the actin cytoskeleton. However, we show that Sec3, Exo70 and Sec5 are transported by the myosin V Myo52 along actin cables. These data suggest that the exocyst holocomplex, including Sec3 and Exo70, is present on exocytic vesicles, which can reach cell poles by either myosin-driven transport or random walk.	[Bendezu, Felipe O.; Vincenzetti, Vincent; Martin, Sophie G.] Univ Lausanne, Fac Biol & Med, Dept Fundamental Microbiol, Lausanne, Switzerland	University of Lausanne	Bendezu, FO (corresponding author), Univ Lausanne, Fac Biol & Med, Dept Fundamental Microbiol, Lausanne, Switzerland.	Sophie.Martin@unil.ch		Bendezu, Felipe/0000-0003-4324-2993; Martin, Sophie/0000-0002-5317-2557	Swiss National Science Foundation (SNF) [PP00A_114936]; SNF [31003A_138177]; HFSP [CDA0016/2008]; European Research Council [260493]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); SNF; HFSP(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission)	This work was supported by a Swiss National Science Foundation (SNF) Professorship grant (PP00A_114936) and a SNF Research grant (31003A_138177) to S.G.M. Research in S.G.M.'s lab is also supported by a HFSP Career Development Award (CDA0016/2008) and a European Research Council Starting Grant (260493). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; Aghamohammadzadeh S, 2009, NAT CELL BIOL, V11, P1039, DOI 10.1038/ncb1918; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Baek K, 2010, J BIOL CHEM, V285, P10424, DOI 10.1074/jbc.M109.096966; Bendezu FO, 2011, MOL BIOL CELL, V22, P44, DOI 10.1091/mbc.E10-08-0720; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006; Clayton JE, 2010, CURR BIOL, V20, P1423, DOI 10.1016/j.cub.2010.07.026; Dong G, 2005, NAT STRUCT MOL BIOL, V12, P1094, DOI 10.1038/nsmb1017; EauClaire S, 2003, NEURON, V37, P369, DOI 10.1016/S0896-6273(03)00059-X; Estravis M, 2011, TRAFFIC, V12, P1744, DOI 10.1111/j.1600-0854.2011.01275.x; Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Ewart MA, 2005, J BIOL CHEM, V280, P3812, DOI 10.1074/jbc.M409928200; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Finger FP, 1998, CELL, V92, P559, DOI 10.1016/S0092-8674(00)80948-4; Grallert A, 2007, J CELL SCI, V120, P4093, DOI 10.1242/jcs.012468; Guo W, 2001, NAT CELL BIOL, V3, P353, DOI 10.1038/35070029; Hamburger ZA, 2006, J MOL BIOL, V356, P9, DOI 10.1016/j.jmb.2005.09.099; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Heider MR, 2012, EXORCISING EXOCYST C; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745; Liu JL, 2007, MOL BIOL CELL, V18, P4483, DOI 10.1091/mbc.E07-05-0461; Lo Presti L, 2011, CURR BIOL, V21, P2064, DOI 10.1016/j.cub.2011.10.033; Martin SG, 2007, MOL BIOL CELL, V18, P4155, DOI 10.1091/mbc.E07-02-0094; Martin SG, 2006, CURR BIOL, V16, P1161, DOI 10.1016/j.cub.2006.04.040; Martin-Cuadrado AB, 2005, MOL BIOL CELL, V16, P4867, DOI 10.1091/mbc.E04-12-1114; Minc N, 2009, CURR BIOL, V19, P83, DOI 10.1016/j.cub.2008.12.008; Motegi F, 2001, MOL BIOL CELL, V12, P1367, DOI 10.1091/mbc.12.5.1367; Mulvihill DP, 2006, CELL MOTIL CYTOSKEL, V63, P149, DOI 10.1002/cm.20113; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Nakano K, 2002, J CELL SCI, V115, P4629, DOI 10.1242/jcs.00150; Nakano K, 2011, TRAFFIC, V12, P726, DOI 10.1111/j.1600-0854.2011.01190.x; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Ory S, 2011, SEMIN CELL DEV BIOL, V22, P27, DOI 10.1016/j.semcdb.2010.12.002; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; Roumanie O, 2005, J CELL BIOL, V170, P583, DOI 10.1083/jcb.200504108; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Sivaram MVS, 2006, NAT STRUCT MOL BIOL, V13, P555, DOI 10.1038/nsmb1096; Snaith HA, 2011, J CELL SCI, V124, P2187, DOI 10.1242/jcs.084038; Tang X, 2011, YEAST, V28, P205, DOI 10.1002/yea.1831; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Wang HY, 2003, GENETICS, V164, P1323; Wang HY, 2002, MOL BIOL CELL, V13, P515, DOI 10.1091/mbc.01-11-0542; Win TZ, 2001, J CELL SCI, V114, P69; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Yamashita M, 2010, NAT STRUCT MOL BIOL, V17, P180, DOI 10.1038/nsmb.1722; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327; Zajac A, 2005, MOL BIOL CELL, V16, P1500, DOI 10.1091/mbc.E04-10-0896; Zhang XY, 2008, J CELL BIOL, V180, P145, DOI 10.1083/jcb.200704128; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200; Zhang YJ, 2000, J BIOL CHEM, V275, P35600, DOI 10.1074/jbc.M005575200	55	46	49	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40248	10.1371/journal.pone.0040248	http://dx.doi.org/10.1371/journal.pone.0040248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768263	Green Published, gold			2022-12-27	WOS:000305892100237
J	Chang, M; Alsaigh, T; Kistler, EB; Schmid-Schonbein, GW				Chang, Marisol; Alsaigh, Tom; Kistler, Erik B.; Schmid-Schoenbein, Geert W.			Breakdown of Mucin as Barrier to Digestive Enzymes in the Ischemic Rat Small Intestine	PLOS ONE			English	Article							CYCLOHEXANE CARBOXYLIC ACID; TOLL-LIKE RECEPTOR; MUCUS GEL LAYER; GASTROINTESTINAL MUCUS; ALPHA-AMYLASE; SECRETION; SHOCK; EXPRESSION; GLYCOPROTEINS; DISRUPTION	Loss of integrity of the epithelial/mucosal barrier in the small intestine has been associated with different pathologies that originate and/or develop in the gastrointestinal tract. We showed recently that mucin, the main protein in the mucus layer, is disrupted during early periods of intestinal ischemia. This event is accompanied by entry of pancreatic digestive enzymes into the intestinal wall. We hypothesize that the mucin-containing mucus layer is the main barrier preventing digestive enzymes from contacting the epithelium. Mucin breakdown may render the epithelium accessible to pancreatic enzymes, causing its disruption and increased permeability. The objective of this study was to investigate the role of mucin as a protection for epithelial integrity and function. A rat model of 30 min splanchnic arterial occlusion (SAO) was used to study the degradation of two mucin isoforms (mucin 2 and 13) and two epithelial membrane proteins (E-cadherin and toll-like receptor 4, TLR4). In addition, the role of digestive enzymes in mucin breakdown was assessed in this model by luminal inhibition with acarbose, tranexamic acid, or nafamostat mesilate. Furthermore, the protective effect of the mucin layer against trypsin-mediated disruption of the intestinal epithelium was studied in vitro. Rats after SAO showed degradation of mucin 2 and fragmentation of mucin 13, which was not prevented by protease inhibition. Mucin breakdown was accompanied by increased intestinal permeability to FITC-dextran as well as degradation of E-cadherin and TLR4. Addition of mucin to intestinal epithelial cells in vitro protected against trypsin-mediated degradation of E-cadherin and TLR4 and reduced permeability of FITC-dextran across the monolayer. These results indicate that mucin plays an important role in the preservation of the mucosal barrier and that ischemia but not digestive enzymes disturbs mucin integrity, while digestive enzymes actively mediate epithelial cell disruption.	[Chang, Marisol; Alsaigh, Tom; Kistler, Erik B.; Schmid-Schoenbein, Geert W.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Kistler, Erik B.] Univ Calif San Diego, Med Ctr, Dept Anesthesiol & Crit Care, San Diego, CA 92103 USA; [Schmid-Schoenbein, Geert W.] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Chang, M (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	gwss@ucsd.edu		Kistler, Erik/0000-0002-6512-4798	National Institutes of Health (NIH) [HL76180, GM85072]; UC San Diego Interfaces Graduate Training Program in Interdisciplinary Specialization in Multiscale Biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085072] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC San Diego Interfaces Graduate Training Program in Interdisciplinary Specialization in Multiscale Biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health (NIH) Grants HL76180 and GM85072 and the UC San Diego Interfaces Graduate Training Program in Interdisciplinary Specialization in Multiscale Biology http://interfaces.ucsd.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBANESE CT, 1994, SURGERY, V116, P76; ALLEN A, 1972, GUT, V13, P666, DOI 10.1136/gut.13.8.666; ANDERSSON L, 1965, SCAND J HAEMATOL, V2, P230; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; BOUNOUS G, 1966, ANN SURG, V164, P13, DOI 10.1097/00000658-196607000-00002; Chang M, 2011, SHOCK; Chang M, 2012, SHOCK, V37, P297, DOI 10.1097/SHK.0b013e318240b59b; Choi YJ, 2010, J BIOL CHEM, V285, P21382, DOI 10.1074/jbc.M110.115022; Corfield AP, 2000, GUT, V47, P589, DOI 10.1136/gut.47.4.589; Corfield AP, 2001, FRONT BIOSCI-LANDMRK, V6, pD1321, DOI 10.2741/Corfield; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; de Zoete MR, 2011, P NATL ACAD SCI USA, V108, P4968, DOI 10.1073/pnas.1018135108; DUBBER AHC, 1965, BRIT J HAEMATOL, V11, P237, DOI 10.1111/j.1365-2141.1965.tb06583.x; Epstein FH, 1994, NEW ENGL J MED, V330, P1580; Faure M, 2005, J NUTR, V135, P486, DOI 10.1093/jn/135.3.486; FORSTNER JF, 1981, AM J PHYSIOL, V240, pG10, DOI 10.1152/ajpgi.1981.240.1.G10; FUJII S, 1981, BIOCHIM BIOPHYS ACTA, V661, P342, DOI 10.1016/0005-2744(81)90023-1; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; GREEN GM, 1980, GASTROENTEROLOGY, V79, P695; Gum JR, 1995, BIOCHEM SOC T, V23, P795, DOI 10.1042/bst0230795; Guzman K, 1996, AM J PHYSIOL-LUNG C, V270, pL846, DOI 10.1152/ajplung.1996.270.5.L846; HAGLUND U, 1976, EUR SURG RES, V8, P435, DOI 10.1159/000127888; Helgason CD, 2005, CULTURE PRIMARY ADHE; HENKEL E, 1984, J CLIN CHEM CLIN BIO, V22, P489; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; KEMPER AC, 1991, ANAT REC, V229, P219, DOI 10.1002/ar.1092290209; Kim MJ, 1999, ARCH BIOCHEM BIOPHYS, V371, P277, DOI 10.1006/abbi.1999.1423; LAMONT JT, 1983, AM J PHYSIOL, V245, pG92, DOI 10.1152/ajpgi.1983.245.1.G92; LAMONT JT, 1992, ANN NY ACAD SCI, V664, P190, DOI 10.1111/j.1749-6632.1992.tb39760.x; LICHTENBERGER LM, 1995, ANNU REV PHYSIOL, V57, P565, DOI 10.1146/annurev.ph.57.030195.003025; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Lu P, 2011, INFLAMM BOWEL DIS, V17, P2047, DOI 10.1002/ibd.21592; Man Y, 2000, AM J RESP CELL MOL, V23, P610, DOI 10.1165/ajrcmb.23.5.4046; MAXSON RT, 1994, J SURG RES, V57, P682, DOI 10.1006/jsre.1994.1201; MERLIN D, 1994, J MEMBRANE BIOL, V137, P137; MIYASAKA K, 1984, GASTROENTEROLOGY, V86, P114; Moses T, 2009, J LEUKOCYTE BIOL, V86, P971, DOI 10.1189/jlb.0708396; NIMMERFALL F, 1980, BIOCHEM BIOPH RES CO, V94, P960, DOI 10.1016/0006-291X(80)91328-5; Rong M, 2005, J CELL PHYSIOL, V202, P275, DOI 10.1002/jcp.20121; Rupani B, 2007, SURGERY, V141, P481, DOI 10.1016/j.surg.2006.10.008; Sodhi C, 2011, AM J PHYSIOL-GASTR L, V300, pG862, DOI 10.1152/ajpgi.00373.2010; STROUS GJ, 1992, CRIT REV BIOCHEM MOL, V27, P57, DOI 10.3109/10409239209082559; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Yu Q, 2000, GENE DEV, V14, P163; ZIMMERMAN M, 1977, ANAL BIOCHEM, V78, P47, DOI 10.1016/0003-2697(77)90006-9	48	78	86	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40087	10.1371/journal.pone.0040087	http://dx.doi.org/10.1371/journal.pone.0040087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768227	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100199
J	Dauvilliers, Y; Jaussent, I; Krams, B; Scholz, S; Lado, S; Levy, P; Pepin, JL				Dauvilliers, Yves; Jaussent, Isabelle; Krams, Benjamin; Scholz, Sabine; Lado, Stephane; Levy, Patrick; Pepin, Jean Louis			Non-Dipping Blood Pressure Profile in Narcolepsy with Cataplexy	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; PERIODIC LEG MOVEMENTS; ENDOTHELIAL DYSFUNCTION; SLEEP; MORTALITY; HYPERTENSION; OREXINS; ASSOCIATION; NUCLEUS; RATS	Background: Patients with narcolepsy-cataplexy (NC) mostly exhibit undetectable hypocretin levels. Hypocretin system is one of the key players in the complex interaction between sleep and the cardiovascular system. We tested the hypothesis that hypocretin deficiency affects cardiovascular risk factors by measuring nighttime and daytime ambulatory blood pressure (BP) and the night-to-day BP ratio as well as endothelial dysfunction by the digital pulse amplitude response in drug-free patients with NC compared to controls. Methodology: Sleep, clinical and biological cardiovascular risk factors, fingertip peripheral arterial tonometry, and 24-hour ambulatory BP monitoring were recorded in 50 drug-free patients with NC and 42 healthy control subjects, except for BP monitoring available in all controls but in 36 patients with NC. Principal Findings: More patients than controls were smokers, obese and with dyslipidemia. One-third of patients with NC were "non-dippers" (defined as,10% drop in BP during sleep) compared to only 3% of controls. The diastolic non-dipper BP profile had up to 12-fold higher odds of being associated with NC. We noted negative correlations between mean diastolic BP fall during night, REM sleep percentage and number of sleep onset REM periods, and a positive correlation with mean sleep latency on the MSLT. The digital pulse amplitude response measured by fingertip was similar between NC and controls. Conclusion: We found a high percentage of non-dippers in patients with NC with association with REM sleep dysregulation. The blunted sleep-related BP dip in NC may be of clinical relevance, as it may indicate increased risk for cardiovascular events.	[Dauvilliers, Yves; Krams, Benjamin; Scholz, Sabine; Lado, Stephane] CHU Montpellier, Hop Gui de Chauliac, Dept Neurol, Natl Reference Network Narcolepsy,Sleep Unit, Montpellier, France; [Dauvilliers, Yves; Jaussent, Isabelle] INSERM, U1061, Montpellier, France; [Dauvilliers, Yves; Jaussent, Isabelle] Univ Montpellier I, Montpellier, France; [Lado, Stephane; Levy, Patrick; Pepin, Jean Louis] Univ Grenoble 1, Univ Hosp Grenoble, Sleep Lab, Hypoxia PathoPhysiol Lab HP2,INSERM 1042, Grenoble, France	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU Grenoble Alpes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Dauvilliers, Y (corresponding author), CHU Montpellier, Hop Gui de Chauliac, Dept Neurol, Natl Reference Network Narcolepsy,Sleep Unit, Montpellier, France.	ydauvilliers@yahoo.fr	Lévy, Patrick/M-6903-2014; PEPIN, Jean-Louis/M-6549-2014; LEVY, Patrick/AAX-2802-2020	Lévy, Patrick/0000-0003-3632-1327; LEVY, Patrick/0000-0003-3174-7935; Jaussent, Isabelle/0000-0002-8205-7590; Pepin, Jean Louis/0000-0003-3832-2358; Dauvilliers, yves/0000-0003-0683-6506	UCB Pharma; Cephalon; Novartis; Bioprojet	UCB Pharma(UCB Pharma SA); Cephalon; Novartis(Novartis); Bioprojet	This was not an industry-supported study. Prs Levy and Pepin, Drs Krams and Lado report no disclosures. Isabelle Jaussent and Sabine Scholz report no disclosures. Prof. Dauvilliers has received speaker's honoraria and funding for travel to conferences from UCB Pharma, Cephalon, Novartis, and Bioprojet. Prof. Dauvilliers has participated in advisory boards of UCB and Bioprojet. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Baguet JP, 2009, J HUM HYPERTENS, V23, P431, DOI 10.1038/jhh.2008.147; Bastianini S, 2011, SLEEP, V34, P213, DOI 10.1093/sleep/34.2.213; Ben-Dov IZ, 2007, HYPERTENSION, V49, P1235, DOI 10.1161/HYPERTENSIONAHA.107.087262; Boggia J, 2007, LANCET, V370, P1219, DOI 10.1016/S0140-6736(07)61538-4; Chen CT, 2000, AM J PHYSIOL-REG I, V278, pR692, DOI 10.1152/ajpregu.2000.278.3.R692; Dauvilliers Y, 2007, LANCET, V369, P499, DOI 10.1016/S0140-6736(07)60237-2; Dauvilliers Y, 2011, SLEEP, V34, P219, DOI 10.1093/sleep/34.2.219; de Oliveira CVR, 2003, AM J PHYSIOL-HEART C, V284, pH1369, DOI 10.1152/ajpheart.00877.2002; Dolan E, 2005, HYPERTENSION, V46, P156, DOI 10.1161/01.HYP.0000170138.56903.7a; Grimaldi D, 2012, SLEEP, V35, P519, DOI 10.5665/sleep.1738; Hamburg NM, 2008, CIRCULATION, V117, P2467, DOI 10.1161/CIRCULATIONAHA.107.748574; Hansen TW, 2005, HYPERTENSION, V45, P499, DOI 10.1161/01.HYP.0000160402.39597.3b; Iber C., 2007, AASM MANUAL SCORING; Kayaba Y, 2003, AM J PHYSIOL-REG I, V285, pR581, DOI 10.1152/ajpregu.00671.2002; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MIDDELKOOP HAM, 1995, PSYCHOPHYSIOLOGY, V32, P286, DOI 10.1111/j.1469-8986.1995.tb02957.x; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; National Cholesterol Education Program Adult Treatment Panel III criteria, 2001, JAMA, V285, P486; Ohkubo T, 2002, J HYPERTENS, V20, P2183, DOI 10.1097/00004872-200211000-00017; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Plazzi G, 2008, SLEEP MED REV, V12, P109, DOI 10.1016/j.smrv.2007.08.010; Poli F, 2009, SLEEP, V32, P1491, DOI 10.1093/sleep/32.11.1491; Quinaglia T, 2011, J HUM HYPERTENS, V25, P656, DOI 10.1038/jhh.2011.43; Rubinshtein R, 2010, EUR HEART J, V31, P1142, DOI 10.1093/eurheartj/ehq010; Samson WK, 2005, SLEEP MED REV, V9, P243, DOI 10.1016/j.smrv.2004.07.006; Shirasaka T, 1999, AM J PHYSIOL-REG I, V277, pR1780, DOI 10.1152/ajpregu.1999.277.6.R1780; Shirasaka T, 2002, REGUL PEPTIDES, V104, P91, DOI 10.1016/S0167-0115(01)00352-4; Smith PM, 2002, BRAIN RES, V950, P261, DOI 10.1016/S0006-8993(02)03048-2; Smolensky MH, 2007, SLEEP MED, V8, P668, DOI 10.1016/j.sleep.2006.11.011; SOMERS VK, 1993, NEW ENGL J MED, V328, P303, DOI 10.1056/NEJM199302043280502; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; Yoshimoto M, 2011, SLEEP, V34, P1093, DOI 10.5665/SLEEP.1168; Zucconi M, 2006, SLEEP MED, V7, P175, DOI 10.1016/j.sleep.2006.01.001	36	66	67	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38977	10.1371/journal.pone.0038977	http://dx.doi.org/10.1371/journal.pone.0038977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768053	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100023
J	Jacob, D; Sauer, U; Housley, R; Washington, C; Sannes-Lowery, K; Ecker, DJ; Sampath, R; Grunow, R				Jacob, Daniela; Sauer, Uschi; Housley, Roberta; Washington, Cicely; Sannes-Lowery, Kristin; Ecker, David J.; Sampath, Rangarajan; Grunow, Roland			Rapid and High-Throughput Detection of Highly Pathogenic Bacteria by Ibis PLEX-ID Technology	PLOS ONE			English	Article							BIOTERRORISM AGENTS; UNIVERSAL BIOSENSOR; MASS-SPECTROMETRY; IDENTIFICATION; SURVEILLANCE	In this manuscript, we describe the identification of highly pathogenic bacteria using an assay coupling biothreat group-specific PCR with electrospray ionization mass spectrometry (PCR/ESI-MS) run on an Ibis PLEX-ID high-throughput platform. The biothreat cluster assay identifies most of the potential bioterrorism-relevant microorganisms including Bacillus anthracis, Francisella tularensis, Yersinia pestis, Burkholderia mallei and pseudomallei, Brucella species, and Coxiella burnetii. DNA from 45 different reference materials with different formulations and different concentrations were chosen and sent to a service screening laboratory that uses the PCR/ESI-MS platform to provide a microbial identification service. The standard reference materials were produced out of a repository built up in the framework of the EU funded project "Establishment of Quality Assurances for Detection of Highly Pathogenic Bacteria of Potential Bioterrorism Risk" (EQADeBa). All samples were correctly identified at least to the genus level.	[Jacob, Daniela; Sauer, Uschi; Grunow, Roland] Robert Koch Inst, Berlin, Germany; [Housley, Roberta; Ecker, David J.; Sampath, Rangarajan] Abbott Co, Ibis Biosci Inc, Carlsbad, CA USA; [Washington, Cicely; Sannes-Lowery, Kristin] Athogen Inc, Irvine, CA USA	Robert Koch Institute	Jacob, D (corresponding author), Robert Koch Inst, Berlin, Germany.	GrunowR@rki.de		Ecker, David/0000-0003-4350-9037	European Commission's Executive Agency for Health and Consumers (EAHC)	European Commission's Executive Agency for Health and Consumers (EAHC)	This publication has been produced with the support of the European Commission's Executive Agency for Health and Consumers (EAHC). Its content is the sole responsibility of Robert Koch-Institut, Centre for Biological Security, and can in no way be taken to reflect the views of the EAHC or any other body of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branda JA, 2002, AM J CLIN PATHOL, V117, P116; Crowder CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010650; Deshpande A, 2010, J MICROBIOL METH, V80, P155, DOI 10.1016/j.mimet.2009.12.001; Ecker D, 2006, J ASS LAB AUTOM, P341; Ecker DJ, 2008, NAT REV MICROBIOL, V6, P553, DOI 10.1038/nrmicro1918; Ecker DJ, 2005, P NATL ACAD SCI USA, V102, P8012, DOI 10.1073/pnas.0409920102; Eshoo MW, 2007, VIROLOGY, V368, P286, DOI 10.1016/j.virol.2007.06.016; He J, 2009, VIRUSES-BASEL, V1, P441, DOI 10.3390/v1030441; Hofstadler SA, 2005, INT J MASS SPECTROM, V242, P23, DOI 10.1016/j.ijms.2004.09.014; Horn Jan K, 2003, Surg Infect (Larchmt), V4, P281, DOI 10.1089/109629603322419625; Janse I, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-314; Lasch P, 2010, ANAL CHEM, V82, P8464, DOI 10.1021/ac101036s; Lasch P, 2009, APPL ENVIRON MICROB, V75, P7229, DOI 10.1128/AEM.00857-09; Pappas Georgios, 2009, J Infect Public Health, V2, P55, DOI 10.1016/j.jiph.2009.03.002; Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489; Sampath R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036528; Wagar EA, 2010, ARCH PATHOL LAB MED, V134, P1490, DOI 10.1043/2010-0098-CP.1	17	34	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39928	10.1371/journal.pone.0039928	http://dx.doi.org/10.1371/journal.pone.0039928			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768173	gold, Green Published			2022-12-27	WOS:000305892100143
J	Masaki, S; Masutani, H; Yoshihara, E; Yodoi, J				Masaki, So; Masutani, Hiroshi; Yoshihara, Eiji; Yodoi, Junji			Deficiency of Thioredoxin Binding Protein-2 (TBP-2) Enhances TGF-beta Signaling and Promotes Epithelial to Mesenchymal Transition	PLOS ONE			English	Article							UP-REGULATED PROTEIN-1; UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; CELL-GROWTH; VDUP1; TRANSCRIPTION; INHIBITOR; ARRESTIN; SMURF2; SNAIL	Background: Transforming growth factor beta (TGF-beta) has critical roles in regulating cell growth, differentiation, apoptosis, invasion and epithelial-mesenchymal transition (EMT) of various cancer cells. TGF-beta-induced EMT is an important step during carcinoma progression to invasion state. Thioredoxin binding protein-2 (TBP-2, also called Txnip or VDUP1) is downregulated in various types of human cancer, and its deficiency results in the earlier onset of cancer. However, it remains unclear how TBP-2 suppresses the invasion and metastasis of cancer. Principal Findings: In this study, we demonstrated that TBP-2 deficiency increases the transcriptional activity in response to TGF-beta and also enhances TGF-beta-induced Smad2 phosphorylation levels. Knockdown of TBP-2 augmented the TGF-beta-responsive expression of Snail and Slug, transcriptional factors related to TGF-beta-mediated induction of EMT, and promoted TGF-beta-induced spindle-like morphology consistent with the depletion of E-Cadherin in A549 cells. Conclusions/Significance: Our results indicate that TBP-2 deficiency enhances TGF-beta signaling and promotes TGF-beta-induced EMT. The control of TGF-beta-induced EMT is critical for the inhibition of the invasion and metastasis. Thus TBP-2, as a novel regulatory molecule of TGF-beta signaling, is likely to be a prognostic indicator or a potential therapeutic target for preventing tumor progression.	[Masaki, So; Masutani, Hiroshi; Yoshihara, Eiji; Yodoi, Junji] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Lab Infect & Prevent, Kyoto 606, Japan; [Yodoi, Junji] Ewha Womans Univ, Ctr Cell Signaling Res, Dept Bioinspired Sci, Seoul, South Korea	Kyoto University; Ewha Womans University	Masaki, S (corresponding author), Kyoto Univ, Inst Virus Res, Dept Biol Responses, Lab Infect & Prevent, Kyoto 606, Japan.	yodoi@virus.kyoto-u.ac.jp	Masutani, Hiroshi/B-5114-2014	Masutani, Hiroshi/0000-0001-7633-2827; Yoshihara, Eiji/0000-0001-6324-6495	Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institute of Biomedical Innovation (NIBIO); World Class University [R31-10010]; Grants-in-Aid for Scientific Research [23126512] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); World Class University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and partly by the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO). This work was also supported by World Class University Grant R31-10010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan MK, 2006, ONCOGENE, V25, P2181, DOI 10.1038/sj.onc.1209256; Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Arai RJ, 2008, TOXICOL APPL PHARM, V233, P227, DOI 10.1016/j.taap.2008.07.023; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Butler LM, 2002, P NATL ACAD SCI USA, V99, P11700, DOI 10.1073/pnas.182372299; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Chen Z, 2011, LEUKEMIA, V25, P440, DOI 10.1038/leu.2010.286; Goldberg SF, 2003, CANCER RES, V63, P432; Hajra KM, 2002, CANCER RES, V62, P1613; Han SH, 2003, ONCOGENE, V22, P4035, DOI 10.1038/sj.onc.1206610; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Hui TY, 2004, J BIOL CHEM, V279, P24387, DOI 10.1074/jbc.M401280200; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Jeon JH, 2005, CANCER RES, V65, P4485, DOI 10.1158/0008-5472.CAN-04-2271; Jin HO, 2011, ONCOGENE, V30, P3792, DOI 10.1038/onc.2011.102; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kim SY, 2007, CELL MOL IMMUNOL, V4, P345; Kuljaca S, 2009, CARCINOGENESIS, V30, P1865, DOI 10.1093/carcin/bgp225; Kwon HJ, 2011, J HEPATOL, V54, P1168, DOI 10.1016/j.jhep.2010.09.025; Kwon HJ, 2010, J IMMUNOL, V185, P3980, DOI 10.4049/jimmunol.1000990; Lee KN, 2005, IMMUNITY, V22, P195, DOI 10.1016/j.immuni.2004.12.012; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nishinaka Y, 2004, J BIOL CHEM, V279, P37559, DOI 10.1074/jbc.M405473200; Nishinaka Y, 2004, CANCER RES, V64, P1287, DOI 10.1158/0008-5472.CAN-03-0908; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Nishizawa K, 2011, CARCINOGENESIS, V32, P1459, DOI 10.1093/carcin/bgr137; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Oka S, 2009, ENDOCRINOLOGY, V150, P1225, DOI 10.1210/en.2008-0646; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Sheth SS, 2006, ONCOGENE, V25, P3528, DOI 10.1038/sj.onc.1209394; Shi WB, 2004, J CELL BIOL, V164, P291, DOI 10.1083/jcb.200307151; Son A, 2008, EUR J IMMUNOL, V38, P1358, DOI 10.1002/eji.200737939; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yoshihara E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1127; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	42	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39900	10.1371/journal.pone.0039900	http://dx.doi.org/10.1371/journal.pone.0039900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768160	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100129
J	Moriishi, T; Fukuyama, R; Ito, M; Miyazaki, T; Maeno, T; Kawai, Y; Komori, H; Komori, T				Moriishi, Takeshi; Fukuyama, Ryo; Ito, Masako; Miyazaki, Toshihiro; Maeno, Takafumi; Kawai, Yosuke; Komori, Hisato; Komori, Toshihisa			Osteocyte Network; a Negative Regulatory System for Bone Mass Augmented by the Induction of Rankl in Osteoblasts and Sost in Osteocytes at Unloading	PLOS ONE			English	Article							SCLEROSTIN; WNT; APOPTOSIS; DENSITY; EXPRESSION; MATURATION; RESORPTION; PROTEIN-1; DELETION; STRAIN	Reduced mechanical stress is a major cause of osteoporosis in the elderly, and the osteocyte network, which comprises a communication system through processes and canaliculi throughout bone, is thought to be a mechanosensor and mechanotransduction system; however, the functions of osteocytes are still controversial and remain to be clarified. Unexpectedly, we found that overexpression of BCL2 in osteoblasts eventually caused osteocyte apoptosis. Osteoblast and osteoclast differentiation were unaffected by BCL2 transgene in vitro. However, the cortical bone mass increased due to enhanced osteoblast function and suppressed osteoclastogenesis at 4 months of age, when the frequency of TUNEL-positive lacunae reached 75%. In the unloaded condition, the trabecular bone mass decreased in both wild-type and BCL2 transgenic mice at 6 weeks of age, while it decreased due to impaired osteoblast function and enhanced osteoclastogenesis in wild-type mice but not in BCL2 transgenic mice at 4 months of age. Rankl and Opg were highly expressed in osteocytes, but Rankl expression in osteoblasts but not in osteocytes was increased at unloading in wild-type mice but not in BCL2 transgenic mice at 4 months of age. Sost was locally induced at unloading in wild-type mice but not in BCL2 transgenic mice, and the dissemination of Sost was severely interrupted in BCL2 transgenic mice, showing the severely impaired osteocyte network. These findings indicate that the osteocyte network is required for the upregulation of Rankl in osteoblasts and Sost in osteocytes in the unloaded condition. These findings suggest that the osteocyte network negatively regulate bone mass by inhibiting osteoblast function and activating osteoclastogenesis, and these functions are augmented in the unloaded condition at least partly through the upregulation of Rankl expression in osteoblasts and that of Sost in osteocytes, although it cannot be excluded that low BCL2 transgene expression in osteoblasts contributed to the enhanced osteoblast function.	[Moriishi, Takeshi; Miyazaki, Toshihiro; Maeno, Takafumi; Kawai, Yosuke; Komori, Hisato; Komori, Toshihisa] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cell Biol, Nagasaki 852, Japan; [Fukuyama, Ryo] Hiroshima Int Univ, Pharmacol Lab, Kure, Japan; [Ito, Masako] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiol & Radiat Biol, Nagasaki 852, Japan; [Maeno, Takafumi] Osaka City Univ, Grad Sch Med, Dept Orthoped Surg, Osaka 558, Japan; [Kawai, Yosuke] Nagasaki Univ, Grad Sch Biomed Sci, Dept Regenerat Oral Surg, Nagasaki 852, Japan	Nagasaki University; Nagasaki University; Osaka Metropolitan University; Nagasaki University	Moriishi, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Cell Biol, Nagasaki 852, Japan.	komorit@nagasaki-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology; Ground-based Research Program for Space Utilization; Nakatomi Foundation; Nagasaki University, Japan	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ground-based Research Program for Space Utilization; Nakatomi Foundation; Nagasaki University, Japan	This work was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology, the "Ground-based Research Program for Space Utilization'' promoted by the Japan Space Forum, the Nakatomi Foundation, and the President's Discretionary Fund of Nagasaki University, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095; Hedgecock NL, 2007, BONE, V40, P627, DOI 10.1016/j.bone.2006.10.006; Heino TJ, 2002, J CELL BIOCHEM, V85, P185, DOI 10.1002/jcb.10109; Jilka RL, 2007, J BONE MINER RES, V22, P1492, DOI 10.1359/JBMR.070518; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; LAZENBY RA, 1990, AM J PHYS ANTHROPOL, V82, P473, DOI 10.1002/ajpa.1330820408; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; MAROTTI G, 1995, BONE, V16, P125, DOI 10.1016/S8756-3282(94)00019-0; Martin RB, 2000, BONE, V26, P71, DOI 10.1016/S8756-3282(99)00242-2; Martin RB, 1998, SKELETAL TISSUE MECH; Metz LN, 2003, BONE, V33, P753, DOI 10.1016/S8756-3282(03)00245-X; Moriishi T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027487; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Moustafa A, 2012, OSTEOPOROSIS INT, V23, P1225, DOI 10.1007/s00198-011-1656-4; Mueller RJ, 2004, J MATER SCI-MATER M, V15, P367, DOI 10.1023/B:JMSM.0000021103.39114.cd; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Noble BS, 2008, ARCH BIOCHEM BIOPHYS, V473, P106, DOI 10.1016/j.abb.2008.04.009; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Qiu S, 2002, BONE, V31, P709, DOI 10.1016/S8756-3282(02)00907-9; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Russo CR, 2006, BONE, V38, P112, DOI 10.1016/j.bone.2005.07.025; Sakai A., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P387; Schulze C, 2008, AUTOIMMUN REV, V8, P5, DOI 10.1016/j.autrev.2008.07.049; Schwab P, 2008, CURR OPIN RHEUMATOL, V20, P213, DOI 10.1097/BOR.0b013e3282f3cbd3; Seeman E, 2001, CALCIFIED TISSUE INT, V69, P205, DOI 10.1007/s00223-001-1040-z; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Silva MT, 2008, APOPTOSIS, V13, P463, DOI 10.1007/s10495-008-0187-8; Tate MLK, 2003, J BIOMECH, V36, P1409, DOI 10.1016/S0021-9290(03)00123-4; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Verborgt O, 2000, J BONE MINER RES, V15, P60, DOI 10.1359/jbmr.2000.15.1.60; Wang YY, 2012, BONE, V50, P409, DOI 10.1016/j.bone.2011.07.012; Weinstein RS, 2000, J CLIN ENDOCR METAB, V85, P2907, DOI 10.1210/jc.85.8.2907; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Wolff J., 2010, GESETZ TRANSFORMATIO; Wu YL, 2008, AUTOIMMUNITY, V41, P183, DOI 10.1080/08916930701693180; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; You LD, 2008, BONE, V42, P172, DOI 10.1016/j.bone.2007.09.047; Zhao WG, 2000, J CLIN INVEST, V106, P941, DOI 10.1172/JCI10158; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	53	65	69	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40143	10.1371/journal.pone.0040143	http://dx.doi.org/10.1371/journal.pone.0040143			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768243	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100216
J	Sinke, CBA; Van den Stock, J; Goebel, R; de Gelder, B				Sinke, Charlotte B. A.; Van den Stock, Jan; Goebel, Rainer; de Gelder, Beatrice			The Constructive Nature of Affective Vision: Seeing Fearful Scenes Activates Extrastriate Body Area	PLOS ONE			English	Article							ANTICIPATION; PERCEPTION; CONTEXT; BRAIN	It is part of basic emotions like fear or anger that they prepare the brain to act adaptively. Hence scenes representing emotional events are normally associated with characteristic adaptive behavior. Normally, face and body representation areas in the brain are modulated by these emotions when presented in the face or body. Here, we provide neuroimaging evidence (using functional magnetic resonance imaging) that the extrastriate body area (EBA) is highly responsive when subjects observe isolated faces presented in emotional scenes. This response of EBA to threatening scenes in which no body is present gives rise to speculation about its function. We discuss the possibility that the brain reacts proactively to the emotional meaning of the scene.	[Sinke, Charlotte B. A.; Van den Stock, Jan; de Gelder, Beatrice] Tilburg Univ, Cognit & Affect Neurosci Lab, NL-5000 LE Tilburg, Netherlands; [Sinke, Charlotte B. A.; Goebel, Rainer] Maastricht Univ, Fac Psychol & Neurosci, Maastricht, Netherlands; [de Gelder, Beatrice] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Martinos Ctr Biomed Imaging, Charlestown, MA USA	Tilburg University; Maastricht University; Harvard University; Massachusetts General Hospital	Sinke, CBA (corresponding author), Tilburg Univ, Cognit & Affect Neurosci Lab, NL-5000 LE Tilburg, Netherlands.	b.degelder@uvt.nl	Van den Stock, J./F-1906-2014	Van den Stock, J./0000-0001-5756-3195; Goebel, Rainer/0000-0003-1780-2467	TANGO grant; Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET-Open [249858]	TANGO grant; Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET-Open	This work was supported by the TANGO grant. The project TANGO acknowledges the financial support of the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET-Open (grant number 249858). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Bar M, 1996, PERCEPTION, V25, P343, DOI 10.1068/p250343; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bar M, 2009, PHILOS T R SOC B, V364, P1235, DOI 10.1098/rstb.2008.0310; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Carlsson K, 2000, J COGNITIVE NEUROSCI, V12, P691, DOI 10.1162/089892900562318; Cox D, 2004, SCIENCE, V304, P115, DOI 10.1126/science.1093110; de Gelder B, 2010, NEUROSCI BIOBEHAV R, V34, P513, DOI 10.1016/j.neubiorev.2009.10.008; De Ridder D, 2007, NEW ENGL J MED, V357, P1829, DOI 10.1056/NEJMoa070010; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Esterman M, 2010, CEREB CORTEX, V20, P1245, DOI 10.1093/cercor/bhp188; Farrer C, 2008, CEREB CORTEX, V18, P254, DOI 10.1093/cercor/bhm050; FRIJDA NH, 1988, AM PSYCHOL, V43, P349, DOI 10.1037/0003-066X.43.5.349; Frijda NH, 2010, BIOL PSYCHOL, V84, P570, DOI 10.1016/j.biopsycho.2010.01.005; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Grezes J, 2007, NEUROIMAGE, V35, P959, DOI 10.1016/j.neuroimage.2006.11.030; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kuhn S, 2011, J COGNITIVE NEUROSCI, V23, P214, DOI 10.1162/jocn.2010.21418; Lamm C, 2008, CEREB CORTEX, V18, P2369, DOI 10.1093/cercor/bhn006; Lundqvist D., 1998, KAROLINSKA DIRECTED; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Righart R, 2006, CEREB CORTEX, V16, P1249, DOI 10.1093/cercor/bhj066; Sabatinelli D, 2001, PSYCHOPHYSIOLOGY, V38, P719, DOI 10.1111/1469-8986.3840719; Sinke CBA, 2010, NEUROIMAGE, V49, P1717, DOI 10.1016/j.neuroimage.2009.09.065	24	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38118	10.1371/journal.pone.0038118	http://dx.doi.org/10.1371/journal.pone.0038118			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768039	Green Submitted, gold, Green Published			2022-12-27	WOS:000305892100010
J	Stellari, FF; Franceschi, V; Capocefalo, A; Ronchei, M; Facchinetti, F; Villetti, G; Donofrio, G				Stellari, Fabio Franco; Franceschi, Valentina; Capocefalo, Antonio; Ronchei, Marcello; Facchinetti, Fabrizio; Villetti, Gino; Donofrio, Gaetano			In Vivo Imaging of Transiently Transgenized Mice with a Bovine Interleukin 8 (CXCL8) Promoter/Luciferase Reporter Construct	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; ALVEOLAR MACROPHAGES; MOLECULAR-CLONING; MESSENGER-RNA; CDNA CLONING; EXPRESSION; NEUTROPHIL; CELLS	One of the most remarkable properties of interleukin 8 (CXCL8/IL-8), a chemokine with known additional functions also in angiogenesis and tissue remodeling, is the variation of its expression levels. In healthy tissues, IL-8 is barely detectable, but it is rapidly induced by several folds in response to proinflammatory cytokines, bacterial or viral products, and cellular stress. Although mouse cells do not bear a clear homologous IL-8 gene, the murine transcriptional apparatus may well be capable of activating or repressing a heterologous IL-8 gene promoter driving a reporter gene. In order to induce a transient transgenic expression, mice were systemically injected with a bovine IL-8 promoter-luciferase construct. Subsequently mice were monitored for luciferase expression in the lung by in vivo bioluminescent image analysis over an extended period of time (up to 60 days). We demonstrate that the bovine IL-8 promoter-luciferase construct is transiently and robustly activated 3-5 hours after LPS and TNF-alpha instillation into the lung, peaking at 35 days after construct delivery. Bovine IL-8 promoter-luciferase activation correlates with white blood cell and neutrophil infiltration into the lung. This study demonstrates that a small experimental rodent model can be utilized for non-invasively monitoring, through a reporter gene system, the activation of an IL-8 promoter region derived from a larger size animal (bovine). This proof of principle study has the potential to be utilized also for studying primate IL-8 promoter regions.	[Stellari, Fabio Franco; Franceschi, Valentina; Capocefalo, Antonio; Ronchei, Marcello; Donofrio, Gaetano] Univ Parma, Dipartimento Salute Anim, Sez Malattie Infett Anim, I-43100 Parma, Italy; [Stellari, Fabio Franco; Facchinetti, Fabrizio; Villetti, Gino] Chiesi Farmaceut SpA, Parma, Italy	University of Parma; Chiesi Pharmaceuticals Inc	Stellari, FF (corresponding author), Univ Parma, Dipartimento Salute Anim, Sez Malattie Infett Anim, I-43100 Parma, Italy.	gaetano.donofrio@unipr.it	Capocefalo, Antonio/O-3027-2017; franceschi, valentina/AAR-5566-2020	Capocefalo, Antonio/0000-0002-4215-4265; Donofrio, Gaetano/0000-0002-8984-0377; franceschi, valentina/0000-0003-3945-2285	Chiesi Farmaceutici; Italian Ministry of University and Scientific Research	Chiesi Farmaceutici(Chiesi Pharmaceuticals Inc); Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR))	This study received financial support from Chiesi Farmaceutici and the Italian Ministry of University and Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bette M, 2003, J COMP NEUROL, V465, P417, DOI 10.1002/cne.10877; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; DEHBI M, 1992, MOL CELL BIOL, V12, P1490, DOI 10.1128/MCB.12.4.1490; DONNELLY SC, 1993, LANCET, V341, P643, DOI 10.1016/0140-6736(93)90416-E; Donofrio G, 2010, BIOL REPROD, V83, P919, DOI 10.1095/biolreprod.110.086074; Doyle TC, 2004, CELL MICROBIOL, V6, P303, DOI 10.1111/j.1462-5822.2004.00378.x; Gesser B, 1996, J LEUKOCYTE BIOL, V59, P407, DOI 10.1002/jlb.59.3.407; Golden JM, 2008, IMMUNOL LETT, V118, P30, DOI 10.1016/j.imlet.2008.02.011; Harada A, 1996, MOL MED TODAY, V2, P482; JORENS PG, 1992, AM J PHYSIOL, V263, pL708, DOI 10.1152/ajplung.1992.263.6.L708; Koay MA, 2002, AM J RESP CELL MOL, V26, P572, DOI 10.1165/ajrcmb.26.5.4748; KUKIELKA GL, 1995, J CLIN INVEST, V95, P89, DOI 10.1172/JCI117680; LATERVEER L, 1995, BLOOD, V85, P2269, DOI 10.1182/blood.V85.8.2269.bloodjournal8582269; LEGASTELOIS I, 1994, GENE, V150, P367, DOI 10.1016/0378-1119(94)90454-5; LIN GF, 1994, J BIOL CHEM, V269, P77; Luscinskas FW, 2000, ANN NY ACAD SCI, V902, P288; Malazdrewich C, 2001, VET PATHOL, V38, P297, DOI 10.1354/vp.38-3-297; MATSUSHIMA K, 1988, J EXP MED, V167, P1883, DOI 10.1084/jem.167.6.1883; Meade KG, 2012, MOL IMMUNOL, V50, P108, DOI 10.1016/j.molimm.2011.12.011; MINNERLY JC, 1995, INFLAMMATION, V19, P313, DOI 10.1007/BF01534390; Moretto N, 2009, AM J PHYSIOL-LUNG C, V296, pL839, DOI 10.1152/ajplung.90570.2008; Morsey MA, 1996, MICROB PATHOGENESIS, V20, P203, DOI 10.1006/mpat.1996.0019; Mukaida N, 2003, AM J PHYSIOL-LUNG C, V284, pL566, DOI 10.1152/ajplung.00233.2002; Murugan V, 2009, EXP LUNG RES, V35, P439, DOI 10.1080/01902140902759290; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Rosenkilde MM, 2004, APMIS, V112, P481, DOI 10.1111/j.1600-0463.2004.apm11207-0808.x; Schmitz ML, 2001, TRENDS BIOCHEM SCI, V26, P186, DOI 10.1016/S0968-0004(00)01753-9; SIMONET WS, 1994, J CLIN INVEST, V94, P1310, DOI 10.1172/JCI117450; Srinivasan S, 2003, CIRC RES, V92, P371, DOI 10.1161/01.RES.0000061714.74668.5C; STANDIFORD TJ, 1990, J CLIN INVEST, V86, P1945, DOI 10.1172/JCI114928; VILLINGER F, 1995, J IMMUNOL, V155, P3946; YOSHIMURA T, 1991, J IMMUNOL, V146, P3483; YOSHIMURA T, 1993, J IMMUNOL, V150, P5025; Zhao XX, 2010, PULM PHARMACOL THER, V23, P22, DOI 10.1016/j.pupt.2009.09.001; Zhao XX, 2009, J IMMUNOL, V182, P3213, DOI 10.4049/jimmunol.0800551	35	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39716	10.1371/journal.pone.0039716	http://dx.doi.org/10.1371/journal.pone.0039716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761878	Green Published, gold, Green Submitted			2022-12-27	WOS:000305826400030
J	Lam, M; Carmichael, AR; Griffiths, HR				Lam, Matt; Carmichael, Amtul R.; Griffiths, Helen R.			An Aqueous Extract of Fagonia cretica Induces DNA Damage, Cell Cycle Arrest and Apoptosis in Breast Cancer Cells via FOXO3a and p53 Expression	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR; SURVIVAL; REPAIR; CHECKPOINTS; PROMOTES; G(1); DIFFERENTIATION; ACTIVATION; PATHWAY	Background: Plants have proved to be an important source of anti-cancer drugs. Here we have investigated the cytotoxic action of an aqueous extract of Fagonia cretica, used widely as a herbal tea-based treatment for breast cancer. Methodology/Principal Findings: Using flow cytometric analysis of cells labeled with cyclin A, annexin V and propidium iodide, we describe a time and dose-dependent arrest of the cell cycle in G0/G1 phase of the cell cycle and apoptosis following extract treatment in MCF-7 (WT-p53) and MDA-MB-231 (mutant-p53) human breast cancer cell lines with a markedly reduced effect on primary human mammary epithelial cells. Analysis of p53 protein expression and of its downstream transcription targets, p21 and BAX, revealed a p53 associated growth arrest within 5 hours of extract treatment and apoptosis within 24 hours. DNA double strand breaks measured as gamma-H2AX were detected early in both MCF-7 and MDA-MB-231 cells. However, loss of cell viability was only partly due to a p53-driven response; as MDA-MB-231 and p53-knockdown MCF-7 cells both underwent cell cycle arrest and death following extract treatment. p53-independent growth arrest and cytotoxicity following DNA damage has been previously ascribed to FOXO3a expression. Here, in MCF-7 and MDA-MB-231 cells, FOXO3a expression was increased significantly within 3 hours of extract treatment and FOXO3 siRNA reduced the extract-induced loss of cell viability in both cell lines. Conclusions/Significance: Our results demonstrate for the first time that an aqueous extract of Fagonia cretica can induce cell cycle arrest and apoptosis via p53-dependent and independent mechanisms, with activation of the DNA damage response. We also show that FOXO3a is required for activity in the absence of p53. Our findings indicate that Fagonia cretica aqueous extract contains potential anti-cancer agents acting either singly or in combination against breast cancer cell proliferation via DNA damage-induced FOXO3a and p53 expression.	[Lam, Matt; Griffiths, Helen R.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Carmichael, Amtul R.] Dudley Grp Hosp, Dudley, England	Aston University	Lam, M (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	h.r.griffiths@aston.ac.uk	Griffiths, Helen R./E-3453-2013	Griffiths, Helen R./0000-0002-2666-2147; Carmichael, Amtul R/0000-0002-3003-8486				Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Al-Mohanna MA, 2001, CARCINOGENESIS, V22, P573, DOI 10.1093/carcin/22.4.573; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Aristotle L, 2004, ANTICANCER RES, V24, P987; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Ben Sahra I, 2008, INT J OBESITY, V32, pS17; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Boehme KA, 2008, P NATL ACAD SCI USA, V105, P7785, DOI 10.1073/pnas.0703423105; Broude EV, 2007, ONCOGENE, V26, P6954, DOI 10.1038/sj.onc.1210516; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Cheng WL, 2011, PLANTA MED, V77, P164, DOI 10.1055/s-0030-1250177; Chiacchiera F, 2010, CELL CYCLE, V9, P1091, DOI 10.4161/cc.9.6.11035; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Fragkos M, 2009, MOL CELL BIOL, V29, P2828, DOI 10.1128/MCB.01830-08; Gao JC, 2012, INT J ONCOL, V40, P1203, DOI 10.3892/ijo.2011.1293; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; Gross DN, 2009, CURR DIABETES REP, V9, P208, DOI 10.1007/s11892-009-0034-5; Habashy HO, 2011, BREAST CANCER RES TR, V129, P11, DOI 10.1007/s10549-010-1161-z; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Herceg Z, 2001, MUTAT RES-FUND MOL M, V477, P97, DOI 10.1016/S0027-5107(01)00111-7; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Ichikawa A, 2008, HUM CELL, V21, P28, DOI 10.1111/j.1749-0774.2008.00048.x; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim SH, 2010, CANCER PREV RES, V3, P718, DOI 10.1158/1940-6207.CAPR-10-0048; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lei H, 2009, MOL CANCER RES, V7, P1294, DOI 10.1158/1541-7786.MCR-08-0531; Lim LY, 2009, BRIT J CANCER, V101, P1606, DOI 10.1038/sj.bjc.6605335; McNamee LM, 2009, GENETICS, V182, P423, DOI 10.1534/genetics.109.102327; McVean M, 2000, CARCINOGENESIS, V21, P633, DOI 10.1093/carcin/21.4.633; Moll UM, 2003, MOL CANCER RES, V1, P1001; Pellegata NS, 1996, P NATL ACAD SCI USA, V93, P15209, DOI 10.1073/pnas.93.26.15209; Said HM, 1969, HAMDARD PHARMACOPOEI; Shah Manish A, 2003, Cancer Chemother Biol Response Modif, V21, P145; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130; Thompson T, 2010, CANCER BIOL THER, V10, P344, DOI 10.4161/cbt.10.4.12366; Tokino T, 2000, CRIT REV ONCOL HEMAT, V33, P1, DOI 10.1016/S1040-8428(99)00051-7; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang JY, 2006, INT J ONCOL, V29, P643; Yin L, 2009, INT J ONCOL, V34, P1691, DOI 10.3892/ijo_00000300; Yoshida K, 2010, CANCER SCI, V101, P831, DOI 10.1111/j.1349-7006.2010.01488.x; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou YY, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1872	46	70	72	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e40152	10.1371/journal.pone.0040152	http://dx.doi.org/10.1371/journal.pone.0040152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761954	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305825800090
J	Rossi, B; Ogden, D; Llano, I; Tan, YP; Marty, A; Collin, T				Rossi, Benedicte; Ogden, David; Llano, Isabel; Tan, Yusuf P.; Marty, Alain; Collin, Thibault			Current and Calcium Responses to Local Activation of Axonal NMDA Receptors in Developing Cerebellar Molecular Layer Interneurons	PLOS ONE			English	Article							PURKINJE CELL SYNAPSES; ENHANCES GABA RELEASE; D-ASPARTATE RECEPTORS; LONG-TERM DEPRESSION; PRESYNAPTIC NMDA; STELLATE CELLS; RAT CEREBELLUM; PARALLEL FIBER; SOMATIC DEPOLARIZATION; SYNAPTIC PLASTICITY	In developing cerebellar molecular layer interneurons (MLIs), NMDA increases spontaneous GABA release. This effect had been attributed to either direct activation of presynaptic NMDA receptors (preNMDARs) or an indirect pathway involving activation of somato-dendritic NMDARs followed by passive spread of somatic depolarization along the axon and activation of axonal voltage dependent Ca2+ channels (VDCCs). Using Ca2+ imaging and electrophysiology, we searched for preNMDARs by uncaging NMDAR agonists either broadly throughout the whole field or locally at specific axonal locations. Releasing either NMDA or glutamate in the presence of NBQX using short laser pulses elicited current transients that were highly sensitive to the location of the spot and restricted to a small number of varicosities. The signal was abolished in the presence of high Mg2+ or by the addition of APV. Similar paradigms yielded restricted Ca2+ transients in interneurons loaded with a Ca2+ indicator. We found that the synaptic effects of NMDA were not inhibited by blocking VDCCs but were impaired in the presence of the ryanodine receptor antagonist dantrolene. Furthermore, in voltage clamped cells, bath applied NMDA triggers Ca2+ elevations and induces neurotransmitter release in the axonal compartment. Our results suggest the existence of preNMDARs in developing MLIs and propose their involvement in the NMDA-evoked increase in GABA release by triggering a Ca2+-induced Ca2+ release process mediated by presynaptic Ca2+ stores. Such a mechanism is likely to exert a crucial role in various forms of Ca2+-mediated synaptic plasticity.	[Rossi, Benedicte; Ogden, David; Llano, Isabel; Tan, Yusuf P.; Marty, Alain; Collin, Thibault] Univ Paris Diderot, Univ Paris Descartes, CNRS UMR 8118, Lab Physiol Cerebrale, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Rossi, B (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	thibault.collin@parisdescartes.fr			Agence Nationale de la Recherche [BLAN08-2_31083]; EU Strep 'Photolysis' [LSHM-CT-2007-037765]; Fondation pour la Recherche Medicale (FRM Team); Medical Research Council [U117512659] Funding Source: researchfish	Agence Nationale de la Recherche(French National Research Agency (ANR)); EU Strep 'Photolysis'; Fondation pour la Recherche Medicale (FRM Team)(Fondation pour la Recherche Medicale); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Agence Nationale de la Recherche (contract BLAN08-2_31083), the EU Strep 'Photolysis' (LSHM-CT-2007-037765), and Fondation pour la Recherche Medicale (FRM Team, A. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hallaq RA, 2002, MOL PHARMACOL, V62, P1119, DOI 10.1124/mol.62.5.1119; Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6; Bidoret C, 2009, P NATL ACAD SCI USA, V106, P14126, DOI 10.1073/pnas.0904284106; Bouhours B, 2011, J NEUROSCI, V31, P5804, DOI 10.1523/JNEUROSCI.5127-10.2011; Bureau I, 1998, J PHYSIOL-LONDON, V509, P817, DOI 10.1111/j.1469-7793.1998.817bm.x; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; Casado M, 2002, NEURON, V33, P123, DOI 10.1016/S0896-6273(01)00568-2; Christie JM, 2008, NEURON, V60, P298, DOI 10.1016/j.neuron.2008.08.028; Christie JM, 2011, NAT NEUROSCI, V14, P62, DOI 10.1038/nn.2718; Christie JM, 2009, J NEUROSCI, V29, P11441, DOI 10.1523/JNEUROSCI.2387-09.2009; Clark BA, 2002, J NEUROSCI, V22, P4428, DOI 10.1523/JNEUROSCI.22-11-04428.2002; Collin T, 2005, J NEUROSCI, V25, P96, DOI 10.1523/JNEUROSCI.3748-04.2005; Corlew R, 2007, J NEUROSCI, V27, P9835, DOI 10.1523/JNEUROSCI.5494-06.2007; Corlew R, 2008, NEUROSCIENTIST, V14, P609, DOI 10.1177/1073858408322675; Duguid I, 2006, CURR OPIN NEUROBIOL, V16, P312, DOI 10.1016/j.conb.2006.05.008; Duguid IC, 2007, J NEUROSCI, V27, P12464, DOI 10.1523/JNEUROSCI.0178-07.2007; Duguid IC, 2004, NAT NEUROSCI, V7, P525, DOI 10.1038/nn1227; Duguid IC, 2009, BIOL NMDA RECEPTOR; Fayyazuddin A, 2000, NEURON, V25, P683, DOI 10.1016/S0896-6273(00)81070-3; Fiszman ML, 2005, J NEUROSCI, V25, P2024, DOI 10.1523/JNEUROSCI.4980-04.2005; Glitsch M, 1996, J PHYSIOL-LONDON, V497, P531, DOI 10.1113/jphysiol.1996.sp021786; Glitsch M, 1999, J NEUROSCI, V19, P511; Glitsch MD, 2008, NEUROSCIENCE, V151, P403, DOI 10.1016/j.neuroscience.2007.10.024; Huang H, 2004, J NEUROSCI, V24, P5659, DOI 10.1523/JNEUROSCI.1338-04.2004; Larsen RS, 2011, NAT NEUROSCI, V14, P338, DOI 10.1038/nn.2750; Lien CC, 2006, NAT NEUROSCI, V9, P372, DOI 10.1038/nn1649; Liu SJ, 2006, J NEUROSCI, V26, P9332, DOI 10.1523/JNEUROSCI.2929-06.2006; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; Llano I, 1997, J PHYSIOL-LONDON, V502, P509, DOI 10.1111/j.1469-7793.1997.509bj.x; Lonchamp E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030180; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P329, DOI 10.1113/jphysiol.1989.sp017724; McDonough SI, 1998, MOL PHARMACOL, V54, P1080, DOI 10.1124/mol.54.6.1080; McGee AW, 2001, J NEUROSCI, V21, P3085, DOI 10.1523/JNEUROSCI.21-09-03085.2001; Molineux ML, 2005, J NEUROSCI, V25, P10863, DOI 10.1523/JNEUROSCI.3436-05.2005; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Pugh JR, 2011, J NEUROSCI, V31, P16550, DOI 10.1523/JNEUROSCI.3910-11.2011; Rancillac A, 2004, J PHYSIOL-LONDON, V554, P707, DOI 10.1113/jphysiol.2003.055871; Rengifo J, 2007, J NEUROSCI, V27, P13813, DOI 10.1523/JNEUROSCI.2069-07.2007; Rodrigo J, 2001, BRAIN RES, V909, P20, DOI 10.1016/S0006-8993(01)02613-0; Rossi B, 2008, J PHYSIOL-LONDON, V586, P5129, DOI 10.1113/jphysiol.2008.159921; Shin JH, 2005, J NEUROPHYSIOL, V94, P4281, DOI 10.1152/jn.00661.2005; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Tan YP, 1999, J PHYSIOL-LONDON, V520, P65, DOI 10.1111/j.1469-7793.1999.00065.x; Trigo FF, 2010, NEURON, V66, P235, DOI 10.1016/j.neuron.2010.03.030; Trigo FF, 2009, J NEUROSCI METH, V180, P9, DOI 10.1016/j.jneumeth.2009.01.032	46	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39983	10.1371/journal.pone.0039983	http://dx.doi.org/10.1371/journal.pone.0039983			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761940	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800084
J	Fattorini, S; Dennis, RLH; Cook, LM				Fattorini, Simone; Dennis, Roger L. H.; Cook, Laurence M.			Use of Cross-Taxon Congruence for Hotspot Identification at a Regional Scale	PLOS ONE			English	Article							SPECIES-AREA RELATIONSHIPS; BIODIVERSITY HOTSPOTS; INDICATOR GROUPS; PRIORITY AREAS; SPATIAL SCALE; CONSERVATION; DIVERSITY; RICHNESS; COMPLEMENTARITY; CONCORDANCE	One of the most debated problems in conservation biology is the use of indicator (surrogate) taxa to predict spatial patterns in other taxa. Cross-taxon congruence in species richness patterns is of paramount importance at regional scales to disclose areas of high conservation value that are significant in a broader biogeographical context but yet placed in the finer, more practical, political context of decision making. We analysed spatial patterns of diversity in six arthropod taxa from the Turkish fauna as a regional case study relevant to global conservation of the Mediterranean basin. Although we found high congruence in cross-taxon comparisons of species richness (0.241<r<0.645), hotspots of different groups show limited overlap, generally less than 50 per cent. The ability of a given taxon to capture diversity of other taxa was usually modest (on average, 50 percent of diversity of non-target taxa), limiting the use of hotspots for effective conservation of non-target groups. Nevertheless, our study demonstrates that a given group may partially stand in for another with similar ecological needs and biogeographical histories. We therefore advocate the use of multiple sets of taxa, chosen so as to be representative of animals with different ecological needs and biogeographical histories.	[Fattorini, Simone] Univ Milano Bicocca, Dept Biosci & Biotechnol, Water Ecol Team, Milan, Italy; [Fattorini, Simone] Univ Acores, Dept Ciencias Agr CITA A, Azorean Biodivers Grp, Pico Da Urze, Angra Do Herois, Portugal; [Dennis, Roger L. H.] Oxford Brookes Univ, Dept Biol & Med Sci, Oxford OX3 0BP, England; [Dennis, Roger L. H.] Staffordshire Univ, Inst Environm Sustainabil & Regenerat, Stoke On Trent ST4 2DE, Staffs, England; [Cook, Laurence M.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Milano-Bicocca; Universidade dos Acores; Oxford Brookes University; Staffordshire University; University of Manchester	Fattorini, S (corresponding author), Univ Milano Bicocca, Dept Biosci & Biotechnol, Water Ecol Team, Milan, Italy.	simone_fattorini@virgilio.it	Fattorini, Simone/AAR-8028-2020; Fattorini, Simone/E-7075-2012	Fattorini, Simone/0000-0002-4517-2135; Fattorini, Simone/0000-0002-4517-2135				Anand M, 2005, CONSERV BIOL, V19, P955, DOI 10.1111/j.1523-1739.2005.00571.x; Atalay I, 2010, J ENVIRON BIOL, V31, P61; Brooks T, 2001, BIOSCIENCE, V51, P613, DOI 10.1641/0006-3568(2001)051[0613:TABFCI]2.0.CO;2; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; Cplak B., 2008, INSECT ECOLOGY CONSE, P135; Dobson AP, 1997, SCIENCE, V275, P550, DOI 10.1126/science.275.5299.550; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Fattorini S, 2009, ANIM CONSERV, V12, P313, DOI 10.1111/j.1469-1795.2009.00251.x; Fattorini S, 2007, BIODIVERS CONSERV, V16, P2531, DOI 10.1007/s10531-006-9029-6; Fattorini S, 2006, CONSERV BIOL, V20, P1169, DOI 10.1111/j.1523-1739.2006.00418.x; Fattorini S, 2011, BIOL CONSERV, V144, P1690, DOI 10.1016/j.biocon.2011.03.002; Flather CH, 1997, ECOL APPL, V7, P531, DOI 10.1890/1051-0761(1997)007[0531:IGICNO]2.0.CO;2; Gaspar C, 2010, BIOL CONSERV, V143, P1287, DOI 10.1016/j.biocon.2010.03.007; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Guclu K, 2004, BIODIVERS CONSERV, V13, P1373, DOI 10.1023/B:BIOC.0000019399.35427.64; Howard PC, 1998, NATURE, V394, P472, DOI 10.1038/28843; Isaac NJB, 2004, DIVERS DISTRIB, V10, P275, DOI 10.1111/j.1366-9516.2004.00092.x; Jetz W, 2009, P ROY SOC B-BIOL SCI, V276, P269, DOI 10.1098/rspb.2008.1005; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Lovell S, 2007, BIOL CONSERV, V139, P113, DOI 10.1016/j.biocon.2007.06.008; Lund MP, 2002, ANIM CONSERV, V5, P163, DOI 10.1017/S1367943002002226; Maes D, 2005, BIODIVERS CONSERV, V14, P1345, DOI 10.1007/s10531-004-9662-x; Martin HG, 2006, P NATL ACAD SCI USA, V103, P10310, DOI 10.1073/pnas.0510605103; Mittermeier R. A., 1999, CHELONIAN CONSERV BI; Moore JL, 2003, CONSERV BIOL, V17, P207, DOI 10.1046/j.1523-1739.2003.01126.x; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pearson DL, 1999, J BIOGEOGR, V26, P1079, DOI 10.1046/j.1365-2699.1999.00337.x; Qian H, 2008, ECOL LETT, V11, P547, DOI 10.1111/j.1461-0248.2008.01168.x; Qian H, 2007, CONSERV BIOL, V21, P937, DOI 10.1111/j.1523-1739.2007.00692.x; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Reyers B, 2000, P ROY SOC B-BIOL SCI, V267, P505, DOI 10.1098/rspb.2000.1029; Rodrigues ASL, 2007, NATURE, V450, pE19, DOI 10.1038/nature06374; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; RYTI RT, 1992, ECOL APPL, V2, P404, DOI 10.2307/1941875; Sekercioglu CH, 2011, BIOL CONSERV, V144, P2752, DOI 10.1016/j.biocon.2011.06.025; Thomas JA, 2005, PHILOS T R SOC B, V360, P339, DOI 10.1098/rstb.2004.1585; Toranza Carolina, 2010, BMC Ecology, V10, P18, DOI 10.1186/1472-6785-10-18; Ulrich W, 2005, BIODIVERS CONSERV, V14, P1977, DOI 10.1007/s10531-004-2526-6; van Jaarsveld AS, 1998, SCIENCE, V279, P2106, DOI 10.1126/science.279.5359.2106; Veech JA, 2000, CONSERV BIOL, V14, P140, DOI 10.1046/j.1523-1739.2000.99064.x; Vessby K, 2002, CONSERV BIOL, V16, P430, DOI 10.1046/j.1523-1739.2002.00198.x; Wang ZH, 2009, P NATL ACAD SCI USA, V106, P13388, DOI 10.1073/pnas.0905030106; Wolters V, 2006, ECOLOGY, V87, P1886, DOI 10.1890/0012-9658(2006)87[1886:RATSRO]2.0.CO;2	48	18	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e40018	10.1371/journal.pone.0040018	http://dx.doi.org/10.1371/journal.pone.0040018			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761947	Green Submitted, Green Published, gold			2022-12-27	WOS:000305808700056
J	Spijkerman, J; Prevaes, SMPJ; van Gils, EJM; Veenhoven, RH; Bruin, JP; Bogaert, D; Wijmenga-Monsuur, AJ; van den Dobbelsteen, GPJM; Sanders, EAM				Spijkerman, Judith; Prevaes, Sabine M. P. J.; van Gils, Elske J. M.; Veenhoven, Reinier H.; Bruin, Jacob P.; Bogaert, Debby; Wijmenga-Monsuur, Alienke J.; van den Dobbelsteen, Germie P. J. M.; Sanders, Elisabeth A. M.			Long-Term Effects of Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis	PLOS ONE			English	Article							ACUTE OTITIS-MEDIA; STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE; INFANT IMMUNIZATION; CO-COLONIZATION; NASAL CARRIAGE; CHILDREN; EPIDEMIOLOGY; IMPACT	Background: Shifts in pneumococcal serotypes following introduction of 7-valent pneumococcal conjugate vaccine (PCV-7) may alter the presence of other bacterial pathogens co-inhabiting the same nasopharyngeal niche. Methodology/Principal Findings: Nasopharyngeal prevalence rates of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis were investigated before, 3 and 4.5 years after introduction of PCV-7 in the national immunisation program in children at 11 and 24 months of age, and parents of 24-month-old children (n approximate to 330/group) using conventional culture methods. Despite a virtual disappearance of PCV-7 serotypes over time, similar overall pneumococcal rates were observed in all age groups, except for a significant reduction in the 11-month-old group (adjusted Odds Ratio after 4.5 years 0.48, 95% Confidence Interval 0.34-0.67). Before, 3 and 4.5 years after PCV-7 implementation, prevalence rates of S. aureus were 5%, 9% and 14% at 11 months of age (3.59, 1.90-6.79) and 20%, 32% and 34% in parents (1.96, 1.36-2.83), but remained similar at 24 months of age, respectively. Prevalence rates of H. influenzae were 46%, 65% and 65% at 11 months (2.22, 1.58-3.13), 52%, 73% and 76% at 24 months of age (2.68, 1.88-3.82) and 23%, 30% and 40% in parents (2.26, 1.58-3.33), respectively. No consistent changes in M. catarrhalis carriage rates were observed over time. Conclusions/Significance: In addition to large shifts in pneumococcal serotypes, persistently higher nasopharyngeal prevalence rates of S. aureus and H. influenzae were observed among young children and their parents after PCV-7 implementation. These findings may have implications for disease incidence and antibiotic treatment in the post-PCV era.	[Spijkerman, Judith; Prevaes, Sabine M. P. J.; van Gils, Elske J. M.; Bogaert, Debby; Sanders, Elisabeth A. M.] Wilhelmina Childrens Hosp, Univ Med Ctr, Dept Pediat Immunol & Infect Dis, Utrecht, Netherlands; [Spijkerman, Judith; Prevaes, Sabine M. P. J.; van Gils, Elske J. M.; Veenhoven, Reinier H.] Spaarne Hosp, Linnaeus Inst, Res Ctr, Hoofddorp, Netherlands; [Bruin, Jacob P.] Reg Publ Hlth Lab, Haarlem, Netherlands; [Wijmenga-Monsuur, Alienke J.; van den Dobbelsteen, Germie P. J. M.] Natl Inst Publ Hlth & Environm, Vaccinol Unit, NL-3720 BA Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Spaarne Hospital; Netherlands National Institute for Public Health & the Environment	Spijkerman, J (corresponding author), Wilhelmina Childrens Hosp, Univ Med Ctr, Dept Pediat Immunol & Infect Dis, Utrecht, Netherlands.	l.sanders@umcutrecht.nl		Bogaert, Debby/0000-0003-2651-7000	Dutch Ministry of Health the Netherlands; Wyeth-Pfizer Vaccines [WS847078/GIPIHP_RG_20101022T1552, 0887X1-4598]; GlaxoSmithKline; Pfizer-Wyeth; Pfizer; Baxter	Dutch Ministry of Health the Netherlands; Wyeth-Pfizer Vaccines; GlaxoSmithKline(GlaxoSmithKline); Pfizer-Wyeth(WyethPfizer); Pfizer(Pfizer); Baxter	This work was supported by the Dutch Ministry of Health the Netherlands. Grant support for pneumococcal surveillance and serotyping was provided by Wyeth-Pfizer Vaccines (grant number WS847078/GIPIHP_RG_20101022T1552, 0887X1-4598). Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: RHV has received research support from GlaxoSmithKline and Pfizer-Wyeth for vaccine studies and consulting fees for GlaxoSmithKline. BD declares to have received consulting fees from Pfizer. EAMS has received unrestricted grant support for research from Pfizer-Wyeth and Baxter, consulting fees for Pfizer-Wyeth and GlaxoSmithKline, lecturing fees from Pfizer-Wyeth and GlaxoSmithKline and grant support for vaccine studies from Pfizer-Wyeth and GlaxoSmithKline. All other authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Cohen R, 2007, CLIN INFECT DIS, V45, P1583, DOI 10.1086/523734; Coker TR, 2010, JAMA-J AM MED ASSOC, V304, P2161, DOI 10.1001/jama.2010.1651; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Dagan R, 2008, LANCET INFECT DIS, V8, P785, DOI 10.1016/S1473-3099(08)70281-0; de Sande-Bruinsma NV, 2008, EMERG INFECT DIS, V14, P1722, DOI 10.3201/eid1411.070467; Enright MC, 1997, J MED MICROBIOL, V46, P360, DOI 10.1099/00222615-46-5-360; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Frederiksen MS, 2007, PEDIATR INFECT DIS J, V26, P398, DOI 10.1097/01.inf.0000261112.53035.4c; Gerber JS, 2009, CLIN INFECT DIS, V49, P65, DOI 10.1086/599348; Grijalva CG, 2008, EXPERT REV VACCINES, V7, P83, DOI 10.1586/14760584.7.1.83; Hill PC, 2010, CLIN INFECT DIS, V50, P1468, DOI 10.1086/652443; Jacoby P, 2011, PEDIATR INFECT DIS J, V30, P480, DOI 10.1097/INF.0b013e318217dc6e; Kayhty H, 2006, EXPERT REV VACCINES, V5, P651, DOI 10.1586/14760584.5.5.651; Kilpi T, 2003, CLIN INFECT DIS, V37, P1155, DOI 10.1086/378744; Kwambana BA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-175; Lebon A, 2008, J CLIN MICROBIOL, V46, P3517, DOI 10.1128/JCM.00641-08; Lee GM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-110; Madhi SA, 2007, J INFECT DIS, V196, P1662, DOI 10.1086/522164; Margolis E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-59; McNally LM, 2006, J INFECT DIS, V194, P385, DOI 10.1086/505076; Murphy TF, 2009, PEDIATR INFECT DIS J, V28, P43, DOI 10.1097/INF.0b013e318184dba2; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Ray GT, 2012, J CLIN MICROBIOL; Regev-Yochay G, 2004, JAMA-J AM MED ASSOC, V292, P716, DOI 10.1001/jama.292.6.716; Regev-Yochay G, 2008, CLIN INFECT DIS, V47, P289, DOI 10.1086/589573; Regev-Yochay G, 2009, CLIN INFECT DIS, V48, P760, DOI 10.1086/597040; Revai K, 2006, PEDIATRICS, V117, P1823, DOI 10.1542/peds.2005-1983; Rose M, 2009, EXPERT REV VACCINES, V8, P1351, DOI [10.1586/erv.09.78, 10.1586/ERV.09.78]; Shrestha NK, 2002, J CLIN MICROBIOL, V40, P2659, DOI 10.1128/JCM.40.7.2659-2661.2002; Spijkerman J, 2011, EMERG INFECT DIS, V17, P584, DOI 10.3201/eid1704.101115; van Gils EJ, 2011, VACCINE; van Gils EJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020229; van Gils EJM, 2009, JAMA-J AM MED ASSOC, V302, P159, DOI 10.1001/jama.2009.975; van Lier E Alies, 2009, Ned Tijdschr Geneeskd, V153, P950; Veenhoven R, 2003, LANCET, V361, P2189, DOI 10.1016/S0140-6736(03)13772-5; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Watt JP, 2004, J CLIN MICROBIOL, V42, P4974, DOI 10.1128/JCM.42.11.4974-4976.2004; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Yildirim I, 2010, VACCINE, V29, P283, DOI 10.1016/j.vaccine.2010.10.032	42	105	105	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39730	10.1371/journal.pone.0039730	http://dx.doi.org/10.1371/journal.pone.0039730			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761879	Green Submitted, gold, Green Published			2022-12-27	WOS:000305781700060
J	O'Dwyer, L; Lamberton, F; Bokde, ALW; Ewers, M; Faluyi, YO; Tanner, C; Mazoyer, B; O'Neill, D; Bartley, M; Collins, R; Coughlan, T; Prvulovic, D; Hampel, H				O'Dwyer, Laurence; Lamberton, Franck; Bokde, Arun L. W.; Ewers, Michael; Faluyi, Yetunde O.; Tanner, Colby; Mazoyer, Bernard; O'Neill, Desmond; Bartley, Mairead; Collins, Ronan; Coughlan, Tara; Prvulovic, David; Hampel, Harald			Sexual Dimorphism in Healthy Aging and Mild Cognitive Impairment: A DTI Study	PLOS ONE			English	Article							WHITE-MATTER MICROSTRUCTURE; HUMAN CORPUS-CALLOSUM; HUMAN CEREBRAL-CORTEX; ALZHEIMERS-DISEASE; GENDER-DIFFERENCES; HUMAN BRAIN; IN-VIVO; HEMISPHERIC-ASYMMETRY; SPATIAL STATISTICS; VASCULAR DEMENTIA	Previous PET and MRI studies have indicated that the degree to which pathology translates into clinical symptoms is strongly dependent on sex with women more likely to express pathology as a diagnosis of AD, whereas men are more resistant to clinical symptoms in the face of the same degree of pathology. Here we use DTI to investigate the difference between male and female white matter tracts in healthy older participants (24 women, 16 men) and participants with mild cognitive impairment (21 women, 12 men). Differences between control and MCI participants were found in fractional anisotropy (FA), radial diffusion (DR), axial diffusion (DA) and mean diffusion (MD). A significant main effect of sex was also reported for FA, MD and DR indices, with male control and male MCI participants having significantly more microstructural damage than their female counterparts. There was no sex by diagnosis interaction. Male MCIs also had significantly less normalised grey matter (GM) volume than female MCIs. However, in terms of absolute brain volume, male controls had significantly more brain volume than female controls. Normalised GM and WM volumes were found to decrease significantly with age with no age by sex interaction. Overall, these data suggest that the same degree of cognitive impairment is associated with greater structural damage in men compared with women.	[O'Dwyer, Laurence; Prvulovic, David; Hampel, Harald] Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany; [Lamberton, Franck; Mazoyer, Bernard] Univ Caen & Paris Descartes, CEA, CNRS, UMR 6232,Ctr Imaging Neurosci & Applicat Pathol, Caen, France; [Bokde, Arun L. W.] Trinity Coll Dublin, Sch Med, Discipline Psychiat, Cognit Syst Grp, Dublin, Ireland; [Bokde, Arun L. W.] Trinity Coll Dublin, TCIN, Dublin, Ireland; [Ewers, Michael] Univ Calif San Francisco, Dept Radiol, VA Med Ctr, San Francisco, CA USA; [Faluyi, Yetunde O.] Addenbrookes Hosp, Liaison Psychiat Serv, Cambridge, England; [Faluyi, Yetunde O.] Cambridgeshire & Peterborough Natl Hlth Serv NHS, Cambridge, England; [Tanner, Colby] Trinity Coll Dublin, Dept Zool, Dublin, Ireland; [Mazoyer, Bernard] Ctr Hosp Univ, Caen, France; [Mazoyer, Bernard] Inst Univ France, Paris, France; [O'Neill, Desmond; Bartley, Mairead; Collins, Ronan; Coughlan, Tara] Trinity Coll Dublin, Dept Med Gerontol, Dublin, Ireland	Goethe University Frankfurt; CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie; Trinity College Dublin; Trinity College Dublin; University of California System; University of California San Francisco; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Trinity College Dublin; CHU de Caen NORMANDIE; Institut Universitaire de France; Trinity College Dublin	O'Dwyer, L (corresponding author), Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany.	larodwyer@gmail.com	mazoyer, bernard m/A-5369-2009; Tanner, Colby/H-4653-2012; Mazoyer, Bernard M/B-6303-2012; O'Dwyer, Laurence/J-1699-2012; Lamberton, Franck/GRO-7517-2022; O'Neill, Desmond/D-1486-2013	mazoyer, bernard m/0000-0003-0970-2837; Mazoyer, Bernard M/0000-0003-0970-2837; Lamberton, Franck/0000-0002-4655-4397; Hampel, Harald/0000-0003-0894-8982; Bokde, Arun/0000-0003-0114-4914; collins, Ronan/0000-0003-0404-8266; O'Neill, Desmond/0000-0002-5542-9897	Science Foundation Ireland (SFI) investigator neuroimaging program [08/IN.1/B1846]; School of Medicine, Goethe University, Frankfurt, Germany; LOEWE (Landesoffensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz) program "Neuronal Coordination Research Focus Frankfurt" (NeFF); Irish Research Council for Science Engineering and Technology (IRCSET)	Science Foundation Ireland (SFI) investigator neuroimaging program(Science Foundation Ireland); School of Medicine, Goethe University, Frankfurt, Germany; LOEWE (Landesoffensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz) program "Neuronal Coordination Research Focus Frankfurt" (NeFF); Irish Research Council for Science Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology)	This work was supported by the Science Foundation Ireland (SFI) investigator neuroimaging program award 08/IN.1/B1846 to HH, and institutional research funds of the School of Medicine, Goethe University, Frankfurt, Germany to HH. This work was also supported by the Neurodegeneration and Alzheimer's disease research grant of the LOEWE (Landesoffensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz) program "Neuronal Coordination Research Focus Frankfurt" (NeFF) to HH and DP. CT was supported by a fellowship from the Irish Research Council for Science Engineering and Technology (IRCSET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; Agosta F, 2010, RADIOLOGY; Allen JS, 2002, AM J PHYS ANTHROPOL, V118, P341, DOI 10.1002/ajpa.10092; Andersen K, 1999, NEUROLOGY, V53, P1992, DOI 10.1212/WNL.53.9.1992; [Anonymous], 2010, R LANG ENV STAT COMP; ARONSON MK, 1991, ARCH INTERN MED, V151, P989, DOI 10.1001/archinte.1991.00400050129024; Austad Steven N, 2006, Gend Med, V3, P79, DOI 10.1016/S1550-8579(06)80198-1; Barnes LL, 2005, ARCH GEN PSYCHIAT, V62, P685, DOI 10.1001/archpsyc.62.6.685; Bartzokis G, 2004, NEUROBIOL AGING, V25, P843, DOI 10.1016/j.neurobiolaging.2003.09.005; Bartzokis G., 2009, NEUROBIOL AGING; Beinhoff U, 2008, J NEUROL, V255, P117, DOI 10.1007/s00415-008-0726-9; Bennett IJ, 2010, HUM BRAIN MAPP, V31, P378, DOI 10.1002/hbm.20872; Bosch B, 2010, NEUROBIOL AGING; BRAYNE C, 1995, BRIT J PSYCHIAT, V167, P255, DOI 10.1192/bjp.167.2.255; Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Chou KH, 2011, NEUROIMAGE, V54, P725, DOI 10.1016/j.neuroimage.2010.07.010; Concha L, 2006, NEUROIMAGE, V32, P1090, DOI 10.1016/j.neuroimage.2006.04.187; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Davis SW, 2012, CEREB CORTEX, V22, P232, DOI 10.1093/cercor/bhr123; Dennis NA, 2007, NEUROPSYCHOLOGIA, V45, P3157, DOI 10.1016/j.neuropsychologia.2007.07.003; Douaud G, NEUROIMAGE IN PRESS; ENGLUND E, 1990, HISTOPATHOLOGY, V16, P433; Englund E, 1998, DEMENT GERIATR COGN, V9, P6, DOI 10.1159/000051183; Fan Y, 2007, NEUROIMAGE, V36, P1189, DOI 10.1016/j.neuroimage.2007.04.009; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; Gao S, 1998, ARCH GEN PSYCHIAT, V55, P809, DOI 10.1001/archpsyc.55.9.809; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Graves AB, 1996, BRIT J PSYCHIAT, V169, P86, DOI 10.1192/bjp.169.1.86; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; Huster RJ, 2009, HUM BRAIN MAPP, V30, P383, DOI 10.1002/hbm.20509; Jalbert JJ, 2008, EPIDEMIOL REV, V30, P15, DOI 10.1093/epirev/mxn008; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; JERNIGAN TL, 1991, BIOL PSYCHIAT, V29, P68, DOI 10.1016/0006-3223(91)90211-4; JORM AF, 1987, ACTA PSYCHIAT SCAND, V76, P465, DOI 10.1111/j.1600-0447.1987.tb02906.x; KATZMAN R, 1993, NEUROLOGY, V43, P13, DOI 10.1212/WNL.43.1_Part_1.13; Kawachi T, 2002, J NEUROL SCI, V199, P79, DOI 10.1016/S0022-510X(02)00112-0; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lemaitre H, 2005, NEUROIMAGE, V26, P900, DOI 10.1016/j.neuroimage.2005.02.042; Liu F, 2010, BRAIN RES, V1343, P37, DOI 10.1016/j.brainres.2010.04.064; Liu Y, 2009, NEUROBIOL AGING; Lloret A, 2008, FREE RADICAL BIO MED, V44, P2019, DOI 10.1016/j.freeradbiomed.2008.02.017; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MOLSA PK, 1982, ACTA NEUROL SCAND, V65, P541; Morcom AM, 2003, BRAIN, V126, P213, DOI 10.1093/brain/awg020; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Dwyer L, 2011, J ALZHEIMERS DIS; O'Dwyer L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021745; Oh JS, 2007, NEUROIMAGE, V36, P606, DOI 10.1016/j.neuroimage.2007.03.020; PAYKEL ES, 1994, ARCH GEN PSYCHIAT, V51, P325; Perneczky R, 2007, INT J GERIATR PSYCH, V22, P1135, DOI 10.1002/gps.1803; Perneczky R, 2007, J NEUROL, V254, P1395, DOI 10.1007/s00415-007-0558-z; Perneczky R, 2009, J ALZHEIMERS DIS, V17, P855, DOI 10.3233/JAD-2009-1117; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Pievani M, 2010, HUM BRAIN MAPP; Piras F, 2010, HUM BRAIN MAPP; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Rabinowicz T, 2002, J NEUROPATH EXP NEUR, V61, P46, DOI 10.1093/jnen/61.1.46; Rabinowicz T, 1999, J CHILD NEUROL, V14, P98, DOI 10.1177/088307389901400207; Rametti G, 2011, J PSYCHIATR RES, V45, P199, DOI 10.1016/j.jpsychires.2010.05.006; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Raz N, 2004, NEUROBIOL AGING, V25, P377, DOI 10.1016/S0197-4580(03)00118-0; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Richards M, 2003, J CLIN EXP NEUROPSYC, V25, P614, DOI 10.1076/jcen.25.5.614.14581; Salat DH, 2010, NEUROBIOL AGING, V31, P244, DOI 10.1016/j.neurobiolaging.2008.03.013; Shan ZY, 2005, J GERONTOL A-BIOL, V60, P165, DOI 10.1093/gerona/60.2.165; Shin YW, 2005, NEUROREPORT, V16, P795, DOI 10.1097/00001756-200505310-00003; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sowell ER, 2004, NEUROSCIENTIST, V10, P372, DOI 10.1177/1073858404263960; Staff RT, 2004, BRAIN, V127, P1191, DOI 10.1093/brain/awh144; Stern Y, 2005, CEREB CORTEX, V15, P394, DOI 10.1093/cercor/bhh142; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Stricker NH, 2009, NEUROIMAGE, V45, P10, DOI 10.1016/j.neuroimage.2008.11.027; Sullivan EV, 2001, NEUROREPORT, V12, P99, DOI 10.1097/00001756-200101220-00027; Szeszko PR, 2003, NEUROREPORT, V14, P2469, DOI 10.1097/00001756-200312190-00035; Tanabe JL, 1997, AM J NEURORADIOL, V18, P115; Teipel SJ, 2007, NEUROIMAGE, V34, P985, DOI 10.1016/j.neuroimage.2006.07.047; Thomalla G, 2005, J NEUROL NEUROSUR PS, V76, P266, DOI 10.1136/jnnp.2004.046375; Thomas B, 2005, BRAIN, V128, P2562, DOI 10.1093/brain/awh600; Turgeon JL, 2006, ENDOCR REV, V27, P575, DOI 10.1210/er.2005-0020; Wahlund LO, 1996, MAGN RESON IMAGING, V14, P601, DOI 10.1016/0730-725X(96)00098-7; Wang Z, 2010, HUM BRAIN MAPP; Westerhausen R, 2004, COGNITIVE BRAIN RES, V21, P418, DOI 10.1016/j.cogbrainres.2004.07.002; Wu YC, 2011, NEUROIMAGE, V54, P1840, DOI 10.1016/j.neuroimage.2010.09.067; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhuang L, 2010, NEUROIMAGE, V53, P16, DOI 10.1016/j.neuroimage.2010.05.068	99	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e37021	10.1371/journal.pone.0037021	http://dx.doi.org/10.1371/journal.pone.0037021			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768288	Green Published, gold, Green Submitted			2022-12-27	WOS:000305966500001
J	Beeharry, N; Rattner, JB; Bellacosa, A; Smith, MR; Yen, TJ				Beeharry, Neil; Rattner, Jerome B.; Bellacosa, Alfonso; Smith, Mitchell R.; Yen, Timothy J.			Dose Dependent Effects on Cell Cycle Checkpoints and DNA Repair by Bendamustine	PLOS ONE			English	Article							HYDROCHLORIDE; APOPTOSIS; EFFICACY	Bendamustine (BDM) is an active chemotherapeutic agent approved in the U. S. for treating chronic lymphocytic leukemia and non-Hodgkin lymphoma. Its chemical structure suggests it may have alkylator and anti-metabolite activities; however the precise mechanism of action is not well understood. Here we report the concentration-dependent effects of BDM on cell cycle, DNA damage, checkpoint response and cell death in HeLa cells. Low concentrations of BDM transiently arrested cells in G2, while a 4-fold higher concentration arrested cells in S phase. DNA damage at 50, but not 200 mu M, was efficiently repaired after 48 h treatment, suggesting a difference in DNA repair efficiency at the two concentrations. Indeed, perturbing base-excision repair sensitized cells to lower concentrations of BDM. Timelapse studies of the checkpoint response to BDM showed that inhibiting Chk1 caused both the S- and G2-arrested cells to prematurely enter mitosis. However, whereas the cells arrested in G2 (low dose BDM) entered mitosis, segregated their chromosomes and divided normally, the S-phase arrested cells (high dose BDM) exhibited a highly aberrant mitosis, whereby EM images showed highly fragmented chromosomes. The vast majority of these cells died without ever exiting mitosis. Inhibiting the Chk1-dependent DNA damage checkpoint accelerated the time of killing by BDM. Our studies suggest that BDM may affect different biological processes depending on drug concentration. Sensitizing cells to killing by BDM can be achieved by inhibiting base-excision repair or disrupting the DNA damage checkpoint pathway.	[Beeharry, Neil; Bellacosa, Alfonso; Smith, Mitchell R.; Yen, Timothy J.] Fox Chase Canc Ctr, Div Basic Sci, Philadelphia, PA 19111 USA; [Rattner, Jerome B.] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB, Canada	Fox Chase Cancer Center; University of Calgary	Beeharry, N (corresponding author), Fox Chase Canc Ctr, Div Basic Sci, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Neil.Beeharry@fccc.edu; Timothy.Yen@fccc.edu		Yen, Tim/0000-0003-2159-0997; Smith, Mitchell/0000-0003-1428-8765	Commonwealth of Pennsylvania; Greenberg Fund; NATIONAL CANCER INSTITUTE [R01CA078412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086877] Funding Source: NIH RePORTER	Commonwealth of Pennsylvania; Greenberg Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the following sources: R01-GM86877, an appropriation from the Commonwealth of Pennsylvania, and the Greenberg Fund (to TJY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellacosa A, 2001, CELL DEATH DIFFER, V8, P1076, DOI 10.1038/sj.cdd.4400948; Blasina A, 2008, MOL CANCER THER, V7, P2394, DOI 10.1158/1535-7163.MCT-07-2391; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Feng J, 2006, CHROMOSOMA, V115, P320, DOI 10.1007/s00412-006-0049-5; Gaul L, 2008, J CANCER RES CLIN, V134, P245, DOI 10.1007/s00432-007-0278-x; Heider A, 2001, ANTI-CANCER DRUG, V12, P725, DOI 10.1097/00001813-200110000-00003; Henegariu O, 2001, CYTOMETRY, V43, P101, DOI 10.1002/1097-0320(20010201)43:2<101::AID-CYTO1024>3.0.CO;2-8; JOHNSON RT, 1970, NATURE, V226, P717, DOI 10.1038/226717a0; Konstantinov SM, 2002, J CANCER RES CLIN, V128, P271, DOI 10.1007/s00432-002-0331-8; Leoni LM, 2008, CLIN CANCER RES, V14, P309, DOI 10.1158/1078-0432.CCR-07-1061; Leoni LM, 2011, SEMIN HEMATOL, V48, pS12, DOI 10.1053/j.seminhematol.2011.03.003; LIUZZI M, 1985, J BIOL CHEM, V260, P5252; Ogura M, 2011, CANCER SCI, V102, P1687, DOI 10.1111/j.1349-7006.2011.01994.x; Ogura M, 2010, CANCER SCI, V101, P2054, DOI 10.1111/j.1349-7006.2010.01633.x; Owen JS, 2010, CANCER CHEMOTH PHARM, V66, P1039, DOI 10.1007/s00280-010-1254-8; RATTNER JB, 1992, J CELL SCI, V103, P1039; Roue G, 2008, CLIN CANCER RES, V14, P6907, DOI 10.1158/1078-0432.CCR-08-0388; Sarkaria JN, 1999, CANCER RES, V59, P4375; Schwanen C, 2002, LEUKEMIA, V16, P2096, DOI 10.1038/sj.leu.2402651; Stevens JB, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-20; Strumberg D, 1996, ANTI-CANCER DRUG, V7, P415, DOI 10.1097/00001813-199606000-00007	22	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40342	10.1371/journal.pone.0040342	http://dx.doi.org/10.1371/journal.pone.0040342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768280	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100254
J	Billeskov, R; Elvang, TT; Andersen, PL; Dietrich, J				Billeskov, Rolf; Elvang, Tara T.; Andersen, Peter L.; Dietrich, Jes			The HyVac4 Subunit Vaccine Efficiently Boosts BCG-Primed Anti-Mycobacterial Protective Immunity	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; TUBERCULOSIS INFECTION; T-CELLS; ANTIGEN 85B; ENVIRONMENTAL MYCOBACTERIA; FUSION PROTEIN; MICE; CORRELATE; EFFICACY; ESAT-6	Background: The current vaccine against tuberculosis (TB), BCG, has failed to control TB worldwide and the protective efficacy is moreover limited to 10-15 years. A vaccine that could efficiently boost a BCG-induced immune response and thus prolong protective immunity would therefore have a significant impact on the global TB-burden. Methods/Findings: In the present study we show that the fusion protein HyVac4 (H4), consisting of the mycobacterial antigens Ag85B and TB10.4, given in the adjuvant IC31 (R) or DDA/MPL effectively boosted and prolonged immunity induced by BCG, leading to improved protection against infection with virulent M. tuberculosis (M.tb). Increased protection correlated with an increased percentage of TB10.4 specific IFN gamma/TNF alpha/IL-2 or TNF alpha/IL-2 producing CD4 T cells at the site of infection. Moreover, this vaccine strategy did not compromise the use of ESAT-6 as an accurate correlate of disease development/vaccine efficacy. Indeed both CD4 and CD8 ESAT-6 specific T cells showed significant correlation with bacterial levels. Conclusions/Significance: H4-IC31 (R) can efficiently boost BCG-primed immunity leading to an increased protective anti-M.tb immune response dominated by IFN gamma/TNF alpha/IL-2 or TNF alpha/IL2 producing CD4 T cells. H4 in the CD4 T cell inducing adjuvant IC31 (R) is presently in clinical trials.	[Billeskov, Rolf; Elvang, Tara T.; Andersen, Peter L.; Dietrich, Jes] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark	Statens Serum Institut	Billeskov, R (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark.	ROB@ssi.dk; JDI@ssi.dk		Andersen, Peter/0000-0002-5869-2551; Billeskov, Rolf/0000-0003-4533-7304	Danish Graduate School of Immunology	Danish Graduate School of Immunology	TE and RB are recipients of PhD scholarships from the Danish Graduate School of Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005930; ANDERSEN P, 1991, INFECT IMMUN, V59, P1558, DOI 10.1128/IAI.59.4.1558-1563.1991; ANDERSEN P, 1994, INFECT IMMUN, V62, P2536, DOI 10.1128/IAI.62.6.2536-2544.1994; Bakir M, 2008, ANN INTERN MED, V149, P777, DOI 10.7326/0003-4819-149-11-200812020-00248; Billeskov R, 2007, J IMMUNOL, V179, P3973, DOI 10.4049/jimmunol.179.6.3973; Billeskov R, 2010, EUR J IMMUNOL, V40, P1342, DOI 10.1002/eji.200939830; Bold TD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002063; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; Brennan MJ, 2012, VACCINE, V30, P2811, DOI 10.1016/j.vaccine.2012.02.036; Brooks JV, 2001, INFECT IMMUN, V69, P2714, DOI 10.1128/IAI.69.4.2714-2717.2001; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Dey B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023360; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Dietrich J, 2006, J IMMUNOL, V177, P6353, DOI 10.4049/jimmunol.177.9.6353; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Dourado I, 2003, INT J TUBERC LUNG D, V7, P399; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Flaherty DK, 2006, J LEUKOCYTE BIOL, V80, P1262, DOI 10.1189/jlb.0606407; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; HUBBARD RD, 1992, CLIN EXP IMMUNOL, V87, P94; Junqueira-Kipnis AP, 2004, INFECT IMMUN, V72, P570, DOI 10.1128/IAI.72.1.570-575.2004; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kipnis A, 2005, INFECT IMMUN, V73, P7759, DOI 10.1128/IAI.73.11.7759-7764.2005; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Lienhardt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010508; Lillebaek T, 2002, J INFECT DIS, V185, P401, DOI 10.1086/338342; Mazurek GH, 2001, JAMA-J AM MED ASSOC, V286, P1740, DOI 10.1001/jama.286.14.1740; Meier T, 2005, EUR J CLIN MICROBIOL, V24, P529, DOI 10.1007/s10096-005-1377-8; Olsen AW, 2001, INFECT IMMUN, V69, P2773, DOI 10.1128/IAI.69.5.2773-2778.2001; Olsen AW, 2004, INFECT IMMUN, V72, P6148, DOI 10.1128/IAI.72.10.6148-6150.2004; Ottenhoff TH, 2010, HUM VACCINES, V6, P1007, DOI 10.4161/hv.6.12.13143; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Rogerson BJ, 2006, IMMUNOLOGY, V118, P195, DOI 10.1111/j.1365-2567.2006.02355.x; Roth AE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c671; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Skeiky YAW, 2010, VACCINE, V28, P1084, DOI 10.1016/j.vaccine.2009.10.114; Sterne JAC, 1998, INT J TUBERC LUNG D, V2, P200; Tchilian EZ, 2009, INFECT IMMUN, V77, P622, DOI 10.1128/IAI.00685-08; Thom M, 2008, TUBERCULOSIS, V88, P324, DOI 10.1016/j.tube.2007.12.002; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; WHO, 2010, GLOB TUB CONTR SUIRV	44	73	79	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39909	10.1371/journal.pone.0039909	http://dx.doi.org/10.1371/journal.pone.0039909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768165	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100134
J	Schramm, F; Kern, A; Barthel, C; Nadaud, S; Meyer, N; Jaulhac, B; Boulanger, N				Schramm, Frederic; Kern, Aurelie; Barthel, Cathy; Nadaud, Sophie; Meyer, Nicolas; Jaulhac, Benoit; Boulanger, Nathalie			Microarray Analyses of Inflammation Response of Human Dermal Fibroblasts to Different Strains of Borrelia burgdorferi Sensu Stricto	PLOS ONE			English	Article							ACRODERMATITIS CHRONICA ATROPHICANS; LYME-DISEASE SPIROCHETE; HUMAN DENDRITIC CELLS; GENE-EXPRESSION; MATRIX METALLOPROTEINASES; ERYTHEMA MIGRANS; SKIN; SALIVA; TICKS; OSPC	In Lymeborreliosis, the skin is the key site of bacterial inoculation by the infected tick, and of cutaneous manifestations, erythema migrans and acrodermatitis chronica atrophicans. We explored the role of fibroblasts, the resident cells of the dermis, in the development of the disease. Using microarray experiments, we compared the inflammation of fibroblasts induced by three strains of Borrelia burgdorferi sensu stricto isolated from different environments and stages of Lyme disease: N40 (tick), Pbre (erythema migrans) and 1408 (acrodermatitis chronica atrophicans). The three strains exhibited a similar profile of inflammation with strong induction of chemokines (CXCL1 and IL-8) and IL-6 cytokine mainly involved in the chemoattraction of of immune cells. Molecules such as TNF-alpha and NF-kappa B factors, metalloproteinases (MMP-1, -3 and -12) and superoxide dismutase (SOD2), also described in inflammatory and cellular events, were up-regulated. In addition, we showed that tick salivary gland extracts induce a cytotoxic effect on fibroblasts and that OspC, essential in the transmission of Borrelia to the vertebrate host, was not responsible for the secretion of inflammatory molecules by fibroblasts. Tick saliva components could facilitate the early transmission of the disease to the site of injury creating a feeding pit. Later in the development of the disease, Borrelia would intensively multiply in the skin and further disseminate to distant organs.	[Schramm, Frederic; Kern, Aurelie; Barthel, Cathy; Jaulhac, Benoit; Boulanger, Nathalie] Univ Strasbourg, Fac Med & Pharm, EA 4438, Strasbourg, France; [Nadaud, Sophie] UPMC Univ Paris 06, INSERM, UMR S 956, Paris, France; [Meyer, Nicolas] Univ Strasbourg, Fac Med, Lab Biostat & Informat Med, Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schramm, F (corresponding author), Univ Strasbourg, Fac Med & Pharm, EA 4438, Strasbourg, France.	nboulanger@unistra.fr	Nadaud, Sophie/GXV-0505-2022; Nadaud, Sophie/A-7063-2013; Schramm, Frédéric/M-8166-2015; Boulanger, Nathalie/ABF-1353-2020; Schramm, Frédéric/R-9953-2019	Nadaud, Sophie/0000-0002-1452-6009; Schramm, Frédéric/0000-0002-6889-515X; Schramm, Frédéric/0000-0002-6889-515X	Conseil Regional d'Alsace and Direction Generale de l'Armement [2009.60.053]; Pasteur Institute [PTR 309]	Conseil Regional d'Alsace and Direction Generale de l'Armement(Region Grand-Est); Pasteur Institute	Aurelie Kern was supported by grant 2009.60.053 from the Conseil Regional d'Alsace and Direction Generale de l'Armement. Part of the research project was supported by the Pasteur Institute, PTR 309 (Programme Transversal de Recherche, Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERER E, 1991, AM J DERMATOPATH, V13, P334, DOI 10.1097/00000372-199108000-00003; Antonara S, 2010, INFECT IMMUN, V78, P4723, DOI 10.1128/IAI.00464-10; BARTHOLD SW, 1991, AM J PATHOL, V139, P263; Behera AK, 2004, INFECT IMMUN, V72, P2864, DOI 10.1128/IAI.72.5.2864-2871.2004; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Castelli E, 2008, AM J DERMATOPATH, V30, P241, DOI 10.1097/DAD.0b013e3181676b60; CINCO M, 1994, FEMS MICROBIOL LETT, V122, P187, DOI 10.1111/j.1574-6968.1994.tb07163.x; Deban L, 2011, CELL TISSUE RES, V343, P237, DOI 10.1007/s00441-010-1018-0; DEKONING J, 1995, J CUTAN PATHOL, V22, P23; DEKONING J, 1993, CLIN DERMATOL, V11, P377, DOI 10.1016/0738-081X(93)90093-R; Diegmann J, 2005, EUR J CANCER, V41, P1794, DOI 10.1016/j.ejca.2005.05.005; Ebnet K, 1997, J IMMUNOL, V158, P3285; Fikrig E, 2000, J IMMUNOL, V164, P5344, DOI 10.4049/jimmunol.164.10.5344; Fikrig E, 2006, MICROBES INFECT, V8, P1390, DOI 10.1016/j.micinf.2005.12.022; Filgueira L, 1996, J IMMUNOL, V157, P2998; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Gronski TJ, 1997, J BIOL CHEM, V272, P12189, DOI 10.1074/jbc.272.18.12189; Hajnicka V, 2011, INT J PARASITOL, V41, P213, DOI 10.1016/j.ijpara.2010.09.005; Hartiala P, 2007, J LEUKOCYTE BIOL, V82, P33, DOI 10.1189/jlb.1106709; Hovius JWR, 2008, PLOS MED, V5, P202, DOI 10.1371/journal.pmed.0050043; Hovius JWR, 2009, J INVEST DERMATOL, V129, P2337, DOI 10.1038/jid.2009.202; Hu LT, 2001, ARTHRITIS RHEUM-US, V44, P1401, DOI 10.1002/1529-0131(200106)44:6<1401::AID-ART234>3.0.CO;2-S; JONES NC, 1994, MICROB PATHOGENESIS, V16, P261, DOI 10.1006/mpat.1994.1027; Kern A, 2011, VECTOR-BORNE ZOONOT, V11, P1343, DOI 10.1089/vbz.2010.0197; LaFrance ME, 2011, INFECT IMMUN, V79, P3249, DOI 10.1128/IAI.05122-11; Liang FT, 2004, AM J PATHOL, V165, P977, DOI 10.1016/S0002-9440(10)63359-7; Lin B, 2001, J INFECT DIS, V184, P174, DOI 10.1086/322000; Marchal C, 2011, INFECT IMMUN, V79, P774, DOI 10.1128/IAI.00482-10; Marchal CMP, 2009, J INVEST DERMATOL, V129, P2515, DOI 10.1038/jid.2009.73; Mullegger RR, 2008, AM J CLIN DERMATOL, V9, P355, DOI 10.2165/0128071-200809060-00002; Mullegger RR, 2007, INFECT IMMUN, V75, P4621, DOI 10.1128/IAI.00263-07; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Pancewicz S A, 2001, Med Sci Monit, V7, P1230; Parsonage G, 2005, TRENDS IMMUNOL, V26, P150, DOI 10.1016/j.it.2004.11.014; Petzke MM, 2009, J IMMUNOL, V183, P5279, DOI 10.4049/jimmunol.0901390; Picken RN, 1998, J INVEST DERMATOL, V110, P211, DOI 10.1046/j.1523-1747.1998.00130.x; Piesman J, 2004, PARASITOLOGY, V129, pS191, DOI 10.1017/S0031182003004694; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Saalbach A, 2007, J IMMUNOL, V178, P4966, DOI 10.4049/jimmunol.178.8.4966; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Salazar JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000444; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Skaleric U, 2000, EUR J ORAL SCI, V108, P130, DOI 10.1034/j.1600-0722.2000.90771.x; Smetanick MT, 2010, CUTIS, V85, P247; Sorrell JM, 2009, INT REV CEL MOL BIO, V276, P161, DOI 10.1016/S1937-6448(09)76004-6; Sorrell JM, 2004, J CELL SCI, V117, P667, DOI 10.1242/jcs.01005; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Strle Franc, 2009, V37, P51, DOI 10.1159/000213070; Suhonen J, 2003, SCAND J IMMUNOL, V58, P67, DOI 10.1046/j.1365-3083.2003.01284.x; Suhonen J, 2000, J INFECT DIS, V181, P195, DOI 10.1086/315195; Talkington J, 1999, INFECT IMMUN, V67, P1107, DOI 10.1128/IAI.67.3.1107-1115.1999; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VANDAM AP, 1993, CLIN INFECT DIS, V17, P708, DOI 10.1093/clinids/17.4.708; Wu J, 2011, INFECT IMMUN, V79, P1338, DOI 10.1128/IAI.01188-10	59	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40046	10.1371/journal.pone.0040046	http://dx.doi.org/10.1371/journal.pone.0040046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768217	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100189
J	Zhou, B; Wang, JL; Ressom, HW				Zhou, Bin; Wang, Jinlian; Ressom, Habtom W.			MetaboSearch: Tool for Mass-Based Metabolite Identification Using Multiple Databases	PLOS ONE			English	Article								Searching metabolites against databases according to their masses is often the first step in metabolite identification for a mass spectrometry-based untargeted metabolomics study. Major metabolite databases include Human Metabolome DataBase (HMDB), Madison Metabolomics Consortium Database (MMCD), Metlin, and LIPID MAPS. Since each one of these databases covers only a fraction of the metabolome, integration of the search results from these databases is expected to yield a more comprehensive coverage. However, the manual combination of multiple search results is generally difficult when identification of hundreds of metabolites is desired. We have implemented a web-based software tool that enables simultaneous mass-based search against the four major databases, and the integration of the results. In addition, more complete chemical identifier information for the metabolites is retrieved by cross-referencing multiple databases. The search results are merged based on IUPAC International Chemical Identifier (InChI) keys. Besides a simple list of m/z values, the software can accept the ion annotation information as input for enhanced metabolite identification. The performance of the software is demonstrated on mass spectrometry data acquired in both positive and negative ionization modes. Compared with search results from individual databases, MetaboSearch provides better coverage of the metabolome and more complete chemical identifier information. Availability: The software tool is available at http://omics.georgetown.edu/MetaboSearch.html.	[Zhou, Bin; Wang, Jinlian; Ressom, Habtom W.] Georgetown Univ, Dept Oncol, Washington, DC 20057 USA	Georgetown University	Zhou, B (corresponding author), Georgetown Univ, Dept Oncol, Washington, DC 20057 USA.	hwr@georgetown.edu	Zhou, Bin/N-3454-2014		National Cancer Institute [R21CA153176]; NATIONAL CANCER INSTITUTE [R21CA153176] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute Grant R21CA153176. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown M, 2011, BIOINFORMATICS; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Draper J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-227; Scheltema RA, 2009, BIOANALYSIS, V1, P1551, DOI [10.4155/bio.09.146, 10.4155/BIO.09.146]; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Tautenhahn R, 2007, LECT NOTES COMPUT SC, V4414, P371; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wohlgemuth G, 2010, BIOINFORMATICS, V26, P2647, DOI 10.1093/bioinformatics/btq476	11	11	12	6	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40096	10.1371/journal.pone.0040096	http://dx.doi.org/10.1371/journal.pone.0040096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768229	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100201
J	Zhao, Y; Kang, L; Gao, S; Gao, X; Xin, WW; Wang, JL				Zhao, Yao; Kang, Lin; Gao, Shan; Gao, Xing; Xin, Wenwen; Wang, Jinglin			Peg Precipitation Coupled with Chromatography Is a New and Sufficient Method for the Purification of Botulinum Neurotoxin Type B	PLOS ONE			English	Article							TOXIN TYPE-B; HYDROPHOBIC INTERACTION CHROMATOGRAPHY; CLOSTRIDIUM-BOTULINUM; CERVICAL DYSTONIA; SEROTYPE-B; EFFICACY; SAFETY; EXPRESSION	Clostridium botulinum neurotoxins are used to treat a variety of neuro-muscular disorders, as well as in cosmetology. The increased demand requires efficient methods for the production and purification of these toxins. In this study, a new purification process was developed for purifying type B neurotoxin. The kinetics of C. botulinum strain growth and neurotoxin production were determined for maximum yield of toxin. The neurotoxin was purified by polyethylene glycol (PEG) precipitation and chromatography. Based on design of full factorial experiment, 20% (w/v) PEG-6000, 4 degrees C, pH 5.0 and 0.3 M NaCl were optimal conditions to obtain a high recovery rate of 87% for the type B neurotoxin complex, as indicated by a purification factor of 61.5 fold. Furthermore, residual bacterial cells, impurity proteins and some nucleic acids were removed by PEG precipitation. The following purification of neurotoxin was accomplished by two chromatography techniques using Sephacryl (TM) S-100 and phenyl HP columns. The neurotoxin was recovered with an overall yield of 21.5% and the purification factor increased to 216.7 fold. In addition, a mouse bioassay determined the purified neurotoxin complex possessed a specific toxicity (LD50) of 4.095 ng/kg.	[Zhao, Yao; Kang, Lin; Gao, Shan; Gao, Xing; Xin, Wenwen; Wang, Jinglin] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Zhao, Y (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	wangjl6481@hotmail.com			National Key Technology R&D Program of China [2008BAK41B04]	National Key Technology R&D Program of China(National Key Technology R&D Program)	Funding for this work was provided by National Key Technology R&D Program of China 2008BAK41B04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimitsu H, 2003, INFECT IMMUN, V71, P1599, DOI 10.1128/IAI.71.3.1599-1603.2003; ATHA DH, 1981, J BIOL CHEM, V256, P2108; Boldt GE, 2006, ORG LETT, V8, P1729, DOI 10.1021/ol0603211; BONVENTRE PF, 1959, APPL MICROBIOL, V7, P374, DOI 10.1128/AEM.7.6.374-377.1959; Bradshaw M, 2004, ANAEROBE, V10, P321, DOI 10.1016/j.anaerobe.2004.07.001; Brashear A, 1999, NEUROLOGY, V53, P1439, DOI 10.1212/WNL.53.7.1439; Brin MF, 1999, NEUROLOGY, V53, P1431, DOI 10.1212/WNL.53.7.1431; Fogle JL, 2006, J CHROMATOGR A, V1121, P209, DOI 10.1016/j.chroma.2006.04.015; Gao YL, 2010, HUM VACCINES, V6, P462, DOI 10.4161/hv.6.6.11709; JANKOVIC J, 1991, NEW ENGL J MED, V324, P1186, DOI 10.1056/nejm199104253241707; Johnson EA, 2001, TOXICON, V39, P1703, DOI 10.1016/S0041-0101(01)00157-X; Karber C, 1937, BIOL STANDARDIZATION, P37; Kato Y, 2004, J CHROMATOGR A, V1036, P45, DOI 10.1016/j.chroma.2004.02.009; KITAMURA M, 1968, BIOCHIM BIOPHYS ACTA, V168, P207, DOI 10.1016/0005-2795(68)90144-X; Lew MF, 2000, NEUROLOGY, V55, pS29; Lew MF, 1997, NEUROLOGY, V49, P701, DOI 10.1212/WNL.49.3.701; Ohye D, 1967, COMBINED EFFECTS TEM, P217; Pearce LB, 1997, TOXICON, V35, P1373, DOI 10.1016/S0041-0101(96)00180-8; Prabakaran S, 2001, TOXICON, V39, P1515, DOI 10.1016/S0041-0101(01)00124-6; SAKAGUCHI G, 1982, PHARMACOL THERAPEUT, V19, P165, DOI 10.1016/0163-7258(82)90061-4; Scarlatos A, 2005, J FOOD SCI, V70, pR121, DOI 10.1111/j.1365-2621.2005.tb11525.x; Schantz E, 1978, J ASS OFF ANAL CHEM, P61; Shukla AA, 2002, BIOTECHNOL PROGR, V18, P556, DOI 10.1021/bp020038a; Sugii S., 1977, Journal of Food Safety, V1, P53, DOI 10.1111/j.1745-4565.1977.tb00259.x; TOWNSEND CT, 1954, FOOD RES, V19, P536; WAGMAN J, 1954, ARCH BIOCHEM BIOPHYS, V50, P104, DOI 10.1016/0003-9861(54)90013-2; Yang GH, 2004, TOXICON, V44, P19, DOI 10.1016/j.toxicon.2004.03.016	27	5	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39670	10.1371/journal.pone.0039670	http://dx.doi.org/10.1371/journal.pone.0039670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761863	Green Published, Green Submitted, gold			2022-12-27	WOS:000305826400024
J	Nieto, K; Weghofer, M; Sehr, P; Ritter, M; Sedlmeier, S; Karanam, B; Seitz, H; Muller, M; Kellner, M; Horer, M; Michaelis, U; Roden, RBS; Gissmann, L; Kleinschmidt, JA				Nieto, Karen; Weghofer, Margit; Sehr, Peter; Ritter, Mirko; Sedlmeier, Sebastian; Karanam, Balasubramanyam; Seitz, Hanna; Mueller, Martin; Kellner, Markus; Hoerer, Markus; Michaelis, Uwe; Roden, Richard B. S.; Gissmann, Lutz; Kleinschmidt, Juergen A.			Development of AAVLP(HPV16/31L2) Particles as Broadly Protective HPV Vaccine Candidate	PLOS ONE			English	Article							MINOR CAPSID PROTEIN; HUMAN-PAPILLOMAVIRUS VACCINES; ADENOASSOCIATED VIRUS TYPE-2; CROSS-NEUTRALIZING EPITOPE; HEPARAN-SULFATE; N-TERMINUS; L2; VECTORS; ANTIBODIES; GENERATION	The human papillomavirus (HPV) minor capsid protein L2 is a promising candidate for a broadly protective HPV vaccine yet the titers obtained in most experimental systems are rather low. Here we examine the potential of empty AAV2 particles (AAVLPs), assembled from VP3 alone, for display of L2 epitopes to enhance their immunogenicity. Insertion of a neutralizing epitope (amino acids 17-36) from L2 of HPV16 and HPV31 into VP3 at positions 587 and 453, respectively, permitted assembly into empty AAV particles (AAVLP(HPV16/31L2)). Intramuscularly vaccination of mice and rabbits with AAVLP(HPV16/31L2)s in montanide adjuvant, induced high titers of HPV16 L2 antibodies as measured by ELISA. Sera obtained from animals vaccinated with the AAVLP(HPV16/31L2) s neutralized infections with several HPV types in a pseudovirion infection assay. Lyophilized AAVLP(HPV16/31L2) particles retained their immunogenicity upon reconstitution. Interestingly, vaccination of animals that were pre-immunized with AAV2 - simulating the high prevalence of AAV2 antibodies in the population - even increased cross neutralization against HPV31, 45 and 58 types. Finally, passive transfer of rabbit antisera directed against AAVLP(HPV16/31L2) s protected naive mice from vaginal challenge with HPV16 pseudovirions. In conclusion, AAVLP(HPV16/31L2) particles have the potential as a broadly protective vaccine candidate regardless of prior exposure to AAV.	[Nieto, Karen; Seitz, Hanna; Mueller, Martin; Gissmann, Lutz; Kleinschmidt, Juergen A.] German Canc Res Ctr, Res Program Infect & Canc, D-6900 Heidelberg, Germany; [Weghofer, Margit; Ritter, Mirko; Sedlmeier, Sebastian; Kellner, Markus; Hoerer, Markus; Michaelis, Uwe] MediGene AG, Planegg Martinsried, Germany; [Sehr, Peter] European Mol Biol Lab, Chem Biol Core Facil, Heidelberg, Germany; [Karanam, Balasubramanyam; Roden, Richard B. S.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA	Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL); Johns Hopkins University	Nieto, K (corresponding author), German Canc Res Ctr, Res Program Infect & Canc, D-6900 Heidelberg, Germany.	k.nieto@dkfz.de	Gissmann, Lutz/H-4688-2011	Sehr, Peter/0000-0002-4348-5066	PHS [P50 CA098252, RC2 CA148499]; Deutsche Krebshilfe [109653]; NATIONAL CANCER INSTITUTE [P50CA098252, RC2CA148499] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); Deutsche Krebshilfe(Deutsche Krebshilfe); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	RBSR and BK were funded by grants from the PHS (P50 CA098252 and RC2 CA148499), JAK and MM were supported by the Deutsche Krebshilfe, grant 109653. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphs HH, 2008, P NATL ACAD SCI USA, V105, P5850, DOI 10.1073/pnas.0800868105; Aucoin Marc G., 2007, V388, P281; Bartel M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00204; Boucas J, 2009, J GENE MED, V11, P1103, DOI 10.1002/jgm.1392; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Calcedo R, 2011, CLIN VACCINE IMMUNOL, V18, P1586, DOI 10.1128/CVI.05107-11; Campo MS, 1997, VIROLOGY, V234, P261, DOI 10.1006/viro.1997.8649; Culp TD, 2006, J VIROL, V80, P8940, DOI 10.1128/JVI.00724-06; Day PM, 2008, J VIROL, V82, P4638, DOI 10.1128/JVI.00143-08; Day PM, 2008, J VIROL, V82, P12565, DOI 10.1128/JVI.01631-08; Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07; Gambhira R, 2007, J VIROL, V81, P11585, DOI 10.1128/JVI.01577-07; Girod A, 1999, NAT MED, V5, P1052, DOI 10.1038/12491; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Guyard-Dangremont V, 1999, PROTEIN SCI, V8, P2392; Jagu S, 2009, JNCI-J NATL CANCER I, V101, P782, DOI 10.1093/jnci/djp106; Johnson KM, 2009, J VIROL, V83, P2067, DOI 10.1128/JVI.02190-08; Kawana K, 1999, J VIROL, V73, P6188, DOI 10.1128/JVI.73.7.6188-6190.1999; Kondo K, 2007, VIROLOGY, V358, P266, DOI 10.1016/j.virol.2006.08.037; Kuck D, 2006, J VIROL, V80, P2621, DOI 10.1128/JVI.80.6.2621-2630.2006; Mckee AS, 2007, IMMUNITY, V27, P687, DOI 10.1016/j.immuni.2007.11.003; Michelfelder S, 2009, ADV GENET, V67, P29, DOI 10.1016/S0065-2660(09)67002-4; Mitchell AM, 2010, CURR GENE THER, V10, P319; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Muzyczka N, 2005, HUM GENE THER, V16, P408, DOI 10.1089/hum.2005.16.408; Naumer M, 2011, HUM GENE THER; Pastrana DV, 2005, VIROLOGY, V337, P365, DOI 10.1016/j.virol.2005.04.011; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Roden RBS, 2000, VIROLOGY, V270, P254, DOI 10.1006/viro.2000.0272; Rubio I, 2011, VIROLOGY, V409, P348, DOI 10.1016/j.virol.2010.10.017; Rubio I, 2009, VACCINE, V27, P1949, DOI 10.1016/j.vaccine.2009.01.102; Schellenbacher C, 2009, J VIROL, V83, P10085, DOI 10.1128/JVI.01088-09; Slupetzky K, 2007, VACCINE, V25, P2001, DOI 10.1016/j.vaccine.2006.11.049; Sonntag F, 2011, J VIROL, V85, P12686, DOI 10.1128/JVI.05359-11; Sonntag F, 2010, P NATL ACAD SCI USA, V107, P10220, DOI 10.1073/pnas.1001673107; Wu P, 2000, J VIROL, V74, P8635, DOI 10.1128/JVI.74.18.8635-8647.2000; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899; Zur Hausen H., 2006, INFECT CAUSING HUMAN, P1	41	59	63	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39741	10.1371/journal.pone.0039741	http://dx.doi.org/10.1371/journal.pone.0039741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761884	Green Published, gold, Green Submitted			2022-12-27	WOS:000305825800064
J	Skerry, C; Harper, J; Klunk, M; Bishai, WR; Jain, SK				Skerry, Ciaran; Harper, Jamie; Klunk, Mariah; Bishai, William R.; Jain, Sanjay K.			Adjunctive TNF Inhibition with Standard Treatment Enhances Bacterial Clearance in a Murine Model of Necrotic TB Granulomas	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MYCOBACTERIUM-TUBERCULOSIS; BCG INFECTION; FACTOR-ALPHA; MOUSE MODEL; MICE; INFLIXIMAB; SAFETY	Background: It has been hypothesized that early host-responses during TB treatment may paradoxically promote survival of persistent bacteria. We therefore evaluated whether adjunctive inhibition of tumor necrosis factor alpha (TNF-alpha)-a key cytokine in host responses against TB-could hasten bacterial clearance in a mouse strain that develops necrotic lesions in response to Mycobacterium tuberculosis infection. Methodology/Principal Findings: Six weeks after an aerosol infection, C3HeB/FeJ mice received standard TB treatment with or without adjunctive TNF inhibition (etanercept for the initial six weeks). Functional TNF-alpha levels and lung pathology were found to be reduced in the mice receiving etanercept. Compared to standard TB treatment, the addition of etanercept resulted in a significantly lower pulmonary bacterial burden, corresponding to the phase when a significant proportion of bacteria are multiplying slowly (p<0.0233). Finally, only 10.5% of mice receiving adjunctive etanercept versus 27.8% receiving standard TB treatment alone relapsed. Conclusion: This study provides proof-of-principle that modulation of TNF-alpha activity can hasten bacterial clearance during standard multi-drug TB treatment. Oral agents that modulate TNF-alpha should therefore be considered as adjunct therapies for shortening TB treatments. However, due to concerns of reactivation disease, additional studies need to be performed before TNF-alpha inhibitors are used for TB treatment in humans.	[Skerry, Ciaran; Harper, Jamie; Klunk, Mariah; Bishai, William R.; Jain, Sanjay K.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA; [Harper, Jamie; Klunk, Mariah; Jain, Sanjay K.] Johns Hopkins Univ, Sch Med, Ctr Infect & Inflammat Imaging Res, Baltimore, MD USA; [Skerry, Ciaran; Harper, Jamie; Klunk, Mariah; Jain, Sanjay K.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Bishai, William R.] KwaZulu Natal Res Inst TB & HIV, Durban, South Africa; [Bishai, William R.] Howard Hughes Med Inst, Chevy Chase, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute	Skerry, C (corresponding author), Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA.	sjain5@jhmi.edu	Skerry, Ciaran/AAX-8291-2020	Jain, Sanjay/0000-0001-9620-7070	National Institutes of Health [OD006492]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health's Director's New Innovator Award OD006492 (S.K.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Bekker LG, 1998, J INFECT DIS, V178, P580, DOI 10.1086/517479; Blackmore TK, 2008, CLIN INFECT DIS, V47, pE83, DOI 10.1086/592695; Caccamo N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005528; COX JH, 1988, APMIS, V96, P927, DOI 10.1111/j.1699-0463.1988.tb00964.x; Dye C, 2008, J R SOC INTERFACE, V5, P653, DOI 10.1098/rsif.2007.1138; ESPEVIK T, 1986, J IMMUNOL METHODS, V95, P99, DOI 10.1016/0022-1759(86)90322-4; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; HAAPANEN JH, 1959, AM REV RESPIR DIS, V80, P1; Harper J, 2012, J INFECT DIS, V205, P595, DOI 10.1093/infdis/jir786; Hu YL, 2007, J INVEST DERM SYMP P, V12, P50, DOI 10.1038/sj.jidsymp.5650030; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Koo MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017091; Kremer JM, 2009, ARTHRITIS RHEUM-US, V60, P1895, DOI 10.1002/art.24567; Lories RJU, 2007, ARTHRITIS RHEUM, V56, P489, DOI 10.1002/art.22372; Maiga M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030749; MMWR, 2004, MMWR-MORBID MORTAL W, V53, P683; Paige C, 2010, CELL MICROBIOL, V12, P301, DOI 10.1111/j.1462-5822.2009.01424.x; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Plessner HL, 2007, J INFECT DIS, V195, P1643, DOI 10.1086/517519; Senaldi G, 1996, J IMMUNOL, V157, P5022; Subbian S, 2011, AM J PATHOL, V179, P289, DOI 10.1016/j.ajpath.2011.03.039; Sweeny DJ, 2010, DRUG METAB DISPOS, V38, P1166, DOI 10.1124/dmd.110.032151; Wallis RS, 2009, CLIN INFECT DIS, V48, P1429, DOI 10.1086/598504; Wallis RS, 2004, AIDS, V18, P257, DOI 10.1097/00002030-200401230-00015; Wallis RS, 2005, CLIN INFECT DIS, V41, P201, DOI 10.1086/430914; Wallis RS, 2004, CLIN INFECT DIS, V38, P1261, DOI 10.1086/383317	28	59	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39680	10.1371/journal.pone.0039680	http://dx.doi.org/10.1371/journal.pone.0039680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761866	Green Submitted, Green Published, gold			2022-12-27	WOS:000305825800060
J	Yanpallewar, SU; Barrick, CA; Buckley, H; Becker, J; Tessarollo, L				Yanpallewar, Sudhirkumar U.; Barrick, Colleen A.; Buckley, Hannah; Becker, Jodi; Tessarollo, Lino			Deletion of the BDNF Truncated Receptor TrkB.T1 Delays Disease Onset in a Mouse Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							MOTOR-NEURON DEGENERATION; NEUROTROPHIN RECEPTOR; IN-VIVO; TRANSGENIC MICE; NERVOUS-SYSTEM; SPINAL-CORDS; FULL-LENGTH; CELL-DEATH; EXPRESSION; GENE	Brain Derived Neurotrophic Factor (BDNF) exerts strong pro-survival effects on developing and injured motoneurons. However, in clinical trials, BDNF has failed to benefit patients with amyotrophic lateral sclerosis (ALS). To date, the cause of this failure remains unclear. Motoneurons express the TrkB kinase receptor but also high levels of the truncated TrkB. T1 receptor isoform. Thus, we investigated whether the presence of this receptor may affect the response of diseased motoneurons to endogenous BDNF. We deleted TrkB. T1 in the hSOD1(G93A) ALS mouse model and evaluated the impact of this mutation on motoneuron death, muscle weakness and disease progression. We found that TrkB. T1 deletion significantly slowed the onset of motor neuron degeneration. Moreover, it delayed the development of muscle weakness by 33 days. Although the life span of the animals was not affected we observed an overall improvement in the neurological score at the late stage of the disease. To investigate the effectiveness of strategies aimed at bypassing the TrkB. T1 limit to BDNF signaling we treated SOD1 mutant mice with the adenosine A2A receptor agonist CGS21680, which can activate motoneuron TrkB receptor signaling independent of neurotrophins. We found that CGS21680 treatment slowed the onset of motor neuron degeneration and muscle weakness similarly to TrkB. T1 removal. Together, our data provide evidence that endogenous TrkB. T1 limits motoneuron responsiveness to BDNF in vivo and suggest that new strategies such as Trk receptor transactivation may be used for therapeutic intervention in ALS or other neurodegenerative disorders.	[Yanpallewar, Sudhirkumar U.; Barrick, Colleen A.; Buckley, Hannah; Becker, Jodi; Tessarollo, Lino] NCI, Neural Dev Sect, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yanpallewar, SU (corresponding author), NCI, Neural Dev Sect, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21701 USA.	tessarol@mail.nih.gov			National Cancer Institute, Center for Cancer Research, NIH; NATIONAL CANCER INSTITUTE [ZIABC010390] Funding Source: NIH RePORTER	National Cancer Institute, Center for Cancer Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendoerfer KL, 1994, J NEUROSCIENCE; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P6639, DOI 10.1167/iovs.10-5431; Beers DR, 2001, J NEUROCHEM, V79, P499, DOI 10.1046/j.1471-4159.2001.00582.x; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Carim-Todd L, 2009, J NEUROSCI, V29, P678, DOI 10.1523/JNEUROSCI.5060-08.2009; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Cheng L, 2002, J NEUROSCI, V22, P3977, DOI 10.1523/JNEUROSCI.22-10-03977.2002; Chou SY, 2005, J NEUROCHEM, V93, P310, DOI 10.1111/j.1471-4159.2005.03029.x; Colombo E, 2012, J EXP MED, V209, P521, DOI 10.1084/jem.20110698; Damiano M, 2006, J NEUROCHEM, V96, P1349, DOI 10.1111/j.1471-4159.2006.03619.x; De Wit J, 2006, J NEUROSCI, V26, P1516, DOI 10.1523/JNEUROSCI.4543-05.2006; Domeniconi M, 2010, HISTOL HISTOPATHOL, V25, P1207, DOI 10.14670/HH-25.1207; Dorsey SG, 2006, NEURON, V51, P21, DOI 10.1016/j.neuron.2006.06.009; ESCANDON E, 1994, J NEUROSCI, V14, P2054; Ferrer I, 1999, J NEUROPATH EXP NEUR, V58, P729, DOI 10.1097/00005072-199907000-00007; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Gomes JR, 2012, J NEUROSCI, V32, P4610, DOI 10.1523/JNEUROSCI.0374-12.2012; Guatteo E, 2007, NEUROBIOL DIS, V28, P90, DOI 10.1016/j.nbd.2007.07.002; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hemendinger R, 2005, EXP NEUROL, V196, P235, DOI 10.1016/j.expneurol.2005.07.025; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Kasarskis EJ, 1999, NEUROLOGY, V52, P1427; Kawamoto Y, 1998, J NEUROPATH EXP NEUR, V57, P822, DOI 10.1097/00005072-199809000-00003; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; Kust BM, 2002, EXP NEUROL, V177, P419, DOI 10.1006/exnr.2002.8011; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; MITSUMOTO H, 1994, SCIENCE, V265, P1107, DOI 10.1126/science.8066451; Mutoh T, 2000, NEUROCHEM RES, V25, P239, DOI 10.1023/A:1007575504321; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Palko ME, 1999, J NEUROSCI, V19, P775; Rose CR, 2003, NATURE, V426, P74, DOI 10.1038/nature01983; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Saarelainen T, 2000, MOL CELL NEUROSCI, V16, P87, DOI 10.1006/mcne.2000.0863; Sebastiao AM, 2009, BRIT J PHARMACOL, V158, P15, DOI 10.1111/j.1476-5381.2009.00157.x; SEEBURGER JL, 1993, BRAIN RES, V621, P111, DOI 10.1016/0006-8993(93)90304-6; Sendtner M, 1996, NEUROCHEM RES, V21, P831, DOI 10.1007/BF02532307; Tessarollo L, 1998, CYTOKINE GROWTH F R, V9, P125, DOI 10.1016/S1359-6101(98)00003-3; Tessarollo L, 1997, P NATL ACAD SCI USA, V94, P14776, DOI 10.1073/pnas.94.26.14776; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; Vidaurre OG, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.143; Wang YM, 2007, J NEUROSCI, V27, P304, DOI 10.1523/JNEUROSCI.4433-06.2007; Wiese S, 2007, P NATL ACAD SCI USA, V104, P17210, DOI 10.1073/pnas.0705267104; Zhai JB, 2011, HUM MOL GENET, V20, P4116, DOI 10.1093/hmg/ddr335	48	56	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39946	10.1371/journal.pone.0039946	http://dx.doi.org/10.1371/journal.pone.0039946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761934	Green Published, gold, Green Submitted			2022-12-27	WOS:000305825800080
J	Dalleau, G; Leroyer, P; Beaulieu, M; Verkindt, C; Rivard, CH; Allard, P				Dalleau, Georges; Leroyer, Pierre; Beaulieu, Marlene; Verkindt, Chantal; Rivard, Charles-Hilaire; Allard, Paul			Pelvis Morphology, Trunk Posture and Standing Imbalance and Their Relations to the Cobb Angle in Moderate and Severe Untreated AIS	PLOS ONE			English	Article							ADOLESCENT IDIOPATHIC SCOLIOSIS; NATURAL-HISTORY; CURVE TYPE; BALANCE; CHILDREN; ROTATION; STATURE; GROWTH; GIRLS	Adolescent idiopathic scoliosis (AIS) is the most common form of scoliosis and usually affects young girls. Studies mostly describe the differences between scoliotic and non-scoliotic girls and focus primarily on a single set of parameters derived from spinal and pelvis morphology, posture or standing imbalance. No study addressed all these three biomechanical aspects simultaneously in pre-braced AIS girls of different scoliosis severity but with similar curve type and their interaction with scoliosis progression. The first objective of this study was to test if there are differences in these parameters between pre-braced AIS girls with a right thoracic scoliosis of moderate (less than 27 degrees) and severe (more than 27 degrees) deformity. The second objective was to identify which of these parameters are related to the Cobb angle progression either individually or in combination of thereof. Forty-five scoliotic girls, randomly selected by an orthopedic surgeon from the hospital scoliosis clinic, participated in this study. Parameters related to pelvis morphology, pelvis orientation, trunk posture and quiet standing balance were measured. Generally moderate pre-brace idiopathic scoliosis patients displayed lower values than the severe group characterized by a Cobb angle greater than 27 degrees. Only pelvis morphology and trunk posture were statistically different between the groups while pelvis orientation and standing imbalance were similar in both groups. Statistically significant Pearson coefficients of correlation between individual parameters and Cobb angle ranged between 0.32 and 0.53. Collectively trunk posture, pelvis morphology and standing balance parameters are correlated with Cobb angle at 0.82. The results suggest that spinal deformity progression is not only a question of trunk morphology distortion by itself but is also related to pelvis asymmetrical bone growth and standing neuromuscular imbalance.	[Dalleau, Georges; Leroyer, Pierre; Verkindt, Chantal] Univ Reunion, CURAPS DIMPS, Fac Sci Homme & Environm, Le Tampon, France; [Dalleau, Georges; Beaulieu, Marlene; Allard, Paul] Univ Montreal, Dept Kinesiol, Montreal, PQ, Canada; [Rivard, Charles-Hilaire] St Justine Hosp, Dept Orthoped Surg, Montreal, PQ, Canada; [Beaulieu, Marlene; Rivard, Charles-Hilaire; Allard, Paul] St Justine Hosp, Res Ctr, Human Movement Lab, Montreal, PQ, Canada	University of La Reunion; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Dalleau, G (corresponding author), Univ Reunion, CURAPS DIMPS, Fac Sci Homme & Environm, Le Tampon, France.	georges.dalleau@univ-reunion.fr	Allard, Paul/ABA-3257-2021		Natural Science and Engineering Council of Canada (NSERC)	Natural Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Partial funding for this project was obtained from Natural Science and Engineering Council of Canada (NSERC). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard P, 2004, AM J PHYS MED REHAB, V83, P689, DOI 10.1097/01.PHM.0000137344.95784.15; AMENDT LE, 1990, PHYS THER, V70, P108, DOI 10.1093/ptj/70.2.108; ARCHER IA, 1985, J BONE JOINT SURG BR, V67, P185, DOI 10.1302/0301-620X.67B2.3980522; Beaulieu M, 2009, EUR SPINE J, V18, P38, DOI 10.1007/s00586-008-0831-6; BELLEFLEUR C, 1994, ANN CHIR, V48, P723; BUNNELL WP, 1986, SPINE, V11, P773, DOI 10.1097/00007632-198610000-00003; BURWELL RG, 1981, ANN ROY COLL SURG, V63, P209; Dalleau G, 2011, EUR SPINE J, V20, P123, DOI 10.1007/s00586-010-1554-z; Dalleau G, 2007, EUR SPINE J, V16, P1593, DOI 10.1007/s00586-007-0404-0; DICKSON RA, 1982, J BONE JOINT SURG BR, V64, P385; Gauchard GC, 2001, SPINE, V26, P1052, DOI 10.1097/00007632-200105010-00014; Goldberg CJ, 2001, SPINE, V26, P42, DOI 10.1097/00007632-200101010-00009; Gum JL, 2007, EUR SPINE J, V16, P1579, DOI 10.1007/s00586-007-0400-4; Haumont T, 2011, SPINE, V36, pE847, DOI 10.1097/BRS.0b013e3181ff5837; HOLLAND BS, 1988, PSYCHOL BULL, V104, P145, DOI 10.1037/0033-2909.104.1.145; ISU T, 1992, CHILD NERV SYST, V8, P97, DOI 10.1007/BF00298449; LeBlanc R, 1997, SPINE, V22, P2532, DOI 10.1097/00007632-199711010-00013; LONSTEIN JE, 1984, J BONE JOINT SURG AM, V66A, P1061, DOI 10.2106/00004623-198466070-00013; Lowe TG, 2000, J BONE JOINT SURG AM, V82A, P1157, DOI 10.2106/00004623-200008000-00014; Mac-Thiong JM, 2003, SPINE, V28, P1404, DOI 10.1097/01.BRS.0000067118.60199.D1; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Masso PD, 2000, SPINE, V25, P457, DOI 10.1097/00007632-200002150-00011; McIlroy WE, 1997, CLIN BIOMECH, V12, P66, DOI 10.1016/S0268-0033(96)00040-X; MORRISSY RT, 1990, J BONE JOINT SURG AM, V72A, P320, DOI 10.2106/00004623-199072030-00002; Mubarak SL, 1985, ORTHOP T, V9, P113; Nault ML, 2002, SPINE, V27, P1911, DOI 10.1097/00007632-200209010-00018; NICOLOPOULOS KS, 1985, J BONE JOINT SURG BR, V67, P594, DOI 10.1302/0301-620X.67B4.4030857; Pasha S, 2010, SPINE, V35, pE820, DOI 10.1097/BRS.0b013e3181e6856d; Ramirez L, 2006, IEEE T INF TECHNOL B, V10, P84, DOI 10.1109/TITB.2005.855526; SAHLSTRAND T, 1979, ACTA ORTHOP SCAND, V50, P275, DOI 10.3109/17453677908989768; Samuelsson L, 1997, ACTA ORTHOP SCAND, V68, P273, DOI 10.3109/17453679708996700; Simoneau M, 2006, EXP BRAIN RES, V170, P576, DOI 10.1007/s00221-005-0246-0; Simoneau M, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-68; Stylianides GA, 2011, EUROPEAN SP IN PRESS; THULBOURNE T, 1976, J BONE JOINT SURG BR, V58, P64, DOI 10.1302/0301-620X.58B1.1270497; Weinstein S., 1994, PEDIAT SPINE PRINCIP, P463; Wong HK, 2010, INDIAN J ORTHOP, V44, P9, DOI 10.4103/0019-5413.58601; Zabjek KF, 2005, CLIN BIOMECH, V20, P483, DOI 10.1016/j.clinbiomech.2005.01.003	38	22	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e36755	10.1371/journal.pone.0036755	http://dx.doi.org/10.1371/journal.pone.0036755			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792155	gold, Green Published			2022-12-27	WOS:000306436300002
J	Tesfay, L; Huhn, AJ; Hatcher, H; Torti, FM; Torti, SV				Tesfay, Lia; Huhn, Annissa J.; Hatcher, Heather; Torti, Frank M.; Torti, Suzy V.			Ferritin Blocks Inhibitory Effects of Two-Chain High Molecular Weight Kininogen (HKa) on Adhesion and Survival Signaling in Endothelial Cells	PLOS ONE			English	Article							H-FERRITIN; ANGIOGENESIS; PROLIFERATION; BRADYKININ; RECEPTOR; KININOSTATIN; MACROPHAGES; EXPRESSION; MIGRATION; PATHWAYS	Angiogenesis is tightly regulated through complex crosstalk between pro- and anti-angiogenic signals. High molecular weight kininogen (HK) is an endogenous protein that is proteolytically cleaved in plasma and on endothelial cell surfaces to HKa, an anti-angiogenic protein. Ferritin binds to HKa and blocks its anti-angiogenic activity. Here, we explore mechanisms underlying the cytoprotective effect of ferritin in endothelial cells exposed to HKa. We observe that ferritin promotes adhesion and survival of HKa-treated cells and restores key survival and adhesion signaling pathways mediated by Erk, Akt, FAK and paxillin. We further elucidate structural motifs of both HKa and ferritin that are required for effects on endothelial cells. We identify an histidine-glycine-lysine (HGK) -rich antiproliferative region within domain 5 of HK as the target of ferritin, and demonstrate that both ferritin subunits of the H and L type regulate HKa activity. We further demonstrate that ferritin reduces binding of HKa to endothelial cells and restores the association of uPAR with alpha 5 beta 1 integrin. We propose that ferritin blocks the anti-angiogenic activity of HKa by reducing binding of HKa to UPAR and interfering with anti-adhesive and anti-proliferative signaling of HKa.	[Tesfay, Lia; Hatcher, Heather; Torti, Frank M.] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC USA; [Huhn, Annissa J.; Torti, Suzy V.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA; [Torti, Frank M.; Torti, Suzy V.] Wake Forest Sch Med, Ctr Comprehens Canc, Winston Salem, NC USA	Wake Forest University; Wake Forest University; Wake Forest University	Tesfay, L (corresponding author), Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT USA.	storti@uchc.edu		Huhn, Annissa/0000-0002-8543-2229	National Institutes of Health [R01DK71892, R37 DK42421]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071892, R01DK042421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (R01DK71892; R37 DK42421). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; CADENA RAD, 1991, TRENDS PHARMACOL SCI, V12, P272, DOI 10.1016/0165-6147(91)90569-E; Cao DJ, 2004, CIRC RES, V94, P1227, DOI 10.1161/01.RES.0000126567.75232.46; Chen TT, 2005, J EXP MED, V202, P955, DOI 10.1084/jem.20042433; Coffman LG, 2008, AM J PHYSIOL-LUNG C, V294, pL505, DOI 10.1152/ajplung.00347.2007; Coffman LG, 2009, P NATL ACAD SCI USA, V106, P570, DOI 10.1073/pnas.0812010106; Cohen LA, 2010, BLOOD, V116, P1574, DOI 10.1182/blood-2009-11-253815; Colman RW, 2006, CURR PHARM DESIGN, V12, P2599, DOI 10.2174/138161206777698710; Colman RW, 2000, BLOOD, V95, P543, DOI 10.1182/blood.V95.2.543; Cyr M, 2001, AM J PHYSIOL-HEART C, V281, pH275, DOI 10.1152/ajpheart.2001.281.1.H275; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; FARGION S, 1991, CURR STUD HEMATOL BL, V58, P164; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; Gray CP, 2001, INT J CANCER, V92, P843, DOI 10.1002/ijc.1269; Guo YL, 2005, J THROMB HAEMOST, V3, P670, DOI 10.1111/j.1538-7836.2005.01218.x; Guo YL, 2003, J CELL BIOCHEM, V89, P622, DOI 10.1002/jcb.10536; Guo YL, 2001, ARTERIOSCL THROM VAS, V21, P1427, DOI 10.1161/hq0901.095277; HASAN AAK, 1995, J BIOL CHEM, V270, P19256, DOI 10.1074/jbc.270.33.19256; Hood JD, 2003, J CELL BIOL, V162, P933, DOI 10.1083/jcb.200304105; Kawasaki M, 2003, J BIOL CHEM, V278, P49301, DOI 10.1074/jbc.M308790200; Kelly RJ, 2010, CANCER J, V16, P635, DOI 10.1097/PPO.0b013e3181ff37cf; Lalmanach G, 2010, BIOCHIMIE, V92, P1568, DOI 10.1016/j.biochi.2010.03.011; LaRusch GA, 2010, BLOOD, V115, P5111, DOI 10.1182/blood-2009-08-236430; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; Leimberg MJ, 2008, J CELL BIOCHEM, V103, P1211, DOI 10.1002/jcb.21499; Li JY, 2009, DEV CELL, V16, P35, DOI 10.1016/j.devcel.2008.12.002; Li L, 2010, P NATL ACAD SCI USA, V107, P3505, DOI 10.1073/pnas.0913192107; Liu YC, 2008, AM J PHYSIOL-CELL PH, V295, pC257, DOI 10.1152/ajpcell.00569.2007; MATZNER Y, 1979, BRIT J HAEMATOL, V42, P345, DOI 10.1111/j.1365-2141.1979.tb01142.x; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; McCrae KR, 2005, CURR CANCER DRUG TAR, V5, P519, DOI 10.2174/156800905774574039; Parthasarathy N, 2002, BIOCHEM J, V365, P279, DOI 10.1042/BJ20011637; Peerschke EIB, 2007, IMMUNOBIOLOGY, V212, P333, DOI 10.1016/j.imbio.2006.11.011; Rajappa M, 2010, ADV CLIN CHEM, V50, P103, DOI 10.1016/S0065-2423(10)50006-4; Rucker P, 1997, PROTEIN ENG, V10, P967, DOI 10.1093/protein/10.8.967; Ruddell RG, 2009, HEPATOLOGY, V49, P887, DOI 10.1002/hep.22716; Schmaier AH, 1998, THROMB RES, V92, P293, DOI 10.1016/S0049-3848(98)00142-X; SIBILLE JC, 1988, HEPATOLOGY, V8, P296, DOI 10.1002/hep.1840080218; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Somanath PR, 2006, CELL CYCLE, V5, P512, DOI 10.4161/cc.5.5.2538; Srinivasan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008283; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Wang ZM, 2006, ACTA CRYSTALLOGR D, V62, P800, DOI 10.1107/S0907444906018294; Zins SR, 2010, ANGIOGENESIS, V13, P293, DOI 10.1007/s10456-010-9186-9	44	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40030	10.1371/journal.pone.0040030	http://dx.doi.org/10.1371/journal.pone.0040030			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768328	gold, Green Published, Green Submitted			2022-12-27	WOS:000305966500041
J	Wang, J; Chen, GY; Gong, HL; Huang, W; Long, D; Tang, WF				Wang, Jia; Chen, Guangyuan; Gong, Hanlin; Huang, Wei; Long, Dan; Tang, Wenfu			Amelioration of Experimental Acute Pancreatitis with Dachengqi Decoction via Regulation of Necrosis-Apoptosis Switch in the Pancreatic Acinar Cell	PLOS ONE			English	Article							CHENG-QI DECOCTION; NITRIC-OXIDE; NECROTIZING PANCREATITIS; INFLAMMATORY RESPONSE; OXIDATIVE STRESS; DEATH; RATS; CYTOKINES; SEVERITY; RADICALS	Severity of acute pancreatitis contributes to the modality of cell death. Pervious studies have demonstrated that the herb medicine formula "Dachengqi Decoction" (DCQD) could ameliorate the severity of acute pancreatitis. However, the biological mechanisms governing its action of most remain unclear. The role of apoptosis/necrosis switch within acute pancreatitis has attracted much interest, because the induction of apoptosis within injured cells might suppress inflammation and ameliorate the disease. In this study, we used cerulein (10(-8) M)-stimulated AR42J cells as an in vitro model of acute pancreatitis and retrograde perfusion into the biliopancreatic duct of 3.5% sodium taurocholate as an in vivo rat model. After the treatment of DCQD, cell viability, levels of apoptosis and necrosis, reactive oxygen species positive cells, serum amylase, concentration of nitric oxide and inducible nitric oxide syntheses, pancreatic tissue pathological score and inflammatory cell infiltration were tested. Pretreatment with DCQD increased cell viability, induced apoptosis, decreased necrosis and reduced the severity of pancreatitis tissue. Moreover, treatment with DCQD reduced the generation of reactive oxygen species in AR42J cells but increased the concentration of nitric oxide of pancreatitis tissues. Therefore, the regulation of apoptosis/necrosis switch by DCQD might contribute to ameliorating the pancreatic inflammation and pathological damage. Further, the different effect on reactive oxygen species and nitric oxide may play an important role in DCQD-regulated apoptosis/necrosis switch in acute pancreatitis.	[Wang, Jia; Chen, Guangyuan; Gong, Hanlin; Tang, Wenfu] Sichuan Univ, Dept Integrated Tradit Chinese & Western Med, W China Hosp, Chengdu 610064, Peoples R China; [Huang, Wei] Univ Liverpool, Physiol Lab, Liverpool L69 3BX, Merseyside, England; [Long, Dan] Sichuan Univ, Dept Lab Transplant Engn & Immunol, W China Hosp, Chengdu 610064, Peoples R China	Sichuan University; University of Liverpool; Sichuan University	Wang, J (corresponding author), Sichuan Univ, Dept Integrated Tradit Chinese & Western Med, W China Hosp, Chengdu 610064, Peoples R China.	wftang900@gmail.com			Natural Science Foundation of China [30400576, 30973711, 30672588]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the grants of Natural Science Foundation of China (No: 30400576, 30973711 and 30672588). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif L, 2006, J GEN VIROL, V87, P2539, DOI 10.1099/vir.0.81915-0; Bhatia M, 2004, AM J PHYSIOL-GASTR L, V286, pG189, DOI 10.1152/ajpgi.00304.2003; Bhatia M, 2004, J CELL MOL MED, V8, P402, DOI 10.1111/j.1582-4934.2004.tb00330.x; Bhatia M, 2009, FRONT BIOSCI-LANDMRK, V14, P2042, DOI 10.2741/3362; Booth DM, 2011, GASTROENTEROLOGY, V140, P2116, DOI 10.1053/j.gastro.2011.02.054; Cevikel MH, 2003, PANCREATOLOGY, V3, P329, DOI 10.1159/000071772; Chang YC, 2011, EVID BASED COMPLEMEN; Chvanov M, 2005, PHILOS T R SOC B, V360, P2273, DOI 10.1098/rstb.2005.1757; Criddle DN, 2007, CELL DEATH DIFFER, V14, P1285, DOI 10.1038/sj.cdd.4402150; Dobosz M, 2005, PHYSIOL RES, V54, P363, DOI 10.33549/physiolres.930637; Gong HL, 2009, WORLD J GASTROENTERO, V15, P5992, DOI 10.3748/wjg.15.5992; HIETARANTA AJ, 1995, J SURG RES, V59, P271, DOI 10.1006/jsre.1995.1164; Hu GY, 2011, GUT, V60, P820, DOI 10.1136/gut.2010.215178; KAISER AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1295, DOI 10.1152/ajpcell.1995.269.5.C1295; Katakai Masumi, 2002, Yakushigaku Zasshi, V37, P28; Kim H, 2000, FREE RADICAL BIO MED, V29, P674, DOI 10.1016/S0891-5849(00)00368-3; Leindler L, 2004, PANCREAS, V29, P157, DOI 10.1097/00006676-200408000-00011; Liu BB, 2011, FREE RADICAL RES, V45, P835, DOI 10.3109/10715762.2011.580343; Lu GH, 2008, CHINESE ARCH TRADITI, V27, P260; Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200; Mofidi R, 2006, BRIT J SURG, V93, P738, DOI 10.1002/bjs.5290; Pereda J, 2006, CURR MED CHEM, V13, P2775, DOI 10.2174/092986706778522011; Rahman SH, 2003, GUT, V52, P270, DOI 10.1136/gut.52.2.270; Rakonczay Z, 2002, PANCREAS, V24, P83, DOI 10.1097/00006676-200201000-00011; RUBANYI GM, 1991, BIOCHEM BIOPH RES CO, V181, P1392, DOI 10.1016/0006-291X(91)92093-Y; Shang D, 2002, CHINESE J SURG INTEG, V8, P70; Tang WF, 2007, BIOMED CHROMATOGR, V21, P1186, DOI 10.1002/bmc.873; Tang Wenfu, 2008, Chin Med, V3, P5, DOI 10.1186/1749-8546-3-5; Tsai K, 1998, GUT, V42, P850, DOI 10.1136/gut.42.6.850; Um SH, 2003, J KOREAN MED SCI, V18, P520, DOI 10.3346/jkms.2003.18.4.520; Wan MH, 2011, CHIN J INTEGR MED, V17, P141, DOI 10.1007/s11655-011-0630-5; Weber H, 2000, DIGEST DIS SCI, V45, P2252, DOI 10.1023/A:1026459001195; Xia Q, 2001, CHIN J BASES CLIN GE, V8, P131; Xia Q, 2006, CHIN J TCM WM CRIT C, V13, P131; Yu JH, 2007, INT J BIOCHEM CELL B, V39, P2063, DOI 10.1016/j.biocel.2007.05.021; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	36	25	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40160	10.1371/journal.pone.0040160	http://dx.doi.org/10.1371/journal.pone.0040160			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768339	Green Published, gold, Green Submitted			2022-12-27	WOS:000305966500052
J	Abe, S; Kurata, M; Suzuki, S; Yamamoto, K; Aisaki, K; Kanno, J; Kitagawa, M				Abe, Shinya; Kurata, Morito; Suzuki, Shiho; Yamamoto, Kouhei; Aisaki, Ken-ichi; Kanno, Jun; Kitagawa, Masanobu			Minichromosome Maintenance 2 Bound with Retroviral Gp70 Is Localized to Cytoplasm and Enhances DNA-Damage-Induced Apoptosis	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; VIRUS-INDUCED LEUKEMOGENESIS; STRAND BREAK REPAIR; S-PHASE; PHOSPHATASE 2A; MCM2-7 COMPLEX; GENE FAMILY; REPLICATION; CELLS; P53	The interaction of viral proteins with host-cellular proteins elicits the activation of cellular signal transduction pathways and possibly leads to viral pathogenesis as well as cellular biological events. Apoptotic signals induced by DNA-damage are remarkably up-regulated by Friend leukemia virus (FLV) exclusively in C3H hosts; however, the mechanisms underlying the apoptosis enhancement and host-specificity are unknown. Here, we show that C3H mouse-derived hematopoietic cells originally express higher levels of the minichromosome maintenance (MCM) 2 protein than BALB/c- or C57BL/6-deriverd cells, and undergo more frequent apoptosis following doxorubicin-induced DNA-damage in the presence of the FLV envelope protein gp70. Dual transfection with gp70/Mcm2 reproduced doxorubicin-induced apoptosis even in BALB/c-derived 3T3 cells. Immunoprecipitation assays using various deletion mutants of MCM2 revealed that gp70 bound to the nuclear localization signal (NLS) 1 (amino acids 18-24) of MCM2, interfered with the function of NLS2 (amino acids 132-152), and suppressed the normal nuclear-import of MCM2. Cytoplasmic MCM2 reduced the activity of protein phosphatase 2A (PP2A) leading to the subsequent hyperphosphorylation of DNA-dependent protein kinase (DNA-PK). Phosphorylated DNA-PK exhibited elevated kinase activity to phosphorylate P53, thereby up-regulating p53-dependent apoptosis. An apoptosis-enhancing domain was identified in the C-terminal portion (amino acids 703-904) of MCM2. Furthermore, simultaneous treatment with FLV and doxorubicin extended the survival of SCID mice bearing 8047 leukemia cells expressing high levels of MCM2. Thus, depending on its subcellular localization, MCM2 plays different roles. It participates in DNA replication in the nucleus as shown previously, and enhances apoptosis in the cytoplasm.	[Abe, Shinya; Kurata, Morito; Suzuki, Shiho; Yamamoto, Kouhei; Kitagawa, Masanobu] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Comprehens Pathol, Tokyo, Japan; [Aisaki, Ken-ichi; Kanno, Jun] Natl Inst Hlth Sci, Div Cellular & Mol Toxicol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); National Institute of Health Sciences - Japan	Abe, S (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Comprehens Pathol, Tokyo, Japan.	masa.pth2@tmd.ac.jp	Kurata, Morito/AAD-3172-2019	Kurata, Morito/0000-0002-1242-6709	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21590432]; Ministry of Health, Labour and Welfare of Japan [H18-Kagaku-001]; Grants-in-Aid for Scientific Research [23790392] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid (21590432) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by Health Sciences Research Grant H18-Kagaku-001 from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemi RO, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001141; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Barlow C, 1997, NAT GENET, V17, P453, DOI 10.1038/ng1297-453; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Chuang LC, 2009, MOL CELL, V35, P206, DOI 10.1016/j.molcel.2009.06.014; Davies RJ, 2002, LANCET, V359, P1917, DOI 10.1016/S0140-6736(02)08739-1; Dehde S, 2001, MOL CELL BIOL, V21, P2581, DOI 10.1128/MCB.21.7.2581-2593.2001; Douglas P, 2001, J BIOL CHEM, V276, P18992, DOI 10.1074/jbc.M011703200; Dudderidge TJ, 2005, CLIN CANCER RES, V11, P2510, DOI 10.1158/1078-0432.CCR-04-1776; Feng PH, 2007, PLOS PATHOG, V3, P1849, DOI 10.1371/journal.ppat.0030174; Freeman A, 1999, CLIN CANCER RES, V5, P2121; Garcia A, 2003, BIOCHIMIE, V85, P721, DOI 10.1016/j.biochi.2003.09.004; Going JJ, 2002, GUT, V50, P373, DOI 10.1136/gut.50.3.373; Goodarzi AA, 2004, EMBO J, V23, P4451, DOI 10.1038/sj.emboj.7600455; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hasegawa M, 2005, LEUKEMIA RES, V29, P933, DOI 10.1016/j.leukres.2005.01.016; Hasegawa M, 2009, LEUKEMIA RES, V33, P1100, DOI 10.1016/j.leukres.2008.10.025; Ishimi Y, 1998, J BIOL CHEM, V273, P8369, DOI 10.1074/jbc.273.14.8369; Ishimi Y, 2001, J BIOL CHEM, V276, P42744, DOI 10.1074/jbc.M106861200; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Kaelin WG, 1999, J NATL CANCER I, V91, P594, DOI 10.1093/jnci/91.7.594; Kanai R, 2012, JNCI-J NATL CANCER I, V104, P42, DOI 10.1093/jnci/djr509; Kanno J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-64; Kennedy AL, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-16; Kitagawa M, 1998, LEUKEMIA, V12, P486, DOI 10.1038/sj.leu.2400980; Kitagawa M, 2002, J VIROL, V76, P7790, DOI 10.1128/JVI.76.15.7790-7798.2002; KITAGAWA M, 1986, CANCER RES, V46, P3034; KITAGAWA M, 1995, BLOOD, V86, P1557, DOI 10.1182/blood.V86.4.1557.bloodjournal8641557; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Labib K, 2001, MOL BIOL CELL, V12, P3658, DOI 10.1091/mbc.12.11.3658; Lau KM, 2010, ONCOGENE, V29, P5475, DOI 10.1038/onc.2010.287; Li HH, 2007, EMBO J, V26, P402, DOI 10.1038/sj.emboj.7601519; Liku ME, 2005, MOL BIOL CELL, V16, P5026, DOI 10.1091/mbc.E05-05-0412; Madine MA, 2000, J STRUCT BIOL, V129, P198, DOI 10.1006/jsbi.2000.4218; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Majid S, 2010, CANCER RES, V70, P2809, DOI 10.1158/0008-5472.CAN-09-4176; Meng MV, 2001, CLIN CANCER RES, V7, P2712; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Mukherjee B, 2006, DNA REPAIR, V5, P575, DOI 10.1016/j.dnarep.2006.01.011; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Neal JA, 2011, MUTAT RES-FUND MOL M, V711, P73, DOI 10.1016/j.mrfmmm.2011.02.010; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Qian ZK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000814; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Tachibana KEK, 2005, J PATHOL, V205, P123, DOI 10.1002/path.1708; Tanaka K, 2004, INT J RADIAT BIOL, V80, P673, DOI 10.1080/09553000400005502; Tenca P, 2007, J BIOL CHEM, V282, P208, DOI 10.1074/jbc.M604457200; Wang QH, 2009, NEOPLASIA, V11, P1012, DOI 10.1593/neo.09720; Woo RA, 2002, EMBO J, V21, P3000, DOI 10.1093/emboj/cdf307; Wu PYJ, 2009, CELL, V136, P852, DOI 10.1016/j.cell.2009.01.017; Yamaguchi S, 2005, LEUKEMIA RES, V29, P307, DOI 10.1016/j.leukres.2004.07.003; Zegerman P, 2010, NATURE, V467, P474, DOI 10.1038/nature09373; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	60	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40129	10.1371/journal.pone.0040129	http://dx.doi.org/10.1371/journal.pone.0040129			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768239	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100211
J	Chen, L; Ge, XC; Wang, XJ; Patel, JR; Xu, P				Chen, Lei; Ge, Xiuchun; Wang, Xiaojing; Patel, Jenishkumar R.; Xu, Ping			SpxA1 Involved in Hydrogen Peroxide Production, Stress Tolerance and Endocarditis Virulence in Streptococcus sanguinis	PLOS ONE			English	Article							GLOBAL TRANSCRIPTIONAL CONTROL; BACILLUS-SUBTILIS; INFECTIVE ENDOCARDITIS; RNA-POLYMERASE; PYRUVATE OXIDASE; COMPETENCE DEVELOPMENT; LACTOCOCCUS-LACTIS; BIOFILM FORMATION; OXIDATIVE STRESS; TERMINAL DOMAIN	Streptococcus sanguinis is one of the most common agents of infective endocarditis. Spx proteins are a group of global regulators that negatively or positively control global transcription initiation. In this study, we characterized the spxA1 gene in S. sanguinis SK36. The spxA1 null mutant displayed opaque colony morphology, reduced hydrogen peroxide (H2O2) production, and reduced antagonistic activity against Streptococcus mutans UA159 relative to the wild type strain. The Delta spxA1 mutant also demonstrated decreased tolerance to high temperature, acidic and oxidative stresses. Further analysis revealed that Delta spxA1 also exhibited a similar to 5-fold reduction in competitiveness in an animal model of endocarditis. Microarray studies indicated that expression of several oxidative stress genes was downregulated in the Delta spxA1 mutant. The expression of spxB and nox was significantly decreased in the Delta spxA1 mutant compared with the wild type. These results indicate that spxA1 plays a major role in H2O2 production, stress tolerance and endocarditis virulence in S. sanguinis SK36. The second spx gene, spxA2, was also found in S. sanguinis SK36. The spxA2 null mutant was found to be defective for growth under normal conditions and showed sensitivity to high temperature, acidic and oxidative stresses.	[Chen, Lei; Ge, Xiuchun; Wang, Xiaojing; Patel, Jenishkumar R.; Xu, Ping] Virginia Commonwealth Univ, Philips Inst Oral & Craniofacial Mol Biol, Richmond, VA USA	Virginia Commonwealth University	Chen, L (corresponding author), Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.	pxu@vcu.edu			National Institutes of Health [R01DE018138]; Virginia Commonwealth University Presidential Research Incentive Program (PRIP) [144602-3]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Commonwealth University Presidential Research Incentive Program (PRIP); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants R01DE018138 from the National Institutes of Health (PX) and in part, by Virginia Commonwealth University Presidential Research Incentive Program (PRIP) 144602-3 (PX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer AS, 1998, CIRCULATION, V98, P2936, DOI 10.1161/01.CIR.98.25.2936; Becker MR, 2002, J CLIN MICROBIOL, V40, P1001, DOI 10.1128/JCM.40.3.1001-1009.2002; Caufield PW, 2000, INFECT IMMUN, V68, P4018, DOI 10.1128/IAI.68.7.4018-4023.2000; Chen L, 2011, MICROBIOL-SGM, V157, P13, DOI 10.1099/mic.0.039669-0; Das S, 2009, J BACTERIOL, V191, P4166, DOI 10.1128/JB.01739-08; DOUGLAS CWI, 1993, J MED MICROBIOL, V39, P179, DOI 10.1099/00222615-39-3-179; DURACK DT, 1973, BRIT J EXP PATHOL, V54, P142; Frees D, 2001, MOL MICROBIOL, V41, P93, DOI 10.1046/j.1365-2958.2001.02503.x; Ge XC, 2008, INFECT IMMUN, V76, P2551, DOI 10.1128/IAI.00338-08; HERZBERG MC, 1992, INFECT IMMUN, V60, P4809, DOI 10.1128/IAI.60.11.4809-4818.1992; Kajfasz JK, 2010, J BACTERIOL, V192, P2546, DOI 10.1128/JB.00028-10; KILIAN M, 1981, INFECT IMMUN, V31, P868, DOI 10.1128/IAI.31.3.868-873.1981; Kreth J, 2005, J BACTERIOL, V187, P7193, DOI 10.1128/JB.187.21.7193-7203.2005; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Liu JJ, 2000, MOL MICROBIOL, V37, P885, DOI 10.1046/j.1365-2958.2000.02053.x; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; Nakano MM, 2000, MOL MICROBIOL, V37, P869, DOI 10.1046/j.1365-2958.2000.02052.x; Nakano MM, 2002, MOL MICROBIOL, V44, P1341, DOI 10.1046/j.1365-2958.2002.02963.x; Nakano MM, 2001, MOL MICROBIOL, V42, P383, DOI 10.1046/j.1365-2958.2001.02639.x; Nakano S, 2005, MOL MICROBIOL, V55, P498, DOI 10.1111/j.1365-2958.2004.04395.x; Nakano S, 2003, P NATL ACAD SCI USA, V100, P13603, DOI 10.1073/pnas.2235180100; Nakano S, 2002, J BACTERIOL, V184, P3664, DOI 10.1128/JB.184.13.3664-3670.2002; Nakano S, 2003, P NATL ACAD SCI USA, V100, P4233, DOI 10.1073/pnas.0637648100; Newberry KJ, 2005, P NATL ACAD SCI USA, V102, P15839, DOI 10.1073/pnas.0506592102; NYVAD B, 1987, SCAND J DENT RES, V95, P369; Paik S, 2005, INFECT IMMUN, V73, P6064, DOI 10.1128/IAI.73.9.6064-6074.2005; Pamp SJ, 2006, J BACTERIOL, V188, P4861, DOI 10.1128/JB.00194-06; Pericone CD, 2003, J BACTERIOL, V185, P6815, DOI 10.1128/JB.185.23.6815-6825.2003; Prabhu RM, 2005, EUR J CLIN MICROBIOL, V24, P832, DOI 10.1007/s10096-005-0037-3; Ramos-Montanez S, 2008, MOL MICROBIOL, V67, P729, DOI 10.1111/j.1365-2958.2007.06082.x; Reyes DY, 2008, MOL MICROBIOL, V69, P765, DOI 10.1111/j.1365-2958.2008.06330.x; Rosan B, 2000, MICROBES INFECT, V2, P1599, DOI 10.1016/S1286-4579(00)01316-2; Tleyjeh IM, 2005, JAMA-J AM MED ASSOC, V293, P3022, DOI 10.1001/jama.293.24.3022; Turlan C, 2009, MOL MICROBIOL, V73, P492, DOI 10.1111/j.1365-2958.2009.06789.x; Turner LS, 2009, INFECT IMMUN, V77, P4966, DOI 10.1128/IAI.00760-09; Turner LS, 2009, MICROBIOL-SGM, V155, P2573, DOI 10.1099/mic.0.024513-0; Veiga P, 2007, J BIOL CHEM, V282, P19342, DOI 10.1074/jbc.M611308200; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Xu P, 2011, SCI REP-UK, V1, DOI 10.1038/srep00125; Zuber P, 2004, J BACTERIOL, V186, P1911, DOI 10.1128/JB.186.7.1911-1918.2004	41	21	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40034	10.1371/journal.pone.0040034	http://dx.doi.org/10.1371/journal.pone.0040034			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768210	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100182
J	Chou, SD; Prince, T; Gong, JL; Calderwood, SK				Chou, Shiuh-Dih; Prince, Thomas; Gong, Jianlin; Calderwood, Stuart K.			mTOR Is Essential for the Proteotoxic Stress Response, HSF1 Activation and Heat Shock Protein Synthesis	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATION; PHOSPHOPROTEOMIC ANALYSIS; BINDING PROTEIN; DNA-BINDING; PHOSPHORYLATION; FACTOR-1; THERMOTOLERANCE; AUTOPHAGY; KINASE; CELLS	The target of rapamycin (TOR) is a high molecular weight protein kinase that regulates many processes in cells in response to mitogens and variations in nutrient availability. Here we have shown that mTOR in human tissue culture cells plays a key role in responses to proteotoxic stress and that reduction in mTOR levels by RNA interference leads to increase sensitivity to heat shock. This effect was accompanied by a drastic reduction in ability to synthesize heat shock proteins (HSP), including Hsp70, Hsp90 and Hsp110. As HSP transcription is regulated by heat shock transcription factor 1 (HSF1), we examined whether mTOR could directly phosphorylate this factor. Indeed, we determined that mTOR could directly phosphorylate HSF1 on serine 326, a key residue in transcriptional activation. HSF1 was phosphorylated on S326 immediately after heat shock and was triggered by other cell stressors including proteasome inhibitors and sodium arsenite. Null mutation of S326 to alanine led to loss of ability to activate an HSF1-regulated promoter-reporter construct, indicating a direct role for mTOR and S326 in transcriptional regulation of HSP genes during stress. As mTOR is known to exist in at least two intracellular complexes, mTORC1 and mTOR2 we examined which complex might interact with HSF1. Indeed mTORC1 inhibitor rapamycin prevented HSF1-S326 phosphorylation, suggesting that this complex is involved in HSF1 regulation in stress. Our experiments therefore suggest a key role for mTORC1 in transcriptional responses to proteotoxic stress.	[Chou, Shiuh-Dih; Prince, Thomas; Calderwood, Stuart K.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA 02115 USA; [Gong, Jianlin] Boston Univ, Med Ctr, Dept Hematol & Med Oncol, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston University	Chou, SD (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA 02115 USA.	scalderw@bidmc.harvard.edu		Gong, Jianlin/0000-0003-0910-014X	National Institutes of Health [RO-1CA047407, R01CA119045, RO-1CA094397]; NATIONAL CANCER INSTITUTE [R01CA047407, R01CA119045, R01CA094397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health research grants RO-1CA047407, R01CA119045 and RO-1CA094397. The funders had no role in study design. data collection and analysis, decision to publish, or preparation of the manuscript.	Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Calderwood S K, 2010, Sign Transduct Insights, V2, P13; Calderwood SK, 2012, J CELL BIOCHEM, V113, P1096, DOI 10.1002/jcb.23461; Calderwood SK, 2009, GERONTOLOGY, V55, P550, DOI 10.1159/000225957; Cantin GT, 2008, J PROTEOME RES, V7, P1346, DOI 10.1021/pr0705441; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Chu BY, 1998, J BIOL CHEM, V273, P18640, DOI 10.1074/jbc.273.29.18640; Chu BY, 1996, J BIOL CHEM, V271, P30847, DOI 10.1074/jbc.271.48.30847; Clemens MJ, 2001, PROG MOLEC, V27, P57; CRAIG EA, 1985, SCIENCE, V230, P800, DOI 10.1126/science.230.4727.800-a; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Hayashida N, 2010, EMBO J, V29, P3459, DOI 10.1038/emboj.2010.225; HENSOLD JO, 1990, MOL CELL BIOL, V10, P1600, DOI 10.1128/MCB.10.4.1600; Iijima-Andot K, 2005, P NATL ACAD SCI USA, V102, P10261, DOI 10.1073/pnas.0503937102; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; LANKS KW, 1986, J CELL PHYSIOL, V129, P385, DOI 10.1002/jcp.1041290317; LI GC, 1982, P NATL ACAD SCI-BIOL, V79, P3218, DOI 10.1073/pnas.79.10.3218; Li GC, 2009, INT J HYPERTHER, V25, P258, DOI 10.1080/02656730902862106; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Murshid A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013830; Petroulakis E, 2007, Br J Cancer, V96 Suppl, pR11; SANDERS MM, 1991, J CELL PHYSIOL, V146, P180, DOI 10.1002/jcp.1041460123; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; Wang XZ, 2006, J BIOL CHEM, V281, P782, DOI 10.1074/jbc.M505822200; Wang XZ, 2003, MOL CELL BIOL, V23, P6013, DOI 10.1128/MCB.23.17.6013-6026.2003; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028950; Zhang Y, 2011, METHODS MOL BIOL, V787, P21, DOI 10.1007/978-1-61779-295-3_2; Zhang Y, 2011, INT J HYPERTHER, V27, P409, DOI 10.3109/02656736.2011.552087	36	154	156	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39679	10.1371/journal.pone.0039679	http://dx.doi.org/10.1371/journal.pone.0039679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768106	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100076
J	Hirschhausen, N; Schlesier, T; Peters, G; Heilmann, C				Hirschhausen, Nina; Schlesier, Tim; Peters, Georg; Heilmann, Christine			Characterization of the Modular Design of the Autolysin/Adhesin Aaa from Staphylococcus Aureus	PLOS ONE			English	Article							FIBRONECTIN-BINDING-PROTEINS; WALL-ASSOCIATED PROTEIN; LISTERIA-MONOCYTOGENES; EUKARYOTIC CELLS; SURFACE PROTEIN; BACTERIAL; DOMAIN; GENE; EPIDERMIDIS; INFECTIONS	Background: Staphylococcus aureus is a frequent cause of serious and life-threatening infections, such as endocarditis, osteomyelitis, pneumonia, and sepsis. Its adherence to various host structures is crucial for the establishment of diseases. Adherence may be mediated by a variety of adhesins, among them the autolysin/adhesins Atl and Aaa. Aaa is composed of three N-terminal repeated sequences homologous to a lysin motif (LysM) that can confer cell wall attachment and a C-terminally located cysteine, histidine-dependent amidohydrolase/peptidase (CHAP) domain having bacteriolytic activity in many proteins. Methodology/Principal Findings: Here, we show by surface plasmon resonance that the LysM domain binds to fibrinogen, fibronectin, and vitronectin respresenting a novel adhesive function for this domain. Moreover, we demonstrated that the CHAP domain not only mediates the bacteriolytic activity, but also adherence to fibrinogen, fibronectin, and vitronectin, thus demonstrating for the first time an adhesive function for this domain. Adherence of an S. aureus aaa mutant and the complemented aaa mutant is slightly decreased and increased, respectively, to vitronectin, but not to fibrinogen and fibronectin, which might at least in part result from an increased expression of atl in the aaa mutant. Furthermore, an S. aureus atl mutant that showed enhanced adherence to fibrinogen, fibronectin, and endothelial cells also demonstrated increased aaa expression and production of Aaa. Thus, the redundant functions of Aaa and Atl might at least in part be interchangeable. Lastly, RT-PCR and zymographic analysis revealed that aaa is negatively regulated by the global virulence gene regulators agr and SarA. Conclusions/Significance: We identified novel functions for two widely distributed protein domains, LysM and CHAP, i.e. the adherence to the extracellular matrix proteins fibrinogen, fibronectin, and vitronectin. The adhesive properties of Aaa might promote S. aureus colonization of host extracellular matrix and tissue, suggesting a role for Aaa in the pathogenesis of S. aureus infections.	[Hirschhausen, Nina; Schlesier, Tim; Peters, Georg; Heilmann, Christine] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany; [Peters, Georg; Heilmann, Christine] Univ Hosp Munster, Interdisciplinary Ctr Clin Res, Munster, Germany	University of Munster; University of Munster	Hirschhausen, N (corresponding author), Univ Hosp Munster, Inst Med Microbiol, Munster, Germany.	heilmac@uni-muenster.de			German National Research Foundation (DFG) [He 3546/2-1]; Graduate School (Munster, Germany) of the DFG [GRK 1409]	German National Research Foundation (DFG)(German Research Foundation (DFG)); Graduate School (Munster, Germany) of the DFG	This study was supported by a grant of the German National Research Foundation (DFG) (http://www.dfg.de) to C. H. (He 3546/2-1) and (in part) by the Graduate School GRK 1409 (Munster, Germany) of the DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allignet J, 2002, FEMS MICROBIOL LETT, V213, P193, DOI 10.1016/S0378-1097(02)00813-3; Bateman A, 2003, TRENDS BIOCHEM SCI, V28, P234, DOI 10.1016/S0968-0004(03)00061-6; Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; Biswas R, 2006, FEMS MICROBIOL LETT, V259, P260, DOI 10.1111/j.1574-6968.2006.00281.x; BRUCKNER R, 1993, J BACTERIOL, V175, P851; BUBERT A, 1992, J BACTERIOL, V174, P8166, DOI 10.1128/JB.174.24.8166-8171.1992; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Cabanes D, 2004, MOL MICROBIOL, V51, P1601, DOI 10.1111/j.1365-2958.2003.03945.x; Chavakis T, 2005, THROMB HAEMOSTASIS, V94, P278, DOI 10.1160/TH05-05-0306; CHEUNG AL, 1994, INFECT IMMUN, V62, P1719, DOI 10.1128/IAI.62.5.1719-1725.1994; CHEUNG AL, 1994, J CLIN INVEST, V94, P1815, DOI 10.1172/JCI117530; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; Downer R, 2002, J BIOL CHEM, V277, P243, DOI 10.1074/jbc.M107621200; Dziewanowska K, 1999, INFECT IMMUN, V67, P4673, DOI 10.1128/IAI.67.9.4673-4678.1999; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; FLOCK JI, 1987, EMBO J, V6, P2351, DOI 10.1002/j.1460-2075.1987.tb02511.x; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Fowler T, 2000, EUR J CELL BIOL, V79, P672, DOI 10.1078/0171-9335-00104; Gibson T. J., 1984, THESIS CAMBRIDGE U C; GOTZ F, 1987, FEMS MICROBIOL LETT, V40, P285, DOI 10.1016/0378-1097(87)90391-0; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Gotz F, 2000, INFECT ASS INDWELLIN, P55; GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x; Hayashi Masao, 1994, Journal of Tissue Culture Methods, V16, P193, DOI 10.1007/BF01540649; Heilmann C, 2003, MICROBIOL-SGM, V149, P2769, DOI 10.1099/mic.0.26527-0; Heilmann C, 2002, J INFECT DIS, V186, P32, DOI 10.1086/341081; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; Heilmann C, 2005, INFECT IMMUN, V73, P4793, DOI 10.1128/IAI.73.8.4793-4802.2005; Heilmann C., 2010, BACTERIAL SIGNALING, P7; Hell W, 1998, MOL MICROBIOL, V29, P871, DOI 10.1046/j.1365-2958.1998.00983.x; Hirschhausen N, 2010, CELL MICROBIOL, V12, P1746, DOI 10.1111/j.1462-5822.2010.01506.x; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Jones RC, 2008, J BACTERIOL, V190, P5265, DOI 10.1128/JB.00383-08; JONSSON K, 1991, EUR J BIOCHEM, V202, P1041, DOI 10.1111/j.1432-1033.1991.tb16468.x; Kajimura J, 2005, MOL MICROBIOL, V58, P1087, DOI 10.1111/j.1365-2958.2005.04881.x; Karlsson A, 2001, INFECT IMMUN, V69, P4742, DOI 10.1128/IAI.69.8.4742-4748.2001; KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9; Layec S, 2008, J MOL MICROB BIOTECH, V14, P31, DOI 10.1159/000106080; Lentino JR, 2003, CLIN INFECT DIS, V36, P1157, DOI 10.1086/374554; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Milohanic E, 2001, MOL MICROBIOL, V39, P1212, DOI 10.1046/j.1365-2958.2001.02208.x; NOVICK RP, 2006, GRAM POSITIVE PATHOG, P496; Rigden DJ, 2003, TRENDS BIOCHEM SCI, V28, P230, DOI 10.1016/S0968-0004(03)00062-8; Roche FM, 2004, J BIOL CHEM, V279, P38433, DOI 10.1074/jbc.M402122200; Sambrook J., 2002, MOL CLONING LAB MANU; SCHLEIFER KH, 1982, INT J SYST BACTERIOL, V32, P153, DOI 10.1099/00207713-32-2-153; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; Tuchscherr L, 2011, EMBO MOL MED, V3, P129, DOI 10.1002/emmm.201000115; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863; Ziebuhr W, 2001, Contrib Microbiol, V8, P102; Zou YM, 2010, COMPUT BIOL CHEM, V34, P251, DOI 10.1016/j.compbiolchem.2010.07.001	52	34	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40353	10.1371/journal.pone.0040353	http://dx.doi.org/10.1371/journal.pone.0040353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768285	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100259
J	Leal, E; Casseb, J; Hendry, M; Busch, MP; Diaz, RS				Leal, Elcio; Casseb, Jorge; Hendry, Michael; Busch, Michael P.; Diaz, Ricardo Sobhie			Relaxation of Adaptive Evolution during the HIV-1 Infection Owing to Reduction of CD4+T Cell Counts	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; IN-VIVO; CORECEPTOR USAGE; ENVELOPE; PHENOTYPE; GENE; NEUTRALIZATION; TRANSMISSION; VARIANTS; TROPISM	Background: The first stages of HIV-1 infection are essential to establish the diversity of virus population within host. It has been suggested that adaptation to host cells and antibody evasion are the leading forces driving HIV evolution at the initial stages of AIDS infection. In order to gain more insights on adaptive HIV-1 evolution, the genetic diversity was evaluated during the infection time in individuals contaminated by the same viral source in an epidemic cluster. Multiple sequences of V3 loop region of the HIV-1 were serially sampled from four individuals: comprising a single blood donor, two blood recipients, and another sexually infected by one of the blood recipients. The diversity of the viral population within each host was analyzed independently in distinct time points during HIV-1 infection. Results: Phylogenetic analysis identified multiple HIV-1 variants transmitted through blood transfusion but the establishing of new infections was initiated by a limited number of viruses. Positive selection (d(N)/d(S)>1) was detected in the viruses within each host in all time points. In the intra-host viruses of the blood donor and of one blood recipient, X4 variants appeared respectively in 1993 and 1989. In both patients X4 variants never reached high frequencies during infection time. The recipient, who X4 variants appeared, developed AIDS but kept narrow and constant immune response against HIV-1 during the infection time. Conclusion: Slowing rates of adaptive evolution and increasing diversity in HIV-1 are consequences of the CD4+ T cells depletion. The dynamic of R5 to X4 shift is not associated with the initial amplitude of humoral immune response or intensity of positive selection.	[Leal, Elcio] Fed Univ Para, Inst Biotechnol, BR-66059 Belem, Para, Brazil; [Casseb, Jorge] Univ Sao Paulo, Inst Trop Med, Sao Paulo, SP, Brazil; [Hendry, Michael] CDC, Ctr Dis Control & Prevent, Branch Lab, Atlanta, GA 30333 USA; [Busch, Michael P.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA; [Busch, Michael P.] Blood Syst Inc, San Francisco, CA USA; [Diaz, Ricardo Sobhie] Univ Fed Sao Paulo, Sao Paulo, Brazil	Universidade Federal do Para; Universidade de Sao Paulo; Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco; Vitalant; Vitalant Research Institute; Vitalant; Universidade Federal de Sao Paulo (UNIFESP)	Leal, E (corresponding author), Fed Univ Para, Inst Biotechnol, BR-66059 Belem, Para, Brazil.	elcioleal@gmail.br	Leal, Elcio/J-6236-2016; casseb, jorge/X-5219-2019; Leal, Elcio/M-5275-2019; Diaz, Ricardo/K-3978-2012	Leal, Elcio/0000-0003-3463-0492; casseb, jorge/0000-0002-4553-2559; Leal, Elcio/0000-0003-3463-0492; 	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Foundation for the Support of Research in the State of Sao Paulo) [07/52841-8]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Foundation for the Support of Research in the State of Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Foundation for the Support of Research in the State of Sao Paulo; grant no. 07/52841-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkowitz RD, 1998, J VIROL, V72, P10108, DOI 10.1128/JVI.72.12.10108-10117.1998; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; BOYD MT, 1993, J VIROL, V67, P3649, DOI 10.1128/JVI.67.6.3649-3652.1993; Bunnik EM, 2008, J VIROL, V82, P7932, DOI 10.1128/JVI.00757-08; Bunnik EM, 2007, J VIROL, V81, P525, DOI 10.1128/JVI.01983-06; Cicala C, 2006, P NATL ACAD SCI USA, V103, P3746, DOI 10.1073/pnas.0511237103; Dacheux L, 2004, J VIROL, V78, P12625, DOI 10.1128/JVI.78.22.12625-12637.2004; Davenport MP, 2002, TRENDS MICROBIOL, V10, P275, DOI 10.1016/S0966-842X(02)02370-3; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Diaz RS, 2008, VIROLOGY, V381, P184, DOI 10.1016/j.virol.2008.08.014; Diaz RS, 1997, AIDS, V11, P415, DOI 10.1097/00002030-199704000-00003; English S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-54; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Herbeck JT, 2006, J VIROL, V80, P1637, DOI 10.1128/JVI.80.4.1637-1644.2006; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; KOOT M, 1993, J INFECT DIS, V168, P733, DOI 10.1093/infdis/168.3.733; Leal ED, 2004, VIROLOGY, V325, P181, DOI 10.1016/j.virol.2004.04.004; Leal E, 2008, VIROLOGY, V381, P222, DOI 10.1016/j.virol.2008.08.029; Leal E, 2007, INFECT GENET EVOL, V7, P694, DOI 10.1016/j.meegid.2007.07.008; Lemey P, 2005, J VIROL, V79, P11981, DOI 10.1128/JVI.79.18.11981-11989.2005; Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029; Li B, 2007, J VIROL, V81, P193, DOI 10.1128/JVI.01231-06; Lusso P, 2005, J VIROL, V79, P6957, DOI 10.1128/JVI.79.11.6957-6968.2005; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; Ribeiro RM, 2006, J VIROL, V80, P802, DOI 10.1128/JVI.80.2.802-809.2006; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; SHIODA T, 1991, NATURE, V349, P167, DOI 10.1038/349167a0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Rij RP, 2003, VIROLOGY, V314, P451, DOI 10.1016/S0042-6822(03)00454-9; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Williamson S, 2003, MOL BIOL EVOL, V20, P1318, DOI 10.1093/molbev/msg144; Yang ZH, 2000, GENETICS, V155, P431; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	40	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39776	10.1371/journal.pone.0039776	http://dx.doi.org/10.1371/journal.pone.0039776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768122	Green Published, gold			2022-12-27	WOS:000305892100092
J	Lipschutz-Powell, D; Woolliams, JA; Bijma, P; Doeschl-Wilson, AB				Lipschutz-Powell, Debby; Woolliams, John A.; Bijma, Piter; Doeschl-Wilson, Andrea B.			Indirect Genetic Effects and the Spread of Infectious Disease: Are We Capturing the Full Heritable Variation Underlying Disease Prevalence?	PLOS ONE			English	Article							BIOLOGICAL GROUPS; SELECTION; RESISTANCE; PARAMETERS; EVOLUTION; HUMANS; MODELS; ORIGIN	Reducing disease prevalence through selection for host resistance offers a desirable alternative to chemical treatment. Selection for host resistance has proven difficult, however, due to low heritability estimates. These low estimates may be caused by a failure to capture all the relevant genetic variance in disease resistance, as genetic analysis currently is not taylored to estimate genetic variation in infectivity. Host infectivity is the propensity of transmitting infection upon contact with a susceptible individual, and can be regarded as an indirect effect to disease status. It may be caused by a combination of physiological and behavioural traits. Though genetic variation in infectivity is difficult to measure directly, Indirect Genetic Effect (IGE) models, also referred to as associative effects or social interaction models, allow the estimation of this variance from more readily available binary disease data (infected/non-infected). We therefore generated binary disease data from simulated populations with known amounts of variation in susceptibility and infectivity to test the adequacy of traditional and IGE models. Our results show that a conventional model fails to capture the genetic variation in infectivity inherent in populations with simulated infectivity. An IGE model, on the other hand, does capture some of the variation in infectivity. Comparison with expected genetic variance suggests that there is scope for further methodological improvement, and that potential responses to selection may be greater than values presented here. Nonetheless, selection using an index of estimated direct and indirect breeding values was shown to have a greater genetic selection differential and reduced future disease risk than traditional selection for resistance only. These findings suggest that if genetic variation in infectivity substantially contributes to disease transmission, then breeding designs which explicitly incorporate IGEs might help reduce disease prevalence.	[Lipschutz-Powell, Debby; Woolliams, John A.; Doeschl-Wilson, Andrea B.] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; [Lipschutz-Powell, Debby; Woolliams, John A.; Doeschl-Wilson, Andrea B.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland; [Bijma, Piter] Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Wageningen University & Research	Lipschutz-Powell, D (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland.	debby.powell@roslin.ed.ac.uk	Lipschutz-Powell, Debby/I-3154-2012	Wilson, Andrea/0000-0002-2658-6973; Lipschutz-Powell, Debby/0000-0003-2845-3557	Biotechnology and Biological Sciences Research Council (BBSRC); Cobb-Vantress Incorporated; Cobb-Vantress Incorporated as part of the BioScience KTN CASE PhD studentship award; Biotechnology and Biological Sciences Research Council [BBS/E/D/20211554, BBS/E/D/05191133] Funding Source: researchfish; BBSRC [BBS/E/D/05191133, BBS/E/D/20211554] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cobb-Vantress Incorporated; Cobb-Vantress Incorporated as part of the BioScience KTN CASE PhD studentship award; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) (http://www.bbsrc.ac.uk; BioScience KTN CASE PhD studentship award) and Cobb-Vantress Incorporated (http://www.cobb-vantress.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was partly funded by Cobb-Vantress Incorporated as part of the BioScience KTN CASE PhD studentship award. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ANDERSON RM, 2006, INFECT DIS HUMANS; Bergsma R, 2008, GENETICS, V178, P1559, DOI 10.1534/genetics.107.084236; Bijma P, 2007, GENETICS, V175, P289, DOI 10.1534/genetics.106.062729; Bijma P, 2010, GENETICS, V186, P1013, DOI 10.1534/genetics.110.120493; Bishop SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008940; Chen J, 2010, MICROB ECOL, V60, P479, DOI 10.1007/s00248-010-9634-5; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Demeler J, 2010, VET PARASITOL, V174, P58, DOI 10.1016/j.vetpar.2010.08.020; DEMPSTER ER, 1950, GENETICS, V35, P212; Denison RF, 2003, Q REV BIOL, V78, P145, DOI 10.1086/374951; Doeschl-Wilson AB, 2011, GENETICS, V188, P683, DOI 10.1534/genetics.110.125625; Doeschl-Wilson AB, 2008, GENET SEL EVOL, V40, P241, DOI 10.1051/gse:2008001; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gilmour A., 2006, ASREML USER GUIDE RE; GRIFFING B, 1967, AUST J BIOL SCI, V20, P127, DOI 10.1071/BI9670127; GRIFFING B, 1976, GENETICS, V82, P723; Houston RD, 2010, HEREDITY, V105, P318, DOI 10.1038/hdy.2009.171; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Keeling, 2008, MODELLING INFECT DIS; Keeling MJ, 2008, J R SOC INTERFACE, V5, P171, DOI 10.1098/rsif.2007.1106; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; Muir WM, 2005, GENETICS, V170, P1247, DOI 10.1534/genetics.104.035956; Muir WM, 1998, POULTRY SCI, V77, P1781, DOI 10.1093/ps/77.12.1781; Nath M, 2004, J ANIM SCI, V82, P384; Pullinger GD, 2010, INFECT IMMUN, V78, P372, DOI 10.1128/IAI.01203-09; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Ramirez-Valverde R, 2001, J ANIM SCI, V79, P333; Van Dyken JD, 2011, AM NAT, V177, P288, DOI 10.1086/658365; Vazquez AI, 2009, J DAIRY SCI, V92, P739, DOI 10.3168/jds.2008-1325; Wilson AJ, 2009, P ROY SOC B-BIOL SCI, V276, P533, DOI 10.1098/rspb.2008.1193; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Yates A, 2006, P ROY SOC B-BIOL SCI, V273, P3075, DOI 10.1098/rspb.2006.3681	33	30	32	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39551	10.1371/journal.pone.0039551	http://dx.doi.org/10.1371/journal.pone.0039551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768088	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100059
J	Monchy, S; Grattepanche, JD; Breton, E; Meloni, D; Sanciu, G; Chabe, M; Delhaes, L; Viscogliosi, E; Sime-Ngando, T; Christaki, U				Monchy, Sebastien; Grattepanche, Jean-David; Breton, Elsa; Meloni, Dionigia; Sanciu, Giovanna; Chabe, Magali; Delhaes, Laurence; Viscogliosi, Eric; Sime-Ngando, Telesphore; Christaki, Urania			Microplanktonic Community Structure in a Coastal System Relative to a Phaeocystis Bloom Inferred from Morphological and Tag Pyrosequencing Methods	PLOS ONE			English	Article							MICROBIAL DIVERSITY; SEQUENCE ALIGNMENT; MOLECULAR ECOLOGY; MYRIONECTA-RUBRA; LIFE-CYCLE; EUKARYOTES; RARE; SIZE; PHYTOPLANKTON; BIODIVERSITY	Background: Massive phytoplankton blooms, like the recurrent Phaeocystis proliferation observed every year in the Eastern English Channel (EEC), have a significant influence on the overall planktonic community structure and their food web dynamics. As well as being an important area for local fisheries, the EEC is an ideal ecosystem for work on microbial diversity. This is because, although its environmental context is relatively complex, it is reasonably well understood due to several years of monitoring and morphological observations of its planktonic organisms. The objective of our study was to better understand the under-explored microbial eukaryotic diversity relative to the Phaeocystis bloom. Methodology and Principal Findings: The community structure of microplankton (diatoms, haptophytes, ciliates and dinoflagellates) was studied through morphological observations and tag pyrosequencing. During the annual Phaeocystis spring bloom, the phytoplankton biomass increased by 34-fold, while the microzooplankton biomass showed a 4-fold increase, representing on average about 4.6% of the biomass of their phytoplankton prey. Tag pyrosequencing unveiled an extensive diversity of Gymnodiniaceae, with G. spirale and G. fusiformis representing the most abundant reads. An extended diversity of Phaeocystales, with partial 18S rDNA genes sequence identity as low as 85% was found, with taxa corresponding to P. globosa, but also to unknown Phaeocystaceae. Conclusions: Morphological analyses and pyrosequencing were generally in accordance with capturing frequency shifts of abundant taxa. Tag pyrosequencing allowed highlighting the maintenance of microplankton diversity during the Phaeocystis bloom and the increase of the taxa presenting low number of reads (minor taxa) along with the dominant ones in response to biotic and/or abiotic changing conditions. Although molecular approaches have enhanced our perception on diversity, it has come to light that the challenge of modelling and predicting ecological change requires the use of different complementary approaches, to link taxonomic data with the functional roles of microbes in biogeochemical cycles.	[Monchy, Sebastien; Grattepanche, Jean-David; Breton, Elsa; Christaki, Urania] Univ Lille Nord, Univ Littoral Cote Opale, LOG, CNRS,UMR 8187, Wimereux, France; [Meloni, Dionigia; Sanciu, Giovanna; Chabe, Magali; Delhaes, Laurence; Viscogliosi, Eric] Univ Lille Nord France, CIIL, Inst Pasteur Lille, Inserm,U1019,CNRS,UMR 8204,EA4547, Lille, France; [Meloni, Dionigia; Sanciu, Giovanna] Univ Sassari, Dept Biol Sci, Div Expt & Clin Microbiol, I-07100 Sassari, Italy; [Sime-Ngando, Telesphore] Univ Blaise Pascal, LMGE, CNRS, UMR 6023, Aubiere, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; Universite du Littoral-Cote-d'Opale; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Sassari; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA)	Monchy, S (corresponding author), Univ Lille Nord, Univ Littoral Cote Opale, LOG, CNRS,UMR 8187, Wimereux, France.	sebmonchy@gmail.com	Meloni, Dionigia/K-4840-2015; Sime-Ngando, Télesphore/M-4134-2019; Delhaes, Laurence/AAD-6930-2020; elsa, Breton/J-4996-2013; Grattepanche, Jean-David/C-7101-2013; Chabe, Magali/H-6045-2017	Meloni, Dionigia/0000-0003-0188-5747; Sime-Ngando, Télesphore/0000-0002-7240-5803; Grattepanche, Jean-David/0000-0002-1854-3762; Breton, Elsa/0000-0002-9569-5436; Viscogliosi, Eric/0000-0002-5805-7179; Christaki, Urania/0000-0002-2061-5278; MONCHY, Sebastien/0000-0001-5808-4700; Chabe, Magali/0000-0002-6732-6772	INSU (Institut National des Sciences de l'Univers) - CNRS (Centre National de la Recherche Scientifique) EC2CO; ANR (Agence Nationale de la Recherche) [DREP 07 BLANC 0372-01]; SOMLIT network (Service d'Observation du Milieu Littoral)	INSU (Institut National des Sciences de l'Univers) - CNRS (Centre National de la Recherche Scientifique) EC2CO; ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); SOMLIT network (Service d'Observation du Milieu Littoral)	This study was supported by the INSU (Institut National des Sciences de l'Univers) - CNRS (Centre National de la Recherche Scientifique) EC2CO, and ANR (Agence Nationale de la Recherche) - DREP 07 BLANC 0372-01 projects and the SOMLIT network (Service d'Observation du Milieu Littoral). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaral-Zettler L, 2010, LIFE WORLDS OCEANS D; Barnes C, 2010, ECOLOGY, V91, P222, DOI 10.1890/08-2061.1; Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x; Brate J, 2010, ISME J, V4, P1144, DOI 10.1038/ismej.2010.39; Breton E, 2006, LIMNOL OCEANOGR, V51, P1401, DOI 10.4319/lo.2006.51.3.1401; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Capnulo GM, 1983, MAR ECOL PROG SER, V10, P277; Caron DA, 2012, ANNU REV MAR SCI, V4, P467, DOI 10.1146/annurev-marine-120709-142802; Caron DA, 2009, ISME J, V3, P4, DOI 10.1038/ismej.2008.101; Casamayor EO, 2002, ENVIRON MICROBIOL, V4, P338, DOI 10.1046/j.1462-2920.2002.00297.x; CHAO A, 1984, SCAND J STAT, V11, P265; Christaki U, 1999, MAR ECOL PROG SER, V181, P297, DOI 10.3354/meps181297; Christaki U, 2009, AQUAT MICROB ECOL, V57, P263, DOI 10.3354/ame01339; Creer S, 2010, MOL ECOL, V19, P2829, DOI 10.1111/j.1365-294X.2010.04670.x; Dawson Scott C, 2009, J Biol, V8, P105, DOI 10.1186/jbiol201; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Doherty M, 2007, AQUAT MICROB ECOL, V48, P141, DOI 10.3354/ame048141; Duffy JE, 2006, MAR ECOL PROG SER, V311, P179, DOI 10.3354/meps311179; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edvardsen B, 2011, EUR J PHYCOL, V46, P202, DOI 10.1080/09670262.2011.594095; Gaebler-Schwarz S, 2010, J PHYCOL, V46, P1006, DOI 10.1111/j.1529-8817.2010.00875.x; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Genitsaris S, 2009, FEMS MICROBIOL ECOL, V69, P75, DOI 10.1111/j.1574-6941.2009.00686.x; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Gomez F, 2008, CR BIOL, V331, P678, DOI 10.1016/j.crvi.2008.06.005; Gomez F, 2007, CR BIOL, V330, P231, DOI 10.1016/j.crvi.2007.02.002; Gomez F, 2010, PROTIST, V161, P466, DOI 10.1016/j.protis.2009.12.005; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grattepanche JD, 2011, J EXP MAR BIOL ECOL, V404, P87, DOI 10.1016/j.jembe.2011.04.004; Grattepanche JD, 2011, J PLANKTON RES, V33, P37, DOI 10.1093/plankt/fbq097; Gribble KE, 2006, J PHYCOL, V42, P1081, DOI 10.1111/j.1529-8817.2006.00267.x; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Johnson MD, 2004, PROTIST, V155, P347, DOI 10.1078/1434461041844222; Jurgens K, 2000, AQUAT MICROB ECOL, V22, P57, DOI 10.3354/ame022057; Karakousis A, 2006, J MICROBIOL METH, V65, P38, DOI 10.1016/j.mimet.2005.06.008; Karayanni H, 2005, J GEOPHYS RES, V10; Ki JS, 2005, J APPL PHYCOL, V17, P147, DOI 10.1007/s10811-005-7211-y; Kirchman DL, 2007, OCEANOGRAPHY, V20, P166, DOI 10.5670/oceanog.2007.62; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lamy D, 2009, AQUAT MICROB ECOL, V58, P95, DOI 10.3354/ame01359; Lange M, 2002, EUR J PHYCOL, V37, P77, DOI 10.1017/S0967026201003481; Lange M, 1997, THESIS U BREMEN BREM; Lepere C, 2006, APPL ENVIRON MICROB, V72, P2971, DOI 10.1128/AEM.72.4.2971-2981.2006; Lopez-Garcia P, 2003, P NATL ACAD SCI USA, V100, P697, DOI 10.1073/pnas.0235779100; Lopez-Garcia P, 2008, RES MICROBIOL, V159, P67, DOI 10.1016/j.resmic.2007.11.019; Marie D, 2010, FEMS MICROBIOL ECOL, V72, P165, DOI 10.1111/j.1574-6941.2010.00842.x; Martin LA, 2002, PROTIST, V153, P275, DOI 10.1078/1434-4610-00104; Massana R, 2004, APPL ENVIRON MICROB, V70, P3528, DOI 10.1128/AEM.70.6.3528-3534.2004; Massana R, 2008, CURR OPIN MICROBIOL, V11, P213, DOI 10.1016/j.mib.2008.04.004; Massana R, 2006, ENVIRON MICROBIOL, V8, P1515, DOI 10.1111/j.1462-2920.2006.01042.x; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; MEDLIN LK, 1994, PHYCOLOGIA, V33, P199, DOI 10.2216/i0031-8884-33-3-199.1; Medlin LK, 1995, NATO ADV SCI INST SE, V38, P133; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Monchy S, 2011, ENVIRON MICROBIOL, V13, P1433, DOI 10.1111/j.1462-2920.2011.02444.x; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Moreira D, 2002, TRENDS MICROBIOL, V10, P31, DOI 10.1016/S0966-842X(01)02257-0; Nolte V, 2010, MOL ECOL, V19, P2908, DOI 10.1111/j.1365-294X.2010.04669.x; Oikonomou A, 2012, SCI WORLD J, DOI 10.1100/2012/504135; Park JS, 2007, AQUAT MICROB ECOL, V48, P83, DOI 10.3354/ame048083; Pawlowski J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018169; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; PUTT M, 1989, LIMNOL OCEANOGR, V34, P1097, DOI 10.4319/lo.1989.34.6.1097; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Quiroga I, 2004, BOT MAR, V47, P341, DOI 10.1515/BOT.2004.040; Rappe MS, 1998, APPL ENVIRON MICROB, V64, P294; Reiss J, 2010, ADV ECOL RES, V43, P45, DOI 10.1016/S0065-2504(10)43002-0; ROUSSEAU V, 1990, MAR BIOL, V107, P305, DOI 10.1007/BF01319830; Savin MC, 2004, MICROBIAL ECOL, V48, P51, DOI 10.1007/s00248-003-1033-8; Schapira M, 2008, J MAR BIOL ASS UK, P88; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; SHELDON RW, 1972, LIMNOL OCEANOGR, V17, P327, DOI 10.4319/lo.1972.17.3.0327; SIMEK K, 1995, LIMNOL OCEANOGR, V40, P1077, DOI 10.4319/lo.1995.40.6.1077; Slapeta J, 2005, P ROY SOC B-BIOL SCI, V272, P2073, DOI 10.1098/rspb.2005.3195; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Spatharis S, 2011, ECOL INDIC, V11, P697, DOI 10.1016/j.ecolind.2010.09.009; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; STOECKER DK, 1994, MAR ECOL PROG SER, V110, P293, DOI 10.3354/meps110293; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uthermol H., 1958, MITTEILINGEN INTERNA, V9, P1, DOI [10.1080/0 5384680.1958.11904091, DOI 10.1080/05384680.1958.11904091]; VAULOT D, 1994, J PHYCOL, V30, P1022, DOI 10.1111/j.0022-3646.1994.01022.x; VERITY PG, 1985, LIMNOL OCEANOGR, V30, P1268, DOI 10.4319/lo.1985.30.6.1268	84	50	52	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39924	10.1371/journal.pone.0039924	http://dx.doi.org/10.1371/journal.pone.0039924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22792138	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100140
J	Remarque, EJ; Roestenberg, M; Younis, S; Walraven, V; van der Werff, N; Faber, BW; Leroy, O; Sauerwein, R; Kocken, CHM; Thomas, AW				Remarque, Edmond J.; Roestenberg, Meta; Younis, Sumera; Walraven, Vanessa; van der Werff, Nicole; Faber, Bart W.; Leroy, Odile; Sauerwein, Robert; Kocken, Clemens H. M.; Thomas, Alan W.			Humoral Immune Responses to a Single Allele PfAMA1 Vaccine in Healthy Malaria-Naive Adults	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; BLOOD-STAGE VACCINE; PLASMODIUM-FALCIPARUM MALARIA; CLINICAL MALARIA; CANDIDATE; AMA1; TRIAL; IMMUNOGENICITY; POLYMORPHISMS; IMMUNIZATION	Plasmodium falciparum: apical membrane antigen 1 (AMA1) is a candidate malaria vaccine antigen expressed on merozoites and sporozoites. The polymorphic nature of AMA1 may compromise vaccine induced protection. The humoral response induced by two dosages (10 and 50 mu g) of a single allele AMA1 antigen (FVO) formulated with Alhydrogel, Montanide ISA 720 or AS02 was investigated in 47 malaria-naive adult volunteers. Volunteers were vaccinated 3 times at 4 weekly intervals and serum samples obtained four weeks after the third immunization were analysed for (i) Antibody responses to various allelic variants, (ii) Domain specificity, (iii) Avidity, (iv) IgG subclass levels, by ELISA and (v) functionality of antibody responses by Growth Inhibition Assay (GIA). About half of the antibodies induced by vaccination cross reacted with heterologous AMA1 alleles. The choice of adjuvant determined the magnitude of the antibody response, but had only a marginal influence on specificity, avidity, domain recognition or subclass responses. The highest antibody responses were observed for AMA1 formulated with AS02. The Growth Inhibition Assay activity of the antibodies was proportional to the amount of antigen specific IgG and the functional capacity of the antibodies was similar for heterologous AMA1-expressing laboratory strains.	[Remarque, Edmond J.; Younis, Sumera; Walraven, Vanessa; van der Werff, Nicole; Faber, Bart W.; Kocken, Clemens H. M.; Thomas, Alan W.] Biomed Primate Res Ctr, Rijswijk, Netherlands; [Roestenberg, Meta; Sauerwein, Robert] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Leroy, Odile] European Vaccine Initiat, Heidelberg, Germany	Radboud University Nijmegen	Remarque, EJ (corresponding author), Biomed Primate Res Ctr, Rijswijk, Netherlands.	Remarque@bprc.nl	Remarque, Ed/AAE-8643-2020; Roestenberg, Meta/AAP-9413-2021; Sauerwein, Robert/C-8519-2013	Roestenberg, Meta/0000-0002-5052-2830; Kocken, Clemens/0000-0002-4784-1734; Faber, Bart/0000-0001-6808-1204	European Malaria Vaccine Initiative	European Malaria Vaccine Initiative	This work was funded by a grant from the European Malaria Vaccine Initiative. Collaborators from the European Malaria Vaccine Initiative have been involved in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Bannister LH, 2003, J CELL SCI, V116, P3825, DOI 10.1242/jcs.00665; Chesne-Seck ML, 2005, MOL BIOCHEM PARASIT, V144, P55, DOI 10.1016/j.molbiopara.2005.07.007; Crewther PE, 1996, INFECT IMMUN, V64, P3310, DOI 10.1128/IAI.64.8.3310-3317.1996; Dodoo D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-142; Draper SJ, 2010, J IMMUNOL, V185, P7583, DOI 10.4049/jimmunol.1001760; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Faber BW, 2007, INFECT IMMUN, V75, P5947, DOI 10.1128/IAI.01804-06; Faber BW, 2008, VACCINE, V26, P6143, DOI 10.1016/j.vaccine.2008.08.055; Hamid MMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020547; HAMMARSTROM L, 1986, MONOGR ALLERGY, V19, P241; Healer J, 2002, INFECT IMMUN, V70, P5751, DOI 10.1128/IAI.70.10.5751-5758.2002; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Howell SA, 2001, J BIOL CHEM, V276, P31311, DOI 10.1074/jbc.M103076200; Kasper DL, 1907, HARRISONS PRINCIPLES, P1907; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Kusi KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015391; Kusi KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-40; Kusi KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008110; Lalitha PV, 2004, INFECT IMMUN, V72, P4464, DOI 10.1128/IAI.72.8.4464-4470.2004; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Mitchell GH, 2004, INFECT IMMUN, V72, P154, DOI 10.1128/IAI.72.1.154-158.2004; Mullen GED, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002940; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Roestenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003960; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Spring MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005254; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; WHO, 2010, WORLD MALARIA REPORT 2010, P1	33	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38898	10.1371/journal.pone.0038898	http://dx.doi.org/10.1371/journal.pone.0038898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768052	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100022
J	Slanina, H; Hebling, S; Hauck, CR; Schubert-Unkmeir, A				Slanina, Heiko; Hebling, Sabrina; Hauck, Christoph R.; Schubert-Unkmeir, Alexandra			Cell Invasion by Neisseria meningitidis Requires a Functional Interplay between the Focal Adhesion Kinase, Src and Cortactin	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; STAPHYLOCOCCUS-AUREUS; TYROSINE-KINASE; ESCHERICHIA-COLI; YERSINIA-PSEUDOTUBERCULOSIS; ARP2/3 COMPLEX; F-ACTIN; INTEGRIN; PROTEIN; FIBRONECTIN	Entry of Neisseria meningitidis (the meningococcus) into human brain microvascular endothelial cells (HBMEC) is mediated by fibronectin or vitronectin bound to the surface protein Opc forming a bridge to the respective integrins. This interaction leads to cytoskeletal rearrangement and uptake of meningococci. In this study, we determined that the focal adhesion kinase (FAK), which directly associates with integrins, is involved in integrin-mediated internalization of N. meningitidis in HBMEC. Inhibition of FAK activity by the specific FAK inhibitor PF 573882 reduced Opc-mediated invasion of HBMEC more than 90%. Moreover, overexpression of FAK mutants that were either impaired in the kinase activity or were not capable of autophosphorylation or overexpression of the dominant-negative version of FAK (FRNK) blocked integrin-mediated internalization of N. meningitidis. Importantly, FAK-deficient fibroblasts were significantly less invaded by N. meningitidis. Furthermore, N. meningitidis induced tyrosine phosphorylation of several host proteins including the FAK/Src complex substrate cortactin. Inhibition of cortactin expression by siRNA silencing and mutation of critical amino acid residues within cortactin, that encompass Arp2/3 association and dynamin binding, significantly reduced meningococcal invasion into eukaryotic cells suggesting that both domains are critical for efficient uptake of N. meningitidis into eukaryotic cells. Together, these results indicate that N. meningitidis exploits the integrin signal pathway for its entry and that FAK mediates the transfer of signals from activated integrins to the cytoskeleton. A cooperative interplay between FAK, Src and cortactin then enables endocytosis of N. meningitidis into host cells.	[Slanina, Heiko; Hebling, Sabrina; Schubert-Unkmeir, Alexandra] Univ Wurzburg, Inst Hyg & Microbiol, Wurzburg, Germany; [Hauck, Christoph R.] Univ Konstanz, Dept Cell Biol, Constance, Germany	University of Wurzburg; University of Konstanz	Slanina, H (corresponding author), Univ Wurzburg, Inst Hyg & Microbiol, Wurzburg, Germany.	aunkmeir@hygiene.uni-wuerzburg.de			German Research Foundation (DFG) [SCHU 2394/1-2]; University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by grants from the German Research Foundation (DFG) (SCHU 2394/1-2) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTMAN M, 1995, TRENDS MICROBIOL, V3, P186, DOI 10.1016/S0966-842X(00)88918-0; Agerer F, 2004, J MICROBIOL METH, V59, P23, DOI 10.1016/j.mimet.2004.05.008; Agerer F, 2005, J CELL SCI, V118, P2189, DOI 10.1242/jcs.02328; Agerer F, 2003, J BIOL CHEM, V278, P42524, DOI 10.1074/jbc.M302096200; Alrutz MA, 1998, P NATL ACAD SCI USA, V95, P13658, DOI 10.1073/pnas.95.23.13658; Alrutz MA, 2001, MOL MICROBIOL, V42, P689, DOI 10.1046/j.1365-2958.2001.02676.x; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Cantarelli VV, 2002, INFECT IMMUN, V70, P2206, DOI 10.1128/IAI.70.4.2206-2209.2002; Cantarelli VV, 2000, INFECT IMMUN, V68, P382, DOI 10.1128/IAI.68.1.382-386.2000; Chen XM, 2003, GASTROENTEROLOGY, V125, P216, DOI 10.1016/S0016-5085(03)00662-0; Cho BA, 2010, INFECT IMMUN, V78, P1915, DOI 10.1128/IAI.01316-09; Comanducci M, 2002, J EXP MED, V195, P1445, DOI 10.1084/jem.20020407; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Cunha CSE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000911; DEHIO C, 1995, EMBO J, V14, P2471, DOI 10.1002/j.1460-2075.1995.tb07244.x; Eitel J, 2005, CELL MICROBIOL, V7, P63, DOI 10.1111/j.1462-5822.2004.00434.x; Fowler T, 2000, EUR J CELL BIOL, V79, P672, DOI 10.1078/0171-9335-00104; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Hauck CR, 2002, IUBMB LIFE, V53, P115, DOI 10.1080/15216540211470; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hoffmann I, 2001, J CELL BIOL, V155, P133, DOI 10.1083/jcb.200106148; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Isberg RR, 2000, MICROBES INFECT, V2, P793, DOI 10.1016/S1286-4579(00)90364-2; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; Kim KS, 2008, NAT REV MICROBIOL, V6, P625, DOI 10.1038/nrmicro1952; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kriz P, 1995, EPIDEMIOL INFECT, V115, P411, DOI 10.1017/S0950268800058568; Lambotin M, 2005, J CELL SCI, V118, P3805, DOI 10.1242/jcs.02514; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; MCGUINNESS BT, 1991, LANCET, V337, P514, DOI 10.1016/0140-6736(91)91297-8; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cellbio.7.1.275; Reddy MA, 2000, INFECT IMMUN, V68, P6423, DOI 10.1128/IAI.68.11.6423-6430.2000; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SARKARI J, 1994, MOL MICROBIOL, V13, P207, DOI 10.1111/j.1365-2958.1994.tb00416.x; SAWAYA R, 1985, NEUROSURGERY, V16, P161, DOI 10.1227/00006123-198502000-00006; Scarselli M, 2006, MOL MICROBIOL, V61, P631, DOI 10.1111/j.1365-2958.2006.05261.x; SCHALLER MD, 1993, MOL CELL BIOL, V13, P785, DOI 10.1128/MCB.13.2.785; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; Schmitt C, 2007, J BACTERIOL, V189, P7968, DOI 10.1128/JB.00851-07; Schubert-Unkmeir A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000874; Selbach M, 2005, TRENDS MICROBIOL, V13, P181, DOI 10.1016/j.tim.2005.02.007; Sieg DJ, 1999, J CELL SCI, V112, P2677; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Slanina H, 2010, INFECT IMMUN, V78, P1905, DOI 10.1128/IAI.01267-09; Sokolova O, 2004, CELL MICROBIOL, V6, P1153, DOI 10.1111/j.1462-5822.2004.00422.x; Stins MF, 1997, J NEUROIMMUNOL, V76, P81, DOI 10.1016/S0165-5728(97)00036-2; Tegtmeyer N, 2011, CELL HOST MICROBE, V9, P520, DOI 10.1016/j.chom.2011.05.007; Tehrani S, 2006, MOL BIOL CELL, V17, P2882, DOI 10.1091/mbc.E06-03-0187; Turner DPJ, 2006, INFECT IMMUN, V74, P2957, DOI 10.1128/IAI.74.5.2957-2964.2006; Unkmeir A, 2002, MOL MICROBIOL, V46, P933, DOI 10.1046/j.1365-2958.2002.03222.x; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; VIRJI M, 1994, MOL MICROBIOL, V14, P173, DOI 10.1111/j.1365-2958.1994.tb01277.x; VIRJI M, 1992, MOL MICROBIOL, V6, P2785, DOI 10.1111/j.1365-2958.1992.tb01458.x; VIRJI M, 1993, MOL MICROBIOL, V10, P499, DOI 10.1111/j.1365-2958.1993.tb00922.x; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; WHALEN CM, 1995, JAMA-J AM MED ASSOC, V273, P390, DOI 10.1001/jama.273.5.390; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zamir E, 2001, J CELL SCI, V114, P3583; Zhu PX, 1999, MOL MICROBIOL, V33, P635, DOI 10.1046/j.1365-2958.1999.01514.x	72	41	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39613	10.1371/journal.pone.0039613	http://dx.doi.org/10.1371/journal.pone.0039613			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768099	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100069
J	van der Werff, SD; Polman, K; Ponce, MC; Twisk, JWR; Diaz, RJ; Gorbea, MB; Van der Stuyft, P				van der Werff, Suzanne D.; Polman, Katja; Ponce, Maiza Campos; Twisk, Jos W. R.; Junco Diaz, Raquel; Bonet Gorbea, Mariano; Van der Stuyft, Patrick			Childhood Atopic Diseases and Early Life Circumstances: An Ecological Study in Cuba	PLOS ONE			English	Article							ECONOMIC-CRISIS; CARDIOVASCULAR-DISEASE; WORLDWIDE VARIATIONS; PRENATAL EXPOSURE; DUTCH FAMINE; HEALTH-CARE; ASTHMA; IMPACT; PREVALENCE; ALLERGIES	Background: Children are especially vulnerable during periods of resource shortage such as economic embargoes. They are likely to suffer most from poor nutrition, infectious diseases, and other ensuing short-term threats. Moreover, early life circumstances can have important consequences for long-term health. We examined the relationship between early childhood exposure to the Cuban economic situation in the nineties and the occurrence of atopic diseases later in childhood. Methodology/Principal Findings: A cross-sectional study of 1321 primary schoolchildren aged 4-14 was conducted in two Cuban municipalities. Asthma, allergic rhinoconjunctivitis and atopic dermatitis were diagnosed using the International Study of Asthma and Allergies in Childhood questionnaire. Children were divided into three groups of exposure to the economic situation in the nineties according to birth date: (1) unexposed; (2) exposed during infancy; (3) exposed during infancy and early childhood. Associations were assessed using multiple logistic regression models. Exposure during infancy had a significant inverse association with the occurrence of asthma (OR 0.56, 95% CI 0.33-0.94) and allergic rhinoconjunctivitis (OR 0.46, 95% CI 0.25-0.85). The associations were stronger after longer exposure, i.e. during infancy and early childhood, for asthma (OR 0.40, 95% CI 0.17-0.95) and allergic rhinoconjunctivitis (OR 0.29, 95% CI 0.11-0.77). No significant associations were found for atopic dermatitis. Conclusions/Significance: Exposure to the economic situation in the nineties during infancy and early childhood was inversely associated with asthma and allergic rhinoconjunctivitis occurrence later in childhood. We hypothesize that factors related to this period, such as infectious diseases and undernutrition, may have an attenuating effect on atopic disease development. The exact cause and underlying mechanisms need to be further elucidated.	[van der Werff, Suzanne D.; Polman, Katja; Ponce, Maiza Campos; Twisk, Jos W. R.] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [van der Werff, Suzanne D.; Polman, Katja] Prince Leopold Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Twisk, Jos W. R.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Junco Diaz, Raquel; Bonet Gorbea, Mariano] Natl Inst Hyg Epidemiol & Microbiol, Havana, Cuba; [Van der Stuyft, Patrick] Prince Leopold Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Van der Stuyft, Patrick] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium	Vrije Universiteit Amsterdam; Institute of Tropical Medicine (ITM); Vrije Universiteit Amsterdam; Institute of Tropical Medicine (ITM); Ghent University	van der Werff, SD (corresponding author), Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands.	suzanne.vander.werff@vu.nl	van der Werff, Suzanne D./ABF-8976-2021	van der Werff, Suzanne D./0000-0001-7162-3844; Campos Ponce, Maiza/0000-0003-1700-4756	Directorate-General for Development Cooperation (DGDC) [ITM-DGD FA2 920501]	Directorate-General for Development Cooperation (DGDC)	This work was supported by a grant of the Directorate-General for Development Cooperation (DGDC) within the Framework Agreement 2 (2003-2007) DGDC-ITM 'IPK/INHEM/CUBA' project [ITM-DGD FA2 920501]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel-Smith B, 1986, Health Policy Plan, V1, P202, DOI 10.1093/heapol/1.3.202; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Barker D. J. P., 2004, Public health nutrition, P302; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Bhaskaram P, 2002, NUTR REV, V60, pS40, DOI 10.1301/00296640260130722; Centers for Disease Control and Prevention, 1994, MMWR-MORBID MORTAL W, V43, P189; Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P189; De Vos P, 2005, INT J HEALTH SERV, V35, P189, DOI 10.2190/M72R-DBKD-2XWV-HJWB; Devereux G, 2005, J ALLERGY CLIN IMMUN, V115, P1109, DOI 10.1016/j.jaci.2004.12.1139; Devereux G, 2006, NAT REV IMMUNOL, V6, P869, DOI 10.1038/nri1958; Eisenbarth SC, 2004, CURR OPIN PEDIATR, V16, P659, DOI 10.1097/01.mop.0000145920.00101.e4; Franco M, 2007, AM J EPIDEMIOL, V166, P1374, DOI 10.1093/aje/kwm226; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; Garfield R, 1997, AM J PUBLIC HEALTH, V87, P15, DOI 10.2105/AJPH.87.1.15; Garfield R, 1997, J Am Med Womens Assoc (1972), V52, P181; Garfield R, 1995, B NEW YORK ACAD MED, V72, P454; Garfield R, 1997, J AM MED WOMEN ASSOC, V52, P198; Hedges TR, 1997, SURV OPHTHALMOL, V41, P341, DOI 10.1016/S0039-6257(96)00008-2; Hopkins S, 2006, HEALTH POLICY, V75, P347, DOI 10.1016/j.healthpol.2005.04.002; Khang YH, 2005, INT J EPIDEMIOL, V34, P1291, DOI 10.1093/ije/dyi224; Koski KG, 2001, ANNU REV NUTR, V21, P297, DOI 10.1146/annurev.nutr.21.1.297; Ligon B Lee, 2006, Semin Pediatr Infect Dis, V17, P36, DOI 10.1053/j.spid.2006.01.002; Lopuhaa CE, 2000, THORAX, V55, P555, DOI 10.1136/thorax.55.7.555; Ministerio de Salud Publica, 2000, AN EST SAL CUB 2000; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Nayeri K, 2005, INT J HEALTH SERV, V35, P797, DOI 10.2190/C1QG-6Y0X-CJJA-863H; Ngoc LP, 2005, CURR OPIN ALLERGY CL, V5, P161, DOI 10.1097/01.all.0000162309.97480.45; Painter RC, 2005, REPROD TOXICOL, V20, P345, DOI 10.1016/j.reprotox.2005.04.005; Rodriguez-Ojea A, 2002, PUBLIC HEALTH NUTR, V5, P129, DOI 10.1079/PHN2001284; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Scrimshaw NS, 2003, J NUTR, V133, p316S, DOI 10.1093/jn/133.1.316S; Shaheen SO, 1999, THORAX, V54, P396, DOI 10.1136/thx.54.5.396; Shore SA, 2006, PHARMACOL THERAPEUT, V110, P83, DOI 10.1016/j.pharmthera.2005.10.002; Sonis J, 1998, Fam Med, V30, P584; Strachan DP, 1997, PEDIAT ALLERG IMM-UK, V8, P161, DOI 10.1111/j.1399-3038.1997.tb00156.x; Suhrcke M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020724; Von Mutius E, 1998, CLIN EXP ALLERGY, V28, P45; Waters H, 2004, INT J EPIDEMIOL, V33, P589, DOI 10.1093/ije/dyh074; Waters H, 2003, HEALTH POLICY PLANN, V18, P172, DOI 10.1093/heapol/czg022; Weiss ST, 2005, NAT IMMUNOL, V6, P537, DOI 10.1038/ni0605-537; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579; Wordemann M, 2006, TROP MED INT HEALTH, V11, P1813, DOI 10.1111/j.1365-3156.2006.01745.x; Wordemann M, 2006, ALLERGY, V61, P1125, DOI 10.1111/j.1398-9995.2006.01129.x	44	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39892	10.1371/journal.pone.0039892	http://dx.doi.org/10.1371/journal.pone.0039892			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768156	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100125
J	Wang, L; Weng, XC; He, S				Wang, Lan; Weng, Xuchu; He, Sheng			Perceptual Grouping without Awareness: Superiority of Kanizsa Triangle in Breaking Interocular Suppression	PLOS ONE			English	Article							BINOCULAR-RIVALRY; CORTICAL RESPONSES; SALIENT REGIONS; ATTENTION; CONSCIOUSNESS; EXPRESSIONS; INFORMATION; CONTOURS; FEARFUL; VISION	Much information could be processed unconsciously. However, there is no direct evidence on whether perceptual grouping could occur without awareness. To answer this question, we investigated whether a Kanizsa triangle (an example of perceptual grouping) is processed differently from stimuli with the same local components but are ungrouped or weakly grouped. Specifically, using a suppression time paradigm we tested whether a Kanizsa triangle would emerge from interocular continuous flash suppression sooner than control stimuli. Results show a significant advantage of the Kanizsa triangle: the Kanizsa triangle emerged from suppression noise significantly faster than the control stimulus with the local Pacmen randomly rotated (t(9) = -2.78, p = 0.02); and also faster than the control stimulus with all Pacmen rotated 180 degrees (t(11) = -3.20, p<0.01). Additional results demonstrated that the advantage of the grouped Kanizsa triangle could not be accounted for by the faster detection speed at the conscious level for the Kanizsa figures on a dynamic noise background. Our results indicate that certain properties supporting perceptual grouping could be processed in the absence of awareness.	[Wang, Lan; Weng, Xuchu] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Wang, Lan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Weng, Xuchu; He, Sheng] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Wang, Lan; He, Sheng] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Hangzhou Normal University; University of Minnesota System; University of Minnesota Twin Cities	Wang, L (corresponding author), Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China.	wengxc@psych.ac.cn; sheng@umn.edu			Natural Science Foundation of China [31070905]; U.S. National Science Foundation [BCS-0818588]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Science Foundation(National Science Foundation (NSF))	This research was supported by grants from the Natural Science Foundation of China (31070905) (http://www.nsfc.gov.cn/Portal0/default124.htm) and U.S. National Science Foundation (BCS-0818588) (http://www.nsf.gov/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Bakar A, 2008, HUM BRAIN MAPP, V29, P1313, DOI 10.1002/hbm.20464; Adams WJ, 2010, PSYCHOL SCI, V21, P205, DOI 10.1177/0956797609359508; Amihai I, 2011, CONSCIOUS COGN, V20, P269, DOI 10.1016/j.concog.2010.08.004; BENAV MB, 1992, PERCEPT PSYCHOPHYS, V52, P277, DOI 10.3758/BF03209145; BRAUN J, 1990, PERCEPT PSYCHOPHYS, V48, P45, DOI 10.3758/BF03205010; Conci M, 2007, PERCEPT PSYCHOPHYS, V69, P32, DOI 10.3758/BF03194451; Conci M, 2009, NEUROPSYCHOLOGIA, V47, P726, DOI 10.1016/j.neuropsychologia.2008.11.029; Fang F, 2005, NAT NEUROSCI, V8, P1380, DOI 10.1038/nn1537; Freeman AW, 2005, J NEUROPHYSIOL, V94, P4412, DOI 10.1152/jn.00557.2005; Harris JJ, 2011, PSYCHOL SCI, V22, P399, DOI 10.1177/0956797611399293; Haynes JD, 2005, NATURE, V438, P496, DOI 10.1038/nature04169; Jiang Y, 2007, PSYCHOL SCI, V18, P349, DOI 10.1111/j.1467-9280.2007.01902.x; Jiang Y, 2006, P NATL ACAD SCI USA, V103, P17048, DOI 10.1073/pnas.0605678103; Jiang Y, 2006, CURR BIOL, V16, P2023, DOI 10.1016/j.cub.2006.08.084; Koch C, 2007, TRENDS COGN SCI, V11, P16, DOI 10.1016/j.tics.2006.10.012; Meng M, 2007, J VISION, V7, DOI 10.1167/7.13.8; Moore CM, 1997, J EXP PSYCHOL HUMAN, V23, P339, DOI 10.1037/0096-1523.23.2.339; Moutoussis K, 2005, VISION RES, V45, P2231, DOI 10.1016/j.visres.2005.02.007; Murray SO, 2004, NEURAL NETWORKS, V17, P695, DOI 10.1016/j.neunet.2004.03.010; Pearson J, 2005, CURR BIOL, V15, P2142, DOI 10.1016/j.cub.2005.10.066; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Sobel KV, 2003, VISION RES, V43, P1533, DOI 10.1016/S0042-6989(03)00178-0; Stanley DA, 2003, NEURON, V37, P323, DOI 10.1016/S0896-6273(02)01148-0; Stein T, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00167; Stein T, 2011, J VISION, V11, DOI 10.1167/11.8.5; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; TREISMAN A, 1982, J EXP PSYCHOL HUMAN, V8, P194, DOI 10.1037/0096-1523.8.2.194; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; van Boxtel JJA, 2010, P NATL ACAD SCI USA, V107, P8883, DOI 10.1073/pnas.0913292107; VANDERZWAN R, 1994, VISUAL NEUROSCI, V11, P823, DOI 10.1017/S0952523800003114; Watanabe M, 2011, SCIENCE, V334, P829, DOI 10.1126/science.1203161; Williams MA, 2004, J NEUROSCI, V24, P2898, DOI 10.1523/JNEUROSCI.4977-03.2004; Wilson HR, 2003, P NATL ACAD SCI USA, V100, P14499, DOI 10.1073/pnas.2333622100; Wunderlich K, 2005, NAT NEUROSCI, V8, P1595, DOI 10.1038/nn1554; Yang E, 2007, EMOTION, V7, P882, DOI 10.1037/1528-3542.7.4.882; Yang E, 2012, J VISION, V12, DOI 10.1167/12.3.8	38	44	45	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40106	10.1371/journal.pone.0040106	http://dx.doi.org/10.1371/journal.pone.0040106			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768232	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100204
J	Xiang, YT; Wang, G; Hu, C; Guo, T; Ungvari, GS; Kilbourne, AM; Lai, KYC; Si, TM; Zheng, QW; Chen, DF; Fang, YR; Lu, Z; Yang, HC; Hu, J; Chen, ZY; Huang, Y; Sun, J; Wang, XP; Li, HC; Zhang, JB; Chiu, HFK				Xiang, Yu-Tao; Wang, Gang; Hu, Chen; Guo, Tong; Ungvari, Gabor S.; Kilbourne, Amy M.; Lai, Kelly Y. C.; Si, Tian-Mei; Zheng, Qi-Wen; Chen, Da-Fang; Fang, Yi-Ru; Lu, Zheng; Yang, Hai-Chen; Hu, Jian; Chen, Zhi-Yu; Huang, Yi; Sun, Jing; Wang, Xiao-Ping; Li, Hui-Chun; Zhang, Jin-Bei; Chiu, Helen F. K.			Demographic and Clinical Features and Prescribing Patterns of Psychotropic Medications in Patients with the Melancholic Subtype of Major Depressive Disorder in China	PLOS ONE			English	Article							NIGELLA-SATIVA SEEDS; 1ST 3 YEARS; OPIOID RECEPTOR; FOOD ALLERGY; MAST-CELLS; DOUBLE-BLIND; PHARMACOLOGICAL CHARACTERIZATION; MOUSE MODEL; THYMOQUINONE; MU	Background: Little has been known about the demographic and clinical features of the melancholic subtype of major depressive disorder (MDD) in Chinese patients. This study examined the frequency of melancholia in Chinese MDD patients and explored its demographic and clinical correlates and prescribing patterns of psychotropic drugs. Methods: A consecutively collected sample of 1,178 patients with MDD were examined in 13 psychiatric hospitals or psychiatric units of general hospitals in China nationwide. The cross-sectional data of patients' demographic and clinical characteristics and prescriptions of psychotropic drugs were recorded using a standardized protocol and data collection procedure. The diagnosis of the melancholic subtype was established using the Mini International Neuropsychiatric Interview (MINI). Medications ascertained included antidepressants, mood stabilizers, antipsychotics and benzodiazepines. Results: Six hundred and twenty nine (53.4%) of the 1,178 patients fulfilled criteria for melancholia. In multiple logistic regression analyses, compared to non-melancholic counterparts, melancholic MDD patients were more likely to be male and receive benzodiazepines, had more frequent suicide ideations and attempts and seasonal depressive episodes, while they were less likely to be employed and receive antidepressants and had less family history of psychiatric disorders and lifetime depressive episodes. Conclusions: The demographic and clinical features of melancholic MDD in Chinese patients were not entirely consistent with those found in Western populations. Compared to non-melancholic MDD patients, melancholic patients presented with different demographic and clinical features, which have implications for treatment decisions.	[Xiang, Yu-Tao; Lai, Kelly Y. C.; Chiu, Helen F. K.] Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Xiang, Yu-Tao; Wang, Gang; Hu, Chen; Guo, Tong] Capital Med Univ, Beijing Anding Hosp, Mood Disorders Ctr, Beijing, Peoples R China; [Ungvari, Gabor S.] Univ Notre Dame Australia, Marian Ctr, Perth, WA, Australia; [Kilbourne, Amy M.] Vet Adm Ann Arbor Ctr Clin Management Res, Ann Arbor, MI USA; [Kilbourne, Amy M.] Univ Michigan, Sch Med, Dept Psychiat, Ann Arbor, MI 48109 USA; [Si, Tian-Mei] Minist Mental Hlth, Key Lab Mental Hlth, Beijing, Peoples R China; [Si, Tian-Mei] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Zheng, Qi-Wen; Chen, Da-Fang] Peking Univ, Hlth Sci Ctr, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China; [Fang, Yi-Ru] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Div Mood Disorders, Shanghai 200030, Peoples R China; [Lu, Zheng] Tongji Univ, Shanghai Tongji Hosp, Sch Med, Shanghai 200092, Peoples R China; [Yang, Hai-Chen] Shenzhen Mental Hlth Ctr, Div Mood Disorders, Shenzhen, Guangdong, Peoples R China; [Hu, Jian] Harbin Med Univ, First Hosp, Harbin, Heilongjiang Pr, Peoples R China; [Chen, Zhi-Yu] Hangzhou Seventh Peoples Hosp, Hangzhou, Zhejiang, Peoples R China; [Huang, Yi] Sichuan Univ, W China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China; [Sun, Jing] Nanjing Med Univ, Affiliated Brain Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Xiao-Ping] Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Changsha, Hunan, Peoples R China; [Li, Hui-Chun] Zhejiang Univ, Affiliated Hosp 2, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Jin-Bei] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China	Chinese University of Hong Kong; Capital Medical University; University of Notre Dame Australia; University of Michigan System; University of Michigan; Peking University; Peking University; Shanghai Jiao Tong University; Tongji University; Harbin Medical University; Sichuan University; Nanjing Medical University; Central South University; Zhejiang University; Sun Yat Sen University	Xiang, YT (corresponding author), Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.	xyutly@gmail.com; gangwangdoc@gmail.com		Zheng, Qiwen/0000-0001-6921-6254	Ministry of Science and Technology of China [2007BAI17B05]; AstraZeneca China	Ministry of Science and Technology of China(Ministry of Science and Technology, China); AstraZeneca China(AstraZeneca)	This study was funded by the National Key Scientific and Technological Projects for the 11th Five-Year from the Ministry of Science and Technology of China (Project Title: Early Diagnostic Assessment and Standardized Treatment Approach for Depression; No. 2007BAI17B05). The study was initiated by the Chinese Society of Psychiatry (CSP) with support from AstraZeneca China. AstraZeneca China had no role in the study design, generating or interpreting the results. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Ayman Talatt, 2005, Egypt J Immunol, V12, P95; Abdel-Fattah AFM, 2000, EUR J PHARMACOL, V400, P89, DOI 10.1016/S0014-2999(00)00340-X; Badary OA, 2001, CANCER DETECT PREV, V25, P362; Banerjee S, 2010, NUTR CANCER, V62, P938, DOI 10.1080/01635581.2010.509832; BARBEZAT GO, 1979, S AFR MED J, V55, P502; BOCK SA, 1987, PEDIATRICS, V79, P683; Boskabady MH, 2010, PHYTOMEDICINE, V17, P707, DOI 10.1016/j.phymed.2010.01.002; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Butt MS, 2010, CRIT REV FOOD SCI, V50, P654, DOI 10.1080/10408390902768797; Buyukozturk S, 2005, J ETHNOPHARMACOL, V100, P295, DOI 10.1016/j.jep.2005.03.007; CHAKRAVARTY N, 1993, ANN ALLERGY, V70, P237; El Gazzar M, 2006, BBA-GEN SUBJECTS, V1760, P1088, DOI 10.1016/j.bbagen.2006.03.006; El Gazzar M, 2006, INT IMMUNOPHARMACOL, V6, P1135, DOI 10.1016/j.intimp.2006.02.004; Finlay TM, 2010, GLYCOCONJUGATE J, V27, P583, DOI 10.1007/s10719-010-9302-5; Garcia-Careaga Manuel Jr, 2005, Nutr Clin Pract, V20, P526, DOI 10.1177/0115426505020005526; Gerez IFA, 2010, EXPERT REV CLIN IMMU, V6, P279, DOI 10.1586/ECI.09.82; Ghosheh OA, 1999, J PHARMACEUT BIOMED, V19, P757, DOI 10.1016/S0731-7085(98)00300-8; GUPTA S, 1979, INDIAN J MED RES, V69, P981; Hosseinzadeh H, 2005, MED SCI MONITOR, V11, pBR106; Hosseinzadeh H, 2004, PHYTOMEDICINE, V11, P56, DOI 10.1078/0944-7113-00376; HOUGHTON PJ, 1995, PLANTA MED, V61, P33, DOI 10.1055/s-2006-957994; Isik F, 2011, DIGEST DIS SCI, V56, P721, DOI 10.1007/s10620-010-1333-z; JAFFE G, 1977, J INT MED RES, V5, P195, DOI 10.1177/030006057700500309; Kanter M, 2006, ARCH TOXICOL, V80, P217, DOI 10.1007/s00204-005-0037-1; Lee DKC, 2003, CLIN EXP ALLERGY, V33, P882, DOI 10.1046/j.1365-2222.2003.01705.x; Luccioli S, 2008, PEDIATRICS, V122, pS105, DOI 10.1542/peds.2008-1315n; Lutterodt H, 2010, LWT-FOOD SCI TECHNOL, V43, P1409, DOI 10.1016/j.lwt.2010.04.009; Mainardi T, 2009, J ALLERGY CLIN IMMUN, V123, P283, DOI 10.1016/j.jaci.2008.12.023; Mansour M, 2004, J ENZYM INHIB MED CH, V19, P431, DOI 10.1080/14756360400002072; MENG F, 1993, P NATL ACAD SCI USA, V90, P9954, DOI 10.1073/pnas.90.21.9954; Nikakhlagh S, 2011, AM J OTOLARYNG, V32, P402, DOI 10.1016/j.amjoto.2010.07.019; Padhye Subhash, 2008, Cancer Ther, V6, P495; Perrier C, 2010, CLIN EXP ALLERGY, V40, P153, DOI 10.1111/j.1365-2222.2009.03329.x; Philippe D, 2003, J CLIN INVEST, V111, P1329, DOI 10.1172/JCI200316750; Poonyachoti S, 2001, J NEUROIMMUNOL, V112, P89, DOI 10.1016/S0165-5728(00)00387-8; Prescott S, 2011, PEDIAT ALLERG IMM-UK, V22, P155, DOI 10.1111/j.1399-3038.2011.01145.x; Ramadan MF, 2002, AID FOOD240 3 0 CO, P2; Ramesh S, 2008, CLIN REV ALLERG IMMU, V34, P217, DOI 10.1007/s12016-007-8034-1; Rogers TJ, 2003, TRENDS IMMUNOL, V24, P116, DOI 10.1016/S1471-4906(03)00003-6; Schempp CA, 2003, PHYTOMEDICINE, V10, P31, DOI 10.1078/1433-187X-00306; Shahbazian A, 2002, BRIT J PHARMACOL, V135, P741, DOI 10.1038/sj.bjp.0704527; SHOOK JE, 1989, J PHARMACOL EXP THER, V249, P83; Sicherer SH, 2011, J ALLERGY CLIN IMMUN, V127, P594, DOI 10.1016/j.jaci.2010.11.044; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, pS116, DOI 10.1016/j.jaci.2009.08.028; SIMONIN F, 1994, MOL PHARMACOL, V46, P1015; Sirohi S, 2007, J PHARMACOL EXP THER, V323, P701, DOI 10.1124/jpet.107.127019; STEAD RH, 1989, GASTROENTEROLOGY, V97, P575, DOI 10.1016/0016-5085(89)90627-6; Stead RH, 2006, AUTON NEUROSCI-BASIC, V125, P53, DOI 10.1016/j.autneu.2006.01.002; Vaillancourt F, 2011, J CELL BIOCHEM, V112, P107, DOI 10.1002/jcb.22884; Venkatachallam SKT, 2010, J FOOD SCI TECH MYS, V47, P598, DOI 10.1007/s13197-010-0109-y; Venter C, 2008, ALLERGY, V63, P354, DOI 10.1111/j.1398-9995.2007.01570.x; Verma-Gandhu M, 2007, AM J PHYSIOL-GASTR L, V292, pG344, DOI 10.1152/ajpgi.00318.2006; WANG JB, 1994, FEBS LETT, V338, P217, DOI 10.1016/0014-5793(94)80368-4; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Wood JD, 2004, NEUROGASTROENT MOTIL, V16, P17, DOI 10.1111/j.1743-3150.2004.00554.x; Zuercher AW, 2010, CLIN EXP ALLERGY, V40, P942, DOI 10.1111/j.1365-2222.2010.03460.x; Zuercher AW, 2006, CURR OPIN BIOTECH, V17, P198, DOI 10.1016/j.copbio.2006.01.010	57	7	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39840	10.1371/journal.pone.0039840	http://dx.doi.org/10.1371/journal.pone.0039840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768140	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100110
J	Heitmann, ER; Lankachandra, KM; Wall, J; Harris, GD; McKinney, HJ; Jalali, GR; Verma, Y; Kershnar, E; Kilpatrick, MW; Tsipouras, P; Harper, DM				Heitmann, Erica R.; Lankachandra, Kamani M.; Wall, Jeff; Harris, George D.; McKinney, Hollie J.; Jalali, G. Reza; Verma, Yogita; Kershnar, Eric; Kilpatrick, Michael W.; Tsipouras, Petros; Harper, Diane M.			3q26 Amplification Is an Effective Negative Triage Test for LSIL: A Historical Prospective Study	PLOS ONE			English	Article							CERVICAL INTRAEPITHELIAL NEOPLASIA; TELOMERASE GENE TERC; SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS INFECTION; GENOMIC AMPLIFICATION; INTEROBSERVER REPRODUCIBILITY; EUROPEAN GUIDELINES; QUALITY-ASSURANCE; RANDOMIZED-TRIAL; PAP-SMEARS	Background: Women with low grade squamous intraepithelial lesions (LSIL) at cervical cancer screening are currently referred for further diagnostic work up despite 80% having no precancerous lesion. The primary purpose of this study is to measure the test characteristics of 3q26 chromosome gain (3q26 gain) as a host marker of carcinogenesis in women with LSIL. A negative triage test may allow these women to be followed by cytology alone without immediate referral to colposcopy. Methods and Findings: A historical prospective study was designed to measure 3q26 gain from the archived liquid cytology specimens diagnosed as LSIL among women attending colposcopy between 2007 and 2009. 3q26 gain was assessed on the index liquid sample; and sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were measured at immediate triage and at 6-16 months after colposcopic biopsy. The sensitivity of 3q26 gain measured at immediate triage from automated and manually reviewed tests in 65 non-pregnant unique women was 70% (95% CI: 35, 93) with a NPV of 89% (95% CI: 78, 96). The sensitivity and NPV increased to 80% (95% CI: 28, 99) and 98% (95% CI: 87, 100), respectively, when only the automated method of detecting 3q26 gain was used. Conclusions: 3q26 gain demonstrates high sensitivity and NPV as a negative triage test for women with LSIL, allowing possible guideline changes to routine surveillance instead of immediate colposcopy. Prospective studies are ongoing to establish the sensitivity, specificity, PPV and NPV of 3q26 gain for LSIL over time.	[Heitmann, Erica R.; Harper, Diane M.] Univ Missouri, Sch Med, Dept Biomed & Hlth Informat, Kansas City, MO 64108 USA; [Heitmann, Erica R.; Wall, Jeff; Harper, Diane M.] Univ Missouri, Sch Med, Dept Obstet & Gynecol, Kansas City, MO 64108 USA; [Lankachandra, Kamani M.] Univ Missouri, Sch Med, Dept Pathol, Kansas City, MO 64108 USA; [Harris, George D.; McKinney, Hollie J.; Harper, Diane M.] Univ Missouri, Sch Med, Dept Community & Family Med, Kansas City, MO 64108 USA; [Heitmann, Erica R.; Harper, Diane M.] Univ Missouri, Sch Med, Ctr Excellence, Kansas City, MO 64108 USA; [Jalali, G. Reza; Verma, Yogita; Kershnar, Eric; Kilpatrick, Michael W.; Tsipouras, Petros] Ikonisys Inc, New Haven, CT USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Ikonisys Inc	Heitmann, ER (corresponding author), Univ Missouri, Sch Med, Dept Biomed & Hlth Informat, Kansas City, MO 64108 USA.	Diane.M.Harper@gmail.com	Harper, Diane M./I-2180-2014	Harper, Diane M./0000-0001-7648-883X	Ikonisys	Ikonisys	UPA and Truman Medical Centers received monies from Ikonisys to conduct this trial. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alameda F, 2009, HUM PATHOL, V40, P1474, DOI 10.1016/j.humpath.2009.03.013; Andersson S, 2006, BRIT J CANCER, V95, P331, DOI 10.1038/sj.bjc.6603253; Andersson S, 2009, AM J PATHOL, V175, P1831, DOI 10.2353/ajpath.2009.090122; Arbyn M, 2010, BJOG-INT J OBSTET GY, V117, P641, DOI 10.1111/j.1471-0528.2010.02521.x; Arbyn M, 2006, VACCINE, V24, P78, DOI 10.1016/j.vaccine.2006.05.117; Arbyn M, 2009, INT J CANCER, V125, P2489, DOI 10.1002/ijc.24774; Arbyn M, 2009, J CELL MOL MED, V13, P648, DOI 10.1111/j.1582-4934.2008.00631.x; Aulmann S, 2008, J CLIN PATHOL, V61, P1034, DOI 10.1136/jcp.2008.056275; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Cao Y, 2008, CANCER SCI, V99, P1092, DOI 10.1111/j.1349-7006.2008.00815.x; Caraway NP, 2008, GYNECOL ONCOL, V110, P37, DOI 10.1016/j.ygyno.2008.01.040; Castle PE, 2010, AM J EPIDEMIOL, V171, P155, DOI 10.1093/aje/kwp390; Castle PE, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.07.049; Cotton S, 2010, BJOG-INT J OBSTET GY, V117, P645, DOI 10.1111/j.1471-0528.2010.02519.x; Cox JT, 2003, AM J OBSTET GYNECOL, V188, P1406, DOI 10.1067/mob.2003.461; Dalstein W, 2003, INT J CANCER, V106, P396, DOI 10.1002/ijc.11222; Eversole GM, 2010, ARCH PATHOL LAB MED, V134, P331, DOI 10.1043/1543-2165-134.3.331; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Hellsten C, 2008, BJOG-INT J OBSTET GY, V115, P212, DOI 10.1111/j.1471-0528.2007.01609.x; Herbert A, 2007, CYTOPATHOLOGY, V18, P213, DOI 10.1111/j.1365-2303.2007.00469.x; Heselmeyer K, 1997, GENE CHROMOSOME CANC, V19, P233, DOI 10.1002/(SICI)1098-2264(199708)19:4<233::AID-GCC5>3.0.CO;2-Y; Heselmeyer-Haddad K, 2005, AM J PATHOL, V166, P1229, DOI 10.1016/S0002-9440(10)62341-3; Heselmeyer-Haddad K, 2003, AM J PATHOL, V163, P1405, DOI 10.1016/S0002-9440(10)63498-0; Hopman AHN, 2006, J PATHOL, V210, P412, DOI 10.1002/path.2070; Hopman AHN, 2004, J PATHOL, V202, P23, DOI 10.1002/path.1490; Hsu CP, 2005, WORLD J GASTROENTERO, V11, P6941, DOI 10.3748/wjg.v11.i44.6941; Huang KF, 2007, J FORMOS MED ASSOC, V106, P894, DOI 10.1016/S0929-6646(08)60059-5; Insinga RP, 2011, CANCER EPIDEM BIOMAR, V20, P287, DOI 10.1158/1055-9965.EPI-10-0791; Jalali GR, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.12.016; Jin GA, 2011, CANCER SCI, V102, P144, DOI 10.1111/j.1349-7006.2010.01782.x; Jordan J, 2008, CYTOPATHOLOGY, V19, P342, DOI 10.1111/j.1365-2303.2008.00623.x; Safont MJ, 2011, CLIN TRANSL ONCOL, V13, P396, DOI 10.1007/s12094-011-0673-2; Kinney WK, 1998, OBSTET GYNECOL, V91, P973, DOI 10.1016/S0029-7844(98)00080-5; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Kokalj-Vokac N, 2009, CANCER GENET CYTOGEN, V195, P19, DOI 10.1016/j.cancergencyto.2009.01.005; Le T, 2006, INT J GYNECOL CANCER, V16, P1089, DOI 10.1111/j.1525-1438.2006.00599.x; Li Y, 2010, INT J GYNECOL CANCER, V20, P631, DOI 10.1111/IGC.0b013e3181c50c7e; Liu Z, 2011, CANC EPIDEM IN PRESS; Ma YY, 2000, ONCOGENE, V19, P2739, DOI 10.1038/sj.onc.1203597; Massad LS, 2004, OBSTET GYNECOL, V104, P1077, DOI 10.1097/01.AOG.0000143256.63961.c0; Nayar Ritu, 2004, Cytojournal, V1, P4, DOI 10.1186/1742-6413-1-4; Nobbenhuis MAE, 1999, LANCET, V354, P20, DOI 10.1016/S0140-6736(98)12490-X; Rijkaart DC, 2012, INT J CANCER, V130, P602, DOI 10.1002/ijc.26056; Schiffman M, 2007, CANCER CYTOPATHOL, V111, P145, DOI 10.1002/cncr.22751; Schlecht NF, 2003, JNCI-J NATL CANCER I, V95, P1336, DOI 10.1093/jnci/djg037; Seppo A, 2009, GYNECOL ONCOL, V114, P80, DOI 10.1016/j.ygyno.2009.03.031; Sherman ME, 2007, CANCER CYTOPATHOL, V111, P15, DOI 10.1002/cncr.22423; Sokolova I, 2007, J MOL DIAGN, V9, P604, DOI 10.2353/jmoldx.2007.070007; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1393, DOI 10.1067/mob.2003.462; StatSoft Inc, 2010, STATISTICA DAT AN SO; Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; Suso EMI, 2011, CANCER IMMUNOL IMMUN, V60, P809, DOI 10.1007/s00262-011-0991-9; Szarewski A, 2008, CANCER EPIDEM BIOMAR, V17, P3033, DOI 10.1158/1055-9965.EPI-08-0508; Tavassoeli FA, 2003, PATHOLOGY GENETICS T; Tu Z, 2009, CANCER GENET CYTOGEN, V191, P10, DOI 10.1016/j.cancergencyto.2009.01.004; Umayahara K, 2002, GENE CHROMOSOME CANC, V33, P98, DOI 10.1002/gcc.1215; Verri A, 2011, LABMEDICINE, V42, P134, DOI 10.1309/LMZXH9BYHV1XVOUH; Wilting S, 2006, J PATHOL, V209, P220, DOI 10.1002/path.1966; Wilting SM, 2009, CANCER RES, V69, P647, DOI 10.1158/0008-5472.CAN-08-2478; Wong G, 2008, CLIN J AM SOC NEPHRO, V3, pS87, DOI 10.2215/CJN.03320807; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P346, DOI 10.1016/j.ajog.2007.07.047; Zhang A, 2002, INT J CANCER, V101, P427, DOI 10.1002/ijc.10627; Zhang B, 2011, LANCET ONCOL, V12, P477, DOI 10.1016/S1470-2045(11)70076-6	64	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39101	10.1371/journal.pone.0039101	http://dx.doi.org/10.1371/journal.pone.0039101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792164	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800006
J	Eisenhardt, M; Glassner, A; Kramer, B; Korner, C; Sibbing, B; Kokordelis, P; Nischalke, HD; Sauerbruch, T; Spengler, U; Nattermann, J				Eisenhardt, Marianne; Glaessner, Andreas; Kraemer, Benjamin; koerner, Christian; Sibbing, Bernhard; Kokordelis, Pavlos; Nischalke, Hans Dieter; Sauerbruch, Tilman; Spengler, Ulrich; Nattermann, Jacob			The CXCR3(+)CD56Bright Phenotype Characterizes a Distinct NK Cell Subset with Anti-Fibrotic Potential That Shows Dys-Regulated Activity in Hepatitis C	PLOS ONE			English	Article							LIVER FIBROSIS; STELLATE CELLS; LIGAND; CXCL10; HEPATOCYTES; ASSOCIATION; EXPRESSION; PROTEIN-10; CHEMOKINES; RIBAVIRIN	Background: In mouse models, natural killer (NK) cells have been shown to exert anti-fibrotic activity via killing of activated hepatic stellate cells (HSC). Chemokines and chemokine receptors critically modulate hepatic recruitment of NK cells. In hepatitis C, the chemokine receptor CXCR3 and its ligands have been shown to be associated with stage of fibrosis suggesting a role of these chemokines in HCV associated liver damage by yet incompletely understood mechanisms. Here, we analyzed phenotype and function of CXCR3 expressing NK cells in chronic hepatitis C. Methods: Circulating NK cells from HCV-infected patients (n = 57) and healthy controls (n = 27) were analyzed with respect to CXCR3 and co-expression of different maturation markers. Degranulation and interferon-gamma secretion of CXCR3(+) and CXCR3(-) NK cell subsets were studied after co-incubation with primary human hepatic stellate cells (HSC). In addition, intra-hepatic frequency of CXCR3(+) NK cells was correlated with stage of liver fibrosis (n = 15). Results: We show that distinct NK cell subsets can be distinguished based on CXCR3 surface expression. In healthy controls CXCR3(+)CD56Bright NK cells displayed strongest activity against HSC. Chronic hepatitis C was associated with a significantly increased frequency of CXCR3(+)CD56Bright NK cells which showed impaired degranulation and impaired IFN-gamma secretion in response to HSC. Of note, we observed intra-hepatic accumulation of this NK cell subset in advanced stages of liver fibrosis. Conclusion: We show that distinct NK cell subsets can be distinguished based on CXCR3 surface expression. Intra-hepatic accumulation of the functionally impaired CXCR3(+) CD56Bright NK cell subset might be involved in HCV-induced liver fibrosis.	[Eisenhardt, Marianne; Glaessner, Andreas; Kraemer, Benjamin; koerner, Christian; Sibbing, Bernhard; Kokordelis, Pavlos; Nischalke, Hans Dieter; Sauerbruch, Tilman; Spengler, Ulrich; Nattermann, Jacob] Univ Bonn, Dept Internal Med 1, Bonn, Germany	University of Bonn	Eisenhardt, M (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.	jacob.nattermann@ukb.uni-bonn.de	Körner, Christian/ABB-8335-2020; Krämer, Benjamin/AAC-9618-2019	Körner, Christian/0000-0002-3431-7319; Krämer, Benjamin/0000-0002-1385-9709; Nischalke, Hans Dieter/0000-0002-3457-0023	German Research Foundation [DFG SFB/TRR 57]; H. W. and J. Hector Foundation [M42]; BMBF (German Ministry for Science and Education) [01KI0791]	German Research Foundation(German Research Foundation (DFG)); H. W. and J. Hector Foundation; BMBF (German Ministry for Science and Education)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Research Foundation (DFG SFB/TRR 57), the H. W. and J. Hector Foundation [grant number M42], and by a grant from the BMBF (German Ministry for Science and Education) [01KI0791]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butera D, 2005, BLOOD, V106, P1175, DOI 10.1182/blood-2005-01-0126; Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; Cruise MW, 2006, J IMMUNOL, V176, P6235, DOI 10.4049/jimmunol.176.10.6235; Diago M, 2006, GUT, V55, P374, DOI 10.1136/gut.2005.074062; Gao Bin, 2007, Expert Rev Gastroenterol Hepatol, V1, P173, DOI 10.1586/17474124.1.1.173; Harvey CE, 2003, J LEUKOCYTE BIOL, V74, P360, DOI 10.1189/jlb.0303093; Helbig KJ, 2004, HEPATOLOGY, V39, P1220, DOI 10.1002/hep.20167; Jeong WI, 2008, J GASTROEN HEPATOL, V23, pS112, DOI 10.1111/j.1440-1746.2007.05274.x; Jeong WI, 2008, GASTROENTEROLOGY, V134, P248, DOI 10.1053/j.gastro.2007.09.034; Jeong WI, 2006, HEPATOLOGY, V44, P1441, DOI 10.1002/hep.21419; Jeong WI, 2011, HEPATOLOGY, V53, P1342, DOI 10.1002/hep.24190; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Melhem A, 2006, J HEPATOL, V45, P60, DOI 10.1016/j.jhep.2005.12.025; Morishima C, 2006, HEPATOLOGY, V43, P573, DOI 10.1002/hep.21073; Muhanna N, 2011, GUT, V60, P90, DOI 10.1136/gut.2010.211136; Norris S, 1998, J HEPATOL, V28, P84, DOI 10.1016/S0168-8278(98)80206-7; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055; Radaeva S, 2007, AM J PHYSIOL-GASTR L, V293, pG809, DOI 10.1152/ajpgi.00212.2007; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; Sene D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001184; Tacke F, 2011, LIVER INT, V31, P842, DOI 10.1111/j.1478-3231.2011.02504.x; Varchetta S, 2009, J HEPATOL, V50, P314, DOI 10.1016/j.jhep.2008.10.018; Zeremski M, 2008, HEPATOLOGY, V48, P1440, DOI 10.1002/hep.22500; Zeremski M, 2011, J INFECT DIS, V204, P832, DOI 10.1093/infdis/jir424; Zeremski M, 2009, J INFECT DIS, V200, P1774, DOI 10.1086/646614	26	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e38846	10.1371/journal.pone.0038846	http://dx.doi.org/10.1371/journal.pone.0038846			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792160	gold, Green Published, Green Submitted			2022-12-27	WOS:000306436300004
J	Schaffhauser, DF; Patti, M; Goda, T; Miyahara, Y; Forster, IC; Dittrich, PS				Schaffhauser, Daniel Felix; Patti, Monica; Goda, Tatsuro; Miyahara, Yuji; Forster, Ian Cameron; Dittrich, Petra Stephanie			An Integrated Field-Effect Microdevice for Monitoring Membrane Transport in Xenopus laevis Oocytes via Lateral Proton Diffusion	PLOS ONE			English	Article							CELL-MEMBRANE; PHOSPHATE COTRANSPORTER; SODIUM-CHANNEL; CLAMP; EXPRESSION; MECHANISM; FLOUNDER; KINETICS; SURFACE; SYSTEM	An integrated microdevice for measuring proton-dependent membrane activity at the surface of Xenopus laevis oocytes is presented. By establishing a stable contact between the oocyte vitelline membrane and an ion-sensitive field-effect (ISFET) sensor inside a microperfusion channel, changes in surface pH that are hypothesized to result from facilitated proton lateral diffusion along the membrane were detected. The solute diffusion barrier created between the sensor and the active membrane area allowed detection of surface proton concentration free from interference of solutes in bulk solution. The proposed sensor mechanism was verified by heterologously expressing membrane transport proteins and recording changes in surface pH during application of the specific substrates. Experiments conducted on two families of phosphate-sodium cotransporters (SLC20 & SLC34) demonstrated that it is possible to detect phosphate transport for both electrogenic and electroneutral isoforms and distinguish between transport of different phosphate species. Furthermore, the transport activity of the proton/amino acid cotransporter PAT1 assayed using conventional whole cell electrophysiology correlated well with changes in surface pH, confirming the ability of the system to detect activity proportional to expression level.	[Schaffhauser, Daniel Felix] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Zurich, Switzerland; [Patti, Monica; Forster, Ian Cameron] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Goda, Tatsuro; Miyahara, Yuji; Dittrich, Petra Stephanie] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Tokyo Medical & Dental University (TMDU)	Schaffhauser, DF (corresponding author), Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Zurich, Switzerland.	miyahara.bsr@tmd.ac.jp; iforster@access.uzh.ch; dittrich@org.chem.eth.ch	Dittrich, Petra S/C-6717-2008; Goda, Tatsuro/B-6484-2011	Dittrich, Petra S/0000-0001-5359-8403; Goda, Tatsuro/0000-0003-2688-8186; Forster, Ian/0000-0003-3087-9952	European Research Council [203428]; National Institute for Materials Science (NIMS, Tsukuba, JPN); JST-CREST (JPN)	European Research Council(European Research Council (ERC)European Commission); National Institute for Materials Science (NIMS, Tsukuba, JPN); JST-CREST (JPN)	Main funding: European Research Council (ERC Starting Grant, nu-LIPIDS, No. 203428); National Institute for Materials Science (NIMS, Tsukuba, JPN): Research visit grant; JST-CREST (JPN): Partial financial support of materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; Antonenko YN, 1998, FEBS LETT, V429, P197, DOI 10.1016/S0014-5793(98)00590-0; ARONSON PS, 1982, NATURE, V299, P161, DOI 10.1038/299161a0; Bacconi A, 2005, P NATL ACAD SCI USA, V102, P12606, DOI 10.1073/pnas.0505882102; Baumann WH, 1999, SENSOR ACTUAT B-CHEM, V55, P77, DOI 10.1016/S0925-4005(99)00116-1; BERGVELD P, 1970, IEEE T BIO-MED ENG, VBM17, P70, DOI 10.1109/TBME.1970.4502688; Blanchard MG, 2008, AM J PHYSIOL-CELL PH, V295, pC1464, DOI 10.1152/ajpcell.00560.2007; Boll M, 2002, J BIOL CHEM, V277, P22966, DOI 10.1074/jbc.M200374200; BURCKHARDT BC, 1992, PFLUG ARCH EUR J PHY, V420, P78, DOI 10.1007/BF00378644; Casans S, 2000, EDN, V45, P164; Cucu D, 2004, PFLUG ARCH EUR J PHY, V447, P934, DOI 10.1007/s00424-003-1171-3; Dahan E, 2007, BIOSENS BIOELECTRON, V22, P3196, DOI 10.1016/j.bios.2007.02.017; DUMONT JN, 1978, J MORPHOL, V155, P73, DOI 10.1002/jmor.1051550106; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; Foltz M, 2005, BIOCHEM J, V386, P607, DOI 10.1042/BJ20041519; Forster IC, 1999, AM J PHYSIOL-RENAL, V276, pF644, DOI 10.1152/ajprenal.1999.276.4.F644; GEORGE AL, 1989, P NATL ACAD SCI USA, V86, P7295, DOI 10.1073/pnas.86.18.7295; GUNDERSEN CB, 1982, PROC R SOC SER B-BIO, V216, P369, DOI 10.1098/rspb.1982.0080; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Lehmann M, 2000, BIOSENS BIOELECTRON, V15, P117, DOI 10.1016/S0956-5663(00)00065-8; MacAulay N, 2001, J BIOL CHEM, V276, P40476, DOI 10.1074/jbc.M105578200; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Marx D, 1999, NATURE, V397, P601, DOI 10.1038/17579; Medvedev ES, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/23/234103; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; OLIVARES W, 1975, BIOPHYS J, V15, P143, DOI 10.1016/S0006-3495(75)85798-5; Papke RL, 2010, METHODS, V51, P121, DOI 10.1016/j.ymeth.2010.01.012; Ravera S, 2007, AM J PHYSIOL-CELL PH, V293, pC606, DOI 10.1152/ajpcell.00064.2007; Sakata T, 2008, ANAL CHEM, V80, P1493, DOI 10.1021/ac701977e; Schaffhauser DF, 2011, LAB CHIP, V11, P3471, DOI 10.1039/c0lc00729c; Schnizler K, 2003, RECEPTOR CHANNEL, V9, P41, DOI 10.1080/10606820308253; Segawa H, 2002, J BIOL CHEM, V277, P19665, DOI 10.1074/jbc.M200943200; STRICKHOLM A, 1961, J GEN PHYSIOL, V44, P1073, DOI 10.1085/jgp.44.6.1073; Taylor PM, 1996, J EXP BIOL, V199, P923; VANHAL REG, 1995, SENSOR ACTUAT B-CHEM, V24, P201, DOI 10.1016/0925-4005(95)85043-0; WERNER A, 1994, AM J PHYSIOL, V267, pF311, DOI 10.1152/ajprenal.1994.267.2.F311	39	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39238	10.1371/journal.pone.0039238	http://dx.doi.org/10.1371/journal.pone.0039238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792166	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000306436300005
J	Ammar, FF; Abdel-Azeim, S; Zargarian, L; Hobaika, Z; Maroun, RG; Fermandjian, S				Ammar, Farah F.; Abdel-Azeim, Safwat; Zargarian, Loussinee; Hobaika, Zeina; Maroun, Richard G.; Fermandjian, Serge			Unprocessed Viral DNA Could Be the Primary Target of the HIV-1 Integrase Inhibitor Raltegravir	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; STRAND TRANSFER INHIBITORS; NUCLEIC-ACID INTERACTIONS; MOLECULAR-DYNAMICS; EXPERIENCED PATIENTS; CATALYTIC DOMAIN; FREE-ENERGIES; ACTIVE-SITE; FORCE-FIELD; IN-VITRO	Integration of HIV DNA into host chromosome requires a 3'-processing (3'-P) and a strand transfer (ST) reactions catalyzed by virus integrase (IN). Raltegravir (RAL), commonly used in AIDS therapy, belongs to the family of IN ST inhibitors (INSTIs) acting on IN-viral DNA complexes (intasomes). However, studies show that RAL fails to bind IN alone, but nothing has been reported on the behaviour of RAL toward free viral DNA. Here, we assessed whether free viral DNA could be a primary target for RAL, assuming that the DNA molecule is a receptor for a huge number of pharmacological agents. Optical spectroscopy, molecular dynamics and free energy calculations, showed that RAL is a tight binder of both processed and unprocessed LTR (long terminal repeat) ends. Complex formation involved mainly van der Waals forces and was enthalpy driven. Dissociation constants (Kds) revealed that RAL affinity for unbound LTRs was stronger than for bound LTRs. Moreover, Kd value for binding of RAL to LTRs and IC50 value (half concentration for inhibition) were in same range, suggesting that RAL binding to DNA and ST inhibition are correlated events. Accommodation of RAL into terminal base-pairs of unprocessed LTR is facilitated by an extensive end fraying that lowers the RAL binding energy barrier. The RAL binding entails a weak damping of fraying and correlatively of 3'-P inhibition. Noteworthy, present calculated RAL structures bound to free viral DNA resemble those found in RAL-intasome crystals, especially concerning the contacts between the fluorobenzyl group and the conserved 5'C(4)pA(3)3' step. We propose that RAL inhibits IN, in binding first unprocessed DNA. Similarly to anticancer drug poisons acting on topoisomerases, its interaction with DNA does not alter the cut, but blocks the subsequent joining reaction. We also speculate that INSTIs having viral DNA rather IN as main target could induce less resistance.	[Ammar, Farah F.; Abdel-Azeim, Safwat; Zargarian, Loussinee; Fermandjian, Serge] Ecole Normale Super, LBPA, UMR8113, CNRS, Cachan, France; [Ammar, Farah F.; Hobaika, Zeina; Maroun, Richard G.] Univ St Joseph, Unite Biochim, Dept SVT, Fac Sci, Cst Mar Roukoz, Beyrouth, Lebanon	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Saint Joseph University Beirut	Ammar, FF (corresponding author), Ecole Normale Super, LBPA, UMR8113, CNRS, Cachan, France.	serge.fermandjian@lbpa.ens-cachan.fr	Maroun, Richard/ABG-6613-2020; Abdel-azeim, Safwat/R-8096-2019	Maroun, Richard/0000-0002-0697-2535; abdel-Azeim, Safwat sayed/0000-0001-8611-1251	French-Lebanese program CEDRE [05 SF21/L14]	French-Lebanese program CEDRE	This work was supported by a grant from the French-Lebanese program CEDRE [05 SF21/L14 to Dr. Fermandjian and Dr. Maroun] (L'accord de cooperation pour l'evaluation et le developpement de la recherche). http://www.enseignementsup-recherche.gouv.fr/cid21216/programme-cedre-cooperation-franco-libanaise.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapkina J, 2004, EUR J BIOCHEM, V271, P205, DOI 10.1046/j.1432-1033.2003.03921.x; Berova N., 2000, CIRCULAR DICHROISM P, DOI DOI 10.1038/natrevmats.2016.21; Bujacz G, 1996, STRUCTURE, V4, P89, DOI 10.1016/S0969-2126(96)00012-3; BUJALOWSKI W, 1987, BIOCHEMISTRY-US, V26, P3099, DOI 10.1021/bi00385a023; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CALLADINE CR, 1992, UNDERSTANDING DNA MO; Chaires JB, 2006, ARCH BIOCHEM BIOPHYS, V453, P26, DOI 10.1016/j.abb.2006.03.027; da Silva D, 2010, J ANTIMICROB CHEMOTH, V65, P1262, DOI 10.1093/jac/dkq099; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dicker IB, 2007, J BIOL CHEM, V282, P31186, DOI 10.1074/jbc.M704935200; DOUGHERTY G, 1982, CRC CR REV BIOCH MOL, V12, P103, DOI 10.3109/10409238209108704; ELLISON V, 1994, P NATL ACAD SCI USA, V91, P7316, DOI 10.1073/pnas.91.15.7316; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Espeseth AS, 2000, P NATL ACAD SCI USA, V97, P11244, DOI 10.1073/pnas.200139397; Fasman G.D., 1996, CIRCULAR DICHROISM C; Fitzkee NC, 2010, J BIOL CHEM, V285, P18072, DOI 10.1074/jbc.M110.113407; GOFF SP, 1992, ANNU REV GENET, V26, P527, DOI 10.1146/annurev.ge.26.120192.002523; Goldgur Y, 1999, P NATL ACAD SCI USA, V96, P13040, DOI 10.1073/pnas.96.23.13040; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Grobler JA, 2002, P NATL ACAD SCI USA, V99, P6661, DOI 10.1073/pnas.092056199; Hare S, 2011, MOL PHARMACOL, V80, P565, DOI 10.1124/mol.111.073189; Hare S, 2010, P NATL ACAD SCI USA, V107, P20057, DOI 10.1073/pnas.1010246107; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Harris SA, 2001, J AM CHEM SOC, V123, P12658, DOI 10.1021/ja016233n; HERTZBERG RP, 1989, BIOCHEMISTRY-US, V28, P4629, DOI 10.1021/bi00437a018; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Hill JJ, 1997, METHOD ENZYMOL, V278, P390; Hobaika Z, 2010, NEUROCHEM RES, V35, P888, DOI 10.1007/s11064-009-0098-2; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurley LH, 2002, NAT REV CANCER, V2, P188, DOI 10.1038/nrc749; Johns B., 2010, 17 C RETR OPP INF SA; Johnson BC, 2012, ANTIMICROB AGENTS CH, V56, P411, DOI 10.1128/AAC.05292-11; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KATZ RA, 1994, ANNU REV BIOCHEM, V63, P133, DOI 10.1146/annurev.bi.63.070194.001025; Katz RA, 2011, J BIOL CHEM, V286, P25710, DOI 10.1074/jbc.M111.229179; Koelsch KK, 2009, CURR OPIN HIV AIDS, V4, P518, DOI 10.1097/COH.0b013e328331b526; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Langley DR, 2008, BIOCHEMISTRY-US, V47, P13481, DOI 10.1021/bi801372d; Li XA, 2011, VIROLOGY, V411, P194, DOI 10.1016/j.virol.2010.12.008; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; Marchand C, 2009, CURR TOP MED CHEM, V9, P1016, DOI 10.2174/156802609789630910; Marinello J, 2008, BIOCHEMISTRY-US, V47, P9345, DOI 10.1021/bi800791q; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; McColl DJ, 2010, ANTIVIR RES, V85, P101, DOI 10.1016/j.antiviral.2009.11.004; Metifiot M, 2011, ANTIMICROB AGENTS CH, V55, P5127, DOI 10.1128/AAC.05288-11; Metifiot M, 2010, VIRUSES-BASEL, V2, P1347, DOI 10.3390/v2071347; MONNOT M, 1991, J BIOL CHEM, V266, P1820; MONNOT M, 1992, EUR J BIOCHEM, V204, P1035, DOI 10.1111/j.1432-1033.1992.tb16725.x; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Rassolov VA, 2001, J COMPUT CHEM, V22, P976, DOI 10.1002/jcc.1058; Reigadas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010311; Renisio JG, 2005, NUCLEIC ACIDS RES, V33, P1970, DOI 10.1093/nar/gki346; ROOTHAAN CCJ, 1951, REV MOD PHYS, V23, P69, DOI 10.1103/RevModPhys.23.69; Sato M, 2006, J MED CHEM, V49, P1506, DOI 10.1021/jm0600139; Scottoline BP, 1997, GENE DEV, V11, P371, DOI 10.1101/gad.11.3.371; Smith GF, 2009, PROGR MED CHEM, V48, P1, DOI 10.1016/S0079-6468(09)04801-2; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Treesuwan W, 2009, PHYS CHEM CHEM PHYS, V11, P10682, DOI 10.1039/b910574c; Vacca J, 2007, 4 IAS C HIV PATH TRE; VINK C, 1991, J VIROL, V65, P4636, DOI 10.1128/JVI.65.9.4636-4644.1991; VINK C, 1991, NUCLEIC ACIDS RES, V19, P6691, DOI 10.1093/nar/19.24.6691; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; WILSON WD, 1990, ANTI-CANCER DRUG DES, V5, P31; Xue WW, 2012, J COMPUT CHEM, V33, P527, DOI 10.1002/jcc.22887; Zargarian L, 2003, J BIOL CHEM, V278, P19966, DOI 10.1074/jbc.M211711200	73	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40223	10.1371/journal.pone.0040223	http://dx.doi.org/10.1371/journal.pone.0040223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768342	Green Submitted, gold, Green Published			2022-12-27	WOS:000305966500055
J	Chang, TC; Liu, CC; Hsing, EW; Liang, SM; Chi, YH; Sung, LY; Lin, SP; Shen, TL; Ko, BS; Yen, BLJ; Yet, SF; Wu, KK; Liou, JY				Chang, Tzu-Ching; Liu, Chia-Chia; Hsing, En-Wei; Liang, Shu-Man; Chi, Ya-Hui; Sung, Li-Ying; Lin, Shau-Ping; Shen, Tang-Long; Ko, Bor-Sheng; Yen, B. Linju; Yet, Shaw-Fang; Wu, Kenneth K.; Liou, Jun-Yang			14-3-3 sigma Regulates beta-Catenin-Mediated Mouse Embryonic Stem Cell Proliferation by Sequestering GSK-3 beta	PLOS ONE			English	Article							EFFICIENT TRANSFECTION METHOD; NEURAL DIFFERENTIATION; STRUCTURAL BASIS; RETINOIC ACID; ACTIVATION; PHOSPHORYLATION; KINASE; CANCER; PROTEINS; PLURIPOTENCY	Background: Pluripotent embryonic stem cells are considered to be an unlimited cell source for tissue regeneration and cell-based therapy. Investigating the molecular mechanism underlying the regulation of embryonic stem cell expansion is thus important. 14-3-3 proteins are implicated in controlling cell division, signaling transduction and survival by interacting with various regulatory proteins. However, the function of 14-3-3 in embryonic stem cell proliferation remains unclear. Methodology and Principal Findings: In this study, we show that all seven 14-3-3 isoforms were detected in mouse embryonic stem cells. Retinoid acid suppressed selectively the expression of 14-3-3 sigma isoform. Knockdown of 14-3-3 sigma with siRNA reduced embryonic stem cell proliferation, while only 14-3-3 sigma transfection increased cell growth and partially rescued retinoid acid-induced growth arrest. Since the growth-enhancing action of 14-3-3s was abrogated by beta-catenin knockdown, we investigated the influence of 14-3-3 sigma overexpression on beta-catenin/GSK-3 beta. 14-3-3 sigma bound GSK-3 beta and increased GSK-3 beta phosphorylation in a PI-3K/Akt-dependent manner. It disrupted beta-catenin binding by the multiprotein destruction complex. 14-3-3 sigma overexpression attenuated beta-catenin phosphorylation and rescued the decline of beta-catenin induced by retinoid acid. Furthermore, 14-3-3 sigma enhanced Wnt3a-induced beta-catenin level and GSK-3 beta phosphorylation. DKK, an inhibitor of Wnt signaling, abolished Wnt3a-induced effect but did not interfere GSK-3b/14-3-3 sigma binding. Significance: Our findings show for the first time that 14-3-3 sigma plays an important role in regulating mouse embryonic stem cell proliferation by binding and sequestering phosphorylated GSK-3 beta and enhancing Wnt-signaled GSK-3 beta inactivation. 14-3-3 sigma is a novel target for embryonic stem cell expansion.	[Chang, Tzu-Ching; Liu, Chia-Chia; Hsing, En-Wei; Liang, Shu-Man; Chi, Ya-Hui; Ko, Bor-Sheng; Yen, B. Linju; Yet, Shaw-Fang; Wu, Kenneth K.; Liou, Jun-Yang] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Liu, Chia-Chia; Sung, Li-Ying; Lin, Shau-Ping] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Shen, Tang-Long] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan; [Ko, Bor-Sheng] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Chang, TC (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan.	kkgo@nhri.org.tw; jliou@nhri.org.tw	Yet, Shaw-Fang/B-1067-2010; Yen, B. Lin-Ju/B-1088-2010; Chi, Ya-Hui/B-1080-2010; Yet, Shaw-Fang/O-8583-2019; Chi, Ya-Hui/ABE-8550-2020; Liou, Jun-Yang/B-1065-2010; Wu, Kenneth Kun-Yu/B-1070-2010	Chi, Ya-Hui/0000-0002-9216-0938; SUNG, LI-YING/0000-0003-1221-2476; Yet, Shaw-Fang/0000-0001-9097-3962; KO, BOR-SHENG/0000-0002-7965-7579; Lin, Shau-Ping/0000-0003-3423-991X; Shen, Tang-Long/0000-0001-6264-3608	National Science Council [99-3111-B-400-001, 100-2321-B-400-021, 99-3111-B-400-005, 100-2321-B-400-020]; National Health Research Institutes of Taiwan [00A1-CSPP08-014]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan)	This work was supported by The National Science Council (99-3111-B-400-001, 100-2321-B-400-021, 99-3111-B-400-005 and 100-2321-B-400-020) and The National Health Research Institutes (00A1-CSPP08-014) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal-Mawal A, 2003, J BIOL CHEM, V278, P12722, DOI 10.1074/jbc.M211491200; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Bouhon IA, 2006, STEM CELLS, V24, P1908, DOI 10.1634/stemcells.2006-0031; Chang TC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009187; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; ISHIGURO K, 1993, FEBS LETT, V325, P167, DOI 10.1016/0014-5793(93)81066-9; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kleber M, 2004, CURR OPIN CELL BIOL, V16, P681, DOI 10.1016/j.ceb.2004.08.006; Ko BS, 2009, GENE THER, V16, P154, DOI 10.1038/gt.2008.125; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Li FQ, 2008, J CELL BIOL, V181, P1141, DOI 10.1083/jcb.200709091; LI SF, 1995, EMBO J, V14, P685, DOI 10.1002/j.1460-2075.1995.tb07047.x; Li Y, 2002, J BIOL CHEM, V277, P44593, DOI 10.1074/jbc.C200510200; Liou JY, 2007, STEM CELLS, V25, P1096, DOI 10.1634/stemcells.2006-0505; Liou JY, 2007, CANCER RES, V67, P3185, DOI 10.1158/0008-5472.CAN-06-3431; Liou JY, 2010, METHODS MOL BIOL, V650, P145, DOI 10.1007/978-1-60761-769-3_12; Liu N, 2007, J CELL PHYSIOL, V211, P279, DOI 10.1002/jcp.20978; Liu P, 2010, J CELL PHYSIOL, V225, P810, DOI 10.1002/jcp.22292; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Martin-Ibanez R, 2007, J NEUROSCI RES, V85, P2686, DOI 10.1002/jnr.21228; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Mwangi S, 2006, NEUROSCIENCE, V143, P241, DOI 10.1016/j.neuroscience.2006.07.050; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Okita Keisuke, 2006, Curr Stem Cell Res Ther, V1, P103, DOI 10.2174/157488806775269061; Sakurai H, 2008, STEM CELLS, V26, P1865, DOI 10.1634/stemcells.2008-0173; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shumway SD, 2003, J BIOL CHEM, V278, P2089, DOI 10.1074/jbc.C200499200; Su YW, 2011, P NATL ACAD SCI USA, V108, P1555, DOI 10.1073/pnas.1017729108; Tian Q, 2004, P NATL ACAD SCI USA, V101, P15370, DOI 10.1073/pnas.0406499101; Welsh GI, 1996, TRENDS CELL BIOL, V6, P274, DOI 10.1016/0962-8924(96)10023-4; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; WOOD SA, 1993, NATURE, V365, P87, DOI 10.1038/365025a0; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yan WL, 2006, J PHARMACOL EXP THER, V317, P267, DOI 10.1124/jpet.105.096826; Yang HY, 2003, MOL CELL BIOL, V23, P7096, DOI 10.1128/MCB.23.20.7096-7107.2003; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	44	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40193	10.1371/journal.pone.0040193	http://dx.doi.org/10.1371/journal.pone.0040193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768254	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100227
J	Goatley, CHR; Hoey, AS; Bellwood, DR				Goatley, Christopher H. R.; Hoey, Andrew S.; Bellwood, David R.			The Role of Turtles as Coral Reef Macroherbivores	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CHELONIA-MYDAS; PHASE-SHIFTS; COMMUNITY STRUCTURE; HAWKSBILL TURTLES; KANEOHE BAY; HOME-RANGE; RESILIENCE; HERBIVORY; CONSERVATION	Herbivory is widely accepted as a vital function on coral reefs. To date, the majority of studies examining herbivory in coral reef environments have focused on the roles of fishes and/or urchins, with relatively few studies considering the potential role of macroherbivores in reef processes. Here, we introduce evidence that highlights the potential role of marine turtles as herbivores on coral reefs. While conducting experimental habitat manipulations to assess the roles of herbivorous reef fishes we observed green turtles (Chelonia mydas) and hawksbill turtles (Eretmochelys imbricata) showing responses that were remarkably similar to those of herbivorous fishes. Reducing the sediment load of the epilithic algal matrix on a coral reef resulted in a forty-fold increase in grazing by green turtles. Hawksbill turtles were also observed to browse transplanted thalli of the macroalga Sargassum swartzii in a coral reef environment. These responses not only show strong parallels to herbivorous reef fishes, but also highlight that marine turtles actively, and intentionally, remove algae from coral reefs. When considering the size and potential historical abundance of marine turtles we suggest that these potentially valuable herbivores may have been lost from many coral reefs before their true importance was understood.	[Goatley, Christopher H. R.; Hoey, Andrew S.; Bellwood, David R.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Goatley, Christopher H. R.; Hoey, Andrew S.; Bellwood, David R.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Hoey, Andrew S.] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia	James Cook University; James Cook University; King Abdullah University of Science & Technology	Goatley, CHR (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	christopher.goatley@jcu.edu.au	Goatley, Christopher/C-1492-2016; Hoey, Andrew S/B-5457-2015	Goatley, Christopher/0000-0002-2930-5591; Hoey, Andrew/0000-0002-4261-5594	Australian Research Council; PADI Foundation; Lizard Island Doctoral Fellowship; Ian Potter Doctoral Fellowship at Lizard Island	Australian Research Council(Australian Research Council); PADI Foundation; Lizard Island Doctoral Fellowship; Ian Potter Doctoral Fellowship at Lizard Island	This work was funded by the Australian Research Council (DRB), the PADI Foundation, a Lizard Island Doctoral Fellowship (CHRG) and an Ian Potter Doctoral Fellowship at Lizard Island (ASH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MS, 2007, CORAL REEFS, V26, P959, DOI 10.1007/s00338-007-0234-x; Alvarez BLA, 2000, P 18 INT SEA TURTL S; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2012, P ROY SOC B-BIOL SCI, V279, P1621, DOI 10.1098/rspb.2011.1906; Bellwood DR, 2008, LIMNOL OCEANOGR, V53, P2695, DOI 10.4319/lo.2008.53.6.2695; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bjorndal KA, 2003, CRC MAR BIOL SER, P259; Bjorndal Karen A., 1997, P199; Bonaldo RM, 2008, MAR ECOL PROG SER, V360, P237, DOI 10.3354/meps07413; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Burkepile DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008963; Carrion-Cortez JA, 2010, J MAR BIOL ASSOC UK, V90, P1005, DOI 10.1017/S0025315410000226; Chaloupka M, 2008, GLOBAL ECOL BIOGEOGR, V17, P297, DOI 10.1111/j.1466-8238.2007.00367.x; Choat J.H., 1991, P120; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; FORBES G.A., 1994, P 13 ANN S SEA TURTL, P57; Fourqurean JW, 2010, MAR ECOL PROG SER, V419, P223, DOI 10.3354/meps08853; Fox RJ, 2008, CORAL REEFS, V27, P605, DOI 10.1007/s00338-008-0359-6; Fox RJ, 2011, FUNCT ECOL, V25, P1096, DOI 10.1111/j.1365-2435.2011.01874.x; Fuentes MMPB, 2011, GLOBAL CHANGE BIOL, V17, P140, DOI 10.1111/j.1365-2486.2010.02192.x; Fuentes MMPB, 2010, AQUAT CONSERV, V20, P132, DOI 10.1002/aqc.1088; GBRMPA, 2009, GREAT BARR REEF OUTL GREAT BARR REEF OUTL; Hoey AS, 2010, CORAL REEFS, V29, P499, DOI 10.1007/s00338-010-0605-6; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; HUNTER CL, 1995, B MAR SCI, V57, P501; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 1997, CORAL REEFS, V16, pS23, DOI 10.1007/s003380050238; Jackson JBC, 2001, P NATL ACAD SCI USA, V98, P5411, DOI 10.1073/pnas.091092898; Lahanas PN, 1998, MAR BIOL, V130, P345, DOI 10.1007/s002270050254; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; Leon YM, 2002, MAR ECOL PROG SER, V245, P249, DOI 10.3354/meps245249; LIMPUS CJ, 1992, WILDLIFE RES, V19, P347, DOI 10.1071/WR9920347; Luschi P, 1996, J COMP PHYSIOL A, V178, P447; Marsh H, 2005, ECOL APPL, V15, P481, DOI 10.1890/04-0673; Marshell A, 2011, CORAL REEFS, V30, P631, DOI 10.1007/s00338-011-0770-2; Mayor PA, 1998, P 17 ANN SEA TURTL S, P244; MCCLANAHAN TR, 1990, OECOLOGIA, V83, P362, DOI 10.1007/BF00317561; McClenachan L, 2006, FRONT ECOL ENVIRON, V4, P290, DOI 10.1890/1540-9295(2006)4[290:CIOHST]2.0.CO;2; Meyer CG, 2005, ENVIRON BIOL FISH, V73, P201, DOI 10.1007/s10641-005-0559-7; MEYLAN A, 1988, SCIENCE, V239, P393, DOI 10.1126/science.239.4838.393; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Nystrom M, 2006, AMBIO, V35, P30, DOI 10.1639/0044-7447(2006)035[0030:RARDOF]2.0.CO;2; Obura DO, 2010, CORAL REEFS, V29, P759, DOI 10.1007/s00338-010-0611-8; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Peterson G, 1998, ECOSYSTEMS, V1, P6, DOI 10.1007/s100219900002; Pike DA, 2007, OECOLOGIA, V153, P471, DOI 10.1007/s00442-007-0732-0; Purcell SW, 2001, CORAL REEFS, V20, P117, DOI 10.1007/s003380100150; Rasher DB, 2012, OECOLOGIA, V169, P187, DOI 10.1007/s00442-011-2174-y; Read Mark A., 2002, Memoirs of the Queensland Museum, V48, P207; Russell DF, 2009, PAC SCI, V63, P181, DOI 10.2984/049.063.0202; Seminoff JA, 2002, MAR ECOL PROG SER, V242, P253, DOI 10.3354/meps242253; Sheppard C., 1995, MAR POLL B, V30, P766; Stampar Sergio N., 2007, Marine Turtle Newsletter, V117, P3; THAYER GW, 1984, ESTUARIES, V7, P351, DOI 10.2307/1351619; Van Houtan KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012900; Wabnitz CCC, 2010, MAR ECOL PROG SER, V420, P27, DOI 10.3354/meps08846; Welsh JQ, 2012, CORAL REEFS, V31, P55, DOI 10.1007/s00338-011-0813-8; Wilson S, 1997, MAR ECOL PROG SER, V153, P299, DOI 10.3354/meps153299; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; [No title captured]	64	31	31	3	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39979	10.1371/journal.pone.0039979	http://dx.doi.org/10.1371/journal.pone.0039979			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768189	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305892100161
J	Hartel, C; Faust, K; Avenarius, S; Bohnhorst, B; Emeis, M; Gebauer, C; Groneck, P; Heitmann, F; Hoehn, T; Hubert, M; Kribs, A; Kuster, H; Laux, R; Mogel, M; Muller, D; Olbertz, D; Roll, C; Siegel, J; Stein, A; Vochem, M; Weller, U; von der Wense, A; Wieg, C; Wintgens, J; Hemmelmann, C; Simon, A; Herting, E; Goopel, W				Haertel, Christoph; Faust, Kirstin; Avenarius, Stefan; Bohnhorst, Bettina; Emeis, Michael; Gebauer, Corinna; Groneck, Peter; Heitmann, Friedhelm; Hoehn, Thomas; Hubert, Mechthild; Kribs, Angela; Kuester, Helmut; Laux, Reinhard; Moegel, Michael; Mueller, Dirk; Olbertz, Dirk; Roll, Claudia; Siegel, Jens; Stein, Anja; Vochem, Matthias; Weller, Ursula; von der Wense, Axel; Wieg, Christian; Wintgens, Juergen; Hemmelmann, Claudia; Simon, Arne; Herting, Egbert; Goepel, Wolfgang		German Neonatal Network GNN	Epidemic Microclusters of Blood-Culture Proven Sepsis in Very-Low-Birth Weight Infants: Experience of the German Neonatal Network	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; GRAM-NEGATIVE BACILLI; LATE-ONSET SEPSIS; STREAM INFECTIONS; SURVEILLANCE SYSTEM; ENTEROBACTER-CLOACAE; PATHOGEN	Introduction: We evaluated blood culture-proven sepsis episodes occurring in microclusters in very-low-birth-weight infants born in the German Neonatal Network (GNN) during 2009-2010. Methods: Thirty-seven centers participated in GNN; 23 centers enrolled >= 50 VLBW infants in the study period. Data quality was approved by on-site monitoring. Microclusters of sepsis were defined as occurrence of at least two blood-culture proven sepsis events in different patients of one center within 3 months with the same bacterial species. For microcluster analysis, we selected sepsis episodes with typically cross-transmitted bacteria of high clinical significance including gram-negative rods and Enterococcus spp. Results: In our cohort, 12/2110 (0.6%) infants were documented with an early-onset sepsis and 235 late-onset sepsis episodes (>= 72 h of age) occurred in 203/2110 (9.6%) VLBW infants. In 182/235 (77.4%) late-onset sepsis episodes gram-positive bacteria were documented, while coagulase negative staphylococci were found to be the most predominant pathogens (48.5%, 95%CI: 42.01-55.01). Candida spp. and gram-negative bacilli caused 10/235 (4.3%, 95%CI: 1.68% -6.83%) and 43/235 (18.5%) late-onset sepsis episodes, respectively. Eleven microclusters of blood-culture proven sepsis were detected in 7 hospitals involving a total 26 infants. 16/26 cluster patients suffered from Klebsiella spp. sepsis. The median time interval between the first patient's Klebsiella spp. sepsis and cluster cases was 14.1 days (interquartile range: 1-27 days). First patients in the cluster, their linked cases and sporadic sepsis events did not show significant differences in short term outcome parameters. Discussion: Microclusters of infection are an important phenomenon for late-onset sepsis. Most gram-negative cluster infections occur within 30 days after the first patient was diagnosed and Klebsiella spp. play a major role. It is essential to monitor epidemic microclusters of sepsis in surveillance networks to adapt clinical practice, inform policy and further improve quality of care.	[Haertel, Christoph; Faust, Kirstin; Herting, Egbert; Goepel, Wolfgang] Univ Lubeck, Dept Pediat, Lubeck, Germany; [Avenarius, Stefan] Univ Magdeburg, Dept Pediat, D-39106 Magdeburg, Germany; [Bohnhorst, Bettina] Med Sch Hanover, Dept Pediat, Hannover, Germany; [Emeis, Michael] Vivantes Klinikum Neukolln, Dept Neonatol, Berlin, Germany; [Gebauer, Corinna] Univ Leipzig, Dept Pediat, Leipzig, Germany; [Groneck, Peter] Klinikum Leverkusen, Dept Neonatol, Leverkusen, Germany; [Heitmann, Friedhelm] Klinikum Dortmund, Dept Neonatol, Dortmund, Germany; [Hoehn, Thomas] Univ Dusseldorf, Dept Pediat, D-40225 Dusseldorf, Germany; [Hubert, Mechthild] Klinikum Siegen, Dept Neonatol, Siegen, Germany; [Kribs, Angela] Univ Cologne, Dept Pediat, D-50931 Cologne, Germany; [Kuester, Helmut] Univ Gottingen, Dept Pediat, D-3400 Gottingen, Germany; [Laux, Reinhard] Asclepios Klin Barmbek, Dept Neonatol, Hamburg, Germany; [Moegel, Michael] Univ Dresden, Dept Pediat, Dresden, Germany; [Mueller, Dirk] Klinikum Kassel, Dept Neonatol, Kassel, Germany; [Olbertz, Dirk] Sudtstadt Klin Rostock, Dept Neonatol, Rostock, Germany; [Roll, Claudia] Vest Klin, Dept Neonatol, Datteln, Germany; [Siegel, Jens] Krankenhaus Aud Bult, Dept Neonatol, Hanover, NH USA; [Stein, Anja] Univ Essen Gesamthsch, Dept Pediat, Essen, Germany; [Vochem, Matthias] Olga Hosp, Dept Neonatol, Stuttgart, Germany; [Weller, Ursula] Klinikum Bielefeld, Dept Neonatol, Bielefeld, Germany; [von der Wense, Axel] Altonaer Kinderkrankenhaus, Dept Neonatol, Hamburg, Germany; [Wieg, Christian] Klinikum Aschaffenburg, Dept Neonatol, Aschaffenburg, Germany; [Wintgens, Juergen] Stadt Klinikum Rheydt, Dept Neonatol, Monchengladbach, Germany; [Hemmelmann, Claudia] Univ Lubeck, Inst Biometry & Med Stat, Lubeck, Germany; [Simon, Arne] Saarland Univ Hosp, Dept Pediat Hematol & Oncol, Homburg, Germany	University of Lubeck; Otto von Guericke University; VIivantes Klinikum Neukolln; Leipzig University; Klinikum Dortmund; Heinrich Heine University Dusseldorf; University of Cologne; University of Gottingen; Technische Universitat Dresden; Klinikum Kassel; University of Duisburg Essen; General Hospital of N. Ionia Agia Olga; Klinikum Stuttgart; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; Universitatsklinikum des Saarlandes	Hartel, C (corresponding author), Univ Lubeck, Dept Pediat, Lubeck, Germany.	haertel@paedia.ukl.mu-luebeck.de	Härtel, Christoph/ABD-8841-2020	Stein, Anja/0000-0002-0497-4609	German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF)	German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by the German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly H, 2005, PEDIATRICS, V115, P1513, DOI 10.1542/peds.2004-1785; Andersen BM, 2002, J HOSP INFECT, V50, P18, DOI 10.1053/jhin.2001.1128; Aziz Khalid, 2005, BMC Pediatr, V5, P22, DOI 10.1186/1471-2431-5-22; Benjamin Daniel K, 2004, J Perinatol, V24, P175, DOI 10.1038/sj.jp.7211068; Cimiotti JP, 2006, ARCH PEDIAT ADOL MED, V160, P832, DOI 10.1001/archpedi.160.8.832; Cordero L, 2004, AM J INFECT CONTROL, V32, P189, DOI 10.1016/j.ajic.2003.07.004; Cotten CM, 2006, PEDIATRICS, V118, P717, DOI 10.1542/peds.2005-2677; Curry S, 2009, NEONATAL NETW, V28, P151, DOI 10.1891/0730-0832.28.3.151; Daley AJ, 2004, PEDIATR INFECT DIS J, V23, P630, DOI 10.1097/01.inf.0000128782.20060.79; Faust K, 2011, CHEMOTHERAPIE J, V20, P1; Gastmeier P, 2007, AM J INFECT CONTROL, V35, P172, DOI 10.1016/j.ajic.2006.07.007; Geffers C, 2008, J HOSP INFECT, V68, P214, DOI 10.1016/j.jhin.2008.01.016; Graham PL, 2007, PEDIATR INFECT DIS J, V26, P1153, DOI 10.1097/INF.0b013e31814619d4; Graham PL, 2004, AM J INFECT CONTROL, V32, P232, DOI 10.1016/j.ajic.2003.07.008; Harbarth S, 1999, INFECT CONT HOSP EP, V20, P598, DOI 10.1086/501677; Makhoul IR, 2005, CLIN INFECT DIS, V40, P218, DOI 10.1086/426444; Reiss I, 2000, LANCET, V356, P310, DOI 10.1016/S0140-6736(00)02509-5; Schwab F, 2007, J HOSP INFECT, V65, P319, DOI 10.1016/j.jhin.2006.12.020; Schwab F, 2012, J HOSP INFECT, V80, P133, DOI 10.1016/j.jhin.2011.11.014; Smith A, 2010, PEDIATR INFECT DIS J, V29, P831, DOI 10.1097/INF.0b013e3181e7884f; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Talon D, 2004, J HOSP INFECT, V57, P119, DOI 10.1016/j.jhin.2004.01.023; Vergnano S, 2011, ARCH DIS CHILD-FETAL, V96, pF9, DOI 10.1136/adc.2009.178798	24	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38304	10.1371/journal.pone.0038304	http://dx.doi.org/10.1371/journal.pone.0038304			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768043	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100014
J	Lijavetzky, D; Carbonell-Bejerano, P; Grimplet, J; Bravo, G; Flores, P; Fenoll, J; Hellin, P; Oliveros, JC; Martinez-Zapater, JM				Lijavetzky, Diego; Carbonell-Bejerano, Pablo; Grimplet, Jerome; Bravo, Gema; Flores, Pilar; Fenoll, Jose; Hellin, Pilar; Carlos Oliveros, Juan; Martinez-Zapater, Jose M.			Berry Flesh and Skin Ripening Features in Vitis vinifera as Assessed by Transcriptional Profiling	PLOS ONE			English	Article							LIPID TRANSFER PROTEIN; GRAPE MUSCAT HAMBURG; GENE-EXPRESSION; ANTHOCYANIN BIOSYNTHESIS; CABERNET-SAUVIGNON; WINE GRAPE; XYLOGLUCAN ENDOTRANSGLUCOSYLASE/HYDROLASE; PLANT DEVELOPMENT; ABC TRANSPORTER; MOLECULAR-BASIS	Background: Ripening of fleshy fruit is a complex developmental process involving the differentiation of tissues with separate functions. During grapevine berry ripening important processes contributing to table and wine grape quality take place, some of them flesh- or skin-specific. In this study, transcriptional profiles throughout flesh and skin ripening were followed during two different seasons in a table grape cultivar 'Muscat Hamburg' to determine tissue-specific as well as common developmental programs. Methodology/Principal Findings: Using an updated GrapeGen Affymetrix GeneChip (R) annotation based on grapevine 126v1 gene predictions, 2188 differentially accumulated transcripts between flesh and skin and 2839 transcripts differentially accumulated throughout ripening in the same manner in both tissues were identified. Transcriptional profiles were dominated by changes at the beginning of veraison which affect both pericarp tissues, although frequently delayed or with lower intensity in the skin than in the flesh. Functional enrichment analysis identified the decay on biosynthetic processes, photosynthesis and transport as a major part of the program delayed in the skin. In addition, a higher number of functional categories, including several related to macromolecule transport and phenylpropanoid and lipid biosynthesis, were over-represented in transcripts accumulated to higher levels in the skin. Functional enrichment also indicated auxin, gibberellins and bHLH transcription factors to take part in the regulation of pre-veraison processes in the pericarp, whereas WRKY and C2H2 family transcription factors seems to more specifically participate in the regulation of skin and flesh ripening, respectively. Conclusions/Significance: A transcriptomic analysis indicates that a large part of the ripening program is shared by both pericarp tissues despite some components are delayed in the skin. In addition, important tissue differences are present from early stages prior to the ripening onset including tissue-specific regulators. Altogether, these findings provide key elements to understand berry ripening and its differential regulation in flesh and skin.	[Lijavetzky, Diego; Carbonell-Bejerano, Pablo; Bravo, Gema; Carlos Oliveros, Juan; Martinez-Zapater, Jose M.] CSIC, Dept Genet Mol Plantas, CNB, Madrid, Spain; [Carbonell-Bejerano, Pablo; Grimplet, Jerome; Martinez-Zapater, Jose M.] Univ La Rioja Gobierno La Rioja, ICVV, Consejo Super Invest Cient, Logrono, La Rioja, Spain; [Flores, Pilar; Fenoll, Jose; Hellin, Pilar] Inst Murciano Invest & Desarrollo Agr & Alimentar, Area Biotecnol, Estac Sericicola, Murcia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-CAR-UR - Instituto de Ciencias de la Vid y del Vino (ICVV); Universidad de La Rioja	Lijavetzky, D (corresponding author), Univ Nacl Cuyo, Inst Biol Agr Mendoza, Consejo Nacl Invest Cient & Tecn CONICET, Fac Ciencias Agr, Chacras De Coria, Argentina.	pablo.carbonell@icvv.es	Flores, Pilar/H-5432-2015; Lijavetzky, Diego/AAF-1557-2020; Grimplet, Jérôme/M-4589-2019; FENOLL, JOSE/L-8098-2014; Carbonell-Bejerano, Pablo/L-6699-2017; Carbonell-Bejerano, Pablo/AAX-3509-2021; Grimplet, Jerome/A-3422-2011; Hellin, Pilar/M-4436-2018; Martinez Zapater, Jose/I-4892-2012	Flores, Pilar/0000-0002-0493-8720; Grimplet, Jérôme/0000-0002-3265-4012; FENOLL, JOSE/0000-0002-9568-1122; Carbonell-Bejerano, Pablo/0000-0002-7266-9665; Carbonell-Bejerano, Pablo/0000-0002-7266-9665; Grimplet, Jerome/0000-0002-3265-4012; Hellin, Pilar/0000-0002-5130-7008; Martinez Zapater, Jose/0000-0001-7217-4454; Oliveros, Juan Carlos/0000-0002-4520-0853; Lijavetzky, Diego/0000-0003-4207-3067	Genoma Espana; Ministerio de Ciencia e Innovacion [BIO2008-03892]; Argentina [AR2009-0021]; GrapeGen Project	Genoma Espana; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Argentina; GrapeGen Project	This study was financially supported by GrapeGen Project funded by Genoma Espana within a collaborative agreement with Genome Canada. The authors also thank The Ministerio de Ciencia e Innovacion for project BIO2008-03892 and a bilateral collaborative grant with Argentina (AR2009-0021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afoufa-Bastien D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-245; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Ali MB, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-7; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Battilana J, 2011, J EXP BOT, V62, P5497, DOI 10.1093/jxb/err231; Battilana J, 2009, THEOR APPL GENET, V118, P653, DOI 10.1007/s00122-008-0927-8; BERNSTEIN Z, 1981, VITIS, V20, P15; Bird D, 2007, PLANT J, V52, P485, DOI 10.1111/j.1365-313X.2007.03252.x; Bottcher C, 2010, J EXP BOT, V61, P3615, DOI 10.1093/jxb/erq174; Boss PK, 1996, PLANT MOL BIOL, V32, P565, DOI 10.1007/BF00019111; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Cameron KD, 2006, PLANT PHYSIOL, V140, P176, DOI 10.1104/pp.105.069724; Cantos E, 2002, J AGR FOOD CHEM, V50, P5691, DOI 10.1021/jf0204102; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; Castellarin SD, 2007, PLANT CELL ENVIRON, V30, P1381, DOI 10.1111/j.1365-3040.2007.01716.x; Castellarin SD, 2011, J EXP BOT, V62, P4345, DOI 10.1093/jxb/err150; CAWTHON DL, 1982, J AM SOC HORTIC SCI, V107, P1097; Chen J, 2011, CARBOHYD RES, V346, P1684, DOI 10.1016/j.carres.2011.05.003; Chira K, 2009, J AGR FOOD CHEM, V57, P545, DOI 10.1021/jf802301g; Cohen SD, 2008, ANAL CHIM ACTA, V621, P57, DOI 10.1016/j.aca.2007.11.029; Coles JP, 1999, PLANT J, V17, P547, DOI 10.1046/j.1365-313X.1999.00410.x; Commenil P, 1997, J EXP BOT, V48, P1599, DOI 10.1093/jexbot/48.313.1599; Conde C, 2007, FOOD, V22, DOI DOI 10.1186/S12864-016-2660-Z; Coombe B. G., 2000, Australian Journal of Grape and Wine Research, V6, P131, DOI 10.1111/j.1755-0238.2000.tb00171.x; COOMBE BG, 1987, AM J ENOL VITICULT, V38, P120; COOMBE BG, 1992, AM J ENOL VITICULT, V43, P101; COOMBE BG, 1973, PLANT PHYSIOL, V51, P629, DOI 10.1104/pp.51.4.629; CRAVERO MC, 1994, VITIS, V33, P75; Cutanda-Perez MC, 2009, PLANT MOL BIOL, V69, P633, DOI 10.1007/s11103-008-9446-x; Davies C, 1997, PLANT PHYSIOL, V115, P1155, DOI 10.1104/pp.115.3.1155; DeBono A, 2009, PLANT CELL, V21, P1230, DOI 10.1105/tpc.108.064451; Deluc LG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-429; Deluc LG, 2011, J AGR FOOD CHEM, V59, P289, DOI 10.1021/jf1024888; Deluc LG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-212; Deytieux-Belleau C, 2008, PLANT PHYSIOL BIOCH, V46, P638, DOI 10.1016/j.plaphy.2008.04.008; Diakou P, 2001, PROTOPLASMA, V218, P225, DOI 10.1007/BF01306611; Duchene E, 2009, THEOR APPL GENET, V118, P541, DOI 10.1007/s00122-008-0919-8; Emanuelli F, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-241; ESCOUBAS JM, 1995, P NATL ACAD SCI USA, V92, P10237, DOI 10.1073/pnas.92.22.10237; Esteban MA, 1999, AM J ENOL VITICULT, V50, P418; Fenoll J, 2009, FOOD CHEM, V114, P420, DOI 10.1016/j.foodchem.2008.09.060; Ford CM, 1998, J BIOL CHEM, V273, P9224, DOI 10.1074/jbc.273.15.9224; Fortes AM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-149; Fournand D, 2006, J AGR FOOD CHEM, V54, P7331, DOI 10.1021/jf061467h; Fung RWM, 2008, PLANT PHYSIOL, V146, P236, DOI 10.1104/pp.107.108712; Garcia-Gago JA, 2009, PLANT SIGNAL BEHAV, V4, P766, DOI 10.1104/pp.109.138297; Gatto P, 2008, J AGR FOOD CHEM, V56, P11773, DOI 10.1021/jf8017707; Gholami M., 1995, Australian Journal of Grape and Wine Research, V1, P19, DOI 10.1111/j.1755-0238.1995.tb00073.x; Grimplet J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-187; Grimplet Jerome, 2012, BMC Res Notes, V5, P213, DOI 10.1186/1756-0500-5-213; Grimplet J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008365; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Guillaumie S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-165; HALE CR, 1970, PLANT PHYSIOL, V45, P620, DOI 10.1104/pp.45.5.620; Hardie W. J., 1996, Australian Journal of Grape and Wine Research, V2, P97, DOI 10.1111/j.1755-0238.1996.tb00101.x; HARDIE WJ, 1988, AUST J BOT, V36, P107, DOI 10.1071/BT9880107; Hayasaka Y, 2003, RAPID COMMUN MASS SP, V17, P9, DOI 10.1002/rcm.869; Hayes MA, 2007, J EXP BOT, V58, P1985, DOI 10.1093/jxb/erm061; Helliwell CA, 1999, PLANT PHYSIOL, V119, P507, DOI 10.1104/pp.119.2.507; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Hollenbach B, 1997, PLANTA, V203, P9, DOI 10.1007/s004250050159; INABA A, 1976, J JPN SOC HORTIC SCI, V45, P245, DOI 10.2503/jjshs.45.245; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Martinez-Esteso MJ, 2011, J EXP BOT, V62, P2521, DOI 10.1093/jxb/erq434; Kennedy JA, 2001, J AGR FOOD CHEM, V49, P5348, DOI 10.1021/jf010758h; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; KLIEWER WM, 1972, AM J ENOL VITICULT, V23, P71; Kobayashi S, 2002, PLANTA, V215, P924, DOI 10.1007/s00425-002-0830-5; Kossmann J, 1999, PLANTA, V208, P503, DOI 10.1007/s004250050587; Koyama K, 2010, FUNCT INTEGR GENOMIC, V10, P367, DOI 10.1007/s10142-009-0145-8; KRIEDEMANN PE, 1968, AUST J BIOL SCI, V21, P907, DOI 10.1071/BI9680907; Laquitaine L, 2006, MOL PLANT MICROBE IN, V19, P1103, DOI 10.1094/MPMI-19-1103; Le Henanff G, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-54; Liu YB, 2007, PLANTA, V226, P1547, DOI 10.1007/s00425-007-0591-2; Luan F, 2002, PHYTOCHEMISTRY, V60, P451, DOI 10.1016/S0031-9422(02)00147-4; Lund ST, 2006, SCIENCE, V311, P804, DOI 10.1126/science.1118962; Lund ST, 2008, PLANT MOL BIOL, V68, P301, DOI 10.1007/s11103-008-9371-z; Maris A, 2009, J EXP BOT, V60, P3959, DOI 10.1093/jxb/erp229; Mateo JJ, 2000, J CHROMATOGR A, V881, P557, DOI 10.1016/S0021-9673(99)01342-4; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Miedes E, 2011, J PLANT PHYSIOL, V168, P196, DOI 10.1016/j.jplph.2010.06.029; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Mori K, 2007, J EXP BOT, V58, P1935, DOI 10.1093/jxb/erm055; Muganu M, 2011, AM J ENOL VITICULT, V62, P91, DOI 10.5344/ajev.2010.10012; Nunan KJ, 1998, PLANT PHYSIOL, V118, P783, DOI 10.1104/pp.118.3.783; Nunan KJ, 2001, PLANTA, V214, P257, DOI 10.1007/s004250100609; PANDEY RM, 1977, VITIS, V16, P106; Panikashvili D, 2010, MOL PLANT, V3, P563, DOI 10.1093/mp/ssp103; PARK SK, 1991, J AGR FOOD CHEM, V39, P514, DOI 10.1021/jf00003a017; Pastore C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-631; Peng FY, 2007, GENE, V402, P40, DOI 10.1016/j.gene.2007.07.016; Pfannschmidt T, 2003, TRENDS PLANT SCI, V8, P33, DOI 10.1016/S1360-1385(02)00005-5; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Piippo M, 2006, PHYSIOL GENOMICS, V25, P142, DOI 10.1152/physiolgenomics.00256.2005; Pilati S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-428; Polaskova P, 2008, CHEM SOC REV, V37, P2478, DOI 10.1039/b714455p; Pontin MA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-224; POSSNER DRE, 1985, VITIS, V24, P229; Prasanna V, 2007, CRIT REV FOOD SCI, V47, P1, DOI 10.1080/10408390600976841; Quesada MA, 2009, PLANT PHYSIOL, V150, P1022, DOI 10.1104/pp.109.138297; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; RIBEREAUGAYON P, 1975, J AGR FOOD CHEM, V23, P1042, DOI 10.1021/jf60202a050; Robinson S. P., 2000, Australian Journal of Grape and Wine Research, V6, P175, DOI 10.1111/j.1755-0238.2000.tb00177.x; Rook F, 2006, PLANT CELL ENVIRON, V29, P426, DOI 10.1111/j.1365-3040.2005.01477.x; ROSENQUIST JK, 1989, AM J ENOL VITICULT, V40, P241; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; RUFFNER HP, 1982, VITIS, V21, P346; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Salzman RA, 1998, PLANT PHYSIOL, V117, P465, DOI 10.1104/pp.117.2.465; Schlosser J, 2008, PROTOPLASMA, V232, P255, DOI 10.1007/s00709-008-0280-9; SHEEN J, 1990, PLANT CELL, V2, P1027, DOI 10.1105/tpc.2.10.1027; Shimada TL, 2010, BIOL PHARM BULL, V33, P360, DOI 10.1248/bpb.33.360; Singleton VL., 1965, AM J ENOL VITICULT, V16, P144, DOI DOI 10.12691/IJEBB-2-1-5; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Swift J. G., 1973, Vitis, V12, P38; Terrier N, 2005, PLANTA, V222, P832, DOI 10.1007/s00425-005-0017-y; Thomas TR, 2008, PLANTA, V228, P1067, DOI 10.1007/s00425-008-0808-z; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Toronen P, 1999, FEBS LETT, V451, P142, DOI 10.1016/S0014-5793(99)00524-4; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vicens A, 2009, J AGR FOOD CHEM, V57, P2955, DOI 10.1021/jf803416w; Vidal S, 2003, J SCI FOOD AGR, V83, P564, DOI 10.1002/jsfa.1394; Wada H, 2009, J EXP BOT, V60, P1773, DOI 10.1093/jxb/erp050; Waterhouse AL, 2002, ANN NY ACAD SCI, V957, P21, DOI 10.1111/j.1749-6632.2002.tb02903.x; Wheeler S, 2009, AUST J GRAPE WINE R, V15, P195, DOI 10.1111/j.1755-0238.2008.00045.x; Yang H. Y., 1955, AM J ENOL VITICULT, V6, P32; Yazaki K, 2006, FEBS LETT, V580, P1183, DOI 10.1016/j.febslet.2005.12.009; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhang XY, 2006, PLANT PHYSIOL, V142, P220, DOI 10.1104/pp.106.081430	133	105	105	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39547	10.1371/journal.pone.0039547	http://dx.doi.org/10.1371/journal.pone.0039547			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768087	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100058
J	Long, DP; Zhao, AC; Chen, XJ; Zhang, Y; Lu, WJ; Guo, Q; Handler, AM; Xiang, ZH				Long, Ding-Pei; Zhao, Ai-Chun; Chen, Xue-Jiao; Zhang, Yang; Lu, Wei-Jian; Guo, Qing; Handler, Alfred M.; Xiang, Zhong-Huai			FLP Recombinase-Mediated Site-Specific Recombination in Silkworm, Bombyx mori	PLOS ONE			English	Article							GERMLINE TRANSFORMATION; TRANSGENIC SILKWORMS; PHI-C31 INTEGRASE; DROSOPHILA-MELANOGASTER; ENHANCER DETECTION; CASSETTE EXCHANGE; 2-MU CIRCLE; CELL-LINES; GENE; TRANSPOSON	A comprehensive understanding of gene function and the production of site-specific genetically modified mutants are two major goals of genetic engineering in the post-genomic era. Although site-specific recombination systems have been powerful tools for genome manipulation of many organisms, they have not yet been established for use in the manipulation of the silkworm Bombyx mori genome. In this study, we achieved site-specific excision of a target gene at predefined chromosomal sites in the silkworm using a FLP/FRT site-specific recombination system. We first constructed two stable transgenic target silkworm strains that both contain a single copy of the transgene construct comprising a target gene expression cassette flanked by FRT sites. Using pre-blastoderm microinjection of a FLP recombinase helper expression vector, 32 G3 site-specific recombinant transgenic individuals were isolated from five of 143 broods. The average frequency of FLP recombinase-mediated site-specific excision in the two target strains genome was approximately 3.5%. This study shows that it is feasible to achieve site-specific recombination in silkworms using the FLP/FRT system. We conclude that the FLP/FRT system is a useful tool for genome manipulation in the silkworm. Furthermore, this is the first reported use of the FLP/FRT system for the genetic manipulation of a lepidopteran genome and thus provides a useful reference for the establishment of genome manipulation technologies in other lepidopteran species.	[Long, Ding-Pei; Zhao, Ai-Chun; Chen, Xue-Jiao; Zhang, Yang; Lu, Wei-Jian; Guo, Qing; Xiang, Zhong-Huai] Southwest Univ, Inst Sericulture & Syst Biol, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Handler, Alfred M.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL USA	Southwest University - China; United States Department of Agriculture (USDA)	Long, DP (corresponding author), Southwest Univ, Inst Sericulture & Syst Biol, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	zhaoaichun@hotmail.com	Zhao, Aichun/T-4308-2018	Zhao, Aichun/0000-0001-6140-0102; Long, Dingpei/0000-0002-2907-6901	Chongqing Science & Technology Commission [CSTC, 2011BA1005, CSTC, 2009AA1024]; Fundamental Research Funds for the Central Universities [XDJK2010B015]	Chongqing Science & Technology Commission(Natural Science Foundation Project of CQ CSTC); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by Chongqing Science & Technology Commission (No. CSTC, 2011BA1005 and CSTC, 2009AA1024) and the Fundamental Research Funds for the Central Universities (No. XDJK2010B015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS BJ, 1985, CELL, V40, P795, DOI 10.1016/0092-8674(85)90339-3; AUSTIN S, 1981, CELL, V25, P729, DOI 10.1016/0092-8674(81)90180-X; Belteki G, 2003, NAT BIOTECHNOL, V21, P321, DOI 10.1038/nbt787; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; BROACH JR, 1982, CELL, V29, P227, DOI 10.1016/0092-8674(82)90107-6; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P4256, DOI 10.1093/nar/24.21.4256; Czeh M, 2010, ONCOGENE, V29, P6591, DOI 10.1038/onc.2010.388; Dafa'alla TH, 2006, NAT BIOTECHNOL, V24, P820, DOI 10.1038/nbt1221; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Esposito D, 1997, NUCLEIC ACIDS RES, V25, P3605, DOI 10.1093/nar/25.18.3605; FRIESEN H, 1992, J MOL BIOL, V225, P313, DOI 10.1016/0022-2836(92)90924-9; Gao G, 2008, P NATL ACAD SCI USA, V105, P13999, DOI 10.1073/pnas.0805843105; Gimond C, 1998, J CELL BIOL, V143, P253, DOI 10.1083/jcb.143.1.253; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Golic KG, 1996, GENETICS, V144, P1693; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Handler AM, 2004, NAT BIOTECHNOL, V22, P1150, DOI 10.1038/nbt1002; Hino R, 2006, BIOMATERIALS, V27, P5715, DOI 10.1016/j.biomaterials.2006.07.028; Horn C, 2005, P NATL ACAD SCI USA, V102, P12483, DOI 10.1073/pnas.0504305102; Horn C, 2003, GENETICS, V163, P647; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Hu Q, 2008, PLANT BIOTECHNOL J, V6, P176, DOI 10.1111/j.1467-7652.2007.00310.x; Ishikawa Y, 2006, J GENE MED, V8, P646, DOI 10.1002/jgm.891; JAYARAM M, 1985, P NATL ACAD SCI USA, V82, P5875, DOI 10.1073/pnas.82.17.5875; Kanginakudru S, 2007, INSECT MOL BIOL, V16, P635, DOI 10.1111/j.1365-2583.2007.00753.x; KUHSTOSS S, 1991, J MOL BIOL, V222, P897, DOI 10.1016/0022-2836(91)90584-S; Li B, 2010, J BIOTECHNOL, V145, P206, DOI 10.1016/j.jbiotec.2009.11.010; Lorenzen MD, 2003, INSECT MOL BIOL, V12, P433, DOI 10.1046/j.1365-2583.2003.00427.x; Mange A, 1997, J MOL BIOL, V265, P266, DOI 10.1006/jmbi.1996.0734; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; MORRIS AC, 1991, NUCLEIC ACIDS RES, V19, P5895, DOI 10.1093/nar/19.21.5895; Nakayama G, 2006, MOL GENET GENOMICS, V275, P1, DOI 10.1007/s00438-005-0026-3; O'Brochta DA, 2011, P NATL ACAD SCI USA, V108, P16339, DOI 10.1073/pnas.1110628108; Ortiz-Urda S, 2002, NAT MED, V8, P1166, DOI 10.1038/nm766; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Sauer Brian, 1994, Current Opinion in Biotechnology, V5, P521, DOI 10.1016/0958-1669(94)90068-X; Siegal ML, 2000, METH MOL B, V136, P487; SONTI RV, 1995, PLANT MOL BIOL, V28, P1127, DOI 10.1007/BF00032673; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; Theodosiou NA, 1998, METHODS, V14, P355, DOI 10.1006/meth.1998.0591; Thomas JL, 2002, INSECT BIOCHEM MOLEC, V32, P247, DOI 10.1016/S0965-1748(01)00150-3; Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771; Tomita S, 1999, APPL ENTOMOL ZOOL, V34, P371, DOI 10.1303/aez.34.371; Turakainen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004341; Turan S, 2011, J MOL BIOL, V407, P193, DOI 10.1016/j.jmb.2011.01.004; Uchino K, 2008, INSECT BIOCHEM MOLEC, V38, P1165, DOI 10.1016/j.ibmb.2008.09.009; Uhlirova M, 2002, DEV GENES EVOL, V212, P145, DOI 10.1007/s00427-002-0221-8; Vazquez-Manrique RP, 2010, GENOMICS, V95, P37, DOI 10.1016/j.ygeno.2009.09.001; Wong AC, 2011, TRANSGENIC RES, V20, P409, DOI 10.1007/s11248-010-9410-9; Woo HJ, 2009, TRANSGENIC RES, V18, P455, DOI 10.1007/s11248-008-9236-x; Wu YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008054; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xiang Z.H., 2005, BIOL SERICULTURE, P1; Zhao AC, 2012, INSECT SCI, V19, P172, DOI 10.1111/j.1744-7917.2011.01422.x; Zhao Ai-chun, 2004, Acta Genetica Sinica, V31, P787; Zhao AC, 2010, TRANSGENIC RES, V19, P29, DOI 10.1007/s11248-009-9295-7; Zuber ME, 2012, GENESIS, V50, P325, DOI 10.1002/dvg.22006	60	51	55	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40150	10.1371/journal.pone.0040150	http://dx.doi.org/10.1371/journal.pone.0040150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768245	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100218
J	Petrus, AK; Swithers, KS; Ranjit, C; Wu, S; Brewer, HM; Gogarten, JP; Pasa-Tolic, L; Noll, KM				Petrus, Amanda K.; Swithers, Kristen S.; Ranjit, Chaman; Wu, Si; Brewer, Heather M.; Gogarten, J. Peter; Pasa-Tolic, Ljiljana; Noll, Kenneth M.			Genes for the Major Structural Components of Thermotogales Species' Togas Revealed by Proteomic and Evolutionary Analyses of OmpA and OmpB Homologs	PLOS ONE			English	Article							CARBOXY-TERMINAL PHENYLALANINE; SEQUENCE ALIGNMENT; COILED-COIL; CELL-WALL; PROTEIN; ALPHA; BACTERIA; SPECTRA; CLONING; MODEL	The unifying structural characteristic of members of the bacterial order Thermotogales is their toga, an unusual cell envelope that includes a loose-fitting sheath around each cell. Only two toga-associated structural proteins have been purified and characterized in Thermotoga maritima: the anchor protein OmpA1 (or Omp alpha) and the porin OmpB (or Omp beta). The gene encoding OmpA1 (ompA1) was cloned and sequenced and later assigned to TM0477 in the genome sequence, but because no peptide sequence was available for OmpB, its gene (ompB) was not annotated. We identified six porin candidates in the genome sequence of T. maritima. Of these candidates, only one, encoded by TM0476, has all the characteristics reported for OmpB and characteristics expected of a porin including predominant beta-sheet structure, a carboxy terminus porin anchoring motif, and a porin-specific amino acid composition. We highly enriched a toga fraction of cells for OmpB by sucrose gradient centrifugation and hydroxyapatite chromatography and analyzed it by LC/MS/MS. We found that the only porin candidate that it contained was the TM0476 product. This cell fraction also had beta-sheet character as determined by circular dichroism, consistent with its enrichment for OmpB. We conclude that TM0476 encodes OmpB. A phylogenetic analysis of OmpB found orthologs encoded in syntenic locations in the genomes of all but two Thermotogales species. Those without orthologs have putative isofunctional genes in their place. Phylogenetic analyses of OmpA1 revealed that each species of the Thermotogales has one or two OmpA homologs. T. maritima has two OmpA homologs, encoded by ompA1 (TM0477) and ompA2 (TM1729), both of which were found in the toga protein-enriched cell extracts. These annotations of the genes encoding toga structural proteins will guide future examinations of the structure and function of this unusual lineage-defining cell sheath.	[Petrus, Amanda K.; Swithers, Kristen S.; Ranjit, Chaman; Gogarten, J. Peter; Noll, Kenneth M.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06340 USA; [Wu, Si; Brewer, Heather M.; Pasa-Tolic, Ljiljana] Pacific NW Natl Lab, Environm Mol Sci Lab, Washington, DC USA	University of Connecticut; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Petrus, AK (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06340 USA.	kenneth.noll@uconn.edu		Gogarten, Johann Peter/0000-0001-6459-6518	US Department of Energy Office of Basic Science program [DE-FG02-08ER64687]; NASA Exobiology program [NNX08AQ10G]; Environmental Molecular Sciences Laboratory of Pacific Northwest National Laboratory [39965]; U. S. Department of Energy (DOE) Office of Biological and Environmental Research; Direct For Biological Sciences [0830024] Funding Source: National Science Foundation	US Department of Energy Office of Basic Science program(United States Department of Energy (DOE)); NASA Exobiology program(National Aeronautics & Space Administration (NASA)); Environmental Molecular Sciences Laboratory of Pacific Northwest National Laboratory; U. S. Department of Energy (DOE) Office of Biological and Environmental Research(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded by grants from the US Department of Energy Office of Basic Science program (DE-FG02-08ER64687), NASA Exobiology program (NNX08AQ10G), and the Environmental Molecular Sciences Laboratory of Pacific Northwest National Laboratory (ID # 39965). Portions of this work were supported by the U. S. Department of Energy (DOE) Office of Biological and Environmental Research and performed in the Environmental Molecular Science Laboratory (EMSL), a DOE national scientific user facility located on the campus of Pacific Northwest National Laboratory (PNNL) in Richland, Washington. The aforementioned funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Beveridge TJ, 2001, BIOTECH HISTOCHEM, V76, P111, DOI 10.1080/714028139; BOLLA JM, 1995, J BACTERIOL, V177, P4266, DOI 10.1128/jb.177.15.4266-4271.1995; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; deCock H, 1997, J MOL BIOL, V269, P473, DOI 10.1006/jmbi.1997.1069; Do CB, 2008, METHODS MOL BIOL, V484, P379, DOI 10.1007/978-1-59745-398-1_25; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; ENGEL AM, 1993, FEMS MICROBIOL LETT, V109, P231, DOI 10.1016/0378-1097(93)90025-W; ENGEL AM, 1992, EMBO J, V11, P4369, DOI 10.1002/j.1460-2075.1992.tb05537.x; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Liebl WG, 2008, J BACTERIOL, V190, P1350, DOI 10.1128/JB.01149-07; Lim WJ, 2003, RES MICROBIOL, V154, P681, DOI 10.1016/j.resmic.2003.09.005; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Livesay EA, 2008, ANAL CHEM, V80, P294, DOI 10.1021/ac701727r; LUPAS A, 1995, J MOL BIOL, V248, P180, DOI 10.1006/jmbi.1995.0210; Mann M, 2001, ANNU REV BIOCHEM, V70, P437, DOI 10.1146/annurev.biochem.70.1.437; Nanavati D, 2002, MICROBIOL-SGM, V148, P3531, DOI 10.1099/00221287-148-11-3531; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Nesbo CL, 2012, EXTREMOPHILES, V16, P387, DOI 10.1007/s00792-012-0437-0; Park JS, 2012, FASEB J, V26, P219, DOI 10.1096/fj.11-188425; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; RACHEL R, 1990, FEBS LETT, V262, P64, DOI 10.1016/0014-5793(90)80155-C; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SCHUMANN J, 1991, FEBS LETT, V282, P122, DOI 10.1016/0014-5793(91)80459-G; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Stenkova AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020546; STRUYVE M, 1991, J MOL BIOL, V218, P141, DOI 10.1016/0022-2836(91)90880-F; Sutcliffe IC, 2010, TRENDS MICROBIOL, V18, P464, DOI 10.1016/j.tim.2010.06.005; Taboada B, 2011, NUCLEIC ACIDS RES, V40, P1; Wang Y, 2002, BIOCHEM BIOPH RES CO, V292, P396, DOI 10.1006/bbrc.2002.6657; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wilkins MR, 1999, METH MOL B, V112, P531; WINTERHALTER C, 1995, APPL ENVIRON MICROB, V61, P1810, DOI 10.1128/AEM.61.5.1810-1815.1995	46	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40236	10.1371/journal.pone.0040236	http://dx.doi.org/10.1371/journal.pone.0040236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768259	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100232
J	Xu, JQ; Sun, YD; Huang, X; Luan, WZ				Xu, Jianqiang; Sun, Yongdong; Huang, Xin; Luan, Wenzhong			Management of Symptomatic Sacral Perineural Cysts	PLOS ONE			English	Article							FIBRIN GLUE THERAPY; MENINGEAL CYSTS; DRAINAGE	Background: There has been no consensus on the optimal treatment of symptomatic sacral perineural cysts. Most previous reports concerning the management methods were either sporadic case reports or a series of limited cases. This study is to further optimize the management for patients with symptomatic sacral perineural cysts by analyzing the outcomes of a cohort of patients who were treated with different strategies. Methods and Findings: We reviewed the outcomes of 15 patients with symptomatic sacral perineural cysts who were managed by three different modalities from 1998 through 2010. Six patients underwent microsurgical cyst fenestration and cyst wall imbrication. Seven patients underwent a modified surgical procedure, during which the cerebrospinal fluid leak aperture was located and repaired. Two patients were treated with medication and physical therapy. Outcomes of the patients were assessed by following up (13 months to 10 years). All of the six patients treated with microsurgical cyst fenestration and cyst wall imbrication experienced complete or substantial relief of their preoperative symptoms. However, the symptoms of one patient reappeared eight months after the operation. Another patient experienced a postoperative cerebrospinal fluid leakage. Six of the seven patients treated with the modified surgical operation experienced complete or substantial resolution of their preoperative symptoms, with only one patient who experienced temporary worsening of his preoperative urine incontinence, which disappeared gradually one month later. No new postoperative neurological deficits, no cerebrospinal fluid leaks and no recurrence were observed in the seven patients. The symptoms of the two patients treated with conservative measures aggravated with time. Conclusions: Microsurgical operation should be a treatment consideration in patients with symptomatic sacral perineural cysts. Furthermore, the surgical procedure with partial cyst removal and aperture repair for prevention of cerebrospinal fluid leakage seemed to be more simple and effective.	[Xu, Jianqiang; Sun, Yongdong; Huang, Xin] Gen Hosp, Fengfeng Grp, Dept Neurosurg, Handan, Peoples R China; [Luan, Wenzhong] Peking Univ, Peoples Hosp, Dept Neurosurg, Beijing 100871, Peoples R China	Peking University	Xu, JQ (corresponding author), Gen Hosp, Fengfeng Grp, Dept Neurosurg, Handan, Peoples R China.	wzh_luan@163.com						Acosta Frank L Jr, 2003, Neurosurg Focus, V15, pE15; Bartels RHMA, 1997, NEUROSURGERY, V40, P861, DOI 10.1097/00006123-199704000-00044; Caspar W, 2003, SURG NEUROL, V59, P101, DOI 10.1016/S0090-3019(02)00981-3; Guo DS, 2007, NEUROSURGERY, V60, P1059, DOI 10.1227/01.NEU.0000255457.12978.78; Kunz U, 1999, EUR SPINE J, V8, P218, DOI 10.1007/s005860050161; Lucantoni C, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11221; Morio Y, 2001, SPINE, V26, P451, DOI 10.1097/00007632-200102150-00025; Mummaneni PV, 2000, NEUROSURGERY, V47, P74, DOI 10.1097/00006123-200007000-00016; NABORS MW, 1988, J NEUROSURG, V68, P366, DOI 10.3171/jns.1988.68.3.0366; Neulen A, 2011, ACTA NEUROCHIR, V153, P1427, DOI 10.1007/s00701-011-1043-0; Patel MR, 1997, AM J ROENTGENOL, V168, P367, DOI 10.2214/ajr.168.2.9016209; PAULSEN RD, 1994, AM J NEURORADIOL, V15, P293; Prashad Bhagwat, 2007, Indian J Orthop, V41, P401, DOI 10.4103/0019-5413.37007; Smith Zachary A, 2011, Surg Neurol Int, V2, P129, DOI 10.4103/2152-7806.85469; Voyadzis JM, 2001, J NEUROSURG, V95, P25, DOI 10.3171/spi.2001.95.1.0025; Zhang T, 2007, J NEUROSURG-SPINE, V7, P145, DOI 10.3171/SPI-07/08/145	16	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39958	10.1371/journal.pone.0039958	http://dx.doi.org/10.1371/journal.pone.0039958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768183	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100155
J	Deng, YY; Yao, JT; Wang, XL; Guo, H; Duan, DL				Deng, Yunyan; Yao, Jianting; Wang, Xiuliang; Guo, Hui; Duan, Delin			Transcriptome Sequencing and Comparative Analysis of Saccharina japonica (Laminariales, Phaeophyceae) under Blue Light Induction	PLOS ONE			English	Article							IRRADIATED YOUNG SPOROPHYTES; SYNTHASE GENE-EXPRESSION; PROTEIN-KINASE CK2; EUKARYOTIC TRANSCRIPTOME; SATURATED PHOTOSYNTHESIS; VAUCHERIA-GEMINATA; PROFILING ANALYSIS; GENOME EXPRESSION; RNA-SEQ; UV-B	Background: Light has significant effect on the growth and development of Saccharina japonica, but there are limited reports on blue light mediated physiological responses and molecular mechanism. In this study, high-throughput paired-end RNA-sequencing (RNA-Seq) technology was applied to transcriptomes of S. japonica exposed to blue light and darkness, respectively. Comparative analysis of gene expression was designed to correlate the effect of blue light and physiological mechanisms on the molecular level. Principal Findings: RNA-seq analysis yielded 70,497 non-redundant unigenes with an average length of 538 bp. 28,358 (40.2%) functional transcripts encoding regions were identified. Annotation through Swissprot, Nr, GO, KEGG, and COG databases showed 25,924 unigenes compared well (E-value <10(-5)) with known gene sequences, and 43 unigenes were putative BL photoreceptor. 10,440 unigenes were classified into Gene Ontology, and 8,476 unigenes were involved in 114 known pathways. Based on RPKM values, 11,660 (16.5%) differentially expressed unigenes were detected between blue light and dark exposed treatments, including 7,808 upregulated and 3,852 downregulated unigenes, suggesting S. japonica had undergone extensive transcriptome re-orchestration during BL exposure. The BL-specific responsive genes were indentified to function in processes of circadian rhythm, flavonoid biosynthesis, photoreactivation and photomorphogenesis. Significance: Transcriptome profiling of S. japonica provides clues to potential genes identification and future functional genomics study. The global survey of expression changes under blue light will enhance our understanding of molecular mechanisms underlying blue light induced responses in lower plants as well as facilitate future blue light photoreceptor identification and specific responsive pathways analysis.	[Deng, Yunyan; Yao, Jianting; Wang, Xiuliang; Guo, Hui; Duan, Delin] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Deng, Yunyan; Guo, Hui] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Deng, YY (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	dlduan@qdio.ac.cn	Duan, Delin/G-9002-2011	Wang, Xiuliang/0000-0003-4262-0083	National Natural Science Foundation of China [40976085]; State 863 project [2012AA10A406]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State 863 project(National High Technology Research and Development Program of China)	This work was funded by the National Natural Science Foundation of China (no. 40976085) and State 863 project (no. 2012AA10A406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beggs CJ, 1994, PHOTOMORPHOGENESIS P, P733; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bernhardt A, 2006, PLANT J, V47, P591, DOI 10.1111/j.1365-313X.2006.02810.x; Bjorn LO, 2001, PLANT ECOL, V154, P1, DOI 10.1023/A:1012985924283; Briggs WR, 2001, PLANT CELL, V13, P993, DOI 10.1105/tpc.13.5.993; Brudler R, 2003, MOL CELL, V11, P59, DOI 10.1016/S1097-2765(03)00008-X; Bunning E., 1967, PHYSL CLOCK; Casal JJ, 2005, INT J DEV BIOL, V49, P501, DOI 10.1387/ijdb.051973jc; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DAZY AC, 1989, BIOL CELL, V67, P227, DOI 10.1016/0248-4900(89)90058-0; DRING MJ, 1981, LIMNOL OCEANOGR, V26, P271, DOI 10.4319/lo.1981.26.2.0271; DRING MJ, 1989, J PHYCOL, V25, P254, DOI 10.1111/j.1529-8817.1989.tb00120.x; Folta KM, 2003, PLANT J, V36, P203, DOI 10.1046/j.1365-313X.2003.01870.x; FORSTER RM, 1994, EUR J PHYCOL, V29, P21, DOI 10.1080/09670269400650441; FORSTER RM, 1992, PLANT CELL ENVIRON, V15, P241, DOI 10.1111/j.1365-3040.1992.tb01478.x; Fuglevand G, 1996, PLANT CELL, V8, P2347, DOI 10.1105/tpc.8.12.2347; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Han LQ, 2004, PLANT J, V40, P291, DOI 10.1111/j.1365-313X.2004.02207.x; HAN T, 1992, J EXP MAR BIOL ECOL, V158, P219, DOI 10.1016/0022-0981(92)90228-3; HAN T, 1993, J PHYCOL, V29, P79, DOI 10.1111/j.1529-8817.1993.tb00282.x; Harmer SL, 2005, PLANT CELL, V17, P1926, DOI 10.1105/tpc.105.033035; Hegemann P, 2008, ANNU REV PLANT BIOL, V59, P167, DOI 10.1146/annurev.arplant.59.032607.092847; Hendricks SB, 1983, PHOTOMORPHOGEN ENC A, V16A, P4; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Ishikawa M, 2009, PLANTA, V230, P543, DOI 10.1007/s00425-009-0967-6; JAFFE LF, 1958, EXP CELL RES, V15, P282, DOI 10.1016/0014-4827(58)90031-4; Jenkins GI, 2001, NEW PHYTOL, V151, P121, DOI 10.1046/j.1469-8137.2001.00151.x; Jiao YL, 2005, PLANT CELL, V17, P3239, DOI 10.1105/tpc.105.035840; Jung KH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000164; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KATAOKA H, 1975, PLANT CELL PHYSIOL, V16, P439; KATAOKA H, 1990, PLANT CELL PHYSIOL, V31, P933; KATAOKA H, 1975, PLANT CELL PHYSIOL, V16, P427; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Kropf DL, 1997, PLANT CELL, V9, P1011, DOI 10.1105/tpc.9.7.1011; Lehmann P, 2011, PLANT BIOLOGY, V13, P349, DOI 10.1111/j.1438-8677.2010.00377.x; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lin CT, 2003, ANNU REV PLANT BIOL, V54, P469, DOI 10.1146/annurev.arplant.54.110901.160901; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; LUNING K, 1980, J PHYCOL, V16, P1; LUNING K, 1975, MAR BIOL, V29, P195, DOI 10.1007/BF00391846; LUNING K, 1972, PLANTA, V104, P252, DOI 10.1007/BF00387080; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mas P, 2003, NATURE, V426, P567, DOI 10.1038/nature02163; Mathews S, 1997, PLANT CELL ENVIRON, V20, P666, DOI 10.1046/j.1365-3040.1997.d01-117.x; Mizuno T, 2005, PLANT CELL PHYSIOL, V46, P677, DOI 10.1093/pcp/pci087; Monnier A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-192; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nultsch W, 1956, ARCH PROTISTENKD, V101, P1; Ono N, 2010, PLANT CELL PHYSIOL, V51, P1800, DOI 10.1093/pcp/pcq140; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; PEPPER A, 1994, CELL, V78, P109, DOI 10.1016/0092-8674(94)90577-0; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Quail PH, 2002, CURR OPIN CELL BIOL, V14, P180, DOI 10.1016/S0955-0674(02)00309-5; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Schwechheimer C, 2001, TRENDS CELL BIOL, V11, P420, DOI 10.1016/S0962-8924(01)02091-8; Shi Cuijuan, 2005, Chinese Journal of Oceanology and Limnology, V23, P323; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Sugano S, 1998, P NATL ACAD SCI USA, V95, P11020, DOI 10.1073/pnas.95.18.11020; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Takahashi F, 2001, PLANT CELL PHYSIOL, V42, P274, DOI 10.1093/pcp/pce033; Takahashi F, 2007, P NATL ACAD SCI USA, V104, P19625, DOI 10.1073/pnas.0707692104; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tepperman JM, 2001, P NATL ACAD SCI USA, V98, P9437, DOI 10.1073/pnas.161300998; Thompson CL, 2002, ONCOGENE, V21, P9043, DOI 10.1038/sj.onc.1205958; Tseng CK, 2001, J APPL PHYCOL, V13, P375, DOI 10.1023/A:1017972812576; Wang B, 2010, NUCLEIC ACIDS RES, V38, P5075, DOI 10.1093/nar/gkq256; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang WJ, 2010, MAR BIOL, V157, P1811, DOI 10.1007/s00227-010-1453-1; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei N, 1998, CURR BIOL, V8, P919, DOI 10.1016/S0960-9822(07)00372-7; WHITAKER D. M., 1942, JOUR GEN PHYSIOL, V25, P391, DOI 10.1085/jgp.25.3.391; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Yao JT, 2009, J APPL PHYCOL, V21, P233, DOI 10.1007/s10811-008-9354-0; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zhang XB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003386	94	56	61	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39704	10.1371/journal.pone.0039704	http://dx.doi.org/10.1371/journal.pone.0039704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761876	Green Submitted, Green Published, gold			2022-12-27	WOS:000305825800063
J	Ying, JM; Shan, L; Li, JS; Zhong, L; Xue, LY; Zhao, H; Li, LL; Langford, C; Guo, L; Qiu, T; Lu, N; Tao, Q				Ying, Jianming; Shan, Ling; Li, Jisheng; Zhong, Lan; Xue, Liyan; Zhao, Hong; Li, Lili; Langford, Cordelia; Guo, Lei; Qiu, Tian; Lu, Ning; Tao, Qian			Genome-Wide Screening for Genetic Alterations in Esophageal Cancer by aCGH Identifies 11q13 Amplification Oncogenes Associated with Nodal Metastasis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DNA MICROARRAYS; BLADDER-CANCER; CTTN EMS1; OVEREXPRESSION; EXPRESSION; HYBRIDIZATION; ARRAY; EPIDEMIOLOGY; CCND1	Background: Esophageal squamous cell carcinoma (ESCC) is highly prevalent in China and other Asian countries, as a major cause of cancer-related mortality. ESCC displays complex chromosomal abnormalities, including multiple structural and numerical aberrations. Chromosomal abnormalities, such as recurrent amplifications and homozygous deletions, directly contribute to tumorigenesis through altering the expression of key oncogenes and tumor suppressor genes. Methodology/Principle Findings: To understand the role of genetic alterations in ESCC pathogenesis and identify critical amplification/deletion targets, we performed genome-wide 1-Mb array comparative genomic hybridization (aCGH) analysis for 10 commonly used ESCC cell lines. Recurrent chromosomal gains were frequently detected on 3q26-27, 5p15-14, 8p12, 8p22-24, 11q13, 13q21-31, 18p11 and 20q11-13, with frequent losses also found on 8p23-22, 11q22, 14q32 and 18q11-23. Gain of 11q13.3-13.4 was the most frequent alteration in ESCC. Within this region, CCND1 oncogene was identified with high level of amplification and overexpression in ESCC, while FGF19 and SHANK2 was also remarkably over-expressed. Moreover, a high concordance (91.5%) of gene amplification and protein overexpression of CCND1 was observed in primary ESCC tumors. CCND1 amplification/overexpression was also significantly correlated with the lymph node metastasis of ESCC. Conclusion: These findings suggest that genomic gain of 11q13 is the major mechanism contributing to the amplification. Novel oncogenes identified within the 11q13 amplicon including FGF19 and SHANK2 may play important roles in ESCC tumorigenesis.	[Ying, Jianming; Shan, Ling; Xue, Liyan; Guo, Lei; Qiu, Tian; Lu, Ning] Peking Union Med Coll, Canc Hosp, Dept Pathol, Beijing 100021, Peoples R China; [Ying, Jianming; Shan, Ling; Xue, Liyan; Zhao, Hong; Guo, Lei; Qiu, Tian; Lu, Ning] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Ying, Jianming; Li, Jisheng; Zhong, Lan; Li, Lili; Tao, Qian] Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, State Key Lab Oncol S China, Canc Epigenet Lab,Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Ying, Jianming; Li, Jisheng; Zhong, Lan; Li, Lili; Tao, Qian] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Li, Jisheng] Shandong Univ, Qilu Hosp, Ctr Canc, Dept Chemotherapy, Jinan 250100, Peoples R China; [Zhao, Hong] Peking Union Med Coll, Canc Hosp, Dept Abdominal Surg Oncol, Beijing 100021, Peoples R China; [Langford, Cordelia] Wellcome Trust Sanger Inst, Microarray Facil, Cambridge, England	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese University of Hong Kong; Chinese University of Hong Kong; Shandong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Wellcome Trust Sanger Institute	Ying, JM (corresponding author), Peking Union Med Coll, Canc Hosp, Dept Pathol, Beijing 100021, Peoples R China.	jmying@hotmail.com; nlu03@126.com; qtao@cuhk.edu.hk	Li, Lili/Q-5750-2018; Tao, Qian/T-4743-2018; Guo, Lei/AEU-0178-2022	Li, Lili/0000-0002-0292-5889; Tao, Qian/0000-0001-5383-4808; 	National Natural Science Foundation of China [30801344, 30928012]; Beijing Nova Program [2009A70]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This study was supported by grants from the National Natural Science Foundation of China (#30801344, #30928012) and the Beijing Nova Program (No. 2009A70). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JW, 1997, SURG ONCOL, V6, P193, DOI 10.1016/S0960-7404(98)00003-6; Arai H, 2003, CANCER GENET CYTOGEN, V146, P16, DOI 10.1016/S0165-4608(03)00106-7; Bass AJ, NAT GENE, V41, P1238; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Brown J, 2011, WORLD J GASTROENTERO, V17, P2909, DOI 10.3748/wjg.v17.i24.2909; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; Carneiro A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-98; Chattopadhyay I, 2010, MUTAT RES-GEN TOX EN, V696, P130, DOI 10.1016/j.mrgentox.2010.01.001; Chi B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-13; Chiang PW, 1999, CLIN CANCER RES, V5, P1381; Chuma M, 2004, J HEPATOL, V41, P629, DOI 10.1016/j.jhep.2004.06.018; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Hibberts NA, 1999, CLIN CANCER RES, V5, P2133; Holmes RS, 2007, SEMIN RADIAT ONCOL, V17, P2, DOI 10.1016/j.semradonc.2006.09.003; Hurst CD, 2004, ONCOGENE, V23, P2250, DOI 10.1038/sj.onc.1207260; Izzo JG, 1998, ONCOGENE, V17, P2313, DOI 10.1038/sj.onc.1202153; Janssen JWG, 2002, J HUM GENET, V47, P460, DOI 10.1007/s100380200065; JIANG W, 1992, CANCER RES, V52, P2980; Kunisaki C, 2004, HEPATO-GASTROENTEROL, V51, P736; Lambert R, 2007, BEST PRACT RES CL GA, V21, P921, DOI 10.1016/j.bpg.2007.10.001; Law FB, 2007, ONCOGENE, V26, P7490; Lin DC, 2009, DIS ESOPHAGUS, V22, P9, DOI 10.1111/j.1442-2050.2008.00845.x; Liu GY, 2008, WORLD J GASTROENTERO, V14, P7199, DOI 10.3748/wjg.14.7199; Luo ML, 2007, CELL RES, V17, P298, DOI 10.1038/cr.2007.17; Luo ML, 2006, CANCER RES, V66, P11690, DOI 10.1158/0008-5472.CAN-06-1484; Maesawa C, 1997, JPN J CANCER RES, V88, P340, DOI 10.1111/j.1349-7006.1997.tb00386.x; Miller CT, 2003, CANCER RES, V63, P4136; Nagasawa S, 2001, J SURG ONCOL, V78, P208, DOI 10.1002/jso.1152; Nandan MO, 2008, GASTROENTEROLOGY, V134, P120, DOI 10.1053/j.gastro.2007.10.023; Park HL, 2008, INT J CANCER, V122, P2498, DOI 10.1002/ijc.23434; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 1993, INT J CANCER, V19, P594; Peng Hui, 2009, Ai Zheng, V28, P38; Pera M, 2005, J SURG ONCOL, V92, P151, DOI 10.1002/jso.20357; Rodrigo JP, 2009, J PATHOL, V217, P516, DOI 10.1002/path.2462; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Shi ZZ, 2011, GENE CHROMOSOME CANC, V50, P518, DOI 10.1002/gcc.20875; Sun XD, 2005, NAT GENET, V37, P407, DOI 10.1038/ng1528; Thompson SK, 2008, ANN SURG ONCOL, V15, P3447, DOI 10.1245/s10434-008-0155-0; Wang XX, 2006, CELL RES, V16, P356, DOI 10.1038/sj.cr.7310046; Yang ZQ, 2000, CANCER RES, V60, P4735; Ying J, 2006, ONCOGENE, V25, P1070, DOI 10.1038/sj.onc.1209154; Ying J, 2006, LEUKEMIA, V20, P1173, DOI 10.1038/sj.leu.2404193; Zen K, 2009, ONCOGENE, V28, P2910, DOI 10.1038/onc.2009.148; Zheng M, 2004, AM J PATHOL, V165, P63, DOI 10.1016/S0002-9440(10)63275-0	45	28	36	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39797	10.1371/journal.pone.0039797	http://dx.doi.org/10.1371/journal.pone.0039797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761904	Green Published, gold, Green Submitted			2022-12-27	WOS:000305781700068
J	Hollister, EB; Forrest, AK; Wilkinson, HH; Ebbole, DJ; Tringe, SG; Malfatti, SA; Holtzapple, MT; Gentry, TJ				Hollister, Emily B.; Forrest, Andrea K.; Wilkinson, Heather H.; Ebbole, Daniel J.; Tringe, Susannah G.; Malfatti, Stephanie A.; Holtzapple, Mark T.; Gentry, Terry J.			Mesophilic and Thermophilic Conditions Select for Unique but Highly Parallel Microbial Communities to Perform Carboxylate Platform Biomass Conversion	PLOS ONE			English	Article							MIXED-CULTURE; DISCOVERY; DYNAMICS; CAPROATE; BAGASSE; ACIDS; FUEL	The carboxylate platform is a flexible, cost-effective means of converting lignocellulosic materials into chemicals and liquid fuels. Although the platform's chemistry and engineering are well studied, relatively little is known about the mixed microbial communities underlying its conversion processes. In this study, we examined the metagenomes of two actively fermenting platform communities incubated under contrasting temperature conditions (mesophilic 40 degrees C; thermophilic 55 degrees C), but utilizing the same inoculum and lignocellulosic feedstock. Community composition segregated by temperature. The thermophilic community harbored genes affiliated with Clostridia, Bacilli, and a Thermoanaerobacterium sp, whereas the mesophilic community metagenome was composed of genes affiliated with other Clostridia and Bacilli, Bacteriodia, gamma-Proteobacteria, and Actinobacteria. Although both communities were able to metabolize cellulosic materials and shared many core functions, significant differences were detected with respect to the abundances of multiple Pfams, COGs, and enzyme families. The mesophilic metagenome was enriched in genes related to the degradation of arabinose and other hemicellulose-derived oligosaccharides, and the production of valerate and caproate. In contrast, the thermophilic community was enriched in genes related to the uptake of cellobiose and the transfer of genetic material. Functions assigned to taxonomic bins indicated that multiple community members at either temperature had the potential to degrade cellulose, cellobiose, or xylose and produce acetate, ethanol, and propionate. The results of this study suggest that both metabolic flexibility and functional redundancy contribute to the platform's ability to process lignocellulosic substrates and are likely to provide a degree of stability to the platform's fermentation processes.	[Hollister, Emily B.; Gentry, Terry J.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Hollister, Emily B.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Forrest, Andrea K.; Holtzapple, Mark T.] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA; [Wilkinson, Heather H.; Ebbole, Daniel J.] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Tringe, Susannah G.; Malfatti, Stephanie A.] Joint Genome Inst, Walnut Creek, CA USA; [Hollister, Emily B.] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Baylor College of Medicine	Hollister, EB (corresponding author), Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA.	holliste@bcm.edu	Tringe, Susannah Green/T-9431-2019	Tringe, Susannah Green/0000-0001-6479-8427; Malfatti, Stephanie/0000-0003-4225-9857	Department of Energy's Joint Genome Institute; Texas AgriLife Research Bioenergy Program; Texas A&M University Office of the Vice President for Research Energy Resources Program; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]	Department of Energy's Joint Genome Institute; Texas AgriLife Research Bioenergy Program; Texas A&M University Office of the Vice President for Research Energy Resources Program; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by grants from the Department of Energy's Joint Genome Institute, the Texas AgriLife Research Bioenergy Program, and the Texas A&M University Office of the Vice President for Research Energy Resources Program. The work conducted by the U.S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agler MT, 2011, TRENDS BIOTECHNOL, V29, P70, DOI 10.1016/j.tibtech.2010.11.006; Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Brazelton WJ, 2009, ISME J, V3, P1420, DOI 10.1038/ismej.2009.79; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; CALDWELL DR, 1986, CURR MICROBIOL, V14, P149, DOI 10.1007/BF01568367; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chan WN, 2003, APPL BIOCHEM BIOTECH, V111, P93, DOI 10.1385/ABAB:111:2:93; Chang VS, 1998, APPL BIOCHEM BIOTECH, V74, P135, DOI 10.1007/BF02825962; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; Ding HB, 2010, BIORESOURCE TECHNOL, V101, P9550, DOI 10.1016/j.biortech.2010.07.056; EPA (U.S. Environmental Protection Agency), 2010, EPA FIN REG NAT REN; Fu ZH, 2010, APPL BIOCHEM BIOTECH, V162, P561, DOI 10.1007/s12010-009-8748-z; Golub KW, 2011, BIORESOURCE TECHNOL, V102, P5066, DOI 10.1016/j.biortech.2011.02.011; Granda CB, 2009, APPL BIOCHEM BIOTECH, V156, P537, DOI 10.1007/s12010-008-8481-z; Hashsham SA, 2000, APPL ENVIRON MICROB, V66, P4050, DOI 10.1128/AEM.66.9.4050-4057.2000; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hollister EB, 2011, J APPL MICROBIOL, V110, P587, DOI 10.1111/j.1365-2672.2010.04919.x; Hollister EB, 2010, APPL MICROBIOL BIOT, V88, P389, DOI 10.1007/s00253-010-2789-7; Hollister EB, 2010, ISME J, V4, P829, DOI 10.1038/ismej.2010.3; Holtzapple MT, 1999, APPL BIOCHEM BIOTECH, V77-9, P609, DOI 10.1385/ABAB:79:1-3:609; Leitao RC, 2006, BIORESOURCE TECHNOL, V97, P1105, DOI 10.1016/j.biortech.2004.12.007; Lykidis A, 2011, ISME J, V5, P122, DOI 10.1038/ismej.2010.125; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Mavromatis K, 2009, STAND GENOMIC SCI, V1, P63, DOI 10.4056/sigs.632; Pham V, 2010, J IND MICROBIOL BIOT, V37, P1157, DOI 10.1007/s10295-010-0763-0; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; STAMS AJM, 1993, APPL ENVIRON MICROB, V59, P1114, DOI 10.1128/AEM.59.4.1114-1119.1993; Steinbusch KJJ, 2011, ENERG ENVIRON SCI, V4, P216, DOI 10.1039/c0ee00282h; Subramani V, 2008, ENERG FUEL, V22, P814, DOI 10.1021/ef700411x; Thanakoses P, 2003, APPL BIOCHEM BIOTECH, V105, P523; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Werner JJ, 2011, P NATL ACAD SCI US; Ye YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000465	37	21	21	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39689	10.1371/journal.pone.0039689	http://dx.doi.org/10.1371/journal.pone.0039689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761870	gold, Green Submitted, Green Published			2022-12-27	WOS:000305730900099
J	McLaughlan, JM; Liti, G; Sharp, S; Maslowska, A; Louis, EJ				McLaughlan, Jenny M.; Liti, Gianni; Sharp, Sarah; Maslowska, Agnieszka; Louis, Edward J.			Apparent Ploidy Effects on Silencing Are Post-Transcriptional at HML and Telomeres in Saccharomyces cerevisiae	PLOS ONE			English	Article							RESOLUTION STRUCTURAL-ANALYSIS; TRANSCRIPTIONAL STATES; TRANSLATIONAL RESPONSE; CHROMATIN; YEAST; LOCUS; SIZE; RECOMBINATION; ESTABLISHMENT; INHERITANCE	The repression of genes in regions of heterochromatin is known as transcriptional silencing. It occurs in a wide range of organisms and can have importance in adaptation to the environment, developmental changes and disease. The model organism Saccharomyces cerevisiae has been used for many years to study transcriptional silencing, but until recently no study has been made in relation to ploidy. The aim of this work was to compare transcriptional silencing in haploids and diploids at both telomeres and the hidden mating-type (HM) loci. Transcriptional silencing was assayed, by growth on 5-fluoroorotic acid (5-FOA) media or by flow cytometry, on strains where a telomere or HM locus was marked. RNA levels were measured by quantitative RT-PCR to confirm that effects were transcriptional. 5-FOA assays and flow cytometry were consistent with transcriptional silencing at telomeres and at HML being reduced as ploidy increases which agreed with conclusions in previous publications. However, QRT-PCR revealed that transcriptional silencing was unaffected by ploidy and thus protein levels were increasing independently of RNA levels. At telomere XI left (XI-L), changes in protein level were strongly influenced by mating-type, whereas at HML mating-type had much less influence. The post-transcriptional effects seen in this study, illustrate the often ignored need to measure RNA levels when assaying transcriptional silencing in Saccharomyces cerevisiae.	[McLaughlan, Jenny M.; Liti, Gianni; Sharp, Sarah; Maslowska, Agnieszka; Louis, Edward J.] Univ Nottingham, Queens Med Ctr, Ctr Genet & Genom, Nottingham NG7 2RD, England	University of Nottingham	McLaughlan, JM (corresponding author), Novozymes Biopharma UK Ltd, Nottingham, England.	jfml@novozymes.com; Ed.Louis@nottingham.ac.uk	Liti, Gianni/I-9929-2014; Louis, Edward/B-7920-2008	Louis, Edward/0000-0003-1157-3608; Liti, Gianni/0000-0002-2318-0775	Wellcome Trust [WT084507]; CRUK [C6950/A9435]; BBSRC Biotechnology and Biological Sciences Research Council [BB/F015216/1]; BBSRC [BB/F015216/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F015216/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); CRUK(Cancer Research UK); BBSRC Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Wellcome Trust (WT084507) http://www.wellcome.ac.uk/, CRUK (C6950/A9435) http://www.cancerresearchuk.org/, the BBSRC Biotechnology and Biological Sciences Research Council(BB/F015216/1) http://www.bbsrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Brachmann CB, 1998, YEAST, V14, P115; BUCK SW, 1995, GENE DEV, V9, P370, DOI 10.1101/gad.9.3.370; Collart MA, 2001, PREPARATION YEAST RN; Cook M, 2007, CURR OPIN BIOTECH, V18, P341, DOI 10.1016/j.copbio.2007.07.006; Fairhead C, 1996, YEAST, V12, P1439; Galgoczy DJ, 2004, P NATL ACAD SCI USA, V101, P18069, DOI 10.1073/pnas.0407611102; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Liti G, 2005, YEAST, V22, P177, DOI 10.1002/yea.1200; Liti G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000659; Loney ER, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-18; Lundberg E, 2008, J PROTEOMICS, V71, P448, DOI 10.1016/j.jprot.2008.06.014; Mazor Y, 2009, NUCLEIC ACIDS RES, V37, P4839, DOI 10.1093/nar/gkp512; Melamed D, 2008, RNA, V14, P1337, DOI 10.1261/rna.864908; Mercier G, 2005, NUCLEIC ACIDS RES, V33, P6635, DOI 10.1093/nar/gki959; PILLUS L, 1989, CELL, V59, P637, DOI 10.1016/0092-8674(89)90009-3; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; Ravindra A, 1999, MOL CELL BIOL, V19, P7944; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; SUSSEL L, 1993, MOL CELL BIOL, V13, P3919, DOI 10.1128/MCB.13.7.3919; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Trcek T, 2010, GENE DEV, V24, P1827, DOI 10.1101/gad.1972810; Warringer J, 2010, MOL BIOL CELL, V21, P3080, DOI 10.1091/mbc.E10-01-0006; Weiss K, 1998, MOL CELL BIOL, V18, P5392, DOI 10.1128/MCB.18.9.5392; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Xu EY, 2006, MOL CELL, V23, P219, DOI 10.1016/j.molcel.2006.05.035; Zhang J, 2002, CURR BIOL, V12, P1992, DOI 10.1016/S0960-9822(02)01305-2	34	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39044	10.1371/journal.pone.0039044	http://dx.doi.org/10.1371/journal.pone.0039044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792162	Green Published, Green Submitted, gold			2022-12-27	WOS:000306354700007
J	Iacona, GD; Kirkman, LK; Bruna, EM				Iacona, Gwenllian D.; Kirkman, L. Katherine; Bruna, Emilio M.			Experimental Test for Facilitation of Seedling Recruitment by the Dominant Bunchgrass in a Fire-Maintained Savanna	PLOS ONE			English	Article							LONGLEAF PINE; POSITIVE INTERACTIONS; PLANT-COMMUNITIES; SPECIES RICHNESS; SHRUB; WATER; AVAILABILITY; INTERFERENCE; COMPETITION; DIVERSITY	Facilitative interactions between neighboring plants can influence community composition, especially in locations where environmental stress is a factor limiting competitive effects. The longleaf pine savanna of the southeastern United States is a threatened and diverse system where seedling recruitment success and understory species richness levels are regulated by the availability of moist microsites. We hypothesized that the dominant bunch grass species (Aristida stricta Michx.) would facilitate moist seedling microsites through shading, but that the effect would depend on stress gradients. Here, we examined the environmental properties modified by the presence of wiregrass and tested the importance of increased shade as a potential facilitative mechanism promoting seedling recruitment across spatial and temporal stress gradients. We showed that environmental gradients, season, and experimental water manipulation influence seedling success. Environmental properties were modified by wiregrass proximity in a manner that could facilitate seedling success, but we showed that shade alone does not provide a facilitative benefit to seedlings in this system.	[Iacona, Gwenllian D.; Kirkman, L. Katherine] JW Jones Ecol Res Ctr, Newton, GA USA; [Iacona, Gwenllian D.; Bruna, Emilio M.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Bruna, Emilio M.] Univ Florida, Ctr Latin Amer Studies, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Iacona, GD (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	giacona@utk.edu	Bruna, Emilio M/H-2769-2012; Iacona, Gwenllian/G-6567-2016	Bruna, Emilio M/0000-0003-3381-8477; Iacona, Gwenllian/0000-0002-7408-3895	J.W. Jones Ecological Research Center; The Robert Woodruff Foundation; The University of Florida College of Agricultural and Life Sciences	J.W. Jones Ecological Research Center; The Robert Woodruff Foundation; The University of Florida College of Agricultural and Life Sciences	Funding was provided by the J.W. Jones Ecological Research Center, The Robert Woodruff Foundation, and The University of Florida College of Agricultural and Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Butterfield BJ, 2009, J ECOL, V97, P1192, DOI 10.1111/j.1365-2745.2009.01569.x; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Cavieres LA, 2009, J ECOL, V97, P1181, DOI 10.1111/j.1365-2745.2009.01579.x; Drew Mark B., 1998, Castanea, V63, P1; Freestone AL, 2006, ECOLOGY, V87, P2728, DOI 10.1890/0012-9658(2006)87[2728:FDLAAR]2.0.CO;2; Fulbright TE, 1995, ACTA OECOL, V16, P621; Goebel P. C., 1997, 971 JW JON EC RES CT; Greenlee JT, 1996, AM NAT, V148, P386, DOI 10.1086/285931; Hacker SD, 1997, ECOLOGY, V78, P1990, DOI 10.1890/0012-9658(1997)078[1990:SIODPI]2.0.CO;2; HACKER SD, 1995, ECOLOGY, V76, P2165, DOI 10.2307/1941690; Hacker SD, 1999, ECOLOGY, V80, P2064, DOI 10.1890/0012-9658(1999)080[2064:EEFFMP]2.0.CO;2; Holmgren M, 2010, J ECOL, V98, P1269, DOI 10.1111/j.1365-2745.2010.01709.x; Holmgren Milena, 1997, Ecology (Washington D C), V78, P1966, DOI 10.1890/0012-9658(1997)078[1966:TIOFAC]2.0.CO;2; Iacona G, 2008, THESIS U FLORDIA GAI; Iacona GD, 2010, OECOLOGIA, V163, P171, DOI 10.1007/s00442-009-1502-y; Keddy PA, 2006, APPL VEG SCI, V9, P17, DOI 10.1658/1402-2001(2006)9[17:POHPDI]2.0.CO;2; Kikvidze Z, 2006, J VEG SCI, V17, P77, DOI 10.1111/j.1654-1103.2006.tb02425.x; Kirkman LK, 2001, AM J BOT, V88, P2119, DOI 10.2307/3558437; MACMAHON J.A., 1981, WATER DESERT ECOSYST, V11, P114; Manson RH, 1998, OIKOS, V82, P37, DOI 10.2307/3546915; McNab WH, 1994, ADM PUBL; Mitchell RJ, 1999, CAN J FOREST RES, V29, P743, DOI 10.1139/cjfr-29-6-743; Olness A, 2005, SOIL SCI, V170, P90, DOI 10.1097/00010694-200502000-00002; Pecot SD, 2007, CAN J FOREST RES, V37, P634, DOI 10.1139/X06-247; Peet RK, 1993, LONGLEAF PINE VEGETA; RAHMAN AAAE, 1965, J ECOL, V53, P267, DOI 10.2307/2257974; Shreve F, 1931, ECOLOGY, V12, P96, DOI 10.2307/1932935; Shumway SW, 2000, OECOLOGIA, V124, P138, DOI 10.1007/s004420050033; Tielborger K, 2000, ECOLOGY, V81, P1544, DOI 10.2307/177305; TOPP GC, 1980, WATER RESOUR RES, V16, P574, DOI 10.1029/WR016i003p00574; VINTON MA, 1995, ECOLOGY, V76, P1116, DOI 10.2307/1940920; Weedon JT, 2008, J ECOL, V96, P1230, DOI 10.1111/j.1365-2745.2008.01427.x; West JB, 2004, J TORREY BOT SOC, V131, P120, DOI 10.2307/4126913; Zou CB, 2005, OECOLOGIA, V145, P32, DOI 10.1007/s00442-005-0110-8	36	11	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39108	10.1371/journal.pone.0039108	http://dx.doi.org/10.1371/journal.pone.0039108			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792165	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800007
J	Ambur, OH; Frye, SA; Nilsen, M; Hovland, E; Tonjum, T				Ambur, Ole Herman; Frye, Stephan A.; Nilsen, Mariann; Hovland, Eirik; Tonjum, Tone			Restriction and Sequence Alterations Affect DNA Uptake Sequence-Dependent Transformation in Neisseria meningitidis	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; MODIFICATION SYSTEMS; HOMOLOGOUS RECOMBINATION; NATURAL TRANSFORMATION; EXTRACELLULAR DNA; BIOFILM FORMATION; GONORRHOEAE; BACTERIA; COMPETENCE; IDENTIFICATION	Transformation is a complex process that involves several interactions from the binding and uptake of naked DNA to homologous recombination. Some actions affect transformation favourably whereas others act to limit it. Here, meticulous manipulation of a single type of transforming DNA allowed for quantifying the impact of three different mediators of meningococcal transformation: NlaIV restriction, homologous recombination and the DNA Uptake Sequence (DUS). In the wildtype, an inverse relationship between the transformation frequency and the number of NlaIV restriction sites in DNA was observed when the transforming DNA harboured a heterologous region for selection (ermC) but not when the transforming DNA was homologous with only a single nucleotide heterology. The influence of homologous sequence in transforming DNA was further studied using plasmids with a small interruption or larger deletions in the recombinogenic region and these alterations were found to impair transformation frequency. In contrast, a particularly potent positive driver of DNA uptake in Neisseria sp. are short DUS in the transforming DNA. However, the molecular mechanism(s) responsible for DUS specificity remains unknown. Increasing the number of DUS in the transforming DNA was here shown to exert a positive effect on transformation. Furthermore, an influence of variable placement of DUS relative to the homologous region in the donor DNA was documented for the first time. No effect of altering the orientation of DUS was observed. These observations suggest that DUS is important at an early stage in the recognition of DNA, but does not exclude the existence of more than one level of DUS specificity in the sequence of events that constitute transformation. New knowledge on the positive and negative drivers of transformation may in a larger perspective illuminate both the mechanisms and the evolutionary role(s) of one of the most conserved mechanisms in nature: homologous recombination.	[Ambur, Ole Herman; Frye, Stephan A.; Nilsen, Mariann; Hovland, Eirik; Tonjum, Tone] Ctr Mol Biol & Neurosci, Oslo, Norway; [Frye, Stephan A.; Nilsen, Mariann; Tonjum, Tone] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Microbiol, N-0027 Oslo, Norway; [Ambur, Ole Herman; Hovland, Eirik; Tonjum, Tone] Univ Oslo, Inst Basic Med Sci, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo	Ambur, OH (corresponding author), Ctr Mol Biol & Neurosci, Oslo, Norway.	o.h.ambur@medisin.uio.no	Tønjum, Tone/J-4581-2014; Ambur, Ole/G-6641-2016; Ambur, Ole Herman/O-5342-2019	Ambur, Ole/0000-0001-9870-6375; Ambur, Ole Herman/0000-0001-9870-6375; Frye, Stephan/0000-0002-0786-8481; Tonjum, Tone/0000-0002-1709-6921	Medical Research Curriculum at the University of Oslo; Research Council of Norway; FUGE platform Consortium for Microbial Science Technology (CAMST)	Medical Research Curriculum at the University of Oslo; Research Council of Norway(Research Council of Norway); FUGE platform Consortium for Microbial Science Technology (CAMST)	This work was supported by The Medical Research Curriculum at the University of Oslo to EH, a Centre of Excellence grant from the Research Council of Norway to Centre for Molecular Biology and Neuroscience (CMBN) and the FUGE platform Consortium for Microbial Science Technology (CAMST) to OHA, SAF, MN and TT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas FE, 2002, MOL MICROBIOL, V46, P1441, DOI 10.1046/j.1365-2958.2002.03265.x; Ambur OH, 2007, J BACTERIOL, V189, P2077, DOI 10.1128/JB.01408-06; Assalkhou R, 2007, MICROBIOL-SGM, V153, P1593, DOI 10.1099/mic.0.2006/004200-0; BISWAS GD, 1977, J BACTERIOL, V129, P983, DOI 10.1128/JB.129.2.983-992.1977; BISWAS GD, 1981, J BACTERIOL, V145, P638, DOI 10.1128/JB.145.1.638-640.1981; BoyleVavra S, 1996, MICROBIOL-SGM, V142, P2839, DOI 10.1099/13500872-142-10-2839; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; Chaussee MS, 1999, MICROBIOL-UK, V145, P389, DOI 10.1099/13500872-145-2-389; Chaussee MS, 1998, J BACTERIOL, V180, P5117, DOI 10.1128/JB.180.19.5117-5122.1998; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Chen I, 2001, J BACTERIOL, V183, P3160, DOI 10.1128/JB.183.10.3160-3168.2001; Chmiel AA, 2005, PROTEIN ENG DES SEL, V18, P181, DOI 10.1093/protein/gzi019; Claus H, 2000, J BACTERIOL, V182, P1296, DOI 10.1128/JB.182.5.1296-1303.2000; Davidsen T, 2006, NAT REV MICROBIOL, V4, P11, DOI 10.1038/nrmicro1324; Davidsen T, 2004, NUCLEIC ACIDS RES, V32, P1050, DOI 10.1093/nar/gkh255; DOUGHERTY TJ, 1979, BIOCHEM BIOPH RES CO, V86, P97, DOI 10.1016/0006-291X(79)90386-3; Duffin PM, 2010, J BACTERIOL, V192, P4436, DOI 10.1128/JB.00442-10; ELKINS C, 1991, J BACTERIOL, V173, P3911, DOI 10.1128/JB.173.12.3911-3913.1991; FROHOLM LO, 1973, ACTA PATH MICRO IM B, VB 81, P525; GOODGAL SH, 1990, J BACTERIOL, V172, P5924, DOI 10.1128/jb.172.10.5924-5928.1990; GOODMAN SD, 1991, J BACTERIOL, V173, P5921, DOI 10.1128/jb.173.18.5921-5923.1991; GOODMAN SD, 1988, P NATL ACAD SCI USA, V85, P6982, DOI 10.1073/pnas.85.18.6982; GRAVES JF, 1982, J BACTERIOL, V152, P1071; Hamilton HL, 2006, MOL MICROBIOL, V59, P376, DOI 10.1111/j.1365-2958.2005.04964.x; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hill SA, 1999, GENE, V240, P175, DOI 10.1016/S0378-1119(99)00414-X; JYSSUM K, 1965, ACTA PATHOL MIC SC, V63, P306, DOI 10.1111/apm.1965.63.2.306; JYSSUM S, 1970, ACTA PATHOLOG MICROB, VB 78, P140; Kaplan JB, 2002, APPL ENVIRON MICROB, V68, P4943, DOI 10.1128/AEM.68.10.4943-4950.2002; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; KOOMEY JM, 1987, J BACTERIOL, V169, P790, DOI 10.1128/jb.169.2.790-795.1987; LABBE D, 1990, MOL GEN GENET, V224, P101; Lang E, 2009, MICROBIOL-SGM, V155, P852, DOI 10.1099/mic.0.022640-0; Lappann M, 2010, MOL MICROBIOL, V75, P1355, DOI 10.1111/j.1365-2958.2010.07054.x; LAU PCK, 1994, MOL GEN GENET, V243, P24, DOI 10.1007/BF00283872; Long CD, 2003, INFECT IMMUN, V71, P6279, DOI 10.1128/IAI.71.11.6279-6291.2003; Majewski J, 2001, FEMS MICROBIOL LETT, V199, P161, DOI 10.1016/S0378-1097(01)00183-5; Mehr IJ, 1998, MOL MICROBIOL, V30, P697, DOI 10.1046/j.1365-2958.1998.01089.x; MICHOD RE, 1988, GENETICS, V118, P31; Michod RE, 2008, INFECT GENET EVOL, V8, P267, DOI 10.1016/j.meegid.2008.01.002; NAITO T, 1995, SCIENCE, V267, P897, DOI 10.1126/science.7846533; NISHIGAKI K, 1985, NUCLEIC ACIDS RES, V13, P5747, DOI 10.1093/nar/13.16.5747; QIANG BQ, 1986, NUCLEIC ACIDS RES, V14, P1991, DOI 10.1093/nar/14.5.1991; RITCHOT N, 1990, GENE, V86, P103, DOI 10.1016/0378-1119(90)90120-G; Roberts Michael S., 1993, Genetics, V134, P401; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Seifert HS, 1997, GENE, V188, P215, DOI 10.1016/S0378-1119(96)00810-4; Smith HO, 1999, RES MICROBIOL, V150, P603, DOI 10.1016/S0923-2508(99)00130-8; Snyder LAS, 2007, MOL BIOL EVOL, V24, P2802, DOI 10.1093/molbev/msm215; SOX TE, 1979, J BACTERIOL, V138, P510, DOI 10.1128/JB.138.2.510-518.1979; SPARLING PF, 1966, J BACTERIOL, V92, P1364, DOI 10.1128/JB.92.5.1364-1371.1966; Srikhanta YN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000400; Stefanelli P, 2001, J ANTIMICROB CHEMOTH, V47, P219, DOI 10.1093/jac/47.2.219; STEIN DC, 1988, INFECT IMMUN, V56, P112, DOI 10.1128/IAI.56.1.112-116.1988; STEIN DC, 1995, GENE, V157, P19, DOI 10.1016/0378-1119(94)00649-D; Szollosi GJ, 2006, GENETICS, V174, P2173, DOI 10.1534/genetics.106.063412; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; TONJUM T, 1995, MOL MICROBIOL, V16, P451, DOI 10.1111/j.1365-2958.1995.tb02410.x; Treangen TJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r60; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wolfgang M, 1999, MOL MICROBIOL, V31, P1345, DOI 10.1046/j.1365-2958.1999.01269.x	63	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39742	10.1371/journal.pone.0039742	http://dx.doi.org/10.1371/journal.pone.0039742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768309	gold, Green Published, Green Submitted			2022-12-27	WOS:000305966500022
J	Ciupe, SM; Hews, S				Ciupe, Stanca M.; Hews, Sarah			Mathematical Models of E-Antigen Mediated Immune Tolerance and Activation following Prenatal HBV Infection	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; REGULATORY T-CELLS; NATURAL-HISTORY; ANTIVIRAL THERAPY; VIRAL CLEARANCE; CORE PROMOTER; SEROCONVERSION; DYNAMICS; KINETICS; PRECORE	We develop mathematical models for the role of hepatitis B e-antigen in creating immunological tolerance during hepatitis B virus infection and propose mechanisms for hepatitis B e-antigen clearance, subsequent emergence of a potent cellular immune response, and the effect of these on liver damage. We investigate the dynamics of virus-immune cells interactions, and derive parameter regimes that allow for viral persistence. We modify the model to account for mechanisms responsible for hepatitis B e-antigen loss, such as seroconversion and virus mutations that lead to emergence of cellular immune response to the mutant virus. Our models demonstrate that either seroconversion or mutations can induce immune activation and that instantaneous loss of e-antigen by either mechanism is associated with least liver damage and is therefore more beneficial for disease outcomes.	[Ciupe, Stanca M.] Virginia Tech, Dept Math, Blacksburg, VA 24061 USA; [Hews, Sarah] Hampshire Coll, Sch Nat Sci, Amherst, MA 01002 USA	Virginia Polytechnic Institute & State University	Ciupe, SM (corresponding author), Virginia Tech, Dept Math, Blacksburg, VA 24061 USA.	stanca@math.vt.edu			National Science Foundation [DMS-1022865]	National Science Foundation(National Science Foundation (NSF))	SMC acknowledges support from National Science Foundation grant DMS-1022865. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Alatrakchi N, 2009, J VIRAL HEPATITIS, V16, P223, DOI 10.1111/j.1365-2893.2009.01081.x; Bertoletti A, 2003, HEPATOLOGY, V38, P4, DOI 10.1053/jhep.2003.50310; BRUNETTO MR, 1991, P NATL ACAD SCI USA, V88, P4186, DOI 10.1073/pnas.88.10.4186; Carman W, 1989, LANCET, V334, P588; Chan HLY, 1999, HEPATOLOGY, V29, P976, DOI 10.1002/hep.510290352; Chang MH, 1998, J GASTROEN HEPATOL, V13, P541, DOI 10.1111/j.1440-1746.1998.tb00685.x; Chen M, 2005, J VIROL, V79, P3016, DOI 10.1128/JVI.79.5.3016-3027.2005; Chen YC, 2010, HEPATOLOGY, V51, P435, DOI 10.1002/hep.23348; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Chu CM, 2007, J VIRAL HEPATITIS, V14, P147, DOI 10.1111/j.1365-2893.2006.00810.x; Ciupe SM, 2007, J THEOR BIOL, V247, P23, DOI 10.1016/j.jtbi.2007.02.017; Ciupe SM, 2007, P NATL ACAD SCI USA, V104, P5050, DOI 10.1073/pnas.0603626104; Ciupe SM, 2011, MATH POPUL STUD, V18, P87, DOI 10.1080/08898480.2011.564563; Colombatto P, 2006, ANTIVIR THER, V11, P197; FATTOVICH G, 1986, HEPATOLOGY, V6, P167, DOI 10.1002/hep.1840060203; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Klenerman P, 1998, NATURE, V394, P482, DOI 10.1038/28860; Lau GK, 2007, ANTIVIR THER, V12, P705; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Li XF, 2010, CELL IMMUNOL, V264, P42, DOI 10.1016/j.cellimm.2010.04.009; Liaw YF, 2003, J GASTROEN HEPATOL, V18, P246, DOI 10.1046/j.1440-1746.2003.02976.x; Liaw YF, 2009, LIVER INT, V29, P100, DOI 10.1111/j.1478-3231.2008.01941.x; Mason WS, 2005, P NATL ACAD SCI USA, V102, P1139, DOI 10.1073/pnas.0409332102; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Milich D, 2003, HEPATOLOGY, V38, P1075, DOI 10.1053/jhep.2003.50453; Milich DR, 1998, J IMMUNOL, V160, P2013; Murray JM, 2005, P NATL ACAD SCI USA, V102, P17780, DOI 10.1073/pnas.0508913102; OKAMOTO H, 1994, J VIROL, V68, P8102, DOI 10.1128/JVI.68.12.8102-8110.1994; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Perelson AS, 2004, SEMIN LIVER DIS, V24, P11, DOI 10.1055/s-2004-828673; REALDI G, 1980, GASTROENTEROLOGY, V79, P195; Ribeiro RM, 2002, MICROBES INFECT, V4, P829, DOI 10.1016/S1286-4579(02)01603-9; STEVENS CE, 1985, JAMA-J AM MED ASSOC, V253, P1740, DOI 10.1001/jama.253.12.1740; Tsiang M, 1999, HEPATOLOGY, V29, P1863, DOI 10.1002/hep.510290626; Wright TL, 2006, AM J GASTROENTEROL, V101, pS1, DOI 10.1111/j.1572-0241.2006.00469.x; Zhao L, 2010, J DIGEST DIS, V11, P126, DOI 10.1111/j.1751-2980.2010.00428.x	40	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39591	10.1371/journal.pone.0039591	http://dx.doi.org/10.1371/journal.pone.0039591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768303	Green Published, Green Submitted, gold			2022-12-27	WOS:000305966500016
J	Kappler, KE; Kaltenbrunner, A				Kappler, Karolin E.; Kaltenbrunner, Andreas			The Power Laws of Violence against Women: Rescaling Research and Policies	PLOS ONE			English	Article							DISTRIBUTIONS	Background: Violence against Women -despite its perpetuation over centuries and its omnipresence at all social levels-entered into social consciousness and the general agenda of Social Sciences only recently, mainly thanks to feminist research, campaigns, and general social awareness. The present article analyzes in a secondary analysis of German prevalence data on Violence against Women, whether the frequency and severity of Violence against Women can be described with power laws. Principal Findings: Although the investigated distributions all resemble power-law distributions, a rigorous statistical analysis accepts this hypothesis at a significance level of 0.1 only for 1 of 5 cases of the tested frequency distributions and with some restrictions for the severity of physical violence. Lowering the significance level to 0.01 leads to the acceptance of the power-law hypothesis in 2 of the 5 tested frequency distributions and as well for the severity of domestic violence. The rejections might be mainly due to the noise in the data, with biases caused by self-reporting, errors through rounding, desirability response bias, and selection bias. Conclusion: Future victimological surveys should be designed explicitly to avoid these deficiencies in the data to be able to clearly answer the question whether Violence against Women follows a power-law pattern. This finding would not only have statistical implications for the processing and presentation of the data, but also groundbreaking consequences on the general understanding of Violence against Women and policy modeling, as the skewed nature of the underlying distributions makes evident that Violence against Women is a highly disparate and unequal social problem. This opens new questions for interdisciplinary research, regarding the interplay between environmental, experimental, and social factors on victimization.	[Kappler, Karolin E.; Kaltenbrunner, Andreas] Barcelona Media Innovat Ctr, Barcelona, Spain		Kappler, KE (corresponding author), Barcelona Media Innovat Ctr, Barcelona, Spain.	karolin.kappler@barcelonamedia.org	Kaltenbrunner, Andreas/A-7301-2016	Kaltenbrunner, Andreas/0000-0002-2271-3066				Agaibi CE, 2005, TRAUMA VIOLENCE ABUS, V6, P195, DOI 10.1177/1524838005277438; Bohorquez JC, 2009, NATURE, V462, P911, DOI 10.1038/nature08631; Clauset A, 2007, J CONFLICT RESOLUT, V51, P58, DOI 10.1177/0022002706296157; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Erturk Y, 2012, CURR SOCIOL, V60, P142, DOI 10.1177/0011392111429216; Ezzati M, 2006, J ROY SOC MED, V99, P250, DOI 10.1258/jrsm.99.5.250; Glammeier S, 2011, ZWISCHEN VERLEIBLICH; Kolivas ED, 2007, AGGRESS VIOLENT BEH, V12, P315, DOI 10.1016/j.avb.2006.10.002; Lietz P, 2010, INT J MARKET RES, V52, P249, DOI 10.2501/S147078530920120X; Mandelbrot B., 1953, COMMUN THEOR, P486; Martinez M, 2007, PERSPECTIVES STANDAR; Martinez Manuela, 2006, STATE EUROPEAN RES P; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Modarres R, 2006, OXFORD B ECON STAT, V68, P385, DOI 10.1111/j.1468-0084.2006.00167.x; Muller U, 2004, LEBENSSITUATION SICH, DOI [10.4232/1.4193, DOI 10.4232/1.4193]; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Roberts DC, 1998, FRACTALS, V6, P351, DOI 10.1142/S0218348X98000407; Schwartz M.D, 2000, VIOLENCE AGAINST WOM, V6, DOI [10.1177/10778010022182164, DOI 10.1177/10778010022182164]; Small M., 1982, RESORT ARMS INT CIVI; Walby S., 2004, DOMESTIC VIOLENCE SE, V276; Wetzels P, 1995, KFN FORSCHUNGSBERICH	21	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40289	10.1371/journal.pone.0040289	http://dx.doi.org/10.1371/journal.pone.0040289			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	968GX	22768348	gold, Green Submitted, Green Published			2022-12-27	WOS:000305966500061
J	Arnusch, CJ; Pieters, RJ; Breukink, E				Arnusch, Christopher J.; Pieters, Roland J.; Breukink, Eefjan			Enhanced Membrane Pore Formation through High-Affinity Targeted Antimicrobial Peptides	PLOS ONE			English	Article							LIPID-II; NISIN; ANTIBIOTICS; MAGAININS; EXPRESSION; PRECURSOR; DEFENSE; MODE	Many cationic antimicrobial peptides (AMPs) target the unique lipid composition of the prokaryotic cell membrane. However, the micromolar activities common for these peptides are considered weak in comparison to nisin, which follows a targeted, pore-forming mode of action. Here we show that AMPs can be modified with a high-affinity targeting module, which enables membrane permeabilization at low concentration. Magainin 2 and a truncated peptide analog were conjugated to vancomycin using click chemistry, and could be directed towards specific membrane embedded receptors both in model membrane systems and whole cells. Compared with untargeted vesicles, a gain in permeabilization efficacy of two orders of magnitude was reached with large unilamellar vesicles that included lipid II, the target of vancomycin. The truncated vancomycin-peptide conjugate showed an increased activity against vancomycin resistant Enterococci, whereas the full-length conjugate was more active against a targeted eukaryotic cell model: lipid II containing erythrocytes. This study highlights that AMPs can be made more selective and more potent against biological membranes that contain structures that can be targeted.	[Arnusch, Christopher J.; Breukink, Eefjan] Univ Utrecht, Dept Membrane Biochem & Biophys, Utrecht, Netherlands; [Arnusch, Christopher J.; Pieters, Roland J.] Univ Utrecht, Dept Med Chem & Chem Biol, Utrecht, Netherlands	Utrecht University; Utrecht University	Arnusch, CJ (corresponding author), Ben Gurion Univ Negev, Dept Desalinat & Water Treatment, Sede Boqer Campus, IL-84105 Beer Sheva, Israel.	r.j.pieters@uu.nl; e.j.breukink@uu.nl	Arnusch, Christopher/F-4069-2012; Pieters, Roland J/A-9254-2008; Breukink, Eefjan/I-3039-2016	Pieters, Roland J/0000-0003-4723-3584; Breukink, Eefjan/0000-0002-7311-0660	council for Chemical Sciences of the Netherlands, Organization for Scientific Research	council for Chemical Sciences of the Netherlands, Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This study was supported by the council for Chemical Sciences of the Netherlands, Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A Richard, 1994, US Patent, Patent No. 5912231; Arnusch CJ, 2007, BIOCHEMISTRY-US, V46, P13437, DOI 10.1021/bi7015553; Arnusch CJ, 2008, BIOCHEMISTRY-US, V47, P12661, DOI 10.1021/bi801597b; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Breukink E, 1997, BIOCHEMISTRY-US, V36, P6968, DOI 10.1021/bi970008u; Breukink E, 1999, BBA-BIOMEMBRANES, V1462, P223, DOI 10.1016/S0005-2736(99)00208-4; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Chamorro C, 2012, BBA-BIOMEMBRANES, V1818, P2171, DOI 10.1016/j.bbamem.2012.04.004; CRUCIANI RA, 1991, P NATL ACAD SCI USA, V88, P3792, DOI 10.1073/pnas.88.9.3792; DARVEAU RP, 1991, ANTIMICROB AGENTS CH, V35, P1153, DOI 10.1128/AAC.35.6.1153; Fernandez DI, 2009, BBA-BIOMEMBRANES, V1788, P1630, DOI 10.1016/j.bbamem.2008.10.007; Hasper HE, 2004, BIOCHEMISTRY-US, V43, P11567, DOI 10.1021/bi049476b; HO SB, 1993, CANCER RES, V53, P641; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Oren Z, 1998, BIOPOLYMERS, V47, P451; Riedl S, 2011, CHEM PHYS LIPIDS, V164, P766, DOI 10.1016/j.chemphyslip.2011.09.004; Schweizer F, 2009, EUR J PHARMACOL, V625, P190, DOI 10.1016/j.ejphar.2009.08.043; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; UTSUGI T, 1991, CANCER RES, V51, P3062; Wiedemann I, 2004, J BACTERIOL, V186, P3259, DOI 10.1128/JB.186.10.3259-3261.2004; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	28	45	48	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39768	10.1371/journal.pone.0039768	http://dx.doi.org/10.1371/journal.pone.0039768			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768121	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100091
J	Bray, TC; Bloomer, P; O'Riain, MJ; Bennett, NC				Bray, Timothy C.; Bloomer, Paulette; O'Riain, M. Justin; Bennett, Nigel C.			How Attractive Is the Girl Next Door? An Assessment of Spatial Mate Acquisition and Paternity in the Solitary Cape Dune Mole-Rat, Bathyergus suillus	PLOS ONE			English	Article							MALE REPRODUCTIVE SUCCESS; CRYPTOMYS-HOTTENTOTUS; BURROW ARCHITECTURE; MULTIPLE PATERNITY; SEXUAL-DIMORPHISM; GENETIC-STRUCTURE; COMPUTER-PROGRAM; MATING SYSTEM; RODENTIA; FAMILY	Behavioural observations of reproduction and mate choice in wild fossorial rodents are extremely limited and consequently indirect methods are typically used to infer mating strategies. We use a combination of morphological, reproductive, spatial, and genetic data to investigate the reproductive strategy of a solitary endemic species, the Cape dune mole-rat Bathyergus suillus. These data provide the first account on the population dynamics of this species. Marked sexual dimorphism was apparent with males being both significantly larger and heavier than females. Of all females sampled 36% had previously reproduced and 12% were pregnant at the time of capture. Post-partum sex ratio was found to be significantly skewed in favour of females. The paternity of fifteen litters (n = 37) was calculated, with sires assigned to progeny using both categorical and full probability methods, and including a distance function. The maximum distance between progeny and a putative sire was determined as 2149 m with males moving between sub-populations. We suggest that above-ground movement should not be ignored in the consideration of mate acquisition behaviour of subterranean mammals. Estimated levels of multiple paternity were shown to be potentially as high as 26%, as determined using sibship and sire assignment methods. Such high levels of multiple paternity have not been found in other solitary mole-rat species. The data therefore suggest polyandry with no evidence as yet for polygyny.	[Bray, Timothy C.; Bennett, Nigel C.] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Bloomer, Paulette] Univ Pretoria, Dept Genet, Mol Ecol & Evolut Programme, ZA-0002 Pretoria, South Africa; [O'Riain, M. Justin] Univ Cape Town, Dept Zool, ZA-7925 Cape Town, South Africa	University of Pretoria; University of Pretoria; University of Cape Town	Bray, TC (corresponding author), Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa.	tim_c_bray@zoology.up.ac.za	Bloomer, Paulette/F-5501-2010; Bennett, Nigel/E-4238-2010	Bloomer, Paulette/0000-0002-6357-0153; Bennett, Nigel/0000-0001-9748-2947; O'Riain, M. Justin/0000-0001-5233-8327	Department of Science and Technology from South African Research Chairs Initiative Chair for Mammal Behavioural Ecology and Physiology; National Research Foundation from South African Research Chairs Initiative Chair for Mammal Behavioural Ecology and Physiology; University of Pretoria; National Research Foundation	Department of Science and Technology from South African Research Chairs Initiative Chair for Mammal Behavioural Ecology and Physiology; National Research Foundation from South African Research Chairs Initiative Chair for Mammal Behavioural Ecology and Physiology; University of Pretoria; National Research Foundation	The authors are grateful to the Department of Science and Technology and the National Research Foundation for funding from the South African Research Chairs Initiative Chair for Mammal Behavioural Ecology and Physiology awarded to NB. Funding was also provided by the University of Pretoria in provision of TB's postdoctoral fellowship. This work is based upon research supported by the National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker RJ, 1999, MOL ECOL, V8, P107, DOI 10.1046/j.1365-294X.1999.00541.x; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Bennett N.C., 2000, AFRICAN MOLE RATS EC; BENNETT NC, 1988, J ZOOL, V214, P95, DOI 10.1111/j.1469-7998.1988.tb04989.x; Bishop JM, 2007, BIOL LETTERS, V3, P176, DOI 10.1098/rsbl.2006.0607; Bishop JM, 2004, MOL ECOL, V13, P1217, DOI 10.1111/j.1365-294X.2004.02131.x; Braude S, 2000, BEHAV ECOL, V11, P7, DOI 10.1093/beheco/11.1.7; Bray TC, 2011, CONSERV GENET RESOUR, V3, P221, DOI 10.1007/s12686-010-9327-x; Burda H, 2000, BEHAV ECOL SOCIOBIOL, V47, P293, DOI 10.1007/s002650050669; Burland TM, 2001, MOL ECOL NOTES, V1, P311, DOI 10.1046/j.1471-8278 .2001.00121.x; CHARNOV E L, 1982; Choate JR, 1998, J MAMMAL, V79, P1416; Ciuti S, 2011, ETHOLOGY, V117, P133, DOI 10.1111/j.1439-0310.2010.01862.x; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Coker CR, 2002, AUK, V119, P403, DOI 10.1642/0004-8038(2002)119[0403:IOMATS]2.0.CO;2; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; DAVIES KC, 1986, J ZOOL, V209, P125, DOI 10.1111/j.1469-7998.1986.tb03570.x; Eberle M, 2004, BEHAV ECOL SOCIOBIOL, V57, P77, DOI 10.1007/s00265-004-0826-1; ESRI, 2011, ARCGIS DESKT REL 10; Faulkes CG, 1997, MOL ECOL, V6, P615, DOI 10.1046/j.1365-294X.1997.00227.x; Fisher RA, 1930, GENETICAL THEORY NAT; FRALEY C, 2006, 504 U WASH DEP STAT; Goossens B, 1998, BEHAV ECOL SOCIOBIOL, V43, P281, DOI 10.1007/s002650050492; Hadfield JD, 2006, MOL ECOL, V15, P3715, DOI 10.1111/j.1365-294X.2006.03050.x; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Hart L, 2006, J MAMMAL, V87, P1078, DOI 10.1644/05-MAMM-A-411R2.1; Hart L, 2007, J MAMMAL, V88, P657, DOI 10.1644/06-MAMM-A-058R1.1; Herbst M, 2006, J ZOOL, V270, P420, DOI 10.1111/j.1469-7998.2006.00151.x; Herbst M, 2004, J ZOOL, V263, P259, DOI 10.1017/S0952836904005114; HETH G, 1989, J ZOOL, V217, P39, DOI 10.1111/j.1469-7998.1989.tb02473.x; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Ingram CM, 2005, THESIS TEXAS A M U; Jacobs DS, 1996, BEHAV ECOL SOCIOBIOL, V39, P401, DOI 10.1007/s002650050307; JARVIS JUM, 1981, SCIENCE, V212, P571, DOI 10.1126/science.7209555; JARVIS JUM, 1994, TRENDS ECOL EVOL, V9, P47, DOI 10.1016/0169-5347(94)90267-4; Jones AG, 2010, MOL ECOL RESOUR, V10, P6, DOI 10.1111/j.1755-0998.2009.02778.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Katsushima K, 2010, MOL ECOL RESOUR, V10, P222, DOI 10.1111/j.1755-0998.2009.02742.x; Kinahan AA, 2007, EVOL ECOL, V21, P201, DOI 10.1007/s10682-006-0022-z; KLEIMAN DG, 1977, Q REV BIOL, V52, P39, DOI 10.1086/409721; LEUTENEGGER W, 1987, AM J PRIMATOL, V13, P171, DOI 10.1002/ajp.1350130207; LOVEGROVE BG, 1989, PHYSIOL ZOOL, V62, P449, DOI 10.1086/physzool.62.2.30156179; Malik A, 2011, POPUL ECOL, V53, P501, DOI 10.1007/s10144-011-0264-7; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McEachern MB, 2009, ANIM BEHAV, V77, P449, DOI 10.1016/j.anbehav.2008.10.024; NARINS PM, 1992, J COMP PHYSIOL A, V170, P13; Nemec P, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P129, DOI 10.1007/978-3-540-69276-8_11; Nielsen CLR, 2007, J MAMMAL, V88, P441, DOI 10.1644/06-MAMM-A-126R2.1; OSTFELD RS, 1990, TRENDS ECOL EVOL, V5, P411, DOI 10.1016/0169-5347(90)90026-A; Patzenhauerova H, 2010, BEHAV ECOL SOCIOBIOL, V64, P757, DOI 10.1007/s00265-009-0893-4; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Porschmann U, 2010, MOL ECOL, V19, P2574, DOI 10.1111/j.1365-294X.2010.04665.x; Randall JA, 2002, ANIM BEHAV, V64, P11, DOI 10.1006/anbe.2002.3029; Rosenfeld CS, 2004, BIOL REPROD, V71, P1063, DOI 10.1095/biolreprod.104.030890; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; RUTBERG AT, 1983, J THEOR BIOL, V104, P93, DOI 10.1016/0022-5193(83)90403-4; Schradin C, 2012, MOL ECOL, V21, P541, DOI 10.1111/j.1365-294X.2011.05256.x; Schradin C, 2011, J ANIM ECOL, V80, P908, DOI 10.1111/j.1365-2656.2011.01831.x; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; Solmsen N, 2011, MOL ECOL, V20, P1624, DOI 10.1111/j.1365-294X.2011.05042.x; STACEY PB, 1982, AM NAT, V120, P51, DOI 10.1086/283969; Steinberg EK, 2000, LIFE UNDERGROUND BIO, P257; STOCKLEY P, 1993, P ROY SOC B-BIOL SCI, V254, P173, DOI 10.1098/rspb.1993.0143; Thomas HG, 2009, J ZOOL, V279, P277, DOI 10.1111/j.1469-7998.2009.00616.x; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Waser PM, 2011, MOL ECOL, V20, P1277, DOI 10.1111/j.1365-294X.2011.05002.x; Wolff JO, 2004, TRENDS ECOL EVOL, V19, P127, DOI 10.1016/j.tree.2003.12.009; Zenuto RR, 2004, J CHEM ECOL, V30, P2111, DOI 10.1023/B:JOEC.0000048777.42945.e4	70	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39866	10.1371/journal.pone.0039866	http://dx.doi.org/10.1371/journal.pone.0039866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768149	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100118
J	Frid, A; Marliave, J; Heithaus, MR				Frid, Alejandro; Marliave, Jeff; Heithaus, Michael R.			Interspecific Variation in Life History Relates to Antipredator Decisions by Marine Mesopredators on Temperate Reefs	PLOS ONE			English	Article							COMPETITION; PREDATION; BEHAVIOR; FISHES; RISK	As upper-level predatory fishes become overfished, mesopredators rise to become the new 'top' predators of over-exploited marine communities. To gain insight into ensuing mechanisms that might alter indirect species interactions, we examined how behavioural responses to an upper-level predatory fish might differ between mesopredator species with different life histories. In rocky reefs of the northeast Pacific Ocean, adult lingcod (Ophiodon elongatus) are upper-level predators that use a sit-and-wait hunting mode. Reef mesopredators that are prey to adult lingcod include kelp greenling (Hexagrammos decagrammus), younger lingcod, copper rockfish (Sebastes caurinus) and quillback rockfish (S. maliger). Across these mesopredators species, longevity and age at maturity increases and, consequently, the annual proportion of lifetime reproductive output decreases in the order just listed. Therefore, we hypothesized that the level of risk taken to acquire resources would vary interspecifically in that same order. During field experiments we manipulated predation risk with a model adult lingcod and used fixed video cameras to quantify interactions between mesopredators and tethered prey (Pandalus shrimps). We predicted that the probabilities of inspecting and attacking tethered prey would rank from highest to lowest and the timing of these behaviours would rank from earliest to latest as follows: kelp greenling, lingcod, copper rockfish, and quillback rockfish. We also predicted that responses to the model lingcod, such as avoidance of interactions with tethered prey, would rank from weakest to strongest in the same order. Results were consistent with our predictions suggesting that, despite occupying similar trophic levels, longer-lived mesopredators with late maturity have stronger antipredator responses and therefore experience lower foraging rates in the presence of predators than mesopredators with faster life histories. The corollary is that the fishery removal of top predators, which relaxes predation risk, could potentially lead to stronger increases in foraging rates for mesopredators with slower life histories.	[Frid, Alejandro; Marliave, Jeff] Vancouver Aquarium, Vancouver, BC, Canada; [Heithaus, Michael R.] Florida Int Univ, Sch Environm Arts & Soc, Dept Biol Sci, N Miami, FL USA	State University System of Florida; Florida International University	Frid, A (corresponding author), Vancouver Aquarium, Vancouver, BC, Canada.	alejfrid@gmail.com	Heithaus, Michael/AAF-9914-2020	Heithaus, Michael/0000-0002-3219-1003	Florida International University Division of Research	Florida International University Division of Research	The study was funded in its entirety through a Seed Funds Award to Michael R Heithaus from the The Florida International University Division of Research. See http://research.fiu.edu/funding/internalFunding/seedFunds.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball SL, 1996, ECOLOGY, V77, P1116, DOI 10.2307/2265580; Beaudreau A. H., 2009, THESIS U WASHINGTON; Beaudreau AH, 2007, T AM FISH SOC, V136, P1438, DOI 10.1577/T06-236.1; Berkeley SA, 2004, ECOLOGY, V85, P1258, DOI 10.1890/03-0706; CASS AJ, 1990, CAN SPEC PUBL FISH A, V109; CLARK CW, 1994, BEHAV ECOL, V5, P159, DOI 10.1093/beheco/5.2.159; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Frid A, 2010, BIOL LETTERS, V6, P533, DOI 10.1098/rsbl.2010.0034; FROESE R., 2012, FISHBASE; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; KING J., 2000, 2000164 CAN STOCK AS; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Love M. S., 2002, ROCKFISHES NE PACIFI; Moller AP, 2010, BEHAV ECOL, V21, P365, DOI 10.1093/beheco/arp199; Murie DJ, 1995, MAR BIOL, V124, P341, DOI 10.1007/BF00363908; Nemeth DH, 1997, J EXP BIOL, V200, P2145; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Shanks AL, 2005, ECOL MONOGR, V75, P505, DOI 10.1890/05-0309; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Strong DR, 2010, ANNU REV ENV RESOUR, V35, P1, DOI 10.1146/annurev-environ-031809-133103; Warner RR, 1998, J FISH BIOL, V53, P82, DOI 10.1111/j.1095-8649.1998.tb01019.x; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Zar JH., 1999, BIOSTAT ANAL	25	18	18	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40083	10.1371/journal.pone.0040083	http://dx.doi.org/10.1371/journal.pone.0040083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768226	Green Published, gold			2022-12-27	WOS:000305892100198
J	Giladi, M; Sasson, Y; Fang, XY; Hiller, R; Buki, T; Wang, YX; Hirsch, JA; Khananshvili, D				Giladi, Moshe; Sasson, Yehezkel; Fang, Xianyang; Hiller, Reuben; Buki, Tal; Wang, Yun-Xing; Hirsch, Joel A.; Khananshvili, Daniel			A Common Ca2+-Driven Interdomain Module Governs Eukaryotic NCX Regulation	PLOS ONE			English	Article							SODIUM-CALCIUM EXCHANGE; CA2+ BINDING DOMAINS; NA+-CA2+ EXCHANGER; NA+/CA2+ EXCHANGER; CRYSTAL-STRUCTURE; EVOLUTIONARY CONSERVATION; CA2+-BINDING DOMAIN; CONSURF; SENSOR; IDENTIFICATION	Na+/Ca2+ exchanger (NCX) proteins mediate Ca2+-fluxes across the cell membrane to maintain Ca2+ homeostasis in many cell types. Eukaryotic NCX contains Ca2+-binding regulatory domains, CBD1 and CBD2. Ca2+ binding to a primary sensor (Ca3-Ca4 sites) on CBD1 activates mammalian NCXs, whereas CALX, a Drosophila NCX ortholog, displays an inhibitory response to regulatory Ca2+. To further elucidate the underlying regulatory mechanisms, we determined the 2.7 angstrom crystal structure of mammalian CBD12-E454K, a two-domain construct that retains wild-type properties. In conjunction with stopped-flow kinetics and SAXS (small-angle X-ray scattering) analyses of CBD12 mutants, we show that Ca2+ binding to Ca3-Ca4 sites tethers the domains via a network of interdomain salt-bridges. This Ca2+-driven interdomain switch controls slow dissociation of "occluded" Ca2+ from the primary sensor and thus dictates Ca2+ sensing dynamics. In the Ca2+-bound conformation, the interdomain angle of CBD12 is very similar in NCX and CALX, meaning that the interdomain distances cannot account for regulatory diversity in NCX and CALX. Since the two-domain interface is nearly identical among eukaryotic NCXs, including CALX, we suggest that the Ca2+-driven interdomain switch described here represents a general mechanism for initial conduction of regulatory signals in NCX variants.	[Giladi, Moshe; Hiller, Reuben; Buki, Tal; Khananshvili, Daniel] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Sasson, Yehezkel; Hirsch, Joel A.] Tel Aviv Univ, Dept Biochem & Mol Biol, Fac Life Sci, IL-69978 Tel Aviv, Israel; [Fang, Xianyang; Wang, Yun-Xing] NCI, Prot Nucle Acid Interact Sect, Struct Biophys Lab, NIH, Frederick, MD 21701 USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Giladi, M (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	jhirsch@post.tau.ac.il; dhanan@post.tau.ac.il	Hirsch, Joel/AAC-8000-2021	Hirsch, Joel/0000-0001-7544-8668; Fang, Xianyang/0000-0001-9432-9736; Giladi, Moshe/0000-0002-8589-6920; Khananshvili, Daniel/0000-0002-4202-9966	Israeli Ministry of Health [2010-3-6266]; USA-Israel Binational Foundation Research [2009-334]; Israel Science Foundation [23/10]; DIP-DFG	Israeli Ministry of Health; USA-Israel Binational Foundation Research(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); DIP-DFG	This work was partially funded by the Israeli Ministry of Health Grant # 2010-3-6266, the USA-Israel Binational Foundation Research Grant # 2009-334, the Israel Science Foundation Grant # 23/10 to DK and a DIP-DFG grant to JAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baumgartner W, 2003, J NEUROSCI, V23, P11008; Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Boyman L, 2011, J BIOL CHEM, V286, P28811, DOI 10.1074/jbc.M110.214106; Boyman L, 2009, J BIOL CHEM, V284, P6185, DOI 10.1074/jbc.M809012200; Chaptal V, 2009, J BIOL CHEM, V284, P14688, DOI 10.1074/jbc.C900037200; Dyck C, 1999, J GEN PHYSIOL, V114, P701, DOI 10.1085/jgp.114.5.701; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Giladi M, 2010, J BIOL CHEM, V285, P28117, DOI 10.1074/jbc.M110.127001; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Haussinger D, 2002, J MOL BIOL, V324, P823, DOI 10.1016/S0022-2836(02)01137-3; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Hryshko LV, 1996, J GEN PHYSIOL, V108, P67, DOI 10.1085/jgp.108.1.67; John SA, 2011, P NATL ACAD SCI USA, V108, P1699, DOI 10.1073/pnas.1016114108; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LEVITSKY DO, 1994, J BIOL CHEM, V269, P22847; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; MATSUOKA S, 1993, P NATL ACAD SCI USA, V90, P3870, DOI 10.1073/pnas.90.9.3870; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Omelchenko A, 1998, J GEN PHYSIOL, V111, P691, DOI 10.1085/jgp.111.5.691; Ottolia M, 2010, CHANNELS, V4, P159, DOI 10.4161/chan.4.3.11386; Ottolia M, 2009, J BIOL CHEM, V284, P32735, DOI 10.1074/jbc.M109.055434; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Salinas RK, 2011, J BIOL CHEM, V286, P32123, DOI 10.1074/jbc.M111.249268; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Stahelin RV, 2005, J BIOL CHEM, V280, P36452, DOI 10.1074/jbc.M506224200; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Wu MS, 2011, STRUCTURE, V19, P1509, DOI 10.1016/j.str.2011.07.008; Wu MS, 2010, J BIOL CHEM, V285, P2554, DOI 10.1074/jbc.M109.059162; Wu MS, 2009, J MOL BIOL, V387, P104, DOI 10.1016/j.jmb.2009.01.045	41	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39985	10.1371/journal.pone.0039985	http://dx.doi.org/10.1371/journal.pone.0039985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768191	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100163
J	Joeris, T; Schmidt, N; Ermert, D; Krienke, P; Visekruna, A; Kuckelkorn, U; Kaufmann, SHE; Steinhoff, U				Joeris, Thorsten; Schmidt, Nicole; Ermert, David; Krienke, Petra; Visekruna, Alexander; Kuckelkorn, Ulrike; Kaufmann, Stefan H. E.; Steinhoff, Ulrich			The Proteasome System in Infection: Impact of beta 5 and LMP7 on Composition, Maturation and Quantity of Active Proteasome Complexes	PLOS ONE			English	Article							MAMMALIAN 20S PROTEASOMES; SUBUNITS; IMMUNOPROTEASOMES; DEGRADATION; EXPRESSION; COMPLETION; MECHANISM; COLITIS; TISSUES; CELLS	Proteasomes are the major enzyme complexes for non-lysosomal protein degradation in eukaryotic cells. Mammals express two sets of catalytic subunits: the constitutive subunits beta 1, beta 2 and beta 5 and the immunosubunits LMP2 (beta 1i), MECL-1 (beta 2i) and LMP7 (beta 5i). The LMP7-propeptide (proLMP7) is required for optimal maturation of LMP2/MECL-1-containing precursors to mature immunoproteasomes, but can also mediate efficient integration into mixed proteasomes containing beta 1 and beta 2. In contrast, the beta 5-propeptide (pro beta 5) has been suggested to promote preferential integration into beta 1/beta 2-containing precursors, consequently favouring the formation of constitutive proteasomes. Here, we show that pro beta 5 predominantly promotes integration into LMP2/MECL-1-containing precursors in IFN gamma-stimulated, LMP7-deficient cells and infected LMP7-deficient mice. This demonstrates that pro beta 5 does not direct preferential integration into beta 1/beta 2-containing precursors, but instead promotes the formation of mixed LMP2/MECL-1/beta 5 proteasomes under inflammatory conditions. Moreover, the propeptides substantially differ in their capacity to promote proteasome maturation, with proLMP7 showing a significantly higher chaperone activity as compared to pro beta 5. Increased efficiency of proteasome maturation mediated by proLMP7 is required for optimal MHC class I cell surface expression and is equally important as the catalytic activity of immunoproteasomes. Intriguingly, induction of LMP7 by infection not only results in rapid exchange of constitutive by immunosubunits, as previously suggested, but also increases the total proteasome abundance within the infected tissue. Hence our data identify a novel LMP7-dependend mechanism to enhance the activity of the proteasome system in infection, which is based on the high chaperone activity of proLMP7 and relies on accelerated maturation of active proteasome complexes.	[Joeris, Thorsten; Schmidt, Nicole; Krienke, Petra; Kaufmann, Stefan H. E.; Steinhoff, Ulrich] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Ermert, David] Max Planck Inst Infect Biol, Dept Cellular Microbiol, Berlin, Germany; [Visekruna, Alexander; Steinhoff, Ulrich] Univ Marburg, Inst Microbiol & Hyg, Marburg, Germany; [Kuckelkorn, Ulrike] Charite, Inst Biochem, Berlin, Germany	Max Planck Society; Max Planck Society; Philipps University Marburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Joeris, T (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany.	ulrich.steinhoff@staff.uni-marburg.de	Ermert, David/I-5879-2013; Kaufmann, Stefan HE/I-5454-2014	Ermert, David/0000-0003-4600-9070; Visekruna, Alexander/0000-0002-5207-9545; Steinhoff, Ulrich/0000-0003-2141-7756; Kaufmann, Stefan HE/0000-0001-9866-8268; Kuckelkorn, Ulrike/0000-0002-3085-9161	German Research Foundation [KU1261/1, SFB650 TP18]; Charite Berlin; Sonnenfeld-Stiftung; IMPRS-IDI	German Research Foundation(German Research Foundation (DFG)); Charite Berlin; Sonnenfeld-Stiftung; IMPRS-IDI	Funding was provided by the following sources: German Research Foundation, projects KU1261/1 and SFB650 TP18 (htt://www.dfg.de), and a PhD grant of the Charite Berlin (http://www.charite.de); a PhD grant of the Sonnenfeld-Stiftung (http://www.sonnenfeld-stiftung.de); and a PhD grant of the IMPRS-IDI (http://www.zibi-graduateschool-berlin.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen P, 1996, CELL, V86, P961, DOI 10.1016/S0092-8674(00)80171-3; Dick TP, 1998, J BIOL CHEM, V273, P25637, DOI 10.1074/jbc.273.40.25637; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; FRUH K, 1994, EMBO J, V13, P3236, DOI 10.1002/j.1460-2075.1994.tb06625.x; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Groettrup M, 2010, NAT REV IMMUNOL, V10, P72, DOI 10.1038/nri2687; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guillaume B, 2010, P NATL ACAD SCI US; Heink S, 2005, P NATL ACAD SCI USA, V102, P9241, DOI 10.1073/pnas.0501711102; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Hirano Y, 2006, MOL CELL, V24, P977, DOI 10.1016/j.molcel.2006.11.015; Khan S, 2001, J IMMUNOL, V167, P6859, DOI 10.4049/jimmunol.167.12.6859; Kingsbury DJ, 2000, J BIOL CHEM, V275, P24156, DOI 10.1074/jbc.M001742200; Kotamraju S, 2006, FREE RADICAL BIO MED, V40, P1034, DOI 10.1016/j.freeradbiomed.2005.10.052; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Li X, 2007, EMBO J; Muchamuel T, 2009, NAT MED; Nandi D, 1997, EMBO J, V16, P5363, DOI 10.1093/emboj/16.17.5363; Ramos PC, 2004, J BIOL CHEM, V279, P14323, DOI 10.1074/jbc.M308757200; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Schmidt M, 1999, J MOL BIOL, V288, P117, DOI 10.1006/jmbi.1999.2660; Schmidt N, 2010, GUT, V59, P896, DOI 10.1136/gut.2009.203554; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Strehl B, 2006, J IMMUNOL, V177, P6238, DOI 10.4049/jimmunol.177.9.6238; Visekruna A, 2006, J CLIN INVEST, V116, P3195, DOI 10.1172/JCI28804; Visekruna A, 2009, INFLAMM BOWEL DIS, V15, P526, DOI 10.1002/ibd.20805; Witt E, 2000, J MOL BIOL, V301, P1, DOI 10.1006/jmbi.2000.3959	29	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39827	10.1371/journal.pone.0039827	http://dx.doi.org/10.1371/journal.pone.0039827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768135	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100105
J	Louie, JK; Yang, S; Yen, C; Acosta, M; Schechter, R; Uyeki, TM				Louie, Janice K.; Yang, Samuel; Yen, Cynthia; Acosta, Meileen; Schechter, Robert; Uyeki, Timothy M.			Use of Intravenous Peramivir for Treatment of Severe Influenza A(H1N1)pdm09	PLOS ONE			English	Article							VIRUS-INFECTION; A H1N1; CHILDREN; OSELTAMIVIR; CALIFORNIA	Oral antiviral agents to treat influenza are challenging to administer in the intensive care unit (ICU). We describe 57 critically ill patients treated with the investigational intravenous neuraminidase inhibitor drug peramivir for influenza A (H1N1)pdm09 [pH1N1]. Most received late peramivir treatment following clinical deterioration in the ICU on enterically-administered oseltamivir therapy. The median age was 40 years (range 5 months-81 years). Common clinical complications included pneumonia or acute respiratory distress syndrome requiring mechanical ventilation (54; 95%), sepsis requiring vasopressor support (34/53; 64%), acute renal failure requiring hemodialysis (19/53; 36%) and secondary bacterial infection (14; 25%). Over half (29; 51%) died. When comparing the 57 peramivir-treated cases with 1627 critically ill cases who did not receive peramivir, peramivir recipients were more likely to be diagnosed with pneumonia/acute respiratory distress syndrome (p = 0.0002) or sepsis (p = <0.0001), require mechanical ventilation (p = <0.0001) or die (p = <0.0001). The high mortality could be due to the pre-existing clinical severity of cases prior to request for peramivir, but also raises questions about peramivir safety and effectiveness in hospitalized and critically ill patients. The use of peramivir merits further study in randomized controlled trials, or by use of methods such as propensity scoring and matching, to assess clinical effectiveness and safety.	[Louie, Janice K.; Yang, Samuel; Yen, Cynthia; Acosta, Meileen; Schechter, Robert] Calif Dept Publ Hlth, Richmond, CA 94804 USA; [Uyeki, Timothy M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	California Department of Public Health; Centers for Disease Control & Prevention - USA	Louie, JK (corresponding author), Calif Dept Publ Hlth, Richmond, CA 94804 USA.	Janice.louie@cdph.ca.gov						[Anonymous], 2010, WHO GUID PHARM MAN P; Ariano RE, 2010, CAN MED ASSOC J, V182, P357, DOI 10.1503/cmaj.092127; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Duval X, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000362; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Fry AM, 2011, JAMA-J AM MED ASSOC, V306, P160, DOI 10.1001/jama.2011.950; Gaur AH, 2010, NEW ENGL J MED, V362, P88, DOI 10.1056/NEJMc0910893; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hernandez JE, 2011, CLIN INFECT DIS, V52, P695, DOI 10.1093/cid/cir001; Kohno S, 2011, ANTIMICROB AGENTS CH, V55, P5267, DOI 10.1128/AAC.00360-11; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Petersen E, 2011, SCAND J INFECT DIS, V43, P495, DOI 10.3109/00365548.2011.556144; Sugaya N, 2012, ANTIMICROB AGENTS CH, V56, P369, DOI 10.1128/AAC.00132-11; *US FDA, EM US AUTH PER 4 FAC; US Food and Drug Administration, PER 4 QUEST ANSW HLT	15	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40261	10.1371/journal.pone.0040261	http://dx.doi.org/10.1371/journal.pone.0040261			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768265	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100239
J	Blanco-Pastor, JL; Vargas, P; Pfeil, BE				Luis Blanco-Pastor, Jose; Vargas, Pablo; Pfeil, Bernard E.			Coalescent Simulations Reveal Hybridization and Incomplete Lineage Sorting in Mediterranean Linaria	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; SPECIES TREES; GENE TREES; EVOLUTIONARY HISTORY; BAYESIAN-INFERENCE; MOSAIC STRUCTURE; NUCLEAR; RECOMBINATION; CHLOROPLAST; SYSTEMATICS	We examined the phylogenetic history of Linaria with special emphasis on the Mediterranean sect. Supinae (44 species). We revealed extensive highly supported incongruence among two nuclear (ITS, AGT1) and two plastid regions (rpl32-trnL(UAG), trnS-trnG). Coalescent simulations, a hybrid detection test and species tree inference in *BEAST revealed that incomplete lineage sorting and hybridization may both be responsible for the incongruent pattern observed. Additionally, we present a multilabelled *BEAST species tree as an alternative approach that allows the possibility of observing multiple placements in the species tree for the same taxa. That permitted the incorporation of processes such as hybridization within the tree while not violating the assumptions of the *BEAST model. This methodology is presented as a functional tool to disclose the evolutionary history of species complexes that have experienced both hybridization and incomplete lineage sorting. The drastic climatic events that have occurred in the Mediterranean since the late Miocene, including the Quaternary-type climatic oscillations, may have made both processes highly recurrent in the Mediterranean flora.	[Luis Blanco-Pastor, Jose; Vargas, Pablo] Real Jardin Bot RJB CSIC, Dept Biodiversidad & Conservac, Madrid, Spain; [Pfeil, Bernard E.] Gothenburg Univ, Dept Biol & Environm Sci, Gothenburg, Sweden	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; University of Gothenburg	Blanco-Pastor, JL (corresponding author), Real Jardin Bot RJB CSIC, Dept Biodiversidad & Conservac, Madrid, Spain.	jlblanco@rjb.csic.es	Pfeil, Bernard E/C-1108-2008; Blanco-Pastor, José Luis/R-2075-2018	Pfeil, Bernard E/0000-0001-8179-2270; Blanco-Pastor, José Luis/0000-0002-7708-1342	Spanish National Research Council grant (CSIC: JAEpre); VR (Swedish Research Council); KVA (Royal Swedish Academy of Sciences); Lars Hiertas Minne fund; Royal Physiographic Society in Lund; Helge Ax:son Johnsons fund; Lundgrenska fund	Spanish National Research Council grant (CSIC: JAEpre); VR (Swedish Research Council)(Swedish Research Council); KVA (Royal Swedish Academy of Sciences); Lars Hiertas Minne fund; Royal Physiographic Society in Lund; Helge Ax:son Johnsons fund; Lundgrenska fund	JLB-P received support from a Spanish National Research Council grant (CSIC: JAEpre). This work is framed within a project from the Spanish Ministry of Environment, reference 005/2008. BEP is supported by grants from VR (Swedish Research Council), KVA (Royal Swedish Academy of Sciences), Lars Hiertas Minne fund, The Royal Physiographic Society in Lund, Helge Ax:son Johnsons fund and the Lundgrenska fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2010, TAXON, V59, P1375, DOI 10.1002/tax.595005; Albaladejo RG, 2005, TAXON, V54, P987, DOI 10.2307/25065483; Ane C, 2007, MOL BIOL EVOL, V24, P412; [Anonymous], 2014, TRACER V1 6; Barres L, 2011, TAXON, V60, P705, DOI 10.1002/tax.603007; Belfiore NM, 2008, SYST BIOL, V57, P294, DOI 10.1080/10635150802044011; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Bentham G, 1846, PRODROMUS SISTEMATIS, P266; Bloomquist EW, 2010, SYST BIOL, V59, P27, DOI 10.1093/sysbio/syp076; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Buckley TR, 2006, SYST BIOL, V55, P411, DOI 10.1080/10635150600697283; Buerkle CA, 2000, HEREDITY, V84, P441, DOI 10.1046/j.1365-2540.2000.00680.x; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Chavannes E, 1833, MONOGRAPHIE ANTIRRHI; Comes HP, 2001, EVOLUTION, V55, P1943, DOI 10.1111/j.0014-3820.2001.tb01312.x; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; del Campo P, 1855, REV PROGRESOS CIENCI, V5, P55; DOYLE JJ, 1992, SYST BOT, V17, P144, DOI 10.2307/2419070; Druce GC, 1925, BOT SOC EXCHANGE CLU, V7, P998; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Emadzade K, 2010, TAXON, V59, P809, DOI 10.1002/tax.593011; Excoffier Laurent, 2003, Human Genomics, V1, P7; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fan HH, 2011, MOL PHYLOGENET EVOL, V59, P354, DOI 10.1016/j.ympev.2011.02.019; Fernandez- Mazuecos M, 2011, PLOS ONE, P6; Fiz-Palacios O, 2010, ANN BOT-LONDON, V106, P871, DOI 10.1093/aob/mcq184; Fournier P, 1946, 4 FLORES FRANCE; Frajman B, 2009, SYST BIOL, V58, P328, DOI 10.1093/sysbio/syp030; Garcia-Castellanos D, 2009, NATURE, V462, P778, DOI 10.1038/nature08555; Gernhard T, 2008, J THEOR BIOL, V253, P769, DOI 10.1016/j.jtbi.2008.04.005; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Gossmann TI, 2010, MOL BIOL EVOL, V27, P1822, DOI 10.1093/molbev/msq079; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo YP, 2004, TAXON, V53, P657, DOI 10.2307/4135441; Guzman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006362; Hamilton MB, 1999, MOL ECOL, V8, P521; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 2011, GENETICA, V139, P617, DOI 10.1007/s10709-011-9547-3; Holland BR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-202; HSU KJ, 1977, NATURE, V267, P399, DOI 10.1038/267399a0; Jakob SS, 2006, MOL BIOL EVOL, V23, P1602, DOI 10.1093/molbev/msl018; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Liepman AH, 2001, PLANT J, V25, P487, DOI 10.1046/j.1365-313x.2001.00961.x; Link-Perez MA, 2011, TAXON, V60, P1255, DOI 10.1002/tax.605003; Liu L, 2008, EVOLUTION, V62, P2080, DOI 10.1111/j.1558-5646.2008.00414.x; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Liu L, 2009, MOL PHYLOGENET EVOL, V53, P320, DOI 10.1016/j.ympev.2009.05.033; Liu ZW, 2010, TAXON, V59, P1690, DOI 10.1002/tax.596004; Lo Presti RM, 2010, TAXON, V59, P1441, DOI 10.1002/tax.595010; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mansion G, 2005, TAXON, V54, P931, DOI 10.2307/25065479; Postigo-Mijarra JM, 2010, REV PALAEOBOT PALYNO, V162, P416, DOI 10.1016/j.revpalbo.2010.02.015; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Martin-Bravo S, 2010, TAXON, V59, P466, DOI 10.1002/tax.592012; Martinez-Azorin M, 2011, ANN BOT-LONDON, V107, P1, DOI 10.1093/aob/mcq207; Maureira-Butler IJ, 2008, SYST BIOL, V57, P466, DOI 10.1080/10635150802172168; Meerow AW, 2006, SYST BOT, V31, P42, DOI 10.1600/036364406775971787; Feliner GN, 2011, TAXON, V60, P365, DOI 10.1002/tax.602007; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Peters JL, 2007, EVOLUTION, V61, P1992, DOI 10.1111/j.1558-5646.2007.00149.x; Pfeil BE, 2005, SYST BIOL, V54, P441, DOI 10.1080/10635150590945359; Pirie MD, 2009, SYST BIOL, V58, P612, DOI 10.1093/sysbio/syp068; Poke FS, 2006, MOL PHYLOGENET EVOL, V39, P160, DOI 10.1016/j.ympev.2005.11.016; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; Rothmaler W., 1943, FEDDES REPERTORIUM S, V52, P16, DOI [10.1002/fedr.19430520103, DOI 10.1002/FEDR.19430520103]; Rouy G, 1909, FLORE FRANCE DESCRIP; Saez L, 2005, BOT J LINN SOC, V148, P229, DOI 10.1111/j.1095-8339.2005.00404.x; Saez L, 2009, FLORA IBERICA, V13, P232; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Scheen AC, 2012, MOL ECOL RESOUR, V12, P128, DOI 10.1111/j.1755-0998.2011.03070.x; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Senchina DS, 2003, MOL BIOL EVOL, V20, P633, DOI 10.1093/molbev/msg065; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SMITH JM, 1992, J MOL EVOL, V34, P126; Steele PR, 2010, AM J BOT, V97, P156, DOI 10.3732/ajb.0900192; Stone RD, 2010, TAXON, V59, P83, DOI 10.1002/tax.591009; SUC JP, 1984, NATURE, V307, P429, DOI 10.1038/307429a0; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Sutton D. A., 1988, REVISION TRIBE ANTIR; Valcarcel V, 2006, TAXON, V55, P297, DOI 10.2307/25065579; Valdes B, 1970, B REAL SOC ESPANOLA, V67, P243; Valdes B., 1970, REVISION ESPECIES EU; Valdes B, 1970, ACTA PHYTOTAXONOMICA, V4; Valente LM, 2010, P ROY SOC B-BIOL SCI, V277, P1489, DOI 10.1098/rspb.2009.2163; van der Niet T, 2008, MOL PHYLOGENET EVOL, V47, P154, DOI 10.1016/j.ympev.2007.12.008; Vargas P, 2004, PLANT SYST EVOL, V249, P151, DOI 10.1007/s00606-004-0216-1; Vargas P, 2009, J BIOGEOGRAPHY; VIANO J, 1978, CARYOLOGIA, V31, P383, DOI 10.1080/00087114.1978.10796761; VIANO J, 1978, Candollea, V33, P209; Viano J, 1978, CANDOLLEA, V33, P33; Vilatersana R, 2010, SYST BOT, V35, P907, DOI 10.1600/036364410X539952; Wendel J.F., 1998, MOL SYSTEMATICS PLAN, P265, DOI 10.1007/978-1-4615-5419-6_10; Wettstein Von Westersheim R., 1895, NATURL PFLANZ, P39; White TJ, 1990, PCR PROTOCOLS GUIDE, DOI [DOI 10.1016/B978-0-12-372180-8.50042-1, 10.1016/B978-0-12-372180-8.50042-1]; Wilson Y, 2011, PLANT J, V66, P1032, DOI 10.1111/j.1365-313X.2011.04563.x; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wong SY, 2010, TAXON, V59, P117, DOI 10.1002/tax.591012; Yu Y, 2011, SYST BIOL, V60, P138, DOI 10.1093/sysbio/syq084	119	94	95	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39089	10.1371/journal.pone.0039089	http://dx.doi.org/10.1371/journal.pone.0039089			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768061	Green Submitted, gold, Green Published			2022-12-27	WOS:000305892100031
J	Neogi, U; Bontell, I; Shet, A; De Costa, A; Gupta, S; Diwan, V; Laishram, RS; Wanchu, A; Ranga, U; Banerjea, AC; Sonnerborg, A				Neogi, Ujjwal; Bontell, Irene; Shet, Anita; De Costa, Ayesha; Gupta, Soham; Diwan, Vishal; Laishram, Ranbir S.; Wanchu, Ajay; Ranga, Udaykumar; Banerjea, Akhil C.; Sonnerborg, Anders			Molecular Epidemiology of HIV-1 Subtypes in India: Origin and Evolutionary History of the Predominant Subtype C	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NORTH-INDIA; STRAINS; RECOMBINANTS; GENOMES	Background: India has the third largest HIV-1 epidemic with 2.4 million infected individuals. Molecular epidemiological analysis has identified the predominance of HIV-1 subtype C (HIV-1C). However, the previous reports have been limited by sample size, and uneven geographical distribution. The introduction of HIV-1C in India remains uncertain due to this lack of structured studies. To fill the gap, we characterised the distribution pattern of HIV-1 subtypes in India based on data collection from nationwide clinical cohorts between 2007 and 2011. We also reconstructed the time to the most recent common ancestor (tMRCA) of the predominant HIV-1C strains. Methodology/Principal Findings: Blood samples were collected from 168 HIV-1 seropositive subjects from 7 different states. HIV-1 subtypes were determined using two or three genes, gag, pol, and env using several methods. Bayesian coalescent-based approach was used to reconstruct the time of introduction and population growth patterns of the Indian HIV-1C. For the first time, a high prevalence (10%) of unique recombinant forms (BC and A1C) was observed when two or three genes were used instead of one gene (p<0.01; p = 0.02, respectively). The tMRCA of Indian HIV-1C was estimated using the three viral genes, ranged from 1967 (gag) to 1974 (env). Pol-gene analysis was considered to provide the most reliable estimate [1971, (95% CI: 1965-1976)]. The population growth pattern revealed an initial slow growth phase in the mid-1970s, an exponential phase through the 1980s, and a stationary phase since the early 1990s. Conclusions/Significance: The Indian HIV-1C epidemic originated around 40 years ago from a single or few genetically related African lineages, and since then largely evolved independently. The effective population size in the country has been broadly stable since the 1990s. The evolving viral epidemic, as indicated by the increase of recombinant strains, warrants a need for continued molecular surveillance to guide efficient disease intervention strategies.	[Neogi, Ujjwal; Bontell, Irene; Sonnerborg, Anders] Karolinska Inst, Infect Dis Unit, Dept Med Huddinge, Stockholm, Sweden; [Neogi, Ujjwal; Gupta, Soham] St Johns Med Coll, Dept Microbiol, Div Clin Virol, Bangalore, Karnataka, India; [Shet, Anita; De Costa, Ayesha] Karolinska Inst, Div Global Hlth IHCAR, Stockholm, Sweden; [Shet, Anita] St Johns Med Coll Hosp, Dept Pediat, Bangalore, Karnataka, India; [Diwan, Vishal] RD Gardi Med Coll, Dept Publ Hlth & Environm, Ujjain, Madhya Pradesh, India; [Laishram, Ranbir S.] Reg Inst Med Sci, Dept Pediat, Imphal, Manipur, India; [Wanchu, Ajay] Postgrad Inst Med Educ & Res, Dept Internal Med, Chandigarh, India; [Wanchu, Ajay] Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis, Portland, OR 97201 USA; [Ranga, Udaykumar] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560012, Karnataka, India; [Banerjea, Akhil C.] Natl Inst Immunol, New Delhi 110067, India; [Sonnerborg, Anders] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Div Clin Virol, Stockholm, Sweden	Karolinska Institutet; St. John's National Academy of Health Sciences; St. John's Medical College; Karolinska Institutet; St. John's National Academy of Health Sciences; St. John's Medical College; Regional Institute of Medical Sciences, Imphal; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Oregon Health & Science University; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Karolinska Institutet; Karolinska University Hospital	Neogi, U (corresponding author), Karolinska Inst, Infect Dis Unit, Dept Med Huddinge, Stockholm, Sweden.	ujjwal.neogi@ki.se	Gupta, Soham/ABC-4407-2021; Neogi, Ujjwal/E-4274-2012; Neogi, Ujjwal/ABF-1172-2021; Sönnerborg, Anders/W-2011-2019	Neogi, Ujjwal/0000-0002-0844-3338; Sönnerborg, Anders/0000-0001-8928-3374; Gupta, Soham/0000-0003-1136-3010; Diwan, Vishal/0000-0001-7948-8579; De Costa, Ayesha/0000-0003-1869-5990; Shet, Anita/0000-0002-7204-8164	European Union; Swedish Physicians against AIDS fund [FOa2011-0014]; Marie Curie ERG (GlobalART) [246599]; Karolinska Institutet [2010Fobi0044]; Department of Biotechnology, Government of India; Swedish Research Council; Lars Hierta Memorial Foundation; Manipur Network of Positive People in northeast India	European Union(European Commission); Swedish Physicians against AIDS fund; Marie Curie ERG (GlobalART); Karolinska Institutet(Karolinska Institutet); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Swedish Research Council(Swedish Research CouncilEuropean Commission); Lars Hierta Memorial Foundation; Manipur Network of Positive People in northeast India	This study has been funded by grants from European Union FP7 and Swedish Physicians against AIDS fund (FOa2011-0014), Marie Curie ERG (GlobalART #246599), Karolinska Institutet (2010Fobi0044), Department of Biotechnology, Government of India, Swedish Research Council and EU FP7 CHAIN (European Union 7th Framework Programme). Dr. Neogi and Dr. Shet acknowledge Erasmus Mundus External Co-operation Window 13 (India) scholarship. Dr. Bontell acknowledges grant received from Lars Hierta Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors would like to thank staff of the respective sites for their support in patient recruitment and sample collection. Authors would like to thank National AIDS Control Organization (NACO) and Karnataka AIDS Prevention Society (KSAPS) for their generous support. A special thanks to The Manipur Network of Positive People in northeast India for their support.	Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09; Bano AS, 2009, J GEN VIROL, V90, P2768, DOI 10.1099/vir.0.011080-0; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Veras NMC, 2011, J GEN VIROL, V92, P1698, DOI 10.1099/vir.0.028951-0; Dalai SC, 2009, AIDS, V23, P2523, DOI 10.1097/QAD.0b013e3283320ef3; de Oliveira T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009311; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Gadkari DA, 1998, INDIAN J MED RES, V107, P1; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Kandathil AJ, 2005, INDIAN J MED RES, V121, P333; Lakhashe S, 2008, AIDS RES HUM RETROV, V24, P229, DOI 10.1089/aid.2007.0229; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mandal D, 2002, AIDS RES HUM RETROV, V18, P1219, DOI 10.1089/08892220260387968; Neogi U, 2008, ARCH VIROL, V153, P1961, DOI 10.1007/s00705-008-0210-y; Neogi U, 2012, JAIDS-J ACQ IMM DEF, V59, P347, DOI 10.1097/QAI.0b013e3182405c7b; Neogi U, 2011, INDIAN J MED RES, V134, P769, DOI 10.4103/0971-5916.92624; Neogi U, 2010, AIDS RES HUM RETROV, V26, P1097, DOI 10.1089/aid.2010.0092; Neogi U, 2009, INDIAN J EXP BIOL, V47, P424; Novitsky V, 2010, VIRUSES-BASEL, V2, P33, DOI 10.3390/v2010033; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Sahni AK, 2002, INT J STD AIDS, V13, P115, DOI 10.1258/0956462021924749; Sengupta S, 2005, ARCH VIROL, V150, P2117, DOI 10.1007/s00705-005-0562-5; Shen CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025956; Siddappa NB, 2005, AIDS, V19, P1426, DOI 10.1097/01.aids.0000180795.49016.89; SIMOES EAF, 1987, INDIAN J MED RES, V85, P335; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Travers SAA, 2004, J VIROL, V78, P10501, DOI 10.1128/JVI.78.19.10501-10506.2004; Tully DC, 2010, AIDS, V24, P1577, DOI 10.1097/QAD.0b013e32833999e1	30	53	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39819	10.1371/journal.pone.0039819	http://dx.doi.org/10.1371/journal.pone.0039819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768132	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000305892100102
J	Singh, N; Zaidi, D; Shyam, H; Sharma, R; Balapure, AK				Singh, Neetu; Zaidi, Deeba; Shyam, Hari; Sharma, Ramesh; Balapure, Anil Kumar			Polyphenols Sensitization Potentiates Susceptibility of MCF-7 and MDA MB-231 Cells to Centchroman	PLOS ONE			English	Article							BREAST-CANCER CELLS; APOPTOSIS INDUCTION; CURCUMIN; RESVERATROL; PHYTOESTROGENS; ACTIVATION; KINASES; PHASE; CYCLE; ANTICANCER	Polyphenols as "sensitizers" together with cytotoxic drugs as "inducers" cooperate to trigger apoptosis in various cancer cells. Hence, their combination having similar mode of mechanism may be a novel approach to enhance the efficacy of inducers. Additionally, this will also enable to achieve the physiological concentrations facilitating significant increase in the activity at concentrations which the compound can individually provide. Here we propose that polyphenols (Resveratrol (RES) and Curcumin (CUR)) pre-treatment may sensitize MCF-7/MDA MB-231 (Human Breast Cancer Cells, HBCCs) to Centchroman (CC, antineoplastic agent). 6 h pre-treated cells with 10 mu M RES/CUR and 100 mu M RES/30 mu M CUR doses, followed by 10 mu M CC for 18 h were investigated for Ser-167 ER-phosphorylation, cell cycle arrest, redox homeostasis, stress activated protein kinase (SAPKs: JNK and p38 MAPK) pathways and downstream apoptosis effectors. Low dose RES/CUR enhances the CC action through ROS mediated JNK/p38 as well as mitochondrial pathway in MCF-7 cells. However, RES/CUR sensitization enhanced apoptosis in p53 mutant MDA MB-231 cells without/with involvement of ROS mediated JNK/p38 adjunct to Caspase-9. Contrarily, through high dose sensitization in CC treated cells, the parameters remained unaltered as in polyphenols alone. We conclude that differential sensitization of HBCCs with low dose polyphenol augments apoptotic efficacy of CC. This may offer a novel approach to achieve enhanced action of CC with concomitant reduction of side effects enabling improved management of hormone-dependent breast cancer.	[Singh, Neetu; Zaidi, Deeba; Shyam, Hari; Sharma, Ramesh; Balapure, Anil Kumar] CSIR, CSIR Cent Drug Res Inst, TCCU, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Singh, N (corresponding author), CSIR, CSIR Cent Drug Res Inst, TCCU, Lucknow, Uttar Pradesh, India.	neetuaashi@yahoo.com	Singh, Neetu/V-4997-2019	Singh, Neetu/0000-0002-5919-655X; Shyam, Hari/0000-0002-5240-3149; BALAPURE, ANIL/0000-0003-1213-4586	Department of Science & Technology (DST) [SR/FT/LS-063/2008]; University Grant Commission (U.G.C) [10-2(5)/2005(i)-E.U.II, CMM-0018]; MOH, New Delhi	Department of Science & Technology (DST)(Department of Science & Technology (India)); University Grant Commission (U.G.C)(University Grants Commission, India); MOH, New Delhi	The work has been supported by funds from Department of Science & Technology (DST) (SR/FT/LS-063/2008), University Grant Commission (U.G.C)(10-2(5)/2005(i)-E.U.II), CMM-0018 and MOH, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Anand P, 2008, CANCER LETT, V267, P133, DOI 10.1016/j.canlet.2008.03.025; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Beutler E., 1975, RED CELL METABOLISM, P89; Blesson CS, 2006, STEROIDS, V71, P993, DOI 10.1016/j.steroids.2006.08.001; Chen Q, 2003, CELL DEATH DIFFER, V10, P323, DOI 10.1038/sj.cdd.4401148; Choudhuri T, 2002, FEBS LETT, V512, P334, DOI 10.1016/S0014-5793(02)02292-5; Choudhuri T, 2005, J BIOL CHEM, V280, P20059, DOI 10.1074/jbc.M410670200; Conklin Kenneth A, 2004, Integr Cancer Ther, V3, P294, DOI 10.1177/1534735404270335; D'Archivio M, 2008, INT J MOL SCI, V9, P213, DOI 10.3390/ijms9030213; Felty Q, 2005, ONCOGENE, V24, P4883, DOI 10.1038/sj.onc.1208667; Filomeni G, 2007, GENES NUTR, V2, P295, DOI 10.1007/s12263-007-0059-9; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Fulda S, 2010, DRUG DISCOV TODAY, V15, P757, DOI 10.1016/j.drudis.2010.07.005; Gosslau A, 2004, NUTRITION, V20, P95, DOI 10.1016/j.nut.2003.09.017; Havens CG, 2006, MOL CELL BIOL, V26, P4701, DOI 10.1128/MCB.00303-06; Howells LM, 2007, ACTA PHARMACOL SIN, V28, P1274, DOI 10.1111/j.1745-7254.2007.00690.x; Kelkel M, 2010, MOLECULES, V15, P7035, DOI 10.3390/molecules15107035; Lal J, 2010, CONTRACEPTION, V81, P275, DOI 10.1016/j.contraception.2009.11.007; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; Lopez-Lazaro M, 2008, MOL NUTR FOOD RES, V52, pS103, DOI 10.1002/mnfr.200700238; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacGregor JI, 1998, PHARMACOL REV, V50, P151; Martin KR, 2010, NUTR DIET SUPPL, V2, P1; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mense SM, 2008, ENVIRON HEALTH PERSP, V116, P426, DOI 10.1289/ehp.10538; MISRA NC, 1989, INT J CANCER, V43, P781, DOI 10.1002/ijc.2910430506; Mueller SO, 2004, TOXICOL SCI, V80, P14, DOI 10.1093/toxsci/kfh147; Murias M, 2008, TOXICOL IN VITRO, V22, P1361, DOI 10.1016/j.tiv.2008.03.002; Nakagawa-Goto K, 2007, BIOORG MED CHEM LETT, V17, P5204, DOI 10.1016/j.bmcl.2007.06.083; Nigam M, 2008, LIFE SCI, V82, P577, DOI 10.1016/j.lfs.2007.11.028; Nigam M, 2010, LIFE SCI, V87, P750, DOI 10.1016/j.lfs.2010.10.015; Pozo-Guisado E, 2002, BIOCHEM PHARMACOL, V64, P1375, DOI 10.1016/S0006-2952(02)01296-0; Ravindran J, 2009, AAPS J, V11, P495, DOI 10.1208/s12248-009-9128-x; Renoir JM, 2008, J MOL ENDOCRINOL, V40, P101, DOI 10.1677/JME-07-0143; Rice S, 2006, ENDOCR-RELAT CANCER, V13, P995, DOI 10.1677/erc.1.01159; Sa G, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-14; She QB, 2002, MOL CARCINOGEN, V33, P244, DOI 10.1002/mc.10041; Singh N, 2011, CANCER SCI, V102, P1059, DOI 10.1111/j.1349-7006.2011.01893.x; Singh N, 2009, J PHARMACOL SCI, V109, P473, DOI 10.1254/jphs.08173FP; Syng-ai C, 2004, MOL CANCER THER, V3, P1101; Torres M, 2003, FRONT BIOSCI, V8, pD369, DOI 10.2741/999; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Waris G, 2006, J CARCINOG, V5, P14, DOI [10.1186/1477-3163-5-14, DOI 10.1186/1477-3163-5-14]; Yallapu MM, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-11	45	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e37736	10.1371/journal.pone.0037736	http://dx.doi.org/10.1371/journal.pone.0037736			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768036	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100007
J	Stuetz, W; Carrara, VI; McGready, R; Lee, SJ; Biesalski, HK; Nosten, FH				Stuetz, Wolfgang; Carrara, Verena Ilona; McGready, Rose; Lee, Sue Jean; Biesalski, Hans Konrad; Nosten, Francois Henry			Thiamine Diphosphate in Whole Blood, Thiamine and Thiamine Monophosphate in Breast-Milk in a Refugee Population	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; CEREBROSPINAL-FLUID; PHOSPHATE-ESTERS; FOLIC-ACID; SERUM; RIBOFLAVIN; POSTPARTUM; VITAMINS; HPLC	Background: The provision of high doses of thiamine may prevent thiamine deficiency in the post-partum period of displaced persons. Methodology/Principal Findings: The study aimed to evaluate a supplementation regimen of thiamine mononitrate (100 mg daily) at the antenatal clinics in Maela refugee camp. Women were enrolled during antenatal care and followed after delivery. Samples were collected at 12 weeks post partum. Thiamine diphosphate (TDP) in whole blood and thiamine in breast-milk of 636 lactating women were measured. Thiamine in breast-milk consisted of thiamine monophosphate (TMP) in addition to thiamine, with a mean TMP to total thiamine ratio of 63%. Mean whole blood TDP (130 nmol/L) and total thiamine in breast-milk (755 nmol/L) were within the upper range reported for well-nourished women. The prevalence of women with low whole blood TDP (<65 nmol/L) was 5% and with deficient breast-milk total thiamine (<300 nmol/L) was 4%. Whole blood TDP predicted both breast-milk thiamine and TMP (R-2 = 0.36 and 0.10, p<0.001). A ratio of TMP to total thiamine >= 63% was associated with a 7.5 and 4-fold higher risk of low whole blood TDP and deficient total breast-milk thiamine, respectively. Routine provision of daily 100 mg of thiamine mononitrate post-partum compared to the previous weekly 10 mg of thiamine hydrochloride resulted in significantly higher total thiamine in breast-milk. Conclusions/Significance: Thiamine supplementation for lactating women in Maela refugee camp is effective and should be continued. TMP and its ratio to total thiamine in breast-milk, reported for the first time in this study, provided useful information on thiamine status and should be included in future studies of breast-milk thiamine.	[Stuetz, Wolfgang] Univ Jena, Inst Nutr, Jena, Germany; [Stuetz, Wolfgang; Biesalski, Hans Konrad] Univ Hohenheim, Inst Biol Chem & Nutr, D-7000 Stuttgart, Germany; [Carrara, Verena Ilona; McGready, Rose; Nosten, Francois Henry] Shoklo Malaria Res Unit, Mae Sot, Thailand; [McGready, Rose; Lee, Sue Jean; Nosten, Francois Henry] Mahidol Univ, Fac Trop Med, Bangkok 10700, Thailand; [McGready, Rose; Lee, Sue Jean; Nosten, Francois Henry] Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford OX3 7LJ, England	Friedrich Schiller University of Jena; University Hohenheim; Mahidol University; Mahidol University; University of Oxford	Stuetz, W (corresponding author), Univ Jena, Inst Nutr, Jena, Germany.	wolfgang.stuetz@uni-jena.de	McGready, Rose/A-3290-2014; Nosten, Francois/AAC-5509-2019; Carrara, Verena/R-6492-2019	McGready, Rose/0000-0003-1621-3257; Nosten, Francois/0000-0002-7951-0745; Carrara, Verena/0000-0002-2758-0872; Stuetz, Wolfgang/0000-0002-8011-5849	Wellcome Trust of Great Britain; Eiselen Foundation in Ulm, Germany	Wellcome Trust of Great Britain(Wellcome Trust); Eiselen Foundation in Ulm, Germany	This work was financially supported by the Wellcome Trust of Great Britain and the Eiselen Foundation in Ulm, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlOthman AA, 1996, ECOL FOOD NUTR, V34, P327, DOI 10.1080/03670244.1996.9991469; [Anonymous], 2001, WHO TECHN REP SER; Bettendorff L, 2009, FEBS J, V276, P2917, DOI 10.1111/j.1742-4658.2009.07019.x; DAVIS RE, 1982, CLIN CHIM ACTA, V123, P321, DOI 10.1016/0009-8981(82)90177-2; Food and Agriculture Organization [FAO], 2001, HUM VIT MIN REQ; Ganapathy V, 2004, PFLUG ARCH EUR J PHY, V447, P641, DOI 10.1007/s00424-003-1068-1; Gangolf M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013616; Gerrits J, 1997, METHOD ENZYMOL, V279, P74; HERVE C, 1995, CLIN CHIM ACTA, V234, P91, DOI 10.1016/0009-8981(94)05980-7; Ihara HHA, 2005, J ANAL BIO SCI, V28, P241; Lu J, 2008, CLIN CHEM, V54, P901, DOI 10.1373/clinchem.2007.099077; Luxemburger C, 2003, T ROY SOC TROP MED H, V97, P251, DOI 10.1016/S0035-9203(03)90134-9; Lynch PLM, 2000, J CHROMATOGR A, V881, P267, DOI 10.1016/S0021-9673(00)00089-3; McGready R, 2001, AM J CLIN NUTR, V74, P808; Molina JA, 2002, J NEURAL TRANSM, V109, P1035, DOI 10.1007/s007020200087; NAIL PA, 1980, AM J CLIN NUTR, V33, P198, DOI 10.1093/ajcn/33.2.198; Ortega RM, 2004, BRIT J NUTR, V92, P129, DOI 10.1079/BJN20041153; RINDI G, 1981, EXPERIENTIA, V37, P975, DOI 10.1007/BF01971788; Stuetz W, 2012, EUR J NUTR, V51, P425, DOI 10.1007/s00394-011-0226-z; TALLAKSEN CME, 1991, J CHROMATOGR-BIOMED, V564, P127, DOI 10.1016/0378-4347(91)80075-N; TALLAKSEN CME, 1992, AM J CLIN NUTR, V56, P559, DOI 10.1093/ajcn/56.3.559; Talwar D, 2000, CLIN CHEM, V46, P704; THOMAS MR, 1980, AM J CLIN NUTR, V33, P2151, DOI 10.1093/ajcn/33.10.2151; VIMOKESANT SL, 1975, AM J CLIN NUTR, V28, P1458, DOI 10.1093/ajcn/28.12.1458; WIELDERS JPM, 1983, J CHROMATOGR, V277, P145, DOI 10.1016/S0378-4347(00)84831-8; World Health Organization (WHO), 1999, SCURV ITS PREV CONTR; Zhao RB, 2002, AM J PHYSIOL-CELL PH, V282, pC1512, DOI 10.1152/ajpcell.00547.2001	27	29	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e36280	10.1371/journal.pone.0036280	http://dx.doi.org/10.1371/journal.pone.0036280			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768031	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100002
J	Fan, L; McElroy, K; Thomas, T				Fan, Lu; McElroy, Kerensa; Thomas, Torsten			Reconstruction of Ribosomal RNA Genes from Metagenomic Data	PLOS ONE			English	Article							MICROBIAL DIVERSITY; PHYLOGENETIC CLASSIFICATION; DNA-SEQUENCES; ACCURATE; BACTERIA; MICROORGANISMS; PROGRAM	Direct sequencing of environmental DNA (metagenomics) has a great potential for describing the 16S rRNA gene diversity of microbial communities. However current approaches using this 16S rRNA gene information to describe community diversity suffer from low taxonomic resolution or chimera problems. Here we describe a new strategy that involves stringent assembly and data filtering to reconstruct full-length 16S rRNA genes from metagenomicpyrosequencing data. Simulations showed that reconstructed 16S rRNA genes provided a true picture of the community diversity, had minimal rates of chimera formation and gave taxonomic resolution down to genus level. The strategy was furthermore compared to PCR-based methods to determine the microbial diversity in two marine sponges. This showed that about 30% of the abundant phylotypes reconstructed from metagenomic data failed to be amplified by PCR. Our approach is readily applicable to existing metagenomic datasets and is expected to lead to the discovery of new microbial phylotypes.	[Fan, Lu] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Fan, L (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	t.thomas@unsw.edu.au	McElroy, Kerensa E/G-1695-2013; Fan, Lu/AAS-5490-2020; Fan, Lu/J-7706-2017	Fan, Lu/0000-0002-4184-7211; Fan, Lu/0000-0002-4184-7211; Thomas, Torsten/0000-0001-9557-3001	Australian Research Council; Gordon and Betty Moore Foundation; Centre for Marine Bio-Innovation	Australian Research Council(Australian Research Council); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Centre for Marine Bio-Innovation	This work was funded by the Australian Research Council, the Gordon and Betty Moore Foundation and the Centre for Marine Bio-Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Bengtsson J, 2011, ANTON LEEUW INT J G, V100, P471, DOI 10.1007/s10482-011-9598-6; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fan L, 2012, PROCNATLACA IN PRESS; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4; Liu M, 2012, ISME J, V6, P1515, DOI 10.1038/ismej.2012.1; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McElroy KE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-74; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Miller CS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r44; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Radax R, 2012, ENVIRON MICROBIOL, V14, P1308, DOI 10.1111/j.1462-2920.2012.02714.x; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Saeed I, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1204; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; Schloss PD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-229; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Sharpton TJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001061; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; Siqueira Jose F Jr, 2012, J Oral Microbiol, V4, DOI 10.3402/jom.v4i0.10743; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stark M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-461; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Taylor MW, 2004, ENVIRON MICROBIOL, V6, P121, DOI 10.1046/j.1462-2920.2003.00545.x; Taylor MW, 2005, ENVIRON MICROBIOL, V7, P419, DOI 10.1111/j.1462-2920.2004.00711.x; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Thomas T, 2010, ISME J, V4, P1557, DOI 10.1038/ismej.2010.74; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Yung PY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp746	53	37	38	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39948	10.1371/journal.pone.0039948	http://dx.doi.org/10.1371/journal.pone.0039948			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761935	Green Published, gold, Green Submitted			2022-12-27	WOS:000305825800081
J	Awuah, PK; Rhieu, BH; Singh, S; Misse, A; Monga, SPS				Awuah, Prince Kwaku; Rhieu, Byung Han; Singh, Sucha; Misse, Amalea; Monga, Satdarshan P. S.			beta-Catenin Loss in Hepatocytes Promotes Hepatocellular Cancer after Diethylnitrosamine and Phenobarbital Administration to Mice	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; THERAPEUTIC TARGET; SIGNALING PATHWAY; TUMOR PROMOTION; MOUSE-LIVER; WNT; HEPATOCARCINOGENESIS; MUTATIONS; CARCINOMA; ALPHA	Hepatocellular Carcinoma (HCC) is the fifth most common cancer worldwide. beta-Catenin, the central orchestrator of the canonical Wnt pathway and a known oncogene is paramount in HCC pathogenesis. Administration of phenobarbital (PB) containing water (0.05% w/v) as tumor promoter following initial injected intraperitoneal (IP) diethylnitrosamine (DEN) injection (5 mu g/gm body weight) as a tumor inducer is commonly used model to study HCC in mice. Herein, nine fifteen-day male beta-catenin knockout mice (KO) and fifteen wild-type littermate controls (WT) underwent DEN/PB treatment and were examined for hepatic tumorigenesis at eight months. Paradoxically, a significantly higher tumor burden was observed in KO (p<0.05). Tumors in KO were beta-catenin and glutamine synthetase negative and HGF/Met, EGFR & IGFR signaling was unremarkable. A significant increase in PDGFR alpha and its ligand PDGF-CC leading to increased phosphotyrosine-720-PDGFR alpha was observed in tumor-bearing KO mice (p<0.05). Simultaneously, these livers displayed increased cell death, stellate cell activation, hepatic fibrosis and cell proliferation. Further, PDGF-CC significantly induced hepatoma cell proliferation especially following beta-catenin suppression. Our studies also demonstrate that the utilized DEN/PB protocol in the WT C57BL/6 mice did not select for beta-catenin gene mutations during hepatocarcinogenesis. Thus, DEN/PB enhanced HCC in mice lacking beta-catenin in the liver may be due to their ineptness at regulating cell survival, leading to enhanced fibrosis and regeneration through PDGFR alpha activation. beta-Catenin downregulation also made hepatoma cells more sensitive to receptor tyrosine kinases and thus may be exploited for therapeutics.	[Awuah, Prince Kwaku; Rhieu, Byung Han; Singh, Sucha; Misse, Amalea; Monga, Satdarshan P. S.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA; [Monga, Satdarshan P. S.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Awuah, PK (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.	smonga@pitt.edu		Monga, Satdarshan/0000-0002-8437-3378	National Institutes of Health [1R01DK62277, 1R01CA124414]; Rango's Fund for the Enhancement of Pathology Research; National Institute of Biomedical Imaging and Bioengineering [T32 EB001026]; NATIONAL CANCER INSTITUTE [R01CA124414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rango's Fund for the Enhancement of Pathology Research; National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants 1R01DK62277 (National Institute of Digestive Diseases and Kidney) and 1R01CA124414 (National Cancer Institute) to S. P. S. M. and by Rango's Fund for the Enhancement of Pathology Research. P. K. A. was funded in part by T32 EB001026 (National Institute of Biomedical Imaging and Bioengineering). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydinlik H, 2001, ONCOGENE, V20, P7812, DOI 10.1038/sj.onc.1204982; BARONE MV, 1995, NATURE, V378, P509, DOI 10.1038/378509a0; Behari J, 2010, AM J PATHOL, V176, P744, DOI 10.2353/ajpath.2010.090667; Cadoret A, 2001, CANCER RES, V61, P3245; Campbell JS, 2005, P NATL ACAD SCI USA, V102, P3389, DOI 10.1073/pnas.0409722102; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; DIWAN BA, 1976, CANCER LETT, V1, P249; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; GOLDFARB S, 1983, ENVIRON HEALTH PERSP, V50, P149, DOI 10.2307/3429545; Harada N, 2004, CANCER RES, V64, P48, DOI 10.1158/0008-5472.CAN-03-2123; Harada N, 2002, CANCER RES, V62, P1971; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kudo M, 2011, DIGEST DIS, V29, P289, DOI 10.1159/000327562; Lehwald N, 2011, GASTROENTEROLOGY, V141, P707, DOI 10.1053/j.gastro.2011.04.051; Liu S, 2011, HEPATOLOGY; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; Matsumoto K, 2010, CARCINOGENESIS, V31, P318, DOI 10.1093/carcin/bgp306; Miyoshi H, 2009, CANCER SCI, V100, P2046, DOI 10.1111/j.1349-7006.2009.01284.x; Monga SPS, 2011, INT J BIOCHEM CELL B, V43, P1021, DOI 10.1016/j.biocel.2009.09.001; Nejak-Bowen KN, 2010, HEPATOLOGY, V51, P1603, DOI 10.1002/hep.23538; Nejak-Bowen KN, 2011, SEMIN CANCER BIOL, V21, P44, DOI 10.1016/j.semcancer.2010.12.010; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ogawa K, 1999, CANCER RES, V59, P1830; Oseini AM, 2009, EXPERT OPIN THER TAR, V13, P443, DOI [10.1517/14728220902719233, 10.1517/14728220902719233 ]; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Rignall B, 2011, CARCINOGENESIS, V32, P52, DOI 10.1093/carcin/bgq226; Sekine S, 2011, CARCINOGENESIS, V32, P622, DOI 10.1093/carcin/bgr002; Stock P, 2007, MOL CANCER THER, V6, P1932, DOI 10.1158/1535-7163.MCT-06-0720; Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042; Tan XP, 2005, GASTROENTEROLOGY, V129, P285, DOI 10.1053/j.gastro.2005.04.013; Thompson MD, 2011, HEPATOLOGY, V54, P1333, DOI 10.1002/hep.24506; Villanueva A, 2007, SEMIN LIVER DIS, V27, P55, DOI 10.1055/s-2006-960171; Wang EY, 2011, P NATL ACAD SCI USA, V108, P18384, DOI 10.1073/pnas.1116386108; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wong CM, 2001, CANCER-AM CANCER SOC, V92, P136, DOI 10.1002/1097-0142(20010701)92:1<136::AID-CNCR1301>3.0.CO;2-R; Zeng G, 2007, NEOPLASIA, V9, P951, DOI 10.1593/neo.07469; Zhang T, 2005, CLIN CANCER RES, V11, P8557, DOI 10.1158/1078-0432.CCR-05-0944; Zhang XF, 2010, HEPATOLOGY, V52, P954, DOI 10.1002/hep.23747	41	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39771	10.1371/journal.pone.0039771	http://dx.doi.org/10.1371/journal.pone.0039771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761897	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000305781700064
J	Huang, ZM; Jiang, HM; Liu, XY; Chen, YY; Wong, JM; Wang, Q; Huang, WK; Shi, T; Zhang, J				Huang, Zhimin; Jiang, Haiming; Liu, Xinyi; Chen, Yingyi; Wong, Jiemin; Wang, Qi; Huang, Wenkang; Shi, Ting; Zhang, Jian			HEMD: An Integrated Tool of Human Epigenetic Enzymes and Chemical Modulators for Therapeutics	PLOS ONE			English	Article							DNA METHYLATION; DATABASE; CANCER; IMPACT	Background: Epigenetic mechanisms mainly include DNA methylation, post-translational modifications of histones, chromatin remodeling and non-coding RNAs. All of these processes are mediated and controlled by enzymes. Abnormalities of the enzymes are involved in a variety of complex human diseases. Recently, potent natural or synthetic chemicals are utilized to establish the quantitative contributions of epigenetic regulation through the enzymes and provide novel insight for developing new therapeutics. However, the development of more specific and effective epigenetic therapeutics requires a more complete understanding of the chemical epigenomic landscape. Description: Here, we present a human epigenetic enzyme and modulator database (HEMD), the database which provides a central resource for the display, search, and analysis of the structure, function, and related annotation for human epigenetic enzymes and chemical modulators focused on epigenetic therapeutics. Currently, HEMD contains 269 epigenetic enzymes and 4377 modulators in three categories (activators, inhibitors, and regulators). Enzymes are annotated with detailed description of epigenetic mechanisms, catalytic processes, and related diseases, and chemical modulators with binding sites, pharmacological effect, and therapeutic uses. Integrating the information of epigenetic enzymes in HEMD should allow for the prediction of conserved features for proteins and could potentially classify them as ideal targets for experimental validation. In addition, modulators curated in HEMD can be used to investigate potent epigenetic targets for the query compound and also help chemists to implement structural modifications for the design of novel epigenetic drugs. Conclusions: HEMD could be a platform and a starting point for biologists and medicinal chemists for furthering research on epigenetic therapeutics. HEMD is freely available at http://mdl.shsmu.edu.cn/HEMD/.	[Huang, Zhimin; Jiang, Haiming; Liu, Xinyi; Chen, Yingyi; Wang, Qi; Huang, Wenkang; Shi, Ting; Zhang, Jian] Shanghai Jiao Tong Univ, Sch Med, Chinese Minist Educ, Dept Pathophysiol, Shanghai 200030, Peoples R China; [Huang, Zhimin; Jiang, Haiming; Liu, Xinyi; Chen, Yingyi; Wang, Qi; Huang, Wenkang; Shi, Ting; Zhang, Jian] Shanghai Jiao Tong Univ, Sch Med, Chinese Minist Educ, Key Lab Cell Differentiat & Apoptosis, Shanghai 200030, Peoples R China; [Wong, Jiemin] E China Normal Univ, Inst Biomed Sci, Shanghai 200062, Peoples R China; [Wong, Jiemin] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Zhang, Jian] Shanghai Jiao Tong Univ, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; East China Normal University; East China Normal University; Shanghai Jiao Tong University	Huang, ZM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Chinese Minist Educ, Dept Pathophysiol, Shanghai 200030, Peoples R China.	jian.zhang@sjtu.edu.cn	liu, xinyi/GWZ-8739-2022; huang, zhimin o/R-4712-2018; Zhang, Jian/GXA-1303-2022; huang, zhimin/H-7878-2013	huang, zhimin o/0000-0001-9230-6039; Zhang, Jian/0000-0002-6558-791X; Wong, Jiemin/0000-0002-5311-842X	National Basic Research Program of China (973 Program) [2011CB504001]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201083]; National Natural Science Foundation of China [21002062]; Innovative Research Team of Shanghai Municipal Education Commission; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning and Shanghai PuJiang Program [10PJ406800]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Research Team of Shanghai Municipal Education Commission; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning and Shanghai PuJiang Program	This work was supported in part by grants from National Basic Research Program of China (973 Program) (2011CB504001), A Foundation for the Author of National Excellent Doctoral Dissertation of PR China (201083), National Natural Science Foundation of China (21002062), Innovative Research Team of Shanghai Municipal Education Commission, the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning and Shanghai PuJiang Program (10PJ406800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Best JD, 2010, DRUG DISCOV TODAY, V15, P1008, DOI 10.1016/j.drudis.2010.10.006; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Copeland RA, 2010, CURR OPIN CHEM BIOL, V14, P505, DOI 10.1016/j.cbpa.2010.06.174; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Cuff AL, 2011, NUCLEIC ACIDS RES, V39, pD420, DOI 10.1093/nar/gkq1001; Enzyme Nomenclature Committee, 1992, REC NOM COMM INT U S; Fingerman IM, 2011, NUCLEIC ACIDS RES, V39, pD908, DOI 10.1093/nar/gkq1146; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gaulton A, NUCL ACIDS IN PRESS; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Grunau C, 2001, NUCLEIC ACIDS RES, V29, P270, DOI 10.1093/nar/29.1.270; Hamm CA, 2011, DRUG DISCOV TODAY, V16, P626, DOI 10.1016/j.drudis.2011.04.007; He XM, 2008, NUCLEIC ACIDS RES, V36, pD836, DOI 10.1093/nar/gkm730; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li GH, 2011, CURR OPIN GENET DEV, V21, P175, DOI 10.1016/j.gde.2011.01.022; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Ongenaert M, 2008, NUCLEIC ACIDS RES, V36, pD842, DOI 10.1093/nar/gkm788; Pray L, 2008, CHEM BIOL, V15, P640, DOI 10.1016/j.chembiol.2008.07.003; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Shipra A, 2006, BIOINFORMATICS, V22, P2940, DOI 10.1093/bioinformatics/btl509; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Sullivan S, 2002, NUCLEIC ACIDS RES, V30, P341, DOI 10.1093/nar/30.1.341; Turinsky AL, 2011, NUCLEIC ACIDS RES, V39, pD889, DOI 10.1093/nar/gkq857; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, pD149, DOI 10.1093/nar/gkp968; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zheng YG, 2008, MED RES REV, V28, P645, DOI 10.1002/med.20120; Zhou HH, 2010, BIOL CELL, V102, P645, DOI 10.1042/BC20100029	40	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39917	10.1371/journal.pone.0039917	http://dx.doi.org/10.1371/journal.pone.0039917			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761927	Green Published, Green Submitted, gold			2022-12-27	WOS:000305781700073
J	Lee, VHY; Lam, IPY; Choi, HS; Chow, BKC; Lee, LTO				Lee, Vien H. Y.; Lam, Ian P. Y.; Choi, Hueng-Sik; Chow, Billy K. C.; Lee, Leo T. O.			The Estrogen-Related Receptor Alpha Upregulates Secretin Expressions in Response to Hypertonicity and Angiotensin II Stimulation	PLOS ONE			English	Article							INDEPENDENT TRANSCRIPTIONAL ACTIVATION; ERR-ALPHA; GENE-EXPRESSION; SUBFORNICAL ORGAN; MULTIPLE ACTIONS; VASOPRESSIN; WATER; MICE; IDENTIFICATION; FLUID	Osmoregulation via maintenance of water and salt homeostasis is a vital process. In the brain, a functional secretin (SCT) and secretin receptor (SCTR) axis has recently been shown to mediate central actions of angiotensin II (ANGII), including initiation of water intake and stimulation of vasopressin (VP) expression and release. In this report, we provide evidence that estrogen-related receptor alpha (ERR alpha, NR3B1), a transcription factor mainly involved in metabolism, acts as an upstream activator of the SCT gene. In vitro studies using mouse hypothalamic cell line N-42 show that ERR alpha upregulates SCT promoter and gene expression. More importantly, knockdown of endogenous ERR alpha abolishes SCT promoter activation in response to hypertonic and ANGII stimulations. In mouse brain, ERR alpha coexpresses with SCT in various osmoregulatory brain regions, including the lamina terminalis and the paraventricular nucleus of the hypothalamus, and its expression is induced by hyperosmotic and ANGII treatments. Based on our data, we propose that both the upregulation of ERR alpha and/or the increased binding of ERR alpha to the mouse SCT promoter are two possible mechanisms for the elevated SCT expression upon hyperosmolality and central ANGII stimulation.	[Lee, Vien H. Y.; Lam, Ian P. Y.; Chow, Billy K. C.; Lee, Leo T. O.] Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju, South Korea	University of Hong Kong; Chonnam National University	Lee, VHY (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China.	ltolee2@hku.hk	Chow, Billy/D-3064-2009; Lee, Leo T.O./AAB-1581-2021	Chow, Billy/0000-0003-3390-0307; 	Research Grants Council (GRF) [GRF768608]; Committee on Research and Conference Grants (CRCG) [CRCG1159084, GRF764510]	Research Grants Council (GRF); Committee on Research and Conference Grants (CRCG)	This work was supported by research grants from Research Grants Council (GRF), GRF768608 and Committee on Research and Conference Grants (CRCG), CRCG1159084 to LTOL and GRF764510 to BKCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariazi EA, 2002, CANCER RES, V62, P6510; Bianco S, 2009, J BIOL CHEM, V284, P23286, DOI 10.1074/jbc.M109.028191; Bolbecker AR, 2009, AM J PSYCHIAT, V166, P460, DOI 10.1176/appi.ajp.2008.08040597; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Cavallini A, 2005, EUR J CANCER, V41, P1487, DOI 10.1016/j.ejca.2005.04.008; Cheng CYY, 2011, NEUROPSYCHOPHARMACOL, V36, P459, DOI 10.1038/npp.2010.178; CHOW BKC, 1991, J BIOL CHEM, V266, P18927; Chu JYS, 2007, MOL CELL BIOL, V27, P2499, DOI 10.1128/MCB.01088-06; Chu JYS, 2011, KIDNEY INT, V79, P280, DOI 10.1038/ki.2010.397; Chu JYS, 2009, P NATL ACAD SCI USA, V106, P15961, DOI 10.1073/pnas.0903695106; Crews EC, 2005, AM J PHYSIOL-REG I, V288, pR638, DOI 10.1152/ajpregu.00525.2004; Duellman SJ, 2010, BIOCHEM PHARMACOL, V80, P819, DOI 10.1016/j.bcp.2010.05.024; Dwyer MA, 2010, CANCER RES, V70, P9298, DOI 10.1158/0008-5472.CAN-10-0226; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P739, DOI 10.1073/pnas.241637298; Franklin K, 1997, SAN DIEGO MOUSE BRAI; GARDINER TW, 1985, AM J PHYSIOL, V249, pR681, DOI 10.1152/ajpregu.1985.249.6.R681; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; Hong H, 1999, J BIOL CHEM, V274, P22618, DOI 10.1074/jbc.274.32.22618; Huang ZB, 2004, J PHYSIOL-LONDON, V558, P181, DOI 10.1113/jphysiol.2004.065540; Johnson RF, 2003, AM J PHYSIOL-REG I, V285, pR394, DOI 10.1152/ajpregu.00130.2003; Kallen J, 2004, J BIOL CHEM, V279, P49330, DOI 10.1074/jbc.M407999200; Lam IPY, 2008, INT REV CYTOL, V265, P159, DOI 10.1016/S0074-7696(07)65004-9; Lam IPY, 2009, AM J PHYSIOL-GASTR L, V297, pG90, DOI 10.1152/ajpgi.00094.2009; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Lee LTO, 2005, J NEUROCHEM, V93, P339, DOI 10.1111/j.1471-4159.2005.03018.x; Lee LTO, 2004, MOL ENDOCRINOL, V18, P1740, DOI 10.1210/me.2003-0461; Lee SMY, 2005, NEUROSCIENCE, V134, P377, DOI 10.1016/j.neuroscience.2005.04.009; Lee VHY, 2010, FASEB J, V24, P5024, DOI 10.1096/fj.10-165399; Lee VHY, 2009, GENE, V443, P55, DOI 10.1016/j.gene.2009.05.003; LIND RW, 1984, PHYSIOL BEHAV, V32, P69; LINDHEIMER MD, 1989, AM J PHYSIOL, V257, pF159, DOI 10.1152/ajprenal.1989.257.2.F159; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo JM, 2003, MOL CELL BIOL, V23, P7947, DOI 10.1128/MCB.23.22.7947-7956.2003; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McKinley MJ, 2004, J NEUROENDOCRINOL, V16, P340, DOI 10.1111/j.0953-8194.2004.01184.x; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ng SSM, 2002, MOL NEUROBIOL, V26, P97, DOI 10.1385/MN:26:1:097; Ray SK, 2007, MOL CELL BIOL, V27, P7839, DOI 10.1128/MCB.00438-07; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Somponpun SJ, 2007, J NEUROENDOCRINOL, V19, P809, DOI 10.1111/j.1365-2826.2007.01587.x; Somponpun SJ, 2004, AM J PHYSIOL-REG I, V287, pR661, DOI 10.1152/ajpregu.00136.2004; SPRUCE BA, 1985, CLIN ENDOCRINOL, V22, P37, DOI 10.1111/j.1365-2265.1985.tb01062.x; Stachenfeld NS, 2001, J APPL PHYSIOL, V91, P1893, DOI 10.1152/jappl.2001.91.4.1893; Sun Peng-ming, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P544; TANAKA J, 1988, NEUROSCI RES, V6, P45, DOI 10.1016/0168-0102(88)90005-3; Teyssier C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007942; Tremblay AM, 2010, MOL ENDOCRINOL, V24, P22, DOI 10.1210/me.2009-0254; Vanacker JM, 1999, MOL ENDOCRINOL, V13, P764, DOI 10.1210/me.13.5.764; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Voisin DL, 1997, NEUROSCIENCE, V78, P215, DOI 10.1016/S0306-4522(96)00551-9; WHEELER MB, 1992, MOL CELL BIOL, V12, P3531, DOI 10.1128/MCB.12.8.3531; Yang NY, 1996, J BIOL CHEM, V271, P5795, DOI 10.1074/jbc.271.10.5795; Yung WH, 2001, J NEUROSCI, V21, P7063, DOI 10.1523/JNEUROSCI.21-18-07063.2001	56	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39913	10.1371/journal.pone.0039913	http://dx.doi.org/10.1371/journal.pone.0039913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761926	Green Published, gold			2022-12-27	WOS:000305781700072
J	Nagao, H; Setoguchi, T; Kitamoto, S; Ishidou, Y; Nagano, S; Yokouchi, M; Abematsu, M; Kawabata, N; Maeda, S; Yonezawa, S; Komiya, S				Nagao, Hiroko; Setoguchi, Takao; Kitamoto, Sho; Ishidou, Yasuhiro; Nagano, Satoshi; Yokouchi, Masahiro; Abematsu, Masahiko; Kawabata, Naoya; Maeda, Shingo; Yonezawa, Suguru; Komiya, Setsuro			RBPJ Is a Novel Target for Rhabdomyosarcoma Therapy	PLOS ONE			English	Article							GAMMA-SECRETASE INHIBITOR; NOTCH; CELL; PATHWAY; GROWTH; CANCER; EXPRESSION; INTEGRATION; ACTIVATION; MECHANISM	The Notch pathway regulates a broad spectrum of cell fate decisions and differentiation processes during fetal and postnatal development. In addition, the Notch pathway plays an important role in controlling tumorigenesis. However, the role of RBPJ, a transcription factor in the Notch pathway, in the development of tumors is largely unknown. In this study, we focused on the role of RBPJ in the pathogenesis of rhabdomyosarcoma (RMS). Our data showed that Notch pathway genes were upregulated and activated in human RMS cell lines and patient samples. Inhibition of the Notch pathway by a gamma-secretase inhibitor (GSI) decreased the in vitro proliferation of RMS cells. Knockdown of RBPJ expression by RNAi inhibited the anchorage-independent growth of RMS cells and the growth of xenografts in vivo. Additionally, overexpression of RBPJ promoted the anchorage-independent growth of RMS cells. Further, we revealed that RBPJ regulated the cell cycle in RMS xenograft tumors and decreased proliferation. Our findings suggest that RBPJ regulates the RMS growth, and that the inhibition of RBPJ may be an effective therapeutic approach for patients with RMS.	[Nagao, Hiroko; Nagano, Satoshi; Yokouchi, Masahiro; Abematsu, Masahiko; Kawabata, Naoya; Komiya, Setsuro] Kagoshima Univ, Dept Orthopaed Surg, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Nagao, Hiroko; Setoguchi, Takao; Abematsu, Masahiko] Kagoshima Univ, Near Future Locomotor Organ Med Creat Course Kusu, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Kitamoto, Sho; Yonezawa, Suguru] Kagoshima Univ, Dept Human Pathol, Grad Sch Med & Dent Sci, Field Oncol, Kagoshima 890, Japan; [Ishidou, Yasuhiro; Maeda, Shingo] Kagoshima Univ, Dept Med Joint Mat, Grad Sch Med & Dent Sci, Kagoshima 890, Japan	Kagoshima University; Kagoshima University; Kagoshima University; Kagoshima University	Nagao, H (corresponding author), Kagoshima Univ, Dept Orthopaed Surg, Grad Sch Med & Dent Sci, Kagoshima 890, Japan.	setoro@m2.kufm.kagoshima-u.ac.jp	Kitamoto, Sho/AAE-4549-2021	Kitamoto, Sho/0000-0003-3597-6647; Nagano, Satoshi/0000-0003-2015-1730	KAKENHI [19591725, 20591786, 21591919, 21591920, 22591663, 24592238, 23592195]; Ministry of Health, Labour, and Welfare of Japan for the Third Term Comprehensive Control Research for Cancer;  [201201976]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labour, and Welfare of Japan for the Third Term Comprehensive Control Research for Cancer; 	This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) (C) 19591725, (C) 20591786, (C) 21591919, (C) 21591920, (C) 22591663, (C) 24592238 and (C) 23592195 and a Grant-in-Aid from the Ministry of Health, Labour, and Welfare of Japan for the Third Term Comprehensive Control Research for Cancer, and Scientific Research on Priority Areas 201201976 to HN from the Grant-in-Aid for JSPS Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Allenspach EJ, 2002, CANCER BIOL THER, V1, P466, DOI 10.4161/cbt.1.5.159; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Belyea BC, 2011, CLIN CANCER RES, V17, P7324, DOI 10.1158/1078-0432.CCR-11-1004; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Fiuza UM, 2007, J ENDOCRINOL, V194, P459, DOI 10.1677/JOE-07-0242; Gordon WR, 2008, J CELL SCI, V121, P3109, DOI 10.1242/jcs.035683; Gupta AA, 2011, CANCER, V118, P1130; Han JX, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2347; Hirotsu M, 2009, BRIT J CANCER, V101, P2030, DOI 10.1038/sj.bjc.6605407; Hirsinger E, 2001, DEVELOPMENT, V128, P107; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Kawabata N, 2011, INT J ONCOL, V39, P899, DOI 10.3892/ijo.2011.1076; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kunigou O, 2011, ONCOL REP, V26, P1337, DOI 10.3892/or.2011.1413; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Matsunoshita Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016234; Mullendore ME, 2009, CLIN CANCER RES, V15, P2291, DOI 10.1158/1078-0432.CCR-08-2004; Nagao H, 2011, J PATHOL, V224, P169, DOI 10.1002/path.2880; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Nickoloff BJ, 2003, ONCOGENE, V22, P6598, DOI 10.1038/sj.onc.1206758; Pannuti A, 2010, CLIN CANCER RES, V16, P3141, DOI 10.1158/1078-0432.CCR-09-2823; Perez EA, 2011, J SURG RES, V170, pE243, DOI 10.1016/j.jss.2011.03.001; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Rodeberg David, 2006, Semin Pediatr Surg, V15, P57, DOI 10.1053/j.sempedsurg.2005.11.009; Roma J, 2011, CLIN CANCER RES, V17, P505, DOI 10.1158/1078-0432.CCR-10-0166; Sana J, 2011, ANAL CELL PATHOL, V34, P303, DOI [10.1155/2011/939457, 10.3233/ACP-2011-0018]; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Sasaki H, 2010, ONCOL REP, V23, P677, DOI 10.3892/or_00000684; Schreck KC, 2010, CLIN CANCER RES, V16, P6060, DOI 10.1158/1078-0432.CCR-10-1624; Serafin V, 2011, J PATHOL, V224, P448, DOI 10.1002/path.2895; Siemers ER, 2006, NEUROLOGY, V66, P602, DOI 10.1212/01.WNL.0000198762.41312.E1; Sivasankaran B, 2009, CANCER RES, V69, P458, DOI 10.1158/0008-5472.CAN-08-2610; Strobl LJ, 1997, IMMUNOBIOLOGY, V198, P299, DOI 10.1016/S0171-2985(97)80050-2; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Sullivan JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881; Tanaka M, 2009, BRIT J CANCER, V100, P1957, DOI 10.1038/sj.bjc.6605060; Tohda S, 2006, LEUKEMIA RES, V30, P1385, DOI 10.1016/j.leukres.2006.05.003; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wachtel M, 2010, CANCER TREAT REV, V36, P318, DOI 10.1016/j.ctrv.2010.02.007; Walter D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019506; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069	48	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39268	10.1371/journal.pone.0039268	http://dx.doi.org/10.1371/journal.pone.0039268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792167	gold, Green Published, Green Submitted			2022-12-27	WOS:000306354700008
J	Huijsmans, CJJ; Poodt, J; Damen, J; van der Linden, JC; Savelkoul, PHM; Pruijt, JFM; Hilbink, M; Hermans, MHA				Huijsmans, Cornelis J. J.; Poodt, Jeroen; Damen, Jan; van der Linden, Johannes C.; Savelkoul, Paul H. M.; Pruijt, Johannes F. M.; Hilbink, Mirrian; Hermans, Mirjam H. A.			Single Nucleotide Polymorphism (SNP)-Based Loss of Heterozygosity (LOH) Testing by Real Time PCR in Patients Suspect of Myeloproliferative Disease	PLOS ONE			English	Article							JAK2 617V-GREATER-THAN-F MUTATION; JAK2(V617F) ALLELE BURDEN; TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; CHROMOSOME 18Q; PRIMARY MYELOFIBROSIS; COLON-CANCER; WILD-TYPE; V617F	During tumor development, loss of heterozygosity (LOH) often occurs. When LOH is preceded by an oncogene activating mutation, the mutant allele may be further potentiated if the wild-type allele is lost or inactivated. In myeloproliferative neoplasms (MPN) somatic acquisition of JAK2V617F may be followed by LOH resulting in loss of the wild type allele. The occurrence of LOH in MPN and other proliferative diseases may lead to a further potentiating the mutant allele and thereby increasing morbidity. A real time PCR based SNP profiling assay was developed and validated for LOH detection of the JAK2 region (JAK2LOH). Blood of a cohort of 12 JAK2V617F-positive patients (n = 6 25-50% and n = 6>50% JAK2V617F) and a cohort of 81 patients suspected of MPN was stored with EDTA and subsequently used for validation. To generate germ-line profiles, non-neoplastic formalin-fixed paraffin-embedded tissue from each patient was analyzed. Results of the SNP assay were compared to those of an established Short Tandem Repeat (STR) assay. Both assays revealed JAK2LOH in 1/6 patients with 25-50% JAK2V617F. In patients with >50% JAK2V617F, JAK2LOH was detected in 6/6 by the SNP assay and 5/6 patients by the STR assay. Of the 81 patients suspected of MPN, 18 patients carried JAK2V617F. Both the SNP and STR assay demonstrated the occurrence of JAK2LOH in 5 of them. In the 63 JAK2V617F-negative patients, no JAK2LOH was observed by SNP and STR analyses. The presented SNP assay reliably detects JAK2LOH and is a fast and easy to perform alternative for STR analyses. We therefore anticipate the SNP approach as a proof of principle for the development of LOH SNP-assays for other clinically relevant LOH loci.	[Huijsmans, Cornelis J. J.; Poodt, Jeroen; Hermans, Mirjam H. A.] Jeroen Bosch Hosp, Lab Mol Diagnost, Shertogenbosch, Netherlands; [Damen, Jan; van der Linden, Johannes C.] Jeroen Bosch Hosp, Pathol Lab, Shertogenbosch, Netherlands; [Savelkoul, Paul H. M.] Vrije Univ VU Univ Med Ctr, Amsterdam, Netherlands; [Pruijt, Johannes F. M.] Jeroen Bosch Hosp, Dept Internal Med, Shertogenbosch, Netherlands; [Hilbink, Mirrian] Jeroen Bosch Hosp, Jeroen Bosch Acad, Shertogenbosch, Netherlands	Jeroen Bosch Ziekenhuis; Jeroen Bosch Ziekenhuis; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Jeroen Bosch Ziekenhuis; Jeroen Bosch Ziekenhuis	Huijsmans, CJJ (corresponding author), Jeroen Bosch Hosp, Lab Mol Diagnost, Shertogenbosch, Netherlands.	r.huysmans@jbz.nl						Antonioli E, 2007, HAEMATOLOGICA, V93, P41, DOI 10.3324/haematol.11653; Barosi G, 2007, BLOOD, V110, P4030, DOI 10.1182/blood-2007-07-099184; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Dupont S, 2007, BLOOD, V110, P1013, DOI 10.1182/blood-2006-10-054940; Huijsmans CJJ, 2011, J MOL DIAGN, V13, P558, DOI 10.1016/j.jmoldx.2011.04.002; Huijsmans R, 2007, J MOL DIAGN, V9, P205, DOI 10.2353/jmoldx.2007.060059; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; JEN J, 1994, NEW ENGL J MED, V331, P213, DOI 10.1056/NEJM199407283310401; Kissel HD, 2009, CANCER BIOMARK, V5, P143, DOI 10.3233/CBM-2009-0618; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lanza G, 1998, INT J CANCER, V79, P390, DOI 10.1002/(SICI)1097-0215(19980821)79:4<390::AID-IJC14>3.3.CO;2-M; Larsen TS, 2007, EUR J HAEMATOL, V79, P508, DOI 10.1111/j.1600-0609.2007.00960.x; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Ogunbiyi OA, 1998, J CLIN ONCOL, V16, P427, DOI 10.1200/JCO.1998.16.2.427; Passamonti F, 2009, HAEMATOL-HEMATOL J, V94, P7, DOI 10.3324/haematol.2008.001271; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Scott LM, 2006, BLOOD, V108, P2435, DOI 10.1182/blood-2006-04-018259; Steensma DP, 2006, J MOL DIAGN, V8, P397, DOI 10.2353/jmoldx.2006.060007; Tefferi A, 2006, CANCER-AM CANCER SOC, V106, P631, DOI 10.1002/cncr.21645; Vannucchi AM, 2007, LEUKEMIA, V21, P1952, DOI 10.1038/sj.leu.2404854; Vannucchi AM, 2007, BLOOD, V110, P840, DOI 10.1182/blood-2006-12-064287; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; WATLING CJ, 1995, CAN J NEUROL SCI, V22, P17, DOI 10.1017/S0317167100040440; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809	24	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e38362	10.1371/journal.pone.0038362	http://dx.doi.org/10.1371/journal.pone.0038362			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768290	Green Published, gold, Green Submitted			2022-12-27	WOS:000305966500003
J	Semeere, AS; Nakanjako, D; Ddungu, H; Kambugu, A; Manabe, YC; Colebunders, R				Semeere, Aggrey S.; Nakanjako, Damalie; Ddungu, Henry; Kambugu, Andrew; Manabe, Yukari C.; Colebunders, Robert			Sub-Optimal Vitamin B-12 Levels among ART-Naive HIV-Positive Individuals in an Urban Cohort in Uganda	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DISEASE PROGRESSION; COBALAMIN DEFICIENCY; SECONDARY MANIA; INFECTION; MICRONUTRIENTS; POPULATION; METABOLISM; ANEMIA; TYPE-1	Malnutrition is common among HIV-infected individuals and is often accompanied by low serum levels of micronutrients. Vitamin B-12 deficiency has been associated with various factors including faster HIV disease progression and CD4 depletion in resource-rich settings. To describe prevalence and factors associated with sub-optimal vitamin B-12 levels among HIV-infected antiretroviral therapy (ART) naive adults in a resource-poor setting, we performed a cross-sectional study with a retrospective chart review among individuals attending either the Mulago-Mbarara teaching hospitals' Joint AIDS Program (MJAP) or the Infectious Diseases Institute (IDI) clinics, in Kampala, Uganda. Logistic regression was used to determine factors associated with sub-optimal vitamin B-12. The mean vitamin B-12 level was 384 pg/ml, normal range (200-900). Sub-optimal vitamin B-12 levels (<300 pg/ml) were found in 75/204 (36.8%). Twenty-one of 204 (10.3%) had vitamin B-12 deficiency (<200 pg/ml) while 54/204 (26.5%) had marginal depletion (200-300 pg/ml). Irritable mood was observed more among individuals with sub-optimal vitamin B-12 levels (OR 2.5, 95% CI; 1.1-5.6, P = 0.03). Increasing MCV was associated with decreasing serum B-12 category; 86.9 fl (+/- 5.1) vs. 83 fl (+/- 8.4) vs. 82 fl (+/- 8.4) for B-12 deficiency, marginal and normal B-12 categories respectively (test for trend, P = 0.017). Compared to normal B-12, individuals with vitamin B-12 deficiency had a longer known duration of HIV infection: 42.2 months (+/- 27.1) vs. 29.4 months (+/- 23.8; P = 0.02). Participants eligible for ART (CD4,350 cells/mu l) with sub-optimal B-12 had a higher mean rate of CD4 decline compared to counterparts with normal B-12; 118 (+/- 145) vs. 22 (+/- 115) cells/mu l/year, P = 0.01 respectively. The prevalence of a sub-optimal vitamin B-12 was high in this HIV-infected, ART-naive adult clinic population in urban Uganda. We recommend prospective studies to further clarify the causal relationships of sub-optimal vitamin B-12, and explore the role of vitamin B-12 supplementation in immune recovery.	[Semeere, Aggrey S.; Nakanjako, Damalie; Kambugu, Andrew; Manabe, Yukari C.] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Nakanjako, Damalie] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Ddungu, Henry] Mulago Hosp, Dept Med, Kampala, Uganda; [Manabe, Yukari C.] Johns Hopkins Sch Med, Dept Med, Div Infect Dis, Baltimore, MD USA; [Colebunders, Robert] Inst Trop Med, B-2000 Antwerp, Belgium; [Colebunders, Robert] Univ Antwerp, B-2020 Antwerp, Belgium	Makerere University; Makerere University; Mulago National Referral Hospital; Johns Hopkins University; Johns Hopkins Medicine; Institute of Tropical Medicine (ITM); University of Antwerp	Semeere, AS (corresponding author), Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.	asemeere@gmail.com		Nakanjako, Damalie/0000-0002-0935-2112; Semeere, Aggrey/0000-0003-1826-2239	Flemish Interuniversity Council (Vlaamse Interuniversitaire Raad/VLIR) through the Infectious Diseases Institute, Mulago Hospital Kampala; United States National Institutes of Health Office of the Director; Fogarty International Center; Office of AIDS Research; National Cancer Center; National Eye Institute; National Heart, Blood, and Lung Institute; National Institute of Dental & Craniofacial Research; National Institute On Drug Abuse; National Institute of Mental Health; National Institute of Allergy and Infectious Diseases Health; NIH Office of Women's Health and Research through Vanderbilt University [R24 TW007988]; American Relief and Recovery Act; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER	Flemish Interuniversity Council (Vlaamse Interuniversitaire Raad/VLIR) through the Infectious Diseases Institute, Mulago Hospital Kampala; United States National Institutes of Health Office of the Director; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Center; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Dental & Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute On Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Diseases Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Office of Women's Health and Research through Vanderbilt University; American Relief and Recovery Act; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was funded in part by The Flemish Interuniversity Council (Vlaamse Interuniversitaire Raad/VLIR) Grant through the Infectious Diseases Institute, Mulago Hospital Kampala. SAS was also supported by the United States National Institutes of Health Office of the Director, Fogarty International Center, Office of AIDS Research, National Cancer Center, National Eye Institute, National Heart, Blood, and Lung Institute, National Institute of Dental & Craniofacial Research, National Institute On Drug Abuse, National Institute of Mental Health, National Institute of Allergy and Infectious Diseases Health, and NIH Office of Women's Health and Research through the International Clinical Research Scholars and Fellows Program at Vanderbilt University (R24 TW007988) and the American Relief and Recovery Act. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Allen LH, 2009, AM J CLIN NUTR, V89, p693S, DOI 10.3945/ajcn.2008.26947A; Balt C A, 2000, J Assoc Nurses AIDS Care, V11, P24, DOI 10.1016/S1055-3290(06)60419-6; Balt CA, 2000, AIDS CARE, V11, P31; BAUM MK, 1995, AIDS, V9, P1051, DOI 10.1097/00002030-199509000-00010; BEACH RS, 1992, ARCH NEUROL-CHICAGO, V49, P501, DOI 10.1001/archneur.1992.00530290089016; COODLEY GO, 1993, AIDS, V7, P1595, DOI 10.1097/00002030-199312000-00008; Erkurt MA, 2008, MED PRIN PRACT, V17, P131, DOI 10.1159/000112967; Fawzi MCS, 2007, HIV MED, V8, P203, DOI 10.1111/j.1468-1293.2007.00454.x; Fawzi WW, 2004, NEW ENGL J MED, V351, P23, DOI 10.1056/NEJMoa040541; Friis H, 2005, MICRONUTRIENTS HIV I; Galukande M, 2011, AFR HEALTH SCI, V11, P240; Gibson RS, 2008, J NUTR, V138, P581, DOI 10.1093/jn/138.3.581; Hepburn MJ, 2004, INT J STD AIDS, V15, P127, DOI 10.1258/095646204322764334; James J S, 1997, AIDS Treat News, P3; KIEBURTZ KD, 1991, ARCH NEUROL-CHICAGO, V48, P312, DOI 10.1001/archneur.1991.00530150082023; LINDENBAUM J, 1988, NEW ENGL J MED, V318, P1720, DOI 10.1056/NEJM198806303182604; McLean ED, 2007, J NUTR, V137, P676, DOI 10.1093/jn/137.3.676; Nakimuli-Mpungu E, 2006, AM J PSYCHIAT, V163, P1349, DOI 10.1176/appi.ajp.163.8.1349; Nakimuli-Mpungu E, 2008, PSYCHOSOMATICS, V49, P530, DOI 10.1176/appi.psy.49.6.530; PALTIEL O, 1995, AM J HEMATOL, V49, P318, DOI 10.1002/ajh.2830490410; Remacha AF, 1999, SEMIN HEMATOL, V36, P75; Remacha AF, 2003, AM J CLIN NUTR, V77, P420, DOI 10.1093/ajcn/77.2.420; ROBERTSON KR, 1993, ARCH NEUROL-CHICAGO, V50, P807, DOI 10.1001/archneur.1993.00540080018007; Tang AM, 2005, AIDS, V19, P847, DOI 10.1097/01.aids.0000171398.77500.a9; Tang AM, 1997, J NUTR, V127, P345, DOI 10.1093/jn/127.2.345; WHO, 2008, ALL PART CONS CONCL	26	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40072	10.1371/journal.pone.0040072	http://dx.doi.org/10.1371/journal.pone.0040072			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768330	Green Submitted, gold, Green Published			2022-12-27	WOS:000305966500043
J	Brockson, ME; Novotny, LA; Jurcisek, JA; McGillivary, G; Bowers, MR; Bakaletz, LO				Brockson, M. Elizabeth; Novotny, Laura A.; Jurcisek, Joseph A.; McGillivary, Glen; Bowers, Martha R.; Bakaletz, Lauren O.			Respiratory Syncytial Virus Promotes Moraxella catarrhalis-Induced Ascending Experimental Otitis Media	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; OUTER-MEMBRANE PROTEIN; STREPTOCOCCUS-PNEUMONIAE; CHINCHILLA MODEL; MIDDLE-EAR; BRANHAMELLA-CATARRHALIS; NONABORIGINAL CHILDREN; BACTERIAL-COLONIZATION; PASSIVE-IMMUNIZATION; BETA-LACTAMASE	Otitis media (OM) is a polymicrobial disease wherein prior or concurrent infection with an upper respiratory tract virus plays an essential role, predisposing the middle ear to bacterial invasion. In episodes of acute bacterial OM, respiratory syncytial virus (RSV) is the most commonly isolated virus and thus serves as an important co-pathogen. Of the predominant bacterial agents of OM, the pathogenesis of disease due to Moraxella catarrhalis is the least well understood. Rigorous study of M. catarrhalis in the context of OM has been significantly hindered by lack of an animal model. To bridge this gap, we assessed whether co-infection of chinchillas with M. catarrhalis and RSV would facilitate ascension of M. catarrhalis from the nasopharynx into the middle ear. Chinchillas were challenged intranasally with M. catarrhalis followed 48 hours later by intranasal challenge with RSV. Within 7 days, 100% of nasopharynges were colonized with M. catarrhalis and homogenates of middle ear mucosa were also culture-positive. Moreover, within the middle ear space, the mucosa exhibited hemorrhagic foci, and a small volume of serosanguinous effusion was present in one of six ears. To improve upon this model, and based on epidemiologic data, nontypeable Haemophilus influenzae (NTHI) was included as an additional bacterial co-pathogen via intranasal administration four days before M. catarrhalis challenge. With this latter protocol, M. catarrhalis was cultured from the nasopharynx and middle ear homogenates of a maximum of 88% and 79% animals, respectively, for up to 17 days after intranasal challenge with M. catarrhalis. Additionally, hemorrhagic foci were observed in 79% of middle ears upon sacrifice. Thus, these data demonstrated that co-infection with RSV and NTHI predisposed to M. catarrhalis-induced ascending experimental OM. This model can be used both in studies of pathogenesis as well as to investigate strategies to prevent or treat OM due to M. catarrhalis.	[Brockson, M. Elizabeth] Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA; Ohio State Univ, Coll Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Brockson, ME (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA.	Lauren.Bakaletz@NationwideChildrens.org	Bakaletz, Lauren/GMW-8490-2022		NIH/NIDCD [R01 DC006468]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006468] Funding Source: NIH RePORTER	NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by NIH/NIDCD R01 DC006468 to L.O.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi C, 2011, ADV EXP MED BIOL, V697, P107, DOI 10.1007/978-1-4419-7185-2_9; Alsarraf R, 1999, ARCH OTOLARYNGOL, V125, P12, DOI 10.1001/archotol.125.1.12; APPELL LH, 1971, AM J VET RES, V32, P1835; Armbruster CE, 2010, MBIO, V1, DOI 10.1128/mBio.00102-10; Armengol CE, 2011, PEDIATR INFECT DIS J, V30, P518, DOI 10.1097/INF.0b013e3182044930; Bakaletz LO, 2010, J LEUKOCYTE BIOL, V87, P213, DOI 10.1189/jlb.0709518; BAKALETZ LO, 1993, J INFECT DIS, V168, P865, DOI 10.1093/infdis/168.4.865; Bakaletz LO, 1999, INFECT IMMUN, V67, P2746, DOI 10.1128/IAI.67.6.2746-2762.1999; BAKALETZ LO, 1995, INFECT IMMUN, V63, P4188, DOI 10.1128/IAI.63.10.4188-4190.1995; BAKALETZ LO, 1988, INFECT IMMUN, V56, P331, DOI 10.1128/IAI.56.2.331-335.1988; Balder R, 2009, INFECT IMMUN, V77, P4597, DOI 10.1128/IAI.00212-09; BALDWIN RL, 1993, AM J OTOL, V14, P601; Bezerra PGM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018928; Binks MJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-161; Block SL, 2004, PEDIATR INFECT DIS J, V23, P829, DOI 10.1097/01.inf.0000136868.91756.80; Broides A, 2009, CLIN INFECT DIS, V49, P1641, DOI 10.1086/647933; Casey JR, 2004, PEDIATR INFECT DIS J, V23, P824, DOI 10.1097/01.inf.0000136871.51792.19; Cassell GH, 1997, NEW REEMERGING INFEC; El Ahmer OR, 2003, J MED MICROBIOL, V52, P853, DOI 10.1099/jmm.0.05124-0; Embers ME, 2011, VET MICROBIOL, V147, P367, DOI 10.1016/j.vetmic.2010.06.029; Gibney Katherine B, 2005, BMC Pediatr, V5, P16, DOI 10.1186/1471-2431-5-16; Giebink GS, 1999, MICROB DRUG RESIST, V5, P57, DOI 10.1089/mdr.1999.5.57; GIEBINK GS, 1980, INFECT IMMUN, V30, P445; Gitiban N, 2005, J VIROL, V79, P6035, DOI 10.1128/JVI.79.10.6035-6042.2005; Grieves JL, 2010, COMPARATIVE MED, V60, P225; Heikkinen T, 2000, VACCINE, V19, pS51, DOI 10.1016/S0264-410X(00)00278-4; Hirano T, 1999, OTOLARYNG HEAD NECK, V121, P616, DOI 10.1016/S0194-5998(99)70068-9; Hong WZ, 2007, INFECT IMMUN, V75, P958, DOI 10.1128/IAI.01691-06; HUNTER LL, 1994, ANN OTO RHINOL LARYN, V103, P59, DOI 10.1177/00034894941030S516; INFANTERIVARD C, 1993, EPIDEMIOL REV, V15, P444, DOI 10.1093/oxfordjournals.epirev.a036129; Jacoby P, 2011, PEDIATR INFECT DIS J, V30, P480, DOI 10.1097/INF.0b013e318217dc6e; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Kaplan B, 1997, PEDIATR INFECT DIS J, V16, pS9, DOI 10.1097/00006454-199702001-00003; Karalus R, 2000, MICROBES INFECT, V2, P547, DOI 10.1016/S1286-4579(00)00314-2; Kennedy BJ, 2000, INFECT IMMUN, V68, P2756, DOI 10.1128/IAI.68.5.2756-2765.2000; Klemens JJ, 2006, LARYNGOSCOPE, V116, P1236, DOI 10.1097/01.mlg.0000224526.43698.52; Kotikoski MJ, 2003, INT J PEDIATR OTORHI, V67, P165, DOI 10.1016/S0165-5876(02)00366-X; Krishnamurthy A, 2009, MICROBES INFECT, V11, P545, DOI 10.1016/j.micinf.2009.03.001; Kyd JM, 2003, INFECT IMMUN, V71, P4691, DOI 10.1128/IAI.71.8.4691-4699.2003; Labout JAM, 2011, EUR J EPIDEMIOL, V26, P61, DOI 10.1007/s10654-010-9500-2; Luke NR, 2007, INFECT IMMUN, V75, P5559, DOI 10.1128/IAI.00946-07; Luke NR, 2004, INFECT IMMUN, V72, P6262, DOI 10.1128/IAI.72.11.6262-6270.2004; Luke NR, 1999, INFECT IMMUN, V67, P681, DOI 10.1128/IAI.67.2.681-687.1999; Martinez-Marin C, 2005, J ANTIMICROB CHEMOTH, V56, P783, DOI 10.1093/jac/dki322; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; McCullers JA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030028; McGillivary G, 2009, CELL MICROBIOL, V11, P1399, DOI 10.1111/j.1462-5822.2009.01339.x; Meek RB, 1999, ANN OTO RHINOL LARYN, V108, P31, DOI 10.1177/000348949910800105; Miyamoto N, 1997, MICROB PATHOGENESIS, V23, P119, DOI 10.1006/mpat.1997.0140; Moore HC, 2010, PEDIATR INFECT DIS J, V29, P540, DOI 10.1097/INF.0b013e3181d067cb; Morton DJ, 2004, MICROB PATHOGENESIS, V36, P25, DOI 10.1016/j.micpath.2003.08.007; Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; Novotny LA, 2011, MUCOSAL IMMUNOL, V4, P456, DOI 10.1038/mi.2011.6; Novotny LA, 2006, VACCINE, V24, P4804, DOI 10.1016/j.vaccine.2006.03.021; Pericone CD, 2000, INFECT IMMUN, V68, P3990, DOI 10.1128/IAI.68.7.3990-3997.2000; Ponte C, 1999, J ANTIMICROB CHEMOTH, V44, P85, DOI 10.1093/jac/44.1.85; Revai K, 2006, PEDIATRICS, V117, P1823, DOI 10.1542/peds.2005-1983; Sakkou Z, 2011, VACCINE, V29, P1167, DOI 10.1016/j.vaccine.2010.12.014; Schaar V, 2011, ANTIMICROB AGENTS CH, V55, P3845, DOI 10.1128/AAC.01772-10; Short KR, 2011, J INFECT DIS; SIRAKOVA T, 1994, INFECT IMMUN, V62, P2002, DOI 10.1128/IAI.62.5.2002-2020.1994; Skoner DP, 2010, CURR ALLERGY ASTHM R, V10, P389, DOI 10.1007/s11882-010-0145-8; STOOL SE, 1994, OTITIS MEDIA EFFUSIO; SUZUKI K, 1994, INFECT IMMUN, V62, P1710, DOI 10.1128/IAI.62.5.1710-1718.1994; Tan TT, 2007, J INFECT DIS, V195, P1661, DOI 10.1086/517611; TEELE DW, 1990, J INFECT DIS, V162, P685, DOI 10.1093/infdis/162.3.685; Thornton RB, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-94; VANDEWOUDE SJ, 1991, LAB ANIM SCI, V41, P401; Verhaegh SJC, 2011, MICROBIOL-SGM, V157, P169, DOI 10.1099/mic.0.042929-0; Watson K, 2006, PEDIATR INFECT DIS J, V25, P782, DOI 10.1097/01.inf.0000232705.49634.68	70	29	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40088	10.1371/journal.pone.0040088	http://dx.doi.org/10.1371/journal.pone.0040088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768228	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100200
J	Chauhan, BC; Stevens, KT; Levesque, JM; Nuschke, AC; Sharpe, GP; O'Leary, N; Archibald, ML; Wang, X				Chauhan, Balwantray C.; Stevens, Kelly T.; Levesque, Julie M.; Nuschke, Andrea C.; Sharpe, Glen P.; O'Leary, Neil; Archibald, Michele L.; Wang, Xu			Longitudinal In Vivo Imaging of Retinal Ganglion Cells and Retinal Thickness Changes Following Optic Nerve Injury in Mice	PLOS ONE			English	Article							SCANNING LASER OPHTHALMOSCOPY; COHERENCE TOMOGRAPHY; INTRAOCULAR-PRESSURE; RODENT RETINA; ADULT-RATS; FIELD LOSS; HIGH-SPEED; GLAUCOMA; AXOTOMY; DAMAGE	Background: Retinal ganglion cells (RGCs) die in sight-threatening eye diseases. Imaging RGCs in humans is not currently possible and proof of principle in experimental models is fundamental for future development. Our objective was to quantify RGC density and retinal thickness following optic nerve transection in transgenic mice expressing cyan fluorescent protein (CFP) under control of the Thy1 promoter, expressed by RGCs and other neurons. Methodology/Principal Findings: A modified confocal scanning laser ophthalmoscopy (CSLO)/spectral-domain optical coherence tomography (SD-OCT) camera was used to image and quantify CFP+ cells in mice from the B6.Cg-Tg(Thy1-CFP)23Jrs/J line. SD-OCT circle (1 B-scan), raster (37 B-scans) and radial (24 B-scans) scans of the retina were also obtained. CSLO was performed at baseline (n = 11) and 3 (n = 11), 5 (n = 4), 7 (n = 10), 10 (n = 6), 14 (n = 7) and 21 (n = 5) days post-transection, while SD-OCT was performed at baseline and 7, 14 and 35 days (n = 9) post-transection. Longitudinal change in CFP+ cell density and retinal thickness were computed. Compared to baseline, the mean (SD) percentage CFP+ cells remaining at 3, 5, 7, 10, 14 and 21 days post-transection was 86 (9)%, 63 (11)%, 45 (11)%, 31 (9)%, 20 (9)% and 8 (4)%, respectively. Compared to baseline, the mean (SD) retinal thickness at 7 days post-transection was 97 (3)%, 98 (2)% and 97 (4)% for the circle, raster and radial scans, respectively. The corresponding figures at 14 and 35 days post-transection were 96 (3)%, 97 (2)% and 95 (3)%; and 93 (3)%, 94 (3)% and 92 (3)%. Conclusions/Significance: Longitudinal imaging showed an exponential decline in CFP+ cell density and a small (<= 8%) reduction in SD-OCT measured retinal thickness post-transection. SD-OCT is a promising tool for detecting structural changes in experimental optic neuropathy. These results represent an important step towards translation for clinical use.	[Chauhan, Balwantray C.; Stevens, Kelly T.; Levesque, Julie M.; Nuschke, Andrea C.; Archibald, Michele L.; Wang, Xu] Dalhousie Univ, Retina & Opt Nerve Res Lab, Halifax, NS, Canada; [Chauhan, Balwantray C.; Stevens, Kelly T.; Levesque, Julie M.; Nuschke, Andrea C.; Archibald, Michele L.; Wang, Xu] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada; [Chauhan, Balwantray C.; Sharpe, Glen P.; O'Leary, Neil] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Chauhan, BC (corresponding author), Dalhousie Univ, Retina & Opt Nerve Res Lab, Halifax, NS, Canada.	bal@dal.ca		O'Leary, Neil/0000-0002-2765-7016; Chauhan, Balwantray/0000-0002-7936-6907	Canadian Institutes of Health Research [MOP-89808]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Supported by Grant MOP-89808 from the Canadian Institutes of Health Research (cihr.ca). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Chauhan BC, 2002, INVEST OPHTH VIS SCI, V43, P2969; Crish SD, 2011, NEUROSCIENCE, V176, P1, DOI 10.1016/j.neuroscience.2010.12.036; DABIN I, 1995, GLIA, V14, P23, DOI 10.1002/glia.440140105; Dowling J. E., 1987, RETINA APPROACHABLE; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gabriele ML, 2011, INVEST OPHTH VIS SCI, V52, P2250, DOI 10.1167/iovs.10-6311; Galindo-Romero C, 2011, EXP EYE RES, V92, P377, DOI 10.1016/j.exer.2011.02.008; Guo L, 2010, INVEST OPHTH VIS SCI, V51, P6504, DOI 10.1167/iovs.10-5551; HOYT WF, 1973, INVEST OPHTH VISUAL, V12, P814; Jia LJ, 2000, INVEST OPHTH VIS SCI, V41, P1380; Komaromy AM, 2003, J GLAUCOMA, V12, P307; Langenegger SJ, 2011, INVEST OPHTH VIS SCI, V52, P3338, DOI 10.1167/iovs.10-6611; Leung CKS, 2009, BRIT J OPHTHALMOL, V93, P964, DOI 10.1136/bjo.2008.150482; Leung CKS, 2008, J NEUROSCI METH, V168, P475, DOI 10.1016/j.jneumeth.2007.10.018; Leung CKS, 2008, INVEST OPHTH VIS SCI, V49, P4898, DOI 10.1167/iovs.07-1447; Mohammadi K, 2004, AM J OPHTHALMOL, V138, P592, DOI 10.1016/j.ajo.2004.05.072; MORRIS R, 1985, DEV NEUROSCI-BASEL, V7, P133, DOI 10.1159/000112283; Morrison JC, 2008, PROG BRAIN RES, V173, P285, DOI 10.1016/S0079-6123(08)01121-7; Murphy JA, 2007, MOL CELL NEUROSCI, V36, P280, DOI 10.1016/j.mcn.2007.07.006; Nickells RW, 2007, VET OPHTHALMOL, V10, P88, DOI 10.1111/j.1463-5224.2007.00564.x; Pang IH, 2007, J GLAUCOMA, V16, P483, DOI 10.1097/IJG.0b013e3181405d4f; PERRY VH, 1984, J NEUROCYTOL, V13, P809, DOI 10.1007/BF01148495; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Raymond ID, 2008, MOL VIS, V14, P1559; Ruggeri M, 2007, INVEST OPHTH VIS SCI, V48, P1808, DOI 10.1167/iovs.06-0815; Schuman J S, 1995, Curr Opin Ophthalmol, V6, P89; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; Srinivasan VJ, 2006, INVEST OPHTH VIS SCI, V47, P5522, DOI 10.1167/iovs.06-0195; THANOS S, 1994, TRENDS NEUROSCI, V17, P177, DOI 10.1016/0166-2236(94)90098-1; van Velthoven MEJ, 2007, PROG RETIN EYE RES, V26, P57, DOI 10.1016/j.preteyeres.2006.10.002; VIDALSANZ M, 1987, J NEUROSCI, V7, P2894; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; Wang X, 2010, NEUROSCI LETT, V468, P110, DOI 10.1016/j.neulet.2009.10.077; Wojtkowski M, 2005, OPHTHALMOLOGY, V112, P1734, DOI 10.1016/j.ophtha.2005.05.023; Wong T, 2008, OPHTHALMOLOGY, V115, P116, DOI 10.1016/j.ophtha.2007.03.008	36	54	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40352	10.1371/journal.pone.0040352	http://dx.doi.org/10.1371/journal.pone.0040352			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768284	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100258
J	De Pourcq, K; Tiels, P; Van Hecke, A; Geysens, S; Vervecken, W; Callewaert, N				De Pourcq, Karen; Tiels, Petra; Van Hecke, Annelies; Geysens, Steven; Vervecken, Wouter; Callewaert, Nico			Engineering Yarrowia lipolytica to Produce Glycoproteins Homogeneously Modified with the Universal Man(3)GlcNAc(2) N-Glycan Core	PLOS ONE			English	Article							II BETA-SUBUNIT; SACCHAROMYCES-CEREVISIAE MUTANT; RETICULUM GLUCOSIDASE-II; ENDOPLASMIC-RETICULUM; ALG3 GENE; HETERODIMERIC STRUCTURE; SUBSTRATE-SPECIFICITY; PROTEIN EXPRESSION; MOLECULAR-CLONING; MRH DOMAIN	Yarrowia lipolytica is a dimorphic yeast that efficiently secretes various heterologous proteins and is classified as "generally recognized as safe." Therefore, it is an attractive protein production host. However, yeasts modify glycoproteins with non-human high mannose-type N-glycans. These structures reduce the protein half-life in vivo and can be immunogenic in man. Here, we describe how we genetically engineered N-glycan biosynthesis in Yarrowia lipolytica so that it produces Man(3)GlcNAc(2) structures on its glycoproteins. We obtained unprecedented levels of homogeneity of this glycanstructure. This is the ideal starting point for building human-like sugars. Disruption of the ALG3 gene resulted in modification of proteins mainly with Man(5)GlcNAc(2) and GlcMan(5)GlcNAc(2) glycans, and to a lesser extent with Glc(2)Man(5)GlcNAc(2) glycans. To avoid underoccupancy of glycosylation sites, we concomitantly overexpressed ALG6. We also explored several approaches to remove the terminal glucose residues, which hamper further humanization of N-glycosylation; overexpression of the heterodimeric Apergillus niger glucosidase II proved to be the most effective approach. Finally, we overexpressed an alpha-1,2-mannosidase to obtain Man(3)GlcNAc(2) structures, which are substrates for the synthesis of complex-type glycans. The final Yarrowia lipolytica strain produces proteins glycosylated with the trimannosyl core N-glycan (Man(3)GlcNAc(2)), which is the common core of all complex-type N-glycans. All these glycans can be constructed on the obtained trimannosyl N-glycan using either in vivo or in vitro modification with the appropriate glycosyltransferases. The results demonstrate the high potential of Yarrowia lipolytica to be developed as an efficient expression system for the production of glycoproteins with humanized glycans.	[De Pourcq, Karen; Tiels, Petra; Van Hecke, Annelies; Geysens, Steven; Vervecken, Wouter; Callewaert, Nico] VIB, Dept Mol Biomed Res, Unit Med Biotechnol, Ghent, Belgium; [Tiels, Petra; Callewaert, Nico] Univ Ghent, Dept Biochem & Microbiol, L Probe, B-9000 Ghent, Belgium; [De Pourcq, Karen; Van Hecke, Annelies; Geysens, Steven; Vervecken, Wouter] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Geysens, Steven; Vervecken, Wouter] Oxyrane Belgium, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	De Pourcq, K (corresponding author), VIB, Dept Mol Biomed Res, Unit Med Biotechnol, Ghent, Belgium.	Nico.Callewaert@dmbr.vib-UGent.be		Callewaert, Nico/0000-0003-2069-6917; Van Hecke, Annelies/0000-0002-3010-8034	EU [MEXT-014292]; Oxyrane UK Ltd. (Manchester UK); Fund for Scientific Research Flanders [FWO-G.0.541.08.N.10]	EU(European Commission); Oxyrane UK Ltd. (Manchester UK); Fund for Scientific Research Flanders(FWO)	This work was supported by Marie Curie Excellence Grant MEXT-014292 under EU Framework Program 6, Oxyrane UK Ltd. (Manchester UK) and the Fund for Scientific Research Flanders grant (FWO-G.0.541.08.N.10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi M, 1996, GLYCOBIOLOGY, V6, P439, DOI 10.1093/glycob/6.4.439; Alonzi DS, 2006, BIOCHEM J, V409, P571; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; BAUSE E, 1993, EUR J BIOCHEM, V217, P535, DOI 10.1111/j.1432-1033.1993.tb18274.x; Burda P, 1999, GLYCOBIOLOGY, V9, P617, DOI 10.1093/glycob/9.6.617; Callewaert N, 2001, FEBS LETT, V503, P173, DOI 10.1016/S0014-5793(01)02676-X; Choi BK, 2003, P NATL ACAD SCI USA, V100, P5022, DOI 10.1073/pnas.0931263100; Cipollo JF, 2000, J BIOL CHEM, V275, P4267, DOI 10.1074/jbc.275.6.4267; D'Alessio C, 1999, J BIOL CHEM, V274, P25899, DOI 10.1074/jbc.274.36.25899; Davidson RC, 2004, GLYCOBIOLOGY, V14, P399, DOI 10.1093/glycob/cwh023; De Pourcq K, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-53; De Pourcq K, 2010, APPL MICROBIOL BIOT, V87, P1617, DOI 10.1007/s00253-010-2721-1; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fickers P, 2005, FUNGAL GENET BIOL, V42, P264, DOI 10.1016/j.fgb.2004.12.003; Fickers P, 2003, J MICROBIOL METH, V55, P727, DOI 10.1016/j.mimet.2003.07.003; GRINNA LS, 1980, J BIOL CHEM, V255, P2255; Henquet M, 2008, PLANT CELL, V20, P1652, DOI 10.1105/tpc.108.060731; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hu D, 2009, GLYCOBIOLOGY, V19, P1127, DOI 10.1093/glycob/cwp104; HUFFAKER TC, 1983, P NATL ACAD SCI-BIOL, V80, P7466, DOI 10.1073/pnas.80.24.7466; Jacobs PP, 2009, NAT PROTOC, V4, P58, DOI 10.1038/nprot.2008.213; Jolivet P, 2007, FEMS YEAST RES, V7, P1317, DOI 10.1111/j.1567-1364.2007.00293.x; Jones D, 2004, BIOCHEM SOC T, V32, P766, DOI 10.1042/BST0320766; Jones DC, 2005, J BIOL CHEM, V280, P35929, DOI 10.1074/jbc.M509130200; Kainz E, 2008, APPL ENVIRON MICROB, V74, P1076, DOI 10.1128/AEM.01058-07; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Laroy W, 2006, NAT PROTOC, V1, P397, DOI 10.1038/nprot.2006.60; Madzak C, 2004, J BIOTECHNOL, V109, P63, DOI 10.1016/j.jbiotec.2003.10.027; Madzak C, 2000, J MOL MICROB BIOTECH, V2, P207; MICHAEL JM, 1980, ARCH BIOCHEM BIOPHYS, V199, P249, DOI 10.1016/0003-9861(80)90278-7; Munro S, 2001, CURR BIOL, V11, pR499, DOI 10.1016/S0960-9822(01)00302-5; NAKAYAMA K, 1992, EMBO J, V11, P2511, DOI 10.1002/j.1460-2075.1992.tb05316.x; Nicaud JM, 2002, FEMS YEAST RES, V2, P371, DOI 10.1111/j.1567-1364.2002.tb00106.x; Oh Doo-Byoung, 2008, Biotechnology Journal, V3, P659, DOI 10.1002/biot.200700252; Pelletier MF, 2000, GLYCOBIOLOGY, V10, P815, DOI 10.1093/glycob/10.8.815; Pignede G, 2000, J BACTERIOL, V182, P2802, DOI 10.1128/JB.182.10.2802-2810.2000; Quinn RP, 2009, GLYCOBIOLOGY, V19, P1408, DOI 10.1093/glycob/cwp087; SAUNIER B, 1982, J BIOL CHEM, V257, P4155; Sharma CB, 2001, BIOL CHEM, V382, P321, DOI 10.1515/BC.2001.039; Song Y, 2007, APPL ENVIRON MICROB, V73, P4446, DOI 10.1128/AEM.02058-06; SPIRO MJ, 1979, J BIOL CHEM, V254, P7668; SPIRO RG, 1979, J BIOL CHEM, V254, P7659; Stigliano ID, 2009, MOL BIOL CELL, V20, P3974, DOI 10.1091/mbc.E09-04-0316; Totani K, 2008, J AM CHEM SOC, V130, P2101, DOI 10.1021/ja077570k; Totani K, 2006, J BIOL CHEM, V281, P31502, DOI 10.1074/jbc.M605457200; Tremblay LO, 2000, J BIOL CHEM, V275, P31655, DOI 10.1074/jbc.M004935200; Tremblay LO, 1998, GLYCOBIOLOGY, V8, P585, DOI 10.1093/glycob/8.6.585; Treml K, 2000, GLYCOBIOLOGY, V10, P493, DOI 10.1093/glycob/10.5.493; TRIMBLE RB, 1995, TRENDS GLYCOSCI GLYC, V7, P1, DOI 10.4052/tigg.7.1; Trombetta ES, 1996, J BIOL CHEM, V271, P27509, DOI 10.1074/jbc.271.44.27509; VEROSTEK MF, 1993, J BIOL CHEM, V268, P12104; VEROSTEK MF, 1993, J BIOL CHEM, V268, P12095; VEROSTEK MF, 1991, J BIOL CHEM, V266, P5547; Watanabe T, 2009, GLYCOBIOLOGY, V19, P834, DOI 10.1093/glycob/cwp061; Wilkinson BM, 2006, J BIOL CHEM, V281, P6325, DOI 10.1074/jbc.M510455200; ZUFFEREY R, 1995, EMBO J, V14, P4949, DOI 10.1002/j.1460-2075.1995.tb00178.x	56	35	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39976	10.1371/journal.pone.0039976	http://dx.doi.org/10.1371/journal.pone.0039976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768188	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100160
J	Jin, HR; Jin, SZ; Cai, XF; Li, DH; Wu, X; Nan, JX; Lee, JJ; Jin, XJ				Jin, Hong Ri; Jin, Song Zhu; Cai, Xing Fu; Li, Donghao; Wu, Xue; Nan, Ji Xing; Lee, Jung Joon; Jin, Xuejun			Cryptopleurine Targets NF-kappa B Pathway, Leading to Inhibition of Gene Products Associated with Cell Survival, Proliferation, Invasion, and Angiogenesis	PLOS ONE			English	Article							CANCER DEVELOPMENT; DRUG DEVELOPMENT; P65 SUBUNIT; KINASE; ACTIVATION; TRANSCRIPTION; INFLAMMATION; EXPRESSION; ALPHA; PROGRESSION	Background: Cryptopleurine, a phenanthroquinolizidine alkaloid, was known to exhibit anticancer activity; however, the underlying mechanism is poorly understood. Because the nuclear factor-kappa B (NF-kappa B) transcription factors control many physiological processes including inflammation, immunity, and development and progression of cancer, we investigated the effects of cryptopleurine on tumor necrosis factor alpha (TNF-alpha)-induced NF-kappa B activation pathway and on the expression of NF-kappa B-regulated gene products associated with many pathophysiological processes. Methodology and Principal Finding: MDA-MB231, MDA-MB435, MCF-7, HEK293, RAW264.7 and Hep3B cells were used to examine cryptopleurine's effect on the NF-kappa B activation pathway. Major assays were promoter-reporter gene assay, electrophoretic mobility shift assay (EMSA), in vitro immune complex kinase assay, real-time PCR, Western blot analysis, and Matrigel invasion assay. Experiments documenting cell proliferation and apoptosis were analyzed by MTT method and flow cytometry, respectively. The results indicated that cryptopleurine suppressed the NF-kappa B activation through the inhibition of I kappa B kinase (IKK) activation, thereby blocking the phosphorylation and degradation of the inhibitor of NF-kappa B alpha (I kappa B alpha) and the nuclear translocation and DNA-binding activity of p65. The suppression of NF-kappa B by cryptopleurine led to the down-regulation of gene products involved in inflammation, cell survival, proliferation, invasion, and angiogenesis. Conclusions and Significance: Our results show that cryptopleurine inhibited NF-kappa B activation pathway, which leads to inhibition of inflammation, proliferation, and invasion, as well as potentiation of apoptosis. Our findings provide a new insight into the molecular mechanisms and a potential application of cryptopleurine for inflammatory diseases as well as certain cancers associated with abnormal NF-kappa B activation.	[Li, Donghao; Wu, Xue; Nan, Ji Xing; Lee, Jung Joon; Jin, Xuejun] Yanbian Univ, Minist Educ, Key Lab Nat Resources Changbai Mt & Funct Mol, Yanji, Jilin, Peoples R China; [Jin, Song Zhu] Yanbian Univ, Coll Basic Med, Dept Immunol & Pathogen Biol, Yanji, Jilin, Peoples R China; [Jin, Hong Ri; Cai, Xing Fu; Lee, Jung Joon] Korea Res Inst Biosci & Biotechnol, Ctr Mol Canc Res, Ochang, Chungbuk, South Korea	Yanbian University; Yanbian University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Jin, HR (corresponding author), Yanbian Univ, Minist Educ, Key Lab Nat Resources Changbai Mt & Funct Mol, Yanji, Jilin, Peoples R China.	jjlee@kribb.re.kr; xjjin0224@yahoo.com.cn	nan, ji-xing/H-5604-2018	nan, ji-xing/0000-0002-6221-4309	National Natural Science Foundation of China [81160250]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially supported by National Natural Science Foundation of China, No. 81160250. This study also received assistance from the China Postdoctoral Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; BALLARD DW, 1992, P NATL ACAD SCI USA, V89, P1875, DOI 10.1073/pnas.89.5.1875; Cai XF, 2006, J NAT PROD, V69, P1095, DOI 10.1021/np060081y; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Chemler Sherry R, 2009, Curr Bioact Compd, V5, P2; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Esteve PO, 2002, J BIOL CHEM, V277, P35150, DOI 10.1074/jbc.M108600200; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Garg A, 2002, LEUKEMIA, V16, P1053, DOI 10.1038/sj.leu.2402482; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hwangbo C, 2010, CANCER RES, V70, P1645, DOI 10.1158/0008-5472.CAN-09-2447; Jin XJ, 2010, J BIOL CHEM, V285, P30539, DOI 10.1074/jbc.M110.129551; John Anitha, 2001, Pathology and Oncology Research, V7, P14; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; Lin Y, 2003, MOL CELL BIOL, V23, P5849, DOI 10.1128/MCB.23.16.5849-5856.2003; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Pandey MK, 2007, J BIOL CHEM, V282, P17340, DOI 10.1074/jbc.M700890200; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Polsky D, 2003, ONCOGENE, V22, P3087, DOI 10.1038/sj.onc.1206449; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Sethi G, 2008, EXP BIOL MED, V233, P21, DOI 10.3181/0707-MR-196; Shen HM, 2009, APOPTOSIS, V14, P348, DOI 10.1007/s10495-009-0315-0; Sigala JLD, 2004, SCIENCE, V304, P1963, DOI 10.1126/science.1098387; Sung B, 2010, CANCER RES, V70, P3259, DOI 10.1158/0008-5472.CAN-09-4230; Umezawa K, 2006, CANCER SCI, V97, P990, DOI 10.1111/j.1349-7006.2006.00285.x; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Wang J, 2000, J CELL SCI, V113, P753; Yang CW, 2007, BIOCHEM BIOPH RES CO, V354, P942, DOI 10.1016/j.bbrc.2007.01.065; You MJ, 1997, MOL CELL BIOL, V17, P7328, DOI 10.1128/MCB.17.12.7328; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	43	48	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40355	10.1371/journal.pone.0040355	http://dx.doi.org/10.1371/journal.pone.0040355			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768286	gold, Green Published			2022-12-27	WOS:000305892100260
J	Khosravi-Hashemi, N; Chacron, MJ				Khosravi-Hashemi, Navid; Chacron, Maurice J.			Bursts and Isolated Spikes Code for Opposite Movement Directions in Midbrain Electrosensory Neurons	PLOS ONE			English	Article							LATERAL GENICULATE NEURONS; ELECTRIC FISH; IN-VIVO; ELECTROPHYSIOLOGICAL PROPERTIES; SYNAPTIC DYNAMICS; RECEPTIVE-FIELDS; MOTION ANALYSIS; OPTIC TECTUM; PREY-CAPTURE; INFORMATION	Directional selectivity, in which neurons respond strongly to an object moving in a given direction but weakly or not at all to the same object moving in the opposite direction, is a crucial computation that is thought to provide a neural correlate of motion perception. However, directional selectivity has been traditionally quantified by using the full spike train, which does not take into account particular action potential patterns. We investigated how different action potential patterns, namely bursts (i.e. packets of action potentials followed by quiescence) and isolated spikes, contribute to movement direction coding in a mathematical model of midbrain electrosensory neurons. We found that bursts and isolated spikes could be selectively elicited when the same object moved in opposite directions. In particular, it was possible to find parameter values for which our model neuron did not display directional selectivity when the full spike train was considered but displayed strong directional selectivity when bursts or isolated spikes were instead considered. Further analysis of our model revealed that an intrinsic burst mechanism based on subthreshold T-type calcium channels was not required to observe parameter regimes for which bursts and isolated spikes code for opposite movement directions. However, this burst mechanism enhanced the range of parameter values for which such regimes were observed. Experimental recordings from midbrain neurons confirmed our modeling prediction that bursts and isolated spikes can indeed code for opposite movement directions. Finally, we quantified the performance of a plausible neural circuit and found that it could respond more or less selectively to isolated spikes for a wide range of parameter values when compared with an interspike interval threshold. Our results thus show for the first time that different action potential patterns can differentially encode movement and that traditional measures of directional selectivity need to be revised in such cases.	[Khosravi-Hashemi, Navid; Chacron, Maurice J.] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Khosravi-Hashemi, Navid; Chacron, Maurice J.] McGill Univ, Ctr Appl Math Biol & Med, Montreal, PQ, Canada; [Chacron, Maurice J.] McGill Univ, Dept Phys, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Khosravi-Hashemi, N (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ, Canada.	maurice.chacron@mcgill.ca		Chacron, Maurice/0000-0002-3032-452X	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council; Canada Research Chairs	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs(Canada Research ChairsCGIAR)	This research was supported by the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council, and the Canada Research Chairs (M.J.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Akerberg OA, 2011, J COMPUT NEUROSCI, V31, P369, DOI 10.1007/s10827-011-0313-4; Avila-Akerberg O, 2010, NEUROSCIENCE, V168, P300, DOI 10.1016/j.neuroscience.2010.03.012; Avila-Akerberg O, 2011, EXP BRAIN RES, V210, P353, DOI [10.1007/s00221-011-2553-y, 10.1007/s00221-011-2639-6]; Bastian J, 2002, J NEUROSCI, V22, P4577, DOI 10.1523/JNEUROSCI.22-11-04577.2002; BASTIAN J, 1982, J COMP PHYSIOL, V147, P287, DOI 10.1007/BF00609662; Bastian J, 2001, J NEUROPHYSIOL, V85, P10, DOI 10.1152/jn.2001.85.1.10; BORST A, 1990, P NATL ACAD SCI USA, V87, P9363, DOI 10.1073/pnas.87.23.9363; BORST A, 1989, TRENDS NEUROSCI, V12, P297, DOI 10.1016/0166-2236(89)90010-6; Borst A, 2007, PHILOS T R SOC B, V362, P369, DOI 10.1098/rstb.2006.1964; Carlson BA, 2009, J NEUROSCI, V29, P9417, DOI 10.1523/JNEUROSCI.1980-09.2009; Carr C.E., 1986, P319; CARR CE, 1985, J COMP NEUROL, V235, P207, DOI 10.1002/cne.902350206; Carver S, 2005, BIOL CYBERN, V92, P147, DOI 10.1007/s00422-004-0535-x; Carver S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040032; Chacron MJ, 2008, J NEUROPHYSIOL, V99, P1825, DOI 10.1152/jn.01266.2007; Chacron MJ, 2007, J COMPUT NEUROSCI, V23, P301, DOI 10.1007/s10827-007-0033-y; Chacron MJ, 2011, CURR OPIN NEUROBIOL, V21, P752, DOI 10.1016/j.conb.2011.05.016; Chacron MJ, 2010, J NEUROPHYSIOL, V104, P449, DOI 10.1152/jn.01113.2009; Chacron MJ, 2009, J NEUROPHYSIOL, V102, P3270, DOI 10.1152/jn.00645.2009; Chacron MJ, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051917; Chacron MJ, 2006, J NEUROPHYSIOL, V95, P2933, DOI 10.1152/jn.01296.2005; Chacron MJ, 2005, J NEUROSCI, V25, P5521, DOI 10.1523/JNEUROSCI.0445-05.2005; Chacron MJ, 2004, J COMPUT NEUROSCI, V17, P127, DOI 10.1023/B:JCNS.0000037677.58916.6b; Chacron MJ, 2001, NEUROCOMPUTING, V38, P129, DOI 10.1016/S0925-2312(01)00549-5; Chance FS, 1998, J NEUROSCI, V18, P4785; Cowan NJ, 2007, J NEUROSCI, V27, P1123, DOI 10.1523/JNEUROSCI.4198-06.2007; DeBusk BC, 1997, J NEUROPHYSIOL, V78, P199, DOI 10.1152/jn.1997.78.1.199; Deemyad T, 2011, J NEUROPHYSIOL, V105, P1276, DOI 10.1152/jn.00792.2010; Derrington AM, 2004, ANNU REV PSYCHOL, V55, P181, DOI 10.1146/annurev.psych.55.090902.141903; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Edwards CJ, 2008, J NEUROPHYSIOL, V100, P3407, DOI 10.1152/jn.90921.2008; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Eyherabide HG, 2008, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.003.2008; Frank K, 1964, PHYS TECHNIQUES BIOL, P23, DOI DOI 10.1016/B978-0-12-514105-5.50009-5; Frye MA, 2001, J EXP BIOL, V204, P3683; Gabbiani F, 1996, NEURAL COMPUT, V8, P44, DOI 10.1162/neco.1996.8.1.44; Gaudry KS, 2008, NETWORK-COMP NEURAL, V19, P69, DOI 10.1080/09548980701819198; George AA, 2011, J NEUROSCI, V31, P14721, DOI 10.1523/JNEUROSCI.1424-11.2011; Green DM, 1966, SIGNAL DETECTION THE; Haag J, 2004, P NATL ACAD SCI USA, V101, P16333, DOI 10.1073/pnas.0407368101; Harvey-Girard E, 2010, J NEUROSCI, V30, P6152, DOI 10.1523/JNEUROSCI.0303-10.2010; HEILIGENBERG W, 1987, NEUROSCIENCE, V22, P331, DOI 10.1016/0306-4522(87)90224-7; Hitschfeld EM, 2009, ILAR J, V50, P361, DOI 10.1093/ilar.50.4.361; Hock HS, 2009, ACTA PSYCHOL, V132, P1, DOI 10.1016/j.actpsy.2009.06.006; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Horak F, 1996, HDB PHYSIOL 12, V12, P255; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; Kepecs A, 2003, NETWORK-COMP NEURAL, V14, P103, DOI 10.1088/0954-898X/14/1/306; Kepecs A, 2002, J NEUROSCI, V22, P9053; Khosravi-Hashemi N, 2011, J NEUROPHYSIOL, V106, P1954, DOI 10.1152/jn.00116.2011; Kiemel T, 2002, BIOL CYBERN, V87, P262, DOI 10.1007/s00422-002-0333-2; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; Krahe R, 2008, J NEUROPHYSIOL, V100, P852, DOI 10.1152/jn.90300.2008; Kuo AD, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S07; Leary CJ, 2008, J NEUROSCI, V28, P5481, DOI 10.1523/JNEUROSCI.5041-07.2008; Lesica NA, 2004, J NEUROSCI, V24, P10731, DOI 10.1523/JNEUROSCI.3059-04.2004; Lewis JE, 2004, J NEUROPHYSIOL, V91, P1064, DOI 10.1152/jn.00856.2003; Lewis JE, 2002, J NEUROPHYSIOL, V88, P1695, DOI 10.1152/jn.2002.88.4.1695; Lindner B, 2009, J NEUROSCI, V29, P2076, DOI 10.1523/JNEUROSCI.3702-08.2009; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; LU SM, 1992, J NEUROPHYSIOL, V68, P2185, DOI 10.1152/jn.1992.68.6.2185; MacIver MA, 2001, J EXP BIOL, V204, P543; MAEX R, 1991, P NATL ACAD SCI USA, V88, P3549, DOI 10.1073/pnas.88.9.3549; Manwani A, 1999, NEURAL COMPUT, V11, P1797, DOI 10.1162/089976699300015972; Marsat G, 2004, J NEUROPHYSIOL, V92, P939, DOI 10.1152/jn.00111.2004; Marsat G, 2010, J NEUROPHYSIOL, V104, P2543, DOI 10.1152/jn.00256.2010; Marsat G, 2010, J COMP PHYSIOL A, V196, P315, DOI 10.1007/s00359-010-0514-8; Marsat G, 2009, J NEUROPHYSIOL, V102, P714, DOI 10.1152/jn.91366.2008; Martinez-Conde S, 2002, P NATL ACAD SCI USA, V99, P13920, DOI 10.1073/pnas.212500599; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; McGillivray P, 2012, J NEUROSCI, V32, P5510, DOI 10.1523/JNEUROSCI.0478-12.2012; MUKHERJEE P, 1995, J NEUROPHYSIOL, V74, P1222, DOI 10.1152/jn.1995.74.3.1222; Nelson ME, 1999, J EXP BIOL, V202, P1195; Oswald AMM, 2004, J NEUROSCI, V24, P4351, DOI 10.1523/JNEUROSCI.0459-04.2004; Oswald AMM, 2007, J NEUROPHYSIOL, V97, P2731, DOI 10.1152/jn.00987.2006; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; Ramcharitar JU, 2006, J NEUROPHYSIOL, V96, P2319, DOI 10.1152/jn.00311.2006; Ramcharitar JU, 2005, J COMP PHYSIOL A, V191, P865, DOI 10.1007/s00359-005-0008-2; REICHARDT W, 1987, J COMP PHYSIOL A, V161, P533, DOI 10.1007/BF00603660; REICHARDT W, 1969, NATURWISSENSCHAFTEN, V56, P424, DOI 10.1007/BF00593644; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; Rose GJ, 1996, NEUROSCI RES, V26, P89, DOI 10.1016/S0168-0102(96)01074-7; ROSE GJ, 1993, J NEUROSCI, V13, P1178; RUSH ME, 1994, BIOL CYBERN, V71, P281, DOI 10.1007/BF00239616; Samengo I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009669; SAUNDERS J, 1984, J COMP PHYSIOL, V154, P199, DOI 10.1007/BF00604985; Sherman, 2006, EXPLORING THALAMUS I, P357; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Sherman SM, 1996, VISUAL NEUROSCI, V13, P205, DOI 10.1017/S0952523800007446; Smith GD, 2000, J NEUROPHYSIOL, V83, P588, DOI 10.1152/jn.2000.83.1.588; Srinivasan MV, 1999, VISION RES, V39, P2749, DOI 10.1016/S0042-6989(99)00002-4; Tammero LF, 2004, J EXP BIOL, V207, P113, DOI 10.1242/jeb.00724; Toporikova N, 2009, J NEUROPHYSIOL, V102, P2273, DOI 10.1152/jn.00282.2009; Turner RW, 1999, J EXP BIOL, V202, P1255; Vonderschen K, 2011, J NEUROPHYSIOL, V106, P3102, DOI 10.1152/jn.00588.2011; Vonderschen K, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-S1-O3; Wolfart J, 2005, NAT NEUROSCI, V8, P1760, DOI 10.1038/nn1591	102	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40339	10.1371/journal.pone.0040339	http://dx.doi.org/10.1371/journal.pone.0040339			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768279	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100253
J	Liu, D; Trojanowicz, B; Ye, LY; Li, C; Zhang, LQ; Li, XW; Li, GG; Zheng, YX; Chen, L				Liu, Daren; Trojanowicz, Bogusz; Ye, Longyun; Li, Chao; Zhang, Luqing; Li, Xiaowen; Li, Guogang; Zheng, Yixiong; Chen, Li			The Invasion and Metastasis Promotion Role of CD97 Small Isoform in Gastric Carcinoma	PLOS ONE			English	Article							CANCER STEM-CELLS; PREMETASTATIC NICHE; TUMOR INVASION; EXPRESSION; RECEPTOR; EGF-TM7; CD55; MOLECULES; PROTEIN; BONE	CD97 is over-expressed in the majority of gastric adenocarcinomas and is associated with its dedifferentiation and aggressiveness. Our previous results demonstrated that out of three CD97 isoforms tested, only the small one was able to promote increased invasiveness in vitro. Based on these data we further aimed to investigate the role of CD97 small isoform in gastric cancer progression in vivo by employing the cells with a stable CD97 small isoform knock-down and an orthotopic gastric cancer mouse model. We could demonstrate that the knock down of CD97/EGF1,2,5, led to a significant decrease in the number of cells penetrating the gelatin coated membrane as compared with control cells. In the gastric cancer mouse model, both the hypodermic and the orthotopic yielded tumor masses of the CD97/EGF1,2,5kd group and were significantly smaller than the control. Metastatic tumor cell number in early metastatic regional lymph nodes on post-operative day 42 was distinctly decreased in the CD97/EGF1,2,5kd group as compared with the SGC-NS group, and was accompanied with the downregulation of CD44, VEGFR, CD31 and CD97. We concluded in this study that CD97 small isoform not only supported gastric cancer local growth, but also promoted metastatic spread in orthotopically implanted mouse model suggesting involvement of the CD97 small isoform in the preparation of (pre) metastatic niche.	[Liu, Daren; Ye, Longyun; Li, Chao; Zhang, Luqing; Li, Xiaowen; Li, Guogang; Zheng, Yixiong; Chen, Li] Zhejiang Univ, Dept Surg, Affiliated Hosp 2, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Trojanowicz, Bogusz] Universitatklinikum Halle Saale, Klin Innere Med 2, Halle, Saale, Germany	Zhejiang University	Liu, D (corresponding author), Zhejiang Univ, Dept Surg, Affiliated Hosp 2, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China.	chenli@mail.hz.zj.cn	Trojanowicz, Bogusz/I-3042-2019	Trojanowicz, Bogusz/0000-0001-7429-381X	National Natural Science Foundation of China [81101837, 81071959]; Research Fund for the Doctoral Program of Higher Education of China [20110101120129]; Science Technology Department of Zhejiang Province [2010C34001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science Technology Department of Zhejiang Province	This study was funded by the National Natural Science Foundation of China (No. 81101837 and No. 81071959), the Research Fund for the Doctoral Program of Higher Education of China (No. 20110101120129) and the Science Technology Department of Zhejiang Province (No. 2010C34001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aust G, 1997, CANCER RES, V57, P1798; Aust G, 2002, AM J CLIN PATHOL, V118, P699; Chidambaram A, 2012, J NEUROSURG, V116, P843, DOI 10.3171/2011.11.JNS111455; EICHLER W, 1994, SCAND J IMMUNOL, V39, P111, DOI 10.1111/j.1365-3083.1994.tb03348.x; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Galle J, 2006, AM J PATHOL, V169, P1802, DOI 10.2353/ajpath.2006.060006; Gray JX, 1996, J IMMUNOL, V157, P5438; Hamann J, 1996, GENOMICS, V32, P144, DOI 10.1006/geno.1996.0092; Hensel F, 2001, LAB INVEST, V81, P1553, DOI 10.1038/labinvest.3780369; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hoang-Vu C, 1999, J CLIN ENDOCR METAB, V84, P1104, DOI 10.1210/jc.84.3.1104; Inoue T, 2002, J CLIN PATHOL-MOL PA, V55, P193, DOI 10.1136/mp.55.3.193; Iwasaki H, 2009, CANCER SCI, V100, P1166, DOI 10.1111/j.1349-7006.2009.01177.x; Jaspars LH, 2001, TISSUE ANTIGENS, V57, P325, DOI 10.1034/j.1399-0039.2001.057004325.x; Joyce JA, 2004, CELL CYCLE, V3, P1516, DOI 10.4161/cc.3.12.1289; Jung T, 2009, NEOPLASIA, V11, P1093, DOI 10.1593/neo.09822; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kaplan RN, 2006, CANCER RES, V66, P11089, DOI 10.1158/0008-5472.CAN-06-2407; Li LH, 2006, CANCER RES, V66, P4553, DOI 10.1158/0008-5472.CAN-05-3986; Liu DR, 2010, INT J ONCOL, V36, P1401, DOI 10.3892/ijo_00000625; Liu Y, 2005, ONCOL REP, V14, P1413; Liu Yong, 2005, J Zhejiang Univ Sci B, V6, P913, DOI 10.1631/jzus.2005.B0913; MARTENS GJM, 1992, PROG BRAIN RES, V92, P201, DOI 10.1016/S0079-6123(08)61176-0; McKnight AJ, 1996, IMMUNOL TODAY, V17, P283, DOI 10.1016/0167-5699(96)80546-9; Mikesch JH, 2006, CELL ONCOL, V28, P223; Nakanishi Y, 2001, CANCER, V91, P1114, DOI 10.1002/1097-0142(20010315)91:6<1114::AID-CNCR1107>3.0.CO;2-Y; Nie D, 2011, FRONT BIOSCI, V2, P184; Park KJ, 2005, DIS COLON RECTUM, V48, P1597, DOI 10.1007/s10350-005-0060-6; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Spendlove I, 2006, CANCER IMMUNOL IMMUN, V55, P987, DOI 10.1007/s00262-006-0136-8; Steinert M, 2002, AM J PATHOL, V161, P1657, DOI 10.1016/S0002-9440(10)64443-4; vanLier RAW, 1996, IMMUNOL LETT, V54, P185, DOI 10.1016/S0165-2478(96)02670-3; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; WEISS L, 1982, BRIT J CANCER, V45, P44, DOI 10.1038/bjc.1982.6; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhang JW, 2008, J BIOL CHEM, V283, P9499, DOI 10.1074/jbc.R700043200; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	38	28	28	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39989	10.1371/journal.pone.0039989	http://dx.doi.org/10.1371/journal.pone.0039989			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768192	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100164
J	Long, T; Vanderstraete, M; Cailliau, K; Morel, M; Lescuyer, A; Gouignard, N; Grevelding, CG; Browaeys, E; Dissous, C				Long, Thavy; Vanderstraete, Mathieu; Cailliau, Katia; Morel, Marion; Lescuyer, Arlette; Gouignard, Nadege; Grevelding, Christoph G.; Browaeys, Edith; Dissous, Colette			SmSak, the Second Polo-Like Kinase of the Helminth Parasite Schistosoma mansoni: Conserved and Unexpected Roles in Meiosis	PLOS ONE			English	Article							CENTROSOME DUPLICATION; CENTRIOLE DUPLICATION; TYROSINE KINASE; SAK; GROWTH; GENE; EXPRESSION; MUTANT; OVERDUPLICATION; PRAZIQUANTEL	Polo-like kinases (Plks) are a family of conserved regulators of a variety of events throughout the cell cycle, expanded from one Plk in yeast to five Plks in mammals (Plk1-5). Plk1 is the best characterized member of the Plk family, homolog to the founding member Polo of Drosophila, and plays a major role in cell cycle progression by triggering G2/M transition. Plk4/Sak (for Snk (Serum-inducible kinase) akin kinase) is a unique member of the family, structurally distinct from other Plk members, with essential functions in centriole duplication. The genome of the trematode parasite Schistosoma mansoni contains only two Plk genes encoding SmPlk1 and SmSak. SmPlk1 has been shown already to be required for gametogenesis and parasite reproduction. In this work, in situ hybridization indicated that the structurally conserved Plk4 protein, SmSak, was largely expressed in schistosome female ovary and vitellarium. Expression of SmSak in Xenopus oocytes confirmed its Plk4 conserved function in centriole amplification. Moreover, analysis of the function of SmSak in meiosis progression of G2-blocked Xenopus oocytes indicated that, in contrast to SmPlk1, SmSak cannot induce G2/M transition in the absence of endogenous Plk1 (Plx1). Unexpectedly, meiosis progression was spontaneously observed in Plx1-depleted oocytes co-expressing SmSak and SmPlk1. Molecular interaction between SmSak and SmPlk1 was confirmed by co-immunoprecipitation of both proteins. These data indicate that Plk1 and Plk4 proteins have the potential to interact and cross-activate in cells, thus attributing for the first time a potential role of Plk4 proteins in meiosis/mitosis entry. This unexpected role of SmSak in meiosis could be relevant to further consider the function of this novel Plk in schistosome reproduction.	[Long, Thavy; Vanderstraete, Mathieu; Morel, Marion; Gouignard, Nadege; Dissous, Colette] Univ Lille Nord France, CNRS, UMR 8204, Inst Pasteur,Inserm,U1019,Ctr Infect & Immun Lill, Lille, France; [Cailliau, Katia; Lescuyer, Arlette; Browaeys, Edith] Univ Lille 1 Sci & Technol, IFR 147, EA 4479, Villeneuve Dascq, France; [Grevelding, Christoph G.] Univ Giessen, Inst Parasitol, Giessen, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Justus Liebig University Giessen	Long, T (corresponding author), Univ Lille Nord France, CNRS, UMR 8204, Inst Pasteur,Inserm,U1019,Ctr Infect & Immun Lill, Lille, France.	colette.dissous@pasteur-lille.fr	Morel, Marion/X-4104-2019	cailliau, katia/0000-0003-1772-1034; Cailliau, Katia/0000-0001-7993-8437; Gouignard, Nadege/0000-0001-8787-2503; Morel, Marion/0000-0002-1439-5360; Dissous, Colette/0000-0002-5003-8205	Institut de la Sante et de la Recherche Medicale; Universite Lille Nord de France; Ministere de l'Education Nationale et de la Recherche, France	Institut de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Lille Nord de France; Ministere de l'Education Nationale et de la Recherche, France	This research was supported by the Institut de la Sante et de la Recherche Medicale and Universite Lille Nord de France. TL, MV, and NG have fellowships through the Ministere de l'Education Nationale et de la Recherche, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrysik Z, 2010, NUCLEIC ACIDS RES, V38, P2931, DOI 10.1093/nar/gkq011; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Beckmann S, 2010, PARASITOLOGY, V137, P497, DOI 10.1017/S0031182010000053; Beckmann S, 2011, J BIOL CHEM, V286, P42325, DOI 10.1074/jbc.M110.210336; Beckmann S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000769; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bonni S, 2008, CELL CYCLE, V7, P545, DOI 10.4161/cc.7.4.5387; Browaeys-Poly E, 2000, EUR J BIOCHEM, V267, P6256, DOI 10.1046/j.1432-1327.2000.01710.x; Chase D, 2000, GENESIS, V26, P26, DOI 10.1002/(SICI)1526-968X(200001)26:1<26::AID-GENE6>3.0.CO;2-O; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; Cunha-Ferreira I, 2009, CURR BIOL, V19, P43, DOI 10.1016/j.cub.2008.11.037; de Carcer G, 2011, CELL CYCLE, V10, P2255, DOI 10.4161/cc.10.14.16494; de Carcer G, 2011, MOL CELL BIOL, V31, P1225, DOI 10.1128/MCB.00607-10; Delattre M, 2004, J CELL SCI, V117, P1619, DOI 10.1242/jcs.01128; DISSOUS C, 1981, MOL BIOCHEM PARASIT, V3, P215, DOI 10.1016/0166-6851(81)90053-0; Dissous C, 2011, AN ACAD BRAS CIENC, V83, P627, DOI 10.1590/S0001-37652011000200022; Dissous C, 2011, TRENDS PARASITOL, V27, P59, DOI 10.1016/j.pt.2010.09.001; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; Eckerdt F, 2011, CURR BIOL, V21, P428, DOI 10.1016/j.cub.2011.01.072; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; FODE C, 1994, P NATL ACAD SCI USA, V91, P6388, DOI 10.1073/pnas.91.14.6388; Fode C, 1996, MOL CELL BIOL, V16, P4665; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Gouignard N, 2012, EXP PARASITOL, V132, P32, DOI 10.1016/j.exppara.2011.05.007; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Harris RM, 2011, ENDOCRINOLOGY, V152, P3975, DOI 10.1210/en.2011-1106; Holland AJ, 2010, J CELL BIOL, V188, P191, DOI 10.1083/jcb.200911102; Hudson JW, 2000, GENE, V241, P65, DOI 10.1016/S0378-1119(99)00467-9; Karn T, 1997, ONCOL REP, V4, P505; KITADA K, 1993, MOL CELL BIOL, V13, P4445, DOI 10.1128/MCB.13.7.4445; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Knobloch J, 2007, EXP PARASITOL, V117, P318, DOI 10.1016/j.exppara.2007.04.006; Krautz-Peterson G, 2010, PARASITOLOGY, V137, P485, DOI 10.1017/S0031182009991168; Lane HA, 1997, TRENDS CELL BIOL, V7, P63, DOI 10.1016/S0962-8924(96)10051-9; Leung GC, 2002, NAT STRUCT BIOL, V9, P719, DOI 10.1038/nsb848; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long T, 2010, INT J PARASITOL, V40, P1075, DOI 10.1016/j.ijpara.2010.03.002; LoVerde PT, 2009, CURR OPIN MICROBIOL, V12, P422, DOI 10.1016/j.mib.2009.06.005; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Melman SD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000504; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; OHKURA H, 1995, GENE DEV, V9, P1059, DOI 10.1101/gad.9.9.1059; Pearson Chad G, 2010, F1000 Biol Rep, V2, P58, DOI 10.3410/B2-58; Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036; Peters N, 2010, J CELL SCI, V123, P795, DOI 10.1242/jcs.050682; Qian YW, 1999, MOL CELL BIOL, V19, P8625; Quack T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006998; Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950; Rogers GC, 2009, J CELL BIOL, V184, P225, DOI 10.1083/jcb.200808049; SCHALLIG HDFH, 1992, PARASITOLOGY, V104, P309, DOI 10.1017/S0031182000061758; Schoffski P, 2009, ONCOLOGIST, V14, P559, DOI 10.1634/theoncologist.2009-0010; Sillibourne JE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-25; Sillibourne JE, 2010, MOL BIOL CELL, V21, P547, DOI 10.1091/mbc.E09-06-0505; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; SUNKEL CE, 1988, J CELL SCI, V89, P25; Swallow CJ, 2005, ONCOGENE, V24, P306, DOI 10.1038/sj.onc.1208275; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Vicogne J, 2004, J BIOL CHEM, V279, P37407, DOI 10.1074/jbc.M313738200; Yan Y, 2007, INT J PARASITOL, V37, P1539, DOI 10.1016/j.ijpara.2007.06.001	66	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40045	10.1371/journal.pone.0040045	http://dx.doi.org/10.1371/journal.pone.0040045			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768216	gold, Green Submitted, Green Published			2022-12-27	WOS:000305892100188
J	Peterson, GJ; Presse, S; Peterson, KS; Dill, KA				Peterson, G. Jack; Presse, Steve; Peterson, Kristin S.; Dill, Ken A.			Simulated Evolution of Protein-Protein Interaction Networks with Realistic Topology	PLOS ONE			English	Article							GENE DUPLICATION; YEAST; MODULARITY; GENOMES; NEOFUNCTIONALIZATION; DIVERGENCE; PREDICTION; DROSOPHILA; LANDSCAPE; BIOLOGY	We model the evolution of eukaryotic protein-protein interaction (PPI) networks. In our model, PPI networks evolve by two known biological mechanisms: (1) Gene duplication, which is followed by rapid diversification of duplicate interactions. (2) Neofunctionalization, in which a mutation leads to a new interaction with some other protein. Since many interactions are due to simple surface compatibility, we hypothesize there is an increased likelihood of interacting with other proteins in the target protein's neighborhood. We find good agreement of the model on 10 different network properties compared to high-confidence experimental PPI networks in yeast, fruit flies, and humans. Key findings are: (1) PPI networks evolve modular structures, with no need to invoke particular selection pressures. (2) Proteins in cells have on average about 6 degrees of separation, similar to some social networks, such as human-communication and actor networks. (3) Unlike social networks, which have a shrinking diameter (degree of maximum separation) over time, PPI networks are predicted to grow in diameter. (4) The model indicates that evolutionarily old proteins should have higher connectivities and be more centrally embedded in their networks. This suggests a way in which present-day proteomics data could provide insights into biological evolution.	[Peterson, G. Jack] Univ Calif San Francisco, Biophys Grad Grp, San Francisco, CA 94143 USA; [Presse, Steve] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Peterson, Kristin S.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Dill, Ken A.] SUNY Stony Brook, Laufer Ctr Phys & Quantitat Biol, New York, NY USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Oregon State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Peterson, GJ (corresponding author), Univ Calif San Francisco, Biophys Grad Grp, San Francisco, CA 94143 USA.	jack@tinybike.net			Department of Defense; Sandler Blue Sky Award; National Science Foundation; National Institutes of Health [GM 34993]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034993] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Sandler Blue Sky Award; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	GJP was funded by a National Defense Science and Engineering Graduate Fellowship from the Department of Defense, SP was funded by a Sandler Blue Sky Award, KSP was funded by a Long Term Ecological Research grant from the National Science Foundation, and KAD was funded by the National Science Foundation and National Institutes of Health GM 34993. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloy P, 2002, FEBS LETT, V530, P253, DOI 10.1016/S0014-5793(02)03427-0; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Beltrao P, 2007, PLOS COMPUTATIONAL B, V3; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-51; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cotton J, 2005, P ROYAL SOC B, V272; Deane CM, 2002, MOL CELL PROTEOMICS, V1, P349, DOI 10.1074/mcp.M100037-MCP200; Deeds EJ, 2006, P NATL ACAD SCI USA, V103, P311, DOI 10.1073/pnas.0509715102; Dutkowski J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-393; ERDOS P, 1960, B INT STATIST INST, V38, P343; Escriva H, 2006, PLOS GENET, V2, P955, DOI 10.1371/journal.pgen.0020102; Espinosa-Soto C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000719; Gao LZ, 2004, SCIENCE, V306, P1367, DOI 10.1126/science.1102033; Gibson TA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000252; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gomez SM, 2003, BIOINFORMATICS, V19, P1875, DOI 10.1093/bioinformatics/btg352; Gu X, 2005, P NATL ACAD SCI USA, V102, P707, DOI 10.1073/pnas.0409186102; Gu ZL, 2002, MOL BIOL EVOL, V19, P256, DOI 10.1093/oxfordjournals.molbev.a004079; Hakes L, 2008, NAT BIOTECHNOL, V26, P69, DOI 10.1038/nbt0108-69; Hallinan J, 2004, BIOSYSTEMS, V74, P51, DOI 10.1016/j.biosystems.2004.02.004; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Heo MY, 2011, P NATL ACAD SCI USA, V108, P4258, DOI 10.1073/pnas.1009392108; Hietpas RT, 2011, P NATL ACAD SCI USA, V108, P7896, DOI 10.1073/pnas.1016024108; Hughes D, 2003, NAT REV GENET, V4, P432, DOI 10.1038/nrg1084; Ispolatov I, 2005, NUCLEIC ACIDS RES, V33, P3629, DOI 10.1093/nar/gki678; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Jothi R, 2005, BIOINFORMATICS, V21, pI241, DOI 10.1093/bioinformatics/bti1009; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; KIMURA M, 1957, ANN MATH STAT, V28, P882, DOI 10.1214/aoms/1177706791; KOCH AL, 1972, GENETICS, V72, P297; Komurov K, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100149; Krapivsky PL, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066123; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Ku HM, 2000, P NATL ACAD SCI USA, V97, P9121, DOI 10.1073/pnas.160271297; Leskovec J., 2005, KNOWLEDGE DISCOVERY; Leskovec J., 2008, P 17 INT C WORLD WID, P915, DOI [10.1145/1367497.1367620, DOI 10.1145/1367497.1367620]; Lipson H, 2002, EVOLUTION, V56, P1549, DOI 10.1111/j.0014-3820.2002.tb01466.x; Liu Y, 2005, BIOINFORMATICS, V21, P3279, DOI 10.1093/bioinformatics/bti492; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2001, GENETICS, V159, P1789; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Lynch Michael, 1998; Lynch Michael, 2003, Journal of Structural and Functional Genomics, V3, P35, DOI 10.1023/A:1022696612931; Marcotte E, 1999, NATURE, V402, P86; Maslov S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-9; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Ohno S., 1970, P1; Osada N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000305; Pan D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r158; Patil A, 2011, NUCLEIC ACIDS RES, V39, pD744, DOI 10.1093/nar/gkq897; Patil A, 2010, PROTEIN SCI, V19, P1461, DOI 10.1002/pro.425; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Qin H, 2003, P NATL ACAD SCI USA, V100, P12820, DOI 10.1073/pnas.2235584100; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Sole RV, 2008, J R SOC INTERFACE, V5, P129, DOI 10.1098/rsif.2007.1108; Soyer OS, 2010, EVOLUTION AFTER GENE DUPLICATION, P215; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Ting CT, 2004, P NATL ACAD SCI USA, V101, P12232, DOI 10.1073/pnas.0401975101; Tovchigrechko A, 2001, PROTEIN SCI, V10, P1572, DOI 10.1110/ps.8701; TRAVERS J, 1969, SOCIOMETRY, V32, P425, DOI 10.2307/2786545; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Valencia A, 2002, CURR OPIN STRUC BIOL, V12, P368, DOI 10.1016/S0959-440X(02)00333-0; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; Vinogradov AE, 2009, GENOMICS, V93, P534, DOI 10.1016/j.ygeno.2009.02.004; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wagner A, 2003, P ROY SOC B-BIOL SCI, V270, P457, DOI 10.1098/rspb.2002.2269; Wagner GP, 2007, NAT REV GENET, V8, P473, DOI 10.1038/nrg2099; WALSH JB, 1995, GENETICS, V139, P421; Wan X, 2010, CHAOS, V20, DOI 10.1063/1.3517107; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wu F, 2007, IEEE INT C BIOINF BI; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhao D, 2007, CHINESE PHYS LETT, V24, P2766, DOI 10.1088/0256-307X/24/10/015; Zhu GM, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-21019-2	91	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39052	10.1371/journal.pone.0039052	http://dx.doi.org/10.1371/journal.pone.0039052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768057	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100027
J	Ribeiro, RJT; Monteiro, CPD; Azevedo, ASM; Cunha, VFM; Ramanakumar, AV; Fraga, AM; Pina, FM; Lopes, CMS; Medeiros, RM; Franco, EL				Ribeiro, Ricardo J. T.; Monteiro, Catia P. D.; Azevedo, Andreia S. M.; Cunha, Virginia F. M.; Ramanakumar, Agnihotram V.; Fraga, Avelino M.; Pina, Francisco M.; Lopes, Carlos M. S.; Medeiros, Rui M.; Franco, Eduardo L.			Performance of an Adipokine Pathway-Based Multilocus Genetic Risk Score for Prostate Cancer Risk Prediction	PLOS ONE			English	Article							LEPTIN RECEPTOR; BINDING PROTEIN-3; ADIPOSE-TISSUE; GROWTH-FACTORS; POLYMORPHISM; OBESITY; ASSOCIATION; EXPRESSION; OSTEOPONTIN; RECLASSIFICATION	Few biomarkers are available to predict prostate cancer risk. Single nucleotide polymorphisms (SNPs) tend to have weak individual effects but, in combination, they have stronger predictive value. Adipokine pathways have been implicated in the pathogenesis. We used a candidate pathway approach to investigate 29 functional SNPs in key genes from relevant adipokine pathways in a sample of 1006 men eligible for prostate biopsy. We used stepwise multivariate logistic regression and bootstrapping to develop a multilocus genetic risk score by weighting each risk SNP empirically based on its association with disease. Seven common functional polymorphisms were associated with overall and high-grade prostate cancer (Gleason >= 7), whereas three variants were associated with high metastatic-risk prostate cancer (PSA >= 20 ng/mL and/or Gleason >= 8). The addition of genetic variants to age and PSA improved the predictive accuracy for overall and high-grade prostate cancer, using either the area under the receiver-operating characteristics curves (P<0.02), the net reclassification improvement (P<0.001) and integrated discrimination improvement (P<0.001) measures. These results suggest that functional polymorphisms in adipokine pathways may act individually and cumulatively to affect risk and severity of prostate cancer, supporting the influence of adipokine pathways in the pathogenesis of prostate cancer. Use of such adipokine multilocus genetic risk score can enhance the predictive value of PSA and age in estimating absolute risk, which supports further evaluation of its clinical significance.	[Ribeiro, Ricardo J. T.; Monteiro, Catia P. D.; Azevedo, Andreia S. M.; Cunha, Virginia F. M.; Fraga, Avelino M.; Medeiros, Rui M.] Portuguese Inst Oncol, Mol Oncol Grp CI, Oporto, Portugal; [Ribeiro, Ricardo J. T.; Fraga, Avelino M.; Lopes, Carlos M. S.; Medeiros, Rui M.] Univ Porto, Abel Salazar Biomed Sci Inst, P-4100 Oporto, Portugal; [Ribeiro, Ricardo J. T.; Ramanakumar, Agnihotram V.; Franco, Eduardo L.] McGill Univ, Dept Oncol, Div Canc Epidemiol, Montreal, PQ, Canada; [Ribeiro, Ricardo J. T.; Monteiro, Catia P. D.; Azevedo, Andreia S. M.; Cunha, Virginia F. M.; Medeiros, Rui M.] LPCC Portuguese League Canc NRNorte, Oporto, Portugal; [Fraga, Avelino M.] D Pedro V Mil Hosp, Dept Urol, Oporto, Portugal; [Pina, Francisco M.] S Joao Hosp, Dept Urol, Oporto, Portugal	Universidade de Coimbra; Universidade do Porto; McGill University; Sao Joao Hospital	Ribeiro, RJT (corresponding author), Portuguese Inst Oncol, Mol Oncol Grp CI, Oporto, Portugal.	oriebir.r@gmail.com	Ribeiro, Ricardo Jorge Teixeira/S-6419-2017; Medeiros, Rui/C-7938-2009; Monteiro, Cátia/L-5409-2014; Franco, Eduardo/C-6445-2014	Ribeiro, Ricardo Jorge Teixeira/0000-0001-9785-857X; Medeiros, Rui/0000-0003-3010-8373; Monteiro, Cátia/0000-0002-0828-4541; Franco, Eduardo/0000-0002-4409-8084; Ferreira, Avelino/0000-0002-2999-0963; Azevedo, Andreia Sofia/0000-0002-0521-2841; Cunha, Virginia/0000-0003-1896-3318	Portuguese Foundation for Science and Technology [PTDC/SAL-FCF/71552/2006]; Research Centre on Environment, Genetics and Oncobiology of the University of Coimbra [CIMAGO 07/09]; Portuguese League Against Cancer - North Centre; Novartis Oncology Portugal; Programa Operacional Potencial Humano/Fundo social Europeu (POPH/FSE) [SFRH/BD/30021/2006]; Union for International Cancer Control (UICC-ICRETT) [ICR/10/079/2010]; Cancer Research Society	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Research Centre on Environment, Genetics and Oncobiology of the University of Coimbra; Portuguese League Against Cancer - North Centre; Novartis Oncology Portugal; Programa Operacional Potencial Humano/Fundo social Europeu (POPH/FSE); Union for International Cancer Control (UICC-ICRETT); Cancer Research Society	This work was supported by the Portuguese Foundation for Science and Technology (PTDC/SAL-FCF/71552/2006); the Research Centre on Environment, Genetics and Oncobiology of the University of Coimbra (CIMAGO 07/09); the Portuguese League Against Cancer - North Centre; and by an unrestricted educational grant for basic research in Molecular Oncology from Novartis Oncology Portugal. RR is the recipient of a PhD grant from Programa Operacional Potencial Humano/Fundo social Europeu (POPH/FSE, SFRH/BD/30021/2006) and of an International Cancer Technology Transfer Fellowship from the Union for International Cancer Control (UICC-ICRETT, ICR/10/079/2010). AVR was supported by funding from the Cancer Research Society to the Division of Cancer Epidemiology at McGill University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Almind K, 1996, J CLIN INVEST, V97, P2569, DOI 10.1172/JCI118705; Aly M, 2011, EUR UROL, V60, P21, DOI 10.1016/j.eururo.2011.01.017; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Cavadas V, 2010, EUR UROL, V58, P551, DOI 10.1016/j.eururo.2010.06.023; Chakraborty G, 2006, CURR MOL MED, V6, P819, DOI 10.2174/156652406779010803; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chen WS, 2009, EUR J HUM GENET, V17, P1668, DOI 10.1038/ejhg.2009.86; Cronauer MV, 2003, EUR UROL, V43, P309, DOI 10.1016/S0302-2838(03)00005-8; Culig Z, 2005, J CELL BIOCHEM, V95, P497, DOI 10.1002/jcb.20477; da Silva BA, 1998, ENDOCRINOLOGY, V139, P3681, DOI 10.1210/en.139.9.3681; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; Danforth KN, 2008, PROSTATE, V68, P400, DOI 10.1002/pros.20694; de Alencar SA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/715139; Deal C, 2001, J CLIN ENDOCR METAB, V86, P1274, DOI 10.1210/jc.86.3.1274; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Dossus L, 2010, CARCINOGENESIS, V31, P455, DOI 10.1093/carcin/bgp307; Fall K, 2008, PROSTATE, V68, P1416, DOI 10.1002/pros.20797; Febbo PG, 2009, CANCER-AM CANCER SOC, V115, P3046, DOI 10.1002/cncr.24350; Gomez-Ambrosi J, 2007, J CLIN ENDOCR METAB, V92, P3719, DOI 10.1210/jc.2007-0349; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Harnden P, 2007, LANCET ONCOL, V8, P411, DOI 10.1016/S1470-2045(07)70136-5; Heidenreich A, 2011, EUR UROL, V59, P61, DOI 10.1016/j.eururo.2010.10.039; Hsing AW, 2007, AM J CLIN NUTR, V86, p843S, DOI 10.1093/ajcn/86.3.843S; Hummelshoj T, 2006, MOL IMMUNOL, V43, P980, DOI 10.1016/j.molimm.2005.05.012; Jacobs EJ, 2008, CANCER EPIDEM BIOMAR, V17, P972, DOI 10.1158/1055-9965.EPI-07-2787; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kote-Jarai Z, 2003, BJU INT, V92, P109, DOI 10.1046/j.1464-410X.2003.04272.x; Li L, 2010, MOL BIOL REP, V37, P127, DOI 10.1007/s11033-009-9552-0; Lindstrom S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017142; Mistry T, 2007, EUR UROL, V52, P46, DOI 10.1016/j.eururo.2007.03.054; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Moore SC, 2009, INT J CANCER, V124, P869, DOI 10.1002/ijc.24043; Morote J, 2002, EUR UROL, V42, P333, DOI 10.1016/S0302-2838(02)00318-4; MULLBERG J, 1994, J IMMUNOL, V152, P4958; Park J, 2011, ENDOCR REV; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Quinton ND, 2001, HUM GENET, V108, P233, DOI 10.1007/s004390100468; Ribeiro R, 2006, PROSTATE CANCER P D, V9, P19, DOI 10.1038/sj.pcan.4500844; Ribeiro R, 2004, PROSTATE, V59, P268, DOI 10.1002/pros.20004; Santer FR, 2010, ENDOCR-RELAT CANCER, V17, P241, DOI 10.1677/ERC-09-0200; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Schulz S, 2005, INT J CARDIOL, V101, P265, DOI 10.1016/j.ijcard.2004.03.049; Silha JV, 2005, INT J OBESITY, V29, P1308, DOI 10.1038/sj.ijo.0802987; Sun Q, 2010, HUM MOL GENET, V19, P1846, DOI 10.1093/hmg/ddq056; Sundstrom J, 2011, SCAND J PUBLIC HEALT, V39, P439, DOI 10.1177/1403494810396556; Tan DF, 2005, J UROLOGY, V174, P753, DOI 10.1097/01.ju.0000168723.42824.40; Terry CF, 2000, J BIOL CHEM, V275, P18138, DOI 10.1074/jbc.M000379200; Vickers AJ, 2011, ANN REV MED; von Hafe P, 2004, OBES RES, V12, P1930, DOI 10.1038/oby.2004.242; Wang MH, 2009, PROSTATE, V69, P874, DOI 10.1002/pros.20933; Weber GF, 2010, BRIT J CANCER, V103, P861, DOI 10.1038/sj.bjc.6605834	54	10	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39236	10.1371/journal.pone.0039236	http://dx.doi.org/10.1371/journal.pone.0039236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22792137	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100035
J	Rogers, MS; Cryan, LM; Habeshian, KA; Bazinet, L; Caldwell, TP; Ackroyd, PC; Christensen, KA				Rogers, Michael S.; Cryan, Lorna M.; Habeshian, Kaiane A.; Bazinet, Lauren; Caldwell, Thomas P.; Ackroyd, P. Christine; Christensen, Kenneth A.			A FRET-Based High Throughput Screening Assay to Identify Inhibitors of Anthrax Protective Antigen Binding to Capillary Morphogenesis Gene 2 Protein	PLOS ONE			English	Article							INDUCED SKIN TUMORIGENESIS; TUMOR ENDOTHELIAL MARKERS; TANNIC-ACID; POLYVALENT INHIBITORS; MONOCLONAL-ANTIBODY; TOXIN; ANGIOGENESIS; THERAPY; RECEPTOR; CANCER	Anti-angiogenic therapies are effective for the treatment of cancer, a variety of ocular diseases, and have potential benefits in cardiovascular disease, arthritis, and psoriasis. We have previously shown that anthrax protective antigen (PA), a nonpathogenic component of anthrax toxin, is an inhibitor of angiogenesis, apparently as a result of interaction with the cell surface receptors capillary morphogenesis gene 2 (CMG2) protein and tumor endothelial marker 8 (TEM8). Hence, molecules that bind the anthrax toxin receptors may be effective to slow or halt pathological vascular growth. Here we describe development and testing of an effective homogeneous steady-state fluorescence resonance energy transfer (FRET) high throughput screening assay designed to identify molecules that inhibit binding of PA to CMG2. Molecules identified in the screen can serve as potential lead compounds for the development of anti-angiogenic and anti-anthrax therapies. The assay to screen for inhibitors of this protein-protein interaction is sensitive and robust, with observed Z' values as high as 0.92. Preliminary screens conducted with a library of known bioactive compounds identified tannic acid and cisplatin as inhibitors of the PA-CMG2 interaction. We have confirmed that tannic acid both binds CMG2 and has anti-endothelial properties. In contrast, cisplatin appears to inhibit PA-CMG2 interaction by binding both PA and CMG2, and observed cisplatin antiangiogenic effects are not mediated by interaction with CMG2. This work represents the first reported high throughput screening assay targeting CMG2 to identify possible inhibitors of both angiogenesis and anthrax intoxication.	[Rogers, Michael S.; Cryan, Lorna M.; Habeshian, Kaiane A.; Bazinet, Lauren] Harvard Univ, Sch Med, Dept Surg, Vasc Biol Program,Childrens Hosp Boston, Boston, MA 02115 USA; [Caldwell, Thomas P.; Ackroyd, P. Christine; Christensen, Kenneth A.] Clemson Univ, Dept Chem, Clemson, SC 29634 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Clemson University	Rogers, MS (corresponding author), Harvard Univ, Sch Med, Dept Surg, Vasc Biol Program,Childrens Hosp Boston, Boston, MA 02115 USA.	kchris@clemson.edu	Rogers, Michael S/A-9814-2009; Christensen, Kenneth/S-1670-2019; Rogers, Michael/AAE-2217-2019	Rogers, Michael S/0000-0002-5250-8434; Christensen, Kenneth/0000-0002-3736-5500; Rogers, Michael/0000-0002-5250-8434; Cryan, Lorna/0000-0002-2604-7996	National Institutes of Health [1R03NS053690-01, 1R01EY018829-01]; Department of Defense [W81XWH-08-1-0710]; NATIONAL EYE INSTITUTE [R01EY018829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS053690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (grants 1R03NS053690-01 to KAC and 1R01EY018829-01 to MSR), and the Department of Defense (grant W81XWH-08-1-0710 to MSR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Adamis A P, 1999, Angiogenesis, V3, P9, DOI 10.1023/A:1009071601454; Alvarez Z, 2007, EXPERT REV ANTI-INFE, V5, P783, DOI 10.1586/14787210.5.5.783; Aulinger BA, 2005, INFECT IMMUN, V73, P3408, DOI 10.1128/IAI.73.6.3408-3414.2005; Bashat S, 2006, P NATL ACAD SCI USA, V103, P13509, DOI 10.1073/pnas.0509870103; Batty S, 2006, CELL MICROBIOL, V8, P130, DOI 10.1111/j.1462-5822.2005.00606.x; Bell SE, 2001, J CELL SCI, V114, P2755; Bijman MNA, 2006, MOL CANCER THER, V5, P2348, DOI 10.1158/1535-7163.MCT-06-0242; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Chaudhary A, 2012, CANCER CELL, V21, P212, DOI 10.1016/j.ccr.2012.01.004; Chen X, 2003, CLIN CANCER RES, V9, P3115; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Cui XZ, 2005, J INFECT DIS, V191, P422, DOI 10.1086/427189; Cullen M, 2009, CANCER RES, V69, P6021, DOI 10.1158/0008-5472.CAN-09-1086; DAMATO RJ, 1995, OPHTHALMOLOGY, V102, P1261, DOI 10.1016/S0161-6420(95)30876-7; DAS M, 1989, INT J CANCER, V43, P468, DOI 10.1002/ijc.2910430321; Davies G, 2006, INT J ONCOL, V29, P1311; Dowling O, 2003, AM J HUM GENET, V73, P957, DOI 10.1086/378781; ENGERMAN RL, 1967, LAB INVEST, V17, P738; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FOLKMAN J, 1975, ANN INTERN MED, V82, P96, DOI 10.7326/0003-4819-82-1-96; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Galoyan AA, 2006, NEUROCHEM RES, V31, P795, DOI 10.1007/s11064-006-9082-2; GORDON VM, 1995, INFECT IMMUN, V63, P82, DOI 10.1128/IAI.63.1.82-87.1995; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Gubbins MJ, 2006, FEMS IMMUNOL MED MIC, V47, P436, DOI 10.1111/j.1574-695X.2006.00114.x; Gujraty KV, 2006, BIOMACROMOLECULES, V7, P2082, DOI 10.1021/bm060210p; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Kamei H, 1999, CANCER BIOTHER RADIO, V14, P135, DOI 10.1089/cbr.1999.14.135; Karginov VA, 2004, FEMS IMMUNOL MED MIC, V40, P71, DOI 10.1016/S0928-8244(03)00302-X; Koide T, 1999, CANCER BIOTHER RADIO, V14, P231, DOI 10.1089/cbr.1999.14.231; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Marienfeld C, 2003, HEPATOLOGY, V37, P1097, DOI 10.1053/jhep.2003.50192; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; Michaelson I.C., 1948, T OPHTHALMOL SOC, V68, P137; Moayeri M, 2006, ANTIMICROB AGENTS CH, V50, P2658, DOI 10.1128/AAC.01412-05; Mock M, 2003, CELL MICROBIOL, V5, P15, DOI 10.1046/j.1462-5822.2003.00253.x; Mogridge J, 2002, P NATL ACAD SCI USA, V99, P7045, DOI 10.1073/pnas.052160199; Mourez M, 2001, NAT BIOTECHNOL, V19, P958, DOI 10.1038/nbt1001-958; MUKHTAR H, 1988, CANCER RES, V48, P2361; Nanda A, 2004, CURR OPIN ONCOL, V16, P44, DOI 10.1097/00001622-200401000-00009; Nanda A, 2004, CANCER RES, V64, P817, DOI 10.1158/0008-5472.CAN-03-2408; Peters DE, 2012, BIOCHEM BIOPH RES CO, V422, P393, DOI 10.1016/j.bbrc.2012.04.160; POOLE TJ, 1989, J EXP ZOOL, V251, P224, DOI 10.1002/jez.1402510210; Reeves CV, 2010, ONCOGENE, V29, P789, DOI 10.1038/onc.2009.383; Reeves CV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034862; REYNOLDS LP, 1992, FASEB J, V6, P886, DOI 10.1096/fasebj.6.3.1371260; Rmali KA, 2005, WORLD J GASTROENTERO, V11, P1283, DOI 10.3748/wjg.v11.i9.1283; Rmali KA, 2005, BIOCHEM BIOPH RES CO, V334, P231, DOI 10.1016/j.bbrc.2005.06.085; Rmali KA, 2004, EJSO-EUR J SURG ONC, V30, P948, DOI 10.1016/j.ejso.2004.07.023; Rogers MS, 2007, CANCER RES, V67, P9980, DOI 10.1158/0008-5472.CAN-07-0829; Rogers MS, 2006, EXP CELL RES, V312, P561, DOI 10.1016/j.yexcr.2005.10.021; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schneemann A, 2009, FUTURE MICROBIOL, V4, P35, DOI 10.2217/17460913.4.1.35; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Scorpio A, 2008, ANTIMICROB AGENTS CH, V52, P1014, DOI 10.1128/AAC.00741-07; Sellman BR, 2001, SCIENCE, V292, P695, DOI 10.1126/science.109563; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; St Croix B, 2000, SCIENCE, V289, P1197; Vitale L, 2006, INFECT IMMUN, V74, P5840, DOI 10.1128/IAI.00712-06; Vuyisich M, 2008, PROTEIN J, V27, P292, DOI 10.1007/s10930-008-9137-0; Werner E, 2006, J BIOL CHEM, V281, P23227, DOI 10.1074/jbc.M603676200; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200; Xiong YS, 2006, BIOORG MED CHEM LETT, V16, P964, DOI 10.1016/j.bmcl.2005.10.088; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	68	20	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39911	10.1371/journal.pone.0039911	http://dx.doi.org/10.1371/journal.pone.0039911			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768167	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100136
J	Jung, HJ; Lim, JS; Choi, HJ; Lee, MS; Kim, JH; Kim, SY; Kim, S; Kim, E; Kwon, TH				Jung, Hyun Jun; Lim, Jung-Suk; Choi, Hyo-Jung; Lee, Mi Suk; Kim, Jong-Ho; Kim, Sang-Yeob; Kim, Soyoun; Kim, Eunjung; Kwon, Tae-Hwan			Vasopressin V2R-Targeting Peptide Carrier Mediates siRNA Delivery into Collecting Duct Cells	PLOS ONE			English	Article							ARGININE-RICH PEPTIDES; DE-NOVO PEPTIDE; STRUCTURE PREDICTION; TYPE-2 RECEPTOR; ANGIOTENSIN-II; AQP2; INTERNALIZATION; AQUAPORIN-2; KIDNEY; INVOLVEMENT	Internalization of receptor proteins after interacting with specific ligands has been proposed to facilitate siRNA delivery into the target cells via receptor-mediated siRNA transduction. In this study, we demonstrated a novel method of vasopressin V2 receptor (V2R)-mediated siRNA delivery against AQP2 in primary cultured inner medullary collecting duct (IMCD) cells of rat kidney. We synthesized the dDAVP conjugated with nine D-arginines (dDAVP-9r) as a peptide carrier for siRNA delivery. The structure of synthetic peptide carrier showed two regions (i.e., ligand domain to V2R (dDAVP) and siRNA carrying domain (nine D-arginine)) bisected with a spacer of four glycines. The results revealed that 1) synthesized dDAVP-9r peptides formed a stable polyplex with siRNA; 2) siRNA/dDAVP-9r polyplex could bind to the V2R of IMCD cells and induced AQP2 phosphorylation (Ser 256); 3) siRNA/dDAVP-9r polyplex was stable in response to the wide range of different osmolalities, pH levels, or to the RNases; 4) fluorescein-labeled siRNA was delivered into V2R-expressing MDCK and LLC-PK1 cells by siRNA/dDAVP-9r polyplex, but not into the V2R-negative Cos-7 cells; and 5) AQP2-siRNA/dDAVP-9r polyplex effectively delivered siRNA into the IMCD cells, resulting in the significant decrease of protein abundance of AQP2, but not AQP4. Therefore, for the first time to our knowledge, we demonstrated that V2R-mediated siRNA delivery could be exploited to deliver specific siRNA to regulate abnormal expression of target proteins in V2R-expressing kidney cells. The methods could be potentially used in vivo to regulate abnormal expression of proteins associated with disease conditions in the V2R-expressing kidney cells.	[Jung, Hyun Jun; Lim, Jung-Suk; Choi, Hyo-Jung; Lee, Mi Suk; Kim, Jong-Ho; Kim, Sang-Yeob; Kim, Soyoun; Kim, Eunjung; Kwon, Tae-Hwan] Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Taegu 702701, South Korea; [Kim, Jong-Ho] Kyung Hee Univ, Coll Pharm, Dept Pharmaceut Sci, Seoul, South Korea	Kyungpook National University; Kyung Hee University	Jung, HJ (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Taegu 702701, South Korea.	thkwon@knu.ac.kr	Kim, Soyoun/Y-1276-2018; Kwon, Tae-Hwan/ABA-1981-2020	Jung, Hyun Jun/0000-0003-0519-5858	National Research Foundation [2010-0008225, 2010-0019393]; Ministry of Education, Science and Technology (MEST), Korea; Korea Healthcare Technology RD Project; Ministry of Health and Welfare, Korea [A100617, A111345]	National Research Foundation; Ministry of Education, Science and Technology (MEST), Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Healthcare Technology RD Project; Ministry of Health and Welfare, Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by National Research Foundation grant (2010-0008225 and 2010-0019393) funded by the Ministry of Education, Science and Technology (MEST), Korea; the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Korea (A100617 and A111345). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balhorn R, 2000, MOL REPROD DEV, V56, P230, DOI 10.1002/(SICI)1098-2795(200006)56:2+<230::AID-MRD3>3.3.CO;2-M; Bartz R, 2011, BIOCHEM J, V435, P475, DOI 10.1042/BJ20101021; Bouley R, 2006, BIOL CELL, V98, P215, DOI 10.1042/BC20040054; Bouley R, 2005, AM J PHYSIOL-CELL PH, V288, pC1390, DOI 10.1152/ajpcell.00353.2004; Bouley R, 2003, AM J PHYSIOL-CELL PH, V285, pC750, DOI 10.1152/ajpcell.00477.2002; Chen Jianmeizi, 2011, J RNAi Gene Silencing, V7, P449; Christensen BM, 2000, AM J PHYSIOL-RENAL, V278, pF29, DOI 10.1152/ajprenal.2000.278.1.F29; Deen PMT, 1997, J AM SOC NEPHROL, V8, P1493; DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; Dominska M, 2010, J CELL SCI, V123, P1183, DOI 10.1242/jcs.066399; Fisher O, 2009, PHARM RES-DORDR, V26, P51, DOI 10.1007/s11095-008-9704-2; Gao J, 2012, BIOMATERIALS, V33, P270, DOI 10.1016/j.biomaterials.2011.09.035; Gewirtz AM, 2007, J CLIN INVEST, V117, P3612, DOI 10.1172/JCI34274; He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065; Herce HD, 2009, BIOPHYS J, V97, P1917, DOI 10.1016/j.bpj.2009.05.066; Kaur H, 2007, PROTEIN PEPTIDE LETT, V14, P626; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Kwon TH, 2003, AM J PHYSIOL-RENAL, V285, pF152, DOI 10.1152/ajprenal.00307.2002; Laufer SD, 2008, CURR PHARM DESIGN, V14, P3637, DOI 10.2174/138161208786898806; Lee YJ, 2007, AM J PHYSIOL-RENAL, V292, pF340, DOI 10.1152/ajprenal.00090.2006; Maupetit J, 2007, PROTEINS, V69, P394, DOI 10.1002/prot.21505; Maupetit J, 2010, J COMPUT CHEM, V31, P726, DOI 10.1002/jcc.21365; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; Morris MC, 1997, NUCLEIC ACIDS RES, V25, P2730, DOI 10.1093/nar/25.14.2730; Nejsum LN, 2005, AM J PHYSIOL-RENAL, V288, pF930, DOI 10.1152/ajprenal.00291.2004; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Robben JH, 2004, MOL BIOL CELL, V15, P5693, DOI 10.1091/mbc.E04-04-0337; Rudolph C, 2003, J BIOL CHEM, V278, P11411, DOI 10.1074/jbc.M211891200; Seyhan AA, 2011, HUM GENET, V130, P583, DOI 10.1007/s00439-011-0995-8; SIMMONS NL, 1992, PFLUG ARCH EUR J PHY, V421, P503, DOI 10.1007/BF00370263; STOKES JB, 1987, AM J PHYSIOL, V253, pF251, DOI 10.1152/ajprenal.1987.253.2.F251; Subramanya S, 2010, J VIROL, V84, P2490, DOI 10.1128/JVI.02105-08; Tagalakis AD, 2011, BIOMATERIALS, V32, P6302, DOI 10.1016/j.biomaterials.2011.05.022; van Rossenberg SMW, 2004, GENE THER, V11, P457, DOI 10.1038/sj.gt.3302183; Zhang KX, 2008, RNA, V14, P577, DOI 10.1261/rna.739308	35	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e40010	10.1371/journal.pone.0040010	http://dx.doi.org/10.1371/journal.pone.0040010			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761946	Green Submitted, gold, Green Published			2022-12-27	WOS:000305826400053
J	Peng, QS; O'Loughlin, JL; Humphrey, MB				Peng, Qisheng; O'Loughlin, Jason L.; Humphrey, Mary Beth			DOK3 Negatively Regulates LPS Responses and Endotoxin Tolerance	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; CBL-B; TYROSINE KINASES; LIPOPOLYSACCHARIDE; INTERLEUKIN-1-BETA; DEGRADATION; ACTIVATION; PHOSPHORYLATION; PHOSPHATASE; CROSSTALK	Innate immune activation via Toll-like receptors (TLRs), although critical for host defense against infection, must be regulated to prevent sustained cell activation that can lead to cell death. Cells repeatedly stimulated with lipopolysaccharide (LPS) develop endotoxin tolerance making the cells hypo-responsive to additional TLR stimulation. We show here that DOK3 is a negative regulator of TLR signaling by limiting LPS-induced ERK activation and cytokine responses in macrophages. LPS induces ubiquitin-mediated degradation of DOK3 leading to SOS1 degradation and inhibition of ERK activation. DOK3 mice are hypersensitive to sublethal doses of LPS and have altered cytokine responses in vivo. During endotoxin tolerance, DOK3 expression remains stable, and it negatively regulates the expression of SHIP1, IRAK-M, SOCS1, and SOS1. As such, DOK3-deficient macrophages are more sensitive to LPS-induced tolerance becoming tolerant at lower levels of LPS than wild type cells. Taken together, the absence of DOK3 increases LPS signaling, contributing to LPS-induced tolerance. Thus, DOK3 plays a role in TLR signaling during both naive and endotoxin-induced tolerant conditions.	[Peng, Qisheng; O'Loughlin, Jason L.; Humphrey, Mary Beth] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73190 USA; [Peng, Qisheng] Jilin Univ, Key Lab Zoonosis Res, Minist Educ, Changchun 130023, Peoples R China; [Humphrey, Mary Beth] Dept Vet Affairs, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Jilin University	Peng, QS (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73190 USA.	marybeth-humphrey@ouhsc.edu			National Institutes of Health [RO1 DE019398]; Veteran's Affairs Career Development Award; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Affairs Career Development Award; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health (RO1 DE019398 to M. B. H.) and Veteran's Affairs Career Development Award (to M. B. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Alves-Rosa F, 2002, CLIN EXP IMMUNOL, V128, P221, DOI 10.1046/j.1365-2249.2002.01828.x; An HZ, 2005, BLOOD, V105, P4685, DOI 10.1182/blood-2005-01-0191; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Berger AH, 2010, NAT GENET, V42, P216, DOI 10.1038/ng.527; BURRELL R, 1994, CIRC SHOCK, V43, P137; Cong F, 1999, MOL CELL BIOL, V19, P8314; Davies GC, 2004, ONCOGENE, V23, P7104, DOI 10.1038/sj.onc.1207952; FRANKENBERGER M, 1995, J INFLAMM, V45, P56; Green NM, 2011, SEMIN IMMUNOL, V23, P106, DOI 10.1016/j.smim.2011.01.016; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Honma M, 2006, GENES CELLS, V11, P143, DOI 10.1111/j.1365-2443.2006.00926.x; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Janas JA, 2011, MOL CELL BIOL, V31, P2552, DOI 10.1128/MCB.05045-11; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Keck S, 2010, J IMMUNOL, V184, P5809, DOI 10.4049/jimmunol.0901423; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lemay S, 2000, MOL CELL BIOL, V20, P2743, DOI 10.1128/MCB.20.8.2743-2754.2000; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Mashima R, 2009, IMMUNOL REV, V232, P273, DOI 10.1111/j.1600-065X.2009.00844.x; MCCALL CE, 1993, J CLIN INVEST, V91, P853, DOI 10.1172/JCI116306; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Ng CH, 2007, BLOOD, V110, P259, DOI 10.1182/blood-2006-10-055194; Pan HJ, 2010, J IMMUNOL, V184, P5502, DOI 10.4049/jimmunol.0901601; Peng QS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000500; Pierre S, 2011, BIOCHEM PHARMACOL, V82, P1049, DOI 10.1016/j.bcp.2011.07.072; Pierre S, 2011, BIOCHEM PHARMACOL, V81, P304, DOI 10.1016/j.bcp.2010.10.003; Robson JD, 2004, MOL CELL BIOL, V24, P2332, DOI 10.1128/MCB.24.6.2332-2343.2004; Sahay B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000687; Senis YA, 2009, J THROMB HAEMOST, V7, P1718, DOI 10.1111/j.1538-7836.2009.03565.x; Shimauchi H, 1999, INFECT IMMUN, V67, P2153, DOI 10.1128/IAI.67.5.2153-2159.1999; Shinohara H, 2005, J EXP MED, V201, P333, DOI 10.1084/jem.20041817; Sly LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2836, DOI 10.2741/2276; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tanabe SI, 2008, J PERIODONTAL RES, V43, P372, DOI 10.1111/j.1600-0765.2007.01049.x	39	26	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39967	10.1371/journal.pone.0039967	http://dx.doi.org/10.1371/journal.pone.0039967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761938	Green Submitted, Green Published, gold			2022-12-27	WOS:000305825800083
J	Ben Mohamed, F; Garcia-Verdugo, I; Medina, M; Balloy, V; Chignard, M; Ramphal, R; Touqui, L				Ben Mohamed, Fatima; Garcia-Verdugo, Ignacio; Medina, Mathieu; Balloy, Viviane; Chignard, Michel; Ramphal, Reuben; Touqui, Lhousseine			A Crucial Role of Flagellin in the Induction of Airway Mucus Production by Pseudomonas aeruginosa	PLOS ONE			English	Article							MUCIN GENE-EXPRESSION; INTERLEUKIN-8 PRODUCTION; BACTERIAL FLAGELLIN; EPITHELIAL-CELLS; INNATE IMMUNITY; LUNG-DISEASE; RECOGNITION; RECEPTOR; MACROPHAGES; LIPOPOLYSACCHARIDE	Pseudomonas aeruginosa is an opportunistic pathogen involved in nosocomial infections. Flagellin is a P. aeruginosa virulence factor involved in host response to this pathogen. We examined the role of flagellin in P. aeruginosa-induced mucus secretion. Using a mouse model of pulmonary infection we showed that PAK, a wild type strain of P. aeruginosa, induced airway mucus secretion and mucin muc5ac expression at higher levels than its flagellin-deficient mutant (Delta FliC). PAK induced expression of MUC5AC and MUC2 in both human airway epithelial NCI-H292 cell line and in primary epithelial cells. In contrast, Delta FliC infection had lower to no effect on MUC5AC and MUC2 expressions. A purified P. aeruginosa flagellin induced MUC5AC expression in parallel to IL-8 secretion in NCI-H292 cells. Accordingly, Delta FliC mutant stimulated IL-8 secretion at significantly lower levels compared to PAK. Incubation of NCI-H292 cells with exogenous IL-8 induced MUC5AC expression and pre-incubation of these cells with an anti-IL-8 antibody abrogated flagellin-mediated MUC5AC expression. Silencing of TLR5 and Naip, siRNA inhibited both flagellin-induced MUC5AC expression and IL-8 secretion. Finally, inhibition of ERK abolished the expression of both PAK- and flagellin-induced MUC5AC. We conclude that: (i) flagellin is crucial in P. aeruginosa-induced mucus hyper-secretion through TLR5 and Naip pathways; (ii) this process is mediated by ERK and amplified by IL-8. Our findings help understand the mechanisms involved in mucus secretion during pulmonary infectious disease induced by P. aeruginosa, such as in cystic fibrosis.	[Ben Mohamed, Fatima; Garcia-Verdugo, Ignacio; Medina, Mathieu; Balloy, Viviane; Chignard, Michel; Touqui, Lhousseine] Inst Pasteur, Unite Def Innee & Inflammat, Paris, France; [Ben Mohamed, Fatima; Garcia-Verdugo, Ignacio; Medina, Mathieu; Balloy, Viviane; Chignard, Michel; Touqui, Lhousseine] INSERM, U874, Paris, France; [Ramphal, Reuben] Univ Florida, Dept Med, Gainesville, FL USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; State University System of Florida; University of Florida	Ben Mohamed, F (corresponding author), Inst Pasteur, Unite Def Innee & Inflammat, Paris, France.	fatima.ben-mohamed@pasteur.fr	Garcia-Verdugo, Ignacio/J-3584-2017; Balloy, Viviane/B-8551-2014; Chignard, Michel/B-4351-2008	Garcia-Verdugo, Ignacio/0000-0003-4535-8316; Balloy, Viviane/0000-0001-9093-9676; Chignard, Michel/0000-0003-3810-6575	Vaincre la Mucoviscidose; Foundation "Legs Poix"; Vaincre la ucoviscidose [RIF20110600609]	Vaincre la Mucoviscidose; Foundation "Legs Poix"; Vaincre la ucoviscidose	This work was supported by "Vaincre la Mucoviscidose", and the Foundation "Legs Poix". Vaincre la ucoviscidose (grant number RIF20110600609). Website:http://www.vaincrelamuco.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora SK, 2000, INFECT IMMUN, V68, P1474, DOI 10.1128/IAI.68.3.1474-1479.2000; Balloy V, 2007, J INFECT DIS, V196, P289, DOI 10.1086/518610; Basbaum C, 1999, AM J RESP CRIT CARE, V160, pS44, DOI 10.1164/ajrccm.160.supplement_1.12; Bautista MV, 2009, J IMMUNOL, V183, P2159, DOI 10.4049/jimmunol.0803022; Buchanan PJ, 2009, BIOCHEM SOC T, V37, P863, DOI 10.1042/BST0370863; Burgel PR, 2001, J IMMUNOL, V167, P5948, DOI 10.4049/jimmunol.167.10.5948; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Dif F, 2010, EUR RESPIR J, V36, P1120, DOI 10.1183/09031936.00183409; Dohrman A, 1998, BBA-MOL BASIS DIS, V1406, P251, DOI 10.1016/S0925-4439(98)00010-6; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Finzi L, 2006, AM J PATHOL, V169, P2031, DOI 10.2353/ajpath.2006.060146; Garcia-Verdugo I, 2012, EUR RESP J IN PRESS; Geddes K, 2009, NAT REV DRUG DISCOV, V8, P465, DOI 10.1038/nrd2783; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; Gomez MI, 2007, CURR OPIN PHARMACOL, V7, P244, DOI 10.1016/j.coph.2006.12.005; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; HO SB, 1993, CANCER RES, V53, P641; Kim S, 2011, EXP CELL RES, V317, P2650, DOI 10.1016/j.yexcr.2011.08.023; Kipnis E, 2006, MED MALADIES INFECT, V36, P78, DOI 10.1016/j.medmal.2005.10.007; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Lau GW, 2005, TRENDS MICROBIOL, V13, P389, DOI 10.1016/j.tim.2005.05.011; Li JD, 2003, J PHARMACOL SCI, V91, P1, DOI 10.1254/jphs.91.1; Li JD, 1998, P NATL ACAD SCI USA, V95, P5718, DOI 10.1073/pnas.95.10.5718; Li JD, 1997, P NATL ACAD SCI USA, V94, P967, DOI 10.1073/pnas.94.3.967; Mayer AK, 2007, J IMMUNOL, V178, P3134, DOI 10.4049/jimmunol.178.5.3134; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Ramphal R, 2008, J IMMUNOL, V181, P586, DOI 10.4049/jimmunol.181.1.586; Raoust E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007259; Rivas-Santiago B, 2007, REV INVEST CLIN, V59, P481; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Rose MC, 2001, AM J RESP CELL MOL, V25, P533, DOI 10.1165/ajrcmb.25.5.f218; Shanks KK, 2010, CLIN VACCINE IMMUNOL, V17, P1196, DOI 10.1128/CVI.00167-10; Song KS, 2009, AM J RESP CELL MOL, V41, P40, DOI 10.1165/rcmb.2008-0280OC; Sun Y, 2010, J IMMUNOL, V185, P4272, DOI 10.4049/jimmunol.1000874; Vargaftig BB, 2003, AM J PHYSIOL-LUNG C, V284, pL260, DOI 10.1152/ajplung.00226.2002; Verma A, 2005, INFECT IMMUN, V73, P8237, DOI 10.1128/IAI.73.12.8237-8246.2005; Vestbo Jorgen, 2002, Ugeskr Laeger, V164, P5510; Vinzing M, 2008, J IMMUNOL, V180, P6808, DOI 10.4049/jimmunol.180.10.6808; Wilmanski JM, 2008, J LEUKOCYTE BIOL, V83, P13, DOI 10.1189/jlb.0607402; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	41	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39888	10.1371/journal.pone.0039888	http://dx.doi.org/10.1371/journal.pone.0039888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768318	gold, Green Published, Green Submitted			2022-12-27	WOS:000305966500031
J	Li, C; Samaranayake, NR; Ong, KL; Wong, HK; Cheung, BMY				Li, Chao; Samaranayake, Nithushi R.; Ong, Kwok Leung; Wong, Hoi Kin; Cheung, Bernard M. Y.			Is Human Cytomegalovirus Infection Associated with Hypertension? The United States National Health and Nutrition Examination Survey 1999-2002	PLOS ONE			English	Article							BLOOD-PRESSURE; T-CELL; ACTIVATION; PREVENTION; ADULTS; COMMON; HEART; RISK	Purpose: Recent studies have implicated the human cytomegalovirus (HCMV) as a possible pathogen for causing hypertension. We aimed to study the association between HCMV infection and hypertension in the United States National Health and Nutrition Examination Survey (NHANES). Methods: We analyzed data on 2979 men and 3324 women in the NHANES 1999-2002. We included participants aged 16-49 years who had valid data on HCMV infection and hypertension. Results: Of the participants, 54.7% had serologic evidence of HCMV infection and 17.5% had hypertension. There were ethnic differences in the prevalence of HCMV infection (P<0.001) and hypertension (P<0.001). The prevalence of both increased with age (P<0.001). Before adjustment, HCMV seropositivity was significantly associated with hypertension in women (OR = 1.63, 95% CI = 1.25-2.13, P = 0.001) but not in men. After adjustment for race/ethnicity, the association between HCMV seropositivity and hypertension in women remained significant (OR = 1.55, 95% CI = 1.20-2.02, P = 0.002). Further adjustment for body mass index, diabetes status and hypercholesterolemia attenuated the association (OR = 1.44, 95% CI = 1.10-1.90, P = 0.010). However, after adjusting for age, the association was no longer significant (OR = 1.24, 95% CI = 0.91-1.67, P = 0.162). Conclusions: In this nationally representative population-based survey, HCMV seropositivity is associated with hypertension in women in the NHANES population. This association is largely explained by the association of hypertension with age and the increase in past exposure to HCMV with age.	[Li, Chao; Samaranayake, Nithushi R.; Wong, Hoi Kin; Cheung, Bernard M. Y.] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Ong, Kwok Leung] Heart Res Inst, Lipid Res Grp, Sydney, NSW, Australia	University of Hong Kong; University of Sydney; Heart Research Institute	Li, C (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China.	mycheung@hku.hk	Ong, Kwok Leung/B-9018-2009; /E-9829-2010	Ong, Kwok Leung/0000-0001-7229-7614; /0000-0001-9106-7363	Faculty Research Fund, Li Ka Shing Faculty of Medicine, University of Hong Kong	Faculty Research Fund, Li Ka Shing Faculty of Medicine, University of Hong Kong(University of Hong Kong)	BMYC received support from the Faculty Research Fund, Li Ka Shing Faculty of Medicine, University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438; Centers for Disease Control and Prevention National Health and Nutrition Examination Survey (NHANES), 1999, NAT HLTH NUTR EX SUR; Chaturvedi S, 2004, NATL MED J INDIA, V17, P227; Cheng JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000427; Cheung BM, 2011, PUBLIC HLTH 21 CENTU, V1, P117; Crough T, 2009, CLIN MICROBIOL REV, V22, P76, DOI 10.1128/CMR.00034-08; Cui JSS, 2003, HYPERTENSION, V41, P207, DOI 10.1161/01.HYP.0000044938.94050.E3; Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1; Fuhrmann S, 2008, J INFECT DIS, V197, P1455, DOI 10.1086/587692; Grahame-Clarke C, 2003, CIRCULATION, V108, P678, DOI 10.1161/01.CIR.0000084505.54603.C7; Grahame-Clarke Cairistine, 2005, Herpes, V12, P42; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Haarala A, 2012, CLIN EXP IMMUNOL, V167, P309, DOI 10.1111/j.1365-2249.2011.04513.x; Kyto V, 2005, CLIN INFECT DIS, V40, P683, DOI 10.1086/427804; Li SQ, 2011, CIRCULATION, V124, P175, DOI 10.1161/CIRCULATIONAHA.110.012237; Martin JM, 2011, PEDIATR TRANSPLANT, V15, P229, DOI 10.1111/j.1399-3046.2010.01454.x; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Petrakopoulou P, 2004, CIRCULATION, V110, pII207, DOI 10.1161/01.CIR.0000138393.99310.1c; Poole E, 2008, J VIROL, V82, P4250, DOI 10.1128/JVI.02156-07; Savoia C, 2007, CLIN SCI, V112, P375, DOI 10.1042/CS20060247; Schieffer B, 2000, CIRC RES, V87, P1195, DOI 10.1161/01.RES.87.12.1195; Shen YH, 2006, CARDIOVASC RES, V69, P502, DOI 10.1016/j.cardiores.2005.10.007; Simanek AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016103; Taal HR, 2012, HYPERTENSION, V59, P241, DOI 10.1161/HYPERTENSIONAHA.111.179481; Weis M, 2004, CIRCULATION, V109, P500, DOI 10.1161/01.CIR.0000109692.16004.AF; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996; Wong WT, 2010, J CARDIOVASC PHARM, V55, P300, DOI 10.1097/FJC.0b013e3181d7671c; Zampetaki A, 2011, CARDIOVASCULAR RES; Zhang MM, 2011, MED HYPOTHESES, V76, P682, DOI 10.1016/j.mehy.2011.01.032	29	16	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39760	10.1371/journal.pone.0039760	http://dx.doi.org/10.1371/journal.pone.0039760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768311	Green Published, gold, Green Submitted			2022-12-27	WOS:000305966500024
J	Malmhall, C; Bossios, A; Radinger, M; Sjostrand, M; Lu, Y; Lundback, B; Lotvall, J				Malmhall, Carina; Bossios, Apostolos; Radinger, Madeleine; Sjostrand, Margareta; Lu, You; Lundback, Bo; Lotvall, Jan			Immunophenotyping of Circulating T Helper Cells Argues for Multiple Functions and Plasticity of T Cells In Vivo in Humans - Possible Role in Asthma	PLOS ONE			English	Article							CLUSTER-ANALYSIS; IDENTIFICATION; TRANSCRIPTION; INFLAMMATION; PHENOTYPES; DIVERSITY; PRODUCE; MEMORY; GAMMA; LUNG	In Background: The immune process driving eosinophilic and non-eosinophilic asthma is likely driven by different subsets of T helper (Th) cells. Recently, in vitro studies and animal studies suggest that Th cell subsets displays plasticity by changing their transcription factor or by expressing multiple transcription factors. Our aim was to determine whether individuals with asthma and elevated circulating eosinophils express signs of different regulatory immune mechanisms compared with asthmatics with low blood eosinophils and non-asthmatic control subjects. In addition, determine the relationship between eosinophilia and circulating Th cell subsets. Methodology/Principal findings: Participants were selected from a random epidemiological cohort, the West Sweden Asthma Study. Immunophenotypes of fresh peripheral blood cells obtained from stable asthmatics, with and without elevated eosinophilic inflammation (EOS high and EOS low respectively) and control subjects, were determined by flow cytometry. No differences in the number of Th1 (T-bet), Th2 (GATA-3), Th17 (ROR gamma t) or Treg (FOXP3) cells were observed between the groups when analysing each subset separately. However, in all groups, each of the Th subsets showed expression of additional canonical transcription factors T-bet, GATA-3, ROR gamma t and FOXP3. Furthermore, by in vitro stimulation with anti-CD3/anti-CD28 there was a significant increase of single expressing GATA-3(+) and co-expressing T-bet(+)GATA-3(+) cells in the EOS high asthmatics in comparison with control subjects. In addition, T-bet(-)GATA-3(+)ROR gamma t(+)FOXP3(+) were decreased in comparison to the EOS low asthmatics. Finally, in a group of control subjects we found that the majority of proliferating Th cells (CD4(+)CD25(+)Ki67(+)) expressed three or four transcription factors. Conclusions: The ability of human Th cells to express several regulatory transcription factors suggests that these cells may display plasticity in vivo.	[Malmhall, Carina; Bossios, Apostolos; Radinger, Madeleine; Sjostrand, Margareta; Lu, You; Lundback, Bo; Lotvall, Jan] Univ Gothenburg, Krefting Res Ctr, Dept Internal Med & Clin Nutr, Inst Med,Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Malmhall, C (corresponding author), Univ Gothenburg, Krefting Res Ctr, Dept Internal Med & Clin Nutr, Inst Med,Sahlgrenska Acad, Gothenburg, Sweden.	jan.lotvall@gu.se	Bossios, Apostolos/ABH-8262-2020	Bossios, Apostolos/0000-0002-0494-2690; Radinger, Madeleine/0000-0002-0652-7378; Lotvall, Jan/0000-0001-9195-9249	VBG-GROUP Centre for Asthma and Allergy Research; Herman Krefting Foundation against Asthma and Allergy; Swedish Research Council [K2011-56X-20676-04-6]; Swedish Heart and Lung Foundation; Swedish Asthma- and Allergy Foundation; GlaxoSmithKline; University of Gothenburg	VBG-GROUP Centre for Asthma and Allergy Research; Herman Krefting Foundation against Asthma and Allergy; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Asthma- and Allergy Foundation; GlaxoSmithKline(GlaxoSmithKline); University of Gothenburg	This study was funded by VBG-GROUP Centre for Asthma and Allergy Research, Herman Krefting Foundation against Asthma and Allergy, the Swedish Research Council (K2011-56X-20676-04-6), the Swedish Heart and Lung Foundation, the Swedish Asthma- and Allergy Foundation and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have declared that no competing interests exist related to this paper. Krefting Research Centre has financial support from the University of Gothenburg structure called "VBG-GROUP Centre for Asthma and Allergy Research", through a long-term agreement between University of Gothenburg and the donors, Herman Krefting Foundation against Asthma/Allergy. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. No commercial entity is involved in the decision or analysis of this study.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Akdis M, 2010, CURR OPIN ALLERGY CL, V10, P443, DOI 10.1097/ACI.0b013e32833d7d48; Cosmi L, 2010, J ALLERGY CLIN IMMUN, V125, P222, DOI 10.1016/j.jaci.2009.10.012; Durrant DM, 2010, IMMUNOL INVEST, V39, P526, DOI 10.3109/08820131003615498; Finotto S, 2004, SPRINGER SEMIN IMMUN, V25, P281, DOI 10.1007/s00281-003-0143-1; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Locksley RM, 2009, J EXP MED, V206, P1643, DOI 10.1084/jem.20091442; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Lotvall J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-94; Matsumoto K, 2009, RESPIROLOGY, V14, P187, DOI 10.1111/j.1440-1843.2008.01472.x; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Mullen AC, 2001, CURR BIOL, V11, P1695, DOI 10.1016/S0960-9822(01)00533-4; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Provoost S, 2009, ALLERGY, V64, P1539, DOI 10.1111/j.1398-9995.2009.02056.x; Raymond M, 2011, J ALLERGY CLIN IMMUN, V128, P192, DOI 10.1016/j.jaci.2011.04.029; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Simon D, 2009, ALLERGY, V64, P1681, DOI 10.1111/j.1398-9995.2009.02097.x; Smyth LJC, 2010, CHEST, V138, P905, DOI 10.1378/chest.09-3079; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	29	19	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40012	10.1371/journal.pone.0040012	http://dx.doi.org/10.1371/journal.pone.0040012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768198	gold, Green Submitted, Green Published			2022-12-27	WOS:000305892100170
J	Nguyen, AD; Mitchell, NF; Lin, S; Macia, L; Yulyaningsih, E; Baldock, PA; Enriquez, RF; Zhang, L; Shi, YC; Zolotukhin, S; Herzog, H; Sainsbury, A				Nguyen, Amy D.; Mitchell, Natalie F.; Lin, Shu; Macia, Laurence; Yulyaningsih, Ernie; Baldock, Paul A.; Enriquez, Ronaldo F.; Zhang, Lei; Shi, Yan-Chuan; Zolotukhin, Serge; Herzog, Herbert; Sainsbury, Amanda			Y1 and Y5 Receptors Are Both Required for the Regulation of Food Intake and Energy Homeostasis in Mice	PLOS ONE			English	Article							NEUROPEPTIDE-Y; FEEDING-BEHAVIOR; TRANSGENIC MICE; WEIGHT-LOSS; RAT-BRAIN; OBESITY; EXPRESSION; HYPOTHALAMUS; NPY; APPETITE	Neuropeptide Y (NPY) acting in the hypothalamus is one of the most powerful orexigenic agents known. Of the five known Y receptors, hypothalamic Y1 and Y5 have been most strongly implicated in mediating hyperphagic effects. However, knockout of individual Y1 or Y5 receptors induces late-onset obesity - and Y5 receptor knockout also induces hyperphagia, possibly due to redundancy in functions of these genes. Here we show that food intake in mice requires the combined actions of both Y1 and Y5 receptors. Germline Y1Y5 ablation in Y1Y5(-/-) mice results in hypophagia, an effect that is at least partially mediated by the hypothalamus, since mice with adult-onset Y1Y5 receptor dual ablation targeted to the paraventricular nucleus (PVN) of the hypothalamus (Y1Y5(Hyp/Hyp)) also exhibit reduced spontaneous or fasting-induced food intake when fed a high fat diet. Interestingly, despite hypophagia, mice with germline or hypothalamus-specific Y1Y5 deficiency exhibited increased body weight and/or increased adiposity, possibly due to compensatory responses to gene deletion, such as the decreased energy expenditure observed in male Y1Y5(-/-) animals relative to wildtype values. While Y1 and Y5 receptors expressed in other hypothalamic areas besides the PVN - such as the dorsomedial nucleus and the ventromedial hypothalamus - cannot be excluded from having a role in the regulation of food intake, these studies demonstrate the pivotal, combined role of both Y1 and Y5 receptors in the mediation of food intake.	[Nguyen, Amy D.; Mitchell, Natalie F.; Lin, Shu; Macia, Laurence; Yulyaningsih, Ernie; Zhang, Lei; Shi, Yan-Chuan; Herzog, Herbert; Sainsbury, Amanda] Garvan Inst Med Res, Neurosci Res Program, Sydney, NSW, Australia; [Baldock, Paul A.; Enriquez, Ronaldo F.] Garvan Inst Med Res, Bone & Mineral Res Program, Sydney, NSW, Australia; [Zolotukhin, Serge] Univ Florida, Div Cell & Mol Therapy, Gainesville, FL USA; [Herzog, Herbert] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Sainsbury, Amanda] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Sainsbury, Amanda] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	Garvan Institute of Medical Research; Garvan Institute of Medical Research; State University System of Florida; University of Florida; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney	Nguyen, AD (corresponding author), Garvan Inst Med Res, Neurosci Res Program, Sydney, NSW, Australia.	amanda.sainsbury-salis@sydney.edu.au	/A-4361-2010; Baldock, Paul/B-3840-2012; Macia, laurence/D-5983-2016; Herzog, Herbert/B-8294-2008; Salis, Amanda/A-3187-2011; Shi, Yanchuan/H-5608-2012; Nguyen, Amy D/K-2588-2019; Yulyaningsih, Ernie/A-6021-2011	Macia, laurence/0000-0003-0835-851X; Salis, Amanda/0000-0001-9176-1574; Shi, Yanchuan/0000-0002-8368-6735; Nguyen, Amy D/0000-0003-4603-564X; lin, shu/0000-0002-4239-2028; , Herbert/0000-0002-1713-1029; Yulyaningsih, Ernie/0000-0003-2110-2017	National Health and Medical Research Council of Australia; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research is supported by the National Health and Medical Research Council of Australia with a research grant, a Postgraduate Scholarship (ADN and EY), Career Development Awards (PAB and AS) and a Research Fellowship (HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldock PA, 2007, J BIOL CHEM, V282, P19092, DOI 10.1074/jbc.M700644200; Batterham RL, 2003, NEW ENGL J MED, V349, P941, DOI 10.1056/NEJMoa030204; Beck B, 2006, PHILOS T R SOC B, V361, P1159, DOI 10.1098/rstb.2006.1855; BERNARDIS L L, 1970, Journal of Neuro-Visceral Relations, V31, P387, DOI 10.1007/BF02312740; Boey D, 2008, NEUROPEPTIDES, V42, P19, DOI 10.1016/j.npep.2007.11.003; Cahill F, 2011, AM J CLIN NUTR, V93, P741, DOI 10.3945/ajcn.110.003624; Chance WT, 2007, PEPTIDES, V28, P295, DOI 10.1016/j.peptides.2006.10.018; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Doucet E, 2000, INT J OBESITY, V24, P906, DOI 10.1038/sj.ijo.0801251; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; Franklin K., 2007, MOUSE BRAIN STEREOTA; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Herzog H, 1997, GENOMICS, V41, P315, DOI 10.1006/geno.1997.4684; Higuchi H, 2008, WORLD J GASTROENTERO, V14, P6312, DOI 10.3748/wjg.14.6312; Iyengar S, 1999, J PHARMACOL EXP THER, V289, P1031; Kalra SP, 2004, NEUROPEPTIDES, V38, P201, DOI 10.1016/j.npep.2004.06.003; Kask A, 2000, CAN J PHYSIOL PHARM, V78, P143, DOI 10.1139/cjpp-78-2-143; Kaspar BK, 2002, P NATL ACAD SCI USA, V99, P2320, DOI 10.1073/pnas.042678699; Kishi T, 2005, J COMP NEUROL, V482, P217, DOI 10.1002/cne.20432; Kushi A, 1998, P NATL ACAD SCI USA, V95, P15659, DOI 10.1073/pnas.95.26.15659; Lin S, 2005, NEUROPEPTIDES, V39, P21, DOI 10.1016/j.npep.2004.10.002; MacLean PS, 2004, AM J PHYSIOL-REG I, V287, pR1306, DOI 10.1152/ajpregu.00463.2004; Majdic G, 2009, ACTA CHIM SLOV, V56, P289; Marsh DJ, 1998, NAT MED, V4, P718, DOI 10.1038/nm0698-718; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Naveilhan P, 1998, NEUROSCIENCE, V87, P289, DOI 10.1016/S0306-4522(98)00141-9; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Oberto A, 2007, EUR J NEUROSCI, V26, P155, DOI 10.1111/j.1460-9568.2007.05631.x; Parker RMC, 1999, EUR J NEUROSCI, V11, P1431, DOI 10.1046/j.1460-9568.1999.00553.x; Pasman WJ, 1999, OBES RES, V7, P43, DOI 10.1002/j.1550-8528.1999.tb00389.x; Pedrazzini T, 1998, NAT MED, V4, P722, DOI 10.1038/nm0698-722; Pittner R, 2004, INT J OBESITY, P1; Raposinho PD, 2004, ENDOCRINOLOGY, V145, P304, DOI 10.1210/en.2003-0914; Rosenbaum M, 1997, J CLIN ENDOCR METAB, V82, P3647, DOI 10.1210/jc.82.11.3647; SAHU A, 1988, PEPTIDES, V9, P83, DOI 10.1016/0196-9781(88)90013-7; Sainsbury A, 2010, MOL CELL ENDOCRINOL, V316, P109, DOI 10.1016/j.mce.2009.09.025; Schwartz MW, 2003, DIABETES, V52, P232, DOI 10.2337/diabetes.52.2.232; STANLEY BG, 1986, PEPTIDES, V7, P1189; Weinberg DH, 1996, J BIOL CHEM, V271, P16435, DOI 10.1074/jbc.271.28.16435; Wisialowski T, 2000, J CLIN INVEST, V105, P1253, DOI 10.1172/JCI8695; Wittmann W, 2005, NEUROSCIENCE, V136, P241, DOI 10.1016/j.neuroscience.2005.07.047; Wolak ML, 2003, J COMP NEUROL, V464, P285, DOI 10.1002/cne.10823; Zhang L, 2010, INT J OBESITY, V34, P357, DOI 10.1038/ijo.2009.232	44	67	69	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40191	10.1371/journal.pone.0040191	http://dx.doi.org/10.1371/journal.pone.0040191			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768253	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100226
J	Stegger, JG; Schmidt, EB; Tjonneland, A; Kopp, TI; Sorensen, TIA; Vogel, U; Overvad, K				Stegger, Jakob Gerhard; Schmidt, Erik Berg; Tjonneland, Anne; Kopp, Tine Iskov; Sorensen, Thorkild I. A.; Vogel, Ulla; Overvad, Kim			Single Nucleotide Polymorphisms in IL1B and the Risk of Acute Coronary Syndrome: A Danish Case-Cohort Study	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; MYOCARDIAL-INFARCTION; MULTIPLE-MYELOMA; GENE AFFECT; YOUNG AGE; NSAID USE; ATHEROSCLEROSIS; DISEASE; MECHANISMS; IL-1-BETA	Background: Interleukin-1B (IL-1B) is a key pro-inflammatory cytokine that has been associated with the development of atherosclerosis and myocardial infarction. However, the prospective associations between functional single nucleotide polymorphisms (SNPs) in IL1B and incident acute coronary syndrome (ACS) have not been thoroughly investigated. The aims of this study were to examine the associations between individual SNPs in and SNP haplotypes of the promoter region of IL1B and incident ACS in a prospective study. Furthermore, we wanted to explore potential interactions with other risk factors for ACS on an additive scale. Methodology/Principal Findings: The present study was based on the Danish prospective study Diet, Cancer and Health comprising more than 57 000 participants aged 50-64 at baseline. During a median follow-up of 7.2 years we identified 989 cases of incident ACS (755 men and 234 women). All cases were validated by review of medical records, and information on covariates was collected by study technicians. The study was conducted according to a case-cohort study design including ACS cases and a sex-stratified sub cohort of 1663 participants drawn randomly from the entire cohort. Weighted Cox proportional hazard models with age as time axis were used in the statistical analyses. Individual IL1B SNPs, SNP haplotypes, or haplotype combinations were not significantly associated with incident ACS, and, likewise, we found no evidence of interaction on an additive scale between IL1B haplotypes and risk factors, respectively. Conclusions/Significance: Genetic variation in the promoter region of IL1B may not be associated with incident ACS in men or women above the age of 50 years.	[Stegger, Jakob Gerhard; Schmidt, Erik Berg; Overvad, Kim] Aarhus Univ Hosp, Aalborg Hosp, Dept Cardiol, Cardiovasc Res Ctr, Aalborg, Denmark; [Tjonneland, Anne] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Kopp, Tine Iskov] Tech Univ Denmark, Natl Food Inst, Soborg, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Inst Prevent Med, Copenhagen, Denmark; [Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Overvad, Kim] Aarhus Univ, Sch Publ Hlth, Dept Epidemiol, Aarhus, Denmark	Aalborg University; Aalborg University Hospital; Aarhus University; Danish Cancer Society; Technical University of Denmark; University of Copenhagen; National Research Centre for the Working Environment; Aarhus University	Stegger, JG (corresponding author), Aarhus Univ Hosp, Aalborg Hosp, Dept Cardiol, Cardiovasc Res Ctr, Aalborg, Denmark.	Jakob.Stegger@rn.dk	Vogel, Ulla/ABC-2212-2020; Vogel, Ulla B/I-5048-2012	Vogel, Ulla/0000-0001-6807-1524; Vogel, Ulla B/0000-0001-6807-1524; Overvad, Kim/0000-0001-6429-7921; Kopp, Tine/0000-0003-3729-4420; Tjonneland, Anne/0000-0003-4385-2097	Danish Cancer Society; Danish Heart Foundation [08-10-R68-A2176-B994-22514, 09-4-R72-A2346-22544]; Danish Obesity Research Centre; Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome	Danish Cancer Society(Danish Cancer Society); Danish Heart Foundation; Danish Obesity Research Centre; Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome	The authors would like to thank the Danish Cancer Society (www.cancer.dk) for the funding of the Diet, Cancer and Health study. The present study was funded by the Danish Heart Foundation (www.hjerteforeningen.dk) (08-10-R68-A2176-B994-22514 and 09-4-R72-A2346-22544) as well as the Danish Obesity Research Centre (www.DanORC.dk) and the Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome (www.HEPADIP.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; Bhaskar V, 2011, ATHEROSCLEROSIS, V216, P313, DOI 10.1016/j.atherosclerosis.2011.02.026; Chamberlain J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005073; Chen HM, 2006, HUM MOL GENET, V15, P519, DOI 10.1093/hmg/ddi469; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harrel F.E., 2001, REGRESSION MODELING; Iacoviello L, 2005, ARTERIOSCL THROM VAS, V25, P222, DOI 10.1161/01.ATV.0000150039.60906.02; Joensen AM, 2009, J CLIN EPIDEMIOL, V62, P188, DOI 10.1016/j.jclinepi.2008.03.005; KALBFLEISCH JD, 1988, STAT MED, V7, P149, DOI 10.1002/sim.4780070116; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Knight JC, 2005, J MOL MED, V83, P97, DOI 10.1007/s00109-004-0603-7; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Latella MC, 2009, IMMUNOL INVEST, V38, P203, DOI 10.1080/08820130902766142; Olofsson PS, 2009, CIRC J, V73, P1531, DOI 10.1253/circj.CJ-08-1150; Ridker PM, 2003, CLIN CARDIOL, V26, P39, DOI 10.1002/clc.4960261508; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rothman K., 1998, MODERN EPIDEMIOLOGY; Stegger JG, 2011, INT J OBES LOND; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Vangsted AJ, 2009, BONE MARROW TRANSPL, V43, P539, DOI 10.1038/bmt.2008.351; Vangsted AJ, 2011, ANN HEMATOL; Vangsted AJ, 2009, HAEMATOL-HEMATOL J, V94, P1274, DOI 10.3324/haematol.2008.004572; Vogel U, 2011, ATHEROSCLEROSIS; Vogel U, 2008, MUTAT RES-FUND MOL M, V639, P89, DOI 10.1016/j.mrfmmm.2007.11.004; Vogel U, 2007, MUTAT RES-FUND MOL M, V624, P88, DOI 10.1016/j.mrfmmm.2007.04.006	28	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e36829	10.1371/journal.pone.0036829	http://dx.doi.org/10.1371/journal.pone.0036829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768033	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100004
J	Wang, XD; Zhang, N; Glorieux, S; Holtappels, G; Vaneechoutte, M; Krysko, O; Zhang, L; Han, DM; Nauwynck, HJ; Bachert, C				Wang, XiangDong; Zhang, Nan; Glorieux, Sarah; Holtappels, Gabriele; Vaneechoutte, Mario; Krysko, Olga; Zhang, Luo; Han, Demin; Nauwynck, Hans J.; Bachert, Claus			Herpes Simplex Virus Type 1 Infection Facilitates Invasion of Staphylococcus aureus into the Nasal Mucosa and Nasal Polyp Tissue	PLOS ONE			English	Article							EPITHELIAL-CELLS; ORGAN-CULTURE; ENTEROTOXIN-B; PROTEIN-A; RHINOVIRUS; SEROPREVALENCE; ASTHMA; MODEL; REPLICATION; ASSOCIATION	Background: Staphylococcus aureus (S. aureus) plays an important role in the pathogenesis of severe chronic airway disease, such as nasal polyps. However the mechanisms underlying the initiation of damage and/or invasion of the nasal mucosa by S. aureus are not clearly understood. The aim of this study was to investigate the interaction between S. aureus and herpes simplex virus type 1 (HSV1) in the invasion of the nasal mucosa and nasal polyp tissue. Methodology/Principal Findings: Inferior turbinate and nasal polyp samples were cultured and infected with either HSV1 alone, S. aureus alone or a combination of both. Both in turbinate mucosa and nasal polyp tissue, HSV1, with or without S. aureus incubation, led to focal infection of outer epithelial cells within 48 h, and loss or damage of the epithelium and invasion of HSV1 into the lamina propria within 72 h. After pre-infection with HSV1 for 24 h or 48 h, S. aureus was able to pass the basement membrane and invade the mucosa. Epithelial damage scores were significantly higher for HSV1 and S. aureus co-infected explants compared with control explants or S. aureus only-infected explants, and significantly correlated with HSV1-invasion scores. The epithelial damage scores of nasal polyp tissues were significantly higher than those of inferior turbinate tissues upon HSV1 infection. Consequently, invasion scores of HSV1 of nasal polyp tissues were significantly higher than those of inferior turbinate mucosa in the HSV1 and co-infection groups, and invasion scores of S. aureus of nasal polyp tissues were significantly higher than those of inferior turbinate tissues in the co-infection group. Conclusions/Significance: HSV1 may lead to a significant damage of the nasal epithelium and consequently may facilitate invasion of S. aureus into the nasal mucosa. Nasal polyp tissue is more susceptible to the invasion of HSV1 and epithelial damage by HSV1 compared with inferior turbinate mucosa.	[Wang, XiangDong; Zhang, Nan; Holtappels, Gabriele; Krysko, Olga; Bachert, Claus] Ghent Univ Hosp, Dept Otorhinolaryngol, Upper Airways Res Lab, Ghent, Belgium; [Wang, XiangDong; Zhang, Luo; Han, Demin] Capital Med Univ, Beijing TongRen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Glorieux, Sarah; Nauwynck, Hans J.] Univ Ghent, Fac Vet Med, Virol Lab, B-9000 Ghent, Belgium; [Vaneechoutte, Mario] Univ Ghent, Dept Clin Chem Microbiol & Immunol, Lab Bacteriol Res, B-9000 Ghent, Belgium; [Zhang, Luo; Han, Demin] Capital Med Univ, Beijing Inst Otolaryngol, Minist Educ, Key Lab Otolaryngol Head & Neck Surg, Beijing, Peoples R China	Ghent University; Ghent University Hospital; Capital Medical University; Ghent University; Ghent University; Capital Medical University	Wang, XD (corresponding author), Ghent Univ Hosp, Dept Otorhinolaryngol, Upper Airways Res Lab, Ghent, Belgium.	Luozhang@trhos.com; handm@trhos.com	Krysko, Olga/C-2481-2009; Zhang, Nan/AAQ-3944-2020; Vaneechoutte, Mario/A-6189-2009; Bachert, Claus/J-8825-2012	Krysko, Olga/0000-0001-5019-0752; Vaneechoutte, Mario/0000-0002-4586-203X; Nauwynck, Hans/0000-0001-5470-0713; Zhang, Luo/0000-0002-0910-9884	European Commission [260895]; Flemish Scientific Research Board, FWO [A12/5-HB-KH3, G.0436.04, 3G.0489, G.0642.10N]; National Science Fund for Distinguished Young Scholars; National Natural Science Foundation of China [30872846, 30973282]; Beijing Natural Science Foundation [7072017]; Beijing Ke-Ji-Xin-Xing Project [2006A67]; Project of Beijing Senior Scholar of Health; Project of Liu-Xue-Gui-Guo Scholar; Global Allergy and Asthma European Network (GA2LEN); Interuniversity Attraction Poles Program - Belgian State Belgian Science Policy [IAP P6/35]	European Commission(European CommissionEuropean Commission Joint Research Centre); Flemish Scientific Research Board, FWO(FWO); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Ke-Ji-Xin-Xing Project; Project of Beijing Senior Scholar of Health; Project of Liu-Xue-Gui-Guo Scholar; Global Allergy and Asthma European Network (GA2LEN); Interuniversity Attraction Poles Program - Belgian State Belgian Science Policy(Belgian Federal Science Policy Office)	This work was supported by grants to Claus Bachert from the European Commission's Seventh Framework programme under grant agreement No 260895 (PREDICTA); by the Flemish Scientific Research Board, FWO, Nr. A12/5-HB-KH3, project G.0436.04, 3G.0489, G.0642.10N; by National Science Fund for Distinguished Young Scholars, National Natural Science Foundation of China (30872846 and 30973282) and Beijing Natural Science Foundation (7072017) to Luo Zhang; Beijing Ke-Ji-Xin-Xing Project grant (2006A67), Project of Beijing Senior Scholar of Health and Project of Liu-Xue-Gui-Guo Scholar to XiangDong Wang; and to Claus Bachert by the Global Allergy and Asthma European Network (GA2LEN), and the Interuniversity Attraction Poles Program - Belgian State Belgian Science Policy, Nr. IAP P6/35. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachert C, 2008, CURR OPIN ALLERGY CL, V8, P34, DOI 10.1097/ACI.0b013e3282f4178f; Becker S, 1997, AM J PHYSIOL-LUNG C, V272, pL512, DOI 10.1152/ajplung.1997.272.3.L512; Bober M, 2010, J INNATE IMMUN, V2, P160, DOI 10.1159/000232587; Bokarewa MI, 2006, INT J BIOCHEM CELL B, V38, P504, DOI 10.1016/j.biocel.2005.07.005; Bunzli D, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-10; Chacko J, 2009, INDIAN J MED MICROBI, V27, P146, DOI 10.4103/0255-0857.49429; Chen TS, 2006, MODERN PATHOL, V19, P726, DOI 10.1038/modpathol.3800584; CHEUNG AL, 1994, J CLIN INVEST, V94, P1815, DOI 10.1172/JCI117530; Cheung AL, 1998, INFECT IMMUN, V66, P5988, DOI 10.1128/IAI.66.12.5988-5993.1998; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Corriveau MN, 2009, AM J RHINOL ALLERGY, V23, P461, DOI 10.2500/ajra.2009.23.3367; de Bentzmann S, 2004, J INFECT DIS, V190, P1506, DOI 10.1086/424521; Dinkla K, 2003, J CLIN INVEST, V111, P1905, DOI 10.1172/JCI200317247; Doi Y, 2009, J EPIDEMIOL, V19, P56, DOI 10.2188/jea.JE20080061; DUPUIT F, 1995, HUM GENE THER, V6, P1185, DOI 10.1089/hum.1995.6.9-1185; EDWARDS KM, 1986, J INFECT DIS, V153, P41, DOI 10.1093/infdis/153.1.41; Engelbert M, 2005, INVEST OPHTH VIS SCI, V46, P2479, DOI 10.1167/iovs.04-1139; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Glorieux S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022160; Glorieux S, 2009, VET MICROBIOL, V136, P341, DOI 10.1016/j.vetmic.2008.11.005; Hollams EM, 2010, EUR RESPIR J, V36, P509, DOI 10.1183/09031936.00184109; Jang YJ, 2005, J VIROL METHODS, V125, P41, DOI 10.1016/j.jviromet.2004.12.004; Kowalski ML, 2011, ALLERGY, V66, P32, DOI 10.1111/j.1398-9995.2010.02379.x; Larkin EA, 2009, CURR MED CHEM, V16, P4003, DOI 10.2174/092986709789352321; Mongodin E, 2000, J HISTOCHEM CYTOCHEM, V48, P523, DOI 10.1177/002215540004800410; Moreilhon C, 2005, PHYSIOL GENOMICS, V20, P244, DOI 10.1152/physiolgenomics.00135.2004; Novo CAP, 2010, CLIN EXP ALLERGY, V40, P1323, DOI 10.1111/j.1365-2222.2010.03577.x; Patou J, 2008, J ALLERGY CLIN IMMUN, V121, P110, DOI 10.1016/j.jaci.2007.08.059; Pitkaranta A, 1997, J CLIN MICROBIOL, V35, P1791; Rabenau HF, 2002, MED MICROBIOL IMMUN, V190, P153, DOI 10.1007/s00430-001-0102-1; Read RC, 1999, INFECT IMMUN, V67, P3082, DOI 10.1128/IAI.67.6.3082-3086.1999; ROLLINS BS, 1993, ANTIVIR RES, V21, P357, DOI 10.1016/0166-3542(93)90013-9; Sajjan U, 2008, AM J RESP CRIT CARE, V178, P1271, DOI 10.1164/rccm.200801-136OC; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Spear PG, 2002, DEV CELL, V3, P462, DOI 10.1016/S1534-5807(02)00298-8; Steukers L, 2011, KINETICS BO IN PRESS; Suptawiwat O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012973; THOMAS, 2007, CHEM IMMUNOL ALLERGY, V93, P24; Van Zele T, 2007, CLIN EXP ALLERGY, V37, P1840, DOI 10.1111/j.1365-2222.2007.02838.x; Van Zele T, 2004, J ALLERGY CLIN IMMUN, V114, P981, DOI 10.1016/j.jaci.2004.07.013; Vandekerckhove AP, 2010, J GEN VIROL, V91, P2019, DOI 10.1099/vir.0.019257-0; Vermeer PD, 2009, AM J PHYSIOL-LUNG C, V296, pL751, DOI 10.1152/ajplung.90578.2008; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wang JH, 2007, AM J RHINOL, V21, P670, DOI 10.2500/ajr.2007.21.3101; Wang JH, 2009, LARYNGOSCOPE, V119, P1406, DOI 10.1002/lary.20498; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964; Yeo NK, 2010, LARYNGOSCOPE, V120, P346, DOI 10.1002/lary.20764; Zaravinos A, 2009, J MED VIROL, V81, P1613, DOI 10.1002/jmv.21534; Zhang N, 2006, AM J RHINOL, V20, P445, DOI 10.2500/ajr.2006.20.2887	51	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39875	10.1371/journal.pone.0039875	http://dx.doi.org/10.1371/journal.pone.0039875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768151	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100120
J	Chu, YH; Tzeng, SL; Lin, CW; Chien, MH; Chen, MK; Yang, SF				Chu, Yin-Hung; Tzeng, Shu-Ling; Lin, Chiao-Wen; Chien, Ming-Hsien; Chen, Mu-Kuan; Yang, Shun-Fa			Impacts of MicroRNA Gene Polymorphisms on the Susceptibility of Environmental Factors Leading to Carcinogenesis in Oral Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PRE-MICRORNAS; RISK; INVASION; DIFFERENTIATION; MIR-146A; CONTRIBUTES; POPULATION; METASTASIS; VARIANTS	Background: MicroRNAs (miRNAs) have been regarded as a critical factor in targeting oncogenes or tumor suppressor genes in tumorigenesis. The genetic predisposition of miRNAs-signaling pathways related to the development of oral squamous cell carcinoma (OSCC) remains unresolved. This study examined the associations of polymorphisms with four miRNAs with the susceptibility and clinicopathological characteristics of OSCC. Methodology/Principal Findings: A total of 895 male subjects, including 425 controls and 470 male oral cancer patients, were selected. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and real-time PCR were used to analyze miRNA146a, miRNA196, miRNA499 and miRNA149 genetic polymorphisms between the control group and the case group. This study determined that a significant association of miRNA499 with CC genotype, as compared to the subjects with TT genotype, had a higher risk (AOR = 4.52, 95% CI = 1.24-16.48) of OSCC. Moreover, an impact of those four miRNAs gene polymorphism on the susceptibility of betel nut and tobacco consumption leading to oral cancer was also revealed. We found a protective effect between clinical stage development (AOR = 0.58, 95% CI = 0.36-0.94) and the tumor size growth (AOR = 0.47, 95% CI = 0.28-0.79) in younger patients (age, 60). Conclusions: Our results suggest that genetic polymorphism of miRNA499 is associated with oral carcinogenesis, and the interaction of the miRNAs genetic polymorphism and environmental carcinogens is also related to an increased risk of oral cancer in Taiwanese.	[Chu, Yin-Hung; Tzeng, Shu-Ling; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Lin, Chiao-Wen; Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Wan Fang Hosp, Taipei, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Chen, Mu-Kuan] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Changhua Christian Hospital	Chu, YH (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	53780@cch.org.tw; ysf@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Biolchini F, 2005, Minerva Stomatol, V54, P405; Catucci I, 2010, HUM MUTAT, V31, pE1052, DOI 10.1002/humu.21141; Chen CY, 2011, J CELL MOL MED, V15, P14, DOI 10.1111/j.1582-4934.2010.01219.x; Christensen BC, 2010, CLIN CANCER RES, V16, P3713, DOI 10.1158/1078-0432.CCR-10-0657; Chung TT, 2011, CARCINOGENESIS, V32, P1063, DOI 10.1093/carcin/bgr083; Clague J, 2010, MOL CARCINOGEN, V49, P183, DOI 10.1002/mc.20588; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Li Y, 2010, CANCER RES, V70, P7894, DOI 10.1158/0008-5472.CAN-10-1675; Liu XQ, 2011, CARCINOGENESIS, V32, P1798, DOI 10.1093/carcin/bgr213; Liu XQ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/837514; Liu Xiqiang, 2009, Cancer Genomics & Proteomics, V6, P131; Liu ZS, 2010, CANCER-AM CANCER SOC, V116, P4753, DOI 10.1002/cncr.25323; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu SY, 2006, CARCINOGENESIS, V27, P1273, DOI 10.1093/carcin/bgi357; Mittal RD, 2011, DNA CELL BIOL, V30, P401, DOI 10.1089/dna.2010.1159; Okubo M, 2010, HELICOBACTER, V15, P524, DOI 10.1111/j.1523-5378.2010.00806.x; Pacifico F, 2010, J CLIN ENDOCR METAB, V95, P1421, DOI 10.1210/jc.2009-1128; Popovic R, 2009, BLOOD, V113, P3314, DOI 10.1182/blood-2008-04-154310; Reis PP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-238; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Scapoli L, 2010, INT J IMMUNOPATH PH, V23, P1229, DOI 10.1177/039463201002300427; Schetter AJ, 2009, CLIN CANCER RES, V15, P5878, DOI 10.1158/1078-0432.CCR-09-0627; Shieh JTC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019481; Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434; Starczynowski DT, 2011, EXP HEMATOL, V39, P167, DOI 10.1016/j.exphem.2010.09.011; Wang JX, 2011, NAT MED, V17, P71, DOI 10.1038/nm.2282; Weng CJ, 2012, J DENT RES, V91, P358, DOI 10.1177/0022034512438402; Wilson KD, 2010, CIRC-CARDIOVASC GENE, V3, P426, DOI 10.1161/CIRCGENETICS.109.934281; Xu B, 2010, PROSTATE, V70, P467, DOI 10.1002/pros.21080; Yu T, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-64; Zavras AI, 2011, ANN SURG ONCOL, V18, P1478, DOI 10.1245/s10434-010-1431-3; Zeng Y, 2010, WORLD J GASTROENTERO, V16, P3578, DOI 10.3748/wjg.v16.i28.3578; Zhou B, 2011, MOL CARCINOGEN, V50, P499, DOI 10.1002/mc.20740; Zhou B, 2010, CLIN CHIM ACTA, V411, P1287, DOI 10.1016/j.cca.2010.05.010	40	57	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39777	10.1371/journal.pone.0039777	http://dx.doi.org/10.1371/journal.pone.0039777			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761899	Green Submitted, Green Published, gold			2022-12-27	WOS:000305826400038
J	Perot, P; Mugnier, N; Montgiraud, C; Gimenez, J; Jaillard, M; Bonnaud, B; Mallet, F				Perot, Philippe; Mugnier, Nathalie; Montgiraud, Cecile; Gimenez, Juliette; Jaillard, Magali; Bonnaud, Bertrand; Mallet, Francois			Microarray-Based Sketches of the HERV Transcriptome Landscape	PLOS ONE			English	Article							HUMAN ENDOGENOUS RETROVIRUS; ZINC-FINGER PROTEIN; MULTIPLEX DEGENERATE PCR; LONG TERMINAL REPEATS; REAL-TIME PCRS; HUMAN GENOME; HUMAN TISSUES; HUMAN GENES; CELL-LINES; TRANSPOSABLE ELEMENTS	Human endogenous retroviruses (HERVs) are spread throughout the genome and their long terminal repeats (LTRs) constitute a wide collection of putative regulatory sequences. Phylogenetic similarities and the profusion of integration sites, two inherent characteristics of transposable elements, make it difficult to study individual locus expression in a large-scale approach, and historically apart from some placental and testis-regulated elements, it was generally accepted that HERVs are silent due to epigenetic control. Herein, we have introduced a generic method aiming to optimally characterize individual loci associated with 25-mer probes by minimizing cross-hybridization risks. We therefore set up a microarray dedicated to a collection of 5,573 HERVs that can reasonably be assigned to a unique genomic position. We obtained a first view of the HERV transcriptome by using a composite panel of 40 normal and 39 tumor samples. The experiment showed that almost one third of the HERV repertoire is indeed transcribed. The HERV transcriptome follows tropism rules, is sensitive to the state of differentiation and, unexpectedly, seems not to correlate with the age of the HERV families. The probeset definition within the U3 and U5 regions was used to assign a function to some LTRs (i.e. promoter or polyA) and revealed that (i) autonomous active LTRs are broadly subjected to operational determinism (ii) the cellular gene density is substantially higher in the surrounding environment of active LTRs compared to silent LTRs and (iii) the configuration of neighboring cellular genes differs between active and silent LTRs, showing an approximately 8 kb zone upstream of promoter LTRs characterized by a drastic reduction in sense cellular genes. These gathered observations are discussed in terms of virus/host adaptive strategies, and together with the methods and tools developed for this purpose, this work paves the way for further HERV transcriptome projects.	[Perot, Philippe; Montgiraud, Cecile; Gimenez, Juliette; Mallet, Francois] Ctr Hosp Lyon Sud, Canc Biomarkers Res Grp, Joint Unit Hosp Civils Lyon, BioMerieux, Lyon, France; [Mugnier, Nathalie; Jaillard, Magali; Bonnaud, Bertrand] BioMerieux, Data & Knowledge Lab, Marcy Letoile, France	bioMerieux; CHU Lyon; bioMerieux	Perot, P (corresponding author), Ctr Hosp Lyon Sud, Canc Biomarkers Res Grp, Joint Unit Hosp Civils Lyon, BioMerieux, Lyon, France.	francois.mallet@biomerieux.com	Pérot, Philippe/ABD-2025-2021; Mallet, Francois/G-4812-2014	Pérot, Philippe/0000-0002-5194-8200; MALLET, Francois/0000-0002-1331-096X; Gimenez, Juliette/0000-0001-7682-7088	bioMerieux SA; French public agency OSEO; French government; Association Nationale de la Recherche et de la Technologie (ANRT); bioMerieux	bioMerieux SA; French public agency OSEO; French government; Association Nationale de la Recherche et de la Technologie (ANRT)(French National Research Agency (ANR)); bioMerieux	This work was supported by bioMerieux SA and the French public agency OSEO (Advanced Diagnostics for New Therapeutic Approaches, a French government-funded program dedicated to personalized medicine). PP was supported by doctoral grants from bioMerieux and the Association Nationale de la Recherche et de la Technologie (ANRT); JG and CM were supported by a doctoral fellowship from bioMerieux; Funding for open access charge: bioMerieux SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruester V, 2004, J VIROL, V78, P10310, DOI 10.1128/JVI.78.19.10310-10319.2004; Armbruester V, 2002, CLIN CANCER RES, V8, P1800; Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Bannert N, 2006, ANNU REV GENOM HUM G, V7, P149, DOI 10.1146/annurev.genom.7.080505.115700; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Belshaw R, 2007, J VIROL, V81, P9437, DOI 10.1128/JVI.02216-06; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bjerregaard B, 2006, CELL MOL LIFE SCI, V63, P1906, DOI 10.1007/s00018-006-6201-9; Blaise S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-19; Blaise S, 2003, P NATL ACAD SCI USA, V100, P13013, DOI 10.1073/pnas.2132646100; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; Boese A, 2000, ONCOGENE, V19, P4328, DOI 10.1038/sj.onc.1203794; Boller K, 1997, J VIROL, V71, P4581, DOI 10.1128/JVI.71.6.4581-4588.1997; BOLLER K, 1983, J GEN VIROL, V64, P2549, DOI 10.1099/0022-1317-64-12-2549; BOLLER K, 1993, VIROLOGY, V196, P349, DOI 10.1006/viro.1993.1487; Brosius J, 1999, GENETICA, V107, P209, DOI 10.1023/A:1004018519722; Buscher K, 2005, CANCER RES, V65, P4172, DOI 10.1158/0008-5472.CAN-04-2983; Buzdin A, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl335; Buzdin A, 2006, J VIROL, V80, P10752, DOI 10.1128/JVI.00871-06; Cheng YH, 2004, BIOL REPROD, V70, P694, DOI 10.1095/biolreprod.103.023473; Cohen CJ, 2009, GENE, V448, P105, DOI 10.1016/j.gene.2009.06.020; Conley AB, 2008, BIOINFORMATICS, V24, P1563, DOI 10.1093/bioinformatics/btn243; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Costas J, 2002, MOL BIOL EVOL, V19, P526, DOI 10.1093/oxfordjournals.molbev.a004108; CULLEN BR, 1984, NATURE, V307, P241, DOI 10.1038/307241a0; de Parseval N, 2003, J VIROL, V77, P10414, DOI 10.1128/JVI.77.19.10414-10422.2003; Denne M, 2007, J VIROL, V81, P5607, DOI 10.1128/JVI.02771-06; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; Dunn CA, 2006, GENE, V366, P335, DOI 10.1016/j.gene.2005.09.003; Dunn CA, 2003, P NATL ACAD SCI USA, V100, P12841, DOI 10.1073/pnas.2134464100; Ehlhardt S, 2006, J RHEUMATOL, V33, P16; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Flockerzi A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-354; Flockerzi A, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-39; Forsman A, 2005, J VIROL METHODS, V129, P16, DOI 10.1016/j.jviromet.2005.04.016; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gimenez J, 2010, NUCLEIC ACIDS RES, V38, P2229, DOI 10.1093/nar/gkp1214; Gimenez J, 2009, DNA RES, V16, P195, DOI 10.1093/dnares/dsp011; Goedert JJ, 1999, CANCER EPIDEM BIOMAR, V8, P293; Gogvadze E, 2009, J VIROL, V83, P6098, DOI 10.1128/JVI.00123-09; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; Hu CL, 2010, J VIROL, V84, P11981, DOI 10.1128/JVI.00723-10; Hughes JF, 2001, NAT GENET, V29, P487, DOI 10.1038/ng775; Hughes JR, 2005, GENETICS, V171, P1183, DOI 10.1534/genetics.105.043976; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; Jjingo D, 2011, GENOME BIOL EVOL, V3, P259, DOI 10.1093/gbe/evr015; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Johnson WE, 1999, P NATL ACAD SCI USA, V96, P10254, DOI 10.1073/pnas.96.18.10254; Katzourakis A, 2004, RETROVIRUSES PRIMATE, P1; Kaufmann S, 2010, J GEN VIROL, V91, P1494, DOI 10.1099/vir.0.014241-0; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee B, 2009, NUCLEIC ACIDS RES, V37, pD686, DOI 10.1093/nar/gkn648; Li F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-22; Liang QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029950; Liang QY, 2009, BIOCHEM BIOPH RES CO, V382, P468, DOI 10.1016/j.bbrc.2009.03.058; Long M, 2001, CURR OPIN GENET DEV, V11, P673, DOI 10.1016/S0959-437X(00)00252-5; LOWER R, 1995, J VIROL, V69, P141; LOWER R, 1993, VIROLOGY, V192, P501, DOI 10.1006/viro.1993.1066; LYDEN TW, 1994, BIOL REPROD, V51, P152, DOI 10.1095/biolreprod51.1.152; Mager DL, 1999, GENOMICS, V59, P255, DOI 10.1006/geno.1999.5877; Mallet F, 2004, P NATL ACAD SCI USA, V101, P1731, DOI 10.1073/pnas.0305763101; Martin U, 1999, TRANSPLANT P, V31, P913, DOI 10.1016/S0041-1345(98)01832-6; Matouskova M, 2006, EXP CELL RES, V312, P1011, DOI 10.1016/j.yexcr.2005.12.010; Medstrand P, 2001, J BIOL CHEM, V276, P1896, DOI 10.1074/jbc.M006557200; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Muradrasoli S, 2006, J VIROL METHODS, V136, P83, DOI 10.1016/j.jviromet.2006.04.005; Navarro G., 2002, FLEXIBLE PATTERN MAT; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Oja M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S2-S11; Okahara G, 2004, GENOMICS, V84, P982, DOI 10.1016/j.ygeno.2004.09.004; Paces J, 2002, NUCLEIC ACIDS RES, V30, P205, DOI 10.1093/nar/30.1.205; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Perot P, 2011, CELL FUSIONS: REGULATION AND CONTROL, P63, DOI 10.1007/978-90-481-9772-9_4; Pichon JP, 2006, NAT PROTOC, V1, P2831, DOI 10.1038/nprot.2006.475; Pichon JP, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl086; Prudhomme S, 2004, J VIROL, V78, P12157, DOI 10.1128/JVI.78.22.12157-12168.2004; Ptolemy AS, 2010, SCAND J CLIN LAB INV, V70, P6, DOI 10.3109/00365513.2010.493354; Rabson A. B., 1997, P205; REARDEN A, 1993, J BIOL CHEM, V268, P2260; Reiss D, 2007, NUCLEIC ACIDS RES, V35, P4743, DOI 10.1093/nar/gkm455; Romanish MT, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030010; Ruda VM, 2004, VIRUS RES, V104, P11, DOI 10.1016/j.virusres.2004.02.036; SAMUELSON LC, 1988, NUCLEIC ACIDS RES, V16, P8261, DOI 10.1093/nar/16.17.8261; SAUTER M, 1995, J VIROL, V69, P414, DOI 10.1128/JVI.69.1.414-421.1995; Schwartz A, 1998, HUM MOL GENET, V7, P1, DOI 10.1093/hmg/7.1.1; Seifarth W, 2005, J VIROL, V79, P341, DOI 10.1128/JVI.79.1.341-352.2005; Smallwood A, 2003, BIOL REPROD, V69, P286, DOI 10.1095/biolreprod.102.013078; Smit A, 1996, REPEATMASKER OPEN 30; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Stauffer Yves, 2004, Cancer Immun, V4, P2; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Strick R, 2007, J MOL MED, V85, P23, DOI 10.1007/s00109-006-0104-y; Sun Y, 2010, LEUKEMIA RES, V34, P1195, DOI 10.1016/j.leukres.2010.03.016; Team RDC, 2019, R LANG ENV STAT COMP; Trejbalova K, 2011, NUCLEIC ACIDS RES, V39, P8728, DOI 10.1093/nar/gkr562; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Lagemaat LN, 2003, TRENDS GENET, V19, P530, DOI 10.1016/j.tig.2003.08.004; van de Lagemaat LN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r86; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang-Johanning F, 2003, CANCER-AM CANCER SOC, V98, P187, DOI 10.1002/cncr.11451; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Webber MM, 2001, PROSTATE, V47, P1; Wentzensen N, 2007, INT J CANCER, V121, P1417, DOI 10.1002/ijc.22826	105	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e40194	10.1371/journal.pone.0040194	http://dx.doi.org/10.1371/journal.pone.0040194			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761958	Green Published, Green Submitted, gold			2022-12-27	WOS:000305826400059
J	Dvorak, P; Hasler, P; Poulickova, A				Dvorak, Petr; Hasler, Petr; Poulickova, Aloisie			Phylogeography of the Microcoleus vaginatus (Cyanobacteria) from Three Continents - A Spatial and Temporal Characterization	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; PHYLOGENETIC ANALYSES; DIVERSITY; RECOMBINATION; BIOGEOGRAPHY; PHORMIDIUM; DISPERSAL; REVISION; BACTERIA; ORIGINS	It has long been assumed that cyanobacteria have, as with other free-living microorganisms, a ubiquitous occurrence. Neither the geographical dispersal barriers nor allopatric speciation has been taken into account. We endeavoured to examine the spatial and temporal patterns of global distribution within populations of the cyanobacterium Microcoleus vaginatus, originated from three continents, and to evaluate the role of dispersal barriers in the evolution of free-living cyanobacteria. Complex phylogeographical approach was applied to assess the dispersal and evolutionary patterns in the cyanobacterium Microcoleus vaginatus (Oscillatoriales). We compared the 16S rRNA and 16S-23S ITS sequences of strains which had originated from three continents (North America, Europe, and Asia). The spatial distribution was investigated using a phylogenetic tree, network, as well as principal coordinate analysis (PCoA). A temporal characterization was inferred using molecular clocks, calibrated from fossil DNA. Data analysis revealed broad genetic diversity within M. vaginatus. Based on the phylogenetic tree, network, and PCoA analysis, the strains isolated in Europe were spatially separated from those which originated from Asia and North America. A chronogram showed a temporal limitation of dispersal barriers on the continental scale. Dispersal barriers and allopatric speciation had an important role in the evolution of M. vaginatus. However, these dispersal barriers did not have a permanent character; therefore, the genetic flow among populations on a continental scale was only temporarily present. Furthermore, M. vaginatus is a recently evolved species, which has been going through substantial evolutionary changes.	[Dvorak, Petr; Hasler, Petr; Poulickova, Aloisie] Palacky Univ Olomouc, Dept Bot, Olomouc, Czech Republic	Palacky University Olomouc	Dvorak, P (corresponding author), Palacky Univ Olomouc, Dept Bot, Olomouc, Czech Republic.	p.dvorak@upol.cz	Hasler, Petr/ABD-9747-2020; Dvorak, Petr/AAC-7610-2020	Hasler, Petr/0000-0003-4658-1114; Dvorak, Petr/0000-0003-0101-9566	Czech Science Foundation [206/07/0115, 206/08/0389]; Internal Grant Agency of Palacky University, Olomouc [PrF_2012_001]; T. Bata Foundation	Czech Science Foundation(Grant Agency of the Czech Republic); Internal Grant Agency of Palacky University, Olomouc; T. Bata Foundation	This study was supported by Czech Science Foundation grants 206/07/0115 and 206/08/0389; and grant PrF_2012_001 from the Internal Grant Agency of Palacky University, Olomouc; as well as the T. Bata Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Andersen R. A., 2005, ALGAL CULTURING TECH; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Baas-Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN, P263; Behnke A, 2004, J PHYCOL, V40, P193, DOI 10.1046/j.1529-8817.2004.03037.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bock C, 2011, FOTTEA, V11, P293, DOI 10.5507/fot.2011.028; Boyer SL, 2002, J PHYCOL, V38, P1222, DOI 10.1046/j.1529-8817.2002.01168.x; Boyer SL, 2001, MOL BIOL EVOL, V18, P1057, DOI 10.1093/oxfordjournals.molbev.a003877; Coesel PFM, 2008, BIODIVERS CONSERV, V17, P381, DOI 10.1007/s10531-007-9256-5; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Cohan FM, 2001, SYST BIOL, V50, P513, DOI 10.1080/106351501750435077; Cohan FM, 2008, CURR BIOL, V18, pR1024, DOI 10.1016/j.cub.2008.09.014; Doroghazi JR, 2010, ISME J, V4, P1136, DOI 10.1038/ismej.2010.45; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Evans KM, 2007, PROTIST, V158, P349, DOI 10.1016/j.protis.2007.04.001; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Garcia-Pichel F, 2001, APPL ENVIRON MICROB, V67, P1902, DOI 10.1128/AEM.67.4.1902-1910.2001; GarciaPichel F, 1996, APPL ENVIRON MICROB, V62, P3284, DOI 10.1128/AEM.62.9.3284-3291.1996; Hajek M, 2011, J BIOGEOGR, V38, P1683, DOI 10.1111/j.1365-2699.2011.02503.x; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hasler P, 2012, FOTTEA, V12, P341, DOI 10.5507/fot.2012.024; Hay WW, 1999, GEOL S AM S, P1; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Iteman I, 2000, MICROBIOL-SGM, V146, P1275, DOI 10.1099/00221287-146-6-1275; Johansen J. R., 2005, ALGOLOGICAL STUDIES, V116, P71, DOI [DOI 10.1127/1864-1318/2005/0117-0071, 10.1127/1864-1318/2005/0117-0071]; Jungblut AD, 2010, ISME J, V4, P191, DOI 10.1038/ismej.2009.113; Kellogg CA, 2006, TRENDS ECOL EVOL, V21, P638, DOI 10.1016/j.tree.2006.07.004; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Komarek J, 2005, SUSSWASSERFLORA MITT, V1; Komarek J, 2010, HYDROBIOLOGIA, V639, P245, DOI 10.1007/s10750-009-0031-3; Kooistra WHCF, 2008, PROTIST, V159, P177, DOI 10.1016/j.protis.2007.09.004; Kuo CH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-35; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lodders N, 2005, ENVIRON MICROBIOL, V7, P434, DOI 10.1111/j.1462-2920.2005.00730.x; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Miehe G., 2001, ERDKUNDE, V55, P94, DOI [10.3112/erdkunde.2001.01.06, DOI 10.3112/ERDKUNDE.2001.01.06]; Miller M.A., 2010, P GAT COMP ENV WORKS; Miller SR, 2007, APPL ENVIRON MICROB, V73, P4751, DOI 10.1128/AEM.02945-06; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Neustupa J, 2011, HYDROBIOLOGIA, V667, P223, DOI 10.1007/s10750-011-0650-3; Norton TA, 1996, PHYCOLOGIA, V35, P308, DOI 10.2216/i0031-8884-35-4-308.1; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; Panieri G, 2010, GEOBIOLOGY, V8, P101, DOI 10.1111/j.1472-4669.2009.00230.x; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Poulickova A, 2010, PROTIST, V161, P353, DOI 10.1016/j.protis.2009.12.003; Rambaut A, 2004, TRACER V1 5; Ramette A, 2007, MICROB ECOL, V53, P197, DOI 10.1007/s00248-005-5010-2; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Siegesmund MA, 2008, J PHYCOL, V44, P1572, DOI 10.1111/j.1529-8817.2008.00604.x; STAUB R., 1961, SCHWEIZ Z HYDROL, V23, P83; Strunecky O, 2011, FOTTEA, V11, P57, DOI 10.5507/fot.2011.007; Strunecky O, 2010, POLAR BIOL, V33, P1419, DOI 10.1007/s00300-010-0834-8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taton A, 2006, J PHYCOL, V42, P1257, DOI 10.1111/j.1529-8817.2006.00278.x; Telford RJ, 2007, SCIENCE, V316, DOI 10.1126/science.1137697; Telford RJ, 2006, SCIENCE, V312, P1015, DOI 10.1126/science.1125669; van Gremberghe I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019561; Vanormelingen P, 2008, PROTIST, V159, P73, DOI 10.1016/j.protis.2007.08.004; Vyverman W, 2007, ECOLOGY, V88, P1924, DOI 10.1890/06-1564.1; Whitaker RJ, 2006, PHILOS T R SOC B, V361, P1975, DOI 10.1098/rstb.2006.1927; Whitton B.A., 2000, ECOLOGY CYANOBACTERI, P669, DOI DOI 10.1007/0-306-4685507; Wiedenbeck J, 2011, FEMS MICROBIOL REV, V35, P957, DOI 10.1111/j.1574-6976.2011.00292.x; Wiley EO, 2000, SPECIES CONCEPTS AND PHYLOGENETIC THEORY: A DEBATE, P70	68	34	34	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e40153	10.1371/journal.pone.0040153	http://dx.doi.org/10.1371/journal.pone.0040153			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761955	Green Submitted, Green Published, gold			2022-12-27	WOS:000305825800091
J	Francis, RW; Thompson-Wicking, K; Carter, KW; Anderson, D; Kees, UR; Beesley, AH				Francis, Richard W.; Thompson-Wicking, Katherine; Carter, Kim W.; Anderson, Denise; Kees, Ursula R.; Beesley, Alex H.			FusionFinder: A Software Tool to Identify Expressed Gene Fusion Candidates from RNA-Seq Data	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; BREAST-CANCER; TRANSCRIPT; IDENTIFICATION; TRANSLOCATION; DISCOVERY; PATIENT; ABL	The hallmarks of many haematological malignancies and solid tumours are chromosomal translocations, which may lead to gene fusions. Recently, next-generation sequencing techniques at the transcriptome level (RNA-Seq) have been used to verify known and discover novel transcribed gene fusions. We present FusionFinder, a Perl-based software designed to automate the discovery of candidate gene fusion partners from single-end (SE) or paired-end (PE) RNA-Seq read data. FusionFinder was applied to data from a previously published analysis of the K562 chronic myeloid leukaemia (CML) cell line. Using FusionFinder we successfully replicated the findings of this study and detected additional previously unreported fusion genes in their dataset, which were confirmed experimentally. These included two isoforms of a fusion involving the genes BRK1 and VHL, whose co-deletion has previously been associated with the prevalence and severity of renal-cell carcinoma. FusionFinder is made freely available for non-commercial use and can be downloaded from the project website (http://bioinformatics.childhealthresearch.org.au/software/fusionfinder/).	[Francis, Richard W.; Carter, Kim W.; Anderson, Denise] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Div Bioinformat & Biostat, Perth, WA 6009, Australia; [Thompson-Wicking, Katherine; Kees, Ursula R.; Beesley, Alex H.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Div Childrens Leukaemia & Canc Res, Perth, WA 6009, Australia	Telethon Kids Institute; University of Western Australia; Telethon Kids Institute; University of Western Australia	Francis, RW (corresponding author), Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Div Bioinformat & Biostat, Perth, WA 6009, Australia.	rfrancis@ichr.uwa.edu.au	Francis, Richard/K-2812-2019; Beesley, Alex H/K-5805-2013	Francis, Richard/0000-0003-1580-7934; Beesley, Alex H/0000-0002-5742-7270; Anderson, Denise/0000-0003-0643-4136	WA State Government Centres of Excellence Program; Children's Leukaemia and Cancer Research Foundation, Perth; Mike Schon-Hegrad Memorial Fund	WA State Government Centres of Excellence Program; Children's Leukaemia and Cancer Research Foundation, Perth; Mike Schon-Hegrad Memorial Fund	The study was funded by the WA State Government Centres of Excellence Program, the Children's Leukaemia and Cancer Research Foundation, Perth and the Mike Schon-Hegrad Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byrne JL, 1998, BRIT J HAEMATOL, V103, P791, DOI 10.1046/j.1365-2141.1998.01043.x; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; Escobar B, 2010, CANCER RES, V70, P9349, DOI 10.1158/0008-5472.CAN-09-4491; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Ge H, 2011, BIOINFORMATICS; Inaki K, 2011, GENOME RES, V21, P676, DOI 10.1101/gr.113225.110; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Levin JZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r115; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2011, BIOINFORMATICS, V27, P1708, DOI 10.1093/bioinformatics/btr265; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Maranchie JK, 2004, HUM MUTAT, V23, P40, DOI 10.1002/humu.10302; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Nacu S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-11; Novo FJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-33; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROWLEY JD, 1973, ANN GENET-PARIS, V16, P109; Sboner A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r104; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Smit A, 1996, REPEATMASKER OPEN 30; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Takahashi T, 2001, GENE CHROMOSOME CANC, V30, P196, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1078>3.0.CO;2-8; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wuyts W, 2000, HUM MUTAT, V15, P220, DOI 10.1002/(SICI)1098-1004(200003)15:3<220::AID-HUMU2>3.0.CO;2-K; Zhao Q, 2009, P NATL ACAD SCI USA, V106, P1886, DOI 10.1073/pnas.0812945106	34	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39987	10.1371/journal.pone.0039987	http://dx.doi.org/10.1371/journal.pone.0039987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761941	Green Published, gold, Green Submitted			2022-12-27	WOS:000305825800085
J	Li, R; Ackerman, WE; Mihai, C; Volakis, LI; Ghadiali, S; Kniss, DA				Li, Ruth; Ackerman, William E.; Mihai, Cosmin; Volakis, Leonithas I.; Ghadiali, Samir; Kniss, Douglas A.			Myoferlin Depletion in Breast Cancer Cells Promotes Mesenchymal to Epithelial Shape Change and Stalls Invasion	PLOS ONE			English	Article							DYSFERLIN; GROWTH; REPAIR; TUMOR; GENE; METALLOPROTEINASES; IDENTIFICATION; TRANSITIONS; ENDOCYTOSIS; EXPRESSION	Myoferlin (MYOF) is a mammalian ferlin protein with homology to ancestral Fer-1, a nematode protein that regulates spermatic membrane fusion, which underlies the amoeboid-like movements of its sperm. Studies in muscle and endothelial cells have reported on the role of myoferlin in membrane repair, endocytosis, myoblast fusion, and the proper expression of various plasma membrane receptors. In this study, using an in vitro human breast cancer cell model, we demonstrate that myoferlin is abundantly expressed in invasive breast tumor cells. Depletion of MYOF using lentiviral-driven shRNA expression revealed that MDA-MB-231 cells reverted to an epithelial morphology, suggesting at least some features of mesenchymal to epithelial transition (MET). These observations were confirmed by the down-regulation of some mesenchymal cell markers (e.g., fibronectin and vimentin) and coordinate up-regulation of the E-cadherin epithelial marker. Cell invasion assays using Boyden chambers showed that loss of MYOF led to a significant diminution in invasion through Matrigel or type I collagen, while cell migration was unaffected. PCR array and screening of serum-free culture supernatants from shRNA(MYOF) transduced MDA-MB-231 cells indicated a significant reduction in the steady-state levels of several matrix metalloproteinases. These data when considered in toto suggest a novel role of MYOF in breast tumor cell invasion and a potential reversion to an epithelial phenotype upon loss of MYOF.	[Li, Ruth; Ackerman, William E.; Kniss, Douglas A.] Ohio State Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Lab Perinatal Res, Columbus, OH 43210 USA; [Volakis, Leonithas I.; Ghadiali, Samir; Kniss, Douglas A.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Ghadiali, Samir] Ohio State Univ, Dept Internal Med, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Mihai, Cosmin] Pacific NW Natl Lab, Richland, WA 99352 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Li, R (corresponding author), Ohio State Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Lab Perinatal Res, Columbus, OH 43210 USA.	kniss.1@osu.edu	Ackerman, William/E-2612-2011; Ghadiali, Samir N./C-5463-2012; Ghadiali, Samir/AAN-7772-2020	Ghadiali, Samir N./0000-0002-6845-774X; Ghadiali, Samir/0000-0002-6845-774X; Ackerman, William/0000-0001-7366-3903	Ohio State University; NIH [K08 HD49628]; National Science Foundation Nanoscience Science and Engineering Center [EEC-0425626]; Chemical, Bioengineering, Environmental, and Transport Systems (CBET) [1134201]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD049628] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; Directorate For Engineering [1134201] Funding Source: National Science Foundation	Ohio State University(Ohio State University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Nanoscience Science and Engineering Center; Chemical, Bioengineering, Environmental, and Transport Systems (CBET); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the Ohio State University Perinatal Research and Development Fund (DAK), NIH K08 HD49628 (WEA), and the National Science Foundation Nanoscience Science and Engineering Center grant #EEC-0425626 (RL) and Chemical, Bioengineering, Environmental, and Transport Systems (CBET) #1134201 (LV, DAK, SG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanzar WE, 1997, J CELL SCI, V110, P1073; Adam PJ, 2003, J BIOL CHEM, V278, P6482, DOI 10.1074/jbc.M210184200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amatschek S, 2004, CANCER RES, V64, P844, DOI 10.1158/0008-5472.CAN-03-2361; American Cancer Society, 2009, BREAST CANC SOURCEBO; ARGON Y, 1980, GENETICS, V96, P413; Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Bernatchez PN, 2007, J BIOL CHEM, V282, P30745, DOI 10.1074/jbc.M704798200; Bernatchez PN, 2009, AM J PHYSIOL-CELL PH, V297, pC484, DOI 10.1152/ajpcell.00498.2008; Caldieri G, 2010, TRENDS CELL BIOL, V20, P64, DOI 10.1016/j.tcb.2009.10.006; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Cheng ASL, 2008, CANCER RES, V68, P1786, DOI 10.1158/0008-5472.CAN-07-5547; Cipta S, 2009, AM J PHYSIOL-CELL PH, V297, pC481, DOI 10.1152/ajpcell.00288.2009; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Demonbreun AR, 2011, HUM MOL GENET, V20, P779, DOI 10.1093/hmg/ddq522; Demonbreun AR, 2010, FASEB J, V24, P1284, DOI 10.1096/fj.09-136309; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Duffy MJ, 2000, BREAST CANCER RES, V2, P252, DOI 10.1186/bcr65; Eisenberg MC, 2011, P NATL ACAD SCI USA, V108, P20078, DOI 10.1073/pnas.1116327108; Fletcher SJ, 2009, BIOCHEM SOC T, V37, P1072, DOI 10.1042/BST0371072; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Frittoli E, 2011, EUR J CELL BIOL, V90, P108, DOI 10.1016/j.ejcb.2010.04.007; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Han R, 2007, CURR OPIN CELL BIOL, V19, P409, DOI 10.1016/j.ceb.2007.07.001; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Horner MJ, 2009, SEER CANC STAT REV 1; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lek A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-231; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Lynch CC, 2002, DIFFERENTIATION, V70, P561, DOI 10.1046/j.1432-0436.2002.700909.x; Mills GB, 2009, J CLIN INVEST, V119, P2123, DOI 10.1172/JCI40256; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pardo A, 2005, INT J BIOCHEM CELL B, V37, P283, DOI 10.1016/j.biocel.2004.06.017; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Sharma A, 2010, ARTERIOSCL THROM VAS, V30, P2196, DOI 10.1161/ATVBAHA.110.208108; SOULE HD, 1990, CANCER RES, V50, P6075; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; THOMPSON EW, 1992, J CELL PHYSIOL, V150, P534, DOI 10.1002/jcp.1041500314; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VUKICEVIC S, 1992, EXP CELL RES, V202, P1, DOI 10.1016/0014-4827(92)90397-Q; Washington NL, 2006, J CELL SCI, V119, P2552, DOI 10.1242/jcs.02980; Yasunaga S, 2000, AM J HUM GENET, V67, P591, DOI 10.1086/303049; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139; Yu C, 2011, VASCUL PHARM	54	33	33	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39766	10.1371/journal.pone.0039766	http://dx.doi.org/10.1371/journal.pone.0039766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761893	gold, Green Submitted, Green Published			2022-12-27	WOS:000305825800067
J	Martos, A; Monterroso, B; Zorrilla, S; Reija, B; Alfonso, C; Mingorance, J; Rivas, G; Jimenez, M				Martos, Ariadna; Monterroso, Begona; Zorrilla, Silvia; Reija, Belen; Alfonso, Carlos; Mingorance, Jesus; Rivas, German; Jimenez, Mercedes			Isolation, Characterization and Lipid-Binding Properties of the Recalcitrant FtsA Division Protein from Escherichia coli	PLOS ONE			English	Article							MEMBRANE TARGETING SEQUENCE; ACTIN-LIKE FTSA; CELL-DIVISION; INORGANIC-PHOSPHATE; Z-RING; VESICLES; ASSAY; ZIPA; PHOSPHOLIPIDS; DOMAIN	We have obtained milligram amounts of highly pure Escherichia coli division protein FtsA from inclusion bodies with an optimized purification method that, by overcoming the reluctance of FtsA to be purified, surmounts a bottleneck for the analysis of the molecular basis of FtsA function. Purified FtsA is folded, mostly monomeric and interacts with lipids. The apparent affinity of FtsA binding to the inner membrane is ten-fold higher than to phospholipids, suggesting that inner membrane proteins could modulate FtsA-membrane interactions. Binding of FtsA to lipids and membranes is insensitive to ionic strength, indicating that a net contribution of hydrophobic interactions is involved in the association of FtsA to lipid/membrane structures.	[Martos, Ariadna; Monterroso, Begona; Alfonso, Carlos; Rivas, German; Jimenez, Mercedes] CSIC, Ctr Invest Biol, Madrid, Spain; [Zorrilla, Silvia; Reija, Belen] CSIC, Inst Quim Fis Rocasolano, Madrid, Spain; [Mingorance, Jesus] IdiPAZ, Hosp Univ La Paz, Microbiol Serv, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Hospital Universitario La Paz	Martos, A (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	grivas@cib.csic.es; enoe@cib.csic.es	Monterroso, Begoña/J-9748-2014; Rivas, German/AAG-7458-2022; Alfonso, Carlos/K-1316-2014; Rivas, German/AFL-7528-2022; Mingorance, Jesus/B-7562-2009; Jimenez Sarmiento, Mercedes/K-2691-2014; Zorrilla, Silvia/J-9771-2014	Monterroso, Begoña/0000-0003-2538-084X; Rivas, German/0000-0003-3450-7478; Alfonso, Carlos/0000-0001-7165-4800; Rivas, German/0000-0003-3450-7478; Mingorance, Jesus/0000-0001-6173-5711; Jimenez Sarmiento, Mercedes/0000-0003-2006-1903; Zorrilla, Silvia/0000-0002-6309-9058	Spanish Government [BIO2008-04478-C03, BIO2011-28941-C03-03, BFU2010-14910, CSIC PIE-201020I001]; European Commission [HEALTH-F3-2009-223431]; Human Frontier Science Program [RGP0050/2010-C102]	Spanish Government(Spanish GovernmentEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Human Frontier Science Program(Human Frontier Science Program)	This work was supported by the Spanish Government through Grants BIO2008-04478-C03 and BIO2011-28941-C03-03 (to G.R.), BFU2010-14910 (to S.Z.), CSIC PIE-201020I001 (to C.A.), by the European Commission through Contract HEALTH-F3-2009-223431, and by the Human Frontier Science Program through Grant RGP0050/2010-C102 (both to G.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard CS, 2007, MOL MICROBIOL, V64, P1289, DOI 10.1111/j.1365-2958.2007.05738.x; Beuria TK, 2009, J BIOL CHEM, V284, P14079, DOI 10.1074/jbc.M808872200; Blin G, 2008, BIOPHYS J, V94, P1021, DOI 10.1529/biophysj.107.110213; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Carettoni D, 2003, PROTEINS, V50, P192, DOI 10.1002/prot.10244; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; de Leeuw E, 2000, EMBO J, V19, P531, DOI 10.1093/emboj/19.4.531; DEVAUX PF, 1985, BIOCHIM BIOPHYS ACTA, V822, P63, DOI 10.1016/0304-4157(85)90004-8; DEVRIJE T, 1987, BIOCHIM BIOPHYS ACTA, V900, P63, DOI 10.1016/0005-2736(87)90278-1; Di Lallo G, 2003, MICROBIOL-SGM, V149, P3353, DOI 10.1099/mic.0.26580-0; Feucht A, 2001, MOL MICROBIOL, V40, P115, DOI 10.1046/j.1365-2958.2001.02356.x; Haney SA, 2001, J BIOL CHEM, V276, P11980, DOI 10.1074/jbc.M009810200; HOENIG M, 1989, J BIOCHEM BIOPH METH, V19, P249, DOI 10.1016/0165-022X(89)90031-6; Jameson DM, 1997, METHOD ENZYMOL, V278, P363; Jimenez M, 2011, J BIOL CHEM, V286, P11236, DOI 10.1074/jbc.M110.194365; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lara B, 2005, MOL MICROBIOL, V55, P699, DOI 10.1111/j.1365-2958.2004.04432.x; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Paradis-Bleau C, 2005, PROTEIN ENG DES SEL, V18, P85, DOI 10.1093/protein/gzi008; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; PLA J, 1990, J BACTERIOL, V172, P5097, DOI 10.1128/jb.172.9.5097-5102.1990; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; SANCHEZ M, 1994, EMBO J, V13, P4919, DOI 10.1002/j.1460-2075.1994.tb06819.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shiomi D, 2008, MOL MICROBIOL, V67, P558, DOI 10.1111/j.1365-2958.2007.06085.x; Shiomi D, 2007, MOL MICROBIOL, V66, P1396, DOI 10.1111/j.1365-2958.2007.05998.x; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; van den Ent F, 2000, EMBO J, V19, P5300, DOI 10.1093/emboj/19.20.5300; van Holde KE, 1985, SEDIMENTATION PHYS B; Vicente M, 2006, J BACTERIOL, V188, P19, DOI 10.1128/JB.188.1.19-27.2006; Yim L, 2000, J BACTERIOL, V182, P6366, DOI 10.1128/JB.182.22.6366-6373.2000	36	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39829	10.1371/journal.pone.0039829	http://dx.doi.org/10.1371/journal.pone.0039829			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761913	Green Published, gold, Green Submitted			2022-12-27	WOS:000305825800075
J	Jiang, J; Lu, CM; Peng, DL; Zhu, CZ; Howell, P				Jiang, Jing; Lu, Chunming; Peng, Danling; Zhu, Chaozhe; Howell, Peter			Classification of Types of Stuttering Symptoms Based on Brain Activity	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; RESONANCE-IMAGING FMRI; FUNCTIONAL SEGREGATION; ACTIVATION PATTERNS; SPEECH PRODUCTION; NEURAL SYSTEMS; INITIAL STATUS; BASAL GANGLIA; LANGUAGE; FLUENT	Among the non-fluencies seen in speech, some are more typical (MT) of stuttering speakers, whereas others are less typical (LT) and are common to both stuttering and fluent speakers. No neuroimaging work has evaluated the neural basis for grouping these symptom types. Another long-debated issue is which type (LT, MT) whole-word repetitions (WWR) should be placed in. In this study, a sentence completion task was performed by twenty stuttering patients who were scanned using an event-related design. This task elicited stuttering in these patients. Each stuttered trial from each patient was sorted into the MT or LT types with WWR put aside. Pattern classification was employed to train a patient-specific single trial model to automatically classify each trial as MT or LT using the corresponding fMRI data. This model was then validated by using test data that were independent of the training data. In a subsequent analysis, the classification model, just established, was used to determine which type the WWR should be placed in. The results showed that the LT and the MT could be separated with high accuracy based on their brain activity. The brain regions that made most contribution to the separation of the types were: the left inferior frontal cortex and bilateral precuneus, both of which showed higher activity in the MT than in the LT; and the left putamen and right cerebellum which showed the opposite activity pattern. The results also showed that the brain activity for WWR was more similar to that of the LT and fluent speech than to that of the MT. These findings provide a neurological basis for separating the MT and the LT types, and support the widely-used MT/LT symptom grouping scheme. In addition, WWR play a similar role as the LT, and thus should be placed in the LT type.	[Jiang, Jing; Lu, Chunming; Peng, Danling; Zhu, Chaozhe] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Howell, Peter] UCL, Div Psychol & Language Sci, London, England	Beijing Normal University; University of London; University College London	Jiang, J (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	luchunming@bnu.edu.cn; p.howell@ucl.ac.uk		Jiang, Jing/0000-0002-2991-2076	National Natural Science Foundation of China (NSFC) [30900393]; State Key Laboratory of Cognitive Neuroscience and Learning	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Cognitive Neuroscience and Learning	This work was supported by a grant from the National Natural Science Foundation of China (NSFC) (30900393) and Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann H, 2008, TRENDS NEUROSCI, V31, P265, DOI 10.1016/j.tins.2008.02.011; Anderson JD, 2007, J SPEECH LANG HEAR R, V50, P229, DOI 10.1044/1092-4388(2007/018); Beal DS, 2011, NEUROIMAGE, V54, P2994, DOI 10.1016/j.neuroimage.2010.11.026; BINDER JR, 1995, ARCH NEUROL-CHICAGO, V52, P593, DOI 10.1001/archneur.1995.00540300067015; BLOODSTEIN O, 1981, J SPEECH HEAR RES, V24, P298, DOI 10.1044/jshr.2402.298; Braun AR, 1997, BRAIN, V120, P761, DOI 10.1093/brain/120.5.761; Brown S, 2005, HUM BRAIN MAPP, V25, P105, DOI 10.1002/hbm.20140; Chang SE, 2011, CEREB CORTEX; Chang SE, 2008, NEUROIMAGE, V39, P1333, DOI 10.1016/j.neuroimage.2007.09.067; Chang SE, 2009, NEUROIMAGE, V46, P201, DOI 10.1016/j.neuroimage.2009.01.066; Conture E. G., 2001, STUTTERING ITS NATUR; Costafreda SG, 2006, HUM BRAIN MAPP, V27, P799, DOI 10.1002/hbm.20221; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cunnington R, 1996, HUM MOVEMENT SCI, V15, P627, DOI 10.1016/0167-9457(96)00018-8; Cykowski MD, 2010, NEUROIMAGE; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; De Nil LF, 2008, BRAIN LANG, V107, P114, DOI 10.1016/j.bandl.2008.07.003; Deng Y, 2008, NEUROPSYCHOLOGIA, V46, P1864, DOI 10.1016/j.neuropsychologia.2007.09.010; DENIL LF, 1991, BRAIN, V114, P2145, DOI 10.1093/brain/114.5.2145; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Ecker C, 2010, J NEUROSCI, V30, P10612, DOI 10.1523/JNEUROSCI.5413-09.2010; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Foundas AL, 2001, NEUROLOGY, V57, P207, DOI 10.1212/WNL.57.2.207; Fox PT, 1996, NATURE, V382, P158, DOI 10.1038/382158a0; Giraud AL, 2008, BRAIN LANG, V104, P190, DOI 10.1016/j.bandl.2007.04.005; Groussard M, 2010, NEUROIMAGE, V49, P2764, DOI 10.1016/j.neuroimage.2009.10.039; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Haslinger B, 2001, BRAIN, V124, P558, DOI 10.1093/brain/124.3.558; Hoeft F, 2011, P NATL ACAD SCI USA, V108, P361, DOI 10.1073/pnas.1008950108; Howell P, 1999, J SPEECH LANG HEAR R, V42, P345, DOI 10.1044/jslhr.4202.345; Howell P, 2011, J DEV BEHAV PEDIAT; Howell P, 2010, CLIN LINGUIST PHON; Howell P., 2002, CURRENT ISSUES LINGU, P95, DOI [10.1075/cilt.227.09how, DOI 10.1075/CILT.227.09HOW]; Howell P, 2007, HUM MOVEMENT SCI, V26, P728, DOI 10.1016/j.humov.2007.07.004; Hulvershorn J, 2005, HUM BRAIN MAPP, V25, P247, DOI 10.1002/hbm.20094; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Ingham RJ, 2000, BRAIN LANG, V75, P163, DOI 10.1006/brln.2000.2351; JOHNSON W, 1959, ONSET STUTTERING RES; KADIHANIFI K, 1992, J FLUENCY DISORD, V17, P151, DOI 10.1016/0094-730X(92)90008-E; Kell CA, 2009, BRAIN, V132, P2747, DOI 10.1093/brain/awp185; Kikuchi Y, 2011, NEUROIMAGE, V55, P891, DOI 10.1016/j.neuroimage.2010.12.083; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Kolk H. H. J., 1997, NATURE TREATMENT STU, P182; LaConte S, 2005, NEUROIMAGE, V26, P317, DOI 10.1016/j.neuroimage.2005.01.048; Lieberman P, 2003, LANGUAGE EVOLUTION S; Lu C, 2009, NEUROSCIENCE, V161, P1008, DOI 10.1016/j.neuroscience.2009.04.020; Lu CM, 2010, EXP NEUROL, V221, P146, DOI 10.1016/j.expneurol.2009.10.016; Lu CM, 2010, CORTEX, V46, P49, DOI 10.1016/j.cortex.2009.02.017; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Mestres-Misse A, 2010, NEUROIMAGE, V49, P2826, DOI 10.1016/j.neuroimage.2009.10.018; Molnar-Szakacs I, 2005, CEREB CORTEX, V15, P986, DOI 10.1093/cercor/bhh199; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Neumann K, 2005, J FLUENCY DISORD, V30, P23, DOI 10.1016/j.jfludis.2004.12.002; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paden EP, 1999, J SPEECH LANG HEAR R, V42, P1113, DOI 10.1044/jslhr.4205.1113; Papoutsi M, 2009, CEREB CORTEX, V19, P2156, DOI 10.1093/cercor/bhn239; Preston JL, 2010, BRAIN, V133, P2185, DOI 10.1093/brain/awq163; RATNER NB, 1997, NATURE TREATMENT STU, P99; Riley G., 1994, STUTTERING SEVERITY; Salmelin R, 2000, BRAIN, V123, P1184, DOI 10.1093/brain/123.6.1184; Schnur TT, 2009, P NATL ACAD SCI USA, V106, P322, DOI 10.1073/pnas.0805874106; Sommer M, 2002, LANCET, V360, P380, DOI 10.1016/S0140-6736(02)09610-1; Specht K, 2003, NEUROIMAGE, V20, P1944, DOI 10.1016/j.neuroimage.2003.07.034; STRICK PL, 1985, BEHAV BRAIN RES, V18, P107, DOI 10.1016/0166-4328(85)90067-1; Toyomura A, 2011, NEUROIMAGE, V57, P1507, DOI 10.1016/j.neuroimage.2011.05.039; Ujihira A, 2011, COMMUN D ACROSS LANG, P139; Van Opstal F, 2009, NEUROIMAGE, V47, P367, DOI 10.1016/j.neuroimage.2009.04.035; Watkins KE, 2008, BRAIN, V131, P50, DOI 10.1093/brain/awm241; Watkins RV, 1999, J SPEECH LANG HEAR R, V42, P1125, DOI 10.1044/jslhr.4205.1125; Wingate M. E., 2002, FDN STUTTERING; Wingate ME, 2001, J SPEECH LANG HEAR R, V44, P381, DOI 10.1044/1092-4388(2001/031); WU JC, 1995, NEUROREPORT, V6, P501, DOI 10.1097/00001756-199502000-00024; Xiong JH, 1995, HUM BRAIN MAPP, V3, P287, DOI 10.1002/hbm.460030404; Yairi E, 1999, J SPEECH LANG HEAR R, V42, P1097, DOI 10.1044/jslhr.4205.1097; Yaruss JS, 2006, J FLUENCY DISORD, V31, P90, DOI 10.1016/j.jfludis.2006.02.002; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029	84	34	34	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39747	10.1371/journal.pone.0039747	http://dx.doi.org/10.1371/journal.pone.0039747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	965QG	22761887	gold, Green Published, Green Submitted			2022-12-27	WOS:000305781700062
J	Tsai, J; Grosse, SD; Grant, AM; Reyes, NL; Hooper, WC; Atrash, HK				Tsai, James; Grosse, Scott D.; Grant, Althea M.; Reyes, Nimia L.; Hooper, W. Craig; Atrash, Hani K.			Correlates of In-Hospital Deaths among Hospitalizations with Pulmonary Embolism: Findings from the 2001-2008 National Hospital Discharge Survey	PLOS ONE			English	Article							CASE-FATALITY RATE; VENOUS THROMBOEMBOLISM RISK; QUALITY-OF-LIFE; THROMBOLYTIC THERAPY; UNITED-STATES; EPIDEMIOLOGY; DIAGNOSIS; MORTALITY; CARE; MULTIMORBIDITY	Background: Deep vein thrombosis and pulmonary embolism (PE) are responsible for substantial mortality, morbidity, and impaired health-related quality of life. The aim of this study was to evaluate the correlates of in-hospital deaths among hospitalizations with a diagnosis of PE in the United States. Methods: By using data from the 2001-2008 National Hospital Discharge Survey, we assessed the correlates of in-hospital deaths among 14,721 hospitalizations with a diagnosis of PE and among subgroups stratified by age, sex, race, days of hospital stay, type of admission, cancer, pneumonia, and fractures. We produced adjusted rate ratios (aRR) and 95% confidence intervals using log-linear multivariate regression models. Results: Regardless of the listing position of diagnostic codes, we observed an increased likelihood of in-hospital death in subgroups of hospitalizations with ages 50 years and older (aRR = 1.82-8.48), less than 7 days of hospital stay (aRR = 1.43-1.57), cancer (aRR = 2.10-2.28), pneumonia (aRR = 1.79-2.20), or fractures (aRR = 2.18) (except for first-listed PE), when compared to the reference groups with ages 1-49 years, 7 days or more of hospital stay, without cancer, pneumonia, or fractures while adjusting for covariates. In addition, we observed an increased likelihood of in-hospital death for first-listed PE in hospitalizations of women, when compared to those of men (aRR = 1.45). Conclusions: The results of this study provide support for identifying, developing, and implementing effective, evidence-based clinical assessment and management strategies to reduce PE-related morbidity and mortality among hospitalized PE patients who may have concurrent health conditions including cancer, pneumonia, and fractures.	[Tsai, James; Grosse, Scott D.; Grant, Althea M.; Reyes, Nimia L.; Hooper, W. Craig; Atrash, Hani K.] Ctr Dis Control & Prevent, Div Blood Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Tsai, J (corresponding author), Ctr Dis Control & Prevent, Div Blood Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.	jxt9@cdc.gov		Grosse, Scott/0000-0003-1078-6855; Tsai, James/0000-0002-3114-124X				Abunasser Jafar, 2012, Conn Med, V76, P5; Agnelli G, 2010, NEW ENGL J MED, V363, P266, DOI 10.1056/NEJMra0907731; Alikhan R, 2004, ARCH INTERN MED, V164, P963, DOI 10.1001/archinte.164.9.963; Alikhan R, 2004, J CLIN PATHOL, V57, P1254, DOI 10.1136/jcp.2003.013581; [Anonymous], 2010, MULT CHRON COND STRA; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Boyd CM, 2010, PUBLIC HEALTH REV, V32, P451, DOI 10.1007/BF03391611; Brogan D, 2005, ENCY BIOSTATISTICS, V8-Set, P5057; CDC, 2010, NAT HLTH STAT REP; CDC/National Center for Health Statistics, 2011, NAT HOSP DISCH SURV; Chughtai HL, 2011, CLIN APPL THROMB-HEM, V17, P656, DOI 10.1177/1076029611405033; Cohen AT, 2005, THROMB HAEMOSTASIS, V94, P750, DOI 10.1160/TH05-06-0385; Cushman M, 2007, SEMIN HEMATOL, V44, P62, DOI 10.1053/j.seminhematol.2007.02.004; DeMonaco NA, 2008, AM J MED, V121, P611, DOI 10.1016/j.amjmed.2008.02.035; DHHS, 2008, SURG GEN CALL ACT PR; Douma RA, 2010, NAT REV CARDIOL, V7, P585, DOI 10.1038/nrcardio.2010.106; Fortin M, 2007, BMJ-BRIT MED J, V334, P1016, DOI 10.1136/bmj.39201.463819.2C; Geerts W, 2009, J THROMB HAEMOST, V7, P1, DOI 10.1111/j.1538-7836.2009.03384.x; Goldhaber SZ, 2010, J AM COLL CARDIOL, V56, P1, DOI 10.1016/j.jacc.2010.01.057; Heit JA, 2005, J THROMB HAEMOST, V3, P1611, DOI 10.1111/j.1538-7836.2005.01415.x; Heit JA, 2008, ARTERIOSCL THROM VAS, V28, P370, DOI 10.1161/ATVBAHA.108.162545; Ho KM, 2010, BRIT J ANAESTH, V105, P596, DOI 10.1093/bja/aeq254; Horlander KR, 2003, ARCH INTERN MED, V163, P1711, DOI 10.1001/archinte.163.14.1711; Klok FA, 2010, J THROMB HAEMOST, V8, P523, DOI 10.1111/j.1538-7836.2009.03726.x; Klok FA, 2010, CHEST, V138, P1432, DOI 10.1378/chest.09-2482; Korn E. L., 1999, ANAL HLTH SURVEYS; Kozak LJ, 1995, NATL CTR HLTH STAT N, V10; Mercer SW, 2009, FAM PRACT, V26, P79, DOI 10.1093/fampra/cmp020; Nicolaides AN, 2006, INT ANGIOL, V25, P101; Prasad V, 2012, ARCH INTERN MED, V172, P955, DOI 10.1001/archinternmed.2012.195; Rosendaal Frits R, 2005, Hematology Am Soc Hematol Educ Program, P1; Rubenfire M, 2007, CRIT CARE CLIN, V23, P801, DOI 10.1016/j.ccc.2007.07.006; Smith SB, 2012, J EMERG MED, V42, P1, DOI 10.1016/j.jemermed.2011.06.004; Smith SM, 2007, BRIT J GEN PRACT, V57, P268; Stein PD, 2012, AM J MED, V125, P465, DOI 10.1016/j.amjmed.2011.10.015; Stein PD, 2012, AM J MED, V125, P471, DOI 10.1016/j.amjmed.2011.12.003; Stein PD, 2012, AM J MED, V125, P478, DOI 10.1016/j.amjmed.2011.05.025; Stein PD, 2011, CLIN APPL THROMB-HEM, V17, P140, DOI 10.1177/1076029610389027; Stein PD, 2010, CLIN CHEST MED, V31, P611, DOI 10.1016/j.ccm.2010.07.001; Stein PD, 2006, AM J MED, V119, P163, DOI 10.1016/j.amjmed.2005.02.028; Stein PD, 2004, AM J CARDIOL, V93, P1194, DOI 10.1016/j.amjcard.2004.01.061; Stein PD, 2004, AM J CARDIOL, V93, P1197, DOI 10.1016/j.amjcard.2004.01.058; Tapson VF, 2008, NEW ENGL J MED, V358, P1037, DOI 10.1056/NEJMra072753; Tsai J, 2012, ARCH INTERN MED, V172, P960, DOI 10.1001/archinternmed.2012.198; Van Es J, 2010, NAT REV CARDIOL, V7, P613, DOI 10.1038/nrcardio.2010.141; Wiener RS, 2011, ARCH INTERN MED, V171, P831, DOI 10.1001/archinternmed.2011.178; Zhu TN, 2009, ARTERIOSCL THROM VAS, V29, P298, DOI 10.1161/ATVBAHA.108.182428	47	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e34048	10.1371/journal.pone.0034048	http://dx.doi.org/10.1371/journal.pone.0034048			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792153	gold, Green Published, Green Submitted			2022-12-27	WOS:000306461800001
J	Rajgor, D; Mellad, JA; Autore, F; Zhang, QP; Shanahan, CM				Rajgor, Dipen; Mellad, Jason A.; Autore, Flavia; Zhang, Qiuping; Shanahan, Catherine M.			Multiple Novel Nesprin-1 and Nesprin-2 Variants Act as Versatile Tissue-Specific Intracellular Scaffolds	PLOS ONE			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; NUCLEAR-ENVELOPE ARCHITECTURE; MEMBRANE PROTEIN; TRANSLATION INITIATION; SUSCEPTIBILITY LOCUS; N-MYRISTOYLATION; PLASMA-MEMBRANE; PROGERIA CELLS; BINDING; LOCALIZATION	Background: Nesprins (Nuclear envelope spectrin-repeat proteins) are a novel family of giant spectrin-repeat containing proteins. The nesprin-1 and nesprin-2 genes consist of 146 and 116 exons which encode proteins of similar to 1mDa and similar to 800 kDa is size respectively when all the exons are utilised in translation. However emerging data suggests that the nesprins have multiple alternative start and termination sites throughout their genes allowing the generation of smaller isoforms. Results: In this study we set out to identify novel alternatively transcribed nesprin variants by screening the EST database and by using RACE analysis to identify cDNA ends. These two methods provided potential hits for alternative start and termination sites that were validated by PCR and DNA sequencing. We show that these alternative sites are not only expressed in a tissue specific manner but by combining different sites together it is possible to create a wide array of nesprin variants. By cloning and expressing small novel nesprin variants into human fibroblasts and U2OS cells we show localization to actin stress-fibres, focal adhesions, microtubules, the nucleolus, nuclear matrix and the nuclear envelope (NE). Furthermore we show that the sub-cellular localization of individual nesprin variants can vary depending on the cell type, suggesting any single nesprin variant may have different functions in different cell types. Conclusions: These studies suggest nesprins act as highly versatile tissue specific intracellular protein scaffolds and identify potential novel functions for nesprins beyond cytoplasmic-nuclear coupling. These alternate functions may also account for the diverse range of disease phenotypes observed when these genes are mutated.	[Rajgor, Dipen; Mellad, Jason A.; Zhang, Qiuping; Shanahan, Catherine M.] Kings Coll London, James Black Ctr, Cardiovasc Div, London WC2R 2LS, England; [Autore, Flavia] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Rajgor, D (corresponding author), Kings Coll London, James Black Ctr, Cardiovasc Div, London WC2R 2LS, England.	cathy.shanahan@kcl.ac.uk	Zhang, Qiuping/L-3522-2019	Zhang, Qiuping/0000-0002-4000-3957; Shanahan, Catherine/0000-0002-8352-8171	Medical Research Council; British Heart Foundation; British Heart Foundation [NH/12/2/29427, RG/11/14/29056, PG/11/58/29004] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	Medical Research Council and the British Heart Foundation provided funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronov S, 2001, J NEUROSCI, V21, P6577, DOI 10.1523/JNEUROSCI.21-17-06577.2001; Attali R, 2009, HUM MOL GENET, V18, P3462, DOI 10.1093/hmg/ddp290; Cottrell JR, 2004, NEURON, V44, P677, DOI 10.1016/j.neuron.2004.10.025; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Dahiya A, 2000, MOL CELL BIOL, V20, P6799, DOI 10.1128/MCB.20.18.6799-6805.2000; Dawe HR, 2009, J CELL SCI, V122, P2716, DOI 10.1242/jcs.043794; di Barletta MR, 2000, AM J HUM GENET, V66, P1407, DOI 10.1086/302869; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Eldad N, 2008, NUCLEIC ACIDS RES, V36, P6728, DOI 10.1093/nar/gkn754; Fabian M.R., 2007, CURR PROTOC MICROBIO, V6, p16E. 11.11, DOI [10.1002/9780471729259.mc16e01s6, DOI 10.1002/9780471729259.MC16E01S6]; Fairley EAL, 1999, J CELL SCI, V112, P2571; Gough LL, 2004, BBA-MOL CELL RES, V1693, P29, DOI 10.1016/j.bbamcr.2004.04.004; Gough LL, 2003, MOL BIOL CELL, V14, P2410, DOI 10.1091/mbc.E02-07-0446; Gros-Louis F, 2007, NAT GENET, V39, P80, DOI 10.1038/ng1927; Hale CM, 2008, BIOPHYS J, V95, P5462, DOI 10.1529/biophysj.108.139428; Kandert S, 2007, HUM MOL GENET, V16, P2944, DOI 10.1093/hmg/ddm255; Ketema M, 2007, J CELL SCI, V120, P3384, DOI 10.1242/jcs.014191; Kobayashi Y, 2006, EXP CELL RES, V312, P3152, DOI 10.1016/j.yexcr.2006.06.026; Koutelou E, 2008, J BIOL CHEM, V283, P3846, DOI 10.1074/jbc.M706974200; Lammerding J, 2005, J CELL BIOL, V170, P781, DOI 10.1083/jcb.200502148; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lindholm E, 2001, AM J HUM GENET, V69, P96, DOI 10.1086/321288; Loya A, 2008, RNA, V14, P1352, DOI 10.1261/rna.867208; Luke Y, 2008, J CELL SCI, V121, P1887, DOI 10.1242/jcs.019075; Marme A, 2008, INT J CANCER, V123, P2048, DOI 10.1002/ijc.23763; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; MELEFORS O, 1993, BLOOD REV, V7, P251, DOI 10.1016/0268-960X(93)90012-S; Nedivi E, 1996, P NATL ACAD SCI USA, V93, P2048, DOI 10.1073/pnas.93.5.2048; Nikolova-Krstevski V, 2011, J MOL CELL CARDIOL, V50, P479, DOI 10.1016/j.yjmcc.2010.12.001; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Pecci A, 2001, J BIOL CHEM, V276, P21062, DOI 10.1074/jbc.M008665200; Puckelwartz MJ, 2009, HUM MOL GENET, V18, P607, DOI 10.1093/hmg/ddn386; QUELLE DE, 1995, CELL, V83, P993; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; Shmelkov SV, 2004, BLOOD, V103, P2055, DOI 10.1182/blood-2003-06-1881; Simpson JG, 2008, BIOCHEM SOC T, V36, P1359, DOI 10.1042/BST0361359; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; Tanguay RL, 1996, MOL CELL BIOL, V16, P146; Tessema M, 2008, CANCER RES, V68, P1707, DOI 10.1158/0008-5472.CAN-07-6325; Utsumi T, 2001, J BIOL CHEM, V276, P10505, DOI 10.1074/jbc.M006134200; VAGNER S, 1995, J BIOL CHEM, V270, P20376, DOI 10.1074/jbc.270.35.20376; Verstraeten VLRM, 2008, AGING CELL, V7, P383, DOI 10.1111/j.1474-9726.2008.00382.x; Warren DT, 2010, J BIOL CHEM, V285, P1311, DOI 10.1074/jbc.M109.032557; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Xin DD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002377; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642; Zhang QP, 2002, GENOMICS, V80, P473, DOI 10.1006/geno.2002.6859; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhen YY, 2002, J CELL SCI, V115, P3207	51	78	80	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40098	10.1371/journal.pone.0040098	http://dx.doi.org/10.1371/journal.pone.0040098			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768332	Green Submitted, gold, Green Published			2022-12-27	WOS:000305966500045
J	Senturia, R; Laganowsky, A; Barr, I; Scheidemantle, BD; Guo, F				Senturia, Rachel; Laganowsky, Arthur; Barr, Ian; Scheidemantle, Brooke D.; Guo, Feng			Dimerization and Heme Binding Are Conserved in Amphibian and Starfish Homologues of the microRNA Processing Protein DGCR8	PLOS ONE			English	Article							CRITICAL REGION 8; MICROPROCESSOR COMPLEX; DROSHA-DGCR8 COMPLEX; PREFRONTAL CORTEX; BIOGENESIS; RNA; SOFTWARE; DEFICITS; PHASER; DOMAIN	Human DiGeorge Critical Region 8 (DGCR8) is an essential microRNA (miRNA) processing factor that is activated via direct interaction with Fe(III) heme. In order for DGCR8 to bind heme, it must dimerize using a dimerization domain embedded within its heme-binding domain (HBD). We previously reported a crystal structure of the dimerization domain from human DGCR8, which demonstrated how dimerization results in the formation of a surface important for association with heme. Here, in an attempt to crystallize the HBD, we search for DGCR8 homologues and show that DGCR8 from Patiria miniata (bat star) also binds heme. The extinction coefficients (epsilon) of DGCR8-heme complexes are determined; these values are useful for biochemical analyses and allow us to estimate the heme occupancy of DGCR8 proteins. Additionally, we present the crystal structure of the Xenopus laevis dimerization domain. The structure is very similar to that of human DGCR8. Our results indicate that dimerization and heme binding are evolutionarily conserved properties of DGCR8 homologues not only in vertebrates, but also in at least some invertebrates.	[Senturia, Rachel; Barr, Ian; Scheidemantle, Brooke D.; Guo, Feng] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Dept Biol Chem, Los Angeles, CA 90095 USA; [Laganowsky, Arthur] Univ Calif Los Angeles, Dept Chem & Biochem, UCLA DOE Inst Genom & Prote, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Senturia, R (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Dept Biol Chem, Los Angeles, CA 90095 USA.	fguo@mbi.ucla.edu	Guo, Feng/HIK-3259-2022	Barr, Ian/0000-0003-1805-1415; Barr, Ian/0000-0002-7351-418X; Laganowsky, Arthur/0000-0001-5012-5547	National Institutes of Health (NIH) [GM080563]; UCLA Dissertation Year Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080563] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Dissertation Year Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant GM080563 to F.G. and by UCLA Dissertation Year Fellowship to R.S. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Barr I, 2012, P NATL ACAD SCI USA, V109, P1919, DOI 10.1073/pnas.1114514109; Barr I, 2011, J BIOL CHEM, V286, P16716, DOI 10.1074/jbc.M110.180844; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Faller M, 2010, RNA, V16, P1570, DOI 10.1261/rna.2111310; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Fenelon K, 2011, P NATL ACAD SCI USA, V108, P4447, DOI 10.1073/pnas.1101219108; Gong M, 2012, PROTEIN SCI, V21, P797, DOI 10.1002/pro.2062; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Ilsley JL, 2002, CELL SIGNAL, V14, P183, DOI 10.1016/S0898-6568(01)00236-4; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kok KH, 2007, J BIOL CHEM, V282, P17649, DOI 10.1074/jbc.M611768200; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Schofield CM, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-11; Senturia R, 2010, PROTEIN SCI, V19, P1354, DOI 10.1002/pro.414; Shiohama A, 2003, BIOCHEM BIOPH RES CO, V304, P184, DOI 10.1016/S0006-291X(03)00554-0; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sohn SY, 2007, NAT STRUCT MOL BIOL, V14, P847, DOI 10.1038/nsmb1294; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; SUDOL M, 2005, MODULAR PROTEIN DOMA, P59; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Yankura KA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-143; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105; Zhang ZD, 2003, J MOL BIOL, V332, P127, DOI 10.1016/S0022-2836(03)00858-1	39	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39688	10.1371/journal.pone.0039688	http://dx.doi.org/10.1371/journal.pone.0039688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768307	Green Published, gold, Green Submitted			2022-12-27	WOS:000305966500020
J	Washimi, K; Yokose, T; Yamashita, M; Kageyama, T; Suzuki, K; Yoshihara, M; Miyagi, Y; Hayashi, H; Tsuji, S				Washimi, Kota; Yokose, Tomoyuki; Yamashita, Makiko; Kageyama, Taihei; Suzuki, Katsuo; Yoshihara, Mitsuyo; Miyagi, Yohei; Hayashi, Hiroyuki; Tsuji, Shoutaro			Specific Expression of Human Intelectin-1 in Malignant Pleural Mesothelioma and Gastrointestinal Goblet Cells	PLOS ONE			English	Article							IMMUNOHISTOCHEMICAL DIAGNOSIS; ADIPOSE-TISSUE; IDENTIFICATION; INFECTION; CLONING; ASTHMA; LECTIN	Malignant pleural mesothelioma (MPM) is a fatal tumor. It is often hard to discriminate MPM from metastatic tumors of other types because currently, there are no reliable immunopathological markers for MPM. MPM is differentially diagnosed by some immunohistochemical tests on pathology specimens. In the present study, we investigated the expression of intelectin-1, a new mesothelioma marker, in normal tissues in the whole body and in many cancers, including MPM, by immunohistochemical analysis. We found that in normal tissues, human intelectin-1 was mainly secreted from gastrointestinal goblet cells along with mucus into the intestinal lumen, and it was also expressed, to a lesser extent, in mesothelial cells and urinary epithelial cells. Eighty-eight percent of epithelioid-type MPMs expressed intelectin-1, whereas sarcomatoid-type MPMs, biphasic MPMs, and poorly differentiated MPMs were rarely positive for intelectin-1. Intelectin-1 was not expressed in other cancers, except in mucus-producing adenocarcinoma. These results suggest that intelectin-1 is a better marker for epithelioid-type MPM than other mesothelioma markers because of its specificity and the simplicity of pathological assessment. Pleural intelectin-1 could be a useful diagnostic marker for MPM with applications in histopathological identification of MPM.	[Washimi, Kota; Yokose, Tomoyuki] Kanagawa Canc Ctr, Dept Pathol, Yokohama, Kanagawa 2410815, Japan; [Yamashita, Makiko; Kageyama, Taihei; Suzuki, Katsuo; Tsuji, Shoutaro] Kanagawa Canc Ctr, Res Inst, Mol Diagnost Project, Yokohama, Kanagawa 2410815, Japan; [Yoshihara, Mitsuyo; Miyagi, Yohei] Kanagawa Canc Ctr, Res Inst, Div Mol Pathol & Genet, Yokohama, Kanagawa 2410815, Japan; [Hayashi, Hiroyuki] Yokohama Municipal Citizens Hosp, Dept Pathol, Yokohama, Kanagawa, Japan	Kanagawa Prefectural Cancer Center; Kanagawa Prefectural Cancer Center; Kanagawa Prefectural Cancer Center	Washimi, K (corresponding author), Kanagawa Canc Ctr, Dept Pathol, 1-1-2 Nakao, Yokohama, Kanagawa 2410815, Japan.	stsuji@gancen.asahi.yokohama.jp			Japan Society for the Promotion of Science; JSPS KAKENHI [22590544]; Immuno-Biological Laboratories Co., Ltd.; Takeda Science Foundation; Kanagawa Cancer Center	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Immuno-Biological Laboratories Co., Ltd.; Takeda Science Foundation(Takeda Science Foundation (TSF)); Kanagawa Cancer Center	This research was supported in part by the following grants: Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (JSPS KAKENHI) (22590544), Immuno-Biological Laboratories Co., Ltd., and Takeda Science Foundation (to ST); the Grant-in-Aid for Collaboration between Hospital and Research Institute, Kanagawa Cancer Center (to KW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 1998, MODERN PATHOL, V11, P155; Datta R, 2005, INFECT IMMUN, V73, P4025, DOI 10.1128/IAI.73.7.4025-4033.2005; French AT, 2008, INT J PARASITOL, V38, P467, DOI 10.1016/j.ijpara.2007.08.015; HIDAKA H, 1983, J BIOL CHEM, V258, P2705; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Komiya T, 1998, BIOCHEM BIOPH RES CO, V251, P759, DOI 10.1006/bbrc.1998.9513; Kuperman DA, 2005, J ALLERGY CLIN IMMUN, V116, P305, DOI 10.1016/j.jaci.2005.03.024; Lee JK, 2001, GLYCOBIOLOGY, V11, P65, DOI 10.1093/glycob/11.1.65; Murayama T, 2006, AM J IND MED, V49, P1, DOI 10.1002/ajim.20246; Ordonez NG, 2003, AM J SURG PATHOL, V27, P1031, DOI 10.1097/00000478-200308000-00001; Ordonez NG, 2002, HUM PATHOL, V33, P953, DOI 10.1053/hupa.2002.128248; Padgett DM, 2008, AM J SURG PATHOL, V32, P123, DOI 10.1097/PAS.0b013e31814faacf; Peto J, 1999, BRIT J CANCER, V79, P666, DOI 10.1038/sj.bjc.6690105; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Rogers DF, 2004, CURR OPIN PHARMACOL, V4, P241, DOI 10.1016/j.coph.2004.01.011; RUFFIE P, 1989, J CLIN ONCOL, V7, P1157, DOI 10.1200/JCO.1989.7.8.1157; Schaffler A, 2005, BBA-GENE STRUCT EXPR, V1732, P96, DOI 10.1016/j.bbaexp.2005.11.005; Suzuki YA, 2001, BIOCHEMISTRY-US, V40, P15771, DOI 10.1021/bi0155899; Tsuji S, 2010, BRIT J CANCER, V103, P517, DOI 10.1038/sj.bjc.6605786; Tsuji S, 2001, J BIOL CHEM, V276, P23456, DOI 10.1074/jbc.M103162200; Tsuji S, 2009, GLYCOBIOLOGY, V19, P518, DOI 10.1093/glycob/cwp013; Wali A, 2005, LUNG CANCER, V48, P19, DOI 10.1016/j.lungcan.2004.10.011	22	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39889	10.1371/journal.pone.0039889	http://dx.doi.org/10.1371/journal.pone.0039889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768319	Green Submitted, Green Published, gold			2022-12-27	WOS:000305966500032
J	Bloes, DA; Otto, M; Peschel, A; Kretschmer, D				Bloes, Dominik Alexander; Otto, Michael; Peschel, Andreas; Kretschmer, Dorothee			Enterococcus faecium Stimulates Human Neutrophils via the Formyl-Peptide Receptor 2	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; VIRULENCE DETERMINANTS; ACTIVATES NEUTROPHILS; SENSING SYSTEM; SEX-PHEROMONES; FAECALIS; INFECTIONS; RESISTANCE; PLASMID; IDENTIFICATION	The human formyl-peptide receptor 2 (FPR2/ALX) senses phenol-soluble modulin (PSM) peptide toxins produced by pathogenic staphylococcal species and plays a crucial role in directing neutrophil influx during staphylococcal infection. However, it has remained unclear if FPR2 responds also to molecules from other bacterial pathogens. Here we analyzed a variety of Gram-positive and Gram-negative pathogens and found that apart from staphylococci only certain enterococcal strains have the capacity to stimulate FPR2/ALX. Most of the analyzed Enterococcus faecium but only sporadic Enterococcus faecalis strains released FPR2/ALX-stimulating molecules leading to neutrophil calcium ion fluxes, chemotaxis, and complement receptor upregulation. Among ten test strains vancomycin-resistant E. faecium had a significantly higher capacity to stimulate FPR2/ALX than vancomycin-susceptible strains, suggesting an association of strong FPR2/ALX activation with health-care associated strains. The enterococcal FPR2/ALX agonists were found to be peptides or proteins, which appear, however, to be unrelated to staphylococcal PSMs in sequence and physicochemical properties. Enterococci are among the most frequent invasive bacterial pathogens but the basis of enterococcal virulence and immune activation has remained incompletely understood. Our study indicates that previously unrecognized proteinaceous agonists contribute to Enterococcus-host interaction and underscores the importance of FPR2/ALX in host defense against major endogenous bacterial pathogens.	[Bloes, Dominik Alexander; Peschel, Andreas; Kretschmer, Dorothee] Univ Tubingen, Cellular & Mol Microbiol Sect, Interfac Inst Microbiol & Infect Med, Tubingen, Germany; [Otto, Michael] NIAID, Pathogen Mol Genet Sect, Lab Human Bacterial Pathogenesis, US NIH, Bethesda, MD 20892 USA	Eberhard Karls University of Tubingen; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Bloes, DA (corresponding author), Univ Tubingen, Cellular & Mol Microbiol Sect, Interfac Inst Microbiol & Infect Med, Tubingen, Germany.	andreas.peschel@uni-tuebingen.de		Otto, Michael/0000-0002-2222-4115	German Research Foundation [SFB685, TRR34]; German Ministry of Education and Research (SkinStaph, Menage); University of Tubingen Medical Faculty; National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000904] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); German Ministry of Education and Research (SkinStaph, Menage)(Federal Ministry of Education & Research (BMBF)); University of Tubingen Medical Faculty; National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was financed by the German Research Foundation grants SFB685 and TRR34 and the German Ministry of Education and Research (SkinStaph, Menage) to AP; the Fortune program of the University of Tubingen Medical Faculty to DK; and the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health to MO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Cheung GYC, 2012, MICROBES INFECT, V14, P380, DOI 10.1016/j.micinf.2011.11.013; CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; Christophe T, 2001, J BIOL CHEM, V276, P21585, DOI 10.1074/jbc.M007769200; Clewell DB, 1993, BACTERIAL CONJUGATIO, P349; Dahlgren C, 2000, BLOOD, V95, P1810, DOI 10.1182/blood.V95.5.1810.005k06_1810_1818; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Durr MC, 2006, CELL MICROBIOL, V8, P207, DOI 10.1111/j.1462-5822.2005.00610.x; EMBER JA, 1989, AM J PATHOL, V134, P797; Fu HM, 2006, J LEUKOCYTE BIOL, V79, P247, DOI 10.1189/jlb.0905498; HEESEMANN J, 1983, J BACTERIOL, V155, P761, DOI 10.1128/JB.155.2.761-767.1983; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hirt H, 2002, INFECT IMMUN, V70, P716, DOI 10.1128/IAI.70.2.716-723.2002; Holtfreter S, 2011, EUR J CLIN MICROBIOL, V30, P707, DOI 10.1007/s10096-010-1136-3; Kretschmer D, 2012, J INNATE IMMUN, V4, P201, DOI 10.1159/000332142; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Mader D, 2010, MICROBES INFECT, V12, P415, DOI 10.1016/j.micinf.2010.01.014; MARASCO WA, 1984, J BIOL CHEM, V259, P5430; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Nanamori M, 2004, MOL PHARMACOL, V66, P1213, DOI 10.1124/mol.104.004309; Passerini R, 2011, ECANCERMEDICALSCIENC, V5, DOI 10.3332/ecancer.2011.191; Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109; Prat C, 2006, J IMMUNOL, V177, P8017, DOI 10.4049/jimmunol.177.11.8017; Prat C, 2009, J IMMUNOL, V183, P6569, DOI 10.4049/jimmunol.0801523; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Queck SY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000533; Rautenberg M, 2011, FASEB J, V25, P1254, DOI 10.1096/fj.10-175208; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; SANNOMIYA P, 1990, P NATL ACAD SCI USA, V87, P66, DOI 10.1073/pnas.87.1.66; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; SCHIFFMANN E, 1975, P NATL ACAD SCI USA, V72, P1059, DOI 10.1073/pnas.72.3.1059; Schlievert PM, 1998, INFECT IMMUN, V66, P218, DOI 10.1128/IAI.66.1.218-223.1998; Schulte B, 2008, EPIDEMIOL INFECT, V136, P1131, DOI 10.1017/S0950268807009508; TSUBOKURA M, 1993, ZBL BAKT-INT J MED M, V278, P500; Verkaik NJ, 2010, CLIN INFECT DIS, V50, P61, DOI 10.1086/648673; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Werth N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011576; WIRTH R, 1994, EUR J BIOCHEM, V222, P235, DOI 10.1111/j.1432-1033.1994.tb18862.x; WISEMAN GM, 1975, BACTERIOL REV, V39, P317, DOI 10.1128/MMBR.39.4.317-344.1975; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	44	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39910	10.1371/journal.pone.0039910	http://dx.doi.org/10.1371/journal.pone.0039910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768166	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100135
J	Bondue, B; De Henau, O; Luangsay, S; Devosse, T; de Nadai, P; Springael, JY; Parmentier, M; Vosters, O				Bondue, Benjamin; De Henau, Olivier; Luangsay, Souphalone; Devosse, Thalie; de Nadai, Patricia; Springael, Jean-Yves; Parmentier, Marc; Vosters, Olivier			The Chemerin/ChemR23 System Does Not Affect the Pro-Inflammatory Response of Mouse and Human Macrophages Ex Vivo	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; RECEPTOR; CHEMR23; ADIPOKINE; ADIPOGENESIS; TRAFFICKING; METABOLISM; ACTIVATION; RESOLUTION; INDUCTION	Macrophages constitute a major component of innate immunity and play an essential role in defense mechanisms against external aggressions and in inflammatory responses. Chemerin, a chemoattractant protein, is generated in inflammatory conditions, and recruits cells expressing the G protein-coupled receptor ChemR23, including macrophages. Chemerin was initially expected to behave as a pro-inflammatory agent. However, recent data described more complex activities that are either pro-or anti-inflammatory, according to the disease model investigated. In the present study, peritoneal macrophages were generated from WT or ChemR23(-/-) mice, stimulated with lipopolyssaccharide in combination or not with IFN-gamma and the production of pro- (TNF-alpha, IL-1 beta and IL-6) and anti-inflammatory (IL-10) cytokines was evaluated using qRT-PCR and ELISA. Human macrophages generated from peripheral blood monocytes were also tested in parallel. Peritoneal macrophages from WT mice, recruited by thioglycolate or polyacrylamide beads, functionally expressed ChemR23, as assessed by flow cytometry, binding and chemotaxis assays. However, chemerin had no effect on the strong upregulation of cytokine release by these cells upon stimulation by LPS or LPS/IFN-gamma, whatever the concentration tested. Similar data were obtained with human macrophages. In conclusion, our results rule out the direct anti-inflammatory effect of chemerin on macrophages ex vivo, described previously in the literature, despite the expression of a functional ChemR23 receptor in these cells.	[Bondue, Benjamin; De Henau, Olivier; Luangsay, Souphalone; Devosse, Thalie; de Nadai, Patricia; Springael, Jean-Yves; Parmentier, Marc; Vosters, Olivier] Univ Libre Brussels, Fac Med, IRIBHM, Brussels, Belgium; [Luangsay, Souphalone] Euroscreen SA, Brussels, Belgium; [Bondue, Benjamin] Univ Libre Brussels, Hop Erasme, Serv Pneumol, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles	Bondue, B (corresponding author), Univ Libre Brussels, Fac Med, IRIBHM, Brussels, Belgium.	mparment@ulb.ac.be		Parmentier, Marc/0000-0001-8081-4685; de NADAI, Patricia/0000-0001-6084-7447	European Union [LSHB-CT-2005-518167/INNOCHEM]; Interuniversity Attraction Poles Programme (P6/14) - Belgian State - Belgian Science Policy; Actions de Recherche Concertees of the Communaute Francaise de Belgique; Fonds de la Recherche Scientifique Medicale of Belgium; Walloon Region (Programme d'excellence "CIBLES''); Fonds Ithier; Fonds Alice and David Van Buuren, Televie; Fondation Medicale Reine Elisabeth	European Union(European Commission); Interuniversity Attraction Poles Programme (P6/14) - Belgian State - Belgian Science Policy(Belgian Federal Science Policy Office); Actions de Recherche Concertees of the Communaute Francaise de Belgique; Fonds de la Recherche Scientifique Medicale of Belgium(Fonds de la Recherche Scientifique - FNRS); Walloon Region (Programme d'excellence "CIBLES''); Fonds Ithier; Fonds Alice and David Van Buuren, Televie; Fondation Medicale Reine Elisabeth	This work was supported by the Interuniversity Attraction Poles Programme (P6/14) - Belgian State - Belgian Science Policy, the Actions de Recherche Concertees of the Communaute Francaise de Belgique, the European Union (LSHB-CT-2005-518167/INNOCHEM), the Fonds de la Recherche Scientifique Medicale of Belgium, the Walloon Region (Programme d'excellence "CIBLES''), the Fonds Ithier, the Fonds Alice and David Van Buuren, Televie and the Fondation Medicale Reine Elisabeth. B.B. and O.D.H. were aspirant of the Belgian National Fund for Scientific Research (FNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Bondue B, 2011, CYTOKINE GROWTH F R, V22, P331, DOI 10.1016/j.cytogfr.2011.11.004; Bondue B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002358; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Demoor T, 2011, J IMMUNOL, V186, P5457, DOI 10.4049/jimmunol.1003862; Devosse T, 2009, J IMMUNOL, V182, P4974, DOI 10.4049/jimmunol.0803128; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Luangsay S, 2009, J IMMUNOL, V183, P6489, DOI 10.4049/jimmunol.0901037; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P403, DOI 10.1513/pats.200508-090JS; Otero K, 2010, BLOOD, V116, P2942, DOI 10.1182/blood-2009-12-259903; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; Roh SG, 2007, BIOCHEM BIOPH RES CO, V362, P1013, DOI 10.1016/j.bbrc.2007.08.104; Samson M, 1998, EUR J IMMUNOL, V28, P1689, DOI 10.1002/(SICI)1521-4141(199805)28:05<1689::AID-IMMU1689>3.0.CO;2-I; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Vermi W, 2005, J EXP MED, V201, P509, DOI 10.1084/jem.20041310; Wittamer V, 2005, J IMMUNOL, V175, P487, DOI 10.4049/jimmunol.175.1.487; Wittamer V, 2004, J BIOL CHEM, V279, P9956, DOI 10.1074/jbc.M313016200; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300	22	28	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40043	10.1371/journal.pone.0040043	http://dx.doi.org/10.1371/journal.pone.0040043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768214	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100186
J	Hu, R; Zhou, P; Peng, YB; Xu, XJ; Ma, J; Liu, Q; Zhang, L; Wen, XD; Qi, LW; Gao, N; Li, P				Hu, Rong; Zhou, Ping; Peng, Yong-Bo; Xu, Xiaojun; Ma, Jiang; Liu, Qun; Zhang, Lei; Wen, Xiao-Dong; Qi, Lian-Wen; Gao, Ning; Li, Ping			6-Shogaol Induces Apoptosis in Human Hepatocellular Carcinoma Cells and Exhibits Anti-Tumor Activity In Vivo through Endoplasmic Reticulum Stress	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; SELECTIVE-INHIBITION; CASPASE ACTIVATION; OXIDATIVE STRESS; DEATH; KINASE; PHOSPHORYLATION; INGREDIENTS; ATTENUATION; INDUCTION	6-Shogaol is an active compound isolated from Ginger (Zingiber officinale Rosc). In this work, we demonstrated that 6-shogaol induces apoptosis in human hepatocellular carcinoma cells in relation to caspase activation and endoplasmic reticulum (ER) stress signaling. Proteomic analysis revealed that ER stress was accompanied by 6-shogaol-induced apoptosis in hepatocellular carcinoma cells. 6-shogaol affected the ER stress signaling by regulating unfolded protein response (UPR) sensor PERK and its downstream target eIF2 alpha. However, the effect on the other two UPR sensors IRE1 and ATF6 was not obvious. In prolonged ER stress, 6-shogaol inhibited the phosphorylation of eIF2 alpha and triggered apoptosis in SMMC-7721 cells. Salubrinal, an activator of the PERK/eIF2 alpha pathway, strikingly enhanced the phosphorylation of eIF2 alpha in SMMC-7721 cells with no toxicity. However, combined treatment with 6-shogaol and salubrinal resulted in significantly increase of apoptosis and dephosphorylation of eIF2 alpha. Overexpression of eIF2 alpha prevented 6-shogaol-mediated apoptosis in SMMC-7721 cells, whereas inhibition of eIF2 alpha by small interfering RNA markedly enhanced 6-shogaol-mediated cell death. Furthermore, 6-shogaol-mediated inhibition of tumor growth of mouse SMMC-7721 xenograft was associated with induction of apoptosis, activation of caspase-3, and inactivation of eIF2 alpha. Altogether our results indicate that the PERK/eIF2 alpha pathway plays an important role in 6-shogaol-mediated ER stress and apoptosis in SMMC-7721 cells in vitro and in vivo.	[Hu, Rong; Zhou, Ping; Peng, Yong-Bo; Xu, Xiaojun; Ma, Jiang; Liu, Qun; Zhang, Lei; Wen, Xiao-Dong; Qi, Lian-Wen; Li, Ping] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Gao, Ning] 3rd Mil Med Univ, Dept Pharmacognosy, Coll Pharm, Chongqing, Peoples R China	China Pharmaceutical University; Army Medical University	Hu, R (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.	gaoning59@yahoo.com.cn; liping2004@126.com	Li, Ping/GYV-4914-2022; Peng, Yong-bo/ADE-0574-2022; LianWen, Qi/H-5020-2014; Li, Ping/A-2615-2013	Peng, Yong-bo/0000-0003-4861-7184; Li, Ping/0000-0002-9669-0231	Program for Changjiang Scholars and Innovative Research Team in University [IRT0868]; National Science and Technology Major Project 'Creation of Major New Drugs' from China [2009ZX09502-020]; National Science Foundation of China [81001618]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Science and Technology Major Project 'Creation of Major New Drugs' from China; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by Program for Changjiang Scholars and Innovative Research Team in University (No. IRT0868), National Science and Technology Major Project 'Creation of Major New Drugs' from China (No. 2009ZX09502-020), and the National Science Foundation of China (No. 81001618). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Bollo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011925; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chen CY, 2007, J AGR FOOD CHEM, V55, P948, DOI 10.1021/jf0624594; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; Drexler HCA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004161; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Gao N, 2006, BLOOD, V107, P241, DOI 10.1182/blood-2005-06-2409; Gao N, 2005, ONCOGENE, V24, P3797, DOI 10.1038/sj.onc.1208530; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Hannun YA, 1997, BLOOD, V89, P1845, DOI 10.1182/blood.V89.6.1845; Hung JY, 2009, J AGR FOOD CHEM, V57, P9809, DOI 10.1021/jf902315e; Ishiguro K, 2007, BIOCHEM BIOPH RES CO, V362, P218, DOI 10.1016/j.bbrc.2007.08.012; Kazemi S, 2007, MOL BIOL CELL, V18, P3635, DOI 10.1091/mbc.E07-01-0053; Kim SO, 2005, ONCOGENE, V24, P2558, DOI 10.1038/sj.onc.1208446; KURODA Y, 1982, SCIENCE, V215, P415, DOI 10.1126/science.7058326; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Pan MH, 2008, MOL NUTR FOOD RES, V52, P527, DOI 10.1002/mnfr.200700157; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Sang SM, 2009, J AGR FOOD CHEM, V57, P10645, DOI 10.1021/jf9027443; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Seimon TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012772; Sharathchandra RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014708; Shieh PC, 2010, J AGR FOOD CHEM, V58, P3847, DOI 10.1021/jf904563c; Soboloff J, 2002, J BIOL CHEM, V277, P13812, DOI 10.1074/jbc.M112129200; Surh YJ, 2002, FOOD CHEM TOXICOL, V40, P1091, DOI 10.1016/S0278-6915(02)00037-6; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Yung HW, 2007, FASEB J, V21, P872, DOI 10.1096/fj.06-6054com	32	75	77	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39664	10.1371/journal.pone.0039664	http://dx.doi.org/10.1371/journal.pone.0039664			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768104	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100074
J	Kuo, KL; Zhu, HN; McNamara, PJ; Leggas, M				Kuo, Kuei-Ling; Zhu, Haining; McNamara, Patrick J.; Leggas, Markos			Localization and Functional Characterization of the Rat Oatp4c1 Transporter in an In Vitro Cell System and Rat Tissues	PLOS ONE			English	Article							ORGANIC ANION TRANSPORTER; CANCER RESISTANCE PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; PH-DEPENDENT TRANSPORT; DRUG DISPOSITION; APICAL MEMBRANE; SHOTGUN PROTEOMICS; PROXIMAL TUBULE; RENAL-CORTEX; KIDNEY-CELLS	The organic anion transporting polypeptide 4c1 (Oatp4c1) was previously identified as a novel uptake transporter predominantly expressed at the basolateral membrane in the rat kidney proximal tubules. Its functional role was suggested to be a vectorial transport partner of an apically-expressed efflux transporter for the efficient translocation of physiological substrates into urine, some of which were suggested to be uremic toxins. However, our in vitro studies with MDCKII cells showed that upon transfection rat Oatp4c1 polarizes to the apical membrane. In this report, we validated the trafficking and function of Oatp4c1 in polarized cell systems as well as its subcellular localization in rat kidney. Using several complementary biochemical, molecular and proteomic methods as well as antibodies amenable to immunohistochemistry, immunofluorescence, and immunobloting we investigated the expression pattern of Oatp4c1 in polarized cell systems and in the rat kidney. Collectively, these data demonstrate that rat Oatp4c1 traffics to the apical cell surface of polarized epithelium and localizes primarily in the proximal straight tubules, the S3 fraction of the nephron. Drug uptake studies in Oatp4c1-overexpressing cells demonstrated that Oatp4c1-mediated estrone-3-sulfate (E3S) uptake was pH-dependent and ATP-independent. These data definitively demonstrate the subcellular localization and histological location of Oatp4c1 and provide additional functional evidence that reconciles expression-function reports found in the literature.	[Kuo, Kuei-Ling; McNamara, Patrick J.; Leggas, Markos] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA; [Zhu, Haining] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY USA	University of Kentucky; University of Kentucky	Kuo, KL (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA.	mark.leggas@uky.edu	Leggas, Markos/E-6618-2011; Zhu, Haining/A-6076-2008	Leggas, Markos/0000-0003-4314-4533; Zhu, Haining/0000-0001-5498-6694	National Center for Research Resources [5P20RR020171-09]; National Institute of General Medical Sciences from the National Institutes of Health [8 P20 GM103486-09]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103486] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were partially supported by grants from the National Center for Research Resources (5P20RR020171-09) and the National Institute of General Medical Sciences (8 P20 GM103486-09) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 1998, J BIOL CHEM, V273, P22395, DOI 10.1074/jbc.273.35.22395; Bao Y, 2002, AM J PHYSIOL-RENAL, V282, pF1103, DOI 10.1152/ajprenal.00152.2001; Bergwerk AJ, 1996, AM J PHYSIOL-GASTR L, V271, pG231, DOI 10.1152/ajpgi.1996.271.2.G231; Bindels R J, 1991, Contrib Nephrol, V91, P7; Bleasby K, 2006, XENOBIOTICA, V36, P963, DOI 10.1080/00498250600861751; Breedveld P, 2007, MOL PHARMACOL, V71, P240, DOI 10.1124/mol.106.028167; BUERKERT J, 1983, AM J PHYSIOL, V244, pF442, DOI 10.1152/ajprenal.1983.244.4.F442; Chu XY, 2007, J PHARMACOL EXP THER, V321, P673, DOI 10.1124/jpet.106.116517; Deguchi T, 2005, J PHARMACOL EXP THER, V314, P932, DOI 10.1124/jpet.105.085613; Deguchi T, 2004, KIDNEY INT, V65, P162, DOI 10.1111/j.1523-1755.2004.00354.x; DUBOSE TD, 1979, J CLIN INVEST, V64, P476, DOI 10.1172/JCI109485; Ekaratanawong S, 2004, J PHARMACOL SCI, V94, P297, DOI 10.1254/jphs.94.297; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Evers R, 1996, J CLIN INVEST, V97, P1211, DOI 10.1172/JCI118535; Fukada K, 2004, MOL CELL PROTEOMICS, V3, P1211, DOI 10.1074/mcp.M400094-MCP200; Goh LB, 2002, BIOCHEM PHARMACOL, V64, P1569, DOI 10.1016/S0006-2952(02)01355-2; GOLDINGER JM, 1984, AM J PHYSIOL, V247, pC217, DOI 10.1152/ajpcell.1984.247.3.C217; Hirano M, 2004, J PHARMACOL EXP THER, V311, P139, DOI 10.1124/jpet.104.068056; Hoque MT, 2009, BIOCHEM BIOPH RES CO, V379, P60, DOI 10.1016/j.bbrc.2008.12.014; Huls M, 2008, KIDNEY INT, V73, P220, DOI 10.1038/sj.ki.5002645; Ito K, 2005, PHARM RES-DORDR, V22, P1559, DOI 10.1007/s11095-005-6810-2; Kobayashi D, 2003, J PHARMACOL EXP THER, V306, P703, DOI 10.1124/jpet.103.051300; Kojima R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134848; Lai LQ, 2002, BIOCHEM J, V361, P497, DOI 10.1042/0264-6021:3610497; Lee W, 2005, J BIOL CHEM, V280, P9610, DOI 10.1074/jbc.M411092200; Leggas M, 2004, MOL CELL BIOL, V24, P7612, DOI 10.1128/MCB.24.17.7612-7621.2004; Leuthold S, 2009, AM J PHYSIOL-CELL PH, V296, pC570, DOI 10.1152/ajpcell.00436.2008; Li L, 2011, DRUG METAB DISPOS, V39, P1478, DOI 10.1124/dmd.111.039370; Liu BL, 1997, J NATL CANCER I, V89, P1524, DOI 10.1093/jnci/89.20.1524; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; MALNIC G, 1972, AM J PHYSIOL, V222, P147, DOI 10.1152/ajplegacy.1972.222.1.147; Masuda S, 1999, MOL PHARMACOL, V55, P743; Masuda S, 1997, FEBS LETT, V407, P127, DOI 10.1016/S0014-5793(97)00314-1; Meier-Abt F, 2004, BBA-BIOMEMBRANES, V1664, P64, DOI 10.1016/j.bbamem.2004.04.004; Mikkaichi T, 2004, P NATL ACAD SCI USA, V101, P3569, DOI 10.1073/pnas.0304987101; MURER H, 1986, KIDNEY INT, V30, P171, DOI 10.1038/ki.1986.169; Mutsaers HAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018438; Nies AT, 2008, EXPERT OPIN DRUG MET, V4, P545, DOI [10.1517/17425255.4.5.545, 10.1517/17425255.4.5.545 ]; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Piepenhagen PA, 1995, AM J PHYSIOL-CELL PH, V269, pC1417, DOI 10.1152/ajpcell.1995.269.6.C1417; Qian YM, 2001, J BIOL CHEM, V276, P6404, DOI 10.1074/jbc.M008251200; Rizwan AN, 2007, PHARM RES-DORDR, V24, P450, DOI 10.1007/s11095-006-9181-4; SABOLIC I, 1992, AM J PHYSIOL, V263, pC1225, DOI 10.1152/ajpcell.1992.263.6.C1225; Saito H, 1996, J BIOL CHEM, V271, P20719, DOI 10.1074/jbc.271.34.20719; Satlin LM, 1997, J BIOL CHEM, V272, P26340, DOI 10.1074/jbc.272.42.26340; SCALERA V, 1981, MEMBRANE BIOCHEM, V4, P49, DOI 10.3109/09687688109065422; Toyohara T, 2009, J AM SOC NEPHROL, V20, P2546, DOI 10.1681/ASN.2009070696; VIEIRA FL, 1968, AM J PHYSIOL, V214, P710, DOI 10.1152/ajplegacy.1968.214.4.710; Walmsley SJ, 2010, AM J PHYSIOL-RENAL, V298, pF1323, DOI 10.1152/ajprenal.00711.2009; Wierdl M, 2003, MOL PHARMACOL, V64, P279, DOI 10.1124/mol.64.2.279; Yamaguchi H, 2010, DRUG METAB PHARMACOK, V25, P314, DOI 10.2133/dmpk.25.314; Yang CH, 2009, TOXICOL LETT, V190, P163, DOI 10.1016/j.toxlet.2009.07.011; Zhai JJ, 2009, FEBS J, V276, P3308, DOI 10.1111/j.1742-4658.2009.07057.x	53	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39641	10.1371/journal.pone.0039641	http://dx.doi.org/10.1371/journal.pone.0039641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768102	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100072
J	Mittal, RA; Hammel, M; Schwarz, J; Heschl, KM; Bretschneider, N; Flemmer, AW; Herber-Jonat, S; Konigshoff, M; Eickelberg, O; Holzinger, A				Mittal, Rashmi A.; Hammel, Markus; Schwarz, Johannes; Heschl, Katharina M.; Bretschneider, Nancy; Flemmer, Andreas W.; Herber-Jonat, Susanne; Koenigshoff, Melanie; Eickelberg, Oliver; Holzinger, Andreas			SFTA2-A Novel Secretory Peptide Highly Expressed in the Lung-Is Modulated by Lipopolysaccharide but Not Hyperoxia	PLOS ONE			English	Article							SURFACTANT PROTEIN-B; PULMONARY SURFACTANT; EPITHELIAL-CELLS; DEFICIENT MICE; SP-A; TRANSCRIPTION; PREDICTION; SEQUENCE; DISEASE; PU.1	Tissue-specific transcripts are likely to be of importance for the corresponding organ. While attempting to define the specific transcriptome of the human lung, we identified the transcript of a yet uncharacterized protein, SFTA2. In silico analyses, biochemical methods, fluorescence imaging and animal challenge experiments were employed to characterize SFTA2. Human SFTA2 is located on Chr. 6p21.33, a disease-susceptibility locus for diffuse panbronchiolitis. RT-PCR verified the abundance of SFTA2-specific transcripts in human and mouse lung. SFTA2 is synthesized as a hydrophilic precursor releasing a 59 amino acid mature peptide after cleavage of an N-terminal secretory signal. SFTA2 has no recognizable homology to other proteins while orthologues are present in all mammals. SFTA2 is a glycosylated protein and specifically expressed in nonciliated bronchiolar epithelium and type II pneumocytes. In accordance with other hydrophilic surfactant proteins, SFTA2 did not colocalize with lamellar bodies but colocalized with golgin97 and clathrin-labelled vesicles, suggesting a classical secretory pathway for its expression and secretion. In the mouse lung, Sfta2 was significantly downregulated after induction of an inflammatory reaction by intratracheal lipopolysaccharides paralleling surfactant proteins B and C but not D. Hyperoxia, however, did not alter SFTA2 mRNA levels. We have characterized SFTA2 and present it as a novel unique secretory peptide highly expressed in the lung.	[Mittal, Rashmi A.; Hammel, Markus; Heschl, Katharina M.; Flemmer, Andreas W.; Herber-Jonat, Susanne; Holzinger, Andreas] Univ Munich, Dr Von Haunerschen Kinderspital, D-80337 Munich, Germany; [Schwarz, Johannes; Koenigshoff, Melanie; Eickelberg, Oliver] Univ Munich, Univ Hosp, Comprehens Pneumol Ctr, Inst Expt Pneumol, Munich, Germany; [Schwarz, Johannes; Koenigshoff, Melanie; Eickelberg, Oliver] Helmholtz Zentrum Munchen, Munich, Germany; [Bretschneider, Nancy] Genomatix Software GmbH, Munich, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Mittal, RA (corresponding author), Univ Munich, Dr Von Haunerschen Kinderspital, Lindwurmstr 4, D-80337 Munich, Germany.	andreas.holzinger@med.uni-muenchen.de	W., Andreas Flemmer/AAQ-5654-2021; Eickelberg, Oliver/A-5461-2013	Eickelberg, Oliver/0000-0001-7170-0360	foundation Kindness for Kids, Munich, Germany; German Federal Ministry of Education and Research [GOLD.net 01GM0858]	foundation Kindness for Kids, Munich, Germany; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Funding was received from the foundation Kindness for Kids, Munich, Germany (http://www.kindness-for-kids.de) and the German Federal Ministry of Education and Research (GOLD.net 01GM0858), website: http://www.bmbf.de/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Diaz J, 2000, SHOCK, V14, P300, DOI 10.1097/00024382-200014030-00010; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412; Garcia-Verdugo I, 2010, INT J BIOCHEM CELL B, V42, P1779, DOI 10.1016/j.biocel.2010.08.003; Glasser SW, 2001, P NATL ACAD SCI USA, V98, P6366, DOI 10.1073/pnas.101500298; Hijikata M, 2011, HUM GENET, V129, P117, DOI 10.1007/s00439-010-0906-4; Jain D, 2007, AM J PHYSIOL-LUNG C, V292, pL861, DOI 10.1152/ajplung.00145.2006; Keicho N, 2000, AM J HUM GENET, V66, P501, DOI 10.1086/302786; Korfhagen TR, 1996, P NATL ACAD SCI USA, V93, P9594, DOI 10.1073/pnas.93.18.9594; Leth-Larsen R, 2004, MOL HUM REPROD, V10, P149, DOI 10.1093/molehr/gah022; Liu JG, 2006, J BIOL CHEM, V281, P19188, DOI 10.1074/jbc.M602059200; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Muller S, 1999, BIOCHEM BIOPH RES CO, V259, P364, DOI 10.1006/bbrc.1999.0677; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; NOGEE LM, 1993, NEW ENGL J MED, V328, P406, DOI 10.1056/NEJM199302113280606; Sato Atsuyasu, 2010, Am J Respir Crit Care Med, V181, P1098, DOI 10.1164/rccm.200912-1818OC; Seaton BA, 2010, INNATE IMMUN-LONDON, V16, P143, DOI 10.1177/1753425910368716; Sorokina EM, 2009, AM J PHYSIOL-LUNG C, V297, pL871, DOI 10.1152/ajplung.00052.2009; Stahlman MT, 1996, J HISTOCHEM CYTOCHEM, V44, P673, DOI 10.1177/44.7.8675988; Weichert N, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-4; White JA, 1997, GENOMICS, V45, P468, DOI 10.1006/geno.1997.4979; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Zhang ZM, 2004, PROTEIN SCI, V13, P2819, DOI 10.1110/ps.04682504	26	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40011	10.1371/journal.pone.0040011	http://dx.doi.org/10.1371/journal.pone.0040011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768197	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100169
J	Pilot, M; Jedrzejewski, W; Sidorovich, VE; Meier-Augenstein, W; Hoelzel, AR				Pilot, Malgorzata; Jedrzejewski, Wlodzimierz; Sidorovich, Vadim E.; Meier-Augenstein, Wolfram; Hoelzel, A. Rus			Dietary Differentiation and the Evolution of Population Genetic Structure in a Highly Mobile Carnivore	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSIS; WOLVES CANIS-LUPUS; HABITAT SPECIALIZATION; FORAGING ECOLOGY; DISPERSAL; FOREST; ECOSYSTEMS; PREDATION; HISTORY; CARBON	Recent studies on highly mobile carnivores revealed cryptic population genetic structures correlated to transitions in habitat types and prey species composition. This led to the hypothesis that natal-habitat-biased dispersal may be responsible for generating population genetic structure. However, direct evidence for the concordant ecological and genetic differentiation between populations of highly mobile mammals is rare. To address this we analyzed stable isotope profiles (delta C-13 and delta N-15 values) for Eastern European wolves (Canis lupus) as a quantifiable proxy measure of diet for individuals that had been genotyped in an earlier study (showing cryptic genetic structure), to provide a quantitative assessment of the relationship between individual foraging behavior and genotype. We found a significant correlation between genetic distances and dietary differentiation (explaining 46% of the variation) in both the marginal test and crucially, when geographic distance was accounted for as a co-variable. These results, interpreted in the context of other possible mechanisms such as allopatry and isolation by distance, reinforce earlier studies suggesting that diet and associated habitat choice are influencing the structuring of populations in highly mobile carnivores.	[Pilot, Malgorzata; Hoelzel, A. Rus] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Pilot, Malgorzata] Polish Acad Sci, Museum Zool, Warsaw, Poland; [Pilot, Malgorzata] Polish Acad Sci, Inst Zool, Warsaw, Poland; [Jedrzejewski, Wlodzimierz] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Jedrzejewski, Wlodzimierz] Ctr Ecol, IVIC, Caracas, Venezuela; [Sidorovich, Vadim E.] Natl Acad Sci Belarus, Inst Zool, Minsk, BELARUS; [Meier-Augenstein, Wolfram] James Hutton Inst, Stable Isotope Lab, Dundee, Scotland	Durham University; Polish Academy of Sciences; Polish Academy of Sciences; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Venezuelan Institute Science Research; National Academy of Sciences of Belarus (NASB); Scientific & Practical Center for Bioresources of the National Academy of Sciences of Belarus; James Hutton Institute	Pilot, M (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	a.r.hoelzel@durham.ac.uk	Meier-Augenstein, Wolfram/F-1895-2011	Meier-Augenstein, Wolfram/0000-0002-9498-5837; Pilot, Malgorzata/0000-0002-6057-5768	British Ecological Society; Foundation for Polish Science; Scottish Government Rural and Environment Research and Analysis Directorate (RERAD)	British Ecological Society; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Scottish Government Rural and Environment Research and Analysis Directorate (RERAD)	This study was funded by a Small Ecological Project Grant from the British Ecological Society. M. Pilot was supported by a postdoctoral fellowship from the Foundation for Polish Science. SCRI gratefully acknowledges the financial support by the Scottish Government Rural and Environment Research and Analysis Directorate (RERAD). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson M.J., 2003, DISTLM FORWARD FORTR; Anderson M.J., 2004, DISTLM V5 FORTRAN CO; Andersone A, 2004, ACTA THERIOL, V49, P357, DOI 10.1007/BF03192534; Carmichael LE, 2007, MOL ECOL, V16, P3466, DOI 10.1111/j.1365-294X.2007.03381.x; Clementz MT, 2001, OECOLOGIA, V129, P461, DOI 10.1007/s004420100745; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Dalen L, 2005, BIOL J LINN SOC, V84, P79, DOI 10.1111/j.1095-8312.2005.00415.x; Darimont CT, 2002, CAN J ZOOL, V80, P1638, DOI 10.1139/Z02-149; Davis JM, 2004, TRENDS ECOL EVOL, V19, P411, DOI 10.1016/j.tree.2004.04.006; Drucker DG, 2008, PALAEOGEOGR PALAEOCL, V266, P69, DOI 10.1016/j.palaeo.2008.03.020; Filonov K, 1989, UNGULATES LARGE PRED; Fox-Dobbs K, 2007, CAN J ZOOL, V85, P458, DOI 10.1139/Z07-018; Gade-Jorgensen I, 2000, ACTA THERIOL, V45, P537, DOI 10.4098/AT.arch.00-52; Garant D, 2005, NATURE, V433, P60, DOI 10.1038/nature03051; Geffen E, 2004, MOL ECOL, V13, P2481, DOI 10.1111/j.1365-294X.2004.02244.x; Germonpre M, 2009, J ARCHAEOL SCI, V36, P473, DOI 10.1016/j.jas.2008.09.033; Hoelzel AR, 2007, MOL BIOL EVOL, V24, P1407, DOI 10.1093/molbev/msm063; Hoelzel A. Rus, 2009, V17, P294; Jedrzejewski W, 2000, J MAMMAL, V81, P197, DOI 10.1644/1545-1542(2000)081&lt;0197:PSAPBW&gt;2.0.CO;2; Jedrzejewski Wlodzimierz, 2010, P207; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kielland K, 2001, ALCES-N AM MOOSE CON, V37, P329; KORNER C, 1991, OECOLOGIA, V88, P30, DOI 10.1007/BF00328400; Leonard JA, 2007, CURR BIOL, V17, P1146, DOI 10.1016/j.cub.2007.05.072; Mattioli L, 2004, J ZOOL, V264, P249, DOI 10.1017/S095283690400576X; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Mech L. David, 2003, P131; Migli Despoina, 2005, Journal of Biological Research (Thessaloniki), V4, P217; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Munoz-Fuentes V, 2009, J BIOGEOGR, V36, P1516, DOI 10.1111/j.1365-2699.2008.02067.x; Musiani M, 2007, MOL ECOL, V16, P4149, DOI 10.1111/j.1365-294X.2007.03458.x; Okarma H, 1995, ACTA THERIOL, V40, P335, DOI 10.4098/AT.arch.95-35; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pelletier F, 2009, PHILOS T R SOC B, V364, P1483, DOI 10.1098/rstb.2009.0027; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Pilot M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-104; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Rueness EK, 2003, NATURE, V425, P69, DOI 10.1038/nature01942; Sacks BN, 2008, MOL BIOL EVOL, V25, P1384, DOI 10.1093/molbev/msn082; Sacks BN, 2005, MOL ECOL, V14, P1241, DOI 10.1111/j.1365-294X.2005.02473.x; Sidorovich VE, 2003, WILDLIFE BIOL, V9, P103, DOI 10.2981/wlb.2003.032; Stenseth NC, 2004, P NATL ACAD SCI USA, V101, P10632, DOI 10.1073/pnas.0308674101; Stevens RE, 2006, OECOLOGIA, V149, P12, DOI 10.1007/s00442-006-0416-1; Urton EJM, 2005, OECOLOGIA, V145, P317, DOI 10.1007/s00442-005-0124-2; Van Treuren R, 1999, MOL ECOL, V8, P181, DOI 10.1046/j.1365-294X.1999.00548.x; Wabakken P, 2007, J WILDLIFE MANAGE, V71, P1631, DOI 10.2193/2006-222; Wellenreuther M, 2009, EVOL ECOL, V23, P557, DOI 10.1007/s10682-008-9255-3; Zunna Agrita, 2009, Estonian Journal of Ecology, V58, P141, DOI 10.3176/eco.2009.2.07	49	34	34	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39341	10.1371/journal.pone.0039341	http://dx.doi.org/10.1371/journal.pone.0039341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768075	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100046
J	Teramoto, W; Sakamoto, S; Furune, F; Gyoba, J; Suzuki, Y				Teramoto, Wataru; Sakamoto, Shuichi; Furune, Fumimasa; Gyoba, Jiro; Suzuki, Yoiti			Compression of Auditory Space during Forward Self-Motion	PLOS ONE			English	Article							RAPID HEAD TURNS; SOUND LOCALIZATION; DISTANCE PERCEPTION; VISUAL SPACE; MOVEMENTS; DIRECTION; LATERALIZATION; LISTENERS; ILLUSION; CORTEX	Background: Spatial inputs from the auditory periphery can be changed with movements of the head or whole body relative to the sound source. Nevertheless, humans can perceive a stable auditory environment and appropriately react to a sound source. This suggests that the inputs are reinterpreted in the brain, while being integrated with information on the movements. Little is known, however, about how these movements modulate auditory perceptual processing. Here, we investigate the effect of the linear acceleration on auditory space representation. Methodology/Principal Findings: Participants were passively transported forward/backward at constant accelerations using a robotic wheelchair. An array of loudspeakers was aligned parallel to the motion direction along a wall to the right of the listener. A short noise burst was presented during the self-motion from one of the loudspeakers when the listener's physical coronal plane reached the location of one of the speakers (null point). In Experiments 1 and 2, the participants indicated which direction the sound was presented, forward or backward relative to their subjective coronal plane. The results showed that the sound position aligned with the subjective coronal plane was displaced ahead of the null point only during forward self-motion and that the magnitude of the displacement increased with increasing the acceleration. Experiment 3 investigated the structure of the auditory space in the traveling direction during forward self-motion. The sounds were presented at various distances from the null point. The participants indicated the perceived sound location by pointing a rod. All the sounds that were actually located in the traveling direction were perceived as being biased towards the null point. Conclusions/Significance: These results suggest a distortion of the auditory space in the direction of movement during forward self-motion. The underlying mechanism might involve anticipatory spatial shifts in the auditory receptive field locations driven by afferent signals from vestibular system.	[Teramoto, Wataru; Sakamoto, Shuichi; Furune, Fumimasa; Suzuki, Yoiti] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi 980, Japan; [Teramoto, Wataru; Gyoba, Jiro] Tohoku Univ, Grad Sch Arts & Letters, Dept Psychol, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Teramoto, W (corresponding author), Muroran Inst Technol, Dept Comp Sci & Syst Engn, Muroran, Hokkaido 050, Japan.	teraw@ais.riec.tohoku.ac.jp	Suzuki, Yoiti/AAC-3765-2019	Gyoba, Jiro/0000-0003-4198-6323	Ministry of Education, Culture, Sports, Science and Technology [19001004, 21730585]; Grants-in-Aid for Scientific Research [23730693] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a Grant-in-Aid for Specially Promoted Research (No. 19001004) and Young Scientists (B) (No. 21730585) from the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOULT MD, 1950, AM J PSYCHOL, V63, P229, DOI 10.2307/1418926; ASHMEAD DH, 1995, J EXP PSYCHOL HUMAN, V21, P239, DOI 10.1037/0096-1523.21.2.239; Bach DR, 2008, CEREB CORTEX, V18, P145, DOI 10.1093/cercor/bhm040; Clark B, 1949, J PSYCHOL, V28, P235, DOI 10.1080/00223980.1949.9916005; Cooper J, 2008, EXP BRAIN RES, V191, P209, DOI 10.1007/s00221-008-1516-4; CORNSWEET TN, 1962, AM J PSYCHOL, V75, P485, DOI 10.2307/1419876; DiZio P, 2001, J NEUROPHYSIOL, V85, P2455, DOI 10.1152/jn.2001.85.6.2455; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Gray R, 2000, CURR BIOL, V10, P587, DOI 10.1016/S0960-9822(00)00493-0; GRAYBIEL A, 1951, J EXP PSYCHOL, V42, P227, DOI 10.1037/h0059186; Hazelhoff F, 1924, Z PSYCHOL, V96, P171; Kim HY, 2001, APPL ACOUST, V62, P245, DOI 10.1016/S0003-682X(00)00023-2; Lackner JR, 2010, EXP BRAIN RES, V202, P513, DOI 10.1007/s00221-009-2149-y; LACKNER JR, 1974, Q J EXP PSYCHOL, V26, P235, DOI 10.1080/14640747408400409; LESTER G, 1970, AM J PSYCHOL, V83, P554, DOI 10.2307/1420689; Leung J, 2008, P NATL ACAD SCI USA, V105, P6492, DOI 10.1073/pnas.0710837105; Lewald J, 2000, J NEUROPHYSIOL, V84, P1107, DOI 10.1152/jn.2000.84.2.1107; Lewald J, 2002, EUR J NEUROSCI, V16, P761, DOI 10.1046/j.1460-9568.2002.02117.x; Lewald J, 2001, EUR J NEUROSCI, V13, P2268, DOI 10.1046/j.0953-816x.2001.01608.x; MacKay DM, 1961, SENS COMMUN, P339; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; Munsterberg H, 1894, PSYCHOL REV, V1, P461; Neuhoff JG, 1998, NATURE, V395, P123, DOI 10.1038/25862; Neuhoff JG, 2001, ECOL PSYCHOL, V13, P87, DOI 10.1207/S15326969ECO1302_2; Neuhoff JG, 2009, J EXP PSYCHOL HUMAN, V35, P225, DOI 10.1037/a0013159; Nijhawan R, 2002, TRENDS COGN SCI, V6, P387, DOI 10.1016/S1364-6613(02)01963-0; Perrett S, 1997, PERCEPT PSYCHOPHYS, V59, P1018, DOI 10.3758/BF03205517; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Seifritz E, 2002, CURR BIOL, V12, P2147, DOI 10.1016/S0960-9822(02)01356-8; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; Speigle J. M., 1993, Proceedings IEEE 1993 Symposium on Research Frontiers in Virtual Reality (Cat. No.93TH0585-0), P92, DOI 10.1109/VRAIS.1993.378257; Stecker GC, 2000, J ACOUST SOC AM, V107, P3358, DOI 10.1121/1.429407; TEUBER HL, 1956, AM PSYCHOL, V11, P430; THURLOW WR, 1967, J ACOUST SOC AM, V42, P480, DOI 10.1121/1.1910604; Wallach H, 1940, J EXP PSYCHOL, V27, P339, DOI 10.1037/h0054629; Wightman FL, 1999, J ACOUST SOC AM, V105, P2841, DOI 10.1121/1.426899; Zahorik P, 2005, ACTA ACUST UNITED AC, V91, P409	37	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39402	10.1371/journal.pone.0039402	http://dx.doi.org/10.1371/journal.pone.0039402			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768076	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100047
J	Zhang, L; Wang, XM; Qian, H; Chi, S; Liu, C; Liu, T				Zhang, Lei; Wang, Xumin; Qian, Hao; Chi, Shan; Liu, Cui; Liu, Tao			Complete Sequences of the Mitochondrial DNA of the Wild Gracilariopsis lemaneiformis and Two Mutagenic Cultivated Breeds (Gracilariaceae, Rhodophyta)	PLOS ONE			English	Article							GENE CONTENT; NUCLEOTIDE-SEQUENCE; CHONDRUS-CRISPUS; GENOME; EVOLUTION; RED; GENERATION; VULGARIS; INSIGHTS	The complete mitochondrial DNA (mtDNA) of Gracilariopsis lemaneiformis was sequenced (25883 bp) and mapped to a circular model. The A+T composition was 72.5%. Forty six genes and two potentially functional open reading frames were identified. They include 24 protein-coding genes, 2 rRNA genes, 20 tRNA genes and 2 ORFs (orf60, orf142). There is considerable sequence synteny across the five red algal mtDNAs falling into Florideophyceae including Gr. lemaneiformis in this study and previously sequenced species. A long stem-loop and a hairpin structure were identified in intergenic regions of mt genome of Gr. lemaneiformis, which are believed to be involved with transcription and replication. In addition, the mtDNAs of two mutagenic cultivated breeds ("981" and "07-2") were also sequenced. Compared with the mtDNA of wild Gr. lemaneiformis, the genome size and gene length and order of three strains were completely identical except nine base mutations including eight in the protein-coding genes and one in the tRNA gene. None of the base mutations caused frameshift or a premature stop codon in the mtDNA genes. Phylogenetic analyses based on mitochondrial protein-coding genes and rRNA genes demonstrated Gracilariopsis andersonii had closer phylogenetic relationship with its parasite Gracilariophila oryzoides than Gracilariopsis lemaneiformis which was from the same genus of Gracilariopsis.	[Zhang, Lei; Qian, Hao; Chi, Shan; Liu, Cui; Liu, Tao] Ocean Univ China, Coll Marine Life Sci, Qingdao, Shandong, Peoples R China; [Wang, Xumin] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China	Ocean University of China; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Zhang, L (corresponding author), Ocean Univ China, Coll Marine Life Sci, Qingdao, Shandong, Peoples R China.	liutao@ouc.edu.cn	wang, xumin/HII-8627-2022		Province Science and Technology in the Guangdong Project [2010B060200010, 2010B020201015]; National Public Benefit Research Foundation of China [201203063]	Province Science and Technology in the Guangdong Project; National Public Benefit Research Foundation of China	This work was supported by Province Science and Technology in the Guangdong Project (2010B060200010, 2010B020201015) and the National Public Benefit Research Foundation of China (201203063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BOYEN C, 1994, NUCLEIC ACIDS RES, V22, P1400, DOI 10.1093/nar/22.8.1400; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Burger G, 1999, PLANT CELL, V11, P1675, DOI 10.1105/tpc.11.9.1675; BURGER G, 1995, J MOL BIOL, V245, P522, DOI 10.1006/jmbi.1994.0043; CHANG DD, 1986, MOL CELL BIOL, V6, P1446, DOI 10.1128/MCB.6.5.1446; [陈伟洲 CHEN Wei-Zhou], 2009, [中国海洋大学学报. 自然科学版, Journal of Ocean University of China], V39, P437; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Conklin KY, 2009, J APPL PHYCOL, V21, P691, DOI 10.1007/s10811-009-9404-2; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Gray MW, 2004, ANNU REV GENET, V38, P477, DOI 10.1146/annurev.genet.37.110801.142526; GRAY MW, 1992, INT REV CYTOL, V141, P233, DOI 10.1016/S0074-7696(08)62068-9; Hancock L, 2010, GENOME BIOL EVOL, V2, P897, DOI 10.1093/gbe/evq075; HOELZEL AR, 1991, MOL BIOL EVOL, V8, P475; Kubo T, 2000, NUCLEIC ACIDS RES, V28, P2571, DOI 10.1093/nar/28.13.2571; LEBLANC C, 1995, J MOL BIOL, V250, P484, DOI 10.1006/jmbi.1995.0392; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Meng L, 2009, PERIOD OCEAN U CHINA, V39, P94; NOSEK J, 2004, J APPL BIOMED, V2, P71; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; Ohta N, 1998, NUCLEIC ACIDS RES, V26, P5190, DOI 10.1093/nar/26.22.5190; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; SANTELICES B, 1989, AQUACULTURE, V78, P95, DOI 10.1016/0044-8486(89)90026-4; Smith DR, 2010, CURR GENET, V56, P427, DOI 10.1007/s00294-010-0311-5; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sui ZH, 2002, ACTA BOT SIN, V44, P557; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turmel M, 2003, PLANT CELL, V15, P1888, DOI 10.1105/tpc.013169; Turmel M, 2002, P NATL ACAD SCI USA, V99, P11275, DOI 10.1073/pnas.162203299; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Van der Meer J P, 1990, BIOL RED ALGAE, P103, DOI [10.1046/j.1420-9101.1992.5030533.x, DOI 10.1046/J.1420-9101.1992.5030533.X]; WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x; WOLFF G, 1994, J MOL BIOL, V237, P75, DOI 10.1006/jmbi.1994.1210; Xia BM, 1999, FLORA ALGARUM MARINA, P55; Xu JT, 2008, J APPL PHYCOL, V20, P681, DOI 10.1007/s10811-007-9247-7; ZHANG XC, 1987, BOT MAR, V30, P309, DOI 10.1515/botm.1987.30.4.309	38	17	17	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40241	10.1371/journal.pone.0040241	http://dx.doi.org/10.1371/journal.pone.0040241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768261	Green Submitted, gold, Green Published			2022-12-27	WOS:000305892100235
J	Zhang, SB; Guan, ZJ; Sun, M; Zhang, JJ; Cao, KF; Hu, H				Zhang, Shi-Bao; Guan, Zhi-Jie; Sun, Mei; Zhang, Juan-Juan; Cao, Kun-Fang; Hu, Hong			Evolutionary Association of Stomatal Traits with Leaf Vein Density in Paphiopedilum, Orchidaceae	PLOS ONE			English	Article							ANATOMICAL CHARACTERISTICS; HYDRAULIC CONDUCTANCE; WATER TRANSPORT; GENOME SIZE; PLANTS; CAPACITY; VENATION; DROUGHT; PHOTOSYNTHESIS; RESPONSES	Background: Both leaf attributes and stomatal traits are linked to water economy in land plants. However, it is unclear whether these two components are associated evolutionarily. Methodology/Principal Findings: In characterizing the possible effect of phylogeny on leaf attributes and stomatal traits, we hypothesized that a correlated evolution exists between the two. Using a phylogenetic comparative method, we analyzed 14 leaf attributes and stomatal traits for 17 species in Paphiopedilum. Stomatal length (SL), stomatal area (SA), upper cuticular thickness (UCT), and total cuticular thickness (TCT) showed strong phylogenetic conservatism whereas stomatal density (SD) and stomatal index (SI) were significantly convergent. Leaf vein density was correlated with SL and SD whether or not phylogeny was considered. The lower epidermal thickness (LET) was correlated positively with SL, SA, and stomatal width but negatively with SD when phylogeny was not considered. When this phylogenetic influence was factored in, only the significant correlation between SL and LET remained. Conclusion/Significance: Our results support the hypothesis for correlated evolution between stomatal traits and vein density in Paphiopedilum. However, they do not provide evidence for an evolutionary association between stomata and leaf thickness. These findings lend insight into the evolution of traits related to water economy for orchids under natural selection.	[Zhang, Shi-Bao; Guan, Zhi-Jie; Zhang, Juan-Juan; Hu, Hong] Chinese Acad Sci, Kunming Inst Bot, Key Lab Econ Plants & Biotechnol, Kunming, Yunnan, Peoples R China; [Zhang, Shi-Bao; Sun, Mei; Cao, Kun-Fang] Chinese Acad Sci, Key Lab Trop Plant Ecol, Kunming, Yunnan, Peoples R China; [Guan, Zhi-Jie] China Agr Univ, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China; [Guan, Zhi-Jie] China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; China Agricultural University; China Agricultural University	Zhang, SB (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Econ Plants & Biotechnol, Kunming, Yunnan, Peoples R China.	huhong@mail.kib.ac.cn	Zhang, Juan/GRX-2638-2022; Cao, Kun-Fang/D-2157-2009	Cao, Kun-Fang/0000-0002-2253-7189	National Natural Science Foundation of China [31170315, 30770226]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is financially supported by the National Natural Science Foundation of China (31170315, 30770226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasamaa K, 2001, AUST J PLANT PHYSIOL, V28, P765, DOI 10.1071/PP00157; Ackerly DD, 1998, AM NAT, V152, P767, DOI 10.1086/286208; ASHTON PMS, 1992, NEW PHYTOL, V121, P587, DOI 10.1111/j.1469-8137.1992.tb01130.x; ASSMANN SM, 1985, PLANT PHYSIOL, V77, P461, DOI 10.1104/pp.77.2.461; Beaulieu JM, 2008, NEW PHYTOL, V179, P975, DOI 10.1111/j.1469-8137.2008.02528.x; Beerling DJ, 1996, NEW PHYTOL, V134, P35, DOI 10.1111/j.1469-8137.1996.tb01144.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Brodribb TJ, 2007, PLANT PHYSIOL, V144, P1890, DOI 10.1104/pp.107.101352; Brodribb TJ, 2010, ECOL LETT, V13, P175, DOI 10.1111/j.1461-0248.2009.01410.x; Brodribb TJ, 2011, NEW PHYTOL, V192, P437, DOI 10.1111/j.1469-8137.2011.03795.x; Bucci SJ, 2004, TREE PHYSIOL, V24, P891, DOI 10.1093/treephys/24.8.891; Bussis D, 2006, FUNCT PLANT BIOL, V33, P1037, DOI 10.1071/FP06078; Carins Murphy MR, 2012, PLANT CELL ENVIRON, V35, P1407, DOI 10.1111/j.1365-3040.2012.02498.x; Caruso CM, 2005, EVOLUTION, V59, P826; Cox AV, 1997, PLANT SYST EVOL, V208, P197, DOI 10.1007/BF00985442; Cribb P., 1998, GENUS PAPHIOPEDILUM; Cunningham SA, 1999, ECOL MONOGR, V69, P569, DOI 10.1890/0012-9615(1999)069[0569:EDILSA]2.0.CO;2; Dunbar-Co S, 2009, INT J PLANT SCI, V170, P61, DOI 10.1086/593111; Edwards D, 1998, J EXP BOT, V49, P255, DOI 10.1093/jexbot/49.suppl_1.255; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Franks PJ, 2009, GEOBIOLOGY, V7, P227, DOI 10.1111/j.1472-4669.2009.00193.x; Franks PJ, 2009, PLANT CELL ENVIRON, V32, P1737, DOI [10.1111/j.1365-3040.2009.02031.x, 10.1111/j.1365-3040.2009.002031.x]; Gentry GL, 2006, ENTOMOL EXP APPL, V121, P115, DOI 10.1111/j.1570-8703.2006.00472.x; Gratani L, 1999, PHOTOSYNTHETICA, V37, P573, DOI 10.1023/A:1007171525298; Guan ZJ, 2011, J PLANT RES, V124, P289, DOI 10.1007/s10265-010-0372-z; Helbsing S, 2000, ANN BOT-LONDON, V86, P765, DOI 10.1006/anbo.2000.1239; Hodgson JG, 2010, ANN BOT-LONDON, V105, P573, DOI 10.1093/aob/mcq011; James SA, 2001, AUST J BOT, V49, P259, DOI 10.1071/BT99044; Jimenez MS, 2000, FLORA, V195, P228; Karasawa K, 1982, B HIROSHIMA BOT GARD, V5, P1; Kembel SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019992; Kerstiens G, 2006, J EXP BOT, V57, P2493, DOI 10.1093/jxb/erl017; MANETAS Y, 1997, PLANT ECOL, V128, P101, DOI DOI 10.1023/A:1009706806427; MUCHOW RC, 1989, PLANT CELL ENVIRON, V12, P425, DOI 10.1111/j.1365-3040.1989.tb01958.x; Nardini A, 2008, PHYSIOL PLANTARUM, V133, P755, DOI 10.1111/j.1399-3054.2008.01087.x; Niklas KJ, 1999, NEW PHYTOL, V143, P19, DOI 10.1046/j.1469-8137.1999.00441.x; Pittermann J, 2010, GEOBIOLOGY, V8, P112, DOI 10.1111/j.1472-4669.2010.00232.x; R Core Team, 2016, R FDN STAT COMP; Raven JA, 2002, NEW PHYTOL, V153, P371, DOI 10.1046/j.0028-646X.2001.00334.x; Riederer M, 2001, J EXP BOT, V52, P2023, DOI 10.1093/jexbot/52.363.2023; Sack L, 2006, ECOLOGY, V87, P483, DOI 10.1890/05-0710; Sack L, 2003, PLANT ECOL, V168, P139, DOI 10.1023/A:1024423820136; Schluter U, 2003, J EXP BOT, V54, P867, DOI 10.1093/jxb/erg087; Schreiber L, 1996, OECOLOGIA, V107, P426, DOI 10.1007/BF00333931; Scoffoni C, 2011, PLANT PHYSIOL, V156, P832, DOI 10.1104/pp.111.173856; TURNER IM, 1994, FUNCT ECOL, V8, P669, DOI 10.2307/2390225; Uhl D, 1999, PALAEOGEOGR PALAEOCL, V149, P15, DOI 10.1016/S0031-0182(98)00189-8; Walls RL, 2011, AM J BOT, V98, P244, DOI 10.3732/ajb.1000154; Wang RZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026209; Watkins JE, 2007, NEW PHYTOL, V176, P708, DOI 10.1111/j.1469-8137.2007.02194.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Willson CJ, 2008, AM J BOT, V95, P299, DOI 10.3732/ajb.95.3.299; Woodward FI, 1998, J EXP BOT, V49, P471, DOI 10.1093/jexbot/49.suppl_1.471; WOODWARD FI, 1987, NATURE, V327, P617, DOI 10.1038/327617a0; Xu Z, 2008, J EXP BOT, V59, P3317, DOI 10.1093/jxb/ern185; Zhang SB, 2011, PHYSIOL PLANTARUM, V142, P118, DOI 10.1111/j.1399-3054.2011.01448.x	56	54	73	12	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40080	10.1371/journal.pone.0040080	http://dx.doi.org/10.1371/journal.pone.0040080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768224	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100196
J	Baloucoune, GA; Chun, L; Zhang, WH; Xu, CJ; Huang, SL; Sun, Q; Wang, YY; Tu, HJ; Liu, JF				Baloucoune, Guillaume A.; Chun, Lei; Zhang, Wenhua; Xu, Chanjuan; Huang, Siluo; Sun, Qian; Wang, Yunyun; Tu, Haijun; Liu, Jianfeng			GABA(B) Receptor Subunit GB1 at the Cell Surface Independently Activates ERK1/2 through IGF-1R Transactivation	PLOS ONE			English	Article							TISSUE DISTRIBUTION; SPLICE VARIANTS; B RECEPTOR; PROTEIN; EXPRESSION; TRAFFICKING; CLONING; BRAIN; MICE; HETERODIMERIZATION	Background: Functional GABA(B) receptor is believed to require hetero-dimerization between GABA(B1) (GB1) and GABA(B2) (GB2) subunits. The GB1 extracellular domain is required for ligand binding, and the GB2 trans-membrane domain is responsible for coupling to G proteins. Atypical GABA(B) receptor responses observed in GB2-deficient mice suggested that GB1 may have activity in the absence of GB2. However the underlying mechanisms remain poorly characterized. Methodology/Principal Findings: Here, by using cells overexpressing a GB1 mutant (GB1asa) with the ability to translocate to the cell surface in the absence of GB2, we show that GABA(B) receptor agonists, such as GABA and Baclofen, can induce ERK1/2 phosphorylation in the absence of GB2. Furthermore, we demonstrate that GB1asa induces ERK1/2 phosphorylation through Gi/o proteins and PLC dependent IGF-1R transactivation. Conclusions/Significance: Our data suggest that GB1 may form a functional receptor at the cell surface in the absence of GB2.	[Baloucoune, Guillaume A.; Chun, Lei; Zhang, Wenhua; Xu, Chanjuan; Huang, Siluo; Sun, Qian; Wang, Yunyun; Tu, Haijun; Liu, Jianfeng] Huazhong Univ Sci & Technol, Sinofrance Lab Drug Screening, Key Lab Mol Biophys, Minist Educ,Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Baloucoune, GA (corresponding author), Huazhong Univ Sci & Technol, Sinofrance Lab Drug Screening, Key Lab Mol Biophys, Minist Educ,Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	jfliu@mail.hust.edu.cn	Sun, Qian/AAU-8410-2020; Liu, Jianfeng/E-2786-2012	Sun, Qian/0000-0002-9532-3042; 	Ministry of Science and Technology [2012CB51800, 2010DFA32140]; National Natural Science Foundation of China (NSFC) [31130028, 30973514]; Ministry of Education [B08029]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Education	This work was supported by grants from Ministry of Science and Technology (Grant 2012CB51800 and 2010DFA32140). ULR: http://www.973.gov.cn/AreaAppl.aspx), National Natural Science Foundation of China (NSFC) (Grant 31130028 and 30973514. URL: http://www.nsfc.gov.cn/Portal0/default152.htm), Program of Introducing Talents of Discipline to Universities of Ministry of Education (B08029. URL: http://www.moe.edu.cn/publicfiles/business/htmlfiles/moe/moe_2792/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2004, J BIOL CHEM, V279, P18840, DOI 10.1074/jbc.M313470200; Binet V, 2004, J BIOL CHEM, V279, P29085, DOI 10.1074/jbc.M400930200; Calver AR, 2000, NEUROSCIENCE, V100, P155, DOI 10.1016/S0306-4522(00)00262-1; Calver AR, 2001, J NEUROSCI, V21, P1203; Cao JH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-67; Clark JA, 2000, BRAIN RES, V860, P41, DOI 10.1016/S0006-8993(00)01958-2; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; David M, 2006, CELL SIGNAL, V18, P2172, DOI 10.1016/j.cellsig.2006.05.014; Dong AQ, 2007, CELL BIOL INT, V31, P500, DOI 10.1016/j.cellbi.2006.11.017; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; Franek M, 1999, NEUROPHARMACOLOGY, V38, P1657, DOI 10.1016/S0028-3908(99)00135-5; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Gassmann M, 2004, J NEUROSCI, V24, P6086, DOI 10.1523/JNEUROSCI.5635-03.2004; Giorelli M, 2001, J INTERF CYTOK RES, V21, P809, DOI 10.1089/107999001753238042; Isomoto S, 1998, BIOCHEM BIOPH RES CO, V253, P10, DOI 10.1006/bbrc.1998.9706; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kantamneni S, 2007, J NEUROCHEM, V100, P1003, DOI 10.1111/j.1471-4159.2006.04271.x; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Laviv T, J NEUROSCI, V31, P12523; Lin X, 2012, BIOCHEM J, V443, P627, DOI 10.1042/BJ20120188; Lujan R, 2005, NEUROSCIENCE, V130, P567, DOI 10.1016/j.neuroscience.2004.09.042; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14649, DOI 10.1073/pnas.251554498; Nakamura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020167; Prosser HM, 2001, MOL CELL NEUROSCI, V17, P1059, DOI 10.1006/mcne.2001.0995; Richer M, 2009, J MOL NEUROSCI, V38, P67, DOI 10.1007/s12031-008-9163-6; Rives ML, 2009, EMBO J, V28, P2195, DOI 10.1038/emboj.2009.177; Schwarz DA, 2000, J BIOL CHEM, V275, P32174, DOI 10.1074/jbc.M005333200; Tu HJ, 2007, CELL SIGNAL, V19, P1996, DOI 10.1016/j.cellsig.2007.05.004; Tu HJ, 2010, J NEUROSCI, V30, P749, DOI 10.1523/JNEUROSCI.2343-09.2010; Vanhoose AM, 2002, J BIOL CHEM, V277, P9049, DOI 10.1074/jbc.M108309200; Villemure JF, 2005, BIOCHEM J, V388, P47, DOI 10.1042/BJ20041435; Wei KR, 2001, NEUROREPORT, V12, P833, DOI 10.1097/00001756-200103260-00042; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354	36	16	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39698	10.1371/journal.pone.0039698	http://dx.doi.org/10.1371/journal.pone.0039698			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761875	Green Submitted, Green Published, gold			2022-12-27	WOS:000305826400029
J	Galeotti, C; Lahlou, Z; Goullon, D; Sarda-Thibault, H; Cahen-Varsaux, J; Bignon-Topalovic, J; Bashamboo, A; McElreavey, K; Brauner, R				Galeotti, Caroline; Lahlou, Zineb; Goullon, Domitille; Sarda-Thibault, Helene; Cahen-Varsaux, Juliette; Bignon-Topalovic, Joelle; Bashamboo, Anu; McElreavey, Ken; Brauner, Raja			Longitudinal Evaluation of the Hypothalamic-Pituitary-Testicular Function in 8 Boys with Adrenal Hypoplasia Congenita (AHC) Due to NR0B1 Mutations	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; SERUM INHIBIN-B; INCOMPLETE HYPOGONADOTROPIC HYPOGONADISM; NONSENSE MUTATION; GONADAL-FUNCTION; DAX-1 GENE; INSUFFICIENCY; MEN; SPERMATOGENESIS; EXPERIENCE	Background: Boys carrying mutations in the NR0B1 gene develop adrenal hypoplasia congenita (AHC) and impaired sexual development due to the combination of hypogonadotropic hypogonadism (HH) and primary defects in spermatogenesis. Methods: We analysed the evolution of hypothalamic-pituitary-testicular function of 8 boys with AHC due to NR0B1 mutations. Our objective was to characterize and monitor the progressive deterioration of this function. Results: The first symptoms appeared in the neonatal period (n = 5) or between 6 months and 8.7 years (n = 3). Basal plasma adrenocorticotrophic hormone (ACTH) concentrations increased in all boys, whilst cortisol levels decreased in one case. The natremia was equal or below 134 mmol/L and kaliemia was over 5 mmol/L. All had increased plasma renin. In 3 of 4 patients diagnosed in the neonatal period and evaluated during the first year, the basal plasma gonadotropins concentrations, and their response to gonadotropin releasing hormone (GnRH) test (n = 2), and those of testosterone were normal. The plasma inhibin B levels were normal in the first year of life. With the exception of two cases these concentrations decreased to below the normal for age. Anti-Mullerian hormone concentrations were normal for age in all except one case, which had low concentrations before the initiation of testosterone treatment. In 3 of the 8 cases the gene was deleted and the remaining 5 cases carried frameshift mutations that are predicted to introduce a downstream nonsense mutation resulting in a truncated protein. Conclusions: The decreases in testosterone and inhibin B levels indicated a progressive loss of testicular function in boys carrying NR0B1 mutations. These non-invasive examinations can help to estimate the age of the testicular degradation and cryopreservation of semen may be considered in these cases as investigational procedure with the aim of restoring fertility.	[Galeotti, Caroline; Lahlou, Zineb; Goullon, Domitille; Brauner, Raja] Univ Paris 05, Sorbonne Paris Cite, France; [Galeotti, Caroline; Lahlou, Zineb; Goullon, Domitille; Brauner, Raja] Hop Bicetre, AP HP, Unite Endocrinol Pediat, Le Kremlin Bicetre, France; [Sarda-Thibault, Helene] Ctr Hosp Rene Dubos, Serv Pediat, Pontoise, France; [Cahen-Varsaux, Juliette] Ctr Hosp Victor Dupuy, Serv Diabetol Endocrinol, Argenteuil, France; [Bignon-Topalovic, Joelle; Bashamboo, Anu; McElreavey, Ken] Inst Pasteur, Human Dev Genet Unit, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Centre Hospitalier Rene Dubos, Pontoise; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Galeotti, C (corresponding author), Univ Paris 05, Sorbonne Paris Cite, France.	raja.brauner@wanadoo.fr						Andersson AM, 2004, J CLIN ENDOCR METAB, V89, P2873, DOI 10.1210/jc.2003-032148; Andersson AM, 1998, J CLIN ENDOCR METAB, V83, P675, DOI 10.1210/jc.83.2.675; Andersson AM, 1997, J CLIN ENDOCR METAB, V82, P3976, DOI 10.1210/jc.82.12.3976; Bergada I, 2008, CLIN ENDOCRINOL, V68, P240, DOI 10.1111/j.1365-2265.2007.03026.x; Bergada I, 2006, J CLIN ENDOCR METAB, V91, P4092, DOI 10.1210/jc.2006-1079; Binder G, 2000, CLIN ENDOCRINOL, V53, P249, DOI 10.1046/j.1365-2265.2000.01038.x; Brown P, 2003, J CLIN ENDOCR METAB, V88, P1341, DOI 10.1210/jc.2002-021560; Crofton PM, 1997, CLIN ENDOCRINOL, V46, P109, DOI 10.1046/j.1365-2265.1997.d01-1744.x; FOREST MG, 1974, J CLIN INVEST, V53, P819, DOI 10.1172/JCI107621; Frapsauce C, HUM REPROD, V26, P724; GUO WW, 1995, JAMA-J AM MED ASSOC, V274, P324, DOI 10.1001/jama.274.4.324; Habiby RL, 1996, J CLIN INVEST, V98, P1055, DOI 10.1172/JCI118866; Jeffs B, 2001, ENDOCRINOLOGY, V142, P4486, DOI 10.1210/en.142.10.4486; Jensen TK, 1997, J CLIN ENDOCR METAB, V82, P4059, DOI 10.1210/jc.82.12.4059; Kaiserman KB, 1998, J PEDIATR-US, V133, P300, DOI 10.1016/S0022-3476(98)70242-2; Landau Z, 2001, CLIN ENDOCRINOL OXF, V72, P448; Li N, 2001, J CLIN ENDOCR METAB, V95, pe104; Lin L, 2006, J CLIN ENDOCR METAB, V91, P3048, DOI 10.1210/jc.2006-0603; Lourenco D, 2009, NEW ENGL J MED, V360, P1200, DOI 10.1056/NEJMoa0806228; Mantovani G, 2002, J CLIN ENDOCR METAB, V87, P44, DOI 10.1210/jc.87.1.44; Meeks JJ, 2003, DEVELOPMENT, V130, P1029, DOI 10.1242/dev.00316; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; Ozisik G, 2003, J CLIN ENDOCR METAB, V88, P417, DOI 10.1210/jc.2002-021034; Peter M, 1998, J CLIN ENDOCR METAB, V83, P2666, DOI 10.1210/jc.83.8.2666; Pierik FH, 1998, J CLIN ENDOCR METAB, V83, P3110, DOI 10.1210/jc.83.9.3110; Rey RA, 1999, J CLIN ENDOCR METAB, V84, P627, DOI 10.1210/jc.84.2.627; Shulman DI, 2007, PEDIATRICS, V119, pE484, DOI 10.1542/peds.2006-1612; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Tabarin A, 2000, J CLIN INVEST, V105, P321, DOI 10.1172/JCI7212; Takahashi T, 1997, J PEDIATR-US, V130, P485, DOI 10.1016/S0022-3476(97)70217-8; Yu RN, 1998, NAT GENET, V20, P353, DOI 10.1038/3822; ZANARIA E, 1994, NATURE, V372, P635, DOI 10.1038/372635a0	32	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39828	10.1371/journal.pone.0039828	http://dx.doi.org/10.1371/journal.pone.0039828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761912	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800074
J	Fenina, M; Simon-Chazottes, D; Vandormael-Pournin, S; Soueid, J; Langa, F; Cohen-Tannoudji, M; Bernard, BA; Panthier, JJ				Fenina, Myriam; Simon-Chazottes, Dominique; Vandormael-Pournin, Sandrine; Soueid, Jihane; Langa, Francina; Cohen-Tannoudji, Michel; Bernard, Bruno A.; Panthier, Jean-Jacques			I-SceI-Mediated Double-Strand Break Does Not Increase the Frequency of Homologous Recombination at the Dct Locus in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; MAMMALIAN-CELLS; TRANSGENE EXPRESSION; GENE; REPAIR; MELANOCYTES; PROMOTER; VECTOR; MODEL; DIFFERENTIATION	Targeted induction of double-strand breaks (DSBs) at natural endogenous loci was shown to increase the rate of gene replacement by homologous recombination in mouse embryonic stem cells. The gene encoding dopachrome tautomerase (Dct) is specifically expressed in melanocytes and their precursors. To construct a genetic tool allowing the replacement of Dct gene by any gene of interest, we generated an embryonic stem cell line carrying the recognition site for the yeast I-SceI meganuclease embedded in the Dct genomic segment. The embryonic stem cell line was electroporated with an I-SceI expression plasmid, and a template for the DSB-repair process that carried sequence homologies to the Dct target. The I-SceI meganuclease was indeed able to introduce a DSB at the Dct locus in live embryonic stem cells. However, the level of gene targeting was not improved by the DSB induction, indicating a limited capacity of I-SceI to mediate homologous recombination at the Dct locus. These data suggest that homologous recombination by meganuclease-induced DSB may be locus dependent in mammalian cells.	[Fenina, Myriam; Simon-Chazottes, Dominique; Vandormael-Pournin, Sandrine; Soueid, Jihane; Cohen-Tannoudji, Michel; Panthier, Jean-Jacques] Inst Pasteur, CNRS, URA 2578, Paris, France; [Langa, Francina] Inst Pasteur, Mouse Genet Engn Ctr, Paris, France; [Fenina, Myriam; Bernard, Bruno A.] LOreal Rech & Innovat, Dept Life Sci, Clichy, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; L'Oreal Group	Panthier, JJ (corresponding author), Inst Pasteur, CNRS, URA 2578, Paris, France.	panthier@pasteur.fr	PANTHIER, Jean-Jacques/I-4366-2014	PANTHIER, Jean-Jacques/0000-0002-7966-0663; Cohen-Tannoudji, Michel/0000-0002-6405-2657; Soueid, Jihane/0000-0002-1973-8705	Association Nationale de la Recherche et de la Technologie (ANRT) [C080052]; L'Oreal Recherche; Fondation pour la Recherche Medicale	Association Nationale de la Recherche et de la Technologie (ANRT)(French National Research Agency (ANR)); L'Oreal Recherche; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by grants from the Association Nationale de la Recherche et de la Technologie (ANRT), research contract C080052, and L'Oreal Recherche. MF was awarded fellowships from the ANRT, L'Oreal Recherche and Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2011, GENESIS, V49, P579, DOI 10.1002/dvg.20753; Aubin-Houzelstein G, 2008, J INVEST DERMATOL, V128, P2686, DOI 10.1038/jid.2008.120; Besaratinia A, 2009, METHODS, V48, P35, DOI 10.1016/j.ymeth.2009.02.008; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; BUDD PS, 1995, GENOMICS, V29, P35, DOI 10.1006/geno.1995.1212; CHOULIKA A, 1994, CR ACAD SCI III-VIE, V317, P1013; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Cohen-Tannoudji M, 1998, MOL CELL BIOL, V18, P1444, DOI 10.1128/MCB.18.3.1444; Connelly JP, 2010, MOL THER, V18, P1103, DOI 10.1038/mt.2010.57; Daboussi F, 2012, NUCL ACIDS IN PRESS; Donoho G, 1998, MOL CELL BIOL, V18, P4070, DOI 10.1128/MCB.18.7.4070; Dunn KJ, 2005, PIGM CELL RES, V18, P167, DOI 10.1111/j.1600-0749.2005.00226.x; Egidy G, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-34; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Guyonneau L, 2004, MOL CELL BIOL, V24, P3396, DOI 10.1128/MCB.24.8.3396-3403.2004; Guyonneau L, 2002, PIGM CELL RES, V15, P305, DOI 10.1034/j.1600-0749.2002.02039.x; Izmiryan A, 2011, NUCLEIC ACIDS RES, V39, P7610, DOI 10.1093/nar/gkr524; Kress C, 1998, MAMM GENOME, V9, P998, DOI 10.1007/s003359900914; Lanning JL, 2005, J INVEST DERMATOL, V125, P805, DOI 10.1111/j.0022-202X.2005.23819.x; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; LUKACSOVICH T, 1994, NUCLEIC ACIDS RES, V22, P5649, DOI 10.1093/nar/22.25.5649; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; PAVAN WJ, 1994, P NATL ACAD SCI USA, V91, P7159, DOI 10.1073/pnas.91.15.7159; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Puchta H, 1996, P NATL ACAD SCI USA, V93, P5055, DOI 10.1073/pnas.93.10.5055; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; Sargent RG, 1997, MOL CELL BIOL, V17, P267, DOI 10.1128/MCB.17.1.267; Serrano L, 2011, STEM CELLS DEV, V20, P363, DOI 10.1089/scd.2010.0159; Smih F, 1995, NUCLEIC ACIDS RES, V23, P5012, DOI 10.1093/nar/23.24.5012; Stambrook PJ, 2010, ADV EXP MED BIOL, V695, P59, DOI 10.1007/978-1-4419-7037-4_5; STEEL KP, 1992, DEVELOPMENT, V115, P1111; Tichy ED, 2010, STEM CELLS DEV, V19, P1699, DOI 10.1089/scd.2010.0058; Vasquez KM, 2001, P NATL ACAD SCI USA, V98, P8403, DOI 10.1073/pnas.111009698; Ward CM, 2002, STEM CELLS, V20, P472, DOI 10.1634/stemcells.20-5-472; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Woods SL, 2011, TRANSGENIC RES, V20, P421, DOI 10.1007/s11248-010-9421-6; Zhao SL, 1999, DEV BIOL, V216, P154, DOI 10.1006/dbio.1999.9480	43	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39895	10.1371/journal.pone.0039895	http://dx.doi.org/10.1371/journal.pone.0039895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761925	Green Published, Green Submitted, gold			2022-12-27	WOS:000305808700054
J	Kemeny, S; Dery, D; Loboda, Y; Rovner, M; Lev, T; Zuri, D; Finberg, JPM; Larisch, S				Kemeny, Stav; Dery, Dikla; Loboda, Yelena; Rovner, Marshall; Lev, Tali; Zuri, Dotan; Finberg, John P. M.; Larisch, Sarit			Parkin Promotes Degradation of the Mitochondrial Pro-Apoptotic ARTS Protein	PLOS ONE			English	Article							RECESSIVE JUVENILE PARKINSONISM; LEWY-BODY FORMATION; CELL-DEATH; ALPHA-SYNUCLEIN; NEURONAL DEATH; MOLECULAR PATHWAYS; BINDING PROTEIN; GROWTH-FACTOR; DISEASE; P53	Parkinson's disease (PD) is associated with excessive cell death causing selective loss of dopaminergic neurons. Dysfunction of the Ubiquitin Proteasome System (UPS) is associated with the pathophysiology of PD. Mutations in Parkin which impair its E3-ligase activity play a major role in the pathogenesis of inherited PD. ARTS (Sept4_i2) is a mitochondrial protein, which initiates caspase activation upstream of cytochrome c release in the mitochondrial apoptotic pathway. Here we show that Parkin serves as an E3-ubiquitin ligase to restrict the levels of ARTS through UPS-mediated degradation. Though Parkin binds equally to ARTS and Sept4_i1 (H5/PNUTL2), the non-apoptotic splice variant of Sept4, Parkin ubiquitinates and degrades only ARTS. Thus, the effect of Parkin on ARTS is specific and probably related to its pro-apoptotic function. High levels of ARTS are sufficient to promote apoptosis in cultured neuronal cells, and rat brains treated with 6-OHDA reveal high levels of ARTS. However, over-expression of Parkin can protect cells from ARTS-induced apoptosis. Furthermore, Parkin loss-of-function experiments reveal that reduction of Parkin causes increased levels of ARTS and apoptosis. We propose that in brain cells in which the E3-ligase activity of Parkin is compromised, ARTS levels increase and facilitate apoptosis. Thus, ARTS is a novel substrate of Parkin. These observations link Parkin directly to a pro-apoptotic protein and reveal a novel connection between Parkin, apoptosis, and PD.	[Kemeny, Stav; Dery, Dikla; Rovner, Marshall; Lev, Tali; Zuri, Dotan; Larisch, Sarit] Univ Haifa, Dept Biol, Fac Sci, Cell Death Res Lab, IL-31999 Haifa, Israel; [Kemeny, Stav; Loboda, Yelena; Finberg, John P. M.] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Dept Mol Pharmacol, Haifa, Israel	University of Haifa; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Kemeny, S (corresponding author), Univ Haifa, Dept Biol, Fac Sci, Cell Death Res Lab, IL-31999 Haifa, Israel.	saritlarisch@gmail.com		Kemeny, Stav/0000-0002-5292-215X	Aubrey and Ella Brown Fellowship; Muriel Edith Rickman Trust (UK); Johnson Johnson	Aubrey and Ella Brown Fellowship; Muriel Edith Rickman Trust (UK); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA)	This work was supported by funds from "The Aubrey and Ella Brown Fellowship'' (supporting a stipend for Dr. Kemeny), The Muriel Edith Rickman Trust (UK) (supporting equipment purchase for Dr. Finberg) and Johnson & Johnson (Focused Giving Program COSAT grant to Dr. Larisch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham MC, 2007, DEV CELL, V13, P464, DOI 10.1016/j.devcel.2007.09.008; Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Bornstein B, 2011, APOPTOSIS       0623; Bornstein B, 2012, INT J BIOCHEM CELL B, V44, P489, DOI 10.1016/j.biocel.2011.12.005; Braak H, 1996, J NEURAL TRANSM-SUPP, P1; Braak H, 1996, ACTA NEUROL SCAND, V93, P3; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Carp MJ, 2008, SEPTINS, P281; Chan NC, 2011, HUM MOL GENET; Chaudhuri KR, 2007, MOVEMENT DISORD, V22, P1901, DOI 10.1002/mds.21596; Choi P, 2003, MOL BRAIN RES, V117, P179, DOI 10.1016/S0169-328X(03)00318-8; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; da Costa CA, 2009, NAT CELL BIOL, V11, P1370, DOI 10.1038/ncb1981; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Dawson TM, 2010, MOVEMENT DISORD, V25, pS32, DOI 10.1002/mds.22798; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Dawson TM, 2002, NATURE NEUROSCIENCE; Dawson V L, 1995, Adv Pharmacol, V34, P323; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Edison N, 2012, CLIN CANC RES; Edison N, 2011, CELL DEATH DIFFER; Elhasid R, 2004, ONCOGENE, V23, P5468, DOI 10.1038/sj.onc.1207725; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Finberg JPM, 2010, RESTOR NEUROL NEUROS, V28, P803, DOI 10.3233/RNN-2010-0551; Foroud T, 2003, NEUROLOGY, V60, P796, DOI 10.1212/01.WNL.0000049470.00180.07; Friedlander RM, 1998, CELL DEATH DIFFER, V5, P823, DOI 10.1038/sj.cdd.4400433; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Garcia-Fernandez M, 2010, GENE DEV, V24, P2282, DOI 10.1101/gad.1970110; Garrison JB, 2011, MOL CELL, V41, P107, DOI 10.1016/j.molcel.2010.12.002; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goetz CG, 2007, MOVEMENT DISORD, V22, P179, DOI 10.1002/mds.21226; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Gottfried Y, 2004, EMBO J, V23, P1627, DOI 10.1038/sj.emboj.7600155; Gottfried Y, 2007, SCHIZOPHR RES, V96, P257, DOI 10.1016/j.schres.2007.05.031; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Ihara M, 2003, J BIOL CHEM, V278, P24095, DOI 10.1074/jbc.M301352200; Joch M, 2007, MOL BIOL CELL, V18, P3105, DOI 10.1091/mbc.E05-11-1027; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006; Kuroda Y, 2006, BIOCHEM BIOPH RES CO, V348, P787, DOI 10.1016/j.bbrc.2006.06.201; Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924; Larisch S, 2000, NAT CELL BIOL, V2, P915, DOI 10.1038/35046566; Larisch-Bloch S, 2000, CELL GROWTH DIFFER, V11, P1; Lee TV, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002261; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Liang ZQ, 2007, BRAIN RES, V1145, P190, DOI 10.1016/j.brainres.2007.01.130; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Lotan R, 2005, J BIOL CHEM, V280, P25802, DOI 10.1074/jbc.M501955200; Lu BW, 2004, MOL PSYCHIATR, V9, P6, DOI 10.1038/sj.mp.4001417; Matsumine H, 2001, METH MOLEC MED, V62, P13, DOI 10.1385/1-59259-142-6:13; McCarthy N, 2010, NAT REV CANCER, V10, P816, DOI 10.1038/nrc2969; Morley JF, 2010, NEUROLOGY, V75, pS9, DOI 10.1212/WNL.0b013e3181fb3628; Morrish PK, 1996, BRAIN, V119, P585, DOI 10.1093/brain/119.2.585; Mouatt-Prigent A, 2004, J NEURAL TRANSM, V111, P1209, DOI 10.1007/s00702-004-0144-9; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Olanow CW, 2007, MOVEMENT DISORD, V22, pS335, DOI 10.1002/mds.21675; Oliveira SA, 2003, ANN NEUROL, V53, P624, DOI 10.1002/ana.10524; PEREZPOLO JR, 1982, DEV NEUROSCI-BASEL, V5, P418, DOI 10.1159/000112702; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Prunell GF, 2004, J NEUROSCI RES, V78, P1, DOI 10.1002/jnr.20252; Ribe EM, 2008, BIOCHEM J, V415, P165, DOI 10.1042/BJ20081118; Ron I, 2010, HUM MOL GENET, V19, P3771, DOI 10.1093/hmg/ddq292; Rosen KM, 2010, J NEUROSCI RES, V88, P167, DOI 10.1002/jnr.22178; Rott R, 2008, J BIOL CHEM, V283, P3316, DOI 10.1074/jbc.M704809200; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Shehadeh L, 2009, MOVEMENT DISORD, V24, P204, DOI 10.1002/mds.22306; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z; Simola N, 2007, NEUROTOX RES, V11, P151, DOI 10.1007/BF03033565; Singh S, 2007, BRAIN RES REV, V54, P233, DOI 10.1016/j.brainresrev.2007.02.001; Sun CH, 2000, J BIOL CHEM, V275, P33777, DOI 10.1074/jbc.M006226200; Tatton WG, 1999, BBA-BIOENERGETICS, V1410, P195, DOI 10.1016/S0005-2728(98)00167-4; Turmel H, 2001, MOVEMENT DISORD, V16, P185, DOI 10.1002/mds.1037; Ulusoy A, 2008, EXP NEUROL, V212, P258, DOI 10.1016/j.expneurol.2008.04.026; Vercammen L, 2006, MOL THER, V14, P716, DOI 10.1016/j.ymthe.2006.06.009; Wild P, 2010, NAT CELL BIOL, V12, P104, DOI 10.1038/ncb0210-104; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Xie H, 1999, CELL MOTIL CYTOSKEL, V43, P52, DOI 10.1002/(SICI)1097-0169(1999)43:1<52::AID-CM6>3.0.CO;2-5; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0; Yi CH, 2009, DEV CELL, V16, P21, DOI 10.1016/j.devcel.2008.12.012; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zieger B, 2000, GENE, V261, P197, DOI 10.1016/S0378-1119(00)00527-8	93	24	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e38837	10.1371/journal.pone.0038837	http://dx.doi.org/10.1371/journal.pone.0038837			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792159	gold, Green Published, Green Submitted			2022-12-27	WOS:000306354700005
J	Getlik, M; Simard, JR; Termathe, M; Grutter, C; Rabiller, M; van Otterlo, WAL; Rauh, D				Getlik, Matthaeus; Simard, Jeffrey R.; Termathe, Martin; Gruetter, Christian; Rabiller, Matthias; van Otterlo, Willem A. L.; Rauh, Daniel			Fluorophore Labeled Kinase Detects Ligands That Bind within the MAPK Insert of p38 alpha Kinase	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; PROTEIN-KINASES; INHIBITORS; SITE; ATP; PATHWAYS; ABL	The vast majority of small molecules known to modulate kinase activity, target the highly conserved ATP-pocket. Consequently, such ligands are often less specific and in case of inhibitors, this leads to the inhibition of multiple kinases. Thus, selective modulation of kinase function remains a major hurdle. One of the next great challenges in kinase research is the identification of ligands which bind to less conserved sites and target the non-catalytic functions of protein kinases. However, approaches that allow for the unambiguous identification of molecules that bind to these less conserved sites are few in number. We have previously reported the use of fluorescent labels in kinases (FLiK) to develop direct kinase binding assays that exclusively detect ligands which stabilize inactive (DFG-out) kinase conformations. Here, we present the successful application of the FLiK approach to develop a high-throughput binding assay capable of directly monitoring ligand binding to a remote site within the MAPK insert of p38 alpha mitogen-activated protein kinase (MAPK). Guided by the crystal structure of an initially identified hit molecule in complex with p38 alpha, we developed a tight binding ligand which may serve as an ideal starting point for further investigations of the biological function of the MAPK insert in regulating the p38 alpha signaling pathway.	[Getlik, Matthaeus; Simard, Jeffrey R.; Termathe, Martin; Gruetter, Christian; Rabiller, Matthias; Rauh, Daniel] Max Planck Gesell, Chem Genom Ctr, Dortmund, Germany; [Gruetter, Christian; Rauh, Daniel] Tech Univ Dortmund, Fak Chem, Dortmund, Germany; [van Otterlo, Willem A. L.] Univ Stellenbosch, Dept Chem & Polymer Sci, ZA-7600 Stellenbosch, South Africa; [Getlik, Matthaeus; Simard, Jeffrey R.; Termathe, Martin; Gruetter, Christian; Rabiller, Matthias; Rauh, Daniel] Max Planck Inst Mol Physiol, D-44139 Dortmund, Germany	Max Planck Society; Dortmund University of Technology; Stellenbosch University; Max Planck Society	Getlik, M (corresponding author), Max Planck Gesell, Chem Genom Ctr, Dortmund, Germany.	daniel.rauh@tu-dortmund.de	van Otterlo, Willem A.L./AAJ-8542-2021; Rauh, Daniel/G-1595-2013	van Otterlo, Willem/0000-0002-3300-6463; Termathe, Martin/0000-0002-5618-4633; Rauh, Daniel/0000-0002-1970-7642	German Federal Ministry for Education and Research through the German National Genome Research Network-Plus (NGFN-Plus) [BMBF 01GS08104]; MSD; Bayer HealthCare; Merck-Serono; Bayer CropScience	German Federal Ministry for Education and Research through the German National Genome Research Network-Plus (NGFN-Plus)(Federal Ministry of Education & Research (BMBF)); MSD; Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); Merck-Serono(Merck & Company); Bayer CropScience(Bayer AG)	The work was supported by the German Federal Ministry for Education and Research through the German National Genome Research Network-Plus (NGFN-Plus) (Grant No. BMBF 01GS08104 to DR). MSD, Bayer HealthCare, Merck-Serono and Bayer CropScience are thanked for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akella R, 2008, BBA-PROTEINS PROTEOM, V1784, P48, DOI 10.1016/j.bbapap.2007.09.016; Comess KM, 2011, ACS CHEM BIOL, V6, P234, DOI 10.1021/cb1002619; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diskin R, 2008, J MOL BIOL, V375, P70, DOI 10.1016/j.jmb.2007.09.002; Eglen R, 2011, PHARMACOL THERAPEUT, V130, P144, DOI 10.1016/j.pharmthera.2011.01.007; Eglen RM, 2009, ASSAY DRUG DEV TECHN, V7, P22, DOI 10.1089/adt.2008.164; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabbro D, 2010, BBA-PROTEINS PROTEOM, V1804, P454, DOI 10.1016/j.bbapap.2009.12.009; Francis DM, 2011, NAT CHEM BIOL, V7, P916, DOI [10.1038/NCHEMBIO.707, 10.1038/nchembio.707]; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Laskowski R.A., 1993, J APPL CRYSTALLOGR, V26, P263; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Michelotti EL, 2005, BIOORG MED CHEM LETT, V15, P5274, DOI 10.1016/j.bmcl.2005.08.038; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perry JJP, 2009, J MOL BIOL, V391, P1, DOI 10.1016/j.jmb.2009.06.005; Rabiller M, 2010, ARCH PHARM, V343, P193, DOI 10.1002/ardp.201000028; Rauch J, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-23; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Sanz V, 2000, FEBS LETT, V474, P169, DOI 10.1016/S0014-5793(00)01598-2; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Simard JR, 2010, J AM CHEM SOC, V132, P4152, DOI 10.1021/ja908083e; Simard JR, 2009, J AM CHEM SOC, V131, P13286, DOI 10.1021/ja902010p; Simard JR, 2009, NAT CHEM BIOL, V5, P394, DOI 10.1038/nchembio.162; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Tong L, 1997, NAT STRUCT BIOL, V4, P311, DOI 10.1038/nsb0497-311; Vogtherr M, 2006, ANGEW CHEM INT EDIT, V45, P993, DOI 10.1002/anie.200502770; Wu WI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012913; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675	32	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39713	10.1371/journal.pone.0039713	http://dx.doi.org/10.1371/journal.pone.0039713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768308	gold, Green Published, Green Submitted			2022-12-27	WOS:000305966500021
J	Beynon, V; Quintana, FJ; Weiner, HL				Beynon, Vanessa; Quintana, Francisco J.; Weiner, Howard L.			Activated Human CD4+CD45RO+Memory T-Cells Indirectly Inhibit NLRP3 Inflammasome Activation through Downregulation of P2X7R Signalling	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; DIFFERENTIATION; CYTOKINES	Inflammasomes are multi-protein complexes that control the production of pro-inflammatory cytokines such as IL-1 beta. Inflammasomes play an important role in the control of immunity to tumors and infections, and also in autoimmune diseases, but the mechanisms controlling the activation of human inflammasomes are largely unknown. We found that human activated CD4+CD45RO+ memory T-cells specifically suppress P2X7R-mediated NLRP3 inflammasome activation, without affecting P2X7R-independent NLRP3 or NLRP1 inflammasome activation. The concomitant increase in pro-IL-1 beta production induced by activated memory T-cells concealed this effect. Priming with IFN beta decreased pro-IL-1 beta production in addition to NLRP3 inflammasome inhibition and thus unmasked the inhibitory effect on NLRP3 inflammasome activation. IFN beta suppresses NLRP3 inflammasome activation through an indirect mechanism involving decreased P2X7R signaling. The inhibition of pro-IL-1 beta production and suppression of NLRP3 inflammasome activation by IFN beta-primed human CD4+CD45RO+ memory T-cells is partly mediated by soluble FasL and is associated with down-regulated P2X7R mRNA expression and reduced response to ATP in monocytes. CD4+CD45RO+ memory T-cells from multiple sclerosis (MS) patients showed a reduced ability to suppress NLRP3 inflammasome activation, however their suppressive ability was recovered following in vivo treatment with IFN beta. Thus, our data demonstrate that human P2X7R-mediated NLRP3 inflammasome activation is regulated by activated CD4+CD45RO+ memory T cells, and provide new information on the mechanisms mediating the therapeutic effects of IFN beta in MS.	[Beynon, Vanessa; Quintana, Francisco J.; Weiner, Howard L.] Harvard Univ, Brigham & Womens Hosp, Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Beynon, V (corresponding author), Harvard Univ, Brigham & Womens Hosp, Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA.	hweiner@rics.bwh.harvard.edu	Quintana, Francisco Javier/AAB-6915-2020		National Multiple Sclerosis Society [RG 4151-A-12]	National Multiple Sclerosis Society(National Multiple Sclerosis Society)	This work was supported by the National Multiple Sclerosis Society, RG 4151-A-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Coclet-Ninin J, 1997, EUR CYTOKINE NETW, V8, P345; Correale J, 2006, NEUROLOGY, V67, P652, DOI 10.1212/01.wnl.0000233834.09743.3b; Dhib-Jalbut S, 2010, NEUROLOGY, V74, pS17, DOI 10.1212/WNL.0b013e3181c97d99; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Durelli L, 2009, ANN NEUROL, V65, P499, DOI 10.1002/ana.21652; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Friedle Scott A, 2010, Recent Pat CNS Drug Discov, V5, P35; Furlan R, 1999, J IMMUNOL, V163, P2403; Genc K, 1997, J CLIN INVEST, V99, P2664, DOI 10.1172/JCI119455; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Graber JJ, 2007, J NEUROIMMUNOL, V185, P168, DOI 10.1016/j.jneuroim.2007.01.011; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Guarda G, 2009, NATURE, V460, P269, DOI 10.1038/nature08100; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Huang WX, 2004, MULT SCLER J, V10, P482, DOI 10.1191/1352458504ms1071oa; Ichinohe T, 2011, P NATL ACAD SCI US; Jha S, 2010, J NEUROSCI, V30, P15811, DOI 10.1523/JNEUROSCI.4088-10.2010; JIANG H, 1995, J NEUROIMMUNOL, V61, P17, DOI 10.1016/0165-5728(95)00072-A; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Latz E, 2010, CURRENT OPINION IMMU, P1; Levings MK, 2001, J IMMUNOL, V166, P5530, DOI 10.4049/jimmunol.166.9.5530; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Ming X, 2002, J NEUROL SCI, V197, P9, DOI 10.1016/S0022-510X(02)00030-8; Murugaiyan G, 2008, J IMMUNOL, V181, P7480, DOI 10.4049/jimmunol.181.11.7480; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rudick RA, 1998, NEUROLOGY, V50, P1294, DOI 10.1212/WNL.50.5.1294; Rudick RA, 1997, NEW ENGL J MED, V337, P1604, DOI 10.1056/NEJM199711273372207; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sharp AJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-33; STONE LA, 1995, ANN NEUROL, V37, P611, DOI 10.1002/ana.410370511; Vallittu AM, 2007, NEUROL RES, V29, P763, DOI 10.1179/016164107X228633; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Wajant H, 2003, CYTOKINE GROWTH F R, V14, P53, DOI 10.1016/S1359-6101(02)00072-2; Weiner HL, 2009, ANN NEUROL, V65, P239, DOI 10.1002/ana.21640; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Witting A, 2006, P NATL ACAD SCI USA, V103, P6362, DOI 10.1073/pnas.0510418103; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Zhang X, 2010, CLIN NEUROL NEUROSUR, V112, P641, DOI 10.1016/j.clineuro.2010.04.020	46	25	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39576	10.1371/journal.pone.0039576	http://dx.doi.org/10.1371/journal.pone.0039576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768094	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100064
J	Chouteau, P; Jiang, ZG; Bravery, BD; Cai, J; Li, ZQ; Pedrono, M; Pays, O				Chouteau, Philippe; Jiang, Zhigang; Bravery, Benjamin D.; Cai, Jing; Li, Zhongqiu; Pedrono, Miguel; Pays, Olivier			Local Extinction in the Bird Assemblage in the Greater Beijing Area from 1877 to 2006	PLOS ONE			English	Article							BODY-SIZE; CHINA; EXPANSION	Recent growth in industrialization and the modernization of agricultural activities, combined with human population growth, has greatly modified China's natural environment, particularly in the vicinity of large cities. We compared avifauna checklists made between 1877 and 1938 with current checklists to determine the extent of local bird extinctions during the last century in the greater Beijing area. Our study shows that of the 411 bird species recorded from 1877-1938, 45 (10.9%) were no longer recorded from 2004-2006. Birds recorded as 'rare' in 1938 were more likely to have disappeared in subsequent years. Migrant status also influenced the probability of local bird extinction with winter migrants being the most affected class. Moreover, larger birds were more likely to have disappeared than smaller ones, potentially explained by differential ecological requirements and anthropogenic exploitation. Although our habitat descriptions and diet classification were not predictors of local bird extinction, the ecological processes driving local bird extinction are discussed in the light of historical changes that have impacted this region since the end of the 1930 s. Our results are of importance to the broader conservation of bird wildlife.	[Chouteau, Philippe; Jiang, Zhigang; Cai, Jing; Li, Zhongqiu] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [Bravery, Benjamin D.] Kexue Commun, Beijing, Peoples R China; [Pedrono, Miguel] Ctr Cooperat Int Rech Agron Dev, Montpellier, France; [Pays, Olivier] Univ Angers, Grp Ecol & Conservat, Angers, France	Chinese Academy of Sciences; Institute of Zoology, CAS; CIRAD; Universite d'Angers	Chouteau, P (corresponding author), Chinese Acad Sci, Inst Zool, Beijing, Peoples R China.	jiangzg@ioz.ac.cn	Bravery, Benjamin/E-7174-2012; Li, Zhong-qiu/A-1748-2011; Jiang, Zhigang/E-4598-2014	Li, Zhong-qiu/0000-0003-2004-293X; Jiang, Zhigang/0000-0003-2154-8588	Chinese Academy of Sciences [KSCX2-EW-Z-4, CXTDS2005-4]; China Commission of Post Doctor Study; French embassy in Beijing	Chinese Academy of Sciences(Chinese Academy of Sciences); China Commission of Post Doctor Study; French embassy in Beijing	This study was supported by the Chinese Academy of Sciences (KSCX2-EW-Z-4, CXTDS2005-4) and Post Doctor Fund of China Commission of Post Doctor Study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the French embassy in Beijing for financial support, particularly Christine M'Rini. We thank Peter J. Jarman and Vincent Bretagnolle for help improving the manuscript. We thank Pere Claude Lautissier and Pere Paul Henzemann (dagger), Directors of the Archives of the Congregation des Lazaristes in Paris, and staff at the library of the Institute of Zoology, Chinese Academy of Sciences in Beijing for help collecting data. Thanks to two anonymous reviewers for constructive comments on an earlier draft of this paper.	[Anonymous], 2009, BIRDS OF E ASIA; Axmacher JC, 2011, BIOL CONSERV, V144, P2362, DOI 10.1016/j.biocon.2011.06.016; Bawa KS, 2010, SCIENCE, V327, P1457, DOI 10.1126/science.1185164; Bennett P. M., 2002, OX ECOL EV; Berthold P, 2001, AUK, V2nd; BirdLife International, 2011, SPEC FACTSH AQ FASC; BirdLife International, 2009, DIR IMP BIRD AR CHIN; Bonter DN, 2009, CONSERV BIOL, V23, P440, DOI 10.1111/j.1523-1739.2008.01085.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Castelletta M, 2000, CONSERV BIOL, V14, P1870, DOI 10.1111/j.1523-1739.2000.99285.x; China Ornithological Society, 2005, CHIN BIRD REP 2004 2; David A., 1877, OISEAUX CHINE; David A, 1868, NOUVELLES ARCH MUSEU, VIII, P18; Droege S, 1998, CONSERV BIOL, V12, P1134, DOI 10.1046/j.1523-1739.1998.96402.x; EBENMAN B, 1995, OIKOS, V73, P225, DOI 10.2307/3545912; Enters T, 2004, WHAT DOES IT TAKE RO; Fang YP, 2007, J ENVIRON MANAGE, V83, P315, DOI 10.1016/j.jenvman.2006.03.007; FAO,, 2022, STAT WORLDS FOR 2022; FAO, 2001, FOR PLANT THEM PAP; Gill F., 2011, IOC WORLD BIRD NAMES; Gondhalekar D, 2007, P INT C CIT PLANN YO; Harris R.B., 2007, WILDLIFE CONSERVATIO; Haskell JP, 2002, NATURE, V418, P527, DOI 10.1038/nature00840; Hutto RL, 1998, AUK, V115, P823, DOI 10.2307/4089500; Jiang Z., 2012, ORYX INT J IN PRESS, V46; [江志红 JIANG Zhihong], 2008, [地理研究, Geographical Research], V27, P787; Kutner M. H., 2004, APPL LINEAR REGRESSI; Liu JG, 2003, SCIENCE, V300, P1240, DOI 10.1126/science.1078868; MacKinnon J, 2000, FIELD GUIDE BIRDS CH; Maclean IMD, 2011, P NATL ACAD SCI USA, V108, P12337, DOI 10.1073/pnas.1017352108; Newton I., 1979, POPULATION ECOLOGY R; Ning DT, 1997, OCCASIONAL PAPERS PR; Nunez D, 2006, ECOL ECON, V58, P606, DOI 10.1016/j.ecolecon.2005.08.010; Ohno Y, 1997, J FOR RES, V2, P153; Padoa-Schioppa E, 2006, ECOL INDIC, V6, P83, DOI 10.1016/j.ecolind.2005.08.006; Paterson AP, 2011, PASSERIFORMES PASSER; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Qian H, 2010, ECOLOGY, V91, P1172, DOI 10.1890/09-0620.1; R Core Team, 2016, R FDN STAT COMP; REMSEN JV, 1994, AUK, V111, P225, DOI 10.2307/4088531; Roberts RL, 2007, ANIM CONSERV, V10, P332, DOI 10.1111/j.1469-1795.2007.00117.x; Shaw T.-H., 1936, BIRDS HOPEI PROVINCE; Sheng Xuebin, 2004, Yingyong Shengtai Xuebao, V15, P589; Skagen SK, 2006, AUK, V123, P313, DOI 10.1642/0004-8038(2006)123[313:MSATCO]2.0.CO;2; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Sun Quan-Hui, 2000, Chinese Journal of Zoology, V35, P45; Tan MH, 2005, SCI CHINA SER D, V48, P1492, DOI 10.1360/03yd0374; Tang LN, 2010, BIOL CONSERV, V143, P1295, DOI 10.1016/j.biocon.2010.01.024; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tsukase Susume., 2007, CHINA WAR REGIONS CH, P110; Wake DB, 2008, P NATL ACAD SCI USA, V108, P9502; Wang HC, 1997, OCCASIONAL PAPERS PR; Wilder GD, 1938, PEKING NATURAL HIST; Woinarski JCZ, 2004, BIOL CONSERV, V116, P379, DOI 10.1016/S0006-3207(03)00231-3; Wood C, 2010, WATERBIRDS, V33, P30, DOI 10.1675/063.033.s103; Wu RD, 2011, FRONT ECOL ENVIRON, V9, P383, DOI 10.1890/100093; Xiao JY, 2006, LANDSCAPE URBAN PLAN, V75, P69, DOI 10.1016/j.landurbplan.2004.12.005; Xie Y, 2004, BIODIVERS CONSERV, V13, P1391, DOI 10.1023/B:BIOC.0000019396.31168.ba; Xie Z, 1994, SCI ATMOSPHERICA SIN, V18, P683; Xinhuanet, 2010, DIFF PRACT POACH CHI; Xu HG, 2009, BIOSCIENCE, V59, P843, DOI 10.1525/bio.2009.59.10.6; Xu YQ, 2001, J GEOGRAPHICAL SCI, V11, P427; Yang Jun, 2007, Urban Forestry & Urban Greening, V6, P287, DOI 10.1016/j.ufug.2007.02.001; Yuan JG, 2006, CHIN J POPUL RESOUR, V4, P28, DOI 10.1080/10042857.2006.10677463; Zhao SQ, 2006, ECOL RES, V21, P890, DOI 10.1007/s11284-006-0048-2; Zitske BP, 2011, CONSERV BIOL, V25, P993, DOI 10.1111/j.1523-1739.2011.01709.x; Zuur Alain F., 2009, P1	67	6	7	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39859	10.1371/journal.pone.0039859	http://dx.doi.org/10.1371/journal.pone.0039859			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768146	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100115
J	Bougard, C; Espie, S; Larnaudie, B; Moussay, S; Davenne, D				Bougard, Clement; Espie, Stephane; Larnaudie, Bruno; Moussay, Sebastien; Davenne, Damien			Effects of Time of Day and Sleep Deprivation on Motorcycle-Driving Performance	PLOS ONE			English	Article							PHYSICAL PERFORMANCE; MANUAL DEXTERITY; ROAD ACCIDENTS; SEVERITY; INJURIES; DRIVERS; ALCOHOL; CONSEQUENCES; TEMPERATURE; IMPAIRMENT	The aim of this study was to investigate whether motorcycle handling capabilities - measured by means of the efficiency of emergency manoeuvres - were dependent on prior sleep deprivation and time of day. Twelve male participants voluntarily took part in four test sessions, starting at 6 a. m., 10 a. m., 2 p. m., and 6 p. m., following a night either with or without sleep. Each test session comprised temperature and sleepiness measurements, before three different types of motorcycling tests were initiated: (1) stability in straight ahead riding at low speed (in "slow motion' mode and in "brakes and clutch" mode), (2) emergency braking and (3) crash avoidance tasks performed at 20 kph and 40 kph. The results indicate that motorcycle control at low speed depends on time of day, with an improvement in performance throughout the day. Emergency braking performance is affected at both speeds by time of day, with poorer performance (longer total stopping distance, reaction time and braking distance) in the morning, and also by sleep deprivation, from measurements obtained at 40 kph (incorrect initial speed). Except for a tendency observed after the sleepless night to deviate from the initial speed, it seems that crash avoidance capabilities are quite unaffected by the two disturbance factors. Consequently, some motorcycle handling capabilities (stability at low speed and emergency braking) change in the same way as the diurnal fluctuation observed in body temperature and sleepiness, whereas for others (crash avoidance) the participants were able to maintain their initial performance level despite the high levels of sleepiness recorded after a sleepless night. Motorcycle riders have to be aware that their handling capabilities are limited in the early morning and/or after sleep deprivation. Both these situations can increase the risk of falls and of being involved in a road accident.	[Bougard, Clement; Moussay, Sebastien; Davenne, Damien] Univ Caen, INSERM ERI27, F-14032 Caen, France; [Bougard, Clement; Espie, Stephane] IFSTTAR IM, Paris, France; [Bougard, Clement] IRBA Dept Environm Operat, Bretigny Sur Orge, France; [Larnaudie, Bruno] Univ Paris 11, CNRS UMR 8622, IEF AXIS, Orsay, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; Universite Gustave-Eiffel; UDICE-French Research Universities; Universite Paris Saclay	Bougard, C (corresponding author), Univ Caen, INSERM ERI27, F-14032 Caen, France.	clementbougard@aol.com	Davenne, Damien/K-2959-2015; Davenne, Damien/K-2432-2019	Davenne, Damien/0000-0002-9399-9970; Davenne, Damien/0000-0002-9399-9970; Bougard, Clement/0000-0001-6293-0041	Conseil Regional de Basse-Normandie (Regional council of Lower Normandy); Institut National de Recherche sur les Transports et leur Securite (The French National Institute for Transport and Safety Research); University of Caen/Basse-Normandie	Conseil Regional de Basse-Normandie (Regional council of Lower Normandy)(Region Normandie); Institut National de Recherche sur les Transports et leur Securite (The French National Institute for Transport and Safety Research); University of Caen/Basse-Normandie(Region Normandie)	This research was supported by a grant from the Conseil Regional de Basse-Normandie (Regional council of Lower Normandy), the Institut National de Recherche sur les Transports et leur Securite (The French National Institute for Transport and Safety Research) and the University of Caen/Basse-Normandie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACEM, 2009, MAIDS DEPTH INV ACC; Amans B, 2005, PROJET RIDER RAPPORT; [Anonymous], 2001, P INT MOT SAF C ORL; Association des Constructeurs Europeens de Motocydes (ACEM), 2006, GUID PTW SAF ROAD DE; Bastos Yara Gerber Lima, 2005, Cad. Saúde Pública, V21, P815, DOI 10.1590/S0102-311X2005000300015; Baxter C, 1983, Br J Sports Med, V17, P122; Bellamy N, 2002, ANN RHEUM DIS, V61, P1075, DOI 10.1136/ard.61.12.1075; BELLAMY N, 1991, ANN RHEUM DIS, V50, P243, DOI 10.1136/ard.50.4.243; Borbely AA, 2009, J SLEEP RES, V18, P1, DOI 10.1111/j.1365-2869.2009.00750.x; Bougard C, 2009, CHRONOBIOL INT, V26, P307, DOI 10.1080/07420520902774532; Bougard C, 2008, ACCIDENT ANAL PREV, V40, P635, DOI 10.1016/j.aap.2007.09.002; Bougard C, 2012, EUR J APPL PHYSIOL, V112, P59, DOI 10.1007/s00421-011-1948-6; Casagrande M, 1997, ERGONOMICS, V40, P613, DOI 10.1080/001401397187919; Cirera E, 2001, EUR J EPIDEMIOL, V17, P201, DOI 10.1023/A:1017961921607; Conrad P, 1996, ACCIDENT ANAL PREV, V28, P193, DOI 10.1016/0001-4575(95)00056-9; Corno M, 2008, CONTROL ENG PRACT, V16, P644, DOI 10.1016/j.conengprac.2007.08.001; Cossalter V, 2004, 20044305 SAE INT; Cossalter V., 2002, MOTORCYCLE DYNAMICS; Creaser JI, 2009, ACCIDENT ANAL PREV, V41, P906, DOI 10.1016/j.aap.2009.04.007; Crundall D, 2008, ACCIDENT ANAL PREV, V40, P983, DOI 10.1016/j.aap.2007.11.004; Dahms P, 1996, Wien Med Wochenschr, V146, P287; Davenne, 2006, RECHERCHE TRANSPORTS, V91, P137, DOI 10.3166/rts.91.137-151; de Lapparent M, 2006, ACCIDENT ANAL PREV, V38, P260, DOI 10.1016/j.aap.2005.09.001; de Rome L., 2002, MCC SURVEY MOTORCYCL; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Ecker H, 2001, P INT MOT SAF C 1 4; Falleti MG, 2003, J SLEEP RES, V12, P265, DOI 10.1111/j.1365-2869.2003.00363.x; Filou C, 1994, P ESV C MUN GERM; Fitzgerald RM, 1976, PHOTOGRAPHIC ANAL CO; Fondation Promocycle, 2003, 0154 FMQTRF FOND PRO; Gillberg M, 1998, PHYSIOL BEHAV, V64, P599, DOI 10.1016/S0031-9384(98)00063-8; Guyot R, 2008, GISEMENT SECURITE RO; Harrison WA, 1997, J SAFETY RES, V28, P105, DOI 10.1016/S0022-4375(96)00042-4; Haworth N., 2005, REV MOTORCYCLE LICEN; Himashree Gidugu, 2002, Indian Journal of Physiology and Pharmacology, V46, P6; Hockey GRJ, 1998, HUM FACTORS, V40, P233, DOI 10.1518/001872098779480479; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Hurt H, 1981, 805862 DOT HS NAT HI; Hurt H, 1984, 28 P HUM FACT SOC SA; Italian National Institute of Statistics (ISTAT), 2003, TRAFF ACC STAT YEAR; Jain A, 2009, J FORENSIC LEG MED, V16, P130, DOI 10.1016/j.jflm.2008.08.019; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kasantikul V, 2005, ACCIDENT ANAL PREV, V37, P357, DOI 10.1016/j.aap.2004.07.006; Klarica AJ, 2001, BRIT J SPORT MED, V35, P290, DOI 10.1136/bjsm.35.5.290; Kraemer S, 2000, BIOL PSYCHIAT, V48, P1069, DOI 10.1016/S0006-3223(00)00908-2; Larnaudie B, 2006, EXPT STUDY MOTORCYCL; Lavie P., 1985, ULTRADIAN RHYTHMS PH, V12, P148, DOI DOI 10.1007/978-3-642-70483-3_11; Limpert R, 2008, ACCIDENT INVESTIGATI, V18, P15; Lin MR, 2003, ANN EMERG MED, V41, P783, DOI 10.1067/mem.2003.186; Maruff P, 2005, J SLEEP RES, V14, P21, DOI 10.1111/j.1365-2869.2004.00438.x; Millar K., 1992, SLEEP AROUSAL PERFOR, P31; Miyata S, 2010, NEUROSCI LETT, V469, P229, DOI 10.1016/j.neulet.2009.12.001; MONK TH, 1982, CHRONOBIOLOGIA, V9, P49; Nakahara S, 2005, ACCIDENT ANAL PREV, V37, P833, DOI 10.1016/j.aap.2005.04.001; ONISR, 2007, SEC ROUT FRANC BIL A SEC ROUT FRANC BIL A; Orzel-Gryglewska J, 2010, INT J OCCUP MED ENV, V23, P95, DOI 10.2478/v10001-010-0004-9; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; Prem H, 1984, MOTORCYCLE RIDER SKI; Quddus MA, 2002, J SAFETY RES, V33, P445, DOI 10.1016/S0022-4375(02)00051-8; REILLY T, 1990, CRIT REV BIOMED ENG, V18, P165; Reilly T, 2003, BIOL RHYTHM RES, V34, P321, DOI 10.1076/brhm.34.4.321.26229; Reilly T, 2007, CHRONOBIOL INT, V24, P507, DOI 10.1080/07420520701420709; Reilly T, 2009, EUR J APPL PHYSIOL, V106, P321, DOI 10.1007/s00421-009-1066-x; Sagberg F, 1999, ACCIDENT ANAL PREV, V31, P639, DOI 10.1016/S0001-4575(99)00023-8; Schmidt R. A., 2008, MOTOR LEARNING PERFO; Sexton BF, 2004, 607 TRL LTD; Sharp RS, 2004, MULTIBODY SYST DYN, V12, P251, DOI 10.1023/B:MUBO.0000049195.60868.a2; SHARP RS, 1971, J MECH ENG SCI, V13, P316, DOI 10.1243/JMES_JOUR_1971_013_051_02; Shuman K, 2006, DO I BRAKE DO I SWER; Simoncic M, 2001, ACCIDENT ANAL PREV, V33, P147, DOI 10.1016/S0001-4575(00)00025-7; Tetard C, 1994, INRETS CONV ARC FRAN; Valent F, 2002, ACCIDENT ANAL PREV, V34, P71, DOI 10.1016/S0001-4575(00)00104-4; vanElslande P., 2002, ANAL APPROFONDIE ACC ANAL APPROFONDIE ACC; Watanabe Y, 1973, P 2 INT C AUT SAF SA; Welford A.T., 1968, FUNDAMENTALS SKILL; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005; Wong T W, 1990, Asia Pac J Public Health, V4, P34; Wright KP, 2002, AM J PHYSIOL-REG I, V283, pR1370, DOI 10.1152/ajpregu.00205.2002; Yokomori M, 2000, JSAE REV, V21, P61, DOI 10.1016/S0389-4304(99)00078-8	79	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39735	10.1371/journal.pone.0039735	http://dx.doi.org/10.1371/journal.pone.0039735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966GR	22761881	Green Published, gold			2022-12-27	WOS:000305826400032
J	Heller, NM; Gwinn, WM; Donnelly, RP; Constant, SL; Keegan, AD				Heller, Nicola M.; Gwinn, William M.; Donnelly, Raymond P.; Constant, Stephanie L.; Keegan, Achsah D.			IL-4 Engagement of the Type I IL-4 Receptor Complex Enhances Mouse Eosinophil Migration to Eotaxin-1 In Vitro	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE GAMMA; SIGNAL-TRANSDUCTION PATHWAYS; PROTEIN-COUPLED RECEPTORS; TUMOR-NECROSIS-FACTOR; INTERLEUKIN-4 RECEPTOR; ALLERGIC INFLAMMATION; AIRWAY INFLAMMATION; CYTOKINE PRODUCTION; BLOOD EOSINOPHILS; INSULIN-RECEPTOR	Background: Previous work from our laboratory demonstrated that IL-4R alpha expression on a myeloid cell type was responsible for enhancement of Th2-driven eosinophilic inflammation in a mouse model of allergic lung inflammation. Subsequently, we have shown that IL-4 signaling through type I IL-4 receptors on monocytes/macrophages strongly induced activation of the IRS-2 pathway and a subset of genes characteristic of alternatively activated macrophages. The direct effect(s) of IL-4 and IL-13 on mouse eosinophils are not clear. The goal of this study was determine the effect of IL-4 and IL-13 on mouse eosinophil function. Methods: Standard Transwell chemotaxis assay was used to assay migration of mouse eosinophils and signal transduction was assessed by Western blotting. Results: Here we determined that (i) mouse eosinophils express both type I and type II IL-4 receptors, (ii) in contrast to human eosinophils, mouse eosinophils do not chemotax to IL-4 or IL-13 although (iii) pre-treatment with IL-4 but not IL-13 enhanced migration to eotaxin-1. This IL-4-mediated enhancement was dependent on type I IL-4 receptor expression: gamma C-deficient eosinophils did not show enhancement of migratory capacity when pre-treated with IL-4. In addition, mouse eosinophils responded to IL-4 with the robust tyrosine phosphorylation of STAT6 and IRS-2, while IL-13-induced responses were considerably weaker. Conclusions: The presence of IL-4 in combination with eotaxin-1 in the allergic inflammatory milieu could potentiate infiltration of eosinophils into the lungs. Therapies that block IL-4 and chemokine receptors on eosinophils might be more effective clinically in reducing eosinophilic lung inflammation.	[Heller, Nicola M.; Keegan, Achsah D.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Heller, Nicola M.; Keegan, Achsah D.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Gwinn, William M.; Constant, Stephanie L.] George Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA; [Donnelly, Raymond P.] US FDA, Div Therapeut Prot, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; George Washington University; US Food & Drug Administration (FDA)	Heller, NM (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	akeegan@som.umaryland.edu	Donnelly, Raymond P./AFT-8600-2022	Donnelly, Raymond P./0000-0002-0695-5276	United States Public Health Service from National Institute of Allergy and Infectious Diseases, National Institutes of Health [AI038985]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI038985, R01AI038985] Funding Source: NIH RePORTER	United States Public Health Service from National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the United States Public Health Service grant AI038985 (to ADK) from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (www.niaid.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SJ, 2007, IMMUNOL ALLERGY CLIN, V27, P357, DOI 10.1016/j.iac.2007.07.004; Andrews AL, 2006, J IMMUNOL, V176, P7456, DOI 10.4049/jimmunol.176.12.7456; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Boehme SA, 1999, J IMMUNOL, V163, P1611; Borchers MT, 2002, J LEUKOCYTE BIOL, V71, P1033; Bracke M, 1998, J IMMUNOL, V161, P6768; Coffer PJ, 1998, BLOOD, V91, P2547, DOI 10.1182/blood.V91.7.2547.2547_2547_2557; Davey EJ, 1998, J IMMUNOL, V160, P5366; Davey EJ, 2000, INT IMMUNOL, V12, P995, DOI 10.1093/intimm/12.7.995; DUBOIS GR, 1994, J INVEST DERMATOL, V102, P843, DOI 10.1111/1523-1747.ep12382362; DUBOIS GR, 1994, ANN NY ACAD SCI, V725, P268, DOI 10.1111/j.1749-6632.1994.tb39809.x; Dubois GR, 1998, AM J RESP CELL MOL, V19, P691, DOI 10.1165/ajrcmb.19.4.3208; Dulkys Y, 2001, J IMMUNOL, V167, P3443, DOI 10.4049/jimmunol.167.6.3443; Dyer KD, 2008, J IMMUNOL, V181, P4004, DOI 10.4049/jimmunol.181.6.4004; Foster PS, 2008, CURR MOL MED, V8, P585, DOI 10.2174/156652408785748013; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Girard D, 1997, BIOCHEM J, V325, P147, DOI 10.1042/bj3250147; Gwinn WM, 2006, J IMMUNOL, V177, P4870, DOI 10.4049/jimmunol.177.7.4870; Hasan AM, 2010, INT IMMUNOPHARMACOL, V10, P1017, DOI 10.1016/j.intimp.2010.05.014; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; Hilton DJ, 1996, P NATL ACAD SCI USA, V93, P497, DOI 10.1073/pnas.93.1.497; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Horie S, 1997, INTERNAL MED, V36, P179, DOI 10.2169/internalmedicine.36.179; Jay SM, 2007, AM J PATHOL, V171, P632, DOI 10.2353/ajpath.2007.061213; Junttila IS, 2008, J EXP MED, V205, P2595, DOI 10.1084/jem.20080452; Justice JP, 2002, AM J PHYSIOL-LUNG C, V282, pL302, DOI 10.1152/ajplung.00158.2001; Kampen GT, 2000, BLOOD, V95, P1911, DOI 10.1182/blood.V95.6.1911; Kelly-Welch AE, 2004, J IMMUNOL, V172, P4545, DOI 10.4049/jimmunol.172.7.4545; Khodoun M, 2007, J IMMUNOL, V179, P6429, DOI 10.4049/jimmunol.179.10.6429; Klion AD, 2004, J ALLERGY CLIN IMMUN, V113, P30, DOI 10.1016/j.jaci.2003.10.050; Kudlacz E, 2002, INFLAMMATION, V26, P111, DOI 10.1023/A:1015548414274; Kuperman DA, 2008, CURR MOL MED, V8, P384, DOI 10.2174/156652408785161032; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Lee NA, 1997, J IMMUNOL, V158, P1332; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Luttmann W, 1999, AM J RESP CELL MOL, V20, P474, DOI 10.1165/ajrcmb.20.3.3326; MAGHAZACHI AA, 1994, J IMMUNOL, V153, P4969; Malm-Erjefalt M, 2004, J IMMUNOL METHODS, V288, P99, DOI 10.1016/j.jim.2004.02.008; MOSER R, 1993, J LAB CLIN MED, V122, P567; Munitz A, 2008, P NATL ACAD SCI USA, V105, P7240, DOI 10.1073/pnas.0802465105; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; Myrtek D, 2004, IMMUNOLOGY, V112, P597, DOI 10.1046/j.1365-2567.2004.01897.x; Nakajima H, 2007, INT ARCH ALLERGY IMM, V142, P265, DOI 10.1159/000097357; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Patel KD, 1998, BLOOD, V92, P3904, DOI 10.1182/blood.V92.10.3904.422k41_3904_3911; PATTI ME, 1995, J BIOL CHEM, V270, P24670, DOI 10.1074/jbc.270.42.24670; Pinho V, 2005, J LEUKOCYTE BIOL, V77, P800, DOI 10.1189/jlb.0704386; Ramalingam TR, 2008, NAT IMMUNOL, V9, P25, DOI 10.1038/ni1544; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; SCHLEIMER RP, 1992, J IMMUNOL, V148, P1086; Simson L, 2000, IMMUNOL CELL BIOL, V78, P415, DOI 10.1046/j.1440-1711.2000.00922.x; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Spencer LA, 2006, P NATL ACAD SCI USA, V103, P3333, DOI 10.1073/pnas.0508946103; Spencer LA, 2010, IMMUNOL CELL BIOL, V88, P250, DOI 10.1038/icb.2009.115; Thomas M, 2009, IMMUNOLOGY, V126, P413, DOI 10.1111/j.1365-2567.2008.02908.x; THORNHILL MH, 1990, J IMMUNOL, V145, P865; Tilton B, 1997, J BIOL CHEM, V272, P28096, DOI 10.1074/jbc.272.44.28096; Tomkinson A, 2001, AM J RESP CRIT CARE, V163, P721, DOI 10.1164/ajrccm.163.3.2005010; Trivedi SG, 2007, CELL MOL LIFE SCI, V64, P1269, DOI 10.1007/s00018-007-6527-y; Walsh ER, 2010, TRENDS IMMUNOL, V31, P39, DOI 10.1016/j.it.2009.10.001; Wang JM, 2000, J IMMUNOL, V165, P2222, DOI 10.4049/jimmunol.165.4.2222; WANG LM, 1992, EMBO J, V11, P4899, DOI 10.1002/j.1460-2075.1992.tb05596.x; Welham MJ, 1997, J BIOL CHEM, V272, P1377, DOI 10.1074/jbc.272.2.1377; Westerberg L, 2001, BLOOD, V98, P1086, DOI 10.1182/blood.V98.4.1086	65	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39673	10.1371/journal.pone.0039673	http://dx.doi.org/10.1371/journal.pone.0039673			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761864	Green Submitted, gold, Green Published			2022-12-27	WOS:000305826400025
J	Theurel, A; Frileux, S; Hatwell, Y; Gentaz, E				Theurel, Anne; Frileux, Stephanie; Hatwell, Yvette; Gentaz, Edouard			The Haptic Recognition of Geometrical Shapes in Congenitally Blind and Blindfolded Adolescents: Is There a Haptic Prototype Effect?	PLOS ONE			English	Article							VISUAL EXPERIENCE; CANONICAL VIEWS; OBJECT; CLASSIFICATION; FORM; REPRESENTATION; PERCEPTION; JUDGMENTS; DRAWINGS; PICTURES	Background: It has been shown that visual geometrical shape categories (rectangle and triangle) are graded structures organized around a prototype as demonstrated by perception and production tasks in adults as well as in children. The visual prototypical shapes are better recognized than other exemplars of the categories. Their existence could emerge from early exposure to these prototypical shapes that are present in our visual environment. The present study examined the role of visual experience in the existence of prototypical shapes by comparing the haptic recognition of geometrical shapes in congenitally blind and blindfolded adolescents. Methodology/Principal Findings: To determine whether the existence of a prototype effect (higher recognition of prototypical shapes than non prototypical shapes) depended on visual experience, congenitally blind and blindfolded sighted adolescents were asked to recognize in the haptic modality three categories of correct shapes (square, rectangle, triangle) varying in orientation (prototypical/canonical orientation vs. non prototypical/canonical orientation rotated by 45 degrees) among a set of other shapes. A haptic prototype effect was found in the blindfolded sighted whereas no difference between prototypical and non prototypical correct shapes was observed in the congenitally blind. A control experiment using a similar visual recognition task confirmed the existence of a visual prototype effect in a group of sighted adolescents. Conclusion/Significance: These findings show that the prototype effect is not intrinsic to the haptic modality but depends on visual experience. This suggests that the occurrence of visual and haptic prototypical shapes in the recognition of geometrical shape seems to depend on visual exposure to these prototypical shapes existing in our environment.	[Theurel, Anne; Hatwell, Yvette; Gentaz, Edouard] Univ Pierre Mendes France, Lab Psychol & NeuroCognit, CNRS, UMR 5105, Grenoble, France; [Frileux, Stephanie] Inst Natl Super Format & Rech Educat Jeunes Handi, Suresnes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie	Theurel, A (corresponding author), Univ Pierre Mendes France, Lab Psychol & NeuroCognit, CNRS, UMR 5105, Grenoble, France.	Edouard.Gentaz@upmf-grenoble.fr		Theurel, Anne/0000-0001-7372-3195				Alary F, 2009, NEUROPSYCHOLOGIA, V47, P2037, DOI 10.1016/j.neuropsychologia.2009.03.014; APPELLE S, 1980, CAN J PSYCHOL, V34, P161, DOI 10.1037/h0081027; CUTZU F, 1994, VISION RES, V34, P3037, DOI 10.1016/0042-6989(94)90277-1; EDELMAN S, 1991, BIOL CYBERN, V64, P209, DOI 10.1007/BF00201981; EWART AG, 1963, AM J PSYCHOL, V76, P488, DOI 10.2307/1419794; Feldman J, 2000, J EXP PSYCHOL HUMAN, V26, P152, DOI 10.1037/0096-1523.26.1.152; Gentaz E., 2008, REV FRANCAISE PEDAGO, V162, P1; Gentaz E, 2008, EXP BRAIN RES, V187, P331, DOI 10.1007/s00221-008-1382-0; Gori M, 2010, CURR BIOL, V20, P223, DOI 10.1016/j.cub.2009.11.069; HATWELL Y, 1959, J Psychol Norm Pathol (Paris), V56, P187; HATWELL Y, 1994, TRAITE PSYCHOL EXPT, P543; Hatwell Y, 1990, DEV EYE HAND COORDIN, P99; HATWELL Y, 2003, TOUCHING KNOWING; HATWELL Y, 1978, HDB SENSORY PHYSL, V7; Hatwell Y, 1985, PRIVATION SENSORIELL; Heller M., 1991, PSYCHOL TOUCH, P239; Heller MA, 1996, PERCEPTION, V25, P321, DOI 10.1068/p250321; HELLER MA, 1993, PERCEPT PSYCHOPHYS, V53, P422, DOI 10.3758/BF03206785; Kalenine S, BRIT J PSYC IN PRESS; Kalenine S, 2011, INT J BEHAV DEV, V35, P18, DOI 10.1177/0165025410367443; KARMILOFFSMITH A, 1990, COGNITION, V34, P57, DOI 10.1016/0010-0277(90)90031-E; Kennedy JM, 2002, PERCEPTION, V31, P1013, DOI 10.1068/p3259; Lange-Kuttner C., 2007, DEV DRAWING NONVERBA; LEDERMAN SJ, 1990, PERCEPT PSYCHOPHYS, V47, P54, DOI 10.3758/BF03208164; LEDERMAN SJ, 1993, ACTA PSYCHOL, V84, P29, DOI 10.1016/0001-6918(93)90070-8; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; LEDERMAN SJ, 1990, COGNITIVE PSYCHOL, V22, P421, DOI 10.1016/0010-0285(90)90009-S; MEDIN DL, 1978, PSYCHOL REV, V85, P207, DOI 10.1037/0033-295X.85.3.207; Millar Susanna, 1994, UNDERSTANDING REPRES, DOI 10.1093/acprof:oso/9780198521426.001.0001; MORRONGIELLO BA, 1994, PERCEPTION, V23, P833, DOI 10.1068/p230833; Newell FN, 2001, PSYCHOL SCI, V12, P37, DOI 10.1111/1467-9280.00307; Noordzij ML, 2007, PERCEPTION, V36, P101, DOI 10.1068/p5390; NOSOFSKY RM, 1988, J EXP PSYCHOL LEARN, V14, P700, DOI 10.1037/0278-7393.14.4.700; Piaget Jean, 1947, REPRESENTATION ESPAC; Picard D, 2005, J EXP CHILD PSYCHOL, V90, P48, DOI 10.1016/j.jecp.2004.09.002; Pick AD, 1966, PSYCHON SCI, V6, P367; Pick HL, 1974, PERCEPTION ESSAYS HO, P317; Pinet L., 2007, GRAND N, V80, P17; Postma A, 2008, PERCEPT PSYCHOPHYS, V70, P1197, DOI 10.3758/PP.70.7.1197; Revesz Geza, 1950, PSYCHOL ART BLIND; ROSCH E, 1975, COGNITIVE PSYCHOL, V7, P573, DOI 10.1016/0010-0285(75)90024-9; ROSCH E, 1975, COGNITIVE PSYCHOL, V7, P532, DOI 10.1016/0010-0285(75)90021-3; Sunanto J, 1998, PERCEPT MOTOR SKILL, V86, P383, DOI 10.2466/pms.1998.86.2.383; Tarr MJ, 1998, COGNITION, V67, P1, DOI 10.1016/S0010-0277(98)00026-2; UNGAR S, 1995, PERCEPTION, V24, P891, DOI 10.1068/p240891; Van Sommers P, 1984, DRAWING COGNITION DE; VERFAILLIE K, 1995, PERCEPT PSYCHOPHYS, V57, P925, DOI 10.3758/BF03205454; Wijntjes MWA, 2008, PERCEPTION, V37, P602, DOI 10.1068/p5714; Woods AT, 2008, PERCEPTION, V37, P1867, DOI 10.1068/p6038; Worchel P., 1951, PSYCHOL MONOGRAPH, V65	50	16	16	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e40251	10.1371/journal.pone.0040251	http://dx.doi.org/10.1371/journal.pone.0040251			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966GR	22761961	gold, Green Submitted, Green Published			2022-12-27	WOS:000305826400062
J	Lin, CH; Paulson, A; Abmayr, SM; Workman, JL				Lin, Chia-Hui; Paulson, Ariel; Abmayr, Susan M.; Workman, Jerry L.			HP1a Targets the Drosophila KDM4A Demethylase to a Subset of Heterochromatic Genes to Regulate H3K36me3 Levels	PLOS ONE			English	Article							HISTONE H3; PROTEIN-1 HP1; CHROMOSOMAL-PROTEIN; MSL COMPLEX; LYSINE 36; MELANOGASTER; METHYLATION; TRIMETHYLATION; TRANSCRIPTION; EXPRESSION	The KDM4 subfamily of JmjC domain-containing demethylases mediates demethylation of histone H3K36me3/me2 and H3K9me3/me2. Several studies have shown that human and yeast KDM4 proteins bind to specific gene promoters and regulate gene expression. However, the genome-wide distribution of KDM4 proteins and the mechanism of genomic-targeting remain elusive. We have previously identified Drosophila KDM4A (dKDM4A) as a histone H3K36me3 demethylase that directly interacts with HP1a. Here, we performed H3K36me3 ChIP-chip analysis in wild type and dkdm4a mutant embryos to identify genes regulated by dKDM4A demethylase activity in vivo. A subset of heterochromatic genes that show increased H3K36me3 levels in dkdm4a mutant embryos overlap with HP1a target genes. More importantly, binding to HP1a is required for dKDM4A-mediated H3K36me3 demethylation at a subset of heterochromatic genes. Collectively, these results show that HP1a functions to target the H3K36 demethylase dKDM4A to heterochromatic genes in Drosophila.	[Lin, Chia-Hui; Paulson, Ariel; Abmayr, Susan M.; Workman, Jerry L.] Stowers Inst Med Res, Kansas City, MO USA; [Abmayr, Susan M.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Lin, CH (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	jlw@stowers.org			National Institute of General Medical Sciences [GM047867]; Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047867, R01GM047867] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM047867 from the National Institute of General Medical Sciences (http://www.nigms.nih.gov/), and funding from the Stowers Institute for Medical Research (http://www.stowers.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2008, CURR OPIN GENET DEV, V18, P159, DOI 10.1016/j.gde.2007.12.003; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Bell O, 2008, MOL CELL BIOL, V28, P3401, DOI 10.1128/MCB.00006-08; Bua DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006789; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chantalat S, 2011, GENOME RES, V21, P1426, DOI 10.1101/gr.118091.110; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Cryderman DE, 2005, DEV DYNAM, V232, P767, DOI 10.1002/dvdy.20310; Cryderman DE, 1999, NUCLEIC ACIDS RES, V27, P3364, DOI 10.1093/nar/27.16.3364; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; De Lucia F, 2005, NUCLEIC ACIDS RES, V33, P2852, DOI 10.1093/nar/gki584; de Wit E, 2005, GENOME RES, V15, P1265, DOI 10.1101/gr.3198905; de Wit E, 2007, PLOS GENET, V3, P346, DOI 10.1371/journal.pgen.0030038; Dhami P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012339; Dinant C, 2009, MOL CELL BIOL, V29, P6335, DOI 10.1128/MCB.01048-09; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Fanti L, 2003, GENETICA, V117, P135, DOI 10.1023/A:1022971407290; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Hillringhaus L, 2011, J BIOL CHEM, V286, P41616, DOI 10.1074/jbc.M111.283689; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Iwamori N, 2011, BIOL REPROD, V84, P1225, DOI 10.1095/biolreprod.110.088955; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johansson AM, 2007, PLOS GENET, V3, P2235, DOI 10.1371/journal.pgen.0030209; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kawazu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017830; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2007, J BIOL CHEM, V282, P20827, DOI 10.1074/jbc.M703034200; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kwon SH, 2011, BIOESSAYS, V33, P280, DOI 10.1002/bies.201000138; Larschan E, 2007, MOL CELL, V28, P121, DOI 10.1016/j.molcel.2007.08.011; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Liang CY, 2011, NUCL ACIDS RES; Lin CH, 2008, MOL CELL, V32, P696, DOI 10.1016/j.molcel.2008.11.008; Lloret-Llinares M, 2008, NUCLEIC ACIDS RES, V36, P2852, DOI 10.1093/nar/gkn098; Lorbeck MT, 2010, GENE, V450, P8, DOI 10.1016/j.gene.2009.09.007; Lu BY, 2000, GENETICS, V155, P699; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Luijsterburg MS, 2009, J CELL BIOL, V185, P577, DOI 10.1083/jcb.200810035; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Piacentini L, 2003, J CELL BIOL, V161, P707, DOI 10.1083/jcb.200303012; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Sandmann T, 2006, NAT PROTOC, V1, P2839, DOI 10.1038/nprot.2006.383; Schwaiger M, 2010, GENOME RES, V20, P771, DOI 10.1101/gr.101790.109; Smith CD, 2007, SCIENCE, V316, P1586, DOI 10.1126/science.1139815; SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824; Spradling AC, 1999, GENETICS, V153, P135; Trojer P, 2009, J BIOL CHEM, V284, P8395, DOI 10.1074/jbc.M807818200; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zhang DZ, 2005, MOL CELL BIOL, V25, P6404, DOI 10.1128/MCB.25.15.6404-6414.2005	62	19	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39758	10.1371/journal.pone.0039758	http://dx.doi.org/10.1371/journal.pone.0039758			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761891	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800066
J	Bangsgaard, N; Houtkamp, M; Schuurhuis, DH; Parren, PWHI; Baadsgaard, O; Niessen, HWM; Skov, L				Bangsgaard, Nannie; Houtkamp, Mischa; Schuurhuis, Danita H.; Parren, Paul W. H. I.; Baadsgaard, Ole; Niessen, Hans W. M.; Skov, Lone			Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor	PLOS ONE			English	Article							CELL LUNG-CANCER; TYROSINE-KINASE INHIBITORS; TUMOR-NECROSIS-FACTOR; EGF RECEPTOR; CHEMOKINE EXPRESSION; MONOCLONAL-ANTIBODY; ACNEIFORM ERUPTION; COLORECTAL-CANCER; SKIN INFLAMMATION; SOLID TUMORS	Epidermal growth factor receptor (EGFR) inhibitors are widely used in the treatment of cancer. EGFR-targeted treatment is known to be associated with a high incidence of dermatological adverse reactions, including papulopustular rash, which can be dose-limiting and may affect compliance to treatment. Currently, the pathways involved in EGFR inhibitor-induced rash are poorly understood and few treatment options for this adverse event are available. Here, we developed a model for induction of papulopustular rash in healthy human volunteers by subcutaneous injection of the anti-EGFR monoclonal antibody zalutumumab. The injection sites and surrounding skin were evaluated by a dermatologist for the presence or absence of papulopustular rash and skin biopsies were taken to confirm the macroscopical findings by immunohistochemistry. Locally injected zalutumumab induced a papulopustular rash, characterized by acute follicular neutrophil-rich hair follicle inflammation, and thus mimicked adverse events induced by systemic administration of EGFR inhibitors. In this model, we tested the hypothesis that neutrophils, attracted by IL-8, play a central role in the observed rash. Indeed, concomitant local repeat dose treatment with HuMab-10F8, a neutralizing human antibody against IL-8, reduced the rash. Inhibition of IL-8 can therefore ameliorate dermatological adverse events induced by treatment with EGFR inhibitors.	[Bangsgaard, Nannie; Skov, Lone] Univ Copenhagen, Gentofte Hosp, Dept Dermatoallergol, Hellerup, Denmark; [Houtkamp, Mischa; Schuurhuis, Danita H.; Parren, Paul W. H. I.] Genmab, Utrecht, Netherlands; [Baadsgaard, Ole] Genmab, Copenhagen, Denmark; [Niessen, Hans W. M.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol & Cardiac Surg, Amsterdam, Netherlands	University of Copenhagen; Herlev & Gentofte Hospital; Genmab; Genmab; Vrije Universiteit Amsterdam	Bangsgaard, N (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Dermatoallergol, Hellerup, Denmark.	Nanban01@geh.regionh.dk	Skov, Lone/W-3575-2018	Skov, Lone/0000-0002-4784-9680; Niessen, Hans/0000-0001-9404-9822; Parren, Paul/0000-0002-4365-3859				Agero ALC, 2006, J AM ACAD DERMATOL, V55, P657, DOI 10.1016/j.jaad.2005.10.010; Alexandrescu DT, 2007, CLIN EXP DERMATOL, V32, P71, DOI 10.1111/j.1365-2230.2006.02285.x; Arenberg DA, 1996, J CLIN INVEST, V97, P2792, DOI 10.1172/JCI118734; Bleeker WK, 2004, J IMMUNOL, V173, P4699, DOI 10.4049/jimmunol.173.7.4699; Busam KJ, 2001, BRIT J DERMATOL, V144, P1169, DOI 10.1046/j.1365-2133.2001.04226.x; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; GUSTERSON B, 1984, CELL BIOL INT REP, V8, P649, DOI 10.1016/0309-1651(84)90045-6; Han SS, 2010, BRIT J DERMATOL, V162, P371, DOI 10.1111/j.1365-2133.2009.09536.x; Hansen LA, 2000, CANCER RES, V60, P3328; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Ho C, 2011, INVEST NEW DRUG, V29, P680, DOI 10.1007/s10637-010-9396-4; Hoffmann TK, 2009, INT J CANCER, V124, P2589, DOI 10.1002/ijc.24269; Hu JC, 2007, J AM ACAD DERMATOL, V56, P317, DOI 10.1016/j.jaad.2006.09.005; Jacot W, 2004, BRIT J DERMATOL, V151, P238, DOI 10.1111/j.1365-2133.2004.06026.x; Jost M, 2000, EUR J DERMATOL, V10, P505; Journagan S, 2006, J AM ACAD DERMATOL, V54, P358, DOI 10.1016/j.jaad.2005.08.033; Kimyai-Asadi A, 2002, ARCH DERMATOL, V138, P129, DOI 10.1001/archderm.138.1.129; Lacouture ME, 2006, NAT REV CANCER, V6, P803, DOI 10.1038/nrc1970; LARSEN CG, 1989, IMMUNOLOGY, V68, P31; LARSEN CG, 1989, SCIENCE, V243, P1464, DOI 10.1126/science.2648569; Machiels JP, 2011, LANCET ONCOL, V12, P333, DOI 10.1016/S1470-2045(11)70034-1; Mascia F, 2003, AM J PATHOL, V163, P303, DOI 10.1016/S0002-9440(10)63654-1; Mimeault M, 2004, SKIN PHARMACOL PHYS, V17, P153, DOI 10.1159/000078818; Molinari E, 2005, DERMATOLOGY, V211, P330, DOI 10.1159/000088502; NANNEY LB, 1990, J INVEST DERMATOL, V94, P742, DOI 10.1111/1523-1747.ep12874601; NANNEY LB, 1984, J INVEST DERMATOL, V83, P385, DOI 10.1111/1523-1747.ep12264708; Pastore S, 2005, J IMMUNOL, V174, P5047, DOI 10.4049/jimmunol.174.8.5047; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; PEREZSOLER R, 1994, J CLIN ONCOL, V12, P730, DOI 10.1200/JCO.1994.12.4.730; Pinto C, 2011, ONCOLOGIST, V16, P228, DOI 10.1634/theoncologist.2010-0298; Robert C, 2005, LANCET ONCOL, V6, P491, DOI 10.1016/S1470-2045(05)70243-6; Rodeck U, 1997, J CELL SCI, V110, P113; Rowinsky EK, 2004, ANNU REV MED, V55, P433, DOI 10.1146/annurev.med.55.091902.104433; Salcedo R, 2002, CLIN CANCER RES, V8, P2655; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; SCHRODER JM, 1987, J IMMUNOL, V139, P3474; Segaert S, 2005, ANN ONCOL, V16, P1425, DOI 10.1093/annonc/mdi279; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Skov L, 2008, J IMMUNOL, V181, P669, DOI 10.4049/jimmunol.181.1.669; Surguladze D, 2009, CANCER RES, V69, P5643, DOI 10.1158/0008-5472.CAN-09-0487; TAKEMATSU H, 1990, TOHOKU J EXP MED, V162, P1, DOI 10.1620/tjem.162.1; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Vivanco I, 2010, CURR OPIN ONCOL, V22, P573, DOI 10.1097/CCO.0b013e32833edbdf	43	33	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39706	10.1371/journal.pone.0039706	http://dx.doi.org/10.1371/journal.pone.0039706			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761877	gold, Green Published			2022-12-27	WOS:000305781700059
J	Puill-Stephan, E; Seneca, FO; Miller, DJ; van Oppen, MJH; Willis, BL				Puill-Stephan, Eneour; Seneca, Francois O.; Miller, David J.; van Oppen, Madeleine J. H.; Willis, Bette L.			Expression of Putative Immune Response Genes during Early Ontogeny in the Coral Acropora millepora	PLOS ONE			English	Article							INVERTEBRATE CUCUMARIA-ECHINATA; LECTIN CEL-III; RECOGNITION; SYSTEM; ALLORECOGNITION; ENDOSYMBIONT; SETTLEMENT; CNIDARIA; ANCIENT; GROWTH	Background: Corals, like many other marine invertebrates, lack a mature allorecognition system in early life history stages. Indeed, in early ontogeny, when corals acquire and establish associations with various surface microbiota and dinoflagellate endosymbionts, they do not efficiently distinguish between closely and distantly related individuals from the same population. However, very little is known about the molecular components that underpin allorecognition and immunity responses or how they change through early ontogeny in corals. Methodology/Principal Findings: Patterns in the expression of four putative immune response genes (apextrin, complement C3, and two CELIII type lectin genes) were examined in juvenile colonies of Acropora millepora throughout a six-month post-settlement period using quantitative real-time PCR (qPCR). Expression of a CELIII type lectin gene peaked in the fourth month for most of the coral juveniles sampled and was significantly higher at this time than at any other sampling time during the six months following settlement. The timing of this increase in expression levels of putative immune response genes may be linked to allorecognition maturation which occurs around this time in A. millepora. Alternatively, the increase may represent a response to immune challenges, such as would be involved in the recognition of symbionts (such as Symbiodinium spp. or bacteria) during winnowing processes as symbioses are fine-tuned. Conclusions/Significance: Our data, although preliminary, are consistent with the hypothesis that lectins may play an important role in the maturation of allorecognition responses in corals. The co-expression of lectins with apextrin during development of coral juveniles also raises the possibility that these proteins, which are components of innate immunity in other invertebrates, may influence the innate immune systems of corals through a common pathway or system. However, further studies investigating the expression of these genes in alloimmune-challenged corals are needed to further clarify emerging evidence of a complex innate immunity system in corals.	[Puill-Stephan, Eneour; Miller, David J.; van Oppen, Madeleine J. H.; Willis, Bette L.] James Cook Univ, AIMS JCU, Townsville, Qld, Australia; [Puill-Stephan, Eneour; Seneca, Francois O.; Miller, David J.; van Oppen, Madeleine J. H.; Willis, Bette L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Puill-Stephan, Eneour; Seneca, Francois O.; van Oppen, Madeleine J. H.; Willis, Bette L.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia; [Puill-Stephan, Eneour; Seneca, Francois O.; van Oppen, Madeleine J. H.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Puill-Stephan, Eneour] Univ Bretagne Occidentale, Lab Optimisat Regulat Physiol, Brest, France; [Seneca, Francois O.; Miller, David J.] James Cook Univ, Sch Pharm & Mol Sci, Townsville, Qld, Australia; [Seneca, Francois O.] Stanford Univ, Dept Biol Sci, Hopkins Marine Stn, Pacific Grove, CA 93950 USA	James Cook University; James Cook University; James Cook University; Australian Institute of Marine Science; Universite de Bretagne Occidentale; James Cook University; Stanford University	Puill-Stephan, E (corresponding author), James Cook Univ, AIMS JCU, Townsville, Qld, Australia.	Bette.Willis@jcu.edu.au	Seneca, Francois/F-9040-2010; van Oppen, Madeleine JH/C-3261-2008	Seneca, Francois/0000-0002-8908-1227; PUILL-STEPHAN, Eneour/0000-0003-0618-8051; van Oppen, Madeleine/0000-0003-4607-0744	Australian Research Council through the ARC Centre of Excellence for Coral Reef Studies; AIMS@JCU; Australian Institute of Marine Science; James Cook University	Australian Research Council through the ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); AIMS@JCU; Australian Institute of Marine Science; James Cook University	This study was supported by the Australian Research Council through the ARC Centre of Excellence for Coral Reef Studies (www.coralcoe.org.au), AIMS@JCU (aims.jcu.edu.au), the Australian Institute of Marine Science (www.aims.gov.au), and James Cook University (www.jcu.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2009, MOL ECOL, V18, P3532, DOI 10.1111/j.1365-294X.2009.04276.x; Anthony KRN, 2004, LIMNOL OCEANOGR, V49, P2201, DOI 10.4319/lo.2004.49.6.2201; Babcock R, 1996, J EXP MAR BIOL ECOL, V206, P179, DOI 10.1016/S0022-0981(96)02622-6; Barki Y, 2002, MAR ECOL PROG SER, V231, P91, DOI 10.3354/meps231091; Csaszar NBM, 2009, MAR ECOL PROG SER, V392, P93, DOI 10.3354/meps08194; Dishaw LJ, 2005, IMMUNOGENETICS, V57, P535, DOI 10.1007/s00251-005-0005-1; Frank U, 1997, P ROY SOC B-BIOL SCI, V264, P99, DOI 10.1098/rspb.1997.0015; Grasso LC, 2011, DEV BIOL, V353, P411, DOI 10.1016/j.ydbio.2011.02.010; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Hughes RN, 2004, EVOL DEV, V6, P431, DOI 10.1111/j.1525-142X.2004.04051.x; Iguchi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020140; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kouzuma Y, 2003, J BIOCHEM, V134, P395, DOI 10.1093/jb/mvg157; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Littman RA, 2009, MAR ECOL PROG SER, V389, P45, DOI 10.3354/meps08180; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; Nozawa Y, 2005, MAR ECOL PROG SER, V286, P115, DOI 10.3354/meps286115; Oren M, 2007, DEV COMP IMMUNOL, V31, P889, DOI 10.1016/j.dci.2006.12.009; Puill-Stephan E, 2012, CORAL REEFS, V31, P1019, DOI 10.1007/s00338-012-0912-1; Puill-Stephan E, 2012, P ROY SOC B-BIOL SCI, V279, P699, DOI 10.1098/rspb.2011.1035; Rebrikov DV, 2006, APPL BIOCHEM MICRO+, V42, P455, DOI 10.1134/S0003683806050024; Rinkevich B, 2011, ISJ-INVERT SURVIV J, V8, P153; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Rosengarten RD, 2011, CURR BIOL, V21, pR82, DOI 10.1016/j.cub.2010.11.061; SALTERCID L, 1991, BIOL BULL-US, V181, P127, DOI 10.2307/1542495; Sekine H, 2001, J IMMUNOL, V167, P4504, DOI 10.4049/jimmunol.167.8.4504; Seneca FO, 2010, MAR BIOTECHNOL, V12, P594, DOI 10.1007/s10126-009-9247-5; Sunagawa S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-258; Uchida T, 2004, J BIOL CHEM, V279, P37133, DOI 10.1074/jbc.M404065200; Van Oppen MJH, 2007, MOL ECOL NOTES, V7, P436, DOI 10.1111/j.1471-8286.2006.01610.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wilson ACC, 2004, BEHAV ECOL SOCIOBIOL, V57, P40, DOI 10.1007/s00265-004-0831-4; Wood-Charlson EM, 2006, CELL MICROBIOL, V8, P1985, DOI 10.1111/j.1462-5822.2006.00765.x	34	19	19	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39099	10.1371/journal.pone.0039099	http://dx.doi.org/10.1371/journal.pone.0039099			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792163	Green Published, Green Accepted, gold			2022-12-27	WOS:000306461800005
J	Mazzuoli, G; Schemann, M				Mazzuoli, Gemma; Schemann, Michael			Mechanosensitive Enteric Neurons in the Myenteric Plexus of the Mouse Intestine	PLOS ONE			English	Article							RHYTHMIC MOTOR PATTERN; GUINEA-PIG ILEUM; SENSORY NEURONS; NERVOUS-SYSTEM; DISTAL COLON; MOVEMENTS; STRETCH	Background: Within the gut the autonomous enteric nervous system (ENS) is able to sense mechanical stimuli and to trigger gut reflex behaviour. We previously proposed a novel sensory circuit in the ENS which consists of multifunctional rapidly adapting mechanosensitive enteric neurons (RAMEN) in the guinea pig. The aim of this study was to validate this concept by studying its applicability to other species or gut regions. Methodology/Principal Findings: We deformed myenteric ganglia in the mouse small and large intestine and recorded spike discharge using voltage sensitive dye imaging. We also analysed expression of markers hitherto proposed to label mouse sensory myenteric neurons in the ileum (NF145kD) or colon (calretinin). RAMEN constituted 22% and 15% of myenteric neurons per ganglion in the ileum and colon, respectively. They encoded dynamic rather than sustained deformation. In the colon, 7% of mechanosensitive neurons fired throughout the sustained deformation, a behaviour typical for slowly adapting echanosensitive neurons (SAMEN). RAMEN and SAMEN responded directly to mechanical deformation as their response remained unchanged after synaptic blockade in low Ca++/high Mg++. Activity levels of RAMEN increased with the degree of ganglion deformation. Recruitment of more RAMEN with stronger stimuli may suggest low and high threshold RAMEN. The majority of RAMEN were cholinergic but most lacked expression of NF145kD or calretinin. Conclusions/Significance: We showed for the first time that fundamental properties of mechanosensitive enteric neurons, such as firing pattern, encoding of dynamic deformation, cholinergic phenotype and their proportion, are conserved across species and regions. We conclude that RAMEN are important for mechanotransduction in the ENS. They directly encode dynamic changes in force as their firing frequency is proportional to the degree of deformation of the ganglion they reside in. The additional existence of SAMEN in the colon is likely an adaptation to colonic motor patterns which consist of phasic and tonic contractions.	[Mazzuoli, Gemma; Schemann, Michael] Tech Univ Munich, Freising Weihenstephan, Germany	Technical University of Munich	Mazzuoli, G (corresponding author), Tech Univ Munich, Freising Weihenstephan, Germany.	gemma.mazzuoli@wzw.tum.de	mazzuoli-weber, gemma/L-2020-2015	mazzuoli-weber, gemma/0000-0001-7803-3556; Schemann, Michael/0000-0003-1007-9843	German Research Council (DFG) [Ma 5202/1-1]	German Research Council (DFG)(German Research Foundation (DFG))	Grant support came from the German Research Council (DFG, Ma 5202/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayliss W M, 1899, J Physiol, V24, P99; Bayliss WM, 1900, J PHYSIOL-LONDON, V26, P107; Bian XC, 2003, J PHYSIOL-LONDON, V551, P309, DOI 10.1113/jphysiol.2003.044172; Blackshaw LA, 2007, NEUROGASTROENT MOTIL, V19, P1, DOI 10.1111/j.1365-2982.2006.00871.x; BROOKES SJH, 1987, J PHYSIOL-LONDON, V390, P305, DOI 10.1113/jphysiol.1987.sp016702; Brown DR, 2004, NEUROGASTROENT MOTIL, V16, P50, DOI 10.1111/j.1743-3150.2004.00475.x; Bush TG, 2000, AUTON NEUROSCI-BASIC, V84, P162, DOI 10.1016/S1566-0702(00)00201-0; DESAI KM, 1991, NATURE, V351, P477, DOI 10.1038/351477a0; Dogiel AS, 1895, ARCH ANAT PHYS, P130; Fida R, 1997, NEUROGASTROENT MOTIL, V9, P99, DOI 10.1046/j.1365-2982.1997.d01-25.x; Furness JB, 2004, CELL TISSUE RES, V317, P1, DOI 10.1007/s00441-004-0895-5; Furness JB, 1998, PROG NEUROBIOL, V54, P1, DOI 10.1016/S0301-0082(97)00051-8; FURUKAWA K, 1986, J NEUROPHYSIOL, V55, P1395, DOI 10.1152/jn.1986.55.6.1395; HIRST GDS, 1974, J PHYSIOL-LONDON, V236, P303, DOI 10.1113/jphysiol.1974.sp010436; KIRCHGESSNER AL, 1992, J NEUROSCI, V12, P235; Kunze WAA, 1998, J PHYSIOL-LONDON, V506, P827, DOI 10.1111/j.1469-7793.1998.827bv.x; Langley JN, 1905, J PHYSIOL-LONDON, V33, P34; Mao YK, 2006, J NEUROPHYSIOL, V96, P998, DOI 10.1152/jn.00204.2006; MAYER CJ, 1975, PFLUG ARCH EUR J PHY, V357, P35, DOI 10.1007/BF00584543; Mazzuoli G, 2009, J PHYSIOL-LONDON, V587, P4681, DOI 10.1113/jphysiol.2009.177105; Neunlist M, 1999, NEUROGASTROENT MOTIL, V11, P393; Nurgali K, 2004, J COMP NEUROL, V468, P112, DOI 10.1002/cne.10948; Qu ZD, 2008, CELL TISSUE RES, V334, P147, DOI 10.1007/s00441-008-0684-7; Ren JH, 2003, J PHYSIOL-LONDON, V552, P809, DOI 10.1113/jphysiol.2003.047944; SCHEMANN M, 1989, J PHYSIOL-LONDON, V417, P501, DOI 10.1113/jphysiol.1989.sp017815; Schemann M, 2010, AUTON NEUROSCI-BASIC, V153, P21, DOI 10.1016/j.autneu.2009.08.003; Spencer NJ, 2004, J PHYSIOL-LONDON, V558, P577, DOI 10.1113/jphysiol.2004.063586; Spencer NJ, 2002, J PHYSIOL-LONDON, V545, P629, DOI 10.1113/jphysiol.2002.028647; Trendelenburg P, 1917, ARCH EXP PATHOL PHAR, V81, P55, DOI 10.1007/BF01862644; Wood J. D., 1974, P 4 INT S GASTR MOT, P387	30	43	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e39887	10.1371/journal.pone.0039887	http://dx.doi.org/10.1371/journal.pone.0039887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768317	Green Published, gold, Green Submitted			2022-12-27	WOS:000305966500030
J	Akle, V; Guelin, E; Yu, LL; Brassard-Giordano, H; Slack, BE; Zhdanova, IV				Akle, Veronica; Guelin, Emmanuel; Yu, Lili; Brassard-Giordano, Helena; Slack, Barbara E.; Zhdanova, Irina V.			F-Spondin/spon1b Expression Patterns in Developing and Adult Zebrafish	PLOS ONE			English	Article							ROSTRAL MIGRATORY STREAM; F-SPONDIN; EXTRACELLULAR-MATRIX; OPTIC TECTUM; TELEOST FISH; FLOOR PLATE; HABENULAR COMPLEX; MIDBRAIN TARGET; GENE-EXPRESSION; NERVOUS-SYSTEM	F-spondin, an extracellular matrix protein, is an important player in embryonic morphogenesis and CNS development, but its presence and role later in life remains largely unknown. We generated a transgenic zebrafish in which GFP is expressed under the control of the F-spondin (spon1b) promoter, and used it in combination with complementary techniques to undertake a detailed characterization of the expression patterns of F-spondin in developing and adult brain and periphery. We found that F-spondin is often associated with structures forming long neuronal tracts, including retinal ganglion cells, the olfactory bulb, the habenula, and the nucleus of the medial longitudinal fasciculus (nMLF). F-spondin expression coincides with zones of adult neurogenesis and is abundant in CSF-contacting secretory neurons, especially those in the hypothalamus. Use of this new transgenic model also revealed F-spondin expression patterns in the peripheral CNS, notably in enteric neurons, and in peripheral tissues involved in active patterning or proliferation in adults, including the endoskeleton of zebrafish fins and the continuously regenerating pharyngeal teeth. Moreover, patterning of the regenerating caudal fin following fin amputation in adult zebrafish was associated with F-spondin expression in the blastema, a proliferative region critical for tissue reconstitution. Together, these findings suggest major roles for F-spondin in the CNS and periphery of the developing and adult vertebrate.	[Akle, Veronica; Guelin, Emmanuel; Yu, Lili; Brassard-Giordano, Helena; Zhdanova, Irina V.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Slack, Barbara E.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA	Boston University; Boston University	Akle, V (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA.	zhdanova@bu.edu	akle, veronica/AAD-7577-2019; Slack, Barbara/AAU-9917-2021	Akle, Veronica/0000-0002-2050-5511; Slack, Barbara/0000-0002-7619-410X; Zhdanova, Irina/0000-0002-8401-9571	Chaikin-Wile Foundation	Chaikin-Wile Foundation	The work was supported by a grant from the Chaikin-Wile Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Aizawa H, 2005, CURR BIOL, V15, P238, DOI 10.1016/j.cub.2005.01.014; Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; ALTABA ARI, 1993, P NATL ACAD SCI USA, V90, P8268, DOI 10.1073/pnas.90.17.8268; Amo R, 2010, J NEUROSCI, V30, P1566, DOI 10.1523/JNEUROSCI.3690-09.2010; Andrade N, 2007, P NATL ACAD SCI USA, V104, P8508, DOI 10.1073/pnas.0611391104; Andreasen EA, 2006, TOXICOL SCI, V92, P254, DOI 10.1093/toxsci/kfj118; Andres KH, 1999, J COMP NEUROL, V407, P130, DOI 10.1002/(SICI)1096-9861(19990428)407:1<130::AID-CNE10>3.0.CO;2-8; Attur MG, 2009, FASEB J, V23, P79, DOI 10.1096/fj.08-114363; Benard C, 2009, CURR TOP DEV BIOL, V87, P175, DOI 10.1016/S0070-2153(09)01206-X; Burstyn-Cohen T, 1998, J NEUROSCI, V18, P8875; Burstyn-Cohen T, 1999, NEURON, V23, P233, DOI 10.1016/S0896-6273(00)80776-X; Colognato H, 2011, DEV NEUROBIOLOGY; de Borsetti NH, 2011, DEV BIOL; Debby-Brafman A, 1999, NEURON, V22, P475, DOI 10.1016/S0896-6273(00)80703-5; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; Feinstein Y, 1999, DEVELOPMENT, V126, P3637; Feinstein Y, 2004, INT J BIOCHEM CELL B, V36, P975, DOI 10.1016/j.biocel.2004.01.002; Folgueira N, 2007, COMP GEN PHARMACOL, V370, P348, DOI [10.1002/cne, DOI 10.1002/CNE]; Gamse JT, 2005, DEVELOPMENT, V132, P4869, DOI 10.1242/dev.02046; Gamse JT, 2003, DEVELOPMENT, V130, P1059, DOI 10.1242/dev.00270; Geisler S, 2003, J COMP NEUROL, V458, P78, DOI 10.1002/cne.10566; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Hadzhiev Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-75; Higashijima S, 1997, DEV BIOL, V192, P211, DOI 10.1006/dbio.1997.8760; Ho A, 2004, P NATL ACAD SCI USA, V101, P2548, DOI 10.1073/pnas.0308655100; Hoe HS, 2008, MOL NEUROBIOL, V37, P64, DOI 10.1007/s12035-008-8017-0; Hoffman GE, 2008, CURR PROTOC NEUROSCI, DOI DOI 10.1002/0471142301; Huysseune A, 2006, INT J DEV BIOL, V50, P637, DOI 10.1387/ijdb.052098ah; Jeong JY, 2008, BRAIN RES BULL, V75, P619, DOI 10.1016/j.brainresbull.2007.10.043; Kani S, 2010, DEV BIOL, V343, P1, DOI 10.1016/j.ydbio.2010.03.024; Kaslin J, 2001, J COMP NEUROL, V440, P342, DOI 10.1002/cne.1390; Kaslin J, 2009, J NEUROSCI, V29, P6142, DOI 10.1523/JNEUROSCI.0072-09.2009; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kinoshita M, 2006, J COMP NEUROL, V499, P546, DOI 10.1002/cne.21080; Kitagawa M, 2006, BIOCHEM BIOPH RES CO, V349, P1050, DOI 10.1016/j.bbrc.2006.08.142; KLAR A, 1992, CELL, V69, P95, DOI 10.1016/0092-8674(92)90121-R; Kuan YS, 2007, J EXP ZOOL PART B, V308B, P669, DOI 10.1002/jez.b.21184; Ma PM, 2003, J COMP NEUROL, V460, P13, DOI 10.1002/cne.10544; Marta W, 2011, GEN COMP ENDOCR, V172, P173, DOI 10.1016/j.ygcen.2011.03.018; MEEK J, 1978, J COMP NEUROL, V182, P89, DOI 10.1002/cne.901820107; Meiniel O, 2008, J MOL EVOL, V66, P1, DOI 10.1007/s00239-007-9055-3; Mueller T, 2009, BRAIN BEHAV EVOLUT, V74, P30, DOI 10.1159/000229011; Mueller T, 2009, J COMP NEUROL, V516, P553, DOI 10.1002/cne.22122; Nevin LM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-126; Nishida E, 2007, GENE, V404, P70, DOI 10.1016/j.gene.2007.09.009; Norton WHJ, 2008, J COMP NEUROL, V511, P521, DOI 10.1002/cne.21831; Persson A, 2010, NEUROSCIENCE, V167, P312, DOI 10.1016/j.neuroscience.2010.01.035; Peterziel H, 2010, MOL CELLULAR NEUROSC; Rink E, 2004, BRAIN RES, V1011, P206, DOI 10.1016/j.brainres.2004.03.027; Rodriguez F, 2002, BRAIN RES BULL, V57, P499, DOI 10.1016/S0361-9230(01)00682-7; Salas R, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00036; Sankrithi NS, 2010, NEUROSCIENCE, V166, P970, DOI 10.1016/j.neuroscience.2010.01.003; Sato T, 2007, J NEUROSCI, V27, P5271, DOI 10.1523/JNEUROSCI.0883-07.2007; Schubert D, 2006, J NEUROCHEM, V96, P444, DOI 10.1111/j.1471-4159.2005.03563.x; Stevens B, 2008, NEUROSIGNALS, V16, P278, DOI 10.1159/000123038; SUTHERLAND RJ, 1982, NEUROSCI BIOBEHAV R, V6, P1, DOI 10.1016/0149-7634(82)90003-3; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Tzarfaty-Majar V, 2001, J BIOL CHEM, V276, P28233, DOI 10.1074/jbc.M102585200; Udvadia AJ, 2003, DEV BIOL, V256, P1, DOI 10.1016/S0012-1606(02)00083-0; Vigh B, 2004, HISTOL HISTOPATHOL, V19, P607, DOI 10.14670/HH-19.607; Vigh B, 2004, MED HYPOTHESES RES, P77; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; Woo WM, 2008, DEVELOPMENT, V135, P2747, DOI 10.1242/dev.015289; Wullimann MF, 2002, BRAIN RES BULL, V57, P363, DOI 10.1016/S0361-9230(01)00666-9; Wullimann MF, 1996, NEUROANATOMY ZEBRAFI, DOI 10.1007/978-3-0348-8979-7_6; Yamamoto K, 2011, J COMP NEUROL, V519, P576, DOI 10.1002/cne.22535; Zisman S, 2007, J CELL BIOL, V178, P1237, DOI 10.1083/jcb.200702184; Zupanc GKH, 2005, J COMP NEUROL, V488, P290, DOI 10.1002/cne.20571; Zupanc GKH, 2001, BRAIN BEHAV EVOLUT, V58, P250, DOI 10.1159/000057569; Zupanc GKH, 1999, EXP NEUROL, V160, P78, DOI 10.1006/exnr.1999.7182	71	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e37593	10.1371/journal.pone.0037593	http://dx.doi.org/10.1371/journal.pone.0037593			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768035	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100006
J	Gostring, L; Malm, M; Hoiden-Guthenberg, I; Frejd, FY; Stahl, S; Lofblom, J; Gedda, L				Gostring, Lovisa; Malm, Magdalena; Hoiden-Guthenberg, Ingmarie; Frejd, Fredrik Y.; Stahl, Stefan; Lofblom, John; Gedda, Lars			Cellular Effects of HER3-Specific Affibody Molecules	PLOS ONE			English	Article							ONCOGENE PRODUCT; EGF RECEPTOR; HUMAN BREAST; CANCER; KINASE; LIGAND; ERBB2; FAMILY; DIFFERENTIATION; TRASTUZUMAB	Recent studies have led to the recognition of the epidermal growth factor receptor HER3 as a key player in cancer, and consequently this receptor has gained increased interest as a target for cancer therapy. We have previously generated several Affibody molecules with subnanomolar affinity for the HER3 receptor. Here, we investigate the effects of two of these HER3-specific Affibody molecules, Z05416 and Z05417, on different HER3-overexpressing cancer cell lines. Using flow cytometry and confocal microscopy, the Affibody molecules were shown to bind to HER3 on three different cell lines. Furthermore, the receptor binding of the natural ligand heregulin (HRG) was blocked by addition of Affibody molecules. In addition, both molecules suppressed HRG-induced HER3 and HER2 phosphorylation in MCF-7 cells, as well as HER3 phosphorylation in constantly HER2-activated SKBR-3 cells. Importantly, Western blot analysis also revealed that HRG-induced downstream signalling through the Ras-MAPK pathway as well as the PI3K-Akt pathway was blocked by the Affibody molecules. Finally, in an in vitro proliferation assay, the two Affibody molecules demonstrated complete inhibition of HRG-induced cancer cell growth. Taken together, our findings demonstrate that Z05416 and Z05417 exert an anti-proliferative effect on two breast cancer cell lines by inhibiting HRG-induced phosphorylation of HER3, suggesting that the Affibody molecules are promising candidates for future HER3-targeted cancer therapy.	[Gostring, Lovisa; Frejd, Fredrik Y.; Gedda, Lars] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden; [Malm, Magdalena; Stahl, Stefan; Lofblom, John] AlbaNova Univ Ctr, Royal Inst Technol KTH, Sch Biotechnol, Dept Mol Biotechnol, Stockholm, Sweden; [Hoiden-Guthenberg, Ingmarie; Frejd, Fredrik Y.] Affibody AB, Solna, Sweden	Uppsala University; Royal Institute of Technology	Gostring, L (corresponding author), Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden.	lofblom@kth.se		Gedda, Lars/0000-0002-3746-6811; Lofblom, John/0000-0001-9423-0541; Malm, Magdalena/0000-0003-1763-9073	Swedish Research Council (VR) [2009-5758]; Governmental Agency for Innovation Systems (excellence center for protein technology, ProNova) [2009-00179]; Swedish Cancer Society [2011/473]; Swedish Foundation for Strategic Research [RBa08-0067]	Swedish Research Council (VR)(Swedish Research Council); Governmental Agency for Innovation Systems (excellence center for protein technology, ProNova); Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by the Swedish Research Council (VR) [2009-5758], Governmental Agency for Innovation Systems [2009-00179; the excellence center for protein technology, ProNova], The Swedish Cancer Society [2011/473] and Swedish Foundation for Strategic Research [RBa08-0067]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar Z, 1999, ONCOGENE, V18, P6050, DOI 10.1038/sj.onc.1202993; Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; BACUS SS, 1992, CELL GROWTH DIFFER, V3, P401; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Baum RP, 2010, J NUCL MED, V51, P892, DOI 10.2967/jnumed.109.073239; Bianco R, 2003, ONCOGENE, V22, P2812, DOI 10.1038/sj.onc.1206388; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; Campbell MR, 2010, CLIN CANCER RES, V16, P1373, DOI 10.1158/1078-0432.CCR-09-1218; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Clark AS, 2002, MOL CANCER THER, V1, P707; Ekerljung L, 2006, TUMOR BIOL, V27, P201, DOI 10.1159/000093023; Friedman M, 2009, BIOTECHNOL APPL BIOC, V54, P121, DOI 10.1042/BA20090096; Gijsen M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000563; Guerra-Vladusic FK, 1999, INT J ONCOL, V15, P883; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kronqvist N, 2008, PROTEIN ENG DES SEL, V21, P247, DOI 10.1093/protein/gzm090; Kronqvist N, 2011, PROTEIN ENG DES SEL, V24, P385, DOI 10.1093/protein/gzq118; Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014; LUPU R, 1990, SCIENCE, V249, P1552, DOI 10.1126/science.2218496; Nord K, 1997, NAT BIOTECHNOL, V15, P772, DOI 10.1038/nbt0897-772; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; Sergina NV, 2007, TRENDS MOL MED, V13, P527, DOI 10.1016/j.molmed.2007.10.002; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Sheng Q, 2010, CANCER CELL, V17, P412, DOI 10.1016/j.ccr.2010.03.014; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Tolmachev V, 2007, CANCER RES, V67, P2773, DOI 10.1158/0008-5472.CAN-06-1630; Tolmachev V, 2009, J NUCL MED, V50, P274, DOI 10.2967/jnumed.108.055525; Worthylake R, 1999, J BIOL CHEM, V274, P8865, DOI 10.1074/jbc.274.13.8865; Yakes FM, 2002, CANCER RES, V62, P4132; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zielinski R, 2011, CLIN CANCER RES, V17, P5071, DOI 10.1158/1078-0432.CCR-10-2887	37	38	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40023	10.1371/journal.pone.0040023	http://dx.doi.org/10.1371/journal.pone.0040023			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768204	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100176
J	Guo, X; Li, HG; Xu, H; Halim, V; Zhang, WY; Wang, H; Ong, KT; Woo, SL; Walzem, RL; Mashek, DG; Dong, H; Lu, FE; Wei, L; Huo, YQ; Wu, CD				Guo, Xin; Li, Honggui; Xu, Hang; Halim, Vera; Zhang, Weiyu; Wang, Huan; Ong, Kuok Teong; Woo, Shih-Lung; Walzem, Rosemary L.; Mashek, Douglas G.; Dong, Hui; Lu, Fuer; Wei, Lai; Huo, Yuqing; Wu, Chaodong			Palmitoleate Induces Hepatic Steatosis but Suppresses Liver Inflammatory Response in Mice	PLOS ONE			English	Article							SYSTEMIC INSULIN-RESISTANCE; FATTY LIVER; ADIPOSE-TISSUE; INDUCIBLE 6-PHOSPHOFRUCTO-2-KINASE; DIABETES-MELLITUS; DISEASE; ACID; ACTIVATION; OBESITY; HEPATOCYTES	The interaction between fat deposition and inflammation during obesity contributes to the development of non-alcoholic fatty liver disease (NAFLD). The present study examined the effects of palmitoleate, a monounsaturated fatty acid (16:1n7), on liver metabolic and inflammatory responses, and investigated the mechanisms by which palmitoleate increases hepatocyte fatty acid synthase (FAS) expression. Male wild-type C57BL/6J mice were supplemented with palmitoleate and subjected to the assays to analyze hepatic steatosis and liver inflammatory response. Additionally, mouse primary hepatocytes were treated with palmitoleate and used to analyze fat deposition, the inflammatory response, and sterol regulatory element-binding protein 1c (SREBP1c) activation. Compared with controls, palmitoleate supplementation increased the circulating levels of palmitoleate and improved systemic insulin sensitivity. Locally, hepatic fat deposition and SREBP1c and FAS expression were significantly increased in palmitoleate-supplemented mice. These pro-lipogenic events were accompanied by improvement of liver insulin signaling. In addition, palmitoleate supplementation reduced the numbers of macrophages/Kupffer cells in livers of the treated mice. Consistently, supplementation of palmitoleate decreased the phosphorylation of nuclear factor kappa B (NF-kappa B, p65) and the expression of proinflammatory cytokines. These results were recapitulated in primary mouse hepatocytes. In terms of regulating FAS expression, treatment of palmitoleate increased the transcription activity of SREBP1c and enhanced the binding of SREBP1c to FAS promoter. Palmitoleate also decreased the phosphorylation of NF-kappa B p65 and the expression of proinflammatory cytokines in cultured macrophages. Together, these results suggest that palmitoleate acts through dissociating liver inflammatory response from hepatic steatosis to play a unique role in NAFLD.	[Guo, Xin; Li, Honggui; Xu, Hang; Halim, Vera; Woo, Shih-Lung; Walzem, Rosemary L.; Wu, Chaodong] Texas A&M Univ, Dept Nutr & Food Sci, Intercollegiate Fac Nutr, College Stn, TX 77843 USA; [Zhang, Weiyu; Wang, Huan] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Ong, Kuok Teong; Mashek, Douglas G.] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN USA; [Dong, Hui; Lu, Fuer] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Integrated Chinese & Western Med, Wuhan 430074, Peoples R China; [Wei, Lai] Peking Univ, Hlth Sci Ctr, Inst Hepatol, Beijing 100871, Peoples R China; [Huo, Yuqing] Georgia Hlth Sci Univ, Dept Cellular Biol & Anat, Augusta, GA USA	Texas A&M University System; Texas A&M University College Station; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Huazhong University of Science & Technology; Peking University; University System of Georgia; Augusta University	Guo, X (corresponding author), Texas A&M Univ, Dept Nutr & Food Sci, Intercollegiate Fac Nutr, College Stn, TX 77843 USA.	YHUO@georgiahealth.edu; cdwu@tamu.edu	Ong, Kuok Teong/H-8274-2015; Mashek, Douglas/ABD-6844-2021	Ong, Kuok Teong/0000-0001-8605-375X; Mashek, Douglas/0000-0001-7033-3386	American Diabetes Association (ADA) [1-10-BS-76, 1-10-JF-54]; National Institutes of Health (NIH) [HL78679, HL080569]; American Heart Association (AHA) [12BGIA9050003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078679, R01HL080569, R01HL095556, R21HL108922] Funding Source: NIH RePORTER	American Diabetes Association (ADA)(American Diabetes Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Diabetes Association (ADA) grant 1-10-BS-76, National Institutes of Health (NIH) HL78679, NIH HL080569, ADA grant 1-10-JF-54, and American Heart Association (AHA) 12BGIA9050003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; Angulo P, 2006, GASTROENTEROLOGY, V130, P1848, DOI 10.1053/j.gastro.2006.03.041; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Bu SY, 2009, J BIOL CHEM, V284, P30474, DOI 10.1074/jbc.M109.036665; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Deng ZB, 2009, HEPATOLOGY, V50, P1412, DOI 10.1002/hep.23148; Dentin R, 2005, J CLIN INVEST, V115, P2843, DOI 10.1172/JCI25256; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Gong JA, 2011, AM J CLIN NUTR, V93, P186, DOI 10.3945/ajcn.110.006502; Guo X, 2010, J BIOL CHEM, V285, P23711, DOI 10.1074/jbc.M110.123174; Huo Y, 2012, J BIOL CHEM; Huo YQ, 2010, J BIOL CHEM, V285, P3713, DOI 10.1074/jbc.M109.058446; Joshi-Barve S, 2007, HEPATOLOGY, V46, P823, DOI 10.1002/hep.21752; Kelley DE, 2003, AM J PHYSIOL-ENDOC M, V285, pE906, DOI 10.1152/ajpendo.00117.2003; Liu XQ, 2010, ARTERIOSCL THROM VAS, V30, P31, DOI 10.1161/ATVBAHA.109.195636; Lonardo A, 2006, J HEPATOL, V44, P190, DOI 10.1016/j.jhep.2005.06.018; Marchesini G, 2001, LANCET, V358, P893, DOI 10.1016/S0140-6736(01)06042-1; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Mozaffarian D, 2010, AM J CLIN NUTR, V92, P1350, DOI 10.3945/ajcn.110.003970; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Neuschwander-Tetri BA, 2010, NAT REV GASTRO HEPAT, V7, P243, DOI 10.1038/nrgastro.2010.50; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Petit JM, 2012, CLIN NUTR; Puri P, 2009, HEPATOLOGY, V50, P1827, DOI 10.1002/hep.23229; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sanyal AJ, 2005, NAT CLIN PRACT GASTR, V2, P46, DOI 10.1038/ncpgasthep0084; Sekiya M, 2007, J LIPID RES, V48, P1581, DOI 10.1194/jlr.M700033-JLR200; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Tauriainen E, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/525094; Tilg H, 2005, NAT CLIN PRACT GASTR, V2, P148, DOI 10.1038/ncpgasthep0116; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Wendel AA, 2008, J LIPID RES, V49, P98, DOI 10.1194/jlr.M700195-JLR200; Wu CD, 2005, CELL METAB, V2, P131, DOI 10.1016/j.cmet.2005.07.003; Wu CD, 2001, J CLIN INVEST, V107, P91, DOI 10.1172/JCI11103; Wu CD, 2006, AM J PHYSIOL-ENDOC M, V291, pE536, DOI 10.1152/ajpendo.00126.2006; Yang ZH, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-120; Zhang JF, 2004, P NATL ACAD SCI USA, V101, P10703, DOI 10.1073/pnas.0403652101	38	93	93	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39286	10.1371/journal.pone.0039286	http://dx.doi.org/10.1371/journal.pone.0039286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768070	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100041
J	Ho, DWH; Yap, MKH; Ng, PW; Fung, WY; Yip, SP				Ho, Daniel W. H.; Yap, Maurice K. H.; Ng, Po Wah; Fung, Wai Yan; Yip, Shea Ping			Association of High Myopia with Crystallin Beta A4 (CRYBA4) Gene Polymorphisms in the Linkage-Identified MYP6 Locus	PLOS ONE			English	Article							REFRACTIVE ERROR; OCULAR REFRACTION; PAX6; SCAN; SCHOOLCHILDREN; HERITABILITY; MICROCORNEA; ENVIRONMENT; PREVALENCE; EXPRESSION	Background: Myopia is the most common ocular disorder worldwide and imposes tremendous burden on the society. It is a complex disease. The MYP6 locus at 22 q12 is of particular interest because many studies have detected linkage signals at this interval. The MYP6 locus is likely to contain susceptibility gene(s) for myopia, but none has yet been identified. Methodology/Principal Findings: Two independent subject groups of southern Chinese in Hong Kong participated in the study an initial study using a discovery sample set of 342 cases and 342 controls, and a follow-up study using a replication sample set of 316 cases and 313 controls. Cases with high myopia were defined by spherical equivalent <= -8 dioptres and emmetropic controls by spherical equivalent within +/- 1.00 dioptre for both eyes. Manual candidate gene selection from the MYP6 locus was supported by objective in silico prioritization. DNA samples of discovery sample set were genotyped for 178 tagging single nucleotide polymorphisms (SNPs) from 26 genes. For replication, 25 SNPs (tagging or located at predicted transcription factor or microRNA binding sites) from 4 genes were subsequently examined using the replication sample set. Fisher P value was calculated for all SNPs and overall association results were summarized by meta-analysis. Based on initial and replication studies, rs2009066 located in the crystallin beta A4 (CRYBA4) gene was identified to be the most significantly associated with high myopia (initial study: P = 0.02; replication study: P = 1.88e-4; meta-analysis: P = 1.54e-5) among all the SNPs tested. The association result survived correction for multiple comparisons. Under the allelic genetic model for the combined sample set, the odds ratio of the minor allele G was 1.41 (95% confidence intervals, 1.21-1.64). Conclusions/Significance: A novel susceptibility gene (CRYBA4) was discovered for high myopia. Our study also signified the potential importance of appropriate gene prioritization in candidate selection.	[Ho, Daniel W. H.; Ng, Po Wah] Hong Kong Polytech Univ, Sch Optometry, Ctr Myopia Res, Hong Kong Sar, Peoples R China; [Ho, Daniel W. H.; Yap, Maurice K. H.; Ng, Po Wah; Fung, Wai Yan; Yip, Shea Ping] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong Sar, Peoples R China	Hong Kong Polytechnic University; Hong Kong Polytechnic University	Ho, DWH (corresponding author), Hong Kong Polytech Univ, Sch Optometry, Ctr Myopia Res, Hong Kong Sar, Peoples R China.	shea.ping.yip@inet.polyu.edu.hk	Yip, Shea Ping/A-1185-2016; Ho, Daniel Wai Hung WH/O-1194-2016; Yap, Maurice KH/K-4927-2016	Yip, Shea Ping/0000-0002-2170-8185; Ho, Daniel Wai Hung WH/0000-0003-3884-296X; Yap, Maurice KH/0000-0003-4687-4101	Hong Kong Polytechnic University [G-YX2V, J-BB7P, 87TP]	Hong Kong Polytechnic University(Hong Kong Polytechnic University)	This study was supported by grants (G-YX2V, J-BB7P and 87TP) from the Hong Kong Polytechnic University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Baird PN, 2010, PROG RETIN EYE RES, V29, P520, DOI 10.1016/j.preteyeres.2010.05.004; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bateman OA, 2003, EXP EYE RES, V77, P409, DOI 10.1016/S0014-4835(03)00173-8; BATRA DV, 1967, BRIT J OPHTHALMOL, V51, P57, DOI 10.1136/bjo.51.1.57; Billingsley G, 2006, AM J HUM GENET, V79, P702, DOI 10.1086/507712; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Coop A, 1998, FEBS LETT, V431, P319, DOI 10.1016/S0014-5793(98)00783-2; COOPER PG, 1993, EUR J BIOCHEM, V213, P321, DOI 10.1111/j.1432-1033.1993.tb17765.x; Cui WW, 2004, J BIOL CHEM, V279, P11088, DOI 10.1074/jbc.M312414200; Dandona R, 2001, B WORLD HEALTH ORGAN, V79, P237; DEJONG WW, 1989, TRENDS BIOCHEM SCI, V14, P365, DOI 10.1016/0968-0004(89)90009-1; Dirani M, 2006, INVEST OPHTH VIS SCI, V47, P4756, DOI 10.1167/iovs.06-0270; Duncan MK, 2004, INVEST OPHTH VIS SCI, V45, P3589, DOI 10.1167/iovs.04-0151; Duncan MK, 1998, MOL CELL BIOL, V18, P5579, DOI 10.1128/MCB.18.9.5579; Fort PE, 2009, MOL CELL PROTEOMICS, V8, P767, DOI 10.1074/mcp.M800326-MCP200; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P1232; Han W, 2009, INVEST OPHTH VIS SCI, V50, P47, DOI 10.1167/iovs.07-0813; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Jacobi FK, 2010, FRONT BIOSCI-LANDMRK, V15, P359, DOI 10.2741/3625; Jiang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019587; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kempen AH, 2004, ARCH OPHTHALMOL-CHIC, V122, P495; Klein AP, 2007, ARCH OPHTHALMOL-CHIC, V125, P80, DOI 10.1001/archopht.125.1.80; Klein AP, 2011, INVEST OPHTH VIS SCI, V52, P5220, DOI 10.1167/iovs.10-7096; Lam CSY, 2012, OPHTHAL PHYSL OPT, V32, P17, DOI 10.1111/j.1475-1313.2011.00886.x; Lampi KJ, 1997, J BIOL CHEM, V272, P2268; Li YJ, 2009, INVEST OPHTH VIS SCI, V50, P3116, DOI 10.1167/iovs.08-2781; Liang CL, 2011, INVEST OPHTH VIS SCI, V52, P3500, DOI 10.1167/iovs.10-5859; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; Lopes MC, 2009, INVEST OPHTH VIS SCI, V50, P126, DOI 10.1167/iovs.08-2385; Lyhne N, 2001, BRIT J OPHTHALMOL, V85, P1470, DOI 10.1136/bjo.85.12.1470; Mak JYY, 2012, ARCH OPHTHALMOL-CHIC, V130, P209, DOI 10.1001/archophthalmol.2011.365; Pirity MK, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-39; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ring BZ, 2000, DEVELOPMENT, V127, P307; Sohajda Z, 2006, GRAEF ARCH CLIN EXP, V244, P1211, DOI 10.1007/s00417-006-0264-z; Stambolian D, 2004, AM J HUM GENET, V75, P448, DOI 10.1086/423789; Stambolian D, 2006, MOL VIS, V12, P1499; Tang WC, 2008, CLIN EXP OPTOM, V91, P4, DOI 10.1111/j.1444-0938.2007.00181.x; Tsonis PA, 2006, EXP EYE RES, V83, P233, DOI 10.1016/j.exer.2005.11.019; Usher C H, 1921, Br J Ophthalmol, V5, P289, DOI 10.1136/bjo.5.7.289; Vazquez-Chona F, 2004, INVEST OPHTH VIS SCI, V45, P2737, DOI 10.1167/iovs.03-1047; Vazquez-Chona FR, 2007, GENE REGUL SYST BIO, V1, P327; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Young TL, 2007, ARCH OPHTHALMOL-CHIC, V125, P38, DOI 10.1001/archopht.125.1.38; Zha Y, 2009, ARCH OPHTHALMOL-CHIC, V127, P541, DOI 10.1001/archophthalmol.2008.623; Zhou GK, 2010, MOL VIS, V16, P1019; Zhou XT, 2010, MOL VIS, V16, P2163	53	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40238	10.1371/journal.pone.0040238	http://dx.doi.org/10.1371/journal.pone.0040238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22792142	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100234
J	Janssen, S; Laermans, J; Iwakura, H; Tack, J; Depoortere, I				Janssen, Sara; Laermans, Jorien; Iwakura, Hiroshi; Tack, Jan; Depoortere, Inge			Sensing of Fatty Acids for Octanoylation of Ghrelin Involves a Gustatory G-Protein	PLOS ONE			English	Article							IN-VIVO; DIETARY LIPIDS; TASTE; CELLS; SECRETION; RECEPTOR; PEPTIDE; GPR120; ACYL; IDENTIFICATION	Background: Ghrelin is an important regulator of energy - and glucose homeostasis. The octanoylation at Ser(3) is essential for ghrelin's biological effects but the mechanisms involved in the octanoylation are unknown. We investigated whether the gustatory G-protein, alpha-gustducin, and the free fatty acid receptors GPR40 and GPR120 are involved in the fatty acid sensing mechanisms of the ghrelin cell. Methods: Wild-type (WT) and alpha-gustducin knockout (gust(-/-)) mice were fed a glyceryl trioctanoate-enriched diet (OD) during 2 weeks. Ghrelin levels and gastric emptying were determined. Co-localization between GPR40, GPR120 and ghrelin or alpha-gustducin/alpha-transducin was investigated by immunofluorescence staining. The role of GPR120 in the effect of medium and long chain fatty acids on the release of ghrelin was studied in the ghrelinoma cell line, MGN3-1. The effect of the GPR40 agonist, MEDICA16, and the GPR120 agonist, grifolic acid, on ghrelin release was studied both in vitro and in vivo. Results: Feeding an OD specifically increased octanoyl ghrelin levels in the stomach of WT mice but not of gust(-/-) mice. Gastric emptying was accelerated in WT but not in gust(-/-) mice. GPR40 was colocalized with desoctanoyl but not with octanoyl ghrelin, alpha-gustducin or alpha-transducin positive cells in the stomach. GPR120 only colocalized with ghrelin in the duodenum. Addition of octanoic acid or alpha-linolenic acid to MGN3-1 cells increased and decreased octanoyl ghrelin levels, respectively. Both effects could not be blocked by GPR120 siRNA. MEDICA16 and grifolic acid did not affect ghrelin secretion in vitro but oral administration of grifolic acid increased plasma ghrelin levels. Conclusion: This study provides the first evidence that alpha-gustducin is involved in the octanoylation of ghrelin and shows that the ghrelin cell can sense long- and medium-chain fatty acids directly. GPR120 but not GPR40 may play a role in the lipid sensing cascade of the ghrelin cell.	[Janssen, Sara; Laermans, Jorien; Tack, Jan; Depoortere, Inge] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders, Louvain, Belgium; [Iwakura, Hiroshi] Kyoto Univ, Kyoto Univ Hosp, Grad Sch Med, Translat Res Ctr,Dept Med, Kyoto, Japan; [Iwakura, Hiroshi] Kyoto Univ, Kyoto Univ Hosp, Grad Sch Med, Translat Res Ctr,Dept Clin Sci, Kyoto, Japan; [Iwakura, Hiroshi] Kyoto Univ, Kyoto Univ Hosp, Grad Sch Med, Translat Res Ctr,Dept Endocrinol & Metab, Kyoto, Japan	KU Leuven; Kyoto University; Kyoto University; Kyoto University	Janssen, S (corresponding author), Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders, Louvain, Belgium.	inge.depoortere@med.kuleuven.be	Depoortere, Inge/I-5019-2013	Depoortere, Inge/0000-0002-0289-2175; Iwakura, Hiroshi/0000-0001-8033-0736; Laermans, Jorien/0000-0002-6695-6019; Tack, Jan/0000-0002-3206-6704	Flemish Foundation for Scientific Research [FWO G. 0670.10]; University of Leuven	Flemish Foundation for Scientific Research(FWO); University of Leuven(KU Leuven)	This work was supported by grants from the Flemish Foundation for Scientific Research (contract FWO G. 0670.10) and by a Methusalem grant from the University of Leuven for research on "The Brain-Gut Axis in Health and Disease: from Mucosal Integrity to Cortical Processing''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezencon C, 2007, CHEM SENSES, V32, P41, DOI 10.1093/chemse/bjl034; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Callahan HS, 2004, J CLIN ENDOCR METAB, V89, P1319, DOI 10.1210/jc.2003-031267; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Choi KC, 2003, ENDOCRINOLOGY, V144, P754, DOI 10.1210/en.2002-220783; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Depoortere I, 2005, EUR J PHARMACOL, V515, P160, DOI 10.1016/j.ejphar.2005.04.008; Depoortere I, 2009, REGUL PEPTIDES, V156, P13, DOI 10.1016/j.regpep.2009.04.002; Dezaki K, 2008, PHARMACOL THERAPEUT, V118, P239, DOI 10.1016/j.pharmthera.2008.02.008; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Foster-Schubert KE, 2008, J CLIN ENDOCR METAB, V93, P1971, DOI 10.1210/jc.2007-2289; Fukuda H, 2004, SCAND J GASTROENTERO, V39, P1209, DOI 10.1080/00365520410007908; FUKUWATARI T, 1997, FEBS LETT, V414, P461; Gahete MD, 2010, MOL CELL ENDOCRINOL, V317, P154, DOI 10.1016/j.mce.2009.12.023; Gillum MP, 2008, CELL, V135, P813, DOI 10.1016/j.cell.2008.10.043; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Hara T, 2009, N-S ARCH PHARMACOL, V380, P247, DOI 10.1007/s00210-009-0425-9; Hass N, 2007, HISTOCHEM CELL BIOL, V128, P457, DOI 10.1007/s00418-007-0325-3; He W, 2004, J NEUROSCI, V24, P7674, DOI 10.1523/JNEUROSCI.2441-04.2004; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hosoda H, 2000, BIOCHEM BIOPH RES CO, V279, P909, DOI 10.1006/bbrc.2000.4039; Iwakura H, 2010, ENDOCRINOLOGY, V151, P2940, DOI 10.1210/en.2010-0090; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Kamegai J, 2001, DIABETES, V50, P2438, DOI 10.2337/diabetes.50.11.2438; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Kitazawa T, 2005, GUT, V54, P1078, DOI 10.1136/gut.2005.065896; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Liou AP, 2011, GASTROENTEROLOGY, V140, P903, DOI 10.1053/j.gastro.2010.10.012; Matsumura S, 2009, NEUROSCI LETT, V450, P186, DOI 10.1016/j.neulet.2008.11.056; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Nishi Y, 2005, ENDOCRINOLOGY, V146, P2255, DOI 10.1210/en.2004-0695; Overduin J, 2005, ENDOCRINOLOGY, V146, P845, DOI 10.1210/en.2004-0609; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Shah BP, 2012, AM J PHYSIOL-CELL PH, V302, pC210, DOI 10.1152/ajpcell.00209.2011; Sutherland K, 2007, AM J PHYSIOL-GASTR L, V292, pG1420, DOI 10.1152/ajpgi.00504.2006; Tanaka T, 2008, N-S ARCH PHARMACOL, V377, P523, DOI 10.1007/s00210-007-0200-8; Tanaka T, 2008, N-S ARCH PHARMACOL, V377, P515, DOI 10.1007/s00210-007-0250-y; Theander-Carrillo C, 2006, J CLIN INVEST, V116, P1983, DOI 10.1172/JCI25811; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Verhulst PJ, 2008, GASTROENTEROLOGY, V135, P1267, DOI 10.1053/j.gastro.2008.06.044; Widmayer P, 2011, INT J OBES LOND; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Young RL, 2009, GUT, V58, P337, DOI 10.1136/gut.2008.148932; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P15868, DOI 10.1073/pnas.1011116107	46	76	81	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40168	10.1371/journal.pone.0040168	http://dx.doi.org/10.1371/journal.pone.0040168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768248	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100221
J	Lange, J; Barz, T; Ekkernkamp, A; Wilke, B; Kloting, I; Follak, N				Lange, Joern; Barz, Thomas; Ekkernkamp, Axel; Wilke, Barbara; Kloeting, Ingrid; Follak, Niels			Phenotypic and Gene Expression Differences between DA, BN and WOKW Rats	PLOS ONE			English	Article							METABOLIC SYNDROME; BODY-FAT; OBESITY; INSULIN; GENOME; MOUSE; LOCI; FEATURES; DISEASE; LINKAGE	Background: Because inbred rat strains are widely used as laboratory models, knowledge of phenotypic and genetic variations between strains will be useful to obtain insight into the relationship between different strains. Methods and Results: We studied phenotypic traits: of each strain - BN/K, DA/K and WOKW -10 male rats were studied for body weight and serum constituents at an age of 10 and 30 weeks. In addition, a total of 95 rats were studied for life expectancy. At an age of 30 weeks, these male rats were killed by an overdose of anesthetic (Sevofluran, Abbott), and the subcutaneous and visceral adipose tissue as well as bone tissue were removed to study the expression of 20 genes. There were significant differences in body weight, serum lipids and leptin at an age of 30 weeks between strains. Regarding life expectancy, BN rats lived longest (1072 +/- 228d). The highest gene expression was found in bone of BN rats. In adipose tissues, Nfkb1 is only expressed in subcutaneous adipocytes, and 5 genes, Col2a1, Mmp9, Tnfa, Ins1 and Cyp24a1, are not expressed in adipocytes. The ranking BN = DA>WOKW was observed in only one gene in subcutaneous (Fto) and visceral adipocytes (Col6a1). There were no significant differences in gene expression of one gene in subcutaneous adipocytes and of 3 genes in visceral adipocytes. Comparing the gene expression in visceral and subcutaneous adipocytes, only one gene showed a comparable behavior (Bmp1). Conclusion: From these results, it can be concluded that obvious phenotypic differences are caused by genetic differences between three rat strains, BN, DA and WOKW, as supported by gene expression studies in bone and adipose tissues. Especially BN rats can be used to study the genetic basis of long life.	[Lange, Joern; Ekkernkamp, Axel] Ernst Moritz Arndt Univ Greifswald, Fac Med, Dept Trauma & Reconstruct Surg, Greifswald, Germany; [Barz, Thomas] Asklepios Clin Uckermark, Dept Orthoped Surg, Schwedt, Germany; [Wilke, Barbara; Kloeting, Ingrid] Ernst Moritz Arndt Univ Greifswald, Fac Med, Dept Lab Anim Sci, Greifswald, Germany; [Follak, Niels] Pfeiffersche Stiftungen, Orthoped Clin, Magdeburg, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Lange, J (corresponding author), Ernst Moritz Arndt Univ Greifswald, Fac Med, Dept Trauma & Reconstruct Surg, Greifswald, Germany.	kloeting@uni-greifswald.de			Deutsche Forschungsgemeinschaft [KL 771/11-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research is partially supported by Grant No. KL 771/11-2 of the Deutsche Forschungsgemeinschaft. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aw D, 2007, IMMUNOLOGY, V120, P435, DOI 10.1111/j.1365-2567.2007.02555.x; Baguhl R, 2009, OBESITY, V17, P1215, DOI 10.1038/oby.2008.658; Bosse Y, 2005, INT J OBESITY, V29, P1338, DOI 10.1038/sj.ijo.0803010; Cheung MC, 2002, BBA-MOL BASIS DIS, V1587, P53, DOI 10.1016/S0925-4439(02)00054-6; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dusserre E, 2000, BBA-MOL BASIS DIS, V1500, P88, DOI 10.1016/S0925-4439(99)00091-5; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; HENRY GA, 1988, CLIN IMMUNOL IMMUNOP, V49, P187, DOI 10.1016/0090-1229(88)90109-2; Jukema JW, 1999, ACTA CARDIOL, V54, P163; Kaser S, 2001, DIABETOLOGIA, V44, P1111, DOI 10.1007/s001250100630; Kloting I, 2001, BIOCHEM BIOPH RES CO, V284, P150, DOI 10.1006/bbrc.2001.4932; Kloting N, 2006, DIABETES-METAB RES, V22, P146, DOI 10.1002/dmrr.582; Kloting N, 2005, DIABETES-METAB RES, V21, P281, DOI 10.1002/dmrr.526; Kovacs P, 2000, BIOCHEM BIOPH RES CO, V269, P660, DOI 10.1006/bbrc.2000.2352; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Lee JH, 1999, AM J HUM GENET, V64, P196, DOI 10.1086/302195; Lembertas AV, 1997, J CLIN INVEST, V100, P1240, DOI 10.1172/JCI119637; Linder K, 2004, J LIPID RES, V45, P148, DOI 10.1194/jlr.M300256-JLR200; Mehrabian M, 1998, J CLIN INVEST, V101, P2485, DOI 10.1172/JCI1748; Mocholi E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019236; Murdoch SJ, 2003, J LIPID RES, V44, P1705, DOI 10.1194/jlr.M300073-JLR200; Napolioni V, 2011, CYTOKINE, V56, P481, DOI 10.1016/j.cyto.2011.07.023; Norman RA, 1998, AM J HUM GENET, V62, P659, DOI 10.1086/301758; Pawelec G, 2008, EXP GERONTOL, V43, P34, DOI 10.1016/j.exger.2007.09.609; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Turner CH, 2001, J BONE MINER RES, V16, P1532, DOI 10.1359/jbmr.2001.16.8.1532; Twigger SN, 2008, NAT GENET, V40, P523, DOI 10.1038/ng0508-523; Vaarhorst AAM, 2011, AGE, V33, P219, DOI 10.1007/s11357-010-9172-6; van den Brandt J, 2000, INT J OBESITY, V24, P1618, DOI 10.1038/sj.ijo.0801444; van den Brandt J, 2000, METABOLISM, V49, P1140, DOI 10.1053/meta.2000.8610; Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015	32	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38981	10.1371/journal.pone.0038981	http://dx.doi.org/10.1371/journal.pone.0038981			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768054	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100024
J	Prabakaran, T; Nielsen, R; Satchell, SC; Mathieson, PW; Feldt-Rasmussen, U; Sorensen, SS; Christensen, EI				Prabakaran, Thaneas; Nielsen, Rikke; Satchell, Simon C.; Mathieson, Peter W.; Feldt-Rasmussen, Ulla; Sorensen, Soren S.; Christensen, Erik I.			Mannose 6-Phosphate Receptor and Sortilin Mediated Endocytosis of alpha-Galactosidase A in Kidney Endothelial Cells	PLOS ONE			English	Article							FABRY-DISEASE; LYSOSOMAL-ENZYME; CEREBRAL HYPERPERFUSION; REPLACEMENT THERAPY; PROTEIN; ACCUMULATION; NEPHROPATHY; DYSFUNCTION; EXPRESSION; CHILDREN	Prominent vasculopathy in Fabry disease patients is caused by excessive intracellular accumulation of globotriaosylceramide (GL-3) throughout the vascular endothelial cells causing progressive cerebrovascular, cardiac and renal impairments. The vascular lesions lead to myocardial ischemia, atherogenesis, stroke, aneurysm, thrombosis, and nephropathy. Hence, injury to the endothelial cells in the kidney is a key mechanism in human glomerular disease and endothelial cell repair is an important therapeutic target. We investigated the mechanism of uptake of alpha-galactosidase A (alpha-Gal A) in renal endothelial cells, in order to clarify if the recombinant enzyme is targeted to the lysosomes via the universal mannose 6-phosphate receptor (M6PR) and possibly other receptors. Immunohistochemical localization of infused recombinant alpha-Gal A in a renal biopsy from a classic Fabry disease patient showed that recombinant protein localize in the endothelial cells of the kidney. Affinity purification studies using alpha-Gal A resins identified M6PR and sortilin as alpha-Gal A receptors in cultured glomerular endothelial cells. Immunohistochemical analyses of normal human kidney with anti-sortilin and anti-M6PR showed that sortilin and M6PR were expressed in the endothelium of smaller and larger vessels. Uptake studies in cultured glomerular endothelial cells of alpha-Gal A labeled with fluorescence and I-125 showed by inhibition with RAP and M6P that sortilin and M6PR mediated uptake of alpha-Gal A. Biacore studies revealed that alpha-Gal A binds to human M6PR with very high affinity, but M6PR also binds to sortilin in a way that prevents alpha-Gal A binding to sortilin. Taken together, our data provide evidence that sortilin is a new alpha-Gal A receptor expressed in renal endothelial cells and that this receptor together with the M6PR is able to internalize circulating alpha-Gal A during enzyme replacement therapy in patients with Fabry disease.	[Prabakaran, Thaneas; Nielsen, Rikke; Christensen, Erik I.] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Satchell, Simon C.; Mathieson, Peter W.] Univ Bristol, Acad Renal Unit, Bristol, Avon, England; [Feldt-Rasmussen, Ulla] Rigshosp, Dept Med Endocrinol, DK-2100 Copenhagen, Denmark; [Sorensen, Soren S.] Rigshosp, Dept Nephrol P, DK-2100 Copenhagen, Denmark	Aarhus University; University of Bristol; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Prabakaran, T (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	eic@ana.au.dk	Prabakaran, Thaneas/K-3021-2019; Feldt-Rasmussen, Ulla/AAB-9218-2021	Feldt-Rasmussen, Ulla/0000-0002-5903-3355; Prabakaran, Thaneas/0000-0002-4698-7563; Nielsen, Rikke/0000-0003-3105-3474	Danish Medical Research Council; Novo Nordisk Foundation; Arvid Nilsson's Foundation; European Commission EUNEFRON [201590]; Aarhus University; Genzyme Corporation; Genzyme Corporation, Framingham, Massachusetts; Genzyme; Medical Research Council [G0800200] Funding Source: researchfish; MRC [G0800200] Funding Source: UKRI	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Arvid Nilsson's Foundation; European Commission EUNEFRON(European Commission); Aarhus University; Genzyme Corporation(Sanofi-AventisGenzyme Corporation); Genzyme Corporation, Framingham, Massachusetts(Sanofi-AventisGenzyme Corporation); Genzyme(Sanofi-AventisGenzyme Corporation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the Danish Medical Research Council, Novo Nordisk Foundation, Arvid Nilsson's Foundation, the European Commission EUNEFRON (FP7, GA#201590), Aarhus University, and Genzyme Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A PhD-grant for T. Prabakaran is in part paid by Genzyme Corporation, Framingham, Massachusetts. U. Feldt-Rasmussen has received unrestricted research grants form Genzyme and serves at the Fabry Registry Advisory Board. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Alroy J, 2002, J AM SOC NEPHROL, V13, pS134, DOI 10.1097/01.ASN.0000016684.07368.75; Altarescu G, 2001, STROKE, V32, P1559, DOI 10.1161/01.STR.32.7.1559; Bodary PF, 2005, CIRCULATION, V111, P629, DOI 10.1161/01.CIR.0000154550.15963.80; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; Branton MH, 2002, MEDICINE, V81, P122, DOI 10.1097/00005792-200203000-00003; Christensen EI, 2007, J AM SOC NEPHROL, V18, P698, DOI 10.1681/ASN.2006080822; Cleaver O, 2003, NAT MED, V9, P661, DOI 10.1038/nm0603-661; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; DeGraba T, 2000, ANN NEUROL, V47, P229, DOI 10.1002/1531-8249(200002)47:2<229::AID-ANA13>3.3.CO;2-K; Desnick RJ, 2006, METABOLIC MOL BASES, P3733; Eitzman DT, 2003, J AM SOC NEPHROL, V14, P298, DOI 10.1097/01.ASN.0000043901.45141.D4; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Fervenza FC, 2008, BIOL-TARGETS THER, V2, P823; Gelderman MP, 2007, ARTERIOSCL THROM VAS, V27, pE138, DOI 10.1161/ATVBAHA.107.143511; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Goligorsky MS, 2001, HYPERTENSION, V37, P744, DOI 10.1161/01.HYP.37.2.744; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; Heare T, 2007, J INHERIT METAB DIS, V30, P79, DOI 10.1007/s10545-006-0473-y; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; KAPLAN A, 1977, P NATL ACAD SCI USA, V74, P2026, DOI 10.1073/pnas.74.5.2026; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; Lee K, 2003, GLYCOBIOLOGY, V13, P305, DOI 10.1093/glycob/cwg034; Mitsias P, 1996, ANN NEUROL, V40, P8, DOI 10.1002/ana.410400105; Moore DF, 2007, J NEUROL SCI, V257, P258, DOI 10.1016/j.jns.2007.01.053; Moore DF, 2001, CIRCULATION, V104, P1506, DOI 10.1161/hc3801.096352; Moore DF, 2004, J MAGN RESON IMAGING, V20, P674, DOI 10.1002/jmri.20162; Ojo A, 2000, TRANSPLANTATION, V69, P2337, DOI 10.1097/00007890-200006150-00020; OKA Y, 1985, J BIOL CHEM, V260, P9435; Petersen CM, 1999, EMBO J, V18, P595, DOI 10.1093/emboj/18.3.595; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Prabakaran T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025065; Quistgaard EM, 2009, NAT STRUCT MOL BIOL, V16, P96, DOI 10.1038/nsmb.1543; SANDO GN, 1977, CELL, V12, P619, DOI 10.1016/0092-8674(77)90262-8; Satchell SC, 2006, KIDNEY INT, V69, P1633, DOI 10.1038/sj.ki.5000277; Schiffmann R, 2000, P NATL ACAD SCI USA, V97, P365, DOI 10.1073/pnas.97.1.365; Shen JS, 2008, MOL GENET METAB, V95, P163, DOI 10.1016/j.ymgme.2008.06.016; Shen JS, 2007, MOL GENET METAB, V92, P137, DOI 10.1016/j.ymgme.2007.06.003; Tauris J, 1998, FEBS LETT, V429, P27, DOI 10.1016/S0014-5793(98)00559-6; Thadhani R, 2002, KIDNEY INT, V61, P249, DOI 10.1046/j.1523-1755.2002.00097.x; Thurberg BL, 2002, KIDNEY INT, V62, P1933, DOI 10.1046/j.1523-1755.2002.00675.x; Tondel C, 2008, AM J KIDNEY DIS, V51, P767, DOI 10.1053/j.ajkd.2007.12.032; Viemann D, 2006, J LEUKOCYTE BIOL, V80, P174, DOI 10.1189/jlb.0905530; Vinge L, 2010, NEPHROL DIAL TRANSPL, V25, P2458, DOI 10.1093/ndt/gfq044; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516	45	20	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39975	10.1371/journal.pone.0039975	http://dx.doi.org/10.1371/journal.pone.0039975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768187	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100159
J	Sloane, PA; Shastry, S; Wilhelm, A; Courville, C; Tang, LP; Backer, K; Levin, E; Raju, SV; Li, Y; Mazur, M; Byan-Parker, S; Grizzle, W; Sorscher, EJ; Dransfield, MT; Rowe, SM				Sloane, Peter A.; Shastry, Suresh; Wilhelm, Andrew; Courville, Clifford; Tang, Li Ping; Backer, Kyle; Levin, Elina; Raju, S. Vamsee; Li, Yao; Mazur, Marina; Byan-Parker, Suzanne; Grizzle, William; Sorscher, Eric J.; Dransfield, Mark T.; Rowe, Steven M.			A Pharmacologic Approach to Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Smoking Related Lung Disease	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CFTR GENE-MUTATIONS; AIRWAY INFLAMMATION; ADENOSINE RECEPTORS; CHLORIDE SECRETION; DELTA-F508 CFTR; IN-VITRO; MUCUS; EXPRESSION; CLEARANCE	Background: Mucus stasis in chronic obstructive pulmonary disease (COPD) is a significant contributor to morbidity and mortality. Potentiators of cystic fibrosis transmembrane conductance regulator (CFTR) activity pharmacologically enhance CFTR function; ivacaftor is one such agent approved to treat CF patients with the G551D-CFTR gating mutation. CFTR potentiators may also be useful for other diseases of mucus stasis, including COPD. Methods and Findings: In primary human bronchial epithelial cells, exposure to cigarette smoke extract diminished CFTR-mediated anion transport (65.8 +/- 0.2% of control, P<0.005) and mucociliary transport (0.17 +/- 0.05 mu m/sec vs. 2.4 +/- 0.47 mu m/sec control, P<0.05) by reducing airway surface liquid depth (7.3 +/- 0.6 mu m vs. 13.0 +/- 0.6 mu m control, P<0.005) and augmenting mucus expression (by 64%, P<0.05) without altering transepithelial resistance. Smokers with or without COPD had reduced CFTR activity measured by nasal potential difference compared to age-matched non-smokers (-6.3 +/- 1.4 and -8.0 +/- 2.0 mV, respectively vs. -15.2 +/- 2.7 mV control, each P<0.005, n = 12-14/group); this CFTR decrement was associated with symptoms of chronic bronchitis as measured by the Breathlessness Cough and Sputum Score (r = 0.30, P<0.05) despite controlling for smoking (r = 0.31, P<0.05). Ivacaftor activated CFTR-dependent chloride transport in non-CF epithelia and ameliorated the functional CFTR defect induced by smoke to 185 +/- 36% of non-CF control (P<0.05), thereby increasing airway surface liquid (from 7.3 +/- 0.6 mu m to 10.1 +/- 0.4 mu m, P<0.005) and mucociliary transport (from 0.27 +/- 0.11 mu m/s to 2.7 +/- 0.28 mu m/s, P<0.005). Conclusions: Cigarette smoking reduces CFTR activity and is causally related to reduced mucus transport in smokers due to inhibition of CFTR dependent fluid transport. These effects are reversible by the CFTR potentiator ivacaftor, representing a potential therapeutic strategy to augment mucociliary clearance in patients with smoking related lung disease.	[Sloane, Peter A.; Shastry, Suresh; Tang, Li Ping; Backer, Kyle; Levin, Elina; Raju, S. Vamsee; Li, Yao; Mazur, Marina; Sorscher, Eric J.; Dransfield, Mark T.; Rowe, Steven M.] Univ Alabama Birmingham, Cyst Fibrosis Res Ctr, Birmingham, AL 35233 USA; [Wilhelm, Andrew; Courville, Clifford; Sorscher, Eric J.; Dransfield, Mark T.; Rowe, Steven M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Rowe, Steven M.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA; [Sorscher, Eric J.; Rowe, Steven M.] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Byan-Parker, Suzanne; Grizzle, William] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Dransfield, Mark T.; Rowe, Steven M.] Univ Alabama Birmingham, UAB Lung Hlth Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sloane, PA (corresponding author), Univ Alabama Birmingham, Cyst Fibrosis Res Ctr, Birmingham, AL 35233 USA.	smrowe@uab.edu		Sorscher, Eric J./0000-0001-9341-3354	National Institutes of Health (NIH) [1R01 HL105487, K23 DK075788, P30 DK072482, 5UL1 RR025777]; Cystic Fibrosis Foundation [R464-CF, CLANCY09Y0]; Vertex Pharmaceuticals; GlaxoSmithKline; Boehringer Ingelheim; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025777] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007473, R01HL105487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK075788, P30DK072482] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Vertex Pharmaceuticals(Vertex Pharmaceuticals); GlaxoSmithKline(GlaxoSmithKline); Boehringer Ingelheim(Boehringer Ingelheim); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was sponsored by National Institutes of Health (NIH) (1R01 HL105487 to Dr. Rowe, K23 DK075788 to Dr. Rowe, P30 DK072482 to Dr. Sorscher and 5UL1 RR025777) and the Cystic Fibrosis Foundation (R464-CF to Dr. Sorscher and CLANCY09Y0 to Dr. Rowe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Rowe served as a consultant for Vertex Pharmaceuticals for the design of CF clinical trials and also served as site PI for CF Clinical Trials sponsored by Vertex Pharmaceuticals. Dr. Dransfield has served on COPD-related advisory boards for Forest, GlaxoSmithKline and Boehringer Ingelheim. Dr. Dransfield has served as site PI for contracted COPD clinical trials sponsored by GlaxoSmithKline and Boehringer Ingelheim. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Amaral MD, 2007, TRENDS PHARMACOL SCI, V28, P334, DOI 10.1016/j.tips.2007.05.004; Martinez-Garcia MA, 2011, CHEST, V140, P1130, DOI 10.1378/chest.10-1758; Azbell C, 2010, OTOLARYNG HEAD NECK, V143, P397, DOI 10.1016/j.otohns.2010.05.021; Barnes PJ, 2004, NEW ENGL J MED, V350, P2635, DOI 10.1056/NEJMp048102; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bodas M, 2011, J IMMUNOL, V186, P602, DOI 10.4049/jimmunol.1002850; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Cobb BR, 2003, AM J RESP CELL MOL, V29, P410, DOI 10.1165/rcmb.2002-0247OC; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; Decramer M, 2005, LANCET, V365, P1552, DOI 10.1016/S0140-6736(05)66456-2; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Girodon E, 1997, EUR J HUM GENET, V5, P149, DOI 10.1159/000484750; Guimbellot JS, 2008, AM J RESP CELL MOL, V39, P514, DOI 10.1165/rcmb.2007-0452OC; Hogg JC, 2007, AM J RESP CRIT CARE, V176, P454, DOI 10.1164/rccm.200612-1772OC; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; Howard MT, 2000, ANN NEUROL, V48, P164, DOI 10.1002/1531-8249(200008)48:2<164::AID-ANA5>3.3.CO;2-2; Innes AL, 2006, CHEST, V130, P1102, DOI 10.1378/chest.130.4.1102; Jurkuvenaite A, 2006, J BIOL CHEM, V281, P3329, DOI 10.1074/jbc.M508131200; Kasai A, 2006, CANCER RES, V66, P7143, DOI 10.1158/0008-5472.CAN-05-4541; Kellermayer R, 2006, J INVEST DERMATOL, V126, P229, DOI 10.1038/sj.jid.5700031; Kerem E, 2008, LANCET, V372, P719, DOI 10.1016/S0140-6736(08)61168-X; Knowles MR, 2002, NEW ENGL J MED, V347, P439, DOI 10.1056/NEJMe020070; Koblizek V, 2011, RHINOLOGY, V49, P397, DOI 10.4193/Rhino11.051; Kreindler JL, 2005, AM J PHYSIOL-LUNG C, V288, pL894, DOI 10.1152/ajplung.00376.2004; Leidy NK, 2003, CHEST, V124, P2182, DOI 10.1378/chest.124.6.2182; Marchand E, 2001, CHEST, V119, P762, DOI 10.1378/chest.119.3.762; Matsui H, 1998, J CLIN INVEST, V102, P1125, DOI 10.1172/JCI2687; Miller PW, 1996, AM J HUM GENET, V59, P45; Mortaz E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004946; Pignatti PF, 1996, AM J HUM GENET, V58, P889; Rab A, 2007, AM J PHYSIOL-CELL PH, V292, pC756, DOI 10.1152/ajpcell.00391.2006; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Rennolds J, 2010, TOXICOL SCI, V116, P349, DOI 10.1093/toxsci/kfq101; Rollins BM, 2008, AM J RESP CELL MOL, V39, P190, DOI 10.1165/rcmb.2007-0450OC; Rowe SM, 2010, PULM PHARMACOL THER, V23, P268, DOI 10.1016/j.pupt.2010.02.001; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Rowe SM, 2010, J CYST FIBROS, VS20; Rowe SM, 2007, AM J RESP CELL MOL, V37, P347, DOI 10.1165/rcmb.2006-0176OC; Rowe SM, 2010, PEDIATR PULM, P216; Sarir H, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-12; Savitski AN, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-120; Sethi S, 2006, AM J RESP CRIT CARE, V173, P991, DOI 10.1164/rccm.200509-1525OC; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; Soler N, 1999, EUR RESPIR J, V14, P1015, DOI 10.1183/09031936.99.14510159; Solomon GM, 2010, CHEST, V138, P919, DOI 10.1378/chest.10-0179; van der Toorn M, 2009, AM J PHYSIOL-LUNG C, V297, pL109, DOI 10.1152/ajplung.90461.2008; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Varga K, 2008, BIOCHEM J, V410, P555, DOI 10.1042/BJ20071420; Vestbo J, 2002, NOVART FDN SYMP, V248, P3; WELSH MJ, 1983, J CLIN INVEST, V71, P1614, DOI 10.1172/JCI110917; Wilschanski M, 2006, AM J RESP CRIT CARE, V174, P787, DOI 10.1164/rccm.200509-1377OC; Zheng JP, 2008, LANCET, V371, P2013, DOI 10.1016/S0140-6736(08)60869-7	54	133	155	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39809	10.1371/journal.pone.0039809	http://dx.doi.org/10.1371/journal.pone.0039809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768130	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100100
J	Sudfeld, CR; Wang, ML; Aboud, S; Giovannucci, EL; Mugusi, FM; Fawzi, WW				Sudfeld, Christopher R.; Wang, Molin; Aboud, Said; Giovannucci, Edward L.; Mugusi, Ferdinand M.; Fawzi, Wafaie W.			Vitamin D and HIV Progression among Tanzanian Adults Initiating Antiretroviral Therapy	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; D DEFICIENCY; 1,25-DIHYDROXYVITAMIN D-3; DISEASE PROGRESSION; REGRESSION-MODELS; IMMUNE-SYSTEM; ASSOCIATION; PREVALENCE; MORTALITY; RISK	Background: There is growing evidence of an association between low vitamin D and HIV disease progression; however, no prospective studies have been conducted among adults receiving antiretroviral therapy (ART) in sub-Saharan Africa. Methods: Serum 25-hydroxyvitamin D (25(OH)D) levels were assessed at ART initiation for a randomly selected cohort of HIV-infected adults enrolled in a trial of multivitamins (not including vitamin D) in Tanzania during 2006-2010. Participants were prospectively followed at monthly clinic visits for a median of 20.6 months. CD4 T-cell measurements were obtained every 4 months. Proportional hazard models were utilized for mortality analyses while generalized estimating equations were used for CD4 T-cell counts. Results: Serum 25(OH)D was measured in 1103 adults 9.2% were classified as vitamin D deficient (<20 ng/ml), 43.6% insufficient (20-30 ng/mL), and 47.2% as sufficient (>30 ng/mL). After multivariate adjustment, vitamin D deficiency was significantly associated with increased mortality as compared to vitamin D sufficiency (HR: 2.00; 95% CI: 1.19-3.37; p = 0.009), whereas no significant association was found for vitamin D insufficiency (HR: 1.24; 95% CI: 0.87-1.78; p = 0.24). No effect modification by ART regimen or change in the associations over time was detected. Vitamin D status was not associated with change in CD4 T-cell count after ART initiation. Conclusions: Deficient vitamin D levels may lead to increased mortality in individuals receiving ART and this relationship does not appear to be due to impaired CD4 T-cell reconstitution. Randomized controlled trials are needed to determine the safety and efficacy of vitamin D supplementation for individuals receiving ART.	[Sudfeld, Christopher R.; Giovannucci, Edward L.; Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Wang, Molin] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Giovannucci, Edward L.; Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Aboud, Said] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania; [Mugusi, Ferdinand M.] Muhimbili Univ Hlth & Allied Sci, Dept Internal Med, Dar Es Salaam, Tanzania; [Giovannucci, Edward L.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Harvard University; Brigham & Women's Hospital	Sudfeld, CR (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	csudfeld@hsph.harvard.edu	Sudfeld, Christopher/AAW-3856-2021	Sudfeld, Christopher/0000-0002-3203-3638	National Institute of Child Health and Human development [R01 HD32257]; National Institute of Allergy and Infectious Diseases [T32AI007358]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007358] Funding Source: NIH RePORTER	National Institute of Child Health and Human development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Child Health and Human development (Grant Number R01 HD32257). C.R. Sudfeld was supported by Award Number T32AI007358 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALROY I, 1995, MOL CELL BIOL, V15, P5789; [Anonymous], 1985, THEORETICAL EPIDEMIO; Arpadi SM, 2009, PEDIATRICS, V123, pE121, DOI 10.1542/peds.2008-0176; BARSHAVIT Z, 1981, CALCIFIED TISSUE INT, V33, P673, DOI 10.1007/BF02409507; BHALLA AK, 1984, J IMMUNOL, V133, P1748; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Boonstra A, 2001, J IMMUNOL, V169, P4974; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brannon PM, 2011, ANNU REV NUTR, V31, P89, DOI 10.1146/annurev.nutr.012809.104807; Brown TT, 2010, ANTIVIR THER, V15, P425, DOI [10.3851/IMP1502, 10.3851/IMP15021]; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; COX DR, 1972, J R STAT SOC B, V34, P187; Cozzolino M, 2003, AIDS, V17, P513, DOI 10.1097/00002030-200303070-00006; Dao CN, 2011, CLIN INFECT DIS, V52, P396, DOI 10.1093/cid/ciq158; Deeks Steven G, 2009, Top HIV Med, V17, P118; Deluca HF, 2001, FASEB J, V15, P2579, DOI 10.1096/fj.01-0433rev; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Fox J, 2011, AIDS RES HUM RETROV, V27, P29, DOI 10.1089/aid.2010.0081; Global HIV/AIDS Response, 2011, EP UPD HLTH SECT PRO; Glymour MM, 2005, AM J EPIDEMIOL, V162, P267, DOI 10.1093/aje/kwi187; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Gorman S, 2007, J IMMUNOL, V179, P6273, DOI 10.4049/jimmunol.179.9.6273; Govindarajulu US, 2007, STAT MED, V26, P3735, DOI 10.1002/sim.2848; Hansen KE, 2008, J BONE MINER RES, V23, P1052, DOI 10.1359/JBMR.080230; HAUG C, 1994, J INFECT DIS, V169, P889, DOI 10.1093/infdis/169.4.889; Haug CJ, 1998, J CLIN ENDOCR METAB, V83, P3832, DOI 10.1210/jc.83.11.3832; Heaney RP, 2004, AM J CLIN NUTR, V80, p1706S, DOI 10.1093/ajcn/80.6.1706S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; Institute of Medicine, 2011, DIETARY REFERENCE IN; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Kakalia S, 2011, J PEDIATR-US, V159, P951, DOI 10.1016/j.jpeds.2011.06.010; Kamen DL, 2010, J MOL MED, V88, P441, DOI 10.1007/s00109-010-0590-9; Kovesdy CP, 2008, ARCH INTERN MED, V168, P397, DOI 10.1001/archinternmed.2007.110; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; LEMIRE JM, 1984, J CLIN INVEST, V74, P657, DOI 10.1172/JCI111465; Lensmeyer GL, 2006, CLIN CHEM, V52, P1120, DOI 10.1373/clinchem.2005.064956; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Martineau AR, 2012, P NUTR SOC, V71, P84, DOI 10.1017/S0029665111003326; Mehta S, 2011, AIDS PATIENT CARE ST, V25, P579, DOI 10.1089/apc.2011.0182; Mehta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008770; Mehta S, 2009, J INFECT DIS, V200, P1022, DOI 10.1086/605699; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Overbergh L, 2000, DIABETES, V49, P1301, DOI 10.2337/diabetes.49.8.1301; Overton Edgar Turner, 2011, Curr Infect Dis Rep, V13, P83, DOI 10.1007/s11908-010-0144-x; Realegeno S, 2011, P NATL ACAD SCI USA, V108, P18861, DOI 10.1073/pnas.1116513108; RIGBY WFC, 1984, J CLIN INVEST, V74, P1451, DOI 10.1172/JCI111557; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Ross AC, 2011, ANTIVIR THER, V16, P555, DOI 10.3851/IMP1784; Souberbielle JC, 2010, AUTOIMMUN REV, V9, P709, DOI 10.1016/j.autrev.2010.06.009; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Stein EM, 2011, OSTEOPOROSIS INT, V22, P477, DOI 10.1007/s00198-010-1299-x; Tang J, 2009, J IMMUNOL, V182, P4624, DOI 10.4049/jimmunol.0801543; Terrier B, 2011, J HEPATOL, V55, P756, DOI 10.1016/j.jhep.2011.01.041; Van Den Bout-Van Den Beukel CJP, 2008, AIDS RES HUM RETROV, V24, P1375, DOI 10.1089/aid.2008.0058; Vescini F, 2011, JAIDS-J ACQ IMM DEF, V58, P163, DOI 10.1097/QAI.0b013e31822e57e9; Viard JP, 2011, AIDS, V25, P1305, DOI 10.1097/QAD.0b013e328347f6f7; Villamor E, 2006, NUTR REV, V64, P226, DOI 10.1111/j.1753-4887.2006.tb00205.x; WACHOLDER S, 1986, AM J EPIDEMIOL, V123, P174, DOI 10.1093/oxfordjournals.aje.a114212; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Welz T, 2010, AIDS, V24, P1923, DOI 10.1097/QAD.0b013e32833c3281; World Health Organization, 2004, SCAL ANT THER RES LT; YANG SL, 1993, ARCH BIOCHEM BIOPHYS, V303, P98, DOI 10.1006/abbi.1993.1260; Yin M, 2011, CLIN INFECT DIS, V52, P406, DOI 10.1093/cid/ciq169; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	66	48	48	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40036	10.1371/journal.pone.0040036	http://dx.doi.org/10.1371/journal.pone.0040036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768212	Green Published, gold			2022-12-27	WOS:000305892100184
J	Catry, FX; Moreira, F; Pausas, JG; Fernandes, PM; Rego, F; Cardillo, E; Curt, T				Catry, Filipe X.; Moreira, Francisco; Pausas, Juli G.; Fernandes, Paulo M.; Rego, Francisco; Cardillo, Enrique; Curt, Thomas			Cork Oak Vulnerability to Fire: The Role of Bark Harvesting, Tree Characteristics and Abiotic Factors	PLOS ONE			English	Article							QUERCUS-SUBER; PHYTOPHTHORA-CINNAMOMI; SLOPE ASPECT; DAMAGE; CLIMATE; IMPACT; FOREST; SURVIVAL; PERFORMANCE; MANAGEMENT	Forest ecosystems where periodical tree bark harvesting is a major economic activity may be particularly vulnerable to disturbances such as fire, since debarking usually reduces tree vigour and protection against external agents. In this paper we asked how cork oak Quercus suber trees respond after wildfires and, in particular, how bark harvesting affects post-fire tree survival and resprouting. We gathered data from 22 wildfires ( 4585 trees) that occurred in three southern European countries (Portugal, Spain and France), covering a wide range of conditions characteristic of Q. suber ecosystems. Post-fire tree responses (tree mortality, stem mortality and crown resprouting) were examined in relation to management and ecological factors using generalized linear mixed-effects models. Results showed that bark thickness and bark harvesting are major factors affecting resistance of Q. suber to fire. Fire vulnerability was higher for trees with thin bark (young or recently debarked individuals) and decreased with increasing bark thickness until cork was 3-4 cm thick. This bark thickness corresponds to the moment when exploited trees are debarked again, meaning that exploited trees are vulnerable to fire during a longer period. Exploited trees were also more likely to be top-killed than unexploited trees, even for the same bark thickness. Additionally, vulnerability to fire increased with burn severity and with tree diameter, and was higher in trees burned in early summer or located in drier south-facing aspects. We provided tree response models useful to help estimating the impact of fire and to support management decisions. The results suggested that an appropriate management of surface fuels and changes in the bark harvesting regime (e. g. debarking coexisting trees in different years or increasing the harvesting cycle) would decrease vulnerability to fire and contribute to the conservation of cork oak ecosystems.	[Catry, Filipe X.; Moreira, Francisco; Fernandes, Paulo M.; Rego, Francisco] Tech Univ Lisbon CEABN ISA UTL, Ctr Appl Ecol, Sch Agr, Lisbon, Portugal; [Pausas, Juli G.] Spanish Natl Res Council CIDE CSIC, Desertificat Res Ctr, Valencia, Spain; [Fernandes, Paulo M.] Univ Tras Os Montes & Alto Douro CIFAP UTAD, Ctr Res & Technol Agroenvironm & Biol Sci, Vila Real, Portugal; [Cardillo, Enrique] Inst Wood Cork & Charcoal IPROCOR, Badajoz, Spain; [Curt, Thomas] Natl Res Inst Sci & Technol Environm & Agr EMAX I, Mediterranean Ecosyst & Risks Res Unit, Aix En Provence, France	Universidade de Lisboa; Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia; CSIC-GV-UV - Centro de Investigaciones sobre Desertificacion (CIDE); University of Tras-os-Montes & Alto Douro; INRAE	Catry, FX (corresponding author), Tech Univ Lisbon CEABN ISA UTL, Ctr Appl Ecol, Sch Agr, Lisbon, Portugal.	fcatry@isa.utl.pt	Fernandes, Paulo M./A-6948-2008; Moreira, Francisco/B-2873-2008; Catry, Filipe/F-5338-2010; Pausas, Juli/C-5794-2008; Castro Rego, Francisco/H-9155-2013	Fernandes, Paulo M./0000-0003-0336-4398; Moreira, Francisco/0000-0003-4393-8018; Catry, Filipe/0000-0003-0668-9323; Pausas, Juli/0000-0003-3533-5786; Cardillo, Enrique/0000-0002-9148-7090; Castro Rego, Francisco/0000-0003-0060-5192	Portuguese government (Fundacao para a Ciencia e a Tecnologia) [POCI/AGR/61407/2004, SFRH/BD/65991/2009]; European Union [COST FP0701, TRANZFOR]; Spanish government [VARQUS, GL2004-04325/BOS, VIRRA, CGL2009-12048/BOS]; French government (Ministry for Ecology) [MEEDATT/DEB/2006]; Provence region [PACA DEB 09-716]; Fundação para a Ciência e a Tecnologia [POCI/AGR/61407/2004, SFRH/BD/114843/2016] Funding Source: FCT	Portuguese government (Fundacao para a Ciencia e a Tecnologia); European Union(European Commission); Spanish government(Spanish GovernmentEuropean Commission); French government (Ministry for Ecology); Provence region; Fundação para a Ciência e a Tecnologia	This work was funded by the Portuguese government (Fundacao para a Ciencia e a Tecnologia: project POCI/AGR/61407/2004 and PhD grant SFRH/BD/65991/2009; Fundo Florestal Permanente: project Recuperacao de Areas Ardidas), the European Union (projects: COST FP0701 and TRANZFOR), the Spanish government (projects: VARQUS, CGL2004-04325/BOS and VIRRA, CGL2009-12048/BOS), and the French government (Ministry for Ecology: project MEEDATT/DEB/2006; Provence region: project PACA DEB 09-716). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, DIG MAP EUR EC REG; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1950, DIRECAO GERAL SERVIC; [Anonymous], 2009, ECOLOGY SILVICULTURE; APCOR, 2009, APCOR YB 2009; Barberis A, 2003, J ARID ENVIRON, V54, P565, DOI 10.1006/jare.2002.1079; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Bergot M, 2004, GLOBAL CHANGE BIOL, V10, P1539, DOI 10.1111/j.1365-2486.2004.00824.x; Bond WJ, 1994, FIRE PLANTS; Botha J, 2004, BIODIVERS CONSERV, V13, P1675, DOI 10.1023/B:BIOC.0000029333.72945.b0; Branco M, 2009, CORK OAK WOODLANDS E, P103; Brando PM, 2012, GLOBAL CHANGE BIOL, V18, P630, DOI 10.1111/j.1365-2486.2011.02533.x; Bugalho MN, 2011, FRONT ECOL ENVIRON, V9, P278, DOI 10.1890/100084; Cardillo E, 2007, ALCORNOCAL FUEGO; Catry FX, 2010, FOREST ECOL MANAG, V260, P1184, DOI 10.1016/j.foreco.2010.07.010; Catry FX, 2012, MANAG FOR ECOSYST, V24, P195, DOI 10.1007/978-94-007-2208-8_9; Catry FX, 2009, EUR J FOREST RES, V128, P231, DOI 10.1007/s10342-009-0259-5; Correia O.A., 1992, SCI GERUND, V18, P195; Costa A, 2004, FORESTRY, V77, P1, DOI 10.1093/forestry/77.1.1; DeBano LF, 1998, FIRES EFFECTS ECOSYS; Delvaux C, 2010, BIOL CONSERV, V143, P2664, DOI 10.1016/j.biocon.2010.07.009; Delvaux C, 2009, J APPL ECOL, V46, P703, DOI 10.1111/j.1365-2664.2009.01639.x; DUMERLE P, 1992, ANN SCI FOREST, V49, P571, DOI 10.1051/forest:19920602; FAO, 2006, GLOB FOR RES ASS 200; Flannigan MD, 2009, INT J WILDLAND FIRE, V18, P483, DOI 10.1071/WF08187; Gaoue OG, 2008, J APPL ECOL, V45, P34, DOI 10.1111/j.1365-2664.2007.01381.x; Gaoue OG, 2010, CONSERV BIOL, V24, P605, DOI 10.1111/j.1523-1739.2009.01345.x; Giannakopoulos C, 2009, GLOBAL PLANET CHANGE, V68, P209, DOI 10.1016/j.gloplacha.2009.06.001; Guedje NM, 2007, FOREST ECOL MANAG, V240, P1, DOI 10.1016/j.foreco.2006.09.029; He TH, 2012, NEW PHYTOL, V194, P751, DOI 10.1111/j.1469-8137.2012.04079.x; HOSMER DW, 1989, APPL LOGISTIC REGRES; Jackson JF, 1999, AM NAT, V153, P614, DOI 10.1086/303201; Kutiel P, 1999, ISRAEL J PLANT SCI, V47, P169, DOI 10.1080/07929978.1999.10676770; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; MARQUES MA, 1992, CATENA, V19, P333, DOI 10.1016/0341-8162(92)90007-X; Martin J, 2005, FOREST ECOL MANAG, V216, P166, DOI 10.1016/j.foreco.2005.05.027; Mendes AMSC, 2009, CORK OAK WOODLANDS E, P59; Miller M, 2000, US FOR SERV RMRS-P, P9; Moreira AC, 2005, FOREST PATHOL, V35, P145, DOI 10.1111/j.1439-0329.2005.00397.x; Moreira F, 2009, PLANT ECOL, V201, P77, DOI 10.1007/s11258-008-9476-0; Moreira F, 2007, FOREST ECOL MANAG, V253, P30, DOI 10.1016/j.foreco.2007.07.001; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; OLIVEIRA G, 1992, VEGETATIO, V100, P199; Paula S., 2009, ECOLOGY, V90, P1420, DOI DOI 10.1890/08-1309.1; Pausas J.G., 2009, CORK OAK WOODLANDS E, P11; Pausas JG, 1997, J VEG SCI, V8, P703, DOI 10.2307/3237375; Pausas JG, 2004, CLIMATIC CHANGE, V63, P337, DOI 10.1023/B:CLIM.0000018508.94901.9c; Pausas JS, 2009, CORK OAK WOODLANDS E, P219; Pausas JG, 2012, CLIMATIC CHANGE, V110, P215, DOI 10.1007/s10584-011-0060-6; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pereira H., 2011, CORK BIOL PRODUCTION; Pereira PM, 2003, CONSERV ECOL, V7; Pinol J, 1998, CLIMATIC CHANGE, V38, P345, DOI 10.1023/A:1005316632105; Purohit A, 2001, CURR SCI INDIA, V81, P586; RUNDEL PW, 1973, ECOLOGY, V54, P210, DOI 10.2307/1934393; RYAN KC, 1988, CAN J FOREST RES, V18, P1291, DOI 10.1139/x88-199; Silva J. S., 2006, International Journal of Environmental Studies, V63, P235, DOI 10.1080/00207230600720829; Silva SP, 2005, INT MATER REV, V50, P345, DOI 10.1179/174328005X41168; Sternberg M, 2001, ECOL RES, V16, P335, DOI 10.1046/j.1440-1703.2001.00393.x; Stewart K, 2009, FOREST ECOL MANAG, V258, P1121, DOI 10.1016/j.foreco.2009.05.039; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Wargo PM, 1996, ANN SCI FOREST, V53, P359, DOI 10.1051/forest:19960218; Whelan R.J.., 1995, ECOLOGY FIRE; Zuur Alain F., 2009, P1	64	42	42	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39810	10.1371/journal.pone.0039810	http://dx.doi.org/10.1371/journal.pone.0039810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22787521	Green Published, gold			2022-12-27	WOS:000305826400040
J	Mir, M; Babacan, SD; Bednarz, M; Do, MN; Golding, I; Popescu, G				Mir, Mustafa; Babacan, S. Derin; Bednarz, Michael; Do, Minh N.; Golding, Ido; Popescu, Gabriel			Visualizing Escherichia coli Sub-Cellular Structure Using Sparse Deconvolution Spatial Light Interference Tomography	PLOS ONE			English	Article							PHASE MICROSCOPY; QUANTITATIVE PHASE; DIFFRACTION TOMOGRAPHY; CELL-CYCLE; RESOLUTION; DIVISION; LIMIT; IMPROVEMENT; PROTEINS; DYNAMICS	Studying the 3D sub-cellular structure of living cells is essential to our understanding of biological function. However, tomographic imaging of live cells is challenging mainly because they are transparent, i.e., weakly scattering structures. Therefore, this type of imaging has been implemented largely using fluorescence techniques. While confocal fluorescence imaging is a common approach to achieve sectioning, it requires fluorescence probes that are often harmful to the living specimen. On the other hand, by using the intrinsic contrast of the structures it is possible to study living cells in a non-invasive manner. One method that provides high-resolution quantitative information about nanoscale structures is a broadband interferometric technique known as Spatial Light Interference Microscopy (SLIM). In addition to rendering quantitative phase information, when combined with a high numerical aperture objective, SLIM also provides excellent depth sectioning capabilities. However, like in all linear optical systems, SLIM's resolution is limited by diffraction. Here we present a novel 3D field deconvolution algorithm that exploits the sparsity of phase images and renders images with resolution beyond the diffraction limit. We employ this label-free method, called deconvolution Spatial Light Interference Tomography (dSLIT), to visualize coiled sub-cellular structures in E. coli cells which are most likely the cytoskeletal MreB protein and the division site regulating MinCDE proteins. Previously these structures have only been observed using specialized strains and plasmids and fluorescence techniques. Our results indicate that dSLIT can be employed to study such structures in a practical and non-invasive manner.	[Mir, Mustafa; Do, Minh N.; Popescu, Gabriel] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA; [Mir, Mustafa; Babacan, S. Derin; Do, Minh N.; Popescu, Gabriel] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA; [Bednarz, Michael; Golding, Ido] Univ Illinois, Dept Phys, Ctr Phys Living Cells, Urbana, IL USA; [Golding, Ido] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Baylor College of Medicine	Mir, M (corresponding author), Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA.	mmir2@illinois.edu	N., Minh/AAX-8498-2020	N., Minh/0000-0001-5132-4986; Mir, Mustafa/0000-0001-8280-2821	National Science Foundation (NSF) under the Science and Technology Center Emergent Behaviors of Integrated Cellular Systems (EBICS) [CBET-0939511]; NSF [CBET 1040462 MRI, CBET 08-46660 CAREER, 082265, CCF-0916953]; National Institutes of Health [R01GM082837]; Human Frontier Science Program [RGY 70/2008]; Beckman Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082837] Funding Source: NIH RePORTER	National Science Foundation (NSF) under the Science and Technology Center Emergent Behaviors of Integrated Cellular Systems (EBICS)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); Beckman Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This material is based upon work supported by the National Science Foundation (NSF) under the Science and Technology Center Emergent Behaviors of Integrated Cellular Systems (EBICS) Grant No. CBET-0939511 to G. P. This work was supported in part by NSF Grants CBET 1040462 MRI and CBET 08-46660 CAREER to G. P. Work in the I. G. laboratory is supported by National Institutes of Health Grant R01GM082837, Human Frontier Science Program Grant RGY 70/2008 and NSF Grant 082265 (Physics Frontiers Center: Center for the Physics of Living Cells). M.N.D. is supported by NSF grant CCF-0916953. S. D. B. is supported by the Beckman Institute Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbe E, 1873, ARCH MIKROSK ANAT, P9; Allain M, 2006, IEEE T IMAGE PROCESS, V15, P1130, DOI 10.1109/TIP.2005.864173; [Anonymous], [No title captured]; Babacan SD, 2011, BIOMED OPT EXPRESS, V2, P1815, DOI 10.1364/BOE.2.001815; Babacan SD, 2010, IEEE INT C IM PROC I; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Charriere F, 2006, OPT LETT, V31, P178, DOI 10.1364/OL.31.000178; Charriere F, 2006, OPT EXPRESS, V14, P7005, DOI 10.1364/OE.14.007005; Chen BQ, 1998, APPL OPTICS, V37, P2996, DOI 10.1364/AO.37.002996; Choi W, 2007, NAT METHODS, V4, P717, DOI 10.1038/NMETH1078; Cotte Y, 2010, OPT EXPRESS, V18, P19462, DOI 10.1364/OE.18.019462; Debailleul M, 2009, OPT LETT, V34, P79, DOI 10.1364/OL.34.000079; Ding H, 2008, PRL, P101; DONACHIE WD, 1993, ANNU REV MICROBIOL, V47, P199, DOI 10.1146/annurev.mi.47.100193.001215; Donachie WD, 2001, MOL MICROBIOL, V40, P779, DOI 10.1046/j.1365-2958.2001.02439.x; Donoho D, 2004, MOST LARGE UNDERDETE; Fiolka R, 2009, OPT EXPRESS, V17, P12407, DOI 10.1364/OE.17.012407; Gbur G, 2001, J OPT SOC AM A, V18, P2132, DOI 10.1364/JOSAA.18.002132; Ghosh AS, 2005, J BACTERIOL, V187, P1913, DOI 10.1128/JB.187.6.1913-1922.2005; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Haldar JP, 2011, IEEE T BIO-MED ENG, V58, P2489, DOI 10.1109/TBME.2011.2158003; HELL S, 1992, OPT COMMUN, V93, P277, DOI 10.1016/0030-4018(92)90185-T; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hess ST, 2007, BIOPHYS J, p419A; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Ikeda T, 2005, OPT LETT, V30, P1165, DOI 10.1364/OL.30.001165; Joo C, 2005, OPT LETT, V30, P2131, DOI 10.1364/OL.30.002131; Maire G, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.213905; Mir M, 2011, BIOMED OPT EXPRESS, V2, P3259, DOI 10.1364/BOE.2.003259; Mir M, 2011, P NATL ACAD SCI USA, V108, P13124, DOI 10.1073/pnas.1100506108; Nikolova M, 2005, SIAM J SCI COMPUT, V27, P937, DOI 10.1137/030600862; Popescu G, 2006, OPT LETT, V31, P775, DOI 10.1364/OL.31.000775; Popescu G, 2004, OPT LETT, V29, P2503, DOI 10.1364/OL.29.002503; Popescu G., 2011, QUANTITATIVE PHASE I; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Rockward WS, 2008, APPL OPTICS, V47, P1684, DOI 10.1364/AO.47.001684; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sarder P, 2006, IEEE SIGNAL PROC MAG, V23, P32, DOI 10.1109/MSP.2006.1628876; Shechtman Y, 2011, OPT EXPRESS, V19, P14807, DOI 10.1364/OE.19.014807; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Sridharan S, 2011, BIOMED OPT EXPRESS, V2, P2815, DOI 10.1364/BOE.2.002815; Stephens DJ, 2003, SCIENCE, V300, P82, DOI 10.1126/science.1082160; Sun Q, 1998, J BACTERIOL, V180, P2050, DOI 10.1128/JB.180.8.2050-2056.1998; Szameit A, 2012, NAT MAT; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Van Aert S, 2006, OPT EXPRESS, V14, P3830, DOI 10.1364/OE.14.003830; Wallace W, 2001, BIOTECHNIQUES, V31, P1076, DOI 10.2144/01315bi01; Wang R, 2011, OPT EXPRESS, V19, P20571, DOI 10.1364/OE.19.020571; Wang Z, 2011, J BIOMED OPT, V16; Wang Z., 2011, J BIOMEDICAL OPTICS, V16; Wang Z, 2011, OPT EXPRESS, V19, P19907, DOI 10.1364/OE.19.019907; Wang Z, 2011, OPT EXPRESS, V19, P1016, DOI 10.1364/OE.19.001016; Wang Z, 2010, OPT LETT, V35, P208, DOI 10.1364/OL.35.000208; Wright SJ, 2002, METHOD CELL BIOL, V70, P1; ZERNIKE F, 1955, SCIENCE, V121, P345, DOI 10.1126/science.121.3141.345; Zysk AM, 2003, OPT LETT, V28, P701, DOI 10.1364/OL.28.000701	57	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39816	10.1371/journal.pone.0039816	http://dx.doi.org/10.1371/journal.pone.0039816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761910	Green Published, gold, Green Submitted			2022-12-27	WOS:000305826400041
J	Yeh, JR; Zhang, XF; Nagano, MC				Yeh, Jonathan R.; Zhang, Xiangfan; Nagano, Makoto C.			Indirect Effects of Wnt3a/beta-Catenin Signalling Support Mouse Spermatogonial Stem Cells In Vitro	PLOS ONE			English	Article							SELF-RENEWAL; STEM/PROGENITOR CELLS; BETA-CATENIN; EXPRESSION; SPERMATOGENESIS; ACTIVATION; PATHWAY; EMBRYOS; NOTCH; ASSAY	Proper regulation of spermatogonial stem cells (SSCs) is crucial for sustaining steady-state spermatogenesis. Previous work has identified several paracrine factors involved in this regulation, in particular, glial cell line-derived neurotrophic factor and fibroblast growth factor 2, which promote long-term SSC self-renewal. Using a SSC culture system, we have recently reported that Wnt5a promotes SSC self-renewal through a beta-catenin-independent Wnt mechanism whereas the beta-catenin-dependent Wnt pathway is not active in SSCs. In contrast, another study has reported that Wnt3a promotes SSC self-renewal through the beta-catenin-dependent pathway, as it can stimulate the proliferation of a spermatogonia cell line. To reconcile these two contradictory reports, we assessed Wnt3a effects on SSCs and progenitor cells, rather than a cell line, in vitro. We observed that Wnt3a induced beta-catenin-dependent signalling in a large subset of germ cells and increased SSC numbers. However, further investigation revealed that cell populations with greater beta-catenin-signalling activity contained fewer SSCs. The increased maintenance of SSCs by Wnt3a coincided with more active cell cycling and the formation of germ cell aggregates, or communities, under feeder-free conditions. Therefore, the results of this study suggest that Wnt3a selectively stimulates proliferation of progenitors that are committed to differentiation or are in the process of exiting the SSC state, leading to enhanced formation of germ cell communities, which indirectly support SSCs and act as an in vitro niche.	[Yeh, Jonathan R.; Zhang, Xiangfan; Nagano, Makoto C.] McGill Univ, Dept Obstet & Gynecol, Div Expt Med, Montreal, PQ H3A 2T5, Canada	McGill University	Yeh, JR (corresponding author), McGill Univ, Dept Obstet & Gynecol, Div Expt Med, Montreal, PQ H3A 2T5, Canada.	makoto.nagano@muhc.mcgill.ca			Canadian Institutes of Health Research [MOP-86532]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Financial support was from the Canadian Institutes of Health Research (MOP-86532). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; De Rooij DG, 2009, MICROSC RES TECHNIQ, V72, P580, DOI 10.1002/jemt.20699; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Ebata KT, 2011, EXP CELL RES, V317, P1319, DOI 10.1016/j.yexcr.2011.03.013; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Golestaneh N, 2009, REPRODUCTION, V138, P151, DOI 10.1530/REP-08-0510; Haegebarth A, 2009, AM J PATHOL, V174, P715, DOI 10.2353/ajpath.2009.080758; Holowacz T, 2011, EUR J NEUROSCI, V33, P1366, DOI 10.1111/j.1460-9568.2011.07632.x; JEN J, 1990, MOL REPROD DEV, V25, P14, DOI 10.1002/mrd.1080250104; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P985, DOI 10.1095/biolreprod.104.036400; Kubo F, 2005, DEVELOPMENT, V132, P2759, DOI 10.1242/dev.01856; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kuehl Michael, 2008, V469, P467, DOI 10.1007/978-1-60327-469-29; Lee J, 2009, CELL STEM CELL, V5, P76, DOI 10.1016/j.stem.2009.04.020; Lin YF, 2001, DEV DYNAM, V222, P26, DOI 10.1002/dvdy.1164; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Marcon L, 2010, BIOL REPROD, V83, P228, DOI 10.1095/biolreprod.110.083568; Mohamed OA, 2004, DEV DYNAM, V231, P416, DOI 10.1002/dvdy.20135; Mohamed OA, 2005, P NATL ACAD SCI USA, V102, P8579, DOI 10.1073/pnas.0500612102; Morimoto H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007909; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Oatley JM, 2009, DEVELOPMENT, V136, P1191, DOI 10.1242/dev.032243; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; SOKOL S, 1991, CELL, V67, P741, DOI 10.1016/0092-8674(91)90069-B; Yeh JR, 2007, BIOL REPROD, V77, P897, DOI 10.1095/biolreprod.107.063057; Yeh JR, 2011, J CELL SCI, V124, P2357, DOI 10.1242/jcs.080903; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhang XF, 2003, BIOL REPROD, V69, P1872, DOI 10.1095/biolreprod.103.019273	39	44	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e40002	10.1371/journal.pone.0040002	http://dx.doi.org/10.1371/journal.pone.0040002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761943	Green Published, gold, Green Submitted			2022-12-27	WOS:000305826400052
J	Luzi, E; Marini, F; Giusti, F; Galli, G; Cavalli, L; Brandi, ML				Luzi, Ettore; Marini, Francesca; Giusti, Francesca; Galli, Gianna; Cavalli, Loredana; Brandi, Maria Luisa			The Negative Feedback-Loop between the Oncomir Mir-24-1 and Menin Modulates the Men1 Tumorigenesis by Mimicking the "Knudson's Second Hit"	PLOS ONE			English	Article							MICRORNAS; CANCER; NOISE; ACCUMULATION; EXPRESSION; NETWORKS; MUTATION; REGIONS	Multiple endocrine neoplasia type 1 (MEN1) syndrome is a rare hereditary cancer disorder characterized by tumors of the parathyroids, of the neuroendocrine cells, of the gastro-entero-pancreatic tract, of the anterior pituitary, and by non-endocrine neoplasms and lesions. MEN1 gene, a tumor suppressor gene, encodes menin protein. Loss of heterozygosity at 11q13 is typical of MEN1 tumors, in agreement with the Knudson's two-hit hypothesis. In silico analysis with Target Scan, Miranda and Pictar-Vert softwares for the prediction of miRNA targets indicated miR-24-1 as capable to bind to the 3'UTR of MEN1 mRNA. We investigated this possibility by analysis of miR-24-1 expression profiles in parathyroid adenomatous tissues from MEN1 gene mutation carriers, in their sporadic non-MEN1 counterparts, and in normal parathyroid tissue. Interestingly, the MEN1 tumorigenesis seems to be under the control of a "negative feedback loop" between miR-24-1 and menin protein, that mimics the second hit of Knudson's hypothesis and that could buffer the effect of the stochastic factors that contribute to the onset and progression of this disease. Our data show an alternative way to MEN1 tumorigenesis and, probably, to the "two-hit dogma". The functional significance of this regulatory mechanism in MEN1 tumorigenesis is also the basis for opening future developments of RNA antagomir(s)-based strategies in the in vivo control of tumorigenesis in MEN1 carriers.	[Luzi, Ettore; Marini, Francesca; Giusti, Francesca; Galli, Gianna; Cavalli, Loredana; Brandi, Maria Luisa] Univ Florence, Bone Metab Unit, Dept Internal Med, Florence, Italy	University of Florence	Luzi, E (corresponding author), Univ Florence, Bone Metab Unit, Dept Internal Med, Florence, Italy.	m.brandi@dmi.unifi.it	L, E/AAG-9596-2019	Luzi, Ettore/0000-0002-8896-241X; Marini, Francesca/0000-0002-3678-4922; Cavalli, Loredana/0000-0003-4075-933X; Giusti, Francesca/0000-0002-8576-9606	Fondazione Raffaella Becagli; Osservatorio Nazionale Salute Donna	Fondazione Raffaella Becagli; Osservatorio Nazionale Salute Donna	EL, PhD was supported by a grant of the Fondazione Raffaella Becagli. FM, PhD was recipient of a fellowship, from Osservatorio Nazionale Salute Donna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK, 2007, NEOPLASIA, V9, P101, DOI 10.1593/neo.06706; Anlauf M, 2007, PATHOBIOLOGY, V74, P279, DOI 10.1159/000105810; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Falchetti A, 2009, GENET MED, V11, P825, DOI 10.1097/GIM.0b013e3181be5c97; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Galasso M, 2010, GENOME MED, V2, DOI 10.1186/gm133; Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Keene JD, 2010, ENDOCRINOLOGY, V151, P1391, DOI 10.1210/en.2009-1250; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Knudson AG, 1996, J CANCER RES CLIN, V122, P135, DOI 10.1007/BF01366952; Luzi E, 2010, CANCER GENE THER, V17, P814, DOI 10.1038/cgt.2010.39; Martinez NJ, 2009, BIOESSAYS, V31, P435, DOI 10.1002/bies.200800212; Michael MZ, 2003, MOL CANCER RES, V1, P882; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Ogino Shuji, 2007, J Genet Couns, V16, P29, DOI 10.1007/s10897-006-9040-9; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Sonnenschein C, 2009, MOL CARCINOG, V29, P205; Soto AM, 2004, BIOESSAYS, V26, P1097, DOI 10.1002/bies.20087; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Veitia RA, 2002, BIOESSAYS, V24, P175, DOI 10.1002/bies.10023; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009	33	66	70	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39767	10.1371/journal.pone.0039767	http://dx.doi.org/10.1371/journal.pone.0039767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761894	Green Submitted, gold, Green Published			2022-12-27	WOS:000305825800068
J	Korcekova, D; Gombitova, A; Raska, I; Cmarko, D; Lanctot, C				Korcekova, Darina; Gombitova, Adriana; Raska, Ivan; Cmarko, Dusan; Lanctot, Christian			Nucleologenesis in the Caenorhabditis elegans Embryo	PLOS ONE			English	Article							RIBOSOMAL-RNA; C-ELEGANS; NUCLEOLAR RNA; POLYMERASE-I; CELL-CYCLE; TRANSCRIPTION; PROTEIN; LOCALIZATION; FIBRILLARIN; DYNAMICS	In the Caenorhabditis elegans nematode, the oocyte nucleolus disappears prior to fertilization. We have now investigated the re-formation of the nucleolus in the early embryo of this model organism by immunostaining for fibrillarin and DAO-5, a putative NOLC1/Nopp140 homolog involved in ribosome assembly. We find that labeled nucleoli first appear in somatic cells at around the 8-cell stage, at a time when transcription of the embryonic genome begins. Quantitative analysis of radial positioning showed the nucleolus to be localized at the nuclear periphery in a majority of early embryonic nuclei. At the ultrastructural level, the embryonic nucleolus appears to be composed of a relatively homogenous core surrounded by a crescent-shaped granular structure. Prior to embryonic genome activation, fibrillarin and DAO-5 staining is seen in numerous small nucleoplasmic foci. This staining pattern persists in the germline up to the similar to 100-cell stage, until the P4 germ cell divides to give rise to the Z2/Z3 primordial germ cells and embryonic transcription is activated in this lineage. In the ncl-1 mutant, which is characterized by increased transcription of rDNA, DAO-5-labeled nucleoli are already present at the 2-cell stage. Our results suggest a link between the activation of transcription and the initial formation of nucleoli in the C. elegans embryo.	[Korcekova, Darina; Gombitova, Adriana; Raska, Ivan; Cmarko, Dusan; Lanctot, Christian] Charles Univ Prague, Inst Cellular Biol & Pathol, Fac Med 1, Prague, Czech Republic	Charles University Prague	Korcekova, D (corresponding author), Charles Univ Prague, Inst Cellular Biol & Pathol, Fac Med 1, Prague, Czech Republic.	christian.lanctot@lf1.cuni.cz	Cmarko, Dusan/G-3712-2017; Raska, Ivan/H-2326-2017; Majovská, Darina/AAS-3786-2021	Cmarko, Dusan/0000-0002-7467-8565; Raska, Ivan/0000-0002-2583-5595; Lanctot, Christian/0000-0003-3211-3061	Charles University in Prague [UNCE 204022, Prvouk/1LF/1]; Czech Science Foundation [P302/11/1262]; NICHD; NIH National Center for Research Resources (NCRR, USA)	Charles University in Prague; Czech Science Foundation(Grant Agency of the Czech Republic); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH National Center for Research Resources (NCRR, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded in part by programs of the Charles University in Prague (UNCE 204022 and Prvouk/1LF/1) as well as by the Czech Science Foundation (grant no. P302/11/1262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof. Thomas Cremer for providing the eADS program, Jens Nagel for help in using it, Jana Smigova for help with high pressure freezing and cryo-embedding, and Dr. Susan Strome for the kind gift of the PGL-1 antiserum. The DAO-5 antibody, developed by M. L. Nonet, was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the Department of Biology at the University of Iowa (USA). The ncl-1(e1865) strain was provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR, USA).	ALBERTSON DG, 1984, EMBO J, V3, P1227, DOI 10.1002/j.1460-2075.1984.tb01957.x; Angelier N, 2005, MOL BIOL CELL, V16, P2862, DOI 10.1091/mbc.e05-01-0041; Baran V, 2001, MOL REPROD DEV, V59, P277, DOI 10.1002/mrd.1032; BARAN V, 1995, MOL REPROD DEV, V40, P305, DOI 10.1002/mrd.1080400306; CAIRNS C, 1995, J CELL SCI, V108, P3339; Cheutin T, 2002, J CELL SCI, V115, P3297; Cmarko D, 2000, HISTOCHEM CELL BIOL, V113, P181, DOI 10.1007/s004180050437; DiMario PJ, 2004, INT REV CYTOL, V239, P99, DOI 10.1016/S0074-7696(04)39003-0; Duerr Janet S, 2006, WormBook, P1; Dundr M, 2000, J CELL BIOL, V150, P433, DOI 10.1083/jcb.150.3.433; Dundr M, 1997, CHROMOSOMA, V105, P407, DOI 10.1007/s004120050202; EDGAR LG, 1994, DEVELOPMENT, V120, P443; ELLIS RE, 1986, NUCLEIC ACIDS RES, V14, P2345, DOI 10.1093/nar/14.5.2345; FERREIRA J, 1995, DEVELOPMENT, V121, P601; Flechon JE, 1998, ZYGOTE, V6, P183, DOI 10.1017/S0967199498000112; Frank DJ, 1998, J CELL BIOL, V140, P1321, DOI 10.1083/jcb.140.6.1321; FRASER RSS, 1976, J CELL SCI, V21, P497; Hadwiger G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010161; HEDGECOCK EM, 1995, GENETICS, V141, P989; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V125, P127, DOI 10.1007/s00418-005-0046-4; Huang ZP, 2007, GENOMICS, V89, P490, DOI 10.1016/j.ygeno.2006.12.002; Isaac C, 1998, J CELL BIOL, V142, P319, DOI 10.1083/jcb.142.2.319; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kudron MM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000181; Kupper K, 2007, RADIAL CHROMATIN POS; McCain J, 2006, CELL TISSUE RES, V323, P105, DOI 10.1007/s00441-005-0044-9; MEDINA FJ, 1995, EXP CELL RES, V221, P111, DOI 10.1006/excr.1995.1358; MEIER UT, 1992, CELL, V70, P127; Meister P, 2010, GENE DEV, V24, P766, DOI 10.1101/gad.559610; Olson MOJ, 2002, INT REV CYTOL, V219, P199; PAI CY, 1995, J CELL SCI, V108, P1911; RASKA I, 1990, J STRUCT BIOL, V104, P120, DOI 10.1016/1047-8477(90)90066-L; RASKA I, 1995, J CELL BIOCHEM, V59, P11, DOI 10.1002/jcb.240590103; Raska I, 2006, INT REV CYTOL, V255, P177, DOI 10.1016/S0074-7696(06)55004-1; Saijou E, 2004, NUCLEIC ACIDS RES, V32, P1028, DOI 10.1093/nar/gkh264; Sasano Y, 2008, BIOCHIMIE, V90, P898, DOI 10.1016/j.biochi.2008.02.001; Seydoux G, 1997, DEVELOPMENT, V124, P2191; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Seydoux G, 2001, INT REV CYTOL, V203, P139; Stiernagle Theresa, 2006, WormBook, P1; Thiry M, 2005, TRENDS CELL BIOL, V15, P194, DOI 10.1016/j.tcb.2005.02.007; Thiry M, 2009, HISTOCHEM CELL BIOL, V132, P129, DOI 10.1007/s00418-009-0599-8; Vancoppenolle B, 2000, MICROSC RES TECHNIQ, V49, P212, DOI 10.1002/(SICI)1097-0029(20000415)49:2<212::AID-JEMT15>3.0.CO;2-1; Verheggen C, 1998, J CELL BIOL, V142, P1167, DOI 10.1083/jcb.142.5.1167; Voit R, 2001, P NATL ACAD SCI USA, V98, P13631, DOI 10.1073/pnas.231071698; Walker AK, 2007, DEV BIOL, V304, P382, DOI 10.1016/j.ydbio.2006.12.039; Yu H, 2001, J MOL BIOL, V314, P1017, DOI 10.1006/jmbi.2000.5210; Zatsepina O, 2003, DEV BIOL, V253, P66, DOI 10.1006/dbio.2002.0865; Zatsepina OV, 2000, DEV BIOL, V223, P354, DOI 10.1006/dbio.2000.9762	49	15	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40290	10.1371/journal.pone.0040290	http://dx.doi.org/10.1371/journal.pone.0040290			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768349	Green Published, Green Submitted, gold			2022-12-27	WOS:000305966500062
J	Zibara, K; Hamdan, R; Dib, L; Sindet-Pedersen, S; Kharfan-Dabaja, M; Bazarbachi, A; El-Sabban, M				Zibara, Kazem; Hamdan, Rima; Dib, Leila; Sindet-Pedersen, Steen; Kharfan-Dabaja, Mohamed; Bazarbachi, Ali; El-Sabban, Marwan			Acellular Bone Marrow Extracts Significantly Enhance Engraftment Levels of Human Hematopoietic Stem Cells in Mouse Xeno-Transplantation Models	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; EX-VIVO EXPANSION; COPPER CHELATOR TETRAETHYLENEPENTAMINE; NOD-SCID MICE; CD34(+) CELLS; OUTCOMES; DIFFERENTIATION; AUGMENTATION; MOBILIZATION; MAINTENANCE	Hematopoietic stem cells (HSC) derived from cord blood (CB), bone marrow (BM), or mobilized peripheral blood (PBSC) can differentiate into multiple lineages such as lymphoid, myeloid, erythroid cells and platelets. The local microenvironment is critical to the differentiation of HSCs and to the preservation of their phenotype in vivo. This microenvironment comprises a physical support supplied by the organ matrix as well as tissue specific cytokines, chemokines and growth factors. We investigated the effects of acellular bovine bone marrow extracts (BME) on HSC in vitro and in vivo. We observed a significant increase in the number of myeloid and erythroid colonies in CB mononuclear cells (MNC) or CB CD34+ cells cultured in methylcellulose media supplemented with BME. Similarly, in xeno-transplantation experiments, pretreatment with BME during ex-vivo culture of HSCs induced a significant increase in HSC engraftment in vivo. Indeed, we observed both an increase in the number of differentiated myeloid, lymphoid and erythroid cells and an acceleration of engraftment. These results were obtained using CB MNCs, BM MNCs or CD34(+) cells, transplanted in immuno-compromised mice (NOD/SCID or NSG). These findings establish the basis for exploring the use of BME in the expansion of CB HSC prior to HSC Transplantation. This study stresses the importance of the mechanical structure and soluble mediators present in the surrounding niche for the proper activity and differentiation of stem cells.	[Zibara, Kazem] Lebanese Univ, DSST, Dept Biol, Beirut, Lebanon; [Hamdan, Rima; Dib, Leila; Bazarbachi, Ali; El-Sabban, Marwan] Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol Sci, Beirut, Lebanon; [Sindet-Pedersen, Steen] Nicolas & Asp Univ Coll, Dept Oral & Maxillofacial Surg, Dubai Healthcare City, Dubai, U Arab Emirates; [Kharfan-Dabaja, Mohamed; Bazarbachi, Ali] Amer Univ Beirut, Dept Internal Med, Beirut, Lebanon	Lebanese University; American University of Beirut; American University of Beirut	Zibara, K (corresponding author), Lebanese Univ, DSST, Dept Biol, Beirut, Lebanon.	bazarbac@aub.edu.lb; me00@aub.edu.lb		Zibara, Kazem/0000-0002-9887-072X; Bazarbachi, Ali/0000-0002-7171-4997	Lebanese National Council for Scientific Research (LNCSR); Biotek APS, Denmark [MC2]	Lebanese National Council for Scientific Research (LNCSR); Biotek APS, Denmark	K.Z. was supported by a grant from Lebanese National Council for Scientific Research (LNCSR). This work was supported by MC2 research grant from Biotek APS, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astori G, 2005, BONE MARROW TRANSPL, V35, P1101, DOI 10.1038/sj.bmt.1704964; Bakhshi T, 2008, TRANSFUSION, V48, P2638, DOI 10.1111/j.1537-2995.2008.01926.x; Barker JN, 2005, BLOOD, V105, P1343, DOI 10.1182/blood-2004-07-2717; Bensinger W, 2009, BONE MARROW TRANSPL, V43, P181, DOI 10.1038/bmt.2008.410; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; de Lima M, 2008, BONE MARROW TRANSPL, V41, P771, DOI 10.1038/sj.bmt.1705979; Delaney C, 2005, BLOOD, V106, P2693, DOI 10.1182/blood-2005-03-1131; El-Sabban ME, 2007, REGEN MED, V2, P383, DOI 10.2217/17460751.2.4.383; Gluckman E, 2004, EXP HEMATOL, V32, P397, DOI 10.1016/j.exphem.2004.01.002; Gluckman E, 2011, BRIT J HAEMATOL, V154, P441, DOI 10.1111/j.1365-2141.2011.08598.x; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Gyurkocza B, 2010, EXPERT REV HEMATOL, V3, P285, DOI 10.1586/EHM.10.21; Ivanovic Z, 2011, CELL TRANSPLANT, V20, P1453, DOI 10.3727/096368910X552853; Jaroscak J, 2003, BLOOD, V101, P5061, DOI 10.1182/blood-2001-12-0290; Kelly SS, 2009, BONE MARROW TRANSPL, V44, P673, DOI 10.1038/bmt.2009.284; Kollet O, 2000, BLOOD, V95, P3102, DOI 10.1182/blood.V95.10.3102.010k14_3102_3105; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Lazzari L, 2001, TRANSFUSION, V41, P718, DOI 10.1046/j.1537-2995.2001.41050718.x; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; McNiece I, 2004, CYTOTHERAPY, V6, P311, DOI 10.1080/14653240410004871; Milpied N, 2011, BLOOD, V118; Mohamed Azza A, 2006, Lab Hematol, V12, P86, DOI 10.1532/LH96.05033; Mohty M, 2010, HEMATOL-AM SOC HEMAT, P229, DOI 10.1182/asheducation-2010.1.229; Nagasawa T, 2011, TRENDS IMMUNOL, V32, P315, DOI 10.1016/j.it.2011.03.009; Pecora AL, 2000, BONE MARROW TRANSPL, V25, P797, DOI 10.1038/sj.bmt.1702222; Pecora AL, 2001, BONE MARROW TRANSPL, V28, P295, DOI 10.1038/sj.bmt.1703137; Peled T, 2004, EXP HEMATOL, V32, P547, DOI 10.1016/j.exphem.2004.03.002; Robert-Richard E, 2006, HAEMATOLOGICA, V91, P1384; Ruscetti FW, 2005, ONCOGENE, V24, P5751, DOI 10.1038/sj.onc.1208921; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shpall EJ, 2002, BIOL BLOOD MARROW TR, V8, P368, DOI 10.1053/bbmt.2002.v8.pm12171483; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Stanevsky A, 2010, LEUKEMIA LYMPHOMA, V51, P975, DOI 10.3109/10428191003699886; Tung SS, 2010, BEST PRACT RES CL HA, V23, P245, DOI 10.1016/j.beha.2010.06.004; van der Loo JCM, 1998, BLOOD, V92, P2556, DOI 10.1182/blood.V92.7.2556.2556_2556_2570; Wingard JR, 2010, INFECT DIS CLIN N AM, V24, P257, DOI 10.1016/j.idc.2010.01.010; Yahata T, 2002, J IMMUNOL, V169, P204, DOI 10.4049/jimmunol.169.1.204; Yao CL, 2006, STEM CELLS DEV, V15, P70, DOI 10.1089/scd.2006.15.70; Yao CL, 2004, EXP HEMATOL, V32, P720, DOI 10.1016/j.exphem.2004.05.021; Young JC, 2004, CYTOTHERAPY, V6, P328, DOI 10.1080/14653240410004899	41	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40140	10.1371/journal.pone.0040140	http://dx.doi.org/10.1371/journal.pone.0040140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768336	Green Published, Green Submitted, gold			2022-12-27	WOS:000305966500049
J	Abu Dawud, R; Schreiber, K; Schomburg, D; Adjaye, J				Abu Dawud, Raed; Schreiber, Kerstin; Schomburg, Dietmar; Adjaye, James			Human Embryonic Stem Cells and Embryonal Carcinoma Cells Have Overlapping and Distinct Metabolic Signatures	PLOS ONE			English	Article							SELF-RENEWAL; COMPLEX-III; ES CELLS; EC CELLS; DIFFERENTIATION; PATHWAY; LINE; IDENTIFICATION; PLURIPOTENCY; EXPRESSION	While human embryonic stem cells (hESCs) and human embryonal carcinoma cells (hECCs) have been studied extensively at the levels of the genome, transcriptome, proteome and epigenome our knowledge of their corresponding metabolomes is limited. Here, we present the metabolic signatures of hESCs and hESCs obtained by untargeted gas chromatography coupled to mass spectrometry (GC-MS). Whilst some metabolites are common to both cell types, representing the self-renewal and house-keeping signatures, others were either higher (e. g., octadecenoic acid, glycerol-3-phosphate, 4-hydroxyproline) or lower (e. g., glutamic acid, mannitol, malic acid, GABA) in hESCs (H9) compared to hECCs (NTERA2), these represent cell type specific signatures. Further, our combined results of GC-MS and microarray based gene expression profiling of undifferentiated and OCT4-depleted hESCs are consistent with the Warburg effect which is increased glycolysis in embryonic cells and tumor cells in the presence of O-2 while oxidative phosphorylation (OXPHOS) is impaired or even shut down. RNAi-based OCT4 knock down mediated differentiation resulted in the activation of the poised OXPHOS machinery by expressing missing key proteins such as NDUFC1, UQCRB and COX, increase in TCA cycle activity and decreased lactate metabolism. These results shed light on the metabolite layer of pluripotent stem cells and could potentially establish novel metabolic markers of self renewal and pluripotency.	[Abu Dawud, Raed; Adjaye, James] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Abu Dawud, Raed; Adjaye, James] King Saud Univ, Stem Cell Unit, Dept Anat, Riyadh, Saudi Arabia; [Schreiber, Kerstin; Schomburg, Dietmar] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, D-38106 Braunschweig, Germany; [Adjaye, James] Univ Dusseldorf, Fac Med, Inst Stem Cell Res & Regenerat Med, D-40225 Dusseldorf, Germany	Max Planck Society; King Saud University; Braunschweig University of Technology; Heinrich Heine University Dusseldorf	Abu Dawud, R (corresponding author), Max Planck Inst Mol Genet, Dept Vertebrate Genom, Ihnestr 73, D-14195 Berlin, Germany.	adjaye@molgen.mpg.de		Schomburg, Dietmar/0000-0002-3354-822X	ENFIN, European Network of Excellence; European Commission [LSHG-CT-2005-518254]	ENFIN, European Network of Excellence; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by ENFIN, the European Network of Excellence, funded by the European Commission within its FP6 Programme, under the thematic area "Life sciences, genomics and biotechnology for health", contract number LSHG-CT-2005-518254 (http://www.enfin.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526; ANDREWS PW, 1984, LAB INVEST, V50, P147; Avery K, 2008, STEM CELLS DEV, V17, P1195, DOI 10.1089/scd.2008.0063; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Bennett BD, 2008, NAT PROTOC, V3, P1299, DOI 10.1038/nprot.2008.107; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Botting NP, 1995, CHEM SOC REV, V24, P401, DOI 10.1039/cs9952400401; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cezar GG, 2007, STEM CELLS DEV, V16, P869, DOI 10.1089/scd.2007.0022; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Fox V, 2008, STEM CELLS, V26, P715, DOI 10.1634/stemcells.2007-0368; Greber B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-46; Greber B, 2008, STEM CELLS DEV, V17, P1065, DOI 10.1089/scd.2008.0035; Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Jung M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010709; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig Tenneille, 2007, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01c02s2; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Prigione A, 2010, INT J DEV BIOL, V54, P1729, DOI 10.1387/ijdb.103198ap; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; STONE TW, 1993, PHARMACOL REV, V45, P309; SUZUKI H, 1989, BIOCHEM BIOPH RES CO, V161, P371, DOI 10.1016/0006-291X(89)91607-0; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Ton C, 1997, BIOCHEM BIOPH RES CO, V241, P589, DOI 10.1006/bbrc.1997.7707; Walsh J, 2003, APMIS, V111, P197, DOI 10.1034/j.1600-0463.2003.1110124.x; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001	42	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39896	10.1371/journal.pone.0039896	http://dx.doi.org/10.1371/journal.pone.0039896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768158	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100127
J	Bai, XF; Song, ZG; Fu, YZ; Yu, ZJ; Zhao, L; Zhao, HS; Yao, WF; Huang, DS; Mi, XY; Wang, EH; Zheng, ZH; Wei, MJ				Bai, Xuefeng; Song, Zhiguo; Fu, Yingzi; Yu, Zhaojin; Zhao, Lin; Zhao, Haishan; Yao, Weifan; Huang, Desheng; Mi, Xiaoyi; Wang, Enhua; Zheng, Zhihong; Wei, Minjie			Clinicopathological Significance and Prognostic Value of DNA Methyltransferase 1, 3a, and 3b Expressions in Sporadic Epithelial Ovarian Cancer	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; LUNG-CANCER; PROTEIN OVEREXPRESSION; CLINICAL-SIGNIFICANCE; PROMOTER METHYLATION; ABERRANT METHYLATION; BREAST CARCINOMAS; DOWN-REGULATION; POOR-PROGNOSIS; GASTRIC-CANCER	Altered DNA methylation of tumor suppressor gene promoters plays a role in human carcinogenesis and DNA methyltransferases (DNMTs) are responsible for it. This study aimed to determine aberrant expression of DNMT1, DNMT3a, and DNMT3b in benign and malignant ovarian tumor tissues for their association with clinicopathological significance and prognostic value. A total of 142 ovarian cancers and 44 benign ovarian tumors were recruited for immunohistochemical analysis of their expression. The data showed that expression of DNMT1, DNMT3a, and DNMT3b was observed in 76 (53.5%), 92 (64.8%) and 79 (55.6%) of 142 cases of ovarian cancer tissues, respectively. Of the serious tumors, DNMT3a protein expression was significantly higher than that in benign tumor samples (P = 0.001); DNMT3b was marginally significant down regulated in ovarian cancers compared to that of the benign tumors (P = 0.054); DNMT1 expression has no statistical difference between ovarian cancers and benign tumor tissues (P = 0.837). Of the mucious tumors, the expression of DNMT3a, DNMT3b, and DNMT1 was not different between malignant and benign tumors. Moreover, DNMT1 expression was associated with DNMT3b expression (P = 0.020, r = 0.195). DNMT1 expression was associated with age of the patients, menopause status, and tumor localization, while DNMT3a expression was associated with histological types and serum CA125 levels and DNMT3b expression was associated with lymph node metastasis. In addition, patients with DNMT1 or DNMT3b expression had a trend of better survival than those with negative expression. Co-expression of DNMT1 and DNMT3b was significantly associated with better overall survival (P = 0.014). The data from this study provided the first evidence for differential expression of DNMTs proteins in ovarian cancer tissues and their associations with clinicopathological and survival data in sporadic ovarian cancer patients.	[Bai, Xuefeng; Song, Zhiguo; Fu, Yingzi; Yu, Zhaojin; Zhao, Lin; Zhao, Haishan; Yao, Weifan; Wei, Minjie] China Med Univ, Dept Pharmacol, Shenyang, Liaoning, Peoples R China; [Huang, Desheng] China Med Univ, Coll Basic Med Sci, Dept Math, Shenyang, Liaoning, Peoples R China; [Mi, Xiaoyi; Wang, Enhua] China Med Univ, Coll Basic Med Sci, Dept Pathol, Shenyang, Liaoning, Peoples R China; [Mi, Xiaoyi; Wang, Enhua; Zheng, Zhihong; Wei, Minjie] China Med Univ, Inst Pathophysiol, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Bai, XF (corresponding author), China Med Univ, Dept Pharmacol, Shenyang, Liaoning, Peoples R China.	weiminjiecmu@163.com			National Natural Science Foundation of China [30873097, 30973559]; Science and Technology Department of Liaoning Province [2010225001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Liaoning Province	This work was supported in part by grants from the National Natural Science Foundation of China (No. 30873097 and No. 30973559) and the Science and Technology Department of Liaoning Province (No. 2010225001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia A, 2001, GYNECOL ONCOL, V82, P299, DOI 10.1006/gyno.2001.6284; Amara K, 2010, CANCER SCI, V101, P1722, DOI 10.1111/j.1349-7006.2010.01569.x; Arai E, 2006, INT J CANCER, V119, P288, DOI 10.1002/ijc.21807; Balch C, 2005, MOL CANCER THER, V4, P1505, DOI 10.1158/1535-7163.MCT-05-0216; Balch C, 2009, ENDOCRINOLOGY, V150, P4003, DOI 10.1210/en.2009-0404; BESTOR TH, 1988, GENE, V74, P9, DOI 10.1016/0378-1119(88)90238-7; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Bukowski RM, 2007, SEMIN ONCOL, V34, pS1, DOI 10.1053/j.seminoncol.2007.03.012; Chaudhry P, 2009, CANCER INVEST, V27, P877, DOI 10.1080/07357900902849699; Chen Chun-ling, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P770; Chen HY, 2011, CANC SCI; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Ding WJ, 2008, DIGEST DIS SCI, V53, P2083, DOI 10.1007/s10620-007-0145-2; Eads CA, 1999, CANCER RES, V59, P2302; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fang F, 2010, CANCER-AM CANCER SOC, V116, P4043, DOI 10.1002/cncr.25204; Fu SQ, 2011, CANCER-AM CANCER SOC, V117, P1661, DOI 10.1002/cncr.25701; Fujii S, 2010, DIGESTION, V82, P179, DOI 10.1159/000311064; Girault I, 2003, CLIN CANCER RES, V9, P4415; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kanai Y, 2001, INT J CANCER, V91, P205, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1040>3.0.CO;2-2; Klisovic RB, 2008, CLIN CANCER RES, V14, P2444, DOI 10.1158/1078-0432.CCR-07-1320; Lin RK, 2007, LUNG CANCER, V55, P205, DOI 10.1016/j.lungcan.2006.10.022; Lin RK, 2010, CANCER RES, V70, P5807, DOI 10.1158/0008-5472.CAN-09-4161; Liu XP, 2011, BRAIN RES, V1391, P125, DOI 10.1016/j.brainres.2011.03.042; Luczak MW, 2006, FOLIA HISTOCHEM CYTO, V44, P143; Lyko F, 2005, JNCI-J NATL CANCER I, V97, P1498, DOI 10.1093/jnci/dji311; MANETTA A, 1995, AM J CLIN ONCOL-CANC, V18, P156, DOI 10.1097/00000421-199504000-00012; Matei DE, 2010, GYNECOL ONCOL, V116, P195, DOI 10.1016/j.ygyno.2009.09.043; Novakovic B, 2010, J BIOL CHEM, V285, P9583, DOI 10.1074/jbc.M109.064956; Oh BK, 2007, INT J MOL MED, V20, P65; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Park HJ, 2006, CANCER LETT, V233, P271, DOI 10.1016/j.canlet.2005.03.017; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Partridge EE, 1999, CA-CANCER J CLIN, V49, P297, DOI 10.3322/canjclin.49.5.297; Peng DF, 2005, CANCER SCI, V96, P403, DOI 10.1111/j.1349-7006.2005.00071.x; Plumb JA, 2000, CANCER RES, V60, P6039; Plummer R, 2009, CLIN CANCER RES, V15, P3177, DOI 10.1158/1078-0432.CCR-08-2859; Pradhan S, 1997, NUCLEIC ACIDS RES, V25, P4666, DOI 10.1093/nar/25.22.4666; Qu Y, 2010, AM J CLIN PATHOL, V134, P826, DOI 10.1309/AJCPHGQ69FXDFWII; Rajendran G, 2011, J NEUROONCOL; Ramzy Iman I, 2011, Arab J Gastroenterol, V12, P139, DOI 10.1016/j.ajg.2011.07.002; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Saito Y, 2003, INT J CANCER, V105, P527, DOI 10.1002/ijc.11127; Sawada M, 2007, CANCER LETT, V251, P211, DOI 10.1016/j.canlet.2006.11.023; Shieh YS, 2005, CANCER-AM CANCER SOC, V104, P1013, DOI 10.1002/cncr.21278; Sun L, 1997, JPN J CANCER RES, V88, P1165, DOI 10.1111/j.1349-7006.1997.tb00345.x; Teodoridis JM, 2005, CANCER RES, V65, P8961, DOI 10.1158/0008-5472.CAN-05-1187; Tessema M, 2003, LEUKEMIA, V17, P910, DOI 10.1038/sj.leu.2402891; Wei SH, 2002, CLIN CANCER RES, V8, P2246; Wei SH, 2006, CLIN CANCER RES, V12, P2788, DOI 10.1158/1078-0432.CCR-05-1551; Wu D., 2011, LUNG CANC; Xing J, 2008, BRIT J CANCER, V98, P1716, DOI 10.1038/sj.bjc.6604343; Xu L, 2011, GUT; Yang B., 2011, UROL ONCOL; Yang J, 2011, MOL MED REP, V4, P1139, DOI 10.3892/mmr.2011.578; Yap TA, 2009, NAT REV CANCER, V9, P167, DOI 10.1038/nrc2583; Zhou W, 2009, J CANCER RES CLIN, V135, P91, DOI 10.1007/s00432-008-0435-x	59	36	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40024	10.1371/journal.pone.0040024	http://dx.doi.org/10.1371/journal.pone.0040024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768205	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100177
J	Barra, NG; Chew, MV; Reid, S; Ashkar, AA				Barra, Nicole G.; Chew, Marianne V.; Reid, Sarah; Ashkar, Ali A.			Interleukin-15 Treatment Induces Weight Loss Independent of Lymphocytes	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ADIPOSE-TISSUE; T-CELLS; GLUCOSE-INTOLERANCE; IMMUNE-RESPONSES; POTENTIAL ROLE; NK CELLS; IL-15; OBESITY; INFLAMMATION	Obesity is a chronic inflammatory condition characterized by activation and infiltration of proinflammatory immune cells and a dysregulated production of proinflammatory cytokines. While known as a key regulator of immune natural killer (NK) cell function and development, we have recently demonstrated that reduced expression of the cytokine Interleukin-15 (IL-15) is closely linked with increased body weight and adiposity in mice and humans. Previously, we and others have shown that obese individuals have lower circulating levels of IL-15 and NK cells. Lean IL-15 overexpressing (IL-15 tg) mice had an accumulation in adipose NK cells compared to wildtype and NK cell deficient obese IL-15(-/-) mice. Since IL-15 induces weight loss in IL-15(-/-) and diet induced obese mice and has effects on various lymphocytes, the aim of this paper was to determine if lymphocytes, particularly NK cells, play a role in IL-15 mediated weight loss. Acute IL-15 treatment resulted in an increased accumulation of NK, NKT, and CD3(+) T cells in adipose tissue of B6 mice. Mice depleted of NK and NKT cells had similar weight loss comparable to controls treated with IL-15. Finally, IL-15 treatment induces significant weight loss in lymphocyte deficient RAG2(-/-) gamma c(-/-) mice independent of food intake. Fat pad cross-sections show decreased pad size with cytokine treatment is due to adipocyte shrinkage. These results clearly suggest that IL-15 mediates weight loss independent of lymphocytes.	[Barra, Nicole G.] McMaster Univ, Dept Pathol & Mol Med, McMaster Immunol Res Ctr, Hamilton, ON, Canada; McMaster Univ, Inst Infect Dis Res, Hamilton, ON, Canada	McMaster University; McMaster University	Barra, NG (corresponding author), McMaster Univ, Dept Pathol & Mol Med, McMaster Immunol Res Ctr, Hamilton, ON, Canada.	ashkara@mcmaster.ca	Barra, Nicole/ABG-2670-2021	Barra, Nicole/0000-0002-2605-0845; Ashkar, Ali/0000-0003-1139-1468	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almendro V, 2006, BBA-MOL CELL BIOL L, V1761, P37, DOI 10.1016/j.bbalip.2005.12.006; Almendro V, 2005, INT J MOL MED, V15, P963; Almendro V, 2008, OBESITY, V16, P285, DOI 10.1038/oby.2007.47; Almendro V, 2009, INT J MOL MED, V24, P453, DOI 10.3892/ijmm_00000252; Alvarez B, 2002, BBA-GEN SUBJECTS, V1570, P33, DOI 10.1016/S0304-4165(02)00148-4; Alves NL, 2003, BLOOD, V102, P2541, DOI 10.1182/blood-2003-01-0183; Barra NG, 2010, OBESITY, V18, P1601, DOI 10.1038/oby.2009.445; Bulfone-Paus S, 2006, BIOESSAYS, V28, P362, DOI 10.1002/bies.20380; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Carbo N, 2001, BBA-GEN SUBJECTS, V1526, P17, DOI 10.1016/S0304-4165(00)00188-4; Carson WE, 1997, J CLIN INVEST, V99, P937, DOI 10.1172/JCI119258; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Chenoweth MJ, 2012, J IMMUNOL, V188, P4149, DOI 10.4049/jimmunol.1101883; Conde J, 2010, EXPERT REV CLIN IMMU, V6, P801, DOI [10.1586/eci.10.48, 10.1586/ECI.10.48]; Davies E, 2010, J LEUKOCYTE BIOL, V88, P529, DOI 10.1189/jlb.0909648; Dunne J, 2001, J IMMUNOL, V167, P3129, DOI 10.4049/jimmunol.167.6.3129; Elinav E, 2006, J PATHOL, V209, P121, DOI 10.1002/path.1950; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fischer-Posovszky P, 2011, ENDOCRINOLOGY, V152, P3074, DOI 10.1210/en.2011-1031; Fuster G, 2011, LIPIDS, V46, P1033, DOI 10.1007/s11745-011-3594-5; Gill N, 2005, J VIROL, V79, P4470, DOI 10.1128/JVI.79.7.4470-4478.2005; Gill N, 2007, EUR J IMMUNOL, V37, P2529, DOI 10.1002/eji.200636997; Kanegane H, 1996, BLOOD, V88, P230; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Lee GA, 2011, J IMMUNOL, V187, P1212, DOI 10.4049/jimmunol.1100331; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lopez-Soriano J, 2004, INT J MOL MED, V13, P817; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lynch LA, 2009, OBESITY, V17, P601, DOI 10.1038/oby.2008.565; Mortier E, 2008, J EXP MED, V205, P1213, DOI 10.1084/jem.20071913; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nielsen AR, 2008, J CLIN ENDOCR METAB, V93, P4486, DOI 10.1210/jc.2007-2561; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ohmura K, 2010, ARTERIOSCL THROM VAS, V30, P193, DOI 10.1161/ATVBAHA.109.198614; Ohteki T, 2001, NAT IMMUNOL, V2, P1138, DOI 10.1038/ni729; Ohteki Toshiaki, 2002, Current Molecular Medicine (Hilversum), V2, P371, DOI 10.2174/1566524023362519; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pond CM, 2005, PROSTAG LEUKOTR ESS, V73, P17, DOI 10.1016/j.plefa.2005.04.005; Pond CM, 2003, TRENDS IMMUNOL, V24, P13, DOI 10.1016/S1471-4906(02)00004-2; Quinn LBS, 2005, CELL BIOL INT, V29, P449, DOI 10.1016/j.cellbi.2005.02.005; Quinn LS, 2009, AM J PHYSIOL-ENDOC M, V296, pE191, DOI 10.1152/ajpendo.90506.2008; Sharif-Askari E, 2001, JNCI-J NATL CANCER I, V93, P1724, DOI 10.1093/jnci/93.22.1724; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Tian ZG, 2002, BIOCHEM BIOPH RES CO, V298, P297, DOI 10.1016/S0006-291X(02)02462-2; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	48	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39553	10.1371/journal.pone.0039553	http://dx.doi.org/10.1371/journal.pone.0039553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768089	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100060
J	Gonzalez-Lopez, A; Aguirre, A; Lopez-Alonso, I; Amado, L; Astudillo, A; Fernandez-Garcia, MS; Suarez, MF; Batalla-Solis, E; Colado, E; Albaiceta, GM				Gonzalez-Lopez, Adrian; Aguirre, Alina; Lopez-Alonso, Ines; Amado, Laura; Astudillo, Aurora; Soledad Fernandez-Garcia, Maria; Suarez, Maria F.; Batalla-Solis, Estefania; Colado, Enrique; Albaiceta, Guillermo M.			MMP-8 Deficiency Increases TLR/RAGE Ligands S100A8 and S100A9 and Exacerbates Lung Inflammation during Endotoxemia	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-8; PROTEINS; INJURY; NEUTROPHILS; INHIBITION; MICE	Matrix metalloproteinase-8, released mainly from neutrophils, is a critical regulator of the inflammatory response by its ability to cleave multiple mediators. Herein, we report the results of a model of endotoxemia after intraperitoneal LPS injection in mice lacking MMP-8 and their wildtype counterparts. Control, saline-treated animals showed no differences between genotypes. However, there was an increased lung inflammatory response, with a prominent neutrophilic infiltration in mutant animals after LPS treatment. Using a proteomic approach, we identify alarmins S100A8 and S100A9 as two of the main differences between genotypes. Mice lacking MMP-8 showed a significant increase in these two molecules in lung homogenates, but not in spleen and serum. Mice lacking MMP-8 also showed an increase in MIP-1 alpha levels and a marked activation of the non-canonical NF-kappa B pathway, with no differences in CXC-chemokines such as MIP-2 or LIX. These results show that MMP-8 can modulate the levels of S100A8 and S100A9 and its absence promotes the lung inflammatory response during endotoxemia.	[Gonzalez-Lopez, Adrian; Aguirre, Alina; Lopez-Alonso, Ines; Batalla-Solis, Estefania; Albaiceta, Guillermo M.] Univ Oviedo, Inst Univ Oncol Principado Asturias, Dept Biol Func, Oviedo, Spain; [Amado, Laura; Batalla-Solis, Estefania; Albaiceta, Guillermo M.] Hosp Univ Cent Asturias, Serv Med Intens, Oviedo, Spain; [Astudillo, Aurora; Soledad Fernandez-Garcia, Maria] Hosp Univ Cent Asturias, Serv Anat Patol, Oviedo, Spain; [Suarez, Maria F.] Univ Oviedo, Inst Univ Oncol Principado Asturias, Dept Bioquim & Biol Mol, Oviedo, Spain; [Colado, Enrique] Hosp Univ Cent Asturias, Serv Hematol & Hemoterapia, Oviedo, Spain; [Albaiceta, Guillermo M.] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain	University of Oviedo; Instituto Universitario de Oncologia de Asturias; Central University Hospital Asturias; Central University Hospital Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Central University Hospital Asturias; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Gonzalez-Lopez, A (corresponding author), Univ Oviedo, Inst Univ Oncol Principado Asturias, Dept Biol Func, Oviedo, Spain.	Guillermo.muniz@sespa.princast.es	López-Alonso, Inés/AAQ-4784-2021; López-Alonso, Inés/ABG-5496-2020; Suárez, María Fernanda Valencia/F-8200-2019; Colado, Enrique/Z-6326-2019; Lopez, Adrian Gonzalez/AAS-9613-2021; Albaiceta, Guillermo/AAU-5069-2020; Gonzalez, Adrian/AAD-2269-2021	López-Alonso, Inés/0000-0001-9183-5457; López-Alonso, Inés/0000-0001-9183-5457; Suárez, María Fernanda Valencia/0000-0001-8987-8431; Colado, Enrique/0000-0001-8675-8207; Albaiceta, Guillermo/0000-0002-9276-3253; Gonzalez-Lopez, Adrian/0000-0001-5347-278X; Astudillo Gonzalez, Maria Aurora/0000-0001-8947-8809	Instituto de Salud Carlos III [FIS PI 07-0597, INT 11/14]; Universidad de Oviedo [UNOV-09-pf]; Instituto Universitario de Oncologia del Principado de Asturias; Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia (FICYT) [COF-11-40]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Universidad de Oviedo; Instituto Universitario de Oncologia del Principado de Asturias; Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia (FICYT)	Supported by Instituto de Salud Carlos III (FIS PI 07-0597). AGL is the recipient of a grant from Universidad de Oviedo (UNOV-09-pf). A. Aguirre is the recipient of a grant from Instituto Universitario de Oncologia del Principado de Asturias. EBS is the recipient of a grant from Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia (FICYT, COF-11-40). GMA is the recipient of a grant from Instituto de Salud Carlos III (Intensificacion de la Actividad Investigadora-INT 11/14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaiceta GM, 2008, AM J PHYSIOL-LUNG C, V294, pL535, DOI 10.1152/ajplung.00334.2007; Albaiceta GM, 2010, AM J RESP CELL MOL, V43, P555, DOI 10.1165/rcmb.2009-0034OC; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Balbin M, 1998, J BIOL CHEM, V273, P23959, DOI 10.1074/jbc.273.37.23959; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3; Dejonckheere E, 2011, CYTOKINE GROWTH F R, V22, P73, DOI 10.1016/j.cytogfr.2011.02.002; Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004; Ferguson ND, 2007, CRIT CARE, V11, DOI 10.1186/cc6113; Folgueras AR, 2008, J BIOL CHEM, V283, P9465, DOI 10.1074/jbc.M709522200; Garcia-Prieto E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013242; Greenlee KJ, 2006, J IMMUNOL, V177, P7312, DOI 10.4049/jimmunol.177.10.7312; Gueders MM, 2005, J IMMUNOL, V175, P2589, DOI 10.4049/jimmunol.175.4.2589; Gustot T, 2011, CURR OPIN CRIT CARE, V17, P153, DOI 10.1097/MCC.0b013e328344b446; Gutierrez-Fernandez A, 2007, FASEB J, V21, P2580, DOI 10.1096/fj.06-7860com; Hergrueter AH, 2011, AM J PHYSIOL-LUNG C, V300, pL512, DOI 10.1152/ajplung.00023.2011; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Khatwa UA, 2010, J LEUKOCYTE BIOL, V87, P69, DOI 10.1189/jlb.0509361; Lauhio A, 2011, PHARMACOL RES, V64, P590, DOI 10.1016/j.phrs.2011.06.019; Menezes SLS, 2005, J APPL PHYSIOL, V98, P1777, DOI 10.1152/japplphysiol.01182.2004; Penzo M, 2010, J IMMUNOL, V184, P4497, DOI 10.4049/jimmunol.0903131; Quintero PA, 2010, J IMMUNOL, V184, P1575, DOI 10.4049/jimmunol.0900290; Raquil MA, 2008, J IMMUNOL, V180, P3366, DOI 10.4049/jimmunol.180.5.3366; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Solan PD, 2012, CRIT CARE MED, V40, P379, DOI 10.1097/CCM.0b013e318232e404; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Van Lint P, 2005, J IMMUNOL, V175, P7642, DOI 10.4049/jimmunol.175.11.7642; Yamakawa N, 2011, AM J PHYSIOL-LUNG C, V300, pL516, DOI 10.1152/ajplung.00118.2010	29	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39940	10.1371/journal.pone.0039940	http://dx.doi.org/10.1371/journal.pone.0039940			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768176	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100146
J	Juhas, M; Stark, M; von Mering, C; Lumjiaktase, P; Crook, DW; Valvano, MA; Eberl, L				Juhas, Mario; Stark, Manuel; von Mering, Christian; Lumjiaktase, Puthapoom; Crook, Derrick W.; Valvano, Miguel A.; Eberl, Leo			High Confidence Prediction of Essential Genes in Burkholderia Cenocepacia	PLOS ONE			English	Article							RHAMNOSE-INDUCIBLE PROMOTER; ESCHERICHIA-COLI; COMPARATIVE GENOMICS; TRANSPOSON MUTAGENESIS; TRANSFER-RNA; DATABASE; IDENTIFICATION; EVOLUTION; EXCISION; ISLAND	Background: Essential genes are absolutely required for the survival of an organism. The identification of essential genes, besides being one of the most fundamental questions in biology, is also of interest for the emerging science of synthetic biology and for the development of novel antimicrobials. New antimicrobial therapies are desperately needed to treat multidrug-resistant pathogens, such as members of the Burkholderia cepacia complex. Methodology/Principal Findings: We hypothesize that essential genes may be highly conserved within a group of evolutionary closely related organisms. Using a bioinformatics approach we determined that the core genome of the order Burkholderiales consists of 649 genes. All but two of these identified genes were located on chromosome 1 of Burkholderia cenocepacia. Although many of the 649 core genes of Burkholderiales have been shown to be essential in other bacteria, we were also able to identify a number of novel essential genes present mainly, or exclusively, within this order. The essentiality of some of the core genes, including the known essential genes infB, gyrB, ubiB, and valS, as well as the so far uncharacterized genes BCAL1882, BCAL2769, BCAL3142 and BCAL3369 has been confirmed experimentally in B. cenocepacia. Conclusions/Significance: We report on the identification of essential genes using a novel bioinformatics strategy and provide bioinformatics and experimental evidence that the large majority of the identified genes are indeed essential. The essential genes identified here may represent valuable targets for the development of novel antimicrobials and their detailed study may shed new light on the functions required to support life.	[Juhas, Mario; Eberl, Leo] Univ Zurich, Inst Plant Biol, Dept Microbiol, CH-8008 Zurich, Switzerland; [Stark, Manuel; von Mering, Christian] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Stark, Manuel; von Mering, Christian] Univ Zurich, Swiss Inst Bioinformat, Zurich, Switzerland; [Lumjiaktase, Puthapoom] Mahidol Univ, Salaya, Nakhon Pathom, Thailand; [Crook, Derrick W.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; [Valvano, Miguel A.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada	University of Zurich; University of Zurich; Swiss Institute of Bioinformatics; University of Zurich; Mahidol University; University of Oxford; Western University (University of Western Ontario)	Juhas, M (corresponding author), Univ Zurich, Inst Plant Biol, Dept Microbiol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	mario.juhas@uzh.ch; leo.eberl@uzh.ch	von Mering, Christian/B-3300-2008; Eberl, Leo/A-8380-2012; Valvano, Miguel A/G-8759-2012; Eberl, Leo/AAE-8165-2019	von Mering, Christian/0000-0001-7734-9102; Eberl, Leo/0000-0002-7241-0864; Valvano, Miguel A/0000-0001-8229-3641; 	European Union; MRC [G0400039] Funding Source: UKRI; Medical Research Council [G0400039] Funding Source: researchfish	European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a grant from the European Union 7th Framework Program, project NABATIVI. M.A.V. holds Canada Research Chair in Infectious Diseases and Pathogenesis, and is a Zeller's Senior Research Scientist from Cystic Fibrosis Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JC, 2005, BIOINFORMATICS, V21, P3665, DOI 10.1093/bioinformatics/bti601; Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bohannon J, 2011, SCIENCE, V333, P1236, DOI 10.1126/science.333.6047.1236; Bottacini F, 2010, MICROBIOL-SGM, V156, P3243, DOI 10.1099/mic.0.039545-0; Boulos L, 1999, J MICROBIOL METH, V37, P77, DOI 10.1016/S0167-7012(99)00048-2; Carbone A, 2006, J MOL EVOL, V63, P733, DOI 10.1007/s00239-005-0250-9; Cardona ST, 2006, APPL ENVIRON MICROB, V72, P2547, DOI 10.1128/AEM.72.4.2547-2555.2006; Cardona ST, 2005, PLASMID, V54, P219, DOI 10.1016/j.plasmid.2005.03.004; Charlebois RL, 2004, GENOME RES, V14, P2469, DOI 10.1101/gr.3024704; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; Drevinek P, 2010, CLIN MICROBIOL INFEC, V16, P821, DOI 10.1111/j.1469-0691.2010.03237.x; Feher T, 2007, CHEM REV, V107, P3498, DOI 10.1021/cr0683111; French CT, 2008, MOL MICROBIOL, V69, P67, DOI 10.1111/j.1365-2958.2008.06262.x; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Hausmann CD, 2008, FEMS MICROBIOL REV, V32, P705, DOI 10.1111/j.1574-6976.2008.00119.x; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Juhas M, 2011, TRENDS CELL BIOL, V21, P562, DOI 10.1016/j.tcb.2011.07.005; Karberg KA, 2011, P NATL ACAD SCI USA, V108, P20154, DOI 10.1073/pnas.1109451108; Kato JI, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100174; King AJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-64; Klasson L, 2004, TRENDS MICROBIOL, V12, P37, DOI 10.1016/j.tim.2003.11.006; Klein J, 2009, NUCLEIC ACIDS RES, V37, pD494, DOI 10.1093/nar/gkn674; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Lechner M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-141; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Loutet Slade A, 2011, Front Cell Infect Microbiol, V1, P6, DOI [10.3389/fmicb.2011.00159, 10.3389/fcimb.2011.00006]; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; McCutcheon JP, 2010, CURR OPIN MICROBIOL, V13, P73, DOI 10.1016/j.mib.2009.12.002; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Moya A, 2009, FEMS MICROBIOL REV, V33, P225, DOI 10.1111/j.1574-6976.2008.00151.x; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Nandagopal N, 2011, SCIENCE, V333, P1244, DOI 10.1126/science.1207084; Ortega XP, 2007, J BACTERIOL, V189, P3639, DOI 10.1128/JB.00153-07; Pang ZH, 2005, J BACTERIOL, V187, P7773, DOI 10.1128/JB.187.22.7773-7783.2005; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Poon WW, 2000, J BACTERIOL, V182, P5139, DOI 10.1128/JB.182.18.5139-5146.2000; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Ruder WC, 2011, SCIENCE, V333, P1248, DOI 10.1126/science.1206843; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Salama NR, 2004, J BACTERIOL, V186, P7926, DOI 10.1128/JB.186.23.7926-7935.2004; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schoeffler AJ, 2010, NUCLEIC ACIDS RES, V38, P7830, DOI 10.1093/nar/gkq665; Sentchilo V, 2009, MOL MICROBIOL, V72, P1293, DOI 10.1111/j.1365-2958.2009.06726.x; Stocks SM, 2004, CYTOM PART A, V61A, P189, DOI 10.1002/cyto.a.20069; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tuanyok A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-566; Tumapa S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-190; Ussery DW, 2009, GENOME DYNAM, V6, P140, DOI 10.1159/000235768; Vandamme P, 2011, SYST APPL MICROBIOL, V34, P87, DOI 10.1016/j.syapm.2010.10.002; Vial L, 2011, ENVIRON MICROBIOL, V13, P1, DOI 10.1111/j.1462-2920.2010.02343.x; Winsor GL, 2008, BIOINFORMATICS, V24, P2803, DOI 10.1093/bioinformatics/btn524; Yoo JH, 2008, MOL MICROBIOL, V67, P1012, DOI 10.1111/j.1365-2958.2008.06104.x; Yu BJ, 2002, NAT BIOTECHNOL, V20, P1018, DOI 10.1038/nbt740; Yu Byung Jo, 2008, V416, P261, DOI 10.1007/978-1-59745-321-9_17; Zhang Chun-Ting, 2008, V416, P391, DOI 10.1007/978-1-59745-321-9_27; Zhang R, 2004, NUCLEIC ACIDS RES, V32, pD271, DOI 10.1093/nar/gkh024; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	66	44	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40064	10.1371/journal.pone.0040064	http://dx.doi.org/10.1371/journal.pone.0040064			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768221	gold, Green Published, Green Accepted			2022-12-27	WOS:000305892100193
J	Meyniel, C; Spelman, T; Jokubaitis, VG; Trojano, M; Izquierdo, G; Grand'Maison, F; Oreja-Guevara, C; Boz, C; Lugaresi, A; Girard, M; Grammond, P; Iuliano, G; Fiol, M; Cabrera-Gomez, JA; Fernandez-Bolanos, R; Giuliani, G; Lechner-Scott, J; Cristiano, E; Herbert, J; Petkovska-Boskova, T; Bergamaschi, R; van Pesch, V; Moore, F; Vella, N; Slee, M; Santiago, V; Barnett, M; Havrdova, E; Young, C; Sirbu, CA; Tanner, M; Rutherford, M; Butzkueven, H				Meyniel, Claire; Spelman, Timothy; Jokubaitis, Vilija G.; Trojano, Maria; Izquierdo, Guillermo; Grand'Maison, Francois; Oreja-Guevara, Celia; Boz, Cavit; Lugaresi, Alessandra; Girard, Marc; Grammond, Pierre; Iuliano, Gerardo; Fiol, Marcela; Antonio Cabrera-Gomez, Jose; Fernandez-Bolanos, Ricardo; Giuliani, Giorgio; Lechner-Scott, Jeannette; Cristiano, Edgardo; Herbert, Joseph; Petkovska-Boskova, Tatjana; Bergamaschi, Roberto; van Pesch, Vincent; Moore, Fraser; Vella, Norbert; Slee, Mark; Santiago, Vetere; Barnett, Michael; Havrdova, Eva; Young, Carolyn; Sirbu, Carmen-Adella; Tanner, Mary; Rutherford, Michelle; Butzkueven, Helmut		MSBasis Study Grp	Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome	PLOS ONE			English	Article							INTERFERON-BETA; ADHERENCE; DEFINITE; CONVERSION; REGISTRY; TRIAL; RISK	Objectives: We conducted a prospective study, MSBASIS, to assess factors leading to first treatment discontinuation in patients with a clinically isolated syndrome (CIS) and early relapsing-remitting multiple sclerosis (RRMS). Methods: The MSBASIS Study, conducted by MSBase Study Group members, enrols patients seen from CIS onset, reporting baseline demographics, cerebral magnetic resonance imaging (MRI) features and Expanded Disability Status Scale (EDSS) scores. Follow-up visits report relapses, EDSS scores, and the start and end dates of MS-specific therapies. We performed a multivariable survival analysis to determine factors within this dataset that predict first treatment discontinuation. Results: A total of 2314 CIS patients from 44 centres were followed for a median of 2.7 years, during which time 1247 commenced immunomodulatory drug (IMD) treatment. Ninety percent initiated IMD after a diagnosis of MS was confirmed, and 10% while still in CIS status. Over 40% of these patients stopped their first IMD during the observation period. Females were more likely to cease medication than males (HR 1.36, p = 0.003). Patients treated in Australia were twice as likely to cease their first IMD than patients treated in Spain (HR 1.98, p = 0.001). Increasing EDSS was associated with higher rate of IMD cessation (HR 1.21 per EDSS unit, p<0.001), and intramuscular interferon-beta-1a (HR 1.38, p = 0.028) and subcutaneous interferon-beta-1a (HR 1.45, p = 0.012) had higher rates of discontinuation than glatiramer acetate, although this varied widely in different countries. Onset cerebral MRI features, age, time to treatment initiation or relapse on treatment were not associated with IMD cessation. Conclusion: In this multivariable survival analysis, female sex, country of residence, EDSS change and IMD choice independently predicted time to first IMD cessation.	[Meyniel, Claire; Spelman, Timothy; Jokubaitis, Vilija G.; Tanner, Mary; Rutherford, Michelle; Butzkueven, Helmut] Royal Melbourne Hosp, Dept Neurol, Parkville, Vic, Australia; [Meyniel, Claire] CHU Nantes, CIC 0004, F-44035 Nantes 01, France; [Trojano, Maria] Univ Bari, Bari, Italy; [Izquierdo, Guillermo] Univ Hosp, Seville, Spain; [Grand'Maison, Francois] Clin Neuro Rive S, Greenfield Pk, PQ, Canada; [Oreja-Guevara, Celia] Univ Hosp La Paz, IdiPAZ, Madrid, Spain; [Boz, Cavit] Karadeniz Tech Univ, Trabzon, Turkey; [Lugaresi, Alessandra] Univ G dAnnunzio, Dept Neurosci & Imaging, MS Ctr, Chieti, Italy; [Girard, Marc; Grammond, Pierre] Hotel Dieu Levis, Dept Neurol, Levis, PQ, Canada; [Iuliano, Gerardo] Osped Riuniti Salerno, Salerno, Italy; [Fiol, Marcela] FLENI, Buenos Aires, DF, Argentina; [Antonio Cabrera-Gomez, Jose] Ctr Int Restaurac Neurol, Havana, Cuba; [Fernandez-Bolanos, Ricardo] Hosp Univ Virgen de Valme, Seville, Spain; [Giuliani, Giorgio] Osped Macerata, Macerata, Italy; [Lechner-Scott, Jeannette] John Hunter Hosp, Newcastle, NSW, Australia; [Cristiano, Edgardo] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina; [Herbert, Joseph] NYU, Hosp Joint Dis, New York, NY USA; [Petkovska-Boskova, Tatjana] Clin Neurol Clin Ctr, Skopje, Macedonia; [Bergamaschi, Roberto] Neurol Inst IRCCS Mondino, Pavia, Italy; [van Pesch, Vincent] Clin Univ St Luc, B-1200 Brussels, Belgium; [Moore, Fraser] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; [Vella, Norbert] Mater Dei Hosp, Msida, Malta; [Slee, Mark] Flinders Univ & Med Ctr, Adelaide, SA 5001, Australia; [Santiago, Vetere] HIGA Gral, San Martin La Plata, Argentina; [Barnett, Michael] Brain Mind Res Inst, Camperdown, NSW, Australia; [Havrdova, Eva] Gen Teaching Hosp, Prague, Czech Republic; [Young, Carolyn] Walton Ctr Neurol & Neurosurg, Liverpool, Merseyside, England; [Sirbu, Carmen-Adella] Cent Univ Emergency Mil Hosp, Bucharest, Romania; [Butzkueven, Helmut] Univ Melbourne, Melbourne Brain Ctr, Dept Med, Melbourne, Vic 3010, Australia; [Butzkueven, Helmut] Monash Univ, Box Hill Hosp, Dept Neurol, Melbourne, Vic 3004, Australia	Royal Melbourne Hospital; Nantes Universite; CHU de Nantes; Universita degli Studi di Bari Aldo Moro; Hospital Universitario La Paz; Karadeniz Technical University; G d'Annunzio University of Chieti-Pescara; Laval University; Hospital Valme; John Hunter Hospital; Hospital Italiano de Buenos Aires; University of Buenos Aires; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; IRCCS Fondazione Casimiro Mondino; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; McGill University; Flinders University South Australia; University of Sydney; General University Hospital Prague; Walton Centre; University of Melbourne; Box Hill Hospital; Monash University	Meyniel, C (corresponding author), Royal Melbourne Hosp, Dept Neurol, Parkville, Vic, Australia.	butz@unimelb.edu.au	pietrolongo, erika/AAC-5694-2020; Lucchese, Guglielmo/AAL-9860-2020; BOZ, Cavit/V-5127-2017; pucci, eugenio/I-1039-2014; SIRBU, Carmen Adella/AAA-9317-2020; Oreja-Guevara, Celia/N-5151-2019; Havrdova, Eva Kubala/P-4892-2017; Slee, Mark/J-4731-2015; Boz, Cavit/AAR-2268-2020; Jokubaitis, Vilija G./AAD-5949-2019; van Pesch, Vincent/AAK-9506-2020; Lugaresi, Alessandra/C-7743-2012	pietrolongo, erika/0000-0002-6311-5994; Lucchese, Guglielmo/0000-0002-1809-6376; pucci, eugenio/0000-0001-7606-7330; SIRBU, Carmen Adella/0000-0002-1982-1066; Oreja-Guevara, Celia/0000-0002-9221-5716; Havrdova, Eva Kubala/0000-0002-9543-4359; Slee, Mark/0000-0003-4323-2453; Boz, Cavit/0000-0003-0956-3304; Jokubaitis, Vilija G./0000-0002-3942-4340; Lugaresi, Alessandra/0000-0003-2902-5589; Young, Carolyn/0000-0003-1745-7720; Kilpatrick, Trevor/0000-0003-3999-085X; Trojano, Maria/0000-0002-6329-8946; Skibina, Olga/0000-0002-6275-8138; , Carolyn/0000-0001-6971-8203; Butzkueven, Helmut/0000-0003-3940-8727; De Luca, Giovanna/0000-0002-7693-2256; Petersen, Thor/0000-0001-5633-2600; van Pesch, Vincent/0000-0003-2885-9004; Cristiano, Edgardo/0000-0002-6400-8277; Lechner-Scott, Jeannette/0000-0002-3850-447X	MSBase Foundation; Journees de Neurologie de Langue Francaise; National Health and Medical Research Council (NHMRC) [628856]; NHMRC Australia [1032484]; Bayer Schering; Biogen Dompe; Biogen Idec; Merck Serono; Novartis; Sanofi Aventis; Teva; EMD Serono; Genzyme; ONO UBC; Associazione Italiana Sclerosi Multipla; Czech Ministry of Education [MSM 0021620849]; MS Society United Kingdom; MND association United Kingdom; British Polio Fellowship; NHMRC [628856, 566513, 628799, 1009757]; NHMRC Centre of Excellence Award [1001216]; ARC Linkage Grant [LP110100473]; National MS Society (United States of America) [RG3850A3/1]	MSBase Foundation; Journees de Neurologie de Langue Francaise; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia); Bayer Schering(Bayer AG); Biogen Dompe(Biogen); Biogen Idec(Biogen); Merck Serono(Merck & Company); Novartis(Novartis); Sanofi Aventis(Sanofi-Aventis); Teva(Teva Pharmaceutical Industries); EMD Serono; Genzyme(Sanofi-AventisGenzyme Corporation); ONO UBC; Associazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); MS Society United Kingdom; MND association United Kingdom; British Polio Fellowship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Centre of Excellence Award(National Health and Medical Research Council (NHMRC) of Australia); ARC Linkage Grant(Australian Research Council); National MS Society (United States of America)	This study was funded by the MSBase Foundation. CM is supported by the Journees de Neurologie de Langue Francaise. HB is supported by National Health and Medical Research Council (NHMRC) Career Development Fellowship 628856, the work was supported by NHMRC Australia grant 1032484. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research Grants: The following authors have received research grants from Bayer Schering: AL, RB & MB; Biogen Dompe: AL & RB; Biogen Idec: MT, FGM, PG & MB; Merck Serono MT, AL, RB & MB; Novartis: MT, FGM, AL, RB & MB; Sanofi Aventis: AL, PG, RB & MB; Teva: FGM & MB. Travel Grants: The following authors have received travel grants from Bayer Schering: AL, VvP & CAS; Biogen Dompe: AL; Biogen Idec: MG, VvP, NV, CY & HB; EMD Serono: MG; Merck Serono: AL, VvP & CY; Novartis: TS, AL, VvP, NV & HB; Sanofi Aventis: AL, VvP & HB; Teva: AL, CY & CAS. Honoraria: The following authors have received honoraria from Bayer Schering: MT, GIz, AL, PG, JLS, JH, RB & MB; Biogen Dompe: AL & RB; Biogen Idec: MT, GIz, MG, PG, JLS, JH, VvP & MB; EMD Serono: MG, PG & FM; Merck Serono: MT, GIz, AL, JLS, JH, RB, & MB; Novartis: GIz, AL, MG, PG, JLS, RB, NV & MB; Sanofi Aventis: MT, GIz, AL, JLS, RB & MB; Teva: GIz, FGM, AL, MG, PG, JH, MB & CAS. Advisory Board Membership: The following authors report sitting on advisory boards for Bayer Schering: COG, AL, MS & CY; Biogen Dompe: AL; Biogen Idec: COG, MG, VvP, MS, CY & HB; Merck Serono: COG, AL, MS & CY; Novartis: FGM, COG, MS, CY & HB; Sanofi Aventis: MS & HB; Teva: COG, MG & CY. FGM also reports receiving research grants from EMD Serono, Genzyme, ONO & UBC. COG has participated in clinical trials and other research projects promoted by Biogen-Idec, GSK, Teva & Novartis. AL has received travel and research grants from the Associazione Italiana Sclerosi Multipla and is a Consultant of "Fondazione Cesare Serono". FM has participated in MS clinical trials sponsored by EMD Serono and Bayer. NV has received travel support from Eisai & GSK. EH acknowledges financial support from the Czech Ministry of Education (research program MSM 0021620849). CY reports sitting on the scientific advisory board of Lilly. CY participates in clinical trials sponsored by Biogen Idec, Merck Serono, Novartis, Roche, Sanofi Aventis, and Teva. CY holds research grants from the MS Society United Kingdom, the MND association United Kingdom and the British Polio Fellowship. CY is on the steering committee for LiCALS. HB serves on steering committees for trials conducted by Merck Serono, Biogen Idec and Novartis. HB has received research support from Merck Serono, Novartis and Biogen Idec in his capacity as honorary chair of the MSBase Foundation. HB is the recipient of an National Health and Medical Research Council (NHMRC) Career Development Award (628856), NHMRC Project Grants (566513, 628799, 1009757), NHMRC Centre of Excellence Award (1001216), an ARC Linkage Grant (LP110100473)RG & a National MS Society (United States of America) Project Grant (RG3850A3/1). These disclosures do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. There are no patents, products in development or marketed products to declare.	Arbizu T, 2000, ACTA NEUROL SCAND, V102, P209, DOI 10.1034/j.1600-0404.2000.102004209.x; Brodsky M, 2008, ARCH NEUROL-CHICAGO, V65, P727, DOI 10.1001/archneur.65.6.727; BRONNUMHANSEN H, 1994, NEUROLOGY, V44, P1901, DOI 10.1212/WNL.44.10.1901; Butzkueven H, 2006, MULT SCLER, V12, P769, DOI 10.1177/1352458506070775; Comi G, 2009, LANCET, V374, P1503, DOI 10.1016/S0140-6736(09)61259-9; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; CONFAVREUX C, 1992, J NEUROL NEUROSUR PS, V55, P671, DOI 10.1136/jnnp.55.8.671; Costello Kathleen, 2008, Medscape J Med, V10, P225; Filippi M, 2004, LANCET, V364, P1489, DOI 10.1016/S0140-6736(04)17271-1; Giordano A, 2008, J NEUROL SCI, V275, P86, DOI 10.1016/j.jns.2008.07.026; Heesen C, 2004, MULT SCLER J, V10, P643, DOI 10.1191/1352458504ms1112oa; Hurwitz BJ, 2011, NEUROLOGY, V76, pS3, DOI 10.1212/WNL.0b013e3182050225; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Kappos L, 2006, NEUROLOGY, V67, P1242, DOI 10.1212/01.wnl.0000237641.33768.8d; Kinkel RP, 2006, NEUROLOGY, V66, P678; Kleinman Nathan L, 2010, J Med Econ, V13, P633, DOI 10.3111/13696998.2010.527588; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Milanese C, 2003, J NEUROL NEUROSUR PS, V74, P1689, DOI 10.1136/jnnp.74.12.1689; Miller DH, 2004, LANCET, V364, P1463, DOI 10.1016/S0140-6736(04)17285-1; Mohr DC, 1999, MULT SCLER, V5, P192, DOI 10.1191/135245899678846069; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Portaccio E, 2008, EUR NEUROL, V59, P131, DOI 10.1159/000111875; Reynolds MW, 2010, CURR MED RES OPIN, V26, P663, DOI 10.1185/03007990903554257; Rio L, 2005, MULT SCLER, V11, P306, DOI 10.1191/1352458505ms1173oa; Ross AP, 2008, NEUROLOGY, V71, pS21, DOI 10.1212/WNL.0b013e31818f3dcb; Ruggieri RM, 2003, NEUROL SCI, V24, P361, DOI 10.1007/s10072-003-0190-3; Tremlett HL, 2003, NEUROLOGY, V61, P551, DOI 10.1212/01.WNL.0000078885.05053.7D	27	28	28	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38661	10.1371/journal.pone.0038661	http://dx.doi.org/10.1371/journal.pone.0038661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768046	Green Published, gold			2022-12-27	WOS:000305892100017
J	Mirelman, A; Herman, T; Brozgol, M; Dorfman, M; Sprecher, E; Schweiger, A; Giladi, N; Hausdorff, JM				Mirelman, Anat; Herman, Talia; Brozgol, Marina; Dorfman, Moran; Sprecher, Elliot; Schweiger, Avraham; Giladi, Nir; Hausdorff, Jeffrey M.			Executive Function and Falls in Older Adults: New Findings from a Five-Year Prospective Study Link Fall Risk to Cognition	PLOS ONE			English	Article							WHITE-MATTER HYPERINTENSITIES; ELDERLY PERSONS; GAIT VARIABILITY; ALZHEIMER-TYPE; COMMUNITY; WALKING; MEMORY; PREVENTION; DEMENTIA; ATTENTION	Background: Recent findings suggest that executive function (EF) plays a critical role in the regulation of gait in older adults, especially under complex and challenging conditions, and that EF deficits may, therefore, contribute to fall risk. The objective of this study was to evaluate if reduced EF is a risk factor for future falls over the course of 5 years of follow-up. Secondary objectives were to assess whether single and dual task walking abilities, an alternative window into EF, were associated with fall risk. Methodology/Main Results: We longitudinally followed 256 community-living older adults (age: 76.4 +/- 4.5 yrs; 61% women) who were dementia free and had good mobility upon entrance into the study. At baseline, a computerized cognitive battery generated an index of EF, attention, a closely related construct, and other cognitive domains. Gait was assessed during single and dual task conditions. Falls data were collected prospectively using monthly calendars. Negative binomial regression quantified risk ratios (RR). After adjusting for age, gender and the number of falls in the year prior to the study, only the EF index (RR: .85; CI: .74-.98, p = .021), the attention index (RR: .84; CI: .75-.94, p = .002) and dual tasking gait variability (RR: 1.11; CI: 1.01-1.23; p = .027) were associated with future fall risk. Other cognitive function measures were not related to falls. Survival analyses indicated that subjects with the lowest EF scores were more likely to fall sooner and more likely to experience multiple falls during the 66 months of follow-up (p < 0.02). Conclusions/Significance: These findings demonstrate that among community-living older adults, the risk of future falls was predicted by performance on EF and attention tests conducted 5 years earlier. The present results link falls among older adults to cognition, indicating that screening EF will likely enhance fall risk assessment, and that treatment of EF may reduce fall risk.	[Mirelman, Anat; Herman, Talia; Brozgol, Marina; Dorfman, Moran; Sprecher, Elliot; Giladi, Nir; Hausdorff, Jeffrey M.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurol, Movement Disorders Unit, IL-69978 Tel Aviv, Israel; [Mirelman, Anat] Ben Gurion Univ Negev, Sch Hlth Related Profess, Beer Sheva, Israel; [Hausdorff, Jeffrey M.] Tel Aviv Univ, Sackler Fac Med, Dept Phys Therapy, IL-69978 Tel Aviv, Israel; [Giladi, Nir] Tel Aviv Univ, Sackler Fac Med, Dept Neurol, IL-69978 Tel Aviv, Israel; [Schweiger, Avraham] Acad Coll Tel Aviv, Dept Behav Sci, Tel Aviv, Israel; [Hausdorff, Jeffrey M.] Harvard Univ, Sch Med, Boston, MA USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Ben Gurion University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Harvard University; Harvard Medical School	Mirelman, A (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurol, Movement Disorders Unit, IL-69978 Tel Aviv, Israel.	jhausdor@bidmc.harvard.edu	Giladi, Nir/AAU-8660-2020	Giladi, Nir/0000-0003-1482-8522	U.S. National Institute on Aging [AG14100]; Israel Ministry of Health; NATIONAL INSTITUTE ON AGING [R29AG014100, R01AG014100] Funding Source: NIH RePORTER	U.S. National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Israel Ministry of Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by grants from the U.S. National Institute on Aging (AG14100) and the Israel Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiron A, 2007, EUR J NEUROL, V14, P1102, DOI 10.1111/j.1468-1331.2007.01909.x; Anstey KJ, 2009, NEUROPSYCHOLOGY, V23, P500, DOI 10.1037/a0015389; Atkinson HH, 2007, J GERONTOL A-BIOL, V62, P844, DOI 10.1093/gerona/62.8.844; Beauchet O, 2011, NEUROLOGY, V76, P1617, DOI 10.1212/WNL.0b013e318219fb08; Beauchet O, 2009, EUR J NEUROL, V16, P786, DOI 10.1111/j.1468-1331.2009.02612.x; Ben-Itzhak R, 2008, J AM GERIATR SOC, V56, P695, DOI 10.1111/j.1532-5415.2007.01623.x; BERG K, 1995, SCAND J REHABIL MED, V27, P27; Blahak C, 2009, J NEUROL NEUROSUR PS, V80, P608, DOI 10.1136/jnnp.2008.154633; Ble A, 2005, J AM GERIATR SOC, V53, P410, DOI 10.1111/j.1532-5415.2005.53157.x; Brauer SG, 2002, GAIT POSTURE, V15, P83, DOI 10.1016/S0966-6362(01)00163-1; BUCHNER DM, 1987, JAMA-J AM MED ASSOC, V257, P1492, DOI 10.1001/jama.257.11.1492; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; de Bruin ED, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-59; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Delbaere K, 2012, AGE AGEING, V41, P404, DOI 10.1093/ageing/afs004; Dwolatzky Tzvi, 2003, BMC Geriatr, V3, P4, DOI 10.1186/1471-2318-3-4; Eggermont LHP, 2012, J AM GERIATR SOC, V60, P230, DOI 10.1111/j.1532-5415.2011.03829.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friedman SM, 2002, J AM GERIATR SOC, V50, P1329, DOI 10.1046/j.1532-5415.2002.50352.x; Hausdorff JM, 2006, EXP AGING RES, V32, P411, DOI 10.1080/03610730600875817; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hausdorff JM, 2005, EXP BRAIN RES, V164, P541, DOI 10.1007/s00221-005-2280-3; Herman T, 2010, J GERONTOL A-BIOL, V65, P1086, DOI 10.1093/gerona/glq077; Hilbe J. M., 2011, NEGATIVE BINOMINAL R; Holtzer R, 2007, NEUROPSYCHOLOGY, V21, P540, DOI 10.1037/0894-4105.21.5.540; Iaboni A, 2012, AM J GERIATR PSYCHIA; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Leveille SG, 2009, JAMA-J AM MED ASSOC, V302, P2214, DOI 10.1001/jama.2009.1738; MORRIS JC, 1987, J GERONTOL, V42, P412, DOI 10.1093/geronj/42.4.412; Nordahl CW, 2006, J COGNITIVE NEUROSCI, V18, P418, DOI 10.1162/089892906775990552; Parks CM, 2011, NEUROPSYCHOLOGIA, V49, P2817, DOI 10.1016/j.neuropsychologia.2011.06.003; Pichierri G, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-29; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Prins ND, 2005, BRAIN, V128, P2034, DOI 10.1093/brain/awh553; Rankin JK, 2000, J GERONTOL A-BIOL, V55, pM112, DOI 10.1093/gerona/55.3.M112; Sasson E, 2010, NEUROIMAGE, V50, P1231, DOI 10.1016/j.neuroimage.2009.12.079; Segev-Jacubovski O, 2011, EXPERT REV NEUROTHER, V11, P1057, DOI [10.1586/ern.11.69, 10.1586/ERN.11.69]; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; ShumwayCook A, 1997, PHYS THER, V77, P812, DOI 10.1093/ptj/77.8.812; Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; TINETTI ME, 1994, PREV MED, V23, P756, DOI 10.1006/pmed.1994.1130; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; van Iersel MB, 2008, J GERONTOL A-BIOL, V63, P1344; VANDIJK PTM, 1993, GERONTOLOGIST, V33, P200, DOI 10.1093/geront/33.2.200; Vannorsdall TD, 2009, ARCH CLIN NEUROPSYCH, V24, P209, DOI 10.1093/arclin/acp037; Venkatraman VK, 2010, NEUROIMAGE, V49, P3436, DOI 10.1016/j.neuroimage.2009.11.019; Verghese J, 2010, J GERONTOL A-BIOL, V65, P1338, DOI 10.1093/gerona/glq127; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	52	268	272	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40297	10.1371/journal.pone.0040297	http://dx.doi.org/10.1371/journal.pone.0040297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768271	Green Published, gold			2022-12-27	WOS:000305892100245
J	Moreno-Lopez, L; Stamatakis, EA; Fernandez-Serrano, MJ; Gomez-Rio, M; Rodriguez-Fernandez, A; Perez-Garcia, M; Verdejo-Garcia, A				Moreno-Lopez, Laura; Stamatakis, Emmanuel A.; Jose Fernandez-Serrano, Maria; Gomez-Rio, Manuel; Rodriguez-Fernandez, Antonio; Perez-Garcia, Miguel; Verdejo-Garcia, Antonio			Neural Correlates of the Severity of Cocaine, Heroin, Alcohol, MDMA and Cannabis Use in Polysubstance Abusers: A Resting-PET Brain Metabolism Study	PLOS ONE			English	Article							MOTOR FUNCTION; ACTIVATION; ECSTASY; TASK; DEFICITS; CORTEX	Introduction: Functional imaging studies of addiction following protracted abstinence have not been systematically conducted to look at the associations between severity of use of different drugs and brain dysfunction. Findings from such studies may be relevant to implement specific interventions for treatment. The aim of this study was to examine the association between resting-state regional brain metabolism (measured with 18F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET) and the severity of use of cocaine, heroin, alcohol, MDMA and cannabis in a sample of polysubstance users with prolonged abstinence from all drugs used. Methods: Our sample consisted of 49 polysubstance users enrolled in residential treatment. We conducted correlation analyses between estimates of use of cocaine, heroin, alcohol, MDMA and cannabis and brain metabolism (BM) (using Statistical Parametric Mapping voxel-based (VB) whole-brain analyses). In all correlation analyses conducted for each of the drugs we controlled for the co-abuse of the other drugs used. Results: The analysis showed significant negative correlations between severity of heroin, alcohol, MDMA and cannabis use and BM in the dorsolateral prefrontal cortex (DLPFC) and temporal cortex. Alcohol use was further associated with lower metabolism in frontal premotor cortex and putamen, and stimulants use with parietal cortex. Conclusions: Duration of use of different drugs negatively correlated with overlapping regions in the DLPFC, whereas severity of cocaine, heroin and alcohol use selectively impact parietal, temporal, and frontal-premotor/basal ganglia regions respectively. The knowledge of these associations could be useful in the clinical practice since different brain alterations have been associated with different patterns of execution that may affect the rehabilitation of these patients.	[Moreno-Lopez, Laura; Perez-Garcia, Miguel; Verdejo-Garcia, Antonio] Univ Granada, Dept Personal Evaluat & Psychol Treatment, Granada, Spain; [Stamatakis, Emmanuel A.] Univ Cambridge, Sch Clin Med, Div Anaesthesia, Cambridge, England; [Jose Fernandez-Serrano, Maria] Univ Jaen, Dept Psychol, Jaen, Spain; [Gomez-Rio, Manuel; Rodriguez-Fernandez, Antonio] Hosp Virgen Nieves Granada, Nucl Med Serv, Granada, Spain; [Perez-Garcia, Miguel] Univ Granada, CIBERSAM, Ctr Invest Biomed Red Salud Mental, Granada, Spain; [Perez-Garcia, Miguel; Verdejo-Garcia, Antonio] Univ Granada, Inst Neurosci Federico Oloriz, Granada, Spain	University of Granada; University of Cambridge; Universidad de Jaen; Hospital Universitario Virgen de las Nieves; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Granada; University of Granada	Moreno-Lopez, L (corresponding author), Univ Granada, Dept Personal Evaluat & Psychol Treatment, Granada, Spain.	lmoreno@ugr.es	Serrano, M Josefa Fernández/V-3124-2019; Verdejo-Garcia, Antonio/AAV-1147-2021; perez, miguel/GXF-5077-2022; García, Miguel Pérez/F-9630-2010; Rodriguez-Fernandez, Antonio/AAB-3469-2019; Fernandez-Serrano, Maria Jose/AGA-6711-2022; Moreno-López, Laura/K-9568-2015	Serrano, M Josefa Fernández/0000-0002-6158-237X; Verdejo-Garcia, Antonio/0000-0001-8874-9339; García, Miguel Pérez/0000-0003-4775-7556; Moreno-López, Laura/0000-0003-3687-7237; Stamatakis, Emmanuel Andreas/0000-0001-6955-9601	Spanish Ministry of Education and Science [SEJ2006-08278]; Council of Science and Innovation [P07-HUM-03089]; FPU from the Spanish Ministry of Science and Innovation [AP2007-03583]; MCINN in the Department of Experimental Psychology, University of Cambridge; Queens' College, Cambridge	Spanish Ministry of Education and Science(Spanish Government); Council of Science and Innovation; FPU from the Spanish Ministry of Science and Innovation; MCINN in the Department of Experimental Psychology, University of Cambridge; Queens' College, Cambridge	This study has been supported with funds from the SEJ2006-08278 project from the Spanish Ministry of Education and Science, the P07-HUM-03089 project from the Council of Science and Innovation. Laura Moreno-Lopez is supported by the FPU grant (AP2007-03583) from the Spanish Ministry of Science and Innovation. Antonio Verdejo-Garcia was supported by a MCINN Jose Castillejo grant in the Department of Experimental Psychology, University of Cambridge. Emmanuel A. Stamatakis is supported by the Stephen Erskine Fellowship from Queens' College, Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron JL, 2007, ADDICTION, V102, P33, DOI 10.1111/j.1360-0443.2006.01778.x; Barros-Loscertales A, 2011, PSYCHIAT RES-NEUROIM, V194, P111, DOI 10.1016/j.pscychresns.2011.05.001; Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; Bustamante JC, 2011, BRAIN RES, V1375, P111, DOI 10.1016/j.brainres.2010.12.042; de Sola S, 2008, PSYCHOPHARMACOLOGY, V200, P425, DOI 10.1007/s00213-008-1217-5; de Win MML, 2008, BRIT J PSYCHIAT, V193, P289, DOI 10.1192/bjp.bp.106.035089; Fehr C, 2007, PSYCHOPHARMACOLOGY, V191, P975, DOI 10.1007/s00213-006-0696-5; Fernandez-Serrano MJ, 2011, NEUROSCI BIOBEHAV R, V35, P377, DOI 10.1016/j.neubiorev.2010.04.008; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Goldstein RZ, 2009, P NATL ACAD SCI USA, V106, P9453, DOI 10.1073/pnas.0900491106; Gruber SA, 2007, NEUROPSYCHOL REV, V17, P299, DOI 10.1007/s11065-007-9041-y; Hanson KL, 2011, PSYCHOL ADDICT BEHAV, V25, P127, DOI 10.1037/a0022350; Johnson-Greene D, 2002, CLIN NEUROPSYCHOL, V16, P300, DOI 10.1076/clin.16.3.300.13845; Jovanovski D, 2005, J CLIN EXP NEUROPSYC, V27, P189, DOI 10.1080/13803390490515694; King GR, 2011, J NEUROSCI, V31, P17923, DOI 10.1523/JNEUROSCI.4148-11.2011; Kish SJ, 2010, BRAIN, V133, P1779, DOI 10.1093/brain/awq103; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Lane SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011591; Martin-Santos R, 2010, PSYCHOL MED, V40, P383, DOI 10.1017/S0033291709990729; Pillay SS, 2008, EXP CLIN PSYCHOPHARM, V16, P22, DOI 10.1037/1064-1297.16.1.22; Pitel AL, 2010, PSYCHOL MED, V40, P497, DOI 10.1017/S0033291709990626; Sullivan EV, 2005, BIOL PSYCHIAT, V57, P768, DOI 10.1016/j.biopsych.2004.12.012; Tomasi D, 2007, BRAIN RES, V1171, P83, DOI 10.1016/j.brainres.2007.06.102; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Holst RJ, 2012, DRUG ALCOHO IN PRESS; Verdejo-Garcia AJ, 2005, ADDICT BEHAV, V30, P89, DOI 10.1016/j.addbeh.2004.04.015; Volkow ND, 2010, NEUROIMAGE, V49, P2536, DOI 10.1016/j.neuroimage.2009.10.088; Yuan Y, 2009, BRAIN COGNITION, V71, P223, DOI 10.1016/j.bandc.2009.08.014; Zakzanis KK, 2007, HUM PSYCHOPHARM CLIN, V22, P427, DOI 10.1002/hup.873; Zinn S, 2004, ALCOHOL CLIN EXP RES, V28, P1338, DOI 10.1097/01.ALC.0000139814.81811.62; Zubieta JK, 2005, AM J PSYCHIAT, V162, P567, DOI 10.1176/appi.ajp.162.3.567	32	43	44	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39830	10.1371/journal.pone.0039830	http://dx.doi.org/10.1371/journal.pone.0039830			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768136	Green Published, gold			2022-12-27	WOS:000305892100106
J	Oyarzun, JP; Lopez-Barroso, D; Fuentemilla, L; Cucurell, D; Pedraza, C; Rodriguez-Fornells, A; de Diego-Balaguer, R				Oyarzun, Javiera P.; Lopez-Barroso, Diana; Fuentemilla, Lluis; Cucurell, David; Pedraza, Carmen; Rodriguez-Fornells, Antoni; de Diego-Balaguer, Ruth			Updating Fearful Memories with Extinction Training during Reconsolidation: A Human Study Using Auditory Aversive Stimuli	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PROTEIN-SYNTHESIS; CONDITIONED FEAR; ANIMAL-MODELS; MECHANISMS; RETRIEVAL; AMYGDALA; REINSTATEMENT; PROPRANOLOL; RESPONSES	Learning to fear danger in the environment is essential to survival, but dysregulation of the fear system is at the core of many anxiety disorders. As a consequence, a great interest has emerged in developing strategies for suppressing fear memories in maladaptive cases. Recent research has focused in the process of reconsolidation where memories become labile after being retrieved. In a behavioral manipulation, Schiller et al., (2010) reported that extinction training, administrated during memory reconsolidation, could erase fear responses. The implications of this study are crucial for the possible treatment of anxiety disorders without the administration of drugs. However, attempts to replicate this effect by other groups have been so far unsuccessful. We sought out to reproduce Schiller et al., (2010) findings in a different fear conditioning paradigm based on auditory aversive stimuli instead of electric shock. Following a within-subject design, participants were conditioned to two different sounds and skin conductance response (SCR) was recorded as a measure of fear. Our results demonstrated that only the conditioned stimulus that was reminded 10 minutes before extinction training did not reinstate a fear response after a reminder trial consisting of the presentation of the unconditioned stimuli. For the first time, we replicated Schiller et al., (2010) behavioral manipulation and extended it to an auditory fear conditioning paradigm.	[Oyarzun, Javiera P.; Lopez-Barroso, Diana; Fuentemilla, Lluis; Cucurell, David; Rodriguez-Fornells, Antoni; de Diego-Balaguer, Ruth] Bellvitge Biomed Res Inst IDIBELL, Cognit & Brain Plast Grp, Barcelona, Spain; [Oyarzun, Javiera P.; Lopez-Barroso, Diana; Rodriguez-Fornells, Antoni; de Diego-Balaguer, Ruth] Univ Barcelona, Dept Basic Psychol, Barcelona, Spain; [Pedraza, Carmen] Univ Malaga, Fac Psychol, Dept Psychobiol, E-29071 Malaga, Spain; [Rodriguez-Fornells, Antoni; de Diego-Balaguer, Ruth] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Universidad de Malaga; ICREA	Oyarzun, JP (corresponding author), Bellvitge Biomed Res Inst IDIBELL, Cognit & Brain Plast Grp, Barcelona, Spain.	ruth.dediego@ub.edu	López-Barroso, Diana/AAH-6830-2019; de Diego-Balaguer, Ruth/V-2131-2017; Rodriguez-Fornells, Antoni/L-5878-2014; Benitez, Carmen Pedraza/K-2328-2017; Fuentemilla, Lluís/E-3926-2012	López-Barroso, Diana/0000-0002-8938-1959; de Diego-Balaguer, Ruth/0000-0002-2357-5195; Rodriguez-Fornells, Antoni/0000-0002-3249-6931; Benitez, Carmen Pedraza/0000-0002-0011-2817; Fuentemilla, Lluís/0000-0002-5482-7615; Oyarzun, Javiera/0000-0002-6486-0689	University of Barcelona; Generalitat of Catalunya; MICINN [PSI2008-03901, PSI2008-3885]; Catalan Government (Generalitat de Catalunya) [2009 SGR 93]; ICREA Funding Source: Custom	University of Barcelona; Generalitat of Catalunya(Generalitat de Catalunya); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Catalan Government (Generalitat de Catalunya)(Generalitat de Catalunya); ICREA(ICREA)	Pre-doctoral research grant to Dr. Oyarzun from the University of Barcelona (http://www.ub.edu/dyn/cms/continguts_es/estudis/suport_estudi/beques_ajuts/fitxes/adr.html), pre-doctoral grant to Dr. Lopez-Barroso from the Generalitat of Catalunya (http://www10.gencat.net/agaur_web/AppJava/a_beca.jsp?categoria=predoctorals&id_beca=17881), Ramon y Cajal position awarded to Dr. Fuentemilla, Spanish grants MICINN (PSI2008-03901 - Dr. Rodriguez-Fornells and PSI2008-3885 Dr. de Diego-Balaguer) and the Catalan Government (Generalitat de Catalunya, 2009 SGR 93) http://www.micinn.es/portal/site/MICINN/menuitem.00d7c011ca2a3753222b7d1001432ea0/?vgnextoid=33881f4368aef110VgnVCM1000001034e20aRCRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav Irit, 2007, Neural Plasticity, V2007, DOI 10.1155/2007/30873; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; BOUTON ME, 1983, J EXP PSYCHOL ANIM B, V9, P248, DOI 10.1037/0097-7403.9.3.248; Brunet A, 2008, J PSYCHIATR RES, V42, P503, DOI 10.1016/j.jpsychires.2007.05.006; Chan Wan Yee Macy, 2010, Learn Mem, V17, P512, DOI 10.1101/lm.1912510; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Debiec J, 2011, DEPRESS ANXIETY, V28, P186, DOI 10.1002/da.20803; Dirikx T, 2004, LEARN MEMORY, V11, P549, DOI 10.1101/lm.78004; Dirikx T, 2007, J BEHAV THER EXP PSY, V38, P237, DOI 10.1016/j.jbtep.2006.04.001; Dirikx T, 2009, ACTA PSYCHOL, V130, P175, DOI 10.1016/j.actpsy.2008.12.002; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; Foricato C, 2009, NEUROBIOL LEARN MEM, V91, P50, DOI 10.1016/j.nlm.2008.09.011; Galvez R, 1996, NEUROBIOL LEARN MEM, V66, P253, DOI 10.1006/nlme.1996.0067; HOLLAND PC, 1990, COGNITION, V37, P105, DOI 10.1016/0010-0277(90)90020-K; HYGGE S, 1978, J PERS SOC PSYCHOL, V36, P271, DOI 10.1037/0022-3514.36.3.271; Indovina I, 2011, NEURON, V69, P563, DOI 10.1016/j.neuron.2010.12.034; Kindt M, 2011, BIOL PSYCHOL    1008; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Krystal JH, 2009, BRAIN RES, V1293, P13, DOI 10.1016/j.brainres.2009.03.044; LABAR KS, 1995, J NEUROSCI, V15, P6846; Lang PJ, 2000, J AFFECT DISORDERS, V61, P137, DOI 10.1016/S0165-0327(00)00343-8; LEATON RN, 1990, J EXP PSYCHOL ANIM B, V16, P279, DOI 10.1037/0097-7403.16.3.279; Lee JLC, 2009, TRENDS NEUROSCI, V32, P413, DOI 10.1016/j.tins.2009.05.002; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McGaugh JL, 2009, PSYCHOPHARMACOLOGY, V202, P3, DOI 10.1007/s00213-008-1285-6; Milad MR, 2012, ANNU REV PSYCHOL, V63, P129, DOI 10.1146/annurev.psych.121208.131631; Milad MR, 2005, PSYCHOPHYSIOLOGY, V42, P456, DOI 10.1111/j.1469-8986.2005.00302.x; Mineka S, 2002, BIOL PSYCHIAT, V52, P927, DOI 10.1016/S0006-3223(02)01669-4; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Muravieva EV, 2010, LEARN MEMORY, V17, P306, DOI 10.1101/lm.1794710; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2010, ANN NY ACAD SCI, V1191, P27, DOI 10.1111/j.1749-6632.2010.05443.x; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; O'Donnell T, 2004, NEUROPSYCHOBIOLOGY, V50, P273, DOI 10.1159/000080952; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Olsson A, 2007, NAT NEUROSCI, V10, P1095, DOI 10.1038/nn1968; Pedreira ME, 2004, LEARN MEMORY, V11, P579, DOI 10.1101/lm.76904; Pedreira ME, 2003, NEURON, V38, P863, DOI 10.1016/S0896-6273(03)00352-0; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; PITMAN RK, 1989, BIOL PSYCHIAT, V26, P221, DOI 10.1016/0006-3223(89)90033-4; Pitman RK, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00011; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rao-Ruiz P, 2011, NAT NEUROSCI, V14, P1302, DOI 10.1038/nn.2907; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rescorla RA, 2004, LEARN MEMORY, V11, P501, DOI 10.1101/lm.77504; RESCORLA RA, 1975, J EXP PSYCHOL-ANIM B, V104, P88, DOI 10.1037/0097-7403.1.1.88; Rothbaum BO, 2005, J TRAUMA STRESS, V18, P607, DOI 10.1002/jts.20069; Rothbaum BO, 1999, J TRAUMA STRESS, V12, P263, DOI 10.1023/A:1024772308758; Schiller D, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00024; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Schmajuk NA, 2007, BEHAV BRAIN RES, V177, P242, DOI 10.1016/j.bbr.2006.11.026; Sevenster D, 2012, NEUROBIOL LEARN MEM, V97, P338, DOI 10.1016/j.nlm.2012.01.009; Soeter M, 2011, LEARN MEMORY, V18, P357, DOI 10.1101/lm.2148511; Soeter M, 2010, NEUROBIOL LEARN MEM, V94, P30, DOI 10.1016/j.nlm.2010.03.004; Strawn JR, 2008, DEPRESS ANXIETY, V25, P260, DOI 10.1002/da.20292; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Tollenaar MS, 2009, PSYCHOPHARMACOLOGY, V203, P793, DOI 10.1007/s00213-008-1427-x; Wang SH, 2009, NAT NEUROSCI, V12, P905, DOI 10.1038/nn.2350; Weike AI, 2007, PSYCHOPHYSIOLOGY, V44, P170, DOI 10.1111/j.1469-8986.2006.00469.x; Westbrook FR, 2002, J EXP PSYCHOL-ANIM B, V28, P97, DOI 10.1037//0097-7403.28.1.97; Yang CH, 2011, NEUROPSYCHOPHARMACOL, V36, P1992, DOI 10.1038/npp.2011.87	64	88	92	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e38849	10.1371/journal.pone.0038849	http://dx.doi.org/10.1371/journal.pone.0038849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	967FO	22768048	Green Published, Green Submitted, gold			2022-12-27	WOS:000305892100019
J	Pando, MA; Balan, IC; Marone, R; Dolezal, C; Leu, CS; Squiquera, L; Barreda, V; Fermepin, MR; Vaulet, LG; Rey, J; Picconi, M; Carballo-Dieguez, A; Avila, MM				Pando, Maria A.; Balan, Ivan C.; Marone, Ruben; Dolezal, Curtis; Leu, Cheng-Shiun; Squiquera, Luis; Barreda, Victoria; Rodriguez Fermepin, Marcelo; Vaulet, Lucia Gallo; Rey, Jorge; Picconi, Maria; Carballo-Dieguez, Alex; Avila, Maria M.			HIV and Other Sexually Transmitted Infections among Men Who Have Sex with Men Recruited by RDS in Buenos Aires, Argentina: High HIV and HPV Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS INFECTION; ANAL HUMAN-PAPILLOMAVIRUS; RISK-FACTORS; HOMOSEXUAL-MEN; HEPATITIS-C; PREVALENCE; SEROPREVALENCE; EPIDEMIOLOGY; COHORT	Background: The aim of this study was to estimate the prevalence of HIV and other STIs, among MSM from Buenos Aires (2007-2009). Methods: Responding Driven Sampling was used for recruitment of MSM. Participants completed a structured web-based survey and provided biological samples. Results: A total of 496 MSM were studied for HIV, HBV, HCV, and T pallidum infections. Chlamydia and HPV diagnoses were only performed in 98 and 109 participants, respectively. Prevalence of HIV was 17.3%, HBV 22.9%, HCV 7.5%, T pallidum 20.5%, HPV 83.5%, and C trachomatis 1.7%. In the year prior to the evaluation, 71% of the participants had had sex with men and/or trans and women (MMW) while 29% had not had sex with women (MM). Comparing MM to MMW, prevalence of HIV (30.7% vs. 11.9%, p<0.001), HBV (36.4% vs. 17.8%, p<0.001), T pallidum (32.1% vs. 15.7%, p<0.001), and HPV (88.3% vs. 70.4%, p = 0.039) were significantly higher among MM, whereas no significant differences were found for HCV and C trachomatis. The MM group had also significantly higher HIV incidence (5.60 vs. 4.28 per 100 persons-year, p = 0.032). HPV genotypes 16, 6, and 11 were the most frequently found; 40.7% of the MSM had more than one genotype and one high risk genotype was detected in 43.6% of participants. Conclusions: Both MM and MMW are at high risk of infection for HIV and other STIs. Rates of HIV, HBV, T pallidum and HPV infections are higher in the MM group.	[Pando, Maria A.; Avila, Maria M.] Univ Buenos Aires, Fac Med, Inst Invest Biomed Retrovirus & SIDA INBIRS, Buenos Aires, Argentina; [Pando, Maria A.; Avila, Maria M.] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, Argentina; [Balan, Ivan C.; Dolezal, Curtis; Leu, Cheng-Shiun; Carballo-Dieguez, Alex] Columbia Univ, New York State Psychiat Inst, HIV Ctr Clin & Behav Studies, New York, NY USA; [Marone, Ruben; Squiquera, Luis; Barreda, Victoria] Nexo Asociac Civil, Buenos Aires, Argentina; [Rodriguez Fermepin, Marcelo; Vaulet, Lucia Gallo] Univ Buenos Aires, Fac Farm & Bioquim, Dept Bioquim Clin, Inmunol Clin, Buenos Aires, Argentina; [Rey, Jorge] Univ Buenos Aires, Hosp Clin Jose San Martin, Div Enfermedades Transmis Transfus, Buenos Aires, Argentina; [Picconi, Maria] Inst Nacl Enfermedades Infecciosas ANLIS, Lab Nacl Referencia HPV, Buenos Aires, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Columbia University; New York State Psychiatry Institute; University of Buenos Aires; University of Buenos Aires; Hospital de Clinicas Jose de San Martin	Pando, MA (corresponding author), Univ Buenos Aires, Fac Med, Inst Invest Biomed Retrovirus & SIDA INBIRS, Buenos Aires, Argentina.	mpando@fmed.uba.ar	RODRIGUEZ FERMEPIN, Marcelo/AAY-7762-2021	RODRIGUEZ FERMEPIN, Marcelo/0000-0003-2543-4262; Rey, Jorge/0000-0001-6148-9346	US National Institute of Mental Health (NIMH) [R01-MH073410]; NIMH [P30-MH43520]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073410, P30MH043520] Funding Source: NIH RePORTER	US National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported with funds from the US National Institute of Mental Health (NIMH) to the HIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia University (R01-MH073410; Principal Investigator: Alex Carballo-Dieguez, Ph.D.). Additional funds came from a grant from NIMH to the HIV Center for Clinical and Behavioral Studies at New York State Psychiatric Institute and Columbia University (P30-MH43520; Principal Investigator: Anke A. Ehrhardt, Ph.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIMH or the National Institutes of Health.	Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P681; [Anonymous], 2011, VAC CONTR VIR PAP HU; Bautista CT, 2004, SEX TRANSM INFECT, V80, P498, DOI 10.1136/sti.2004.013094; Boletin sobre el VIH-SIDA en la Argentina, 2011, B VIH SIDA ARGENTINA, V28; Carballo-Dieguez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027447; Centers for Disease Control and Prevention, 2009, GON CHLAM PROP MSM T; Centers for Disease Control and Prevention (CDCP), 2010, SEX TRANSM DIS SURV; Chin-Hong PV, 2004, J INFECT DIS, V190, P2070, DOI 10.1086/425906; Chin-Hong PV, 2002, CLIN INFECT DIS, V35, P1127, DOI 10.1086/344057; Ciesielski Carol A., 2003, Curr Infect Dis Rep, V5, P145, DOI 10.1007/s11908-003-0051-5; Comite Nacional de Infectologia, 2000, ARCH ARGENT PEDIATR, V98, P138; Dang T, 2009, CLIN INFECT DIS, V49, P1532, DOI 10.1086/644740; Dietz CA, 2011, J AM OSTEOPATH ASSOC, V111, pS19; Farias MSD, 2011, J CLIN VIROL, V51, P96, DOI 10.1016/j.jcv.2011.03.008; Fenton KA, 2005, INFECT DIS CLIN N AM, V19, P311, DOI 10.1016/j.idc.2005.04.004; Fermepin MR, 2007, SEX TRANSM DIS, V34, P1041, DOI 10.1097/OLQ.0b013e31815c1bf1; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015256; Goel S, 2010, P NATL ACAD SCI USA, V107, P6743, DOI 10.1073/pnas.1000261107; Goldstone S, 2011, J INFECT DIS, V203, P66, DOI 10.1093/infdis/jiq016; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Jin F, 2007, SEX TRANSM DIS, V34, P488, DOI 10.1097/01.olq.0000245960.52668.e5; Kumta S, 2010, JAIDS-J ACQ IMM DEF, V53, P227, DOI 10.1097/QAI.0b013e3181c354d8; Marcus U, 2011, SEX HEALTH, V8, P184, DOI 10.1071/SH10053; McWalter TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007368; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nicol AF, 2005, DIAGN MOL PATHOL, V14, P39, DOI 10.1097/01.pas.0000143309.81183.6c; Nyitray AG, 2011, SEX TRANSM DIS, V38, P932, DOI 10.1097/OLQ.0b013e31822154f9; O'Leary A, 2006, SEX TRANSM DIS, V33, P594, DOI 10.1097/01.olq.0000225280.44538.f6; Palefsky JM, 1998, J INFECT DIS, V177, P361, DOI 10.1086/514194; Palefsky JM, 2010, J ADOLESCENT HEALTH, V46, pS12, DOI 10.1016/j.jadohealth.2010.01.010; Palefsky JM, 2009, OBSTET GYN CLIN N AM, V36, P187, DOI 10.1016/j.ogc.2009.02.003; Pando MA, 2011, AIDS RES HUM RETROV, V27, P17, DOI 10.1089/aid.2010.0013; Pando MA, 2006, SEX TRANSM DIS, V33, P307, DOI 10.1097/01.olq.0000194578.06795.2d; Pando MD, 2003, INT J EPIDEMIOL, V32, P735, DOI 10.1093/ije/dyg104; Philip SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012662; SAYADA C, 1991, FEMS MICROBIOL LETT, V83, P73; Segura M, 2007, AIDS RES HUM RETROV, V23, P1322, DOI 10.1089/aid.2007.0063; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Stolte IG, 2004, AIDS, V18, P303, DOI 10.1097/00002030-200401230-00021; UNAIDS, 2008, REP GLOB AIDS EP; van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5; van den Brule AJC, 2002, J CLIN MICROBIOL, V40, P779, DOI 10.1128/JCM.40.3.779-787.2002; van der Bij AK, 2005, SEX TRANSM INFECT, V81, P34, DOI 10.1136/sti.2003.007997; van der Helm JJ, 2011, AIDS, V25, P1083, DOI 10.1097/QAD.0b013e3283471cce; van Griensven F, 2009, CURR OPIN HIV AIDS, V4, P300, DOI 10.1097/COH.0b013e32832c3bb3; Vignoles M, 2006, JAIDS-J ACQ IMM DEF, V42, P494, DOI 10.1097/01.qai.0000221678.06822.8b	47	47	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39834	10.1371/journal.pone.0039834	http://dx.doi.org/10.1371/journal.pone.0039834			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768137	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100107
J	Davies, ZG; Fuller, RA; Dallimer, M; Loram, A; Gaston, KJ				Davies, Zoe G.; Fuller, Richard A.; Dallimer, Martin; Loram, Alison; Gaston, Kevin J.			Household Factors Influencing Participation in Bird Feeding Activity: A National Scale Analysis	PLOS ONE			English	Article							FOOD SUPPLEMENTATION; BIODIVERSITY CONSERVATION; GREEN SPACE; URBAN; GARDENS; HEALTH; ENVIRONMENTS; ASSOCIATIONS; PATTERNS; BENEFITS	Ameliorating pressures on the ecological condition of the wider landscape outside of protected areas is a key focus of conservation initiatives in the developed world. In highly urbanized nations, domestic gardens can play a significant role in maintaining biodiversity and facilitating human-wildlife interactions, which benefit personal and societal health and wellbeing. The extent to which sociodemographic and socioeconomic factors are associated with engagement in wildlife gardening activities remain largely unresolved. Using two household-level survey datasets gathered from across Britain, we determine whether and how the socioeconomic background of a household influences participation in food provision for wild birds, the most popular and widespread form of human-wildlife interaction. A majority of households feed birds (64% across rural and urban areas in England, and 53% within five British study cities). House type, household size and the age of the head of the household were all important predictors of bird feeding, whereas gross annual household income, the occupation of the head of the household, and whether the house is owned or rented were not. In both surveys, the prevalence of bird feeding rose as house type became more detached and as the age of the head of the household increased. A clear, consistent pattern between households of varying size was less evident. When regularity of food provision was examined in the study cities, just 29% of households provided food at least once a week. The proportion of households regularly feeding birds was positively related to the age of the head of the household, but declined with gross annual income. As concerns grow about the lack of engagement between people and the natural environment, such findings are important if conservation organizations are successfully to promote public participation in wildlife gardening specifically and environmentally beneficial behaviour in society more generally.	[Davies, Zoe G.] Univ Kent, DICE, Canterbury, Kent, England; [Fuller, Richard A.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Dallimer, Martin] Univ Copenhagen, Div Econ Policy & Management Planning, Copenhagen, Denmark; [Dallimer, Martin] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Loram, Alison] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Gaston, Kevin J.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England	University of Kent; University of Queensland; University of Copenhagen; University of Copenhagen; University of Sheffield; University of Exeter	Davies, ZG (corresponding author), Univ Kent, DICE, Canterbury, Kent, England.	z.g.davies@kent.ac.uk	Dallimer, Martin/I-1547-2019; Fuller, Richard/B-7971-2008	Fuller, Richard/0000-0001-9468-9678; Gaston, Kevin J./0000-0002-7235-7928; Dallimer, Martin/0000-0001-8120-3309	Engineering and Physical Sciences Research Council through the CityForm research consortium; Countryside Council for Wales; Department for Environment, Food and Rural Affairs; Environment and Heritage Service; English Nature; Scotland and Northern Ireland Forum for Environmental Research	Engineering and Physical Sciences Research Council through the CityForm research consortium(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Countryside Council for Wales; Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Environment and Heritage Service; English Nature; Scotland and Northern Ireland Forum for Environmental Research	This work was funded by the Engineering and Physical Sciences Research Council (www.epsrc.ac.uk) (through the CityForm research consortium), and the Countryside Council for Wales, the Department for Environment, Food and Rural Affairs, the Environment and Heritage Service, English Nature, and Scotland and Northern Ireland Forum for Environmental Research (through the BUGS II project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Barton J, 2010, ENVIRON SCI TECHNOL, V44, P3947, DOI 10.1021/es903183r; Bland RL, 2004, BIRD STUDY, V51, P97, DOI 10.1080/00063650409461340; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; Bowler DE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/147-2458-10-456; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; BRITTINGHAM MC, 1992, J FIELD ORNITHOL, V63, P190; Brown C., 2005, BUILD ENVIRON, V31, P326, DOI [10.2148/benv.2005.31.4.326, DOI 10.2148/BENV.2005.31.4.326]; Bunker D.E., 2009, BIODIVERSITY ECOSYST; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burton R, 2004, RSPB POCKET BIRDFEED; CABE Space, 2004, VAL PUBL SPAC HIGH Q; Cardiff Biodiversity Partnership, 2008, CARD LOC BIOD ACT PL; Chamberlain DE, 2005, IBIS, V147, P563, DOI 10.1111/j.1474-919x.2005.00430.x; COWIE RJ, 1988, BIRD STUDY, V35, P163, DOI 10.1080/00063658809476985; Crawley M.J., 2007, R BOOK; Dallimer M, 2012, BIOSCIENCE, V62, P47, DOI 10.1525/bio.2012.62.1.9; Daniels GD, 2006, BIOL CONSERV, V133, P326, DOI 10.1016/j.biocon.2006.06.011; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; DCLG, 2010, ENGL HOUS SURV DAT S; de Vries S, 2003, ENVIRON PLANN A, V35, P1717, DOI 10.1068/a35111; Defra, 2002, WORK GRAIN NAT BIOD; Defra, 2011, BIOD STRAT ENGL MEAS; Defra, 2003, MEAS PROGR BAS ASS; Edinburgh Biodiversity Partnership, 2010, ED BIOD ACT PLAN 201; European Commission, 2010, EUR 2010 SURV ATT EU; Fabos JG, 2006, LANDSCAPE URBAN PLAN, V76, P1, DOI 10.1016/j.landurbplan.2004.09.028; Freyfogle ET, 2003, CONSERV BIOL, V17, P354, DOI 10.1046/j.1523-1739.2003.01724.x; Fuller RA, 2008, DIVERS DISTRIB, V14, P131, DOI 10.1111/j.1472-4642.2007.00439.x; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Gaston KJ, 2007, BIODIVERS CONSERV, V16, P3227, DOI 10.1007/s10531-007-9174-6; Glasgow Biodiversity Action Plan Steering Group, 2008, GLASG CIT BIOD ACT P; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Good Robert, 2000, British Wildlife, V12, P77; GRUBB TC, 1990, ORNIS SCAND, V21, P277, DOI 10.2307/3676392; Harrison TJE, 2010, OECOLOGIA, V164, P311, DOI 10.1007/s00442-010-1645-x; HARTIG T, 1991, ENVIRON BEHAV, V23, P3, DOI 10.1177/0013916591231001; Hedblom M, 2010, J BIOGEOGR, V37, P1302, DOI 10.1111/j.1365-2699.2010.02299.x; Hope D, 2003, P NATL ACAD SCI USA, V100, P8788, DOI 10.1073/pnas.1537557100; Irvine KN, 2010, FUTURE CITY, V2, P215, DOI 10.1007/978-1-4020-8647-2_10; James P, 2009, URBAN FOR URBAN GREE, V8, P65, DOI 10.1016/j.ufug.2009.02.001; Jones DN, 2008, J AVIAN BIOL, V39, P265, DOI 10.1111/j.0908-8857.2008.04271.x; Kaplan R, 1989, EXPERIENCE NATURE PS; Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170; Kinzig AP, 2005, ECOL SOC, V10; Kuo FE, 2001, ENVIRON BEHAV, V33, P343, DOI 10.1177/00139160121973025; Lepczyk CA, 2004, ENVIRON MANAGE, V33, P110, DOI 10.1007/s00267-003-0036-z; Lin E, 2005, PRODUCTION PROCESSIN; Loram A, 2007, LANDSCAPE ECOL, V22, P601, DOI 10.1007/s10980-006-9051-9; Loram A, 2011, ENVIRON MANAGE, V48, P808, DOI 10.1007/s00267-011-9723-3; Louv R., 2005, LAST CHILD WOODS WHY; Luck GW, 2009, ECOSYSTEMS, V12, P604, DOI 10.1007/s10021-009-9244-6; Maas J, 2006, J EPIDEMIOL COMMUN H, V60, P587, DOI 10.1136/jech.2005.043125; Maller C, 2006, HEALTH PROMOT INT, V21, P45, DOI 10.1093/heapro/dai032; Mason J, 2007, LANDSCAPE URBAN PLAN, V80, P153, DOI 10.1016/j.landurbplan.2006.07.002; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Moss S, 2003, GARDEN BIRD HDB ATTR; National Centre for Social Research and Department for Transport Local Government and the Regions, 2004, SN5021 DEP TRANSP LO; Natural England, 2010, MON ENG NAT ENV NAT; Newton I., 1998, POPULATION LIMITATIO; Office for National Statistics, 2006, TIM US SURV 2005 WE; Parsons H, 2006, AUSTRAL ECOL, V31, P217, DOI 10.1111/j.1442-9993.2006.01584.x; Pretty J. N., 2007, EARTH ONLY ENDURES R; RICHNER H, 1992, ECOLOGY, V73, P330, DOI 10.2307/1938744; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Robinson RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012215; Ryall Colin, 2003, Environmentalist, V23, P81, DOI 10.1023/A:1022995610486; Savard JPL, 2000, LANDSCAPE URBAN PLAN, V48, P131, DOI 10.1016/S0169-2046(00)00037-2; Schoech SJ, 2008, BIOL CONSERV, V141, P162, DOI 10.1016/j.biocon.2007.09.009; Schwartz MW, 2006, CONSERV BIOL, V20, P1550, DOI 10.1111/j.1523-1739.2006.00421.x; Siriwardena GM, 2007, J APPL ECOL, V44, P920, DOI 10.1111/j.1365-2664.2007.01339.x; Soper T, 2006, BIRD TABLE BOOK COMP; Stigsdotter UK, 2010, SCAND J PUBLIC HEALT, V38, P411, DOI 10.1177/1403494810367468; Stilgoe JR, 2001, AM J PREV MED, V20, P243, DOI 10.1016/S0749-3797(00)00319-6; Strohbach MW, 2009, ECOL SOC, V14; Sullivan WC, 2004, ENVIRON BEHAV, V36, P678, DOI 10.1177/0193841x04264945; Sutherland WJ, 2008, J APPL ECOL, V45, P821, DOI 10.1111/j.1365-2664.2008.01474.x; Takano T, 2002, J EPIDEMIOL COMMUN H, V56, P913, DOI 10.1136/jech.56.12.913; The Horticultural Trades Association, 2012, IND FACTS FIG; Toms M. P., 2008, GARDEN BIRDS WILDLIF; Toms MP, 2003, BTO CJ GARDEN BIRDWA; Tratalos J, 2007, LANDSCAPE URBAN PLAN, V83, P308, DOI 10.1016/j.landurbplan.2007.05.003; Tyrvainen L, 2001, J ENVIRON MANAGE, V62, P75, DOI 10.1006/jema.2001.0421; UK National Ecosystem Assessment, 2011, UK NAT EC ASS TECHN; UN (United Nations), 2009, WORLD URB PROSP 2009; USFWS, 2006, 2006 NAT SURV FISH H; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Whittingham MJ, 2005, J APPL ECOL, V42, P270, DOI 10.1111/j.1365-2664.2005.01007.x; Wilson WH, 2001, WILSON BULL, V113, P65, DOI 10.1676/0043-5643(2001)113[0065:TEOSFO]2.0.CO;2; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	91	49	52	2	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39692	10.1371/journal.pone.0039692	http://dx.doi.org/10.1371/journal.pone.0039692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966GR	22761872	Green Published, Green Accepted, gold			2022-12-27	WOS:000305826400027
J	Turk, HF; Barhoumi, R; Chapkin, RS				Turk, Harmony F.; Barhoumi, Rola; Chapkin, Robert S.			Alteration of EGFR Spatiotemporal Dynamics Suppresses Signal Transduction	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; POLYUNSATURATED FATTY-ACIDS; RECTAL CELL-PROLIFERATION; DOCOSAHEXAENOIC ACID; LIPID RAFTS; PLASMA-MEMBRANE; FISH-OIL; H-RAS; CHOLESTEROL DEPLETION; CANCER-RISK	The epidermal growth factor receptor (EGFR), which regulates cell growth and survival, is integral to colon tumorigenesis. Lipid rafts play a role in regulating EGFR signaling, and docosahexaenoic acid (DHA) is known to perturb membrane domain organization through changes in lipid rafts. Therefore, we investigated the mechanistic link between EGFR function and DHA. Membrane incorporation of DHA into immortalized colonocytes altered the lateral organization of EGFR. DHA additionally increased EGFR phosphorylation but paradoxically suppressed downstream signaling. Assessment of the EGFR-Ras-ERK1/2 signaling cascade identified Ras GTP binding as the locus of the DHA-induced disruption of signal transduction. DHA also antagonized EGFR signaling capacity by increasing receptor internalization and degradation. DHA suppressed cell proliferation in an EGFR-dependent manner, but cell proliferation could be partially rescued by expression of constitutively active Ras. Feeding chronically-inflamed, carcinogen-injected C57BL/6 mice a fish oil containing diet enriched in DHA recapitulated the effects on the EGFR signaling axis observed in cell culture and additionally suppressed tumor formation. We conclude that DHA-induced alteration in both the lateral and subcellular localization of EGFR culminates in the suppression of EGFR downstream signal transduction, which has implications for the molecular basis of colon cancer prevention by DHA.	[Turk, Harmony F.; Chapkin, Robert S.] Texas A&M Univ, Program Integrat Nutr & Complex Dis, College Stn, TX 77843 USA; [Barhoumi, Rola] Texas A&M Univ, Image Anal Lab, College Stn, TX USA; [Chapkin, Robert S.] Texas A&M Univ, Ctr Environm & Rural Hlth, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Turk, HF (corresponding author), Texas A&M Univ, Program Integrat Nutr & Complex Dis, College Stn, TX 77843 USA.	r-chapkin@tamu.edu		Chapkin, Robert/0000-0002-6515-3898	National Institutes of Health [CA59034, CA168312]; NATIONAL CANCER INSTITUTE [R01CA059034, R01CA168312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants CA59034 and CA168312. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTI M, 1992, GASTROENTEROLOGY, V103, P883, DOI 10.1016/0016-5085(92)90021-P; ANTI M, 1994, GASTROENTEROLOGY, V107, P1709, DOI 10.1016/0016-5085(94)90811-7; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Augsten M, 2006, EMBO REP, V7, P46, DOI 10.1038/sj.embor.7400560; BARTRAM HP, 1993, GASTROENTEROLOGY, V105, P1317, DOI 10.1016/0016-5085(93)90135-Y; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Byers Tim, 1996, Cancer, V78, P1612, DOI 10.1002/(SICI)1097-0142(19961001)78:7+<1612::AID-CNCR17>3.3.CO;2-G; Caygill CPJ, 1996, BRIT J CANCER, V74, P159, DOI 10.1038/bjc.1996.332; Chang WCL, 1998, J NUTR, V128, P491, DOI 10.1093/jn/128.3.491; Chapkin RS, 2008, BRIT J NUTR, V100, P1152, DOI 10.1017/S0007114508992576; Chen X, 2002, J BIOL CHEM, V277, P49631, DOI 10.1074/jbc.M208327200; Cheng JL, 2003, CANCER LETT, V193, P17, DOI 10.1016/S0304383502007176; Cohen G, 2006, CANCER RES, V66, P5656, DOI 10.1158/0008-5472.CAN-05-0308; Collett ED, 2001, AM J PHYSIOL-CELL PH, V280, pC1066, DOI 10.1152/ajpcell.2001.280.5.C1066; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108; Davidson LA, 1999, CARCINOGENESIS, V20, P785, DOI 10.1093/carcin/20.5.785; Davidson LA, 2004, CANCER RES, V64, P6797, DOI 10.1158/0008-5472.CAN-04-1068; Di Fiore F, 2010, BRIT J CANCER, V103, P1765, DOI 10.1038/sj.bjc.6606008; Diaz O, 2002, J BIOL CHEM, V277, P39368, DOI 10.1074/jbc.M202376200; Eden ER, 2011, TRAFFIC; Eisenberg S, 2008, CELL SIGNAL, V20, P31, DOI 10.1016/j.cellsig.2007.07.012; Fan YY, 2004, J IMMUNOL, V173, P6151, DOI 10.4049/jimmunol.173.10.6151; Fan YY, 2003, J NUTR, V133, P1913, DOI 10.1093/jn/133.6.1913; Galizia G, 2006, ANN SURG ONCOL, V13, P823, DOI 10.1245/ASO.2006.05.052; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Geelen A, 2007, AM J EPIDEMIOL, V166, P1116, DOI 10.1093/aje/kwm197; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Grant S, 2002, FRONT BIOSCI-LANDMRK, V7, pD376, DOI 10.2741/grant; Hall MN, 2008, CANCER EPIDEM BIOMAR, V17, P1136, DOI 10.1158/1055-9965.EPI-07-2803; Hall MN, 2007, CANCER EPIDEM BIOMAR, V16, P314, DOI 10.1158/1055-9965.EPI-06-0346; Hofman EG, 2008, J CELL SCI, V121, P2519, DOI 10.1242/jcs.028753; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kim S, 2010, AM J EPIDEMIOL, V171, P969, DOI 10.1093/aje/kwq032; Kim W, 2008, J IMMUNOL, V181, P6236, DOI 10.4049/jimmunol.181.9.6236; KORETZ K, 1990, VIRCHOWS ARCH A, V416, P343, DOI 10.1007/BF01605295; Liao HJ, 2007, MOL BIOL CELL, V18, P1064, DOI 10.1091/mbc.E06-09-0802; Lievre A, 2010, ONCOGENE, V29, P3033, DOI 10.1038/onc.2010.89; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu GM, 2001, P NATL ACAD SCI USA, V98, P7510, DOI 10.1073/pnas.131195198; Ma DWL, 2004, FASEB J, V18, P1040, DOI 10.1096/fj.03-1430fje; Matallanas D, 2003, J BIOL CHEM, V278, P4572, DOI 10.1074/jbc.M209807200; Matveev SV, 2002, AM J PHYSIOL-CELL PH, V282, pC935, DOI 10.1152/ajpcell.00349.2001; MAYER A, 1993, CANCER, V71, P2454, DOI 10.1002/1097-0142(19930415)71:8<2454::AID-CNCR2820710805>3.0.CO;2-2; McKay JA, 2002, EUR J CANCER, V38, P2258, DOI 10.1016/S0959-8049(02)00234-4; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 2005, J BIOL CHEM, V280, P26796, DOI 10.1074/jbc.M503805200; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P10315, DOI 10.1021/bi025943i; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; Plaza-Menacho I, 2007, J BIOL CHEM, V282, P6415, DOI 10.1074/jbc.M608952200; Plesec TP, 2009, ADV ANAT PATHOL, V16, P196, DOI 10.1097/PAP.0b013e3181a9d4ed; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Pot GK, 2008, INT J CANCER, V123, P1974, DOI 10.1002/ijc.23729; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Puri C, 2005, MOL BIOL CELL, V16, P2704, DOI 10.1091/mbc.e04-07-0596; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; Radinsky R, 1995, CANCER METAST REV, V14, P323, DOI 10.1007/BF00690601; Rao CV, 2001, CANCER RES, V61, P1927; Ringerike T, 2002, J CELL SCI, V115, P1331; Roberts RB, 2002, P NATL ACAD SCI USA, V99, P1521, DOI 10.1073/pnas.032678499; Roepstorff K, 2002, J BIOL CHEM, V277, P18954, DOI 10.1074/jbc.M201422200; Rogers KR, 2010, CARCINOGENESIS, V31, P1523, DOI 10.1093/carcin/bgq111; Rosetti C, 2011, J PHYS CHEM B, V115, P1002, DOI 10.1021/jp1082888; Rotblat B, 2004, MOL CELL BIOL, V24, P6799, DOI 10.1128/MCB.24.15.6799-6810.2004; Schley PD, 2007, J NUTR, V137, P548, DOI 10.1093/jn/137.3.548; Sehgal PB, 2002, J BIOL CHEM, V277, P12067, DOI 10.1074/jbc.M200018200; Seo J, 2006, FASEB J, V20, P770, DOI 10.1096/fj.05-4683fje; Shaikh SR, 2009, J NUTR, V139, P1632, DOI 10.3945/jn.109.108720; Shia J, 2005, MODERN PATHOL, V18, P1350, DOI 10.1038/modpathol.3800417; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Soni SP, 2008, BIOPHYS J, V95, P203, DOI 10.1529/biophysj.107.123612; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Stillwell W, 2003, CHEM PHYS LIPIDS, V126, P1, DOI 10.1016/S0009-3084(03)00101-4; Tavani A, 2003, INT J CANCER, V105, P113, DOI 10.1002/ijc.11018; Turk HF, 2011, INT J CANCER, V128, P63, DOI 10.1002/ijc.25323; Umebayashi K, 2008, MOL BIOL CELL, V19, P3454, DOI 10.1091/mbc.E07-10-0988; Wassall SR, 2004, CHEM PHYS LIPIDS, V132, P79, DOI 10.1016/j.chemphyslip.2004.09.007; Wassall SR, 2008, CHEM PHYS LIPIDS, V153, P57, DOI 10.1016/j.chemphyslip.2008.02.010; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Westover EJ, 2003, J BIOL CHEM, V278, P51125, DOI 10.1074/jbc.M304332200; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Yamazaki T, 2002, J CELL SCI, V115, P1791; YASUI W, 1988, CANCER RES, V48, P137; Yeh HH, 2009, DNA CELL BIOL, V28, P131, DOI 10.1089/dna.2008.0762	95	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39682	10.1371/journal.pone.0039682	http://dx.doi.org/10.1371/journal.pone.0039682			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761867	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800061
J	Gan, L; Ni, PY; Ge, Y; Xiao, YF; Sun, CY; Deng, L; Zhang, W; Wu, SS; Liu, Y; Jiang, W; Xin, HB				Gan, Lu; Ni, Pei-Yan; Ge, Yan; Xiao, Yun-Fei; Sun, Chang-Yan; Deng, Lin; Zhang, Wei; Wu, Si-Si; Liu, Ying; Jiang, Wei; Xin, Hong-Bo			Histone Deacetylases Regulate Gonadotropin-Releasing Hormone I Gene Expression via Modulating Otx2-Driven Transcriptional Activity	PLOS ONE			English	Article							NEURON-SPECIFIC EXPRESSION; HYPOGONADOTROPIC HYPOGONADISM; OTX2 HOMEOPROTEIN; PROMOTER ELEMENT; INHIBITORS; ACETYLATION; CELLS; VIVO; IDENTIFICATION; ACTIVATION	Background: Precise coordination of the hypothalamic-pituitary-gonadal axis orchestrates the normal reproductive function. As a central regulator, the appropriate synthesis and secretion of gonadotropin-releasing hormone I (GnRH-I) from the hypothalamus is essential for the coordination. Recently, emerging evidence indicates that histone deacetylases (HDACs) play an important role in maintaining normal reproductive function. In this study, we identify the potential effects of HDACs on Gnrh1 gene transcription. Methodology/Principal Findings: Inhibition of HDACs activities by trichostatin A (TSA) and valproic acid (VPA) promptly and dramatically repressed transcription of Gnrh1 gene in the mouse immortalized mature GnRH neuronal cells GT1-7. The suppression was connected with a specific region of Gnrh1 gene promoter, which contains two consensus Otx2 binding sites. Otx2 has been known to activate the basal and also enhancer-driven transcription of Gnrh1 gene. The transcriptional activity of Otx2 is negatively modulated by Grg4, a member of the Groucho-related-gene (Grg) family. In the present study, the expression of Otx2 was downregulated by TSA and VPA in GT1-7 cells, accompanied with the opposite changes of Grg4 expression. Chromatin immunoprecipitation and electrophoretic mobility shift assays demonstrated that the DNA-binding activity of Otx2 to Gnrh1 gene was suppressed by TSA and VPA. Overexpression of Otx2 partly abolished the TSA- and VPA-induced downregulation of Gnrh1 gene expression. Conclusions/Significance: Our data indicate that HDAC inhibitors downregulate Gnrh1 gene expression via repressing Otx2-driven transcriptional activity. This study should provide an insight for our understanding on the effects of HDACs in the reproductive system and suggests that HDACs could be potential novel targets for the therapy of GnRH-related diseases.	[Gan, Lu; Ni, Pei-Yan; Ge, Yan; Sun, Chang-Yan; Deng, Lin; Zhang, Wei; Wu, Si-Si; Liu, Ying; Jiang, Wei; Xin, Hong-Bo] Sichuan Univ, W China Hosp, Lab Cardiovasc Dis, Chengdu 610064, Peoples R China; [Gan, Lu; Ni, Pei-Yan; Ge, Yan; Sun, Chang-Yan; Deng, Lin; Zhang, Wei; Wu, Si-Si; Liu, Ying; Jiang, Wei; Xin, Hong-Bo] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Lab Cellular & Mol Biol, Chengdu 610064, Peoples R China; [Xiao, Yun-Fei; Xin, Hong-Bo] Nanchang Univ, Inst Translat Med, Nanchang, Peoples R China	Sichuan University; Sichuan University; Nanchang University	Gan, L (corresponding author), Sichuan Univ, W China Hosp, Lab Cardiovasc Dis, Chengdu 610064, Peoples R China.	xinhb2012@yahoo.com	Gan, Lu/GLU-5032-2022	Gan, Lu/0000-0001-8665-2760	National Natural Science Foundation of China [30770791, 81070095]; National Basic Research Program of China [2007CB512100]; Postgraduate Student Foundation for supervisor in the Ministry of Education of China [20113601110001]; China Postdoctoral Science Foundation [2011M 501416]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Postgraduate Student Foundation for supervisor in the Ministry of Education of China(Ministry of Education, China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (30770791 and 81070095 to HBX), the National Basic Research Program of China (2007CB512100 to HBX), the Postgraduate Student Foundation for supervisor in the Ministry of Education of China (20113601110001 to HBX) and China Postdoctoral Science Foundation (2011M 501416 to LG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley GE, 2010, BRAIN RES, V1364, P62, DOI 10.1016/j.brainres.2010.10.001; Bliss SP, 2010, FRONT NEUROENDOCRIN, V31, P322, DOI 10.1016/j.yfrne.2010.04.002; Bouligand J, 2010, FRONT HORM RES, V39, P111, DOI 10.1159/000312697; Chen B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-78; Danno H, 2008, P NATL ACAD SCI USA, V105, P5408, DOI 10.1073/pnas.0710954105; Daschner M, 2002, KIDNEY INT, V62, P1582, DOI 10.1046/j.1523-1755.2002.00616.x; Diaczok D, 2011, MOL ENDOCRINOL, V25, P833, DOI 10.1210/me.2010-0271; Duan H, 2005, MOL CELL BIOL, V25, P1608, DOI 10.1128/MCB.25.5.1608-1619.2005; Fenic I, 2004, J ANDROL, V25, P811; Fernald RD, 1999, FRONT NEUROENDOCRIN, V20, P224, DOI 10.1006/frne.1999.0181; Fossat N, 2005, DEV DYNAM, V233, P154, DOI 10.1002/dvdy.20287; Ge Y, 2010, BIOCHEM BIOPH RES CO, V399, P167, DOI 10.1016/j.bbrc.2010.07.040; Glaser KB, 2003, MOL CANCER THER, V2, P151; Heider U, 2006, EUR J HAEMATOL, V76, P42, DOI 10.1111/j.1600-0609.2005.00546.x; Jepsen K, 2002, J CELL SCI, V115, P689; Joseph J, 2004, ONCOGENE, V23, P6304, DOI 10.1038/sj.onc.1207852; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Kelley CG, 2000, MOL ENDOCRINOL, V14, P1246, DOI 10.1210/me.14.8.1246; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kim HH, 2007, SEMIN REPROD MED, V25, P326, DOI 10.1055/s-2007-984738; Kim HH, 2007, SEMIN REPROD MED, V25, P313, DOI 10.1055/s-2007-984737; Kim HH, 2007, MOL ENDOCRINOL, V21, P457, DOI 10.1210/me.2005-0216; Kim HH, 2002, J BIOL CHEM, V277, P5194, DOI 10.1074/jbc.M110535200; Kim MS, 2001, NAT MED, V7, P437, DOI 10.1038/86507; Korkmaz CG, 2004, J ENDOCRINOL, V182, P377, DOI 10.1677/joe.0.1820377; Larder R, 2009, J BIOL CHEM, V284, P16966, DOI 10.1074/jbc.M109.002485; Lee VHY, 2008, FEBS J, V275, P5458, DOI 10.1111/j.1742-4658.2008.06676.x; Lim S, 2007, MOL CELL BIOL, V27, P4105, DOI 10.1128/MCB.00248-07; Makki MS, 2008, NUCLEIC ACIDS RES, V36, P4067, DOI 10.1093/nar/gkn356; Mallamaci A, 1996, MECH DEVELOP, V58, P165, DOI 10.1016/S0925-4773(96)00571-0; Marshall JC, 2001, MOL CELL ENDOCRINOL, V183, P29, DOI 10.1016/S0303-7207(01)00611-6; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Matheu A, 2005, J BIOL CHEM, V280, P42433, DOI 10.1074/jbc.M508270200; Melamed P, 2008, TRENDS ENDOCRIN MET, V19, P25, DOI 10.1016/j.tem.2007.10.008; Mochizuki T, 2000, DEV BIOL, V224, P470, DOI 10.1006/dbio.2000.9778; Mul D, 2008, EUR J ENDOCRINOL, V159, pS3, DOI 10.1530/EJE-08-0814; Nakano T, 2000, BIOCHEM BIOPH RES CO, V267, P64, DOI 10.1006/bbrc.1999.1872; Nelson SB, 2000, MOL ENDOCRINOL, V14, P1509, DOI 10.1210/me.14.9.1509; Nusinzon Inna, 2005, Sci STKE, V2005, pre11, DOI 10.1126/stke.2962005re11; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Tarlatzis Basil C, 2004, Expert Opin Drug Saf, V3, P39, DOI 10.1517/14740338.3.1.39; Wetsel WC, 2002, PROG BRAIN RES, V141, P221	43	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39770	10.1371/journal.pone.0039770	http://dx.doi.org/10.1371/journal.pone.0039770			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761896	Green Submitted, Green Published, gold			2022-12-27	WOS:000305781700063
J	Koo, DH; Park, CY; Lee, ES; Ro, J; Oh, SW				Koo, Dong Hoe; Park, Cheol-Young; Lee, Eun Sook; Ro, Jungsil; Oh, Sang Woo			Progranulin as a Prognostic Biomarker for Breast Cancer Recurrence in Patients Who Had Hormone Receptor-Positive Tumors: A Cohort Study	PLOS ONE			English	Article							GRANULIN-EPITHELIN PRECURSOR; GROWTH-FACTOR; STIMULATES PROLIFERATION; INSULIN-RESISTANCE; THERAPY; SERUM	Background: Progranulin (PGRN) is considered to play an important role in breast cancer tumorigenesis and in inhibiting tamoxifen-induced apoptosis. We aimed to determine whether PGRN levels are associated with breast cancer recurrence after curative surgery. Methodology/Principal Findings: We evaluated the associations between preoperative serum PGRN levels and breast cancer recurrence in a cohort of 697 newly diagnosed breast cancer patients who underwent curative surgery between April 2001 and December 2004. The mean age +/- standard deviation (SD) was 46 +/- 9.8 years, and all patients with hormone receptor (HR)-positive tumors received adjuvant tamoxifen therapy. At a median follow-up of 62.2 months (range, 2.9-98.2), 89 patients (12.8%) had experienced a recurrence and 51 patients (7.3%) had died. In the HR-positive group, serum PGRN levels were associated with recurrence according to the log-rank test for trend (p for trend = 0.049). There was no association between PGRN levels and recurrence in the HR-negative group (p for trend = 0.658). Adjusted hazard ratios, including possible confounders, revealed a linear relationship between serum PGRN levels and recurrence in the HR-positive group (p for trend = 0.049), and this association was further strengthened after excluding patients who had no lymph node metastasis (p for trend = 0.038). Conclusions/Significance: Serum PGRN levels were clinically significant for predicting recurrence in patients with HR-positive breast cancer during adjuvant tamoxifen therapy.	[Koo, Dong Hoe; Park, Cheol-Young] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med, Seoul, South Korea; [Lee, Eun Sook; Ro, Jungsil] Natl Canc Ctr, Res Inst & Hosp, Ctr Breast Canc, Goyang Si, Gyeonggi Do, South Korea; [Oh, Sang Woo] Dongguk Univ, Coll Med, Ilsan Hosp, Ctr Obes Nutr & Metab,Dept Family Med, Goyang Si, Gyeonggi Do, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; National Cancer Center - Korea (NCC); Dongguk University; NHIS Ilsan Hospital	Koo, DH (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med, Seoul, South Korea.	cydoctor@chol.com; osw6021@yahoo.co.kr	Koo, Dong-Hoe/K-7561-2019; Park, Cheol-Young/C-6690-2018	Koo, Dong-Hoe/0000-0001-9913-8883; Oh, Sang Woo/0000-0002-5623-6720; Park, Cheol-Young/0000-0002-9415-9965	National Research Foundation of Korea; Korean Government [KRF-2008-314-E00201]	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government)	This study was supported by a grant from the National Research Foundation of Korea funded by the Korean Government (KRF-2008-314-E00201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V366, P2087; Abrhale T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-231; BHANDARI V, 1992, P NATL ACAD SCI USA, V89, P1715, DOI 10.1073/pnas.89.5.1715; Cameron DA, 2000, EUR J CANCER, V36, P845, DOI 10.1016/S0959-8049(00)00013-7; Clarke R, 2001, J STEROID BIOCHEM, V76, P71, DOI 10.1016/S0960-0760(00)00193-X; EPANECHN.VA, 1969, THEOR PROBAB APPL+, V14, P153, DOI 10.1137/1114019; Frampton G, 2012, GUT, V61, P268, DOI 10.1136/gutjnl-2011-300643; Han JJ, 2011, GYNECOL ONCOL, V120, P5, DOI 10.1016/j.ygyno.2010.09.006; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Ho JC, 2008, HEPATOLOGY, V47, P1524, DOI 10.1002/hep.22191; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim WE, 2006, CLIN CANCER RES, V12, P4192, DOI 10.1158/1078-0432.CCR-05-2663; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Oh SW, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2856; Okura H, 2010, J ATHEROSCLEROSIS TH; Rakha EA, 2008, EUR J CANCER, V44, P73, DOI 10.1016/j.ejca.2007.10.009; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Serrero G, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.22064; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tangkeangsirisin W, 2004, CANCER RES, V64, P1737, DOI 10.1158/0008-5472.CAN-03-2364; Tian Changsheng, 2006, Proceedings of the American Association for Cancer Research Annual Meeting, V47, P691; Tkaczuk KR, 2011, BREAST CANCER-BASIC, V5, P155, DOI 10.4137/BCBCR.S7224; Wang M, 2011, IEEE MTT S INT MICR, P1; Wells CA, 2004, VIRCHOWS ARCH, V445, P119, DOI 10.1007/s00428-004-1063-8; Winer EP, 2005, J CLIN ONCOL, V23, P1609, DOI 10.1200/JCO.2005.01.005; Youn BS, 2009, DIABETES, V58, P627, DOI 10.2337/db08-1147	27	35	40	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39880	10.1371/journal.pone.0039880	http://dx.doi.org/10.1371/journal.pone.0039880			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761921	Green Published, gold, Green Submitted			2022-12-27	WOS:000305781700071
J	Buga, AM; Vintilescu, R; Balseanu, AT; Pop, OT; Streba, C; Toescu, E; Popa-Wagner, A				Buga, Ana-Maria; Vintilescu, Raluca; Balseanu, Adrian Tudor; Pop, Oltin Tiberiu; Streba, Costin; Toescu, Emil; Popa-Wagner, Aurel			Repeated PTZ Treatment at 25-Day Intervals Leads to a Highly Efficient Accumulation of Doublecortin in the Dorsal Hippocampus of Rats	PLOS ONE			English	Article							ENHANCED SYNAPTIC PLASTICITY; GENERATED GRANULE CELLS; ADULT DENTATE GYRUS; NITRIC-OXIDE; NEURONAL DIFFERENTIATION; SUBVENTRICULAR ZONE; PROGENITOR CELLS; CRITICAL PERIOD; SPATIAL MEMORY; DOWN-SYNDROME	Background: Neurogenesis persists throughout life in the adult mammalian brain. Because neurogenesis can only be assessed in postmortem tissue, its functional significance remains undetermined, and identifying an in vivo correlate of neurogenesis has become an important goal. By studying pentylenetetrazole-induced brain stimulation in a rat model of kindling we accidentally discovered that 25+/-1 days periodic stimulation of Sprague-Dawley rats led to a highly efficient increase in seizure susceptibility. Methodology/Principal Findings: By EEG, RT-PCR, western blotting and immunohistochemistry, we show that repeated convulsive seizures with a periodicity of 25+/-1 days led to an enrichment of newly generated neurons, that were BrdU-positive in the dentate gyrus at day 25+/-1 post-seizure. At the same time, there was a massive increase in the number of neurons expressing the migratory marker, doublecortin, at the boundary between the granule cell layer and the polymorphic layer in the dorsal hippocampus. Some of these migrating neurons were also positive for NeuN, a marker for adult neurons. Conclusion/Significance: Our results suggest that the increased susceptibility to seizure at day 25+/-1 post-treatment is coincident with a critical time required for newborn neurons to differentiate and integrate into the existing hippocampal network, and outlines the importance of the dorsal hippocampus for seizure-related neurogenesis. This model can be used as an in vivo correlate of neurogenesis to study basic questions related to neurogenesis and to the neurogenic mechanisms that contribute to the development of epilepsy.	[Buga, Ana-Maria; Balseanu, Adrian Tudor; Popa-Wagner, Aurel] Univ Rostock, Sch Med, Dept Psychiat, Rostock, Germany; [Buga, Ana-Maria; Vintilescu, Raluca; Balseanu, Adrian Tudor; Pop, Oltin Tiberiu; Streba, Costin; Popa-Wagner, Aurel] Univ Med & Pharm, Dept Funct Sci, Craiova, Romania; [Toescu, Emil] Univ Birmingham Edgbaston, Coll Med & Dent Sci, Dept Clin & Expt Med, Birmingham, W Midlands, England	University of Rostock; University of Medicine & Pharmacy of Craiova; University of Birmingham	Buga, AM (corresponding author), Univ Rostock, Sch Med, Dept Psychiat, Rostock, Germany.	aurel.popa-wagner@med.uni-rostock.de	Alexandru, Dragos Ovidiu/AAM-8276-2020; Popa-Wagner, Aurel/E-2541-2013; Scholz, Claus Jürgen/H-3202-2019; Balseanu, Tudor Adrian/O-2289-2018; Buga, Ana-Maria I/P-1478-2014; Buga, Ana Maria/ABA-8108-2021; Streba, Costin Teodor T/C-4196-2011; Popa-Wagner, Aurel/I-2581-2019; Vintilescu, Raluca/A-9499-2018; Dandekar, Thomas/A-4431-2017; Balseanu, Tudor Adrian/T-8118-2019	Alexandru, Dragos Ovidiu/0000-0001-7578-8048; Scholz, Claus Jürgen/0000-0002-6406-7859; Balseanu, Tudor Adrian/0000-0002-0047-3436; Streba, Costin Teodor T/0000-0001-9590-3197; Dandekar, Thomas/0000-0003-1886-7625; Balseanu, Tudor Adrian/0000-0002-0047-3436; Sivanesan, Senthilkumar/0000-0001-5133-7090	Ministry of Research and Education of Germany [0314107]; National Council for Scientific Research of Romania [PN-II-ID-PCE-2011-3-0848]; European project ERA-NET FLARE2 of United Kingdom; Executive Unit for Funding Higher Education, Scientific Research, Development and Innovation (UEFISCDI) of Romania [8555/2011]; CNCS-UEFISCDI [PN-II-ID-PCE-2011-3-0848]; ERA-NET FLARE2/UEFISCDI [8555/2011]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	Ministry of Research and Education of Germany; National Council for Scientific Research of Romania(Consiliul National al Cercetarii Stiintifice (CNCS)); European project ERA-NET FLARE2 of United Kingdom; Executive Unit for Funding Higher Education, Scientific Research, Development and Innovation (UEFISCDI) of Romania(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); CNCS-UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); ERA-NET FLARE2/UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from the Ministry of Research and Education of Germany (No 0314107) and from National Council for Scientific Research of Romania (No PN-II-ID-PCE-2011-3-0848). Dr. Ana-Maria Buga and Dr. Toescu were supported by a grant from the European project ERA-NET FLARE2 of United Kingdom and the Executive Unit for Funding Higher Education, Scientific Research, Development and Innovation (UEFISCDI) of Romania (No 8555/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Popa-Wagner was supported by a grant from CNCS-UEFISCDI, project No PN-II-ID-PCE-2011-3-0848. Dr. Ana-Maria Buga was supported by a grant from ERA-NET FLARE2/UEFISCDI, project No 8555/2011. We also acknowledge the critical reading of the manuscript by Lary Walker.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Babb T L, 1986, Adv Neurol, V44, P949; Banasr M, 2006, BIOL PSYCHIAT, V59, P1087, DOI 10.1016/j.biopsych.2005.11.025; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Buckmaster PS, 2002, J NEUROSCI, V22, P6650; Dashtipour K, 2001, BRAIN RES, V890, P261, DOI 10.1016/S0006-8993(00)03119-X; Detour J, 2005, EPILEPSIA, V46, P499, DOI 10.1111/j.0013-9580.2005.38704.x; Devinsky Orrin, 2004, Rev Neurol Dis, V1, P2; ENGEL J, 1993, ELECTROEN CLIN NEURO, V87, P437, DOI 10.1016/0013-4694(93)90158-R; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Ferland RJ, 2002, NEUROSCI LETT, V332, P131, DOI 10.1016/S0304-3940(02)00808-X; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Geoghegan D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-2; Hosseini M, 2009, SEIZURE-EUR J EPILEP, V18, P695, DOI 10.1016/j.seizure.2009.09.008; Huttmann K, 2003, EUR J NEUROSCI, V18, P2769, DOI 10.1111/j.1460-9568.2003.03002.x; Junker H, 2005, EPILEPSIA, V46, P339, DOI 10.1111/j.0013-9580.2005.46904.x; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kheirbek MA, 2011, NEUROPSYCHOPHARMACOL, V36, P373, DOI 10.1038/npp.2010.148; Kim SU, 2004, NEUROPATHOLOGY, V24, P159, DOI 10.1111/j.1440-1789.2004.00552.x; Kohler SJ, 2011, P NATL ACAD SCI USA, V108, P10326, DOI 10.1073/pnas.1017099108; Kron MM, 2010, J NEUROSCI, V30, P2051, DOI 10.1523/JNEUROSCI.5655-09.2010; Marson A, 2005, LANCET, V365, P2007, DOI 10.1016/S0140-6736(05)66694-9; Moreno-Lopez B, 2004, J NEUROSCI, V24, P85, DOI 10.1523/JNEUROSCI.1574-03.2004; Parent JM, 1997, J NEUROSCI, V17, P3727; Piatti VC, 2011, J NEUROSCI, V31, P7715, DOI 10.1523/JNEUROSCI.1380-11.2011; Pinnock SB, 2007, NEUROPSYCHOPHARMACOL, V32, P493, DOI 10.1038/sj.npp.1301245; Popa-Wagner A, 2007, CURR NEUROVASC RES, V4, P216; PopaWagner A, 1997, EXP NEUROL, V148, P73, DOI 10.1006/exnr.1997.6652; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rueda N, 2008, NEUROSCI LETT, V433, P22, DOI 10.1016/j.neulet.2007.12.039; Scharfman HE, 2004, ADV EXP MED BIOL, V548, P192; Scharfman Helen E., 2002, Epilepsy Curr, V2, P63, DOI 10.1046/j.1535-7597.2002.00023.x; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Schmoll H, 2003, AM J PATHOL, V162, P1027, DOI 10.1016/S0002-9440(10)63897-7; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Torroglosa A, 2007, STEM CELLS, V25, P88, DOI 10.1634/stemcells.2006-0131; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	42	71	73	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39302	10.1371/journal.pone.0039302	http://dx.doi.org/10.1371/journal.pone.0039302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768071	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100042
J	Shiryaev, SA; Thomsen, ER; Cieplak, P; Chudin, E; Cheltsov, AV; Chee, MS; Kozlov, IA; Strongin, AY				Shiryaev, Sergey A.; Thomsen, Elliot R.; Cieplak, Piotr; Chudin, Eugene; Cheltsov, Anton V.; Chee, Mark S.; Kozlov, Igor A.; Strongin, Alex Y.			New Details of HCV NS3/4A Proteinase Functionality Revealed by a High-Throughput Cleavage Assay	PLOS ONE			English	Article							HEPATITIS-C VIRUS; IN-VITRO SELECTION; SUBSTRATE-SPECIFICITY; SERINE PROTEINASE; PROTEASE; NS4A; ACTIVATION; DOMAIN; IDENTIFICATION; DETERMINANTS	Background: The hepatitis C virus (HCV) genome encodes a long polyprotein, which is processed by host cell and viral proteases to the individual structural and non-structural (NS) proteins. HCV NS3/4A serine proteinase (NS3/4A) is a non-covalent heterodimer of the N-terminal, similar to 180-residue portion of the 631-residue NS3 protein with the NS4A co-factor. NS3/4A cleaves the polyprotein sequence at four specific regions. NS3/4A is essential for viral replication and has been considered an attractive drug target. Methodology/Principal Findings: Using a novel multiplex cleavage assay and over 2,660 peptide sequences derived from the polyprotein and from introducing mutations into the known NS3/4A cleavage sites, we obtained the first detailed fingerprint of NS3/4A cleavage preferences. Our data identified structural requirements illuminating the importance of both the short-range (P1-P1') and long-range (P6-P5) interactions in defining the NS3/4A substrate cleavage specificity. A newly observed feature of NS3/4A was a high frequency of either Asp or Glu at both P5 and P6 positions in a subset of the most efficient NS3/4A substrates. In turn, aberrations of this negatively charged sequence such as an insertion of a positively charged or hydrophobic residue between the negatively charged residues resulted in inefficient substrates. Because NS5B misincorporates bases at a high rate, HCV constantly mutates as it replicates. Our analysis revealed that mutations do not interfere with polyprotein processing in over 5,000 HCV isolates indicating a pivotal role of NS3/4A proteolysis in the virus life cycle. Conclusions/Significance: Our multiplex assay technology in light of the growing appreciation of the role of proteolytic processes in human health and disease will likely have widespread applications in the proteolysis research field and provide new therapeutic opportunities.	[Shiryaev, Sergey A.; Cieplak, Piotr; Cheltsov, Anton V.; Strongin, Alex Y.] Sanford Burnham Med Res Inst, Inflammatory & Infect Dis Ctr, La Jolla, CA 92037 USA; [Thomsen, Elliot R.; Chudin, Eugene; Chee, Mark S.; Kozlov, Igor A.] Prognosys Biosci Inc, R&D Dept, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Shiryaev, SA (corresponding author), Sanford Burnham Med Res Inst, Inflammatory & Infect Dis Ctr, La Jolla, CA 92037 USA.	strongin@sanfordburnham.org	Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	NIH [R43GM085884, R01GM98835, R01CA83017, R01CA157328]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by the NIH grants R43GM085884 (IAK), R01GM98835 (PC), and R01CA83017 and R01CA157328 (AYS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barbato G, 1999, J MOL BIOL, V289, P371, DOI 10.1006/jmbi.1999.2745; BARTENSCHLAGER R, 1993, J VIROL, V67, P3835, DOI 10.1128/JVI.67.7.3835-3844.1993; Bartenschlager R, 1999, J VIRAL HEPATITIS, V6, P165, DOI 10.1046/j.1365-2893.1999.00152.x; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; BARTENSCHLAGER R, 1995, J VIROL, V69, P198, DOI 10.1128/JVI.69.1.198-205.1995; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett F, 2010, BIOORG MED CHEM LETT, V20, P2617, DOI 10.1016/j.bmcl.2010.02.063; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Case D.A., 2022, AMBER 2020; Chayama K, 2011, J GASTROEN HEPATOL, V26, P83, DOI 10.1111/j.1440-1746.2010.06550.x; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Dubuisson J, 2007, WORLD J GASTROENTERO, V13, P2406, DOI 10.3748/wjg.v13.i17.2406; Fan XF, 2009, HEPATOLOGY, V50, P1765, DOI 10.1002/hep.23290; Gawlik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005031; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Hagel M, 2011, NAT CHEM BIOL, V7, P22, DOI 10.1038/NCHEMBIO.492; Hellen CUT, 1999, J VIRAL HEPATITIS, V6, P79, DOI 10.1046/j.1365-2893.1999.00150.x; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Koch JO, 1997, VIROLOGY, V237, P78, DOI 10.1006/viro.1997.8760; Kurz M, 2001, CHEMBIOCHEM, V2, P666, DOI 10.1002/1439-7633(20010903)2:9<666::AID-CBIC666>3.0.CO;2-#; Kwong AD, 2011, NAT BIOTECHNOL, V29, P993, DOI 10.1038/nbt.2020; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; LIN C, 1995, J VIROL, V69, P4373, DOI 10.1128/JVI.69.7.4373-4380.1995; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Martin MM, 2011, BIOL CHEM, V392, P927, DOI 10.1515/BC.2011.076; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Morikawa K, 2011, J VIRAL HEPATITIS, V18, P305, DOI 10.1111/j.1365-2893.2011.01451.x; Pietschmann T, 2001, J VIROL, V75, P1252, DOI 10.1128/JVI.75.3.1252-1264.2001; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Schregel V, 2009, P NATL ACAD SCI USA, V106, P5342, DOI 10.1073/pnas.0810950106; Shimizu Y, 1996, J VIROL, V70, P127, DOI 10.1128/JVI.70.1.127-132.1996; Shiryaev SA, 2006, BIOCHEM J, V393, P503, DOI 10.1042/BJ20051374; Shiryaev SA, 2007, J VIROL, V81, P4501, DOI 10.1128/JVI.02719-06; Steinkuhler C, 1996, J VIROL, V70, P6694; Stempniak M, 1997, J VIROL, V71, P2881, DOI 10.1128/JVI.71.4.2881-2886.1997; Suzuki R, 1999, INTERVIROLOGY, V42, P145, DOI 10.1159/000024973; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Urbani A, 1997, J BIOL CHEM, V272, P9204; Wang WY, 2004, J VIROL, V78, P700, DOI 10.1128/JVI.78.2.700-709.2004; Zhang RM, 1997, J VIROL, V71, P6208, DOI 10.1128/JVI.71.8.6208-6213.1997; Zhu HM, 2011, PROTEINS, V79, P2428, DOI 10.1002/prot.23064	48	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35759	10.1371/journal.pone.0035759	http://dx.doi.org/10.1371/journal.pone.0035759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22768327	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000057
J	Malik, SZ; Lewis, M; Isaacs, A; Haskins, M; Van Winkle, T; Vite, CH; Watson, DJ				Malik, Saafan Z.; Lewis, Melissa; Isaacs, Alison; Haskins, Mark; Van Winkle, Thomas; Vite, Charles H.; Watson, Deborah J.			Identification of the Rostral Migratory Stream in the Canine and Feline Brain	PLOS ONE			English	Article							NEURAL PROGENITOR CELLS; SUBVENTRICULAR ZONE; STEM-CELLS; OLFACTORY-BULB; PET DOGS; TRANSPLANTATION; DIFFERENTIATION; GLIOBLASTOMA; NEURONS; MODELS	In the adult rodent brain, neural progenitor cells migrate from the subventricular zone of the lateral ventricle towards the olfactory bulb in a track known as the rostral migratory stream (RMS). To facilitate the study of neural progenitor cells and stem cell therapy in large animal models of CNS disease, we now report the location and characteristics of the normal canine and feline RMS. The RMS was found in Nissl-stained sagittal sections of adult canine and feline brains as a prominent, dense, continuous cellular track beginning at the base of the anterior horn of the lateral ventricle, curving around the head of the caudate nucleus and continuing laterally and ventrally to the olfactory peduncle before entering the olfactory tract and bulb. To determine if cells in the RMS were proliferating, the thymidine analog 5-bromo-2-deoxyuridine (BrdU) was administered and detected by immunostaining. BrdU-immunoreactive cells were present throughout this track. The RMS was also immunoreactive for markers of proliferating cells, progenitor cells and immature neurons (Ki-67 and doublecortin), but not for NeuN, a marker of mature neurons. Luxol fast blue and CNPase staining indicated that myelin is closely apposed to the RMS along much of its length and may provide guidance cues for the migrating cells. Identification and characterization of the RMS in canine and feline brain will facilitate studies of neural progenitor cell biology and migration in large animal models of neurologic disease.	[Malik, Saafan Z.; Isaacs, Alison; Watson, Deborah J.] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Lewis, Melissa; Haskins, Mark; Vite, Charles H.] Univ Penn, Dept Clin Studies, Philadelphia, PA 19104 USA; [Haskins, Mark; Van Winkle, Thomas] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Malik, SZ (corresponding author), Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA.	djw3@mail.med.upenn.edu		Lewis, Melissa J/0000-0001-6643-191X	University of Pennsylvania Department of Neurosurgery funds; National Institutes of Health [DK54481, DK25759, RR02512]; Ara Parseghian Medical Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054481, R01DK025759] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010939] Funding Source: NIH RePORTER	University of Pennsylvania Department of Neurosurgery funds; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ara Parseghian Medical Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by University of Pennsylvania Department of Neurosurgery funds (DW), National Institutes of Health DK54481, DK25759 and RR02512 (MH), and the Ara Parseghian Medical Research Foundation (CV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexanian AR, 2006, J NEUROSCI METH, V150, P41, DOI 10.1016/j.jneumeth.2005.05.024; Bedard A, 2002, EUR J NEUROSCI, V16, P1917, DOI 10.1046/j.1460-9568.2002.02263.x; Berman A.L., 1968, BRAIN STEM CAT CYTOA; Berman AL, 1982, THALAMUS BASAL TELEN; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Chandler K, 2006, VET J, V172, P207, DOI 10.1016/j.tvjl.2005.07.001; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fitzgerald TC, 1961, VET MED, V56, P38; Gil-Perotin S, 2009, J COMP NEUROL, V514, P533, DOI 10.1002/cne.22026; Higgins RJ, 2010, J NEURO-ONCOL, V98, P49, DOI 10.1007/s11060-009-0072-5; Jenkins T, 1972, FUNCATIONAL MAMMALIA; Kimmelman J, 2007, CANCER RES, V67, P4541, DOI 10.1158/0008-5472.CAN-06-3792; Klassen H, 2007, VET OPHTHALMOL, V10, P245, DOI 10.1111/j.1463-5224.2007.00547.x; Koestner A, 1999, HISTOLOGIC CLASSIFIC; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lipsitz D, 2003, VET PATHOL, V40, P659, DOI 10.1354/vp.40-6-659; Luzzati F, 2003, P NATL ACAD SCI USA, V100, P13036, DOI 10.1073/pnas.1735482100; Menezes JRL, 1995, MOL CELL NEUROSCI, V6, P496, DOI 10.1006/mcne.1995.0002; Milward EA, 1997, J NEUROSCI RES, V50, P862, DOI 10.1002/(SICI)1097-4547(19971201)50:5<862::AID-JNR22>3.0.CO;2-1; Muller FJ, 2006, NAT REV NEUROSCI, V7, P75, DOI 10.1038/nrn1829; Pencea V, 2001, EXP NEUROL, V172, P1, DOI 10.1006/exnr.2001.7768; Rosomoff HL, 1996, CRIT CARE MED, V24, pS48; Rossignol S, 2002, PROG BRAIN RES, V137, P151; Sanai N, 2007, SCIENCE, V318, DOI 10.1126/science.1145011; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Sawamoto K, 2011, J COMP NEUROL, V519, P690, DOI 10.1002/cne.22543; Smitka M, 2009, NEUROSCIENCE, V162, P482, DOI 10.1016/j.neuroscience.2009.04.058; Snyder JM, 2006, J VET INTERN MED, V20, P669, DOI 10.1892/0891-6640(2006)20[669:CIPNC]2.0.CO;2; Stoica G, 2004, VET PATHOL, V41, P10, DOI 10.1354/vp.41-1-10; Stoica G, 2009, VET PATHOL, V46, P391, DOI 10.1354/vp.08-VP-0218-S-FL; Tang XB, 2007, J NEUROSCI, V27, P5837, DOI 10.1523/JNEUROSCI.5048-06.2007; Thomson SAM, 2005, VET PATHOL, V42, P550, DOI 10.1354/vp.42-5-550; Trojanowski JQ, 2008, ALZHEIMERS DEMENT, V4, P1, DOI 10.1016/j.jalz.2007.09.007; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Vite C H, 2006, BRAUNDS CLIN NEUROLO; Walton RM, 2008, J NEUROPATH EXP NEUR, V67, P954, DOI 10.1097/NEN.0b013e3181875b2f; Walton RM, 2008, J NEUROSCI METH, V169, P158, DOI 10.1016/j.jneumeth.2007.12.011; Wang L, 2007, NEUROSCI RES, V59, P327, DOI 10.1016/j.neures.2007.08.011; Waters DJ, 2006, SCI AM, V295, P94, DOI 10.1038/scientificamerican1206-94; WATSON DJ, 2002, VIRAL VECTORS GENE T, P383	43	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36016	10.1371/journal.pone.0036016	http://dx.doi.org/10.1371/journal.pone.0036016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606243	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338200016
J	Zhang, X; Mao, Y; Huang, ZX; Qu, M; Chen, J; Ding, SX; Hong, JN; Sun, TT				Zhang, Xiang; Mao, Yong; Huang, Zixia; Qu, Meng; Chen, Jun; Ding, Shaoxiong; Hong, Jingni; Sun, Tiantian			Transcriptome Analysis of the Octopus vulgaris Central Nervous System	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; GROWTH-PERFORMANCE; ENDOTHELIAL-CELLS; MOLECULAR ANATOMY; TISSUES; IDENTIFICATION; SYNAPTOTAGMIN; LOCALIZATION; PERMEABILITY; MICROVESSELS	Background: Cephalopoda are a class of Mollusca species found in all the world's oceans. They are an important model organism in neurobiology. Unfortunately, the lack of neuronal molecular sequences, such as ESTs, transcriptomic or genomic information, has limited the development of molecular neurobiology research in this unique model organism. Results: With high-throughput Illumina Solexa sequencing technology, we have generated 59,859 high quality sequences from 12,918,391 paired-end reads. Using BLASTx/BLASTn, 12,227 contigs have blast hits in the Swissprot, NR protein database and NT nucleotide database with E-value cutoff 1e(-5). The comparison between the Octopus vulgaris central nervous system (CNS) library and the Aplysia californica/Lymnaea stagnalis CNS ESTs library yielded 5.93%/13.45% of O. vulgaris sequences with significant matches (1e(-5)) using BLASTn/tBLASTx. Meanwhile the hit percentage of the recently published Schistocerca gregaria, Tilapia or Hirudo medicinalis CNS library to the O. vulgaris CNS library is 21.03%-46.19%. We constructed the Phylogenetic tree using two genes related to CNS function, Synaptotagmin-7 and Synaptophysin. Lastly, we demonstrated that O. vulgaris may have a vertebrate-like Blood-Brain Barrier based on bioinformatic analysis. Conclusion: This study provides a mass of molecular information that will contribute to further molecular biology research on O. vulgaris. In our presentation of the first CNS transcriptome analysis of O. vulgaris, we hope to accelerate the study of functional molecular neurobiology and comparative evolutionary biology.	[Chen, Jun; Ding, Shaoxiong] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Zhang, Xiang; Qu, Meng; Ding, Shaoxiong] Xiamen Univ, Lab Marine Biodivers & Global Change, Xiamen, Peoples R China; [Zhang, Xiang; Mao, Yong; Huang, Zixia; Qu, Meng; Chen, Jun; Ding, Shaoxiong; Hong, Jingni; Sun, Tiantian] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Zhang, X (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	sxding@xmu.edu.cn	Huang, Zixia/AAO-6936-2021; Ding, SX/G-4137-2010; zhang, menghui/Q-3752-2016; Xu, Jia/GSD-6115-2022	Li, Xiaoying/0000-0002-9383-5757; zhang, menghui/0000-0002-9274-487X; Huang, Zixia/0000-0002-1298-0486; Zhang, Xu/0000-0003-2406-9478; Xu, Jia/0000-0002-3341-7668	National fund for oceanography research in Public Interest [201005013]; National Key Technology RD Program [2011BAD13]	National fund for oceanography research in Public Interest; National Key Technology RD Program(National Key Technology R&D Program)	This work was supported by the National fund for oceanography research in Public Interest (201005013) and the National Key Technology R&D Program (2011BAD13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT VR, 1987, J BIOL CHEM, V262, P9404; Begley DJ, 1996, J PHARM PHARMACOL, V48, P136, DOI 10.1111/j.2042-7158.1996.tb07112.x; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Cha SH, 2001, MOL PHARMACOL, V59, P1277, DOI 10.1124/mol.59.5.1277; Choi YK, 2008, BMB REP, V41, P345, DOI 10.5483/BMBRep.2008.41.5.345; Cordenonsi M, 1999, J CELL BIOL, V147, P1569, DOI 10.1083/jcb.147.7.1569; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277, DOI 10.1177/38.9.1974900; Erickson Kathryn K., 2007, Angiogenesis, V10, P103, DOI 10.1007/s10456-007-9067-z; Feng ZP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-451; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; Gutnick T, 2011, CURR BIOL, V21, P460, DOI 10.1016/j.cub.2011.01.052; HARDEBO JE, 1980, ANN NEUROL, V8, P1, DOI 10.1002/ana.410080102; Hawkins RA, 2006, J NUTR, V136, p218S, DOI 10.1093/jn/136.1.218S; Hormiga JA, 2010, J BIOTECHNOL, V149, P209, DOI 10.1016/j.jbiotec.2009.12.008; KALARIA RN, 1987, J NEUROCHEM, V49, P856, DOI 10.1111/j.1471-4159.1987.tb00973.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lee BY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-278; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Macagno ER, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-407; Monteiro A, 2011, HARMFUL ALGAE, V10, P732, DOI 10.1016/j.hal.2011.06.004; Morita T, 2010, MAR POLLUT BULL, V60, P1193, DOI 10.1016/j.marpolbul.2010.03.031; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Navarro P, 1998, J CELL BIOL, V140, P1475, DOI 10.1083/jcb.140.6.1475; Perales-Raya C, 2010, FISH RES, V106, P171, DOI 10.1016/j.fishres.2010.05.003; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Prato E, 2010, AQUACULTURE, V309, P203, DOI 10.1016/j.aquaculture.2010.09.036; Quintana D, 2008, AQUACULTURE, V280, P161, DOI 10.1016/j.aquaculture.2008.04.017; Raimundo J, 2010, CHEMOSPHERE, V81, P1314, DOI 10.1016/j.chemosphere.2010.08.029; Raimundo J, 2010, COMP BIOCHEM PHYS C, V152, P139, DOI 10.1016/j.cbpc.2010.03.009; Raimundo J, 2010, ECOTOX ENVIRON SAFE, V73, P1543, DOI 10.1016/j.ecoenv.2010.07.034; Raimundo J, 2010, ENVIRON POLLUT, V158, P2094, DOI 10.1016/j.envpol.2010.03.005; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Schwabe T, 2005, CELL, V123, P133, DOI 10.1016/j.cell.2005.08.037; Seixas P, 2008, AQUACULTURE, V283, P83, DOI 10.1016/j.aquaculture.2008.06.019; Seixas P, 2010, AQUACULTURE, V300, P156, DOI 10.1016/j.aquaculture.2009.12.021; Shih JC, 2004, CURR MED CHEM, V11, P1995, DOI 10.2174/0929867043364757; Shomrat T, 2010, NEUROSCIENCE, V169, P52, DOI 10.1016/j.neuroscience.2010.04.050; Simionescu M, 2002, MICROSC RES TECHNIQ, V57, P269, DOI 10.1002/jemt.10086; Sobrino I, 2011, FISH RES, V108, P283, DOI 10.1016/j.fishres.2010.12.022; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Ueno M, 2007, CURR MED CHEM, V14, P1199, DOI 10.2174/092986707780597943; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Vargas-Yanez M, 2009, FISH RES, V99, P159, DOI 10.1016/j.fishres.2009.05.013; Vazquez-Rowe I, 2012, MAR POLICY, V36, P180, DOI 10.1016/j.marpol.2011.05.002; Villanueva R, 2009, AQUACULTURE, V286, P277, DOI 10.1016/j.aquaculture.2008.09.032; Vorbrodt AW, 2008, BRAIN CELL BIOL, V36, P203, DOI 10.1007/s11068-008-9038-3; Vorbrodt AW, 2003, BRAIN RES REV, V42, P221, DOI 10.1016/S0165-0173(03)00177-2; WAGNER MC, 1992, J CELL BIOL, V119, P163, DOI 10.1083/jcb.119.1.163; Weksler BB, 2005, FASEB J; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Wolburg H, 2009, CELL TISSUE RES, V335, P75, DOI 10.1007/s00441-008-0658-9; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zheng J, 2011, PLOS ONE, V6; Zheng W, 2003, TOXICOL APPL PHARM, V192, P1, DOI 10.1016/S0041-008X(03)00251-5; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	59	285	298	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40320	10.1371/journal.pone.0040320	http://dx.doi.org/10.1371/journal.pone.0040320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768275	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100249
J	Buga, AM; Scholz, CJ; Kumar, S; Herndon, JG; Alexandru, D; Cojocaru, GR; Dandekar, T; Popa-Wagner, A				Buga, Ana-Maria; Scholz, Claus Juergen; Kumar, Senthil; Herndon, James G.; Alexandru, Dragos; Cojocaru, Gabriel Radu; Dandekar, Thomas; Popa-Wagner, Aurel			Identification of New Therapeutic Targets by Genome-Wide Analysis of Gene Expression in the Ipsilateral Cortex of Aged Rats after Stroke	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; COLONY-STIMULATING FACTOR; CEREBRAL-ISCHEMIA; RECEPTOR; BRAIN; PROTEIN; INHIBITOR; MOUSE; GAMMA; DIFFERENTIATION	Background: Because most human stroke victims are elderly, studies of experimental stroke in the aged rather than the young rat model may be optimal for identifying clinically relevant cellular responses, as well for pinpointing beneficial interventions. Methodology/Principal Findings: We employed the Affymetrix platform to analyze the whole-gene transcriptome following temporary ligation of the middle cerebral artery in aged and young rats. The correspondence, heat map, and dendrogram analyses independently suggest a differential, age-group-specific behaviour of major gene clusters after stroke. Overall, the pattern of gene expression strongly suggests that the response of the aged rat brain is qualitatively rather than quantitatively different from the young, i.e. the total number of regulated genes is comparable in the two age groups, but the aged rats had great difficulty in mounting a timely response to stroke. Our study indicates that four genes related to neuropathic syndrome, stress, anxiety disorders and depression (Acvr1c, Cort, Htr2b and Pnoc) may have impaired response to stroke in aged rats. New therapeutic options in aged rats may also include Calcrl, Cyp11b1, Prcp, Cebpa, Cfd, Gpnmb, Fcgr2b, Fcgr3a, Tnfrsf26, Adam 17 and Mmp14. An unexpected target is the enzyme 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 in aged rats, a key enzyme in the cholesterol synthesis pathway. Post-stroke axonal growth was compromised in both age groups. Conclusion/Significance: We suggest that a multi-stage, multimodal treatment in aged animals may be more likely to produce positive results. Such a therapeutic approach should be focused on tissue restoration but should also address other aspects of patient post-stroke therapy such as neuropathic syndrome, stress, anxiety disorders, depression, neurotransmission and blood pressure.	[Buga, Ana-Maria; Popa-Wagner, Aurel] Univ Med, Dept Psychiat, Rostock, Germany; [Buga, Ana-Maria; Alexandru, Dragos; Cojocaru, Gabriel Radu] Univ Med, Dept Funct Sci, Craiova, Romania; [Scholz, Claus Juergen] Univ Wurzburg, Lab Microarray Applicat, Interdisciplinary Ctr Clin Res, D-97070 Wurzburg, Germany; [Kumar, Senthil] Iowa State Univ Sci & Technol, Coll Vet Med, Dept Biomed Sci, Ames, IA 50011 USA; [Herndon, James G.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Dandekar, Thomas] Bioctr Hubland, Dept Bioinformat, Wurzburg, Germany	University of Medicine & Pharmacy of Craiova; University of Wurzburg; Iowa State University; Emory University	Popa-Wagner, A (corresponding author), Univ Med, Dept Psychiat, Rostock, Germany.	aurel.popa-wagner@med.uni-rostock.de	Alexandru, Dragos Ovidiu/AAM-8276-2020; Popa-Wagner, Aurel/E-2541-2013; Scholz, Claus Jürgen/H-3202-2019; Balseanu, Tudor Adrian/O-2289-2018; Buga, Ana-Maria I/P-1478-2014; Buga, Ana Maria/ABA-8108-2021; Streba, Costin Teodor T/C-4196-2011; Popa-Wagner, Aurel/I-2581-2019; Vintilescu, Raluca/A-9499-2018; Dandekar, Thomas/A-4431-2017; Balseanu, Tudor Adrian/T-8118-2019	Alexandru, Dragos Ovidiu/0000-0001-7578-8048; Scholz, Claus Jürgen/0000-0002-6406-7859; Balseanu, Tudor Adrian/0000-0002-0047-3436; Streba, Costin Teodor T/0000-0001-9590-3197; Dandekar, Thomas/0000-0003-1886-7625; Balseanu, Tudor Adrian/0000-0002-0047-3436; Sivanesan, Senthilkumar/0000-0001-5133-7090	Federal Ministry of Education and Research [01GN0982]; CNCS-UEFISCDI [PN-II-ID-PCE-2011-3-0848]; NIH [OD P51OD11132]; ERA-NET FLARE2/UEFISCDI [8555/2011]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); CNCS-UEFISCDI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERA-NET FLARE2/UEFISCDI; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported financially by the Federal Ministry of Education and Research (Grant No 01GN0982) and by a grant from CNCS-UEFISCDI, project No PN-II-ID-PCE-2011-3-0848 to A. P. W. and by NIH grant OD P51OD11132 to the Yerkes National Primate Research Center. Dr. Ana-Maria Buga was supported by a grant from ERA-NET FLARE2/UEFISCDI, project No 8555/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer HL, 2006, AM J MED GENET A, V140A, P691, DOI 10.1002/ajmg.a.31133; Badan I, 2004, EUR J NEUROSCI, V19, P2270, DOI 10.1111/j.0953-816X.2004.03323.x; Badan I, 2003, GERONTOLOGY, V49, P356, DOI 10.1159/000073763; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borday C, 2004, PROG BIOPHYS MOL BIO, V84, P89, DOI 10.1016/j.pbiomolbio.2003.11.002; Buga AM, 2008, J CELL MOL MED, V12, P2731, DOI 10.1111/j.1582-4934.2008.00252.x; Byfield SD, 2004, MOL PHARMACOL, V65, P744, DOI 10.1124/mol.65.3.744; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Chae JI, 2009, PROTEOMICS, V9, P1128, DOI 10.1002/pmic.200800234; Chiou LC, 2007, CURR DRUG TARGETS, V8, P117, DOI 10.2174/138945007779315605; Chnari E, 2006, BIOMACROMOLECULES, V7, P1796, DOI 10.1021/bm0600872; Cruz C, 2010, P NATL ACAD SCI USA, V107, P3564, DOI 10.1073/pnas.1000389107; Deshmukh HS, 2009, AM J RESP CRIT CARE, V180, P834, DOI 10.1164/rccm.200903-0328OC; Deussing JM, 2007, J CEREBR BLOOD F MET, V27, P1476, DOI 10.1038/sj.jcbfm.9600451; Durlu-Kandilci NT, 2010, J BIOL CHEM, V285, P24925, DOI 10.1074/jbc.M110.129833; Fischer T, 2011, DEV BIOL, V350, P496, DOI 10.1016/j.ydbio.2010.12.017; Gavioli EC, 2008, PEPTIDES, V29, P1404, DOI 10.1016/j.peptides.2008.04.004; Ghzili H, 2006, REGUL PEPTIDES, V137, P89, DOI 10.1016/j.regpep.2006.06.015; Gierten J, 2008, BRIT J PHARMACOL, V154, P1680, DOI 10.1038/bjp.2008.213; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Hemley CF, 2007, CURR DRUG TARGETS, V8, P105, DOI 10.2174/138945007779315542; Huang JJ, 2012, BRAIN BEHAV, V2, P85, DOI 10.1002/brb3.39; Irizarry RA, 2003, STAT APPL GENET MOL, V2, DOI DOI 10.2202/1544-6115.1002; Islam O, 2009, MOL BIOL CELL, V20, P188, DOI 10.1091/mbc.E08-05-0463; Jackson AC, 2011, J NEUROSCI, V31, P3939, DOI 10.1523/JNEUROSCI.5134-10.2011; Jang JE, 2012, CIRC RES, V110, P1057, DOI 10.1161/CIRCRESAHA.112.266411; Kagerer SM, 2011, PEPTIDES, V32, P839, DOI 10.1016/j.peptides.2011.01.004; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Kennett GA, 1998, NEUROPHARMACOLOGY, V37, P1603, DOI 10.1016/S0028-3908(98)00115-4; Kirton JP, 2006, CIRC RES, V98, P1264, DOI 10.1161/01.RES.0000223056.68892.8b; Kurnellas MP, 2004, FASEB J, V18, P298, DOI 10.1096/fj.04-2549fje; Leitch B, 2009, J COMP NEUROL, V512, P52, DOI 10.1002/cne.21890; Lewis J, 2010, NEURON, V68, P601, DOI 10.1016/j.neuron.2010.11.014; Li FB, 2011, SCIENCE, V333, P1030, DOI 10.1126/science.1206954; Li SL, 2010, NAT NEUROSCI, V13, P1496, DOI 10.1038/nn.2674; Lin SY, 2011, J NEUROSCI, V31, P1410, DOI 10.1523/JNEUROSCI.4682-10.2011; Lindner MD, 2003, J NEUROSCI, V23, P10913; Little GE, 2009, PLOS BIOL, V7, P756, DOI 10.1371/journal.pbio.1000098; Liu RZ, 2004, EUR J BIOCHEM, V271, P339, DOI 10.1046/j.1432-1033.2003.03932.x; Liu YL, 2008, BIOL PSYCHIAT, V64, P789, DOI 10.1016/j.biopsych.2008.04.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu AG, 2003, J CEREBR BLOOD F MET, V23, P786, DOI 10.1097/01.WCB.0000062340.80057.06; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Markus TM, 2005, ANN NEUROL, V58, P950, DOI 10.1002/ana.20676; Martinez-Ferrer M, 2010, AM J PATHOL, V176, P98, DOI 10.2353/ajpath.2010.090283; Martinowich K, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-11; Matsuo R, 2001, BIOCHEM BIOPH RES CO, V289, P479, DOI 10.1006/bbrc.2001.5975; Mertsch S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-302; Moore EL, 2010, BIOCHEM BIOPH RES CO, V394, P141, DOI 10.1016/j.bbrc.2010.02.131; Morikis D, 2002, BIOCHEM SOC T, V30, P1026, DOI 10.1042/BST0301026; Na IK, 2009, J IMMUNOTHER, V32, P907, DOI 10.1097/CJI.0b013e3181b7be60; Papac-Milicevic N, 2012, CIRC RES, V110, pE50, DOI 10.1161/CIRCRESAHA.111.258814; Popa-Wagner A, 1999, J CEREBR BLOOD F MET, V19, P425, DOI 10.1097/00004647-199904000-00008; Popa-Wagner A, 2011, AGEING RES REV, V10, P71, DOI 10.1016/j.arr.2009.10.008; Popa-Wagner A, 2010, STROKE, V41, P1027, DOI 10.1161/STROKEAHA.109.575621; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Roohi J, 2009, J MED GENET, V46, P176, DOI 10.1136/jmg.2008.057505; Saleh S, 2005, J PHYSIOL-LONDON, V568, P155, DOI 10.1113/jphysiol.2005.090951; Schmidt-Kastner R, 2002, MOL BRAIN RES, V108, P81, DOI 10.1016/S0169-328X(02)00516-8; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shariat-Madar Z, 2002, J BIOL CHEM, V277, P17962, DOI 10.1074/jbc.M106101200; Siehler S, 2008, MOL CELL ENDOCRINOL, V286, P26, DOI 10.1016/j.mce.2007.12.007; Spoorendonk KM, 2008, DEVELOPMENT, V135, P3765, DOI 10.1242/dev.024034; Tanaka M, 2009, J IMMUNOL, V183, P2349, DOI 10.4049/jimmunol.0801683; Tanji K, 2010, NEUROBIOL DIS, V38, P210, DOI 10.1016/j.nbd.2010.01.007; Teronen O, 1997, J DENT RES, V76, P1529, DOI 10.1177/00220345970760090401; Trumbach D, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-159; Tseveleki V, 2010, GENOMICS, V96, P82, DOI 10.1016/j.ygeno.2010.04.004; Tuomi JM, 2010, AM J PHYSIOL-HEART C, V298, pH554, DOI 10.1152/ajpheart.00779.2009; Wang QF, 2002, BLOOD, V99, P2776, DOI 10.1182/blood.V99.8.2776; Welt C, 2002, EXP BIOL MED, V227, P724, DOI 10.1177/153537020222700905; Wunder F, 2008, MOL PHARMACOL, V73, P1235, DOI 10.1124/mol.107.042283; Yamada Y, 2011, EUR J PHARMACOL, V667, P113, DOI 10.1016/j.ejphar.2011.05.072; Zarrabi K, 2011, J BIOL CHEM, V286, P33167, DOI 10.1074/jbc.M111.256644; Zhang GX, 2010, HYPERTENS RES, V33, P478, DOI 10.1038/hr.2010.21; Zhou CY, 2010, J MED CHEM, V53, P7251, DOI 10.1021/jm101013m; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	78	71	73	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50985	10.1371/journal.pone.0050985	http://dx.doi.org/10.1371/journal.pone.0050985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	22768071	Green Published, gold			2022-12-27	WOS:000313236200051
J	Jones, DT; Vemuri, P; Murphy, MC; Gunter, JL; Senjem, ML; Machulda, MM; Przybelski, SA; Gregg, BE; Kantarci, K; Knopman, DS; Boeve, BF; Petersen, RC; Jack, CR				Jones, David T.; Vemuri, Prashanthi; Murphy, Matthew C.; Gunter, Jeffrey L.; Senjem, Matthew L.; Machulda, Mary M.; Przybelski, Scott A.; Gregg, Brian E.; Kantarci, Kejal; Knopman, David S.; Boeve, Bradley F.; Petersen, Ronald C.; Jack, Clifford R., Jr.			Non-Stationarity in the "Resting Brain's" Modular Architecture	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; DEFAULT MODE NETWORK; AGE-RELATED-CHANGES; SMALL-WORLD; MRI; ORGANIZATION; FMRI; RECONFIGURATION; DYNAMICS; ADULTS	Task-free functional magnetic resonance imaging (TF-fMRI) has great potential for advancing the understanding and treatment of neurologic illness. However, as with all measures of neural activity, variability is a hallmark of intrinsic connectivity networks (ICNs) identified by TF-fMRI. This variability has hampered efforts to define a robust metric of connectivity suitable as a biomarker for neurologic illness. We hypothesized that some of this variability rather than representing noise in the measurement process, is related to a fundamental feature of connectivity within ICNs, which is their non-stationary nature. To test this hypothesis, we used a large (n = 892) population-based sample of older subjects to construct a well characterized atlas of 68 functional regions, which were categorized based on independent component analysis network of origin, anatomical locations, and a functional meta-analysis. These regions were then used to construct dynamic graphical representations of brain connectivity within a sliding time window for each subject. This allowed us to demonstrate the non-stationary nature of the brain's modular organization and assign each region to a "meta-modular" group. Using this grouping, we then compared dwell time in strong sub-network configurations of the default mode network (DMN) between 28 subjects with Alzheimer's dementia and 56 cognitively normal elderly subjects matched 1: 2 on age, gender, and education. We found that differences in connectivity we and others have previously observed in Alzheimer's disease can be explained by differences in dwell time in DMN sub-network configurations, rather than steady state connectivity magnitude. DMN dwell time in specific modular configurations may also underlie the TF-fMRI findings that have been described in mild cognitive impairment and cognitively normal subjects who are at risk for Alzheimer's dementia.	[Jones, David T.; Knopman, David S.; Boeve, Bradley F.; Petersen, Ronald C.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Vemuri, Prashanthi; Murphy, Matthew C.; Gunter, Jeffrey L.; Senjem, Matthew L.; Gregg, Brian E.; Kantarci, Kejal; Jack, Clifford R., Jr.] Mayo Clin, Dept Radiol, Rochester, MN USA; [Machulda, Mary M.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; [Przybelski, Scott A.] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Jones, DT (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.	jack.clifford@mayo.edu	Senjem, Matthew L/GRF-6799-2022; Jack, Clifford R/F-2508-2010; Vemuri, Prashanthi/K-7030-2012; Harris, Adrian/ABA-3343-2020; Buffa, Francesca M./D-2574-2013	Senjem, Matthew L/0000-0001-9308-9275; Jack, Clifford R/0000-0001-7916-622X; Lechertier, Tanguy/0000-0002-0202-8424; Kantarci, Kejal/0000-0002-8001-2081; Bicknell, Roy/0000-0002-0941-8919; Harris, Adrian/0000-0003-1376-8409; Jones, J Louise/0000-0003-3880-3274; Hodivala-Dilke, Kairbaan/0000-0002-2859-749X; Buffa, Francesca M./0000-0003-0409-406X; Mitter, Richard/0000-0002-1279-3760; Jones, David/0000-0002-4807-9833	National Institute on Aging [R01AG11378, P50 AG16574, U01 AG06786, K99AG37573]; Mayo Foundation; Alzheimer's Association; NATIONAL INSTITUTE ON AGING [U01AG006786, P50AG016574, K99AG037573, R01AG011378, R01AG041851] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Mayo Foundation; Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by The National Institute on Aging (R01AG11378, P50 AG16574, U01 AG06786, K99AG37573), the Alexander Family Alzheimer's Disease Research Professorship of the Mayo Foundation, and Alzheimer's Association New Investigator grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2011, AM J NEURORADIOL, V32, P548, DOI 10.3174/ajnr.A2330; Bai F, 2009, BRAIN RES, V1302, P167, DOI 10.1016/j.brainres.2009.09.028; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Britz J, 2010, NEUROIMAGE, V52, P1162, DOI 10.1016/j.neuroimage.2010.02.052; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cate AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004645; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; de Pasquale F, 2010, P NATL ACAD SCI USA, V107, P6040, DOI 10.1073/pnas.0913863107; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; GLOOR P, 1994, ELECTROEN CLIN NEURO, V90, P253, DOI 10.1016/0013-4694(94)90143-0; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Jones DT, 2011, NEUROLOGY, V77, P1524, DOI 10.1212/WNL.0b013e318233b33d; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Li SJ, 2002, RADIOLOGY, V225, P253, DOI 10.1148/radiol.2251011301; Machulda MM, 2011, ARCH NEUROL-CHICAGO, V68, P1131, DOI 10.1001/archneurol.2011.108; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Maxim V, 2005, NEUROIMAGE, V25, P141, DOI 10.1016/j.neuroimage.2004.10.044; McGonigle DJ, 2000, NEUROIMAGE, V11, P708, DOI 10.1006/nimg.2000.0562; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Roberts RO, 2008, NEUROEPIDEMIOLOGY, V30, P58, DOI 10.1159/000115751; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seeley WW, 2011, ARCH NEUROL-CHICAGO, V68, P1107, DOI 10.1001/archneurol.2011.202; Seibert TM, 2012, NEUROIMAGE, V59, P2452, DOI 10.1016/j.neuroimage.2011.08.105; Sheline YI, 2010, J NEUROSCI, V30, P17035, DOI 10.1523/JNEUROSCI.3987-10.2010; Sheline YI, 2010, BIOL PSYCHIAT, V67, P584, DOI 10.1016/j.biopsych.2009.08.024; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Van de Ville D, 2010, P NATL ACAD SCI USA, V107, P18179, DOI 10.1073/pnas.1007841107; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Vemuri P, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt100; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013	47	280	286	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39731	10.1371/journal.pone.0039731	http://dx.doi.org/10.1371/journal.pone.0039731			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761880	gold, Green Submitted, Green Published			2022-12-27	WOS:000305826400031
J	Li, XH; Ha, CT; Fu, DD; Xiao, M				Li, Xiang Hong; Ha, Cam T.; Fu, Dadin; Xiao, Mang			REDD1 Protects Osteoblast Cells from Gamma Radiation-Induced Premature Senescence	PLOS ONE			English	Article							HUMAN HEMATOPOIETIC PROGENITORS; MARROW STROMAL CELLS; NF-KAPPA-B; CELLULAR SENESCENCE; IN-VITRO; DNA-DAMAGE; LIFE-SPAN; P53; MTOR; STRESS	Radiotherapy is commonly used for cancer treatment. However, it often results in side effects due to radiation damage in normal tissue, such as bone marrow (BM) failure. Adult hematopoietic stem and progenitor cells (HSPC) reside in BM next to the endosteal bone surface, which is lined primarily by hematopoietic niche osteoblastic cells. Osteoblasts are relatively more radiation-resistant than HSPCs, but the mechanisms are not well understood. In the present study, we demonstrated that the stress response gene REDD1 (regulated in development and DNA damage responses 1) was highly expressed in human osteoblast cell line (hFOB) cells after gamma irradiation. Knockdown of REDD1 with siRNA resulted in a decrease in hFOB cell numbers, whereas transfection of PCMV6-AC-GFP-REDD1 plasmid DNA into hFOB cells inhibited mammalian target of rapamycin (mTOR) and p21 expression and protected these cells from radiation-induced premature senescence (PS). The PS in irradiated hFOB cells were characterized by significant inhibition of clonogenicity, activation of senescence biomarker SA-beta-gal, and the senescence-associated cytokine secretory phenotype (SASP) after 4 or 8 Gy irradiation. Immunoprecipitation assays demonstrated that the stress response proteins p53 and nuclear factor kappa B (NFkB) interacted with REDD1 in hFOB cells. Knockdown of NFkB or p53 gene dramatically suppressed REDD1 protein expression in these cells, indicating that REDD1 was regulated by both factors. Our data demonstrated that REDD1 is a protective factor in radiation-induced osteoblast cell premature senescence.	[Li, Xiang Hong; Ha, Cam T.; Fu, Dadin; Xiao, Mang] Uniformed Serv Univ Hlth Sci, Radiat Countermeasures Program, Armed Forces Radiobiol Res Inst, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense	Li, XH (corresponding author), Uniformed Serv Univ Hlth Sci, Radiat Countermeasures Program, Armed Forces Radiobiol Res Inst, Bethesda, MD 20814 USA.	xiao@afrri.usuhs.mil			Armed Forces Radiobiology Research Institute [RAB2EI]; American Congressional Grant [G1B2EP]	Armed Forces Radiobiology Research Institute; American Congressional Grant	This study was supported by Armed Forces Radiobiology Research Institute intramural grant (RAB2EI) to MX and an American Congressional Grant (G1B2EP) to MX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Braunstein S, 2009, MOL CELL BIOL, V29, P5645, DOI 10.1128/MCB.00711-09; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919; Demidenko ZN, 2010, P NATL ACAD SCI USA, V107, P9660, DOI 10.1073/pnas.1002298107; Demidenko ZN, 2009, AGING-US, V1, P1008, DOI 10.18632/aging.100115; Demidenko ZN, 2009, CELL CYCLE, V8, P1896, DOI 10.4161/cc.8.12.8809; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Drakos E, 2009, LEUKEMIA, V23, P784, DOI 10.1038/leu.2008.348; Ellisen LW, 2005, CELL CYCLE, V4, P1500, DOI 10.4161/cc.4.11.2139; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Gery S, 2007, EXP HEMATOL, V35, P572, DOI 10.1016/j.exphem.2007.01.049; HARRIS SA, 1995, J BONE MINER RES, V10, P178; Hill R, 2008, CELL CYCLE, V7, P2535; Hotz ME, 2010, HEALTH PHYS, V98, P894, DOI 10.1097/HP.0b013e3181ab3e71; Katiyar S, 2009, EMBO REP, V10, P866, DOI 10.1038/embor.2009.93; Kim BY, 2005, CARCINOGENESIS, V26, P1395, DOI 10.1093/carcin/bgi081; Korotchkina LG, 2010, AGING-US, V2, P344, DOI 10.18632/aging.100160; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Li XH, 2010, HAEMATOL-HEMATOL J, V95, P1996, DOI 10.3324/haematol.2010.026492; Lin L, 2005, BIOCHEM J, V392, P93, DOI 10.1042/BJ20050553; Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016; Salminen A, 2011, CELL SIGNAL, V23, P747, DOI 10.1016/j.cellsig.2010.10.012; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Singh VK, 2010, INT J RADIAT BIOL, V86, P12, DOI 10.3109/09553000903264515; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Subramaniam M, 2002, J CELL BIOCHEM, V87, P9, DOI 10.1002/jcb.10259; Taichman RS, 1996, BLOOD, V87, P518, DOI 10.1182/blood.V87.2.518.bloodjournal872518; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Xiao M, 2007, MOL PHARMACOL, V72, P370, DOI 10.1124/mol.107.035394; Xiao Mang, 2009, Curr Mol Pharmacol, V2, P122; Xiao M, 2009, EXP HEMATOL, V37, P52, DOI 10.1016/j.exphem.2008.09.001; Yen ML, 2007, STEM CELLS, V25, P125, DOI 10.1634/stemcells.2006-0295; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	40	41	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36604	10.1371/journal.pone.0036604	http://dx.doi.org/10.1371/journal.pone.0036604			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22768107	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500020
J	Lin, ZJ; Lu, J; Zhou, WH; Shen, YQ				Lin, Zhijie; Lu, Jing; Zhou, Weihong; Shen, Yuequan			Structural Insights into TIR Domain Specificity of the Bridging Adaptor Mal in TLR4 Signaling	PLOS ONE			English	Article							KAPPA-B ACTIVATION; CRYSTAL-STRUCTURE; RECEPTOR DOMAIN; GENETIC-VARIATIONS; TRANSDUCTION; REVEALS; MOLECULE; SEPSIS; DIMERIZATION; TUBERCULOSIS	MyD88 adaptor-like protein (Mal) is a crucial adaptor that acts as a bridge to recruit the MyD88 molecule to activated TLR4 receptors in response to invading pathogens. The specific assembly of the Toll/interleukin-1 receptor (TIR) domains of TLR4, Mal and MyD88 is responsible for proper signal transduction in the TLR4 signaling pathway. However, the molecular mechanism for the specificity of these TIR domains remains unclear. Here, we present the crystal structure of the TIR domain of the human Mal molecule (Mal-TIR) at a resolution of 2.4 angstrom. Unexpectedly, Mal-TIR exhibits an extraordinarily long AB loop, but no alpha B helix or BB loop, distinguishing it from other TIR domains. More importantly, the Mal-TIR AB loop is capable of mediating direct binding to the TIR domains of TLR4 and MyD88 simultaneously. We also found that Mal-TIR can form a back-to-back dimer that may resemble the dimeric assembly of the entire Mal molecule. Our data demonstrate the bridge role of the Mal-TIR domain and provide important information about TIR domain specificity.	[Lin, Zhijie; Lu, Jing; Zhou, Weihong; Shen, Yuequan] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Lin, Zhijie; Lu, Jing; Zhou, Weihong; Shen, Yuequan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Shen, YQ (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	yuequan74@yahoo.com	Shen, Yuequan/C-8950-2013; Lin, Zhijie/Y-4836-2019	Shen, Yuequan/0000-0002-3775-0900; LU, JINJIAN/0000-0001-6703-3120; yuanjia, Hu/0000-0001-5244-8577	973 Program [2007CB914301, 2009CB825504]; NSFC [31170684]; TBR [08QTPTJC28200, 08SYSYTC00200]	973 Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); TBR	This work was funded by the 973 Program (grants 2007CB914301 and 2009CB825504), NSFC (grant 31170684) and the TBR program (grants 08QTPTJC28200 and 08SYSYTC00200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; An Y, 2011, INT J MOL MED, V27, P795, DOI 10.3892/ijmm.2011.645; [Anonymous], ACTA CRYSTALLOGR D, V50, P760; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Castiblanco J, 2008, INFECT GENET EVOL, V8, P541, DOI 10.1016/j.meegid.2008.03.001; Chan SL, 2010, PROTEIN SCI, V19, P155, DOI 10.1002/pro.275; Chan SL, 2009, J BIOL CHEM, V284, P21386, DOI 10.1074/jbc.C109.007591; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Dissanayeke SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006698; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Durrani O, 2011, RHEUMATOLOGY, V50, P1760, DOI 10.1093/rheumatology/ker200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferwerda B, 2009, P NATL ACAD SCI USA, V106, P10272, DOI 10.1073/pnas.0811273106; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; George J, 2010, J IMMUNOL, V184, P3025, DOI 10.4049/jimmunol.0901156; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Kumpf O, 2010, CRIT CARE, V14, DOI 10.1186/cc9047; Li CS, 2005, J BIOL CHEM, V280, P26152, DOI 10.1074/jbc.M503262200; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Mansell A, 2004, J BIOL CHEM, V279, P37227, DOI 10.1074/jbc.C400289200; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Nagpal K, 2009, J BIOL CHEM, V284, P25742, DOI 10.1074/jbc.M109.014886; Nejentsev S, 2008, NAT GENET, V40, P261, DOI 10.1038/ng0308-261; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Piao W, 2008, J BIOL CHEM, V283, P3109, DOI 10.1074/jbc.M707400200; Song ZJ, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-168; Takashima K, 2009, BRIT J PHARMACOL, V157, P1250, DOI 10.1111/j.1476-5381.2009.00297.x; Toshchakov VY, 2011, J IMMUNOL, V186, P4819, DOI 10.4049/jimmunol.1002424; Toshchakov VU, 2005, J IMMUNOL, V175, P494, DOI 10.4049/jimmunol.175.1.494; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	52	129	129	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34202	10.1371/journal.pone.0034202	http://dx.doi.org/10.1371/journal.pone.0034202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087PX	22485159	Green Published, gold, Green Submitted			2022-12-27	WOS:000314775500001
J	Park, HK; Ha, MH; Park, SG; Kim, MN; Kim, BJ; Kim, W				Park, Hee Kuk; Ha, Myung-Ho; Park, Sang-Gue; Kim, Myeung Nam; Kim, Beom Joon; Kim, Wonyong			Characterization of the Fungal Microbiota (Mycobiome) in Healthy and Dandruff-Afflicted Human Scalps	PLOS ONE			English	Article							HUMAN SKIN; DERMATITIS; ETIOLOGY; YEAST	The human scalp harbors a vast community of microbial mutualists, the composition of which is difficult to elucidate as many of the microorganisms are not culturable using current culture techniques. Dandruff, a common scalp disorder, is known as a causative factor of a mild seborrheic dermatitis as well as pityriasis versicolor, seborrheic dermatitis, and atopic dermatitis. Lipophilic yeast Malassezia is widely accepted to play a role in dandruff, but relatively few comprehensive studies have been reported. In order to investigate fungal biota and genetic resources of dandruff, we amplified the 26S rRNA gene from samples of healthy scalps and dandruff-afflicted scalps. The sequences were analyzed by a high throughput method using a GS-FLX 454 pyrosequencer. Of the 74,811 total sequence reads, Basidiomycota (Filobasidium spp.) was the most common phylum associated with dandruff. In contrast, Ascomycota (Acremonium spp.) was common in the healthy scalps. Our results elucidate the distribution of fungal communities associated with dandruff and provide new avenues for the potential prevention and treatment of dandruff.	[Park, Hee Kuk; Kim, Wonyong] Chung Ang Univ, Dept Microbiol, Seoul 156756, South Korea; [Kim, Myeung Nam; Kim, Beom Joon] Chung Ang Univ, Coll Med, Dept Dermatol, Seoul 156756, South Korea; [Ha, Myung-Ho; Park, Sang-Gue] Chung Ang Univ, Dept Appl Stat, Fac Business & Econ, Seoul 156756, South Korea	Chung Ang University; Chung Ang University; Chung Ang University Hospital; Chung Ang University	Park, HK (corresponding author), Chung Ang Univ, Dept Microbiol, Seoul 156756, South Korea.	kimwy@cau.ac.kr	Park, Heekuk/Y-2097-2019; PARK, Sang-Gue/V-7768-2019; Park, Heekuk/G-5292-2016	Park, Heekuk/0000-0001-5815-9717; Park, Heekuk/0000-0001-5815-9717; FERKO, Boris/0000-0001-5340-4437; Kim, Beom Joon/0000-0003-2320-7621	Ministry for Health & Welfare, Republic of Korea [A085138]	Ministry for Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant of the Korea Healthcare Technology Research & Development Project, Ministry for Health & Welfare, Republic of Korea (A085138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Butler G, 2010, CLIN MICROBIOL REV, V23, P140, DOI 10.1128/CMR.00053-09; Das S, 2010, MYCOPATHOLOGIA, V170, P361, DOI 10.1007/s11046-010-9334-1; Erchiga VC, 2002, CURR OPIN INFECT DIS, V15, P133, DOI 10.1097/00001432-200204000-00006; Geyer AS, 2006, J AM ACAD DERMATOL, V55, P1095, DOI 10.1016/j.jaad.2006.08.001; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Gueho E, 1998, MED MYCOL, V36, P220; Gupta AK, 2004, DERMATOLOGY, V208, P89, DOI 10.1159/000076478; Gupta AK, 2001, MED MYCOL, V39, P199, DOI 10.1080/mmy.39.2.199.206; Gupta M, 2007, INDIAN J DERMATOL VE, V73, P389; Jo JH, 2005, CONTACT DERMATITIS, V52, P142, DOI 10.1111/j.0105-1873.2005.00528.x; 박주희, 2009, [Korean Journal of Dermatology, 대한피부과학회지], V47, P875; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; LEYDEN JJ, 1976, ARCH DERMATOL, V112, P333, DOI 10.1001/archderm.112.3.333; MCGINLEY KJ, 1975, J INVEST DERMATOL, V64, P401, DOI 10.1111/1523-1747.ep12512335; Miyazaki J, 1996, J FERMENT BIOENG, V81, P315, DOI 10.1016/0922-338X(96)80583-6; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Ohtake S, 2011, J PHARM SCI-US, V100, P2020, DOI 10.1002/jps.22458; PERFECT JR, 2006, FUNGAL PATHOGENESIS, P3; Pierard G E, 1995, Skin Res Technol, V1, P137, DOI 10.1111/j.1600-0846.1995.tb00033.x; Pierard-Franchimont C., 2006, International Journal of Cosmetic Science, V28, P311, DOI 10.1111/j.1467-2494.2006.00326.x; Pierard-Franchimont C, 2000, DERMATOLOGY, V200, P93, DOI 10.1159/000018337; Prohic Asja, 2003, Acta Dermatovenerol Croat, V11, P10; Ranganathan S, 2010, Indian J Dermatol, V55, P130, DOI 10.4103/0019-5154.62734; Ro BI, 2005, J INVEST DERM SYMP P, V10, P194, DOI 10.1111/j.1087-0024.2005.10104.x; Sugita T, 2002, J CLIN MICROBIOL, V40, P1363, DOI 10.1128/JCM.40.4.1363-1367.2002	27	255	268	7	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32847	10.1371/journal.pone.0032847	http://dx.doi.org/10.1371/journal.pone.0032847			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22761928	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500109
J	Wang, DH; Hu, JR; Wang, LY; Hu, YJ; Tan, FQ; Zhou, H; Shao, JZ; Yang, WX				Wang, Da-Hui; Hu, Jian-Rao; Wang, Li-Ya; Hu, Yan-Jun; Tan, Fu-Qing; Zhou, Hong; Shao, Jian-Zhong; Yang, Wan-Xi			The Apoptotic Function Analysis of p53, Apaf1, Caspase3 and Caspase7 during the Spermatogenesis of the Chinese Fire-Bellied Newt Cynops orientalis	PLOS ONE			English	Article							GERM-CELL APOPTOSIS; CADMIUM-INDUCED APOPTOSIS; FOLLICLE-STIMULATING-HORMONE; GLUCOSE-METABOLISM; OXIDATIVE STRESS; STRUCTURAL BASIS; DNA-DAMAGE; SPERMATOGONIAL APOPTOSIS; TESTOSTERONE WITHDRAWAL; SIGNALING PATHWAY	Background: Spontaneous and stress-induced germ cell apoptosis during spermatogenesis of multicellular organisms have been investigated broadly in mammals. Spermatogenetic process in urodele amphibians was essentially like that in mammals in spite of morphological differences; however, the mechanism of germ cell apoptosis in urodele amphibians remains unknown. The Chinese fire-belly newt, Cynops orientalis, was an excellent organism for studying germ cell apoptosis due to its sensitiveness to temperature, strong endurance of starvation, and sensitive skin to heavy metal exposure. Methodology/Principal Findings: TUNEL result showed that spontaneous germ cell apoptosis took place in normal newt, and severe stress-induced apoptosis occurred to spermatids and sperm in response to heat shock (40 degrees C 2 h), cold exposure(4 degrees C 12 h), cadmium exposure(Cd 36 h), and starvation stress. Quantitative reverse transcription polymerase chain reactions (qRT-PCR) showed that gene expression of Caspase3 or Caspase7 was obviously elevated after stress treatment. Apaf1 was not altered at its gene expression level, and p53 was significantly decreased after various stress treatment. Caspase assay demonstrated that Caspase-3, -8,-9 enzyme activities in newt testis were significantly elevated after heat shock (40 degrees C 2 h), cold exposure(4 degrees C 12 h), and cadmium exposure(Cd 36 h), while Caspase3 and Caspase8 activities were increased with Caspase9 significantly decreased after starvation treatment. Conclusions/Significance: Severe germ cell apoptosis triggered by heat shock, cold exposure, and cadmium exposure was Caspase3 dependent, which probably involved both extrinsic and intrinsic pathways. Apaf1 may be involved in this process without elevating its gene expression. But starvation-induced germ cell apoptosis was likely mainly through extrinsic pathway. p53 was probably not responsible for stress-induced germ cell apoptosis in newt testis. The intriguing high occurrence of spermatid and sperm apoptosis probably resulted from the sperm morphology and unique reproduction policy of Chinese fire-belly newt, Cynops orientalis.	[Wang, Da-Hui; Zhou, Hong; Shao, Jian-Zhong; Yang, Wan-Xi] Zhejiang Univ, Coll Life Sci, Sperm Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Jian-Rao] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Wang, Li-Ya; Hu, Yan-Jun] Zhejiang Univ, Womens Hosp, Sch Med, Dept Reprod Endocrinol, Hangzhou 310003, Zhejiang, Peoples R China; [Tan, Fu-Qing] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Hangzhou Normal University; Zhejiang University; Zhejiang University	Wang, DH (corresponding author), Zhejiang Univ, Coll Life Sci, Sperm Lab, Hangzhou 310003, Zhejiang, Peoples R China.	wxyang@spermlab.org	Yang, Wan-Xi/D-4401-2011	wang, dahui/0000-0001-6435-5132; Yang, Wan-Xi/0000-0001-5695-0150; Yang, Wan-Xi/0000-0001-9304-195X	National Natural Science Foundation of China [31072198, 81100393]; National Basic Research Program of China (973 Program) [2012CB967902]; Zhejiang Provincial Natural Science Foundation of China [Y2100296]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported in part by the following projects: National Natural Science Foundation of China (No. 31072198 and 81100393), the National Basic Research Program of China (973 Program, Grant number: No. 2012CB967902), Zhejiang Provincial Natural Science Foundation of China (No. Y2100296). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE SI, 1994, INT J DEV BIOL, V38, P201; ALLAN DJ, 1992, CELL PROLIFERAT, V25, P241, DOI 10.1111/j.1365-2184.1992.tb01399.x; Allemand I, 1999, ONCOGENE, V18, P6521, DOI 10.1038/sj.onc.1203052; Allsopp TE, 2000, CELL DEATH DIFFER, V7, P984, DOI 10.1038/sj.cdd.4400733; BAKALKIN G, 1994, P NATL ACAD SCI USA, V91, P413, DOI 10.1073/pnas.91.1.413; BARTKE A, 1995, ENDOCRINOLOGY, V136, P3, DOI 10.1210/en.136.1.3; Bernal-Manas CM, 2005, ACTA HISTOCHEM, V107, P365, DOI 10.1016/j.acthis.2005.07.002; Beumer TL, 1997, MOL REPROD DEV, V47, P240, DOI 10.1002/(SICI)1098-2795(199707)47:3&lt;240::AID-MRD2&gt;3.0.CO;2-L; Beumer TL, 1998, CELL DEATH DIFFER, V5, P669, DOI 10.1038/sj.cdd.4400396; BILLIG H, 1995, ENDOCRINOLOGY, V136, P5, DOI 10.1210/en.136.1.5; Blanco-Rodriguez J, 2003, REPRODUCTION, V126, P661, DOI 10.1530/reprod/126.5.661; Bonini P, 2004, J NEUROSCI RES, V75, P83, DOI 10.1002/jnr.10822; BRINKWORTH MH, 1995, J REPROD FERTIL, V105, P25, DOI 10.1530/jrf.0.1050025; CANMAN CE, 1995, GENE DEV, V9, P600, DOI 10.1101/gad.9.5.600; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; CHOWDHURY AK, 1964, AM J ANAT, V115, P509, DOI 10.1002/aja.1001150307; Ciesielska AS, 2000, TOXICOLOGY, V145, P171; Coureui M, 2006, CELL DEATH DIFFER, V13, P1927, DOI 10.1038/sj.cdd.4401887; de Rooij DG, 1998, CURR OPIN CELL BIOL, V10, P694, DOI 10.1016/S0955-0674(98)80109-9; Ekert PG, 2005, CURR OPIN CELL BIOL, V17, P626, DOI 10.1016/j.ceb.2005.09.001; Ekert PG, 2004, J CELL BIOL, V165, P835, DOI 10.1083/jcb.200312031; Embree-Ku M, 2002, BIOL REPROD, V66, P1456, DOI 10.1095/biolreprod66.5.1456; Fadeel B, 2008, CELL DEATH DIFFER, V15, P443, DOI 10.1038/sj.cdd.4402265; Furuchi T, 1996, DEVELOPMENT, V122, P1703; Glander HJ, 2002, ANDROLOGIA, V34, P227, DOI 10.1046/j.1439-0272.2002.00501.x; Gordo S, 2008, P NATL ACAD SCI USA, V105, P16426, DOI 10.1073/pnas.0805658105; Gosden R, 1997, BRIT MED BULL, V53, P644; Hall JL, 2001, DIABETES, V50, P1171, DOI 10.2337/diabetes.50.5.1171; Hamroun D, 2006, HUM MUTAT, V27, P14, DOI 10.1002/humu.20269; Hasegawa M, 1998, RADIAT RES, V149, P263, DOI 10.2307/3579959; Hassoun EA, 1996, TOXICOLOGY, V112, P219, DOI 10.1016/0300-483X(96)03404-X; HECKERT L, 1993, RECENT PROG HORM RES, V48, P61; HENRIKSEN K, 1995, ENDOCRINOLOGY, V136, P3285, DOI 10.1210/en.136.8.3285; HEW KW, 1993, TOXICOL APPL PHARM, V121, P15, DOI 10.1006/taap.1993.1123; Hikim APS, 1997, BIOL REPROD, V57, P1193, DOI 10.1095/biolreprod57.5.1193; Hikim APS, 1999, REV REPROD, V4, P38; Hikim APS, 2003, J STEROID BIOCHEM, V85, P175, DOI 10.1016/S0960-0760(03)00193-6; HIKIM APS, 1995, ENDOCRINOLOGY, V136, P2770, DOI 10.1210/en.136.6.2770; Hikim APS, 1998, J CLIN ENDOCR METAB, V83, P152; Ho WC, 2006, J BIOL CHEM, V281, P20494, DOI 10.1074/jbc.M603634200; Honarpour N, 2000, DEV BIOL, V218, P248, DOI 10.1006/dbio.1999.9585; HUCKINS C, 1978, ANAT REC, V190, P905, DOI 10.1002/ar.1091900410; Hueber AO, 1997, SCIENCE, V278, P1305, DOI 10.1126/science.278.5341.1305; Ji YL, 2010, REPROD TOXICOL, V29, P176, DOI 10.1016/j.reprotox.2009.10.014; Ji Zai-Si, 1994, Zygote, V2, P53; Jimi S, 2004, ANN NY ACAD SCI, V1011, P325, DOI 10.1196/annals.1293.032; Kasahara E, 2002, BIOCHEM J, V365, P849, DOI 10.1042/BJ20020254; Kaufmann SH, 2001, TRENDS CELL BIOL, V11, P526, DOI 10.1016/S0962-8924(01)02173-0; Kilic M, 2002, CELL DEATH DIFFER, V9, P125, DOI 10.1038/sj/cdd/4400968; Kim J, 2009, TOXICOL LETT, V188, P45, DOI 10.1016/j.toxlet.2009.03.006; Kim MS, 2000, TOXICOLOGY, V145, P27, DOI 10.1016/S0300-483X(99)00176-6; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kondoh M, 2002, TOXICOLOGY, V170, P111, DOI 10.1016/S0300-483X(01)00536-4; KRAJEWSKI S, 1994, AM J PATHOL, V145, P1323; Lafuente A, 2004, TOXICOL LETT, V146, P175, DOI 10.1016/j.toxlet.2003.10.004; Lafuente A, 2003, BIOMETALS, V16, P243, DOI 10.1023/A:1020658128413; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; LASKEY JW, 1991, TOXICOL APPL PHARM, V108, P296, DOI 10.1016/0041-008X(91)90119-Y; Lee J, 1999, ENDOCRINOLOGY, V140, P852, DOI 10.1210/en.140.2.852; Lee JW, 1997, ENDOCRINOLOGY, V138, P2081, DOI 10.1210/en.138.5.2081; LEE S, 1995, CELL, V81, P1013, DOI 10.1016/S0092-8674(05)80006-6; Li LH, 1996, J ANDROL, V17, P538; Li M, 2000, J BIOL CHEM, V275, P39702, DOI 10.1074/jbc.M007369200; Lia MY, 2011, FISH SHELLFISH IMMUN, V30, P910, DOI 10.1016/j.fsi.2011.01.018; Liao CH, 2010, ENDOCR-RELAT CANCER, V17, P99, DOI 10.1677/ERC-09-0050; Liu J, 2001, LIFE SCI, V69, P1833, DOI 10.1016/S0024-3205(01)01267-X; LOCKSHIN RA, 1964, J INSECT PHYSIOL, V10, P643, DOI 10.1016/0022-1910(64)90034-4; Lomb DJ, 2009, MOL PHARMACOL, V75, P1198, DOI 10.1124/mol.108.053157; Lue Y, 1997, J ANDROL, V18, P166; Lue YH, 1999, ENDOCRINOLOGY, V140, P1709, DOI 10.1210/en.140.4.1709; Lue YH, 2000, ENDOCRINOLOGY, V141, P1414, DOI 10.1210/en.141.4.1414; Mason EF, 2011, BBA-MOL CELL RES, V1813, P645, DOI 10.1016/j.bbamcr.2010.08.011; Matsui Y, 1998, APMIS, V106, P142, DOI 10.1111/j.1699-0463.1998.tb01329.x; McClure RF, 1999, J BIOL CHEM, V274, P7756, DOI 10.1074/jbc.274.12.7756; MIEUSSET R, 1995, INT J ANDROL, V18, P169, DOI 10.1111/j.1365-2605.1995.tb00408.x; Morissette MR, 2003, J MOL CELL CARDIOL, V35, P1217, DOI 10.1016/S0022-2828(03)00212-8; Nandi S, 1999, BIOL REPROD, V61, P70, DOI 10.1095/biolreprod61.1.70; Nowicki A, 1996, INT J CANCER, V65, P112, DOI 10.1002/(SICI)1097-0215(19960103)65:1<112::AID-IJC19>3.3.CO;2-R; OBEROSLER P, 1993, EMBO J, V12, P2389, DOI 10.1002/j.1460-2075.1993.tb05893.x; ODonnell L, 1996, BIOL REPROD, V55, P895, DOI 10.1095/biolreprod55.4.895; Ohta H, 2003, BIOL REPROD, V68, P2249, DOI 10.1095/biolreprod.102.014779; Ozawa N, 2002, J CLIN INVEST, V109, P457, DOI [10.1172/JCI0213190, 10.1172/JCI200213190]; Paasch U, 2003, J ANDROL, V24, P246; PACKER AI, 1995, MOL REPROD DEV, V42, P303, DOI 10.1002/mrd.1080420307; Pant N, 2003, REPROD TOXICOL, V17, P447, DOI 10.1016/S0890-6238(03)00036-4; Pareek TK, 2007, APOPTOSIS, V12, P1085, DOI 10.1007/s10495-006-0039-3; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Print CG, 2000, BIOESSAYS, V22, P423, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;423::AID-BIES4&gt;3.0.CO;2-0; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; RAGAN HA, 1990, REV ENVIRON CONTAM T, V114, P1; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Reubold TF, 2011, STRUCTURE, V19, P1074, DOI 10.1016/j.str.2011.05.013; Richburg JH, 2000, TOXICOL LETT, V112, P79, DOI 10.1016/S0378-4274(99)00253-2; Ricote M, 2002, MOL REPROD DEV, V63, P202, DOI 10.1002/mrd.10167; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; ROBERTS KP, 1991, ANN NY ACAD SCI, V637, P90, DOI 10.1111/j.1749-6632.1991.tb27303.x; Rodriguez I, 1997, EMBO J, V16, P2262, DOI 10.1093/emboj/16.9.2262; Roy A, 2011, JOVE-J VIS EXP, DOI 10.3791/3259; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Russell LD, 2002, BIOL REPROD, V66, P950, DOI 10.1095/biolreprod66.4.950; Said TM, 2004, HUM REPROD UPDATE, V10, P39, DOI 10.1093/humupd/dmh003; Salazar G, 2005, DEV DYNAM, V234, P114, DOI 10.1002/dvdy.20533; Schamberger CJ, 2005, EXP CELL RES, V302, P115, DOI 10.1016/j.yexcr.2004.08.026; Sen Gupta R, 2004, MOL CELL ENDOCRINOL, V221, P57, DOI 10.1016/j.mce.2004.03.012; Siu ER, 2009, TOXICOL APPL PHARM, V238, P240, DOI 10.1016/j.taap.2009.01.028; Speidel D, 2010, TRENDS CELL BIOL, V20, P14, DOI 10.1016/j.tcb.2009.10.002; STOCCO DM, 1993, ENDOCRINOLOGY, V133, P2827, DOI 10.1210/en.133.6.2827; Stohs Sidney J., 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P201; Thangaraju M, 2000, J BIOL CHEM, V275, P33487, DOI 10.1074/jbc.M005824200; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Vera Y, 2004, BIOL REPROD, V70, P1534, DOI 10.1095/biolreprod.103.024661; Vera Y, 2006, MOL ENDOCRINOL, V20, P1597, DOI 10.1210/me.2005-0395; Vousden KH, 2006, J CELL SCI, V119, P5015, DOI 10.1242/jcs.03293; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang Q, 2010, TOXICOL LETT, V199, P129, DOI 10.1016/j.toxlet.2010.08.014; Wang X, 2003, FERTIL STERIL, V80, P531, DOI 10.1016/S0015-0282(03)00756-8; Weng SL, 2002, MOL HUM REPROD, V8, P984, DOI 10.1093/molehr/8.11.984; Wolgemuth DJ, 2003, CYTOGENET GENOME RES, V103, P256, DOI 10.1159/000076811; Woolveridge L, 1999, BIOL REPROD, V60, P461, DOI 10.1095/biolreprod60.2.461; Wu XD, 2002, REPROD TOXICOL, V16, P379, DOI 10.1016/S0890-6238(02)00039-4; Xu CY, 1996, TOXICOLOGY, V107, P1, DOI 10.1016/0300-483X(95)03195-L; Xu GG, 2010, BIOL REPROD, V83, P979, DOI 10.1095/biolreprod.110.085415; Xu Jian, 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P25; Yan N, 2005, ANNU REV CELL DEV BI, V21, P35, DOI 10.1146/annurev.cellbio.21.012704.131040; Yang JM, 2003, REPROD TOXICOL, V17, P553, DOI 10.1016/S0890-6238(03)00100-X; Yazawa T, 1999, GEN COMP ENDOCR, V113, P302, DOI 10.1006/gcen.1998.7207; Yazawa T, 2000, ENDOCRINOLOGY, V141, P2027, DOI 10.1210/en.141.6.2027; Yazawa T, 2003, MOL REPROD DEV, V66, P60, DOI 10.1002/mrd.10328; Yazawa T, 2001, GEN COMP ENDOCR, V122, P296, DOI 10.1006/gcen.2001.7631; Yazawa T, 2001, MOL REPROD DEV, V59, P209, DOI 10.1002/mrd.1024; Yin YZ, 1998, BIOL REPROD, V58, P492, DOI 10.1095/biolreprod58.2.492; Yin YZ, 1998, DEV BIOL, V204, P165, DOI 10.1006/dbio.1998.9074; Yin YZ, 2002, J ANDROL, V23, P64, DOI 10.1002/jand.2002.23.1.64; Young KA, 1999, ENDOCRINOLOGY, V140, P3133, DOI 10.1210/en.140.7.3133; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006; Yuan SJ, 2010, STRUCTURE, V18, P571, DOI 10.1016/j.str.2010.04.001; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang ZH, 2003, CONTRACEPTION, V68, P297, DOI 10.1016/S0010-7824(03)00176-8; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07; Zhao YX, 2008, J BIOL CHEM, V283, P36344, DOI 10.1074/jbc.M803580200; Zheng H, 1996, TOXICOL APPL PHARM, V136, P229, DOI 10.1006/taap.1996.0029; Zhou T, 1999, TOXICOLOGY, V142, P1, DOI 10.1016/S0300-483X(99)00115-8; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	147	117	120	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39920	10.1371/journal.pone.0039920	http://dx.doi.org/10.1371/journal.pone.0039920			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22808142	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100139
J	Shiryaev, SA; Cheltsov, AV; Strongin, AY				Shiryaev, Sergey A.; Cheltsov, Anton V.; Strongin, Alex Y.			Probing of Exosites Leads to Novel Inhibitor Scaffolds of HCV NS3/4A Proteinase	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; WEST-NILE-VIRUS; SERINE-PROTEASE INHIBITORS; NS4A COFACTOR PEPTIDE; IN-VITRO RESISTANCE; MACROCYCLIC INHIBITORS; POLYMERASE INHIBITORS; ANTIVIRAL THERAPY; DRUG-RESISTANCE; DENGUE-VIRUS	Background: Hepatitis C is a treatment-resistant disease affecting millions of people worldwide. The hepatitis C virus (HCV) genome is a single-stranded RNA molecule. After infection of the host cell, viral RNA is translated into a polyprotein that is cleaved by host and viral proteinases into functional, structural and non-structural, viral proteins. Cleavage of the polyprotein involves the viral NS3/4A proteinase, a proven drug target. HCV mutates as it replicates and, as a result, multiple emerging quasispecies become rapidly resistant to anti-virals, including NS3/4A inhibitors. Methodology/Principal Findings: To circumvent drug resistance and complement the existing anti-virals, NS3/4A inhibitors, which are additional and distinct from the FDA-approved telaprevir and boceprevir alpha-ketoamide inhibitors, are required. To test potential new avenues for inhibitor development, we have probed several distinct exosites of NS3/4A which are either outside of or partially overlapping with the active site groove of the proteinase. For this purpose, we employed virtual ligand screening using the 275,000 compound library of the Developmental Therapeutics Program (NCI/NIH) and the X-ray crystal structure of NS3/4A as a ligand source and a target, respectively. As a result, we identified several novel, previously uncharacterized, nanomolar range inhibitory scaffolds, which suppressed of the NS3/4A activity in vitro and replication of a sub-genomic HCV RNA replicon with a luciferase reporter in human hepatocarcinoma cells. The binding sites of these novel inhibitors do not significantly overlap with those of alpha-ketoamides. As a result, the most common resistant mutations, including V36M, R155K, A156T, D168A and V170A, did not considerably diminish the inhibitory potency of certain novel inhibitor scaffolds we identified. Conclusions/Significance: Overall, the further optimization of both the in silico strategy and software platform we developed and lead compounds we identified may lead to advances in novel anti-virals.	[Shiryaev, Sergey A.; Strongin, Alex Y.] Sanford Burnham Med Res Inst, Inflammatory & Infect Dis Ctr, La Jolla, CA USA; [Cheltsov, Anton V.] Q MOL LLC, R&D Dept, San Diego, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Shiryaev, SA (corresponding author), Sanford Burnham Med Res Inst, Inflammatory & Infect Dis Ctr, La Jolla, CA USA.	anton@q-mol.com; strongin@sanfordburnham.org	Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	National Institutes of Health [R01CA83017, R01CA157328]; NIAID [HHSN272201000009C]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by National Institutes of Health grants R01CA83017 and R01CA157328 to Alex Y. Strongin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Marintha Heil (Southern Research Institute, Birmingham, AL) for performing tests in human hepatocarcinoma cell line Huh7 ET (luc-ubi-neo/ET) that exhibits a sub-genomic HCV RNA replicon with a firefly luciferase reporter (NIAID Contract No. HHSN272201000009C). The authors are also grateful to Drs. Nicholas Cosford and Robert Ardecky (Sanford-Burnham Medical Research Institute, La Jolla, CA) for their expert support in performing our study.	Barbato G, 1999, J MOL BIOL, V289, P371, DOI 10.1006/jmbi.1999.2745; BARTENSCHLAGER R, 1993, J VIROL, V67, P3835, DOI 10.1128/JVI.67.7.3835-3844.1993; Bennett F, 2010, BIOORG MED CHEM LETT, V20, P2617, DOI 10.1016/j.bmcl.2010.02.063; Buhler S, 2012, LIVER INT, V32, P9, DOI 10.1111/j.1478-3231.2011.02701.x; Chen X, 2002, J CHEM INF COMP SCI, V42, P1407, DOI 10.1021/ci025531g; Chevaliez S., 2006, HEPATITIS C VIRUSES, V1, P5; Cubero M, 2008, VIROLOGY, V370, P237, DOI 10.1016/j.virol.2007.10.006; Delang L, 2011, ANTIMICROB AGENTS CH, V55, P4103, DOI 10.1128/AAC.00294-11; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Fan XF, 2009, HEPATOLOGY, V50, P1765, DOI 10.1002/hep.23290; Flores MV, 2009, BBA-PROTEINS PROTEOM, V1794, P1441, DOI 10.1016/j.bbapap.2009.06.004; Fonseca-Coronado S, 2012, J CLIN MICROBIOL, V50, P281, DOI 10.1128/JCM.05842-11; Fusco DN, 2012, ANNU REV MED, V63, P373, DOI 10.1146/annurev-med-042010-085715; Gawlik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005031; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Hagel M, 2011, NAT CHEM BIOL, V7, P22, DOI 10.1038/NCHEMBIO.492; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; He Y, 2008, ANTIMICROB AGENTS CH, V52, P1101, DOI 10.1128/AAC.01149-07; Hinrichsen H, 2004, GASTROENTEROLOGY, V127, P1347, DOI 10.1053/j.gastro.2004.08.002; Hiraga N, 2011, HEPATOLOGY, V54, P781, DOI 10.1002/hep.24460; Jesudian Arun B, 2012, Gastroenterol Hepatol (N Y), V8, P91; Johnston PA, 2007, ASSAY DRUG DEV TECHN, V5, P737, DOI 10.1089/adt.2007.101; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kieffer TL, 2007, HEPATOLOGY, V46, P631, DOI 10.1002/hep.21781; Kieffer TL, 2010, J ANTIMICROB CHEMOTH, V65, P202, DOI 10.1093/jac/dkp388; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Kwo PY, 2011, GUT LIVER, V5, P406, DOI 10.5009/gnl.2011.5.4.406; Kwong AD, 1999, ANTIVIR RES, V41, P65; Kwong AD, 2011, NAT BIOTECHNOL, V29, P993, DOI 10.1038/nbt.2020; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09; Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200; Lin C, 2004, J BIOL CHEM, V279, P17508, DOI 10.1074/jbc.M313020200; Lin C, 2005, J BIOL CHEM, V280, P36784, DOI 10.1074/jbc.M506462200; LIN C, 1995, J VIROL, V69, P4373, DOI 10.1128/JVI.69.7.4373-4380.1995; Liverton NJ, 2010, ANTIMICROB AGENTS CH, V54, P305, DOI 10.1128/AAC.00677-09; Llinas-Brunet M, 2004, J MED CHEM, V47, P1605, DOI 10.1021/jm0342414; Ma C, 2011, ACS COMB SCI, V13, P223, DOI 10.1021/co100033m; Malcolm BA, 2006, ANTIMICROB AGENTS CH, V50, P1013, DOI 10.1128/AAC.50.3.1013-1020.2006; Manns MP, 2007, NAT REV DRUG DISCOV, V6, P991, DOI 10.1038/nrd2411; Margeridon-Thermet S, 2010, VIRUSES-BASEL, V2, P2696, DOI 10.3390/v2122696; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Morikawa K, 2011, J VIRAL HEPATITIS, V18, P305, DOI 10.1111/j.1365-2893.2011.01451.x; Nicholls A, 2010, J MED CHEM, V53, P3862, DOI 10.1021/jm900818s; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Ortqvist P, 2010, ANTIVIR THER, V15, P841, DOI 10.3851/IMP1655; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; Raboisson P, 2008, BIOORG MED CHEM LETT, V18, P4853, DOI 10.1016/j.bmcl.2008.07.088; Romano KP, 2010, P NATL ACAD SCI USA, V107, P20986, DOI 10.1073/pnas.1006370107; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Schaefer EAK, 2012, GASTROENTEROLOGY, V142, P1340, DOI 10.1053/j.gastro.2012.02.015; Seiwert SD, 2008, ANTIMICROB AGENTS CH, V52, P4432, DOI 10.1128/AAC.00699-08; Shimizu Y, 1996, J VIROL, V70, P127, DOI 10.1128/JVI.70.1.127-132.1996; Shiryaev SA, 2007, J VIROL, V81, P4501, DOI 10.1128/JVI.02719-06; Shiryaev SA, 2007, PROTEIN EXPRES PURIF, V52, P334, DOI 10.1016/j.pep.2006.11.009; Shiryaev SA, 2007, BIOCHEM J, V401, P743, DOI 10.1042/BJ20061136; Shiryaev SA, 2011, ASSAY DRUG DEV TECHN, V9, P69, DOI 10.1089/adt.2010.0309; Sidique S, 2009, BIOORG MED CHEM LETT, V19, P5773, DOI 10.1016/j.bmcl.2009.07.150; Stempniak M, 1997, J VIROL, V71, P2881, DOI 10.1128/JVI.71.4.2881-2886.1997; Susser S, 2009, HEPATOLOGY, V50, P1709, DOI 10.1002/hep.23192; Urbani A, 1999, BIOCHEMISTRY-US, V38, P5206, DOI 10.1021/bi982773u; Venkatraman S, 2009, BIOORG MED CHEM LETT, V19, P180, DOI 10.1016/j.bmcl.2008.10.124; Vermehren J, 2012, J VIRAL HEPATITIS, V19, P120, DOI 10.1111/j.1365-2893.2011.01449.x; Vermehren J, 2011, EUR J MED RES, V16, P303, DOI 10.1186/2047-783X-16-7-303; Vicenti I, 2012, J ANTIMICROB CHEMOTH, V67, P984, DOI 10.1093/jac/dkr581; Welsch C, 2012, GUT, V61, P36, DOI 10.1136/gutjnl-2012-302144; Wolynes PG, 1997, P NATL ACAD SCI USA, V94, P6170, DOI 10.1073/pnas.94.12.6170; Zhou Y, 2008, ANTIMICROB AGENTS CH, V52, P110, DOI 10.1128/AAC.00863-07; Zhu HM, 2011, PROTEINS, V79, P2428, DOI 10.1002/prot.23064	75	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40029	10.1371/journal.pone.0040029	http://dx.doi.org/10.1371/journal.pone.0040029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768327	Green Submitted, gold, Green Published			2022-12-27	WOS:000305966500040
J	Wang, GY; Zhang, JW; Liu, LY; Sharma, S; Dong, QH				Wang, Guanyu; Zhang, Jiawei; Liu, Luying; Sharma, Sherven; Dong, Qinghua			Quercetin Potentiates Doxorubicin Mediated Antitumor Effects against Liver Cancer through p53/Bcl-xl	PLOS ONE			English	Article							INDUCED APOPTOSIS; P-GLYCOPROTEIN; HEPATOCELLULAR-CARCINOMA; CELLS; EXPRESSION; FLAVONOIDS; CARDIOTOXICITY; MITOCHONDRIA; ADRIAMYCIN; TOXICITY	Background: The dose-dependent toxicities of doxorubicin (DOX) limit its clinical applications, particularly in drug-resistant cancers, such as liver cancer. In this study, we investigated the role of quercetin on the antitumor effects of DOX on liver cancer cells and its ability to provide protection against DOX-mediated liver damage in mice. Methodology and Results: The MTT and Annexin V/PI staining assay demonstrated that quercetin selectively sensitized DOX-induced cytotoxicity against liver cancer cells while protecting normal liver cells. The increase in DOX-mediated apoptosis in hepatoma cells by quercetin was p53-dependent and occurred by downregulating Bcl-xl expression. Z-VAD-fmk (caspase inhibitor), pifithrin-alpha (p53 inhibitor), or overexpressed Bcl-xl decreased the effects of quercetin on DOX-mediated apoptosis. The combined treatment of quercetin and DOX significantly reduced the growth of liver cancer xenografts in mice. Moreover, quercetin decreased the serum levels of alanine aminotransferase and aspartate aminotransferase that were increased in DOX-treated mice. Quercetin also reversed the DOX-induced pathological changes in mice livers. Conclusion and Significance: These results indicate that quercetin potentiated the antitumor effects of DOX on liver cancer cells while protecting normal liver cells. Therefore, the development of quercetin may be beneficial in a combined treatment with DOX for increased therapeutic efficacy against liver cancer.	[Dong, Qinghua] Zhejiang Univ, Sch Med, Biomed Res Ctr, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Guanyu] Zhejiang Univ, Sch Med, Dept Gen Surg, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Jiawei] Zhejiang Univ, Inst Canc, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Luying] Zhejiang Canc Hosp, Dept Radiotherapy, Hangzhou, Zhejiang, Peoples R China; [Sharma, Sherven] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Sharma, Sherven] W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA; [Dong, Qinghua] China Natl Minist Educ, Key Lab Canc Prevent & Intervent, Key Lab Canc Biotherapy Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang Cancer Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Dong, QH (corresponding author), Zhejiang Univ, Sch Med, Biomed Res Ctr, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China.	dongqinghua@zju.edu.cn	Wang, Ge/AAH-8592-2020; Vannier, Michael W/AAI-6951-2021; Yu, Hengyong/AAH-5726-2019	Wang, Ge/0000-0002-2656-7705; Yu, Hengyong/0000-0002-5852-0813; Vannier, Michael/0000-0001-9898-384X	National Natural Science Foundation of China [30400521]; Science Technology Department of Zhejiang Province [2012R10047, 2012C33116]; Education Department of Zhejiang Province [Y201224108]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011785] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Department of Zhejiang Province; Education Department of Zhejiang Province; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Natural Science Foundation of China (No.: 30400521), the Science Technology Department of Zhejiang Province (No.: 2012R10047 to QD and No.: 2012C33116 to GW) and the Education Department of Zhejiang Province (No.: Y201224108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshabanah OA, 2010, OXID MED CELL LONGEV, V3, P428, DOI 10.4161/oxim.3.6.14416; BENJAMIN RS, 1974, CANCER, V33, P19, DOI 10.1002/1097-0142(197401)33:1<19::AID-CNCR2820330107>3.0.CO;2-M; Bulucu F, 2009, BIOL TRACE ELEM RES, V132, P184, DOI 10.1007/s12011-009-8377-y; Chipuk JE, 2009, CELL CYCLE, V8, P2692, DOI 10.4161/cc.8.17.9412; Choi KC, 2010, FOOD CHEM TOXICOL, V48, P2747, DOI 10.1016/j.fct.2010.07.001; de David C, 2011, TOXICOL PATHOL, V39, P949, DOI 10.1177/0192623311418680; Donmez Y, 2011, CANCER CHEMOTH PHARM, V67, P823, DOI 10.1007/s00280-010-1385-y; Du GJ, 2010, INT IMMUNOPHARMACOL, V10, P819, DOI 10.1016/j.intimp.2010.04.018; Du GJ, 2010, CANCER CHEMOTH PHARM, V65, P277, DOI 10.1007/s00280-009-1032-7; Dudka J, 2005, BASIC CLIN PHARMACOL, V97, P74, DOI 10.1111/j.1742-7843.2005.pto_98.x; Duraj J, 2005, NEOPLASMA, V52, P273; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fotsis T, 1997, CANCER RES, V57, P2916; Gibellini L, 2011, EVID BASED COMPLEMEN; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Hovorka O, 2010, EUR J PHARM BIOPHARM, V76, P514, DOI 10.1016/j.ejpb.2010.07.008; Jing S, 2008, INT J HYPERTHER, V24, P151, DOI 10.1080/02656730701843109; Kahraman A, 2012, MOL BIOL REP, V39, P2789, DOI 10.1007/s11033-011-1037-2; Kaiserova H, 2007, BBA-MOL BASIS DIS, V1772, P1065, DOI 10.1016/j.bbadis.2007.05.002; Kawaii S, 1999, BIOSCI BIOTECH BIOCH, V63, P896, DOI 10.1271/bbb.63.896; Kebieche M, 2009, EXP TOXICOL PATHOL, V61, P161, DOI 10.1016/j.etp.2008.06.002; King PD, 2001, ONCOLOGIST, V6, P162, DOI 10.1634/theoncologist.6-2-162; Krizkova Jitka, 2009, Interdiscip Toxicol, V2, P201, DOI 10.2478/v10102-009-0018-y; Li L, 2006, BIOCHEM PHARMACOL, V71, P584, DOI 10.1016/j.bcp.2005.11.026; Limtrakul P, 2005, J CHEMOTHERAPY, V17, P86, DOI 10.1179/joc.2005.17.1.86; Llambi F, 2011, CURR OPIN GENET DEV, V21, P12, DOI 10.1016/j.gde.2010.12.001; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Mukhopadhyay P, 2009, AM J PHYSIOL-HEART C, V296, pH1466, DOI 10.1152/ajpheart.00795.2008; Nessa MU, 2011, ANTICANCER RES, V31, P3789; Nowak AK, 2004, EUR J CANCER, V40, P1474, DOI 10.1016/j.ejca.2004.02.027; Odbayar TO, 2009, MOL CELL BIOCHEM, V325, P121, DOI 10.1007/s11010-009-0026-4; Park MH, 2011, BIOCHEM BIOPH RES CO, V412, P710, DOI 10.1016/j.bbrc.2011.08.037; Pei Tian-xian, 2007, Yaoxue Xuebao, V42, P1029; Riad A, 2009, CANCER RES, V69, P695, DOI 10.1158/0008-5472.CAN-08-3076; SCAMBIA G, 1994, CANCER CHEMOTH PHARM, V34, P459, DOI 10.1007/BF00685655; SILBER JH, 1995, NEW ENGL J MED, V333, P1359; Staedler D, 2011, CANCER CHEMOTH PHARM, V68, P1161, DOI 10.1007/s00280-011-1596-x; Suematsu N, 2011, NEUROSCI LETT, V504, P223, DOI 10.1016/j.neulet.2011.09.028; Szanto M, 2011, CARDIOVASC RES, V92, P430, DOI 10.1093/cvr/cvr246; Tiong KH, 2010, XENOBIOTICA, V40, P458, DOI 10.3109/00498251003786749; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Walia V, 2011, FRONT BIOSCI-LANDMRK, V16, P749, DOI 10.2741/3717; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Wang YA, 2008, INT J CANCER, V123, P1536, DOI 10.1002/ijc.23671; Wiegand H, 2009, NUTR CANCER, V61, P717, DOI 10.1080/01635580902825621; Yague E, 2003, J BIOL CHEM, V278, P10344, DOI 10.1074/jbc.M211093200; Zordoky BNM, 2011, DRUG METAB DISPOS, V39, P1440, DOI 10.1124/dmd.111.039123	50	211	237	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51764	10.1371/journal.pone.0051764	http://dx.doi.org/10.1371/journal.pone.0051764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240061	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800097
J	Wang, G; Zhang, J; Gao, H; Weir, V; Yu, HY; Cong, WX; Xu, XC; Shen, HO; Bennett, J; Furth, M; Wang, Y; Vannier, M				Wang, Ge; Zhang, Jie; Gao, Hao; Weir, Victor; Yu, Hengyong; Cong, Wenxiang; Xu, Xiaochen; Shen, Haiou; Bennett, James; Furth, Mark; Wang, Yue; Vannier, Michael			Towards Omni-Tomography-Grand Fusion of Multiple Modalities for Simultaneous Interior Tomography	PLOS ONE			English	Article							NANOPARTICLE-LOADED OBJECTS; LINEAR INVERSE PROBLEMS; COMPUTED-TOMOGRAPHY; PHYSIOME PROJECT; PET/CT; SPECT/CT; RECONSTRUCTION; MRI; INTEGRATION; PROTEINS	We recently elevated interior tomography from its origin in computed tomography (CT) to a general tomographic principle, and proved its validity for other tomographic modalities including SPECT, MRI, and others. Here we propose "omni-tomography", a novel concept for the grand fusion of multiple tomographic modalities for simultaneous data acquisition in a region of interest (ROI). Omni-tomography can be instrumental when physiological processes under investigation are multi-dimensional, multi-scale, multi-temporal and multi-parametric. Both preclinical and clinical studies now depend on in vivo tomography, often requiring separate evaluations by different imaging modalities. Over the past decade, two approaches have been used for multimodality fusion: Software based image registration and hybrid scanners such as PET-CT, PET-MRI, and SPECT-CT among others. While there are intrinsic limitations with both approaches, the main obstacle to the seamless fusion of multiple imaging modalities has been the bulkiness of each individual imager and the conflict of their physical (especially spatial) requirements. To address this challenge, omni-tomography is now unveiled as an emerging direction for biomedical imaging and systems biomedicine.	[Wang, Ge; Cong, Wenxiang; Shen, Haiou; Bennett, James] Virginia Tech, VT WFU Sch Biomed Engn & Sci, Biomed Imaging Div, Blacksburg, VA 24061 USA; [Zhang, Jie] Univ Kentucky, Dept Radiol, Lexington, KY USA; [Gao, Hao] Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90024 USA; [Weir, Victor] Baylor Hlth Care Syst, Dept Med Phys & Radiat Safety, Dallas, TX USA; [Wang, Ge; Yu, Hengyong] Wake Forest Univ Hlth Sci, VT WFU Sch Biomed Engn & Sci, Biomed Imaging Div, Winston Salem, NC USA; [Xu, Xiaochen] Texas Instruments Inc, Med Business Unit, Dallas, TX USA; [Furth, Mark] Wake Forest Univ Hlth Sci, Ctr Comprehens Canc, Winston Salem, NC USA; [Wang, Yue] Virginia Tech, Dept Elect & Comp Engn, Blacksburg, VA USA; [Vannier, Michael] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA	Virginia Polytechnic Institute & State University; University of Kentucky; University of California System; University of California Los Angeles; Baylor Health Care System; Wake Forest University; Wake Forest University School of Medicine; Texas Instruments; Wake Forest University; Wake Forest University School of Medicine; Virginia Polytechnic Institute & State University; University of Chicago	Wang, G (corresponding author), Virginia Tech, VT WFU Sch Biomed Engn & Sci, Biomed Imaging Div, Blacksburg, VA 24061 USA.	ge-wang@ieee.org	Wang, Ge/AAH-8592-2020; Vannier, Michael W/AAI-6951-2021; Yu, Hengyong/AAH-5726-2019	Wang, Ge/0000-0002-2656-7705; Yu, Hengyong/0000-0002-5852-0813; Vannier, Michael/0000-0001-9898-384X	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering (NIH/NIBIB) [EB011785]; National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NIH/NHLBI) [HL098912]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011785] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering (NIH/NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NIH/NHLBI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was partially supported by National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering (NIH/NIBIB) grant EB011785 and National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NIH/NHLBI) grant HL098912. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahn PH, 2008, SEMIN NUCL MED, V38, P141, DOI 10.1053/j.semnuclmed.2007.11.002; Annie M, 2007, 29 ANN INT C IEEE EN; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Bieri O, 2005, MAGNET RESON MED, V54, P129, DOI 10.1002/mrm.20527; Bockisch A, 2009, SEMIN NUCL MED, V39, P276, DOI 10.1053/j.semnuclmed.2009.03.003; Boles CD, 1998, IEEE J SOLID-ST CIRC, V33, P733, DOI 10.1109/4.668988; Boss A, 2011, EUR RADIOL, V21, P1439, DOI 10.1007/s00330-011-2072-z; Boss A, 2010, J NUCL MED, V51, P1198, DOI 10.2967/jnumed.110.074773; Chen XY, 2011, NANOPLATFORM-BASED MOLECULAR IMAGING, pIX; Cheong SK, 2010, PHYS MED BIOL, V55, P647, DOI 10.1088/0031-9155/55/3/007; Cherry SR, 2009, SEMIN NUCL MED, V39, P348, DOI 10.1053/j.semnuclmed.2009.03.001; Cong WX, 2012, PHYS MED BIOL, V57, P2905, DOI 10.1088/0031-9155/57/10/2905; Cong WX, 2012, J OPTICAL S IN PRESS; Courdurier M, 2008, INVERSE PROBL, V24, DOI 10.1088/0266-5611/24/6/065001; Daubechies I, 2008, J FOURIER ANAL APPL, V14, P764, DOI 10.1007/s00041-008-9039-8; Delbeke D, 2009, SEMIN NUCL MED, V39, P308, DOI 10.1053/j.semnuclmed.2009.03.002; Even-Sapir E, 2009, SEMIN NUCL MED, V39, P264, DOI 10.1053/j.semnuclmed.2009.03.004; Fessler JA, 2010, IEEE SIGNAL PROC MAG, V27, P81, DOI 10.1109/MSP.2010.936726; Gao H, 2011, INVERSE PROBL, V27, DOI 10.1088/0266-5611/27/11/115012; Gao H, 2011, PHYS MED BIOL, V56, P3181, DOI 10.1088/0031-9155/56/11/002; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Han WM, 2009, INT J BIOMED IMAGING, V2009, DOI 10.1155/2009/125871; Hunter P, 2005, MECH AGEING DEV, V126, P187, DOI 10.1016/j.mad.2004.09.025; Hunter P, 2002, PFLUG ARCH EUR J PHY, V445, P1, DOI 10.1007/s00424-002-0890-1; Hunter PJ, 2003, NAT REV MOL CELL BIO, V4, P237, DOI 10.1038/nrm1054; Jin YD, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1042; Jones BL, 2011, PHYS MED BIOL, V56, P3719, DOI 10.1088/0031-9155/56/12/017; Katsevich E, 2012, INVERSE PRO IN PRESS; Kaufmann PA, 2009, SEMIN NUCL MED, V39, P341, DOI 10.1053/j.semnuclmed.2009.03.007; Kudo H, 2008, PHYS MED BIOL, V53, P2207, DOI 10.1088/0031-9155/53/9/001; Laskaris ET, 1995, OPEN MRI MAGNET WTH; Mah D, 2008, SEMIN NUCL MED, V38, P114, DOI 10.1053/j.semnuclmed.2007.11.003; Moon CH, 2000, MEAS SCI TECHNOL, V11, pN89, DOI 10.1088/0957-0233/11/8/401; Patton JA, 2009, SEMIN NUCL MED, V39, P247, DOI 10.1053/j.semnuclmed.2009.03.005; Pichler BJ, 2008, SEMIN NUCL MED, V38, P199, DOI 10.1053/j.semnuclmed.2008.02.001; Rutman AM, 2009, EUR J RADIOL, V70, P232, DOI 10.1016/j.ejrad.2009.01.050; Tumer TO, 2006, IEEE NUCL SCI CONF R, P384, DOI 10.1109/NSSMIC.2006.356181; van Houten VMM, 2000, CLIN CANCER RES, V6, P3803; Wang G, 2011, ARXIV11062124PHYSICS; Wang G, 2010, P NATL ACAD SCI USA, V107, pE92, DOI 10.1073/pnas.1002473107; Wang G, 2009, MED PHYS, V36, P3575, DOI 10.1118/1.3157103; While PT, 2010, J MAGN RESON, V207, P124, DOI 10.1016/j.jmr.2010.08.017; Xu Q, 2012, IEEE T BIOM IN PRESS; Yang J., 2011, INVERSE PROBL, V28; Yang JS, 2010, INVERSE PROBL, V26, DOI 10.1088/0266-5611/26/3/035013; Ye YB, 2007, INT J BIOMED IMAGING, V2007, DOI 10.1155/2007/63634; Yu HY, 2011, J COMPUT ASSIST TOMO, V35, P762, DOI 10.1097/RCT.0b013e318231c578; Yu HY, 2009, PHYS MED BIOL, V54, pN425, DOI 10.1088/0031-9155/54/18/N04; Yu HY, 2009, COMMUN NUMER METH EN, V25, P693, DOI 10.1002/cnm.1206; Yu HY, 2008, J X-RAY SCI TECHNOL, V16, P243; Yu HY, 2009, PHYS MED BIOL, V54, P2791, DOI 10.1088/0031-9155/54/9/014; Yu HY, 2012, J XRAY SCI TECHNOLOG	52	211	237	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39700	10.1371/journal.pone.0039700	http://dx.doi.org/10.1371/journal.pone.0039700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	23240061	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100078
J	Wang, G; Li, CX; Guo, XX; Xing, D; Dong, YD; Wang, ZM; Zhang, YM; Liu, MD; Zheng, Z; Zhang, HD; Zhu, XJ; Wu, ZM; Zhao, TY				Wang, Gang; Li, Chunxiao; Guo, Xiaoxia; Xing, Dan; Dong, Yande; Wang, Zhongming; Zhang, Yingmei; Liu, Meide; Zheng, Zhong; Zhang, Hengduan; Zhu, Xiaojuan; Wu, Zhiming; Zhao, Tongyan			Identifying the Main Mosquito Species in China Based on DNA Barcoding	PLOS ONE			English	Article							CODON USAGE; SPARIDAE; TAXONOMY; DIPTERA	Mosquitoes are insects of the Diptera, Nematocera, and Culicidae families, some species of which are important disease vectors. Identifying mosquito species based on morphological characteristics is difficult, particularly the identification of specimens collected in the field as part of disease surveillance programs. Because of this difficulty, we constructed DNA barcodes of the cytochrome c oxidase subunit 1, the COI gene, for the more common mosquito species in China, including the major disease vectors. A total of 404 mosquito specimens were collected and assigned to 15 genera and 122 species and subspecies on the basis of morphological characteristics. Individuals of the same species grouped closely together in a Neighborhood- Joining tree based on COI sequence similarity, regardless of collection site. COI gene sequence divergence was approximately 30 times higher for species in the same genus than for members of the same species. Divergence in over 98% of congeneric species ranged from 2.3% to 21.8%, whereas divergence in conspecific individuals ranged from 0% to 1.67%. Cryptic species may be common and a few pseudogenes were detected.	[Wang, Gang; Li, Chunxiao; Guo, Xiaoxia; Xing, Dan; Dong, Yande; Wang, Zhongming; Zhang, Yingmei; Liu, Meide; Zheng, Zhong; Zhang, Hengduan; Zhu, Xiaojuan; Wu, Zhiming; Zhao, Tongyan] Acad Mil Med Sci, Inst Microbiol & Epidemiol, Beijing, Peoples R China; [Zheng, Zhong] Mil Area Command, Ctr Dis Control & Prevent, Xinjiang, Peoples R China	Academy of Military Medical Sciences - China; Chinese Center for Disease Control & Prevention	Zhao, TY (corresponding author), Acad Mil Med Sci, Inst Microbiol & Epidemiol, Beijing, Peoples R China.	aedes@263.net	Wang, Ge/AAH-8592-2020; Vannier, Michael W/AAI-6951-2021; Yu, Hengyong/AAH-5726-2019	Wang, Ge/0000-0002-2656-7705; Yu, Hengyong/0000-0002-5852-0813; Vannier, Michael/0000-0001-9898-384X	Infective Diseases Prevention and Cure Project of China [2008ZX10402, 2012ZX10004219]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011785] Funding Source: NIH RePORTER	Infective Diseases Prevention and Cure Project of China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Infective Diseases Prevention and Cure Project of China (NO: 2008ZX10402) and (NO: 2012ZX10004219).	AKASHI H, 1994, GENETICS, V136, P927; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Baolin L, 1997, FAUNA SINICA INSECTA, V9; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Brown JW, 2003, P ENTOMOL SOC WASH, V105, P1043; Burns JM, 2007, PNAS, V105, p6 350; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; De la Herran R, 2001, HEREDITY, V87, P691, DOI 10.1046/j.1365-2540.2001.00967.x; Edwards FW, 1932, GENERA INSECTORUM DI; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FENG Lan-chou, 1938, Peking Natural History Bulletin, V12, P285; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gao Q, 2004, J MED ENTOMOL, V41, P5, DOI 10.1603/0022-2585-41.1.5; Hanel R, 2000, J MOL EVOL, V50, P276, DOI 10.1007/s002399910032; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar NP, 2007, J MED ENTOMOL, V44, P1, DOI 10.1603/0022-2585(2007)44[1:DBCDSO]2.0.CO;2; LI WH, 1981, NATURE, V292, P237, DOI 10.1038/292237a0; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; Marko PB, 2002, EVOLUTION, V56, P1303; Moftah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027001; Monaghan M, 2005, PHIL TRAMS R SOCB, V360; Moriyama EN, 1997, J MOL EVOL, V45, P514, DOI 10.1007/PL00006256; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Phuc HK, 2003, MED VET ENTOMOL, V17, P423, DOI 10.1111/j.1365-2915.2003.00462.x; Remigio EA, 2003, MOL PHYLOGENET EVOL, V29, P641, DOI 10.1016/S1055-7903(03)00140-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sirivanakarn S., 1976, Contributions Am ent Inst, V12, P1; Smith MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036514; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Tautz D, 2002, NATURE, V418, P479, DOI 10.1038/418479a; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716	35	211	237	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47051	10.1371/journal.pone.0047051	http://dx.doi.org/10.1371/journal.pone.0047051			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23240061	Green Submitted, gold, Green Published			2022-12-27	WOS:000312385200072
J	Liu, YJ; Ding, YC; Alonas, E; Zhao, WL; Santangelo, PJ; Jin, DY; Piper, JA; Teng, JL; Ren, QS; Xi, P				Liu, Yujia; Ding, Yichen; Alonas, Eric; Zhao, Wenli; Santangelo, Philip J.; Jin, Dayong; Piper, James A.; Teng, Junlin; Ren, Qiushi; Xi, Peng			Achieving lambda/10 Resolution CW STED Nanoscopy with a Ti:Sapphire Oscillator	PLOS ONE			English	Article							STIMULATED-EMISSION-DEPLETION; 2-PHOTON EXCITATION; MICROSCOPY; BREAKING; REVEALS; LIMIT	In this report, a Ti: Sapphire oscillator was utilized to realize synchronization-free stimulated emission depletion (STED) microscopy. With pump power of 4.6 W and sample irradiance of 310 mW, we achieved super-resolution as high as 71 nm. With synchronization-free STED, we imaged 200 nm nanospheres as well as all three cytoskeletal elements (microtubules, intermediate filaments, and actin filaments), clearly demonstrating the resolving power of synchronization-free STED over conventional diffraction limited imaging. It also allowed us to discover that, Dylight 650, exhibits improved performance over ATTO647N, a fluorophore frequently used in STED. Furthermore, we applied synchronization-free STED to image fluorescently-labeled intracellular viral RNA granules, which otherwise cannot be differentiated by confocal microscopy. Thanks to the widely available Ti:Sapphire oscillators in multiphoton imaging system, this work suggests easier access to setup super-resolution microscope via the synchronization-free STED.	[Liu, Yujia; Ren, Qiushi] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Liu, Yujia; Ding, Yichen; Ren, Qiushi; Xi, Peng] Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China; [Alonas, Eric; Santangelo, Philip J.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Alonas, Eric; Santangelo, Philip J.] Emory Univ, Atlanta, GA 30322 USA; [Jin, Dayong; Piper, James A.] Macquarie Univ, Adv Cytometry Labs, MQphoton Res Ctr, Sydney, NSW 2109, Australia; [Zhao, Wenli; Teng, Junlin] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China	Shanghai Jiao Tong University; Peking University; University System of Georgia; Georgia Institute of Technology; Emory University; Macquarie University; Peking University	Liu, YJ (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.	xipeng@pku.edu.cn	Xi, Peng/A-9768-2012; jin, dayong/U-6740-2018; Jin, Dayong/D-9652-2011; Jin, Dayong/AAY-2402-2021	Xi, Peng/0000-0001-6626-4840; Jin, Dayong/0000-0003-1046-2666; Jin, Dayong/0000-0003-1046-2666; Liu, Jian-Feng/0000-0002-5766-7864; Piper, James/0000-0001-9503-6855	"973" Major State Basic Research Development Program of China [2011CB809101, 2010CB933901, 2011CB707502]; National Natural Science Foundation of China [61178076]; PKU-GT/Emory University BME Seed Grant; Wallace H. Coulter Foundation; Olympus Australia; NATIONAL EYE INSTITUTE [R01EY016206] Funding Source: NIH RePORTER	"973" Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PKU-GT/Emory University BME Seed Grant; Wallace H. Coulter Foundation; Olympus Australia; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research is supported by the "973" Major State Basic Research Development Program of China (2011CB809101, 2010CB933901, 2011CB707502), the National Natural Science Foundation of China (61178076), PKU-GT/Emory University BME Seed Grant funded by Wallace H. Coulter Foundation, and seed fund support from Olympus Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchini P, 2012, P NATL ACAD SCI USA, V109, P6390, DOI 10.1073/pnas.1119129109; Buckers J, 2011, OPT EXPRESS, V19, P3130, DOI 10.1364/OE.19.003130; Cao YY, 2011, OPT EXPRESS, V19, P19486, DOI 10.1364/OE.19.019486; Diaspro A, 2005, Q REV BIOPHYS, V38, P97, DOI 10.1017/S0033583505004129; Ding JB, 2009, NEURON, V63, P429, DOI 10.1016/j.neuron.2009.07.011; Hanssen E, 2010, INT J PARASITOL, V40, P123, DOI 10.1016/j.ijpara.2009.09.004; Harke B, 2008, OPT EXPRESS, V16, P4154, DOI 10.1364/OE.16.004154; Hell SW, 2010, SPRINGER SER CHEM PH, V96, P365, DOI 10.1007/978-3-642-02597-6_19; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hirvonen LM, 2011, AUST J CHEM, V64, P41, DOI 10.1071/CH10333; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Hyeon C, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2364190; Kasper R, 2010, SMALL, V6, P1379, DOI 10.1002/smll.201000203; Keller J, 2007, OPT EXPRESS, V15, P3361, DOI 10.1364/OE.15.003361; Moneron G, 2010, OPT EXPRESS, V18, P1302, DOI 10.1364/OE.18.001302; Moneron G, 2009, OPT EXPRESS, V17, P14567, DOI 10.1364/OE.17.014567; Oliva A, 1997, COGNITIVE PSYCHOL, V34, P72, DOI 10.1006/cogp.1997.0667; Rankin BR, 2009, OPT EXPRESS, V17, P15679, DOI 10.1364/OE.17.015679; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Santangelo PJ, 2009, NAT METHODS, V6, P347, DOI [10.1038/nmeth.1316, 10.1038/NMETH.1316]; Scheul T, 2011, OPT EXPRESS, V19, P18036, DOI 10.1364/OE.19.018036; Schrof S, 2011, OPT EXPRESS, V19, P8066, DOI 10.1364/OE.19.008066; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; So PTC, 2000, ANNU REV BIOMED ENG, V2, P399, DOI 10.1146/annurev.bioeng.2.1.399; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; Wang WC, 2010, APPL OPTICS, V49, P6703, DOI 10.1364/AO.49.006703; Westphal V, 2003, APPL PHYS LETT, V82, P3125, DOI 10.1063/1.1571656; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Wildanger D, 2008, OPT EXPRESS, V16, P9614, DOI 10.1364/OE.16.009614; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049; Willig KI, 2007, NAT METHODS, V4, P915, DOI 10.1038/NMETH1108; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Wurm CA, 2010, METHODS MOL BIOL, V591, P185, DOI 10.1007/978-1-60761-404-3_11; Xi P, 2008, OPT COMMUN, V281, P1841, DOI 10.1016/j.optcom.2007.09.066; Xi P, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3059629	38	239	252	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e40003	10.1371/journal.pone.0040003	http://dx.doi.org/10.1371/journal.pone.0040003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22615852	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800086
J	Fu, WX; Liu, Y; Lu, X; Niu, XY; Ding, XD; Liu, JF; Zhang, Q				Fu, Wei-Xuan; Liu, Yang; Lu, Xin; Niu, Xiao-Yan; Ding, Xiang-Dong; Liu, Jian-Feng; Zhang, Qin			A Genome-Wide Association Study Identifies Two Novel Promising Candidate Genes Affecting Escherichia coli F4ab/F4ac Susceptibility in Swine	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; POPULATION STRATIFICATION; INTESTINAL RECEPTOR; EPITHELIAL-CELLS; MILK-PRODUCTION; DAIRY-CATTLE; INTEGRIN; BINDING; PROTEIN; F4AC	Enterotoxigenic Escherichia coli (ETEC) expressing F4 fimbria is the major pathogenic bacteria causing diarrhoea in neonatal and post-weaning piglets. Previous studies have revealed that the susceptibility to ETEC F4ab/F4ac is an autosomal Mendelian dominant trait and the loci controlling the F4ab/F4ac receptor are located on SSC13q41, between markers SW207 and S0283. To pinpoint these loci and further validate previous findings, we performed a genome-wide association study (GWAS) using a two generation family-based population, consisting of 301 piglets with phenotypes of susceptibility to ETEC F4ab/F4ac by the vitro adhesion test. The DNA of all piglets and their parents was genotyped using the Illumina PorcineSNP60 BeadChip, and 50,972 and 50,483 SNPs were available for F4ab and F4ac susceptibility, respectively, in the association analysis after quality control. In summary, 28 and 18 significant SNPs (p < 0.05) were detected associated with F4ab and F4ac susceptibility respectively at genome-wide significance level. From these significant findings, two novel candidate genes, HEG1 and ITGB5, were firstly identified as the most promising genes underlying F4ab/F4ac susceptibility in swine according to their functions and positions. Our findings herein provide a novel evidence for unravelling genetic mechanism of diarrhoea risk in piglets.	[Fu, Wei-Xuan; Liu, Yang; Lu, Xin; Niu, Xiao-Yan; Ding, Xiang-Dong; Liu, Jian-Feng; Zhang, Qin] China Agr Univ, Coll Anim Sci & Technol, Minist Agr, Key Lab Anim Genet Breeding & Reprod, Beijing 100094, Peoples R China; [Lu, Xin] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Fu, WX (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Minist Agr, Key Lab Anim Genet Breeding & Reprod, Beijing 100094, Peoples R China.	liujf@cau.edu.cn; qzhang@cau.edu.cn	Xi, Peng/A-9768-2012; jin, dayong/U-6740-2018; Jin, Dayong/D-9652-2011; Jin, Dayong/AAY-2402-2021	Xi, Peng/0000-0001-6626-4840; Jin, Dayong/0000-0003-1046-2666; Jin, Dayong/0000-0003-1046-2666; Liu, Jian-Feng/0000-0002-5766-7864; Piper, James/0000-0001-9503-6855	National Natural Science Foundations of China [30972092, 30800776]; National High Technology Research and Development Program of China (863 Program) [2011AA100302]; National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms [2009ZX08009-146B]; Natural Science Foundations of Beijing [6102016]; New-Century Training Programme Foundation for the Talents by the State Education Commission of China [NETC-10-0783]; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry; NATIONAL EYE INSTITUTE [R01EY016206] Funding Source: NIH RePORTER	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms; Natural Science Foundations of Beijing; New-Century Training Programme Foundation for the Talents by the State Education Commission of China; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Natural Science Foundations of China (30972092, 30800776), the National High Technology Research and Development Program of China (863 Program 2011AA100302), the National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms (2009ZX08009-146B), the Natural Science Foundations of Beijing (6102016), New-Century Training Programme Foundation for the Talents by the State Education Commission of China (NETC-10-0783) and Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON L, 1994, SCIENCE, V263, P1771, DOI 10.1126/science.8134840; Andersson L, 2009, GENETICA, V136, P341, DOI 10.1007/s10709-008-9312-4; Aplin JD, 1996, MOL HUM REPROD, V2, P527, DOI 10.1093/molehr/2.7.527; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BIJLSMA IGW, 1987, VET RES COMMUN, V11, P509, DOI 10.1007/BF00396368; Billey LO, 1998, VET MICROBIOL, V59, P203, DOI 10.1016/S0378-1135(97)00193-4; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; CHHATWAL GS, 1987, INFECT IMMUN, V55, P1878, DOI 10.1128/IAI.55.8.1878-1883.1987; de Koning DJ, 1999, GENETICS, V152, P1679; Duijvesteijn N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-42; EDFORSLILJA I, 1995, ANIM GENET, V26, P237, DOI 10.1111/j.1365-2052.1995.tb03250.x; ERICKSON AK, 1994, INFECT IMMUN, V62, P5404, DOI 10.1128/IAI.62.12.5404-5410.1994; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GEORGES M, 1995, GENETICS, V139, P907; GUINEE PAM, 1979, INFECT IMMUN, V23, P700; Jacobsen M, 2010, ANIM GENET, V41, P21, DOI 10.1111/j.1365-2052.2009.01952.x; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Joller D, 2009, ANIM GENET, V40, P749, DOI 10.1111/j.1365-2052.2009.01881.x; Joller D, 2009, COMP MOL APPROACHES; Jorgensen CB, 2003, CYTOGENET GENOME RES, V102, P157, DOI 10.1159/000075742; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kasuga I, 2009, RESP MED, V103, P1672, DOI 10.1016/j.rmed.2009.05.008; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; Lagarrigue S, 2006, GENET SEL EVOL, V38, P85, DOI 10.1051/gse:2005028; Lang TG, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-197; Li Yuhua, 2007, Journal of Genetics and Genomics, V34, P591, DOI 10.1016/S1673-8527(07)60067-8; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Marquardt RR, 1999, FEMS IMMUNOL MED MIC, V23, P283, DOI 10.1016/S0928-8244(98)00147-3; Memmo LM, 1998, J CELL SCI, V111, P425; Mousa SA, 1999, J CELL BIOCHEM, V74, P135, DOI 10.1002/(SICI)1097-4644(19990701)74:1<135::AID-JCB15>3.3.CO;2-R; Pongpanich M, 2010, BIOINFORMATICS, V26, P1731, DOI 10.1093/bioinformatics/btq272; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Pryce JE, 2010, J DAIRY SCI, V93, P3331, DOI 10.3168/jds.2009-2893; Python P, 2005, J ANIM BREED GENET, V122, P5, DOI 10.1111/j.1439-0388.2005.00490.x; Python P, 2002, ANIM GENET, V33, P441, DOI 10.1046/j.1365-2052.2002.00915.x; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Rampoldi A, 2011, MAMM GENOME, V22, P122, DOI 10.1007/s00335-010-9305-3; Ren J, 2009, J ANIM BREED GENET, V126, P30, DOI 10.1111/j.1439-0388.2008.00751.x; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Thornton T, 2010, AM J HUM GENET, V86, P172, DOI 10.1016/j.ajhg.2010.01.001; WANG YK, 1993, MOL CELL BIOL, V13, P5691, DOI 10.1128/MCB.13.9.5691; Williams SJ, 2001, J BIOL CHEM, V276, P18327, DOI 10.1074/jbc.M008850200; Wu CQ, 2011, ANN HUM GENET, V75, P418, DOI 10.1111/j.1469-1809.2010.00639.x; Zhang B, 2008, ANIM GENET, V39, P258, DOI 10.1111/j.1365-2052.2008.01721.x	46	239	252	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e32127	10.1371/journal.pone.0032127	http://dx.doi.org/10.1371/journal.pone.0032127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22615852	Green Published, gold, Green Submitted			2022-12-27	WOS:000304046900001
J	Singh, A; Baranwal, V; Shankar, A; Kanwar, P; Ranjan, R; Yadav, S; Pandey, A; Kapoor, S; Pandey, GK				Singh, Amarjeet; Baranwal, Vinay; Shankar, Alka; Kanwar, Poonam; Ranjan, Rajeev; Yadav, Sandeep; Pandey, Amita; Kapoor, Sanjay; Pandey, Girdhar K.			Rice Phospholipase A Superfamily: Organization, Phylogenetic and Expression Analysis during Abiotic Stresses and Development	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; PATATIN-RELATED PHOSPHOLIPASES; LIPID ACYL HYDROLASE; GENE FAMILY; SHOOT GRAVITROPISM; PHOSPHATIDIC-ACID; DROUGHT STRESS; GUARD-CELL; REPRODUCTIVE DEVELOPMENT; SIGNAL-TRANSDUCTION	Background: Phospholipase A (PLA) is an important group of enzymes responsible for phospholipid hydrolysis in lipid signaling. PLAs have been implicated in abiotic stress signaling and developmental events in various plants species. Genome-wide analysis of PLA superfamily has been carried out in dicot plant Arabidopsis. A comprehensive genome-wide analysis of PLAs has not been presented yet in crop plant rice. Methodology/Principal Findings: A comprehensive bioinformatics analysis identified a total of 31 PLA encoding genes in the rice genome, which are divided into three classes; phospholipase A(1) (PLA(1)), patatin like phospholipases (pPLA) and low molecular weight secretory phospholipase A(2) (sPLA(2)) based on their sequences and phylogeny. A subset of 10 rice PLAs exhibited chromosomal duplication, emphasizing the role of duplication in the expansion of this gene family in rice. Microarray expression profiling revealed a number of PLA members expressing differentially and significantly under abiotic stresses and reproductive development. Comparative expression analysis with Arabidopsis PLAs revealed a high degree of functional conservation between the orthologs in two plant species, which also indicated the vital role of PLAs in stress signaling and plant development across different plant species. Moreover, sub-cellular localization of a few candidates suggests their differential localization and functional role in the lipid signaling. Conclusion/Significance: The comprehensive analysis and expression profiling would provide a critical platform for the functional characterization of the candidate PLA genes in crop plants.	[Singh, Amarjeet; Baranwal, Vinay; Shankar, Alka; Kanwar, Poonam; Ranjan, Rajeev; Yadav, Sandeep; Pandey, Amita; Kapoor, Sanjay; Pandey, Girdhar K.] Dept Plant Mol Biol, New Delhi, India		Singh, A (corresponding author), Dept Plant Mol Biol, Univ Delhi S Campus, New Delhi, India.	gkpandey@south.du.ac.in	Sharma, Prabhat/AAW-6558-2021; Ranjan, Rajeev/AAY-3243-2021	Ranjan, Rajeev/0000-0002-1344-4044; Kapoor, Sanjay/0000-0002-0283-1137; Pandey, Amita/0000-0001-8717-3227; SINGH, ASHUTOSH/0000-0002-0995-6696; Singh, Abhishek/0000-0001-6263-4410; SHARMA, PRABHAT/0000-0002-2638-2321; Kanwar, Poonam/0000-0002-9328-9274; PANDEY, GIRDHAR KUMAR/0000-0001-9180-0924; Pallikadavath, Saseendran/0000-0002-2598-9949; Ogollah, Reuben/0000-0002-5777-4117	Department of Biotechnology, Council of Scientific and Industrial Research, University Grant Commission, Government of India	Department of Biotechnology, Council of Scientific and Industrial Research, University Grant Commission, Government of India	This work was supported by the Department of Biotechnology, Council of Scientific and Industrial Research, University Grant Commission, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN EJ, 1994, J BIOL CHEM, V269, P9227; Agarwal P, 2007, PLANT MOL BIOL, V65, P467, DOI 10.1007/s11103-007-9199-y; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Bahn SC, 2003, FEBS LETT, V553, P113, DOI 10.1016/S0014-5793(03)00982-7; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Bargmann BO, 2006, CURR OPIN PLANT BIOL, V9, P515, DOI 10.1016/j.pbi.2006.07.011; Boss WF, 2008, ANNU PLANT REV, V33, P202, DOI 10.1111/b.9781405160025.2008.00008.x; Chakrabarty R, 2007, MOL PLANT MICROBE IN, V20, P740, DOI 10.1094/MPMI-20-7-0740; Chen GQ, 2011, CRIT REV PLANT SCI, V30, P239, DOI 10.1080/07352689.2011.572033; Clewley J P, 1997, Methods Mol Biol, V70, P119; Cusack BP, 2007, TRENDS GENET, V23, P270, DOI 10.1016/j.tig.2007.03.010; Dessen A, 2000, BBA-MOL CELL BIOL L, V1488, P40, DOI 10.1016/S1388-1981(00)00108-6; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hetherington AM, 2001, CELL, V107, P711, DOI 10.1016/S0092-8674(01)00606-7; Higgs HN, 1998, J BIOL CHEM, V273, P5468, DOI 10.1074/jbc.273.10.5468; Hirschberg HJHB, 2001, EUR J BIOCHEM, V268, P5037, DOI 10.1046/j.0014-2956.2001.02411.x; Holk A, 2002, PLANT PHYSIOL, V130, P90, DOI 10.1104/pp.006288; Hong YY, 2008, PLANT CELL, V20, P803, DOI 10.1105/tpc.107.056390; Hong YY, 2009, PLANT J, V58, P376, DOI 10.1111/j.1365-313X.2009.03788.x; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang SS, 2001, PLANT PHYSIOL, V125, P573, DOI 10.1104/pp.125.2.573; Hubbard KE, 2010, GENE DEV, V24, P1695, DOI 10.1101/gad.1953910; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Kato T, 2002, PLANT CELL, V14, P33, DOI 10.1105/tpc.010215; Kim HJ, 2011, PLANT CELL, V23, P94, DOI 10.1105/tpc.110.074799; Laxalt AM, 2002, CURR OPIN PLANT BIOL, V5, P332, DOI 10.1016/S1369-5266(02)00268-6; Lee HY, 2005, PROG LIPID RES, V44, P52, DOI 10.1016/j.plipres.2004.10.002; Lee HY, 2003, PLANT CELL, V15, P1990, DOI 10.1105/tpc.014423; Lee OR, 2010, PLANT CELL, V22, P1812, DOI 10.1105/tpc.110.074211; Li MY, 2011, PLANT CELL, V23, P1107, DOI 10.1105/tpc.110.081240; Li MY, 2009, BBA-MOL CELL BIOL L, V1791, P927, DOI 10.1016/j.bbalip.2009.02.017; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mansfeld J, 2006, BIOCHEMISTRY-US, V45, P5687, DOI 10.1021/bi052563z; Matos AR, 2008, PHYSIOL PLANTARUM, V134, P110, DOI 10.1111/j.1399-3054.2008.01123.x; Matos AR, 2009, PLANT PHYSIOL BIOCH, V47, P491, DOI 10.1016/j.plaphy.2009.02.011; Matos AR, 2001, FEBS LETT, V491, P188, DOI 10.1016/S0014-5793(01)02194-9; Matsui K, 2004, FEBS LETT, V569, P195, DOI 10.1016/j.febslet.2004.05.064; MAY C, 1998, BBA-LIPID LIPID MET, V1393, P267; Morita MT, 2002, PLANT CELL, V14, P47, DOI 10.1105/tpc.010216; Munnik T, 2001, FEBS LETT, V498, P172, DOI 10.1016/S0014-5793(01)02492-9; Munnik T, 2009, J LIPID RES, V50, pS260, DOI 10.1194/jlr.R800098-JLR200; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Narusaka Y, 2003, PLANT CELL PHYSIOL, V44, P1246, DOI 10.1093/pcp/pcg138; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; O'Luanaigh N, 2002, MOL BIOL CELL, V13, P3730, DOI 10.1091/mbc.E02-04-0213; Paul RU, 1998, PLANT J, V16, P601, DOI 10.1046/j.1365-313x.1998.00333.x; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Ray S, 2007, MOL GENET GENOMICS, V278, P493, DOI 10.1007/s00438-007-0267-4; Rietz S, 2010, MOL PLANT, V3, P524, DOI 10.1093/mp/ssp109; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Ryu SB, 2004, TRENDS PLANT SCI, V9, P229, DOI 10.1016/j.tplants.2004.03.004; Scherer GFE, 2002, PLANT MOL BIOL, V49, P357, DOI 10.1023/A:1015290510483; Scherer GFE, 2010, TRENDS PLANT SCI, V15, P693, DOI 10.1016/j.tplants.2010.09.005; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Singh A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-435; Sirichandra C, 2009, J EXP BOT, V60, P1439, DOI 10.1093/jxb/ern340; Stahl U, 1998, PLANT PHYSIOL, V117, P197, DOI 10.1104/pp.117.1.197; Stahl U, 1999, PLANT MOL BIOL, V41, P481, DOI 10.1023/A:1006323405788; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tuteja N, 2008, PLANT SIGNAL BEHAV, V3, P79, DOI 10.4161/psb.3.2.5303; Vij S, 2008, MOL PLANT, V1, P732, DOI 10.1093/mp/ssn047; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang XM, 2001, ANNU REV PLANT PHYS, V52, P211, DOI 10.1146/annurev.arplant.52.1.211; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	67	174	181	7	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30947	10.1371/journal.pone.0030947	http://dx.doi.org/10.1371/journal.pone.0030947			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	23028594	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600094
J	Singh, A; Dey, AB; Mohan, A; Sharma, PK; Mitra, DK				Singh, Amar; Dey, Aparajita Ballave; Mohan, Anant; Sharma, Prabhat Kumar; Mitra, Dipendra Kumar			Foxp(3+) Regulatory T Cells among Tuberculosis Patients: Impact on Prognosis and Restoration of Antigen Specific IFN-gamma Producing T Cells	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PD-1 EXPRESSION; ACTIVE TUBERCULOSIS; PULMONARY TUBERCULOSIS; IMMUNE-RESPONSES; TH1 RESPONSES; INFECTION; SUPPRESSION; EXPANSION; LIGANDS	CD(4+)CD(25+)Foxp(3+) Regulatory T cells (Treg) and programmed death-1 (PD-1) molecules have emerged as pivotal players in immune suppression of chronic diseases. However, their impact on the disease severity, therapeutic response and restoration of immune response in human tuberculosis remains unclear. Here, we describe the possible role of Treg cells, their M. tuberculosis driven expansion and contribution of PD-1 pathway to the suppressive function of Treg cells among pulmonary tuberculosis (PTB) patients. Multicolor flow cytometry, cell culture, cells sorting and ELISA were employed to execute the study. Our results showed significant increase in frequency of antigen-reactive Treg cells, which gradually declined during successful therapy and paralleled with decline of M. tuberculosis-specific IL-10 along with elevation of IFN-gamma production, and raising the IFN-gamma/IL-4 ratio. Interestingly, persistence of Treg cells tightly correlated with MDR tuberculosis. Also, we show that blocking PD-1/PD-L1 pathway abrogates Treg-mediated suppression, suggesting that the PD-1/PD-L1 pathway is required for Treg-mediated suppression of the antigen-specific T cells. Treg cells possibly play a role in dampening the effector immune response and abrogating PD-1 pathway on Treg cells significantly rescued protective T cell response, suggesting its importance in immune restoration among tuberculosis patients.	[Singh, Amar; Sharma, Prabhat Kumar; Mitra, Dipendra Kumar] All India Inst Med Sci, Cellular Immunol Div, Dept TII, New Delhi, India; [Dey, Aparajita Ballave; Mohan, Anant] All India Inst Med Sci, Dept Med, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Mitra, DK (corresponding author), All India Inst Med Sci, Cellular Immunol Div, Dept TII, New Delhi, India.	salilmitra1@yahoo.com	Sharma, Prabhat/AAW-6558-2021; Ranjan, Rajeev/AAY-3243-2021	Ranjan, Rajeev/0000-0002-1344-4044; Kapoor, Sanjay/0000-0002-0283-1137; Pandey, Amita/0000-0001-8717-3227; SINGH, ASHUTOSH/0000-0002-0995-6696; Singh, Abhishek/0000-0001-6263-4410; SHARMA, PRABHAT/0000-0002-2638-2321; Kanwar, Poonam/0000-0002-9328-9274; PANDEY, GIRDHAR KUMAR/0000-0001-9180-0924; Pallikadavath, Saseendran/0000-0002-2598-9949; Ogollah, Reuben/0000-0002-5777-4117	Department of Biotechnology; Indian Council of Medical Research, Government of India, New Delhi, India	Department of Biotechnology; Indian Council of Medical Research, Government of India, New Delhi, India(Indian Council of Medical Research (ICMR))	The study was supported by the Department of Biotechnology and the Indian Council of Medical Research, Government of India, New Delhi, India. For this study the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez IB, 2010, J INFECT DIS, V202, P524, DOI 10.1086/654932; Amarnath S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000302; Antas PRZ, 2007, AM J RESP CRIT CARE, V176, P214, DOI 10.1164/ajrccm.176.2.214; Aramaki O, 2004, TRANSPLANTATION, V77, P6, DOI 10.1097/01.TP.0000108637.65091.4B; Barber DL, 2011, J IMMUNOL, V186, P1598, DOI 10.4049/jimmunol.1003304; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Burl S, 2007, CLIN EXP IMMUNOL, V149, P117, DOI 10.1111/j.1365-2249.2007.03399.x; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dong HD, 1999, NAT MED, V5, P1365; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Gong JH, 1996, INFECT IMMUN, V64, P913, DOI 10.1128/IAI.64.3.913-918.1996; Green AM, 2010, J INFECT DIS, V202, P533, DOI 10.1086/654896; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Handzel ZT, 2007, ISR MED ASSOC J, V9, P479; Hirsch CS, 1996, P NATL ACAD SCI USA, V93, P3193, DOI 10.1073/pnas.93.8.3193; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; HUYGEN K, 1988, SCAND J IMMUNOL, V27, P187, DOI 10.1111/j.1365-3083.1988.tb02338.x; Jaron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002833; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; Katara GK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001171; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Keir ME, 2007, CURR OPIN IMMUNOL, V19, P309, DOI 10.1016/j.coi.2007.04.012; Kitazawa Y, 2007, TRANSPLANTATION, V83, P774, DOI 10.1097/01.tp.0000256293.90270.e8; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; Lazar-Molnar E, 2010, P NATL ACAD SCI USA, V107, P13402, DOI 10.1073/pnas.1007394107; Maier H, 2007, J IMMUNOL, V178, P2714, DOI 10.4049/jimmunol.178.5.2714; Mitra DK, 2009, MICROBES INFECT, V11, P1122, DOI 10.1016/j.micinf.2009.08.006; Mitra DK, 2005, EUR J IMMUNOL, V35, P2367, DOI 10.1002/eji.200525977; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Periasamy S, 2011, J INFECT DIS, V203, P1256, DOI 10.1093/infdis/jir011; Punkosdy GA, 2011, P NATL ACAD SCI USA, V108, P3677, DOI 10.1073/pnas.1100213108; Raimondi G, 2006, J IMMUNOL, V176, P2808, DOI 10.4049/jimmunol.176.5.2808; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Sharma S, 2009, AM J RESP CRIT CARE, V179; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Shen T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-279; TOOSSI Z, 1986, J EXP MED, V163, P1162, DOI 10.1084/jem.163.5.1162; TORRES M, 1994, CLIN EXP IMMUNOL, V96, P75, DOI 10.1111/j.1365-2249.1994.tb06233.x; Totsuka T, 2005, EUR J IMMUNOL, V35, P1773, DOI 10.1002/eji.200425109; Tousif S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019864; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; ZHANG M, 1994, J CLIN INVEST, V94, P2435, DOI 10.1172/JCI117611	49	174	181	7	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44728	10.1371/journal.pone.0044728	http://dx.doi.org/10.1371/journal.pone.0044728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028594	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400035
J	Liu, Y; Costa, MB; Gerhardinger, C				Liu, Yang; Costa, Montserrat Biarnes; Gerhardinger, Chiara			IL-1 beta Is Upregulated in the Diabetic Retina and Retinal Vessels: Cell-Specific Effect of High Glucose and IL-1 beta Autostimulation	PLOS ONE			English	Article							PROTEIN-KINASE-C; INTERLEUKIN-1 INDUCES INTERLEUKIN-1; MULLER CELLS; MICROGLIAL ACTIVATION; ADHESION MOLECULE-1; ENDOTHELIAL-CELLS; GENE-EXPRESSION; RETINOPATHY; BRAIN; INDUCTION	Many molecular and cellular abnormalities detected in the diabetic retina support a role for IL-1 beta-driven neuroinflammation in the pathogenesis of diabetic retinopathy. IL-1 beta is well known for its role in the induction and, through autostimulation, amplification of neuroinflammation. Upregulation of IL-1 beta has been consistently detected in the diabetic retina; however, the mechanisms and cellular source of IL-1 beta overexpression are poorly understood. The aim of this study was to investigate the effect of high glucose and IL-1 beta itself on IL-1 beta expression in microglial, macroglial (astrocytes and Muller cells) and retinal vascular endothelial cells; and to study the effect of diabetes on the expression of IL-1 beta in isolated retinal vessels and on the temporal pattern of IL-1 beta upregulation and glial reactivity in the retina of streptozotocin-diabetic rats. IL-1 beta was quantified by RealTime RT-PCR and ELISA, glial fibrillar acidic protein, alpha 2-macroglobulin, and ceruloplasmin by immunoblotting. We found that high glucose induced a 3-fold increase of IL-1 beta expression in retinal endothelial cells but not in macroglia and microglia. IL-1 beta induced its own synthesis in endothelial and macroglial cells but not in microglia. In retinal endothelial cells, the high glucose-induced IL-1 beta overexpression was prevented by calphostin C, a protein kinase C inhibitor. The retinal vessels of diabetic rats showed increased IL-1 beta expression as compared to non-diabetic rats. Retinal expression of IL-1 beta increased early after the induction of diabetes, continued to increase with progression of the disease, and was temporally associated with upregulation of markers of glial activation. These findings point to hyperglycemia as the trigger and to the endothelium as the origin of the initial retinal upregulation of IL-1 beta in diabetes; and to IL-1 beta itself, via autostimulation in endothelial and macroglial cells, as the mechanism of sustained IL-1 beta overexpression. Interrupting the vicious circle triggered by IL-1 beta autostimulation could limit the progression of diabetic retinopathy.	[Liu, Yang] Harvard Univ, Schepens Eye Res Inst, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School	Liu, Y (corresponding author), Harvard Univ, Schepens Eye Res Inst, Sch Med, Boston, MA 02115 USA.	chiara.gerhardinger@schepens.harvard.edu	Xi, Peng/A-9768-2012; jin, dayong/U-6740-2018; Jin, Dayong/D-9652-2011; Jin, Dayong/AAY-2402-2021	Xi, Peng/0000-0001-6626-4840; Jin, Dayong/0000-0003-1046-2666; Jin, Dayong/0000-0003-1046-2666; Liu, Jian-Feng/0000-0002-5766-7864; Piper, James/0000-0001-9503-6855	National Institutes of Health [R01EY016206]; NATIONAL EYE INSTITUTE [R01EY016206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health (R01EY016206). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Asakawa H, 1997, J DIABETES COMPLICAT, V11, P176, DOI 10.1016/S1056-8727(97)00004-4; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; CAGLIERO E, 1991, J BIOL CHEM, V266, P14244; Carmo A, 2000, NITRIC OXIDE-BIOL CH, V4, P590, DOI 10.1006/niox.2000.0312; Chakrabarti S, 2000, DIABETES-METAB RES, V16, P393, DOI 10.1002/1520-7560(0000)9999:9999<::AID-DMRR157>3.0.CO;2-G; Dagher Z, 2004, DIABETES, V53, P2404, DOI 10.2337/diabetes.53.9.2404; DALTON BJ, 1989, ARTHRITIS RHEUM, V32, P279, DOI 10.1002/anr.1780320309; Dasu MR, 2007, AM J PHYSIOL-ENDOC M, V293, pE337, DOI 10.1152/ajpendo.00718.2006; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Fassbender K, 2000, NEUROSCI LETT, V284, P135, DOI 10.1016/S0304-3940(00)00977-0; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Gerhardinger C, 2005, INVEST OPHTH VIS SCI, V46, P349, DOI 10.1167/iovs.04-0860; Gerhardinger C, 2009, DIABETES, V58, P1659, DOI 10.2337/db08-1008; GIULIAN D, 1988, J NEUROSCI, V8, P2485; HICKS D, 1990, EXP EYE RES, V51, P119, DOI 10.1016/0014-4835(90)90063-Z; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; HURME M, 1990, BLOOD, V76, P2198; Ibrahim AS, 2011, DIABETES, V60, P1122, DOI 10.2337/db10-1160; John GR, 2005, GLIA, V49, P161, DOI 10.1002/glia.20109; Joussen AM, 2002, FASEB J, V16, P438, DOI 10.1096/fj.01-0707fje; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Kowluru RA, 2004, INVEST OPHTH VIS SCI, V45, P4161, DOI 10.1167/iovs.04-0633; Kowluru RA, 2004, BRIT J OPHTHALMOL, V88, P1343, DOI 10.1136/bjo.2003.038133; Krady JK, 2005, DIABETES, V54, P1559, DOI 10.2337/diabetes.54.5.1559; LEE SC, 1993, J IMMUNOL, V150, P2659; MCLEOD DS, 1995, AM J PATHOL, V147, P642; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Mohr S, 2002, DIABETES, V51, P1172, DOI 10.2337/diabetes.51.4.1172; Park JY, 2000, DIABETES, V49, P1239, DOI 10.2337/diabetes.49.7.1239; Pinteaux E, 2002, J NEUROCHEM, V83, P754, DOI 10.1046/j.1471-4159.2002.01184.x; Pinteaux E, 2009, CYTOKINE, V45, P1, DOI 10.1016/j.cyto.2008.10.008; Ramsauer M, 2002, FASEB J, V16, P1274, DOI 10.1096/fj.01-0814fje; Romeo G, 2002, DIABETES, V51, P2241, DOI 10.2337/diabetes.51.7.2241; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; SHIBA T, 1993, AM J PHYSIOL, V265, pE783, DOI 10.1152/ajpendo.1993.265.5.E783; Sun W, 2005, DIABETES, V54, P3418, DOI 10.2337/diabetes.54.12.3418; Tham CS, 2003, INT J DEV NEUROSCI, V21, P431, DOI 10.1016/j.ijdevneu.2003.09.003; Toda Y, 2002, J IMMUNOL, V168, P1984, DOI 10.4049/jimmunol.168.4.1984; Vincent JA, 2007, DIABETES, V56, P224, DOI 10.2337/db06-0427; WARNER SJC, 1987, J EXP MED, V165, P1316, DOI 10.1084/jem.165.5.1316; WARNER SJC, 1987, J IMMUNOL, V139, P1911; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Yang L, 2011, INVEST OPHTH VIS SCI, V50, P2319; Yego ECK, 2009, INVEST OPHTH VIS SCI, V50, P1920, DOI 10.1167/iovs.08-2082; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111; Zhang ZG, 1998, BRAIN RES, V784, P210, DOI 10.1016/S0006-8993(97)01317-6	52	239	252	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36949	10.1371/journal.pone.0036949	http://dx.doi.org/10.1371/journal.pone.0036949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615852	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341300046
